<SEC-DOCUMENT>0000859737-21-000019.txt : 20210728
<SEC-HEADER>0000859737-21-000019.hdr.sgml : 20210728
<ACCEPTANCE-DATETIME>20210728161331
ACCESSION NUMBER:		0000859737-21-000019
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		97
CONFORMED PERIOD OF REPORT:	20210626
FILED AS OF DATE:		20210728
DATE AS OF CHANGE:		20210728

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HOLOGIC INC
		CENTRAL INDEX KEY:			0000859737
		STANDARD INDUSTRIAL CLASSIFICATION:	X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844]
		IRS NUMBER:				042902449
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0928

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36214
		FILM NUMBER:		211122678

	BUSINESS ADDRESS:	
		STREET 1:		250 CAMPUS DRIVE
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752
		BUSINESS PHONE:		5082632900

	MAIL ADDRESS:	
		STREET 1:		250 CAMPUS DRIVE
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>holx-20210626.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:c74485e8-ec97-423d-9317-27784965d1fb,g:cd3e0a2e-ccc2-417e-9556-0c4f43775051,d:181d930c7b854595977e17db8fd84eb4--><html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:holx="http://www.hologic.com/20210626" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>holx-20210626</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80L2ZyYWc6YWM0NmVjMzg2NTJmNDUwMTkwZGNhYWE5MWY3NzNlYmYvdGFibGU6NGUxZjE1ZDc0YmExNGNmMzlhZDJjZmU5ZmY5N2VhNDMvdGFibGVyYW5nZTo0ZTFmMTVkNzRiYTE0Y2YzOWFkMmNmZTlmZjk3ZWE0M18yLTEtMS0xLTA_21c9534f-40c0-4e7e-9e6d-d93c854d33bd">false</ix:nonNumeric><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80L2ZyYWc6YWM0NmVjMzg2NTJmNDUwMTkwZGNhYWE5MWY3NzNlYmYvdGFibGU6NGUxZjE1ZDc0YmExNGNmMzlhZDJjZmU5ZmY5N2VhNDMvdGFibGVyYW5nZTo0ZTFmMTVkNzRiYTE0Y2YzOWFkMmNmZTlmZjk3ZWE0M18zLTEtMS0xLTA_2f43af16-ffd8-48a7-bc82-59c1e8ce653e">2021</ix:nonNumeric><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80L2ZyYWc6YWM0NmVjMzg2NTJmNDUwMTkwZGNhYWE5MWY3NzNlYmYvdGFibGU6NGUxZjE1ZDc0YmExNGNmMzlhZDJjZmU5ZmY5N2VhNDMvdGFibGVyYW5nZTo0ZTFmMTVkNzRiYTE0Y2YzOWFkMmNmZTlmZjk3ZWE0M180LTEtMS0xLTA_3b302a5a-bfa2-4bb2-b02a-afe9821a967c">Q3</ix:nonNumeric><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80L2ZyYWc6YWM0NmVjMzg2NTJmNDUwMTkwZGNhYWE5MWY3NzNlYmYvdGFibGU6NGUxZjE1ZDc0YmExNGNmMzlhZDJjZmU5ZmY5N2VhNDMvdGFibGVyYW5nZTo0ZTFmMTVkNzRiYTE0Y2YzOWFkMmNmZTlmZjk3ZWE0M181LTEtMS0xLTA_8a443a5a-6da7-4d8e-b1f1-e67be2047279">0000859737</ix:nonNumeric><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80L2ZyYWc6YWM0NmVjMzg2NTJmNDUwMTkwZGNhYWE5MWY3NzNlYmYvdGFibGU6NGUxZjE1ZDc0YmExNGNmMzlhZDJjZmU5ZmY5N2VhNDMvdGFibGVyYW5nZTo0ZTFmMTVkNzRiYTE0Y2YzOWFkMmNmZTlmZjk3ZWE0M182LTEtMS0xLTA_0f795e9d-b201-4fbb-9e6b-4c8b7a8f7fbf">9-28</ix:nonNumeric><ix:nonNumeric contextRef="i3077d84f238341b6b299f541f5f835d3_I20210626" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80MC9mcmFnOjQ5ZjJhN2I2MWFhNDRhYTNhZmE5ODgxZGRmZTI0Mjk1L3RhYmxlOmMzYjNlN2ViOGJlYjRlMjFhYTA0NjYzZTNiMGMwY2NjL3RhYmxlcmFuZ2U6YzNiM2U3ZWI4YmViNGUyMWFhMDQ2NjNlM2IwYzBjY2NfMi0yLTEtMS0w_dd27be1a-a7a0-4c4f-ad50-de8c54948322">P6M</ix:nonNumeric><ix:nonNumeric contextRef="i6ac5e12a191d4b3dba030b9849f5d77b_I20210626" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80MC9mcmFnOjQ5ZjJhN2I2MWFhNDRhYTNhZmE5ODgxZGRmZTI0Mjk1L3RhYmxlOmMzYjNlN2ViOGJlYjRlMjFhYTA0NjYzZTNiMGMwY2NjL3RhYmxlcmFuZ2U6YzNiM2U3ZWI4YmViNGUyMWFhMDQ2NjNlM2IwYzBjY2NfMy0yLTEtMS0w_570c00d9-8466-4c74-925b-0be94c984bf2">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i4fa166ab972a4216b61bb29fe09583b5_I20210626" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80MC9mcmFnOjQ5ZjJhN2I2MWFhNDRhYTNhZmE5ODgxZGRmZTI0Mjk1L3RhYmxlOmMzYjNlN2ViOGJlYjRlMjFhYTA0NjYzZTNiMGMwY2NjL3RhYmxlcmFuZ2U6YzNiM2U3ZWI4YmViNGUyMWFhMDQ2NjNlM2IwYzBjY2NfNC0yLTEtMS0w_b3aba6b8-441e-4e3d-9158-47417e00db3b">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="ia3c7225d747b441aa0d9f695fe415128_I20210626" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80MC9mcmFnOjQ5ZjJhN2I2MWFhNDRhYTNhZmE5ODgxZGRmZTI0Mjk1L3RhYmxlOmMzYjNlN2ViOGJlYjRlMjFhYTA0NjYzZTNiMGMwY2NjL3RhYmxlcmFuZ2U6YzNiM2U3ZWI4YmViNGUyMWFhMDQ2NjNlM2IwYzBjY2NfNS0yLTEtMS0w_de12258c-b2f8-4b4c-8220-b1719e072561">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="icaee218d084046ed9e76934876d4b3ff_I20210626" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80MC9mcmFnOjQ5ZjJhN2I2MWFhNDRhYTNhZmE5ODgxZGRmZTI0Mjk1L3RhYmxlOmMzYjNlN2ViOGJlYjRlMjFhYTA0NjYzZTNiMGMwY2NjL3RhYmxlcmFuZ2U6YzNiM2U3ZWI4YmViNGUyMWFhMDQ2NjNlM2IwYzBjY2NfNi0yLTEtMS0w_542a2827-6f2e-42b9-87b9-de0ee0b34bd0">P1Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="holx-20210626.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i0a0de2fed4294accb0517140fae5643e_I20210722"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-07-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ie7b19d82c50249db846d3d1201e12c40_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01a2cc93a0514785a37164641018ee66_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62775b7338924094b35155c0fdc56937_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcdf880adb9b48f2929f4a34dd835119_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6acad958eada4806ab9891959584319e_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b3baf3186c74c05b772abe2f32104e9_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7667b1c57034541bf5cdb336c4b3647_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1bbf9311cb649308affbf16f61bb3ff_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id01db50d7a6347809cb98adf4b5c0c66_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c7cb3ce35044cba97822b408ab5d23c_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201801Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6977def5ccec49a2980c424062f9fee1_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i309460864a314d9aa0d13fb0a8698091_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1bc73f8ae9c492f9eb4404fb7e44230_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia342626413704afc8513005d7219aead_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22a1e068cbb54742b0e792558e5f9d7c_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide9ab086aa8846ac877a20195abb5f25_I20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id78e1a3ad6024d799c3f1727c967cf29_I20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77063f41174f4d989415517706f4fb93_I20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc0e0f0a89824c5996ab98b928cc9aa4_I20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe21cf98d68c43dca6569043732410ff_I20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i419ae5d90cab427883eac5b35fd93d36_I20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02e7a8da3b754bdb85993a3ca3484508_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2ba3a87732c4c6ab5006e5cb0228a5d_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i588c3d9c7d924cc6a15149930f01d74e_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33460b16b0364f3589df795f209d0c8d_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8b6b6f42e894fca9dca1d45bc960c8a_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17e8693dbcd546e5a55176fe7546128f_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0657c7323336470abd636ab465e98a96_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia15ef37ae8ca4fbca76c1b7b2851f56c_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i047c6f422b294cb08c1476a194dc7470_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4470f8e9e21d45a78c67f110baf7a543_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i490aca9b8aa2403e8983cfb2aee1071b_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ae541164c564e1394017ca8fb281f3c_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bf322985c424f509995e217f5ba7921_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73253768170f4c9b8e05dfb1368cf18d_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd3a77457cf340cf9428c91d5c99c147_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc53cfef88da4ccfb2e145cc906d6511_I20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfd99b340a8c407e9acd3394fcb87cb8_I20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63c68ea38c5d4987adbac8981ccfb7a3_I20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe15f7e0e20e47c29d5afb6680fcde66_I20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i226a72a6ad6e4aa4a08a9eaebf99bb78_I20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81ab5863e2124accb342d2df86a1ee96_I20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i738e3649fa5648b981781aa15132a8f6_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8272ade1ac594482a34d29229657da9b_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09304699beed432b98cea40faccb3e67_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic24013ff47294a37b8d0497bd4190df5_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9d0114a6df941bbb221d574874bf165_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib40a5a6185e8452498ab7f6ce2457f01_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88ca4c5253d94e03a7eb9af69544692d_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i237512b46fca4a7db28715ee5c66af27_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b78eb3d900e4dc388e35dc09cd76568_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i820217fec55c42d7a9aeb5cfc0f49fdb_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52f506beb69441ce875d650d0e5966ba_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9223d1ed5b7d47208efe550fae77bef3_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a980ec9354548a89245ad56600f024d_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3516193c4744e1cb240679a20e265f8_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if83bdefcff814ab0800ee9e105ed777e_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c17808393cc4b1a91fd6c22e278253d_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e2de70ed942467287b4930863d9692e_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebc58209d8514f5c93b78fa003903508_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73d6f95b696549cfb0e4d525d8488ac7_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4bb35a550a74469afbfef16e89e4881_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9811e9a2cf24d19b278bc2bf9a5c5cb_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdca8dc2d5f84891bd139bc79d3231ab_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36833f09bd344e93a23947c92c866cf5_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8c4f5a123e145abb53ba94d3255b7da_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i049e1cee29c84dde8735ff6f859f7c56_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84edd5ea5c5241b5a06d1be5e9eb4872_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2c3c861c8f34c17aa93621dcb13cd4a_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6cf91736f1949678b7354ef10d99150_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc0d86296d91494f843aeb441d2af697_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0aa0fa3e3474453bc759752889ebcd8_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i379f68e2cb5c471e83994c37a86c01b6_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31e8abc772ad4ffe894ec7ec188dc5df_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c99a5bb5b144cf9b610e175a4ecc587_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic97a10fe6e144c24b4eafc07f4a2428b_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8226181576f245bba94e4a5ec64e87f6_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i537a20393d1e493cbe6493d3a8188d64_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bae2f1749954b73b3a6ead022748861_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e17ab66a75e4420b799cd5146ba9ceb_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71a06870de924d918ff5abbf56a8d25d_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i875c4235807f46d2acc9a2e5e2e9e7a8_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i999599ea2b584e2d8e6e8e7edce3637b_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e77ae6b121e4933b196860cc147365e_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a4ec39647f042768fb079e46c124d64_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe2790b0becc4992ab4a86ed0f47b8b0_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b4d9d4a1d51468d9eb84de80c70c52f_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if395d4107ff1436d8ecfbc976a4eccac_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89acd5d341534bbfacfac9fb7fd346a3_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6e8ba7ac1ad4788936366e6a2a40bcf_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14b4ef7fc8f6486f8099a60d145ae4e9_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac5bd9bb07344043bdbb2c9c3b03b313_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if23b3ae36b644acc87ec67b72cd7b730_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i531234c15a6c43f8ba2e74a3bc5979be_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i441afbe7ea704a97a13d7f01cda317fe_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cd4c64d0a9b44e7b731b80d7ff2cff9_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0450e1103e8241cc93052d9df1a6f6bf_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf7456bf9a8f47acacea66bd647d61be_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14fe0f286fe8418d8408a5ef9a8ded4b_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ce0088f110146f9abc2c378a66d90fd_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0db9249ce324df6b69e1002079a0170_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief5d5ac299f444e7a11589340f1d8811_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b8441cccd184c4486e57f87f71f3656_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i286bca0d89644bd0b3205f4b93ed5c1d_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ee2782511e24cde8d011a55e9af48b7_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i410f2d6c20c4496eb68a1ac00b260536_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79c862e1f99d4e7bb053e7bea309372c_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75e45ed7d25546e591e76bfdf91c98d0_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ed178edd5ad495c90c1b54255909fa8_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if47061debb804420a5e14a803176e8ce_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia942e9f26e244360b3ce4f6c390b9d93_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f248925f2ee4c69b3f784a04ba9a364_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcf29874b0924e36855919d6b73c66f7_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic22fe1d383e84feaadba1dc8f408d3dc_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9c3b5b875444c0689eae7d05cf36d7e_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bf0a79818e54f1fbf147be4c1ef864d_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3ce04ac38db44279190e17fe5e2384a_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60f75ab143d84b689500c2e5bfebcf87_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5393210c850e49b78aace5bb63c4e69c_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b239d22f00e4502a2fe462334f74606_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i942bad789f284e31a5f43dcf1fedf43d_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id09b1799f368487b906ce59a96d2e408_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfcab7983d0848b082ee034a8af8e64b_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa28816934d4448282f6c7faf7a4d548_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9773235748348dd8da0c1995d6ed993_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57d8e5448f0d4ad48c2c716944cec78f_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id31306d0e2234478a749fe0b4889a65a_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4cc1b7e15e774991a987400605125d1c_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i987b8ad71b084e15ae9ba9e8338b3bd0_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85493aa01af94bd8b1f7328b463dd8e5_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia27da4de68874f0fb714ee7967b38fd7_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf75ce65865145c3aa67cc9f1814b5d6_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96d4eb19ed154f9f9df012f7ce7ee57a_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd7f591f4d6846419f3ba29d469f7d3f_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcbb80af093740f9a361c5448ab37e4c_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icabdcbbe69c545579aa33835b5f3d4eb_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16a0b171d8b2414ebdc3554e167249d2_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cc68c7458734cd2a8a7c981e8515c76_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8818dd7702142cf95a9d19c729ddf8a_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88586a6659324a6e94cec1cb09cf2a46_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9991425506644c169e0b162c4eec7947_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iace9270559714986aaabca0d4ebdff24_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieeb7d864535e4e7f9bce653f4b168b96_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8be39ed1f1aa46c3894324d319834486_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4c0e43445d04743bcb9261bbcc78b53_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f0c0208131f49b39c73659c82a02222_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea063f8d161b4a0b85a574fa46b7f7b4_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1feb000741a14589b76e0f21beb6c5c0_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id62f94911ce54ef68438afc76c05b4b2_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99435d39a02440deadad10c369f19565_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87eaf0bf3c6d48658f4c2c3e78a71ac2_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7491e43b952d4c61b87c261b016b3e1b_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d6ad39df725417db4cda9327284076d_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i075e000f08f64e8883de52eb2ec429b6_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie416f1bb45be4de39749bd46c36fe698_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i869637ca6659448691978af8788531f9_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i163df94df0de411eb1ec6ff91ad044d1_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1aa19225dcc7437aad83c6bad124ebec_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e4faefdffaf4617a9f21a886228d428_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9ba7888ec484e89a44484a6c3048d8f_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a7e9769dab647d2ba4a287635864018_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27eae9a50641400fb1c2541bd52dad61_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff62125937204878a658f0c5628606fa_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie82bb12476164052a5d97847ecbff323_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibac682b2841e4347b6671d6949367197_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa51fa0830194b718e4598c66cc20822_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idaa1c66f7d6d4ab9b6669c1d61bd937a_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46fb7e93d58d4db1824c75dcbca92ff7_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7a0cc313a77477ba010d815081c9a07_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie85bcce039094bae9db0bf4313fb7e60_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7711c49f92c04e2b9466ed524ee8bc2e_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if96887e76d944d08b5519f53cef01904_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1eca047fb0c84048ab9cb90facfbf706_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3df779d8bf47483e9f292cc7612b6774_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee9eab84d6ad4c45a2dd7d811f7fb06e_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebeafdaf8b04495394d947c38fcd54be_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad6089c03fe04694a4932756918fb99d_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6fbe86d934c4d18a2a5e07b6312d943_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd2db6ee06b94cddafde9fe932029265_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic99b704f095f4cd69b8a4ae90368d2d7_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94cf4a747ee64dfd93739c74eb4cd66d_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0fc4831c77847b3a201ce54a4e2db2f_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbfaf422f9724422b8b06418613c842d_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i561c02d7c245409293cfa0a1562f677a_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id50cd5f65a25492abef4ce8286035326_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5293327445f541ed891801a24fba467c_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bdefe68c3ea42e58988c6e8a69fd673_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25dced02445e4b87a13031b8d51a8173_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d4e9da2a2c14f13984e3286a479cede_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i391a26685f56401ea4adc59b7d80011f_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52c4985d417b4421a13ef783c7e19a9f_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa3d63fea23c46bcb179fec3fd524a11_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03551c738e78426f82dbe57a0c1bf66e_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2a56d2bb725478f82e31f1329449f9a_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bafd189711f4ec19e64d26761bc3318_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0c8406167274863803b6b1fb7cf1d04_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86db2b9cd67f4199811130ee684b41e2_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85f7ecac32784df6a536dad78a0e43e9_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf42837162e3410ea1fc194837543b32_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1af39200976349b393f0094f2c751da6_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ed43d6f3b9e467c9e24d43594b26b14_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i386d807f9c604702afb89ac48d4f3997_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i476b388d782a4d1188664e75bb1926f9_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2107dfda459c464ba7795fbb3263a45f_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3db408b0437e4aee94b6507a2f00f132_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82e0f458672c41aabd0a7ccc0ecba719_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63bf14aa150b470d8cda291a8e3dd66f_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if97a9823a91c48f6879659548ae4a3e1_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9aa28665b0b14585a3f36c725cdb23a2_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idadd999b632a42d7b0d65121528aa81a_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i877644a05fce44e28b7a923b72578d44_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9abeb75d8db4dec84473529c4e293f5_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i070ab836e0a141d2815638fcced72af6_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba84d4a948cd406cad1198d4bdc90dcb_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:RestofWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic351acb54a3849d8aedcfca04d87ab1d_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:RestofWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7d1d8a90959436b8aca4870757f76ba_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:RestofWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98e039107e7742dc92ff616d5e0b45fa_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:RestofWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfb85da295454d3fa7ac34d45ba8399a_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i997d2963735445798702be9238bd61d3_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fc238f172a84daa9f0b0b392fc8265b_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i969332a55fc94c40b1890a3c159072e5_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaea9eeace8bc48a6853ad4eb8c570984_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if064abfbec784952a50564f775aa48b4_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i066e06a75605450685297c3e282a6b6f_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93a5b58ca8ab490bb807f3f47ed0695a_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5fbe2f2ff664952a86162b814c29dc5_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39c233f5360f46839440a89ec92db102_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7caffadd2bf4a08a5a93de29b5b1702_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4271982162541bca84afd4b29071784_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i125ef810b16745dbb51cab70e0c74868_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b102cbde6ac4145a026f275552c9233_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i615b149ad3534e4ba9e847115a8c8104_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia599da9d0cec404bb29f0dc029068fb1_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i3077d84f238341b6b299f541f5f835d3_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2020-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6ac5e12a191d4b3dba030b9849f5d77b_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2021-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fa166ab972a4216b61bb29fe09583b5_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3c7225d747b441aa0d9f695fe415128_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icaee218d084046ed9e76934876d4b3ff_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08c883de92e74d7b85fd3ca1fb82d546_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02c12e832a964220b8e957d85bd7f1be_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefc73cc720144ee2abfd4e56a2ab1c22_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib02ab7302c2f46079c7e79da871a6eb7_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id05ddebb6ac948d3924f040045e9f869_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a527b50af5e47a99433bc012cfe40e9_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d9a236240c14cf8bef2d68626067a47_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f25431c4bd346aca079e50943a25050_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59f5f7477c54411fb844f52b13896113_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib04dea42a16c43599c49cc706c336cc8_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia57c3dc6f5744ed28ba4ec3d78ac0431_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcbbabd8e7cd43b49b4c4141972ac3df_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44028ddaa4d449f19b250514e6f25c11_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87af1fc6220349d08bb58531b16ae309_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e4d1ac8689444b3b830cfd194640a8d_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7359c2fb7ca43ffb3bf9416afa4079f_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i354883b38ce9409b8864c231c916bc8b_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8ccf9bb036a4a48a18392eeed90c59b_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67c6607b6ca1481688b2c7ed6a2b6fab_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i421a1ec2406e4269a476846874e71421_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id56c8faa0e884b19a2eebe191531428a_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2bfa4cc508a42c08b7fe0e7f3b786a3_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1493df5a7c09426b9e8dba13c3704251_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92fd2ed585e64792981f77c6077751ee_D20210617-20210617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-17</xbrli:startDate><xbrli:endDate>2021-06-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30d680096df04f59bf3edf5694f74758_I20210617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93d6e126b5db43d7917d1e320241c5a5_D20210617-20210617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-17</xbrli:startDate><xbrli:endDate>2021-06-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e9787cddf8548e6b7fe58450c3ac4ea_D20210617-20210617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-17</xbrli:startDate><xbrli:endDate>2021-06-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="project"><xbrli:measure>holx:project</xbrli:measure></xbrli:unit><xbrli:context id="i2cc7db962d0a469b91ad71f47641afa1_D20210617-20210617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-17</xbrli:startDate><xbrli:endDate>2021-06-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b84fc74ea2e43499ee65a3ee48d7788_D20210617-20210617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-17</xbrli:startDate><xbrli:endDate>2021-06-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia28b5293c7a442a1b282883ce9f51714_D20210617-20210617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-17</xbrli:startDate><xbrli:endDate>2021-06-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0b5328ab51c4ca5b5843c926066e713_D20210617-20210617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-17</xbrli:startDate><xbrli:endDate>2021-06-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0066f33074743339653dd14619b7e1e_D20210617-20210617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-17</xbrli:startDate><xbrli:endDate>2021-06-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4cf345ba0efd409ab1d3a3013de7de83_D20210617-20210617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-17</xbrli:startDate><xbrli:endDate>2021-06-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33bd27ed8fae4b699caa054e910ef6da_D20210222-20210222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BiotheranosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-22</xbrli:startDate><xbrli:endDate>2021-02-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec8c75e6a6ac424c8336a8c73d23c503_I20210222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BiotheranosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf15ef9e7b8d4ce0b6f697ed71d50240_D20210301-20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:DiagenodeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfa5ce4594b64da29ce0bdebe52e6a48_I20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:DiagenodeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ff71b48fe0e4e9d9e59ac8a919283de_D20210301-20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:DiagenodeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e52565dcf6d4e319cc9bb4516138aec_D20210301-20210301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:DiagenodeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i601f6bd5a6a04f1ba94dff4501f86d1d_D20210104-20210104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SomatexMedicalTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-04</xbrli:startDate><xbrli:endDate>2021-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9cb5bfd9d0b4a7bb1e06960147c3f37_I20210104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SomatexMedicalTechnologiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95400d7ffd0145a6902213bb3a8fd6e5_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:NXCImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7e22da3089645eda9e0ac21e97119f1_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:NXCImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if19332d7f2bc4032add3a47ca74898dd_D20200823-20200823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-23</xbrli:startDate><xbrli:endDate>2020-08-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2c5f4cc59d642e7b734717eb34e002e_I20200823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">holx:ContingentHoldbackMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if929571277ff41218f0486d616483faa_I20200823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb56805faa3a44cd9925ebb00f16e8b2_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f02945eed7a4b80bf799a5f378886e3_D20200823-20200823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-23</xbrli:startDate><xbrli:endDate>2020-08-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb63ed4e502448c29aeca44e256133e3_D20200823-20200823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-23</xbrli:startDate><xbrli:endDate>2020-08-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c4ac52d74224b66838d0679adb1ed3b_D20200203-20200203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:HealthBeaconsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-03</xbrli:startDate><xbrli:endDate>2020-02-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1847e23bfb6472dbc395f6d1338a8db_I20200203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:HealthBeaconsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i264ebea292b04fd29f44c37de6914f8c_D20191230-20191230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AlphaImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2019-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i043ca86798494f61b2666b1a7f46ddd4_I20191230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AlphaImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6fd1be7827e4d14a8a0c3642ea41642_D20191230-20191230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AlphaImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2019-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7606589a8d9a46508518e654ca7bc3cd_I20190801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee122e2193954283b59296f2f329c3f5_D20190801-20190801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09ddd178ba8e4ea48372984e4d5984f4_D20190901-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafd366364b034ade874e71b313ac5811_I20191120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d5a252316d24ba8bf7db1b4788097eb_D20191121-20191121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-21</xbrli:startDate><xbrli:endDate>2019-11-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14f9866ecdf54b2f82e4e696f4ee2148_D20191101-20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2019-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cf6aa2100404a05becfe250085e5d00_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14df8e75f81d4e468e9e9ccc3560103e_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1eaaa8f5b1844eca34f3c569e39abce_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64adc24ac247463eb19f42515cbcb2b1_I20191121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93381ce7098c4e4fa2bb4eea52c5dce4_D20191121-20191121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-21</xbrli:startDate><xbrli:endDate>2019-11-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13826201466c4300b5dd607143edc940_D20191121-20191121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-21</xbrli:startDate><xbrli:endDate>2019-11-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa6bff4ae2dc4a33986e101d589e889a_D20191121-20191121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-21</xbrli:startDate><xbrli:endDate>2019-11-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89c6030b3fa74130a05c86c5566ac9b5_I20191120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd5055934cbe40cc89289656c936a8cd_D20191120-20191120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-20</xbrli:startDate><xbrli:endDate>2019-11-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id999567ff4ad4d47967ba1b3ba2d4f74_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb526c3393b94999af44e0f2283027b9_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie01a803f233b45f4a49380b21ad6bb32_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d24eb58cd394fae908cb1b14bef726b_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife6cd667a004466dbd21c797fb6eb40b_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4475d98ff97042aab50ce4cee82db95b_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice236c25c4d740418e834bf0afc51506_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1964d49d44004c788bf1f11e793a2e68_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ff6e83c3f4f43a292e67915ac446908_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c8160a52fd54288931c8a6169582fbc_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f1fa7442a694b4fbb79b5dea180468f_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5529a4948994271968a3ed7d11437fa_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf97edf455654668b98e5a775e14b2d5_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i023aa7ed3f4f4c63b7915aaca3a74a20_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfa1efc297734235ad6cd2cb7b00179e_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27fc517175434926997757aeb6acf88f_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e480c0e3a7a477b9e530aae1be7fb57_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07ebc1d0fd124863ae761151644bf529_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31d3ec20ba1341c886214cb33feb29ee_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:PercentageAddedtoEurodollarRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f04002445d14733ac6500556e77b603_I20181217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9dcce0b55c1f4c47947079e2231dd5ff_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:RevolverMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:PercentageAddedtoEurodollarRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i452a598227b942de9d498139c901ddd7_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e72c82ce3de4fdfbe618331b89acadd_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b58c2da43604857b653e5db4b73edfd_D20201227-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b5b7a6104f348f895e5d94b65b73817_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i445296b9bcdf4ecfb15eb4fdf4e5f027_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ce4e8f765314eb29fce3b97b407943b_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i591133f22d3243e1ad73bed94da1fe58_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3a95a70aff44f249453fd1c435fc905_I20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4907eca3275146f2be21f4eb741ba4b0_I20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6dadc087c8a44b1da848875eb301fdf0_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb207831ddaa4d53943e75a7eb55d27d_I20201015"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcd52cb6d519499f96285824f70d71e3_D20201015-20201015"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-15</xbrli:startDate><xbrli:endDate>2020-10-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35ee10ac5818441fa558f668e84866f4_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99efd783beac43bc87299f6deef20b60_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5751d5d110e4560bd36bc872e1c4b0e_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia37016a8326544bf8a213352899c6992_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i272408a201f84cd288d1a786c8851839_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58a7d1a68082480f9d9f002f635ba871_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fbee7ea3857414fa862793ac5e38693_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b55461839564a798b7bb1fc48436aca_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i258e1d37987f4730b42e74f9f49dd3b4_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f78f01fcb324006bd1e7e387d41e29e_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i329f003f9cc04450b29fe980f0e42689_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie522d6c7b67b40d19313f779c8b07346_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d1ba28aff8c4b5eb47bf61baea22a44_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2247e22bbae24374988ac11163883a5c_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8698881588e046c79a6a901616722216_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if54bade04c4249debfc877171a9be8f7_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaeeaee82866e48a589b1b33acc7cf61a_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id87e5e40d00a4f109965253aef07499a_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f75b26e46cf4818a4e3b058a04c9785_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e93a00f39ec434891148097002f9117_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice0bd1095b304c78a2f49ad45c325064_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i866deb20efa24ed4b2313072a748ba62_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i683d2ded0a1c4448856d8951affc8993_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51b89923ffd8491d8c6ac3b49ee1985b_D20210326-20210326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-26</xbrli:startDate><xbrli:endDate>2021-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i799dc9d3fd134b658546a8859e0bb7ae_I20210611"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50f502634b964d3ca840a4e7ff046d9d_I20210617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d26208b685b4dc0a4c5422ac184fb3b_I20210617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04634b19698943588e231edf3a1fa51a_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1965b6dfa45f42e1a36b9b6f6c6d19d2_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2fab027ef184f10a81089fce6835a3e_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cfbe0dfa54a401c9663f0101346df6a_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53fb7ba0b756458fae9440481e4b1c22_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib59ed9e2e7fe4b71b57f28d948814de5_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1ec4ff7f312462e92283befc2b78645_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic77447b8b8db4b3697eaad437ad6372d_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23614fef663042c1aef8cb0f986983b3_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52de0b3b7ed043329021533a23fc5c50_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b050d1edde04dccb1a376a9d0b26d1f_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b53a2d42b634620b3416e3dd2c3f7fd_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02decbf01d7d47ad8413a646bb6b58c6_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd2ee8ee3be840b8b6afa6175fefbb69_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icee5b045a830452083febd09cec762d0_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41d042b1583d4cb0a63cc089c4cd48d0_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8538addfef6040808efa59ad875c5c67_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18ac8b8a2f674e00a863ad723f51cfd6_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8385c3be2e32406d80f1e6926ed63258_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ba1880cecac4f61867704cf61543765_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if95c5e17cb0246e28396e701eba8a8b6_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5816cff90a9247a296c2e48045af6f9b_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1aa79e6d2f224939b78d3422b131e66e_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied7c65430e934024b713ad4d1d12d274_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc35c56bdabd41c5a37c1ec58d24f4f5_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd682c98bcc54a639ecf216a7a2959ac_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic10b5e7bddbb4679b081afb2b91bfb10_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f76a7b44a7f4089bbc36c650997a1cf_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fe6078ee0384409bc3ef5dd79db3bdd_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e9af5310502412a90c2f809682d972d_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03f4085d035d44bdb57e7576c9d82462_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00326496b5524aacb14a40d333ddb070_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8706ab009f34acbab9f1c8ba66a6842_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieab668871ebf4bef88a6c7d0534148b3_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16e7d68e0cf04c83bf036bb7dfc90e9b_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaae1b64b6b3f48efa2eeddd04c00405c_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4dd1442bbab54dbc9df7a9a1b52d46fe_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39a6ba9e2ef34dbe8c1dcffcf164d2cf_I20180727"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:MinervaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="petition"><xbrli:measure>holx:petition</xbrli:measure></xbrli:unit><xbrli:context id="ie3638767d08c4249aa0ae3d34c62d59b_D20160304-20160304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:MinervaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-03-04</xbrli:startDate><xbrli:endDate>2016-03-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9a4160e20ff4e29b6e0bd222066214d_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idaa68ec927564bfca7dcc39909e9c4fa_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1234ad1f257543fbb603a27545e882e2_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d84692aad2a413f82da74256f73cc99_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2230d555087a45db84354397ed80a969_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida25fb7963fd417b8fbb79c5404488ed_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0987e1d0aaa4f3383d2308a12f86767_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i553a342864f64203bc6682daf196a414_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic39037a65c534a348a1153bbf85b4fc5_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59e3e6acc75043868fc4bc1208d0fa04_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c5f40b1155e42a0be6aa12fbb7f0a8f_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a1e2756a1a84d33aa95630ed4272394_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idaa0f682791b44ba8313cfd9634b51ee_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9731e33a8f0b424eaba61dcf82dc6156_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b98263fc02a43c48ac6469052188efc_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2537666870e44ae59702cc35894247ad_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic00ad5ce544040b6afe86e61bdea57b5_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i435b9707d2fe407aa57aa940706fcc51_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b21698ef10e487fa17ed0655685000f_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i264336fb43c14902b7b5f7a3b3df7d37_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d848d86c60e4d0aa176969dea483771_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18f952d8a51d45a9bffe628448f2117a_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1422e12662974138ae356309626aef3b_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic793a7813f49401bb24c5dd7cc020e8e_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib360d5983d9344da99378ac890629c00_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cf709f04c574bb7bf53a2294a770b40_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icddd037fe3094f77b5b90963f5441115_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84f82c4a5b2041568af213a793563e12_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a91ec6a807647289f3e38f578c2885a_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27dc34faa8364f4eb609e7d27d755da2_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24d5fbce3a404b1b9a92d452b7bb7142_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f3a48b77de044949e38a6dcf4477c25_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fa919d800b84313aa121769ee6efa38_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e3cad14bf6540c18eb9197a41e6af8e_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if46a501e3c8143fda11f33dbbf4fbbcd_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia749d5e6937a406db2e72272ecc2a906_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib37462047fc345a18bfadcd2c9728203_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:MarketBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8baaf1fbd5542649315b37eae7cf33e_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:PSUFreeCashFlowMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77a3c47ab1fb449ba0ebc5b0c207c416_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:PSUFreeCashFlowMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c9fca34b58b4ebba0cc95c584d6b02b_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:MarketBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4b184eeb519428da954a2668ba86020_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:RSUPSUMSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3caedad63674472cbf33284dfc9a7524_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>holx:Segment</xbrli:measure></xbrli:unit><xbrli:context id="ie88ebb9dd3ef4963ba6b902a27fde1c5_D20200927-20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a95db51a148444d8df50afc67ece6af_D20190929-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic40f282c064341a7b2e6d34548211fb3_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19b4c219fe024c889dd3632f6507458c_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if66a8dd5446541e3be680d3c337846e5_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib955694d82bc4bff8c3031d2c76b5e8e_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide8ecf9b05cf4aea8c640173d743b3ce_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id09f54a49ec641f7a9c21dbaaf2c903b_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia95ae01021fa4b75996e32a548c2726f_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic41dd5b435484b6ba40f0f2cd734acdc_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea58530cbef34fd4931abfeb77c65007_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1dbaa5c4c5c5468289373830c34f9e6e_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica1034e428864cd1afdca20ce40a8586_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17f5a2a375e1486ca6d00e2139870be1_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5912cf2562634c4897ffcde39c504296_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idaca532c37e24e76abac2b8d66a14f2a_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee210605634a465684ebf982ac3ed2bc_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9a3a9e2d8cd44ed88d12970a32c6cef_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9949f8f813ca4908bd00edad279fdace_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18d768e600b245188ed95ec4ca093d27_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia430a857ed8348cb98df45af3bff355a_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0eacccfdfc914a0fb2100fb0647df849_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d7a7aca5d7d45618edcd0ce6bd59a88_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6943392b65c14cf3ab969335b3f5c944_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cad5c97002944c5ab199f630a9804e6_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i028a89b44bdc443fbc942f81e8a81c2a_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e661b9ad8374ea08e1defa5f7c60aba_I20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cc9805487b14e7296d764cc86233f69_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43cbf5cabe2d4af2b65badbd45477dcf_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i169a132e711041b39b7f4c5100d3224a_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49753b0eae784ff2ab9d20c18d01ffec_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57d0a50ebf48490aa0a913feb0708380_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CustomerRelationshipsContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i863480533e024d8fa95b6d2bedd39955_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CustomerRelationshipsContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i354e119d0fae46c79299b854fd149cf0_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i777f5551309a464794664ce33991c02b_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a1d948b692943219190603362c58948_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a5f442490284f8eb7d19616e6f5a406_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i216e8a1391484fcf90993e52fcce3926_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:BusinessLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80816070e8814fa082717580347899ab_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:BusinessLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71465b2ac88b48b0a8a65c9d19ca9e43_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:AcquiredintangibleassetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6d5a0c8113a44b1ab58702864454fbd_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:AcquiredintangibleassetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c78f81f4dc14e4c80085b6397cfbbc4_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:InternalusesoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9346ea30a0ce48709755099832433c82_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:InternalusesoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9374a44c792409bb6e84be04009cf2c_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CapitalizedsoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id992e72f22404311bf2349ba1f18c100_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CapitalizedsoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17ce81e7ee4c430192d40261507faf9e_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67bef9095bf547108bf64353f12a5efa_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1d03b89c2cd46c8b689923ced265e84_I20210327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ff2910c781f4a73b76fc57f6588936e_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie54cb9e528944fd09a387c1fbd3869b2_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10eb8034808e433f8c962dfd384c4804_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifebb08681666403a84ebbf74112b4eb6_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94e3de8bf3624135ab7d18e1e91c29f6_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0087149b23e7436988b3b251c5cba1cd_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d4b5d09721f44e6aab3f827d2d52aee_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61d813ca92d74906813eda4366974a47_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c7acad28e074461824c04de2811d59b_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4cda94d3c28e41afb2a42d1c640a9558_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b595945346f488591f6734675e5bbc7_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e9aeea6421a483a9877f65783d68521_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc95c0525971424ca911fedd93ca98cf_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d40f0fd77d34330b52e8a8f921c4b22_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fe14ed2af474833a427512772ec787c_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c2348d216e0450a960b7ddce90b14d8_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f16f7fecd444a7e839c00b1e6b16900_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1db5b374d2e42f2980c21955a6c48d7_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bf24f113b134bd6ad61f3c2d4372c97_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d147650821f4b7eafa8239fe1a67337_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i202bf7e9908f4a88988d987295f24bf9_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50d0a909334a49d38f7058d971ae3d3e_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id83350261e414219bbdc2563d9573d29_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i082299dec4444554933007b3eb2589d9_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id64f5775615a48e3b594627ba96e48e2_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa6aa9d198924a13b4507ae621cfca92_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i961c9373b1364d32bae836297e84a344_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4e6817a851b427a92b0c7fe72a3bbfb_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20f566a19c874603ae7ac1c2f276af8b_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4075c4c45421491e8f17e3328901d09b_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d085e73dd1a41b2ac1e4ef320989c1c_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3114f8a48396426d88640981268e8d43_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccef93e68c604a7c8257204c91951d7d_D20190929-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab35dca88c4a489cb3a6e5e8db0006d8_I20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa0f9b8412b64c26a40f845a43f78503_I20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91d506f85cee45e586282ab07a85b12d_I20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a003aff269b4a04b704dad4de10b923_I20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0df6681d8a44b95b7eecdf8e0e95b6c_I20191211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">holx:December112019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42410f9e1104449eae75741c00a10044_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:December112019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbb1f800737f42a09fc4ad36d6f50272_D20201209-20201209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">holx:December112020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-09</xbrli:startDate><xbrli:endDate>2020-12-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecca63b99d6b4da2bfd35be5986c1ad1_I20201209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">holx:December112020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2af30393c63846529254a9f5fdc55b28_D20210328-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:December112020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-28</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae354d54c17140f88ee32c1be6023458_D20200927-20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:December112020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2021-06-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44c5cb5c5b47462190024c645f543472_I20210626"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:December112020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-26</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i181d930c7b854595977e17db8fd84eb4_1"></div><div style="min-height:27pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________________________&#160;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGV4dHJlZ2lvbjo0NDVhODZmOTNmNTE0YTAyODU0YWIyNzBhMDZkMjVkZF8yMjg0_bd765da0-bcbc-4a25-bcff-4aa026ac5f28">10-Q</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;__________________________________________________________&#160;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGFibGU6YmRiMDBmNWVkNmVlNGJiODkzNzQ1OWIwNjQzODk5ZWQvdGFibGVyYW5nZTpiZGIwMGY1ZWQ2ZWU0YmI4OTM3NDU5YjA2NDM4OTllZF8wLTAtMS0xLTA_c1135136-72b0-421c-8b8a-c3a991780082">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGV4dHJlZ2lvbjo0NDVhODZmOTNmNTE0YTAyODU0YWIyNzBhMDZkMjVkZF8yNjA_0e7ce81f-a331-495d-a2cd-453aad64cb35">June&#160;26, 2021</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">or</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:4.5pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGFibGU6N2Q5OWRkZTQ1ODFmNDJjMDhlYzQ4MTBjNzc1YWNiMzIvdGFibGVyYW5nZTo3ZDk5ZGRlNDU4MWY0MmMwOGVjNDgxMGM3NzVhY2IzMl8wLTAtMS0xLTA_5fba6855-4dcd-449e-9480-2d20a07d1416">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGV4dHJlZ2lvbjo0NDVhODZmOTNmNTE0YTAyODU0YWIyNzBhMDZkMjVkZF8yMjg1_a3a82e30-5d8f-4c96-9977-59202e8a9d0b">1-36214</ix:nonNumeric> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________________________&#160;</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGV4dHJlZ2lvbjo0NDVhODZmOTNmNTE0YTAyODU0YWIyNzBhMDZkMjVkZF8yMjg2_77da53cf-4d29-40cb-8394-85abd4728bf0">HOLOGIC, INC</ix:nonNumeric>. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________________________</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.486%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGFibGU6ZDE0YjJkZGM0M2NhNGEwMmJlYmU3MWI4OTlmOTM4MmUvdGFibGVyYW5nZTpkMTRiMmRkYzQzY2E0YTAyYmViZTcxYjg5OWY5MzgyZV8wLTAtMS0xLTA_b105c742-2eea-404a-99cb-7539f37f2644">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGFibGU6ZDE0YjJkZGM0M2NhNGEwMmJlYmU3MWI4OTlmOTM4MmUvdGFibGVyYW5nZTpkMTRiMmRkYzQzY2E0YTAyYmViZTcxYjg5OWY5MzgyZV8wLTItMS0xLTA_ca732fe7-52bf-4eef-b151-3c982b205807">04-2902449</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGFibGU6ZDE0YjJkZGM0M2NhNGEwMmJlYmU3MWI4OTlmOTM4MmUvdGFibGVyYW5nZTpkMTRiMmRkYzQzY2E0YTAyYmViZTcxYjg5OWY5MzgyZV8yLTAtMS0xLTA_083ce827-142f-4fd3-950e-3865c8bedbb3">250 Campus Drive,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGFibGU6ZDE0YjJkZGM0M2NhNGEwMmJlYmU3MWI4OTlmOTM4MmUvdGFibGVyYW5nZTpkMTRiMmRkYzQzY2E0YTAyYmViZTcxYjg5OWY5MzgyZV8zLTAtMS0xLTA_a8b5f758-5eb9-4a74-995e-0bcc284e5e06">Marlborough,</ix:nonNumeric> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGFibGU6ZDE0YjJkZGM0M2NhNGEwMmJlYmU3MWI4OTlmOTM4MmUvdGFibGVyYW5nZTpkMTRiMmRkYzQzY2E0YTAyYmViZTcxYjg5OWY5MzgyZV80LTAtMS0xLTA_5e35f54c-e1ed-4b4c-92d6-185f81aa1c08">Massachusetts</ix:nonNumeric><br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGFibGU6ZDE0YjJkZGM0M2NhNGEwMmJlYmU3MWI4OTlmOTM4MmUvdGFibGVyYW5nZTpkMTRiMmRkYzQzY2E0YTAyYmViZTcxYjg5OWY5MzgyZV80LTItMS0xLTA_aaa739dd-0975-4c78-ad75-afd8b783f507">01752</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGV4dHJlZ2lvbjo0NDVhODZmOTNmNTE0YTAyODU0YWIyNzBhMDZkMjVkZF8yMjg3_3cbf6238-8e1d-4345-a9e0-48d5b6fa4ede">(508)</ix:nonNumeric> <ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGV4dHJlZ2lvbjo0NDVhODZmOTNmNTE0YTAyODU0YWIyNzBhMDZkMjVkZF8yMjg4_d594aae1-6940-4ced-b42d-5fcb232c2429">263-2900</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________________________</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">*Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGFibGU6Nzk0NGM0OWNlMWU1NDAxNDkyN2UzMGNiYWE5MTJiYTYvdGFibGVyYW5nZTo3OTQ0YzQ5Y2UxZTU0MDE0OTI3ZTMwY2JhYTkxMmJhNl8xLTAtMS0xLTA_98be97c2-5800-4d92-980e-3944931ab35e">Common Stock, $0.01 par value</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGFibGU6Nzk0NGM0OWNlMWU1NDAxNDkyN2UzMGNiYWE5MTJiYTYvdGFibGVyYW5nZTo3OTQ0YzQ5Y2UxZTU0MDE0OTI3ZTMwY2JhYTkxMmJhNl8xLTEtMS0xLTA_ee630f55-fded-40b8-9b07-92dd60cbebbb">HOLX</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGFibGU6Nzk0NGM0OWNlMWU1NDAxNDkyN2UzMGNiYWE5MTJiYTYvdGFibGVyYW5nZTo3OTQ0YzQ5Y2UxZTU0MDE0OTI3ZTMwY2JhYTkxMmJhNl8xLTItMS0xLTA_f7cff6a2-47d3-477b-b4fc-6ead0f71d0e0">NASDAQ</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:4pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGV4dHJlZ2lvbjo0NDVhODZmOTNmNTE0YTAyODU0YWIyNzBhMDZkMjVkZF8yMjg5_05a9c17c-3b25-4b9c-a3ec-02cac8b5ed84">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGV4dHJlZ2lvbjo0NDVhODZmOTNmNTE0YTAyODU0YWIyNzBhMDZkMjVkZF8yMjkw_626ea319-8bf1-476d-b3f2-58e1c99b8152">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule 12b-2 of the Exchange Act.:</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.089%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.281%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.573%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGFibGU6ZDhlODRmY2FmYWMxNGQyNmExNTA1NjA2MDMxNTg1ODQvdGFibGVyYW5nZTpkOGU4NGZjYWZhYzE0ZDI2YTE1MDU2MDYwMzE1ODU4NF8wLTAtMS0xLTA_30cdc33f-0852-42d9-b2b8-ad1fb10e059a">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGFibGU6ZDhlODRmY2FmYWMxNGQyNmExNTA1NjA2MDMxNTg1ODQvdGFibGVyYW5nZTpkOGU4NGZjYWZhYzE0ZDI2YTE1MDU2MDYwMzE1ODU4NF8xLTYtMS0xLTA_72eb0257-280b-40f7-be71-bba1a6b18927">&#9744;</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGFibGU6ZDhlODRmY2FmYWMxNGQyNmExNTA1NjA2MDMxNTg1ODQvdGFibGVyYW5nZTpkOGU4NGZjYWZhYzE0ZDI2YTE1MDU2MDYwMzE1ODU4NF8yLTYtMS0xLTA_602b87ea-66dc-470f-9763-ad2f682e9422">&#9744;</ix:nonNumeric></span></div></td></tr></table></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;<ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGV4dHJlZ2lvbjo0NDVhODZmOTNmNTE0YTAyODU0YWIyNzBhMDZkMjVkZF8yMjgz_eca745e8-e025-4205-9372-20c616cb2681">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of July&#160;22, 2021, <ix:nonFraction unitRef="shares" contextRef="i0a0de2fed4294accb0517140fae5643e_I20210722" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGV4dHJlZ2lvbjo0NDVhODZmOTNmNTE0YTAyODU0YWIyNzBhMDZkMjVkZF8yMjAz_4a2f1032-5fe7-4868-b81f-8ca3a1143fff">253,487,389</ix:nonFraction> shares of the registrant&#8217;s Common Stock, $0.01 par value, were outstanding.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i181d930c7b854595977e17db8fd84eb4_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HOLOGIC, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.439%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_10">PART I &#8211; FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_13">Consolidated Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_16">Consolidated Statements of Income for the Three and Nine Months Ended June 26, 2021 and June 27, 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_16">4</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_19">Consolidated Statements of Comprehensive Income for the Three and Nine Months Ended June 26, 2021 and June 27, 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_19">5</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_22">Consolidated Balance Sheets as of June 26, 2021 and September 26, 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_22">6</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_25">Consolidated Statements of Stockholders' Equity for the Three and Nine Months Ended June 26, 2021 and Year Ended September 26, 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_25">7</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_28">Consolidated Statements of Cash Flows for the Nine Months Ended June 26, 2021 and June 27, 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_28">10</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_31">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_31">11</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_100">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_100">36</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_121">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_121">55</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_124">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_124">56</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_127">PART II &#8211; OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_130">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_130">57</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_133">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_133">57</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_136">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_136">58</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_139">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_139">59</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_142">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_142">60</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">EXHIBITS</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:17pt;margin-top:12pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i181d930c7b854595977e17db8fd84eb4_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I &#8211; FINANCIAL INFORMATION</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i181d930c7b854595977e17db8fd84eb4_13"></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1.&#160;&#160;&#160;&#160;Financial Statements (unaudited)</span></div><div id="i181d930c7b854595977e17db8fd84eb4_16"></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HOLOGIC, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In millions, except number of shares, which are reflected in thousands, and per share data)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.543%"><tr><td style="width:1.0%"></td><td style="width:43.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.170%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.170%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.170%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.174%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="holx:ProductRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMy0xLTEtMS0w_9543635d-51f6-4f97-b86f-a91d6f4300a9">995.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="holx:ProductRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMy0zLTEtMS0w_e02d1b2a-9efb-4260-a357-edc9318778c8">701.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="holx:ProductRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMy01LTEtMS0w_2013a8c3-83bf-4166-aa84-577bed122f19">3,829.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" format="ixt:numdotdecimal" name="holx:ProductRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMy03LTEtMS0w_d0a65780-42bd-4d54-a15f-15a2d2224eb2">2,024.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="holx:ServiceRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfNC0xLTEtMS0w_d9330061-7f7c-4e92-87f6-e658deda902a">173.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="holx:ServiceRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfNC0zLTEtMS0w_94da7801-dfea-46fd-8531-2206dbbbdac8">121.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="holx:ServiceRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfNC01LTEtMS0w_a653ba17-0c2e-4789-96aa-2029ecc5e330">486.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="holx:ServiceRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfNC03LTEtMS0w_d4472762-d5ae-4b18-bd0a-ef33e8780382">405.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfNS0xLTEtMS0w_312fc218-9ab3-43c9-8ab4-3ad6183f2466">1,168.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfNS0zLTEtMS0w_17f44034-2541-4073-8560-fd5c966a6454">822.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfNS01LTEtMS0w_b689516e-3744-4e8e-a46a-075a6a9e432b">4,315.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfNS03LTEtMS0w_763908e1-036d-4620-af2b-5e0c0436eded">2,429.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs of revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfNy0xLTEtMS0w_5b702baf-26f5-4937-a9ce-dd33cdbdf996">303.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfNy0zLTEtMS0w_4597afb3-3394-4be4-b988-5f7508a45d1a">225.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfNy01LTEtMS0w_d8bed872-9932-44df-94b5-fbbd6b08612d">889.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfNy03LTEtMS0w_e48f5e1e-5e49-455b-a5d1-35d10364a4c9">685.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="holx:AmortizationCostofGoodsSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfOC0xLTEtMS0w_3e3604f7-4b77-44e2-ab92-5654b1750482">68.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="holx:AmortizationCostofGoodsSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfOC0zLTEtMS0w_24d6d1b2-7385-43cc-a4a8-1b3398af507d">62.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="holx:AmortizationCostofGoodsSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfOC01LTEtMS0w_1136fd77-31d4-408e-baf0-876406acd696">194.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="holx:AmortizationCostofGoodsSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfOC03LTEtMS0w_2653d55c-4a0c-44e3-b94f-80f5f96146d3">189.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of intangible assets and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" format="ixt:zerodash" name="holx:CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfOS0xLTEtMS0w_832d7d68-e0a5-455d-a974-87f622ca6f3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" format="ixt:zerodash" name="holx:CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfOS0zLTEtMS0w_71e52ea5-6836-405a-a2e4-a1482956988d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" format="ixt:zerodash" name="holx:CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfOS01LTEtMS0w_a90ff3a7-806f-47c3-9d2a-6326bed84d9f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="holx:CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfOS03LTEtMS0w_cedffe0c-4155-4618-aa40-29847bc70f39">25.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="holx:Costofservice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTAtMS0xLTEtMA_56afa27c-b0d5-4042-9c63-40ab2bb83874">94.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="holx:Costofservice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTAtMy0xLTEtMA_3d89f044-7e36-47f3-9863-e7db3cc20ecc">68.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="holx:Costofservice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTAtNS0xLTEtMA_d3e9d840-2f92-4d0a-b8ff-702eaf0757bc">264.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="holx:Costofservice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTAtNy0xLTEtMA_b73eb6ea-bc67-4c70-b5f2-8722ce129c19">232.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTEtMS0xLTEtMA_4fa75c3c-421c-4d20-b016-e754c4974979">701.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTEtMy0xLTEtMA_e59be032-7f80-4f03-84ac-bdfca1ed9613">466.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTEtNS0xLTEtMA_034fb45f-af87-46c0-a70d-8c2742d6700d">2,967.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTEtNy0xLTEtMA_76143fc7-915d-4ecb-93e3-62bb001ac89e">1,295.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTMtMS0xLTEtMA_ad238b92-a588-4e79-81fe-3f5b1e5ea6ce">69.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTMtMy0xLTEtMA_a9439290-93bc-4642-ac88-6849f3df5e79">55.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTMtNS0xLTEtMA_054f94ab-9bca-4e12-a669-a79840498b53">199.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTMtNy0xLTEtMA_692e7a30-9bea-4fd4-9c29-8856198d5b67">165.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="us-gaap:SellingAndMarketingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTQtMS0xLTEtMA_26d18212-2ae5-4a36-805b-fb9851276c8d">142.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="us-gaap:SellingAndMarketingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTQtMy0xLTEtMA_5036c692-f956-403b-bc72-4025ecc159b7">103.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:SellingAndMarketingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTQtNS0xLTEtMA_f044f2bc-1095-484e-bf08-b1d9cddc486b">402.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:SellingAndMarketingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTQtNy0xLTEtMA_a0261263-55a4-41cd-b108-b87b6cb7b97a">359.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTUtMS0xLTEtMA_129fb652-1b39-4e80-a84e-cd578f319ff8">117.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTUtMy0xLTEtMA_21bde664-d234-48d8-9d2c-3a4b9e6d067f">105.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTUtNS0xLTEtMA_414c1bc3-8933-43c5-8ae4-7409fa70703d">297.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTUtNy0xLTEtMA_83d23c2e-93db-4d1c-8827-b0a7a643bca3">259.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTYtMS0xLTEtMA_e76e7404-dd26-4f5a-8d85-d52e93633157">10.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTYtMy0xLTEtMA_d31487b4-c4a7-4e20-8d24-3c3410bee113">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTYtNS0xLTEtMA_82dbddec-94ce-4efb-aba6-167be3eed86a">30.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTYtNy0xLTEtMA_48512354-b84f-4fcd-a132-f17c28539393">29.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of intangible assets and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTctMS0xLTEtMA_160c6ef0-214e-4957-b892-4795222b6798">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" format="ixt:zerodash" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTctMy0xLTEtMA_6e657c59-e810-4190-bd0e-0856d5590323">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTctNS0xLTEtMA_53a3196b-1911-4c98-9e44-2baceb19ff14">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTctNy0xLTEtMA_c5283d0b-ac61-4288-b916-c0116272c220">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration fair value adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTktMS0xLTEtMA_83acd7ee-2328-484b-99fa-783c4f80dba5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTktMy0xLTEtMA_3258d143-f592-4840-9d78-0ce5e2939ebd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTktNS0xLTEtMA_9ae1dbb0-c7ab-4e3f-8013-aa52a0816d8f">10.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTktNy0xLTEtMA_f7b0535c-08c5-4699-977d-1a51e953c09f">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and divestiture charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjItMS0xLTEtMA_869e0323-2ca2-4e28-9450-76e6109290ac">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjItMy0xLTEtMA_a7195ec8-0dd5-4f5a-b943-4e3c09722e9c">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjItNS0xLTEtMA_13e53d86-9a2a-40a0-a48f-65353feb16de">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjItNy0xLTEtMA_947738a0-6f9a-4883-abad-c4e246829377">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjMtMS0xLTEtMA_96d2cc75-5846-4c77-a7ff-c997fa2a4cb5">343.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjMtMy0xLTEtMA_4964d5c5-2795-4228-a00b-3d129eebd8e3">275.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjMtNS0xLTEtMA_7f3d472d-bb90-440e-b906-b44af687ae90">926.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjMtNy0xLTEtMA_e4746e27-d93d-4cf6-8a8b-7d98688191b7">823.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjQtMS0xLTEtMA_a68e90c2-0c54-422e-9b58-eb749531f3b1">358.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjQtMy0xLTEtMA_cbcd2a9a-35b4-4499-a563-125a9adedf73">191.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjQtNS0xLTEtMA_8d58ca43-afbb-4127-8e04-d528368e53f2">2,040.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjQtNy0xLTEtMA_74001d05-4e4e-42ad-a21f-b5a9a6211014">472.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjUtMS0xLTEtMA_f0c85aa1-5327-4391-829d-c461682bb167">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjUtMy0xLTEtMA_09039469-0ac2-43d3-b460-291dabb78c39">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjUtNS0xLTEtMA_a50b20d6-d968-45a2-9ee5-8c94e14d9810">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjUtNy0xLTEtMA_f8a801c0-1467-47eb-91a9-1d1f8d720ab4">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjYtMS0xLTEtMA_b5a6012b-6449-4215-84d2-813a9a895a74">21.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjYtMy0xLTEtMA_1c10482e-9afc-4b24-b526-921d2c2c9d80">27.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjYtNS0xLTEtMA_98980795-615f-4128-ba9d-e19061e2ede8">70.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjYtNy0xLTEtMA_b3a9b826-6212-46d0-9da7-4253747cc557">91.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt extinguishment loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjctMS0xLTEtMA_3687952c-68da-47c6-9da8-a2197f652e23">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjctMy0xLTEtMA_864387c1-44ad-48b4-8ea6-e510d4697152">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjctNS0xLTEtMA_8195198f-e725-4c5e-9beb-5278ef1db3cc">21.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjctNy0xLTEtMA_83546580-672f-42ab-b12f-c103ca0c953e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjgtMS0xLTEtMA_f8a6f053-8886-451c-805d-d0c115d45cb0">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjgtMy0xLTEtMA_e32fe34c-bffd-40ce-a686-f57cc466dde7">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjgtNS0xLTEtMA_57a371d8-c9f9-494d-a841-1a4bdfa25ea7">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjgtNy0xLTEtMA_fc3df5f0-16dd-48bc-a357-d927c081797a">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjktMS0xLTEtMA_b60b5bd3-028a-4f98-8279-bc4030d824d6">337.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjktMy0xLTEtMA_5375fb48-8425-41a2-ae07-d461d4c296b0">168.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjktNS0xLTEtMA_0ecc1f44-5804-46d3-9f67-4e3b739540a2">1,950.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjktNy0xLTEtMA_dbbc108f-606e-42a9-a1c2-cbb0a6abf246">384.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision (benefit) for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzAtMS0xLTEtMA_d13b4276-349a-43d3-a5e5-f22dbeed6e84">69.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzAtMy0xLTEtMA_984443da-51b5-4d0d-a05c-cac122559464">32.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzAtNS0xLTEtMA_8208f5ab-1a5f-4c0c-a1bf-bf531798df32">409.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzAtNy0xLTEtMA_10676aab-9b1f-487c-918b-efb57ee72923">232.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzEtMS0xLTEtMA_fc9b4fef-c11b-4cd3-81c9-7f1164e45bb4">268.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzEtMy0xLTEtMA_a1ebf42e-bb5c-46e2-93f9-1044ea1a8174">136.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzEtNS0xLTEtMA_651bfd97-03b2-4653-857b-b53624225f52">1,540.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzEtNy0xLTEtMA_cb3f2730-aad4-4f8e-a6a6-8383a256931c">616.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzItMS0xLTEtMA_54279529-6acd-4f45-a5fe-e4239c14eb40">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzItMy0xLTEtMA_36ed1392-db9d-42d9-8fb1-9e1e03ccebf0">1.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzItNS0xLTEtMA_be77ce92-4aaa-49e1-9cf1-12524c78932e">1.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzItNy0xLTEtMA_b297c116-208f-48f3-af3d-e831b996d536">3.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Hologic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzMtMS0xLTEtMA_d8bf7c9c-44c2-4989-83a6-57eaab86be7d">268.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzMtMy0xLTEtMA_250b96c7-e4ab-410b-80ac-dedcdae2989c">137.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzMtNS0xLTEtMA_637f45a2-dc7c-40c4-993b-8faf33f0fe02">1,542.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzMtNy0xLTEtMA_a813372d-4043-4d28-b213-2bca83195895">620.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per common share attributable to Hologic:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzUtMS0xLTEtMA_610e8576-0ecb-4a67-a78a-ceca357884e5">1.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzUtMy0xLTEtMA_9ad4235b-f39e-4f70-a61b-f4af47635f6b">0.53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzUtNS0xLTEtMA_0d66fbb0-8a82-41d4-88e3-4504209d05a1">5.98</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzUtNy0xLTEtMA_7fbc003c-e502-4c23-b575-a6f4df56c87b">2.35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzYtMS0xLTEtMA_295030a6-d060-45e1-959b-103c012444b7">1.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzYtMy0xLTEtMA_8c3cc91c-a419-49b5-a96e-72e0b7d6b335">0.53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzYtNS0xLTEtMA_eb23d583-dd05-437a-b5c8-2613bb7c161e">5.93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzYtNy0xLTEtMA_a97f8a71-41d3-4559-8d88-68476e64c6db">2.34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzgtMS0xLTEtMA_0fff3b40-380a-4443-a811-a4b559c5d641">256,230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzgtMy0xLTEtMA_b187e632-cc16-4fd9-9939-e41a4155c9e4">259,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzgtNS0xLTEtMA_1335417b-5c06-4f73-b2ec-79f5127d930b">257,769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzgtNy0xLTEtMA_3d7a9c80-2894-468b-9596-366c73cfa8ce">263,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzktMS0xLTEtMA_00d58d21-d25a-40d4-b31e-a81ef9b7c2c6">258,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzktMy0xLTEtMA_1fc915a6-24af-4008-adb8-5d63fd26c1be">261,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzktNS0xLTEtMA_38ac8521-10d3-4b91-8bfd-3e3358acd0c8">260,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzktNy0xLTEtMA_37edcb67-8d3f-4ad1-9446-866ea5ac24ec">265,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i181d930c7b854595977e17db8fd84eb4_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> HOLOGIC, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.368%"><tr><td style="width:1.0%"></td><td style="width:45.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.662%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.662%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.662%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.550%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.668%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMi0xLTEtMS0w_e10b46f3-b3eb-4e43-b621-366801f97a21">268.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMi0zLTEtMS0w_989be1f3-bf70-4b60-a186-4034e9d2ce36">136.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMi01LTEtMS0w_651bfd97-03b2-4653-857b-b53624225f52">1,540.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMi03LTEtMS0w_1861cdbd-4db1-4278-853a-c662afed091d">616.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMy0xLTEtMS0w_5873000a-67ca-4131-b35e-9a7b5d5cc5ac">9.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMy0zLTEtMS0w_a72ba506-561e-4f08-ac3f-61b00045bdcf">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMy01LTEtMS0w_6d412da7-9a20-4915-bd73-d567516f00f7">1.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMy03LTEtMS0w_8909b7d5-9c7c-453e-af95-08d840acdfb2">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in value of hedged interest rate swaps and interest rate caps, net of tax of $<ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfOC0wLTEtMS0wL3RleHRyZWdpb246ZGZjYzgyZGEyY2MxNDIyNmJkMjA5ZmQ1MDc3YTIxMTRfODk_9c035bbb-340d-41da-aecd-e4b9c71e66e9">1.0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfOC0wLTEtMS0wL3RleHRyZWdpb246ZGZjYzgyZGEyY2MxNDIyNmJkMjA5ZmQ1MDc3YTIxMTRfOTc_6d36c724-6659-47f2-beda-c8de0cd074c2">2.2</ix:nonFraction> for the three and nine months ended June 26, 2021 and $(<ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfOC0wLTEtMS0wL3RleHRyZWdpb246ZGZjYzgyZGEyY2MxNDIyNmJkMjA5ZmQ1MDc3YTIxMTRfMTU0_e33a6d9d-3497-4968-bff7-a4d3dfcaf3a9">1.5</ix:nonFraction>) and $(<ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfOC0wLTEtMS0wL3RleHRyZWdpb246ZGZjYzgyZGEyY2MxNDIyNmJkMjA5ZmQ1MDc3YTIxMTRfMTYy_947ed9e6-3e1d-4aa2-ab17-dc81c1cf7ff7">7.9</ix:nonFraction>) for the three and nine months ended June 27, 2020.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) recognized in other comprehensive income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfOS0xLTEtMS0w_66a72ab3-9e71-4b74-9d06-e7f0855ee5a8">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfOS0zLTEtMS0w_b5cf0b1a-3e1a-401b-ac2c-92e19583ecec">4.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfOS01LTEtMS0w_923b734c-2453-483e-aede-c825fd2773d4">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfOS03LTEtMS0w_51c990d5-7523-4ea4-80e2-f6189c11b9a2">25.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss reclassified from accumulated other comprehensive loss to the statements of income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTAtMS0xLTEtMA_d2be1ce7-0e3e-46f0-a061-024c7cdedd4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTAtMy0xLTEtMA_cdf89676-fc94-4d8f-8687-6d8e4b4c6981">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTAtNS0xLTEtMA_f3845a6b-6740-4a79-8a6e-11405eeeabd0">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTAtNy0xLTEtMA_ad9c3767-74c5-4151-995a-906bf555d7bc">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTEtMS0xLTEtMA_4f8dd1ed-034c-4cfa-a3c3-137f7ea4b885">6.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTEtMy0xLTEtMA_0332b86b-6cda-4e3e-b044-0ee23c38d5b0">3.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTEtNS0xLTEtMA_886d9648-4e20-4c83-b28f-2a593b7badb5">7.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTEtNy0xLTEtMA_71d193dd-2374-4f98-bb4d-0670a72c3248">19.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTItMS0xLTEtMA_9088cd85-0398-42ce-a646-18a5275e91e0">261.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTItMy0xLTEtMA_49578e4f-4562-4175-bf25-7d9c9b74166e">133.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTItNS0xLTEtMA_9cd1a76d-0769-4f12-be74-dfb9e222a9f8">1,548.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTItNy0xLTEtMA_10cb266f-5ca3-4dea-9b42-13d6bf5588f2">597.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Components of comprehensive income attributable to noncontrolling interest:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTQtMS0xLTEtMA_b4697293-8317-4ee5-bdf1-90bdb17eb1a0">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTQtMy0xLTEtMA_baf871c4-e459-44c0-b602-4c9ef98ceb42">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTQtNS0xLTEtMA_f0635d2c-ec55-4197-abb6-d96f53c04f08">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTQtNy0xLTEtMA_2085b6e3-991a-4ad6-a446-2b68891eee07">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTUtMS0xLTEtMA_dda4abfe-db5c-42bd-9185-58aa2e54b0df">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTUtMy0xLTEtMA_8150b6b2-b2dd-4648-af4b-db6fe4599da9">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTUtNS0xLTEtMA_38f4354b-82bd-4f69-9a33-c08cd85461c9">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTUtNy0xLTEtMA_ae5cff80-e1e9-4109-b1d2-7de52f4a3bac">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to Hologic</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="holx:ComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTYtMS0xLTEtMA_e0d5488c-e377-437a-bba4-a9ea6821fb01">262.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="holx:ComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTYtMy0xLTEtMA_1b29d958-279b-45bc-8f94-58d17184413a">134.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="holx:ComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTYtNS0xLTEtMA_9957ed99-c527-4a54-827f-ea6320419e9e">1,550.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="holx:ComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTYtNy0xLTEtMA_e6806ab5-d881-4665-956d-e840627f1196">600.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i181d930c7b854595977e17db8fd84eb4_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HOLOGIC, INC.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In millions, except number of shares, which are reflected in thousands, and par value)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:66.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.883%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMy0xLTEtMS0w_6dd967ae-8687-4b85-8947-7c92d6e245c8">827.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMy0zLTEtMS0w_b89d31bd-b627-4353-b179-f19147bfcda4">701.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, less reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfNi0xLTEtMS0w_c62c8e90-a562-4228-b0af-ae0922f25e55">943.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfNi0zLTEtMS0w_64204c86-94a6-4dbc-814a-70360cf10a3d">1,028.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfNy0xLTEtMS0w_3b3fcb34-33e8-4a96-bb81-a727020df461">502.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfNy0zLTEtMS0w_4537c19e-de87-402b-b914-2c321ddfdcf1">395.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="holx:PrepaidIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfOC0xLTEtMS0w_716a56ec-54e0-4226-91d1-d33c94ade517">63.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="holx:PrepaidIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfOC0zLTEtMS0w_8f5cc89c-d255-4d80-8288-9c7718cf76de">38.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfOS0xLTEtMS0w_19b6f43a-3cb8-444f-8ad6-841e9f732a7f">81.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfOS0zLTEtMS0w_4b82bcf8-c2a3-44c7-a3a8-12237cc9aa60">58.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMTItMS0xLTEtMA_73417dc9-06c7-41c8-bae8-c11e888cad57">2,418.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMTItMy0xLTEtMA_43bad2c5-e829-4a23-a68f-a7c4f40c8290">2,222.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMTMtMS0xLTEtMA_9791000b-90ca-4479-8acc-e32b25aa10c0">551.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMTMtMy0xLTEtMA_8d674908-8012-4d75-a5ec-76dfa6ccd3ad">491.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMTQtMS0xLTEtMA_433a8292-0163-4413-a80c-d2c0445f9b14">1,800.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMTQtMy0xLTEtMA_3efa6c0a-94b7-4f1d-b333-8e3c14ab136d">1,307.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMTUtMS0xLTEtMA_b5b2c5cc-0156-4797-8781-fad84f6a87e3">3,264.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMTUtMy0xLTEtMA_24839604-c22b-4616-bbbb-22d797592782">2,657.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMTYtMS0xLTEtMA_0f05393c-b302-420e-96c6-fafc9123ee20">556.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMTYtMy0xLTEtMA_10c04409-1a2a-450f-ad5a-2ec83047d92d">516.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMTctMS0xLTEtMA_7562b4d6-162d-4af7-b299-2c3cd2a78f83">8,590.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMTctMy0xLTEtMA_2e60659e-553f-4f9a-b8e0-78dc273068c1">7,195.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMjAtMS0xLTEtMA_689f8290-1786-4b9a-a4ba-175b11108222">460.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMjAtMy0xLTEtMA_beff2aec-4971-4e2e-9b92-6d26c5a53e7a">324.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMjEtMS0xLTEtMA_37083d92-319c-4a9c-95a3-62e762ff6376">208.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMjEtMy0xLTEtMA_b63aaddb-7690-4c05-8e94-f870501fc3a4">178.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMjItMS0xLTEtMA_1d9d1912-55bd-4bb8-921b-9e59e8961254">579.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMjItMy0xLTEtMA_492f9c09-f27d-46b9-b7e6-4badec9884b9">547.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMjMtMS0xLTEtMA_333b4e10-799f-48db-a947-235ad3552d43">213.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMjMtMy0xLTEtMA_0d6c99b7-9526-4f17-acff-c68f9bf7b193">186.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:CapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMjQtMS0xLTEtMA_ce977045-3114-44f8-aafc-3243600918a1">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="us-gaap:CapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMjQtMy0xLTEtMA_c373ef6d-e504-41c8-aca7-a9e147e73981">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMjctMS0xLTEtMA_fb870b34-be40-4266-9cc8-04c43840252b">1,464.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMjctMy0xLTEtMA_f8a9a4cb-dece-43b0-9ba0-26d4802b6350">1,239.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMjgtMS0xLTEtMA_daf12290-fa96-488a-bbf5-a9c507febfff">2,654.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMjgtMy0xLTEtMA_71aeed95-50d1-42f7-80ee-7bb52bb51aaa">2,713.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:CapitalLeaseObligationsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMjktMS0xLTEtMA_dbef0bbe-5c3b-4c4f-8cca-8684b653f6de">22.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="us-gaap:CapitalLeaseObligationsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMjktMy0xLTEtMA_6bd321be-9794-4e6d-bb03-4894482d228a">17.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzAtMS0xLTEtMA_747f2d79-2856-4b9e-a7c3-d3d923c106ea">284.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzAtMy0xLTEtMA_e0dc1347-3528-4baf-8dfc-31d0bba4d91d">201.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:DeferredRevenueNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzEtMS0xLTEtMA_9e19c38a-49af-492e-bc42-7e80b9421b80">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="us-gaap:DeferredRevenueNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzEtMy0xLTEtMA_ff478743-93b3-4ee8-bec5-39df567d4ff5">12.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzItMS0xLTEtMA_bb0efb0f-8b98-4b4f-a7da-8a7cbdc1ee31">271.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzItMy0xLTEtMA_02efb039-2c1a-4c04-80e0-f5e1a496fe38">303.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjkxY2YyOGY4ZmFmNDRlMWRhMzk0MmVhNDFlNzM3YTY5XzIx_5b1262b5-59fb-4ff0-aa1d-025c0ffb1f5c"><ix:nonFraction unitRef="usdPerShare" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjkxY2YyOGY4ZmFmNDRlMWRhMzk0MmVhNDFlNzM3YTY5XzIx_c499fc67-d275-4819-bf8e-6ec8e7c4f404">0.01</ix:nonFraction></ix:nonFraction> par value &#8211; <ix:nonFraction unitRef="shares" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjkxY2YyOGY4ZmFmNDRlMWRhMzk0MmVhNDFlNzM3YTY5XzM2_0621e09d-bedf-41e7-bfae-304b46990e64"><ix:nonFraction unitRef="shares" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjkxY2YyOGY4ZmFmNDRlMWRhMzk0MmVhNDFlNzM3YTY5XzM2_3b883b56-dff9-490b-a89c-88af7c1019c5">1,623</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-3" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjkxY2YyOGY4ZmFmNDRlMWRhMzk0MmVhNDFlNzM3YTY5XzU4_27dea9cd-7d0e-441b-bd0b-760bab0da13d"><ix:nonFraction unitRef="shares" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-3" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjkxY2YyOGY4ZmFmNDRlMWRhMzk0MmVhNDFlNzM3YTY5XzU4_7f17c873-6f52-4274-b999-43226676340d">0</ix:nonFraction></ix:nonFraction> shares issued</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzQtMS0xLTEtMA_226f563e-f253-43a9-b9de-dc0760175007">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzQtMy0xLTEtMA_8c22a550-85ad-4b2b-958d-37ed1ac12c3b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjY5YmRlYTRlNTVlZDQyMWE5MWVmMWYzYTRhOTFiMzc1XzE4_2ad48f27-32c7-42af-a127-3f6ed41aaa9f"><ix:nonFraction unitRef="usdPerShare" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjY5YmRlYTRlNTVlZDQyMWE5MWVmMWYzYTRhOTFiMzc1XzE4_64c7e6a6-260a-456e-9723-69c211be2d29">0.01</ix:nonFraction></ix:nonFraction> par value &#8211;<ix:nonFraction unitRef="shares" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjY5YmRlYTRlNTVlZDQyMWE5MWVmMWYzYTRhOTFiMzc1XzMy_311b56f1-81d5-4e79-9f33-2ad9291843dd"><ix:nonFraction unitRef="shares" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjY5YmRlYTRlNTVlZDQyMWE5MWVmMWYzYTRhOTFiMzc1XzMy_b01fd910-9b1a-49e1-8093-c1b2eda1e177">750,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjY5YmRlYTRlNTVlZDQyMWE5MWVmMWYzYTRhOTFiMzc1XzU0_101b0337-9b03-475a-bb4e-21546a379e7f">296,945</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjY5YmRlYTRlNTVlZDQyMWE5MWVmMWYzYTRhOTFiMzc1XzYx_1cfd0fae-21b7-47b3-ac30-408aaf40b512">295,107</ix:nonFraction> shares issued, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzUtMS0xLTEtMA_a16d13fa-60ed-4225-925a-ec4df277ea31">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzUtMy0xLTEtMA_f953cdee-a4d5-4bd9-806f-1e6a926ecbf2">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in-capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzYtMS0xLTEtMA_35e3e702-90f6-4bd5-8ddb-8ae4a67b178f">5,936.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzYtMy0xLTEtMA_1066b4c3-2615-4a1a-a401-7318df96d40d">5,904.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzctMS0xLTEtMA_f6902628-635c-4c00-b1a3-690cfbee943d">30.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzctMy0xLTEtMA_aa40629d-82f2-43fe-9a1d-de48eb5b1a7c">1,573.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost &#8211; <ix:nonFraction unitRef="shares" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOmExODI0MzQ3NzgyYzQ2MDE5YTdjMGE2NTA0MmZmMzIzXzMw_472359dd-1773-483c-814c-53e036aba2fd">43,653</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOmExODI0MzQ3NzgyYzQ2MDE5YTdjMGE2NTA0MmZmMzIzXzM3_61e4a9c7-b7cf-40e7-88fb-a91b993347c8">37,609</ix:nonFraction> shares, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzgtMS0xLTEtMA_a70008a9-9a1b-4679-9125-f330dd341c7a">1,989.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzgtMy0xLTEtMA_0fb4b95f-4f6f-46aa-b497-d993525fdda0">1,579.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzktMS0xLTEtMA_a17ce489-22b9-4fd9-8202-139a6b82c119">42.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzktMy0xLTEtMA_b02dab79-21d6-4230-8000-ab4b75d86702">49.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Hologic's stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfNDAtMS0xLTEtMA_47875c6b-b2d4-4df6-bf26-bf386ff200c2">3,877.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfNDAtMy0xLTEtMA_801f02f7-9bc7-4009-986b-799a7bb6dc37">2,705.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfNDEtMS0xLTEtMA_0394f3b0-0d03-490e-ac50-532c29f49a64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfNDEtMy0xLTEtMA_3fe6df03-fdf9-4bad-853b-bb0655dc7d93">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfNDItMS0xLTEtMA_8e1aa11d-bb02-4922-8b5f-9c6ecf7f6521">3,877.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfNDItMy0xLTEtMA_1696be9d-b722-48b4-9a2c-b75c2da46948">2,707.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfNDMtMS0xLTEtMA_52f08bba-7e1a-431d-9e26-719a36d3c5ac">8,590.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfNDMtMy0xLTEtMA_87f7e87d-736d-45f0-a6dd-be29308e95fd">7,195.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i181d930c7b854595977e17db8fd84eb4_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hologic, Inc.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Stockholders' Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In millions, except number of shares, which are reflected in thousands)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:15.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.171%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-in-<br/>Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:26pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Par&#160;Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 28, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i62775b7338924094b35155c0fdc56937_I20190928" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTE2LTItMS0xLTA_9203bc09-5472-4d9b-a067-cd5b9958a615">292,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62775b7338924094b35155c0fdc56937_I20190928" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTE2LTQtMS0xLTA_7c040cb8-3d69-415c-97dd-f532306cdd4a">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcdf880adb9b48f2929f4a34dd835119_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTE2LTYtMS0xLTA_d34b5e49-9a10-447f-997a-6458f14ea5a7">5,769.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6acad958eada4806ab9891959584319e_I20190928" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTE2LTgtMS0xLTA_24e73de9-b58d-4680-9e9a-eeac013819a7">2,688.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b3baf3186c74c05b772abe2f32104e9_I20190928" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTE2LTEwLTEtMS0w_85ae6a58-8a4b-4ffc-af7d-df8e9abde274">42.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib7667b1c57034541bf5cdb336c4b3647_I20190928" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTE2LTEyLTEtMS0w_43f3e3c6-1b18-4843-b412-be35817effe6">24,638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib7667b1c57034541bf5cdb336c4b3647_I20190928" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTE2LTE0LTEtMS0w_0469b3b5-4a7d-49c5-8e1d-9b986c30107c">926.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1bbf9311cb649308affbf16f61bb3ff_I20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTE2LTE2LTEtMS0w_b43dd327-8af5-4231-a76c-da8fd765e742">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1bbf9311cb649308affbf16f61bb3ff_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTE2LTE4LTEtMS0w_741b865d-b97e-4eb7-9f49-9afdfff4b8be">2,115.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncontrolling interest created in acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id01db50d7a6347809cb98adf4b5c0c66_D20190929-20191228" decimals="-5" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTE3LTE2LTEtMS0w_452d0449-5485-480c-8e24-1c5398a5847f">8.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id01db50d7a6347809cb98adf4b5c0c66_D20190929-20191228" decimals="-5" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTE3LTE4LTEtMS0w_ab1ca06e-16f7-4995-af71-f2626c56455f">8.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounting standard transition adjustment - ASC 842</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c7cb3ce35044cba97822b408ab5d23c_I20190928" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTE4LTgtMS0xLTA_e4ec3fc8-20de-417e-bb3e-e2dbd23e3cd0">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c7cb3ce35044cba97822b408ab5d23c_I20190928" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTE4LTE4LTEtMS0w_e629100d-8688-4f52-84fa-6f0f6b09c465">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6977def5ccec49a2980c424062f9fee1_D20190929-20191228" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTE5LTItMS0xLTA_aed311f9-ee18-4bea-9a60-1589795d7309">540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i309460864a314d9aa0d13fb0a8698091_D20190929-20191228" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTE5LTYtMS0xLTA_5b1ceec9-59b6-462d-aa84-73e5cec8ea51">13.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i309460864a314d9aa0d13fb0a8698091_D20190929-20191228" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTE5LTE4LTEtMS0w_4f36a172-4830-4912-aeab-87d944cfcb19">13.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net of shares withheld for employee taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6977def5ccec49a2980c424062f9fee1_D20190929-20191228" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTIwLTItMS0xLTA_19efcff5-8aed-4837-b039-b2ad759c77c0">476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i309460864a314d9aa0d13fb0a8698091_D20190929-20191228" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTIwLTYtMS0xLTA_f93fd7db-b6b5-4a5f-9ed7-ac3f9b15666e">10.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i309460864a314d9aa0d13fb0a8698091_D20190929-20191228" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTIwLTE4LTEtMS0w_10eb0f6f-f9b9-4bf9-91c1-697367da2c1d">10.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i309460864a314d9aa0d13fb0a8698091_D20190929-20191228" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTIyLTYtMS0xLTA_c1345c00-1561-4538-8cd0-261a10276790">18.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i309460864a314d9aa0d13fb0a8698091_D20190929-20191228" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTIyLTE4LTEtMS0w_db8cfe82-8cbb-4e9c-89a2-c09d7762ff72">18.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id01db50d7a6347809cb98adf4b5c0c66_D20190929-20191228" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTIzLTgtMS0xLTA_7e7e4dc3-a622-48ca-81e8-f443fe200f02">386.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id01db50d7a6347809cb98adf4b5c0c66_D20190929-20191228" decimals="-5" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTIzLTE2LTEtMS0w_7eac629a-c013-470c-8fa2-f5ad80df60fa">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id01db50d7a6347809cb98adf4b5c0c66_D20190929-20191228" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTIzLTE4LTEtMS0w_3a3f495a-0863-403f-b5f4-71090dbfff86">385.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income activity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1bc73f8ae9c492f9eb4404fb7e44230_D20190929-20191228" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI0LTEwLTEtMS0w_3abb2424-614e-431e-b02a-ef386f8f0e0c">13.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1bc73f8ae9c492f9eb4404fb7e44230_D20190929-20191228" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI0LTE4LTEtMS0w_cd7cac61-219d-496a-bbc4-fdb65e0ed16d">13.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia342626413704afc8513005d7219aead_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI1LTEyLTEtMS0w_900fe666-be4d-45f7-88f0-d23b9c9c2a2a">1,545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia342626413704afc8513005d7219aead_D20190929-20191228" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI1LTE0LTEtMS0w_b40ceb1c-73aa-4f42-850d-3608f20218b3">80.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id01db50d7a6347809cb98adf4b5c0c66_D20190929-20191228" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI1LTE4LTEtMS0w_818fc339-299b-4625-b047-418ca8d3b46b">80.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated share repurchase agreement</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia342626413704afc8513005d7219aead_D20190929-20191228" decimals="-5" sign="-" name="us-gaap:AcceleratedShareRepurchaseProgramAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI2LTYtMS0xLTA_55e05655-17ea-4bf8-b855-520d530ab9c0">41.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i22a1e068cbb54742b0e792558e5f9d7c_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI2LTEyLTEtMS0w_cf39eba5-b8a2-427d-b576-f9bf7183e4b1">3,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i22a1e068cbb54742b0e792558e5f9d7c_D20190929-20191228" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI2LTE0LTEtMS0w_f7e876a8-908b-4009-9651-b88d2bc1075b">164.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id01db50d7a6347809cb98adf4b5c0c66_D20190929-20191228" decimals="-5" name="holx:Acceleratedsharerepurchaseagreement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI2LTE4LTEtMS0w_a55a8eb7-d025-47ea-a4aa-edf4199f7408">205.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of non-controlling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id01db50d7a6347809cb98adf4b5c0c66_D20190929-20191228" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI3LTE2LTEtMS0w_6741434b-75ea-4e19-a871-79847cebb81e">1.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id01db50d7a6347809cb98adf4b5c0c66_D20190929-20191228" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI3LTE4LTEtMS0w_7e4b3d0e-9a41-4ea3-b27c-9782cbdb1c60">1.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 28, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ide9ab086aa8846ac877a20195abb5f25_I20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI4LTItMS0xLTA_e3d43ca7-6fa8-47c4-ad6d-d4bb3470919e">293,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide9ab086aa8846ac877a20195abb5f25_I20191228" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI4LTQtMS0xLTA_42608091-4d0b-4075-98cb-714240a0ec79">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id78e1a3ad6024d799c3f1727c967cf29_I20191228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI4LTYtMS0xLTA_13b48de0-ecbf-4f50-9336-56ab37e80c88">5,749.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77063f41174f4d989415517706f4fb93_I20191228" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI4LTgtMS0xLTA_b0b88996-cc67-4c29-bff7-e2b6823e1291">2,302.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc0e0f0a89824c5996ab98b928cc9aa4_I20191228" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI4LTEwLTEtMS0w_723286ee-91d8-4c3f-87b2-511e4aea4cb5">28.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibe21cf98d68c43dca6569043732410ff_I20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI4LTEyLTEtMS0w_8c6a0823-cde4-412d-97b6-535194037381">29,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe21cf98d68c43dca6569043732410ff_I20191228" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI4LTE0LTEtMS0w_8794d984-429e-4d37-8188-cda3e44aba60">1,170.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i419ae5d90cab427883eac5b35fd93d36_I20191228" decimals="-5" name="us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI4LTE2LTEtMS0w_bd3da1e5-07bd-45dc-b8b4-808386c6ff2e">6.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i419ae5d90cab427883eac5b35fd93d36_I20191228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI4LTE4LTEtMS0w_73439a5e-71b7-45d6-ab0e-69fc7e8f7653">2,257.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i02e7a8da3b754bdb85993a3ca3484508_D20191229-20200328" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTMxLTItMS0xLTA_b08f99a6-886e-4a53-8036-835bfd8ea14a">503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2ba3a87732c4c6ab5006e5cb0228a5d_D20191229-20200328" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTMxLTYtMS0xLTA_fbfec4f5-34ce-4164-b945-010e64b2ddfe">13.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2ba3a87732c4c6ab5006e5cb0228a5d_D20191229-20200328" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTMxLTE4LTEtMS0w_f65aedf9-0785-47d5-88e4-a2fac92909d1">13.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net of shares withheld for employee taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i02e7a8da3b754bdb85993a3ca3484508_D20191229-20200328" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTMyLTItMS0xLTA_4f68edf0-0fc4-4a76-9f3a-459c86dc429c">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2ba3a87732c4c6ab5006e5cb0228a5d_D20191229-20200328" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTMyLTYtMS0xLTA_f75aa1cd-6d7d-4282-9238-d4f609f475e2">1.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia2ba3a87732c4c6ab5006e5cb0228a5d_D20191229-20200328" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTMyLTE4LTEtMS0w_48e3d35b-2162-413f-97fd-c957f7959d80">1.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued under the employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i02e7a8da3b754bdb85993a3ca3484508_D20191229-20200328" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTMzLTItMS0xLTA_e60adc55-26c6-48b4-917f-157c5740f635">214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2ba3a87732c4c6ab5006e5cb0228a5d_D20191229-20200328" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTMzLTYtMS0xLTA_807022b5-2471-4228-9fc8-6ec2ff989537">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2ba3a87732c4c6ab5006e5cb0228a5d_D20191229-20200328" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTMzLTE4LTEtMS0w_1473ee57-e0f2-4cd2-be61-1221b3de6319">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2ba3a87732c4c6ab5006e5cb0228a5d_D20191229-20200328" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTM0LTYtMS0xLTA_4a7a259d-2367-42dc-9aae-42697bb64222">15.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2ba3a87732c4c6ab5006e5cb0228a5d_D20191229-20200328" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTM0LTE4LTEtMS0w_4ceef810-9218-4bcb-b417-983dbee24dde">15.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588c3d9c7d924cc6a15149930f01d74e_D20191229-20200328" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTM1LTgtMS0xLTA_38a92f2a-4cea-4e5f-8cc1-3866901dd699">96.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588c3d9c7d924cc6a15149930f01d74e_D20191229-20200328" decimals="-5" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTM1LTE2LTEtMS0w_09fdf48b-b856-4c31-bba1-025f201af1da">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588c3d9c7d924cc6a15149930f01d74e_D20191229-20200328" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTM1LTE4LTEtMS0w_a552f777-dfe3-4d51-b45a-0cbb67c4c438">94.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income activity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33460b16b0364f3589df795f209d0c8d_D20191229-20200328" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTM2LTEwLTEtMS0w_f85c66ba-f699-4d9e-a28b-7ed8cb3bc77b">30.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33460b16b0364f3589df795f209d0c8d_D20191229-20200328" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTM2LTE4LTEtMS0w_f4eda854-33b0-48ae-84a3-bf8ae4872c36">30.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib8b6b6f42e894fca9dca1d45bc960c8a_D20191229-20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTM3LTEyLTEtMS0w_2737e6b2-d607-4db2-9a2d-5928793a665e">5,851</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8b6b6f42e894fca9dca1d45bc960c8a_D20191229-20200328" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTM3LTE0LTEtMS0w_5942eecc-ff02-4fda-90d8-4b1621390c38">267.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8b6b6f42e894fca9dca1d45bc960c8a_D20191229-20200328" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTM3LTE4LTEtMS0w_027746cf-bec6-4954-9ebf-cdb35dafa6b7">267.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Completion of Accelerated share repurchase agreement</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8b6b6f42e894fca9dca1d45bc960c8a_D20191229-20200328" decimals="-5" name="us-gaap:AcceleratedShareRepurchaseProgramAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTM4LTYtMS0xLTA_97e46c3a-de23-4c4b-840d-cae64ce6e30a">41.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i17e8693dbcd546e5a55176fe7546128f_D20191229-20200328" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTM4LTEyLTEtMS0w_99d15781-e675-4515-83b8-894d7a854975">628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17e8693dbcd546e5a55176fe7546128f_D20191229-20200328" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTM4LTE0LTEtMS0w_103fb101-42cd-4d16-b72c-39204a3591e2">41.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i588c3d9c7d924cc6a15149930f01d74e_D20191229-20200328" decimals="-5" format="ixt:zerodash" name="holx:Acceleratedsharerepurchaseagreement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTM4LTE4LTEtMS0w_581c1ad8-8fd9-4a78-a50a-8858deeec1c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of non-controlling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588c3d9c7d924cc6a15149930f01d74e_D20191229-20200328" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTM5LTE2LTEtMS0w_5ec57aae-89e9-4520-9ffa-a411a602a5e6">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i588c3d9c7d924cc6a15149930f01d74e_D20191229-20200328" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTM5LTE4LTEtMS0w_a94c3dad-71f6-46c9-b9ea-1e624736252e">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at March 28, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0657c7323336470abd636ab465e98a96_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQwLTItMS0xLTA_e755de3a-f9a5-4c9b-b70d-58b57ff26f4b">294,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0657c7323336470abd636ab465e98a96_I20200328" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQwLTQtMS0xLTA_dd2abacb-2767-477a-b85e-8565ec3db93c">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia15ef37ae8ca4fbca76c1b7b2851f56c_I20200328" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQwLTYtMS0xLTA_b13bff8c-9af8-4034-a126-98838d495193">5,827.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i047c6f422b294cb08c1476a194dc7470_I20200328" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQwLTgtMS0xLTA_76d792de-596f-4f3c-a82c-a8c5bed5bf8e">2,206.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4470f8e9e21d45a78c67f110baf7a543_I20200328" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQwLTEwLTEtMS0w_1cb385e1-1b0d-40cd-89e3-c6a936855f2f">58.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i490aca9b8aa2403e8983cfb2aee1071b_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQwLTEyLTEtMS0w_b072054f-1d28-4d28-9da5-933d6653571b">35,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i490aca9b8aa2403e8983cfb2aee1071b_I20200328" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQwLTE0LTEtMS0w_0b62215e-16d3-4edf-b5b6-86ca0124ca04">1,479.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ae541164c564e1394017ca8fb281f3c_I20200328" decimals="-5" name="us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQwLTE2LTEtMS0w_487e3893-8626-44af-9661-1b7391188773">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ae541164c564e1394017ca8fb281f3c_I20200328" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQwLTE4LTEtMS0w_de9ea802-2b2b-4049-8726-8d68ff0cabab">2,091.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5bf322985c424f509995e217f5ba7921_D20200329-20200627" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQxLTItMS0xLTA_a027aefc-fcd0-4c3e-bf62-789774f3b8c6">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73253768170f4c9b8e05dfb1368cf18d_D20200329-20200627" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQxLTYtMS0xLTA_f067aae4-81d5-411a-a186-24fac89c5717">14.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73253768170f4c9b8e05dfb1368cf18d_D20200329-20200627" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQxLTE4LTEtMS0w_ce1cecf8-7525-4715-ae1d-8766016bb9e3">14.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:15.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.171%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net of shares withheld for employee taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5bf322985c424f509995e217f5ba7921_D20200329-20200627" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQyLTItMS0xLTA_06f326a9-d0d5-4223-8954-aad7c74b59d8">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73253768170f4c9b8e05dfb1368cf18d_D20200329-20200627" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQyLTYtMS0xLTA_1f480f36-e817-4617-8826-bd8a879a7758">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73253768170f4c9b8e05dfb1368cf18d_D20200329-20200627" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQyLTE4LTEtMS0w_aeac6d1d-ac92-4bbb-a602-4abc3a742d59">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73253768170f4c9b8e05dfb1368cf18d_D20200329-20200627" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQ0LTYtMS0xLTA_07a15f04-fa6d-4821-aa1a-106f3e47f559">19.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73253768170f4c9b8e05dfb1368cf18d_D20200329-20200627" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQ0LTE4LTEtMS0w_32273420-5c2c-4c6e-9d24-5b4384edf82a">19.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQ1LTgtMS0xLTA_461a906f-97e1-4b10-9a32-ea3d0335ac45">137.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQ1LTE2LTEtMS0w_f3082797-e9b0-4b04-9508-e2a2fa1d24b7">1.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQ1LTE4LTEtMS0w_7a126a52-3992-44a5-a15f-d1d67584c051">136.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income activity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd3a77457cf340cf9428c91d5c99c147_D20200329-20200627" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQ2LTEwLTEtMS0w_528786a1-d8be-450a-aae6-3b23f1059b77">3.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd3a77457cf340cf9428c91d5c99c147_D20200329-20200627" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQ2LTE4LTEtMS0w_28c66ca3-8b14-45c2-96df-34db9177ac76">3.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of non-controlling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQ5LTE2LTEtMS0w_7e8758f9-154c-4c41-821b-4469356f77cd">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQ5LTE4LTEtMS0w_36429e5d-2b29-44e4-9efd-37f91acdcd62">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 27, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idc53cfef88da4ccfb2e145cc906d6511_I20200627" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUwLTItMS0xLTA_b2602d50-a6fc-4482-9a72-8a7a3f39b765">294,684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc53cfef88da4ccfb2e145cc906d6511_I20200627" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUwLTQtMS0xLTA_9a9458db-9de7-47a4-9bcf-91ce2c74507f">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfd99b340a8c407e9acd3394fcb87cb8_I20200627" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUwLTYtMS0xLTA_26d7d3dd-8d8f-4ad5-8d48-d2e7982bd217">5,861.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i63c68ea38c5d4987adbac8981ccfb7a3_I20200627" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUwLTgtMS0xLTA_7d3a5b85-c874-4b07-b7f9-d6bb7853acf4">2,068.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe15f7e0e20e47c29d5afb6680fcde66_I20200627" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUwLTEwLTEtMS0w_252d8fe9-d90c-44d0-909f-aec8cd52c35b">61.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i226a72a6ad6e4aa4a08a9eaebf99bb78_I20200627" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUwLTEyLTEtMS0w_fb6939b4-c082-4416-a61b-f7f1cefe6243">35,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i226a72a6ad6e4aa4a08a9eaebf99bb78_I20200627" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUwLTE0LTEtMS0w_89023960-3937-4d80-bd42-fd08ae42b329">1,479.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81ab5863e2124accb342d2df86a1ee96_I20200627" decimals="-5" name="us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUwLTE2LTEtMS0w_cdccdda6-c5a3-4291-9765-8007aebcbf87">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81ab5863e2124accb342d2df86a1ee96_I20200627" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUwLTE4LTEtMS0w_3f250061-4995-4c17-ae20-ae292139b744">2,258.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i738e3649fa5648b981781aa15132a8f6_D20200628-20200926" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUxLTItMS0xLTA_b5eaba8a-fe28-41f8-9e6a-ba96a63801d6">185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8272ade1ac594482a34d29229657da9b_D20200628-20200926" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUxLTYtMS0xLTA_c43299ea-af7e-4927-aa3f-5ca0deb02a94">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8272ade1ac594482a34d29229657da9b_D20200628-20200926" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUxLTE4LTEtMS0w_7d7cd21e-eabb-4046-92cb-8baefee052d8">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net of shares withheld for employee taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i738e3649fa5648b981781aa15132a8f6_D20200628-20200926" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUyLTItMS0xLTA_c8840748-e4db-41fe-ac50-892b77e1a56e">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8272ade1ac594482a34d29229657da9b_D20200628-20200926" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUyLTYtMS0xLTA_51391415-c8c2-411a-aaea-f14134849973">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8272ade1ac594482a34d29229657da9b_D20200628-20200926" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUyLTE4LTEtMS0w_e1fbaf4b-c897-4b4b-b5f0-b033f685b949">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued under the employee stock purchase plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i738e3649fa5648b981781aa15132a8f6_D20200628-20200926" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUzLTItMS0xLTA_65f11b40-d50b-40dd-b94b-d7b900a39097">198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8272ade1ac594482a34d29229657da9b_D20200628-20200926" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUzLTYtMS0xLTA_3bc16e8c-b302-4687-90a6-04b0012bb4e4">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09304699beed432b98cea40faccb3e67_D20200927-20201226" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUzLTE4LTEtMS0w_dc1e549c-c880-48db-8314-362cfffb4f3f">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8272ade1ac594482a34d29229657da9b_D20200628-20200926" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU0LTYtMS0xLTA_dc0ce5db-ec73-4808-8b15-d0ad5b8ab0f3">29.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8272ade1ac594482a34d29229657da9b_D20200628-20200926" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU0LTE4LTEtMS0w_03ae74e0-f2f9-4f27-94a3-e95bf2d1a893">29.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic24013ff47294a37b8d0497bd4190df5_D20200628-20200926" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU1LTgtMS0xLTA_f87eb752-dc68-4e8a-9295-fc4541650a0f">494.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic24013ff47294a37b8d0497bd4190df5_D20200628-20200926" decimals="-5" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU1LTE2LTEtMS0w_17d8249b-2dcd-4d48-975d-f53bc91aa679">1.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic24013ff47294a37b8d0497bd4190df5_D20200628-20200926" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU1LTE4LTEtMS0w_28483331-60eb-4c04-8742-ad8fe385a2c0">493.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income activity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9d0114a6df941bbb221d574874bf165_D20200628-20200926" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU2LTEwLTEtMS0w_bf7c9b3b-c8f1-4440-b107-f2e72aadbe4c">12.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9d0114a6df941bbb221d574874bf165_D20200628-20200926" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU2LTE4LTEtMS0w_8d66f0c8-5249-4220-a0f6-097dd9683f39">12.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib40a5a6185e8452498ab7f6ce2457f01_D20200628-20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU3LTEyLTEtMS0w_24213c5f-7e53-4730-8ba4-567d97fb719f">1,668</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib40a5a6185e8452498ab7f6ce2457f01_D20200628-20200926" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU3LTE0LTEtMS0w_22731bf9-a7db-45bf-b3b8-6973f4fe0895">100.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib40a5a6185e8452498ab7f6ce2457f01_D20200628-20200926" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU3LTE4LTEtMS0w_47d67673-798b-4ce2-a03a-586f2d4dcdb5">100.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 26, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i88ca4c5253d94e03a7eb9af69544692d_I20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU4LTItMS0xLTA_c4475933-8f33-4631-ae58-fd8f0422d816">295,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88ca4c5253d94e03a7eb9af69544692d_I20200926" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU4LTQtMS0xLTA_745eccf4-afb2-450c-bb87-1df513708454">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i237512b46fca4a7db28715ee5c66af27_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU4LTYtMS0xLTA_f95c2833-01f2-44c7-b0cb-62aa4492d94c">5,904.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b78eb3d900e4dc388e35dc09cd76568_I20200926" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU4LTgtMS0xLTA_c2ab79ca-b4be-40af-98ce-6771c0f442ab">1,573.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820217fec55c42d7a9aeb5cfc0f49fdb_I20200926" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU4LTEwLTEtMS0w_e168cbc6-e130-4b7b-8ec1-9f5e1389f198">49.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i52f506beb69441ce875d650d0e5966ba_I20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU4LTEyLTEtMS0w_41e3e148-d43f-4c68-8c17-cbcbe271eaf5">37,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52f506beb69441ce875d650d0e5966ba_I20200926" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU4LTE0LTEtMS0w_fd37e4b5-e3d2-4999-81e4-0acf12e7324d">1,579.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU4LTE2LTEtMS0w_cf55c24b-2d90-4d1e-ab38-bdd58aff65cf">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU4LTE4LTEtMS0w_9d505173-a9b5-461e-ac72-60cc83f87e38">2,707.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9223d1ed5b7d47208efe550fae77bef3_D20200927-20201226" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU5LTItMS0xLTA_999f9724-a331-4f85-9be5-2d855184f8f4">490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09304699beed432b98cea40faccb3e67_D20200927-20201226" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU5LTYtMS0xLTA_99a9086c-5fda-47f4-8e06-813a73a6079c">18.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09304699beed432b98cea40faccb3e67_D20200927-20201226" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU5LTE4LTEtMS0w_798fc86a-25e0-4a1b-b369-679b9861a3a9">18.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net of shares withheld for employee taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9223d1ed5b7d47208efe550fae77bef3_D20200927-20201226" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTYwLTItMS0xLTA_d53d80e4-ca29-46a6-8109-d1ec0c74bf79">936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a980ec9354548a89245ad56600f024d_D20200927-20201226" decimals="5" name="holx:ChangeInParValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTYwLTQtMS0xLTA_67407553-061a-42cf-ac05-13511749642f">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09304699beed432b98cea40faccb3e67_D20200927-20201226" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTYwLTYtMS0xLTA_f6c9228f-4df7-4e99-9118-06a635817396">46.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a980ec9354548a89245ad56600f024d_D20200927-20201226" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTYwLTE4LTEtMS0w_69ceb1c0-106e-43e0-acde-98a650d001de">46.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09304699beed432b98cea40faccb3e67_D20200927-20201226" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTYyLTYtMS0xLTA_5d23320b-c60f-4a21-99a7-aa0859ff5851">18.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09304699beed432b98cea40faccb3e67_D20200927-20201226" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTYyLTE4LTEtMS0w_8c7dfedc-3577-43c4-949c-562d6ac82a4d">18.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a980ec9354548a89245ad56600f024d_D20200927-20201226" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTYzLTgtMS0xLTA_48716e85-0af6-46a1-a009-99ae1b924301"><ix:nonFraction unitRef="usd" contextRef="i8a980ec9354548a89245ad56600f024d_D20200927-20201226" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTYzLTgtMS0xLTA_eedf81ba-bcd7-4b5d-a021-87cf7f273232">654.4</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a980ec9354548a89245ad56600f024d_D20200927-20201226" decimals="-5" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTYzLTE2LTEtMS0w_f7ed223b-1700-4e8d-b458-efbede899921">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a980ec9354548a89245ad56600f024d_D20200927-20201226" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTYzLTE4LTEtMS0w_2a598ba8-9cba-4fcf-9c7b-6686ea266e41">653.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income activity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3516193c4744e1cb240679a20e265f8_D20200927-20201226" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY0LTEwLTEtMS0w_e8c97110-d7a4-49d1-a307-70443745e1f6">19.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3516193c4744e1cb240679a20e265f8_D20200927-20201226" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY0LTE4LTEtMS0w_1bfc8548-32b7-4a46-af8e-a9b542ab4350">19.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if83bdefcff814ab0800ee9e105ed777e_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY1LTEyLTEtMS0w_bbc70406-a934-47c0-a331-994c9eca4108">1,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if83bdefcff814ab0800ee9e105ed777e_D20200927-20201226" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY1LTE0LTEtMS0w_92c961e6-b84f-4241-96da-b31e768b9cf7">101.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a980ec9354548a89245ad56600f024d_D20200927-20201226" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY1LTE4LTEtMS0w_979c90fc-277e-4992-9c19-cb6f0d76a14f">101.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 26, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2c17808393cc4b1a91fd6c22e278253d_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY2LTItMS0xLTA_6279d874-f8d4-4ccc-a636-9e1152593cbf">296,533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c17808393cc4b1a91fd6c22e278253d_I20201226" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY2LTQtMS0xLTA_c21d71cd-071a-4748-b672-bdc0863f3840">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e2de70ed942467287b4930863d9692e_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY2LTYtMS0xLTA_3fdae514-ffd1-421f-bade-5099db6e5b21">5,895.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iebc58209d8514f5c93b78fa003903508_I20201226" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY2LTgtMS0xLTA_79c5d9d7-7fd2-41ff-bbe0-3b378530d159">918.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73d6f95b696549cfb0e4d525d8488ac7_I20201226" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY2LTEwLTEtMS0w_63abd14f-fbeb-4cfe-b74d-d600d03d17a6">30.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia4bb35a550a74469afbfef16e89e4881_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY2LTEyLTEtMS0w_60941eac-ce41-42a3-893f-0f5b25237ae2">39,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4bb35a550a74469afbfef16e89e4881_I20201226" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY2LTE0LTEtMS0w_f4fb7078-0eef-4229-bcea-d922966d2203">1,680.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9811e9a2cf24d19b278bc2bf9a5c5cb_I20201226" decimals="-5" name="us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY2LTE2LTEtMS0w_951da207-dbd5-4bc3-bd5e-7651a79ac5bf">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9811e9a2cf24d19b278bc2bf9a5c5cb_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY2LTE4LTEtMS0w_6cdd6b88-4e8a-4cc1-9e90-fcd1e1b452dc">3,269.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icdca8dc2d5f84891bd139bc79d3231ab_D20201227-20210327" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY3LTItMS0xLTA_83f1667d-2cdb-4b40-82aa-4abb05f13fb9">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36833f09bd344e93a23947c92c866cf5_D20201227-20210327" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY3LTYtMS0xLTA_5a52f80b-27d4-411e-b227-7a7ac6d93d32">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36833f09bd344e93a23947c92c866cf5_D20201227-20210327" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY3LTE4LTEtMS0w_7b31437e-e44f-49f0-85ab-2e8a7da1df18">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net of shares withheld for employee taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icdca8dc2d5f84891bd139bc79d3231ab_D20201227-20210327" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY4LTItMS0xLTA_74ac1a23-d529-4a77-ba35-01aafcc08dae">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36833f09bd344e93a23947c92c866cf5_D20201227-20210327" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY4LTYtMS0xLTA_027dc74f-be9d-4727-9f7c-ce6eecf7f8a6">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8c4f5a123e145abb53ba94d3255b7da_D20201227-20210327" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY4LTE4LTEtMS0w_577db626-c91b-4ebe-a897-bc8f3c4199e0">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued under the employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icdca8dc2d5f84891bd139bc79d3231ab_D20201227-20210327" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY5LTItMS0xLTA_267c9ae4-faca-4011-9762-8de75490ac21">191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36833f09bd344e93a23947c92c866cf5_D20201227-20210327" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY5LTYtMS0xLTA_b682331e-b598-40f3-8ebe-a835dabc8317">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36833f09bd344e93a23947c92c866cf5_D20201227-20210327" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY5LTE4LTEtMS0w_6c5fef7f-4fec-4805-b2f3-d37b8715846d">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36833f09bd344e93a23947c92c866cf5_D20201227-20210327" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTcwLTYtMS0xLTA_5434b0ae-88af-4433-9ad7-ef0645131d23">17.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36833f09bd344e93a23947c92c866cf5_D20201227-20210327" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTcwLTE4LTEtMS0w_01743b50-16eb-47ec-933a-b1f5ebb8fc27">17.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8c4f5a123e145abb53ba94d3255b7da_D20201227-20210327" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTcxLTgtMS0xLTA_a2c02458-3bca-496c-97c2-644c600a0835">619.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8c4f5a123e145abb53ba94d3255b7da_D20201227-20210327" decimals="-5" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTcxLTE2LTEtMS0w_a70686b3-9653-44d3-b0b0-23f6e882668a">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8c4f5a123e145abb53ba94d3255b7da_D20201227-20210327" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTcxLTE4LTEtMS0w_95836592-f4c7-401d-bb23-54aad6da4a65">619.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income activity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i049e1cee29c84dde8735ff6f859f7c56_D20201227-20210327" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTcyLTEwLTEtMS0w_28771092-ee4b-4c5b-a369-4acd1bc8b9de">5.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i049e1cee29c84dde8735ff6f859f7c56_D20201227-20210327" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTcyLTE4LTEtMS0w_66860e2e-522d-42af-8825-41dab289d0b6">5.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:15.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.171%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i84edd5ea5c5241b5a06d1be5e9eb4872_D20201227-20210327" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTczLTEyLTEtMS0w_a938eb13-e641-4e9c-99c7-c7ec0b679598">1,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i84edd5ea5c5241b5a06d1be5e9eb4872_D20201227-20210327" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTczLTE0LTEtMS0w_e3e8ac00-fa0c-4489-9888-41242eddb4e6">120.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8c4f5a123e145abb53ba94d3255b7da_D20201227-20210327" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTczLTE4LTEtMS0w_b9e2b137-7fc1-4876-a84e-2f6629f2148a">120.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at March 27, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib2c3c861c8f34c17aa93621dcb13cd4a_I20210327" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc0LTItMS0xLTA_676daf4d-eb8f-41c7-908c-2f3faffe9f98">296,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2c3c861c8f34c17aa93621dcb13cd4a_I20210327" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc0LTQtMS0xLTA_8ce28c86-32ba-4baf-8e6f-c3e9d28400c4">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6cf91736f1949678b7354ef10d99150_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc0LTYtMS0xLTA_b1940ab1-0921-41a4-b9df-f44496443ddc">5,927.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icc0d86296d91494f843aeb441d2af697_I20210327" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc0LTgtMS0xLTA_ca7d01f7-351a-4d4f-bc51-ad904c754651">298.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0aa0fa3e3474453bc759752889ebcd8_I20210327" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc0LTEwLTEtMS0w_300e96a6-cff0-49d6-b3dc-b10afaf93cba">35.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i379f68e2cb5c471e83994c37a86c01b6_I20210327" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc0LTEyLTEtMS0w_bba5bde0-721b-4e15-ac5d-215c20efde20">40,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i379f68e2cb5c471e83994c37a86c01b6_I20210327" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc0LTE0LTEtMS0w_cacc1505-6595-4539-bc79-f3d864f98500">1,801.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31e8abc772ad4ffe894ec7ec188dc5df_I20210327" decimals="-5" name="us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc0LTE2LTEtMS0w_bdce3537-c995-461b-a550-422646707413">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31e8abc772ad4ffe894ec7ec188dc5df_I20210327" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc0LTE4LTEtMS0w_8744301c-f270-4533-967b-ba84d5465473">3,795.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1c99a5bb5b144cf9b610e175a4ecc587_D20210328-20210626" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc1LTItMS0xLTUzMDA_0c0f393e-d6bb-4d53-ad1e-bcc544e1c52d">53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic97a10fe6e144c24b4eafc07f4a2428b_D20210328-20210626" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc1LTYtMS0xLTUzMDY_c5f89666-ebf1-48f1-915f-38dc4ec634ae">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic97a10fe6e144c24b4eafc07f4a2428b_D20210328-20210626" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc1LTE4LTEtMS01MzQw_c4165ff9-4e24-48af-8a64-de82cc67dd5a">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net of shares withheld for employee taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1c99a5bb5b144cf9b610e175a4ecc587_D20210328-20210626" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc2LTItMS0xLTUzMDI_54cab8aa-22ec-451f-98da-c14b08bd2fe9">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic97a10fe6e144c24b4eafc07f4a2428b_D20210328-20210626" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc2LTYtMS0xLTUzMDg_0d28c677-b4c0-462f-9be9-2a10f887630b">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc2LTE4LTEtMS01MzQy_5af1daaf-e3cb-484f-a544-ba3069f30508">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic97a10fe6e144c24b4eafc07f4a2428b_D20210328-20210626" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc4LTYtMS0xLTUzMTA_ccc3eda3-4dcb-4486-acd1-5b150481e66d">15.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic97a10fe6e144c24b4eafc07f4a2428b_D20210328-20210626" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc4LTE4LTEtMS01MzQ0_780edf8c-94dc-4e92-b65f-5ba83b5f8174">15.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc5LTgtMS0xLTMzNjY_c9e1ff1f-8994-4982-9140-87a46aebf59d">268.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc5LTE2LTEtMS01MzM0_ff57ba87-2265-4d1b-ac24-845b5477b9c8">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc5LTE4LTEtMS0zMzY4_7fdc7730-e6d3-42c5-bc33-d2c1ffdd578c">268.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income activity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8226181576f245bba94e4a5ec64e87f6_D20210328-20210626" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTgwLTEwLTEtMS01MzIy_42d58ac2-a4f4-4446-bb35-72d00fe1b0dc">6.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8226181576f245bba94e4a5ec64e87f6_D20210328-20210626" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTgwLTE4LTEtMS01MzQ4_938e810b-cc8b-46cd-aa18-aa34ac60993a">6.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i537a20393d1e493cbe6493d3a8188d64_D20210328-20210626" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTgxLTEyLTEtMS01MzI2_964b34a1-62c1-4f6f-80ca-aad1eb92daa6">2,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i537a20393d1e493cbe6493d3a8188d64_D20210328-20210626" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTgxLTE0LTEtMS01MzMw_b3bd3712-16e4-4de0-bdf4-c0ac43287ed1">188.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTgxLTE4LTEtMS01MzUw_cca94616-0eb7-4174-bb2e-b31e7f5a85dc">188.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of non-controlling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="holx:PurchaseOfNonControllingInterestReclassifiedToAPIC" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTgzLTYtMS0xLTMzNzQ_1a49c3aa-598a-485b-85d5-778ff3741722">8.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTgzLTE2LTEtMS0zMzc2_6dc622d3-03f2-4084-9f73-e29ad8ea7a83">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="holx:TotalPaymentsToNonControllingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTgyLTE4LTEtMS01MzUy_ff932259-6a1f-45bc-9353-600bced5ab5d">8.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 26, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6bae2f1749954b73b3a6ead022748861_I20210626" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTgzLTItMS0xLTUzMDQ_e7ed4d96-00a3-4042-96c6-ef53ada8e7e4">296,945</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bae2f1749954b73b3a6ead022748861_I20210626" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTgzLTQtMS0xLTUzMTU_91f78c69-a5e5-40d3-b341-ee0d3df65b7c">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e17ab66a75e4420b799cd5146ba9ceb_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTgzLTYtMS0xLTUzMTQ_c744f8d9-298d-40c7-bfad-31b9a6c937d2">5,936.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71a06870de924d918ff5abbf56a8d25d_I20210626" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTgzLTgtMS0xLTUzMjA_b7c47077-b412-4685-8826-f759c098d0e2">30.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i875c4235807f46d2acc9a2e5e2e9e7a8_I20210626" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTgzLTEwLTEtMS01MzI0_bf24642a-7e12-4be0-870e-1687d75f8bd8">42.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i999599ea2b584e2d8e6e8e7edce3637b_I20210626" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTgzLTEyLTEtMS01MzI4_bb145879-8a1f-4742-ab24-724ab2787f05">43,653</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i999599ea2b584e2d8e6e8e7edce3637b_I20210626" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTgzLTE0LTEtMS01MzMy_732665eb-e737-47f9-a149-d02cba63ad46">1,989.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTgzLTE2LTEtMS01MzM4_281378ee-7ffd-4009-b023-492fb1516ca6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTgzLTE4LTEtMS01MzU0_353b8d3d-b793-42f1-a189-20175055df73">3,877.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i181d930c7b854595977e17db8fd84eb4_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">HOLOGIC, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Unaudited) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OPERATING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMy0xLTEtMS0w_9b6a7727-8c4d-4df3-991c-6ef060d57a17">1,540.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMy0zLTEtMS0w_1861cdbd-4db1-4278-853a-c662afed091d">616.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNS0xLTEtMS0w_5739fdb9-322b-44c5-ae07-88e7931ff975">64.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNS0zLTEtMS0w_e005c4bb-c776-42e6-97c8-7c1e16382e43">62.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangibles</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNi0xLTEtMS0w_58ae0d8a-8b21-4359-aac6-8ffd4fe1b954">224.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNi0zLTEtMS0w_f8bffb0f-f54f-4ef9-8011-b289fcda5487">218.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfOC0xLTEtMS0w_99dd7f92-494b-4850-938f-789cc5ebd4ca">51.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfOC0zLTEtMS0w_ca560f43-f4b0-4496-a8ad-891cac8807ba">53.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfOS0xLTEtMS0w_ec647ce5-3253-4806-ad63-f513a1ba5e95">44.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfOS0zLTEtMS0w_ae561ff9-0895-461b-9784-9b36b1c13fb9">63.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible asset and equipment impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMTEtMS0xLTEtMA_7f0cc88e-0807-4902-aba7-b29bab46f59b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMTEtMy0xLTEtMA_00b38f96-01b0-4a69-bee1-3a4c2a7767b9">30.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt extinguishment loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMTMtMS0xLTEtMA_4e5035f3-cbb9-463c-8707-81d43d19174b">21.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="5" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMTMtMy0xLTEtMA_cf33cc48-4d9e-43bd-8ecb-3ec465b9b54e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other adjustments and non-cash items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjAtMS0xLTEtMA_0f56269f-19d5-4c4e-98bf-87b70b6a0550">19.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjAtMy0xLTEtMA_7cd609c1-f8fb-478f-b3ad-4acc3e37cbfd">23.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, excluding the effect of acquisitions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjItMS0xLTEtMA_39bee1ee-22e3-42cc-9f28-ad95cd7264be">111.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjItMy0xLTEtMA_d06e6c65-cb66-4c8b-9f94-7c4427db63f0">130.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjMtMS0xLTEtMA_3237f1f3-43bf-4173-a021-20edb7215c1f">82.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjMtMy0xLTEtMA_e994907c-f0c5-4ddf-bc8f-03fdf15c2e19">48.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjQtMS0xLTEtMA_5471a5ae-a7ca-470b-99f2-58919bc5e630">24.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjQtMy0xLTEtMA_c8695318-b6c3-4a3c-bb0b-935e84de2a7a">10.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjUtMS0xLTEtMA_f8cb9945-327e-4e92-99d7-77bbb757d75b">22.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjUtMy0xLTEtMA_dd939c09-f61a-49c8-97fd-58e78e6c3017">290.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjYtMS0xLTEtMA_32aae1ad-1016-4c2b-bddd-2052a5546c68">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjYtMy0xLTEtMA_d6cead3a-47e3-474f-8ea7-546e967c177d">55.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjctMS0xLTEtMA_46ec33be-c4cb-43a5-9d55-93da3679bb6f">27.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjctMy0xLTEtMA_094aedb3-ddf6-47c4-9dc0-14a56e28ae35">40.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjgtMS0xLTEtMA_a5b54173-19e4-454a-8023-308fe1aaa413">22.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjgtMy0xLTEtMA_0df12021-7776-4781-afc8-8f9d77797181">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjktMS0xLTEtMA_562deff8-176e-429e-8349-2c6a37feac9e">1,865.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjktMy0xLTEtMA_4a6214f0-898b-4697-9049-f60838139131">454.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition of businesses, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMzEtMS0xLTEtMA_7ecae9ab-32a0-4628-adb1-686b2a2b3e6a">1,163.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMzEtMy0xLTEtMA_a518e8ed-d6fb-4756-a116-ab1a86fd6dc9">43.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net proceeds from sale of business</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" format="ixt:zerodash" name="holx:ProceedsFromSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMzMtMS0xLTEtMA_3ba67aeb-8cc7-4f4c-91bb-d508fd8077c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="holx:ProceedsFromSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMzMtMy0xLTEtMA_a8bb46a9-b823-4add-b106-fad83f16fbd7">142.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMzQtMS0xLTEtMA_5f102bc4-cd90-4ca9-ab5e-63ec967d4a89">71.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMzQtMy0xLTEtMA_a1484124-d48b-4b4c-b2ec-a21053963ea9">53.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Increase in equipment under customer usage agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMzYtMS0xLTEtMA_d3e97054-a361-4a7b-84a4-a82e3d3af29a">43.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMzYtMy0xLTEtMA_813dc368-c6f3-42db-ae42-f0d35b810160">44.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of intellectual property</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="holx:PurchaseOfIntellectualProperty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNDQtMS0xLTEtMA_f4b30046-ff42-4827-9753-4aca37393e60">6.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" format="ixt:zerodash" name="holx:PurchaseOfIntellectualProperty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNDQtMy0xLTEtMA_be04cf95-1eb3-4076-8b72-df3b71f5b5a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other activity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNDYtMS0xLTEtMA_25cb6143-b736-4dbd-8833-270615a3fdf5">2.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNDYtMy0xLTEtMA_e3df5dee-79a5-45b0-9d6f-b30b83e6c076">5.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNDctMS0xLTEtMA_30a5e237-6b5c-46cd-abbe-4383ca9aa370">1,286.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNDctMy0xLTEtMA_f37cdfe2-e458-4e93-83af-a408bec00e7e">3.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayment of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTAtMS0xLTEtMA_9ce1874b-d22a-4e2e-9565-c8431f5f16e1">56.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTAtMy0xLTEtMA_c3509f72-4121-4bb9-b7c5-01eb0f9166b3">36.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="5" name="holx:ProceedsFromSeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTEtMS0xLTEtMA_2572245b-49fe-4dad-b382-bf07878be1cd">950.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="5" format="ixt:zerodash" name="holx:ProceedsFromSeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTEtMy0xLTEtMA_7c38e6e3-3014-4e13-9ef6-585462517a4a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayment of senior notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="5" name="holx:RepaymentOfSeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTItMS0xLTEtMA_6908338f-e246-45e5-80d1-4ba191e9c3b1">970.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="5" format="ixt:zerodash" name="holx:RepaymentOfSeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTItMy0xLTEtMA_d5c00464-71d0-4c31-ba11-3083ecf15bdd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from revolving credit line</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:ProceedsFromLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTQtMS0xLTEtMA_846e349c-3e35-4589-8281-d302f52f599a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:ProceedsFromLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTQtMy0xLTEtMA_c6f12928-8355-46f4-b067-9b558a5e2778">750.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayment under revolving credit line</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTUtMS0xLTEtMA_69aaab0b-ead0-48ae-826f-899edcabef38">250.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTUtMy0xLTEtMA_9a1599c0-8243-461b-86c2-4b6a31644818">250.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from accounts receivable securitization agreement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:ProceedsFromAccountsReceivableSecuritization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTYtMS0xLTEtMA_020c9c68-a867-4fc8-a988-40650f2fb0af">320.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:ProceedsFromAccountsReceivableSecuritization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTYtMy0xLTEtMA_e53f2203-09e1-47c0-b5f7-e205a82204ba">16.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayment under accounts receivable securitization agreement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:RepaymentsOfAccountsReceivableSecuritization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTctMS0xLTEtMA_1060b722-ceb6-4a43-b74c-fc0ba820693e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:RepaymentsOfAccountsReceivableSecuritization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTctMy0xLTEtMA_85efedc6-bab7-494c-b0f4-f3934bb3fad9">250.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of non-controlling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTgtMS0xLTEtMA_dada700d-1575-46eb-a666-123b5d1d8e0e">8.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTgtMy0xLTEtMA_42b0865f-6016-4d6f-b8ca-ee23be595342">1.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payment of deferred acquisition consideration</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTktMS0xLTEtMA_253632cb-ef0b-48e4-a5e8-d69154e17780">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTktMy0xLTEtMA_e00a31de-f22c-48cc-9366-20443c832451">24.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payment of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNjEtMS0xLTEtMA_e457878d-a559-43bc-84f2-09c79fc05b06">13.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNjEtMy0xLTEtMA_b7aa5592-e8ed-4a97-8f52-0b4da40baea7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNjMtMS0xLTEtMA_49883ebd-ea6b-45be-a4c8-2341f9261265">409.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNjMtMy0xLTEtMA_325d7d23-6ba9-47ba-ae16-27fc4c116ac1">553.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock pursuant to employee stock plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNjUtMS0xLTEtMA_2c5316d9-40e1-4c51-be31-e2b438de72b6">39.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNjUtMy0xLTEtMA_78eba778-5fb0-4736-87bd-269f489ff370">54.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payment of minimum tax withholdings on net share settlements of equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNjYtMS0xLTEtMA_0c5d4fff-9a6c-4010-bbea-495544d293eb">46.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNjYtMy0xLTEtMA_d4ed78f1-d19a-460c-97d0-c0cf2deb9b3b">12.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments under finance lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:RepaymentsOfLongTermCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNjctMS0xLTEtMA_d83876ce-9f96-4456-915b-b67194a381b0">1.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:RepaymentsOfLongTermCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNjctMy0xLTEtMA_1904f55e-d5f7-40d3-a123-d58d3eacb0ef">1.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNjgtMS0xLTEtMA_bea1b884-640a-4bf0-bc1b-aaca1c7fb1e7">447.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNjgtMy0xLTEtMA_9ddfaaa7-2ec8-451d-89fa-f82582479592">309.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNjktMS0xLTEtMA_0e25d147-12af-47c4-a5c0-92c0477ee9d5">4.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNjktMy0xLTEtMA_987b9ef5-5523-47fd-af28-160dff9e5d88">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNzAtMS0xLTEtMA_b2ed1147-60c3-47ca-9662-eafc1ed2904a">126.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNzAtMy0xLTEtMA_3de96b3f-7a3c-4d5b-b3ad-eae0abb4d01b">142.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNzEtMS0xLTEtMA_b89d31bd-b627-4353-b179-f19147bfcda4">701.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1bbf9311cb649308affbf16f61bb3ff_I20190928" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNzEtMy0xLTEtMA_613e19f1-f3b8-4c77-bb77-eff44a98005d">601.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents, end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNzItMS0xLTEtMA_ec14872f-db16-49f1-9285-fed5fadc92f8">827.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81ab5863e2124accb342d2df86a1ee96_I20200627" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNzItMy0xLTEtMA_e783db22-588e-4089-acf8-69b6869ae14b">744.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="i181d930c7b854595977e17db8fd84eb4_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HOLOGIC, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(all tabular amounts in millions, except number of shares, which are reflected in thousands, and per share data)</span></div><div id="i181d930c7b854595977e17db8fd84eb4_34"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(1) <ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNC9mcmFnOmZmZjg4ZDIzNTBiNzQ1NDg5NDNhNDUwY2EwOTYzMGM0L3RleHRyZWdpb246ZmZmODhkMjM1MGI3NDU0ODk0M2E0NTBjYTA5NjMwYzRfNDU2OQ_6320dd15-948a-4998-a377-214a34b6fc0a" continuedAt="i9c1860e3823d4d08851615679989e7c7" escape="true">Basis of Presentation</ix:nonNumeric></span></div><ix:continuation id="i9c1860e3823d4d08851615679989e7c7" continuedAt="i06aa32b8fcac4ed69649aa0e1ec868eb"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements of Hologic, Inc. (&#8220;Hologic&#8221; or the &#8220;Company&#8221;) presented herein have been prepared pursuant to the rules of the Securities and Exchange Commission (the &#8220;SEC&#8221;) for quarterly reports on Form 10-Q and do not include all of the information and disclosures required by U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) for annual financial statements. These financial statements should be read in conjunction with the consolidated financial statements and related notes for the fiscal year ended September&#160;26, 2020 included in the Company&#8217;s Form&#160;10-K filed with the SEC on November&#160;17, 2020. In the opinion of management, the financial statements and notes contain all adjustments (consisting of normal recurring accruals and all other necessary adjustments) considered necessary for a fair presentation of the Company&#8217;s financial position, results of operations and cash flows for the periods presented.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from management&#8217;s estimates if past experience or other assumptions do not turn out to be substantially accurate. Operating results for the three and nine months ended June&#160;26, 2021 are not necessarily indicative of the results to be expected for any other interim period or the entire fiscal year ending September&#160;25, 2021. </span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments &#8211; Credit Losses (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The purpose of ASU 2016-13 is to replace the current incurred loss impairment methodology for financial assets measured at amortized cost with a methodology that reflects expected credit losses over the lifetime of the financial asset. As a result, credit losses are recorded when financial assets are established if credit losses are expected over the asset's contractual life. The measurement of expected credit losses is based upon historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The Company adopted the standard during the first quarter of fiscal 2021. The adoption of ASU 2016-13 did not have a material effect on the Company's consolidated financial statements. See Note 8 for additional information.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, the FASB issued ASU No. 2019-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Stock Compensation (Topic 718) and Revenue from Contracts with Customers (Topic 606)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This ASU identifies, evaluates, and improves areas of GAAP for which cost and complexity can be reduced while maintaining or improving the usefulness of the information provided. The amendments in this Update expanded the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. The Company adopted this ASU in the first quarter of fiscal 2021, which did not have a material effect on the Company's financial statements.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events Consideration</span></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i06aa32b8fcac4ed69649aa0e1ec868eb">The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence for certain estimates or to identify matters that may require additional disclosure. Subsequent events have been evaluated as required. There were no material recognized or unrecognized subsequent events affecting the unaudited consolidated financial statements as of and for the three and nine months ended June&#160;26, 2021.</ix:continuation> </span></div><div style="margin-bottom:18pt;margin-top:6pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="i181d930c7b854595977e17db8fd84eb4_37"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(2) Revenue</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for revenue pursuant to ASC Update No. 2014-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 606) and generates revenue from the sale of its products, primarily medical imaging systems and related components and software, diagnostic tests and assays and surgical disposable products, and related services, which are primarily support and maintenance services on its medical imaging systems, and to a lesser extent installation training and repairs. Prior to the Cynosure divestiture, the Company also generated revenue from the sale and service of medical aesthetic treatment systems. The Company's products are sold primarily through a direct sales force, and within international markets, there is more reliance on distributors and resellers. Revenue is recorded net of sales tax. <ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RleHRyZWdpb246M2M2NDJkZDhmZjJhNDczOWJkMzNkYTQwMzU5ODMxNDVfODA1Nw_8ad255d5-dfed-48b1-9691-de06061f2cd5" continuedAt="i12c30c395fd04e8cb6803fb5113e959e" escape="true">The following tables provide revenue from contracts with customers by business and geographic region on a disaggregated basis:&#160;&#160;&#160;&#160;</ix:nonNumeric></span></div><ix:continuation id="i12c30c395fd04e8cb6803fb5113e959e" continuedAt="i4c7d2793bc1f486580b43f1e24a3ebe2"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"></td><td style="width:3.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.226%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.230%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 26, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 27, 2020</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytology &amp; Perinatal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e77ae6b121e4933b196860cc147365e_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMy0yLTEtMS0w_a2c48536-8c3a-4f50-a394-dd0ad460ace1">73.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a4ec39647f042768fb079e46c124d64_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMy0zLTEtMS0w_5850130f-a403-473c-8591-cd1f4e4259fc">42.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe2790b0becc4992ab4a86ed0f47b8b0_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMy00LTEtMS0w_7c729952-acee-4b44-8335-6901ae924b05">115.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b4d9d4a1d51468d9eb84de80c70c52f_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMy02LTEtMS0w_5c0251ed-17be-4791-ae22-63b103e63faa">40.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if395d4107ff1436d8ecfbc976a4eccac_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMy03LTEtMS0w_4809e500-fdb7-4414-975a-8c1ea72fc009">23.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89acd5d341534bbfacfac9fb7fd346a3_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMy04LTEtMS0w_0ba17a42-875b-4680-a9e0-1dd15f3e462b">64.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6e8ba7ac1ad4788936366e6a2a40bcf_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNC0yLTEtMS0w_48f81116-281b-4782-99fd-d371550c93a7">270.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14b4ef7fc8f6486f8099a60d145ae4e9_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNC0zLTEtMS0w_a2f54c6f-da88-4e5a-9a19-519a219bf91e">266.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac5bd9bb07344043bdbb2c9c3b03b313_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNC00LTEtMS0w_25bb6406-b04c-4c10-964d-5d763c28e0d0">536.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if23b3ae36b644acc87ec67b72cd7b730_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNC02LTEtMS0w_c6e62d56-ce51-4a9f-b0e2-1445dac093e0">391.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i531234c15a6c43f8ba2e74a3bc5979be_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNC03LTEtMS0w_50877d4a-469f-4521-8c15-698b422a7fd7">69.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i441afbe7ea704a97a13d7f01cda317fe_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNC04LTEtMS0w_226f9c3a-a59e-4dac-8af1-3249eb4853b7">460.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Screening</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cd4c64d0a9b44e7b731b80d7ff2cff9_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNS0yLTEtMS0w_0ee94c7f-2bf6-4335-818f-28eaceabecc7">13.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0450e1103e8241cc93052d9df1a6f6bf_D20210328-20210626" decimals="-6" format="ixt:zerodash" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNS0zLTEtMS0w_a8ed2f75-a8c6-45c0-8cf1-351de347c049">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf7456bf9a8f47acacea66bd647d61be_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNS00LTEtMS0w_ad77e71a-9616-42fd-81db-42090f0ea323">13.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14fe0f286fe8418d8408a5ef9a8ded4b_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNS02LTEtMS0w_60d8770e-b20e-45e1-8a35-46443d6c7b5d">7.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ce0088f110146f9abc2c378a66d90fd_D20200329-20200627" decimals="-5" format="ixt:zerodash" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNS03LTEtMS0w_5c2d703d-f89f-475c-b59d-d0917798e1a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0db9249ce324df6b69e1002079a0170_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNS04LTEtMS0w_e2d1a2a1-50f9-4ada-b959-36e1a9ea7761">7.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief5d5ac299f444e7a11589340f1d8811_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNi0yLTEtMS0w_471b3962-fc5f-4b00-ae50-d605dc994849">357.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b8441cccd184c4486e57f87f71f3656_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNi0zLTEtMS0w_c725214d-c393-4c39-9c68-e0267037fa25">308.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i286bca0d89644bd0b3205f4b93ed5c1d_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNi00LTEtMS0w_0a896b00-266b-4cfa-841b-a0db41046438">665.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ee2782511e24cde8d011a55e9af48b7_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNi02LTEtMS0w_6086127a-1e75-45c5-9c95-3514ce2aa612">439.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i410f2d6c20c4496eb68a1ac00b260536_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNi03LTEtMS0w_e4229594-5905-44f2-b05c-14775fedb2cb">93.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79c862e1f99d4e7bb053e7bea309372c_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNi04LTEtMS0w_9dc2c0a5-dc34-4cd2-9bed-f5404c831195">532.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Imaging</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75e45ed7d25546e591e76bfdf91c98d0_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfOS0yLTEtMS0w_d15f88e5-1579-42e9-922f-ffb72b584994">218.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ed178edd5ad495c90c1b54255909fa8_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfOS0zLTEtMS0w_5509f631-ee70-4695-9916-451bbc0f07c8">61.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if47061debb804420a5e14a803176e8ce_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfOS00LTEtMS0w_1a00e149-3fb6-4d95-813c-a842ab5f9b63">280.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia942e9f26e244360b3ce4f6c390b9d93_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfOS02LTEtMS0w_fb8cee79-dc94-4005-b821-860cb9c7d990">145.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f248925f2ee4c69b3f784a04ba9a364_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfOS03LTEtMS0w_c74bf305-c436-44c5-b241-ea0afa18d5d5">47.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcf29874b0924e36855919d6b73c66f7_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfOS04LTEtMS0w_ed03630a-14b7-4c97-b553-711081b4a840">193.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Breast Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic22fe1d383e84feaadba1dc8f408d3dc_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTAtMi0xLTEtMA_5baa43ed-36e8-4d9e-9615-ee22f320ce91">54.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9c3b5b875444c0689eae7d05cf36d7e_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTAtMy0xLTEtMA_28b862e7-171b-405c-a872-60cb0cfcd721">13.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bf0a79818e54f1fbf147be4c1ef864d_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTAtNC0xLTEtMA_a97ca196-f5e2-45db-bd52-088b8c5ecf0a">68.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3ce04ac38db44279190e17fe5e2384a_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTAtNi0xLTEtMA_0d6ab3f5-ba9c-4611-ab98-0eb931a80f19">25.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60f75ab143d84b689500c2e5bfebcf87_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTAtNy0xLTEtMA_3d175ef8-45d6-436b-a535-63a0be1aa15e">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5393210c850e49b78aace5bb63c4e69c_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTAtOC0xLTEtMA_32112115-52ce-4fda-9e9a-4c97d7612dc9">30.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b239d22f00e4502a2fe462334f74606_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTItMi0xLTEtMA_b04ab474-c798-4f02-9f58-94f9bf68c2e2">273.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i942bad789f284e31a5f43dcf1fedf43d_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTItMy0xLTEtMA_1bd6c41e-5a19-4482-b953-db7d3fc7b647">75.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id09b1799f368487b906ce59a96d2e408_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTItNC0xLTEtMA_b7d15e56-6d7c-423c-800b-d9e01422c512">349.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfcab7983d0848b082ee034a8af8e64b_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTItNi0xLTEtMA_d3512c6a-428d-4d12-b508-ce58fb8a2330">170.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa28816934d4448282f6c7faf7a4d548_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTItNy0xLTEtMA_ffcd6976-673c-4f1b-9140-d1ee9e0ea9e0">53.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9773235748348dd8da0c1995d6ed993_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTItOC0xLTEtMA_71591dc0-f605-4e84-8170-7e867db230c0">224.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57d8e5448f0d4ad48c2c716944cec78f_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTQtMi0xLTEtMA_5f88439d-b168-4e78-8b8a-746fb9709d2b">103.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id31306d0e2234478a749fe0b4889a65a_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTQtMy0xLTEtMA_a7f3e01f-2dae-4d94-aca9-3d5f58e8ca7a">24.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc1b7e15e774991a987400605125d1c_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTQtNC0xLTEtMA_e8f344ba-5c20-41a2-9f81-a2310c7f7511">127.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i987b8ad71b084e15ae9ba9e8338b3bd0_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTQtNi0xLTEtMA_00753fc4-9087-437b-802d-da1719d125f4">42.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85493aa01af94bd8b1f7328b463dd8e5_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTQtNy0xLTEtMA_fe29701b-3479-4e07-a81b-2c32ff5a3d5f">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia27da4de68874f0fb714ee7967b38fd7_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTQtOC0xLTEtMA_8f8e7b70-4a3f-4d00-b22d-5dd914e0324e">51.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf75ce65865145c3aa67cc9f1814b5d6_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTgtMi0xLTEtMA_2205aab7-e024-4436-a68b-b75b92fcb4b2">15.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d4eb19ed154f9f9df012f7ce7ee57a_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTgtMy0xLTEtMA_de06b7f8-83ca-42d5-8dea-9b561029fc6c">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd7f591f4d6846419f3ba29d469f7d3f_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTgtNC0xLTEtMA_17df26f8-ea69-4ff5-80cc-66bf694d7951">25.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcbb80af093740f9a361c5448ab37e4c_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTgtNi0xLTEtMA_d9f50185-ed68-492b-9efe-096b60491009">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icabdcbbe69c545579aa33835b5f3d4eb_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTgtNy0xLTEtMA_a198f6f6-967c-4674-9ef3-b932b553f839">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16a0b171d8b2414ebdc3554e167249d2_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTgtOC0xLTEtMA_794a8f58-da36-48ae-b830-7314d4d714c5">15.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cc68c7458734cd2a8a7c981e8515c76_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTktMi0xLTEtMA_875c5629-911e-4ae7-83fe-ac7e4d936e5d">749.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8818dd7702142cf95a9d19c729ddf8a_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTktMy0xLTEtMA_ae1e4615-18a8-4d59-bfbd-69a58ee06dc8">418.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTktNC0xLTEtMA_5762fa3b-c80e-4681-8108-73ef237c70ca">1,168.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88586a6659324a6e94cec1cb09cf2a46_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTktNi0xLTEtMA_5e0b78b5-69b2-44e8-bec2-d4d2b7c047b2">660.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9991425506644c169e0b162c4eec7947_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTktNy0xLTEtMA_c7d83dc6-11a7-4c66-b44f-384c6f8fd452">162.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTktOC0xLTEtMA_d68912bb-907a-448c-ba37-5eba33468fb2">822.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.869%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended June 26, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended June 27, 2020</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytology &amp; Perinatal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace9270559714986aaabca0d4ebdff24_D20200927-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMy0yLTEtMS0w_abf1c56f-4919-4981-b993-61ba26e074d9">230.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieeb7d864535e4e7f9bce653f4b168b96_D20200927-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMy0zLTEtMS0w_cbd0ea0e-ad2c-4762-a9ec-39f4426c544a">127.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8be39ed1f1aa46c3894324d319834486_D20200927-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMy00LTEtMS0w_98ca27a1-424f-4fb1-b575-95216dba20da">357.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4c0e43445d04743bcb9261bbcc78b53_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMy02LTEtMS0w_db18111d-5a5f-4a71-88b0-b67df855d4c2">191.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f0c0208131f49b39c73659c82a02222_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMy03LTEtMS0w_26c7a52f-d215-4c66-954a-6ddc01a52d7b">107.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea063f8d161b4a0b85a574fa46b7f7b4_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMy04LTEtMS0w_9f6487af-5d07-4783-a4f8-fce6ee626221">298.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1feb000741a14589b76e0f21beb6c5c0_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNC0yLTEtMS0w_f941b559-9db0-4094-987a-df3bff945add">1,561.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id62f94911ce54ef68438afc76c05b4b2_D20200927-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNC0zLTEtMS0w_f77550b5-e778-4ec0-bcc5-99acb8e9b5d6">905.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99435d39a02440deadad10c369f19565_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNC00LTEtMS0w_9ad0517f-a151-4364-8cdc-12ec8ff7bbee">2,467.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87eaf0bf3c6d48658f4c2c3e78a71ac2_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNC02LTEtMS0w_3a51ef39-11d2-45ba-9b6f-5a4be6e121e0">683.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7491e43b952d4c61b87c261b016b3e1b_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNC03LTEtMS0w_985231d7-24a8-4cad-9810-6bb94389f984">146.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d6ad39df725417db4cda9327284076d_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNC04LTEtMS0w_49368b42-7530-4783-8444-4100b6d5c15b">829.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Screening</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i075e000f08f64e8883de52eb2ec429b6_D20200927-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNS0yLTEtMS0w_8604ee62-1f31-4240-9471-25d92a46497d">33.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie416f1bb45be4de39749bd46c36fe698_D20200927-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNS0zLTEtMS0w_34a02216-d21c-4e10-a8a6-85bb5862b556">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i869637ca6659448691978af8788531f9_D20200927-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNS00LTEtMS0w_56e91df6-6053-4c8c-9dfe-2fc4f8b79af5">33.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i163df94df0de411eb1ec6ff91ad044d1_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNS02LTEtMS0w_3aac70fd-f973-4d99-b913-a5757b688ccb">35.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1aa19225dcc7437aad83c6bad124ebec_D20190929-20200627" decimals="-5" format="ixt:zerodash" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNS03LTEtMS0w_de871912-5458-4aca-97a3-613315c335be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e4faefdffaf4617a9f21a886228d428_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNS04LTEtMS0w_2ed1d855-c646-4c54-906c-c02da488b3bd">35.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9ba7888ec484e89a44484a6c3048d8f_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNi0yLTEtMS0w_9da9b5ca-fd03-46c1-ae40-44491b8dd117">1,825.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a7e9769dab647d2ba4a287635864018_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNi0zLTEtMS0w_7deac6cf-d473-4d12-af76-2fa0eab6d85e">1,032.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27eae9a50641400fb1c2541bd52dad61_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNi00LTEtMS0w_b4b579ba-5fca-4a07-ba08-5c93ce15682a">2,858.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff62125937204878a658f0c5628606fa_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNi02LTEtMS0w_fd9a634d-8aa9-49ab-a61a-4f094101650f">909.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie82bb12476164052a5d97847ecbff323_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNi03LTEtMS0w_9131e926-a2e8-4ed4-a9b6-827a484c424e">254.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibac682b2841e4347b6671d6949367197_D20190929-20200627" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNi04LTEtMS0w_c82014f2-f285-4257-bf9c-24fbb5ae85e8">1,163.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Imaging</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa51fa0830194b718e4598c66cc20822_D20200927-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfOS0yLTEtMS0w_5f8fd101-ef3a-4ea2-b2c4-6e98c3b36976">619.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa1c66f7d6d4ab9b6669c1d61bd937a_D20200927-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfOS0zLTEtMS0w_10108484-8faf-43ac-b9fb-b7e9da26c63d">198.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46fb7e93d58d4db1824c75dcbca92ff7_D20200927-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfOS00LTEtMS0w_349fdf40-650d-497a-ba0c-8da2c048eb4c">817.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7a0cc313a77477ba010d815081c9a07_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfOS02LTEtMS0w_7c3613da-8539-4cea-9e57-f0a5c3482752">541.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie85bcce039094bae9db0bf4313fb7e60_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfOS03LTEtMS0w_44ab6c8c-d181-42c6-9052-99557541e21c">177.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7711c49f92c04e2b9466ed524ee8bc2e_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfOS04LTEtMS0w_95439d69-2229-47f7-a4f9-ccf4a9103f4e">718.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Breast Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96887e76d944d08b5519f53cef01904_D20200927-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTAtMi0xLTEtMA_215693e7-c40d-4503-abd8-2fc37817dbd6">164.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eca047fb0c84048ab9cb90facfbf706_D20200927-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTAtMy0xLTEtMA_2087a179-c42f-4201-b38e-4a8aa0b8292c">35.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3df779d8bf47483e9f292cc7612b6774_D20200927-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTAtNC0xLTEtMA_110527a9-e73f-46f4-ace3-25e2cb2336bb">200.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee9eab84d6ad4c45a2dd7d811f7fb06e_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTAtNi0xLTEtMA_da6d6849-43fa-47b8-8118-1febd3923b62">120.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebeafdaf8b04495394d947c38fcd54be_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTAtNy0xLTEtMA_e97833e1-e77d-45a1-907c-087112a11a17">24.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad6089c03fe04694a4932756918fb99d_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTAtOC0xLTEtMA_2486a2bf-9904-4e5a-a38a-43257c2bce28">144.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6fbe86d934c4d18a2a5e07b6312d943_D20200927-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTItMi0xLTEtMA_f7619571-2e78-4b8d-b750-91d09a1633fc">784.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd2db6ee06b94cddafde9fe932029265_D20200927-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTItMy0xLTEtMA_4bcefd0e-d27e-40a6-9225-fcfcdc579171">233.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic99b704f095f4cd69b8a4ae90368d2d7_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTItNC0xLTEtMA_b5586500-cc62-4a64-9a69-d28d0bd996bb">1,018.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94cf4a747ee64dfd93739c74eb4cd66d_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTItNi0xLTEtMA_1dee606c-fdaa-4bda-9dbb-2d1a1f0ca6fa">661.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0fc4831c77847b3a201ce54a4e2db2f_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTItNy0xLTEtMA_a4d907af-940a-4403-9fb0-f26ad69cc743">201.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbfaf422f9724422b8b06418613c842d_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTItOC0xLTEtMA_be54ea39-0046-4617-b2ef-374848d78dfe">862.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i561c02d7c245409293cfa0a1562f677a_D20200927-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTQtMi0xLTEtMA_df9ff96e-000d-41d1-9a8b-380db78bc6ea">296.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id50cd5f65a25492abef4ce8286035326_D20200927-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTQtMy0xLTEtMA_194a4b1f-9d03-46bf-8987-458e3f20c54e">69.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5293327445f541ed891801a24fba467c_D20200927-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTQtNC0xLTEtMA_f33be3db-322f-44b2-b9d2-868706af8a61">366.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bdefe68c3ea42e58988c6e8a69fd673_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTQtNi0xLTEtMA_5be488e3-8135-4cbe-b0e9-9c102840bda7">227.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25dced02445e4b87a13031b8d51a8173_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTQtNy0xLTEtMA_61494ab3-caed-45c1-8287-a0639ee08f99">48.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d4e9da2a2c14f13984e3286a479cede_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTQtOC0xLTEtMA_2888f419-e040-49a6-836c-71a524f5164c">275.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i391a26685f56401ea4adc59b7d80011f_D20200927-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTYtMi0xLTEtMA_74acd5ae-4651-44a0-804f-2bb2baf67d5e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52c4985d417b4421a13ef783c7e19a9f_D20200927-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTYtMy0xLTEtMA_b63260d4-db59-4cc4-a7a0-57520f7433de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa3d63fea23c46bcb179fec3fd524a11_D20200927-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTYtNC0xLTEtMA_422e1860-952d-42a6-959a-9071107c7900">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03551c738e78426f82dbe57a0c1bf66e_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTYtNi0xLTEtMA_2c5a3240-4cad-4c17-b4cb-dde109951844">30.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2a56d2bb725478f82e31f1329449f9a_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTYtNy0xLTEtMA_99dfa7b2-fbc7-4c3f-ae88-148c535961b8">34.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bafd189711f4ec19e64d26761bc3318_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTYtOC0xLTEtMA_3eb3790d-bff3-4ab6-bbf4-fe168c4f18ef">65.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0c8406167274863803b6b1fb7cf1d04_D20200927-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTgtMi0xLTEtMA_cabac798-0901-4302-b1ec-5f3ea51bbcdc">44.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86db2b9cd67f4199811130ee684b41e2_D20200927-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTgtMy0xLTEtMA_5164dba0-684e-41b8-9849-9ac45d474965">28.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85f7ecac32784df6a536dad78a0e43e9_D20200927-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTgtNC0xLTEtMA_f80778fa-ba23-4dfc-abd8-a75bd3cfbab1">73.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf42837162e3410ea1fc194837543b32_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTgtNi0xLTEtMA_9c7458ea-5133-477a-a91d-9b3d5abb37e8">39.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1af39200976349b393f0094f2c751da6_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTgtNy0xLTEtMA_b4f0948e-8d57-4d40-87e0-bdda7cf22a76">22.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ed43d6f3b9e467c9e24d43594b26b14_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTgtOC0xLTEtMA_2f70c751-8772-4e02-bfe9-236d2138ee39">62.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i386d807f9c604702afb89ac48d4f3997_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTktMi0xLTEtMA_fc3f6bf1-3017-4fe5-87be-67e8d63cb170">2,951.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i476b388d782a4d1188664e75bb1926f9_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTktMy0xLTEtMA_64129c3c-9bf4-48ee-9118-4e8c4a95b641">1,364.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTktNC0xLTEtMA_d36baca5-3d84-40a9-aeb9-c62399ea7dd9">4,315.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2107dfda459c464ba7795fbb3263a45f_D20190929-20200627" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTktNi0xLTEtMA_739bbc52-3f6a-4fc4-b55d-583b3d1d663a">1,868.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3db408b0437e4aee94b6507a2f00f132_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTktNy0xLTEtMA_42392dd8-fbd6-4603-b6b8-91db196fce83">561.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTktOC0xLTEtMA_6de2f5a4-ba79-42f7-8437-d4dfb4771c63">2,429.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><ix:continuation id="i4c7d2793bc1f486580b43f1e24a3ebe2"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"><tr><td style="width:1.0%"></td><td style="width:30.358%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:15.769%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.863%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.769%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.772%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Geographic Regions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 27, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 27, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5cc68c7458734cd2a8a7c981e8515c76_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfMi0yLTEtMS0w_7ae7a8a5-0c7c-49f4-94a3-d6d5c92efba8">749.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88586a6659324a6e94cec1cb09cf2a46_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfMi0zLTEtMS0w_75ef292c-99d7-4ce5-b124-de4d0e677450">660.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i386d807f9c604702afb89ac48d4f3997_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfMi01LTEtMS0w_1b80ca1f-e5d5-46a9-b37b-76ae40a4e50f">2,951.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2107dfda459c464ba7795fbb3263a45f_D20190929-20200627" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfMi02LTEtMS0w_d002950e-14fd-43b8-9cb5-30984cba4b9a">1,868.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82e0f458672c41aabd0a7ccc0ecba719_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfMy0yLTEtMS0w_4027cf4c-4829-4928-8441-a22350f6b210">289.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63bf14aa150b470d8cda291a8e3dd66f_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfMy0zLTEtMS0w_7bc9dd80-d377-4f2b-8c4f-fe8de99d301d">101.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if97a9823a91c48f6879659548ae4a3e1_D20200927-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfMy01LTEtMS0w_ce720e0c-b4e2-4588-8f46-1c483a96b6b5">963.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9aa28665b0b14585a3f36c725cdb23a2_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfMy02LTEtMS0w_870f0c24-f292-4f9a-9900-f3aed54c3c1f">322.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idadd999b632a42d7b0d65121528aa81a_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfNC0yLTEtMS0w_48ed8e37-f3e7-4bc5-b7c1-2c968f1e9771">89.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i877644a05fce44e28b7a923b72578d44_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfNC0zLTEtMS0w_7c909443-8deb-403f-a344-3875357008bf">43.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9abeb75d8db4dec84473529c4e293f5_D20200927-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfNC01LTEtMS0w_21facb2d-63f6-4e51-a56f-a2a209c00edd">268.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i070ab836e0a141d2815638fcced72af6_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfNC02LTEtMS0w_a9ce2570-8a42-49af-a0b6-99e338f43c16">155.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba84d4a948cd406cad1198d4bdc90dcb_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfNS0yLTEtMS0w_ad28ad22-ceb5-4c83-a07f-f803b1e2d20d">39.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic351acb54a3849d8aedcfca04d87ab1d_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfNS0zLTEtMS0w_36659d6f-956a-40b3-b758-42a452255c4e">16.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7d1d8a90959436b8aca4870757f76ba_D20200927-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfNS01LTEtMS0w_d1f8bd02-6e6d-44e6-a8c2-74db0a560fe7">132.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98e039107e7742dc92ff616d5e0b45fa_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfNS02LTEtMS0w_0f5d8ff3-73b4-4cfb-87a3-d31140e2593a">82.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfNi0yLTEtMS0w_fb89469b-58e4-4d74-9b32-a309a65b22e0">1,168.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfNi0zLTEtMS0w_584bca47-51a3-4bb7-a053-16f6b6c71b28">822.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfNi01LTEtMS0w_74b6804e-6609-4b2f-ac3b-226d4a7fdae5">4,315.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfNi02LTEtMS0w_5eef2c15-87ee-4566-91bb-679978a2fb58">2,429.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides revenue recognized by source:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.543%"><tr><td style="width:1.0%"></td><td style="width:31.601%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:16.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.961%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.065%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.333%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue by type </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 27, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 27, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposables</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfb85da295454d3fa7ac34d45ba8399a_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfMi0yLTEtMS0w_3a15aba3-a3ac-45f5-b61f-4b4a341761a3">797.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i997d2963735445798702be9238bd61d3_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfMi0zLTEtMS0w_cdc2d482-9b97-4c20-98a2-0c23d33cb249">588.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fc238f172a84daa9f0b0b392fc8265b_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfMi01LTEtMS0w_ae7f44c4-66ff-48b1-8c94-ae208007610a">3,239.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i969332a55fc94c40b1890a3c159072e5_D20190929-20200627" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfMi02LTEtMS0w_8373f0f5-2308-4955-9c12-e228ee644770">1,511.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital equipment, components and software</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea9eeace8bc48a6853ad4eb8c570984_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfMy0yLTEtMS0w_e13df379-bc2f-4c7e-a0ae-abf688b2d559">197.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if064abfbec784952a50564f775aa48b4_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfMy0zLTEtMS0w_6e70514e-9d6a-4f3d-aa63-ac2eaf05dc74">113.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i066e06a75605450685297c3e282a6b6f_D20200927-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfMy01LTEtMS0w_0d8cb356-f77c-4f1a-ac79-a3954908bf27">590.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i93a5b58ca8ab490bb807f3f47ed0695a_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfMy02LTEtMS0w_f6414cd9-f13c-491b-bef5-0e720d02be4a">513.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5fbe2f2ff664952a86162b814c29dc5_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfNC0yLTEtMS0w_76120852-9a3a-4fa4-bfa3-4791f320b25f">158.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39c233f5360f46839440a89ec92db102_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfNC0zLTEtMS0w_1eb13208-d0e6-43f4-bedd-850e3f14bc98">116.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7caffadd2bf4a08a5a93de29b5b1702_D20200927-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfNC01LTEtMS0w_d1bebb99-8e1b-4965-af16-65b0c7f9e46f">437.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4271982162541bca84afd4b29071784_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfNC02LTEtMS0w_4440be1a-1c8a-4bfe-86bf-7adacf848177">388.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i125ef810b16745dbb51cab70e0c74868_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfNS0yLTEtMS0w_94a1fbb6-f750-400c-9f6e-5a089c83b014">14.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b102cbde6ac4145a026f275552c9233_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfNS0zLTEtMS0w_258117ea-7832-4d04-b8dc-828366fc7bf9">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i615b149ad3534e4ba9e847115a8c8104_D20200927-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfNS01LTEtMS0w_05c3a6d6-8fa5-4e6a-938d-c56300ed44c0">49.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia599da9d0cec404bb29f0dc029068fb1_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfNS02LTEtMS0w_003cd07d-d167-44ca-b9dd-09661147a917">16.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfNi0yLTEtMS0w_df9b8024-f04c-4161-9969-6eb1fb558da4">1,168.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfNi0zLTEtMS0w_5bb9435d-ed3f-42fd-8411-04489eb2ad97">822.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfNi01LTEtMS0w_1140b57f-8ec6-42a6-89b5-65529c810d1a">4,315.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfNi02LTEtMS0w_8ca19062-94ee-4bf7-bfec-31c4f8e01edd">2,429.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers revenue to be earned when all of the following criteria are met: the Company has a contract with a customer that creates enforceable rights and obligations; promised products or services are identified; the transaction price, or the amount the Company expects to receive, including an estimate of uncertain amounts subject to a constraint to ensure revenue is not recognized in an amount that would result in a significant reversal upon resolution of the uncertainty, is determinable; and the Company has transferred control of the promised items to the customer. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer, and is the unit of account in the contract. The transaction price for the contract is measured as the amount of consideration the Company expects to receive in exchange for the goods and services expected to be transferred. A contract's transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, control of the distinct good or service is transferred. Transfer of control for the Company's products is generally at shipment or delivery, depending on contractual terms, but occurs when title and risk of loss transfers to the customer which represents the point in time when the customer obtains the use of and substantially all of the benefits of the product. As such, the Company's performance obligation related to product sales is satisfied at a point in time. Revenue from support and maintenance contracts, extended warranty and professional services for installation, training and repairs is recognized over time based on the period contracted or as the services are performed as these methods represent a faithful depiction of the transfer of goods and services.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes a receivable when it has an unconditional right to payment, which represents the amount the Company expects to collect in a transaction and is most often equal to the transaction price in the contract. Payment terms are typically 30 days in the U.S. but may be longer in international markets. The Company treats shipping and handling costs performed after a customer obtains control of the good as a fulfillment cost and records these costs within costs of product revenue when the corresponding revenue is recognized.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also places instruments (or equipment) at customer sites but retains title to the instrument. The customer has the right to use the instrument for a period of time, and the Company recovers the cost of providing the instrument through the sales of disposables, namely tests and assays in Diagnostics and handpieces in GYN Surgical. These types of agreements include an embedded lease, which is generally an operating lease, for the right to use an instrument and no instrument revenue is recognized at the time of instrument delivery. The Company recognizes a portion of the revenue allocated to the embedded lease concurrent with the sale of disposables over the term of the agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company's contracts have multiple performance obligations. For contracts with multiple performance obligations, the Company allocates the transaction price to each performance obligation using its best estimate of the standalone selling price of each distinct good or service in the contract. The Company determines its best estimate of standalone selling price using average selling prices over three to twelve month periods of data depending on the products or nature of the services coupled with current market considerations. If the product or service does not have a history of sales or if sales volume is not sufficient, the Company relies on prices set by its pricing committees or applicable marketing department adjusted for expected discounts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Consideration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company exercises judgment in estimating variable consideration, which includes volume discounts, sales rebates, product returns and other adjustments. These amounts are recorded as a reduction to revenue and classified as a current liability. The Company bases its estimates for volume discounts and sales rebates on historical information to the extent it is reasonable to be used as a predictive tool of expected future rebates. To the extent the transaction price includes variable consideration, the Company applies judgment in constraining the estimated variable consideration due to factors that could cause reversal of revenue. The Company evaluates constraints based on its historical and projected experience with similar customer contracts.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's contracts typically do not provide the right to return product. In general, estimates of variable consideration and constraints are not material to the Company's financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Remaining Performance Obligations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 26, 2021, the estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied was approximately $<ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RleHRyZWdpb246M2M2NDJkZDhmZjJhNDczOWJkMzNkYTQwMzU5ODMxNDVfNjAyOA_2d2d2590-efed-40e8-976c-553a6029b6c8">804.4</ix:nonFraction> million. These remaining performance obligations primarily relate to extended warranty and support and maintenance obligations in the Company's Breast Health and Skeletal Health reportable segments. The Company expects to recognize approximately <ix:nonFraction unitRef="number" contextRef="i3077d84f238341b6b299f541f5f835d3_I20210626" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RleHRyZWdpb246M2M2NDJkZDhmZjJhNDczOWJkMzNkYTQwMzU5ODMxNDVfNjI2OQ_34c9699d-c180-4d1d-b37f-27eab9b6cb75">11</ix:nonFraction>% of this amount as revenue in 2021, <ix:nonFraction unitRef="number" contextRef="i6ac5e12a191d4b3dba030b9849f5d77b_I20210626" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RleHRyZWdpb246M2M2NDJkZDhmZjJhNDczOWJkMzNkYTQwMzU5ODMxNDVfNjMwNw_07161c37-099a-46d9-9cab-6592e9926ca0">36</ix:nonFraction>% in 2022, <ix:nonFraction unitRef="number" contextRef="i4fa166ab972a4216b61bb29fe09583b5_I20210626" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RleHRyZWdpb246M2M2NDJkZDhmZjJhNDczOWJkMzNkYTQwMzU5ODMxNDVfNjMxOQ_d54d474a-131a-411f-ad57-167ab242d60e">25</ix:nonFraction>% in 2023, <ix:nonFraction unitRef="number" contextRef="ia3c7225d747b441aa0d9f695fe415128_I20210626" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RleHRyZWdpb246M2M2NDJkZDhmZjJhNDczOWJkMzNkYTQwMzU5ODMxNDVfNjMzMQ_8776263c-fbf9-4c5b-a168-fd05f79ca1d7">16</ix:nonFraction>% in 2024, and <ix:nonFraction unitRef="number" contextRef="icaee218d084046ed9e76934876d4b3ff_I20210626" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RleHRyZWdpb246M2M2NDJkZDhmZjJhNDczOWJkMzNkYTQwMzU5ODMxNDVfNjM0Nw_d1c9014a-8778-430c-91ac-978b06b70be8">12</ix:nonFraction>% thereafter. The Company has applied the practical expedient to not include remaining performance obligations related to contracts with original expected durations of one year or less in the amounts above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Assets and Liabilities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company discloses accounts receivable separately in the Consolidated Balance Sheets at their net realizable value. Contract assets primarily relate to the Company's conditional right to consideration for work completed but not billed at the reporting date. Contract assets at the beginning and end of the reporting period, as well as the changes in the balance, were immaterial. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily relate to payments received from customers in advance of performance under the contract. The Company records a contract liability, or deferred revenue, when it has an obligation to provide service, and to a much lesser extent product, to the customer and payment is received or due in advance of performance. Deferred revenue primarily relates to support and maintenance contracts and extended warranty obligations within the Company's Breast Health and Skeletal Health reportable segments and, until December 30, 2019, the divested Medical Aesthetics segment. Contract liabilities are classified as other current liabilities and other long-term liabilities on the Consolidated Balance Sheets. The Company recognized revenue of $<ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RleHRyZWdpb246M2M2NDJkZDhmZjJhNDczOWJkMzNkYTQwMzU5ODMxNDVfNzczMw_a365bb26-9aa7-4f9a-b05f-c0635cc90afa">20.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RleHRyZWdpb246M2M2NDJkZDhmZjJhNDczOWJkMzNkYTQwMzU5ODMxNDVfNzc0MA_9f6807d1-abdc-4677-9e70-8f8e68cfe8d2">100.9</ix:nonFraction>&#160;million for the three and nine months ended June 26, 2021, respectively, that was included in the contract liability balance at September 26, 2020. The Company recognized $<ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RleHRyZWdpb246M2M2NDJkZDhmZjJhNDczOWJkMzNkYTQwMzU5ODMxNDVfNzkwNg_69b3b4ae-8ced-43f6-adf4-5ae87cb73433">18.0</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RleHRyZWdpb246M2M2NDJkZDhmZjJhNDczOWJkMzNkYTQwMzU5ODMxNDVfNzkxMw_b1ac8df7-a0af-4292-b636-10f41858016b">95.5</ix:nonFraction>&#160;million for the three and nine months ended June 27, 2020, respectively, that was included in the contract liability balance at September 28, 2019. </span></div><div style="text-align:justify"><span><br/></span></div><div id="i181d930c7b854595977e17db8fd84eb4_43"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(3) <ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80My9mcmFnOjgyNWUyNjIwMTBmOTQwZDBhOTI5YWU5Yjg0M2IxYTMyL3RleHRyZWdpb246ODI1ZTI2MjAxMGY5NDBkMGE5MjlhZTliODQzYjFhMzJfMTAyNA_466c406e-ae6e-4fc9-a311-8389b8f707b1" continuedAt="i523d62cc4973451a84f642420c1cf7d4" escape="true"><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:LesseeFinanceLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80My9mcmFnOjgyNWUyNjIwMTBmOTQwZDBhOTI5YWU5Yjg0M2IxYTMyL3RleHRyZWdpb246ODI1ZTI2MjAxMGY5NDBkMGE5MjlhZTliODQzYjFhMzJfMTAyNA_eea5321e-bd63-467f-ac3b-ba9123a1ae30" continuedAt="ic7efef10374040ab93400e0e5bb3d02f" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:continuation id="i523d62cc4973451a84f642420c1cf7d4" continuedAt="i82cacb0165384481a90282c3b707aa89"><ix:continuation id="ic7efef10374040ab93400e0e5bb3d02f" continuedAt="ibe290f90993e4dabac98eb3604ae5836">Lessor Activity - Leases where Hologic is the Lessor</ix:continuation></ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i82cacb0165384481a90282c3b707aa89"><ix:continuation id="ibe290f90993e4dabac98eb3604ae5836">Certain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating lease and performance obligations for disposables, reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. Sales-type leases are immaterial. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented less than <ix:nonFraction unitRef="number" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="2" name="holx:LeaseRevenuePercentageOfTotalRevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80My9mcmFnOjgyNWUyNjIwMTBmOTQwZDBhOTI5YWU5Yjg0M2IxYTMyL3RleHRyZWdpb246ODI1ZTI2MjAxMGY5NDBkMGE5MjlhZTliODQzYjFhMzJfOTU1_0f83b7d1-0f55-405a-8127-9b6f55034098">5</ix:nonFraction>% of the Company's consolidated revenue for all periods presented.</ix:continuation></ix:continuation> </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div id="i181d930c7b854595977e17db8fd84eb4_46"></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(4) <ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RleHRyZWdpb246MzhjYmIwNzRhYjM5NGNmMzgwNDBiODE0YjNkY2FjMzRfMzMwNg_ed6d74c1-3bb9-4bff-ad1c-c7b9d70395db" continuedAt="i5dfc22dd9bd04eaf822939bbed4f26b3" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="i5dfc22dd9bd04eaf822939bbed4f26b3" continuedAt="i6568be2a7e5e42c5b69a882995643cfe"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets/Liabilities Measured and Recorded at Fair Value on a Recurring Basis</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has investments in derivative instruments comprised of an interest rate swap, forward foreign currency contracts and foreign currency option contracts, which are valued using analyses obtained from independent third party valuation specialists based on market observable inputs, representing Level 2 measurements. The fair values of these derivative </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><ix:continuation id="i6568be2a7e5e42c5b69a882995643cfe" continuedAt="i54ada2c7d1554f6ca88b201c91a44bfe"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">contracts represent the estimated amounts the Company would receive or pay to terminate the contracts. Refer to Note 9 for further discussion and information on derivative instruments. </span></div><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RleHRyZWdpb246MzhjYmIwNzRhYjM5NGNmMzgwNDBiODE0YjNkY2FjMzRfMzMwMg_9c060bb2-0285-481f-bae9-0248d23784a1" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following at June&#160;26, 2021:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:17pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.029%"><tr><td style="width:1.0%"></td><td style="width:37.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.130%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.130%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.288%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at Reporting Date Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of June 26, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices&#160;in<br/>Active&#160;Market&#160;for<br/>Identical&#160;Assets<br/>(Level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs&#160;(Level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs&#160;(Level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08c883de92e74d7b85fd3ca1fb82d546_I20210626" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfNS0xLTEtMS0w_0a0a8b40-a6fe-4365-8c38-b545d3c4abb1">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02c12e832a964220b8e957d85bd7f1be_I20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfNS0zLTEtMS0w_aa238754-3188-4765-a4da-19a744b5e4e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iefc73cc720144ee2abfd4e56a2ab1c22_I20210626" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfNS01LTEtMS0w_709f9026-2011-4c6c-bb97-993121b84c2c">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib02ab7302c2f46079c7e79da871a6eb7_I20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfNS03LTEtMS0w_2a62ee0e-bf8c-4998-8c97-3abd3cf6bed8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfNy0xLTEtMS0w_fa728f27-4b59-4a16-8e24-af02f6127aa3">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id05ddebb6ac948d3924f040045e9f869_I20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfNy0zLTEtMS0w_7b3e85ff-1475-4a1a-855c-f38d7b1d443f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a527b50af5e47a99433bc012cfe40e9_I20210626" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfNy01LTEtMS0w_6e270279-1584-44f4-85cd-a0b89de714ba">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d9a236240c14cf8bef2d68626067a47_I20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfNy03LTEtMS0w_fe823c6b-5f3a-4dfb-adf1-a0add47a69bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f25431c4bd346aca079e50943a25050_I20210626" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfOS0xLTEtMS0w_3488e63f-2263-432d-b704-83028408702f">71.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59f5f7477c54411fb844f52b13896113_I20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfOS0zLTEtMS0w_cebf20cd-29f1-4354-bdea-5a4c8aa2e610">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib04dea42a16c43599c49cc706c336cc8_I20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfOS01LTEtMS0w_15549268-d9cc-4643-821e-f97a96da68a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia57c3dc6f5744ed28ba4ec3d78ac0431_I20210626" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfOS03LTEtMS0w_3330f02d-b22f-4e6c-817d-37171f3cef24">71.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcbbabd8e7cd43b49b4c4141972ac3df_I20210626" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfMTAtMS0xLTEtMA_5b7c645a-8aa0-449a-af29-0bcc084f59bd">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44028ddaa4d449f19b250514e6f25c11_I20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfMTAtMy0xLTEtMA_abad229b-752c-4881-971a-4097dfe0f405">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87af1fc6220349d08bb58531b16ae309_I20210626" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfMTAtNS0xLTEtMA_95994028-ab37-461e-a8db-d2946d536c59">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e4d1ac8689444b3b830cfd194640a8d_I20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfMTAtNy0xLTEtMA_fc70c21c-36d8-4894-aa46-ebddd04f4a1c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7359c2fb7ca43ffb3bf9416afa4079f_I20210626" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfMTEtMS0xLTEtMA_4bec210a-da23-4075-8faa-3f2c3f3cd0e0">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i354883b38ce9409b8864c231c916bc8b_I20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfMTEtMy0xLTEtMA_fd213735-5ac9-4905-986d-d91d8a63ec39">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8ccf9bb036a4a48a18392eeed90c59b_I20210626" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfMTEtNS0xLTEtMA_06544307-b283-4123-9233-77674723c486">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67c6607b6ca1481688b2c7ed6a2b6fab_I20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfMTEtNy0xLTEtMA_494a7de3-3ae5-4513-8384-816b61b4c0a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfMTItMS0xLTEtMA_0a23a611-173d-4a23-a831-6995a82b9087">94.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id05ddebb6ac948d3924f040045e9f869_I20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfMTItMy0xLTEtMA_4dc2e705-9192-4651-8fb3-e259634a72d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a527b50af5e47a99433bc012cfe40e9_I20210626" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfMTItNS0xLTEtMA_bec9c561-1661-42bf-b391-98da26630fb0">22.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d9a236240c14cf8bef2d68626067a47_I20210626" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfMTItNy0xLTEtMA_04521731-ef46-4611-8cfd-a4f982127cc9">71.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:13pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liabilities Measured and Recorded at Fair Value on a Recurring Basis</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of recurring fair value measurements using significant unobservable inputs (Level 3), which solely consisted of contingent consideration liabilities, during the three and nine month periods ended June 26, 2021 and June 27, 2020 were as follows:</span></div><div style="margin-top:18pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:6.148%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.473%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.480%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Month Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27, 2020</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31e8abc772ad4ffe894ec7ec188dc5df_I20210327" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfMi0yLTEtMS0w_3862beeb-733a-4bda-bfed-2671c17b35ae">71.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ae541164c564e1394017ca8fb281f3c_I20200328" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfMi00LTEtMS0w_67c556a8-3178-4108-aae8-0806f29c3c44">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfMi02LTEtMS0w_04a182a8-e2fc-4dd0-803a-7d5d747e2f80">81.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1bbf9311cb649308affbf16f61bb3ff_I20190928" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfMi04LTEtMS0w_eebcfa08-8529-4c0f-8b15-db4136863f40">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration recorded at acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfMy0yLTEtMS0w_4055dc58-e2d7-4056-ac39-686b3f0c2b0f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfMy00LTEtMS0w_1ed97780-62a8-48c9-8935-1ebda6f2ac9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfMy02LTEtMS0w_1736c441-acb9-4a7b-b2ef-25b641a3a02a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfMy04LTEtMS0w_42b494a8-d384-438e-9581-2b57789099e6">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfNC0yLTEtMS0w_1136f44d-248b-44ef-aac4-2841f8aa97a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfNC00LTEtMS0w_73891b79-fe20-49ef-8623-1dae7fdb13e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfNC02LTEtMS0w_607e76d4-3869-4b89-a243-50efb434fbcd">10.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfNC04LTEtMS0w_ef63ca9c-9ef0-446d-b0bd-c5793a732964">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfNS0yLTEtMS0w_237a0cc0-8245-4ead-a86f-c206bcb08918">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfNS00LTEtMS0w_63c6517e-8884-4820-9345-4d8bb224b2d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfNS02LTEtMS0w_6ddcc2e0-7f97-4855-b05b-2c3af49df9f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfNS04LTEtMS0w_93cce32e-9a25-4110-9d05-6ce5ff1e2c72">9.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfNi0yLTEtMS0w_5475427f-6f1e-4f85-88bb-5654fa295b14">71.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81ab5863e2124accb342d2df86a1ee96_I20200627" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfNi00LTEtMS0w_83c32252-9b13-47b7-a9b8-d8be3fc25f82">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfNi02LTEtMS0w_813270dd-796f-4e5a-954e-f2b14e8c8d7e">71.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81ab5863e2124accb342d2df86a1ee96_I20200627" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfNi04LTEtMS0w_7c45e0f1-46a5-41d9-93f4-14731b8de0d9">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:4pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets Measured and Recorded at Fair Value on a Nonrecurring Basis</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company remeasures the fair value of certain assets and liabilities upon the occurrence of certain events. Such assets are comprised of equity investments and long-lived assets, including property, plant and equipment, intangible assets and goodwill. There were no such remeasurements to equity investments in the three and nine months ended June&#160;26, 2021 and June&#160;27, 2020. During the first quarter of fiscal 2020, the Company's Medical Aesthetics division met the criteria to be classified as assets-held-for sale, and the Company recorded a $<ix:nonFraction unitRef="usd" contextRef="i421a1ec2406e4269a476846874e71421_D20190929-20191228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RleHRyZWdpb246MzhjYmIwNzRhYjM5NGNmMzgwNDBiODE0YjNkY2FjMzRfMTY5Ng_919e5f18-6ddc-47c2-b3cf-9c48d0ee775a">30.2</ix:nonFraction> million loss to record the asset group at its fair value less costs to sell. This was a level 1 measurement. See Note 6 for additional information. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosure of Fair Value of Financial Instruments</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial instruments mainly consist of cash and cash equivalents, accounts receivable, equity investments, an interest rate swap, forward foreign currency contracts, foreign currency option contracts, insurance contracts, accounts payable and debt obligations. The carrying amounts of the Company&#8217;s cash and cash equivalents, accounts receivable and accounts payable approximate their fair value due to the short-term nature of these instruments. The Company&#8217;s interest rate swap, forward foreign currency contracts and foreign currency option contracts are recorded at fair value. The carrying amount of the insurance contracts are recorded at the cash surrender value, as required by GAAP, which approximates fair value. The Company believes the carrying amounts of its cost-method equity investments approximate fair value.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i54ada2c7d1554f6ca88b201c91a44bfe">Amounts outstanding under the Company&#8217;s 2018 Credit Agreement (as defined below) of $<ix:nonFraction unitRef="usd" contextRef="id56c8faa0e884b19a2eebe191531428a_I20210626" decimals="-8" format="ixt:numdotdecimal" name="holx:PrincipalAmountOfBorrowings" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RleHRyZWdpb246MzhjYmIwNzRhYjM5NGNmMzgwNDBiODE0YjNkY2FjMzRfMjgxNQ_9fb9d3c7-ada9-4ebf-be85-89a7ac76f486">1.4</ix:nonFraction> billion aggregate principal as of June&#160;26, 2021 are subject to variable interest rates of interest based on current market rates, and as such, the Company believes the carrying amount of these obligations approximates fair value. The Company&#8217;s 2028 Senior Notes and 2029 Senior Notes had fair values of $<ix:nonFraction unitRef="usd" contextRef="ie2bfa4cc508a42c08b7fe0e7f3b786a3_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RleHRyZWdpb246MzhjYmIwNzRhYjM5NGNmMzgwNDBiODE0YjNkY2FjMzRfMzEwMg_df639a5a-a344-4b7e-8004-cbefcb37defd">420.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1493df5a7c09426b9e8dba13c3704251_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RleHRyZWdpb246MzhjYmIwNzRhYjM5NGNmMzgwNDBiODE0YjNkY2FjMzRfMzEwOQ_3ad7df4e-22c3-44f9-9a96-a8a2933ed86f">940.0</ix:nonFraction> million, respectively, as of June&#160;26, 2021 based on their trading prices, representing Level 1 measurements. Refer to Note 7 for the carrying amounts of the various components of the Company&#8217;s debt.</ix:continuation></span></div><div style="text-indent:24.75pt"><span><br/></span></div><div id="i181d930c7b854595977e17db8fd84eb4_49"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(5) <ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTU2OTY_d28d2f59-74e6-457b-8f88-a7995b33c384" continuedAt="i7b37baf3e30241f8a47101d6d61ba0a2" escape="true">Business Combinations</ix:nonNumeric></span></div><div style="text-indent:27pt"><span><br/></span></div><ix:continuation id="i7b37baf3e30241f8a47101d6d61ba0a2" continuedAt="iaa4116beb35b4c2ab764ded8b090ce3e"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal 2021 Acquisitions</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Mobidiag Oy</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 17, 2021, the Company completed the acquisition of Mobidiag Oy ("Mobidiag"), for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="i92fd2ed585e64792981f77c6077751ee_D20210617-20210617" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTA5OTUxMTY0NDA3NA_37d12040-b2a2-4dd2-b837-230a78e18442">729.6</ix:nonFraction>&#160;million. Mobidiag, located in Finland, manufactures molecular diagnostic solutions for gastrointestinal infections, antimicrobial resistance management and other infections. Mobidiag's results of operations are reported in the Company's Diagnostics reportable segment from the date of acquisition.</span></div><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI2NDQzODM3NTIxMTU_14d00b1a-f96e-4637-8e76-98312895f74f" continuedAt="ia56c2242329846f98f77f6d337de5028" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Mobidiag's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of June 17, 2021, as set forth below.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="margin-top:6pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.865%"><tr><td style="width:1.0%"></td><td style="width:7.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:62.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.878%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30d680096df04f59bf3edf5694f74758_I20210617" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjA0Zjc1ZjFkZWNkZDQ3Mjc5OWVkODUyMDQ4YjU0YzhkL3RhYmxlcmFuZ2U6MDRmNzVmMWRlY2RkNDcyNzk5ZWQ4NTIwNDhiNTRjOGRfMC0yLTEtMS02MjMy_8e7cc23a-1581-405a-bfd2-571337e9bf04">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30d680096df04f59bf3edf5694f74758_I20210617" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjA0Zjc1ZjFkZWNkZDQ3Mjc5OWVkODUyMDQ4YjU0YzhkL3RhYmxlcmFuZ2U6MDRmNzVmMWRlY2RkNDcyNzk5ZWQ4NTIwNDhiNTRjOGRfMS0yLTEtMS02MjMy_011e6eae-e5cf-424d-883e-b3d02b6a9e8f">8.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30d680096df04f59bf3edf5694f74758_I20210617" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjA0Zjc1ZjFkZWNkZDQ3Mjc5OWVkODUyMDQ4YjU0YzhkL3RhYmxlcmFuZ2U6MDRmNzVmMWRlY2RkNDcyNzk5ZWQ4NTIwNDhiNTRjOGRfMi0yLTEtMS02MjMy_e1478a00-6c52-4106-91a7-a9216363591b">11.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30d680096df04f59bf3edf5694f74758_I20210617" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjA0Zjc1ZjFkZWNkZDQ3Mjc5OWVkODUyMDQ4YjU0YzhkL3RhYmxlcmFuZ2U6MDRmNzVmMWRlY2RkNDcyNzk5ZWQ4NTIwNDhiNTRjOGRfNC0yLTEtMS02MjMy_d04e81a9-8dc8-4cb5-b2de-208a1fa39cbb">26.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30d680096df04f59bf3edf5694f74758_I20210617" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjA0Zjc1ZjFkZWNkZDQ3Mjc5OWVkODUyMDQ4YjU0YzhkL3RhYmxlcmFuZ2U6MDRmNzVmMWRlY2RkNDcyNzk5ZWQ4NTIwNDhiNTRjOGRfNS0yLTEtMS02MjM1_80502f49-b33d-41ed-9880-a362c56bdbf0">18.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30d680096df04f59bf3edf5694f74758_I20210617" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjA0Zjc1ZjFkZWNkZDQ3Mjc5OWVkODUyMDQ4YjU0YzhkL3RhYmxlcmFuZ2U6MDRmNzVmMWRlY2RkNDcyNzk5ZWQ4NTIwNDhiNTRjOGRfNi0yLTEtMS02MjM1_6b16a29c-6615-4394-81d3-26c92d3ed119">7.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30d680096df04f59bf3edf5694f74758_I20210617" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjA0Zjc1ZjFkZWNkZDQ3Mjc5OWVkODUyMDQ4YjU0YzhkL3RhYmxlcmFuZ2U6MDRmNzVmMWRlY2RkNDcyNzk5ZWQ4NTIwNDhiNTRjOGRfOS0yLTEtMS02MjM3_0fd0ad1a-817f-45a2-a242-c86f52e50233">284.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30d680096df04f59bf3edf5694f74758_I20210617" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjA0Zjc1ZjFkZWNkZDQ3Mjc5OWVkODUyMDQ4YjU0YzhkL3RhYmxlcmFuZ2U6MDRmNzVmMWRlY2RkNDcyNzk5ZWQ4NTIwNDhiNTRjOGRfMTAtMi0xLTEtNjIzNw_d1b08647-e8a7-40c2-8a4d-f24d8583be1e">103.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30d680096df04f59bf3edf5694f74758_I20210617" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjA0Zjc1ZjFkZWNkZDQ3Mjc5OWVkODUyMDQ4YjU0YzhkL3RhYmxlcmFuZ2U6MDRmNzVmMWRlY2RkNDcyNzk5ZWQ4NTIwNDhiNTRjOGRfMTEtMi0xLTEtNjIzNw_a2e8afe7-da03-48a0-bf90-8581d0b01d18">26.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30d680096df04f59bf3edf5694f74758_I20210617" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjA0Zjc1ZjFkZWNkZDQ3Mjc5OWVkODUyMDQ4YjU0YzhkL3RhYmxlcmFuZ2U6MDRmNzVmMWRlY2RkNDcyNzk5ZWQ4NTIwNDhiNTRjOGRfMTItMi0xLTEtNjIzNw_e8e8d410-d626-40f7-8775-77377605282a">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30d680096df04f59bf3edf5694f74758_I20210617" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjA0Zjc1ZjFkZWNkZDQ3Mjc5OWVkODUyMDQ4YjU0YzhkL3RhYmxlcmFuZ2U6MDRmNzVmMWRlY2RkNDcyNzk5ZWQ4NTIwNDhiNTRjOGRfMTQtMi0xLTEtNjIzOQ_6296ff5e-7599-4668-838a-e1991fa82ed4">66.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30d680096df04f59bf3edf5694f74758_I20210617" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjA0Zjc1ZjFkZWNkZDQ3Mjc5OWVkODUyMDQ4YjU0YzhkL3RhYmxlcmFuZ2U6MDRmNzVmMWRlY2RkNDcyNzk5ZWQ4NTIwNDhiNTRjOGRfMTUtMi0xLTEtNjIzOQ_49a04688-ca11-4805-b08a-8ffc0da68fdc">72.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30d680096df04f59bf3edf5694f74758_I20210617" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjA0Zjc1ZjFkZWNkZDQ3Mjc5OWVkODUyMDQ4YjU0YzhkL3RhYmxlcmFuZ2U6MDRmNzVmMWRlY2RkNDcyNzk5ZWQ4NTIwNDhiNTRjOGRfMTYtMi0xLTEtNjIzOQ_8d57d108-51d1-4c53-adaf-06802046922f">406.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30d680096df04f59bf3edf5694f74758_I20210617" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjA0Zjc1ZjFkZWNkZDQ3Mjc5OWVkODUyMDQ4YjU0YzhkL3RhYmxlcmFuZ2U6MDRmNzVmMWRlY2RkNDcyNzk5ZWQ4NTIwNDhiNTRjOGRfMTctMi0xLTEtNjIzOQ_ade56395-38d9-46ff-b0b0-d5ae3a960368">729.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Mobidiag's business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, including but not limited to the estimation of the fair value of the identifiable intangible assets, long-term debt, and deferred income taxes.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets are development technology, in-process research and development ("IPR&amp;D"), customer relationships and trade names. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using rates ranging from <ix:nonFraction unitRef="number" contextRef="i93d6e126b5db43d7917d1e320241c5a5_D20210617-20210617" decimals="3" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI2NDQzODM3NTIxMTc_c0adeda3-68a9-46d6-af7b-74218193cd52">14.5</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i7e9787cddf8548e6b7fe58450c3ac4ea_D20210617-20210617" decimals="3" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI2NDQzODM3NTIxMjQ_0a023ce6-9f8e-4150-9ec8-639d85f1a12a">16.0</ix:nonFraction>%. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The developed technology assets are comprised of know-how, patents and technologies embedded in Mobidiag's products and relate to currently marketed products. The developed technology assets comprise the primary product families under the Novodiag and Amplidiag technology platforms.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><ix:continuation id="iaa4116beb35b4c2ab764ded8b090ce3e" continuedAt="ia099a4240ad04d4b91a164072e33d670"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IPR&amp;D projects relate to in-process projects that have not reached technological feasibility as of the acquisition date and have no alternative future use. The primary basis for determining technological feasibility of these projects is obtaining regulatory approval to market the underlying project or expected commercial release depending on the project. The Company recorded, on a preliminary basis, $<ix:nonFraction unitRef="usd" contextRef="i30d680096df04f59bf3edf5694f74758_I20210617" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI2NDQzODM3NTIxMzE_02f1651e-c137-4895-a8ec-70951f5dbf36">103.0</ix:nonFraction>&#160;million of IPR&amp;D related to <ix:nonFraction unitRef="project" contextRef="i30d680096df04f59bf3edf5694f74758_I20210617" decimals="INF" format="ixt-sec:numwordsen" name="holx:ResearchAndDevelopmentInProcessNumberOfProjects" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI2NDQzODM3NTIyNjA_b866724d-5a17-4c26-99d9-cff53fddd3be">three</ix:nonFraction> projects. The Company expects to complete these <ix:nonFraction unitRef="project" contextRef="i30d680096df04f59bf3edf5694f74758_I20210617" decimals="INF" format="ixt-sec:numwordsen" name="holx:ResearchAndDevelopmentInProcessNumberOfProjects" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI2NDQzODM3NTIyNzY_b866724d-5a17-4c26-99d9-cff53fddd3be">three</ix:nonFraction> projects over the next <ix:nonNumeric contextRef="i92fd2ed585e64792981f77c6077751ee_D20210617-20210617" format="ixt-sec:durwordsen" name="holx:ResearchAndDevelopmentInProcessCompletionPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI2NDQzODM3NTIxNTU_b2c9f4e2-972f-4dd7-a2d6-3cb570bc9acd">three years</ix:nonNumeric>. Given the uncertainties inherent with product development and introduction, there can be no assurance that any of the Company's product development efforts will be successful, completed on a timely basis or within budget, if at all. All of the IPR&amp;D assets were valued using the income approach.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary estimate of the weighted average life for the developed technology assets range from <ix:nonNumeric contextRef="i2cc7db962d0a469b91ad71f47641afa1_D20210617-20210617" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI2NDQzODM3NTIxNzM_ea5af693-cb35-4e7b-b9a0-c4eb596b9402">10</ix:nonNumeric> to <ix:nonNumeric contextRef="i5b84fc74ea2e43499ee65a3ee48d7788_D20210617-20210617" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI2NDQzODM3NTIxODU_b4632894-d8b2-4c26-a067-0f643bff5c08">12</ix:nonNumeric> years, customer relationships range from <ix:nonNumeric contextRef="ia28b5293c7a442a1b282883ce9f51714_D20210617-20210617" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI2NDQzODM3NTIyMDY_fcca8d9e-b97d-4d99-8491-f9b524124dfc">5</ix:nonNumeric> to <ix:nonNumeric contextRef="if0b5328ab51c4ca5b5843c926066e713_D20210617-20210617" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI2NDQzODM3NTIyMTc_32cb1724-1f12-4ab5-8ad1-31c1a89fe50e">11</ix:nonNumeric> years, and tradenames range from <ix:nonNumeric contextRef="ia0066f33074743339653dd14619b7e1e_D20210617-20210617" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI2NDQzODM3NTIyMzY_6f6140d8-0796-4c7d-af0c-63b952df7a94">10</ix:nonNumeric> to <ix:nonNumeric contextRef="i4cf345ba0efd409ab1d3a3013de7de83_D20210617-20210617" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI2NDQzODM3NTIyNDg_97d91a79-10e5-4d81-9cb8-7d77746056b4">12</ix:nonNumeric> years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the preliminary amount of goodwill were primarily based on anticipated strategic and synergistic benefits that are expected to be realized from the Mobidiag acquisition. These benefits include expanding the Company's molecular diagnostics portfolio into the near-patient testing market and utilizing Diagnostic's sales and regulatory expertise to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Biotheranostics</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 22, 2021, the Company completed the acquisition of Biotheranostics, Inc. ("Biotheranostics"), for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="i33bd27ed8fae4b699caa054e910ef6da_D20210222-20210222" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMjA2_56cb34cf-cc7a-49c7-8af0-b32d6acef640">231.3</ix:nonFraction>&#160;million. Biotheranostics, located in San Diego, California, manufactures molecular diagnostic tests for breast and metastatic cancers and performs the lab testing procedures at its facility. Biotheranostics' results of operations are reported in the Company's Diagnostics reportable segment from the date of acquisition and its revenues are reported within Service and other revenue in the Company's Consolidated Statements of Income and within service revenue in our disclosure of disaggregated revenue in Note 2.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><ix:continuation id="ia56c2242329846f98f77f6d337de5028" continuedAt="i591eade5d2b9403c93ffab1dd4a79ccd"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Biotheranostics' preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of February 22, 2021, as set forth below.</span></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.865%"><tr><td style="width:1.0%"></td><td style="width:7.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:62.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.878%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec8c75e6a6ac424c8336a8c73d23c503_I20210222" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZkNTkyNDQ1NTE5ZTQ1OWRhMjQ5OTY5YjBlNjc3M2VlL3RhYmxlcmFuZ2U6ZmQ1OTI0NDU1MTllNDU5ZGEyNDk5NjliMGU2NzczZWVfMS0yLTEtMS0w_c054d48f-2823-404f-9196-1ebe92b5c3b5">9.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec8c75e6a6ac424c8336a8c73d23c503_I20210222" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZkNTkyNDQ1NTE5ZTQ1OWRhMjQ5OTY5YjBlNjc3M2VlL3RhYmxlcmFuZ2U6ZmQ1OTI0NDU1MTllNDU5ZGEyNDk5NjliMGU2NzczZWVfMi0yLTEtMS0w_648b8e83-0766-4c79-8972-4c9d371e0586">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec8c75e6a6ac424c8336a8c73d23c503_I20210222" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZkNTkyNDQ1NTE5ZTQ1OWRhMjQ5OTY5YjBlNjc3M2VlL3RhYmxlcmFuZ2U6ZmQ1OTI0NDU1MTllNDU5ZGEyNDk5NjliMGU2NzczZWVfNS0yLTEtMS0w_ed54d3d6-bc07-4ace-b73d-a29b2149dbdf">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec8c75e6a6ac424c8336a8c73d23c503_I20210222" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZkNTkyNDQ1NTE5ZTQ1OWRhMjQ5OTY5YjBlNjc3M2VlL3RhYmxlcmFuZ2U6ZmQ1OTI0NDU1MTllNDU5ZGEyNDk5NjliMGU2NzczZWVfNi0yLTEtMS0w_96ff4692-a4f7-4bf1-98d3-6d1cc89f2a82">8.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec8c75e6a6ac424c8336a8c73d23c503_I20210222" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZkNTkyNDQ1NTE5ZTQ1OWRhMjQ5OTY5YjBlNjc3M2VlL3RhYmxlcmFuZ2U6ZmQ1OTI0NDU1MTllNDU5ZGEyNDk5NjliMGU2NzczZWVfNy0yLTEtMS0w_05bec8d7-953e-44fd-8a81-2c95160c8d73">8.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec8c75e6a6ac424c8336a8c73d23c503_I20210222" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZkNTkyNDQ1NTE5ZTQ1OWRhMjQ5OTY5YjBlNjc3M2VlL3RhYmxlcmFuZ2U6ZmQ1OTI0NDU1MTllNDU5ZGEyNDk5NjliMGU2NzczZWVfOS0yLTEtMS0w_71269855-ef00-463d-afa1-c043c2115d5f">160.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec8c75e6a6ac424c8336a8c73d23c503_I20210222" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZkNTkyNDQ1NTE5ZTQ1OWRhMjQ5OTY5YjBlNjc3M2VlL3RhYmxlcmFuZ2U6ZmQ1OTI0NDU1MTllNDU5ZGEyNDk5NjliMGU2NzczZWVfMTEtMi0xLTEtMA_04fa0e91-b2d7-4e58-8b4e-bbe11813ccd7">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec8c75e6a6ac424c8336a8c73d23c503_I20210222" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZkNTkyNDQ1NTE5ZTQ1OWRhMjQ5OTY5YjBlNjc3M2VlL3RhYmxlcmFuZ2U6ZmQ1OTI0NDU1MTllNDU5ZGEyNDk5NjliMGU2NzczZWVfMTQtMi0xLTEtMA_293755c7-bd62-46df-a204-ff3b5e91a436">18.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec8c75e6a6ac424c8336a8c73d23c503_I20210222" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZkNTkyNDQ1NTE5ZTQ1OWRhMjQ5OTY5YjBlNjc3M2VlL3RhYmxlcmFuZ2U6ZmQ1OTI0NDU1MTllNDU5ZGEyNDk5NjliMGU2NzczZWVfMTUtMi0xLTEtMA_ae44bca1-3735-4a98-a800-2fb2623b6e93">84.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec8c75e6a6ac424c8336a8c73d23c503_I20210222" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZkNTkyNDQ1NTE5ZTQ1OWRhMjQ5OTY5YjBlNjc3M2VlL3RhYmxlcmFuZ2U6ZmQ1OTI0NDU1MTllNDU5ZGEyNDk5NjliMGU2NzczZWVfMTYtMi0xLTEtMA_fd79b650-c904-40eb-a4ad-c00d92b12285">231.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Biotheranostics' business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, the estimation of the fair value of the identifiable intangible assets, and income taxes.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets are developed technology and trade names. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a <ix:nonFraction unitRef="number" contextRef="i33bd27ed8fae4b699caa054e910ef6da_D20210222-20210222" decimals="3" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTcyOA_19431878-22c8-4815-9042-aedc6226057e">18.0</ix:nonFraction>% rate. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and trade names is <ix:nonNumeric contextRef="i33bd27ed8fae4b699caa054e910ef6da_D20210222-20210222" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMjAzNg_e1ceef20-b18b-46b6-ae6a-72ea8b8d493d">10</ix:nonNumeric> years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the preliminary amount of goodwill were primarily based on anticipated synergistic benefits of adding Biotheranostics' CLIA (Clinical </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><ix:continuation id="ia099a4240ad04d4b91a164072e33d670" continuedAt="i9721e575fb0441239171f1a20f27f368"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laboratory Improvement Amendments) lab to the Company's portfolio of offerings and utilizing Diagnostic's marketing and regulatory expertise to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diagenode</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, the Company completed the acquisition of Diagenode SA ("Diagenode") for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="icf15ef9e7b8d4ce0b6f697ed71d50240_D20210301-20210301" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMjc3NA_874624d9-258f-4e08-8b3c-8d19248cfba7">155.1</ix:nonFraction>&#160;million. Diagenode, located in Belgium, is a developer and manufacturer of molecular diagnostic assays based on PCR (polymerase chain reaction) technology to detect infectious diseases of bacterial, viral or parasite origin. Diagenode's results of operations are reported in the Company's Diagnostics reportable segment from the date of acquisition. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><ix:continuation id="i591eade5d2b9403c93ffab1dd4a79ccd" continuedAt="i77e56361f67e4f65bb2c6c8fedda5180"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Diagenode's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of March 1, 2021, as set forth below.</span></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.865%"><tr><td style="width:1.0%"></td><td style="width:7.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:62.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.878%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfa5ce4594b64da29ce0bdebe52e6a48_I20210301" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZhNjFjZDQ5ZTUxOTQ3YTdhMGE1ZmFkYjI5ZmI1NGI3L3RhYmxlcmFuZ2U6ZmE2MWNkNDllNTE5NDdhN2EwYTVmYWRiMjlmYjU0YjdfMS0yLTEtMS0w_cbf1ed33-015c-4b95-9d31-32bb1a821f77">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfa5ce4594b64da29ce0bdebe52e6a48_I20210301" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZhNjFjZDQ5ZTUxOTQ3YTdhMGE1ZmFkYjI5ZmI1NGI3L3RhYmxlcmFuZ2U6ZmE2MWNkNDllNTE5NDdhN2EwYTVmYWRiMjlmYjU0YjdfMi0yLTEtMS0w_2083f08b-e16c-4458-8330-0ba47312530a">9.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfa5ce4594b64da29ce0bdebe52e6a48_I20210301" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZhNjFjZDQ5ZTUxOTQ3YTdhMGE1ZmFkYjI5ZmI1NGI3L3RhYmxlcmFuZ2U6ZmE2MWNkNDllNTE5NDdhN2EwYTVmYWRiMjlmYjU0YjdfMy0yLTEtMS0w_4f003f4d-7ce0-4ca0-ae57-79e05268ee7e">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfa5ce4594b64da29ce0bdebe52e6a48_I20210301" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZhNjFjZDQ5ZTUxOTQ3YTdhMGE1ZmFkYjI5ZmI1NGI3L3RhYmxlcmFuZ2U6ZmE2MWNkNDllNTE5NDdhN2EwYTVmYWRiMjlmYjU0YjdfNS0yLTEtMS0w_701555d4-4340-4bf1-8820-1e553423d0ae">13.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfa5ce4594b64da29ce0bdebe52e6a48_I20210301" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZhNjFjZDQ5ZTUxOTQ3YTdhMGE1ZmFkYjI5ZmI1NGI3L3RhYmxlcmFuZ2U6ZmE2MWNkNDllNTE5NDdhN2EwYTVmYWRiMjlmYjU0YjdfNi0yLTEtMS0w_0c9e8f0e-bfdf-4236-8391-adc1b102e863">12.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfa5ce4594b64da29ce0bdebe52e6a48_I20210301" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZhNjFjZDQ5ZTUxOTQ3YTdhMGE1ZmFkYjI5ZmI1NGI3L3RhYmxlcmFuZ2U6ZmE2MWNkNDllNTE5NDdhN2EwYTVmYWRiMjlmYjU0YjdfNy0yLTEtMS0w_68ceeaee-8cd5-4f0f-afc3-cf890a2449a9">9.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfa5ce4594b64da29ce0bdebe52e6a48_I20210301" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZhNjFjZDQ5ZTUxOTQ3YTdhMGE1ZmFkYjI5ZmI1NGI3L3RhYmxlcmFuZ2U6ZmE2MWNkNDllNTE5NDdhN2EwYTVmYWRiMjlmYjU0YjdfOS0yLTEtMS0w_57e7694e-040f-4d26-894b-6c189ec72d83">69.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfa5ce4594b64da29ce0bdebe52e6a48_I20210301" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZhNjFjZDQ5ZTUxOTQ3YTdhMGE1ZmFkYjI5ZmI1NGI3L3RhYmxlcmFuZ2U6ZmE2MWNkNDllNTE5NDdhN2EwYTVmYWRiMjlmYjU0YjdfMTEtMi0xLTEtMA_0af40759-912c-4180-b97d-a37dd2533f81">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfa5ce4594b64da29ce0bdebe52e6a48_I20210301" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZhNjFjZDQ5ZTUxOTQ3YTdhMGE1ZmFkYjI5ZmI1NGI3L3RhYmxlcmFuZ2U6ZmE2MWNkNDllNTE5NDdhN2EwYTVmYWRiMjlmYjU0YjdfMTQtMi0xLTEtMA_e36fbb56-d0d5-480c-9275-726e51d62019">19.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfa5ce4594b64da29ce0bdebe52e6a48_I20210301" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZhNjFjZDQ5ZTUxOTQ3YTdhMGE1ZmFkYjI5ZmI1NGI3L3RhYmxlcmFuZ2U6ZmE2MWNkNDllNTE5NDdhN2EwYTVmYWRiMjlmYjU0YjdfMTUtMi0xLTEtMA_118081ab-171f-40e8-9913-2020c3291086">79.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfa5ce4594b64da29ce0bdebe52e6a48_I20210301" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZhNjFjZDQ5ZTUxOTQ3YTdhMGE1ZmFkYjI5ZmI1NGI3L3RhYmxlcmFuZ2U6ZmE2MWNkNDllNTE5NDdhN2EwYTVmYWRiMjlmYjU0YjdfMTYtMi0xLTEtMA_5cbe90ba-bdef-419e-b16a-9e8caa51fff0">155.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Diagenode's business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, the estimation of the fair value of the identifiable intangible assets, and income taxes.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets are developed technology and customer relationships. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a <ix:nonFraction unitRef="number" contextRef="i2ff71b48fe0e4e9d9e59ac8a919283de_D20210301-20210301" decimals="3" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfNDEzMQ_ac75ff99-0acf-4e45-8c43-329c5383ab73">14.5</ix:nonFraction>% rate for developed technology and a <ix:nonFraction unitRef="number" contextRef="i0e52565dcf6d4e319cc9bb4516138aec_D20210301-20210301" decimals="3" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfNDE3MA_e1acd291-7e1e-479c-bd32-3186aa2f77f2">13.5</ix:nonFraction>% rate for customer relationships. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and customer relationships is <ix:nonNumeric contextRef="icf15ef9e7b8d4ce0b6f697ed71d50240_D20210301-20210301" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfNDUxNg_749e3168-f38d-45a5-9ff4-a9164e2d4836">10</ix:nonNumeric> years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the preliminary amount of goodwill were based on anticipated synergistic benefits of Diagenode's products broadening the Diagnostics portfolio of molecular diagnostics products primarily in the transplant and acute care gastrointestinal and respiratory space as customers seek a broader menu of tests, utilizing Diagnostic's sales force to drive menu expansion and revenue growth and gaining additional PCR assay development expertise. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Somatex Medical Technologies</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2020, the Company completed the acquisition of Somatex Medical Technologies GmbH ("Somatex") for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="i601f6bd5a6a04f1ba94dff4501f86d1d_D20210104-20210104" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfNTQxNg_a7ca6325-0daa-4449-b939-ea8cd0a9b12f">62.9</ix:nonFraction>&#160;million. Somatex, located in Germany, is a manufacturer of biopsy site markers, including the Tumark product line of tissue markers, which were distributed by the Company in the U.S. prior to the acquisition. The allocation of the purchase price is based on the Company's preliminary valuation, and it allocated $<ix:nonFraction unitRef="usd" contextRef="id9cb5bfd9d0b4a7bb1e06960147c3f37_I20210104" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfNTcyMw_f3172cd6-60a8-43ac-a544-453cbf0b353a">38.0</ix:nonFraction>&#160;million to the preliminary value of developed technology, $<ix:nonFraction unitRef="usd" contextRef="id9cb5bfd9d0b4a7bb1e06960147c3f37_I20210104" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfNTc3Ng_ae929107-b869-4d8b-bc90-81562154f2dd">1.2</ix:nonFraction>&#160;million to customer relationships, $<ix:nonFraction unitRef="usd" contextRef="id9cb5bfd9d0b4a7bb1e06960147c3f37_I20210104" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfNTgwNg_014d630c-781f-4a84-9314-d9de55ae7cbb">0.9</ix:nonFraction>&#160;million to trade names and $<ix:nonFraction unitRef="usd" contextRef="id9cb5bfd9d0b4a7bb1e06960147c3f37_I20210104" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfNTgyOA_50718179-3873-4e39-bdaa-1eed0a821dbd">32.4</ix:nonFraction>&#160;million to goodwill. The remaining $<ix:nonFraction unitRef="usd" contextRef="id9cb5bfd9d0b4a7bb1e06960147c3f37_I20210104" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfNTg1OA_eea65f3b-4f78-4d05-b559-9b664f3f9e77">9.6</ix:nonFraction>&#160;million of the purchase price was allocated to the net acquired tangible assets and liabilities. The allocation of the purchase price is preliminary as the Company continues to gather information supporting </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><ix:continuation id="i9721e575fb0441239171f1a20f27f368" continuedAt="i2fbc7c8cbea6439f85fd7017bccba4fc"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the acquired assets and liabilities. Somatex' results of operations are reported in the Company's Breast Health reportable segment from the date of acquisition. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NXC Imaging</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2020, the Company completed the acquisition of assets from NXC Imaging, for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="i95400d7ffd0145a6902213bb3a8fd6e5_D20200928-20200928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfNjM0OQ_6f1979b4-2856-4206-bbd5-28988e6757ec">5.6</ix:nonFraction>&#160;million. NXC Imaging was a long-standing distributor of the Company's Breast and Skeletal products in the U.S. Based on the Company's preliminary valuation, the majority of the purchase price was allocated to a customer relationships intangible asset with a useful life of <ix:nonNumeric contextRef="ic7e22da3089645eda9e0ac21e97119f1_D20200928-20200928" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfNjYxNw_ce61d0d1-c94e-4d5a-b575-8de194ea0a00">5</ix:nonNumeric> years. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal 2020 Acquisitions</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acessa Health</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 23, 2020, the Company completed the acquisition of Acessa Health, Inc. ("Acessa") for a purchase price of </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="if19332d7f2bc4032add3a47ca74898dd_D20200823-20200823" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfNjkyNw_e1bb1389-eb66-4487-a465-626fd045ab8d">161.3</ix:nonFraction>&#160;million, which included a hold-back of $<ix:nonFraction unitRef="usd" contextRef="ib2c5f4cc59d642e7b734717eb34e002e_I20200823" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfNjk2MQ_44cc8579-b1d5-4162-b304-278864f76467">3.0</ix:nonFraction>&#160;million that was paid in January 2021, and contingent consideration, which the Company estimated the fair value to be $<ix:nonFraction unitRef="usd" contextRef="if929571277ff41218f0486d616483faa_I20200823" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfNzA3NA_5a9dbfe3-7e8d-47e1-b108-63bf8996ac6d">81.8</ix:nonFraction>&#160;million as of the measurement date. Acessa, located in Austin, Texas, manufactures and markets its ProVu system, a laparoscopic radio frequency ablation system for use in treatment of uterine fibroids. Acessa's results of operations are reported in the Company's GYN Surgical reportable segment from the date of acquisition.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent payments are based on a multiple of annual incremental revenue growth over a <ix:nonNumeric contextRef="if19332d7f2bc4032add3a47ca74898dd_D20200823-20200823" format="ixt-sec:durwordsen" name="holx:AnnualIncrementalRevenueGrowthPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTU3MDE_b7e4cbe8-c4c9-4d34-9c5d-560912a5f31f">three-year</ix:nonNumeric> period ending annually in December. There is no maximum earnout. Pursuant to ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company recorded its estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation based on future revenue projections of Acessa, comparable companies revenue growth rates, implied volatility and applying a risk adjusted discount rate. Each quarter the Company will be required to remeasure the fair value of the liability as assumptions change and such adjustments will be recorded in operating expenses. This fair value measurement was based on significant inputs not observable in the market and thus represented a Level 3 measurement as defined in ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This fair value measurement is directly impacted by the Company's estimate of future incremental revenue growth of the business. Accordingly, if actual revenue growth is higher or lower than the estimates within the fair value measurement, the Company would record additional charges or benefits, respectively. There was no remeasurement for the three months ended June 26, 2021. For the nine months ended June 26, 2021, the Company remeasured the contingent consideration liability and recorded a gain of $<ix:nonFraction unitRef="usd" contextRef="icb56805faa3a44cd9925ebb00f16e8b2_D20200927-20210626" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfODczMg_4a36a2d2-829f-4d80-9d22-93afaad775d7">10.1</ix:nonFraction>&#160;million to record the liability at fair value. The reduction in fair value was primarily due to a decrease in forecasted revenues over the measurement period.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="i77e56361f67e4f65bb2c6c8fedda5180" continuedAt="i335f4a44c34842f4a96f0406944230d0"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Acessa's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of August 23, 2020, as set forth below.</span></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.596%"><tr><td style="width:1.0%"></td><td style="width:7.865%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:71.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.292%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if929571277ff41218f0486d616483faa_I20200823" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmY3OTYzZTgxMzUzMjQzNGRiZGZiOGU3NDc3MjllM2VkL3RhYmxlcmFuZ2U6Zjc5NjNlODEzNTMyNDM0ZGJkZmI4ZTc0NzcyOWUzZWRfMC0yLTEtMS0w_f230b0a9-e568-4d12-9859-1f8d3597e9e0">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if929571277ff41218f0486d616483faa_I20200823" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmY3OTYzZTgxMzUzMjQzNGRiZGZiOGU3NDc3MjllM2VkL3RhYmxlcmFuZ2U6Zjc5NjNlODEzNTMyNDM0ZGJkZmI4ZTc0NzcyOWUzZWRfMS0yLTEtMS0w_1449a909-0fd8-46aa-8dd2-af42af1eefd2">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if929571277ff41218f0486d616483faa_I20200823" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmY3OTYzZTgxMzUzMjQzNGRiZGZiOGU3NDc3MjllM2VkL3RhYmxlcmFuZ2U6Zjc5NjNlODEzNTMyNDM0ZGJkZmI4ZTc0NzcyOWUzZWRfMi0yLTEtMS0w_296de96e-947c-4c5b-b171-074752e83eba">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if929571277ff41218f0486d616483faa_I20200823" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmY3OTYzZTgxMzUzMjQzNGRiZGZiOGU3NDc3MjllM2VkL3RhYmxlcmFuZ2U6Zjc5NjNlODEzNTMyNDM0ZGJkZmI4ZTc0NzcyOWUzZWRfMy0yLTEtMS0w_3e6e33ea-8a18-47b7-849d-9bcf8c87c13c">4.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if929571277ff41218f0486d616483faa_I20200823" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmY3OTYzZTgxMzUzMjQzNGRiZGZiOGU3NDc3MjllM2VkL3RhYmxlcmFuZ2U6Zjc5NjNlODEzNTMyNDM0ZGJkZmI4ZTc0NzcyOWUzZWRfNS0yLTEtMS0w_b2434819-478a-452e-b98d-62d979baecca">127.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if929571277ff41218f0486d616483faa_I20200823" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmY3OTYzZTgxMzUzMjQzNGRiZGZiOGU3NDc3MjllM2VkL3RhYmxlcmFuZ2U6Zjc5NjNlODEzNTMyNDM0ZGJkZmI4ZTc0NzcyOWUzZWRfNy0yLTEtMS0w_281492b2-daad-4c03-937c-8749b45b33a8">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if929571277ff41218f0486d616483faa_I20200823" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmY3OTYzZTgxMzUzMjQzNGRiZGZiOGU3NDc3MjllM2VkL3RhYmxlcmFuZ2U6Zjc5NjNlODEzNTMyNDM0ZGJkZmI4ZTc0NzcyOWUzZWRfOC0yLTEtMS0w_0672512b-9ecc-46ce-83e9-d7170b797140">20.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if929571277ff41218f0486d616483faa_I20200823" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmY3OTYzZTgxMzUzMjQzNGRiZGZiOGU3NDc3MjllM2VkL3RhYmxlcmFuZ2U6Zjc5NjNlODEzNTMyNDM0ZGJkZmI4ZTc0NzcyOWUzZWRfOS0yLTEtMS0w_e2a02c04-b732-44a1-9035-8767d042341d">48.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if929571277ff41218f0486d616483faa_I20200823" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmY3OTYzZTgxMzUzMjQzNGRiZGZiOGU3NDc3MjllM2VkL3RhYmxlcmFuZ2U6Zjc5NjNlODEzNTMyNDM0ZGJkZmI4ZTc0NzcyOWUzZWRfMTAtMi0xLTEtMA_8c2721c7-7913-4120-998c-eaba947345b2">161.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Acessa's business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, primarily taxes.</span></div></ix:continuation><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><ix:continuation id="i2fbc7c8cbea6439f85fd7017bccba4fc" continuedAt="icf0597e03578405bb1e69077cb25488a"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets were developed technology and trade names. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using an <ix:nonFraction unitRef="number" contextRef="if19332d7f2bc4032add3a47ca74898dd_D20200823-20200823" decimals="3" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfOTg0NQ_bdcb1374-c3ba-4f9d-9def-e5c2aaa08171">18.0</ix:nonFraction>% rate. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and trade names was <ix:nonNumeric contextRef="i0f02945eed7a4b80bf799a5f378886e3_D20200823-20200823" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTAxNTM_729cba18-d389-47c1-956e-d08b70455b0b"><ix:nonNumeric contextRef="icb63ed4e502448c29aeca44e256133e3_D20200823-20200823" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTAxNTM_ec635e29-32df-476b-947f-da27d878f349">10</ix:nonNumeric></ix:nonNumeric> years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the preliminary amount of goodwill were based on anticipated synergistic benefits of Acessa's products being complementary to the GYN Surgical portfolio of products and utilizing the GYN Surgical sales force to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Beacons</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 3, 2020, the Company completed the acquisition of Health Beacons, Inc. ("Health Beacons"), for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="i7c4ac52d74224b66838d0679adb1ed3b_D20200203-20200203" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTA4NDU_3907a7df-ad40-4569-af78-286db00f9600">19.7</ix:nonFraction>&#160;million, which included hold-backs of $<ix:nonFraction unitRef="usd" contextRef="ie1847e23bfb6472dbc395f6d1338a8db_I20200203" decimals="-5" format="ixt:numdotdecimal" name="holx:Holdback" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTA4Nzg_bc01203a-8e46-4818-b43d-86f7ef178d38">2.3</ix:nonFraction>&#160;million that are payable up to eighteen months from the date of acquisition. Health Beacons manufactures the LOCalizer product. Based on the Company's valuation, it allocated $<ix:nonFraction unitRef="usd" contextRef="ie1847e23bfb6472dbc395f6d1338a8db_I20200203" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTEwNDg_10d50452-69ce-44cc-b33b-f7a475e3574d">10.7</ix:nonFraction>&#160;million to developed technology and $<ix:nonFraction unitRef="usd" contextRef="ie1847e23bfb6472dbc395f6d1338a8db_I20200203" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTEwNzk_f13c2646-b1ff-45a0-b1ff-370a38e87649">6.2</ix:nonFraction>&#160;million to goodwill. The remaining $<ix:nonFraction unitRef="usd" contextRef="ie1847e23bfb6472dbc395f6d1338a8db_I20200203" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTExMDk_410f07ac-6802-429b-a24b-7d699af34a86">2.8</ix:nonFraction>&#160;million of the purchase price was allocated to acquired tangible assets and liabilities. Health Beacons' results of operations are reported in the Company's Breast Health reportable segment from the date of acquisition. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Alpha Imaging</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2019, the Company completed the acquisition of assets from Alpha Imaging, LLC ("Alpha Imaging"), for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="i264ebea292b04fd29f44c37de6914f8c_D20191230-20191230" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTE0Nzg_841dd99a-ea17-4796-b5b8-0359b9757478">18.0</ix:nonFraction>&#160;million, which included a hold-back of $<ix:nonFraction unitRef="usd" contextRef="i043ca86798494f61b2666b1a7f46ddd4_I20191230" decimals="-5" format="ixt:numdotdecimal" name="holx:Holdback" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTE1MTI_01a33698-78c9-4331-abdc-1c6840cd7b2b">1.0</ix:nonFraction>&#160;million and contingent consideration, which the Company has estimated at $<ix:nonFraction unitRef="usd" contextRef="i043ca86798494f61b2666b1a7f46ddd4_I20191230" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTE1Nzk_5b49e0ae-5e66-4510-ac1b-5e5e0b5105d7">0.9</ix:nonFraction>&#160;million. The contingent consideration was payable upon shipment of backlog orders entered into by Alpha Imaging prior to the acquisition. Alpha Imaging was a long-standing distributor of the Company's Breast and Skeletal products in the U.S. The majority of the purchase price was allocated to a customer relationships intangible asset with a useful life of <ix:nonNumeric contextRef="ie6fd1be7827e4d14a8a0c3642ea41642_D20191230-20191230" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTE5MzI_628a6373-6e6b-4fec-aa96-e4534033607f">5</ix:nonNumeric> years.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SuperSonic Imagine</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2019, the Company purchased <ix:nonFraction unitRef="number" contextRef="i7606589a8d9a46508518e654ca7bc3cd_I20190801" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTE5OTg_46e45725-3a42-44b9-930f-4038c201f3eb">46</ix:nonFraction>% of the outstanding shares of SuperSonic Imagine ("SSI") for $<ix:nonFraction unitRef="usd" contextRef="iee122e2193954283b59296f2f329c3f5_D20190801-20190801" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTIwNjE_3e52ed1b-5730-4cd5-9607-07a4b41b3183">18.2</ix:nonFraction> million. SSI was a public company located in Aix-en-Provence, France that manufactures and markets ultrasound medical imaging equipment. In September 2019, the Company launched a cash tender offer to acquire the remaining outstanding shares for a price of&#160;&#8364;<ix:nonFraction unitRef="usdPerShare" contextRef="i09ddd178ba8e4ea48372984e4d5984f4_D20190901-20190930" decimals="INF" name="holx:BusinessAcquisitionCashTenderOfferPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTIzMTE_c9d3c0c8-5c37-4adf-8549-db1ee06cfb8c">1.50</ix:nonFraction> per share in cash. The Company determined that SSI was a Variable Interest Entity (&#8220;VIE&#8221;) but it was not the primary beneficiary as it was not a party to the initial design of the entity nor did it have control over SSI's operations until November 21, 2019 when the Company's ownership of SSI's voting stock exceeded <ix:nonFraction unitRef="number" contextRef="iafd366364b034ade874e71b313ac5811_I20191120" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI2MzE_16c5d34a-64a8-4985-bb71-a9144a27d1a1">50</ix:nonFraction>%. Accordingly, the Company initially accounted for this investment under the equity method of accounting.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 21, 2019, the Company acquired an additional <ix:nonFraction unitRef="shares" contextRef="i2d5a252316d24ba8bf7db1b4788097eb_D20191121-20191121" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationAdditionalSharesAcquiredShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI3OTc_125fa98d-0db6-48f3-90c5-1bfc9cc00af6">7.6</ix:nonFraction> million shares of SSI for $<ix:nonFraction unitRef="usd" contextRef="i2d5a252316d24ba8bf7db1b4788097eb_D20191121-20191121" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationAdditionalSharesAcquiredValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI4MTg_b5f5e325-7c4f-4f4c-bfa1-c1139f02c421">12.6</ix:nonFraction> million. As a result, the Company's ownership interest increased to approximately <ix:nonFraction unitRef="number" contextRef="i2d5a252316d24ba8bf7db1b4788097eb_D20191121-20191121" decimals="2" name="holx:BusinessCombinationOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI4OTU_644a5877-43cc-430a-8c97-ebe8d7b5bfd0">78</ix:nonFraction>% of the outstanding common shares of SSI at November 21, 2019, and it now controlled SSI's voting interest and operations. The Company performed purchase accounting as of November 21, 2019 and beginning on that date the financial results of SSI are included within the Company's consolidated financial statements, specifically the Breast Health reportable segment. The Company remeasured the initial investment of <ix:nonFraction unitRef="number" contextRef="i7606589a8d9a46508518e654ca7bc3cd_I20190801" decimals="2" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTMzMTE_d34e4654-e584-44b0-b087-5944dc2cdb72">46</ix:nonFraction>% of the outstanding shares of SSI to its fair value at the acquisition date, resulting in a gain of $<ix:nonFraction unitRef="usd" contextRef="i2d5a252316d24ba8bf7db1b4788097eb_D20191121-20191121" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTM0MTM_d28ff541-a106-4e3e-ac4e-5013e660a6c2">3.2</ix:nonFraction> million recorded to other income (expense), net in the first quarter of fiscal 2020. The total accounting purchase price was $<ix:nonFraction unitRef="usd" contextRef="i2d5a252316d24ba8bf7db1b4788097eb_D20191121-20191121" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTM1MzM_b4bc0632-9661-4680-ab83-1ea7095479de">69.3</ix:nonFraction> million, which consisted of $<ix:nonFraction unitRef="usd" contextRef="i2d5a252316d24ba8bf7db1b4788097eb_D20191121-20191121" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTM1NTY_c5ba7483-76aa-4ca4-9e34-d940007bdc43">17.9</ix:nonFraction> million for the equity method investment in SSI, $<ix:nonFraction unitRef="usd" contextRef="i14f9866ecdf54b2f82e4e696f4ee2148_D20191101-20191130" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTM2MDA_79940b52-1f70-469b-a071-69a01011e894">12.6</ix:nonFraction> million for shares acquired on November 21, 2019, $<ix:nonFraction unitRef="usd" contextRef="i2d5a252316d24ba8bf7db1b4788097eb_D20191121-20191121" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTM2NDU_dc478deb-3734-4bcc-88ec-b41dd29959bc">30.2</ix:nonFraction> million for loans the Company provided to SSI prior to the acquisition to pay-off pre-existing loans and fund operations that are considered forgiven, and $<ix:nonFraction unitRef="usd" contextRef="i2d5a252316d24ba8bf7db1b4788097eb_D20191121-20191121" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTM3OTU_aa4ab261-47e8-4073-8bfa-75c0ac0e9ff2">8.6</ix:nonFraction> million representing the fair value of the noncontrolling interest as of November 21, 2019. The Company purchased an additional <ix:nonFraction unitRef="shares" contextRef="i6cf6aa2100404a05becfe250085e5d00_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationAdditionalSharesAcquiredShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTM5MTg_91c5a8e3-b4b9-4068-ade0-996642166e55">1.1</ix:nonFraction>&#160;million outstanding shares in fiscal 2020 for $<ix:nonFraction unitRef="usd" contextRef="i6cf6aa2100404a05becfe250085e5d00_D20190929-20200926" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationAdditionalSharesAcquiredValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTM5NTk_cc94fdc3-fcc6-4a58-b9fe-cbc170c32700">1.8</ix:nonFraction>&#160;million. In the third quarter of fiscal 2021, the Company purchased the remaining <ix:nonFraction unitRef="shares" contextRef="i14df8e75f81d4e468e9e9ccc3560103e_D20210328-20210626" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationAdditionalSharesAcquiredShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI2NDQzODM3NTIyNzk_fbdf0096-0fe7-49f2-a3ba-ca6b4d0c79b6">4.8</ix:nonFraction>&#160;million shares outstanding for $<ix:nonFraction unitRef="usd" contextRef="i14df8e75f81d4e468e9e9ccc3560103e_D20210328-20210626" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationAdditionalSharesAcquiredValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI2NDQzODM3NTIyOTI_653a2cb8-830f-4ff0-9b50-974f2e501300">8.5</ix:nonFraction>&#160;million, and as of June 26, 2021, the Company owned <ix:nonFraction unitRef="number" contextRef="id1eaaa8f5b1844eca34f3c569e39abce_I20210626" decimals="2" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTQwMjE_79f9ed76-5b03-4264-9d7e-aab8586d2ed5">100</ix:nonFraction>% of the outstanding shares of SSI.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i335f4a44c34842f4a96f0406944230d0" continuedAt="i745e504057b343e9b5649e1ea6771f83">The total purchase price was allocated to SSI's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of November 21, 2019, as set forth below.</ix:continuation></span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><ix:continuation id="icf0597e03578405bb1e69077cb25488a"><div style="text-align:center;text-indent:22.5pt"><ix:continuation id="i745e504057b343e9b5649e1ea6771f83"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.333%"><tr><td style="width:1.0%"></td><td style="width:78.849%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.951%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64adc24ac247463eb19f42515cbcb2b1_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjYyYzk3YjI4YmVjZjRjNzJiNWI0NjE4MmQwYmFiMWIzL3RhYmxlcmFuZ2U6NjJjOTdiMjhiZWNmNGM3MmI1YjQ2MTgyZDBiYWIxYjNfMC0xLTEtMS0w_28f3c723-f4f7-4a25-b9f8-76e64ad3a35b">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64adc24ac247463eb19f42515cbcb2b1_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjYyYzk3YjI4YmVjZjRjNzJiNWI0NjE4MmQwYmFiMWIzL3RhYmxlcmFuZ2U6NjJjOTdiMjhiZWNmNGM3MmI1YjQ2MTgyZDBiYWIxYjNfMS0xLTEtMS0w_42e4b7fc-4604-40c6-82f2-256a61946944">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64adc24ac247463eb19f42515cbcb2b1_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjYyYzk3YjI4YmVjZjRjNzJiNWI0NjE4MmQwYmFiMWIzL3RhYmxlcmFuZ2U6NjJjOTdiMjhiZWNmNGM3MmI1YjQ2MTgyZDBiYWIxYjNfMi0xLTEtMS0w_f257ba7d-e98f-45b2-8e06-b6d86256ef58">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64adc24ac247463eb19f42515cbcb2b1_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjYyYzk3YjI4YmVjZjRjNzJiNWI0NjE4MmQwYmFiMWIzL3RhYmxlcmFuZ2U6NjJjOTdiMjhiZWNmNGM3MmI1YjQ2MTgyZDBiYWIxYjNfMy0xLTEtMS0w_406c5844-3563-421d-a666-278ee72e9f85">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64adc24ac247463eb19f42515cbcb2b1_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjYyYzk3YjI4YmVjZjRjNzJiNWI0NjE4MmQwYmFiMWIzL3RhYmxlcmFuZ2U6NjJjOTdiMjhiZWNmNGM3MmI1YjQ2MTgyZDBiYWIxYjNfNC0xLTEtMS0w_487a0e75-4fda-4b12-8e89-fb2ccf001367">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64adc24ac247463eb19f42515cbcb2b1_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjYyYzk3YjI4YmVjZjRjNzJiNWI0NjE4MmQwYmFiMWIzL3RhYmxlcmFuZ2U6NjJjOTdiMjhiZWNmNGM3MmI1YjQ2MTgyZDBiYWIxYjNfNS0xLTEtMS0w_641751cc-7705-4a29-ba09-b5194ee1452a">24.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64adc24ac247463eb19f42515cbcb2b1_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjYyYzk3YjI4YmVjZjRjNzJiNWI0NjE4MmQwYmFiMWIzL3RhYmxlcmFuZ2U6NjJjOTdiMjhiZWNmNGM3MmI1YjQ2MTgyZDBiYWIxYjNfNi0xLTEtMS0w_f6ac2c4c-5706-4d97-bd43-e92e906001df">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short and long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64adc24ac247463eb19f42515cbcb2b1_I20191121" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjYyYzk3YjI4YmVjZjRjNzJiNWI0NjE4MmQwYmFiMWIzL3RhYmxlcmFuZ2U6NjJjOTdiMjhiZWNmNGM3MmI1YjQ2MTgyZDBiYWIxYjNfNy0xLTEtMS0w_bc89d158-4038-4731-8a05-5ea8b25081fc">8.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64adc24ac247463eb19f42515cbcb2b1_I20191121" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjYyYzk3YjI4YmVjZjRjNzJiNWI0NjE4MmQwYmFiMWIzL3RhYmxlcmFuZ2U6NjJjOTdiMjhiZWNmNGM3MmI1YjQ2MTgyZDBiYWIxYjNfOC0xLTEtMS0w_19863086-a1f8-488d-87c2-cb32633da7f8">3.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64adc24ac247463eb19f42515cbcb2b1_I20191121" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjYyYzk3YjI4YmVjZjRjNzJiNWI0NjE4MmQwYmFiMWIzL3RhYmxlcmFuZ2U6NjJjOTdiMjhiZWNmNGM3MmI1YjQ2MTgyZDBiYWIxYjNfMTAtMS0xLTEtMA_e0e8be6f-8a67-4c7b-b9b2-31862147e41a">38.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64adc24ac247463eb19f42515cbcb2b1_I20191121" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjYyYzk3YjI4YmVjZjRjNzJiNWI0NjE4MmQwYmFiMWIzL3RhYmxlcmFuZ2U6NjJjOTdiMjhiZWNmNGM3MmI1YjQ2MTgyZDBiYWIxYjNfMTEtMS0xLTEtMA_3dc64a8c-8337-48ee-97fa-2444edf43b97">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64adc24ac247463eb19f42515cbcb2b1_I20191121" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjYyYzk3YjI4YmVjZjRjNzJiNWI0NjE4MmQwYmFiMWIzL3RhYmxlcmFuZ2U6NjJjOTdiMjhiZWNmNGM3MmI1YjQ2MTgyZDBiYWIxYjNfMTItMS0xLTEtMA_f691f872-b309-4685-b41f-9cd09236e44d">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64adc24ac247463eb19f42515cbcb2b1_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjYyYzk3YjI4YmVjZjRjNzJiNWI0NjE4MmQwYmFiMWIzL3RhYmxlcmFuZ2U6NjJjOTdiMjhiZWNmNGM3MmI1YjQ2MTgyZDBiYWIxYjNfMTMtMS0xLTEtMA_04d90bae-f0fd-4828-af5c-c5bcbba520a4">1.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64adc24ac247463eb19f42515cbcb2b1_I20191121" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjYyYzk3YjI4YmVjZjRjNzJiNWI0NjE4MmQwYmFiMWIzL3RhYmxlcmFuZ2U6NjJjOTdiMjhiZWNmNGM3MmI1YjQ2MTgyZDBiYWIxYjNfMTQtMS0xLTEtMA_4bbc48ea-a9d6-4900-aa34-41a1080a7333">34.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64adc24ac247463eb19f42515cbcb2b1_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjYyYzk3YjI4YmVjZjRjNzJiNWI0NjE4MmQwYmFiMWIzL3RhYmxlcmFuZ2U6NjJjOTdiMjhiZWNmNGM3MmI1YjQ2MTgyZDBiYWIxYjNfMTUtMS0xLTEtMA_1d7398be-1907-4498-8e15-9dd100dc9fae">69.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of SSI's business. As part of the purchase price allocation, the Company determined the identifiable intangible assets were developed technology, customer relationships, and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a <ix:nonFraction unitRef="number" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="3" name="holx:FairValueAssumptionDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTQ4MDU_4b515330-da55-48e8-921f-ff3ee73d4d2b">12.0</ix:nonFraction>% rate. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life for the developed technology is <ix:nonNumeric contextRef="i93381ce7098c4e4fa2bb4eea52c5dce4_D20191121-20191121" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTUxMDQ_3fc71a54-2ef6-4482-b2e7-876e69b5a9a0">9</ix:nonNumeric> years, customer relationships is <ix:nonNumeric contextRef="i13826201466c4300b5dd607143edc940_D20191121-20191121" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTUxMzQ_39baf0e4-c7e0-413d-9d5f-159dbeec50b1">9</ix:nonNumeric> years and trade names is <ix:nonNumeric contextRef="iaa6bff4ae2dc4a33986e101d589e889a_D20191121-20191121" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTUxNTY_5a5ad9f1-22af-4e28-a8b8-d894a585a500">8.6</ix:nonNumeric> years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the amount of goodwill were based on anticipated synergistic benefits of SSI's products being complementary to Breast Health's 3D mammography systems and using the Company's existing U.S. sales force as SSI's presence in the U.S. is limited. None of the goodwill is expected to be deductible for income tax purposes.</span></div></ix:continuation><div id="i181d930c7b854595977e17db8fd84eb4_55"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(6) <ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81NS9mcmFnOmUxMzBmYjUzYzZhMzQ1Mjk5NzAwODk4YjczYTI5MjY5L3RleHRyZWdpb246ZTEzMGZiNTNjNmEzNDUyOTk3MDA4OThiNzNhMjkyNjlfMjYwOQ_ee265667-0747-4fe6-831d-fd075f42cbc0" continuedAt="ib393b1ded6c747d08e79c0e1c2e0078e" escape="true">Disposition - Sale of Medical Aesthetics</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><ix:continuation id="ib393b1ded6c747d08e79c0e1c2e0078e" continuedAt="i509e2f5e5ce9491bb1029becd1f442c8"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 20, 2019, the Company entered into a definitive agreement to sell its Medical Aesthetics business to Clayton Dubilier &amp; Rice ("CD&amp;R") for a sales price of&#160;$<ix:nonFraction unitRef="usd" contextRef="i89c6030b3fa74130a05c86c5566ac9b5_I20191120" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81NS9mcmFnOmUxMzBmYjUzYzZhMzQ1Mjk5NzAwODk4YjczYTI5MjY5L3RleHRyZWdpb246ZTEzMGZiNTNjNmEzNDUyOTk3MDA4OThiNzNhMjkyNjlfMjE5_ca7d0151-4c75-44e4-906c-3b1a4c12f61d">205.0</ix:nonFraction> million&#160;in cash, less certain adjustments. The sale was completed on December 30, 2019, and the Company received cash proceeds of $<ix:nonFraction unitRef="usd" contextRef="icd5055934cbe40cc89289656c936a8cd_D20191120-20191120" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81NS9mcmFnOmUxMzBmYjUzYzZhMzQ1Mjk5NzAwODk4YjczYTI5MjY5L3RleHRyZWdpb246ZTEzMGZiNTNjNmEzNDUyOTk3MDA4OThiNzNhMjkyNjlfMzQ0_5938d7d3-a8a8-4294-9b6a-be179507934f">153.4</ix:nonFraction> million in the second quarter of fiscal 2020. The sale price was subject to adjustment pursuant to the terms of the definitive agreement, and the parties agreed to a final sales price of $<ix:nonNumeric contextRef="id999567ff4ad4d47967ba1b3ba2d4f74_D20200628-20200926" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81NS9mcmFnOmUxMzBmYjUzYzZhMzQ1Mjk5NzAwODk4YjczYTI5MjY5L3RleHRyZWdpb246ZTEzMGZiNTNjNmEzNDUyOTk3MDA4OThiNzNhMjkyNjlfNTI2_7dc954db-1903-40a8-a1f0-53b0016d14f1">150.0&#160;million</ix:nonNumeric> in the fourth quarter of fiscal 2020. The Company agreed to provide certain transition services for three to fifteen months, depending on the nature of the service. The Company also agreed to indemnify CD&amp;R for certain legal and tax matters that existed as of the date of disposition. In connection with its accounting for the sale, the Company recorded indemnification liabilities of $<ix:nonFraction unitRef="usd" contextRef="ieb526c3393b94999af44e0f2283027b9_I20210626" decimals="-5" format="ixt:numdotdecimal" name="holx:IndemnificationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81NS9mcmFnOmUxMzBmYjUzYzZhMzQ1Mjk5NzAwODk4YjczYTI5MjY5L3RleHRyZWdpb246ZTEzMGZiNTNjNmEzNDUyOTk3MDA4OThiNzNhMjkyNjlfOTE0_54af8c59-c56e-4851-8613-3dd613e715cc">10.9</ix:nonFraction>&#160;million within accrued expenses associated with its obligations under the sale agreement.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of this transaction, the Medical Aesthetics asset group was designated as assets held-for-sale in the first quarter of fiscal 2020. Pursuant to ASC 360, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment and Disposal of Long-Lived Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, asset groups under this designation are required to be recorded at fair value less costs to sell. The Company determined that this disposal did not qualify as a discontinued operation as the sale of the Medical Aesthetics business was deemed to not be a strategic shift having or will have a major effect on the Company's operations and financial results. Based on the terms in the agreement of the sales price and formula for net working capital and related adjustments, its estimate of the fair value for transition services and the amount that must be carved out of the sale proceeds, and liabilities the Company will retain or for which it has agreed to indemnify CD&amp;R, the Company recorded an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="id01db50d7a6347809cb98adf4b5c0c66_D20190929-20191228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81NS9mcmFnOmUxMzBmYjUzYzZhMzQ1Mjk5NzAwODk4YjczYTI5MjY5L3RleHRyZWdpb246ZTEzMGZiNTNjNmEzNDUyOTk3MDA4OThiNzNhMjkyNjlfMTg4NA_f13495b7-8caf-4a87-862d-3eaeaa94a2a9">30.2</ix:nonFraction> million in the first quarter of fiscal 2020. The impairment charge was allocated to Medical Aesthetics long-lived assets, of which $<ix:nonFraction unitRef="usd" contextRef="ie01a803f233b45f4a49380b21ad6bb32_D20190929-20191228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81NS9mcmFnOmUxMzBmYjUzYzZhMzQ1Mjk5NzAwODk4YjczYTI5MjY5L3RleHRyZWdpb246ZTEzMGZiNTNjNmEzNDUyOTk3MDA4OThiNzNhMjkyNjlfMjAxMA_1e189e89-1f5f-4f20-9ccf-70c63cd7fb78">25.8</ix:nonFraction> million was allocated to cost of product revenues and $<ix:nonFraction unitRef="usd" contextRef="i8d24eb58cd394fae908cb1b14bef726b_D20190929-20191228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81NS9mcmFnOmUxMzBmYjUzYzZhMzQ1Mjk5NzAwODk4YjczYTI5MjY5L3RleHRyZWdpb246ZTEzMGZiNTNjNmEzNDUyOTk3MDA4OThiNzNhMjkyNjlfMjA1OQ_154429d4-cc1a-4d2c-a19d-afacd0e25d36">4.4</ix:nonFraction> million to operating expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of fiscal 2020, this business incurred a loss from operations of $<ix:nonFraction unitRef="usd" contextRef="id01db50d7a6347809cb98adf4b5c0c66_D20190929-20191228" decimals="5" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81NS9mcmFnOmUxMzBmYjUzYzZhMzQ1Mjk5NzAwODk4YjczYTI5MjY5L3RleHRyZWdpb246ZTEzMGZiNTNjNmEzNDUyOTk3MDA4OThiNzNhMjkyNjlfMjE3Mg_738e2815-469c-44ec-b1ef-53b3a6701384">46.5</ix:nonFraction>&#160;million, which excludes corporate allocations. The operating expenses include only those that were incurred directly by and were retained by the </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i509e2f5e5ce9491bb1029becd1f442c8">disposed business. The Company will continue to incur expenses related to this business under the indemnification provisions primarily related to legal and tax matters that existed as of the date of disposition. These expenses were not significant in the first, second and third quarters of fiscal 2021.</ix:continuation></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div id="i181d930c7b854595977e17db8fd84eb4_58"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(7) <ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfNjQ4MA_75cca42c-ff40-45ed-8e0e-cd6a53c580dd" continuedAt="if4545968c3e6427483c09f710fe965cc" escape="true">Borrowings and Credit Arrangements</ix:nonNumeric></span></div><ix:continuation id="if4545968c3e6427483c09f710fe965cc" continuedAt="i72616b5ad06541c68d1e8f772d902016"><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfNjUwMw_1a7c383a-63bf-43b3-8381-04452204b4da" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s borrowings consisted of the following:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.365%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current debt obligations, net of debt discount and deferred issuance costs:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife6cd667a004466dbd21c797fb6eb40b_I20210626" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfMi0xLTEtMS0w_dabf2107-3f78-40eb-835f-58f352229243">74.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4475d98ff97042aab50ce4cee82db95b_I20200926" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfMi0zLTEtMS0w_546e2b79-2c98-4753-b6f2-d67236a61467">74.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice236c25c4d740418e834bf0afc51506_I20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfMy0xLTEtMS0w_d73356d8-9535-4a50-a2c3-0cf4572d9c1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1964d49d44004c788bf1f11e793a2e68_I20200926" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfMy0zLTEtMS0w_87bc71b1-ffa0-4d22-965b-1405a03780de">250.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securitization Program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ff6e83c3f4f43a292e67915ac446908_I20210626" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfNC0xLTEtMS0w_24a91a74-79a3-40eb-8ccb-99603f26ee05">320.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c8160a52fd54288931c8a6169582fbc_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfNC0zLTEtMS0w_ee5d8130-16bd-4114-963c-0f8f9863a4ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f1fa7442a694b4fbb79b5dea180468f_I20210626" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfNi0xLTEtMS01MjYx_67416232-8002-4986-864b-456b3c7ea66f">65.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5529a4948994271968a3ed7d11437fa_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfNi0zLTEtMS01MjYz_6885c5ec-8442-4db4-8de5-6b62fdf5bfa4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current debt obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfNi0xLTEtMS0w_731abf7b-d73f-4c71-b942-513e80888ced">460.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfNi0zLTEtMS0w_beff2aec-4971-4e2e-9b92-6d26c5a53e7a">324.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt obligations, net of debt discount and issuance costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife6cd667a004466dbd21c797fb6eb40b_I20210626" decimals="-5" format="ixt:numdotdecimal" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfOC0xLTEtMS0w_ad04bf16-ee81-4d8d-af51-100c510196b1">1,325.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4475d98ff97042aab50ce4cee82db95b_I20200926" decimals="-5" format="ixt:numdotdecimal" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfOC0zLTEtMS0w_8378578c-23f9-42e1-9fd0-69df5f91456a">1,379.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf97edf455654668b98e5a775e14b2d5_I20210626" decimals="-5" format="ixt:zerodash" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfMTAtMS0xLTEtMA_7308072d-057f-4383-9b1a-5d7758413a50">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i023aa7ed3f4f4c63b7915aaca3a74a20_I20200926" decimals="-5" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfMTAtMy0xLTEtMA_8f022b9d-3203-419f-a620-8888eab2b85c">939.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfa1efc297734235ad6cd2cb7b00179e_I20210626" decimals="-5" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfMTEtMS0xLTEtMA_364793b0-405a-472a-96e4-ad7c318a8dd4">395.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27fc517175434926997757aeb6acf88f_I20200926" decimals="-5" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfMTEtMy0xLTEtMA_c3c0d486-3dae-436b-80e0-b75e1cad6bf2">394.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e480c0e3a7a477b9e530aae1be7fb57_I20210626" decimals="-5" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfMTItMS0xLTEtMA_1bbac5cc-f972-4eb6-beec-c9f6081604b2">934.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07ebc1d0fd124863ae761151644bf529_I20200926" decimals="-5" format="ixt:zerodash" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfMTItMy0xLTEtMA_c6fbb597-6f5f-410b-bbf3-3343ee3017f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfMTMtMS0xLTEtMA_682228ac-da58-4640-b51e-5d841b21b469">2,654.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfMTMtMy0xLTEtMA_71aeed95-50d1-42f7-80ee-7bb52bb51aaa">2,713.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfMTQtMS0xLTEtMA_ccbd6289-5e68-4eb3-bd35-c16e401c8bd2">3,115.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfMTQtMy0xLTEtMA_e54219bd-01a4-481f-9a16-ebeaf4da0365">3,038.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:4pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2018 Amended and Restated Credit Agreement</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 17, 2018, the Company and certain of its subsidiaries refinanced its term loan and revolving credit facility by entering into an Amended and Restated Credit and Guaranty Agreement as of December 17, 2018 (the "2018 Credit Agreement") with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders. The 2018 Credit Agreement amended and restated the Company's prior credit and guaranty agreement dated as of October 3, 2017 (the "2017 Credit Agreement"). As of June 26, 2021, the principal amount outstanding of the term loan under the 2018 Credit Agreement (the "Term Loan") was $<ix:nonFraction unitRef="usd" contextRef="ife6cd667a004466dbd21c797fb6eb40b_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfODAw_f715ebd5-e8bb-403b-8629-c2669685db84">1.4</ix:nonFraction>&#160;billion. The Term Loan bears interest at an annual rate equal to the Eurocurrency Rate (i.e., the LIBOR rate) plus an Applicable Rate, which was <ix:nonFraction unitRef="number" contextRef="i31d3ec20ba1341c886214cb33feb29ee_D20200927-20210626" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfOTQw_472cbb06-2f38-4fe0-a2be-b91c1b971c1a">1.00</ix:nonFraction>% as of June 26, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has a $<ix:nonFraction unitRef="usd" contextRef="i4f04002445d14733ac6500556e77b603_I20181217" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfOTg5_062c26ad-5dfb-42a7-b292-5fedfd66df6d">1.5</ix:nonFraction>&#160;billion revolving credit facility (the "Revolver") under the 2018 Credit Agreement. The borrowings of the Revolver bear interest at a rate equal to the LIBOR Daily Floating Rate plus an Applicable Rate, which was <ix:nonFraction unitRef="number" contextRef="i9dcce0b55c1f4c47947079e2231dd5ff_D20200927-20210626" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMTI2NDQzODM3NDY0MzY_e527e139-c599-4d30-9a3e-ddf258366a26">1.00</ix:nonFraction>% as of June 26, 2021. In response to the market uncertainties created by the COVID-19 pandemic in March 2020, the Company borrowed $<ix:nonFraction unitRef="usd" contextRef="i452a598227b942de9d498139c901ddd7_I20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMTMzNA_d5757540-1bb5-48ad-9235-e2de26093510">750.0</ix:nonFraction> million under the Revolver, $<ix:nonFraction unitRef="usd" contextRef="i7e72c82ce3de4fdfbe618331b89acadd_D20190929-20200627" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMTM1Nw_623c2bc6-5df5-4970-ba74-556d58cebe7b">250.0</ix:nonFraction> million of which, at the time, was used to pay off amounts outstanding under the asset securitization agreement, in order to have sufficient cash on hand. During the first quarter of fiscal 2021, the Company paid off the remaining outstanding balance of $<ix:nonFraction unitRef="usd" contextRef="i4b58c2da43604857b653e5db4b73edfd_D20201227-20210327" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMTU5Mg_faa0c58e-f6ce-4139-9a0d-e20579d15d7a">250.0</ix:nonFraction>&#160;million. As of June 26, 2021, the full amount of the Revolver was available to borrow by the Company.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfNjQ5Mg_ee5fcef2-3f02-4aa8-953d-a890b9114ddd" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, weighted average interest rates, and the interest rate at the end of period under the Credit Agreements were as follows:&#160;</span></div><div style="text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.590%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.590%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.669%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5b7a6104f348f895e5d94b65b73817_D20210328-20210626" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQzNDBhY2ZmZWZkNzQwYTRhMjZhOGQ4Yzc2NzBhOWNlL3RhYmxlcmFuZ2U6ZDM0MGFjZmZlZmQ3NDBhNGEyNmE4ZDhjNzY3MGE5Y2VfMi0xLTEtMS0w_13ddeb07-8947-4cd3-b6b4-d37eee2ee6d8">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i445296b9bcdf4ecfb15eb4fdf4e5f027_D20200329-20200627" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQzNDBhY2ZmZWZkNzQwYTRhMjZhOGQ4Yzc2NzBhOWNlL3RhYmxlcmFuZ2U6ZDM0MGFjZmZlZmQ3NDBhNGEyNmE4ZDhjNzY3MGE5Y2VfMi0zLTEtMS0w_f72b5c1f-62c4-4347-a453-1a9648934fd2">11.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ce4e8f765314eb29fce3b97b407943b_D20200927-20210626" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQzNDBhY2ZmZWZkNzQwYTRhMjZhOGQ4Yzc2NzBhOWNlL3RhYmxlcmFuZ2U6ZDM0MGFjZmZlZmQ3NDBhNGEyNmE4ZDhjNzY3MGE5Y2VfMi01LTEtMS0w_bdb84baf-bb4c-43f7-a495-c05189b2edda">17.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i591133f22d3243e1ad73bed94da1fe58_D20190929-20200627" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQzNDBhY2ZmZWZkNzQwYTRhMjZhOGQ4Yzc2NzBhOWNlL3RhYmxlcmFuZ2U6ZDM0MGFjZmZlZmQ3NDBhNGEyNmE4ZDhjNzY3MGE5Y2VfMi03LTEtMS0w_04928a41-eb48-425f-8532-29090f2dfc8c">38.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9b5b7a6104f348f895e5d94b65b73817_D20210328-20210626" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQzNDBhY2ZmZWZkNzQwYTRhMjZhOGQ4Yzc2NzBhOWNlL3RhYmxlcmFuZ2U6ZDM0MGFjZmZlZmQ3NDBhNGEyNmE4ZDhjNzY3MGE5Y2VfMy0xLTEtMS0w_05163d96-8106-4767-86f1-b42085a9cbf3">1.10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i445296b9bcdf4ecfb15eb4fdf4e5f027_D20200329-20200627" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQzNDBhY2ZmZWZkNzQwYTRhMjZhOGQ4Yzc2NzBhOWNlL3RhYmxlcmFuZ2U6ZDM0MGFjZmZlZmQ3NDBhNGEyNmE4ZDhjNzY3MGE5Y2VfMy0zLTEtMS0w_f58280d4-0201-47c2-a376-d85149b3d6a4">1.68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8ce4e8f765314eb29fce3b97b407943b_D20200927-20210626" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQzNDBhY2ZmZWZkNzQwYTRhMjZhOGQ4Yzc2NzBhOWNlL3RhYmxlcmFuZ2U6ZDM0MGFjZmZlZmQ3NDBhNGEyNmE4ZDhjNzY3MGE5Y2VfMy01LTEtMS0w_ed541452-6ced-4e12-b53d-d11dfa2242ce">1.15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i591133f22d3243e1ad73bed94da1fe58_D20190929-20200627" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQzNDBhY2ZmZWZkNzQwYTRhMjZhOGQ4Yzc2NzBhOWNlL3RhYmxlcmFuZ2U6ZDM0MGFjZmZlZmQ3NDBhNGEyNmE4ZDhjNzY3MGE5Y2VfMy03LTEtMS0w_d278f5be-572c-44a9-b344-62473047efde">2.52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate at end of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id56c8faa0e884b19a2eebe191531428a_I20210626" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQzNDBhY2ZmZWZkNzQwYTRhMjZhOGQ4Yzc2NzBhOWNlL3RhYmxlcmFuZ2U6ZDM0MGFjZmZlZmQ3NDBhNGEyNmE4ZDhjNzY3MGE5Y2VfNC0xLTEtMS0w_69b23baf-be89-4aff-911e-0c4c19d7e246">1.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic3a95a70aff44f249453fd1c435fc905_I20200627" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQzNDBhY2ZmZWZkNzQwYTRhMjZhOGQ4Yzc2NzBhOWNlL3RhYmxlcmFuZ2U6ZDM0MGFjZmZlZmQ3NDBhNGEyNmE4ZDhjNzY3MGE5Y2VfNC0zLTEtMS0w_2a3dd4b1-da32-4228-89c6-01b5d07cc0e8">1.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id56c8faa0e884b19a2eebe191531428a_I20210626" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQzNDBhY2ZmZWZkNzQwYTRhMjZhOGQ4Yzc2NzBhOWNlL3RhYmxlcmFuZ2U6ZDM0MGFjZmZlZmQ3NDBhNGEyNmE4ZDhjNzY3MGE5Y2VfNC01LTEtMS0w_f03a4b49-d00d-43e3-b856-d742c319a4bb">1.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic3a95a70aff44f249453fd1c435fc905_I20200627" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQzNDBhY2ZmZWZkNzQwYTRhMjZhOGQ4Yzc2NzBhOWNlL3RhYmxlcmFuZ2U6ZDM0MGFjZmZlZmQ3NDBhNGEyNmE4ZDhjNzY3MGE5Y2VfNC03LTEtMS0w_6adaaa6e-763e-42e2-9cc0-598d292e4458">1.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Credit Agreement contains two financial covenants; a total leverage ratio and an interest coverage ratio, both of which are measured as of the last day of each fiscal quarter. These terms, and calculations thereof, are defined in further detail in the 2018 Credit Agreement. As of June 26, 2021, the Company was in compliance with these covenants.</span></div></ix:continuation><div style="padding-left:72pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><ix:continuation id="i72616b5ad06541c68d1e8f772d902016" continuedAt="id6c59ab2e7a64778ad799a06eea00ff2"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2020, the Company completed a private placement of $<ix:nonFraction unitRef="usd" contextRef="i4907eca3275146f2be21f4eb741ba4b0_I20200928" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMjI4Mg_80dda7ae-6f48-46a5-84d6-34135a900655">950</ix:nonFraction>&#160;million aggregate principal amount of its <ix:nonFraction unitRef="number" contextRef="i4907eca3275146f2be21f4eb741ba4b0_I20200928" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMjMxOQ_0484746d-8282-4b11-a553-0140039fc48d">3.250</ix:nonFraction>% Senior Notes due 2029 (the "2029 Senior Notes") at an offering price of <ix:nonFraction unitRef="number" contextRef="i4907eca3275146f2be21f4eb741ba4b0_I20200928" decimals="INF" name="holx:DebtInstrumentOfferingPricePercentOfFaceValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMjM5NA_056d10d1-d7e7-4802-9d04-a4587d53d92c">100</ix:nonFraction>% of the aggregate principal amount of the 2029 Senior Notes. The Company used the net proceeds of the 2029 Senior Notes offering and cash on hand to redeem in full its <ix:nonFraction unitRef="number" contextRef="i6dadc087c8a44b1da848875eb301fdf0_I20210626" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMjU2NA_59e2f53b-7db2-45de-b763-340a2fd289ea">4.375</ix:nonFraction>% Senior Notes due 2025 (the "2025 Senior Notes") in the aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="icb207831ddaa4d53943e75a7eb55d27d_I20201015" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfNjUwNQ_f6fda12e-719f-4759-b0e4-d883ef9ca28c">950.0</ix:nonFraction>&#160;million on October 15, 2020 at an aggregate redemption price of $<ix:nonFraction unitRef="usd" contextRef="idcd52cb6d519499f96285824f70d71e3_D20201015-20201015" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMjcxMQ_7a5e3ece-5baf-415b-89af-07a7bcdaf37f">970.8</ix:nonFraction>&#160;million, which included a premium payment $<ix:nonFraction unitRef="usd" contextRef="idcd52cb6d519499f96285824f70d71e3_D20201015-20201015" decimals="-5" format="ixt:numdotdecimal" name="holx:DebtRedemptionPremiumPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMjc0Mw_6bf98ab3-ea05-400f-ac45-b9997d63383f">20.8</ix:nonFraction>&#160;million.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2025 Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immediately prior to redemption in full of the 2025 Senior Notes on October 15, 2020, the total aggregate principal balance of 2025 Senior Notes was $<ix:nonFraction unitRef="usd" contextRef="i6dadc087c8a44b1da848875eb301fdf0_I20210626" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMjkxNg_6fd2f9a7-334d-4647-abe0-e5aa86437fb1">950.0</ix:nonFraction> million. As the Company planned to use the proceeds from the 2029 Senior Notes offering to redeem the 2025 Senior Notes, the Company evaluated the accounting for this transaction under ASC 470, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to determine modification versus extinguishment accounting on a creditor-by-creditor basis. Certain 2025 Senior Note holders either did not participate in this refinancing transaction or reduced their holdings, and these transactions were accounted for as extinguishments. As a result, the Company recorded a debt extinguishment loss in the first quarter of fiscal 2021 of $<ix:nonFraction unitRef="usd" contextRef="i35ee10ac5818441fa558f668e84866f4_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMzQ4NA_d4ce094c-de2e-4ac1-b52c-0d0549c05191">21.6</ix:nonFraction>&#160;million. For the remaining 2025 Senior Notes holders who participated in the refinancing, these transactions were accounted for as modifications because on a creditor-by-creditor basis the present value of the cash flows between the debt instruments before and after the transaction was less than 10%. The Company recorded a portion of the transaction expenses of $<ix:nonFraction unitRef="usd" contextRef="i35ee10ac5818441fa558f668e84866f4_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMzg0Mw_ee8674e5-fcc2-456d-bd20-2f91fd8c42f0">5.8</ix:nonFraction>&#160;million to interest expense pursuant to ASC 470, subtopic 50-40. The remaining debt issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i99efd783beac43bc87299f6deef20b60_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMzk0MA_d794aca4-3985-4391-baf8-622aaf795e12">7.9</ix:nonFraction>&#160;million and debt discount of $<ix:nonFraction unitRef="usd" contextRef="i99efd783beac43bc87299f6deef20b60_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMzk2NA_e116d04c-61e6-4312-8514-d7c4fe5590cc">6.4</ix:nonFraction>&#160;million related to the modified debt will be amortized over the new term of the 2029 Senior Notes using the effective interest method.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2028 Senior Notes</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 26, 2021, the Company had <ix:nonFraction unitRef="number" contextRef="if5751d5d110e4560bd36bc872e1c4b0e_I20210626" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfNDE1Mw_e6efa623-1243-4cc7-a259-cae01cf12950">4.625</ix:nonFraction>% Senior Notes due 2028 (the "2028 Senior Notes") outstanding in the aggregate principal balance of $<ix:nonFraction unitRef="usd" contextRef="ibfa1efc297734235ad6cd2cb7b00179e_I20210626" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfNDI1NA_72318e01-36a8-4223-9998-226b6ad2235b">400</ix:nonFraction> million. The 2028 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries and mature on February&#160;1, 2028. </span></div><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="holx:ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfNjQ5NA_d2b323f6-4d4d-4dbd-8ae6-9f9f2c7fe9a3" continuedAt="i0c42d5213d4743f7837b4663372950b0" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2029 Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 26, 2021, the Company had 2029 Senior Notes outstanding in the aggregate principal balance of $<ix:nonFraction unitRef="usd" contextRef="ia37016a8326544bf8a213352899c6992_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfNDU3NA_be253faf-0e5d-4258-b127-24148dce2b11">950</ix:nonFraction>&#160;million. The 2029 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2029 Senior Notes mature on February&#160;15, 2029 and bear interest at the rate of <ix:nonFraction unitRef="number" contextRef="ia37016a8326544bf8a213352899c6992_I20210626" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfNDgyMA_92915cb3-fff4-4c97-8f5a-62c8498513ec">3.250</ix:nonFraction>%&#160;per year, payable semi-annually on February&#160;15 and August&#160;15 of each year, commencing on February&#160;15, 2021.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may redeem the 2029 Senior Notes at any time prior to September 28, 2023 at a price equal to <ix:nonFraction unitRef="number" contextRef="i272408a201f84cd288d1a786c8851839_D20200928-20200928" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfNTAzNw_3fea4054-2a60-4cd4-be72-a1c958ecdf68">100</ix:nonFraction>% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. The Company may also redeem up to <ix:nonFraction unitRef="number" contextRef="i58a7d1a68082480f9d9f002f635ba871_D20200928-20200928" decimals="3" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfNTIzOQ_eeb9151f-6379-46d9-80f3-93573c46a005">40</ix:nonFraction>% of the aggregate principal amount of the 2029 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before September 28, 2023, at a redemption price equal to <ix:nonFraction unitRef="number" contextRef="i1fbee7ea3857414fa862793ac5e38693_D20200928-20200928" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfNTQ0OA_b04808d5-a796-42e1-b91a-859c3cf1faf4">103.250</ix:nonFraction>% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. The Company also has the option to redeem the 2029 Senior Notes on or after: September 28, 2023 through September 27, 2024 at <ix:nonFraction unitRef="number" contextRef="i9b55461839564a798b7bb1fc48436aca_D20200928-20200928" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfNTY5MA_b1b8b1ac-8563-482a-9a20-be51e167009b">101.625</ix:nonFraction>% of par; September 28, 2024 through September 27, 2025 at <ix:nonFraction unitRef="number" contextRef="i258e1d37987f4730b42e74f9f49dd3b4_D20200928-20200928" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfNTc1MA_80b33dce-2d0f-48f7-9a4a-a4b0b5af6d3e">100.813</ix:nonFraction>% of par; and September 28, 2025 and thereafter at <ix:nonFraction unitRef="number" contextRef="i7f78f01fcb324006bd1e7e387d41e29e_D20200928-20200928" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfNTgwMg_5f92c525-ec25-4565-aece-8cc128ab739a">100</ix:nonFraction>% of par. In addition, if the Company undergoes a change of control coupled with a decline in ratings, as provided in the indenture, the Company will be required to make an offer to purchase each holder&#8217;s 2029 Senior Notes at a price equal to <ix:nonFraction unitRef="number" contextRef="i329f003f9cc04450b29fe980f0e42689_D20200928-20200928" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfNjA0Ng_f00fbb36-0bd4-4cff-a313-e72e7db15bd3">101</ix:nonFraction>% of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated the 2029 Senior Notes for derivatives pursuant to ASC 815, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and did not identify any embedded derivatives that require bifurcation. All features were deemed to be clearly and closely related to the host instrument.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><ix:continuation id="id6c59ab2e7a64778ad799a06eea00ff2"><ix:continuation id="i0c42d5213d4743f7837b4663372950b0"><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the 2029 Senior Notes, 2028 Senior Notes and 2025 Senior Notes was as follows:</span></div><div style="margin-top:17pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.503%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 27, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 27, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6dadc087c8a44b1da848875eb301fdf0_I20210626" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfMy0xLTEtMS0w_f242c0b8-f448-4778-b68d-f0bad62451ca">4.375</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie522d6c7b67b40d19313f779c8b07346_D20210328-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfMy0zLTEtMS0w_7cb3f9c3-17c3-4879-bed9-6d0a9a86907f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d1ba28aff8c4b5eb47bf61baea22a44_D20200329-20200627" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfMy01LTEtMS0w_c8de5b91-313c-4836-babe-dca61501fb25">10.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2247e22bbae24374988ac11163883a5c_D20200927-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfMy03LTEtMS0w_f27db88f-6aa3-4573-8107-47c4c0a391ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8698881588e046c79a6a901616722216_D20190929-20200627" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfMy05LTEtMS0w_7a60b88c-775b-45a4-85f3-1f2245aec583">32.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if5751d5d110e4560bd36bc872e1c4b0e_I20210626" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfNC0xLTEtMS0w_4b0bd42e-6522-4fd6-a8f3-7d7f79f26659">4.625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if54bade04c4249debfc877171a9be8f7_D20210328-20210626" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfNC0zLTEtMS0w_568d60a0-80b5-47bf-8b4b-935fc440d2b2">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaeeaee82866e48a589b1b33acc7cf61a_D20200329-20200627" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfNC01LTEtMS0w_11ce1f0b-fc29-4660-aa91-e17892155409">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id87e5e40d00a4f109965253aef07499a_D20200927-20210626" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfNC03LTEtMS0w_6e032e01-f5e3-4aeb-9e5d-87730b97acaf">14.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f75b26e46cf4818a4e3b058a04c9785_D20190929-20200627" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfNC05LTEtMS0w_c4a6010f-8232-44c8-8724-d202ed7a3b49">14.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia37016a8326544bf8a213352899c6992_I20210626" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfNS0xLTEtMS0w_f2bbedae-6c39-41b8-9fa1-47adae5a0e28">3.250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e93a00f39ec434891148097002f9117_D20210328-20210626" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfNS0zLTEtMS0w_d9e4c66f-f17c-4009-a492-c6150657539e">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice0bd1095b304c78a2f49ad45c325064_D20200329-20200627" decimals="-5" format="ixt:zerodash" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfNS01LTEtMS0w_4b05c5a5-b635-4d5c-b893-abb34df2aee4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i866deb20efa24ed4b2313072a748ba62_D20200927-20210626" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfNS03LTEtMS0w_db1975ec-7f0e-4dd8-90f0-d4153d9e5c53">24.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i683d2ded0a1c4448856d8951affc8993_D20190929-20200627" decimals="-5" format="ixt:zerodash" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfNS05LTEtMS0w_82945d49-8a92-4544-b7ca-45668f12323b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfNi0zLTEtMS0w_09d7a0fd-893e-4a5a-9352-61ec76292456">13.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfNi01LTEtMS0w_e6dbf3b2-1681-4fd9-b55a-63cdb8b3975b">15.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfNi03LTEtMS0w_9435b2ca-a3d8-4c3c-9044-6513bc45b95d">38.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfNi05LTEtMS0w_c56accb9-71a3-488c-a6c4-0584d4c4652d">47.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:17pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable Securitization Program</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the market uncertainties created by the COVID-19 pandemic, on March 26, 2020, the Company paid-off the total amount outstanding of $<ix:nonFraction unitRef="usd" contextRef="i51b89923ffd8491d8c6ac3b49ee1985b_D20210326-20210326" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMTA5OTUxMTY0ODYyNQ_02330f6e-2d9c-4ef4-b3d4-dc7e727d2a94">250.0</ix:nonFraction>&#160;million previously borrowed under the Accounts Receivable Securitization Program (the "Securitization Program"). On April 13, 2020, the Company amended the Credit and Security agreement with the lenders, temporarily suspending the ability to borrow and the need to comply with covenants for up to a year. On June 11, 2021, the Company amended and restated the Credit and Security agreement to restart the Securitization Program and increase the maximum borrowing amount to $<ix:nonFraction unitRef="usd" contextRef="i799dc9d3fd134b658546a8859e0bb7ae_I20210611" decimals="-5" format="ixt:numdotdecimal" name="holx:MaximumBorrowingUnderAssetSecuritizationAgreement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMTA5OTUxMTY0ODYwOQ_2e4cdc95-32c5-4591-bd50-38ede911fb78">320.0</ix:nonFraction>&#160;million. Loans outstanding under the Securitization Program bear interest at LIBOR plus an applicable margin for defined tranches. As of June 26, 2021, there was $<ix:nonFraction unitRef="usd" contextRef="i5ff6e83c3f4f43a292e67915ac446908_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMTA5OTUxMTY0ODU5Mw_916e363d-30ad-43ee-97f8-bee350e66f84">320.0</ix:nonFraction>&#160;million outstanding under this program. The weighted average interest rate under the Securitization Program was <ix:nonFraction unitRef="number" contextRef="i5ff6e83c3f4f43a292e67915ac446908_I20210626" decimals="4" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMTI2NDQzODM3NDY0NDQ_2cf15a27-d40f-421a-bc98-48956a71b8fb">0.78</ix:nonFraction>% as of June 26, 2021.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other represents debt acquired in the Mobidiag acquisition, which is primarily with the European Investment Bank ("EIB"). Multiple tranches were withdrawn under the agreement and were primarily used to fund research and development projects and expansion efforts. The debt agreement contains change-in-control provisions allowing the EIB to call the debt at any time after a change-in-control, which occurred as a result of Hologic acquiring Mobidiag. Accordingly, the Company has classified the debt as current. The tranches withdrawn under this agreement have interest rates ranging from <ix:nonFraction unitRef="number" contextRef="i50f502634b964d3ca840a4e7ff046d9d_I20210617" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMTI2NDQzODM3NDY0NTE_2daaf552-1a14-458d-aab1-ea8248816da3">6.0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i9d26208b685b4dc0a4c5422ac184fb3b_I20210617" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMTI2NDQzODM3NDY0NTc_9fea5e37-3e32-45a5-8b7f-960c7bfe8b77">7.0</ix:nonFraction>%. The debt agreement includes additional payments to the EIB based on revenues generated by products developed under the funding as well as prepayment penalties.</span></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div id="i181d930c7b854595977e17db8fd84eb4_61"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(8) <ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82MS9mcmFnOjAxZjlmNmM4ZjZiYjRhNzg5N2QwNWE5ODI3YzE3NDQ2L3RleHRyZWdpb246MDFmOWY2YzhmNmJiNGE3ODk3ZDA1YTk4MjdjMTc0NDZfMTgzOQ_70ad0325-fdae-4437-9691-0474d4249cbd" continuedAt="i87a1bc3193d34933aff789f8da1e037c" escape="true">Trade Receivables and Allowance for Credit Losses</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i87a1bc3193d34933aff789f8da1e037c" continuedAt="i4cffb4ed6d4d45058906be1fd4984c9d"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Effective September 27, 2020, the Company adopted Topic 326, which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The expected credit losses are developed using an estimated loss rate method that considers historical collection experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The estimated loss rates are applied to trade receivables with similar risk characteristics such as the length of time the balance has been outstanding and the location of the customer. In certain instances, the Company may identify individual trade receivable assets that do not share risk characteristics with other trade receivables, in which case the Company records its expected credit losses on an individual asset basis. For example, potential adverse changes to customer liquidity from new macroeconomic events, such as the COVID-19 pandemic, must be taken into consideration. To date, the Company has not experienced significant customer payment defaults, or identified other significant collectability concerns as a result of the pandemic. In connection with assessing credit losses for individual trade receivable assets, the Company considers significant factors relevant to collectability including those specific to the customer such as bankruptcy, length of time an account is outstanding, and the liquidity and financial position of the customer. If a trade receivable asset is evaluated on an individual basis, the Company excludes those assets from the portfolios of trade receivables evaluated on a collective basis. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82MS9mcmFnOjAxZjlmNmM4ZjZiYjRhNzg5N2QwNWE5ODI3YzE3NDQ2L3RleHRyZWdpb246MDFmOWY2YzhmNmJiNGE3ODk3ZDA1YTk4MjdjMTc0NDZfMTg0MA_59da240e-6a36-4852-8335-1985d167deb5" escape="true">The following is a rollforward of the allowance for credit losses as of June 26, 2021 compared to June 27, 2020:</ix:nonNumeric></span></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div style="text-align:center"><ix:continuation id="i4cffb4ed6d4d45058906be1fd4984c9d"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:25.839%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.662%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.812%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning<br/>of Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Credit Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divested</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Write-<br/>offs and<br/>Payments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End of<br/>Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 26, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82MS9mcmFnOjAxZjlmNmM4ZjZiYjRhNzg5N2QwNWE5ODI3YzE3NDQ2L3RhYmxlOjAyNGRlNGEwODE2NjQ1MWI5YWMxMzBlMzI4YzZkMTgwL3RhYmxlcmFuZ2U6MDI0ZGU0YTA4MTY2NDUxYjlhYzEzMGUzMjhjNmQxODBfMi0yLTEtMS0w_1c594bb4-c898-4de2-a12b-3896796d803a">31.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82MS9mcmFnOjAxZjlmNmM4ZjZiYjRhNzg5N2QwNWE5ODI3YzE3NDQ2L3RhYmxlOjAyNGRlNGEwODE2NjQ1MWI5YWMxMzBlMzI4YzZkMTgwL3RhYmxlcmFuZ2U6MDI0ZGU0YTA4MTY2NDUxYjlhYzEzMGUzMjhjNmQxODBfMi00LTEtMS0w_bddd5a2d-9d87-4c1e-b4d9-2c4d24793b70">11.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" format="ixt:zerodash" name="holx:AccountsReceivableAllowanceForCreditLossTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82MS9mcmFnOjAxZjlmNmM4ZjZiYjRhNzg5N2QwNWE5ODI3YzE3NDQ2L3RhYmxlOjAyNGRlNGEwODE2NjQ1MWI5YWMxMzBlMzI4YzZkMTgwL3RhYmxlcmFuZ2U6MDI0ZGU0YTA4MTY2NDUxYjlhYzEzMGUzMjhjNmQxODBfMi02LTEtMS0w_1ba36a3e-4000-44da-8653-5cd3463b58be">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82MS9mcmFnOjAxZjlmNmM4ZjZiYjRhNzg5N2QwNWE5ODI3YzE3NDQ2L3RhYmxlOjAyNGRlNGEwODE2NjQ1MWI5YWMxMzBlMzI4YzZkMTgwL3RhYmxlcmFuZ2U6MDI0ZGU0YTA4MTY2NDUxYjlhYzEzMGUzMjhjNmQxODBfMi04LTEtMS0w_e3d63614-95e3-42d4-84f1-6083df57e754">3.4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82MS9mcmFnOjAxZjlmNmM4ZjZiYjRhNzg5N2QwNWE5ODI3YzE3NDQ2L3RhYmxlOjAyNGRlNGEwODE2NjQ1MWI5YWMxMzBlMzI4YzZkMTgwL3RhYmxlcmFuZ2U6MDI0ZGU0YTA4MTY2NDUxYjlhYzEzMGUzMjhjNmQxODBfMi0xMC0xLTEtMA_9d481f7c-7f5a-45d2-aa97-2601e8283832">39.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 27, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1bbf9311cb649308affbf16f61bb3ff_I20190928" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82MS9mcmFnOjAxZjlmNmM4ZjZiYjRhNzg5N2QwNWE5ODI3YzE3NDQ2L3RhYmxlOjAyNGRlNGEwODE2NjQ1MWI5YWMxMzBlMzI4YzZkMTgwL3RhYmxlcmFuZ2U6MDI0ZGU0YTA4MTY2NDUxYjlhYzEzMGUzMjhjNmQxODBfMy0yLTEtMS0w_7dac5462-841b-48bc-9048-b122120b9044">17.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82MS9mcmFnOjAxZjlmNmM4ZjZiYjRhNzg5N2QwNWE5ODI3YzE3NDQ2L3RhYmxlOjAyNGRlNGEwODE2NjQ1MWI5YWMxMzBlMzI4YzZkMTgwL3RhYmxlcmFuZ2U6MDI0ZGU0YTA4MTY2NDUxYjlhYzEzMGUzMjhjNmQxODBfMy00LTEtMS0w_778d6230-0146-45a6-be1d-8a17f7ff207a">19.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="holx:AccountsReceivableAllowanceForCreditLossTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82MS9mcmFnOjAxZjlmNmM4ZjZiYjRhNzg5N2QwNWE5ODI3YzE3NDQ2L3RhYmxlOjAyNGRlNGEwODE2NjQ1MWI5YWMxMzBlMzI4YzZkMTgwL3RhYmxlcmFuZ2U6MDI0ZGU0YTA4MTY2NDUxYjlhYzEzMGUzMjhjNmQxODBfMy02LTEtMS0w_6c8a76e6-881d-4bfc-814f-b3c0871f0e01">5.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82MS9mcmFnOjAxZjlmNmM4ZjZiYjRhNzg5N2QwNWE5ODI3YzE3NDQ2L3RhYmxlOjAyNGRlNGEwODE2NjQ1MWI5YWMxMzBlMzI4YzZkMTgwL3RhYmxlcmFuZ2U6MDI0ZGU0YTA4MTY2NDUxYjlhYzEzMGUzMjhjNmQxODBfMy04LTEtMS0w_e7cbcecc-76a0-4688-a1b4-7ec85cf02191">3.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81ab5863e2124accb342d2df86a1ee96_I20200627" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82MS9mcmFnOjAxZjlmNmM4ZjZiYjRhNzg5N2QwNWE5ODI3YzE3NDQ2L3RhYmxlOjAyNGRlNGEwODE2NjQ1MWI5YWMxMzBlMzI4YzZkMTgwL3RhYmxlcmFuZ2U6MDI0ZGU0YTA4MTY2NDUxYjlhYzEzMGUzMjhjNmQxODBfMy0xMC0xLTEtMA_455ae26b-854f-4c85-bab8-490e5c45d220">27.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div id="i181d930c7b854595977e17db8fd84eb4_64"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(9) <ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:DerivativesAndFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RleHRyZWdpb246NDBhMWQ0MDcyNTNlNGYyMDhiZGQxMzVlYWNkYzUxZDVfNTg5MA_e8d857a7-8eb9-4233-9bfe-79910b1b8e04" continuedAt="i1bff2d8f4bdf42a08508cddff4e6b8b3" escape="true">Derivatives</ix:nonNumeric></span></div><ix:continuation id="i1bff2d8f4bdf42a08508cddff4e6b8b3" continuedAt="i1ea4ea0858e249649b44c4118f394de0"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Cap - Cash Flow Hedge</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages its exposure to some of its interest rate risk through the use of interest rate caps, which are derivative financial instruments. The Company does not use derivatives for speculative purposes. For a derivative that is designated as a cash flow hedge, changes in the fair value of the derivative are recognized in accumulated other comprehensive income ("AOCI") to the extent the derivative is effective at offsetting the changes in the cash flows being hedged until the hedged item affects earnings. To the extent there is any hedge ineffectiveness, changes in fair value relating to the ineffective portion are immediately recognized in earnings in other income (expense), net in the Consolidated Statements of Income.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2018, the Company entered into separate interest rate cap agreements with multiple counter-parties to mitigate the interest rate volatility associated with the variable interest rate on amounts borrowed under the term loan feature of its credit facilities (see Note 7). Interest rate cap agreements provide the right to receive cash if the reference interest rate rises above a contractual rate. The aggregate premium paid for these interest rate cap agreements was $<ix:nonFraction unitRef="usd" contextRef="i04634b19698943588e231edf3a1fa51a_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="holx:InterestRateCapAgreementsAggregatePremiumPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RleHRyZWdpb246NDBhMWQ0MDcyNTNlNGYyMDhiZGQxMzVlYWNkYzUxZDVfMTM4NA_d6e76e57-ceda-4088-abb8-c1c80e480e5a">3.7</ix:nonFraction> million, which was the initial fair value of the instruments recorded in the Company's financial statements. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2019, the Company entered into additional separate interest rate cap agreements with multiple counter-parties to extend the expiration date of its hedges by an additional year. The aggregate premium paid for these interest cap agreements was $<ix:nonFraction unitRef="usd" contextRef="i1965b6dfa45f42e1a36b9b6f6c6d19d2_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="holx:InterestRateCapAgreementsAggregatePremiumPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RleHRyZWdpb246NDBhMWQ0MDcyNTNlNGYyMDhiZGQxMzVlYWNkYzUxZDVfMTc0NQ_2a4abe12-fa7f-4082-9ee5-6209889f89f4">1.5</ix:nonFraction> million, which was the initial fair value of the instruments recorded in the Company&#8217;s financial statements. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical terms of the interest rate caps were designed to mirror the terms of the Company&#8217;s LIBOR-based borrowings under its Credit Agreement, that has been amended multiple times, and therefore are highly effective at offsetting the cash flows being hedged. The Company designated these derivatives as cash flow hedges of the variability of the LIBOR-based interest payments on $<ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-8" format="ixt:numdotdecimal" name="holx:PrincipalAmountOfBorrowings" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RleHRyZWdpb246NDBhMWQ0MDcyNTNlNGYyMDhiZGQxMzVlYWNkYzUxZDVfMjIzMw_2b097873-1a1a-472d-9ea3-ad0a2bb1bac6">1.0</ix:nonFraction> billion of principal, which ended on December 27, 2019 (the first quarter of fiscal 2020) for the contracts entered into in fiscal 2018, and on December 23, 2020 (the first quarter of fiscal 2021) for the interest rate cap agreements entered into in fiscal 2019.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rate cap agreements matured as of December 26, 2020.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Swap - Cash Flow Hedge</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2019, in order to hedge a portion of its variable rate debt beyond the contracted period under interest cap agreements, the Company entered into an interest rate swap contract with an effective date of December 23, 2020 and a termination date of December 17, 2023. The notional amount of this swap is $<ix:nonFraction unitRef="usd" contextRef="ic2fab027ef184f10a81089fce6835a3e_I20190928" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RleHRyZWdpb246NDBhMWQ0MDcyNTNlNGYyMDhiZGQxMzVlYWNkYzUxZDVfMjgzNQ_7289618a-3a07-4d6e-8a70-2f5ef95bd342">1.0</ix:nonFraction> billion. The interest rate swap effectively fixes the LIBOR component of the variable interest rate on $<ix:nonFraction unitRef="usd" contextRef="ic2fab027ef184f10a81089fce6835a3e_I20190928" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RleHRyZWdpb246NDBhMWQ0MDcyNTNlNGYyMDhiZGQxMzVlYWNkYzUxZDVfMjkzMw_cd707f95-d6be-4829-9308-7fc94d67e8a5">1.0</ix:nonFraction> billion of the notional amount under the 2018 Credit Agreement at <ix:nonFraction unitRef="number" contextRef="ic2fab027ef184f10a81089fce6835a3e_I20190928" decimals="4" name="us-gaap:DerivativeVariableInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RleHRyZWdpb246NDBhMWQ0MDcyNTNlNGYyMDhiZGQxMzVlYWNkYzUxZDVfMjk5NA_71b66e75-5b48-4dc8-87d6-4decf89bfd93">1.23</ix:nonFraction>%. The critical terms of the interest rate swap are designed to mirror the terms of the Company&#8217;s LIBOR-based borrowings under its credit agreement and therefore are highly effective at offsetting the cash flows being hedged. The Company designated this derivative as a cash flow hedge of the variability of the LIBOR-based interest payments on $<ix:nonFraction unitRef="usd" contextRef="ic2fab027ef184f10a81089fce6835a3e_I20190928" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RleHRyZWdpb246NDBhMWQ0MDcyNTNlNGYyMDhiZGQxMzVlYWNkYzUxZDVfMzM0MA_26383b0e-bd20-4187-be9a-d44e9a42bf75">1.0</ix:nonFraction> billion of principal. Therefore, changes in the fair value of the swap are recorded in AOCI. The fair value of this derivative was in a liability position of $<ix:nonFraction unitRef="usd" contextRef="i2cfbe0dfa54a401c9663f0101346df6a_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RleHRyZWdpb246NDBhMWQ0MDcyNTNlNGYyMDhiZGQxMzVlYWNkYzUxZDVfMzQ5Mw_24801a38-8903-4a81-85de-5dda592f0e59">21.0</ix:nonFraction> million as of June&#160;26, 2021.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Forward Foreign Currency Contracts and Foreign Currency Option Contracts</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into forward foreign currency exchange contracts and foreign currency option contracts to mitigate a portion of its cash balances and certain operational exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company's cash and operations that are denominated in currencies other than the U.S. dollar, primarily the Euro, the UK Pound, the Australian dollar, the Canadian dollar, the Chinese Yuan and the Japanese Yen. These foreign currency exchange contracts are entered into to support transactions made in the ordinary course of business and are not speculative in nature. The contracts are generally for periods of one year or less. The Company did not elect hedge accounting for these contracts; however, the Company may seek to apply hedge accounting in future scenarios. The change in the fair value of these contracts is recognized directly in earnings as a component of other income (expense), net. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><ix:continuation id="i1ea4ea0858e249649b44c4118f394de0" continuedAt="i594233f37f3b4477a9b921e842f4b301"><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized and unrealized gains and losses from these contracts, which were the only derivative contracts not designated for hedge accounting, for the three and nine months ended June 26, 2021 and June 27, 2020, respectively, were as follows:</span></div><div style="margin-top:9pt;text-align:center;text-indent:22.5pt"><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RleHRyZWdpb246NDBhMWQ0MDcyNTNlNGYyMDhiZGQxMzVlYWNkYzUxZDVfNTg4MQ_a37e2a29-df32-4139-bbbc-20543afe1d0b" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.695%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 27, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 27, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of realized gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53fb7ba0b756458fae9440481e4b1c22_D20210328-20210626" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfMy0xLTEtMS0w_a38c3d1e-9170-4d66-ad55-731e85590366">7.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib59ed9e2e7fe4b71b57f28d948814de5_D20200329-20200627" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfMy0zLTEtMS0w_5fcd222c-b6ba-4d0b-9064-96097cf539a8">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1ec4ff7f312462e92283befc2b78645_D20200927-20210626" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfMy01LTEtMS0w_a242642f-e0b5-4116-a1a5-b9f9969f45e9">6.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic77447b8b8db4b3697eaad437ad6372d_D20190929-20200627" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfMy03LTEtMS0w_03421c46-17aa-405b-9af8-bbf98e1d9c70">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i23614fef663042c1aef8cb0f986983b3_D20210328-20210626" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfNC0xLTEtMS0w_19400763-f783-451c-bed5-836c116bb09a">1.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52de0b3b7ed043329021533a23fc5c50_D20200329-20200627" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfNC0zLTEtMS0w_a37b104a-d374-4e6e-8905-1996864af2e0">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b050d1edde04dccb1a376a9d0b26d1f_D20200927-20210626" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfNC01LTEtMS0w_c3271bd6-39ce-41a1-b92a-8502b5aa25c2">4.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b53a2d42b634620b3416e3dd2c3f7fd_D20190929-20200627" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfNC03LTEtMS0w_9c781348-d0be-4126-b512-1459945d635a">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i02decbf01d7d47ad8413a646bb6b58c6_D20210328-20210626" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfNS0xLTEtMS0w_923b6487-467c-4fcb-90ac-e37a1456c364">8.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd2ee8ee3be840b8b6afa6175fefbb69_D20200329-20200627" decimals="-5" format="ixt:zerodash" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfNS0zLTEtMS0w_8e51ea97-d369-4ec6-bc90-c9f925373e99">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icee5b045a830452083febd09cec762d0_D20200927-20210626" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfNS01LTEtMS0w_61e37496-9008-478e-87a9-ab215056ab3e">10.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41d042b1583d4cb0a63cc089c4cd48d0_D20190929-20200627" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfNS03LTEtMS0w_71611153-5b48-4fdf-b566-6ca3654afeb4">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of unrealized gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53fb7ba0b756458fae9440481e4b1c22_D20210328-20210626" decimals="-5" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfNy0xLTEtMS0w_b37cc9f3-a61d-4aaa-a184-b43256d67c73">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib59ed9e2e7fe4b71b57f28d948814de5_D20200329-20200627" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfNy0zLTEtMS0w_7eb0d558-cbac-429d-9728-39132116e252">1.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic1ec4ff7f312462e92283befc2b78645_D20200927-20210626" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfNy01LTEtMS0w_f7ee34fe-0cdb-4cc1-b46b-a4ed3a675189">2.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic77447b8b8db4b3697eaad437ad6372d_D20190929-20200627" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfNy03LTEtMS0w_4d97d9a8-7a9c-4437-a118-1d56988efbea">0.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23614fef663042c1aef8cb0f986983b3_D20210328-20210626" decimals="-5" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfOC0xLTEtMS0w_f448fac5-c436-4b5d-9614-df69abdcfdec">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52de0b3b7ed043329021533a23fc5c50_D20200329-20200627" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfOC0zLTEtMS0w_c0cbdde3-bea2-44b3-9ae0-446d1d8b238f">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b050d1edde04dccb1a376a9d0b26d1f_D20200927-20210626" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfOC01LTEtMS0w_02703afb-db67-42a0-a293-64ec11482bbf">5.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b53a2d42b634620b3416e3dd2c3f7fd_D20190929-20200627" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfOC03LTEtMS0w_4088afbb-b4b5-4313-b8bd-b96772748ede">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02decbf01d7d47ad8413a646bb6b58c6_D20210328-20210626" decimals="-5" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfOS0xLTEtMS0w_32143e39-bbeb-4f2f-b223-4814bbd1e289">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd2ee8ee3be840b8b6afa6175fefbb69_D20200329-20200627" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfOS0zLTEtMS0w_614addb5-5678-4d62-9d9f-ca92bff651ec">2.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icee5b045a830452083febd09cec762d0_D20200927-20210626" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfOS01LTEtMS0w_17f26cd4-986b-48e7-9101-710d7c081c59">7.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41d042b1583d4cb0a63cc089c4cd48d0_D20190929-20200627" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfOS03LTEtMS0w_4bf6eb13-ecd3-4003-9e68-43f22a302320">1.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfMTEtMS0xLTEtMA_44e8d427-4a7c-4bbd-b46b-47810caf3981">6.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfMTEtMy0xLTEtMA_58f55289-2177-4fc7-b340-b11dd3e1b4ae">2.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfMTEtNS0xLTEtMA_3839c8cd-0fec-4591-832a-53d397a3d16d">18.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfMTEtNy0xLTEtMA_00f4c6cc-83b9-41e5-8aa7-143400e742c6">1.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:5pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;26, 2021, the Company had outstanding forward foreign currency contracts that were not designated for hedge accounting and were used to hedge fluctuations in the U.S. dollar of certain of our cash balances denominated in the Euro and UK pound, as well as forecasted transactions denominated in the Euro, UK pound, Australian Dollar, Canadian Dollar, Chinese Yuan and Japanese Yen with an aggregate notional amount of $<ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" format="ixt:numdotdecimal" name="holx:NotationalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RleHRyZWdpb246NDBhMWQ0MDcyNTNlNGYyMDhiZGQxMzVlYWNkYzUxZDVfNTIzNQ_4174a764-ed43-4bae-b35e-6b2452a4cf0c">253.8</ix:nonFraction>&#160;million. As of June&#160;26, 2021, the Company had outstanding foreign currency option contracts that were not designated for hedge accounting and were used to hedge fluctuations in the U.S. dollar of forecasted transactions denominated in the Euro and UK Pound with a notional amount of $<ix:nonFraction unitRef="usd" contextRef="i8538addfef6040808efa59ad875c5c67_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RleHRyZWdpb246NDBhMWQ0MDcyNTNlNGYyMDhiZGQxMzVlYWNkYzUxZDVfNTUwMg_3f402662-220c-4cf4-a40c-b0cc04ad8d8e">65.0</ix:nonFraction> million.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instrument Presentation</span></div><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RleHRyZWdpb246NDBhMWQ0MDcyNTNlNGYyMDhiZGQxMzVlYWNkYzUxZDVfNTg2OQ_6d8a8f20-1e8f-41c7-8b18-97cd0658acfa" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of June&#160;26, 2021: </span></div><div style="margin-top:11pt;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.524%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18ac8b8a2f674e00a863ad723f51cfd6_I20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjhhODcyNjk0NGVlMTQ0MzQ4NjE5ZjZlZWJlYzdkY2Q3L3RhYmxlcmFuZ2U6OGE4NzI2OTQ0ZWUxNDQzNDg2MTlmNmVlYmVjN2RjZDdfOS0zLTEtMS0w_58b33cdd-daa1-4c48-a7b3-a72d824865d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8385c3be2e32406d80f1e6926ed63258_I20200926" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjhhODcyNjk0NGVlMTQ0MzQ4NjE5ZjZlZWJlYzdkY2Q3L3RhYmxlcmFuZ2U6OGE4NzI2OTQ0ZWUxNDQzNDg2MTlmNmVlYmVjN2RjZDdfOS01LTEtMS0w_164b439b-1a2e-41a2-8112-706dc1a4e934">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ba1880cecac4f61867704cf61543765_I20210626" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjhhODcyNjk0NGVlMTQ0MzQ4NjE5ZjZlZWJlYzdkY2Q3L3RhYmxlcmFuZ2U6OGE4NzI2OTQ0ZWUxNDQzNDg2MTlmNmVlYmVjN2RjZDdfMTAtMy0xLTEtMA_db410383-e136-4c03-9440-4cd25ac622cc">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if95c5e17cb0246e28396e701eba8a8b6_I20200926" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjhhODcyNjk0NGVlMTQ0MzQ4NjE5ZjZlZWJlYzdkY2Q3L3RhYmxlcmFuZ2U6OGE4NzI2OTQ0ZWUxNDQzNDg2MTlmNmVlYmVjN2RjZDdfMTAtNS0xLTEtMA_609f568b-c772-4bc6-990f-38420c02428c">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5816cff90a9247a296c2e48045af6f9b_I20210626" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjhhODcyNjk0NGVlMTQ0MzQ4NjE5ZjZlZWJlYzdkY2Q3L3RhYmxlcmFuZ2U6OGE4NzI2OTQ0ZWUxNDQzNDg2MTlmNmVlYmVjN2RjZDdfMTEtMy0xLTEtMA_817ac381-e9aa-4822-b702-bc8fc5d1ec7d">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1aa79e6d2f224939b78d3422b131e66e_I20200926" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjhhODcyNjk0NGVlMTQ0MzQ4NjE5ZjZlZWJlYzdkY2Q3L3RhYmxlcmFuZ2U6OGE4NzI2OTQ0ZWUxNDQzNDg2MTlmNmVlYmVjN2RjZDdfMTEtNS0xLTEtMA_12baaaee-15fa-40cf-870b-a780a2990c9a">11.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments designated as a cash flow hedge:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied7c65430e934024b713ad4d1d12d274_I20210626" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjhhODcyNjk0NGVlMTQ0MzQ4NjE5ZjZlZWJlYzdkY2Q3L3RhYmxlcmFuZ2U6OGE4NzI2OTQ0ZWUxNDQzNDg2MTlmNmVlYmVjN2RjZDdfMTUtMy0xLTEtMA_be2c1410-a6b9-4086-8709-749a310e6d7a">11.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc35c56bdabd41c5a37c1ec58d24f4f5_I20200926" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjhhODcyNjk0NGVlMTQ0MzQ4NjE5ZjZlZWJlYzdkY2Q3L3RhYmxlcmFuZ2U6OGE4NzI2OTQ0ZWUxNDQzNDg2MTlmNmVlYmVjN2RjZDdfMTUtNS0xLTEtMA_54fa0540-270a-459c-a2f7-663359697344">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd682c98bcc54a639ecf216a7a2959ac_I20210626" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjhhODcyNjk0NGVlMTQ0MzQ4NjE5ZjZlZWJlYzdkY2Q3L3RhYmxlcmFuZ2U6OGE4NzI2OTQ0ZWUxNDQzNDg2MTlmNmVlYmVjN2RjZDdfMTYtMy0xLTEtMA_335797ea-887a-48ac-8051-487c16233def">9.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic10b5e7bddbb4679b081afb2b91bfb10_I20200926" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjhhODcyNjk0NGVlMTQ0MzQ4NjE5ZjZlZWJlYzdkY2Q3L3RhYmxlcmFuZ2U6OGE4NzI2OTQ0ZWUxNDQzNDg2MTlmNmVlYmVjN2RjZDdfMTYtNS0xLTEtMA_8a383165-af78-4096-9118-d7f0c4585877">23.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjhhODcyNjk0NGVlMTQ0MzQ4NjE5ZjZlZWJlYzdkY2Q3L3RhYmxlcmFuZ2U6OGE4NzI2OTQ0ZWUxNDQzNDg2MTlmNmVlYmVjN2RjZDdfMTctMy0xLTEtMA_26e2a606-8001-4cdf-9c04-1f07f2e370f9">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjhhODcyNjk0NGVlMTQ0MzQ4NjE5ZjZlZWJlYzdkY2Q3L3RhYmxlcmFuZ2U6OGE4NzI2OTQ0ZWUxNDQzNDg2MTlmNmVlYmVjN2RjZDdfMTctNS0xLTEtMA_5b400ea5-7978-453f-aa9d-ab0c3940a1f5">31.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f76a7b44a7f4089bbc36c650997a1cf_I20210626" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjhhODcyNjk0NGVlMTQ0MzQ4NjE5ZjZlZWJlYzdkY2Q3L3RhYmxlcmFuZ2U6OGE4NzI2OTQ0ZWUxNDQzNDg2MTlmNmVlYmVjN2RjZDdfMTktMy0xLTEtMA_41f265e9-8b1a-45f0-82dc-779a37b6c2a2">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe6078ee0384409bc3ef5dd79db3bdd_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjhhODcyNjk0NGVlMTQ0MzQ4NjE5ZjZlZWJlYzdkY2Q3L3RhYmxlcmFuZ2U6OGE4NzI2OTQ0ZWUxNDQzNDg2MTlmNmVlYmVjN2RjZDdfMTktNS0xLTEtMA_c1a1b08d-ac17-4d27-b42a-3405eb57dfe0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:13pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RleHRyZWdpb246NDBhMWQ0MDcyNTNlNGYyMDhiZGQxMzVlYWNkYzUxZDVfNTg3Ng_d136a2a2-3c9b-4f4a-9d3f-ad9e5818211f" continuedAt="i9e4d45b4f35a46878358338261a8170b" escape="true">The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate caps and interest rate swap for the following reporting periods:</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div style="margin-top:11pt;text-align:center;text-indent:27pt"><ix:continuation id="i594233f37f3b4477a9b921e842f4b301"><ix:continuation id="i9e4d45b4f35a46878358338261a8170b"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) recognized in other comprehensive income, net of taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e9af5310502412a90c2f809682d972d_D20210328-20210626" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjJhMTgyZWI4ZWQ4MjRjOTc5NTE0MTc0YjAyZmJkNjIwL3RhYmxlcmFuZ2U6MmExODJlYjhlZDgyNGM5Nzk1MTQxNzRiMDJmYmQ2MjBfMy0xLTEtMS0w_f951af9d-0593-4f2e-b30f-de674070cb28">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03f4085d035d44bdb57e7576c9d82462_D20200329-20200627" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjJhMTgyZWI4ZWQ4MjRjOTc5NTE0MTc0YjAyZmJkNjIwL3RhYmxlcmFuZ2U6MmExODJlYjhlZDgyNGM5Nzk1MTQxNzRiMDJmYmQ2MjBfMy0zLTEtMS0w_9e3050f9-ca9e-4ce0-ac5c-857473f4e346">4.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00326496b5524aacb14a40d333ddb070_D20200927-20210626" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjJhMTgyZWI4ZWQ4MjRjOTc5NTE0MTc0YjAyZmJkNjIwL3RhYmxlcmFuZ2U6MmExODJlYjhlZDgyNGM5Nzk1MTQxNzRiMDJmYmQ2MjBfMy01LTEtMS0w_3de039c7-38c4-493c-9288-54bd37956539">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8706ab009f34acbab9f1c8ba66a6842_D20190929-20200627" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjJhMTgyZWI4ZWQ4MjRjOTc5NTE0MTc0YjAyZmJkNjIwL3RhYmxlcmFuZ2U6MmExODJlYjhlZDgyNGM5Nzk1MTQxNzRiMDJmYmQ2MjBfMy03LTEtMS0w_96e0d39b-d8b4-43bd-9330-5de68a7c4bd3">25.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieab668871ebf4bef88a6c7d0534148b3_D20210328-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjJhMTgyZWI4ZWQ4MjRjOTc5NTE0MTc0YjAyZmJkNjIwL3RhYmxlcmFuZ2U6MmExODJlYjhlZDgyNGM5Nzk1MTQxNzRiMDJmYmQ2MjBfNC0xLTEtMS0w_418a6a0c-881e-4302-b0ba-ce35b917901f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16e7d68e0cf04c83bf036bb7dfc90e9b_D20200329-20200627" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjJhMTgyZWI4ZWQ4MjRjOTc5NTE0MTc0YjAyZmJkNjIwL3RhYmxlcmFuZ2U6MmExODJlYjhlZDgyNGM5Nzk1MTQxNzRiMDJmYmQ2MjBfNC0zLTEtMS0w_131d4cb1-f7e9-490d-bb11-f2ef6153196b">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaae1b64b6b3f48efa2eeddd04c00405c_D20200927-20210626" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjJhMTgyZWI4ZWQ4MjRjOTc5NTE0MTc0YjAyZmJkNjIwL3RhYmxlcmFuZ2U6MmExODJlYjhlZDgyNGM5Nzk1MTQxNzRiMDJmYmQ2MjBfNC01LTEtMS0w_3ea08217-849e-42ad-84b7-5d2bb6d8fa17">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4dd1442bbab54dbc9df7a9a1b52d46fe_D20190929-20200627" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjJhMTgyZWI4ZWQ4MjRjOTc5NTE0MTc0YjAyZmJkNjIwL3RhYmxlcmFuZ2U6MmExODJlYjhlZDgyNGM5Nzk1MTQxNzRiMDJmYmQ2MjBfNC03LTEtMS0w_8273c67d-48d9-4348-bead-60099851dc8d">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjJhMTgyZWI4ZWQ4MjRjOTc5NTE0MTc0YjAyZmJkNjIwL3RhYmxlcmFuZ2U6MmExODJlYjhlZDgyNGM5Nzk1MTQxNzRiMDJmYmQ2MjBfNS0xLTEtMS0w_792f321c-6419-4ce7-ab8c-59207862579f">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjJhMTgyZWI4ZWQ4MjRjOTc5NTE0MTc0YjAyZmJkNjIwL3RhYmxlcmFuZ2U6MmExODJlYjhlZDgyNGM5Nzk1MTQxNzRiMDJmYmQ2MjBfNS0zLTEtMS0w_a4a98021-40dd-4720-9aea-e69e88bc1592">4.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjJhMTgyZWI4ZWQ4MjRjOTc5NTE0MTc0YjAyZmJkNjIwL3RhYmxlcmFuZ2U6MmExODJlYjhlZDgyNGM5Nzk1MTQxNzRiMDJmYmQ2MjBfNS01LTEtMS0w_65068e10-aad0-437e-bd87-99bd055727d8">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjJhMTgyZWI4ZWQ4MjRjOTc5NTE0MTc0YjAyZmJkNjIwL3RhYmxlcmFuZ2U6MmExODJlYjhlZDgyNGM5Nzk1MTQxNzRiMDJmYmQ2MjBfNS03LTEtMS0w_794a7407-d3a3-4969-9ef9-bb16903de3a4">25.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div style="text-align:center"><span><br/></span></div><div id="i181d930c7b854595977e17db8fd84eb4_67"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(10) <ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82Ny9mcmFnOmY2ZGJhMzg2YzA0MjRlMTFiZmNiYWY5YjliMGMyZGZhL3RleHRyZWdpb246ZjZkYmEzODZjMDQyNGUxMWJmY2JhZjliOWIwYzJkZmFfNjk0NA_7122888d-e964-4db3-909e-c030f8959f1f" continuedAt="icac72efb2e5c46208224f0d38f877288" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="icac72efb2e5c46208224f0d38f877288" continuedAt="i04efb63b3489431c81b63ba40a42c45b"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation and Related Matters</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On November 6, 2015, the Company filed a suit against Minerva Surgical, Inc. (&#8220;Minerva&#8221;) in the United States District Court for the District of Delaware, alleging that Minerva&#8217;s endometrial ablation device infringes U.S. Patent 6,872,183 (the '183 patent), U.S. Patent 8,998,898 and U.S. Patent 9,095,348 (the '348 patent). On January 25, 2016, the Company amended the complaint to include claims against Minerva for unfair competition, deceptive trade practices and tortious interference with business relationships. On February 5, 2016, the Company filed a second amended complaint to additionally allege that Minerva&#8217;s endometrial ablation device infringes U.S. Patent 9,247,989 (the '989 patent). On March 4, 2016, Minerva filed an answer and counterclaims against the Company, seeking declaratory judgment on the Company&#8217;s claims and asserting claims against the Company for unfair competition, deceptive trade practices, interference with contractual relationships, breach of contract and trade libel. On June 2, 2016, the Court denied the Company&#8217;s motion for a preliminary injunction on its patent claims and denied Minerva&#8217;s request for preliminary injunction related to the Company&#8217;s alleged false and deceptive statements regarding the Minerva product. On June 28, 2018, the Court granted the Company's summary judgment motions on infringement and no invalidity with respect to the &#8216;183 and &#8216;348 patents. The Court also granted the Company&#8217;s motion for summary judgment on assignor estoppel, which bars Minerva&#8217;s invalidity defenses or any reliance on collateral findings regarding invalidity from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> review proceedings. The Court also denied all of Minerva&#8217;s defenses, including its motions for summary judgment on invalidity, non-infringement, no willfulness, and no unfair competition.</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July 27, 2018, after a two-week trial, a jury returned a verdict that: (1) awarded the Company $<ix:nonFraction unitRef="usd" contextRef="i39a6ba9e2ef34dbe8c1dcffcf164d2cf_I20180727" decimals="-5" format="ixt:numdotdecimal" name="holx:AmountAssessedInDamages" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82Ny9mcmFnOmY2ZGJhMzg2YzA0MjRlMTFiZmNiYWY5YjliMGMyZGZhL3RleHRyZWdpb246ZjZkYmEzODZjMDQyNGUxMWJmY2JhZjliOWIwYzJkZmFfMTk4Mg_24e81642-5e57-465d-9d5a-5f8da86fa9f3">4.8</ix:nonFraction> million in damages for Minerva&#8217;s infringement; (2) found that Minerva&#8217;s infringement was not willful; and (3) found for the Company regarding Minerva&#8217;s counterclaims. Damages continued to accrue as Minerva continues its infringing conduct. On May 2, 2019, the Court issued rulings that denied the parties' post-trial motions, including the Company's motion for a permanent injunction seeking to prohibit Minerva from selling infringing devices. Both parties appealed the Court's rulings regarding the post-trial motions. On March 4, 2016, Minerva filed <ix:nonFraction unitRef="petition" contextRef="ie3638767d08c4249aa0ae3d34c62d59b_D20160304-20160304" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyNewClaimsFiledNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82Ny9mcmFnOmY2ZGJhMzg2YzA0MjRlMTFiZmNiYWY5YjliMGMyZGZhL3RleHRyZWdpb246ZjZkYmEzODZjMDQyNGUxMWJmY2JhZjliOWIwYzJkZmFfMjUzMA_fffc145b-255d-4908-a358-229c4c24cf8b">two</ix:nonFraction> petitions at the USPTO for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> review of the '348 patent. On September 12, 2016, the PTAB declined both petitions to review patentability of the '348 patent. On April 11, 2016, Minerva filed a petition for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> review of the '183 patent. On October 6, 2016, the PTAB granted the petition and instituted a review of the '183 patent. On December 15, 2017, the PTAB issued a final written decision invalidating all claims of the &#8216;183 patent. On February 9, 2018 the Company appealed this decision to the United States Court of Appeals for the Federal Circuit ("Court of Appeals"). On April 19, 2019, the Court of Appeals affirmed the PTAB's final written decision regarding the '183 patent. On July 16, 2019, the Court of Appeals denied the Company&#8217;s petition for rehearing in the appeal regarding the '183 patent. On April 22, 2020, the Court of Appeals affirmed the district court&#8217;s summary judgment ruling in favor of the Company of no invalidity and infringement, and summary judgment that assignor estoppel bars Minerva from challenging the validity of the &#8216;348 patent. The Court of Appeals also denied the Company&#8217;s motion for a permanent injunction and ongoing royalties for infringement of the &#8216;183 patent. The Court of Appeals denied Minerva&#8217;s arguments for no damages or, alternatively, a new trial. On May 22, 2020 both parties petitioned for en banc review of the Court of Appeals decision. On July 22, 2020, the Court of Appeals denied both parties' petitions for en banc review. On August 28, 2020, the district court entered final judgment against Minerva but stayed execution pending resolution of Minerva&#8217;s petition for Supreme Court review. On September 30, 2020, Minerva filed a petition requesting Supreme Court review on the issue of assignor estoppel. On November 5, 2020, Hologic filed a cross-petition requesting Supreme Court review on the issue of assignor estoppel. On January 8, 2021, the Supreme Court granted Minerva&#8217;s petition to address the issue of assignor estoppel and denied Hologic's petition. Oral argument before the Supreme Court was held on April 21, 2021. On June 29, 2021, the Supreme Court ruled 5-4 to uphold but narrow assignor estoppel but limited its application to situations in which an assignor&#8217;s claim of invalidity contradicts a prior representation the assignor made in assigning the patent. The Court also vacated the ruling of the Court of Appeals and remanded the case for further proceedings consistent with its opinion.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 11, 2017, Minerva filed suit against the Company and Cytyc Surgical Products, LLC (&#8220;Cytyc&#8221;) in the United States District Court for the Northern District of California alleging that the Company&#8217;s and Cytyc&#8217;s NovaSure ADVANCED endometrial ablation device infringes Minerva&#8217;s U.S. patent 9,186,208. Minerva is seeking a preliminary and permanent injunction against the Company and Cytyc from selling this NovaSure device as well as enhanced damages and interest, including lost profits, price erosion and/or royalty. On January 5, 2018, the Court denied Minerva's motion for a preliminary injunction. On February 2, 2018, at the parties&#8217; joint request, this action was transferred to the District of Delaware. On March </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><ix:continuation id="i04efb63b3489431c81b63ba40a42c45b"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26, 2019, the Magistrate Judge issued a claims construction ruling regarding the disputed terms in the patent, which the District Court Judge adopted in all respects on October 21, 2019. The original trial date of July 20, 2020 was vacated. On October 21, 2020, the trial court scheduled a 10-day trial beginning on August 9, 2021. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or a range of estimates, of potential losses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Note 6, the Company has agreed to indemnify CD&amp;R for certain legal matters related to the Medical Aesthetics business that existed at the date of disposition. The Company currently has $<ix:nonFraction unitRef="usd" contextRef="id9a4160e20ff4e29b6e0bd222066214d_I20210626" decimals="5" format="ixt:numdotdecimal" name="holx:LegalAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82Ny9mcmFnOmY2ZGJhMzg2YzA0MjRlMTFiZmNiYWY5YjliMGMyZGZhL3RleHRyZWdpb246ZjZkYmEzODZjMDQyNGUxMWJmY2JhZjliOWIwYzJkZmFfNjEyOA_8176383b-1204-4ac1-bc46-7dd49482790a">8.5</ix:nonFraction>&#160;million accrued for such matters as of June&#160;26, 2021. While the Company believes the estimated amounts accrued are reasonable, certain matters are still ongoing and additional accruals could be recorded in the future. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to various other legal proceedings and claims arising out of the ordinary course of its business. The Company believes that except for those matters described above there are no other proceedings or claims pending against it the ultimate resolution of which could have a material adverse effect on its financial condition or results of operations. In all cases, at each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Legal costs are expensed as incurred.</span></div></ix:continuation><div><span><br/></span></div><div id="i181d930c7b854595977e17db8fd84eb4_70"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(11) <ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RleHRyZWdpb246MjMyZjhkZmIwYWRiNGZlNGFkZjg0ZDM5ZGFiY2VmNWZfMTAy_9a4332da-fa97-4d25-ab2c-fba1c062d64f" continuedAt="ie407ff7b34e0483daf20a09d18d7237c" escape="true">Net Income Per Share</ix:nonNumeric></span></div><ix:continuation id="ie407ff7b34e0483daf20a09d18d7237c"><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RleHRyZWdpb246MjMyZjhkZmIwYWRiNGZlNGFkZjg0ZDM5ZGFiY2VmNWZfMTA2_65c9e0ac-e65e-4105-ab73-0809b286fa70" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of basic and diluted share amounts is as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfMi0xLTEtMS0w_0fff3b40-380a-4443-a811-a4b559c5d641">256,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfMi0zLTEtMS0w_b187e632-cc16-4fd9-9939-e41a4155c9e4">259,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfMi01LTEtMS0w_1335417b-5c06-4f73-b2ec-79f5127d930b">257,769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfMi03LTEtMS0w_3d7a9c80-2894-468b-9596-366c73cfa8ce">263,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common stock equivalents from assumed exercise of stock options and issuance of stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfMy0xLTEtMS0w_baf42871-8a2c-4602-b956-6cc438967d6a">2,351</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfMy0zLTEtMS0w_e9504c68-3a9a-43a1-8ad2-43016ad7d119">1,177</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfMy01LTEtMS0w_19c8bb63-8593-470c-a7b1-676a62535c62">2,602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfMy03LTEtMS0w_82032bd4-50f9-4869-ac53-42f940c5664c">1,425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfNS0xLTEtMS0w_c3571c2b-b60c-402c-a83d-08370dcf30db">258,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfNS0zLTEtMS0w_ee58e722-e902-455d-b75d-808532a5587f">261,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfNS01LTEtMS0w_ba1d6cad-91d4-4b13-b492-91ccf7934e71">260,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfNS03LTEtMS0w_1813f30a-aea7-4bcb-b22a-1af7a0765963">265,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average anti-dilutive shares related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idaa68ec927564bfca7dcc39909e9c4fa_D20210328-20210626" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfNy0xLTEtMS0w_31ad7e39-eb6b-401e-a4c1-2028eaab343e">648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1234ad1f257543fbb603a27545e882e2_D20200329-20200627" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfNy0zLTEtMS0w_05c70228-ee79-41f6-87b0-579bea867891">1,597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9d84692aad2a413f82da74256f73cc99_D20200927-20210626" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfNy01LTEtMS0w_e31ac888-1371-484e-9ffc-cea2da3bd744">513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2230d555087a45db84354397ed80a969_D20190929-20200627" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfNy03LTEtMS0w_8f53de85-3431-4a5a-8e65-b8034b94b352">1,521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ida25fb7963fd417b8fbb79c5404488ed_D20210328-20210626" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfOC0xLTEtMS0w_b23e76dc-6dbc-448a-992f-4f0b693d4f89">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id0987e1d0aaa4f3383d2308a12f86767_D20200329-20200627" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfOC0zLTEtMS0w_e8f0ae3c-5d35-4924-85f6-561e30d68afa">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i553a342864f64203bc6682daf196a414_D20200927-20210626" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfOC01LTEtMS0w_14b6aac3-9bc0-4b28-b156-b488f93f648b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic39037a65c534a348a1153bbf85b4fc5_D20190929-20200627" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfOC03LTEtMS0w_95cfdc61-c2b5-4c1e-807e-7ffb18407d47">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:4pt;text-indent:24.75pt"><span><br/></span></div><div id="i181d930c7b854595977e17db8fd84eb4_73"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(12) <ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMzE5Mw_2eeafa40-0ec4-42d7-ba7d-512921672f0c" continuedAt="i4024fe8c5c664ae8a5c71c0b14fdced6" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><ix:continuation id="i4024fe8c5c664ae8a5c71c0b14fdced6" continuedAt="i4cf635e435634e6e977130b8a23a7ca9"><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMzE5NQ_6db959e9-1fba-4c57-919d-dc0e57014946" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents stock-based compensation expense in the Company&#8217;s Consolidated Statements of Income:</span></div><div style="margin-top:5pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59e3e6acc75043868fc4bc1208d0fa04_D20210328-20210626" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfMi0xLTEtMS0w_d5a04e41-33a8-49de-9444-82fb911e8f97">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c5f40b1155e42a0be6aa12fbb7f0a8f_D20200329-20200627" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfMi0zLTEtMS0w_dc14acd9-607b-46e0-a0ee-f5cf8436c863">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a1e2756a1a84d33aa95630ed4272394_D20200927-20210626" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfMi01LTEtMS0w_2ff601c3-e448-4c23-b247-41487d142bd9">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa0f682791b44ba8313cfd9634b51ee_D20190929-20200627" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfMi03LTEtMS0w_a1070455-f227-40a3-bb2b-209281f98eb3">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9731e33a8f0b424eaba61dcf82dc6156_D20210328-20210626" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfMy0xLTEtMS0w_5b038063-917e-4507-93db-3efbe59aab12">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b98263fc02a43c48ac6469052188efc_D20200329-20200627" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfMy0zLTEtMS0w_6e0022c9-7843-4f64-8719-fe760165286b">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2537666870e44ae59702cc35894247ad_D20200927-20210626" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfMy01LTEtMS0w_0298e196-75d2-4b6c-8f6f-1304471c891c">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic00ad5ce544040b6afe86e61bdea57b5_D20190929-20200627" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfMy03LTEtMS0w_56ca8d04-de6a-4d50-8703-e86f01866f9f">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i435b9707d2fe407aa57aa940706fcc51_D20210328-20210626" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfNC0xLTEtMS0w_838d8854-1907-4fce-8d3b-c82326b16aa4">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b21698ef10e487fa17ed0655685000f_D20200329-20200627" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfNC0zLTEtMS0w_f1a6e418-f7d1-4cbb-a393-5a77ff31b76d">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i264336fb43c14902b7b5f7a3b3df7d37_D20200927-20210626" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfNC01LTEtMS0w_6654a2cd-8f2d-43b0-88e0-dbdd8dd2a35c">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d848d86c60e4d0aa176969dea483771_D20190929-20200627" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfNC03LTEtMS0w_494c330c-315e-4207-b715-514a17afd431">7.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18f952d8a51d45a9bffe628448f2117a_D20210328-20210626" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfNS0xLTEtMS0w_950ea0b9-3451-46a8-876a-27df3b444876">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1422e12662974138ae356309626aef3b_D20200329-20200627" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfNS0zLTEtMS0w_c3f5d9e0-1bfe-4841-a647-04a10f69f14a">14.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic793a7813f49401bb24c5dd7cc020e8e_D20200927-20210626" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfNS01LTEtMS0w_fcd26c15-2416-4655-a5a4-935542b3035e">29.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib360d5983d9344da99378ac890629c00_D20190929-20200627" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfNS03LTEtMS0w_f89a6d2d-cc6a-4421-828b-163a25e8c632">31.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cf709f04c574bb7bf53a2294a770b40_D20210328-20210626" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfNi0xLTEtMS0w_bf4c076d-9a03-41f4-8bb4-7a697c52a764">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icddd037fe3094f77b5b90963f5441115_D20200329-20200627" decimals="-5" format="ixt:zerodash" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfNi0zLTEtMS0w_89fec224-5cde-482d-b05a-43343d7579fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f82c4a5b2041568af213a793563e12_D20200927-20210626" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfNi01LTEtMS0w_603180a6-d06e-4391-8404-9fb9b5050cb1">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a91ec6a807647289f3e38f578c2885a_D20190929-20200627" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfNi03LTEtMS0w_52b9f37e-1b42-4aab-b426-c797d26613de">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfNy0xLTEtMS0w_32cd50a9-819c-459c-99f2-687720364be5">15.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfNy0zLTEtMS0w_f8453769-06d3-4dd9-aa67-2a38d793feb7">19.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfNy01LTEtMS0w_99dd7f92-494b-4850-938f-789cc5ebd4ca">51.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfNy03LTEtMS0w_ca560f43-f4b0-4496-a8ad-891cac8807ba">53.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="margin-top:7pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted options to purchase <ix:nonFraction unitRef="shares" contextRef="i27dc34faa8364f4eb609e7d27d755da2_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMTg1_ca009ba1-1f64-4399-a7e6-d9f78b164b87">0.6</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i24d5fbce3a404b1b9a92d452b7bb7142_D20190929-20200627" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMTky_26c29191-255f-46d6-aade-efa00d6b45af">0.9</ix:nonFraction> million shares of the Company's common stock during the nine months ended June&#160;26, 2021 and June&#160;27, 2020, respectively, with weighted-average exercise prices of $<ix:nonFraction unitRef="usdPerShare" contextRef="i27dc34faa8364f4eb609e7d27d755da2_D20200927-20210626" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMzEy_9d71f514-adae-47d9-8888-b8227fd4e6e4">68.62</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i24d5fbce3a404b1b9a92d452b7bb7142_D20190929-20200627" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMzE5_99ca3949-b8b3-425a-acf2-d3cfd6d44b85">45.54</ix:nonFraction>, respectively. There were <ix:nonFraction unitRef="shares" contextRef="i5f3a48b77de044949e38a6dcf4477c25_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMzQ4_fe88e180-db26-44fe-82ae-169b2e3af24f">4.4</ix:nonFraction> million options outstanding at June&#160;26, 2021 with a weighted-average exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i5f3a48b77de044949e38a6dcf4477c25_I20210626" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfNDE5_21fab5a3-8dc9-4213-8859-7ab465c67850">44.51</ix:nonFraction>.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><ix:continuation id="i4cf635e435634e6e977130b8a23a7ca9"><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMzIxNQ_335daaf2-2a2d-4557-877f-01d300413ef6" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a binomial model to determine the fair value of its stock options. The weighted-average assumptions utilized to value these stock options are indicated in the following table:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfMi0xLTEtMS0w_da345a48-48ea-438f-9745-af767ecbf7e9">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfMi0zLTEtMS0w_ecbd5382-25d1-423f-8c01-9d84c9115d37">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfMi01LTEtMS0w_d462981b-6139-40d8-827e-654f30fda794">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfMi03LTEtMS0w_aa4ddaae-c348-4593-ab24-28d00cf00119">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfMy0xLTEtMS0w_242b7744-208c-488d-a04b-7fbdf3f17ea0">35.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfMy0zLTEtMS0w_1f4607a7-6f7c-4a08-94ce-380c08fd9658">33.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfMy01LTEtMS0w_0cdcac8f-e8bb-4393-a1d7-e068134746a5">35.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfMy03LTEtMS0w_12d4ecbe-21b1-40ad-9aa6-77d4adb4b825">33.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfNC0xLTEtMS0w_f1bb251d-ff93-4c88-85ae-9311ee37284c">4.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfNC0zLTEtMS0w_44f751a0-eabc-4d7e-9e4a-93e86f59d514">4.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfNC01LTEtMS0w_90ca979f-7287-4488-b284-57bde762ad63">4.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfNC03LTEtMS0w_16a21b1b-3c83-4f63-ac5a-e5876b451be4">4.8</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfNS0xLTEtMS0w_7c57cc9b-1540-48e0-ad43-4afcae46444f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfNS0zLTEtMS0w_e6771479-ced3-4b99-978b-ae5c59f0b5dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfNS01LTEtMS0w_d96e5679-071e-482f-a3d3-32df4f2542db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfNS03LTEtMS0w_d468b4ff-0610-4ce2-95aa-8975d18c842e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average fair value of options granted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfNi0xLTEtMS0w_c0a86caa-6181-4196-bf46-73865aeb98d9">19.17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfNi0zLTEtMS0w_155c2f78-7eda-4d7e-abb5-761da3e89040">9.90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfNi01LTEtMS0w_4b543b53-8174-43fc-8d75-fd9be12bcdde">20.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfNi03LTEtMS0w_5cb78a9a-dc62-4ec3-b10d-20f6d608a37b">13.79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:7pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted <ix:nonFraction unitRef="shares" contextRef="i6fa919d800b84313aa121769ee6efa38_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfNjQw_9d08c89b-81e0-4f9c-8ea1-32193ac7ac19">0.5</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i4e3cad14bf6540c18eb9197a41e6af8e_D20190929-20200627" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfNjQ3_33b3db6e-d6f9-4ad8-8139-0cf86eb8cdc0">0.8</ix:nonFraction> million restricted stock units (RSUs) during the nine months ended June&#160;26, 2021 and June&#160;27, 2020, respectively, with weighted-average grant date fair values of $<ix:nonFraction unitRef="usdPerShare" contextRef="i6fa919d800b84313aa121769ee6efa38_D20200927-20210626" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfNzgw_127aa3a4-92c4-40fc-a09e-8fdbcd9c41fe">68.45</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i4e3cad14bf6540c18eb9197a41e6af8e_D20190929-20200627" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfNzg3_c6737ebf-f6e2-41e0-ad7e-6079565c7c68">45.67</ix:nonFraction> per unit, respectively. In addition, the Company granted <ix:nonFraction unitRef="shares" contextRef="if46a501e3c8143fda11f33dbbf4fbbcd_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfODQ3_4ae0e5cb-2d25-4c2d-8ff6-d2766eeaa65f">0.1</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="ia749d5e6937a406db2e72272ecc2a906_D20190929-20200627" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfODU0_941bba1e-28a3-46e8-9c3b-063403555af7">0.1</ix:nonFraction> million performance stock units (PSUs) during the nine months ended June&#160;26, 2021 and June&#160;27, 2020, respectively, to members of its senior management team, which have a weighted-average grant date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="if46a501e3c8143fda11f33dbbf4fbbcd_D20200927-20210626" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMTAzNw_d4a877d1-2f15-424e-bed1-fea86013819e">68.51</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="ia749d5e6937a406db2e72272ecc2a906_D20190929-20200627" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMTA0NA_47f1277d-285d-49f4-8ce7-871e3348397f">45.38</ix:nonFraction> per unit, respectively. Each recipient of PSUs is eligible to receive between <ix:nonFraction unitRef="number" contextRef="ib37462047fc345a18bfadcd2c9728203_D20200927-20210626" decimals="INF" format="ixt-sec:numwordsen" name="holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMTEyNQ_1f806f37-c3f8-4047-a4de-eb1217cede09">zero</ix:nonFraction> and <ix:nonFraction unitRef="number" contextRef="ib37462047fc345a18bfadcd2c9728203_D20200927-20210626" decimals="INF" name="holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMTEzMg_41cd81c7-f4b2-4c75-854b-047fbf5475e0">200</ix:nonFraction>% of the target number of shares of the Company&#8217;s common stock at the end of <ix:nonNumeric contextRef="ib37462047fc345a18bfadcd2c9728203_D20200927-20210626" format="ixt-sec:durwordsen" name="holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMTIxMA_b0cfe67b-eceb-41c1-a851-d4db4ae3d92d">three years</ix:nonNumeric> provided the Company&#8217;s defined Return on Invested Capital metrics are achieved. The Company also granted <ix:nonFraction unitRef="shares" contextRef="id8baaf1fbd5542649315b37eae7cf33e_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMTMxOA_7fa8cd00-9888-446c-a2da-5a30be81c908">0.1</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i77a3c47ab1fb449ba0ebc5b0c207c416_D20190929-20200627" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMTMyNQ_49180577-f9a9-40a6-83ba-844cb7a3fe54">0.1</ix:nonFraction>&#160;million of PSUs based on a one-year free cash flow measure (FCF) to its senior management team, which had a grant date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="id8baaf1fbd5542649315b37eae7cf33e_D20200927-20210626" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMTQ1Mw_65a81fad-81a8-4192-9e25-d90374ad8274">68.51</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i77a3c47ab1fb449ba0ebc5b0c207c416_D20190929-20200627" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMTQ2MA_74fd8bad-b27a-4c6b-a043-75b71887a310">45.38</ix:nonFraction> per unit during the nine months ended June 26, 2021 and June 27, 2020, respectively. Each recipient of FCF PSUs is eligible to receive between <ix:nonFraction unitRef="number" contextRef="id8baaf1fbd5542649315b37eae7cf33e_D20200927-20210626" decimals="INF" format="ixt-sec:numwordsen" name="holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMTI2NDQzODM3MjI4Mzg_52e5d9dd-a548-4444-9ab5-8a5bfb1502a4">zero</ix:nonFraction> and <ix:nonFraction unitRef="number" contextRef="id8baaf1fbd5542649315b37eae7cf33e_D20200927-20210626" decimals="INF" name="holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMTYxNg_fcb0216b-02ca-4c5f-be9d-cc2b7581e8cd">200</ix:nonFraction>% of the target number of shares of the Company's common stock at the end of the one-year measurement period, but the FCF PSUs vest at the end of the <ix:nonNumeric contextRef="id8baaf1fbd5542649315b37eae7cf33e_D20200927-20210626" format="ixt-sec:durwordsen" name="holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMTI2NDQzODM3MjI4NjM_378cd063-6c53-4437-b8a7-db47be8fd83d">three year</ix:nonNumeric> service period. The PSUs and FCF PSUs cliff-vest <ix:nonNumeric contextRef="id8baaf1fbd5542649315b37eae7cf33e_D20200927-20210626" format="ixt-sec:durwordsen" name="holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMTI2NDQzODM3MjI4Nzk_f7d5081f-2518-47b7-a2a4-c658095424e0">three years</ix:nonNumeric> from the date of grant, and the Company recognizes compensation expense ratably over the required service period based on its estimate of the number of shares that will vest upon achieving the measurement criteria. If there is a change in the estimate of the number of shares that are probable of vesting, the Company will cumulatively adjust compensation expense in the period that the change in estimate is made. The Company also granted <ix:nonFraction unitRef="shares" contextRef="ib37462047fc345a18bfadcd2c9728203_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMjI3OQ_217495da-8f4a-495a-9a8f-72c89f305db7">0.1</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i6c9fca34b58b4ebba0cc95c584d6b02b_D20190929-20200627" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMjI4Ng_c946e91b-91c2-42aa-9292-65d8acdac4ef">0.1</ix:nonFraction> million market-based awards (MSUs) to its senior management team during the nine months ended June&#160;26, 2021 and June&#160;27, 2020, respectively. Each recipient of MSUs is eligible to receive between <ix:nonFraction unitRef="number" contextRef="ib37462047fc345a18bfadcd2c9728203_D20200927-20210626" decimals="INF" format="ixt-sec:numwordsen" name="holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMjQ1NQ_1f806f37-c3f8-4047-a4de-eb1217cede09">zero</ix:nonFraction> and <ix:nonFraction unitRef="number" contextRef="ib37462047fc345a18bfadcd2c9728203_D20200927-20210626" decimals="INF" name="holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMjQ2Mg_41cd81c7-f4b2-4c75-854b-047fbf5475e0">200</ix:nonFraction>% of the target number of shares of the Company&#8217;s common stock at the end of <ix:nonNumeric contextRef="ib37462047fc345a18bfadcd2c9728203_D20200927-20210626" format="ixt-sec:durwordsen" name="holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMjU0MA_b0cfe67b-eceb-41c1-a851-d4db4ae3d92d">three years</ix:nonNumeric> based upon achieving a certain total shareholder return relative to a defined peer group. The MSUs were valued at $<ix:nonFraction unitRef="usdPerShare" contextRef="ib37462047fc345a18bfadcd2c9728203_D20200927-20210626" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMjY1Nw_c044f2de-e4df-4a4e-a393-d46c681cdd7c">82.51</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i6c9fca34b58b4ebba0cc95c584d6b02b_D20190929-20200627" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMjY2NA_d8f42c4c-a571-4267-997a-361b8f72f2dd">43.54</ix:nonFraction> per share using the Monte Carlo simulation model. These awards cliff-vest <ix:nonNumeric contextRef="ib37462047fc345a18bfadcd2c9728203_D20200927-20210626" format="ixt-sec:durwordsen" name="holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMTI2NDQzODM3MjI4Mjc_85e4fb6a-d349-4668-a45f-203ae4984224">three years</ix:nonNumeric> from the date of grant, and the Company recognizes compensation expense for the MSUs ratably over the service period. At June&#160;26, 2021, there was <ix:nonFraction unitRef="shares" contextRef="id4b184eeb519428da954a2668ba86020_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMjg4OA_69b89e1f-ce67-488a-8e35-7d52986d42b0">3.0</ix:nonFraction> million in aggregate RSUs, PSUs, FCF PSUs and MSUs outstanding. </span></div><div style="margin-bottom:18pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;26, 2021, there was $<ix:nonFraction unitRef="usd" contextRef="i5f3a48b77de044949e38a6dcf4477c25_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMjk2NQ_8a2fad9d-14d7-4479-b5e9-47e144d79cbf">19.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3caedad63674472cbf33284dfc9a7524_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMjk3Mg_8355aa24-3ce5-456b-ac16-bed18f3dcabe">61.1</ix:nonFraction> million of unrecognized compensation expense related to stock options and stock units (comprised of RSUs, PSUs, FCF PSUs and MSUs), respectively, to be recognized over a weighted-average period of <ix:nonNumeric contextRef="i27dc34faa8364f4eb609e7d27d755da2_D20200927-20210626" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMzE2NA_ed7790c5-36e0-4abd-a36b-89242183046d">2.4</ix:nonNumeric> and <ix:nonNumeric contextRef="i6fa919d800b84313aa121769ee6efa38_D20200927-20210626" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMzE3MQ_4ada7906-8d06-455f-b9ca-4e5ea5e3d69e">2.0</ix:nonNumeric> years, respectively.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="i181d930c7b854595977e17db8fd84eb4_76"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(13) <ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="holx:DetailsOfCertainBalanceSheetAccountsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RleHRyZWdpb246M2I4YjY0YzE1ODBmNDhjNGEwZDcyYWM0YTgwZTI1NDVfMTAyNw_c006eabb-8a32-4c95-b8a3-c893850a2e5d" continuedAt="ib0232112aad54fe9b2a7eb679141a78a" escape="true">Other Balance Sheet Information</ix:nonNumeric></span></div><ix:continuation id="ib0232112aad54fe9b2a7eb679141a78a"><div style="text-align:center"><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RleHRyZWdpb246M2I4YjY0YzE1ODBmNDhjNGEwZDcyYWM0YTgwZTI1NDVfMTAyMQ_8051ffc7-bbcf-47ac-9ead-a598e2d2451a" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:71.318%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.321%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.324%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmZjMGE5Mzg0ZjMzOTRkMTNhNzU0MjIxNTRhZWM0OThjL3RhYmxlcmFuZ2U6ZmMwYTkzODRmMzM5NGQxM2E3NTQyMjE1NGFlYzQ5OGNfMi0xLTEtMS0w_197e5c96-cdaa-42f6-b8be-5b035c9712ca">159.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmZjMGE5Mzg0ZjMzOTRkMTNhNzU0MjIxNTRhZWM0OThjL3RhYmxlcmFuZ2U6ZmMwYTkzODRmMzM5NGQxM2E3NTQyMjE1NGFlYzQ5OGNfMi0zLTEtMS0w_4db16a4d-2ef9-4247-8639-c9af2516152a">152.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmZjMGE5Mzg0ZjMzOTRkMTNhNzU0MjIxNTRhZWM0OThjL3RhYmxlcmFuZ2U6ZmMwYTkzODRmMzM5NGQxM2E3NTQyMjE1NGFlYzQ5OGNfMy0xLTEtMS0w_27931022-1c5f-4760-bd50-76bd8a7c3cc9">58.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmZjMGE5Mzg0ZjMzOTRkMTNhNzU0MjIxNTRhZWM0OThjL3RhYmxlcmFuZ2U6ZmMwYTkzODRmMzM5NGQxM2E3NTQyMjE1NGFlYzQ5OGNfMy0zLTEtMS0w_d9f718b4-386d-4b5e-bdd5-86c8387e9f01">46.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmZjMGE5Mzg0ZjMzOTRkMTNhNzU0MjIxNTRhZWM0OThjL3RhYmxlcmFuZ2U6ZmMwYTkzODRmMzM5NGQxM2E3NTQyMjE1NGFlYzQ5OGNfNC0xLTEtMS0w_e52fe3eb-0ee4-40bf-bd53-6c8b8810d0f0">285.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmZjMGE5Mzg0ZjMzOTRkMTNhNzU0MjIxNTRhZWM0OThjL3RhYmxlcmFuZ2U6ZmMwYTkzODRmMzM5NGQxM2E3NTQyMjE1NGFlYzQ5OGNfNC0zLTEtMS0w_22573c55-e390-479e-b8c5-b0c8f589559e">196.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmZjMGE5Mzg0ZjMzOTRkMTNhNzU0MjIxNTRhZWM0OThjL3RhYmxlcmFuZ2U6ZmMwYTkzODRmMzM5NGQxM2E3NTQyMjE1NGFlYzQ5OGNfNS0xLTEtMS0w_d51e5251-4d25-470a-a85b-e9a5dd0cc6a8">502.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmZjMGE5Mzg0ZjMzOTRkMTNhNzU0MjIxNTRhZWM0OThjL3RhYmxlcmFuZ2U6ZmMwYTkzODRmMzM5NGQxM2E3NTQyMjE1NGFlYzQ5OGNfNS0zLTEtMS0w_4537c19e-de87-402b-b914-2c321ddfdcf1">395.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:18pt"><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RleHRyZWdpb246M2I4YjY0YzE1ODBmNDhjNGEwZDcyYWM0YTgwZTI1NDVfMTAzMg_a2643b23-e047-4136-bcee-7b74c06c645c" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:71.318%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.321%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.324%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="holx:ManufacturingEquipmentAndSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfMS0xLTEtMS0w_083654ae-89fc-4c71-966e-d736a86e2275">541.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="holx:ManufacturingEquipmentAndSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfMS0zLTEtMS0w_14005c2d-694d-462f-96f4-30f4bed4f1af">460.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment under customer usage agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="holx:EquipmentUnderCustomerUsageAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfMi0xLTEtMS0w_ec9b5f86-55b7-49ec-b55c-42836c3edbf3">446.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="holx:EquipmentUnderCustomerUsageAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfMi0zLTEtMS0w_60259bdb-f354-49ff-8645-10ab504314dd">456.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:BuildingsAndImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfMy0xLTEtMS0w_2bd0ae7a-0966-4537-a193-9ca08ccfdb87">187.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="us-gaap:BuildingsAndImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfMy0zLTEtMS0w_6e622004-cb2d-479f-9bef-0b7c947cd36b">167.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:LeaseholdImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfNC0xLTEtMS0w_48b84802-0093-4b58-9a9d-e3bde6b38e9f">48.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="us-gaap:LeaseholdImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfNC0zLTEtMS0w_3732a162-5c33-4ba0-a8ef-7aa075877226">44.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfNS0xLTEtMS0w_26df57da-0590-4d9d-b548-1c6fe3d07875">41.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfNS0zLTEtMS0w_097ee870-69cb-4aca-acf9-31018c6eb37e">40.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:FurnitureAndFixturesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfNi0xLTEtMS0w_826e0ba8-59c7-4345-bff5-cf9f7b95f7ef">16.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="us-gaap:FurnitureAndFixturesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfNi0zLTEtMS0w_7aaaa87b-8168-459e-a1b4-4858d1b44a18">16.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfNy0xLTEtMS0w_d6b5a9a9-2c38-4cd5-a558-3e04331725c5">8.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfNy0zLTEtMS0w_8f228573-377e-4e6e-8cd4-9a27f0ce556b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfOC0xLTEtMS0w_a9836856-4a92-483c-a631-63079a9d67ce">1,290.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfOC0zLTEtMS0w_b90fdc43-38d9-4050-9736-d144b9021f0a">1,185.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less &#8211; accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfOS0xLTEtMS0w_da4b4998-8d58-4e51-9995-93f3d7e9c0f6">739.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfOS0zLTEtMS0w_29d833af-1894-4b5b-a4e9-b7a69a7e3547">694.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfMTAtMS0xLTEtMA_7b93c8b4-bdb2-4a52-9fa2-1282696c45c3">551.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfMTAtMy0xLTEtMA_8d674908-8012-4d75-a5ec-76dfa6ccd3ad">491.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-top:1pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020 and October 2020, the Company received grants of $<ix:nonFraction unitRef="usd" contextRef="ic24013ff47294a37b8d0497bd4190df5_D20200628-20200926" decimals="-5" format="ixt:numdotdecimal" name="holx:GrantsReceivedFromDepartmentOfDefense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RleHRyZWdpb246M2I4YjY0YzE1ODBmNDhjNGEwZDcyYWM0YTgwZTI1NDVfMTA5OTUxMTYzMTA0Ng_f5e51fd7-20e8-4d4a-be5a-c26eeb249126">7.6</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i8a980ec9354548a89245ad56600f024d_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="holx:GrantsReceivedFromDepartmentOfDefense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RleHRyZWdpb246M2I4YjY0YzE1ODBmNDhjNGEwZDcyYWM0YTgwZTI1NDVfMTA5OTUxMTYzMTA2MA_97e2fe11-c631-484b-a98d-7a4f55ad8959">119.3</ix:nonFraction>&#160;million, respectively, from the Department of Defense Joint Acquisition Task Force ("DOD") to expand production capacity for the Company's two SARS-CoV-2 assays. These grants are specifically to fund the capital equipment and labor investments needed to increase manufacturing capacity to enable the Company to provide a certain amount of COVID-19 tests per month for the U.S. market. The Company is accounting for the funds received under these grants as a reimbursement of the purchased capital equipment. The DOD retains title to assets purchased under the agreement, and title is transferred to the Company upon meeting certain milestones of the manufacturing efforts. In the current three and nine month periods, the Company received $<ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" format="ixt:numdotdecimal" name="holx:DepartmentOfDefenseFundsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RleHRyZWdpb246M2I4YjY0YzE1ODBmNDhjNGEwZDcyYWM0YTgwZTI1NDVfMTA5OTUxMTYyODkwOA_cdc9919a-bfe9-466f-829a-30503e57b7cb">8.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="holx:DepartmentOfDefenseFundsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RleHRyZWdpb246M2I4YjY0YzE1ODBmNDhjNGEwZDcyYWM0YTgwZTI1NDVfMTA5OTUxMTYyODk1MA_bf95e083-7a0b-4f76-860e-bd005d2a4ef7">19.4</ix:nonFraction>&#160;million, respectively, from the DOD under these grants which has been recorded as a reduction of the cost basis of the purchased equipment.</span></div></ix:continuation><div><span><br/></span></div><div id="i181d930c7b854595977e17db8fd84eb4_79"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(14) <ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RleHRyZWdpb246MmIwYjU5YjNhN2MwNGQ1M2I4OWZkNDQ3MTEzMTE4MWZfMTkxNQ_87376520-3ff5-42ac-9e7a-880eb134ed07" continuedAt="id6f2a5dd330b4c99b64dad32b3ac0173" escape="true">Business Segments and Geographic Information</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id6f2a5dd330b4c99b64dad32b3ac0173" continuedAt="i349e9c71a98f4d309c56fb0bec5f2434">During fiscal 2021, the Company had <ix:nonFraction unitRef="segment" contextRef="ie88ebb9dd3ef4963ba6b902a27fde1c5_D20200927-20210327" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RleHRyZWdpb246MmIwYjU5YjNhN2MwNGQ1M2I4OWZkNDQ3MTEzMTE4MWZfMTI2NDQzODM3MjEzNjM_d5311ddd-08f5-4b39-bf7e-426b7b0fd803">four</ix:nonFraction> reportable segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. During fiscal 2020, the Company had <ix:nonFraction unitRef="segment" contextRef="i2a95db51a148444d8df50afc67ece6af_D20190929-20200926" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RleHRyZWdpb246MmIwYjU5YjNhN2MwNGQ1M2I4OWZkNDQ3MTEzMTE4MWZfMjE1_78107585-6771-40bc-b9fc-5ebbcf0bd2e6">five</ix:nonFraction> reportable segments that included Medical Aesthetics. The Company completed the sale of its Medical Aesthetics business on December 30, 2019. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense, intangible asset and goodwill impairment charges, transaction and integration expenses for acquisitions, restructuring, consolidation and divestiture charges, litigation charges, and other one-time or unusual items.</ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><ix:continuation id="i349e9c71a98f4d309c56fb0bec5f2434" continuedAt="i2d19074a718b46f791f0c3c417dfb147"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identifiable assets for the reportable segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its reportable segments. The Company has presented all other identifiable assets as corporate assets. There were <ix:nonFraction unitRef="usd" contextRef="ic40f282c064341a7b2e6d34548211fb3_D20190929-20200627" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RleHRyZWdpb246MmIwYjU5YjNhN2MwNGQ1M2I4OWZkNDQ3MTEzMTE4MWZfMTA4Mg_71614188-af56-4a8d-8f8f-37452fe033b9"><ix:nonFraction unitRef="usd" contextRef="i19b4c219fe024c889dd3632f6507458c_D20200927-20210626" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RleHRyZWdpb246MmIwYjU5YjNhN2MwNGQ1M2I4OWZkNDQ3MTEzMTE4MWZfMTA4Mg_a4fba974-4e1c-4c49-9a00-fea87d009943"><ix:nonFraction unitRef="usd" contextRef="if66a8dd5446541e3be680d3c337846e5_D20210328-20210626" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RleHRyZWdpb246MmIwYjU5YjNhN2MwNGQ1M2I4OWZkNDQ3MTEzMTE4MWZfMTA4Mg_f10e3a74-64de-4f6e-bf70-069c214cf29b"><ix:nonFraction unitRef="usd" contextRef="ib955694d82bc4bff8c3031d2c76b5e8e_D20200329-20200627" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RleHRyZWdpb246MmIwYjU5YjNhN2MwNGQ1M2I4OWZkNDQ3MTEzMTE4MWZfMTA4Mg_fe88c3af-f528-41cb-98fe-d8a5327b59d2">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> inter-segment revenues during the three and nine months ended June&#160;26, 2021 and June&#160;27, 2020. S<ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RleHRyZWdpb246MmIwYjU5YjNhN2MwNGQ1M2I4OWZkNDQ3MTEzMTE4MWZfMTkwOQ_59263da7-0468-4af3-a448-a1811d5dedd4" continuedAt="i796edb070c57456a8c8fa136628483b9" escape="true">egment information is as follows:</ix:nonNumeric></span></div><ix:continuation id="i796edb070c57456a8c8fa136628483b9"><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i286bca0d89644bd0b3205f4b93ed5c1d_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMy0xLTEtMS0w_e7fde3c9-6bda-42b7-8c04-d97a385407c2">665.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79c862e1f99d4e7bb053e7bea309372c_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMy0zLTEtMS0w_8ff1606f-58b8-4c19-8875-993b8b241c4d">532.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27eae9a50641400fb1c2541bd52dad61_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMy01LTEtMS0w_07bf9fe7-b712-405d-b594-79d83000d7d1">2,858.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibac682b2841e4347b6671d6949367197_D20190929-20200627" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMy03LTEtMS0w_7c792d69-c420-4060-99ae-8e3820b1f7f9">1,163.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id09b1799f368487b906ce59a96d2e408_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfNC0xLTEtMS0w_d08c24c1-e03a-4f09-8dd1-33755a0207fa">349.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9773235748348dd8da0c1995d6ed993_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfNC0zLTEtMS0w_885d28fe-d03a-410a-8115-a33b9767d226">224.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic99b704f095f4cd69b8a4ae90368d2d7_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfNC01LTEtMS0w_602cddd1-b211-4346-ad4f-764b14da6cae">1,018.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbfaf422f9724422b8b06418613c842d_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfNC03LTEtMS0w_47a417c8-a6a7-4064-b969-802bb27c5e2f">862.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc1b7e15e774991a987400605125d1c_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfNS0xLTEtMS0w_10085ae2-e4d0-48fe-80a0-1ff3ce67079e">127.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia27da4de68874f0fb714ee7967b38fd7_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfNS0zLTEtMS0w_72f76dd7-ceaf-41c7-8034-1cfef44a6568">51.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5293327445f541ed891801a24fba467c_D20200927-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfNS01LTEtMS0w_7f87c3f4-3c6e-4a0d-ba88-575b35d0a57a">366.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d4e9da2a2c14f13984e3286a479cede_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfNS03LTEtMS0w_9f57c3e0-6d14-4623-843a-aaaaad18b836">275.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd7f591f4d6846419f3ba29d469f7d3f_D20210328-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfNi0xLTEtMS0w_8c495a37-4e3f-4caf-ac3d-a0df4a357ca8">25.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16a0b171d8b2414ebdc3554e167249d2_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfNi0zLTEtMS0w_2e208235-3298-4e96-83c8-051ed68a5b99">15.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85f7ecac32784df6a536dad78a0e43e9_D20200927-20210626" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfNi01LTEtMS0w_750c18d2-e0d9-4773-8335-87f9c80ef557">73.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ed43d6f3b9e467c9e24d43594b26b14_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfNi03LTEtMS0w_245dac5d-087d-453d-94be-a728d14192cb">62.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide8ecf9b05cf4aea8c640173d743b3ce_D20210328-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfNy0xLTEtMS0w_e4bc99ee-0f96-4188-b0a2-f203cdbf71fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id09f54a49ec641f7a9c21dbaaf2c903b_D20200329-20200627" decimals="-5" format="ixt:zerodash" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfNy0zLTEtMS0w_1e22a24b-7f09-435b-a703-6156b7ee83ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa3d63fea23c46bcb179fec3fd524a11_D20200927-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfNy01LTEtMS0w_8e0262f6-2c06-4139-b9e1-587ec0019062">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bafd189711f4ec19e64d26761bc3318_D20190929-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfNy03LTEtMS0w_44a4b10f-5f9e-42d7-bf16-1f01e2881280">65.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfOC0xLTEtMS0w_f84eedb0-4d42-4091-9ab2-6bb58a2cbbeb">1,168.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfOC0zLTEtMS0w_51e74edf-ee11-4716-8a2c-cb06788696eb">822.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfOC01LTEtMS0w_11e49031-d2a3-4cd4-b787-e5d74be27fcf">4,315.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfOC03LTEtMS0w_7381c286-17d8-4d47-9147-f01c702aff04">2,429.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i286bca0d89644bd0b3205f4b93ed5c1d_D20210328-20210626" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTAtMS0xLTEtMA_947af22c-0336-4d5a-b1f1-2fd55f068eca">260.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79c862e1f99d4e7bb053e7bea309372c_D20200329-20200627" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTAtMy0xLTEtMA_d232419f-21d0-4b96-8c7e-9a971eadb5a4">233.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27eae9a50641400fb1c2541bd52dad61_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTAtNS0xLTEtMA_f7484b2f-e613-4d7e-bd99-7600cb45a842">1,745.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibac682b2841e4347b6671d6949367197_D20190929-20200627" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTAtNy0xLTEtMA_ba304741-3909-400a-9def-0458447f6843">340.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id09b1799f368487b906ce59a96d2e408_D20210328-20210626" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTEtMS0xLTEtMA_f541c8f0-8994-45f8-b6cf-4518eee31e28">81.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie9773235748348dd8da0c1995d6ed993_D20200329-20200627" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTEtMy0xLTEtMA_9e3e160d-3d02-4522-8910-6307b78c2b27">11.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic99b704f095f4cd69b8a4ae90368d2d7_D20200927-20210626" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTEtNS0xLTEtMA_4f34094b-0cb7-416b-b5a2-4ad037793865">235.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbfaf422f9724422b8b06418613c842d_D20190929-20200627" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTEtNy0xLTEtMA_c5ce94f7-3d1b-4765-8199-3130e0560228">158.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc1b7e15e774991a987400605125d1c_D20210328-20210626" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTItMS0xLTEtMA_3133ab0e-ed1a-4f67-a21a-c35058f3a0cf">18.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia27da4de68874f0fb714ee7967b38fd7_D20200329-20200627" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTItMy0xLTEtMA_f34b41d5-be15-4f05-b8c0-26d46bfc71e0">23.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5293327445f541ed891801a24fba467c_D20200927-20210626" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTItNS0xLTEtMA_97debaed-cae6-4072-84f7-546b84ba95ff">60.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d4e9da2a2c14f13984e3286a479cede_D20190929-20200627" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTItNy0xLTEtMA_10a76dc5-a605-45cd-854e-3661549406e2">32.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd7f591f4d6846419f3ba29d469f7d3f_D20210328-20210626" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTMtMS0xLTEtMA_5e658b9f-de49-4412-b2ce-57e8a89d4f5e">0.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16a0b171d8b2414ebdc3554e167249d2_D20200329-20200627" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTMtMy0xLTEtMA_67fc6f14-0d85-4c25-9fb9-1b2f8b03ed88">7.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85f7ecac32784df6a536dad78a0e43e9_D20200927-20210626" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTMtNS0xLTEtMA_d9606c3e-20bf-4ff3-a715-634929e95c90">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ed43d6f3b9e467c9e24d43594b26b14_D20190929-20200627" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTMtNy0xLTEtMA_bb7a3220-0466-42e1-91ad-b07c8a53c1be">4.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide8ecf9b05cf4aea8c640173d743b3ce_D20210328-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTQtMS0xLTEtMA_8d07e5a0-1682-4e91-a089-eea7dfc09875">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id09f54a49ec641f7a9c21dbaaf2c903b_D20200329-20200627" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTQtMy0xLTEtMA_73796767-fac9-4b25-86d2-7f49361f2701">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa3d63fea23c46bcb179fec3fd524a11_D20200927-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTQtNS0xLTEtMA_648b7a3d-1541-4449-8107-9527bfbd43e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6bafd189711f4ec19e64d26761bc3318_D20190929-20200627" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTQtNy0xLTEtMA_968dc7e0-1853-414c-ac80-2441f889e776">54.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTUtMS0xLTEtMA_12ad83b9-f87d-4330-9967-add79d0f1bd4">358.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTUtMy0xLTEtMA_559e9444-9e05-4d98-9539-a7779dd7ba4b">191.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTUtNS0xLTEtMA_350654b3-65cb-411e-98a9-72945533b788">2,040.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTUtNy0xLTEtMA_3a9b5c9a-9794-441d-b870-c11bac05feac">472.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i286bca0d89644bd0b3205f4b93ed5c1d_D20210328-20210626" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTctMS0xLTEtMA_f2c72c05-fd71-4075-afb0-b9b7fe145dec">63.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79c862e1f99d4e7bb053e7bea309372c_D20200329-20200627" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTctMy0xLTEtMA_92c4107a-293a-4809-8eae-4b937827b250">59.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27eae9a50641400fb1c2541bd52dad61_D20200927-20210626" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTctNS0xLTEtMA_6a5448d4-b999-4e38-8362-7ad1b16f70d6">179.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibac682b2841e4347b6671d6949367197_D20190929-20200627" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTctNy0xLTEtMA_98c0d839-4b6c-4cba-987b-fc61681e6579">177.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id09b1799f368487b906ce59a96d2e408_D20210328-20210626" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTgtMS0xLTEtMA_1c87acb9-0d21-4a0b-a1e4-7ba93b5ccc31">13.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9773235748348dd8da0c1995d6ed993_D20200329-20200627" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTgtMy0xLTEtMA_bce5e0c1-9317-4456-acdf-7ca341450246">13.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic99b704f095f4cd69b8a4ae90368d2d7_D20200927-20210626" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTgtNS0xLTEtMA_ed12b763-bac6-4624-9227-cb0824a50532">39.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbfaf422f9724422b8b06418613c842d_D20190929-20200627" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTgtNy0xLTEtMA_a6414222-97f4-43c2-bbd8-64bfc4f8c31b">36.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc1b7e15e774991a987400605125d1c_D20210328-20210626" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTktMS0xLTEtMA_d682d0a5-e382-4b18-a240-41afb1504064">23.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia27da4de68874f0fb714ee7967b38fd7_D20200329-20200627" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTktMy0xLTEtMA_33bc7b2b-729a-4f7b-b096-49ea9cb9468b">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5293327445f541ed891801a24fba467c_D20200927-20210626" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTktNS0xLTEtMA_b830ad4e-33a8-4306-994b-0a4e506aeb1e">69.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d4e9da2a2c14f13984e3286a479cede_D20190929-20200627" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTktNy0xLTEtMA_d4809709-6342-4c46-aadf-f725a1301671">63.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd7f591f4d6846419f3ba29d469f7d3f_D20210328-20210626" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjAtMS0xLTEtMA_58a4e091-29ff-4e38-9616-9b6fef3a5117">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16a0b171d8b2414ebdc3554e167249d2_D20200329-20200627" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjAtMy0xLTEtMA_12be434a-b8f1-41e2-b423-1fe8dec5e93f">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85f7ecac32784df6a536dad78a0e43e9_D20200927-20210626" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjAtNS0xLTEtMA_4d6c199e-407c-42de-8552-9a3a7bcfb34b">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ed43d6f3b9e467c9e24d43594b26b14_D20190929-20200627" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjAtNy0xLTEtMA_982e3275-77d5-48ed-b9bb-37c5dc5f51d3">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide8ecf9b05cf4aea8c640173d743b3ce_D20210328-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjEtMS0xLTEtMA_072ac205-ce25-40aa-9265-7217e340644c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id09f54a49ec641f7a9c21dbaaf2c903b_D20200329-20200627" decimals="-5" format="ixt:zerodash" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjEtMy0xLTEtMA_6df0973a-f028-40bf-b672-ef1249ecfc9c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa3d63fea23c46bcb179fec3fd524a11_D20200927-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjEtNS0xLTEtMA_7c457c5c-6d7f-4762-b178-c7dd624f52ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bafd189711f4ec19e64d26761bc3318_D20190929-20200627" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjEtNy0xLTEtMA_a3427029-e933-4d8a-bd22-ad2da3d7d9d6">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjItMS0xLTEtMA_74635725-a9e7-4af5-94ee-7fef2012bd61">100.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjItMy0xLTEtMA_9fe497b8-b26b-44c8-9efb-3e8de8609d1d">93.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjItNS0xLTEtMA_86d6c9d8-7654-46d2-8dd8-462571e653eb">289.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjItNy0xLTEtMA_8acf2a9f-cef1-4231-9eab-f7cc05baa405">281.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i286bca0d89644bd0b3205f4b93ed5c1d_D20210328-20210626" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjQtMS0xLTEtMA_9931df18-74af-4cb9-8d67-e252b9f9988b">27.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79c862e1f99d4e7bb053e7bea309372c_D20200329-20200627" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjQtMy0xLTEtMA_298b982a-bfa7-40c0-9384-de1410e5cc93">28.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27eae9a50641400fb1c2541bd52dad61_D20200927-20210626" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjQtNS0xLTEtMA_7215f41c-aadd-4037-b7f6-59517e40f137">93.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibac682b2841e4347b6671d6949367197_D20190929-20200627" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjQtNy0xLTEtMA_df9e9bcf-7dd4-496f-b48b-c9a1387e18b4">63.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id09b1799f368487b906ce59a96d2e408_D20210328-20210626" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjUtMS0xLTEtMA_99c3ea42-8d3f-4092-ad8c-5ace96f18994">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9773235748348dd8da0c1995d6ed993_D20200329-20200627" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjUtMy0xLTEtMA_0f7100ba-61af-43d1-95eb-d1d2abb50d09">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic99b704f095f4cd69b8a4ae90368d2d7_D20200927-20210626" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjUtNS0xLTEtMA_3c5484ae-2e69-400e-9c5c-06687d641a9d">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbfaf422f9724422b8b06418613c842d_D20190929-20200627" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjUtNy0xLTEtMA_ec95a4f8-89f3-446d-823a-7b673e088a46">17.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc1b7e15e774991a987400605125d1c_D20210328-20210626" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjYtMS0xLTEtMA_8fffd4da-c485-4516-8f21-62f19aa2b1c9">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia27da4de68874f0fb714ee7967b38fd7_D20200329-20200627" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjYtMy0xLTEtMA_d97b34a9-0c58-4bb9-b74d-07876494d9d2">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5293327445f541ed891801a24fba467c_D20200927-20210626" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjYtNS0xLTEtMA_5a925fc6-2323-47a1-a0fc-61dcdaf240d7">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d4e9da2a2c14f13984e3286a479cede_D20190929-20200627" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjYtNy0xLTEtMA_cd68c397-2b10-4838-b65d-349486d6c988">12.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd7f591f4d6846419f3ba29d469f7d3f_D20210328-20210626" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjctMS0xLTEtMA_85eb2d6a-99ff-47bb-aa93-eb381cd6cc72">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16a0b171d8b2414ebdc3554e167249d2_D20200329-20200627" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjctMy0xLTEtMA_fdbd7802-e1e9-4ddd-bdff-8cb324c93512">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85f7ecac32784df6a536dad78a0e43e9_D20200927-20210626" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjctNS0xLTEtMA_34248c88-2fcc-439e-86dc-2863634c0e50">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ed43d6f3b9e467c9e24d43594b26b14_D20190929-20200627" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjctNy0xLTEtMA_6bd0ef67-f4ae-48e9-8610-8f90d9d162fa">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide8ecf9b05cf4aea8c640173d743b3ce_D20210328-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjgtMS0xLTEtMA_458411c7-d869-430e-8239-6672a71f7e3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id09f54a49ec641f7a9c21dbaaf2c903b_D20200329-20200627" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjgtMy0xLTEtMA_8e0f854e-d98b-4d68-a346-8040483d0ce6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa3d63fea23c46bcb179fec3fd524a11_D20200927-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjgtNS0xLTEtMA_14dd8c78-95eb-4bb5-9c9e-f2dbe8a41d0d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bafd189711f4ec19e64d26761bc3318_D20190929-20200627" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjgtNy0xLTEtMA_7de3f209-e3c1-45d9-9cca-3ae04f7b05c2">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia95ae01021fa4b75996e32a548c2726f_D20210328-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjktMS0xLTEtMA_1d63b0f6-30c3-4ee1-b3ec-44a77b3fb63a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic41dd5b435484b6ba40f0f2cd734acdc_D20200329-20200627" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjktMy0xLTEtMA_a31aefcc-ffd6-473e-bbc7-aca8ce223f3b">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea58530cbef34fd4931abfeb77c65007_D20200927-20210626" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjktNS0xLTEtMA_60aaba1e-fd19-4e19-92aa-7d3d13349d96">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dbaa5c4c5c5468289373830c34f9e6e_D20190929-20200627" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjktNy0xLTEtMA_2debe929-b304-4838-a198-da7ca33a71e5">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMzAtMS0xLTEtMA_334343f8-bba5-4ebb-9361-48f354083c98">35.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMzAtMy0xLTEtMA_8c82e3ac-3ab3-4ee8-a6ca-8799ac0f9a3d">35.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMzAtNS0xLTEtMA_64ecd441-8fdd-4c9d-bfeb-e4554240b765">114.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMzAtNy0xLTEtMA_773aae40-0d29-42ea-b9a6-a715a2306b32">98.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.058%"><tr><td style="width:1.0%"></td><td style="width:69.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.023%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.611%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.025%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica1034e428864cd1afdca20ce40a8586_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjhmMjY4ZDJmY2RhMzQ3MzhhZWQ2ODQwMjk1ODQ2NjBmL3RhYmxlcmFuZ2U6OGYyNjhkMmZjZGEzNDczOGFlZDY4NDAyOTU4NDY2MGZfMi0xLTEtMS0w_83f8f1a2-dbc1-431b-b3f8-e65648f5554c">3,440.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17f5a2a375e1486ca6d00e2139870be1_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjhmMjY4ZDJmY2RhMzQ3MzhhZWQ2ODQwMjk1ODQ2NjBmL3RhYmxlcmFuZ2U6OGYyNjhkMmZjZGEzNDczOGFlZDY4NDAyOTU4NDY2MGZfMi0zLTEtMS0w_849ae2ca-cf17-4254-b7f6-a66563866087">2,161.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5912cf2562634c4897ffcde39c504296_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjhmMjY4ZDJmY2RhMzQ3MzhhZWQ2ODQwMjk1ODQ2NjBmL3RhYmxlcmFuZ2U6OGYyNjhkMmZjZGEzNDczOGFlZDY4NDAyOTU4NDY2MGZfMy0xLTEtMS0w_ffd4a097-a3d9-46cb-aa98-996e32e68030">1,253.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaca532c37e24e76abac2b8d66a14f2a_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjhmMjY4ZDJmY2RhMzQ3MzhhZWQ2ODQwMjk1ODQ2NjBmL3RhYmxlcmFuZ2U6OGYyNjhkMmZjZGEzNDczOGFlZDY4NDAyOTU4NDY2MGZfMy0zLTEtMS0w_c2533a25-6d0b-4249-a2ec-8db43f370316">1,200.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee210605634a465684ebf982ac3ed2bc_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjhmMjY4ZDJmY2RhMzQ3MzhhZWQ2ODQwMjk1ODQ2NjBmL3RhYmxlcmFuZ2U6OGYyNjhkMmZjZGEzNDczOGFlZDY4NDAyOTU4NDY2MGZfNC0xLTEtMS0w_f37ce6f5-522f-4198-8e40-9d1a4d4f14f9">1,383.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9a3a9e2d8cd44ed88d12970a32c6cef_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjhmMjY4ZDJmY2RhMzQ3MzhhZWQ2ODQwMjk1ODQ2NjBmL3RhYmxlcmFuZ2U6OGYyNjhkMmZjZGEzNDczOGFlZDY4NDAyOTU4NDY2MGZfNC0zLTEtMS0w_17c21d90-a39e-42f3-8714-f1893f56d414">1,438.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9949f8f813ca4908bd00edad279fdace_I20210626" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjhmMjY4ZDJmY2RhMzQ3MzhhZWQ2ODQwMjk1ODQ2NjBmL3RhYmxlcmFuZ2U6OGYyNjhkMmZjZGEzNDczOGFlZDY4NDAyOTU4NDY2MGZfNi0xLTEtMS0w_545bd352-ae56-4977-bdf0-b05ad88caf3b">31.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d768e600b245188ed95ec4ca093d27_I20200926" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjhmMjY4ZDJmY2RhMzQ3MzhhZWQ2ODQwMjk1ODQ2NjBmL3RhYmxlcmFuZ2U6OGYyNjhkMmZjZGEzNDczOGFlZDY4NDAyOTU4NDY2MGZfNi0zLTEtMS0w_6ddc8d99-1c36-4bfd-84d1-1106c3722f4a">38.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia430a857ed8348cb98df45af3bff355a_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjhmMjY4ZDJmY2RhMzQ3MzhhZWQ2ODQwMjk1ODQ2NjBmL3RhYmxlcmFuZ2U6OGYyNjhkMmZjZGEzNDczOGFlZDY4NDAyOTU4NDY2MGZfNy0xLTEtMS0w_43fb8214-9944-4a38-a1af-a6b472539d88">2,481.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0eacccfdfc914a0fb2100fb0647df849_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjhmMjY4ZDJmY2RhMzQ3MzhhZWQ2ODQwMjk1ODQ2NjBmL3RhYmxlcmFuZ2U6OGYyNjhkMmZjZGEzNDczOGFlZDY4NDAyOTU4NDY2MGZfNy0zLTEtMS0w_45585969-7737-4285-af08-e63f7a9d6657">2,355.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjhmMjY4ZDJmY2RhMzQ3MzhhZWQ2ODQwMjk1ODQ2NjBmL3RhYmxlcmFuZ2U6OGYyNjhkMmZjZGEzNDczOGFlZDY4NDAyOTU4NDY2MGZfOC0xLTEtMS0w_b4ff26b2-38b3-4f74-860d-94f5977985d3">8,590.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjhmMjY4ZDJmY2RhMzQ3MzhhZWQ2ODQwMjk1ODQ2NjBmL3RhYmxlcmFuZ2U6OGYyNjhkMmZjZGEzNDczOGFlZDY4NDAyOTU4NDY2MGZfOC0zLTEtMS0w_642e732c-36cc-454e-a8c9-9ae83a8c2e16">7,195.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><ix:continuation id="i2d19074a718b46f791f0c3c417dfb147"><div style="margin-top:7pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no customers that represented greater than 10% of consolidated revenues during the three and nine months ended June&#160;26, 2021 and June&#160;27, 2020.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in the following major geographic areas noted in the below chart. Revenue data is based upon customer location. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company&#8217;s sales in Europe are predominantly derived from France, the United Kingdom and Germany. The Company&#8217;s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The &#8220;Rest of world&#8221; designation includes Canada, Latin America and the Middle East.</span></div><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RleHRyZWdpb246MmIwYjU5YjNhN2MwNGQ1M2I4OWZkNDQ3MTEzMTE4MWZfMTkyNw_36c57924-00f6-4c58-9113-7a39fe282b24" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues by geography as a percentage of total revenues were as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:18pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5cc68c7458734cd2a8a7c981e8515c76_D20210328-20210626" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfMi0xLTEtMS0w_481a2fb7-c8fa-46b7-8527-31813fde95de">64.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i88586a6659324a6e94cec1cb09cf2a46_D20200329-20200627" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfMi0zLTEtMS0w_fba8a480-b677-4c97-a348-45d41a2f93d1">80.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i386d807f9c604702afb89ac48d4f3997_D20200927-20210626" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfMi01LTEtMS0w_986b9f5f-3159-4992-9f71-c7569aa1effc">68.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2107dfda459c464ba7795fbb3263a45f_D20190929-20200627" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfMi03LTEtMS0w_ebd7423e-914f-43a2-a788-948bd83353c3">76.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i82e0f458672c41aabd0a7ccc0ecba719_D20210328-20210626" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfMy0xLTEtMS0w_4e616136-fad3-4a72-85d4-f3981ad1736b">24.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i63bf14aa150b470d8cda291a8e3dd66f_D20200329-20200627" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfMy0zLTEtMS0w_cc1850f1-e05e-4d33-905c-9a22db8d46ba">12.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if97a9823a91c48f6879659548ae4a3e1_D20200927-20210626" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfMy01LTEtMS0w_3b935bac-cfa2-4fd7-888f-d8d0d64ad1cc">22.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9aa28665b0b14585a3f36c725cdb23a2_D20190929-20200627" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfMy03LTEtMS0w_efd5ae97-8fba-44d9-893e-f124ff381bbd">13.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idadd999b632a42d7b0d65121528aa81a_D20210328-20210626" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfNC0xLTEtMS0w_51107f8d-1938-4321-9ea1-18d49cd0d42e">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i877644a05fce44e28b7a923b72578d44_D20200329-20200627" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfNC0zLTEtMS0w_ca03866a-b66f-469e-b700-51adea632722">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie9abeb75d8db4dec84473529c4e293f5_D20200927-20210626" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfNC01LTEtMS0w_f53d798e-350d-41f5-9fcb-9aeb559294d2">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i070ab836e0a141d2815638fcced72af6_D20190929-20200627" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfNC03LTEtMS0w_6d2e38da-94fa-41c4-ba3b-54e3df6581a9">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4d7a7aca5d7d45618edcd0ce6bd59a88_D20210328-20210626" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfNS0xLTEtMS0w_7a6236a8-d23a-4e09-8e8b-35bbb3de3782">3.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6943392b65c14cf3ab969335b3f5c944_D20200329-20200627" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfNS0zLTEtMS0w_ef509cc3-03a7-4cf0-a0d9-b27c4f32287f">2.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8cad5c97002944c5ab199f630a9804e6_D20200927-20210626" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfNS01LTEtMS0w_1cbe4d35-7c39-401c-b258-17bd67e0f62a">3.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i028a89b44bdc443fbc942f81e8a81c2a_D20190929-20200627" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfNS03LTEtMS0w_839b10a3-d6db-47f3-af55-bcf68e296269">3.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="INF" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfNi0xLTEtMS0w_749a6123-ce96-4e8f-90d4-bdbe22d54aab">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="INF" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfNi0zLTEtMS0w_c50430b2-484f-4e98-97f1-2b59c8a59342">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="INF" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfNi01LTEtMS0w_98763229-c4b9-4667-9324-68e6c2559ca4">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="INF" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfNi03LTEtMS0w_b6136227-2146-47b2-a234-3300c800b94f">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="i181d930c7b854595977e17db8fd84eb4_82"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(15) <ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84Mi9mcmFnOmViYThlM2M1OWQ1MjQ1Y2RiYTkyMzJkNzFlOGU5MTM1L3RleHRyZWdpb246ZWJhOGUzYzU5ZDUyNDVjZGJhOTIzMmQ3MWU4ZTkxMzVfMjg4OA_409fd1cd-998e-4bb3-b727-53c0b75fe647" continuedAt="if916a54c736949608c8666dada5e12b1" escape="true">Income Taxes</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><ix:continuation id="if916a54c736949608c8666dada5e12b1"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 740, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 740), each interim period is considered integral to the annual period, and tax expense is measured using an estimated annual effective tax rate. An entity is required to record income tax expense each quarter based on its annual effective tax rate estimated for the full fiscal year and use that rate to provide for income taxes on a current year-to-date basis, adjusted for discrete taxable events that occur during the interim period.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s effective tax rate for the three and nine months ended June 26, 2021 was a provision of <ix:nonFraction unitRef="number" contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84Mi9mcmFnOmViYThlM2M1OWQ1MjQ1Y2RiYTkyMzJkNzFlOGU5MTM1L3RleHRyZWdpb246ZWJhOGUzYzU5ZDUyNDVjZGJhOTIzMmQ3MWU4ZTkxMzVfNjEw_8d4ffb6c-a953-49fc-8077-392a35afe005">20.6</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84Mi9mcmFnOmViYThlM2M1OWQ1MjQ1Y2RiYTkyMzJkNzFlOGU5MTM1L3RleHRyZWdpb246ZWJhOGUzYzU5ZDUyNDVjZGJhOTIzMmQ3MWU4ZTkxMzVfNjE3_4226fa8e-3bf6-4382-a867-1f4c10b4e231">21.0</ix:nonFraction>%, respectively, compared to a provision of <ix:nonFraction unitRef="number" contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84Mi9mcmFnOmViYThlM2M1OWQ1MjQ1Y2RiYTkyMzJkNzFlOGU5MTM1L3RleHRyZWdpb246ZWJhOGUzYzU5ZDUyNDVjZGJhOTIzMmQ3MWU4ZTkxMzVfNjYy_4eaf074c-a1fc-4185-9d52-fa4391be0268">19.0</ix:nonFraction>% and a net benefit of <ix:nonFraction unitRef="number" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84Mi9mcmFnOmViYThlM2M1OWQ1MjQ1Y2RiYTkyMzJkNzFlOGU5MTM1L3RleHRyZWdpb246ZWJhOGUzYzU5ZDUyNDVjZGJhOTIzMmQ3MWU4ZTkxMzVfNjg2_55f0825e-0aff-49e3-8edb-d115667d3458">60.3</ix:nonFraction>%, respectively, for the corresponding periods in the prior year. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate for the three months ended June 26, 2021 was lower than the U.S. statutory tax rate primarily due to the impact of the U.S. deduction for foreign derived intangible income and the geographic mix of income earned by our international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, and federal and state tax credits, partially offset by state income taxes. The effective tax rate for the nine months ended June 26, 2021 was equal to the U.S. statutory tax rate as the impact of the U.S. deduction for foreign derived intangible income and the geographic mix of income earned by our international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, were offset by state income taxes.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate for the three months ended June 27, 2020 was lower than the U.S. statutory tax rate primarily due to the geographic mix of income earned by our international subsidiaries which are taxed at rates lower than the U.S. statutory tax rate, including the impact of the U.S. tax imposed on global intangible low-taxed income and the U.S. deduction for foreign derived intangible income, and reserve releases resulting from statute of limitations expirations, partially offset by unbenefited foreign losses. The effective tax rate for the nine months ended June 27, 2020 differed from the statutory tax rate primarily due to a $<ix:nonFraction unitRef="usd" contextRef="i1e661b9ad8374ea08e1defa5f7c60aba_I20200627" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84Mi9mcmFnOmViYThlM2M1OWQ1MjQ1Y2RiYTkyMzJkNzFlOGU5MTM1L3RleHRyZWdpb246ZWJhOGUzYzU5ZDUyNDVjZGJhOTIzMmQ3MWU4ZTkxMzVfMjAyNQ_096ec097-7429-4cbc-9c26-639631c2ca9f">312.8</ix:nonFraction>&#160;million discrete net tax benefit related to the loss on the sale of the Medical Aesthetics business. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Income Tax Matters</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to tax examinations for value-added, sales-based, payroll, and other non-income tax items. A number of these examinations are ongoing in various jurisdictions. The Company takes certain non-income tax positions in the jurisdictions in which it operates. In the normal course of business, the Company's positions and conclusions related to its non-income tax positions could be challenged, resulting in assessments by governmental authorities. Pursuant to ASC 450, the Company has recorded loss contingencies with respect to some of these positions. While the Company believes estimated losses previously recorded are reasonable, certain audits are still ongoing and additional charges could be recorded in the future.</span></div></ix:continuation><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="i181d930c7b854595977e17db8fd84eb4_85"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(16) <ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RleHRyZWdpb246NmNkNTRiNzAxNzRkNDdmYTk0YTU0Yzc2NDI0ODViMzdfMjQ5_9e618dc4-1ed5-458a-9c20-7cf8468ab04e" continuedAt="i5979852c698b4c78b2f4ea42f05a858c" escape="true">Intangible Assets</ix:nonNumeric></span></div><ix:continuation id="i5979852c698b4c78b2f4ea42f05a858c"><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RleHRyZWdpb246NmNkNTRiNzAxNzRkNDdmYTk0YTU0Yzc2NDI0ODViMzdfMjYx_a8a8364a-3331-4889-9254-f7b4120f9432" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consisted of the following:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June 26, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 26, 2020</span></td></tr><tr style="height:29pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed&#160;technology</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cc9805487b14e7296d764cc86233f69_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMy0xLTEtMS0w_32b98212-8909-47dc-af5f-024be3507e92">4,604.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cc9805487b14e7296d764cc86233f69_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMy0zLTEtMS0w_21886e1a-0e5e-4458-b609-b1ef72f98260">3,102.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43cbf5cabe2d4af2b65badbd45477dcf_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMy01LTEtMS0w_91631670-616a-48a3-a321-1c82d61820ec">4,054.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43cbf5cabe2d4af2b65badbd45477dcf_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMy03LTEtMS0w_9c92dfeb-e1fd-4c8e-b758-f835094f0857">2,907.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i169a132e711041b39b7f4c5100d3224a_I20210626" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfNC0xLTEtMS0w_a3adaf7e-35fb-445a-9dfa-d04d71b958d9">102.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i169a132e711041b39b7f4c5100d3224a_I20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfNC0zLTEtMS0w_74371eda-a81e-4a38-a525-f50e65e11e0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49753b0eae784ff2ab9d20c18d01ffec_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfNC01LTEtMS0w_e6fe615e-64fc-4463-95ce-75b71408b296">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49753b0eae784ff2ab9d20c18d01ffec_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfNC03LTEtMS0w_36a3581a-c17c-4da3-89d0-7bc7bdca0847">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57d0a50ebf48490aa0a913feb0708380_I20210626" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfNS0xLTEtMS0w_f8b78222-2ddb-443d-8dbd-a248f2bb4722">598.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57d0a50ebf48490aa0a913feb0708380_I20210626" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfNS0zLTEtMS0w_dd6413f0-9402-4d33-ab4d-62b1406d335e">502.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i863480533e024d8fa95b6d2bedd39955_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfNS01LTEtMS0w_44293ed8-db4c-47f6-bef1-6ea18660a43b">549.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i863480533e024d8fa95b6d2bedd39955_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfNS03LTEtMS0w_f216c4c1-723f-4eed-9215-17862fd97257">477.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i354e119d0fae46c79299b854fd149cf0_I20210626" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfNi0xLTEtMS0w_bb95e74d-d86c-4eed-8847-20969a1cea00">269.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i354e119d0fae46c79299b854fd149cf0_I20210626" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfNi0zLTEtMS0w_ae0a8f82-d7c8-4183-a613-f2d7bb7b3cbb">188.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i777f5551309a464794664ce33991c02b_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfNi01LTEtMS0w_a7b0b6e9-1431-430e-8f0e-0d9462ddc680">245.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i777f5551309a464794664ce33991c02b_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfNi03LTEtMS0w_164926b5-d395-4422-9400-12518f700dfd">181.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-competition agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a1d948b692943219190603362c58948_I20210626" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfOC0xLTEtMS0w_9274a206-fadc-4231-822e-ae1201229a98">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a1d948b692943219190603362c58948_I20210626" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfOC0zLTEtMS0w_c0d653cb-5a5a-4fde-97f2-aebaf7b7c45b">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a5f442490284f8eb7d19616e6f5a406_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfOC01LTEtMS0w_1809d065-367f-4249-a089-8cb8359f38a8">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a5f442490284f8eb7d19616e6f5a406_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfOC03LTEtMS0w_ad5fb185-03ec-4ba8-b882-59decba4a08f">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i216e8a1391484fcf90993e52fcce3926_I20210626" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfOS0xLTEtMS0w_b0e77703-f2bd-4515-ad14-2400c241c72e">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i216e8a1391484fcf90993e52fcce3926_I20210626" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfOS0zLTEtMS0w_890cbbed-19c3-40aa-aecc-14b06d25774b">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80816070e8814fa082717580347899ab_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfOS01LTEtMS0w_4dc47011-94bb-48d8-bf5a-85cc98312b42">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80816070e8814fa082717580347899ab_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfOS03LTEtMS0w_25841c77-d21e-493c-888d-3ceedf8309cd">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71465b2ac88b48b0a8a65c9d19ca9e43_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMTAtMS0xLTEtMA_0d1686b6-23a7-4a71-84c4-d5c8d8f3a3a1">5,578.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71465b2ac88b48b0a8a65c9d19ca9e43_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMTAtMy0xLTEtMA_e29566f4-9ab6-4498-a099-75fb1a671b84">3,797.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6d5a0c8113a44b1ab58702864454fbd_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMTAtNS0xLTEtMA_2db14045-19f4-424c-83e7-12c12343183c">4,852.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6d5a0c8113a44b1ab58702864454fbd_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMTAtNy0xLTEtMA_afc0d991-a87b-43de-8320-254b6fbdf0b5">3,569.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal-use software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c78f81f4dc14e4c80085b6397cfbbc4_I20210626" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMTItMS0xLTEtMA_5e1d0ad3-6280-4ed9-b4a4-1161ea164167">55.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c78f81f4dc14e4c80085b6397cfbbc4_I20210626" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMTItMy0xLTEtMA_fc6be72a-fa86-4def-a96e-52c459780771">47.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9346ea30a0ce48709755099832433c82_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMTItNS0xLTEtMA_ed0cedd3-f767-4475-8ec1-b03a4f888ee4">51.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9346ea30a0ce48709755099832433c82_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMTItNy0xLTEtMA_5496496f-fbe5-4b18-ad2b-6a1d08c3afb1">43.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software embedded in products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9374a44c792409bb6e84be04009cf2c_I20210626" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMTMtMS0xLTEtMA_ddd357ca-9a66-4a0c-91b4-bc3f20643c0c">25.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9374a44c792409bb6e84be04009cf2c_I20210626" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMTMtMy0xLTEtMA_1dd90bf9-3c5c-45a9-85ca-09b7b0703832">14.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id992e72f22404311bf2349ba1f18c100_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMTMtNS0xLTEtMA_3c6f49c8-643c-4698-9d4c-4b0827813224">26.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id992e72f22404311bf2349ba1f18c100_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMTMtNy0xLTEtMA_2635361f-d72c-4c56-9eb6-c4bb19f4fe82">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMTQtMS0xLTEtMA_d441eeb6-ec22-4eee-9163-e6bc38b10a1e">5,660.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMTQtMy0xLTEtMA_31a29a69-13ae-4d6d-b6af-db8b8a20b809">3,859.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMTQtNS0xLTEtMA_fc962ba7-d1e5-4173-8cb9-c30db2420d8b">4,931.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMTQtNy0xLTEtMA_e0f55649-79b3-4222-81d5-b33b67096ed2">3,623.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RleHRyZWdpb246NmNkNTRiNzAxNzRkNDdmYTk0YTU0Yzc2NDI0ODViMzdfMjQx_9edb567f-346e-4980-9066-8af726efee5a" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated remaining amortization expense of the Company's acquired intangible assets as of June&#160;26, 2021 for each of the five succeeding fiscal years is as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.766%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of Fiscal 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOmEyMWY3ZTNhNzAyYTQwNDlhN2RhNDc4NWRlYWFlODEyL3RhYmxlcmFuZ2U6YTIxZjdlM2E3MDJhNDA0OWE3ZGE0Nzg1ZGVhYWU4MTJfMC0xLTEtMS0w_7135548e-c4e5-4a26-9b66-aca980c5fc62">86.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOmEyMWY3ZTNhNzAyYTQwNDlhN2RhNDc4NWRlYWFlODEyL3RhYmxlcmFuZ2U6YTIxZjdlM2E3MDJhNDA0OWE3ZGE0Nzg1ZGVhYWU4MTJfMS0xLTEtMS0w_24fdcd69-ac2c-40a8-80d3-8be04064ffd0">332.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOmEyMWY3ZTNhNzAyYTQwNDlhN2RhNDc4NWRlYWFlODEyL3RhYmxlcmFuZ2U6YTIxZjdlM2E3MDJhNDA0OWE3ZGE0Nzg1ZGVhYWU4MTJfMi0xLTEtMS0w_72289df2-4d51-4e18-bfec-794fe1cc508b">235.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOmEyMWY3ZTNhNzAyYTQwNDlhN2RhNDc4NWRlYWFlODEyL3RhYmxlcmFuZ2U6YTIxZjdlM2E3MDJhNDA0OWE3ZGE0Nzg1ZGVhYWU4MTJfMy0xLTEtMS0w_9c2e66e5-946b-4fc9-8957-0fec47431b81">223.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOmEyMWY3ZTNhNzAyYTQwNDlhN2RhNDc4NWRlYWFlODEyL3RhYmxlcmFuZ2U6YTIxZjdlM2E3MDJhNDA0OWE3ZGE0Nzg1ZGVhYWU4MTJfNC0xLTEtMS0w_8834c452-16fd-4f06-8088-215805d84d9a">210.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i181d930c7b854595977e17db8fd84eb4_88"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(17) <ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:ProductWarrantyDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84OC9mcmFnOjY1ZjlhMjJiNzJhZjQyMTNiYzhkZjk1M2RjYzVlNzQxL3RleHRyZWdpb246NjVmOWEyMmI3MmFmNDIxM2JjOGRmOTUzZGNjNWU3NDFfODk_583e77ce-d0b9-4265-8ecd-a7df947e7e51" continuedAt="ie59bdb1fc18f4cd98a8a26b95f0d7a5a" escape="true">Product Warranties</ix:nonNumeric></span></div><ix:continuation id="ie59bdb1fc18f4cd98a8a26b95f0d7a5a"><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84OC9mcmFnOjY1ZjlhMjJiNzJhZjQyMTNiYzhkZjk1M2RjYzVlNzQxL3RleHRyZWdpb246NjVmOWEyMmI3MmFmNDIxM2JjOGRmOTUzZGNjNWU3NDFfODI_40e04978-da13-4a44-bb8b-58afd152c504" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product warranty activity was as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:18pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.625%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.873%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning&#160;of<br/>Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provisions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acquired</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divested</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlements/<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End&#160;of&#160;Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 26, 2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01a2cc93a0514785a37164641018ee66_I20200926" decimals="-5" name="us-gaap:ProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84OC9mcmFnOjY1ZjlhMjJiNzJhZjQyMTNiYzhkZjk1M2RjYzVlNzQxL3RhYmxlOjhlZTIzYTFjMWFhYjRiOTE4MjE3YjEzMDU4NTNjNjU5L3RhYmxlcmFuZ2U6OGVlMjNhMWMxYWFiNGI5MTgyMTdiMTMwNTg1M2M2NTlfMi0xLTEtMS0w_def8d330-aaf5-43f6-952a-7d795985a19b">9.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:ProductWarrantyAccrualWarrantiesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84OC9mcmFnOjY1ZjlhMjJiNzJhZjQyMTNiYzhkZjk1M2RjYzVlNzQxL3RhYmxlOjhlZTIzYTFjMWFhYjRiOTE4MjE3YjEzMDU4NTNjNjU5L3RhYmxlcmFuZ2U6OGVlMjNhMWMxYWFiNGI5MTgyMTdiMTMwNTg1M2M2NTlfMi0zLTEtMS0w_65413d02-aef6-47da-8890-7595a68913be">6.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:ProductWarrantyAccrualAdditionsFromBusinessAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84OC9mcmFnOjY1ZjlhMjJiNzJhZjQyMTNiYzhkZjk1M2RjYzVlNzQxL3RhYmxlOjhlZTIzYTFjMWFhYjRiOTE4MjE3YjEzMDU4NTNjNjU5L3RhYmxlcmFuZ2U6OGVlMjNhMWMxYWFiNGI5MTgyMTdiMTMwNTg1M2M2NTlfMi01LTEtMS0w_ddb58c60-f8bd-4626-822a-5c1e6a12a73e">0.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:StandardProductWarrantyAccrualPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84OC9mcmFnOjY1ZjlhMjJiNzJhZjQyMTNiYzhkZjk1M2RjYzVlNzQxL3RhYmxlOjhlZTIzYTFjMWFhYjRiOTE4MjE3YjEzMDU4NTNjNjU5L3RhYmxlcmFuZ2U6OGVlMjNhMWMxYWFiNGI5MTgyMTdiMTMwNTg1M2M2NTlfMi03LTEtMS0w_7ba8da93-daaa-40ef-99d2-67df87e98c23">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" decimals="-5" name="us-gaap:ProductWarrantyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84OC9mcmFnOjY1ZjlhMjJiNzJhZjQyMTNiYzhkZjk1M2RjYzVlNzQxL3RhYmxlOjhlZTIzYTFjMWFhYjRiOTE4MjE3YjEzMDU4NTNjNjU5L3RhYmxlcmFuZ2U6OGVlMjNhMWMxYWFiNGI5MTgyMTdiMTMwNTg1M2M2NTlfMi05LTEtMS0w_9e264810-e57e-43c9-9290-d02a90845f74">6.7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626" decimals="-5" name="us-gaap:ProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84OC9mcmFnOjY1ZjlhMjJiNzJhZjQyMTNiYzhkZjk1M2RjYzVlNzQxL3RhYmxlOjhlZTIzYTFjMWFhYjRiOTE4MjE3YjEzMDU4NTNjNjU5L3RhYmxlcmFuZ2U6OGVlMjNhMWMxYWFiNGI5MTgyMTdiMTMwNTg1M2M2NTlfMi0xMS0xLTEtMA_9985e26e-f86d-47f3-9f50-252af386dcf4">9.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 27, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1bbf9311cb649308affbf16f61bb3ff_I20190928" decimals="-5" name="us-gaap:ProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84OC9mcmFnOjY1ZjlhMjJiNzJhZjQyMTNiYzhkZjk1M2RjYzVlNzQxL3RhYmxlOjhlZTIzYTFjMWFhYjRiOTE4MjE3YjEzMDU4NTNjNjU5L3RhYmxlcmFuZ2U6OGVlMjNhMWMxYWFiNGI5MTgyMTdiMTMwNTg1M2M2NTlfMy0xLTEtMS0w_b770a811-4ec6-4d86-9738-06f2c484d470">13.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:ProductWarrantyAccrualWarrantiesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84OC9mcmFnOjY1ZjlhMjJiNzJhZjQyMTNiYzhkZjk1M2RjYzVlNzQxL3RhYmxlOjhlZTIzYTFjMWFhYjRiOTE4MjE3YjEzMDU4NTNjNjU5L3RhYmxlcmFuZ2U6OGVlMjNhMWMxYWFiNGI5MTgyMTdiMTMwNTg1M2M2NTlfMy0zLTEtMS0w_660a7563-8adf-4a1b-b509-d67c7310b863">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:ProductWarrantyAccrualAdditionsFromBusinessAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84OC9mcmFnOjY1ZjlhMjJiNzJhZjQyMTNiYzhkZjk1M2RjYzVlNzQxL3RhYmxlOjhlZTIzYTFjMWFhYjRiOTE4MjE3YjEzMDU4NTNjNjU5L3RhYmxlcmFuZ2U6OGVlMjNhMWMxYWFiNGI5MTgyMTdiMTMwNTg1M2M2NTlfMy01LTEtMS0w_4d6a18ed-321c-47bd-9ec8-544037e75f13">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" sign="-" name="us-gaap:StandardProductWarrantyAccrualPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84OC9mcmFnOjY1ZjlhMjJiNzJhZjQyMTNiYzhkZjk1M2RjYzVlNzQxL3RhYmxlOjhlZTIzYTFjMWFhYjRiOTE4MjE3YjEzMDU4NTNjNjU5L3RhYmxlcmFuZ2U6OGVlMjNhMWMxYWFiNGI5MTgyMTdiMTMwNTg1M2M2NTlfMy03LTEtMS0w_d1881c2a-e79f-4057-9326-aa889d6c1c1d">6.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627" decimals="-5" name="us-gaap:ProductWarrantyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84OC9mcmFnOjY1ZjlhMjJiNzJhZjQyMTNiYzhkZjk1M2RjYzVlNzQxL3RhYmxlOjhlZTIzYTFjMWFhYjRiOTE4MjE3YjEzMDU4NTNjNjU5L3RhYmxlcmFuZ2U6OGVlMjNhMWMxYWFiNGI5MTgyMTdiMTMwNTg1M2M2NTlfMy05LTEtMS0w_7a49ca2c-eb8e-45a8-91d2-e6e1d1f3bdee">7.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81ab5863e2124accb342d2df86a1ee96_I20200627" decimals="-5" name="us-gaap:ProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84OC9mcmFnOjY1ZjlhMjJiNzJhZjQyMTNiYzhkZjk1M2RjYzVlNzQxL3RhYmxlOjhlZTIzYTFjMWFhYjRiOTE4MjE3YjEzMDU4NTNjNjU5L3RhYmxlcmFuZ2U6OGVlMjNhMWMxYWFiNGI5MTgyMTdiMTMwNTg1M2M2NTlfMy0xMS0xLTEtMA_f323f944-419d-459e-8ece-4b28c6bac09f">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="i181d930c7b854595977e17db8fd84eb4_91"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(18) <ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RleHRyZWdpb246ZTIwMjg0ZTZkMjUxNGI4NzhhY2ZkNGIxMzljYThhNzVfMjAx_66a60d17-b39b-442b-960d-e37057149c60" continuedAt="id1199e1f930443d9861d08edcb3b3b25" escape="true">Accumulated Other Comprehensive Loss</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="id1199e1f930443d9861d08edcb3b3b25"><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RleHRyZWdpb246ZTIwMjg0ZTZkMjUxNGI4NzhhY2ZkNGIxMzljYThhNzVfMTk3_1623b512-5230-4242-a2e6-2ea22705b0fd" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the changes in accumulated balances of other comprehensive loss for the periods presented:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.952%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.242%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended June 26, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine Months Ended June 26, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17ce81e7ee4c430192d40261507faf9e_I20210327" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMi0xLTEtMS0w_32496006-1209-4102-b80d-6a8ff1cb228e">14.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67bef9095bf547108bf64353f12a5efa_I20210327" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMi0zLTEtMS0w_94ac8ed3-27b5-464e-b617-3663cbe12a14">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1d03b89c2cd46c8b689923ced265e84_I20210327" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMi03LTEtMS0w_fff5ee6d-f7b2-42a0-805d-3f26ede150da">19.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0aa0fa3e3474453bc759752889ebcd8_I20210327" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMi05LTEtMS0w_0765e6bd-354d-413b-90bd-6faeeceb8a5c">35.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ff2910c781f4a73b76fc57f6588936e_I20200926" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMi0xMS0xLTEtMA_5a5466ee-3dbe-4748-9c24-998402df4e3a">22.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie54cb9e528944fd09a387c1fbd3869b2_I20200926" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMi0xMy0xLTEtMA_6c461e96-24bd-42d7-85a5-5540cc01df04">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10eb8034808e433f8c962dfd384c4804_I20200926" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMi0xNS0xLTEtMA_3ebe1787-6da0-48ca-afa1-dcb8e7390790">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifebb08681666403a84ebbf74112b4eb6_I20200926" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMi0xNy0xLTEtMA_634b904c-2636-4916-9b1f-138ba923b12a">24.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i820217fec55c42d7a9aeb5cfc0f49fdb_I20200926" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMi0xOC0xLTEtMA_e140fb8b-6fae-4610-8e85-4de1a2e5eef7">49.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i94e3de8bf3624135ab7d18e1e91c29f6_D20210328-20210626" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMy0xLTEtMS0w_b874c964-12f1-4aeb-8e6a-a79bad94313f">9.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0087149b23e7436988b3b251c5cba1cd_D20210328-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMy0zLTEtMS0w_e97f133d-5179-4470-a1c9-f21dce7e770f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d4b5d09721f44e6aab3f827d2d52aee_D20210328-20210626" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMy03LTEtMS0w_520a7ed0-9e94-4bee-968f-cca94fd53602">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8226181576f245bba94e4a5ec64e87f6_D20210328-20210626" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMy05LTEtMS0w_993b9f60-d431-4c1e-a348-17467bdd3a45">6.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61d813ca92d74906813eda4366974a47_D20200927-20210626" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMy0xMS0xLTEtMA_452b87e3-1440-4e4f-b7e1-c382e4897f33">1.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c7acad28e074461824c04de2811d59b_D20200927-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMy0xMy0xLTEtMA_a5c6152f-0358-400e-9cea-2dd8a7ed9db6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda94d3c28e41afb2a42d1c640a9558_D20200927-20210626" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMy0xNS0xLTEtMA_b03623e4-07a6-4da2-86bf-184f18e6d7ff">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b595945346f488591f6734675e5bbc7_D20200927-20210626" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMy0xNy0xLTEtMA_30e93f19-04d0-4233-b2df-63875a2cd7df">7.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e9aeea6421a483a9877f65783d68521_D20200927-20210626" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMy0xOC0xLTEtMA_3da80bca-f33a-466c-87d7-f34673eec8a0">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified to statement of income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94e3de8bf3624135ab7d18e1e91c29f6_D20210328-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNC0xLTEtMS0w_c8de0a3f-23b5-4f62-a6f3-963bbbfc7224">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0087149b23e7436988b3b251c5cba1cd_D20210328-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNC0zLTEtMS0w_779ddee9-cc60-41e9-bc29-22e6b97ac493">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d4b5d09721f44e6aab3f827d2d52aee_D20210328-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNC03LTEtMS0w_77acfc3d-d494-4b6d-8d7d-3a4078dfa20e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8226181576f245bba94e4a5ec64e87f6_D20210328-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNC05LTEtMS0w_911eb8e8-74e0-4efd-985d-c9cc1aafc05a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61d813ca92d74906813eda4366974a47_D20200927-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNC0xMS0xLTEtMA_7330cef5-55a8-4441-9b8e-0ecc58d13cde">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c7acad28e074461824c04de2811d59b_D20200927-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNC0xMy0xLTEtMA_47fcc03c-144a-464b-97ec-136d36773b38">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cda94d3c28e41afb2a42d1c640a9558_D20200927-20210626" decimals="-5" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNC0xNS0xLTEtMA_cf810313-254d-4b6a-a0e9-df40fdf04362">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b595945346f488591f6734675e5bbc7_D20200927-20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNC0xNy0xLTEtMA_558ff939-649b-4aa5-8388-3ffd668b1c7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e9aeea6421a483a9877f65783d68521_D20200927-20210626" decimals="-5" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNC0xOC0xLTEtMA_b6f9c43d-376b-4e8d-8b1d-69023a6a258f">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc95c0525971424ca911fedd93ca98cf_I20210626" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNi0xLTEtMS0w_dc214241-45a1-414b-bf5e-8e97702767d8">23.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d40f0fd77d34330b52e8a8f921c4b22_I20210626" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNi0zLTEtMS0w_68b3c0fb-8c61-4348-b77b-a30a8b357270">1.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8fe14ed2af474833a427512772ec787c_I20210626" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNi03LTEtMS0w_a22a8d85-7dd8-4095-b78d-5e1adba1bb71">16.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i875c4235807f46d2acc9a2e5e2e9e7a8_I20210626" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNi05LTEtMS0w_36d13fef-9802-4290-a46b-f27d46ce7a75">42.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc95c0525971424ca911fedd93ca98cf_I20210626" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNi0xMS0xLTEtMA_a75f5e85-9259-4e2c-bd7f-c3da493bd970">23.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d40f0fd77d34330b52e8a8f921c4b22_I20210626" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNi0xMy0xLTEtMA_139d7aff-ef4c-4ef1-aab3-d1e08224ed21">1.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c2348d216e0450a960b7ddce90b14d8_I20210626" decimals="-5" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNi0xNS0xLTEtMA_df36cb89-8e53-4cf3-a54d-2694cd7e8725">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8fe14ed2af474833a427512772ec787c_I20210626" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNi0xNy0xLTEtMA_dd6d8877-5ac1-4c8d-9d2c-f5dcf81ba3b8">16.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i875c4235807f46d2acc9a2e5e2e9e7a8_I20210626" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNi0xOC0xLTEtMA_c9e9b633-a27d-4604-9aae-36d73835a831">42.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.490%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.366%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended June 27, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine Months Ended June 27, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8f16f7fecd444a7e839c00b1e6b16900_I20200328" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMi0xLTEtMS0w_b8402bc8-ed8f-4019-a6ee-60df04731b3b">38.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1db5b374d2e42f2980c21955a6c48d7_I20200328" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMi01LTEtMS0w_26fab6e3-735d-4bc1-9441-c80ee563765d">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bf24f113b134bd6ad61f3c2d4372c97_I20200328" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMi03LTEtMS0w_3a23faa3-991e-48b4-87e4-dd909b7cfbcb">1.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d147650821f4b7eafa8239fe1a67337_I20200328" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMi05LTEtMS0w_b426acbd-0f71-4116-9cd2-73fa4f6f5ece">17.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4470f8e9e21d45a78c67f110baf7a543_I20200328" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMi0xMS0xLTEtMA_e150b667-eddb-4d03-baab-0aa03ddcaab6">58.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i202bf7e9908f4a88988d987295f24bf9_I20190928" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMi0xMy0xLTEtMA_0f8c5bcd-7b9c-4675-8cc1-d772bf0fcc48">41.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i50d0a909334a49d38f7058d971ae3d3e_I20190928" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMi0xNS0xLTEtMA_e9d45d18-708c-4ea9-a84b-2f0fd5df2bef">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id83350261e414219bbdc2563d9573d29_I20190928" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMi0xNy0xLTEtMA_34ebdd3b-455d-4315-a9ac-df8075d6dcb2">2.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i082299dec4444554933007b3eb2589d9_I20190928" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMi0xOS0xLTEtMA_e05a1717-9b7c-4406-89bb-dc3ec7f00924">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b3baf3186c74c05b772abe2f32104e9_I20190928" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMi0yMC0xLTEtMA_2cf469c6-0257-4ea9-b876-32faec89caef">42.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id64f5775615a48e3b594627ba96e48e2_D20200329-20200627" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMy0xLTEtMS0w_4d569cde-0fec-4495-8d74-43387aee6726">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa6aa9d198924a13b4507ae621cfca92_D20200329-20200627" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMy01LTEtMS0w_517b42e8-3e38-494f-b25f-ea1021071a02">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i961c9373b1364d32bae836297e84a344_D20200329-20200627" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMy03LTEtMS0w_b2d388df-0797-48b5-aa21-656eb6377fa8">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id4e6817a851b427a92b0c7fe72a3bbfb_D20200329-20200627" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMy05LTEtMS0w_f32938e7-0301-4f72-8f78-2f0098b93a30">4.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd3a77457cf340cf9428c91d5c99c147_D20200329-20200627" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMy0xMS0xLTEtMA_da65f616-7dcf-4752-ac52-545012fb5aa5">3.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20f566a19c874603ae7ac1c2f276af8b_D20190929-20200627" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMy0xMy0xLTEtMA_e12d1500-fadc-41d2-9976-a6a32617ebe1">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4075c4c45421491e8f17e3328901d09b_D20190929-20200627" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMy0xNS0xLTEtMA_5bab18ef-3fd0-41e8-a02f-5b356d86e78a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2d085e73dd1a41b2ac1e4ef320989c1c_D20190929-20200627" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMy0xNy0xLTEtMA_f7530e66-44a6-4352-82bf-ec45167c90c9">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3114f8a48396426d88640981268e8d43_D20190929-20200627" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMy0xOS0xLTEtMA_9477307f-0771-4f95-85bd-2f896222a1c2">25.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iccef93e68c604a7c8257204c91951d7d_D20190929-20200627" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMy0yMC0xLTEtMA_856c5ac7-c543-4432-a7f5-dd0439c96395">21.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified to statement of income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id64f5775615a48e3b594627ba96e48e2_D20200329-20200627" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNC0xLTEtMS0w_68d88443-7006-4213-a617-466da102ba77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa6aa9d198924a13b4507ae621cfca92_D20200329-20200627" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNC01LTEtMS0w_01dbf37b-57e1-4b57-878d-74e1c77454aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i961c9373b1364d32bae836297e84a344_D20200329-20200627" decimals="-5" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNC03LTEtMS0w_b22b3bef-5965-4514-b2ab-0485e440dd9f">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4e6817a851b427a92b0c7fe72a3bbfb_D20200329-20200627" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNC05LTEtMS0w_b557b8e7-1ffc-41e9-85df-123ee41d945c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd3a77457cf340cf9428c91d5c99c147_D20200329-20200627" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNC0xMS0xLTEtMA_b99dc45c-2c70-48a5-a436-db3bf6453c20">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20f566a19c874603ae7ac1c2f276af8b_D20190929-20200627" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNC0xMy0xLTEtMA_962b8a07-e73d-4d23-abf9-4a8c4a54dd16">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4075c4c45421491e8f17e3328901d09b_D20190929-20200627" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNC0xNS0xLTEtMA_938696d2-1781-4c46-8f72-0b4e2dc3c6fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d085e73dd1a41b2ac1e4ef320989c1c_D20190929-20200627" decimals="-5" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNC0xNy0xLTEtMA_4f9589d8-8f5a-4caf-9511-686a7d6016ca">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3114f8a48396426d88640981268e8d43_D20190929-20200627" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNC0xOS0xLTEtMA_f6e5ce43-18f9-4625-bf68-b60fad9b82bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccef93e68c604a7c8257204c91951d7d_D20190929-20200627" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNC0yMC0xLTEtMA_9e97b953-0d63-41a8-98b3-788c90399d40">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab35dca88c4a489cb3a6e5e8db0006d8_I20200627" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNS0xLTEtMS0w_91da94a7-4f8a-4a29-ad56-eb1268b61cbe">37.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa0f9b8412b64c26a40f845a43f78503_I20200627" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNS01LTEtMS0w_b764e097-6fab-45c9-8f98-842c0c76a6d4">1.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91d506f85cee45e586282ab07a85b12d_I20200627" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNS03LTEtMS0w_9eba5799-64e2-4672-beb5-6186d2c2f69d">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a003aff269b4a04b704dad4de10b923_I20200627" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNS05LTEtMS0w_28f6993a-c301-40a6-ae93-eddeb6e63809"><ix:nonFraction unitRef="usd" contextRef="i2a003aff269b4a04b704dad4de10b923_I20200627" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNS05LTEtMS0w_55db1ba4-1373-481d-9448-33dd46c839a5">22.2</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe15f7e0e20e47c29d5afb6680fcde66_I20200627" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNS0xMS0xLTEtMA_ba2d6ba6-d110-4c9d-8dab-34c51ebaefb5">61.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab35dca88c4a489cb3a6e5e8db0006d8_I20200627" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNS0xMy0xLTEtMA_4b927cfe-5c60-4f8c-85d5-45ec36187664">37.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaa0f9b8412b64c26a40f845a43f78503_I20200627" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNS0xNS0xLTEtMA_911a4ad6-10a1-4670-af58-fea4c9e1d8aa">1.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i91d506f85cee45e586282ab07a85b12d_I20200627" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNS0xNy0xLTEtMA_65a15125-9890-4caf-a42a-1a5fc6bf9c1b">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a003aff269b4a04b704dad4de10b923_I20200627" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNS0xOS0xLTEtMA_8e28921b-93d3-4e0e-acc2-940e66cecd1a">22.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibe15f7e0e20e47c29d5afb6680fcde66_I20200627" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNS0yMC0xLTEtMA_785af136-25a7-4e69-b8b4-86dc552e7007">61.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="i181d930c7b854595977e17db8fd84eb4_94"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(19) <ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85NC9mcmFnOmFhYWUyNWYwZmIxZDQ0YWQ4ODk0Mjc5YjE3N2Q1YjMwL3RleHRyZWdpb246YWFhZTI1ZjBmYjFkNDRhZDg4OTQyNzliMTc3ZDViMzBfMTI2NDQzODM3MjE0MDI_d54fd652-0e99-4cd6-9483-073aa581ed9c" continuedAt="i62a7ba7405444c8e9749ba57f6c8fc36" escape="true">Share Repurchase</ix:nonNumeric></span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i62a7ba7405444c8e9749ba57f6c8fc36">On December 11, 2019, the Board of Directors authorized a share repurchase plan to purchase up to $<ix:nonFraction unitRef="usd" contextRef="ib0df6681d8a44b95b7eecdf8e0e95b6c_I20191211" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85NC9mcmFnOmFhYWUyNWYwZmIxZDQ0YWQ4ODk0Mjc5YjE3N2Q1YjMwL3RleHRyZWdpb246YWFhZTI1ZjBmYjFkNDRhZDg4OTQyNzliMTc3ZDViMzBfMTI3_365d7391-48cc-4265-a893-febc7d590b54">500.0</ix:nonFraction>&#160;million of the Company's outstanding common stock, effective March 2, 2020. During the first quarter of fiscal 2021, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="i42410f9e1104449eae75741c00a10044_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85NC9mcmFnOmFhYWUyNWYwZmIxZDQ0YWQ4ODk0Mjc5YjE3N2Q1YjMwL3RleHRyZWdpb246YWFhZTI1ZjBmYjFkNDRhZDg4OTQyNzliMTc3ZDViMzBfMjc1_b93f874c-06fe-49c0-846a-b507de15334a">1.5</ix:nonFraction>&#160;million shares of its common stock under this plan for a total consideration of $<ix:nonFraction unitRef="usd" contextRef="i42410f9e1104449eae75741c00a10044_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromRepurchaseOfEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85NC9mcmFnOmFhYWUyNWYwZmIxZDQ0YWQ4ODk0Mjc5YjE3N2Q1YjMwL3RleHRyZWdpb246YWFhZTI1ZjBmYjFkNDRhZDg4OTQyNzliMTc3ZDViMzBfMzM0_406ff201-8355-4882-9854-f62986be90bf">101.3</ix:nonFraction>&#160;million. On December 9, 2020, the Board of Directors authorized a new <ix:nonNumeric contextRef="icbb1f800737f42a09fc4ad36d6f50272_D20201209-20201209" format="ixt-sec:durwordsen" name="us-gaap:StockRepurchaseProgramPeriodInForce1" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85NC9mcmFnOmFhYWUyNWYwZmIxZDQ0YWQ4ODk0Mjc5YjE3N2Q1YjMwL3RleHRyZWdpb246YWFhZTI1ZjBmYjFkNDRhZDg4OTQyNzliMTc3ZDViMzBfMTI2NDQzODM3MjE0MTY_bd7862b0-7c3d-41c1-ac95-6a9d900f9ee5">five-year</ix:nonNumeric> share repurchase plan to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="iecca63b99d6b4da2bfd35be5986c1ad1_I20201209" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85NC9mcmFnOmFhYWUyNWYwZmIxZDQ0YWQ4ODk0Mjc5YjE3N2Q1YjMwL3RleHRyZWdpb246YWFhZTI1ZjBmYjFkNDRhZDg4OTQyNzliMTc3ZDViMzBfNDc3_b440bba0-451b-41aa-bb6d-8f731e98fe89">1.0</ix:nonFraction>&#160;billion of the Company's outstanding common stock. The prior plan was terminated in connection with this new authorization. Under the new authorization, during the three and nine months ended June 26, 2021, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="i2af30393c63846529254a9f5fdc55b28_D20210328-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85NC9mcmFnOmFhYWUyNWYwZmIxZDQ0YWQ4ODk0Mjc5YjE3N2Q1YjMwL3RleHRyZWdpb246YWFhZTI1ZjBmYjFkNDRhZDg4OTQyNzliMTc3ZDViMzBfMTA5OTUxMTYyODc4Mg_c6bece2e-fcba-4c29-bf13-90e0ff5ffe50">3.0</ix:nonFraction>&#160;million and <ix:nonFraction unitRef="shares" contextRef="iae354d54c17140f88ee32c1be6023458_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85NC9mcmFnOmFhYWUyNWYwZmIxZDQ0YWQ4ODk0Mjc5YjE3N2Q1YjMwL3RleHRyZWdpb246YWFhZTI1ZjBmYjFkNDRhZDg4OTQyNzliMTc3ZDViMzBfNjkw_b33506d0-3c41-4578-8548-429bcc575674">4.6</ix:nonFraction>&#160;million shares of its common stock for a total consideration of $<ix:nonFraction unitRef="usd" contextRef="i2af30393c63846529254a9f5fdc55b28_D20210328-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromRepurchaseOfEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85NC9mcmFnOmFhYWUyNWYwZmIxZDQ0YWQ4ODk0Mjc5YjE3N2Q1YjMwL3RleHRyZWdpb246YWFhZTI1ZjBmYjFkNDRhZDg4OTQyNzliMTc3ZDViMzBfNzQ5_7917c17b-6590-44f7-a41f-ca20b78bf8c6">188.4</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="iae354d54c17140f88ee32c1be6023458_D20200927-20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromRepurchaseOfEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85NC9mcmFnOmFhYWUyNWYwZmIxZDQ0YWQ4ODk0Mjc5YjE3N2Q1YjMwL3RleHRyZWdpb246YWFhZTI1ZjBmYjFkNDRhZDg4OTQyNzliMTc3ZDViMzBfMTA5OTUxMTYyODgwMw_1bd7007f-f4c2-40f6-8b68-18bd3afe8439">308.5</ix:nonFraction>&#160;million, respectively. As of June 26, 2021, $<ix:nonFraction unitRef="usd" contextRef="i44c5cb5c5b47462190024c645f543472_I20210626" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85NC9mcmFnOmFhYWUyNWYwZmIxZDQ0YWQ4ODk0Mjc5YjE3N2Q1YjMwL3RleHRyZWdpb246YWFhZTI1ZjBmYjFkNDRhZDg4OTQyNzliMTc3ZDViMzBfNzc1_5a75c250-30aa-4d96-a983-9fe6f5d80563">691.6</ix:nonFraction>&#160;million remained available under this authorization.</ix:continuation></span></div><div><span><br/></span></div><div id="i181d930c7b854595977e17db8fd84eb4_97"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(20) <ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85Ny9mcmFnOjVmZDA1ZmJlZjU2NjQyZjg5YTBlOWUzZmM0NDBhZDhhL3RleHRyZWdpb246NWZkMDVmYmVmNTY2NDJmODlhMGU5ZTNmYzQ0MGFkOGFfMzc4MQ_7453268f-adab-4c1c-805d-d6a9bdf491c9" continuedAt="ie694714791614cb5830a9168737259f3" escape="true">New Accounting Pronouncements</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ie694714791614cb5830a9168737259f3" continuedAt="ic6022c4d57024d84a49e423a61c0dff0"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 1 for Recently Adopted Accounting Pronouncements.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><ix:nonNumeric contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85Ny9mcmFnOjVmZDA1ZmJlZjU2NjQyZjg5YTBlOWUzZmM0NDBhZDhhL3RleHRyZWdpb246NWZkMDVmYmVmNTY2NDJmODlhMGU5ZTNmYzQ0MGFkOGFfMzc3MA_83bdc655-16f3-41d0-8e75-b62fe708470c" continuedAt="i91c04f3fa5184001a9f588dcc5fcf29c" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Board issued this Update as part of its initiative to reduce complexity in accounting standards (the Simplification Initiative). For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020 and is applicable to the Company in fiscal 2022. The Company is currently evaluating the impact of the adoption of ASU 2019-12 on its consolidated financial position and results of operations.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU No. 2020-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Board issued this Update to clarify certain interactions between the guidance to account for certain equity securities under Topic 321, the guidance to account for investments under the equity method of accounting in Topic 323, and the guidance in Topic 815. This update could change how an entity accounts for an equity security under the measurement alternative or a forward contract or purchased option to purchase securities that, upon settlement of the forward contract or exercise of the purchased option, would be accounted for under the equity method of accounting or the fair value option in accordance with Topic 825, Financial Instruments. For entities that have adopted the amendments in Update 2020-01, the updated guidance is effective for annual periods beginning after December 15, 2020, and is applicable to the Company in fiscal 2022. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2020-01 on its consolidated financial position and results of operations.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:27pt"><ix:continuation id="ic6022c4d57024d84a49e423a61c0dff0" continuedAt="iff826e33b5bb4c1f9cde93e36fdd7480"><ix:continuation id="i91c04f3fa5184001a9f588dcc5fcf29c" continuedAt="ia812b2a87c0a448994fbc2e52970cf87"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Board issued this Update as optional guidance for a limited period of time to ease the potential burden in accounting for or recognizing the effects of reference rate reform on financial reporting. This update will provide optional expedients and exceptions for applying GAAP to only contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. For entities that have adopted the amendments in Update 2020-04, the updated guidance is effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of the adoption of ASU 2020-04 on its consolidated financial position and results of operations.</span></ix:continuation></ix:continuation></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><ix:continuation id="iff826e33b5bb4c1f9cde93e36fdd7480" continuedAt="i7e15d0597dd04a6191b0ad4fff6c7a77"><ix:continuation id="ia812b2a87c0a448994fbc2e52970cf87" continuedAt="iad7038a0c7314cc4bb0f0061e28e0e17"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, FASB issued ASU No. 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848) Scope. </span></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7e15d0597dd04a6191b0ad4fff6c7a77"><ix:continuation id="iad7038a0c7314cc4bb0f0061e28e0e17">The board issued this Update in response to stakeholder concerns about potential diversity in practice. The Boards decided to clarify the scope of Topic 848 so that derivatives affected by the discounting transition are explicitly eligible for certain optional expedients and exceptions in Topic 848. This update provides optional expedients and exceptions for applying generally accepted accounting principles (GAAP) to only contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. For entities that have adopted the amendments in Update 2021-01, the updated guidance is effective for all entities immediately as of January 2021. The Company is currently evaluating the impact of the adoption of ASU 2021-01 on its consolidated financial position and results of operations.</ix:continuation></ix:continuation> </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><div id="i181d930c7b854595977e17db8fd84eb4_100"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY STATEMENT</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the statements contained in this report and documents incorporated by reference herein are forward-looking statements within the meaning of Section&#160;27A of the Securities Act of 1933 and Section&#160;21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These statements involve known and unknown risks, uncertainties and other factors which may cause our or our industry&#8217;s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements may include, but are not limited to, statements regarding:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ongoing and possible future effects of the global COVID-19 pandemic and associated economic disruptions on our business, financial condition, results of operations and cash flows and our ability to draw down our revolver;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ongoing and possible future effects of the global COVID-19 pandemic on our customers and suppliers;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continued demand for our COVID-19 assays; </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing, scope and effect of further U.S. and international governmental, regulatory, fiscal, monetary and public health responses to the COVID-19 pandemic;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to manufacture, on a scale necessary to meet demand, our COVID-19 assays as well as the systems on which the assays run; </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to predict accurately the demand for our products, and products under development and to develop strategies to address markets successfully;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effect of the continuing worldwide macroeconomic uncertainty, including the UK's decision to leave the European Union (known as Brexit), on our business and results of operations;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact and anticipated benefits of completed acquisitions, and acquisitions we may complete in the future</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effect of the current trade war between the U.S. and other nations, most notably China, and the impending impact of tariffs on the sale of our products in those countries and potential increased costs we may incur to purchase materials from our suppliers to manufacture our products;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the development of new competitive technologies and products, and the impact and anticipated benefits of completed acquisitions and acquisitions we may complete in the future;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability to consolidate certain of our manufacturing and other operations on a timely basis and within budget, without disrupting our business and to achieve anticipated cost synergies related to such actions;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability to successfully manage ongoing organizational and strategic changes, including our ability to attract, motivate and retain key employees and maintain engagement and efficiency in remote work environments;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain regulatory approvals and clearances for our products, including the implementation of the new European Union Medical Device Regulations, and maintain compliance with complex and evolving regulations; </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential cybersecurity threats and targeted computer crime;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the coverage and reimbursement decisions of third-party payors; </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the uncertainty of the impact of cost containment efforts and federal healthcare reform legislation on our business and results of operations;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the guidelines, recommendations, and studies published by various organizations relating to the use of our products;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effect of consolidation in the healthcare industry;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the possibility of interruptions or delays at our manufacturing facilities, or the failure to secure alternative suppliers if any of our sole source third-party manufacturers fail to supply us;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to meet production and delivery schedules for our products; </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to protect our intellectual property rights; </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the possibility that products may contain undetected errors or defects or otherwise not perform as anticipated;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the anticipated development of markets we sell our products into and the success of our products in these markets; </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the anticipated performance and benefits of our products; </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">business strategies;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">estimated asset and liability values;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">conducting business internationally;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact and costs and expenses of any litigation we may be subject to now or in the future;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our compliance with covenants contained in our debt agreements;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">anticipated trends relating to our financial condition or results of operations, including the impact of interest rate and foreign currency exchange fluctuations, including the potential impact of the proposed phase out of LIBOR by the end of 2023; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our liquidity, capital resources and the adequacy thereof.</span></div><div style="margin-bottom:18pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some cases, you can identify forward-looking statements by terms such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;expects,&#8221; &#8220;plans,&#8221; "intends," &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;projects,&#8221; &#8220;predicts,&#8221; "likely," "future," "strategy." &#8220;potential,&#8221; "seeks," "goal" and similar expressions intended to identify forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by such forward-looking statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Also, these forward-looking statements represent our estimates and assumptions only as of the date of this report. Except as otherwise required by law, we expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statement contained in this report to reflect any change in our expectations or any change in events, conditions or circumstances on which any of our forward-looking statements are based. Factors that could cause or contribute to differences in our future financial results include the cautionary statements set forth herein and in our other filings with the Securities and Exchange Commission, including those set forth under "Risk Factors" set forth in Part II, Item 1A of this Quarterly Report, as well as those described in our Annual Report on Form 10-K for the fiscal year ended September&#160;26, 2020 or any other of our subsequently filed reports. We qualify all of our forward-looking statements by these cautionary statements.</span></div><div id="i181d930c7b854595977e17db8fd84eb4_103"></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OVERVIEW</span></div><div style="margin-top:5pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a developer, manufacturer and supplier of premium diagnostics products, medical imaging systems, and surgical products focused on women's health and well-being through early detection and treatment. We sell and service our products through a combination of direct sales and service personnel and a network of independent distributors and sales representatives. We operate in four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. Until December 30, 2019, our product portfolio included aesthetic and medical treatments systems sold by our former Medical Aesthetic business. We completed the sale of our Medical Aesthetics segment on December 30, 2019 (the first day of the second quarter of fiscal 2020).</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our Diagnostics segment, we offer a wide range of diagnostics products, which are used primarily to aid in the screening and diagnosis of human diseases. Our primary Diagnostics products include our molecular diagnostic assays, which run on our advanced instrumentation systems (Panther, Panther Fusion and Tigris), our ThinPrep cytology system, and the Rapid Fetal Fibronectin Test. Our Aptima family of molecular diagnostic assays is used to detect, among other things, the infectious microorganisms that cause the common sexually transmitted diseases, or STDs, such as chlamydia and gonorrhea, or CTGC, certain high-risk strains of human papillomavirus, or HPV, and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Trichomonas vaginalis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the parasite that causes trichomoniasis. In addition, in 2017 and 2018 we introduced the Aptima quantitative viral load tests for HIV, Hepatitis C and Hepatitis B. Our assay portfolio also includes diagnostic tests for a range of acute respiratory infections, including SARS-CoV-2, as well as a test for the detection of Group B Streptococcus, or GBS, that are run on the Panther Fusion system, a field upgradeable instrument addition to the base Panther system. In 2020, in response to the COVID-19 global pandemic, we developed and launched the Aptima SARS-CoV-2 assay (which runs on our standard Panther system) and the Panther Fusion SARS-CoV-2 assay (which runs on our Panther Fusion system). The Panther Fusion SARS-CoV-2 assay and the Aptima SARS-CoV-2 assay were launched at the end of our second quarter and in the third quarter of fiscal 2020, respectively. The ThinPrep System is primarily used in cytology applications, such as cervical cancer screening, and the Rapid Fetal Fibronectin Test assists physicians in assessing the risk of pre-term birth. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Breast Health segment offers a broad portfolio of solutions for breast cancer care for radiology, pathology and surgery. These solutions include breast imaging and analytics, such as our 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, ultrasound and connectivity solutions and breast conserving surgery products. Our most advanced breast imaging platforms, Selenia Dimensions and 3Dimensions, utilize a technology called tomosynthesis to produce 3D images that show multiple contiguous slice images of the breast, which we refer to as the Genius 3D Mammography exam, as well as conventional 2D full field digital mammography images. With the acquisition of SuperSonic Imagine in the first quarter of fiscal 2020, we now offer premium ultrasound imaging, further connecting Hologic capabilities across the continuum of breast care from screening to diagnosis and treatment. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our GYN Surgical products include our NovaSure Endometrial Ablation System, or NovaSure, and our MyoSure Hysteroscopic Tissue Removal System, or MyoSure, as well as our Fluent Fluid Management system, or Fluent. The NovaSure portfolio is comprised of the NovaSure CLASSIC and NovaSure ADVANCED devices and involves a trans-cervical procedure </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the treatment of abnormal uterine bleeding. The MyoSure suite of devices offers four options to provide incision-less removal of fibroids, polyps, and other pathology within the uterus. The Fluent system is a fluid management system that provides liquid distention during diagnostic and operative hysteroscopic procedures.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Skeletal Health segment's products includes the Horizon DXA, a dual energy x-ray system, which evaluates bone density and performs body composition assessments, and the Fluoroscan Insight FD mini C-arm, which assists in performing minimally invasive orthopedic surgical procedures on a patient's extremities, such as the hand, wrist, knee, foot, and ankle.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the context otherwise requires, references to we, us, Hologic or our company refer to Hologic, Inc. and its consolidated subsidiaries.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 Considerations</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global COVID-19 pandemic has created significant volatility, uncertainty, and economic disruption in the markets we sell our products into, primarily the U.S., Europe and Asia-Pacific. Starting in the second quarter of fiscal 2020, the spread of COVID-19 negatively impacted business and healthcare activity globally. In particular, due to government measures, elective procedures and exams were delayed or cancelled, there were significant reductions in physician office visits, and hospitals postponed or canceled capital purchases as well as limited or eliminated services; however, in the second half of the third quarter of fiscal 2020, we started to see a recovery of elective procedures and exams as economies were opened back up and restrictions eased, which has continued through the third quarter of fiscal 2021. The reductions in testing and procedures had a negative impact on our operating results and cash flows in fiscal 2020, however, the impact of the commercial release of our COVID-19 assays more than offset those negative impacts as we generated significant revenue from the sales of these assays starting in the third quarter of fiscal 2020 through the third quarter of fiscal 2021.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While our results of operations and cash flows since the third quarter of fiscal 2020 have been positively impacted by the sale of our COVID-19 assays as well the continued recovery of our other primary product lines and businesses to pre-COVID levels, the COVID-19 pandemic could have an adverse impact on our operating results, cash flows and financial condition in the future. The factors that could create such adverse impact include: continued demand for COVID-19 testing; competition from existing and new COVID-19 testing technologies and products as well as the timing and effectiveness of distributing vaccines; the severity and duration of the COVID-19 pandemic; the resurgence of COVID-19 infections; the emergence of new COVID strain variants; the COVID-19 pandemic's impact on the U.S. and international healthcare systems, the U.S. economy and worldwide economy; and the timing, scope and effectiveness of U.S. and international governmental, regulatory, fiscal, monetary and public health responses to the COVID-19 pandemic and associated economic disruptions. We expect that as the current COVID-19 pandemic subsides, there may be a significantly reduced demand for ongoing testing, and thus, for our COVID-19 assays. As expected in the third quarter of fiscal 2021, revenues generated from the sale of our COVID-19 assays decreased significantly in the U.S. compared to the prior year period and the first and second quarters of fiscal 2021 as the population of vaccinated people continues to grow in the U.S. We expect this trend to continue in the fourth quarter of fiscal 2021.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the negative impact of COVID-19 on our business, in April 2020, we initiated cost-cutting measures, which included not only reducing discretionary and variable spend, such as travel, marketing programs and the use of contractors, consultants and temporary help, but we also implemented employee furloughs, salary cuts primarily in the U.S., reduced hours and in certain instances, employee terminations. Further in April 2020, we shut down certain manufacturing facilities temporarily and implemented reduced work-week schedules in response to lower near-term demand for many of our products. As of the end of the third quarter of fiscal 2020, substantially all of the Company's employee cost-cutting measures ceased, and the majority of the impacted manufacturing facilities were back to pre-COVID-19 pandemic levels. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also taken and continue to take measures to ensure the safety of our employees and to comply with governmental orders. These measures could require that our employees continue to work remotely or otherwise refrain from reporting to their normal workplace for extended periods of time, which in turn could result in a decrease in our commercial and marketing activities. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trademark Notice</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hologic is a trademark of Hologic, Inc. Other trademarks, logos, and slogans registered or used by Hologic and its divisions and subsidiaries in the United States and other countries include, but are not limited to, the following: 3Dimensions, 3D Mammography, Acessa, Acessa Health, Acessa ProVu, Affirm, Affirm Prone, Amplidiag, Alpha Imaging, Aptima, Biotheranostics, Brevera, Clarity HD, Diagenode, Fluent, Fluoroscan, Genius 3D, Genius 3D Mammography, Health Beacons, Hologic, Horizon DXA, Insight, Intelligent 2D, LOCalizer, Mobidiag, MyoSure, Novodiag, NovaSure, NXC Imaging, Panther, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Panther Fusion, Rapid fFN, Selenia, Selenia Dimensions, SmartCurve, Somatex, SuperSonic Imagine, ThinPrep, Tigris, and Tumark. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other brand names or trademarks appearing in this Quarterly Report on Form 10-Q are the property of their respective owners. Hologic's use or display of other parties' trademarks, trade dress or products in this offering circular does not imply that Hologic has a relationship with, or endorsement or sponsorship of, the trademark or trade dress owners.</span></div><div id="i181d930c7b854595977e17db8fd84eb4_106"></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ACQUISITIONS</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following sets forth descriptions of acquisitions and dispositions we have completed in fiscal 2021 and 2020.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Mobidiag</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 17, 2021, we completed the acquisition of Mobidiag Oy, or Mobidiag, for a purchase price of $729.6&#160;million. Mobidiag, located in Finland, manufactures molecular diagnostic solutions for gastrointestinal infections, antimicrobial resistance management and other infections. This acquisition expands our molecular diagnostics portfolio into the near-patient testing market. Mobidiag's results of operations are reported in the our Diagnostics segment.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Biotheranostics</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 22, 2021, we completed the acquisition of Biotheranostics, Inc., or Biotheranostics, for a purchase price of $231.3 million. Biotheranostics, located in San Diego, California, manufactures molecular diagnostic tests for breast and metastatic cancers and performs lab testing procedures at its facility. Biotheranostics' results of operations are included in our Diagnostics segment and its revenues are reported within Service and other revenue in our Consolidated Statements of Income.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diagenode</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, we completed the acquisition of Diagenode SA, or Diagenode, for a purchase price of $155.1&#160;million. Diagenode, located in Belgium, is a developer and manufacturer of molecular diagnostic assays based on PCR technology to detect infectious diseases of bacterial, viral or parasite origin. Diagenode's results of operations are included in our Diagnostics segment.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Somatex Medical Technologies</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2020, we completed the acquisition of Somatex Medical Technologies GmbH, or Somatex, for a purchase price of $62.9&#160;million. Somatex, located in Germany, is a manufacturer of biopsy site markers, including the Tumark product line of tissue markers, which we distributed in the U.S. prior to the acquisition. Somatex's results of operations are included in our Breast Health segment.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NXC Imaging</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2020, we completed the acquisition of assets from NXC Imaging, for a purchase price of $5.6 million. NXC Imaging was a long-standing distributor of our Breast and Skeletal products in the U.S. NXC's results of operations are included in our Breast Health and Skeletal segment, as applicable to their operations. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acessa Health</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 23, 2020, we completed the acquisition of Acessa Health, Inc., or Acessa, for a purchase price of $161.3 million, which included contingent consideration and was estimated at $81.8 million as of the measurement date. Acessa, located in Austin, Texas, manufactures and markets the Acessa ProVu system, a laparoscopic radio frequency ablation system for use in treatment of uterine fibroids. Acessa's results of operations are included in our GYN Surgical segment. The contingent consideration is based on annual incremental revenue growth over a three-year period ending annually in December. The contingent consideration is payable after each annual measurement period. We remeasure the contingent consideration liability on a quarterly basis, and for the nine months ended we recorded a gain of $10.1 million to decrease the liability to its fair value. The reduction in fair value was primarily due to a decrease in forecasted revenues over the measurement period.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Beacons</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 3, 2020, we completed the acquisition of Health Beacons, Inc., or Health Beacons, for a purchase price of $19.7 million. Health Beacons manufactures the LOCalizer product and its results of operations are included in our Breast Health segment.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Alpha Imaging</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2019, we completed the acquisition of assets from Alpha Imaging, LLC, or Alpha Imaging, for a purchase price of $18.0 million. Alpha Imaging was a long-standing distributor of our Breast and Skeletal Health products in the U.S. Alpha Imaging's result of operations are included in our Breast Health and Skeletal segment, as applicable to their operations. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SuperSonic Imagine</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2019, we acquired approximately 46% of the outstanding shares of SuperSonic Imagine S.A., or SSI, which is headquartered in France. SSI specializes in ultrasound imaging and designs, and develops and markets an ultrasound platform used in the non-invasive care path for the characterization of breast, liver and prostate diseases. We initially accounted for this investment as an equity method investment.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 21, 2019, we acquired an additional 7.6 million shares of SSI for $12.6 million. As a result, we owned approximately 78% of the outstanding shares of SSI at November 21, 2019 and controlled SSI's voting interest and operations. We performed purchase accounting as of November 21, 2019 and beginning on that date the financial results of SSI are included within our consolidated financial statements within our Breast Health segment. We remeasured the initial investment of 46% of the outstanding shares of SSI to its fair value at the acquisition date, resulting in a gain of $3.2 million recorded in Other income (expense), net in the first quarter of fiscal 2020.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the third quarter of fiscal 2021, we acquired the remaining 4.8 million shares outstanding of SSI for $8.5 million. As of June 26, 2021, we owned 100% of SSI. Accordingly we have recorded an adjustment to our net income for the non-controlling interest we did not own of $0.3 million and $1.8 million for the three and nine months ended June 26, 2021, respectively, and $1.5 million and $3.4 million for the three and nine months ended June 27, 2020, respectively.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disposition</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2019, we completed the sale of our Medical Aesthetics business. At the closing, we received cash proceeds of $153.4 million. The sales price was finalized in the fourth quarter of fiscal 2020, and we repaid $3.4 million, resulting in a final sales price of $150.0 million. As a result of the sale, we recorded a $30.2 million impairment charge in the first quarter of fiscal 2020 to record the asset group at fair value less costs to dispose as it met the assets held-for-sale criteria. For additional information, see Note 6 to our consolidated financial statements included herein. Following the sale of our Medical Aesthetics business, we have not generated any further product revenue related to this business, although additional expenses will be incurred primarily in connection with the indemnification of legal and tax matters that existed as of the date of disposition. In addition, we agreed to provide transition services for a period of up to 15 months, which ended in March 2021.</span></div><div><span><br/></span></div><div id="i181d930c7b854595977e17db8fd84eb4_109"></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All dollar amounts in tables are presented in millions.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Revenues</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:11.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.105%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.105%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.105%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.105%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.105%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.105%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.105%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.105%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.105%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.105%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.105%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:5.969%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="18" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="18" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of<br/>Total<br/>Revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of<br/>Total<br/>Revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of<br/>Total<br/>Revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Product Revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">637.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">528.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">108.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,793.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,149.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">47.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,644.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">143.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">211.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">111.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">89.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">617.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">506.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">110.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">127.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">76.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">148.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">365.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">275.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">90.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Skeletal&#160;Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(49.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">995.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">701.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">85.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">293.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,829.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,024.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">83.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,804.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">89.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We generated an increase in product revenues in both the current three and nine month periods of 41.8% and 89.2%, respectively, compared to the corresponding periods in the prior year primarily due to the significant increase in revenues in the Diagnostics business, which for the current nine month period was principally from sales of our two COVID-19 assays, one of which was launched near the end of the second quarter of fiscal 2020 and the other in the third quarter of fiscal 2020. Excluding sales of our COVID-19 assays, product revenues in the prior year periods were adversely impacted by the COVID-19 pandemic, and product revenues in the current year periods have increased across our divisions. We primarily attribute this increase to recovery of elective procedures and exams as economies were opened back up and restrictions eased. In the current three month period, the increases in product revenues were partially offset by a reduction in sales of our COVID-19 assays. We attribute this decrease primarily to reduced testing resulting from the extensive distribution of vaccines in the U.S. The increase in product revenues in the current nine month period compared to the corresponding prior year period was partially offset by no revenues from the Medical Aesthetics business in the current fiscal year as we disposed of this business segment on December 30, 2019, the beginning of our second quarter of fiscal 2020. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostics product revenues increased $108.6 million and $1,644.4 million, or 20.5% and 143.1%, respectively, in the current three and nine month periods compared to the corresponding periods in the prior year primarily due to increases in Molecular Diagnostics of $52.2 million and $1,585.9 million, respectively, and increases in Cytology &amp; Perinatal of $51.5 million and $58.4 million, respectively. Blood Screening product revenue increased $4.9 million in the current three month period and was flat in the current nine month period compared to the corresponding periods in the prior year. While we divested our Blood Screening business in the second quarter of fiscal 2017, we continue to provide long-term access to Panther instrumentation and certain supplies to the purchaser of that business. Molecular Diagnostics product revenue was $511.1 million and $2,410.6 million, respectively, in the current three and nine month periods compared to $459.0 million and $824.7 million in the corresponding periods in the prior year. The increase in the current three month period compared to the corresponding period in the prior year was primarily attributable to sales of our Aptima assays (exclusive of our Aptima SARS-CoV-2 assay), which primarily consist of our CTGC, HPV and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trichomonas vaginalis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> assays, on a worldwide basis, as well as an increase in collection kits due to a return to pre-COVID testing levels and the prior year periods sales were adversely impacted due to the COVID-19 pandemic and related lockdowns across the globe. These increases were partially offset by a decrease in revenue from our two SARS-CoV-2 assays in the U.S. in the current quarter compared to the corresponding period in the prior year as volumes declined and to a lesser extent average sales prices declined, as well as lower sales of Panther instruments. Sales of our COVID-19 assays declined to $291.2 million in the current three month period compared to $324.0 million in the corresponding period in the prior year. We primarily attribute this decline to lower COVID-19 testing in the U.S. resulting from the continued distribution of vaccines and higher inventory levels at our laboratory customers. This decline was partially offset by increased international revenues, as the distribution of vaccines has been slower outside of the U.S. The increase in the current nine month period compared to the corresponding period in the prior year was primarily attributable to sales of our COVID-19 assays, which increased to $1,716.2 million in the current nine month period compared to $328.1 million in the corresponding period in the prior year, an increase in our Aptima assays, an increase in collection kits and Panther and Panther Fusion instrument sales primarily due to demand for increased testing capacity for COVID-19. However, we do expect that sales of our COVID-19 assays will continue to decline, primarily in the U.S. in the fourth quarter of fiscal 2021 compared to the current quarter due to the continued distribution of vaccines and higher inventory levels at our laboratory customers. Cytology &amp; Perinatal product revenue increased in the current three and nine month periods compared to the corresponding periods in the prior year primarily due to higher ThinPrep test volumes in the U.S. and Asia-Pacific, which we primarily attribute to the recovery of wellness office visits that had previously been delayed or cancelled in response to the COVID-19 pandemic, and the prior year periods sales were adversely impacted due to the COVID-19 pandemic and related </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lockdowns across the globe, partially offset by lower average selling prices and lower Perinatal product volumes. The inclusion of Diagenode contributed $10.1 million and $13.6 million of product revenue in the current three and nine month periods, respectively. We also experienced an increase in revenue from the favorable foreign currency exchange impact of the weakened U.S. dollar against a number of currencies in both the current three and nine month periods. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Breast Health product revenues increased $100.1 million and $110.9 million, or 89.8% and 21.9%, respectively, in the current three and nine month periods compared to the corresponding periods in the prior year as product revenues in the prior year periods were adversely impacted by the COVID-19 pandemic and related lockdowns across the globe. These increases were primarily due to an increase in sales volume of our digital mammography systems and related workflow products (primarily Intelligent 2D, Clarity HD and SmartCurve), Affirm Prone breast biopsy tables, and our interventional breast solutions products, primarily Eviva, ATEC, and Brevera disposables (relaunched in the fourth quarter of fiscal 2020). In addition, we had higher sales of our breast conserving surgery products and ultrasound imaging products. We primarily attribute the increase in revenues to hospitals and imaging centers purchasing capital equipment to fulfill their budgets and demand has increased in sequential quarters, which we attribute to the recovery of elective procedures and exams as elective procedures and wellness visits have recovered from the initial cancellation and deferrals due to the COVID-19 pandemic in fiscal 2020. We also experienced an increase in revenue from the favorable foreign currency exchange impact of the weakened U.S. dollar against a number of currencies in both the current three and nine month periods.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GYN Surgical product revenues increased $76.1 million and $90.2 million, or 148.3% and 32.8 %, respectively, in the current three and nine month periods compared to the corresponding periods in the prior year primarily due to the GYN Surgical business recovering as a result of the recovery of elective medical visits and procedures that had previously been delayed or cancelled in response to the COVID-19 pandemic and to a lesser extent healthcare providers increasing their inventory levels to ensure there are no supply constraints. These increases were primarily due to increases in the sales volume of MyoSure systems, NovaSure systems, Fluent Fluid Management systems and to a lesser extent sales of ProVu systems, acquired in the Acessa acquisition in the fourth quarter of fiscal 2020. We also experienced an increase in revenue from the favorable foreign currency exchange impact of the weakened U.S. dollar against a number of currencies.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Skeletal Health product revenues increased $8.8 million and $9.1 million, or 88.0% and 20.9%, respectively, in the current three and nine month periods compared to the corresponding periods in the prior year primarily due to an increase in sales volume of both our Insight FD mini C-arm and Horizon DXA systems. We primarily attribute this increase to the increase in wellness visits and healthcare screenings in 2021 as a result of the ongoing recovery from the COVID-19 pandemic.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We divested the Medical Aesthetics segment on December 30, 2019, the beginning of our second quarter of fiscal 2020.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product revenues by geography as a percentage of total product revenues were as follows:</span></div><div style="margin-top:5pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.670%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:13pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the current three and nine month periods compared to the corresponding periods in the prior year, the percentage of product revenue derived from the U.S. decreased while Europe increased, which we primarily attributed to strong sales of our SARS-CoV-2 assays in Europe and growth in our Aptima assays in Europe as we expanded our customer base and increased sales from the adoption of co-testing for cervical cancer screening in Germany and to a lesser extent in the UK. Asia-Pacific product revenue as a percentage of total product revenue increased in the current three month period compared to the corresponding period in the prior year primarily due to an increase in sales of our SARS-CoV-2 assays in the region, an increase in sales of our mammography systems and growth in ThinPrep and Molecular Diagnostics primarily due to the recovery of wellness office visits that had previously been delayed or cancelled in response to the COVID-19 pandemic. </span></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service and Other Revenues</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.496%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Service and Other Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">173.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">121.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">51.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">42.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">486.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">405.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">81.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:7pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service and other revenues consist primarily of revenue generated from our field service organization to provide ongoing service, installation, and repair of our products. The majority of these revenues are generated within our Breast Health segment. The increase in service and other revenue in the current three and nine month periods compared to the corresponding periods in the prior year was primarily due to an increase in Breast Health service contract revenue as the Breast Health business continued to convert a high percentage of our installed base of digital mammography systems to service contracts upon expiration of the warranty period, as well as additions from our distributor acquisitions. We also experienced an increase in spare parts revenue in the current three and nine month periods for services that had previously been delayed or cancelled due to the COVID-19 pandemic. In our Diagnostics business, we had additional royalty revenue in the current three and nine month periods of $9.8 million, and $32.6 million, respectively, from Grifols related to licensing our intellectual property to our COVID-19 assays for their sale in Spain. In addition, the inclusion of Biotheranostics added $13.2 million and $17.2 million in the current three and nine month periods, respectively. These increases were partially offset by the sale of the Medical Aesthetics business which contributed $15.6 million of revenue in the prior year nine month period.</span></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Product Revenues</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.186%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.204%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Product<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Product<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of<br/>Product<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Product<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Cost of Product Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">303.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">225.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">78.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">889.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">685.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">203.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Amortization of Intangible Assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">68.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">62.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">194.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">189.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Impairment of Intangible Assets and Equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">372.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">288.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">41.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">84.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,083.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">901.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">182.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div style="margin-top:7pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Product Revenues.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The cost of product revenues as a percentage of product revenues was 30.5% and 23.2% in the current three and nine month periods, respectively, compared to 32.1% and 33.9% in the corresponding periods in the prior year, respectively. Cost of product revenues as a percentage of revenue decreased in the current three and nine month periods primarily due to sales of our SARS-CoV-2 assays, which have higher gross margins compared to our other diagnostic products, and comprised 29.3% and 44.8% of total product revenue in the current three and nine month periods, respectively, compared to 46.2% and 16.2% in the corresponding periods in the prior year, respectively. Also benefiting gross margin in the current year period was higher sales volumes from our other businesses and product lines as they have continued to recover from the COVID-19 pandemic as economies opened back up and restrictions eased and the disposition of Medical Aesthetics, which had lower gross margins compared to our remaining businesses. Partially offsetting these decreases were higher field service costs for our expanded instrument installed base for the Diagnostics business and higher freight costs.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostics' product costs as a percentage of revenue increased in the current three month period compared to the corresponding period in the prior year primarily due to lower sales of our SARS-CoV-2 assays, an increase in reserves, higher field service costs for our expanded instrument installed base, increased amortization of placed instruments, higher freight charges and a slight decline in average selling prices. These increases were partially offset by increased volumes of our Aptima assays and ThinPrep Pap Test. Diagnostics' product costs as a percentage of revenue decreased in the current nine month period compared to the corresponding period in the prior year primarily due to higher sales of our SARS-CoV-2 assays and higher overall production of our Aptima assays and ThinPrep Pap Test reducing fixed overhead on a unit basis, partially offset by higher field service costs for our expanded instrument installed base, freight charges, inventory reserves and a slight decline in average selling prices.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Breast Health&#8217;s product costs as a percentage of revenue decreased in the current three and nine month periods compared to the corresponding periods in the prior year primarily due to the impact of the COVID-19 pandemic in the prior year periods, which resulted in decreased sales volume across the majority of our product lines, period costs for temporary facility shut-downs and reduced manufacturing utilization and increased inventory reserves. In the current three and nine month periods sales volumes have increased for our higher margin 3Dimensions systems, higher-margin workflow products, consisting of Intelligent 2D, Clarity HD and SmartCurve upgrades, and our breast biopsy and breast conserving surgery disposable products.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GYN Surgical&#8217;s product costs as a percentage of revenue decreased in the current three and nine month periods compared to the corresponding periods in the prior year primarily due to the impact of the COVID-19 pandemic in the prior year periods, which resulted in significant decreases in sales volume of our NovaSure and MyoSure devices, period costs for the temporary shutdown of our manufacturing facility and reduced manufacturing utilization. In the current three and nine month periods, the Surgical business has recovered to which significantly improved margins, partially offset by product mix of higher volumes of lower margin products, including our Fluent Fluid Management systems and ProVu systems, acquired in the Acessa acquisition.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Skeletal Health&#8217;s product costs as a percentage of revenue decreased in the current three and nine month periods compared to the corresponding periods in the prior year due to higher sales volume of both our Insight FD mini C-arm and Horizon DXA systems and higher inventory reserves in the prior year periods.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We divested the Medical Aesthetics segment on December 30, 2019, the beginning of our second quarter of fiscal 2020.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization of Intangible Assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Amortization of intangible assets relates to acquired developed technology, which is generally amortized over its estimated useful life of between 5 and 15 years using a straight-line method or, if reliably determinable, based on the pattern in which the economic benefits of the assets are expected to be consumed. Amortization expense increased in the current three and nine month periods compared to the corresponding periods in the prior year primarily due to intangible assets acquired in the Biotheranostics, Diagenode, Somatex and Acessa acquisitions, partially offset by lower amortization of intangible assets acquired in the Cytyc acquisition which reduces over time.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Intangible Assets and Equipment. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 6 to the consolidated financial statements, we recorded an aggregate impairment charge of $30.2 million during the first quarter of fiscal 2020. The impairment charge was allocated to the Medical Aesthetics long-lived assets, of which $25.8 million was allocated to developed technology assets and written off to cost of revenues. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Service and Other Revenues</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.478%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.625%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.201%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Service<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Service<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Service<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Service<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Cost of Service and Other Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">94.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">68.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">56.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">264.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">232.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">57.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:7pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service and other revenues gross margin increased to 45.3% and 45.6%, respectively, in the current three and nine month periods compared to 43.2% and 42.5%, respectively, in the corresponding periods in the prior year. The increase in the current year periods was primarily due to additional royalty revenue from Grifols related to licensing our intellectual property related to our COVID-19 assays for their sale in Spain, which has a high margin. In addition, in the current year periods the Breast Health business had an increase in service contract revenue which benefited gross margin as service contract revenue has higher margins compared to revenue from spare parts, installation and training.</span></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.785%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Operating Expenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">199.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">165.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">142.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">103.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">402.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">359.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">43.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">117.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">105.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">297.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">259.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairment of intangible assets and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent consideration - fair value adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(10.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(10.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restructuring and Divestiture charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">260.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">37.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">343.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">275.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">67.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">926.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">823.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">103.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:27pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**Percentage not meaningful</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Research and development expenses increased 25.2% and 20.7% in the current three and nine month periods compared to the corresponding periods in the prior year primarily due to higher R&amp;D project spend in Diagnostics, Breast Health and Surgical, the inclusion of expenses from the Acessa, Biotheranostics, Diagenode and Somatex acquisitions, higher consulting spending and increased spending to implement the European Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) requirements. In the current nine month period, we recorded a $7.0 million charge related to the purchase of intellectual property in Breast Health. Partially offsetting these increases in the current nine month period was the reduction of expense due to the disposition of the Medical Aesthetics business which contributed $7.3 million of expense in the prior year nine month period. In addition, in the current three and nine month periods we recorded a credit to research and development expenses of $2.4 million and $10.1 million, respectively, from the Biomedical Advanced Research and Development Authority (BARDA) in connection with a grant to expand manufacturing capacity and obtain FDA approval of our SARS-CoV-2 assays compared to a credit of $4.7 million in the prior year three and nine month periods. At any point in time, we have a number of different research projects and clinical trials being conducted and the timing of these projects and related costs can vary from period to period.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling and Marketing Expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Selling and marketing expenses increased 37.9% and 12.0% in the current three and nine months periods, respectively, compared to the corresponding periods in the prior year primarily due to an increase in commissions in Breast Health, Surgical and Diagnostics from higher revenues, an increase in marketing initiatives and consulting spending, and the inclusion of expenses in the aggregate from the Acessa, Biotheranostics, Diagenode and Somatex acquisitions of $12.2 million and $20.9 million in the current three and nine month periods, respectively. Partially offsetting these increases in the current nine month period was the disposition of the Medical Aesthetics business which contributed $23.7 million of expense in the prior year nine month period, lower travel expenses in response to the COVID pandemic and decreases in meeting expenses primarily related to cancelling our national sales meeting and not having an in-person RSNA conference as a result of the COVID pandemic.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative Expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> General and administrative expenses increased 11.4% and 14.5% in the current three and nine month periods, respectively, compared to the corresponding periods in the prior year primarily due to the inclusion of expenses from the Acessa, Biotheranostics, Diagenode and Somatex acquisitions, increased acquisition transaction costs including $11.5 million for a transfer tax related to the Mobidiag acquisition, higher litigation and settlement costs, increased consulting spend for corporate initiatives and information system implementation projects, higher salary expenses due to pay reductions and furloughs implemented in April 2020 due to the COVID pandemic, and lower credits in the current year periods of $5.7 million and $3.5 million, respectively, related to transition services provided to Cynosure, partially offset by lower bonus and stock-based compensation, and lower bad debt expense. In the current three month period, we had lower charitable donations. In the current nine month period, we had higher expense from our deferred compensation plan, partially offset by the disposition of the Medical Aesthetics business, which contributed $5.5 million of expenses in the prior year period, expenses incurred to separate and dispose of that business, and a $3.3 million benefit due to reversal of a tax reserve.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization of Intangible Assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Amortization of intangible assets results from customer relationships, trade names, distributor relationships and business licenses related to our acquisitions. These intangible assets are generally amortized over their estimated useful lives of between 2 and 30 years using a straight-line method or, if reliably determinable, based on the pattern in which the economic benefits of the assets are expected to be consumed utilizing expected undiscounted future cash flows. Amortization expense was relatively consistent in both periods compared to the prior year periods as we had increases from recent acquisitions offset by assets from older acquisitions becoming fully amortized. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Consideration Fair Value Adjustments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition of Acessa, we are obligated to make contingent earn-out payments. The payments are based on achieving incremental revenue growth over a three-year period ending annually in December. As of the acquisition date for Acessa, we recorded a contingent consideration liability for the estimated fair value of the amount we expected to pay to the former shareholders of the acquired business. This liability is not contingent on future employment, and we recorded our estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation based on future revenue projections of Acessa, comparable companies revenue growth rates, implied volatility and applying a risk adjusted discount rate. Increases or decreases in the fair value of contingent consideration liabilities can result from the passage of time, changes in discount rates, and changes in the timing, probabilities and amount of revenue estimates. No adjustment was made to the liability in the current quarter, and for the current nine month period we recorded a gain of $10.1 million to decrease the liability to its fair value. The reduction in fair value was primarily due to a decrease in forecasted revenues over the measurement period.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Intangible Assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;As discussed in Note 6 to the consolidated financial statements, we recorded an aggregate impairment charge of $30.2 million during the first quarter of fiscal 2020. The impairment charge was allocated to the Medical Aesthetics long-lived assets of which $4.4 million was written off to operating expenses. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructuring and Divestiture Charges.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We have implemented various cost reduction initiatives to align our cost structure with our operations and related integration activities. These actions have primarily resulted in the termination of employees. As a result, we recorded charges of $3.6 million and $6.6 million in the current three and nine month periods, respectively, and $1.0 million and $4.8 million in the corresponding prior year periods, respectively, primarily related to severance benefits. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:14.126%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.856%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.858%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Interest Expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense consists primarily of the cash interest costs and the related amortization of the debt discount and deferred issuance costs on our outstanding debt. Interest expense in the current three and nine month periods decreased primarily due to a decrease in LIBOR year over year, the basis for determining interest expense under our 2018 Credit Agreement, lower interest rates on our Senior Notes due to issuing our 2029 Senior Notes and paying off our 2025 Senior Notes, and the pay-off of amounts outstanding under our accounts receivable asset securitization agreement in the prior year, partially offset by issuance costs expensed from the issuance of the 2029 Senior Notes and higher interest rate swap expenses.</span></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Extinguishment Loss</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.705%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Debt Extinguishment Loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2021, we completed a private placement of $950 million aggregate principal amount of our 2029 Senior Notes. The proceeds under the 2029 Senior Notes offering, together with available cash, were used to redeem our 2025 Senior Notes in the same principal amount. In connection with this transaction, we recorded a debt extinguishment loss of $21.6 million in the first quarter of fiscal 2021.</span></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income (Expense), net</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.707%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other Income (Expense), net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the current three month period, this account primarily consisted of a gain of $3.4 million on the cash surrender value of life insurance contracts related to our deferred compensation plan driven by stock market gains, partially offset by net foreign currency exchange losses of $3.9 million, primarily from the mark-to-market of outstanding forward foreign currency exchange and foreign currency option contracts. For the third quarter of fiscal 2020, this account primarily consisted of a gain of $5.8 million on the cash surrender value of life insurance contracts, partially offset by net foreign currency exchange losses of $1.4 million, primarily from the mark-to-market and settling of outstanding forward foreign currency exchange and foreign currency option contracts.</span></div><div style="padding-left:27pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the current nine month period, this account primarily consisted of a gain of $12.2 million on the cash surrender value of life insurance contracts related to our deferred compensation plan, partially offset by net foreign currency exchange losses of $11.4 million, primarily from the mark-to-market and settling of outstanding forward foreign currency exchange and foreign currency option contracts. For the prior year corresponding nine month period, this account primarily consisted of net foreign currency exchange losses of $3.1 million primarily from mark-to-market of outstanding forward foreign currency and foreign currency option exchange contracts, partially offset by a net gain of $3.2 million to reflect an adjustment to remeasure our initial investment in SSI in connection with purchase accounting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provision (Benefit) for Income Taxes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.705%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Provision (Benefit) for Income Taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">409.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(232.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td></tr></table></div><div style="padding-left:27pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**Percentage not meaningful</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate for the three and nine months ended June 26, 2021 was a provision of 20.6% and 21.0%, respectively, compared to a provision of 19.0% and a net benefit of 60.3%, respectively, for the corresponding periods in the prior year. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate for the three months ended June 26, 2021 was lower than the U.S. statutory tax rate primarily due to the impact of the U.S. deduction for foreign derived intangible income and the geographic mix of income earned by our international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, and federal and state tax credits, partially offset by state income taxes. Our effective tax rate for the nine months ended June 26, 2021 was equal to the U.S. statutory tax rate as the impact of the U.S. deduction for foreign derived intangible income and the geographic mix of income earned by our international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, were offset by state income taxes. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate for the three months ended June 27, 2020 was lower than the U.S. statutory tax rate primarily due to the geographic mix of income earned by our international subsidiaries which are taxed at rates lower than the U.S. statutory tax rate, including the impact of the U.S. tax imposed on global intangible low-taxed income and the U.S. deduction for foreign derived intangible income, and reserve releases resulting from statute of limitations expirations, partially offset by unbenefited foreign losses. Our effective tax rate for the nine months ended June 27, 2020 differed from the statutory tax rate primarily due to a $312.8 million discrete net tax benefit related to the loss on the sale of the Medical Aesthetics business. </span></div><div style="text-indent:24pt"><span><br/></span></div><div id="i181d930c7b854595977e17db8fd84eb4_112"></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Results of Operations</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. Until December 30, 2019, our product portfolio included aesthetic and medical treatments systems sold by our former Medical Aesthetic business. We completed the disposition of the Medical Aesthetics segment on December 30, 2019 (the first day of the second quarter of fiscal 2020). The accounting policies of the segments are the same as those described in the Notes to the Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended September&#160;26, 2020. We measure segment performance based on total revenues and operating income (loss). Revenues from product sales of each of these segments are described in further detail above. The discussion that follows is a summary analysis of total revenues and the primary changes in operating income or loss by segment.</span></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diagnostics</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.826%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">665.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">532.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">133.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,858.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,163.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,695.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">145.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">260.1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">233.9&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,745.1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">340.7&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,404.4&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">412.2&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income as a % of Segment Revenue</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">61.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:7pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostics revenues increased in the current three and nine month periods compared to the corresponding periods in the prior year primarily due to the increase in product revenues from the recovery of our core product lines and current year acquisitions, and an increase in royalty revenue from Grifols related to licensing our intellectual property to our COVID-19 assays for their sale in Spain. In addition, revenues were higher in the current nine month period from the introduction of our SARS-CoV-2 assays in the prior year, however revenue from our COVID-19 assays were lower in the current three month period due to a decline in volume in the U.S. as discussed above,</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income for this business segment increased in the current three and nine month periods compared to the corresponding periods in the prior year due to an increase in gross profit from higher revenues, partially offset by an increase in operating expenses. Gross margin was 62.5% and 74.9% in the current three and nine month periods, respectively, compared to 64.9% and 55.8% in the corresponding periods in the prior year, respectively. The increase in gross profit in the current three and nine month periods was primarily due to sales of our Aptima assays and ThinPrep Pap Test, partially offset by an increase in freight costs to ship product internationally, an increase in inventory reserves, higher field service costs and an increase in amortization of placed Panther instruments as the installed base has increased significantly year over year. In addition, gross profit in the current nine month period was higher due to sales volume of our SARS-CoV-2 assays, however, in the current three month period the increase in gross profit was partially offset by lower volumes of our SARS-CoV-2 assays.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses increased in the current three and nine month periods compared to the corresponding periods in the prior year primarily due to higher compensation and benefits driven by our deferred compensation plan and salary, an increase in headcount in the operations and sales departments, an increase in marketing initiatives, an increase in R&amp;D project spend, a lower BARDA credit of $2.3 million in the current three month period, higher acquisition transaction expenses, which included $11.5 million for a transfer tax related to the Mobidiag acquisition, and additional expenses from the Biotheranostics and Diagenode acquisitions. In addition, in the current nine month period we had higher bad debt expense. These increases were partially offset by a higher BARDA credit of $5.4 million in the current nine month period, lower bonus expense and a decrease in spending for travel.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Breast Health</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.826%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">349.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">224.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">125.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,018.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">862.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">155.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81.0&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11.1)</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92.1&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">235.1&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">158.6&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.5&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.2&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income as a % of Segment Revenue</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt;padding-left:27pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**Percentage not meaningful</span></div><div style="margin-top:7pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Breast Health revenues increased in the current three and nine month periods compared to the corresponding periods in the prior year primarily due to an increase of $100.1 million and $110.9 million in product revenue, respectively, discussed above and an increase of $24.9 and $44.4 million in service revenue, respectively. The increase in service revenue in the current three and nine month periods was primarily due to an increase in service contract revenue as the Breast Health business continued to convert a high percentage of our installed base of digital mammography systems to service contracts upon expiration of the warranty period, the addition of service contracts from the NXC Imaging acquisition and an increase in spare parts revenue.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income for this business segment increased in the current three and nine month periods compared to the corresponding periods in the prior year primarily due to an increase in gross profit from higher product and service revenues, partially offset by an increase in operating expenses. Gross margin was 56.9% in both the current three and nine month periods compared to 45.4% and 53.5% in the corresponding periods in the prior year, respectively. The increase in gross profit was primarily due to the increase in product revenue and service revenue discussed above, partially offset by a charge of $2.3 million related to the impact of stepping-up the acquired inventory to fair value in purchase accounting for the Somatex acquisition. In addition, gross profit in the corresponding prior year periods was impacted by the COVID-19 pandemic, which resulted in decreased sales volume across the majority of our product lines, period costs for temporary facility shut-downs and reduced manufacturing utilization and increased inventory reserves. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses increased in the current three and nine month periods compared to the corresponding periods in the prior year primarily due to higher compensation and benefits driven by higher commissions from increased sales and our deferred compensation plan, a $7.0 million charge related to the purchase of intellectual property in the current quarter, an increase in R&amp;D project spend, an increase in marketing initiatives and an increase in consulting spend. These increases were partially offset by lower bonus expense, a decrease in travel, meetings, trade show expenses and bad debt expense. The increase in the current nine month period is also a result of the corresponding prior year period including a benefit from the reversal of acquisition related accruals and a holdback.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">GYN Surgical</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.826%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">127.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">76.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">148.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">366.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">275.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.2&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23.4)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.6&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.5&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.5&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89.1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income as a % of Segment Revenue</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(45.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt;padding-left:27pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**Percentage not meaningful</span></div><div style="margin-top:7pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GYN Surgical revenues increased in the current three and nine month periods compared to the corresponding periods in the prior year primarily due to the increase in product revenues discussed above. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income for this business segment increased in the current three and nine month periods compared to the corresponding periods in the prior year primarily due to an increase in gross profit from higher revenues, partially offset by an increase in operating expenses. Gross margin was 62.5% and 61.6% in the current three and nine month periods, respectively, compared to 36.7% and 59.2% in the corresponding periods in the prior year, respectively. The increase in gross margin was primarily due to the increased sales volume in the current year periods as the GYN Surgical business recovered to pre-COVID levels and the impact of the COVID-19 pandemic on the prior year periods, which resulted in decreased sales volume across the majority of our product lines, period costs for temporary facility shut-downs and reduced manufacturing utilization and increased inventory reserves. The increase in gross margin was partially offset by unfavorable product mix discussed above and higher intangible asset amortization expense from the Acessa acquisition.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses increased in the current three and nine month periods compared to the corresponding periods in the prior year primarily due to the inclusion in of Acessa expenses of $3.7 million and $11.6 million, respectively, increased spending on research and development projects, higher marketing initiative spend, higher consulting spend, higher compensation and benefits driven by our deferred compensation plan and higher commissions from the increase in sales, partially offset by a gain of $10.1 million in the current nine month period related to the fair value adjustments for contingent consideration related to the Acessa acquisition.</span></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Skeletal Health</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.826%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.4)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">90.5&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">**</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income as a % of Segment Revenue</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(48.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:5pt;padding-left:27pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**Percentage not meaningful</span></div><div style="margin-top:7pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Skeletal Health revenues increased in the current three and nine month periods compared to the corresponding periods in the prior year primarily due to the change in product revenues discussed above. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income for this business segment increased in the current three and nine month periods compared to the corresponding periods in the prior year primarily due to an increase in gross profit from higher revenues. Gross margin was 28.5% and 33.1% in the current three and nine month periods, respectively, compared to 2.8% and 31.2% in the corresponding periods in the prior year, respectively. The increase in gross margin was primarily due to higher sales volume of our products and higher inventory reserves in the prior year periods.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses were consistent in the current three and nine month periods compared to the corresponding periods in the prior year.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Aesthetics</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.818%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.826%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(65.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Loss</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(54.3)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54.3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Loss as a % of Segment Revenue</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(83.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:7pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical Aesthetics revenue and operating loss decreased in the current three and nine month periods compared to the corresponding periods in the prior year due to the divestiture of the Medical Aesthetics segment on December 30, 2019, the first day of our second quarter of fiscal 2020. The operating loss in fiscal 2020 included an intangible assets and equipment impairment charges of $30.2 million.</span></div><div><span><br/></span></div><div id="i181d930c7b854595977e17db8fd84eb4_115"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIQUIDITY AND CAPITAL RESOURCES</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;26, 2021, we had $1,019.3 million of working capital and our cash and cash equivalents totaled $827.6 million. Our cash and cash equivalents balance increased by $126.6 million during the first nine months of fiscal 2021 primarily due to cash generated from operating activities, partially offset by cash used in investing and financing activities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first nine months of fiscal 2021, our operating activities provided cash of $1,865.0 million, primarily due to net income of $1,540.9 million, non-cash charges for depreciation and amortization aggregating $289.1 million, stock-based compensation expense of $51.0 million, and a debt extinguishment loss of $21.6 million, partially offset by a decrease in deferred income taxes of $44.3 million primarily due to the amortization of intangible assets. Cash provided by operations was negatively impacted by a net cash outflow of $13.1 million from changes in our operating assets and liabilities. The net cash outflow was primarily driven by a $82.4 million increase in inventory primarily due to an increase in Diagnostics inventory to support the SARS-CoV-2 assay demand and production as well as an increase in Breast Health to support the increase in mammography systems, a decrease in accrued expenses of $27.6 million primarily due to payments for federal income taxes and value-added tax payments, partially offset by an increase in accrued compensation and employee benefits, an increase in prepaid income taxes of $24.3 and an increase in prepaid expenses and other assets of $22.3 million primarily due to an increase in technology implementation costs and the timing of value-added tax receivables. These cash outflows were partially offset by a decrease in accounts receivable of $111.5 million primarily due to payments received from customers that had large balances from COVID-19 assay sales in our Diagnostics division and lower revenues in the third quarter of fiscal 2021 compared to the fourth quarter of fiscal 2020, and an increase in accounts payable of $9.4 million primarily due to the timing of payments. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first nine months of fiscal 2021, our investing activities used cash of $1,286.5 million primarily related to net cash paid for our fiscal 2021 acquisitions of Biotheranostics, Diagenode, Somatex and Mobidiag Oy of $1,163.3 million and net capital expenditures of $114.6 million, which primarily consisted of the placement of equipment under customer usage agreements and purchases of manufacturing equipment to expand capacity of our molecular diagnostics manufacturing facilities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first nine months of fiscal 2021, our financing activities used cash of $447.8 million primarily related to $970.8 million for the repayment of our 2025 Senior Notes, $250.0 million for the net repayment of amounts borrowed under our revolving credit line, $409.7 million for repurchases of our common stock, $56.3 million for scheduled principal payments under our 2018 Credit Agreement and $46.9 million for the payment of employee taxes withheld for the net share settlement of vested restricted stock units. Partially offsetting these uses of cash were net proceeds of $950.0 million under our 2029 Senior Notes, $320.0 million of proceeds under the accounts receivable securitization agreement that we restarted in the third quarter of fiscal 2021 to partially fund the Mobidiag acquisition, and $39.6 million from our equity plans, primarily from the exercise of stock options.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had total recorded debt outstanding of $3.12 billion at June&#160;26, 2021, which was comprised of amounts outstanding under our 2018 Credit Agreement of $1.40 billion (principal of $1.41 billion), 2029 Senior Notes of $934.0 million (principal of $950.0 million), 2028 Senior Notes of $395.2 million (principal of $400.0 million), Securitization Program of $320.0 million, and $66.0 million in debt acquired in the Mobidiag acquisition.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2018 Credit Agreement</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 17, 2018, we refinanced our term loan and revolving credit facility by entering into an Amended and Restated Credit and Guaranty Agreement as of December 17, 2018 (the "2018 Credit Agreement") with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders. The 2018 Credit Agreement amended and restated the Company's prior credit and guaranty agreement, amended and restated as of October 3, 2017 ("2017 Credit Agreement"). </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit facilities under the 2018 Credit Agreement consisted of:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">A $1.5 billion secured term loan ("2018 Amended Term Loan") with a maturity date of December 17, 2023; and</span></div><div style="text-align:justify;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">A secured revolving credit facility (the "2018 Amended Revolver") under which the Company may borrow up to $1.5 </span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">billion, subject to certain sublimits, with a maturity date of December 17, 2023.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The borrowings of the 2018 Amended Term Loan bear interest at an annual rate equal to the Eurocurrency Rate (i.e., the LIBOR rate) plus an Applicable Rate, which was equal to 1.0% as of June 26, 2021. The borrowings of the 2018 Amended Revolver bear interest at a rate equal to the LIBOR Daily Floating Rate plus an Applicable Rate equal to 1.0% as of June 26, 2021. At June 26, 2021, borrowings under the 2018 Amended Term Loan were subject to an interest rate of 1.11%.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to make scheduled principal payments under the 2018 Amended Term Loan in increasing amounts ranging from $9.375 million per three-month period commencing with the three-month period ending on December&#160;27, 2019 to $28.125 million per three-month period commencing with the three-month period ending on December&#160;29, 2022 and ending on September 29, 2023. The remaining balance of the 2018 Amended Term Loan after the scheduled principal payments, which was $1.2 billion as of June 26, 2021, and any amount outstanding under the 2018 Amended Revolver are due at maturity. In addition, subject to the terms and conditions set forth in the 2018 Credit Agreement, we may be required to make certain mandatory prepayments from the net proceeds of specified types of asset sales (subject to certain reinvestment rights), debt issuances and insurance recoveries (subject to certain reinvestment rights). These mandatory prepayments are required to be applied by us,&#160;first, to the 2018 Amended Term Loan,&#160;second, to any outstanding amount under any Swing Line Loans,&#160;third,&#160;to the 2018 Amended Revolver,&#160;fourth&#160;to prepay any outstanding reimbursement obligations with respect to Letters of Credit and&#160;fifth, to cash collateralize any Letters of Credit. Subject to certain limitations, the Company may voluntarily prepay any of the 2018 Credit Facilities without premium or penalty.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings are secured by first-priority liens on, and a first-priority security interest in, substantially all of the assets of the Company and its U.S. subsidiaries, with certain exceptions. For example, borrowings under the 2018 Credit Agreement are not secured by those accounts receivable that are transferred to the special purpose entity under a qualifying accounts receivable securitization program.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Credit Agreement contains affirmative and negative covenants customarily applicable to senior secured credit facilities, including covenants restricting our ability, subject to negotiated exceptions, to incur additional indebtedness and grant additional liens on its assets, engage in mergers or acquisitions or dispose of assets, enter into sale-leaseback transactions, pay dividends or make other distributions, voluntarily prepay other indebtedness, enter into transactions with affiliated persons, make investments, and change the nature of their businesses. In addition, the 2018 Credit Agreement requires us to maintain certain financial ratios. The 2018 Credit Agreement also contains customary representations and warranties and events of default, including payment defaults, breach of representations and warranties, covenant defaults, cross defaults and an event of default upon a change of control of the company.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Credit Agreement contains two financial covenants (a total net leverage ratio and an interest coverage ratio) measured as of the last day of each fiscal quarter. As of June 26, 2021, we were in compliance with these covenants.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The UK Financial Conduct Authority announced in 2017 that it intended to phase out LIBOR by the end of 2021, which has been extended to June 30, 2023. If changes are made to the method of calculating LIBOR or LIBOR ceases to exist, we may need to amend certain contracts, including our 2018 Credit Agreement, and we cannot predict what alternative rate or benchmark would be negotiated or the extent to which this would adversely affect our interest rate and the effectiveness of our interest rate hedging activity.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2028 Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total aggregate principal balance of the 2028 Senior Notes is $400.0 million. The 2028 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain of the Company's domestic subsidiaries. The 2028 Senior Notes were issued pursuant to an indenture, dated as of January 19, 2018, among the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company, the guarantors and Wells Fargo Bank, National Association, as trustee. The 2028 Senior Notes mature on February&#160;1, 2028 and bear interest at the rate of&#160;4.625%&#160;per year, payable semi-annually on February&#160;1 and August&#160;1 of each year. We may redeem the 2028 Senior Notes at any time prior to February 1, 2023 at a price equal to&#160;100%&#160;of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. We may also redeem up to&#160;35%&#160;of the aggregate principal amount of the 2028 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before February&#160;1, 2021, at a redemption price equal to&#160;104.625%&#160;of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. We also have the option to redeem the 2028 Senior Notes on or after: February 1, 2023 through February 1, 2024 at&#160;102.312%&#160;of par; February 1, 2024 through February 1, 2025 at&#160;101.541%&#160;of par; February 1, 2025 through February 1, 2026 at&#160;100.770%&#160;of par; and February 1, 2026 and thereafter at&#160;100%&#160;of par. In addition, if there is a change of control coupled with a decline in ratings, as provided in the indenture, we will be required to make an offer to purchase each holder&#8217;s 2028 Senior Notes at a price equal to&#160;101%&#160;of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2029 Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total aggregate principal balance of the 2029 Senior Notes is $950.0 million. The 2029 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2029 Senior Notes mature on February 15, 2029 and bear interest at the rate of 3.250%&#160;per year, payable semi-annually on February&#160;15 and August&#160;15 of each year, commencing on February 15, 2021. We may redeem the 2029 Senior Notes at any time prior to September 28, 2023 at a price equal to 100% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. We may also redeem up to 40% of the aggregate principal amount of the 2029 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before September 28, 2023, at a redemption price equal to 103.250% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. We have the option to redeem the 2029 Senior Notes on or after: September 28, 2023 through September 27, 2024 at 101.625% of par; September 28, 2024 through September 27, 2025 at 100.813% of par; and September 28, 2025 and thereafter at 100% of par. In addition, if there is a change of control coupled with a decline in ratings, as provided in the indenture, we will be required to make an offer to purchase each holder&#8217;s 2029 Senior Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable Securitization Program</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 25, 2016, we entered into a one-year accounts receivable securitization program (the "Securitization Program") with several of our wholly owned subsidiaries and certain financial institutions. The Securitization Program provides for annual renewals. Under the terms of the Securitization Program, we and certain of our wholly-owned subsidiaries sell our customer receivables to a bankruptcy remote special purpose entity, which is wholly-owned by us. The special purpose entity, as borrower, and we, as servicer, have entered into a Credit and Security Agreement with several lenders pursuant to which the special purpose entity may borrow from the lenders up to the maximum borrowing amount allowed, with the loans secured by the receivables. The amount that the special purpose entity may borrow at a given point in time is determined based on the amount of qualifying receivables that are present in the special purpose entity at such point in time. The assets of the special purpose entity secure the amounts borrowed and cannot be used to pay our other debts or liabilities. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the market uncertainties created by the COVID-19 pandemic, on March 26, 2020, we paid-off the total amount outstanding of $250.0 million previously borrowed. On April 13, 2020, we amended the Credit and Security agreement with the lenders, temporarily suspending the ability to borrow and the need to comply with covenants for up to a year. On June 11, 2021, we amended and restated the Credit and Security agreement to restart the Securitization Program and increase the maximum borrowing amount to $320.0 million. Loans outstanding under the Securitization Program bear interest at LIBOR plus an applicable margin for defined tranches. As of June 26, 2021, there was $320.0 million outstanding under this program. The weighted average interest rate under the Securitization Program was 0.78% as of June 26, 2021.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Consideration Earn-Out Payments</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with certain of our acquisitions, we have incurred the obligation to make contingent earn-out payments tied to performance criteria, principally revenue growth of the acquired business over a specified period. In addition, contractual provisions relating to these contingent earn-out obligations may result in the risk of litigation relating to the calculation of the amount due or our operation of the acquired business. Such litigation could be expensive and divert management attention and resources. Our obligation to make contingent payments may also result in significant operating expenses.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contingent consideration arrangements are recorded as either additional purchase price or compensation expense if continuing employment is required to receive such payments. Pursuant to ASC 805, contingent consideration that is deemed to be part of the purchase price is recorded as a liability based on the estimated fair value of the consideration we expect to pay to the former shareholders of the acquired business as of the acquisition date. This liability is re-measured each reporting period with the change in fair value recorded through a separate line item within our Consolidated Statements of Income. Increases or decreases in the fair value of contingent consideration liabilities can result from changes in discount rates, changes in the timing, probabilities and amount of revenue estimates, and accretion of the liability for the passage of time. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary contingent consideration liability is from our Acessa acquisition. We have an obligation to the former Acessa shareholders to make contingent payments based on a multiple of annual incremental revenue growth over a three-year period ending annually in December. There is no maximum earnout. Pursuant to ASC 805, the contingent consideration was deemed to be part of the purchase price, and we recorded our estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation based on future revenue projections of the business, comparable companies revenue growth rates, implied volatility and applying a risk adjusted discount rate. At June 26, 2021 this liability was recorded at its fair value of $71.7 million, and no contingent payments have been earned or made.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Repurchase Program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 9, 2020, the Board of Directors authorized a new five-year share repurchase plan, to purchase up to $1.0&#160;billion of our outstanding common stock. The prior plan was terminated in connection with this new authorization. During the third quarter of fiscal 2021, we repurchased 3.0 million shares of our common stock for a total consideration of $188.4 million. As of June 26, 2021, $691.6&#160;million remained available under this authorization.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Contingencies</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently involved in several legal proceedings and claims. In connection with these legal proceedings and claims, management periodically reviews estimates of potential costs to be incurred by us in connection with the adjudication or settlement, if any, of these proceedings. These estimates are developed, as applicable in consultation with outside counsel, and are based on an analysis of potential litigation outcomes and settlement strategies. In accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, loss contingencies are accrued if, in the opinion of management, an adverse outcome is probable and such financial outcome can be reasonably estimated. It is possible that future results for any particular quarter or annual period may be materially affected by changes in our assumptions or the effectiveness of our strategies relating to these proceedings. Information with respect to this disclosure may be found in Note 10 to the Consolidated Financial Statements in this Quarterly Report on Form 10-Q, which information is incorporated herein by reference.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Future Liquidity Considerations</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to review and evaluate potential strategic transactions that we believe will complement our current or future business. Subject to the &#8220;Risk Factors&#8221; set forth in Part II, Item 1A of this Quarterly Report, if any, as well as those described in our Annual Report on Form 10-K for the fiscal year ended September&#160;26, 2020 or any other of our subsequently filed reports, and the general disclaimers set forth in our Special Note Regarding Forward-Looking Statements at the outset of this MD&amp;A, we believe that our cash and cash equivalents, cash flows from operations, and the cash available under our 2018 Amended Revolver will provide us with sufficient funds in order to fund our expected normal operations and debt payments over the next twelve months. Our longer-term liquidity is contingent upon future operating performance. We may also require additional capital in the future to fund capital expenditures, repayment of debt, acquisitions, strategic transactions or other investments. As described above, we have significant indebtedness outstanding under our 2018 Credit Agreement, 2028 Senior Notes, 2029 Senior Notes and Securitization Program. These capital requirements could be substantial. For a description of risks to our operating performance and our indebtedness, see &#8220;Risk Factors&#8221; in Part I, Item&#160;1A in our Annual Report on Form 10-K for the fiscal year ended September&#160;26, 2020.</span></div><div><span><br/></span></div><div id="i181d930c7b854595977e17db8fd84eb4_118"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING POLICIES AND ESTIMATES</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discussion and analysis of our financial condition and results of operations are based upon our interim consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates, including those related to revenue recognition for multiple element arrangements, allowance for doubtful accounts, reserves for excess and obsolete inventories, valuations, purchase price allocations and contingent consideration related to business combinations, expected future cash flows including growth rates, discount rates, terminal </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">values and other assumptions used to evaluate the recoverability of long-lived assets and goodwill, estimated fair values of intangible assets and goodwill, amortization methods and periods, warranty reserves, certain accrued expenses, restructuring and other related charges, stock-based compensation, contingent liabilities, tax reserves and recoverability of our net deferred tax assets and related valuation allowances. We base our estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances. Actual results could differ from these estimates if past experience or other assumptions do not turn out to be substantially accurate. Any differences may have a material impact on our financial condition and results of operations. For a discussion of how these and other factors may affect our business, see the &#8220;Cautionary Statement&#8221; above and &#8220;Risk Factors&#8221; set forth in Part II, Item 1A of this Quarterly Report as well as those described in our Annual Report on Form 10-K for the fiscal year ended September&#160;26, 2020 or any other of our subsequently filed reports.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical accounting estimates that we believe affect our more significant judgments and estimates used in the preparation of our consolidated financial statements presented in this report are described in Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations and in the Notes to the Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended September&#160;26, 2020. There have been no material changes to our critical accounting policies or estimates from those set forth in our Annual Report on Form 10-K for the fiscal year ended September&#160;26, 2020.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div id="i181d930c7b854595977e17db8fd84eb4_121"></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures About Market Risk.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments, Other Financial Instruments, and Derivative Commodity Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Financial instruments consist of cash and cash equivalents, accounts receivable, equity investments, foreign currency derivative (forward or option) contracts, interest rate swap agreements, insurance contracts, accounts payable and debt obligations. Except for our outstanding 2028 Senior Notes and 2029 Senior Notes, the fair value of these financial instruments approximates their carrying amount. The fair value of our 2028 Senior Notes and 2029 Senior Notes as of June&#160;26, 2021 was $420.8 million and $940.0 million, respectively. Amounts outstanding under our 2018 Credit Agreement of $1.4 billion and Securitization Program of $320.0 million as of June&#160;26, 2021 are subject to variable rates of interest based on current market rates, and as such, we believe the carrying amount of these obligations approximates fair value. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Primary Market Risk Exposures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our primary market risk exposure is in the areas of interest rate risk and foreign currency exchange rate risk. We incur interest expense on borrowings outstanding under our 2028 Senior Notes, 2029 Senior Notes, 2018 Credit Agreement and Securitization Program. The 2028 Senior Notes and 2029 Senior Notes have fixed interest rates. Borrowings under our 2018 Credit Agreement currently bear interest at the Eurocurrency Rate (i.e., LIBOR) plus the applicable margin of 1.0% per annum, and borrowings under our Securitization Program bear interest at LIBOR plus 0.70% per annum.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As noted above, as of June&#160;26, 2021, there was $1.4 billion of aggregate principal outstanding under the 2018 Credit Agreement and $320.0 million outstanding under the Securitization Program. Since these debt obligations are variable rate instruments, our interest expense associated with these instruments is subject to change. A hypothetical 10% adverse movement (increase in LIBOR rate) would increase annual interest expense by approximately $0.1 million. We entered into an interest rate swap agreement to help mitigate the interest rate volatility associated with the variable rate interest on the amounts outstanding under the 2018 Credit Agreement. The critical terms of the interest rate swap were designed to mirror the terms of our LIBOR-based borrowings under the 2018 Credit Agreement, and therefore the interest rate swap is highly effective at offsetting the cash flows being hedged. We designated this derivative instrument as a cash flow hedge of the variability of the LIBOR-based interest payments on $1.0 billion of principal. These interest rate swap contract expires on December 17, 2023.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The UK Financial Conduct Authority announced in 2017 that it intended to phase out LIBOR by the end of 2021, which was recently extended to the end of 2023. If changes are made to the method of calculating LIBOR or LIBOR ceases to exist, we may need to amend certain contracts, including our 2018 Credit Agreement and related interest rate swap agreements, and we cannot predict what alternative rate or benchmark would be negotiated or the extent to which this would adversely affect our interest rate and the effectiveness of our interest rate hedging activity.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The return from cash and cash equivalents will vary as short-term interest rates change. A hypothetical 10% increase or decrease in interest rates, however, would not have a material adverse effect on our business, financial condition or results of operations.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Exchange Risk.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our international business is subject to risks, including, but not limited to: unique economic conditions, changes in political climate, differing tax structures, other regulations and restrictions, and foreign </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">exchange rate volatility. Accordingly, our future results could be materially adversely impacted by changes in these or other factors.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct business worldwide and maintain sales and service offices outside the United States as well as manufacturing facilities in Costa Rica and the United Kingdom. Our international sales are denominated in a number of currencies, primarily the Euro, U.S. dollar, UK Pound and Renminbi. The majority of our foreign subsidiaries' functional currency is the local currency, although certain foreign subsidiaries functional currency is the U.S. dollar based on the nature of their operations or functions. Our revenues denominated in foreign currencies are positively affected when the U.S. dollar weakens against them and adversely affected when the U.S. dollar strengthens. Fluctuations in foreign currency rates could affect our sales, cost of goods and operating margins and could result in exchange losses. In addition, currency devaluations can result in a loss if we hold deposits of that currency. We have executed forward foreign currency contracts and foreign currency option contracts to hedge a portion of results denominated in the Euro, UK Pound, Australian dollar, Japanese Yen, Chinese Yuan and Canadian dollar. These contracts do not qualify for hedge accounting. As a result, we may experience volatility in our Consolidated Statements of Income due to (i) the impact of unrealized gains and losses reported in other income (expense), net from the mark-to-market of outstanding contracts and (ii) realized gains and losses recognized in other income (expense), net, whereas the offsetting economic gains and losses are reported in the line item of the underlying cash flow, for example, revenue. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the operating expenses of our international subsidiaries that are incurred in local currencies will not have a material adverse effect on our business, results of operations or financial condition. Our operating results and certain assets and liabilities that are denominated in foreign currencies are affected by changes in the relative strength of the U.S. dollar against those currencies. Our expenses, denominated in foreign currencies, are positively affected when the U.S. dollar strengthens against them and adversely affected when the U.S. dollar weakens. However, we believe that the foreign currency exchange risk is not significant. A hypothetical 10% increase or decrease in foreign currencies in which we transact would not have a material adverse impact on our business, financial condition or results of operations.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div id="i181d930c7b854595977e17db8fd84eb4_124"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;Controls and Procedures.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, as ours are designed to do, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 26, 2021, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules&#160;13a-15(e) and 15d-15(e) under the Exchange Act. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective as of June&#160;26, 2021. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An evaluation was also performed under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of any change in our internal control over financial reporting that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. That evaluation did not identify any change in our internal control over financial reporting that occurred during our latest fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><div id="i181d930c7b854595977e17db8fd84eb4_127"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II &#8211; OTHER INFORMATION</span></div><div id="i181d930c7b854595977e17db8fd84eb4_130"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1.&#160;&#160;&#160;&#160;Legal Proceedings.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information with respect to this Item may be found in Note 10 to the Consolidated Financial Statements in this Quarterly Report on Form 10-Q, which information is incorporated herein by reference.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information on our commitments and contingencies can be found in our Annual Report on Form 10-K for our fiscal year ended September&#160;26, 2020.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div id="i181d930c7b854595977e17db8fd84eb4_133"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1A. Risk Factors.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no material changes from the risk factors as previously disclosed in our Annual Report on Form 10-K for our fiscal year ended September&#160;26, 2020 or any of our subsequently filed reports.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><div id="i181d930c7b854595977e17db8fd84eb4_136"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. Unregistered Sales of Equity Securities and Use of Proceeds.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Issuer's Purchases of Equity Securities</span></div><div style="text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.918%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period of Repurchase</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of<br/>Shares&#160;Purchased<br/>(#)&#160;(1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average&#160;Price<br/>Paid&#160;Per&#160;Share<br/>($)&#160;(1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of<br/>Shares Purchased As Part of Publicly<br/>Announced Plans or Programs&#160;<br/>(#)&#160;(2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price Paid Per Share As Part of Publicly Announced Plans or Programs($)&#160;(2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum<br/>Number (or Approximate Dollar Value) of Shares That May Yet Be Purchased Under Our<br/>Programs  <br/>(in millions)      ($) (2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 28, 2021 &#8211; April 24, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,514&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">880.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 25, 2021 &#8211; May 22, 2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,946,518&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">754.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 23, 2021 &#8211; June 26, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,023,237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">691.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,753&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,969,755&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">691.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;___________________________________</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">For the majority of restricted stock units granted, the number of shares issued on the date that the restricted stock units vest is net of the minimum statutory tax withholding requirements that we pay in cash to the appropriate taxing authorities on behalf of our employees. These repurchases of our common stock were to cover employee income tax withholding obligations in connection with the vesting of restricted stock units under our equity incentive plans.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">On December 9, 2020, the Board of Directors authorized a new share repurchase plan to repurchase up to $1.0 billion of the Company's outstanding common stock, effective December 11, 2020. In connection with this authorization, the prior plan was terminated. </span></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><div id="i181d930c7b854595977e17db8fd84eb4_139"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.&#160;&#160;&#160;&#160;Exhibits.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(a) Exhibits </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Incorporated by<br/>Reference</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing&#160;Date/<br/>Period End<br/>Date</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex101-hellmanncic.htm">Severance and Change of Control Agreement dated June 28, 2021 by and between Elisabeth (Lisa) Hellmann and Hologic, Inc. (1)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex102-bebotransitionagreem.htm">Transition Agreement by and between Allison P. Bebo and Hologic, Inc. dated July 2, 2021 (1)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="holx_q3-2021xex311.htm">Certification of Hologic&#8217;s CEO pursuant to Item&#160;601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="holx_q3-2021xex312.htm">Certification of Hologic&#8217;s CFO pursuant to Item&#160;601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="holx_q3-2021xex321.htm">Certification of Hologic&#8217;s CEO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="holx_q3-2021xex322.htm">Certification of Hologic&#8217;s CFO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(1) Indicates management contract or compensatory plan, contract or arrangement.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*             Filed herewith.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**&#160;&#160;&#160;&#160;Furnished herewith.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><div id="i181d930c7b854595977e17db8fd84eb4_142"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i181d930c7b854595977e17db8fd84eb4_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.926%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.517%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic, Inc.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 28, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;Stephen P. MacMillan&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stephen P. MacMillan<br/>Chairman, President and Chief Executive Officer<br/>(Principal Executive Officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 28, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;Karleen M. Oberton&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Karleen M. Oberton</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer<br/>(Principal Financial Officer)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex101-hellmanncic.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i5715be3e97c34bed8ba3d848c9dd60fd_1"></div><div style="min-height:68pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit 10.1</font></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SEVERANCE AND</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CHANGE OF CONTROL AGREEMENT</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;CHANGE OF CONTROL AGREEMENT by and between HOLOGIC, INC., a Delaware corporation (the &#34;Company&#34;), and Elisabeth (Lisa) A. Hellmann (the &#34;Executive&#34;), dated as of June 28, 2021.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;WHEREAS, the Executive serves as a senior executive of the Company&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;WHEREAS, the Board of Directors of the Company (the &#34;Board&#34;), has determined that it is in the best interests of the Company and its shareholders to assure that the Company will have the continued dedication of the Executive, notwithstanding the possibility, threat, or occurrence of a Change of Control (as defined below) of the Company. The Board believes it is imperative to diminish the inevitable distraction of the Executive by virtue of the personal uncertainties and risks created by a pending or threatened Change of Control and to encourage the Executive's full attention and dedication to the Company currently and in the event of any threatened or pending Change of Control, and to provide the Executive with compensation and benefits arrangements upon a Change of Control which ensure that the compensation and benefits expectations of the Executive will be satisfied and which are competitive with those of other corporations&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;WHEREAS, in recognition of the Executive&#8217;s role, the Company and Executive now desire to enter into this Severance and Change of Control Agreement, which is consistent with the change of control and severance protection provided to the Company&#8217;s most senior officers (the &#8220;Agreement&#8221;)&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;WHEREAS, this Agreement shall supersede and replace any existing or previous Change of Control Agreement  Severance Agreement, and benefits provided under any such existing agreements or Company policies.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;NOW, THEREFORE, in consideration of the mutual covenants and agreements hereinafter set forth, the parties hereto, each intending to be legally bound, do hereby agree as follows&#58;</font></div><div><font><br></font></div><div style="height:48.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:68pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="padding-left:18pt;padding-right:5.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:9pt;text-decoration:underline">Certain Definitions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="padding-left:18pt;padding-right:5.75pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;The &#34;Effective Date&#34; shall be the first date during the &#34;Change of Control Period&#34; (as defined in Section 1(b)) on which a Change of Control occurs. Anything in this Agreement to the contrary notwithstanding, if the Executive's employment with the Company is terminated or the Executive ceases to be an officer of the Company prior to the date on which a Change of Control occurs, and it is reasonably demonstrated that such termination of employment (1) was at the request of a third party who has taken steps reasonably calculated to effect the Change of Control or (2) otherwise arose in connection with or in anticipation of the Change of Control, then for all purposes of this Agreement the &#34;Effective Date&#34; shall mean the date immediately prior to the date of such termination of employment. If prior to the Effective Date, the Executive&#8217;s employment with the Company terminates, then the Executive shall have no further rights under this Agreement, except with respect to benefits under Section 6(e), if applicable, or unless such termination of Employment was in anticipation of the Change of Control in which case the termination shall be deemed to have occurred after the consummation of the Change of Control.</font></div><div style="height:48.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i5715be3e97c34bed8ba3d848c9dd60fd_4"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;The &#34;Change of Control Period&#34; is the period commencing on the date hereof and ending on December 31, 2023&#59; provided, that commencing on December 31, 2023 and each December 31 thereafter (each such date to be referred to as the &#8220;Renewal Date&#8221;), the term of this Agreement shall automatically be extended, without any further action by the Company or the Executive, so as to terminate three years from such Renewal Date&#59; provided, however that if the Company shall give notice in writing to the Executive at least thirty (30) days prior to a Renewal Date (the &#8220;Pending Renewal Date&#8221;), stating that the Change of Control Period shall not be extended, then the Change of Control Period shall expire two years from the Pending Renewal Date.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;padding-right:5.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:9pt;text-decoration:underline">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. For the purpose of this Agreement, a &#34;Change of Control&#34; shall mean&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;The acquisition by any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)) of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of 30% or more of the Voting Stock of the Company&#59; provided, however, that any acquisition by the Company or its subsidiaries, or any employee benefit plan (or related trust) of the Company or its subsidiaries of 30% or more of Voting Stock shall not constitute a Change in Control&#59; and provided, further, that any acquisition by a corporation with respect to which, following such acquisition, more than 50% of the Voting Stock of such corporation, is then beneficially owned, directly or indirectly, by all or substantially all of the individuals and entities who were the beneficial owners of the Voting Stock immediately prior to such acquisition in substantially the same proportion as their ownership, immediately prior to such acquisition, of the Voting Stock, shall not constitute a Change in Control&#59; or</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;Any transaction which results in the Continuing Directors (as defined in the Certificate of Incorporation of the Company) constituting less than a majority of the Board of Directors of the Company (the &#8220;Board&#8221;)&#59; or</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;The consummation of (i) a Merger with respect to which all or substantially all of the individuals and entities who were the beneficial owners of the Voting Stock immediately prior to such Merger do not, following such Merger, beneficially own, directly or indirectly, more than 50% of the Voting Stock of the corporation resulting from the Merger (the &#8220;Resulting Corporation&#8221;) as a result of the individuals&#8217; and entities&#8217; shareholdings in the Company immediately prior to the consummation of the Merger, (ii) a complete liquidation or dissolution of the Company or (iii) the sale or other disposition of all or substantially all (as defined under Delaware General Corporation Law) of the assets of the Company excluding a sale or other disposition of assets to a subsidiary of the Company. For purposes of this Agreement &#8220;Merger&#8221; means a reorganization, merger or consolidation involving the Company, including without limitation as a parent of a direct or indirect subsidiary of the Company effecting such transaction.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Anything in this Agreement to the contrary notwithstanding, if an event that would, but for this paragraph, constitute a Change of Control results from or arises out of a purchase or other acquisition of the Company, directly or indirectly, by a corporation or other entity in which the</font></div><div style="height:49pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i5715be3e97c34bed8ba3d848c9dd60fd_7"></div><hr style="page-break-after:always"><div style="min-height:68pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Executive has a greater than ten percent (10%) direct or indirect equity interest, such event shall not constitute a Change of Control.</font></div><div><font><br></font></div><div style="padding-right:5.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt;text-decoration:underline">Employment Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Subject to the terms and conditions hereof, the Company hereby agrees to continue the Executive in its employ, and the Executive hereby agrees to remain in the employ of the Company, for the period commencing on the Effective Date and ending on the last day of the thirty-sixth month following the month in which the Effective Date occurs (the &#34;Employment Period&#34;).</font></div><div><font><br></font></div><div style="padding-left:18pt;padding-right:5.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:9pt;text-decoration:underline">Terms of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Position and Duties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(i)&#160;&#160;&#160;&#160;During the Employment Period, (A) the Executive's position (including status, offices, titles and reporting requirements), authority, duties and responsibilities shall be at least commensurate in all material respects with the most significant of those held, exercised and assigned at any time during the 90-day period immediately preceding the Effective Date and (B) the Executive's services shall be performed at the location where the Executive was employed immediately preceding the Effective Date or any office or location less than 35 miles from such location.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(ii)&#160;&#160;&#160;&#160;During the Employment Period, and excluding any periods of vacation and sick leave to which the Executive is entitled, the Executive agrees to devote her full business time to the business and affairs of the Company and, to the extent necessary to discharge the responsibilities assigned to the Executive hereunder, to use the Executive's reasonable best efforts to perform faithfully and efficiently such responsibilities. During the Employment Period it shall not be a violation of this Agreement for the Executive to (A) serve on corporate, civic or charitable boards or committees, (B) deliver lectures, fulfill speaking engagements or teach at educational institutions and (C) manage personal investments, so long as such activities do not significantly interfere with the performance of the Executive's responsibilities as an employee of the Company in accordance with this Agreement. It is expressly understood and agreed that to the extent that any such activities have been conducted by the Executive prior to the Effective Date, the continued conduct of such activities (or the conduct of activities similar in nature and scope thereto) subsequent to the Effective Date.</font></div><div><font><br></font></div><div style="height:49pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:68pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Base Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. During the Employment Period, the Executive shall receive an annual base salary (&#34;Annual Base Salary&#34;), which shall be paid monthly, having a value at least equal to twelve times the highest monthly base salary paid or payable to the Executive by the Company and its affiliated companies in respect of the twelve-month period immediately preceding the month in which the Effective Date occurs. During the Employment Period, the Annual Base Salary shall be reviewed at least annually and shall be increased at any time and from time to time as shall be substantially consistent with increases in base salary awarded in the ordinary course of business to other peer executives of the Company and its affiliated companies. Any increase in Annual Base Salary shall not serve to limit or reduce any other obligation to the Executive under this Agreement. Annual Base Salary shall not be reduced after any such increase and the term Annual Base Salary as utilized in this Agreement shall refer to Annual Base Salary as so increased. As used in this Agreement, the term &#34;affiliated companies&#34; includes any company controlled by, controlling or under common control with the Company.</font></div><div><font><br></font></div><div style="height:49pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:68pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Annual Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In addition to Annual Base Salary, the Executive shall be awarded, for each fiscal year during the Employment Period, an annual cash bonus (the &#34;Annual Bonus&#34;&#59; which  shall include, without limitation, any other annual cash bonus plan or program provided to Executive such as the Short Term Incentive Plan or any other similar plan, but shall not include any cash sign-on, relocation, retention or other special bonus or payments. ) in cash at least equal to the greater of (a) the average (annualized for any fiscal year consisting of less than twelve full months or with respect to which the Executive has been employed by the Company for less than twelve full months) bonus (the &#34;Average Annual Bonus&#34;) paid or that has been earned and accrued, but unpaid to the Executive by the Company and its affiliated companies in respect of the three fiscal years immediately preceding the fiscal year in which the Effective Date occurs, (b) the Annual Bonus paid for the fiscal year immediately preceding the Effective Date, or (c) the target bonus associated with the Company achieving its 100 percent target payout level as determined in accordance with the terms of the Company&#8217;s bonus plans for senior executives for the fiscal year immediately preceding the Effective Date (the &#8220;Target Bonus&#8221;&#59; the greater of clauses (a), (b) or to be referred to as the &#8220;Highest Annual Bonus&#8221;)&#59; for the avoidance of doubt, the determination of bonus under clause (c) above shall not be reduced for the application of the Compensation Committee&#8217;s discretion to reduce such bonus or bonus funding, or increased to reflect additional amounts that may be paid or payable if the Company exceeds target. Each such Annual Bonus shall be paid no later than the 15th day of the third month of the fiscal year next following the fiscal year for which the Annual Bonus is awarded, unless the Executive shall elect to defer the receipt of such Annual Bonus pursuant to any nonqualified plan of the Company. Notwithstanding anything herein to the contrary, any portion of Annual Base Salary or Annual Bonus electively deferred by the Executive pursuant to a qualified or a non-qualified plan including, but not limited to, the Hologic, Inc. Deferred Compensation Plan or any successor thereto (&#8220;DCP&#8221;) shall be included in determining the Annual Base Salary, Annual Bonus and the Average Annual Bonus. If the fiscal year of any successor to this Agreement, as described by Section 11(c) herein, is different than the Company&#8217;s fiscal year at the time of the Change of Control, then the Executive shall be paid (i) the Annual Bonus that would have been paid upon the end of Company&#8217;s fiscal year ending after the Change of Control, and (ii) a pro-rata Annual Bonus for any months of service performed following the end of the Company&#8217;s fiscal year, but prior to the first day of the successor&#8217;s fiscal year immediately following the Change of Control. The Annual Bonuses thereafter shall be based on the successor&#8217;s first full fiscal year beginning after the Change of Control and successive fiscal years thereafter. &#8220;Pro Rata Bonus&#34; shall mean an amount equal to the Bonus Amount (average of the Annual Bonuses paid or that has been earned and accrued, but unpaid during the three full fiscal years ended prior to the Date of Termination) multiplied by a fraction the numerator of which is the number of months worked in the fiscal year through the Date of Termination and the denominator of which is 12. Any partial months shall be rounded to the nearest whole number using normal mathematical convention.</font></div><div style="height:49pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i5715be3e97c34bed8ba3d848c9dd60fd_10"></div><hr style="page-break-after:always"><div style="min-height:68pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(iii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Incentive, Savings and Retirement Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In addition to Annual Base Salary and Annual Bonus payable as hereinabove provided, the Executive shall be entitled to participate during the Employment Period in all incentive, savings and retirement plans, practices, policies and programs applicable to other peer executives of the Company and its affiliated companies, but in no event shall such plans practices, policies and programs provide the Executive with incentive, savings and retirement benefits opportunities, in each case, less favorable, in the aggregate, than the most favorable of those provided by the Company and its affiliated companies for the Executive under such plans, practices, policies and programs as in effect at any time during the one-year immediately preceding the Effective Date, or, if more favorable to the Executive, those provided generally at any time after the Effective Date to other peer executives of the Company and its affiliated companies.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(iv)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Welfare Benefit Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. During the Employment Period, the Executive and&#47;or the Executive's family, as the case may be, shall be eligible for participation in and shall receive all benefits under welfare benefit plans, practices, policies and programs provided by the Company and its affiliated companies (including, without limitation, medical, prescription, dental, disability, salary continuance, employee life, group life, accidental death and travel accident insurance plans and programs) and applicable to other peer executives of the Company and its affiliated companies, but in no event shall such plans, practices, policies and programs provide benefits which are less favorable, in the aggregate, than the most favorable of such plans, practices, policies and programs in effect at any time during the one-year period immediately preceding the Effective Date, or, if more favorable to the Executive, those provided generally at any time after the Effective Date to other peer executives of the Company and its affiliated companies.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(v)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. During the Employment Period, the Executive shall be entitled to receive prompt reimbursement for all reasonable expenses incurred by the Executive upon submission of appropriate accountings in accordance with the most favorable policies, practices and procedures of the Company and its affiliated companies in effect at any time during the one-year period immediately preceding the Effective Date or, if more favorable to the Executive, as in effect at any time thereafter with respect to other peer executives of the Company and its affiliated companies.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(vi)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Fringe Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. During the Employment Period, the Executive shall be entitled to fringe benefits in accordance with the most favorable plans, practices, programs and policies of the Company and its affiliated companies in effect at any time during the one-year period immediately preceding the Effective Date or, if more favorable to the Executive, as in effect at any time thereafter with respect to other peer executives of the Company and its affiliated companies.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(vii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Office and Support Staff</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. During the Employment Period, the Executive shall be entitled to an office or offices of a size and with furnishings and other appointments, and to exclusive personal secretarial and other assistance, at least equal to the most favorable of the foregoing provided to the Executive by the Company and its affiliated companies at any time during the one-year period immediately preceding the Effective Date </font></div><div style="height:49pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:68pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or, if more favorable to the Executive, as provided at any time thereafter with respect to other peer executives of the Company and its affiliated companies.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(viii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Vacation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. During the Employment Period, the Executive shall be entitled to paid vacation of at least five (5) weeks and in accordance with the most favorable plans, policies, programs and practices of the Company and its affiliated companies as in effect at any time during the one-year period immediately preceding the Effective Date or, if more favorable to the Executive, as in effect at any time thereafter with respect to other peer incentives of the Company and its affiliated companies.</font></div><div><font><br></font></div><div style="padding-left:18pt;padding-right:5.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:9pt;text-decoration:underline">Termination of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Death or Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Executive's employment shall terminate automatically upon the Executive's death during the Employment Period. If the Company determines in good faith that the Disability of the Executive has occurred during the Employment Period (pursuant to the definition of &#34;Disability&#34; set forth below), it may give to the Executive written notice in accordance with Section 13(b) of this Agreement of its intention to terminate the Executive's employment. In such event, the Executive's employment with the Company shall terminate effective on the 30th day after receipt of such notice by the Executive (the &#34;Disability Effective Date&#34;), provided that, within the 30 days after such receipt, the Executive shall not have returned to full-time performance of the Executive's duties. For purposes of this Agreement, &#34;Disability&#34; means the absence of the Executive from the Executive's duties with the Company on a full-time basis for 180 consecutive business days as a result of incapacity due to mental or physical illness which is determined to be total and permanent by a physician selected by the Company or its insurers and acceptable to the Executive or the Executive's legal representative (such agreement as to acceptability not to be withheld unreasonably).</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company may terminate the Executive's employment during the Employment Period for &#34;Cause&#34;. For purposes of this Agreement, &#34;Cause&#34; means (i) an act or acts of personal dishonesty taken by the Executive and intended to result in substantial personal enrichment of the Executive at the expense of the Company, (ii) repeated violations by the Executive of the Executive's obligations under Section 4(a) of this Agreement (other than as a result of incapacity due to physical or mental illness) which are demonstrably willful and deliberate on the Executive's part, which are committed in bad faith or without reasonable belief that such violations are in the best interests of the Company and which are not remedied in a reasonable period of time after receipt of written notice from the Company or (iii) the conviction of the Executive of a felony involving moral turpitude. The Company shall provide the Executive with 30 days written notice of any determination of Cause and provide the Executive, for a period of 30 days following such notice, with the opportunity to appear before the Board, with or without legal representation, to present arguments and evidence on her behalf and following such presentation to the Board, the Executive may only be terminated for Cause if the Board (excluding the Executive if she is a member of the Board), by unanimous consent reasonably determines in good faith that her actions did, in fact, constitute for Cause.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Executive's employment may be terminated during the Employment Period by the Executive for Good Reason. For purposes of this Agreement, &#34;Good Reason&#34; means&#58;</font></div><div style="height:49pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:68pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(i)&#160;&#160;&#160;&#160;A material diminution in the Executive&#8217;s base compensation&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(ii)&#160;&#160;&#160;&#160;A material diminution in the Executive&#8217;s authority, duties and responsibilities as in effect immediately prior to the Change of Control or, if applicable, the Date of Termination&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(iii)&#160;&#160;&#160;&#160;A material diminution in the authority, duties and responsibilities of the supervisor to whom the Executive is required to report as in effect immediately prior to the Change of Control or, if applicable, the Date of Termination&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(iv)&#160;&#160;&#160;&#160;A material change in the geographic location in which Executive&#8217;s principal office was located immediately prior to the Change of Control or, if applicable, the Date of Termination&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(v)&#160;&#160;&#160;&#160;A material diminution in the budget over which the Executive had authority immediately prior to the of the Change of Control or, if applicable, the Date of Termination&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(vi)&#160;&#160;&#160;&#160;Any other action or inaction that constitutes a material breach by the Company of this Agreement or any other agreement under which the Executive provides services&#59;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">provided, however, that Good Reason shall not exist unless the Executive has given written notice to the Company within ninety (90) days of the initial existence of the Good Reason event or condition(s) giving specific details regarding the event or condition&#59; and unless the Company has had at least thirty (30) days to cure such Good Reason event or condition after the delivery of such written notice and has failed to cure such event or condition within such thirty (30) day cure period.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Notice of Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Any termination by the Company for Cause or by the Executive for Good Reason shall be communicated by Notice of Termination to the other party hereto given in accordance with Section 13(b) of this Agreement. For purposes of this Agreement, a &#34;Notice of Termination&#34; means a written notice which (i) indicates the specific termination provision in this Agreement relied upon, (ii) to the extent applicable, sets forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of the Executive's employment under the provision so indicated and (iii) if the Date of Termination (as defined below) is other than the date of receipt of such notice, specifies the termination date (which date shall be not more than fifteen days after the giving of such notice). The failure by the Executive or the Company to set forth in the Notice of Termination any fact or circumstance which contributes to a showing of Good Reason or Cause shall not waive any right of the Executive or the Company hereunder or preclude the Executive or the Company from asserting such fact or circumstance in enforcing the Executive's or the Company&#8217;s rights hereunder.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Date of Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. &#34;Date of Termination&#34; means the date of receipt of the Notice of Termination or any later date (taking into account any applicable notice and cure period) specified therein, as the case may be&#59; provided however, that (i) if the Executive's employment is terminated by the Company other than for Cause, death or Disability, the Date of Termination shall be the date on which the Company notifies the Executive of such termination, and (ii) if the </font></div><div style="height:49pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:68pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Executive's employment is terminated by reason of death or Disability, the Date of Termination shall be the date of death of the Executive or the Disability Effective Date, as the case may be.</font></div><div><font><br></font></div><div style="padding-left:18pt;padding-right:5.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:9pt;text-decoration:underline">Obligations of the Company upon Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Death</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If the Executive's employment is terminated by reason of the Executive's death during the Employment Period, this Agreement shall terminate without further obligations to the Executive's legal representatives under this Agreement, other than for (i) payment of the sum of the following amounts&#58; (A) the Executive's Annual Base Salary through the Date of Termination to the extent not theretofore paid, (B) the product of (I) the Highest Annual Bonus and (II) a fraction, the numerator of which is the number of days in the current fiscal year through the Date of Termination, and the denominator of which is 365, and (C) any accrued and unpaid Annual Bonus amounts, compensation or vacation pay, in each case, to the extent not yet paid by the Company (the amounts described in subparagraphs (A), (B) and (C) are hereafter referred to as &#34;Accrued Obligations&#34; and shall be paid to the Executive&#8217;s estate or beneficiary, as applicable, in a lump sum in cash within 30 days of the Date of Termination), (ii) any other benefits or compensation payable under any employee benefit plan in accordance with the applicable plans&#8217; terms, including, without limitation, any non-qualified plan or DCP&#59; (iii) for the remainder of the Employment Period, or such longer period as any plan, program, practice or policy may provide, the Company shall continue benefits to the Executive and&#47;or the Executive's family at least equal to those which would have been provided in accordance with the applicable plans, programs, practices and policies described in Section 4(b)(v) and (vi) of this Agreement as if the Executive's employment had not been terminated in accordance with the most favorable plans, practices, programs or policies of the Company and its affiliated companies as in effect and applicable generally to other peer executives and their families during the one year period immediately preceding the Effective Date or, if more favorable to the Executive, as in effect at any time thereafter with respect to other peer executives of the Company and its affiliated companies and their families (such continuation of such benefits for the applicable period herein set forth and such transfer of the Individual Policy shall be hereinafter referred to as &#8220;Welfare Benefit Continuation&#8221;&#59; for purposes of determining eligibility of the Executive for retiree benefits pursuant to such plans, practices, programs and policies, the Executive shall be considered to have remained employed until the end of the Employment Period and to have retired on the last day of such period), and (iv) payment to the Executive&#8217;s estate or beneficiary, as applicable, in a lump sum in cash within 30 days of the Date of Termination of an amount equal to the sum of the Executive&#8217;s Annual Base Salary and the Highest Annual Bonus. Subject to the provisions of Section 9 hereof, but, otherwise, anything herein to the contrary notwithstanding, the Executive's family shall be entitled to receive benefits at least equal to the most favorable benefits provided by the Company and any of its affiliated companies to surviving families of peer executives of the Company and such affiliated companies under such plans, programs, practices and policies relating to family death benefits, if any, as in effect with respect to other peer executives and their families at any time during the one year period immediately preceding the Effective Date or, if more favorable to the Executive and&#47;or the Executive's family, as in effect on the date of the Executive's death with respect to other peer executives of the Company and its affiliated companies and their families.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If the Executive's employment is terminated by reason of the Executive's Disability during the Employment Period, this Agreement shall terminate without further obligations to the Executive, other than for (i) payment of the Accrued Obligations (which shall be </font></div><div style="height:49pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:68pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">paid in a lump sum in cash within 30 days of the Date of Termination), (ii) the timely payment and provision of the Welfare Benefit Continuation, and (iii) payment to the Executive in a lump sum in cash within 30 days of the Date of Termination of an amount equal to the sum of the Executive&#8217;s Annual Base Salary and the Highest Annual Bonus. Subject to the provisions of Section 9 hereof, but, otherwise, anything herein to the contrary notwithstanding, the Executive shall be entitled after the Disability Effective Date to receive disability and other benefits at least equal to the most favorable of those provided by the Company and its affiliated companies to disabled executives and&#47;or their families in accordance with such plans, programs, practices and policies relating to disability, if any, as in effect with respect to other peer executives and their families at any time during the one year period immediately preceding the Effective Date or, if more favorable to the Executive and&#47;or the Executive's family, as in effect at any time thereafter with respect to other peer executives of the Company and its affiliated companies and their families.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Cause, Other than for Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If the Executive's employment shall be terminated by the Company for Cause or by the Executive other than for Good Reason (and other than by reason of her death or disability) during the Employment Period, this Agreement shall terminate without further obligations to the Executive other than the obligation to pay to the Executive Annual Base Salary through the Date of Termination. In such case, such amounts shall be paid to the Executive in a lump sum in cash within 30 days of the Date of Termination. The Executive shall, in such event, also be entitled to any benefits required by law that are not otherwise provided by this Agreement.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Termination Following a Change of Control by the Company without Cause or by the Executive for Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If during the Employment Period the Executive is terminated by the Company without Cause or she resigns for Good Reason, then the Company shall pay the Executive the following&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(i)&#160;&#160;&#160;&#160;the Company shall pay to the Executive in a lump sum in cash within 30 days after the Date of Termination all Accrued Obligations&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(ii)&#160;&#160;&#160;&#160;the Company shall pay to the Executive a lump sum amount in cash within 30 days after the Date of Termination equal to the (such amount shall be hereinafter referred to as the &#8220;Change of Control Payment&#8221;) to the product of (X) two point ninety nine (2.99) multiplied by the sum of (i) (Y) the Annual Base Salary for the fiscal year immediately preceding the Date of Termination and (ii) Highest Annual Bonus&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(iii)&#160;&#160;&#160;&#160;notwithstanding any other provisions to the contrary contained herein or in any option agreement, restricted stock agreement, performance stock unit or other equity compensation agreement, between the Company and the Executive, or any stock option, restricted stock or other equity compensation plans sponsored by the Company, unless such agreement or plan expressly references and supersedes this Agreement, then all such unvested equity awards which Executive holds as of the Effective Date shall be immediately and automatically exercisable and&#47;or vested, and the Executive shall have the right to exercise any such equity awards (to the extent applicable) for the shorter of one year after the Date of Termination or the remaining term of the applicable equity award.</font></div><div><font><br></font></div><div style="height:49pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:68pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Termination by the Company Without Cause or by Executive for Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If the Executive's employment with the Company shall be terminated by the Company without Cause or by the Executive for Good Reason (as defined in Section 5(c) without regard to whether a Change of Control has occurred) at any time prior to the Effective Date, then the Executive shall be entitled to each and all of the following&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(i)&#160;&#160;&#160;&#160;the Company shall pay the Executive all Accrued Obligations&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(ii)&#160;&#160;&#160;&#160;the Company shall continue to pay the Executive her Base Salary and an amount equal to the Average Annual Bonus divided by the number of payroll periods during the one year severance period for the period of one (1) year from the Date of Termination in accordance with its normal payroll practices and subject to applicable tax withholding&#59; and</font></div><div style="padding-left:36pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(iii)&#160;&#160;&#160;&#160;provide the Executive and her family with the Welfare Benefit Continuation for a period of one (1) year from the Date of Termination.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Mitigation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Executive shall not be required to mitigate the amount of any payment provided for in this Agreement by seeking other employment or otherwise and no such payment shall be offset or reduced by the amount of any compensation or benefits provided to the Executive in any subsequent employment.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(g)&#160;&#160;&#160;&#160;Other Severance Benefits. The severance pay and benefits provided for in Section 6(e) shall be in lieu of any other severance or termination pay to which the Executive may be entitled under any Company severance or termination plan, program, practice or arrangement. The Executive's entitlement to any other compensation or benefits shall be determined in accordance with the Company's employee benefit plans and other applicable programs, policies and practices then in effect.</font></div><div><font><br></font></div><div style="padding-right:5.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt;text-decoration:underline">Non-exclusivity of Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Except as provided in Section 6, nothing in this Agreement shall prevent or limit the Executive's continuing or future participation in any benefit, bonus, incentive or other plans, programs, policies or practices, provided by the Company or any of its affiliated companies and for which the Executive may qualify, nor shall anything herein limit or otherwise affect such rights as the Executive may have under any other agreements with the Company or any of its affiliated companies. Amounts which are vested benefits or which the Executive is otherwise entitled to receive under any plan, policy, practice or program of the Company or any of its affiliated companies at or subsequent to the Date of Termination shall be payable in accordance with such plan, policy, practice or program except as explicitly modified by this Agreement.</font></div><div><font><br></font></div><div style="padding-left:18pt;padding-right:5.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:9pt;text-decoration:underline">Full Settlement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;The Company's obligation to make the payments provided for in this Agreement and otherwise to perform its obligations hereunder shall not be affected by any set-off, counterclaim, recoupment, defense or other claim, right or action which the Company may have against the Executive or others. In no event shall the Executive be obligated to seek other employment or take any other action by way of mitigation of the amounts payable to the Executive under any of the </font></div><div style="height:49pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:68pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">provisions of this Agreement and such amounts shall not be reduced whether or not the Executive obtains other employment.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;Prior to the occurrence of a Change of Control, the Company agrees to reimburse the Executive for all legal fees and expenses which the Executive may reasonably incur as a result of any contest by the Company, the Executive or others of the validity or enforceability of, or liability under, any provision of this Agreement or any guarantee of performance thereof, if the Executive prevails in such contest. Following a Change of Control, the Company agrees to pay promptly as incurred, to the full extent permitted by law, all legal fees and expenses which the Executive may reasonably incur as a result of any contest (regardless of the outcome thereof) by the Company, the Executive or others of the validity or enforceability of, or liability under, any provision of this Agreement or any guarantee of performance thereof.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;If there shall be any dispute between the Company and the Executive (i) in the event of any termination of the Executive&#8217;s employment by the Company, whether such termination was for Cause, or (ii) in the event of any termination of employment by the Executive, whether Good Reason existed, then, unless and until there is a final, nonappealable judgment by a court of competent jurisdiction declaring that such termination was for Cause or that the determination by the Executive of the existence of Good Reason was not made in good faith, the Company shall pay all amounts, and provide all benefits, to the Executive and&#47;or the Executive&#8217;s family or other beneficiaries, as the case may be, that the Company would be required to pay or provide pursuant to Section 6(d) as though such termination were by the Company without Cause, or by the Executive with Good Reason&#59; provided, however, that the Company shall not be required to pay any disputed amount pursuant to this paragraph except upon receipt of an undertaking by or on behalf of the Executive to repay all such amounts to which the Executive is ultimately adjudged by such court not to be entitled.</font></div><div><font><br></font></div><div style="padding-left:18pt;padding-right:5.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:9pt;text-decoration:underline">280G Protection</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;In the event that the Executive shall become entitled to payment and&#47;or benefits provided by this Agreement or any other amounts in the &#8220;nature of compensation&#8221; (whether pursuant to the terms of this Agreement or any other plan, arrangement or agreement with the Company, any person whose actions result in a change of ownership or effective control covered by Section 280G(b)(2) of the Internal Revenue Code (the &#8220;Code&#8221;) or any person affiliated with the Company or such person) as a result of such change in ownership or effective control (collectively the &#8220;Company Payments&#8221;), and such Company Payments will be subject to the tax (the &#8220;Excise Tax&#8221;) imposed by Section 4999 of the Code (and any similar tax that may hereafter be imposed by any taxing authority) the Company shall pay to the Executive the greater of the following, whichever gives the Executive the highest net after-tax amount (after taking into account federal, state, local and social security taxes at the maximum marginal rates) (x) the Company Payments or (y) one dollar less than the amount of the Company Payments that would subject the Executive to the Excise Tax. In the event that the Company Payments are required to be reduced pursuant to the foregoing sentence, then the Company Payments shall be reduced as mutually agreed between the Company and the Executive or, in the event the parties cannot agree, in the following order (1) any lump sum severance based on Base Salary or Annual Bonus, (2) any other cash amounts payable to the Executive, (3) any benefits valued as parachute payments&#59; and (4) acceleration of vesting of any equity.</font></div><div style="height:49pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:68pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;For purposes of determining whether any of the Company Payments will be subject to the Excise Tax and the amount of such Excise Tax, (x) the Company Payments shall be treated as &#8220;parachute payments&#8221; within the meaning of Section 280G(b)(2) of the Code, and all &#8220;parachute payments&#8221; in excess of the &#8220;base amount&#8221; (as defined under Code Section 280G(b)(3) of the Code) shall be treated as subject to the Excise Tax, unless and except to the extent that, in the opinion of the Company&#8217;s independent certified public accountants appointed prior to any change in ownership (as defined under Section 280G(b)(2) of the Code) or tax counsel selected by such accountants or the Company (the &#8220;Accountants&#8221;) such Company Payments (in whole or in part) either expressly do not constitute &#8220;parachute payments,&#8221; represent reasonable compensation for services actually rendered within the meaning of Section 280G(b)(4) of the Code in excess of the &#8220;base amount&#8221; or are otherwise not subject to the Excise Tax, and (y) the value of any non-cash benefits or any deferred payment or benefit shall be determined by the Accountants. All determinations hereunder shall be made by the Accountants which shall provide detailed supporting calculations both to the Company and the Executive at such time as it is requested by the Company or the Executive. If the Accountants determine that payments under this Agreement must be reduced pursuant to this paragraph, they shall furnish the Executive with a written opinion to such effect. The determination of the Accountants shall be final and binding upon the Company and the Executive.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;In the event of any controversy with the Internal Revenue Service (or other taxing authority) with regard to the Excise Tax, the Executive shall permit the Company to control issues related to the Excise Tax (at its expense), provided that such issues do not potentially materially adversely affect the Executive, but the Executive shall control any other issues. In the event the issues are interrelated, the Executive and the Company shall in good faith cooperate so as not to jeopardize resolution of either issue, but if the parties cannot agree the Executive shall make the final determination with regard to the issues. In the event of any conference with any taxing authority regarding the Excise Tax or associated income taxes, the Executive shall permit the representative of the Company to accompany the Executive, and the Executive and the Executive&#8217;s representative shall cooperate with the Company and its representative.</font></div><div><font><br></font></div><div style="padding-right:5.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Executive shall hold in a fiduciary capacity for the benefit of the Company all secret or confidential information, knowledge or data relating to the Company or any of its affiliated companies, and their respective businesses, which shall have been obtained by the Executive during the Executive's employment by the Company or any of its affiliated companies and which shall not be or become public knowledge (other than by acts by the Executive or representatives of the Executive in violation of this Agreement). After termination of the Executive's employment with the Company, the Executive shall not, without the prior written consent of the Company or as may otherwise be required by law or legal process, communicate or divulge any such information, knowledge or data to anyone other than the Company and those designated by it. In no event shall an asserted violation of the provisions of this Section 10 constitute a basis for deferring or withholding any amounts otherwise payable to the Executive under this Agreement.</font></div><div><font><br></font></div><div style="padding-left:18pt;padding-right:5.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:3pt;text-decoration:underline">Successors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;This Agreement is personal to the Executive and without the prior written consent of the Company shall not be assignable by the Executive otherwise than by will or the laws of descent </font></div><div style="height:49pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:68pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">and distribution. This Agreement shall inure to the benefit of and be enforceable by the Executive's legal representatives.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;This Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;The Company will require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business and&#47;or assets of the Company to assume expressly and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place. The Company shall provide written evidence to the Executive to document compliance with the foregoing sentence within ten (10) business days of the Effective Date. As used in this Agreement, &#34;Company&#34; shall mean the Company as hereinbefore defined and any successor to its business and&#47;or assets as aforesaid which assumes and agrees to perform this Agreement by operation of law, or otherwise. In addition, the Executive shall be entitled, upon exercise of any outstanding stock options or stock appreciation rights of the Company, to receive in lieu of shares of the Company&#8217;s stock, shares of such stock or other securities of such successor as the holders of shares of the Company&#8217;s stock received pursuant to the terms of the merger, consolidation or sale.</font></div><div><font><br></font></div><div><font><br></font></div><div style="padding-right:5.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Compliance With Section 409A of the Internal Revenue Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. To the extent applicable, it is intended that this Agreement comply with the provisions of Section 409A of the Code (hereinafter referred to as &#8220;Section 409A&#8221;). This Agreement shall be administered in a manner consistent with its intent, and any provision that would cause the Agreement to fail to satisfy Section 409A shall have no force and effect until amended to comply with Section 409A. Notwithstanding any provision of this Agreement to the contrary, in the event any payment or benefit hereunder is determined to constitute non-qualified deferred compensation subject to Section 409A, then to the extent necessary to comply with Section 409A, such payment or benefits shall not be made, provided or commenced until six (6) months after the Executive&#8217;s &#8220;separation from service&#8221; as such phrase is defined for the purposes of Section 409A.</font></div><div><font><br></font></div><div style="padding-right:5.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Executive agrees that, with the exception of the Accrued Obligations due to her in accordance with the terms hereunder, that the payment of any severance under this Agreement to the Executive by the Company, is subject to and conditioned on Executive executing a general release of the Company in a form and scope determined by the Company in its sole discretion (the &#8220;Release Agreement&#8221;), without Executive revoking such Release Agreement within fifty-two (52) days of the Date of Termination (the &#8220;Consideration Period&#8221;) and provided that (a) if the Date of Termination occurs in one calendar year and the Consideration Period (including the payment date) expires during the following calendar year, then notwithstanding anything herein to the contrary, the payments of severance under Section 6(e) will be paid by the Company to the Executive in the second calendar year&#59; (b) the Executive continues to comply with the provisions of the Non-Competition Agreement&#59; and (c) prior to the expiration of the Consideration Period (i) Executive provides satisfactory evidence to the Company that she has returned all Company property, confidential information and documentation to the Company, and (ii) provides the Company with a signed written resignation of Executive&#8217;s status as an officer of the Company or any of its affiliates, if applicable.</font></div><div><font><br></font></div><div style="height:49pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:68pt;width:100%"><div><font><br></font></div></div><div style="padding-left:18pt;padding-right:5.75pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:3pt;text-decoration:underline">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;This Agreement shall be governed by and construed in accordance with the laws of the Commonwealth of Massachusetts, without reference to principles of conflict of laws. The captions of this Agreement are not part of the provisions hereof and shall have no force or effect. This Agreement may not be amended or modified otherwise than by a written agreement executed by the parties hereto or their respective successors and legal representatives.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(b)&#160;&#160;&#160;&#160;All notices and other communications hereunder shall be in writing and shall be given by hand delivery to the other party or by registered or certified mail, return receipt requested, postage prepaid, addressed as follows&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;If to the Executive&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Elisabeth (Lisa) A. Hellmann</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(at the address on record with the company)</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;If to the Company&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Hologic, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;250 Campus Drive</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Marlborough, Massachusetts 01752 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Attention&#58; Chief Executive Officer</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or to such other address as either party shall have furnished to the other in writing in accordance herewith. Notices and communications shall be effective when actually received by the addressee.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(c)&#160;&#160;&#160;&#160;The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(d)&#160;&#160;&#160;&#160;The Company may withhold from any amounts payable under this Agreement such Federal, state or local taxes as shall be required to be withheld pursuant to any applicable law or regulation.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(e)&#160;&#160;&#160;&#160;The Executive's or the Company&#8217;s failure to insist upon strict compliance with any provision hereof shall not be deemed to be a waiver of such provision or any other provision thereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(f)&#160;&#160;&#160;&#160;This Agreement contains the entire understanding of the Company and the Executive with respect to the rights and other benefits that the Executive shall be entitled during the Employment Period, and in connection therewith shall supersede all prior oral and written communications with the Executive with respect thereto&#59; provided, however, that the Offer Letter, and Employee Intellectual Property Rights and Non-Competition Agreement, option or other equity </font></div><div style="height:49pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:68pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">agreements or other employment agreement by and between the Company and Executive shall remain in full force and effect and if the Company&#8217;s separation policy would provide greater benefits to the Executive than this Agreement, then the Executive may elect to receive benefits under the Company&#8217;s separation policy in lieu of the benefits provided hereunder. Nothing herein shall affect the application of the Company&#8217;s separation policy in lieu of the benefits provided hereunder. Nothing herein shall affect the application of the Company&#8217;s separation policy prior to the Effective Date.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;(g)&#160;&#160;&#160;&#160;The Executive and the Company acknowledge that, except as may otherwise be provided under this Agreement or any other written agreement between the Executive and the Company, prior to the Effective Date, the employment of the Executive by the Company is &#8220;at will&#8221; and may be terminated by either the Executive or the Company at any time. Notwithstanding anything contained herein, if during or prior to the Employment Period, the Executive shall terminate employment with the Company other than for Good Reason, then the Executive shall have no liability to the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;Signature page follows&#93;</font></div><div style="height:49pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i5715be3e97c34bed8ba3d848c9dd60fd_13"></div><hr style="page-break-after:always"><div style="min-height:75pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;IN WITNESS WHEREOF, the Executive has hereunto set her hand and, pursuant to the authorization from its Board of Directors, the Company has caused these presents to be executed in its name on its behalf, all as of the day and year first above written.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">HOLOGIC, INC.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; John M. Griffin&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Name&#58; John M. Griffin </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Title&#58; General Counsel &#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EXECUTIVE</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Elisabeth Hellmann&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Elisabeth (Lisa) Hellmann</font></div><div style="height:49pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ex102-bebotransitionagreem.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i697214a678274001abe0d4ef8725506b_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit 10.2</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">TRANSITION AGREEMENT</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;AGREEMENT entered into as of this 2nd day of July, 2021 by and between Hologic, Inc., a Delaware corporation with its principal place of business at 250 Campus Drive, Massachusetts 01752 (the &#8220;Company&#8221;), and Allison P. Bebo, an individual having her principal residence in Stowe, Vermont (the &#8220;Executive&#8221;).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;WHEREAS, the Executive currently serves as Senior Vice President, Human Resources of the Company&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;WHEREAS, the Executive and the Company previously entered into a Severance and Change of Control Agreement, dated September 13, 2017 (the &#8220;Severance Agreement&#8221;)&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;WHEREAS, capitalized terms used but not defined herein shall have the meanings provided in the Severance Agreement&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;WHEREAS, the Company has notified the Executive that it intends to terminate the Executive&#8217;s employment with the Company without Cause&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;WHEREAS, the Executive and the Company desire to provide for an amicable separation to their mutual benefit on the terms and conditions set forth herein.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;NOW, THEREFORE, in consideration of the mutual covenants and agreements hereinafter set forth, the parties hereto, each intending to be legally bound, do hereby agree as follows&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt;text-decoration:underline">Termination as Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Transition Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Effective on July 2, 2021 (the &#8220;Transition Date&#8221;), without any further notice required of the Company or the Executive, the Executive shall be terminated by the Company from her position as Senior Vice President, Human Resources of the Company, as well as any and all positions held by her including, without limitation, as an employee, officer, director, manager, or member, as applicable, of the Company and all direct or indirect subsidiaries of the Company without Cause.  Nothing herein shall preclude the Executive from resigning or the Company from terminating the Executive from any positions prior to the Transition Date. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Duties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Prior to the Transition Date, the Executive shall continue to serve as Senior Vice President, Human Resources of the Company, with all the responsibilities and duties associated with such position.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  From the date hereof until the Transition Date, unless the Executive&#8217;s employment with the Company is terminated earlier, pursuant to Section&#160;2(b) below, (i)&#160;the Executive shall be entitled to continue to receive base salary at a rate equal to her current Annual Base Salary, payable in accordance with the Company&#8217;s regular payroll practices&#59; (ii)&#160;as </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">applicable, the Executive&#8217;s outstanding stock options, restricted stock units and performance stock units, if any, will continue to vest in accordance with and subject to the terms and conditions set forth in the applicable equity incentive plans and award agreements&#59; and (iii)&#160;the Executive shall be entitled to participate in any and all retirement (both qualified and non-qualified), vacation and&#47;or sick pay, medical, dental, life insurance and other employee benefit plans in which she currently participates, all to the extent the Executive remains eligible under the terms of such plans and subject to the terms and conditions of such plans as may be in effect from time to time, including (without limitation) the Company&#8217;s car allowance program. On the Transition Date, the Executive will receive her final paycheck with accrued and unpaid pay through that date as well as accrued and unpaid vacation time and payment of all outstanding business expense reimbursements according to Company policy.  </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt;text-decoration:underline">Separation Benefits.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Separation Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. As a consequence of the termination of the Executive&#8217;s employment as contemplated herein and in full discharge of the Company&#8217;s obligations due to the Executive thereunder, the Company shall pay to the Executive or her heirs or estate, if applicable, subject to the Executive executing this Agreement and executing the Release Agreement attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> (the &#8220;Release&#8221;) within twenty-one (21) days of the Transition Date and the Release becoming effective and irrevocable in accordance with its terms (the &#8220;Severance Amount&#8221;)&#58; (i)&#160;the Executive&#8217;s Annual Base Salary for twelve (12) months following the Transition Date, payable in accordance with the Company&#8217;s normal payroll practices&#59; (ii) the Executive&#8217;s Average Annual Bonus, payable in lump sum&#59; (iii) an amount equal to the product of (A) the Highest Annual Bonus and (B) a fraction, the numerator of which is the number of days in the current fiscal year through the Transition Date, and the denominator of which is 365, payable in lump sum&#59; and (iv) a cash payment in lieu of Welfare Benefit Continuation  to the Executive and her family for twelve (12) months following the Transition Date, payable in lump sum.  In addition to the foregoing, the Company shall take all necessary action to provide that all of the Executive&#8217;s accounts under the Company&#8217;s Amended and Restated Deferred Compensation Program shall be fully vested as of the Transition Date.  Payments relating to the preceding subsections (i) through (iv) shall commence (or be paid in full, with respect to lump sum payments) on the first regular payroll period that follows the expiration of the Release Agreement revocation period (the &#8220;Payment Commencement Date&#8221;)&#59; provided, that any payments relating the preceding subsection (i) for payroll periods occurring after the Transition Date and prior to the Payment Commencement Date shall be made on the Payment Commencement Date, without interest. The payments under this Section&#160;2 are subject to applicable withholding and taxes.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Termination for Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding anything to the contrary herein, if the Executive is terminated by the Company for Cause at any time prior to the Transition Date, then the Executive shall not be entitled to receive any further payments or benefits under this Agreement and the Company shall have no further obligations to the Executive under this Agreement, except to the extent required by law.       </font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt;text-decoration:underline">Transition Period.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Consulting Services</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Commencing on the Transition Date, the Executive agrees to provide reasonable consulting services to the Company through December 31, 2021 (the &#8220;Termination Date&#8221; and the time between the Transition Date and the Termination Date the &#8220;Transition Period&#8221;), subject to the terms and conditions of this Agreement.  Said services shall be during ordinary business hours, shall not require travel or weekend work and time spent shall be as mutually and reasonably agreed by the parties.  Executive shall have no liability to Company whatsoever for any liabilities, damages, costs or expenses incurred by Company with respect to any consulting services so performed by Executive except for damages caused by her intentional misconduct or gross negligence.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Consulting Services Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Subject to the Executive&#8217;s continuing availability to provide consulting services in accordance with the terms hereof, during the Transition Period the Executive shall be considered a &#8220;Service Provider&#8221; to the Company as defined in the applicable equity incentive plans and award agreements.  To the extent applicable and notwithstanding anything to the contrary in any applicable equity incentive plans and award agreements, the Executive&#8217;s outstanding stock options, restricted stock units and performance stock units will remain outstanding and will continue to vest in accordance with and subject to the terms and conditions set forth in the applicable equity incentive plans and award agreements.  For the avoidance of doubt, during the Transition Period, the Executive shall receive no consideration other than the separation benefits set forth in Section 2, subject to the terms and conditions set forth herein and therein, and to the extent applicable, the continued vesting of any outstanding stock options, restricted stock units and performance stock units.   </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt;text-decoration:underline">Non-Competition Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As additional consideration for the substantial benefits being provided to the Executive hereunder, the Executive agrees to continue to comply with the Non-Competition and Proprietary Information Agreement previously executed and agreed to by Executive (the &#8220;Non-Competition Agreement&#8221;) and Executive&#8217;s confidentiality covenants set forth in Section 10 of the Severance Agreement.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding anything herein, the Non-Competition Agreement and Section 10 of the Severance Agreement, pursuant to the federal Defend Trade Secrets Act of 2016, an individual shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that&#58; (A) is made (1) in confidence to a federal, state or local government official, either directly or indirectly, or to an attorney and (2) solely for the purpose of reporting or investigating a suspected violation of law&#59; (B) is made to the individual&#8217;s attorney in relation to a lawsuit for retaliation against the individual for reporting a suspected violation of law&#59; or (C) is made in a complaint or other document filed in a lawsuit or proceeding, if such filing is made under seal.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt;text-decoration:underline">Other Severance Pay or Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The separation benefits provided for in Section 2 shall be in lieu of any other severance or termination pay to which the Executive may </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">be entitled under any Company severance or termination plan, program or practice (whether written or unwritten) or agreement.  Except as otherwise provided herein, the Executive&#8217;s entitlement to any other compensation or benefits shall be determined in accordance with the terms and conditions of the Company&#8217;s employee benefit plans (other than severance or termination plans, programs, practices or agreements) and other applicable programs, policies and practices then in effect.  Company agrees that it will not oppose any application for unemployment benefits submitted by the Executive.</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt;text-decoration:underline">Successors&#58; Binding Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Agreement shall be binding upon and shall inure to the benefit of the Company, and its successors and assigns, and the Company shall require any successors and assigns to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession or assignment had taken place.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Neither this Agreement nor any right or interest hereunder shall be assignable or transferable by the Executive, her beneficiaries or legal representatives, except by will or by the laws of descent and distribution.  This Agreement shall inure to the benefit of and be enforceable by the Executive&#8217;s personal representative.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt;text-decoration:underline">Tax Treatment&#59; Tax Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company and the Executive hereby acknowledge and agree that and agree that the compensation provided for in Section&#160;1 and the severance pay provided for in Section&#160;2 shall be treated and reported by the Company and the Executive as additional compensation for services rendered and as ordinary income.  The Executive also acknowledges and agrees that the Company may withhold from any compensation or other benefits to which the Executive is entitled hereunder such amounts as may be required to satisfy all federal, state and local withholding and employment tax obligations.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt;text-decoration:underline">General Provisions.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">No Special Employment Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  No provision of this Agreement shall grant or confer upon, or shall be construed to grant or confer upon, the Executive any right with respect to the continuation of her employment by the Company or to otherwise affect in any respect the terms and conditions of such employment except to the extent expressly provided hereunder.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Any and all notices or other communications required or permitted to be given in connection with this Agreement shall be in writing (or in the form of a facsimile or electronic transmission) addressed as provided below and shall be (i)&#160;delivered by hand, (ii)&#160;delivered by overnight courier service with confirmed receipt or (iii)&#160;mailed by first class U.S. mail, postage prepaid and registered or certified, return receipt requested&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If to the Company to&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Hologic, Inc.<br>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;250 Campus Drive<br>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Marlborough, MA 01752<br>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Attn&#58; General Counsel<br>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Facsimile Number&#58; 8555116538&#64;fax2mail.com<br>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;E-Mail Address&#58; john.griffin&#64;hologic.com</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If to the Executive, to&#58;<br><br>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Allison P. Bebo at the address on file with the Company.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><br>and in any case at such other address as the addressee shall have specified by written notice.  Any notice or other communication given in accordance with this Section&#160;8 shall be deemed delivered and effective upon receipt, except those notices and other communications sent by mail, which shall be deemed delivered and effective three (3)&#160;business days following deposit with the United States Postal Service.  All periods of notice shall be measured from the date of delivery thereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Entire Agreement&#59; Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The recitals hereto are hereby incorporated herein by this reference.  This Agreement, together with the exhibits hereto, constitute the entire agreement between the parties hereto with regard to the subject matter hereof and thereof, superseding all prior understandings and agreements, whether written or oral, including, without limitation, the Severance Agreement&#59; provided, however, that any indemnification agreement and any outstanding vested equity award agreements (including, without limitation, any outstanding vested option agreement, restricted stock unit agreement, performance stock unit agreement, market stock unit agreement or other equity instrument by and between the Company and the Executive), the Non-Competition Agreement and Section 10 of the Severance Agreement shall remain in full force and effect in accordance with the terms and conditions herein and therein.  This Agreement may not be changed orally, but only by an agreement in writing signed by the party against whom enforcement of any such change is sought.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">409A Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding any other provision herein to the contrary, the Company shall make the payments required hereunder in compliance with the requirements of Section&#160;409A and any interpretative guidance issued thereunder.  The Company may, in its sole and absolute discretion, delay payments hereunder or make such other modifications with respect to the timing of payments as it deems necessary to comply with Section&#160;409A. Notwithstanding any provision herein to the contrary, in the event any payment or benefit hereunder is determined to constitute non-qualified deferred compensation subject to Section 409A, then to the extent necessary to comply with Section 409A, such payment or benefits shall not be made, provided or commenced until six (6) months after the Executive&#8217;s &#8220;separation from service&#8221; as such phrase is defined for the purposes of Section 409A. For purposes of Section 409A, each right to receive a payment hereunder shall be treated as a right to receive a series of separate payments and, accordingly, any installment payment shall at all times </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">be considered a separate and distinct payment. For the avoidance of doubt, the Transition Date shall be the date of the Executive&#8217;s &#8220;separation from service&#8221; for purposes of Section 409A. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Interpretation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The parties hereto acknowledge and agree that&#58; (i)&#160;each party and its counsel reviewed and negotiated the terms and provisions of this Agreement and have contributed to its revision&#59; (ii)&#160;the rule of construction to the effect that any ambiguities are resolved against the drafting party shall not be employed in the interpretation of this Agreement&#59; and (iii)&#160;the terms and provisions of this Agreement shall be construed fairly as to all parties hereto and not in favor of or against any party, regardless of which party was generally responsible for the preparation of this Agreement.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Effect of Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The titles of section headings herein contained have been provided solely for convenience of reference and in no way define, limit or describe the scope or substance of any provision of this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The provisions of this Agreement are severable, and the invalidity of any provision shall not affect the validity of any other provision.  In the event that any court of competent jurisdiction shall determine that any provision of this Agreement or the application thereof is unenforceable because of the duration or scope thereof, the parties hereto agree that said court in making such determination shall have the power to reduce the duration and scope of such provision to the extent necessary to make it enforceable, and that the Agreement in its reduced form shall be valid and enforceable to the full extent permitted by law.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Governing Law&#47;Jurisdiction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement shall be binding upon the Executive and shall inure to the benefit of the Company and its successors and interest and assigns, and shall be construed in accordance with and governed by the laws of the Commonwealth of Massachusetts without regard to conflicts of laws.  The parties hereto intend and hereby confer jurisdiction to enforce the covenants contained herein upon the state and federal courts sitting in the Commonwealth of Massachusetts.  In the event that such courts shall hold any such covenant wholly unenforceable by reason of the breadth of scope or otherwise, it is the intention of the parties hereto that such determination not bar or in any way affect the Company&#8217;s right to the relief provided above in the courts of any other states within the geographical scope of such other covenants having appropriate personal and subject matter jurisdiction over the parties, as to breaches of such covenants in such other respective jurisdictions, the above covenants as they relate to each state being, for this purpose, severable into diverse and independent covenants.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement may be executed in multiple original or facsimile counterparts (including *.pdf and the like), each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement as a binding contract as of the date first above written.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">HOLOGIC, INC.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; John M. Griffin&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<br>Name&#160;&#160;&#160;&#160;John M. Griffin<br>Title&#58; &#160;&#160;&#160;&#160;General Counsel</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EXECUTIVE</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Allison P. Bebo&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<br>Allison P. Bebo</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div></div></div><div id="i697214a678274001abe0d4ef8725506b_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT A</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">GENERAL RELEASE OF ALL CLAIMS</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;AGREEMENT entered into as of this 2nd day of July, 2021 by and between Hologic, Inc., a Delaware corporation with its principal place of business at 250 Campus Drive, Marlborough, Massachusetts 01752 (the &#8220;Company&#8221;), and Allison P. Bebo, an individual having her principal residence in Stowe, Vermont (the &#8220;Executive&#8221;).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;WHEREAS, the Executive and the Company previously entered into a transition agreement, dated as of July 2, 2021 (the &#8220;Transition Agreement&#8221;)&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;WHEREAS, terms not defined herein shall have the meaning ascribed to them in the Transition Agreement&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;WHEREAS, in consideration of the amounts payable pursuant to the Transition Agreement, and for other consideration, the Executive agrees to release and waive any and all claims against the Company Releasees (as defined below), subject to the terms and conditions herein&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;NOW, THEREFORE, in consideration of the mutual covenants and agreements hereinafter set forth and in the Transition Agreement, the parties hereto, each intending to be legally bound, do hereby agree as follows&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt;text-decoration:underline">Separation Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Subject to and conditioned upon the release of claims herein and the Executive not revoking this Release Agreement pursuant to Section&#160;7 hereof, as a consequence of the termination of the Executive&#8217;s employment with the Company in accordance with the Transition Agreement and in full discharge of the Company&#8217;s obligations due to the Executive thereunder (excepting those arising under Section 3 and the last sentence of Section 5 thereof), the Company agrees to pay the Executive the severance payments set forth under Section&#160;2 of the Transition Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt;text-decoration:underline">Non-Competition Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Executive agrees and covenants that the Non-Competition Agreement (as defined in the Transition Agreement) and Section 10 of the Severance Agreement remain in full force and effect.   </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt;text-decoration:underline">Executive Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In consideration for the substantial benefits being provided to the Executive in the Transition Agreement, the Executive, for herself, her agents, legal representatives, assigns, heirs, distributees, devisees, legatees, administrators, personal representatives and executors (collectively with the Executive, the &#8220;Releasing Parties&#8221;), hereby releases and discharges, to the extent permitted by law, the Company and its present and past subsidiaries and affiliates, its and their respective successors and assigns, and the present and past shareholders, officers, directors, employees, agents and representatives of each of the foregoing (collectively, the &#8220;Company Releasees&#8221;), from any and all claims, demands, actions, liabilities and other claims for relief and remuneration whatsoever, whether known or unknown, from the beginning of the world to the date the Executive signs this Release Agreement, but </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">otherwise including, without limitation, any claims arising out of or relating to the Executive&#8217;s employment with and termination of employment from the Company, for wrongful discharge, for breach of contract, for discrimination or retaliation under any federal, state or local fair employment practices law, including, Massachusetts General Laws Chapter 149, Section&#160;148, Title VII of the Civil Rights Act of 1964 (as amended by the Civil Rights Act of 1991), the Family and Medical Leave Act, the Americans with Disabilities Act, the Older Workers Benefit Protection Act of 1990, the Age Discrimination in Employment Act, for defamation or other torts, for wages, bonuses, incentive compensation, unvested equity, vacation pay or any other compensation or benefit, any claims under any tort or contract (express or implied) theory, and any of the claims, matters and issues which could have been asserted by the Releasing Parties against the Company Releasees in any legal, administrative or other proceeding in any jurisdiction.  Notwithstanding the foregoing, nothing in this Release Agreement is intended to release or waive&#58; (a) the Executive&#8217;s rights under the Transition Agreement&#59; (b) to COBRA, unemployment insurance benefits, any other vested retirement benefits or vested equity awards&#59; (c) the right to seek enforcement of this Release Agreement&#59; (d) any rights of indemnification under the Company&#8217;s certificate of incorporation, bylaws under applicable law or otherwise referenced in any indemnification agreement by and between the Executive and the Company&#59; or (e) entitlement to coverage under separate directors&#160;&#38; officers insurance policies or other insurance policies maintained by the Company, if applicable, each of which is expressly excepted from the scope of this release.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt;text-decoration:underline">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  It is understood and agreed that, with the exception of (i)&#160;obligations set forth or confirmed in the Transition Agreement or this Release Agreement, (ii)&#160;obligations of the Executive under the Non-Competition Agreement and Section 10 of the Severance Agreement, and (iii)&#160;any of the Executive&#8217;s rights to indemnification as provided in indemnification agreement by and between the Executive and the Company and the Company&#8217;s certificate of incorporation and bylaws (it being acknowledged and agreed by the Executive that, as of the date of this Release Agreement, there are no amounts owed to the Executive pursuant to any such indemnification rights), all of which shall remain fully binding and in full effect subsequent to the execution of this Release Agreement, the release set forth in Section&#160;3 is intended and shall be deemed to be a full and complete release of any and all claims that the Releasing Parties may or might have against the Company Releasees arising out of any occurrence on or before the effective date of this Release Agreement and this Release Agreement is intended to cover and does cover any and all future damages not now known to the Releasing Parties or which may later develop or be discovered, including all causes of action arising out of or in connection with any occurrence on or before the effective date of this Release Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt;text-decoration:underline">Exceptions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Release Agreement does not (i)&#160;prohibit or restrict the Executive from communicating, providing relevant information to or otherwise cooperating with the Equal Employment Opportunity Commission (the &#8220;EEOC&#8221;) or any other governmental authority with responsibility for the administration of fair employment practices laws regarding a possible violation of such laws or responding to any inquiry from such authority, including an inquiry about the existence of this Release Agreement or its underlying facts, or (ii)&#160;preclude the Executive from benefiting from classwide injunctive relief awarded in any fair employment </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">practices case brought by any governmental agency, provided such relief does not result in Executive&#8217;s receipt of any monetary benefit or substantial equivalent thereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt;text-decoration:underline">ADEA Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This paragraph is intended to comply with the Older Workers Benefit Protection Act of 1990 (&#8220;OWBPA&#8221;) with regard to the Executive&#8217;s waiver of rights under the Age Discrimination in Employment Act of 1967 (&#8220;ADEA&#8221;).  By signing and returning this Release Agreement, the Executive acknowledges that she&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">has carefully read and fully understands the terms of this Release Agreement&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">is entering into this Release Agreement voluntarily and knowing that he is releasing claims that he has or may have against the Company Releasees&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">is specifically waiving rights and claims under ADEA&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">understands that the waiver of rights under ADEA does not extend to any rights or claims arising after the date this Release Agreement is signed by the Executive&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">consulted with an attorney before signing this Release Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt;text-decoration:underline">ADEA Revocation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Executive acknowledges that he has been given the opportunity to consider this Release Agreement for twenty-one (21)&#160;days before signing it.  For a period of seven (7)&#160;days from the date Executive signs this Release Agreement, Executive has the right to revoke this Release Agreement by written notice pursuant to Section&#160;10(b).  This Release Agreement shall not become effective or enforceable until the expiration of the revocation period.  This Release Agreement shall become effective on the first business day following the expiration of the revocation period.</font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt;text-decoration:underline">Other Severance Pay and Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">.  T</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">he separation benefits provided for in Section&#160;1 shall be in lieu of any other severance, separation or termination pay to which the Executive may be entitled under any Company severance or termination plan, program, practice (whether written or unwritten) or agreement.  Except as otherwise provided herein, the Executive&#8217;s entitlement to any other compensation or benefits shall be determined in accordance with the terms and conditions of the Company&#8217;s employee benefit plans (other than severance or termination plans, programs, practices or agreements) and other applicable programs, policies and practices then in effect.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt;text-decoration:underline">Successors&#58; Binding Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Release Agreement shall be binding upon and shall inure to the benefit of the Company, and its successors and assigns, and the Company shall require any successors and assigns to expressly assume and agree to perform this Release Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession or assignment had taken place.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Neither this Release Agreement nor any right or interest hereunder shall be assignable or transferable by the Executive, her beneficiaries or legal representatives, except by will or by the laws of descent and distribution.  This Release Agreement shall inure to the benefit of and be enforceable by the Executive&#8217;s personal representative.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:21pt;text-decoration:underline">General Provisions.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Non-Disparagement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Executive agrees not to make any adverse or disparaging comments (oral or written, including, without limitation, via any form of electronic media) about the Company, its affiliates, or any of their respective officers, directors, managers or employees which may tend to impugn or injure their reputation, goodwill and relationships with their past, present and future customers, employees, vendors, investors or with the business community generally.  The Company agrees that its executive officers and directors shall be directed not to make any disparaging comments (oral or written, including, without limitation, via any form of electronic media) about the Executive.  Nothing in this Section&#160;10(a) is intended to prohibit, limit or prevent the Executive or the Company&#8217;s officers or directors from providing truthful testimony in a court of law, to a regulatory or law enforcement agency or pursuant to a properly issued subpoena, and such testimony will not be deemed to be a violation of this Section 10(a).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Any and all notices or other communications required or permitted to be given in connection with this Release Agreement shall be in writing (or in the form of a facsimile or electronic transmission) addressed as provided below and shall be (i)&#160;delivered by hand, (ii)&#160;delivered by overnight courier service with confirmed receipt or (iii)&#160;mailed by first class U.S. mail, postage prepaid and registered or certified, return receipt requested&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Hologic, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;250 Campus Drive</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Marlborough, MA 01752</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Attn&#58; General Counsel</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Facsimile Number&#58; 8555116538&#64;fax2mail.com</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;E-Mail Address&#58; john.griffin&#64;hologic.com</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><br>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If to the Executive, to&#58;<br><br>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Allison P. Bebo on file with the Company.<br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">and in any case at such other address as the addressee shall have specified by written notice.  Any notice or other communication given in accordance with this Section&#160;10 shall be deemed delivered and effective upon receipt, except those notices and other communications sent by mail, which shall be deemed delivered and effective three (3)&#160;business days following deposit with the United States Postal Service.  All periods of notice shall be measured from the date of delivery thereof.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Confidentiality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  By employment with Company, Executive has had, or will have, contact with and gain knowledge of certain confidential and proprietary information and trade secrets, including without limitation, analyses of Company&#8217;s prospects and opportunities&#59; programs (including advertising)&#59; direct mail and telephone lists, customer lists and potential customer lists&#59; Company&#8217;s plans for present and future developments&#59; marketing information including strategies, tactics, methods, customer&#8217;s market research data&#59; financial information, including reports, records, costs, and performance data, debt arrangements, holdings, income statements, annual and&#47;or quarterly statements and accounting records and&#47;or tax returns&#59; operational information, including operating procedures, products, methods, service techniques, &#8220;know-how&#8221;, tooling, plans, concepts, designs, specifications, trade secrets, processes, methods and suppliers&#59; technical information, including computer software programs&#59; research and development projects&#59; product formulae, processes, inventions, designs, or discoveries, which information Company treats as confidential.  Executive agrees that Executive will not communicate or disclose to any third party or use for Executive&#8217;s own account, without the written consent of Company, any of the aforementioned information or material, except as required by law, unless and until such information or material becomes generally available to the public through sources other than Executive. Notwithstanding any other provision of this Release Agreement or any other agreement, pursuant to the federal Defend Trade Secrets Act of 2016, an individual shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that&#58; (A) is made (1) in confidence to a federal, state or local government official, either directly or indirectly, or to an attorney and (2) solely for the purpose of reporting or investigating a suspected violation of law&#59; (B) is made to the individual&#8217;s attorney in relation to a lawsuit for retaliation against the individual for reporting a suspected violation of law&#59; or (C) is made in a complaint or other document filed in a lawsuit or proceeding, if such filing is made under seal.  Moreover, nothing in this Release Agreement or any other agreement shall prevent Executive from making a confidential disclosure of any other confidential information to a government official, to an attorney as necessary to obtain legal advice or in a court filing under seal.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Return of Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive will deliver to Company all property, documents, or materials in her possession or custody, of any nature belonging to Company whether in original form or copies of any kind, including any trade secrets and proprietary information upon or prior to the effective date of this Agreement&#59; provided, however, that Executive shall be permitted to keep her cell phone number and cell phone (Company IT personnel may clear the phone of Company data prior to her departure).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Entire Agreement&#59; Amendment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The recitals hereto are hereby incorporated herein by this reference.  This Release Agreement, together with the Transition Agreement and the exhibits thereto and hereto, constitute the entire agreement between the parties hereto and thereto with regard to the subject matter hereof and thereof, superseding all prior understandings and agreements, whether written or oral, including, without limitation, the Severance Agreement&#59; provided, however, that any indemnification agreement, any outstanding vested equity award agreements (including, without limitation, any outstanding vested option agreement, restricted stock unit agreement, performance stock unit agreement, market stock unit </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">agreement or other equity instrument by and between the Company and the Executive), the Non-Competition Agreement and Section 10 of the Severance Agreement shall remain in full force and effect in accordance with the terms and conditions herein and therein.  This Release Agreement may not be changed orally, but only by an agreement in writing signed by the party against whom enforcement of any such change is sought.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Interpretation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The parties hereto acknowledge and agree that&#58; (i)&#160;each party and its counsel reviewed and negotiated the terms and provisions of this Release Agreement and have contributed to its revision&#59; (ii)&#160;the rule of construction to the effect that any ambiguities are resolved against the drafting party shall not be employed in the interpretation of this Release Agreement&#59; and (iii)&#160;the terms and provisions of this Release Agreement shall be construed fairly as to all parties hereto and not in favor of or against any party, regardless of which party was generally responsible for the preparation of this Release Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Effect of Headings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The titles of section headings herein contained have been provided solely for convenience of reference and in no way define, limit or describe the scope or substance of any provision of this Release Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The provisions of this Release Agreement are severable, and the invalidity of any provision shall not affect the validity of any other provision.  In the event that any court of competent jurisdiction shall determine that any provision of this Release Agreement or the application thereof is unenforceable because of the duration or scope thereof, the parties hereto agree that said court in making such determination shall have the power to reduce the duration and scope of such provision to the extent necessary to make it enforceable, and that the Release Agreement in its reduced form shall be valid and enforceable to the full extent permitted by law.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Governing Law&#47;Jurisdiction</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Release Agreement shall be binding upon the Executive and shall inure to the benefit of the Company and its successors and interest and assigns, and shall be construed in accordance with and governed by the laws of the Commonwealth of Massachusetts without regard to conflicts of laws.  The parties hereto intend and hereby confer jurisdiction to enforce the covenants contained herein upon the state and federal courts sitting in the Commonwealth of Massachusetts.  In the event that such courts shall hold any such covenant wholly unenforceable by reason of the breadth of scope or otherwise, it is the intention of the parties hereto that such determination not bar or in any way affect the Company&#8217;s right to relief in the courts of any other states within the geographical scope of such other covenants having appropriate personal and subject matter jurisdiction over the parties, as to breaches of such covenants in such other respective jurisdictions, the above covenants as they relate to each state being, for this purpose, severable into diverse and independent covenants.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(j)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Release Agreement may be executed in multiple original or facsimile counterparts (including *.pdf and the like), each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#91;Signature Page to Follow&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font><br></font></div></div></div><div id="i697214a678274001abe0d4ef8725506b_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;IN WITNESS WHEREOF, the parties hereto have duly executed this Release Agreement as a binding contract as of the date first above written.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">HOLOGIC, INC.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; John M. Griffin&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<br><br>Name&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">John M. Griffin&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<br><br>Title&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">General Counsel&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EXECUTIVE</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Allison P. Bebo&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Allison P. Bebo</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>holx_q3-2021xex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="id2e21531a1144fa085a9496da800fc2f_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Stephen P. MacMillan, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Hologic, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; July&#160;28, 2021 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Stephen P. MacMillan&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stephen P. MacMillan</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chairman, President and Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>holx_q3-2021xex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i7538ba41cc8448c28b01d47824531d01_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Karleen M. Oberton, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Hologic, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; July&#160;28, 2021 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Karleen M. Oberton</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Karleen M. Oberton</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>holx_q3-2021xex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i6051b94d815c454ab2ffa2f6074cd37b_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Subsections (a)&#160;and (b)&#160;of Section&#160;1350, Chapter 63 of Title 18, United States Code)</font></div><div style="margin-top:12pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Stephen P. MacMillan, Chief Executive Officer of Hologic, Inc., a Delaware corporation (the &#8220;Company&#8221;), do hereby certify, pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 (subsections (a)&#160;and (b)&#160;of Section&#160;1350, Chapter 63 of Title 18, United States Code), that&#58;</font></div><div style="margin-top:12pt;padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Quarterly Report on Form 10-Q for the quarter ended June 26, 2021 (the &#8220;Form 10-Q&#8221;) of the Company fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:12pt;padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; July 28, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Stephen P. MacMillan&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stephen P. MacMillan</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chairman, President and Chief Executive Officer</font></td></tr></table></div><div style="margin-top:7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A SIGNED ORIGINAL OF THIS WRITTEN STATEMENT REQUIRED BY SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 HAS BEEN PROVIDED TO HOLOGIC, INC. AND WILL BE RETAINED BY HOLOGIC, INC. AND FURNISHED TO THE SECURITIES AND EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>7
<FILENAME>holx_q3-2021xex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i3af7a789da024daf887ea2b876a2e510_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Subsections (a)&#160;and (b)&#160;of Section&#160;1350, Chapter 63 of Title 18, United States Code)</font></div><div style="margin-top:12pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Karleen M. Oberton, Chief Financial Officer of Hologic, Inc., a Delaware corporation (the &#8220;Company&#8221;), do hereby certify, pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 (subsections (a)&#160;and (b)&#160;of Section&#160;1350, Chapter 63 of Title 18, United States Code), that&#58;</font></div><div style="margin-top:12pt;padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Quarterly Report on Form 10-Q for the quarter ended June 26, 2021 (the &#8220;Form 10-Q&#8221;) of the Company fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:12pt;padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; July 28, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Karleen M. Oberton</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Karleen M. Oberton</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="margin-top:7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A SIGNED ORIGINAL OF THIS WRITTEN STATEMENT REQUIRED BY SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 HAS BEEN PROVIDED TO HOLOGIC, INC. AND WILL BE RETAINED BY HOLOGIC, INC. AND FURNISHED TO THE SECURITIES AND EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>holx-20210626.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c74485e8-ec97-423d-9317-27784965d1fb,g:cd3e0a2e-ccc2-417e-9556-0c4f43775051-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:holx="http://www.hologic.com/20210626" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.hologic.com/20210626">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="holx-20210626_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="holx-20210626_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="holx-20210626_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="holx-20210626_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.hologic.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofIncome" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofIncome">
        <link:definition>1001002 - Statement - Consolidated Statements of Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveLoss" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss">
        <link:definition>1002003 - Statement - Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveLossParenthetical" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical">
        <link:definition>1003004 - Statement - Consolidated Statements of Comprehensive Loss (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheets">
        <link:definition>1004005 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>1005006 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquity" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity">
        <link:definition>1006007 - Statement - Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>1007008 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentation" roleURI="http://www.hologic.com/role/BasisofPresentation">
        <link:definition>2101101 - Disclosure - Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenue" roleURI="http://www.hologic.com/role/Revenue">
        <link:definition>2102102 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://www.hologic.com/role/RevenueTables">
        <link:definition>2303301 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueBusinessRevenueDetails" roleURI="http://www.hologic.com/role/RevenueBusinessRevenueDetails">
        <link:definition>2404401 - Disclosure - Revenue - Business Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueGeographicalRevenueDetails" roleURI="http://www.hologic.com/role/RevenueGeographicalRevenueDetails">
        <link:definition>2405402 - Disclosure - Revenue - Geographical Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRevenuebyTypeDetails" roleURI="http://www.hologic.com/role/RevenueRevenuebyTypeDetails">
        <link:definition>2406403 - Disclosure - Revenue - Revenue by Type (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueNarrativeDetails" roleURI="http://www.hologic.com/role/RevenueNarrativeDetails">
        <link:definition>2407404 - Disclosure - Revenue - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRemainingPerformanceObligationDetails" roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails">
        <link:definition>2408405 - Disclosure - Revenue - Remaining Performance Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRemainingPerformanceObligationDetails_1" roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails_1">
        <link:definition>2408405 - Disclosure - Revenue - Remaining Performance Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.hologic.com/role/Leases">
        <link:definition>2109103 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAdditionalLeaseInformationDetails" roleURI="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails">
        <link:definition>2410406 - Disclosure - Leases - Additional Lease Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.hologic.com/role/FairValueMeasurements">
        <link:definition>2111104 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.hologic.com/role/FairValueMeasurementsTables">
        <link:definition>2312302 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" roleURI="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail">
        <link:definition>2413407 - Disclosure - Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAdditionalInformationDetail" roleURI="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail">
        <link:definition>2414408 - Disclosure - Fair Value Measurements - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsRollForwardDetails" roleURI="http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails">
        <link:definition>2415409 - Disclosure - Fair Value Measurements - Roll Forward (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinations" roleURI="http://www.hologic.com/role/BusinessCombinations">
        <link:definition>2116105 - Disclosure - Business Combinations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsTables" roleURI="http://www.hologic.com/role/BusinessCombinationsTables">
        <link:definition>2317303 - Disclosure - Business Combinations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationNarrativeDetails" roleURI="http://www.hologic.com/role/BusinessCombinationNarrativeDetails">
        <link:definition>2418410 - Disclosure - Business Combination - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" roleURI="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails">
        <link:definition>2419411 - Disclosure - Business Combinations Business Combinations - Purchase Price Allocation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TradeReceivablesandAllowanceforCreditLosses" roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses">
        <link:definition>2120106 - Disclosure - Trade Receivables and Allowance for Credit Losses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TradeReceivablesandAllowanceforCreditLossesTables" roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables">
        <link:definition>2321304 - Disclosure - Trade Receivables and Allowance for Credit Losses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TradeReceivablesandAllowanceforCreditLossesDetails" roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails">
        <link:definition>2422412 - Disclosure - Trade Receivables and Allowance for Credit Losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Disposition" roleURI="http://www.hologic.com/role/Disposition">
        <link:definition>2123107 - Disclosure - Disposition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DispositionDetails" roleURI="http://www.hologic.com/role/DispositionDetails">
        <link:definition>2424413 - Disclosure - Disposition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangements" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangements">
        <link:definition>2125108 - Disclosure - Borrowings and Credit Arrangements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsTables" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsTables">
        <link:definition>2326305 - Disclosure - Borrowings and Credit Arrangements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsCompanysBorrowingsDetail" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail">
        <link:definition>2427414 - Disclosure - Borrowings and Credit Arrangements - Company's Borrowings (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsAdditionalInformationDetail" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail">
        <link:definition>2428415 - Disclosure - Borrowings and Credit Arrangements - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails">
        <link:definition>2429416 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails">
        <link:definition>2430417 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Derivatives" roleURI="http://www.hologic.com/role/Derivatives">
        <link:definition>2131109 - Disclosure - Derivatives</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesTables" roleURI="http://www.hologic.com/role/DerivativesTables">
        <link:definition>2332306 - Disclosure - Derivatives (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesAdditionalInformationDetails" roleURI="http://www.hologic.com/role/DerivativesAdditionalInformationDetails">
        <link:definition>2433418 - Disclosure - Derivatives - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails" roleURI="http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails">
        <link:definition>2434419 - Disclosure - Derivatives - Schedule Of Change in Fair Value Of Derivative Contracts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesFairValueofDerivativeFinancialInstrumentsDetails" roleURI="http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails">
        <link:definition>2435420 - Disclosure - Derivatives - Fair Value of Derivative Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails" roleURI="http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails">
        <link:definition>2436421 - Disclosure - Derivatives - Gain (Loss) on Fair Value Hedges Recognized in AOCI (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.hologic.com/role/CommitmentsandContingencies">
        <link:definition>2137110 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetail" roleURI="http://www.hologic.com/role/CommitmentsandContingenciesDetail">
        <link:definition>2438422 - Disclosure - Commitments and Contingencies (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShare" roleURI="http://www.hologic.com/role/NetIncomeLossPerShare">
        <link:definition>2139111 - Disclosure - Net Income (Loss) Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShareTables" roleURI="http://www.hologic.com/role/NetIncomeLossPerShareTables">
        <link:definition>2340307 - Disclosure - Net Income (Loss) Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" roleURI="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail">
        <link:definition>2441423 - Disclosure - Net Income (Loss) Per Share - Reconciliation of Basic and Diluted Share Amounts (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.hologic.com/role/StockBasedCompensation">
        <link:definition>2142112 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://www.hologic.com/role/StockBasedCompensationTables">
        <link:definition>2343308 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail" roleURI="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail">
        <link:definition>2444424 - Disclosure - Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statements of Operations (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationAdditionalInformationDetail" roleURI="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail">
        <link:definition>2445425 - Disclosure - Stock-Based Compensation - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail" roleURI="http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail">
        <link:definition>2446426 - Disclosure - Stock-Based Compensation - Weighted-Average Assumptions Utilized to Value Stock Options (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetInformation" roleURI="http://www.hologic.com/role/OtherBalanceSheetInformation">
        <link:definition>2147113 - Disclosure - Other Balance Sheet Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetInformationTables" roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationTables">
        <link:definition>2348309 - Disclosure - Other Balance Sheet Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetInformationInventoriesDetail" roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail">
        <link:definition>2449427 - Disclosure - Other Balance Sheet Information - Inventories (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetInformationPropertyPlantandEquipmentDetail" roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail">
        <link:definition>2450428 - Disclosure - Other Balance Sheet Information - Property, Plant and Equipment (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformation" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformation">
        <link:definition>2151114 - Disclosure - Business Segments and Geographic Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformationTables" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables">
        <link:definition>2352310 - Disclosure - Business Segments and Geographic Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformationAdditionalInformationDetail" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail">
        <link:definition>2453429 - Disclosure - Business Segments and Geographic Information - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformationSegmentInformationDetail" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail">
        <link:definition>2454430 - Disclosure - Business Segments and Geographic Information - Segment Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail">
        <link:definition>2455431 - Disclosure - Business Segments and Geographic Information - Revenues by Geography (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.hologic.com/role/IncomeTaxes">
        <link:definition>2156115 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.hologic.com/role/IncomeTaxesDetails">
        <link:definition>2457432 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwill" roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwill">
        <link:definition>2158116 - Disclosure - Intangible Assets and Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwillTables" roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillTables">
        <link:definition>2359311 - Disclosure - Intangible Assets and Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail" roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail">
        <link:definition>2460433 - Disclosure - Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail" roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail">
        <link:definition>2461434 - Disclosure - Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductWarranties" roleURI="http://www.hologic.com/role/ProductWarranties">
        <link:definition>2162117 - Disclosure - Product Warranties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductWarrantiesTables" roleURI="http://www.hologic.com/role/ProductWarrantiesTables">
        <link:definition>2363312 - Disclosure - Product Warranties (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductWarrantiesProductWarrantyActivityDetail" roleURI="http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail">
        <link:definition>2464435 - Disclosure - Product Warranties - Product Warranty Activity (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLoss" roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss">
        <link:definition>2165118 - Disclosure - Accumulated Other Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossTables" roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables">
        <link:definition>2366313 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeDetail" roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail">
        <link:definition>2467436 - Disclosure - Accumulated Other Comprehensive Income (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareRepurchase" roleURI="http://www.hologic.com/role/ShareRepurchase">
        <link:definition>2168119 - Disclosure - Share Repurchase</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareRepurchaseSharerepurchaseDetails" roleURI="http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails">
        <link:definition>2469437 - Disclosure - Share Repurchase Share repurchase (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncements" roleURI="http://www.hologic.com/role/NewAccountingPronouncements">
        <link:definition>2170120 - Disclosure - New Accounting Pronouncements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncementsPolicies" roleURI="http://www.hologic.com/role/NewAccountingPronouncementsPolicies">
        <link:definition>2271201 - Disclosure - New Accounting Pronouncements (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="holx_AlphaImagingMember" abstract="true" name="AlphaImagingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_AmendedTermLoanMember" abstract="true" name="AmendedTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_SomatexMedicalTechnologiesMember" abstract="true" name="SomatexMedicalTechnologiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BloodScreeningMember" abstract="true" name="BloodScreeningMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BusinessAcquisitionCashTenderOfferPricePerShare" abstract="false" name="BusinessAcquisitionCashTenderOfferPricePerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="holx_RevolverMember" abstract="true" name="RevolverMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" abstract="false" name="BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AssetsofBusinessHeldforSaleAbstract" abstract="true" name="AssetsofBusinessHeldforSaleAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_InterestRateCapAgreementsAggregatePremiumPayable" abstract="false" name="InterestRateCapAgreementsAggregatePremiumPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_MinervaMember" abstract="true" name="MinervaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_RepaymentOfSeniorNotes" abstract="false" name="RepaymentOfSeniorNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_SharerepurchaseplanLineItems" abstract="true" name="SharerepurchaseplanLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" abstract="false" name="MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_AmountAssessedInDamages" abstract="false" name="AmountAssessedInDamages" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_Holdback" abstract="false" name="Holdback" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BreastImagingMember" abstract="true" name="BreastImagingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_December112019Member" abstract="true" name="December112019Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_ResearchAndDevelopmentInProcessCompletionPeriod" abstract="false" name="ResearchAndDevelopmentInProcessCompletionPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" abstract="false" name="ScheduleOfShareBasedCompensationExpenseTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="holx_BreastHealthMember" abstract="true" name="BreastHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BusinessCombinationAdditionalSharesAcquiredValue" abstract="false" name="BusinessCombinationAdditionalSharesAcquiredValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BiotheranosticsMember" abstract="true" name="BiotheranosticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_EarningsPerShareTable" abstract="true" name="EarningsPerShareTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="holx_AcquiredintangibleassetsMember" abstract="true" name="AcquiredintangibleassetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_DebtRedemptionPremiumPaid" abstract="false" name="DebtRedemptionPremiumPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_CapitalEquipmentComponentsandSoftwareMember" abstract="true" name="CapitalEquipmentComponentsandSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_AllOtherCountriesMember" abstract="true" name="AllOtherCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_OtherTypeofRevenueMember" abstract="true" name="OtherTypeofRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_InternalusesoftwareMember" abstract="true" name="InternalusesoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_ManufacturingEquipmentAndSoftware" abstract="false" name="ManufacturingEquipmentAndSoftware" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessCombinationOwnershipPercentage" abstract="false" name="BusinessCombinationOwnershipPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_Acceleratedsharerepurchaseagreement" abstract="false" name="Acceleratedsharerepurchaseagreement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ScheduleOfGeographicalSegmentsTable" abstract="true" name="ScheduleOfGeographicalSegmentsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="holx_SegmentReportingDisclosureLineItems" abstract="true" name="SegmentReportingDisclosureLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_EquipmentUnderCustomerUsageAgreements" abstract="false" name="EquipmentUnderCustomerUsageAgreements" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_NXCImagingMember" abstract="true" name="NXCImagingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_DevelopedTechnologyMember" abstract="true" name="DevelopedTechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_NotationalAmount" abstract="false" name="NotationalAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ProceedsFromSaleOfBusiness" abstract="false" name="ProceedsFromSaleOfBusiness" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessLicensesMember" abstract="true" name="BusinessLicensesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_AccumulatedOtherComprehensiveIncomeAbstract" abstract="true" name="AccumulatedOtherComprehensiveIncomeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_PrincipalAmountOfBorrowings" abstract="false" name="PrincipalAmountOfBorrowings" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" abstract="false" name="PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_PSUFreeCashFlowMember" abstract="true" name="PSUFreeCashFlowMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_LongTermDebtObligationsWithoutConvertibleNotes" abstract="false" name="LongTermDebtObligationsWithoutConvertibleNotes" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_Netincome" abstract="false" name="Netincome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_SkeletalHealthMember" abstract="true" name="SkeletalHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_A2029SeniorNotesMember" abstract="true" name="A2029SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_RSUPSUMSUMember" abstract="true" name="RSUPSUMSUMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_InternationalMember" abstract="true" name="InternationalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_AccountsReceivableAllowanceForCreditLossTransfers" abstract="false" name="AccountsReceivableAllowanceForCreditLossTransfers" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_CytologyPerinatalMember" abstract="true" name="CytologyPerinatalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" abstract="false" name="MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_InterventionalBreastSolutionsMember" abstract="true" name="InterventionalBreastSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_DiagnosticsMember" abstract="true" name="DiagnosticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_DiagenodeMember" abstract="true" name="DiagenodeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_SharerepurchaseplanTable" abstract="true" name="SharerepurchaseplanTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="holx_PrepaidIncomeTaxesCurrent" abstract="false" name="PrepaidIncomeTaxesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_Costofservice" abstract="false" name="Costofservice" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_DepartmentOfDefenseFundsReceived" abstract="false" name="DepartmentOfDefenseFundsReceived" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_CreditAgreementMember" abstract="true" name="CreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_FairValueAssumptionDiscountRate" abstract="false" name="FairValueAssumptionDiscountRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="holx_BasisofPresentationAbstract" abstract="true" name="BasisofPresentationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_GrantsReceivedFromDepartmentOfDefense" abstract="false" name="GrantsReceivedFromDepartmentOfDefense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_PercentageOfRevenues" abstract="false" name="PercentageOfRevenues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_LeaseRevenuePercentageOfTotalRevenue" abstract="false" name="LeaseRevenuePercentageOfTotalRevenue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="holx_PurchaseOfIntellectualProperty" abstract="false" name="PurchaseOfIntellectualProperty" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_MobidiagOyMember" abstract="true" name="MobidiagOyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_December112020Member" abstract="true" name="December112020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_AcessaHealthMember" abstract="true" name="AcessaHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_A2025SeniorNotesMember" abstract="true" name="A2025SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_CapitalizedsoftwareMember" abstract="true" name="CapitalizedsoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_ContingentHoldbackMember" abstract="true" name="ContingentHoldbackMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_MolecularDiagnosticsMember" abstract="true" name="MolecularDiagnosticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_SuperSonicImagineMember" abstract="true" name="SuperSonicImagineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" abstract="false" name="ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="holx_EarningsPerShareLineItems" abstract="true" name="EarningsPerShareLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_ProceedsFromSeniorNotes" abstract="false" name="ProceedsFromSeniorNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ContingentConsiderationMember" abstract="true" name="ContingentConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ServiceRevenue" abstract="false" name="ServiceRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_MedicalAestheticsMember" abstract="true" name="MedicalAestheticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_MarketBasedAwardsMember" abstract="true" name="MarketBasedAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_PercentageAddedtoEurodollarRateMember" abstract="true" name="PercentageAddedtoEurodollarRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_IndemnificationLiability" abstract="false" name="IndemnificationLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ResearchAndDevelopmentInProcessNumberOfProjects" abstract="false" name="ResearchAndDevelopmentInProcessNumberOfProjects" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" abstract="false" name="BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" abstract="false" name="BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessCombinationAdditionalSharesAcquiredShares" abstract="false" name="BusinessCombinationAdditionalSharesAcquiredShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="holx_DebtInstrumentOfferingPricePercentOfFaceValue" abstract="false" name="DebtInstrumentOfferingPricePercentOfFaceValue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_DetailsOfCertainBalanceSheetAccountsTextBlock" abstract="false" name="DetailsOfCertainBalanceSheetAccountsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="holx_MaximumBorrowingUnderAssetSecuritizationAgreement" abstract="false" name="MaximumBorrowingUnderAssetSecuritizationAgreement" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" abstract="false" name="BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AccountsReceivableSecuritizationMember" abstract="true" name="AccountsReceivableSecuritizationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_ChangeInParValue" abstract="false" name="ChangeInParValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ComprehensiveIncome" abstract="false" name="ComprehensiveIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_ProductRevenue" abstract="false" name="ProductRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ConsumablesMember" abstract="true" name="ConsumablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_LegalAccrual" abstract="false" name="LegalAccrual" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_A2028SeniorNotesMember" abstract="true" name="A2028SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_CustomerRelationshipsContractsMember" abstract="true" name="CustomerRelationshipsContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_PurchaseOfNonControllingInterestReclassifiedToAPIC" abstract="false" name="PurchaseOfNonControllingInterestReclassifiedToAPIC" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" abstract="false" name="SharedBasedCompensationArrangementRestrictedStockVestingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="holx_ShareRepurchaseProgramMember" abstract="true" name="ShareRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_AnnualIncrementalRevenueGrowthPeriod" abstract="false" name="AnnualIncrementalRevenueGrowthPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="holx_GynSurgicalMember" abstract="true" name="GynSurgicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment" abstract="false" name="CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ScheduleOfGeographicalSegmentsLineItems" abstract="true" name="ScheduleOfGeographicalSegmentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_AmortizationCostofGoodsSold" abstract="false" name="AmortizationCostofGoodsSold" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" abstract="false" name="PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_TermLoanMember" abstract="true" name="TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_TotalPaymentsToNonControllingInterest" abstract="false" name="TotalPaymentsToNonControllingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_HealthBeaconsMember" abstract="true" name="HealthBeaconsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_RestofWorldMember" abstract="true" name="RestofWorldMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>holx-20210626_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c74485e8-ec97-423d-9317-27784965d1fb,g:cd3e0a2e-ccc2-417e-9556-0c4f43775051-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="holx-20210626.xsd#ConsolidatedStatementsofIncome"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_8417f825-9ce6-436b-8ca7-8b9d6cbc136d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2f72f460-e744-4d88-bf3b-c74fa5279220" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_8417f825-9ce6-436b-8ca7-8b9d6cbc136d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2f72f460-e744-4d88-bf3b-c74fa5279220" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1d1606e5-e657-4d3e-873b-295597d2542c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_8417f825-9ce6-436b-8ca7-8b9d6cbc136d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1d1606e5-e657-4d3e-873b-295597d2542c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e72cb564-2e75-4699-9f94-63d4d03ff65d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_3a92f9d7-31e7-4221-ab52-d59cdbfad766" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_e72cb564-2e75-4699-9f94-63d4d03ff65d" xlink:to="loc_us-gaap_GrossProfit_3a92f9d7-31e7-4221-ab52-d59cdbfad766" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_e5de7d82-6b42-48a5-b455-7011b772bcdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_e72cb564-2e75-4699-9f94-63d4d03ff65d" xlink:to="loc_us-gaap_OperatingExpenses_e5de7d82-6b42-48a5-b455-7011b772bcdb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_f8c85d51-cd9c-4430-9ec5-56fa86c28ca6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProductRevenue_725910b2-ac10-4399-825a-392f02fc74ff" xlink:href="holx-20210626.xsd#holx_ProductRevenue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_f8c85d51-cd9c-4430-9ec5-56fa86c28ca6" xlink:to="loc_holx_ProductRevenue_725910b2-ac10-4399-825a-392f02fc74ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ServiceRevenue_7a011b4f-84cc-4f1c-98be-8b0671f628f8" xlink:href="holx-20210626.xsd#holx_ServiceRevenue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_f8c85d51-cd9c-4430-9ec5-56fa86c28ca6" xlink:to="loc_holx_ServiceRevenue_7a011b4f-84cc-4f1c-98be-8b0671f628f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e37c8c4a-7141-4963-a85c-cff9daa1f72e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_8fd6a6dc-abf6-4fc6-bc7a-8d1c01222ca3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e37c8c4a-7141-4963-a85c-cff9daa1f72e" xlink:to="loc_us-gaap_OperatingIncomeLoss_8fd6a6dc-abf6-4fc6-bc7a-8d1c01222ca3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_83d48eb0-6ab0-4ccf-87ef-b75af0d590d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e37c8c4a-7141-4963-a85c-cff9daa1f72e" xlink:to="loc_us-gaap_InvestmentIncomeInterest_83d48eb0-6ab0-4ccf-87ef-b75af0d590d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_ea757087-52a7-47e5-999a-cf9e307dc049" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e37c8c4a-7141-4963-a85c-cff9daa1f72e" xlink:to="loc_us-gaap_InterestExpense_ea757087-52a7-47e5-999a-cf9e307dc049" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_4277ed1e-803a-492f-8713-79d9ec66eba2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e37c8c4a-7141-4963-a85c-cff9daa1f72e" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_4277ed1e-803a-492f-8713-79d9ec66eba2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_19be1dfa-734d-4121-8e27-72862e521691" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e37c8c4a-7141-4963-a85c-cff9daa1f72e" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_19be1dfa-734d-4121-8e27-72862e521691" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_6fc72806-c6ae-435e-af78-3ffa2e96ec56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_29b25f75-4ca8-4717-877f-df9e67ae94b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_6fc72806-c6ae-435e-af78-3ffa2e96ec56" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_29b25f75-4ca8-4717-877f-df9e67ae94b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_5c3873d9-eaf0-4430-b0a2-3493b62312f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_6fc72806-c6ae-435e-af78-3ffa2e96ec56" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_5c3873d9-eaf0-4430-b0a2-3493b62312f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_8e6c3582-51e0-417c-b1a2-4fc90c5f8290" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_6fc72806-c6ae-435e-af78-3ffa2e96ec56" xlink:to="loc_us-gaap_SellingAndMarketingExpense_8e6c3582-51e0-417c-b1a2-4fc90c5f8290" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_cfba9834-1935-4616-8da1-276100db3e66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_6fc72806-c6ae-435e-af78-3ffa2e96ec56" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_cfba9834-1935-4616-8da1-276100db3e66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_681a4bf2-4a5b-4e06-8068-ea7edd4a3147" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_6fc72806-c6ae-435e-af78-3ffa2e96ec56" xlink:to="loc_us-gaap_RestructuringCharges_681a4bf2-4a5b-4e06-8068-ea7edd4a3147" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_ff408c38-5dbe-41cd-832e-4954f40fef83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_6fc72806-c6ae-435e-af78-3ffa2e96ec56" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_ff408c38-5dbe-41cd-832e-4954f40fef83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_5d770093-9652-493f-8102-4ebe4a481a0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_6fc72806-c6ae-435e-af78-3ffa2e96ec56" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_5d770093-9652-493f-8102-4ebe4a481a0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Netincome_cfec858f-e973-4832-97f0-d5e5e28bb665" xlink:href="holx-20210626.xsd#holx_Netincome"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b8bf219f-3078-4eb3-bb21-ed7355966cb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_holx_Netincome_cfec858f-e973-4832-97f0-d5e5e28bb665" xlink:to="loc_us-gaap_NetIncomeLoss_b8bf219f-3078-4eb3-bb21-ed7355966cb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_8d4e1070-df04-48bb-af56-1c18d2b5d3ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_holx_Netincome_cfec858f-e973-4832-97f0-d5e5e28bb665" xlink:to="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_8d4e1070-df04-48bb-af56-1c18d2b5d3ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_c823fa44-b3b8-47a2-94be-124e6826d6c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_c4c070cf-1f9a-4f3b-abb2-0f42094a9e89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_c823fa44-b3b8-47a2-94be-124e6826d6c4" xlink:to="loc_us-gaap_Revenues_c4c070cf-1f9a-4f3b-abb2-0f42094a9e89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_a3e26994-7304-46b6-990a-6fcf18b0600b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_c823fa44-b3b8-47a2-94be-124e6826d6c4" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_a3e26994-7304-46b6-990a-6fcf18b0600b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmortizationCostofGoodsSold_0dc84f16-3244-4961-85cc-153260937e5e" xlink:href="holx-20210626.xsd#holx_AmortizationCostofGoodsSold"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_c823fa44-b3b8-47a2-94be-124e6826d6c4" xlink:to="loc_holx_AmortizationCostofGoodsSold_0dc84f16-3244-4961-85cc-153260937e5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment_6ab1e857-cf92-4000-ae3f-e374e98b0f27" xlink:href="holx-20210626.xsd#holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_c823fa44-b3b8-47a2-94be-124e6826d6c4" xlink:to="loc_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment_6ab1e857-cf92-4000-ae3f-e374e98b0f27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Costofservice_9050f6d6-2941-490a-9d4a-725240d8ad0c" xlink:href="holx-20210626.xsd#holx_Costofservice"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_c823fa44-b3b8-47a2-94be-124e6826d6c4" xlink:to="loc_holx_Costofservice_9050f6d6-2941-490a-9d4a-725240d8ad0c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="holx-20210626.xsd#ConsolidatedStatementsofComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_ComprehensiveIncome_1a30f2f1-f78a-47ec-8fa9-4967fb96221c" xlink:href="holx-20210626.xsd#holx_ComprehensiveIncome"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_593ca549-f04e-4811-aefe-0adf1ac4ba7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_holx_ComprehensiveIncome_1a30f2f1-f78a-47ec-8fa9-4967fb96221c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_593ca549-f04e-4811-aefe-0adf1ac4ba7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_c7e78608-b1c0-4e03-bc43-307fc16a570f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_holx_ComprehensiveIncome_1a30f2f1-f78a-47ec-8fa9-4967fb96221c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_c7e78608-b1c0-4e03-bc43-307fc16a570f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_d285b73a-6759-4c81-8375-085c7c7b5c2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0e3bb918-780f-48a3-aa80-a2fb52257b9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_d285b73a-6759-4c81-8375-085c7c7b5c2b" xlink:to="loc_us-gaap_NetIncomeLoss_0e3bb918-780f-48a3-aa80-a2fb52257b9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_7f0fbb2f-3c1c-4071-8971-4b7a0d1ea32d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_d285b73a-6759-4c81-8375-085c7c7b5c2b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_7f0fbb2f-3c1c-4071-8971-4b7a0d1ea32d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9e3ed764-99ea-43ec-80b2-0537ccd13dfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_99c872c1-fbf2-453d-b637-7acc79155a22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9e3ed764-99ea-43ec-80b2-0537ccd13dfe" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_99c872c1-fbf2-453d-b637-7acc79155a22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_91bfac36-4431-4899-bc2c-1b5f4d4be928" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9e3ed764-99ea-43ec-80b2-0537ccd13dfe" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_91bfac36-4431-4899-bc2c-1b5f4d4be928" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_7b2f3817-4b28-4038-af77-100a43e3933b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9e3ed764-99ea-43ec-80b2-0537ccd13dfe" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_7b2f3817-4b28-4038-af77-100a43e3933b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="holx-20210626.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_fd37c75a-00ad-4f7d-98d8-b6d252fc06db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_886ee48b-3ac9-47fd-8afb-d7474e3b6f64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_fd37c75a-00ad-4f7d-98d8-b6d252fc06db" xlink:to="loc_us-gaap_LiabilitiesCurrent_886ee48b-3ac9-47fd-8afb-d7474e3b6f64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_d671d606-8d27-45ab-b1cd-106d6040917d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_fd37c75a-00ad-4f7d-98d8-b6d252fc06db" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_d671d606-8d27-45ab-b1cd-106d6040917d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsNoncurrent_03f75a53-f029-477e-a7f9-e49e0231d31b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_fd37c75a-00ad-4f7d-98d8-b6d252fc06db" xlink:to="loc_us-gaap_CapitalLeaseObligationsNoncurrent_03f75a53-f029-477e-a7f9-e49e0231d31b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_fbdcc4a5-bf53-4574-9962-8c938883235c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_fd37c75a-00ad-4f7d-98d8-b6d252fc06db" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_fbdcc4a5-bf53-4574-9962-8c938883235c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_197ae5e0-57da-4add-9fd8-fc63b888e526" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_fd37c75a-00ad-4f7d-98d8-b6d252fc06db" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_197ae5e0-57da-4add-9fd8-fc63b888e526" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_c1be2126-48ee-4ef4-8439-3e75e8e98046" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_fd37c75a-00ad-4f7d-98d8-b6d252fc06db" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_c1be2126-48ee-4ef4-8439-3e75e8e98046" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1fa838f9-b2fe-46f3-94f4-0a003834908b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_fd37c75a-00ad-4f7d-98d8-b6d252fc06db" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1fa838f9-b2fe-46f3-94f4-0a003834908b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_959de6fb-12f6-497f-9619-12ff64aaee8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_ba73fe1a-c334-4614-899b-fce9f4816112" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_959de6fb-12f6-497f-9619-12ff64aaee8d" xlink:to="loc_us-gaap_PreferredStockValue_ba73fe1a-c334-4614-899b-fce9f4816112" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_f5c0d83d-3829-4b0f-900e-7a2840021014" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_959de6fb-12f6-497f-9619-12ff64aaee8d" xlink:to="loc_us-gaap_CommonStockValue_f5c0d83d-3829-4b0f-900e-7a2840021014" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_614eb2bf-7940-43ad-aa44-bafe225dba14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_959de6fb-12f6-497f-9619-12ff64aaee8d" xlink:to="loc_us-gaap_AdditionalPaidInCapital_614eb2bf-7940-43ad-aa44-bafe225dba14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_26663da8-54b6-4d92-b523-0fca218bd8da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_959de6fb-12f6-497f-9619-12ff64aaee8d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_26663da8-54b6-4d92-b523-0fca218bd8da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_69040e6f-2a4b-4d99-b600-c6dc577465c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_959de6fb-12f6-497f-9619-12ff64aaee8d" xlink:to="loc_us-gaap_TreasuryStockValue_69040e6f-2a4b-4d99-b600-c6dc577465c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d1fb26a7-6ef1-4e37-89ea-8c13060351bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_959de6fb-12f6-497f-9619-12ff64aaee8d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d1fb26a7-6ef1-4e37-89ea-8c13060351bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1888e854-497e-4094-a66d-eae0e9d50ebf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8d782e4c-e2e1-4b24-8e45-232964aafa59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1888e854-497e-4094-a66d-eae0e9d50ebf" xlink:to="loc_us-gaap_StockholdersEquity_8d782e4c-e2e1-4b24-8e45-232964aafa59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_105149ef-046d-499f-a6f8-8b8dab4a6bb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1888e854-497e-4094-a66d-eae0e9d50ebf" xlink:to="loc_us-gaap_MinorityInterest_105149ef-046d-499f-a6f8-8b8dab4a6bb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_0920cfd4-f583-48f3-8743-6ee263d0ecaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_7c5f7535-9dbc-4ca3-91a1-fa5937d72228" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0920cfd4-f583-48f3-8743-6ee263d0ecaf" xlink:to="loc_us-gaap_LongTermDebtCurrent_7c5f7535-9dbc-4ca3-91a1-fa5937d72228" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_d8866884-e1cb-48a8-abea-b7d1a03a2564" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0920cfd4-f583-48f3-8743-6ee263d0ecaf" xlink:to="loc_us-gaap_AccountsPayableCurrent_d8866884-e1cb-48a8-abea-b7d1a03a2564" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_ee4ae25e-312b-4dea-9482-49559a29b150" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0920cfd4-f583-48f3-8743-6ee263d0ecaf" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_ee4ae25e-312b-4dea-9482-49559a29b150" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_f01fd287-7453-4d7e-bb89-cb12a5821136" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0920cfd4-f583-48f3-8743-6ee263d0ecaf" xlink:to="loc_us-gaap_DeferredRevenueCurrent_f01fd287-7453-4d7e-bb89-cb12a5821136" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsCurrent_e43fbe0e-7087-429f-8c63-3c1a6055c4a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0920cfd4-f583-48f3-8743-6ee263d0ecaf" xlink:to="loc_us-gaap_CapitalLeaseObligationsCurrent_e43fbe0e-7087-429f-8c63-3c1a6055c4a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b3a8cea0-be9d-4dce-9de6-1363b4ce13d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3a3c1937-5e06-4984-862c-edf69cdfab24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b3a8cea0-be9d-4dce-9de6-1363b4ce13d3" xlink:to="loc_us-gaap_AssetsCurrent_3a3c1937-5e06-4984-862c-edf69cdfab24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_88129f59-0c52-4b85-bc05-13693b50d6da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b3a8cea0-be9d-4dce-9de6-1363b4ce13d3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_88129f59-0c52-4b85-bc05-13693b50d6da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d38ab469-f074-4f08-a429-78dcd7f1281e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b3a8cea0-be9d-4dce-9de6-1363b4ce13d3" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_d38ab469-f074-4f08-a429-78dcd7f1281e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_140c9e99-0730-4c30-b7cd-ad31fd3fd8b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b3a8cea0-be9d-4dce-9de6-1363b4ce13d3" xlink:to="loc_us-gaap_Goodwill_140c9e99-0730-4c30-b7cd-ad31fd3fd8b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_4730db6a-b711-4453-b6e5-413c708713ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_b3a8cea0-be9d-4dce-9de6-1363b4ce13d3" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_4730db6a-b711-4453-b6e5-413c708713ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_903f174f-49fa-4bda-aac9-50de9de461b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_97b53798-a798-4d08-8509-5013d6912e28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_903f174f-49fa-4bda-aac9-50de9de461b3" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_97b53798-a798-4d08-8509-5013d6912e28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_aa621572-069d-4670-a402-ae3e98f05a5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_903f174f-49fa-4bda-aac9-50de9de461b3" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_aa621572-069d-4670-a402-ae3e98f05a5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_ed92d6d1-34c9-4404-b7c8-7edfa9d6b8e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_903f174f-49fa-4bda-aac9-50de9de461b3" xlink:to="loc_us-gaap_InventoryNet_ed92d6d1-34c9-4404-b7c8-7edfa9d6b8e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrepaidIncomeTaxesCurrent_eb80d69f-5dc6-40d8-ba74-6f9602afc7a4" xlink:href="holx-20210626.xsd#holx_PrepaidIncomeTaxesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_903f174f-49fa-4bda-aac9-50de9de461b3" xlink:to="loc_holx_PrepaidIncomeTaxesCurrent_eb80d69f-5dc6-40d8-ba74-6f9602afc7a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_2bfe240f-b051-4276-9b33-77a657bf2752" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_903f174f-49fa-4bda-aac9-50de9de461b3" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_2bfe240f-b051-4276-9b33-77a657bf2752" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="holx-20210626.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97b7fb2f-fdbb-4bb8-8d96-5c26ae415450" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_a8be022d-bec7-43eb-829a-ab06dd3b01d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97b7fb2f-fdbb-4bb8-8d96-5c26ae415450" xlink:to="loc_us-gaap_ShareBasedCompensation_a8be022d-bec7-43eb-829a-ab06dd3b01d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_075f7201-12a4-4efa-901e-e96f63f63781" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97b7fb2f-fdbb-4bb8-8d96-5c26ae415450" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_075f7201-12a4-4efa-901e-e96f63f63781" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_9f764032-55c6-4447-910c-82277d724552" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97b7fb2f-fdbb-4bb8-8d96-5c26ae415450" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_9f764032-55c6-4447-910c-82277d724552" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_18bcfcf0-4a8b-4f51-aafc-49dfe612d926" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97b7fb2f-fdbb-4bb8-8d96-5c26ae415450" xlink:to="loc_us-gaap_NetIncomeLoss_18bcfcf0-4a8b-4f51-aafc-49dfe612d926" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_1c7dab7f-5512-4c9b-b924-0e40f4919956" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97b7fb2f-fdbb-4bb8-8d96-5c26ae415450" xlink:to="loc_us-gaap_AdjustmentForAmortization_1c7dab7f-5512-4c9b-b924-0e40f4919956" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_e7e7c79a-958b-4cb4-93c1-a778aff667f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97b7fb2f-fdbb-4bb8-8d96-5c26ae415450" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_e7e7c79a-958b-4cb4-93c1-a778aff667f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_57407a7e-e945-4d09-a06f-6e5cda4f8dfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97b7fb2f-fdbb-4bb8-8d96-5c26ae415450" xlink:to="loc_us-gaap_Depreciation_57407a7e-e945-4d09-a06f-6e5cda4f8dfe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f289c132-1504-4a11-8e44-62dac895b63b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97b7fb2f-fdbb-4bb8-8d96-5c26ae415450" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f289c132-1504-4a11-8e44-62dac895b63b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_3d340229-9920-42f6-96ba-387dc1ed8e69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97b7fb2f-fdbb-4bb8-8d96-5c26ae415450" xlink:to="loc_us-gaap_AssetImpairmentCharges_3d340229-9920-42f6-96ba-387dc1ed8e69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_115d7872-7877-4805-9faa-d46a5bc2f183" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97b7fb2f-fdbb-4bb8-8d96-5c26ae415450" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_115d7872-7877-4805-9faa-d46a5bc2f183" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_abb54409-8167-4c80-90fb-a1b99f6fe2bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97b7fb2f-fdbb-4bb8-8d96-5c26ae415450" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_abb54409-8167-4c80-90fb-a1b99f6fe2bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3019cadb-58d7-4221-b318-d6bc161d61b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97b7fb2f-fdbb-4bb8-8d96-5c26ae415450" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_3019cadb-58d7-4221-b318-d6bc161d61b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_3c24810a-6bee-4907-bea2-3999f10f02d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97b7fb2f-fdbb-4bb8-8d96-5c26ae415450" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_3c24810a-6bee-4907-bea2-3999f10f02d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_098c8f7c-c89a-4ebc-9f2d-16ebfbf4aedf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97b7fb2f-fdbb-4bb8-8d96-5c26ae415450" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_098c8f7c-c89a-4ebc-9f2d-16ebfbf4aedf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_f317024d-96a2-42bc-ae87-ca949fa61987" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_97b7fb2f-fdbb-4bb8-8d96-5c26ae415450" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_f317024d-96a2-42bc-ae87-ca949fa61987" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f6c2f15c-bc42-490e-b7be-2cb976f0f2b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProceedsFromSaleOfBusiness_3c8360c3-3781-43db-a201-e3286c2b218d" xlink:href="holx-20210626.xsd#holx_ProceedsFromSaleOfBusiness"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f6c2f15c-bc42-490e-b7be-2cb976f0f2b2" xlink:to="loc_holx_ProceedsFromSaleOfBusiness_3c8360c3-3781-43db-a201-e3286c2b218d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_f46eef9d-399b-4fe7-89b0-46b8630ab854" xlink:href="holx-20210626.xsd#holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f6c2f15c-bc42-490e-b7be-2cb976f0f2b2" xlink:to="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_f46eef9d-399b-4fe7-89b0-46b8630ab854" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_c892d149-2809-4021-9546-25c7f143ce54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f6c2f15c-bc42-490e-b7be-2cb976f0f2b2" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_c892d149-2809-4021-9546-25c7f143ce54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_ed9d1290-0fab-45cb-91a7-4de87f862990" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f6c2f15c-bc42-490e-b7be-2cb976f0f2b2" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_ed9d1290-0fab-45cb-91a7-4de87f862990" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_43f5b5e3-7824-4428-943d-f74a48ab9bf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f6c2f15c-bc42-490e-b7be-2cb976f0f2b2" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_43f5b5e3-7824-4428-943d-f74a48ab9bf6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PurchaseOfIntellectualProperty_cfea5909-8b8e-49d0-998b-212e55f72d0d" xlink:href="holx-20210626.xsd#holx_PurchaseOfIntellectualProperty"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f6c2f15c-bc42-490e-b7be-2cb976f0f2b2" xlink:to="loc_holx_PurchaseOfIntellectualProperty_cfea5909-8b8e-49d0-998b-212e55f72d0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f06dbfdc-04a4-49a1-9bd1-ea0e4dc9b791" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bcb81887-1906-4d17-9e5d-05aa82ae4aef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f06dbfdc-04a4-49a1-9bd1-ea0e4dc9b791" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_bcb81887-1906-4d17-9e5d-05aa82ae4aef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_17736b9d-9546-488e-b777-e2a068cd7e56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f06dbfdc-04a4-49a1-9bd1-ea0e4dc9b791" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_17736b9d-9546-488e-b777-e2a068cd7e56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_808d8db7-e0e1-4e29-bca8-6c35f595438e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f06dbfdc-04a4-49a1-9bd1-ea0e4dc9b791" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_808d8db7-e0e1-4e29-bca8-6c35f595438e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_d52ea49f-7586-4679-a167-9a4453c8899f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_f06dbfdc-04a4-49a1-9bd1-ea0e4dc9b791" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_d52ea49f-7586-4679-a167-9a4453c8899f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dd5557d4-0ef0-484c-a885-c9bb150390fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromAccountsReceivableSecuritization_46d829e5-8122-48cc-8a3a-59f1eac6d868" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromAccountsReceivableSecuritization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dd5557d4-0ef0-484c-a885-c9bb150390fe" xlink:to="loc_us-gaap_ProceedsFromAccountsReceivableSecuritization_46d829e5-8122-48cc-8a3a-59f1eac6d868" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d7570a1d-40c1-4afa-97fb-0f15c8f7b3c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dd5557d4-0ef0-484c-a885-c9bb150390fe" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d7570a1d-40c1-4afa-97fb-0f15c8f7b3c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RepaymentOfSeniorNotes_442157be-ddcc-4f2a-9017-57ad7ea25c8e" xlink:href="holx-20210626.xsd#holx_RepaymentOfSeniorNotes"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dd5557d4-0ef0-484c-a885-c9bb150390fe" xlink:to="loc_holx_RepaymentOfSeniorNotes_442157be-ddcc-4f2a-9017-57ad7ea25c8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProceedsFromSeniorNotes_d0b486bc-e712-4023-ae92-9fdbcc05150f" xlink:href="holx-20210626.xsd#holx_ProceedsFromSeniorNotes"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dd5557d4-0ef0-484c-a885-c9bb150390fe" xlink:to="loc_holx_ProceedsFromSeniorNotes_d0b486bc-e712-4023-ae92-9fdbcc05150f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_a7a50241-7152-44c7-9d13-a108e15b9ccc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dd5557d4-0ef0-484c-a885-c9bb150390fe" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_a7a50241-7152-44c7-9d13-a108e15b9ccc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_9e6cba5c-2ad2-40c3-8b1c-ccc4410766f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dd5557d4-0ef0-484c-a885-c9bb150390fe" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_9e6cba5c-2ad2-40c3-8b1c-ccc4410766f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_4a492b49-bbd7-403b-807f-76bb33504eeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dd5557d4-0ef0-484c-a885-c9bb150390fe" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_4a492b49-bbd7-403b-807f-76bb33504eeb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_092d0a0c-eb2a-49f2-88dd-ba2653a5a9c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dd5557d4-0ef0-484c-a885-c9bb150390fe" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_092d0a0c-eb2a-49f2-88dd-ba2653a5a9c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_aac8f03b-cf8d-4c94-8987-0a67aa1d6245" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dd5557d4-0ef0-484c-a885-c9bb150390fe" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_aac8f03b-cf8d-4c94-8987-0a67aa1d6245" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_d5d92753-3e8c-4168-87f5-77b9f6e01f5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dd5557d4-0ef0-484c-a885-c9bb150390fe" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_d5d92753-3e8c-4168-87f5-77b9f6e01f5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_139a8890-96b4-41ea-9aef-01cf710ec5c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dd5557d4-0ef0-484c-a885-c9bb150390fe" xlink:to="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_139a8890-96b4-41ea-9aef-01cf710ec5c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_9307c44f-3b11-4571-8019-815ae4e660ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dd5557d4-0ef0-484c-a885-c9bb150390fe" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_9307c44f-3b11-4571-8019-815ae4e660ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfAccountsReceivableSecuritization_13c38900-b46c-4ade-a6f3-9bf07428bf9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfAccountsReceivableSecuritization"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dd5557d4-0ef0-484c-a885-c9bb150390fe" xlink:to="loc_us-gaap_RepaymentsOfAccountsReceivableSecuritization_13c38900-b46c-4ade-a6f3-9bf07428bf9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_6afa9660-0633-4abf-8052-9ec089bc32d3" xlink:href="holx-20210626.xsd#holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_dd5557d4-0ef0-484c-a885-c9bb150390fe" xlink:to="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_6afa9660-0633-4abf-8052-9ec089bc32d3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_83d0b006-295e-4bd8-a9d7-ea1d42bf0317" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_25af42ef-23ff-46e2-b6ec-3b7380ccb6d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_83d0b006-295e-4bd8-a9d7-ea1d42bf0317" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_25af42ef-23ff-46e2-b6ec-3b7380ccb6d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_215425e9-8b0a-494e-8c2b-e1d95ec6ae58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_83d0b006-295e-4bd8-a9d7-ea1d42bf0317" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_215425e9-8b0a-494e-8c2b-e1d95ec6ae58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_b55da26a-2548-4028-8674-0f7523b48601" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_83d0b006-295e-4bd8-a9d7-ea1d42bf0317" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_b55da26a-2548-4028-8674-0f7523b48601" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_bf77c8bc-0bf5-4450-831f-e7eb68f726d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_83d0b006-295e-4bd8-a9d7-ea1d42bf0317" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_bf77c8bc-0bf5-4450-831f-e7eb68f726d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_02094d41-4424-4552-9fc7-6b8f8cc16a2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_83d0b006-295e-4bd8-a9d7-ea1d42bf0317" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_02094d41-4424-4552-9fc7-6b8f8cc16a2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_7780ffef-c79c-4311-8ced-efd4fa1e0911" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_83d0b006-295e-4bd8-a9d7-ea1d42bf0317" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_7780ffef-c79c-4311-8ced-efd4fa1e0911" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_4bb8ca40-2035-4e19-8a39-3380186d0157" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_83d0b006-295e-4bd8-a9d7-ea1d42bf0317" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_4bb8ca40-2035-4e19-8a39-3380186d0157" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_fde7badf-92f6-4ae7-aba4-9a26e487836a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_83d0b006-295e-4bd8-a9d7-ea1d42bf0317" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_fde7badf-92f6-4ae7-aba4-9a26e487836a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_f8ce9eff-cb25-4662-a903-0a98fb8343ec" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_83d0b006-295e-4bd8-a9d7-ea1d42bf0317" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_f8ce9eff-cb25-4662-a903-0a98fb8343ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_c0fbcf6e-575e-4acd-b482-77bde44a95b9" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_83d0b006-295e-4bd8-a9d7-ea1d42bf0317" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_c0fbcf6e-575e-4acd-b482-77bde44a95b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b785236d-1f52-47ab-82df-227af11bc997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_83d0b006-295e-4bd8-a9d7-ea1d42bf0317" xlink:to="loc_us-gaap_Goodwill_b785236d-1f52-47ab-82df-227af11bc997" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_36f8d156-4612-4b86-a25a-96c11ce8c044" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_83d0b006-295e-4bd8-a9d7-ea1d42bf0317" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_36f8d156-4612-4b86-a25a-96c11ce8c044" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_9f6164c7-7fd1-4b34-9c96-12909740ef9a" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_83d0b006-295e-4bd8-a9d7-ea1d42bf0317" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_9f6164c7-7fd1-4b34-9c96-12909740ef9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_442f6207-f8f8-44e0-a3be-d8e8ced6321b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_83d0b006-295e-4bd8-a9d7-ea1d42bf0317" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_442f6207-f8f8-44e0-a3be-d8e8ced6321b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess_ad37b26c-b355-40e4-b335-97e8fca337c1" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_83d0b006-295e-4bd8-a9d7-ea1d42bf0317" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess_ad37b26c-b355-40e4-b335-97e8fca337c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_eb479254-c5db-49d2-ac5e-686ed997a7f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_83d0b006-295e-4bd8-a9d7-ea1d42bf0317" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_eb479254-c5db-49d2-ac5e-686ed997a7f3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#BorrowingsandCreditArrangementsCompanysBorrowingsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_cc522490-8ef1-489b-99c7-0b2a97a73510" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_f5fc3e6f-ce73-4fe0-9854-55c604dd2a68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_cc522490-8ef1-489b-99c7-0b2a97a73510" xlink:to="loc_us-gaap_LongTermDebtCurrent_f5fc3e6f-ce73-4fe0-9854-55c604dd2a68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_8df285c1-b819-4183-8321-25d0f50cbea0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_cc522490-8ef1-489b-99c7-0b2a97a73510" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_8df285c1-b819-4183-8321-25d0f50cbea0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_8b2882c4-9b28-4a3e-9106-82877a070fa7" xlink:href="holx-20210626.xsd#holx_LongTermDebtObligationsWithoutConvertibleNotes"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_cc522490-8ef1-489b-99c7-0b2a97a73510" xlink:to="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_8b2882c4-9b28-4a3e-9106-82877a070fa7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0f79f3a2-aefe-4dc4-b014-680952a348fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d2e7d02a-ddff-444e-8c07-50660ab3d2b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0f79f3a2-aefe-4dc4-b014-680952a348fa" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d2e7d02a-ddff-444e-8c07-50660ab3d2b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_fe684ef3-0372-42cd-b48a-075391480aea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0f79f3a2-aefe-4dc4-b014-680952a348fa" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_fe684ef3-0372-42cd-b48a-075391480aea" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#OtherBalanceSheetInformationInventoriesDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_38924223-2850-4a79-a189-ecee4f2482e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_8764f96a-4b7f-4716-93fc-dd99caa9c64e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_38924223-2850-4a79-a189-ecee4f2482e5" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_8764f96a-4b7f-4716-93fc-dd99caa9c64e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_95d834a8-e59f-4257-a38f-75ee437d404e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_38924223-2850-4a79-a189-ecee4f2482e5" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_95d834a8-e59f-4257-a38f-75ee437d404e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_49910bef-7c56-4995-9d4f-4246ef3ad5e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_38924223-2850-4a79-a189-ecee4f2482e5" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_49910bef-7c56-4995-9d4f-4246ef3ad5e6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_4a44bc18-e495-48b0-a599-10eb66357c7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ManufacturingEquipmentAndSoftware_933d20a1-d249-4368-88e7-0a543e359193" xlink:href="holx-20210626.xsd#holx_ManufacturingEquipmentAndSoftware"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_4a44bc18-e495-48b0-a599-10eb66357c7e" xlink:to="loc_holx_ManufacturingEquipmentAndSoftware_933d20a1-d249-4368-88e7-0a543e359193" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquipmentUnderCustomerUsageAgreements_4e633f37-d60d-4a75-a013-3525ddf9c86e" xlink:href="holx-20210626.xsd#holx_EquipmentUnderCustomerUsageAgreements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_4a44bc18-e495-48b0-a599-10eb66357c7e" xlink:to="loc_holx_EquipmentUnderCustomerUsageAgreements_4e633f37-d60d-4a75-a013-3525ddf9c86e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_fea43d8d-8686-4a5f-9146-caddf45a5476" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_4a44bc18-e495-48b0-a599-10eb66357c7e" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_fea43d8d-8686-4a5f-9146-caddf45a5476" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_4710b623-173b-4096-b0e6-2336499878b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_4a44bc18-e495-48b0-a599-10eb66357c7e" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_4710b623-173b-4096-b0e6-2336499878b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_84d69c4a-df79-48e6-bbed-ac5bb88fad72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Land"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_4a44bc18-e495-48b0-a599-10eb66357c7e" xlink:to="loc_us-gaap_Land_84d69c4a-df79-48e6-bbed-ac5bb88fad72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_5fcc4563-7415-45c2-8095-7dd33485f929" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_4a44bc18-e495-48b0-a599-10eb66357c7e" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_5fcc4563-7415-45c2-8095-7dd33485f929" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_e8cd81dd-1d4f-4656-9b99-7f9ed295294b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_4a44bc18-e495-48b0-a599-10eb66357c7e" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_e8cd81dd-1d4f-4656-9b99-7f9ed295294b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_667a069e-1aaf-4da0-bb69-0c2ee8da286a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_312c060b-8829-4cd5-ac43-0c5b3ffa9db4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_667a069e-1aaf-4da0-bb69-0c2ee8da286a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_312c060b-8829-4cd5-ac43-0c5b3ffa9db4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_4f511442-ec72-455d-bba4-373842d701c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_667a069e-1aaf-4da0-bb69-0c2ee8da286a" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_4f511442-ec72-455d-bba4-373842d701c3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#AccumulatedOtherComprehensiveIncomeDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_d2635d20-a7e7-4894-b5d7-99798381c218" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_ebbd6023-530f-481e-8c87-51dbaafe3c8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_d2635d20-a7e7-4894-b5d7-99798381c218" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_ebbd6023-530f-481e-8c87-51dbaafe3c8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_27382256-8ef8-4771-a1df-404aee78e91b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_d2635d20-a7e7-4894-b5d7-99798381c218" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_27382256-8ef8-4771-a1df-404aee78e91b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_459c8bdd-31b9-436c-b638-25dd13591966" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_d2635d20-a7e7-4894-b5d7-99798381c218" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_459c8bdd-31b9-436c-b638-25dd13591966" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_f385e104-db5b-4fcb-a9f0-381ba6874858" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_d2635d20-a7e7-4894-b5d7-99798381c218" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_f385e104-db5b-4fcb-a9f0-381ba6874858" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>holx-20210626_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c74485e8-ec97-423d-9317-27784965d1fb,g:cd3e0a2e-ccc2-417e-9556-0c4f43775051-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="holx-20210626.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended" id="i8bcee1c7bb674021bbf94f58893ca80a_ConsolidatedStatementsofStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_8f01ef4f-7890-4426-a706-5691a3080d92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount_f6630350-c857-476e-b55a-e660fc579007" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8f01ef4f-7890-4426-a706-5691a3080d92" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount_f6630350-c857-476e-b55a-e660fc579007" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_4f480f20-c791-47fa-a282-d7d2916810f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8f01ef4f-7890-4426-a706-5691a3080d92" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_4f480f20-c791-47fa-a282-d7d2916810f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8f01ef4f-7890-4426-a706-5691a3080d92" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_66c86142-e19a-413b-b6ff-b9605a7e86a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_us-gaap_SharesIssued_66c86142-e19a-413b-b6ff-b9605a7e86a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_099460bb-cb74-4da7-bde3-537a04cc6ca8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_us-gaap_StockholdersEquity_099460bb-cb74-4da7-bde3-537a04cc6ca8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_59f5f746-6545-4ba2-9152-7d358672f054" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_59f5f746-6545-4ba2-9152-7d358672f054" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_8da3f7ea-b0f6-4708-b57e-3fedcae3e396" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_8da3f7ea-b0f6-4708-b57e-3fedcae3e396" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ChangeInParValue_9eeb0702-7f38-43be-9d0a-c54b8bdc1e1e" xlink:href="holx-20210626.xsd#holx_ChangeInParValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_holx_ChangeInParValue_9eeb0702-7f38-43be-9d0a-c54b8bdc1e1e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_44f2020e-ec60-4558-979c-7944f558a547" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_44f2020e-ec60-4558-979c-7944f558a547" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_9d6c7854-83b2-4f6a-ae68-7066aca2c573" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_9d6c7854-83b2-4f6a-ae68-7066aca2c573" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e764c8a1-300a-42b9-ab88-b4a3923d3a35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e764c8a1-300a-42b9-ab88-b4a3923d3a35" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_023681ed-2970-4f19-b4ad-0d7595ff7473" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_023681ed-2970-4f19-b4ad-0d7595ff7473" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b7905574-0234-4463-9fff-35b684e00847" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b7905574-0234-4463-9fff-35b684e00847" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_503f84c6-3771-48a7-a263-b91bfbd312fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_us-gaap_NetIncomeLoss_503f84c6-3771-48a7-a263-b91bfbd312fc" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ca22ad0c-6538-4d09-82b1-82b7150a7410" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ca22ad0c-6538-4d09-82b1-82b7150a7410" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_9be9ce60-298e-441e-a51b-e732753c3734" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_9be9ce60-298e-441e-a51b-e732753c3734" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_09960130-ff3d-4482-ba60-19f4e960b210" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_09960130-ff3d-4482-ba60-19f4e960b210" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TotalPaymentsToNonControllingInterest_086977c2-cb6b-4733-9b27-7adf3b661be6" xlink:href="holx-20210626.xsd#holx_TotalPaymentsToNonControllingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_holx_TotalPaymentsToNonControllingInterest_086977c2-cb6b-4733-9b27-7adf3b661be6" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PurchaseOfNonControllingInterestReclassifiedToAPIC_967d7c32-4850-4cd3-80d1-50842c4ba33b" xlink:href="holx-20210626.xsd#holx_PurchaseOfNonControllingInterestReclassifiedToAPIC"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_holx_PurchaseOfNonControllingInterestReclassifiedToAPIC_967d7c32-4850-4cd3-80d1-50842c4ba33b" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchaseProgramAdjustment_5703c8d1-05dd-437b-ad7c-1bdce9a5bdfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchaseProgramAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_us-gaap_AcceleratedShareRepurchaseProgramAdjustment_5703c8d1-05dd-437b-ad7c-1bdce9a5bdfe" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_30c6bb15-d273-4186-b9a4-f477faa320fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5a43be3b-206d-4661-9ca2-53a1324ce24f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_22cae603-da2b-47e8-ae03-11b58eb234c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_22cae603-da2b-47e8-ae03-11b58eb234c1" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Netincome_af061996-849d-40e7-a0d4-a6395e6f6f5d" xlink:href="holx-20210626.xsd#holx_Netincome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_holx_Netincome_af061996-849d-40e7-a0d4-a6395e6f6f5d" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Acceleratedsharerepurchaseagreement_93abb125-4048-4818-846c-f6b705a68194" xlink:href="holx-20210626.xsd#holx_Acceleratedsharerepurchaseagreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_holx_Acceleratedsharerepurchaseagreement_93abb125-4048-4818-846c-f6b705a68194" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_2c405b31-6a40-4df5-a5c3-3efa64b5096b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_2c405b31-6a40-4df5-a5c3-3efa64b5096b" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_154e1729-0b92-401d-8c1f-a926f0da2d8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8f01ef4f-7890-4426-a706-5691a3080d92" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_154e1729-0b92-401d-8c1f-a926f0da2d8c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_331e5282-773d-45e9-9d98-f8537bce7e6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_8f01ef4f-7890-4426-a706-5691a3080d92" xlink:to="loc_us-gaap_StatementTable_331e5282-773d-45e9-9d98-f8537bce7e6a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_50218818-d525-45db-bfea-1b606c556f40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_331e5282-773d-45e9-9d98-f8537bce7e6a" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_50218818-d525-45db-bfea-1b606c556f40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_50218818-d525-45db-bfea-1b606c556f40_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_50218818-d525-45db-bfea-1b606c556f40" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_50218818-d525-45db-bfea-1b606c556f40_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_c39d93a2-e666-4715-b42b-d593723dcd51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_50218818-d525-45db-bfea-1b606c556f40" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_c39d93a2-e666-4715-b42b-d593723dcd51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareRepurchaseProgramMember_a874cda5-3abb-4af6-8758-14aac73ea6b1" xlink:href="holx-20210626.xsd#holx_ShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_c39d93a2-e666-4715-b42b-d593723dcd51" xlink:to="loc_holx_ShareRepurchaseProgramMember_a874cda5-3abb-4af6-8758-14aac73ea6b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e4a83df5-3b16-412e-bc8a-8885f90cfa10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_331e5282-773d-45e9-9d98-f8537bce7e6a" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e4a83df5-3b16-412e-bc8a-8885f90cfa10" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e4a83df5-3b16-412e-bc8a-8885f90cfa10_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e4a83df5-3b16-412e-bc8a-8885f90cfa10" xlink:to="loc_us-gaap_EquityComponentDomain_e4a83df5-3b16-412e-bc8a-8885f90cfa10_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2c160712-15a5-4213-9369-df4ba38414a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e4a83df5-3b16-412e-bc8a-8885f90cfa10" xlink:to="loc_us-gaap_EquityComponentDomain_2c160712-15a5-4213-9369-df4ba38414a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_3524e9e5-b2a3-44eb-b14b-c8652acd6296" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2c160712-15a5-4213-9369-df4ba38414a8" xlink:to="loc_us-gaap_CommonStockMember_3524e9e5-b2a3-44eb-b14b-c8652acd6296" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_99c80f8c-0bf6-45a4-8247-25852f39c448" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2c160712-15a5-4213-9369-df4ba38414a8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_99c80f8c-0bf6-45a4-8247-25852f39c448" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_83705582-9d61-4ac2-a609-e8244ef92abc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2c160712-15a5-4213-9369-df4ba38414a8" xlink:to="loc_us-gaap_RetainedEarningsMember_83705582-9d61-4ac2-a609-e8244ef92abc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_22f6d8cc-e5c0-4dd0-b274-eb3e8b1b6c92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2c160712-15a5-4213-9369-df4ba38414a8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_22f6d8cc-e5c0-4dd0-b274-eb3e8b1b6c92" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_a4ae47f2-3d4c-43ec-9cbe-d4e7c7e236f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2c160712-15a5-4213-9369-df4ba38414a8" xlink:to="loc_us-gaap_TreasuryStockMember_a4ae47f2-3d4c-43ec-9cbe-d4e7c7e236f0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9f3cedad-38de-49d3-b646-b10d1021af60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_331e5282-773d-45e9-9d98-f8537bce7e6a" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9f3cedad-38de-49d3-b646-b10d1021af60" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_9f3cedad-38de-49d3-b646-b10d1021af60_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9f3cedad-38de-49d3-b646-b10d1021af60" xlink:to="loc_us-gaap_TypeOfAdoptionMember_9f3cedad-38de-49d3-b646-b10d1021af60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_38c86c26-9da0-4991-80c8-4d54187eea36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9f3cedad-38de-49d3-b646-b10d1021af60" xlink:to="loc_us-gaap_TypeOfAdoptionMember_38c86c26-9da0-4991-80c8-4d54187eea36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201801Member_3f9efae3-85b3-482f-ab35-501cf11baddd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201801Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_38c86c26-9da0-4991-80c8-4d54187eea36" xlink:to="loc_us-gaap_AccountingStandardsUpdate201801Member_3f9efae3-85b3-482f-ab35-501cf11baddd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueBusinessRevenueDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#RevenueBusinessRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueBusinessRevenueDetails" xlink:type="extended" id="i7f7deaaf2d2b464394279055e855fcd3_RevenueBusinessRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_36c77692-5065-4ab7-a84b-b492f0ceecd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_39607065-f55a-4834-ad36-06438a41b679" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_36c77692-5065-4ab7-a84b-b492f0ceecd8" xlink:to="loc_us-gaap_Revenues_39607065-f55a-4834-ad36-06438a41b679" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_7f38a409-c122-4952-ab63-3554a10f16d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_36c77692-5065-4ab7-a84b-b492f0ceecd8" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_7f38a409-c122-4952-ab63-3554a10f16d2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_bcfe787a-4b39-4289-9435-646bb0a44860" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_7f38a409-c122-4952-ab63-3554a10f16d2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_bcfe787a-4b39-4289-9435-646bb0a44860" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bcfe787a-4b39-4289-9435-646bb0a44860_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bcfe787a-4b39-4289-9435-646bb0a44860" xlink:to="loc_us-gaap_SegmentDomain_bcfe787a-4b39-4289-9435-646bb0a44860_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1855fc41-0f91-4e4d-b83d-741701c95af5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bcfe787a-4b39-4289-9435-646bb0a44860" xlink:to="loc_us-gaap_SegmentDomain_1855fc41-0f91-4e4d-b83d-741701c95af5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember_5ac7bf4f-da15-42dc-9914-680c4f9f93aa" xlink:href="holx-20210626.xsd#holx_DiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1855fc41-0f91-4e4d-b83d-741701c95af5" xlink:to="loc_holx_DiagnosticsMember_5ac7bf4f-da15-42dc-9914-680c4f9f93aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember_c2cb152e-6778-4492-ae50-efe29885d381" xlink:href="holx-20210626.xsd#holx_BreastHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1855fc41-0f91-4e4d-b83d-741701c95af5" xlink:to="loc_holx_BreastHealthMember_c2cb152e-6778-4492-ae50-efe29885d381" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember_3cc08746-656b-48ac-9be1-72a102f17657" xlink:href="holx-20210626.xsd#holx_GynSurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1855fc41-0f91-4e4d-b83d-741701c95af5" xlink:to="loc_holx_GynSurgicalMember_3cc08746-656b-48ac-9be1-72a102f17657" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_55b9ff20-a32d-4449-a47f-4c814f4cc884" xlink:href="holx-20210626.xsd#holx_MedicalAestheticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1855fc41-0f91-4e4d-b83d-741701c95af5" xlink:to="loc_holx_MedicalAestheticsMember_55b9ff20-a32d-4449-a47f-4c814f4cc884" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember_613ef2f1-c638-426a-98b4-0eff8a9b6c9e" xlink:href="holx-20210626.xsd#holx_SkeletalHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1855fc41-0f91-4e4d-b83d-741701c95af5" xlink:to="loc_holx_SkeletalHealthMember_613ef2f1-c638-426a-98b4-0eff8a9b6c9e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9553ea8a-6dab-4fef-8b90-8d3eb58b3e8e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_7f38a409-c122-4952-ab63-3554a10f16d2" xlink:to="loc_srt_ProductOrServiceAxis_9553ea8a-6dab-4fef-8b90-8d3eb58b3e8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9553ea8a-6dab-4fef-8b90-8d3eb58b3e8e_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_9553ea8a-6dab-4fef-8b90-8d3eb58b3e8e" xlink:to="loc_srt_ProductsAndServicesDomain_9553ea8a-6dab-4fef-8b90-8d3eb58b3e8e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d2ca2b6e-6432-4ca7-9888-69092da50cdd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_9553ea8a-6dab-4fef-8b90-8d3eb58b3e8e" xlink:to="loc_srt_ProductsAndServicesDomain_d2ca2b6e-6432-4ca7-9888-69092da50cdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CytologyPerinatalMember_0d93f185-b103-4eca-bb0e-b3322fc95780" xlink:href="holx-20210626.xsd#holx_CytologyPerinatalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d2ca2b6e-6432-4ca7-9888-69092da50cdd" xlink:to="loc_holx_CytologyPerinatalMember_0d93f185-b103-4eca-bb0e-b3322fc95780" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MolecularDiagnosticsMember_238a80c4-be6b-4a4b-ba62-ea202c20130e" xlink:href="holx-20210626.xsd#holx_MolecularDiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d2ca2b6e-6432-4ca7-9888-69092da50cdd" xlink:to="loc_holx_MolecularDiagnosticsMember_238a80c4-be6b-4a4b-ba62-ea202c20130e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BloodScreeningMember_cc18fc9a-07fb-4be6-beec-f4d988313f9c" xlink:href="holx-20210626.xsd#holx_BloodScreeningMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d2ca2b6e-6432-4ca7-9888-69092da50cdd" xlink:to="loc_holx_BloodScreeningMember_cc18fc9a-07fb-4be6-beec-f4d988313f9c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastImagingMember_ff962e9d-07eb-4daa-93f0-790298393539" xlink:href="holx-20210626.xsd#holx_BreastImagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d2ca2b6e-6432-4ca7-9888-69092da50cdd" xlink:to="loc_holx_BreastImagingMember_ff962e9d-07eb-4daa-93f0-790298393539" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterventionalBreastSolutionsMember_d887a6c1-da71-4bb8-a840-532a1368012a" xlink:href="holx-20210626.xsd#holx_InterventionalBreastSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_d2ca2b6e-6432-4ca7-9888-69092da50cdd" xlink:to="loc_holx_InterventionalBreastSolutionsMember_d887a6c1-da71-4bb8-a840-532a1368012a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_53678891-6810-4119-975f-48d5f36c5c1f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_7f38a409-c122-4952-ab63-3554a10f16d2" xlink:to="loc_srt_StatementGeographicalAxis_53678891-6810-4119-975f-48d5f36c5c1f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_53678891-6810-4119-975f-48d5f36c5c1f_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_53678891-6810-4119-975f-48d5f36c5c1f" xlink:to="loc_srt_SegmentGeographicalDomain_53678891-6810-4119-975f-48d5f36c5c1f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_50701e57-2949-4ffc-af6c-ea63da84db19" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_53678891-6810-4119-975f-48d5f36c5c1f" xlink:to="loc_srt_SegmentGeographicalDomain_50701e57-2949-4ffc-af6c-ea63da84db19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_824276f0-e54b-47d4-b2f2-3100cfdc7c91" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_50701e57-2949-4ffc-af6c-ea63da84db19" xlink:to="loc_country_US_824276f0-e54b-47d4-b2f2-3100cfdc7c91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternationalMember_ec06cde6-b022-4259-91d6-8468a776a957" xlink:href="holx-20210626.xsd#holx_InternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_50701e57-2949-4ffc-af6c-ea63da84db19" xlink:to="loc_holx_InternationalMember_ec06cde6-b022-4259-91d6-8468a776a957" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueGeographicalRevenueDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#RevenueGeographicalRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueGeographicalRevenueDetails" xlink:type="extended" id="if44b23aad37c42c39199271f6618ae93_RevenueGeographicalRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_6f005080-c395-4426-8f3b-caf64aa10876" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_dbe91f2e-046e-46ed-993d-512a85335a43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_6f005080-c395-4426-8f3b-caf64aa10876" xlink:to="loc_us-gaap_Revenues_dbe91f2e-046e-46ed-993d-512a85335a43" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_1b7837da-1438-49a4-b4b4-913b0f42dd06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_6f005080-c395-4426-8f3b-caf64aa10876" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_1b7837da-1438-49a4-b4b4-913b0f42dd06" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_0c00d131-04c7-4841-a5e7-6959e3d8bb8b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1b7837da-1438-49a4-b4b4-913b0f42dd06" xlink:to="loc_srt_StatementGeographicalAxis_0c00d131-04c7-4841-a5e7-6959e3d8bb8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0c00d131-04c7-4841-a5e7-6959e3d8bb8b_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_0c00d131-04c7-4841-a5e7-6959e3d8bb8b" xlink:to="loc_srt_SegmentGeographicalDomain_0c00d131-04c7-4841-a5e7-6959e3d8bb8b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8bce6e3d-114e-41db-a500-4454fe676323" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_0c00d131-04c7-4841-a5e7-6959e3d8bb8b" xlink:to="loc_srt_SegmentGeographicalDomain_8bce6e3d-114e-41db-a500-4454fe676323" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_25f0b197-dcb3-460a-a0db-c4a3a8717cb4" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8bce6e3d-114e-41db-a500-4454fe676323" xlink:to="loc_country_US_25f0b197-dcb3-460a-a0db-c4a3a8717cb4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_395d64fa-052b-45d0-8e53-b9d005011022" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8bce6e3d-114e-41db-a500-4454fe676323" xlink:to="loc_srt_EuropeMember_395d64fa-052b-45d0-8e53-b9d005011022" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_f531c3e3-6dee-490b-867e-6af43496fbcb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8bce6e3d-114e-41db-a500-4454fe676323" xlink:to="loc_srt_AsiaPacificMember_f531c3e3-6dee-490b-867e-6af43496fbcb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RestofWorldMember_f853de0b-3796-4a20-b9c8-105bc178824f" xlink:href="holx-20210626.xsd#holx_RestofWorldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8bce6e3d-114e-41db-a500-4454fe676323" xlink:to="loc_holx_RestofWorldMember_f853de0b-3796-4a20-b9c8-105bc178824f" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRevenuebyTypeDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#RevenueRevenuebyTypeDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueRevenuebyTypeDetails" xlink:type="extended" id="i40b6bf72506a49be818c033940e4331c_RevenueRevenuebyTypeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_bfc903e2-28c5-49dd-baeb-adba74d2e1cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_b08b985e-0a3c-4338-8792-49e6a5dbe5b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_bfc903e2-28c5-49dd-baeb-adba74d2e1cb" xlink:to="loc_us-gaap_Revenues_b08b985e-0a3c-4338-8792-49e6a5dbe5b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_48336bf8-a10f-4dee-906a-67fd5f547474" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_bfc903e2-28c5-49dd-baeb-adba74d2e1cb" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_48336bf8-a10f-4dee-906a-67fd5f547474" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a06ce225-c28a-43a9-94a7-61f0d491a0f2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_48336bf8-a10f-4dee-906a-67fd5f547474" xlink:to="loc_srt_ProductOrServiceAxis_a06ce225-c28a-43a9-94a7-61f0d491a0f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a06ce225-c28a-43a9-94a7-61f0d491a0f2_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_a06ce225-c28a-43a9-94a7-61f0d491a0f2" xlink:to="loc_srt_ProductsAndServicesDomain_a06ce225-c28a-43a9-94a7-61f0d491a0f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_cf93a43a-7766-4ccb-9c5e-842b306193a2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_a06ce225-c28a-43a9-94a7-61f0d491a0f2" xlink:to="loc_srt_ProductsAndServicesDomain_cf93a43a-7766-4ccb-9c5e-842b306193a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ConsumablesMember_7cbc64d5-ee72-423c-8b88-efdd7f4724f9" xlink:href="holx-20210626.xsd#holx_ConsumablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_cf93a43a-7766-4ccb-9c5e-842b306193a2" xlink:to="loc_holx_ConsumablesMember_7cbc64d5-ee72-423c-8b88-efdd7f4724f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalEquipmentComponentsandSoftwareMember_24c90b4d-74bb-49cc-b427-1cba0f7063b2" xlink:href="holx-20210626.xsd#holx_CapitalEquipmentComponentsandSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_cf93a43a-7766-4ccb-9c5e-842b306193a2" xlink:to="loc_holx_CapitalEquipmentComponentsandSoftwareMember_24c90b4d-74bb-49cc-b427-1cba0f7063b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_2b0855cb-8583-43fb-a191-d2fa38545bda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_cf93a43a-7766-4ccb-9c5e-842b306193a2" xlink:to="loc_us-gaap_ServiceMember_2b0855cb-8583-43fb-a191-d2fa38545bda" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherTypeofRevenueMember_7de345a4-fb6e-498b-b3d7-62738013fc33" xlink:href="holx-20210626.xsd#holx_OtherTypeofRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_cf93a43a-7766-4ccb-9c5e-842b306193a2" xlink:to="loc_holx_OtherTypeofRevenueMember_7de345a4-fb6e-498b-b3d7-62738013fc33" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#RevenueRemainingPerformanceObligationDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails" xlink:type="extended" id="i7cb3bd0a32a44852b90438fd9dd199d9_RevenueRemainingPerformanceObligationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_f15efe8d-94bb-43b5-ad3b-9676537c5e01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_b36f9731-a774-4567-a7af-f28abffd771b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f15efe8d-94bb-43b5-ad3b-9676537c5e01" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_b36f9731-a774-4567-a7af-f28abffd771b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_bc17ef7b-65d0-478f-9b71-499b998c60ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f15efe8d-94bb-43b5-ad3b-9676537c5e01" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_bc17ef7b-65d0-478f-9b71-499b998c60ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_1e88c274-8d12-481e-b96b-04707b240563" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f15efe8d-94bb-43b5-ad3b-9676537c5e01" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_1e88c274-8d12-481e-b96b-04707b240563" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_5663e44e-336b-40b5-818f-711a097cfe67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1e88c274-8d12-481e-b96b-04707b240563" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_5663e44e-336b-40b5-818f-711a097cfe67" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails_1" xlink:type="simple" xlink:href="holx-20210626.xsd#RevenueRemainingPerformanceObligationDetails_1"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails_1" xlink:type="extended" id="i297e56daa2ba4486b2b6f75272c54151_RevenueRemainingPerformanceObligationDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_f15efe8d-94bb-43b5-ad3b-9676537c5e01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_b36f9731-a774-4567-a7af-f28abffd771b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f15efe8d-94bb-43b5-ad3b-9676537c5e01" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_b36f9731-a774-4567-a7af-f28abffd771b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_bc17ef7b-65d0-478f-9b71-499b998c60ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f15efe8d-94bb-43b5-ad3b-9676537c5e01" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_bc17ef7b-65d0-478f-9b71-499b998c60ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_1e88c274-8d12-481e-b96b-04707b240563" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f15efe8d-94bb-43b5-ad3b-9676537c5e01" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_1e88c274-8d12-481e-b96b-04707b240563" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" xlink:type="extended" id="if5aa2507382945bd899abd895a31ac9c_FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_d6afe43d-20ad-4815-98ab-c33a224b5bab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_8231e69b-f88b-4a3b-abaf-412cfbd2d78c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_d6afe43d-20ad-4815-98ab-c33a224b5bab" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_8231e69b-f88b-4a3b-abaf-412cfbd2d78c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_f3157519-cd64-4fa0-9e9c-b35db9032b2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_8231e69b-f88b-4a3b-abaf-412cfbd2d78c" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_f3157519-cd64-4fa0-9e9c-b35db9032b2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_7d2cabcc-3964-4fd1-a380-2a38dcd0a53c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_d6afe43d-20ad-4815-98ab-c33a224b5bab" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_7d2cabcc-3964-4fd1-a380-2a38dcd0a53c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_164267f7-8e54-4274-9f94-354afea634a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_7d2cabcc-3964-4fd1-a380-2a38dcd0a53c" xlink:to="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_164267f7-8e54-4274-9f94-354afea634a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_b61eb4cf-fbbb-43f2-82ad-89c69269a0ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_7d2cabcc-3964-4fd1-a380-2a38dcd0a53c" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_b61eb4cf-fbbb-43f2-82ad-89c69269a0ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d8324262-118e-44b0-8f83-c40e5e497381" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_d6afe43d-20ad-4815-98ab-c33a224b5bab" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d8324262-118e-44b0-8f83-c40e5e497381" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_35e43f59-cfe1-4ddf-a95c-3a24507282dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d8324262-118e-44b0-8f83-c40e5e497381" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_35e43f59-cfe1-4ddf-a95c-3a24507282dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_35e43f59-cfe1-4ddf-a95c-3a24507282dd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_35e43f59-cfe1-4ddf-a95c-3a24507282dd" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_35e43f59-cfe1-4ddf-a95c-3a24507282dd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3060c27e-fbf2-480c-9a7f-a133d8891701" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_35e43f59-cfe1-4ddf-a95c-3a24507282dd" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3060c27e-fbf2-480c-9a7f-a133d8891701" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_297b4724-90ed-4b86-919a-5fc26045733f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3060c27e-fbf2-480c-9a7f-a133d8891701" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_297b4724-90ed-4b86-919a-5fc26045733f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_2e6b6acb-1ca2-4611-8c30-6e56da27138d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3060c27e-fbf2-480c-9a7f-a133d8891701" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_2e6b6acb-1ca2-4611-8c30-6e56da27138d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_3b2e16f3-85c3-4883-ae52-d0b89a743e29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3060c27e-fbf2-480c-9a7f-a133d8891701" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_3b2e16f3-85c3-4883-ae52-d0b89a743e29" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a1021f34-b2eb-47b4-a26c-dbba1014e922" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d8324262-118e-44b0-8f83-c40e5e497381" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a1021f34-b2eb-47b4-a26c-dbba1014e922" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a1021f34-b2eb-47b4-a26c-dbba1014e922_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a1021f34-b2eb-47b4-a26c-dbba1014e922" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a1021f34-b2eb-47b4-a26c-dbba1014e922_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ff213eac-6505-4465-ae7f-501551a3f1fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a1021f34-b2eb-47b4-a26c-dbba1014e922" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ff213eac-6505-4465-ae7f-501551a3f1fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_92834ab1-efa0-4ce8-ae8a-703385cdd0fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ff213eac-6505-4465-ae7f-501551a3f1fc" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_92834ab1-efa0-4ce8-ae8a-703385cdd0fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ContingentConsiderationMember_5ad4c59f-1cf7-4af3-bade-8a526cd7460c" xlink:href="holx-20210626.xsd#holx_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ff213eac-6505-4465-ae7f-501551a3f1fc" xlink:to="loc_holx_ContingentConsiderationMember_5ad4c59f-1cf7-4af3-bade-8a526cd7460c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_2a99b58b-210e-424c-a707-089aa8999a1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ff213eac-6505-4465-ae7f-501551a3f1fc" xlink:to="loc_us-gaap_InterestRateSwapMember_2a99b58b-210e-424c-a707-089aa8999a1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_9dbd8627-6659-4339-96c2-07863ca2f546" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ff213eac-6505-4465-ae7f-501551a3f1fc" xlink:to="loc_us-gaap_ForeignExchangeContractMember_9dbd8627-6659-4339-96c2-07863ca2f546" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_04573e02-b167-4234-8990-d4306d29f74a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d8324262-118e-44b0-8f83-c40e5e497381" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_04573e02-b167-4234-8990-d4306d29f74a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_04573e02-b167-4234-8990-d4306d29f74a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_04573e02-b167-4234-8990-d4306d29f74a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_04573e02-b167-4234-8990-d4306d29f74a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_906a04a9-ba6e-4500-be6c-fe6fab089741" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_04573e02-b167-4234-8990-d4306d29f74a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_906a04a9-ba6e-4500-be6c-fe6fab089741" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_04d370c9-1aec-421a-a673-4899ab876928" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_906a04a9-ba6e-4500-be6c-fe6fab089741" xlink:to="loc_us-gaap_LiabilityMember_04d370c9-1aec-421a-a673-4899ab876928" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#FairValueMeasurementsAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="extended" id="i9ea4ac467ef74f94b764606bfb6c5053_FairValueMeasurementsAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_4fa566e1-a8d8-4694-8811-88fd96e896ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_c29ce980-36b1-4b31-ad6c-a8ce5e92fc1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_4fa566e1-a8d8-4694-8811-88fd96e896ed" xlink:to="loc_us-gaap_AssetImpairmentCharges_c29ce980-36b1-4b31-ad6c-a8ce5e92fc1e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrincipalAmountOfBorrowings_a2693702-f4ae-4d14-ad04-0596bb7cceb6" xlink:href="holx-20210626.xsd#holx_PrincipalAmountOfBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_4fa566e1-a8d8-4694-8811-88fd96e896ed" xlink:to="loc_holx_PrincipalAmountOfBorrowings_a2693702-f4ae-4d14-ad04-0596bb7cceb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_8ec171cc-231a-4c23-99e4-8e79f2a605d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_4fa566e1-a8d8-4694-8811-88fd96e896ed" xlink:to="loc_us-gaap_DebtInstrumentFairValue_8ec171cc-231a-4c23-99e4-8e79f2a605d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_9b94d4c0-6670-4450-a21b-1f677bb816c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_4fa566e1-a8d8-4694-8811-88fd96e896ed" xlink:to="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_9b94d4c0-6670-4450-a21b-1f677bb816c9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0d5e8fe6-0f08-4a4b-9f75-b03988b315e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_9b94d4c0-6670-4450-a21b-1f677bb816c9" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0d5e8fe6-0f08-4a4b-9f75-b03988b315e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0d5e8fe6-0f08-4a4b-9f75-b03988b315e6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0d5e8fe6-0f08-4a4b-9f75-b03988b315e6" xlink:to="loc_us-gaap_SegmentDomain_0d5e8fe6-0f08-4a4b-9f75-b03988b315e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_43771b9f-cc78-484d-a1ea-4750f738b88f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0d5e8fe6-0f08-4a4b-9f75-b03988b315e6" xlink:to="loc_us-gaap_SegmentDomain_43771b9f-cc78-484d-a1ea-4750f738b88f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_d90950b4-7ed1-41eb-8255-eab6d97750a9" xlink:href="holx-20210626.xsd#holx_MedicalAestheticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_43771b9f-cc78-484d-a1ea-4750f738b88f" xlink:to="loc_holx_MedicalAestheticsMember_d90950b4-7ed1-41eb-8255-eab6d97750a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_dbc4ab08-c04a-4279-b682-81b27716fda4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_9b94d4c0-6670-4450-a21b-1f677bb816c9" xlink:to="loc_us-gaap_DebtInstrumentAxis_dbc4ab08-c04a-4279-b682-81b27716fda4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dbc4ab08-c04a-4279-b682-81b27716fda4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_dbc4ab08-c04a-4279-b682-81b27716fda4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dbc4ab08-c04a-4279-b682-81b27716fda4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_00c853ae-04ae-48a2-90d1-a72e3deb6fae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_dbc4ab08-c04a-4279-b682-81b27716fda4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_00c853ae-04ae-48a2-90d1-a72e3deb6fae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember_ab8f05b3-c725-486b-a144-1f8cb19f695c" xlink:href="holx-20210626.xsd#holx_CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_00c853ae-04ae-48a2-90d1-a72e3deb6fae" xlink:to="loc_holx_CreditAgreementMember_ab8f05b3-c725-486b-a144-1f8cb19f695c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_87a99cbb-60df-446a-b7d3-e56dad4d7e85" xlink:href="holx-20210626.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_00c853ae-04ae-48a2-90d1-a72e3deb6fae" xlink:to="loc_holx_A2028SeniorNotesMember_87a99cbb-60df-446a-b7d3-e56dad4d7e85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_0ce59da9-7a31-4133-ae59-e5f9b86944a4" xlink:href="holx-20210626.xsd#holx_A2029SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_00c853ae-04ae-48a2-90d1-a72e3deb6fae" xlink:to="loc_holx_A2029SeniorNotesMember_0ce59da9-7a31-4133-ae59-e5f9b86944a4" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationNarrativeDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#BusinessCombinationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessCombinationNarrativeDetails" xlink:type="extended" id="ie4a96064e3d04faabdbf1ec9c1490ce3_BusinessCombinationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_aaa4c39d-4c0d-4dee-82ac-e92c7594b828" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_aaa4c39d-4c0d-4dee-82ac-e92c7594b828" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_016c1cf6-c887-44e2-9690-c6230fa98d19" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_016c1cf6-c887-44e2-9690-c6230fa98d19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess_ad1bc0a2-1d3f-4e15-a0d1-d851a17d79f0" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess_ad1bc0a2-1d3f-4e15-a0d1-d851a17d79f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ResearchAndDevelopmentInProcessNumberOfProjects_f04ae630-81ef-414b-851a-1d7b7dce2324" xlink:href="holx-20210626.xsd#holx_ResearchAndDevelopmentInProcessNumberOfProjects"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_ResearchAndDevelopmentInProcessNumberOfProjects_f04ae630-81ef-414b-851a-1d7b7dce2324" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ResearchAndDevelopmentInProcessCompletionPeriod_e285ffca-7229-4619-9021-62c92b3f893a" xlink:href="holx-20210626.xsd#holx_ResearchAndDevelopmentInProcessCompletionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_ResearchAndDevelopmentInProcessCompletionPeriod_e285ffca-7229-4619-9021-62c92b3f893a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_3b94870a-6dcc-460c-8f5c-322ea4d4f258" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_3b94870a-6dcc-460c-8f5c-322ea4d4f258" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_e2ce522e-8ed6-4e4b-a8e2-7f59d29d71a5" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_e2ce522e-8ed6-4e4b-a8e2-7f59d29d71a5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_f234ffe6-5598-4975-b884-4393130aa098" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_f234ffe6-5598-4975-b884-4393130aa098" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_521fd77d-2b4f-4d5a-8729-c20587f1634f" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_521fd77d-2b4f-4d5a-8729-c20587f1634f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_454eda22-0d7a-434d-a06a-1433ef8f6c08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_454eda22-0d7a-434d-a06a-1433ef8f6c08" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_66514d8e-3424-472e-bf11-dd675a2a1bb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_66514d8e-3424-472e-bf11-dd675a2a1bb5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AnnualIncrementalRevenueGrowthPeriod_1c30a933-3fbf-44f7-bdb6-0368924d2015" xlink:href="holx-20210626.xsd#holx_AnnualIncrementalRevenueGrowthPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_AnnualIncrementalRevenueGrowthPeriod_1c30a933-3fbf-44f7-bdb6-0368924d2015" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_e7edebd5-2c7d-4ae4-8d1c-62ec7f1b8d6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_e7edebd5-2c7d-4ae4-8d1c-62ec7f1b8d6e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Holdback_aa6abb3d-8817-4333-8bef-ca9a2f27a8ec" xlink:href="holx-20210626.xsd#holx_Holdback"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_Holdback_aa6abb3d-8817-4333-8bef-ca9a2f27a8ec" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_95e6b473-f49f-4471-9ccb-97aa6bc07063" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_95e6b473-f49f-4471-9ccb-97aa6bc07063" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_43bca03a-45d3-406d-8861-2687bb52c330" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_us-gaap_Goodwill_43bca03a-45d3-406d-8861-2687bb52c330" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_4b991acb-9ac3-41be-9820-f418f62f0933" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_4b991acb-9ac3-41be-9820-f418f62f0933" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_404230a4-dd84-432a-a24f-d12e613ae73b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_404230a4-dd84-432a-a24f-d12e613ae73b" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessAcquisitionCashTenderOfferPricePerShare_0768b85a-949b-47a5-ad0a-0b13695dce80" xlink:href="holx-20210626.xsd#holx_BusinessAcquisitionCashTenderOfferPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_BusinessAcquisitionCashTenderOfferPricePerShare_0768b85a-949b-47a5-ad0a-0b13695dce80" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationOwnershipPercentage_32d35a2c-d0aa-478c-adde-9b49d87fed7d" xlink:href="holx-20210626.xsd#holx_BusinessCombinationOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_BusinessCombinationOwnershipPercentage_32d35a2c-d0aa-478c-adde-9b49d87fed7d" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_cbb839bd-6df0-4322-96a7-1fc52c07b9bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_cbb839bd-6df0-4322-96a7-1fc52c07b9bb" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_bd382f31-ffd9-4d5c-9c48-de76b18de6c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_bd382f31-ffd9-4d5c-9c48-de76b18de6c9" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_18938555-65b7-45c6-8282-3ce4bf8d1cfa" xlink:href="holx-20210626.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_18938555-65b7-45c6-8282-3ce4bf8d1cfa" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_fb73de15-11e6-44f8-9de9-af2ad2f4520c" xlink:href="holx-20210626.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_fb73de15-11e6-44f8-9de9-af2ad2f4520c" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_4368fcd7-5428-4fc3-9445-59e7823bfce5" xlink:href="holx-20210626.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_4368fcd7-5428-4fc3-9445-59e7823bfce5" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_41bb7c14-b356-4ef4-b624-5e30081b1521" xlink:href="holx-20210626.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_41bb7c14-b356-4ef4-b624-5e30081b1521" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationAdditionalSharesAcquiredShares_e877ac87-fd5c-4add-ba11-f15682513983" xlink:href="holx-20210626.xsd#holx_BusinessCombinationAdditionalSharesAcquiredShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_BusinessCombinationAdditionalSharesAcquiredShares_e877ac87-fd5c-4add-ba11-f15682513983" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationAdditionalSharesAcquiredValue_1ccffdfc-8f4d-4677-8aff-0e80ab3b13f0" xlink:href="holx-20210626.xsd#holx_BusinessCombinationAdditionalSharesAcquiredValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_BusinessCombinationAdditionalSharesAcquiredValue_1ccffdfc-8f4d-4677-8aff-0e80ab3b13f0" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FairValueAssumptionDiscountRate_c85fbd8e-8ac8-4ea8-aae1-358bd2a3c9be" xlink:href="holx-20210626.xsd#holx_FairValueAssumptionDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_FairValueAssumptionDiscountRate_c85fbd8e-8ac8-4ea8-aae1-358bd2a3c9be" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c8ef2378-7379-4b48-999b-ec90851a7e46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c8ef2378-7379-4b48-999b-ec90851a7e46" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_99dc0aa8-644d-483e-badf-8ca1b95cb811" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c8ef2378-7379-4b48-999b-ec90851a7e46" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_99dc0aa8-644d-483e-badf-8ca1b95cb811" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_99dc0aa8-644d-483e-badf-8ca1b95cb811_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_99dc0aa8-644d-483e-badf-8ca1b95cb811" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_99dc0aa8-644d-483e-badf-8ca1b95cb811_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9640387e-b989-423c-b1e3-6ba03bb38bca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_99dc0aa8-644d-483e-badf-8ca1b95cb811" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9640387e-b989-423c-b1e3-6ba03bb38bca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MobidiagOyMember_5cf4e84a-3dfb-4f30-b7ca-bdb742eec27e" xlink:href="holx-20210626.xsd#holx_MobidiagOyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9640387e-b989-423c-b1e3-6ba03bb38bca" xlink:to="loc_holx_MobidiagOyMember_5cf4e84a-3dfb-4f30-b7ca-bdb742eec27e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BiotheranosticsMember_fb4a3688-3e69-40af-a801-ae80b04f84e5" xlink:href="holx-20210626.xsd#holx_BiotheranosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9640387e-b989-423c-b1e3-6ba03bb38bca" xlink:to="loc_holx_BiotheranosticsMember_fb4a3688-3e69-40af-a801-ae80b04f84e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagenodeMember_488e70a0-d01e-42de-a3a8-bbf68bc04010" xlink:href="holx-20210626.xsd#holx_DiagenodeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9640387e-b989-423c-b1e3-6ba03bb38bca" xlink:to="loc_holx_DiagenodeMember_488e70a0-d01e-42de-a3a8-bbf68bc04010" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SomatexMedicalTechnologiesMember_45f73345-6ecf-4605-aa15-f20e510764c9" xlink:href="holx-20210626.xsd#holx_SomatexMedicalTechnologiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9640387e-b989-423c-b1e3-6ba03bb38bca" xlink:to="loc_holx_SomatexMedicalTechnologiesMember_45f73345-6ecf-4605-aa15-f20e510764c9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NXCImagingMember_6bbf93d9-4268-4871-856e-e5d2df57b566" xlink:href="holx-20210626.xsd#holx_NXCImagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9640387e-b989-423c-b1e3-6ba03bb38bca" xlink:to="loc_holx_NXCImagingMember_6bbf93d9-4268-4871-856e-e5d2df57b566" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_fa91b2a2-560f-41e4-8040-61c235ccbbc9" xlink:href="holx-20210626.xsd#holx_AcessaHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9640387e-b989-423c-b1e3-6ba03bb38bca" xlink:to="loc_holx_AcessaHealthMember_fa91b2a2-560f-41e4-8040-61c235ccbbc9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_HealthBeaconsMember_b3db07aa-d489-4333-ae6b-7f68d22d80a5" xlink:href="holx-20210626.xsd#holx_HealthBeaconsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9640387e-b989-423c-b1e3-6ba03bb38bca" xlink:to="loc_holx_HealthBeaconsMember_b3db07aa-d489-4333-ae6b-7f68d22d80a5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AlphaImagingMember_64a97ffa-8e98-4ad7-849b-9fc63bb8efcb" xlink:href="holx-20210626.xsd#holx_AlphaImagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9640387e-b989-423c-b1e3-6ba03bb38bca" xlink:to="loc_holx_AlphaImagingMember_64a97ffa-8e98-4ad7-849b-9fc63bb8efcb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SuperSonicImagineMember_0182b56f-9bd8-4428-bc81-88dac3a6cc9c" xlink:href="holx-20210626.xsd#holx_SuperSonicImagineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9640387e-b989-423c-b1e3-6ba03bb38bca" xlink:to="loc_holx_SuperSonicImagineMember_0182b56f-9bd8-4428-bc81-88dac3a6cc9c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_4243d672-8cff-42a3-bc42-a0764d43f62b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c8ef2378-7379-4b48-999b-ec90851a7e46" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_4243d672-8cff-42a3-bc42-a0764d43f62b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_4243d672-8cff-42a3-bc42-a0764d43f62b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_4243d672-8cff-42a3-bc42-a0764d43f62b" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_4243d672-8cff-42a3-bc42-a0764d43f62b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_a1a2b277-7b27-4699-b18d-b86abc5f65bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_4243d672-8cff-42a3-bc42-a0764d43f62b" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_a1a2b277-7b27-4699-b18d-b86abc5f65bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ContingentHoldbackMember_0075b26a-ccb7-415f-bcb0-1f82544519ad" xlink:href="holx-20210626.xsd#holx_ContingentHoldbackMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_a1a2b277-7b27-4699-b18d-b86abc5f65bc" xlink:to="loc_holx_ContingentHoldbackMember_0075b26a-ccb7-415f-bcb0-1f82544519ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_56b8f4a5-7a97-4d9e-9841-66323041aae1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c8ef2378-7379-4b48-999b-ec90851a7e46" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_56b8f4a5-7a97-4d9e-9841-66323041aae1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_56b8f4a5-7a97-4d9e-9841-66323041aae1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_56b8f4a5-7a97-4d9e-9841-66323041aae1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_56b8f4a5-7a97-4d9e-9841-66323041aae1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_83d0a54e-dd05-47a1-a32e-14be35a14f13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_56b8f4a5-7a97-4d9e-9841-66323041aae1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_83d0a54e-dd05-47a1-a32e-14be35a14f13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_a0bd42d3-250a-41d2-a158-248b779119e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_83d0a54e-dd05-47a1-a32e-14be35a14f13" xlink:to="loc_us-gaap_CustomerRelationshipsMember_a0bd42d3-250a-41d2-a158-248b779119e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_9e230ce6-b811-405f-be74-d12205730428" xlink:href="holx-20210626.xsd#holx_DevelopedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_83d0a54e-dd05-47a1-a32e-14be35a14f13" xlink:to="loc_holx_DevelopedTechnologyMember_9e230ce6-b811-405f-be74-d12205730428" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_15913130-0f1a-4b35-aae3-0c7f7514f1b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_83d0a54e-dd05-47a1-a32e-14be35a14f13" xlink:to="loc_us-gaap_TradeNamesMember_15913130-0f1a-4b35-aae3-0c7f7514f1b0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d7865881-c9d5-4505-ab74-fbb6618b2d3f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c8ef2378-7379-4b48-999b-ec90851a7e46" xlink:to="loc_srt_RangeAxis_d7865881-c9d5-4505-ab74-fbb6618b2d3f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d7865881-c9d5-4505-ab74-fbb6618b2d3f_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d7865881-c9d5-4505-ab74-fbb6618b2d3f" xlink:to="loc_srt_RangeMember_d7865881-c9d5-4505-ab74-fbb6618b2d3f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f0085273-afe2-46bf-9890-b4b8df103355" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d7865881-c9d5-4505-ab74-fbb6618b2d3f" xlink:to="loc_srt_RangeMember_f0085273-afe2-46bf-9890-b4b8df103355" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2358ce64-ca50-45c4-8902-17f7a5d00d1b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f0085273-afe2-46bf-9890-b4b8df103355" xlink:to="loc_srt_MinimumMember_2358ce64-ca50-45c4-8902-17f7a5d00d1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9a9f6908-89ed-41a5-a4d9-412bf1c76131" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f0085273-afe2-46bf-9890-b4b8df103355" xlink:to="loc_srt_MaximumMember_9a9f6908-89ed-41a5-a4d9-412bf1c76131" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="extended" id="i1ac6e52fc7424f03a20aaf387f496b31_BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_03aa3b9e-5766-44d7-880c-8419e784c7ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_03aa3b9e-5766-44d7-880c-8419e784c7ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_3c55cb53-8207-4653-9738-cfbd39ee253d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_3c55cb53-8207-4653-9738-cfbd39ee253d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_70e159f5-f027-4116-ac25-cd7c9ec37926" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_70e159f5-f027-4116-ac25-cd7c9ec37926" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c46fc1a1-90c2-4396-ac21-ab28eb0706c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c46fc1a1-90c2-4396-ac21-ab28eb0706c0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_59cb32e3-8fc6-4feb-891c-1e31ee2f9cb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_59cb32e3-8fc6-4feb-891c-1e31ee2f9cb8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_08a57502-6663-4617-a66a-44021c074d8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_08a57502-6663-4617-a66a-44021c074d8c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_ff0c378f-c3d8-496f-8dbe-7ae5d06b7200" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_ff0c378f-c3d8-496f-8dbe-7ae5d06b7200" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_0903a5d4-8934-4fda-8921-93e580b7a774" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_0903a5d4-8934-4fda-8921-93e580b7a774" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_a010591e-2946-4f2b-bb17-2234e4744580" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_a010591e-2946-4f2b-bb17-2234e4744580" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_c347705f-6f8a-4fb8-b121-5658684ccca2" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_c347705f-6f8a-4fb8-b121-5658684ccca2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess_1d27b018-33c9-491a-bc3e-1cb7bbcf51b5" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess_1d27b018-33c9-491a-bc3e-1cb7bbcf51b5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_26ffcd45-8b9b-42e1-9d9b-cd4c919ed95f" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_26ffcd45-8b9b-42e1-9d9b-cd4c919ed95f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_568b06fd-0026-4723-833c-186f5a47e221" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_568b06fd-0026-4723-833c-186f5a47e221" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_7eecd64e-a686-40a0-a68a-0e3d89956bd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_7eecd64e-a686-40a0-a68a-0e3d89956bd2" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0c405d7f-e1dc-4111-b4e5-43fb4df668d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0c405d7f-e1dc-4111-b4e5-43fb4df668d5" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_89df20fa-7988-4209-b168-1fe99fc1ae0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_us-gaap_Goodwill_89df20fa-7988-4209-b168-1fe99fc1ae0b" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d80cfdbd-af9d-4230-91a0-b7a71d5b2716" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d80cfdbd-af9d-4230-91a0-b7a71d5b2716" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e2518124-fa0b-40c2-aeb8-6c3f5f431584" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e2518124-fa0b-40c2-aeb8-6c3f5f431584" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d3a12313-dc3b-4cb6-8260-11acee4e0437" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e2518124-fa0b-40c2-aeb8-6c3f5f431584" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d3a12313-dc3b-4cb6-8260-11acee4e0437" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d3a12313-dc3b-4cb6-8260-11acee4e0437_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d3a12313-dc3b-4cb6-8260-11acee4e0437" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d3a12313-dc3b-4cb6-8260-11acee4e0437_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98323aad-fadd-40d9-82a7-c6bedd3c0cff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d3a12313-dc3b-4cb6-8260-11acee4e0437" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98323aad-fadd-40d9-82a7-c6bedd3c0cff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MobidiagOyMember_63aebd2e-1bb6-4783-9e2e-fcb62f5fe1ee" xlink:href="holx-20210626.xsd#holx_MobidiagOyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98323aad-fadd-40d9-82a7-c6bedd3c0cff" xlink:to="loc_holx_MobidiagOyMember_63aebd2e-1bb6-4783-9e2e-fcb62f5fe1ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BiotheranosticsMember_c5d61b5c-7cfc-4f8f-a7f2-93c81c29fb45" xlink:href="holx-20210626.xsd#holx_BiotheranosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98323aad-fadd-40d9-82a7-c6bedd3c0cff" xlink:to="loc_holx_BiotheranosticsMember_c5d61b5c-7cfc-4f8f-a7f2-93c81c29fb45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagenodeMember_e77edcc6-aed9-4abb-b69e-a8962eabe805" xlink:href="holx-20210626.xsd#holx_DiagenodeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98323aad-fadd-40d9-82a7-c6bedd3c0cff" xlink:to="loc_holx_DiagenodeMember_e77edcc6-aed9-4abb-b69e-a8962eabe805" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SuperSonicImagineMember_219e468b-1261-455f-ab37-71f60f898601" xlink:href="holx-20210626.xsd#holx_SuperSonicImagineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98323aad-fadd-40d9-82a7-c6bedd3c0cff" xlink:to="loc_holx_SuperSonicImagineMember_219e468b-1261-455f-ab37-71f60f898601" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_208ddf43-560e-43bd-b219-c7de7655fb2b" xlink:href="holx-20210626.xsd#holx_AcessaHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98323aad-fadd-40d9-82a7-c6bedd3c0cff" xlink:to="loc_holx_AcessaHealthMember_208ddf43-560e-43bd-b219-c7de7655fb2b" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DispositionDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#DispositionDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DispositionDetails" xlink:type="extended" id="if35476d7b1c44d5aa100d12ae70c793c_DispositionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7f8dea2a-8a95-4c2c-a325-6e911cdf4814" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_58b5e890-703f-404c-97c2-f65b80d1cd96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7f8dea2a-8a95-4c2c-a325-6e911cdf4814" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_58b5e890-703f-404c-97c2-f65b80d1cd96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_0da91749-3191-4845-88df-3774577614be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7f8dea2a-8a95-4c2c-a325-6e911cdf4814" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_0da91749-3191-4845-88df-3774577614be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IndemnificationLiability_44d8aee7-f602-4505-b00a-fd1621268c80" xlink:href="holx-20210626.xsd#holx_IndemnificationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7f8dea2a-8a95-4c2c-a325-6e911cdf4814" xlink:to="loc_holx_IndemnificationLiability_44d8aee7-f602-4505-b00a-fd1621268c80" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_db447216-cd0f-495d-9428-7220e36b7adb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7f8dea2a-8a95-4c2c-a325-6e911cdf4814" xlink:to="loc_us-gaap_AssetImpairmentCharges_db447216-cd0f-495d-9428-7220e36b7adb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_4c78aec8-7d3a-4128-a563-c142cabb45cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7f8dea2a-8a95-4c2c-a325-6e911cdf4814" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_4c78aec8-7d3a-4128-a563-c142cabb45cf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup_706b7cf6-8743-4cca-a185-755e1278ffc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7f8dea2a-8a95-4c2c-a325-6e911cdf4814" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup_706b7cf6-8743-4cca-a185-755e1278ffc5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_02f174bc-7494-4f08-80a6-1e61ec6dcffd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7f8dea2a-8a95-4c2c-a325-6e911cdf4814" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_02f174bc-7494-4f08-80a6-1e61ec6dcffd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_05ed65e4-087f-45d1-b023-3fa305a68b65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_02f174bc-7494-4f08-80a6-1e61ec6dcffd" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_05ed65e4-087f-45d1-b023-3fa305a68b65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_05ed65e4-087f-45d1-b023-3fa305a68b65_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_05ed65e4-087f-45d1-b023-3fa305a68b65" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_05ed65e4-087f-45d1-b023-3fa305a68b65_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5115ed43-2373-48d4-9e95-5e7c385dc0cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_05ed65e4-087f-45d1-b023-3fa305a68b65" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5115ed43-2373-48d4-9e95-5e7c385dc0cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_57d255ce-379f-49fc-ac53-72929025d463" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5115ed43-2373-48d4-9e95-5e7c385dc0cb" xlink:to="loc_us-gaap_CostOfSalesMember_57d255ce-379f-49fc-ac53-72929025d463" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenseMember_9439c94b-82c5-419d-982a-74adad608449" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5115ed43-2373-48d4-9e95-5e7c385dc0cb" xlink:to="loc_us-gaap_OperatingExpenseMember_9439c94b-82c5-419d-982a-74adad608449" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_40754a4c-2e78-44b7-ab9f-60e70beaf8c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_02f174bc-7494-4f08-80a6-1e61ec6dcffd" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_40754a4c-2e78-44b7-ab9f-60e70beaf8c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_40754a4c-2e78-44b7-ab9f-60e70beaf8c8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_40754a4c-2e78-44b7-ab9f-60e70beaf8c8" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_40754a4c-2e78-44b7-ab9f-60e70beaf8c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d856b36c-ca63-4cb6-bb1e-394035a2f58d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_40754a4c-2e78-44b7-ab9f-60e70beaf8c8" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d856b36c-ca63-4cb6-bb1e-394035a2f58d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_24f34915-ce46-4f64-b16a-915fb9a659c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_d856b36c-ca63-4cb6-bb1e-394035a2f58d" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_24f34915-ce46-4f64-b16a-915fb9a659c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_71dc922f-89ba-40c1-8c27-ff62a646cb43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_02f174bc-7494-4f08-80a6-1e61ec6dcffd" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_71dc922f-89ba-40c1-8c27-ff62a646cb43" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_71dc922f-89ba-40c1-8c27-ff62a646cb43_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_71dc922f-89ba-40c1-8c27-ff62a646cb43" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_71dc922f-89ba-40c1-8c27-ff62a646cb43_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_07225120-a6d1-46c1-b283-cc7f2056d9f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_71dc922f-89ba-40c1-8c27-ff62a646cb43" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_07225120-a6d1-46c1-b283-cc7f2056d9f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_b46eebe4-5a49-42cd-97e7-3af6e75f381a" xlink:href="holx-20210626.xsd#holx_MedicalAestheticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_07225120-a6d1-46c1-b283-cc7f2056d9f6" xlink:to="loc_holx_MedicalAestheticsMember_b46eebe4-5a49-42cd-97e7-3af6e75f381a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#BorrowingsandCreditArrangementsCompanysBorrowingsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="extended" id="id8ab7b655bc24af9a1d98e7791701b52_BorrowingsandCreditArrangementsCompanysBorrowingsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_69edbeff-b84a-491a-93ed-5d8fe7ca1d4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_218913c2-060c-4405-928a-dbb8b2f26453" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_69edbeff-b84a-491a-93ed-5d8fe7ca1d4f" xlink:to="loc_us-gaap_LongTermDebtCurrent_218913c2-060c-4405-928a-dbb8b2f26453" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_4904b4aa-461b-4177-b73d-f3b863112c8e" xlink:href="holx-20210626.xsd#holx_LongTermDebtObligationsWithoutConvertibleNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_69edbeff-b84a-491a-93ed-5d8fe7ca1d4f" xlink:to="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_4904b4aa-461b-4177-b73d-f3b863112c8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_1f4f00e6-2060-48e3-82af-5d41ed33591d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_69edbeff-b84a-491a-93ed-5d8fe7ca1d4f" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_1f4f00e6-2060-48e3-82af-5d41ed33591d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_cccc207f-3bb7-4bf9-a87a-380bb2b989be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_69edbeff-b84a-491a-93ed-5d8fe7ca1d4f" xlink:to="loc_us-gaap_LongTermDebt_cccc207f-3bb7-4bf9-a87a-380bb2b989be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_1d2cb7cb-e9c5-4e77-9f96-6aa4fd0fef82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_69edbeff-b84a-491a-93ed-5d8fe7ca1d4f" xlink:to="loc_us-gaap_DebtInstrumentTable_1d2cb7cb-e9c5-4e77-9f96-6aa4fd0fef82" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_984002a8-a312-4ca3-86fd-35d5403c7fbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_1d2cb7cb-e9c5-4e77-9f96-6aa4fd0fef82" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_984002a8-a312-4ca3-86fd-35d5403c7fbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_984002a8-a312-4ca3-86fd-35d5403c7fbf_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_984002a8-a312-4ca3-86fd-35d5403c7fbf" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_984002a8-a312-4ca3-86fd-35d5403c7fbf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1701b899-d708-4c8c-afd2-0477857b2c84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_984002a8-a312-4ca3-86fd-35d5403c7fbf" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1701b899-d708-4c8c-afd2-0477857b2c84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember_3c079caa-e9f3-427e-8daf-397b722404ed" xlink:href="holx-20210626.xsd#holx_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1701b899-d708-4c8c-afd2-0477857b2c84" xlink:to="loc_holx_TermLoanMember_3c079caa-e9f3-427e-8daf-397b722404ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevolverMember_be774fa9-4a24-4e22-88ea-2e01ded298e6" xlink:href="holx-20210626.xsd#holx_RevolverMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1701b899-d708-4c8c-afd2-0477857b2c84" xlink:to="loc_holx_RevolverMember_be774fa9-4a24-4e22-88ea-2e01ded298e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_a0518c08-3249-449c-8c44-a71c0d86350d" xlink:href="holx-20210626.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1701b899-d708-4c8c-afd2-0477857b2c84" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_a0518c08-3249-449c-8c44-a71c0d86350d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_ea191a31-c811-4ee3-9321-eef9f0042c3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1701b899-d708-4c8c-afd2-0477857b2c84" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_ea191a31-c811-4ee3-9321-eef9f0042c3c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_9e120d5d-187d-4d21-ad31-26be11601e73" xlink:href="holx-20210626.xsd#holx_A2025SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1701b899-d708-4c8c-afd2-0477857b2c84" xlink:to="loc_holx_A2025SeniorNotesMember_9e120d5d-187d-4d21-ad31-26be11601e73" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_75e05d48-47e6-4a1d-9b36-03028e5d2c07" xlink:href="holx-20210626.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1701b899-d708-4c8c-afd2-0477857b2c84" xlink:to="loc_holx_A2028SeniorNotesMember_75e05d48-47e6-4a1d-9b36-03028e5d2c07" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_52a12c2b-bc47-4f3b-8740-4cab8eb11102" xlink:href="holx-20210626.xsd#holx_A2029SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1701b899-d708-4c8c-afd2-0477857b2c84" xlink:to="loc_holx_A2029SeniorNotesMember_52a12c2b-bc47-4f3b-8740-4cab8eb11102" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#BorrowingsandCreditArrangementsAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail" xlink:type="extended" id="iec6c27fe20a5439c8f94fa0972b1c582_BorrowingsandCreditArrangementsAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_729c0af7-239d-4231-a662-ce3f8212c9c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_729c0af7-239d-4231-a662-ce3f8212c9c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_fc1fa81e-7fbe-4a32-8e5c-680616f8ea9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_us-gaap_LongTermDebt_fc1fa81e-7fbe-4a32-8e5c-680616f8ea9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_62276867-e9f8-4518-b6af-64bc7b7894e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_62276867-e9f8-4518-b6af-64bc7b7894e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_32d44ece-ddd8-4a31-9c65-142979de6a18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_32d44ece-ddd8-4a31-9c65-142979de6a18" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_f807525f-6a34-434a-99a1-8813066acb54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_f807525f-6a34-434a-99a1-8813066acb54" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_31c2c244-bc04-4047-8cc4-0e979146d3d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_us-gaap_LongTermDebtCurrent_31c2c244-bc04-4047-8cc4-0e979146d3d0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_52ed67f0-0359-4d29-b39a-ebfc5ec38d92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_us-gaap_RepaymentsOfDebt_52ed67f0-0359-4d29-b39a-ebfc5ec38d92" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_51448a73-bdbf-4449-9507-5ce7e62238e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_51448a73-bdbf-4449-9507-5ce7e62238e3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_2a984e8b-a80b-4e48-8443-911b53aa790a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_us-gaap_SeniorNotes_2a984e8b-a80b-4e48-8443-911b53aa790a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentOfferingPricePercentOfFaceValue_26f74cfb-496e-4d50-9b38-18cb7b9df468" xlink:href="holx-20210626.xsd#holx_DebtInstrumentOfferingPricePercentOfFaceValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_holx_DebtInstrumentOfferingPricePercentOfFaceValue_26f74cfb-496e-4d50-9b38-18cb7b9df468" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_f5c9eddf-c689-438a-86d4-4bfea3aaad44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_f5c9eddf-c689-438a-86d4-4bfea3aaad44" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_0c6e4737-12b4-4f1e-b50a-9812b478da76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_us-gaap_InterestExpenseDebt_0c6e4737-12b4-4f1e-b50a-9812b478da76" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_239892f9-5053-45c2-8832-5d206a83256f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_239892f9-5053-45c2-8832-5d206a83256f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_fc31eea6-3e7b-4d6e-a086-ac8367343a93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_fc31eea6-3e7b-4d6e-a086-ac8367343a93" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e7a8f883-aa34-4852-9a2e-732826fe4c5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e7a8f883-aa34-4852-9a2e-732826fe4c5c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtRedemptionPremiumPaid_9a341902-4e5f-4248-8521-de38d907d833" xlink:href="holx-20210626.xsd#holx_DebtRedemptionPremiumPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_holx_DebtRedemptionPremiumPaid_9a341902-4e5f-4248-8521-de38d907d833" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_57e4f53e-96db-43bb-b03f-835ae2a36af6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_57e4f53e-96db-43bb-b03f-835ae2a36af6" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumBorrowingUnderAssetSecuritizationAgreement_f8e581a8-1a45-40ee-bc19-a55799554a69" xlink:href="holx-20210626.xsd#holx_MaximumBorrowingUnderAssetSecuritizationAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_holx_MaximumBorrowingUnderAssetSecuritizationAgreement_f8e581a8-1a45-40ee-bc19-a55799554a69" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_e35af8b6-c1a6-4699-bd1b-006e1231563d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_e35af8b6-c1a6-4699-bd1b-006e1231563d" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c6e55fcf-e03c-4d03-8b62-861c16d215d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_us-gaap_DebtInstrumentTable_c6e55fcf-e03c-4d03-8b62-861c16d215d9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7923bade-0584-4d0a-9bec-2467568e9da3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c6e55fcf-e03c-4d03-8b62-861c16d215d9" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7923bade-0584-4d0a-9bec-2467568e9da3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7923bade-0584-4d0a-9bec-2467568e9da3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7923bade-0584-4d0a-9bec-2467568e9da3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7923bade-0584-4d0a-9bec-2467568e9da3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_04f8ec9c-b8bb-4683-85f2-99d61aed96ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7923bade-0584-4d0a-9bec-2467568e9da3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_04f8ec9c-b8bb-4683-85f2-99d61aed96ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevolverMember_d661ba7d-5775-4033-9cfe-0888ffaee481" xlink:href="holx-20210626.xsd#holx_RevolverMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_04f8ec9c-b8bb-4683-85f2-99d61aed96ae" xlink:to="loc_holx_RevolverMember_d661ba7d-5775-4033-9cfe-0888ffaee481" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmendedTermLoanMember_6719ece2-3257-43ac-ad89-6a86383a147c" xlink:href="holx-20210626.xsd#holx_AmendedTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_04f8ec9c-b8bb-4683-85f2-99d61aed96ae" xlink:to="loc_holx_AmendedTermLoanMember_6719ece2-3257-43ac-ad89-6a86383a147c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_00203cef-3224-479d-af24-a45ddc6316a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_04f8ec9c-b8bb-4683-85f2-99d61aed96ae" xlink:to="loc_us-gaap_SeniorNotesMember_00203cef-3224-479d-af24-a45ddc6316a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_8573c58e-e6c0-4a01-b9b1-200f1c81e4d5" xlink:href="holx-20210626.xsd#holx_A2025SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_04f8ec9c-b8bb-4683-85f2-99d61aed96ae" xlink:to="loc_holx_A2025SeniorNotesMember_8573c58e-e6c0-4a01-b9b1-200f1c81e4d5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_72c27ed6-fae5-4bf7-887d-3c8c8614afc1" xlink:href="holx-20210626.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_04f8ec9c-b8bb-4683-85f2-99d61aed96ae" xlink:to="loc_holx_A2028SeniorNotesMember_72c27ed6-fae5-4bf7-887d-3c8c8614afc1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_c59394d6-fc68-46b9-8332-c96fb2ed44ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_04f8ec9c-b8bb-4683-85f2-99d61aed96ae" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_c59394d6-fc68-46b9-8332-c96fb2ed44ff" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember_ba094eb2-6978-475f-ae4c-8348883aa72c" xlink:href="holx-20210626.xsd#holx_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_04f8ec9c-b8bb-4683-85f2-99d61aed96ae" xlink:to="loc_holx_TermLoanMember_ba094eb2-6978-475f-ae4c-8348883aa72c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_d902eaa9-269c-4a67-8788-71515eb2c079" xlink:href="holx-20210626.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_04f8ec9c-b8bb-4683-85f2-99d61aed96ae" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_d902eaa9-269c-4a67-8788-71515eb2c079" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_bde4861c-6b7f-4610-8e15-ae64d9a1a3da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c6e55fcf-e03c-4d03-8b62-861c16d215d9" xlink:to="loc_us-gaap_DebtInstrumentAxis_bde4861c-6b7f-4610-8e15-ae64d9a1a3da" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_bde4861c-6b7f-4610-8e15-ae64d9a1a3da_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_bde4861c-6b7f-4610-8e15-ae64d9a1a3da" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_bde4861c-6b7f-4610-8e15-ae64d9a1a3da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ddb20d3a-f5fa-468a-9ac5-53a86dbc1095" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_bde4861c-6b7f-4610-8e15-ae64d9a1a3da" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ddb20d3a-f5fa-468a-9ac5-53a86dbc1095" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmendedTermLoanMember_b7c1f250-08a1-48d0-8c50-15204c4ff63a" xlink:href="holx-20210626.xsd#holx_AmendedTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ddb20d3a-f5fa-468a-9ac5-53a86dbc1095" xlink:to="loc_holx_AmendedTermLoanMember_b7c1f250-08a1-48d0-8c50-15204c4ff63a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember_693bf82c-4ef6-47ef-924f-f6b45195752e" xlink:href="holx-20210626.xsd#holx_CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ddb20d3a-f5fa-468a-9ac5-53a86dbc1095" xlink:to="loc_holx_CreditAgreementMember_693bf82c-4ef6-47ef-924f-f6b45195752e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_938eab67-1c15-48a0-bee4-78442c4e188e" xlink:href="holx-20210626.xsd#holx_A2025SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ddb20d3a-f5fa-468a-9ac5-53a86dbc1095" xlink:to="loc_holx_A2025SeniorNotesMember_938eab67-1c15-48a0-bee4-78442c4e188e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_f82fb057-c749-4280-8aa2-0477933ebaf2" xlink:href="holx-20210626.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ddb20d3a-f5fa-468a-9ac5-53a86dbc1095" xlink:to="loc_holx_A2028SeniorNotesMember_f82fb057-c749-4280-8aa2-0477933ebaf2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_f3861eca-20fc-4ece-8d76-d3af29f88994" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ddb20d3a-f5fa-468a-9ac5-53a86dbc1095" xlink:to="loc_us-gaap_SeniorNotesMember_f3861eca-20fc-4ece-8d76-d3af29f88994" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_dbe895ef-e2be-4827-8d07-9f28f0fc4c4e" xlink:href="holx-20210626.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ddb20d3a-f5fa-468a-9ac5-53a86dbc1095" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_dbe895ef-e2be-4827-8d07-9f28f0fc4c4e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_b252be82-00ec-4de3-abf3-d8d5efe4235f" xlink:href="holx-20210626.xsd#holx_A2029SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ddb20d3a-f5fa-468a-9ac5-53a86dbc1095" xlink:to="loc_holx_A2029SeniorNotesMember_b252be82-00ec-4de3-abf3-d8d5efe4235f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevolverMember_9370a249-dfe7-43d1-b7e1-299e27813a07" xlink:href="holx-20210626.xsd#holx_RevolverMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ddb20d3a-f5fa-468a-9ac5-53a86dbc1095" xlink:to="loc_holx_RevolverMember_9370a249-dfe7-43d1-b7e1-299e27813a07" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_eb1856ee-b1cc-4a2d-b633-b223fbccfe38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c6e55fcf-e03c-4d03-8b62-861c16d215d9" xlink:to="loc_us-gaap_FinancialInstrumentAxis_eb1856ee-b1cc-4a2d-b633-b223fbccfe38" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eb1856ee-b1cc-4a2d-b633-b223fbccfe38_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_eb1856ee-b1cc-4a2d-b633-b223fbccfe38" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_eb1856ee-b1cc-4a2d-b633-b223fbccfe38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7b8e9d27-a8b4-4a57-89a4-507a16ce6e08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_eb1856ee-b1cc-4a2d-b633-b223fbccfe38" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7b8e9d27-a8b4-4a57-89a4-507a16ce6e08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageAddedtoEurodollarRateMember_4da735c2-5d8c-47d1-b13d-8e0dd234ad5c" xlink:href="holx-20210626.xsd#holx_PercentageAddedtoEurodollarRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7b8e9d27-a8b4-4a57-89a4-507a16ce6e08" xlink:to="loc_holx_PercentageAddedtoEurodollarRateMember_4da735c2-5d8c-47d1-b13d-8e0dd234ad5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_574701e1-397b-4870-af46-16935c29e315" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c6e55fcf-e03c-4d03-8b62-861c16d215d9" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_574701e1-397b-4870-af46-16935c29e315" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_574701e1-397b-4870-af46-16935c29e315_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_574701e1-397b-4870-af46-16935c29e315" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_574701e1-397b-4870-af46-16935c29e315_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_fe098ed3-6f2f-415c-96c9-35e939a24476" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_574701e1-397b-4870-af46-16935c29e315" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_fe098ed3-6f2f-415c-96c9-35e939a24476" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_70d07e99-98dc-43ae-b7a7-c3020bb8a96b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_fe098ed3-6f2f-415c-96c9-35e939a24476" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_70d07e99-98dc-43ae-b7a7-c3020bb8a96b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_b6b4caae-0e68-469c-b6f8-8661f690ea70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_fe098ed3-6f2f-415c-96c9-35e939a24476" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_b6b4caae-0e68-469c-b6f8-8661f690ea70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_784fb3b5-4f25-403f-a9fc-44c8ccbea7a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_fe098ed3-6f2f-415c-96c9-35e939a24476" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_784fb3b5-4f25-403f-a9fc-44c8ccbea7a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_09dafc4f-6688-4c2d-b580-09d3a53bfe79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_fe098ed3-6f2f-415c-96c9-35e939a24476" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_09dafc4f-6688-4c2d-b580-09d3a53bfe79" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_7b164839-3d26-4aec-9ff2-62c39d511185" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_fe098ed3-6f2f-415c-96c9-35e939a24476" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_7b164839-3d26-4aec-9ff2-62c39d511185" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cd8bf7b0-07df-400d-b1f0-39b900cf0632" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c6e55fcf-e03c-4d03-8b62-861c16d215d9" xlink:to="loc_srt_RangeAxis_cd8bf7b0-07df-400d-b1f0-39b900cf0632" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cd8bf7b0-07df-400d-b1f0-39b900cf0632_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_cd8bf7b0-07df-400d-b1f0-39b900cf0632" xlink:to="loc_srt_RangeMember_cd8bf7b0-07df-400d-b1f0-39b900cf0632_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_86cdda0d-679e-47ad-b5a3-41e27226bd12" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_cd8bf7b0-07df-400d-b1f0-39b900cf0632" xlink:to="loc_srt_RangeMember_86cdda0d-679e-47ad-b5a3-41e27226bd12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_822c49c8-679c-477b-9726-ae955800dfbf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_86cdda0d-679e-47ad-b5a3-41e27226bd12" xlink:to="loc_srt_MinimumMember_822c49c8-679c-477b-9726-ae955800dfbf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_46aa5a47-d733-4fd0-acba-8bcc83bb14c4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_86cdda0d-679e-47ad-b5a3-41e27226bd12" xlink:to="loc_srt_MaximumMember_46aa5a47-d733-4fd0-acba-8bcc83bb14c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_36e9bc9b-faa4-4880-bef1-a747f05a9bb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_c6e55fcf-e03c-4d03-8b62-861c16d215d9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_36e9bc9b-faa4-4880-bef1-a747f05a9bb7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_36e9bc9b-faa4-4880-bef1-a747f05a9bb7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_36e9bc9b-faa4-4880-bef1-a747f05a9bb7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_36e9bc9b-faa4-4880-bef1-a747f05a9bb7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0ed584bc-791b-4b3f-b997-3d25f678b9ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_36e9bc9b-faa4-4880-bef1-a747f05a9bb7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0ed584bc-791b-4b3f-b997-3d25f678b9ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MobidiagOyMember_bf4fd532-d9ad-41c8-a861-9c78c75d1483" xlink:href="holx-20210626.xsd#holx_MobidiagOyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0ed584bc-791b-4b3f-b997-3d25f678b9ab" xlink:to="loc_holx_MobidiagOyMember_bf4fd532-d9ad-41c8-a861-9c78c75d1483" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" xlink:type="extended" id="icc8e8e518e2047b3a54fbd4181fc4d4a_BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_9bdac77e-c8d0-4c6d-9d17-644395c335b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_743e000d-b3da-4917-871d-9643f2b29b00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9bdac77e-c8d0-4c6d-9d17-644395c335b1" xlink:to="loc_us-gaap_InterestExpenseBorrowings_743e000d-b3da-4917-871d-9643f2b29b00" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_123e70e4-65c0-4759-b216-d7c15fa28bab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9bdac77e-c8d0-4c6d-9d17-644395c335b1" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_123e70e4-65c0-4759-b216-d7c15fa28bab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_9ca7b1f0-040d-459d-8f67-c0c34e3fd86d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9bdac77e-c8d0-4c6d-9d17-644395c335b1" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_9ca7b1f0-040d-459d-8f67-c0c34e3fd86d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_03cd8246-7797-4b48-9980-84a001134c64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9bdac77e-c8d0-4c6d-9d17-644395c335b1" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_03cd8246-7797-4b48-9980-84a001134c64" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_df41ac5b-c3fb-4337-aa18-67ca2531092a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_03cd8246-7797-4b48-9980-84a001134c64" xlink:to="loc_us-gaap_DebtInstrumentAxis_df41ac5b-c3fb-4337-aa18-67ca2531092a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_df41ac5b-c3fb-4337-aa18-67ca2531092a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_df41ac5b-c3fb-4337-aa18-67ca2531092a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_df41ac5b-c3fb-4337-aa18-67ca2531092a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e3b08bcb-5964-4e34-a317-48ac30f174e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_df41ac5b-c3fb-4337-aa18-67ca2531092a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e3b08bcb-5964-4e34-a317-48ac30f174e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember_afc45884-2983-4171-8e1d-4a5d0f4144d2" xlink:href="holx-20210626.xsd#holx_CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e3b08bcb-5964-4e34-a317-48ac30f174e8" xlink:to="loc_holx_CreditAgreementMember_afc45884-2983-4171-8e1d-4a5d0f4144d2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" xlink:type="extended" id="i8fb808882222459185eeaebebf2f2873_BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_c394fbee-0ccc-4b29-978e-129209699f25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8a319a84-6d96-4e65-840c-41e0d843ad61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c394fbee-0ccc-4b29-978e-129209699f25" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8a319a84-6d96-4e65-840c-41e0d843ad61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_f991c0fa-2b7a-471c-8c56-b714e3876f0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c394fbee-0ccc-4b29-978e-129209699f25" xlink:to="loc_us-gaap_InterestExpenseBorrowings_f991c0fa-2b7a-471c-8c56-b714e3876f0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_bd32cf71-0eb1-4b60-85d1-b1a340a39075" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c394fbee-0ccc-4b29-978e-129209699f25" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_bd32cf71-0eb1-4b60-85d1-b1a340a39075" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_41d0da95-45cb-4688-822d-d909c68d5057" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_bd32cf71-0eb1-4b60-85d1-b1a340a39075" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_41d0da95-45cb-4688-822d-d909c68d5057" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_41d0da95-45cb-4688-822d-d909c68d5057_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_41d0da95-45cb-4688-822d-d909c68d5057" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_41d0da95-45cb-4688-822d-d909c68d5057_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5ab16e9c-292b-4daa-b816-98967f0d9726" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_41d0da95-45cb-4688-822d-d909c68d5057" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5ab16e9c-292b-4daa-b816-98967f0d9726" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_2d959bd4-2a09-4ff6-a0dd-9893fa6ce695" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5ab16e9c-292b-4daa-b816-98967f0d9726" xlink:to="loc_us-gaap_SeniorNotesMember_2d959bd4-2a09-4ff6-a0dd-9893fa6ce695" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_67647cd7-d1b7-4ad1-8f51-dec019dc0fec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_bd32cf71-0eb1-4b60-85d1-b1a340a39075" xlink:to="loc_us-gaap_DebtInstrumentAxis_67647cd7-d1b7-4ad1-8f51-dec019dc0fec" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_67647cd7-d1b7-4ad1-8f51-dec019dc0fec_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_67647cd7-d1b7-4ad1-8f51-dec019dc0fec" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_67647cd7-d1b7-4ad1-8f51-dec019dc0fec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b84011df-ba38-454c-91a2-0e3f9448dc41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_67647cd7-d1b7-4ad1-8f51-dec019dc0fec" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b84011df-ba38-454c-91a2-0e3f9448dc41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_ce3d6cab-6008-4732-9b32-2a724e97d78d" xlink:href="holx-20210626.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b84011df-ba38-454c-91a2-0e3f9448dc41" xlink:to="loc_holx_A2028SeniorNotesMember_ce3d6cab-6008-4732-9b32-2a724e97d78d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_541e8ec0-4874-47fa-b755-7461c765b155" xlink:href="holx-20210626.xsd#holx_A2025SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b84011df-ba38-454c-91a2-0e3f9448dc41" xlink:to="loc_holx_A2025SeniorNotesMember_541e8ec0-4874-47fa-b755-7461c765b155" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_dafb40b2-7e87-4b9e-8426-f28427c84bdb" xlink:href="holx-20210626.xsd#holx_A2029SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b84011df-ba38-454c-91a2-0e3f9448dc41" xlink:to="loc_holx_A2029SeniorNotesMember_dafb40b2-7e87-4b9e-8426-f28427c84bdb" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesAdditionalInformationDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#DerivativesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DerivativesAdditionalInformationDetails" xlink:type="extended" id="i891a5eabcc3043e6a98a3bc8c01381d2_DerivativesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_f0c4aa91-c9c2-4559-89df-39c178520139" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable_bc57870d-5b27-4aad-a017-14302e5c5436" xlink:href="holx-20210626.xsd#holx_InterestRateCapAgreementsAggregatePremiumPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_f0c4aa91-c9c2-4559-89df-39c178520139" xlink:to="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable_bc57870d-5b27-4aad-a017-14302e5c5436" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrincipalAmountOfBorrowings_33b1f513-2aec-414d-a5a7-5261a485ddc1" xlink:href="holx-20210626.xsd#holx_PrincipalAmountOfBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_f0c4aa91-c9c2-4559-89df-39c178520139" xlink:to="loc_holx_PrincipalAmountOfBorrowings_33b1f513-2aec-414d-a5a7-5261a485ddc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_28fbc374-9098-4752-b739-ab72d2ffe6c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_f0c4aa91-c9c2-4559-89df-39c178520139" xlink:to="loc_us-gaap_DerivativeNotionalAmount_28fbc374-9098-4752-b739-ab72d2ffe6c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate_9f17df8c-dfd0-4975-83e9-8bfad8b346a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_f0c4aa91-c9c2-4559-89df-39c178520139" xlink:to="loc_us-gaap_DerivativeVariableInterestRate_9f17df8c-dfd0-4975-83e9-8bfad8b346a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_ac893e19-49ee-4bdc-9581-cd20e8d26589" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_f0c4aa91-c9c2-4559-89df-39c178520139" xlink:to="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_ac893e19-49ee-4bdc-9581-cd20e8d26589" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NotationalAmount_9cad12bd-082a-473b-a1b1-dde7dea16bd9" xlink:href="holx-20210626.xsd#holx_NotationalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_f0c4aa91-c9c2-4559-89df-39c178520139" xlink:to="loc_holx_NotationalAmount_9cad12bd-082a-473b-a1b1-dde7dea16bd9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_7dc18f90-d221-4fd1-a1a2-f71a2cbf6524" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_f0c4aa91-c9c2-4559-89df-39c178520139" xlink:to="loc_us-gaap_DerivativeTable_7dc18f90-d221-4fd1-a1a2-f71a2cbf6524" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_38ebb5be-79f5-466a-a8f8-eb00671f4571" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_7dc18f90-d221-4fd1-a1a2-f71a2cbf6524" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_38ebb5be-79f5-466a-a8f8-eb00671f4571" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_38ebb5be-79f5-466a-a8f8-eb00671f4571_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_38ebb5be-79f5-466a-a8f8-eb00671f4571" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_38ebb5be-79f5-466a-a8f8-eb00671f4571_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_58407cbc-116e-4e0c-8729-00b0cffaba46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_38ebb5be-79f5-466a-a8f8-eb00671f4571" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_58407cbc-116e-4e0c-8729-00b0cffaba46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_2adf2556-3808-48b9-88dc-4ae97a88e545" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_58407cbc-116e-4e0c-8729-00b0cffaba46" xlink:to="loc_us-gaap_InterestRateSwapMember_2adf2556-3808-48b9-88dc-4ae97a88e545" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_dee19026-e881-4a17-a549-2b69301abd0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_58407cbc-116e-4e0c-8729-00b0cffaba46" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_dee19026-e881-4a17-a549-2b69301abd0f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails" xlink:type="extended" id="i9f5a829544e2472690ac39b8e5351d9d_DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0023d1e7-ff67-4096-93da-7425e31b5998" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_21256a78-bc3f-4ecb-9bd1-06fc659703cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0023d1e7-ff67-4096-93da-7425e31b5998" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_21256a78-bc3f-4ecb-9bd1-06fc659703cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_24dfa582-7037-413a-9372-b5a6e3027f68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0023d1e7-ff67-4096-93da-7425e31b5998" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_24dfa582-7037-413a-9372-b5a6e3027f68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_e14ff7c3-5f33-4d65-8837-3580ad22b49c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0023d1e7-ff67-4096-93da-7425e31b5998" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_e14ff7c3-5f33-4d65-8837-3580ad22b49c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a0c96686-e503-41e9-9d3d-4ade4f4e966f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0023d1e7-ff67-4096-93da-7425e31b5998" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a0c96686-e503-41e9-9d3d-4ade4f4e966f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8c57c533-2c37-4c1f-8674-1128b1b876e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a0c96686-e503-41e9-9d3d-4ade4f4e966f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8c57c533-2c37-4c1f-8674-1128b1b876e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8c57c533-2c37-4c1f-8674-1128b1b876e2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8c57c533-2c37-4c1f-8674-1128b1b876e2" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8c57c533-2c37-4c1f-8674-1128b1b876e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0b77ec31-6832-48de-86ac-818d51a7cf84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8c57c533-2c37-4c1f-8674-1128b1b876e2" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0b77ec31-6832-48de-86ac-818d51a7cf84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_9feca2de-ab73-4b3b-a80a-86f4436fa582" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0b77ec31-6832-48de-86ac-818d51a7cf84" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_9feca2de-ab73-4b3b-a80a-86f4436fa582" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_893e1342-39d6-4956-bb76-cf7a9e9dcf2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0b77ec31-6832-48de-86ac-818d51a7cf84" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_893e1342-39d6-4956-bb76-cf7a9e9dcf2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d51e77f4-f31c-4792-85ba-11e1e54316af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a0c96686-e503-41e9-9d3d-4ade4f4e966f" xlink:to="loc_us-gaap_HedgingDesignationAxis_d51e77f4-f31c-4792-85ba-11e1e54316af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d51e77f4-f31c-4792-85ba-11e1e54316af_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_d51e77f4-f31c-4792-85ba-11e1e54316af" xlink:to="loc_us-gaap_HedgingDesignationDomain_d51e77f4-f31c-4792-85ba-11e1e54316af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5aa94975-4694-4f33-9a34-b7a085f020e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_d51e77f4-f31c-4792-85ba-11e1e54316af" xlink:to="loc_us-gaap_HedgingDesignationDomain_5aa94975-4694-4f33-9a34-b7a085f020e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_ba977ceb-ddc9-43be-97bc-72842bb79888" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_5aa94975-4694-4f33-9a34-b7a085f020e5" xlink:to="loc_us-gaap_NondesignatedMember_ba977ceb-ddc9-43be-97bc-72842bb79888" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#DerivativesFairValueofDerivativeFinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails" xlink:type="extended" id="i2306c6a00c5a4dbaa754d05df1345a51_DerivativesFairValueofDerivativeFinancialInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_e4b247f3-3a42-434a-9412-b23473bc1678" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_c495b042-4136-4e75-abb7-45c309b9ae38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_e4b247f3-3a42-434a-9412-b23473bc1678" xlink:to="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_c495b042-4136-4e75-abb7-45c309b9ae38" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_1a24597b-c856-43a7-b02d-c909b6b71489" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_e4b247f3-3a42-434a-9412-b23473bc1678" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_1a24597b-c856-43a7-b02d-c909b6b71489" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_0b3d5aad-aaa5-4bac-8de9-959da688690a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_e4b247f3-3a42-434a-9412-b23473bc1678" xlink:to="loc_us-gaap_DerivativeLiabilities_0b3d5aad-aaa5-4bac-8de9-959da688690a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_32368712-65a3-48f2-bd5b-1ac255864009" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_e4b247f3-3a42-434a-9412-b23473bc1678" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_32368712-65a3-48f2-bd5b-1ac255864009" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_188e47e9-aa4a-44e5-825f-eae6c3475de0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_32368712-65a3-48f2-bd5b-1ac255864009" xlink:to="loc_us-gaap_HedgingDesignationAxis_188e47e9-aa4a-44e5-825f-eae6c3475de0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_188e47e9-aa4a-44e5-825f-eae6c3475de0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_188e47e9-aa4a-44e5-825f-eae6c3475de0" xlink:to="loc_us-gaap_HedgingDesignationDomain_188e47e9-aa4a-44e5-825f-eae6c3475de0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_61dfb6ed-1130-4f2e-84aa-a8f8b042eed0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_188e47e9-aa4a-44e5-825f-eae6c3475de0" xlink:to="loc_us-gaap_HedgingDesignationDomain_61dfb6ed-1130-4f2e-84aa-a8f8b042eed0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_df31a199-78a9-4a8b-9dc0-673fa6774b05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_61dfb6ed-1130-4f2e-84aa-a8f8b042eed0" xlink:to="loc_us-gaap_NondesignatedMember_df31a199-78a9-4a8b-9dc0-673fa6774b05" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_cea25d52-4e67-49ad-9628-5bff29ed7cac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_32368712-65a3-48f2-bd5b-1ac255864009" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_cea25d52-4e67-49ad-9628-5bff29ed7cac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_cea25d52-4e67-49ad-9628-5bff29ed7cac_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_cea25d52-4e67-49ad-9628-5bff29ed7cac" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_cea25d52-4e67-49ad-9628-5bff29ed7cac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b7f0748f-a3bd-4c16-a540-e08ab0ee32e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_cea25d52-4e67-49ad-9628-5bff29ed7cac" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b7f0748f-a3bd-4c16-a540-e08ab0ee32e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_57ecafb4-38a1-49c5-bd7d-43ebfc31b397" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b7f0748f-a3bd-4c16-a540-e08ab0ee32e6" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_57ecafb4-38a1-49c5-bd7d-43ebfc31b397" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_f0827d06-4bea-4902-8f88-1fbeb1d55d36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b7f0748f-a3bd-4c16-a540-e08ab0ee32e6" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_f0827d06-4bea-4902-8f88-1fbeb1d55d36" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_b7dab071-18ef-4c4c-9561-9d8e014b856c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b7f0748f-a3bd-4c16-a540-e08ab0ee32e6" xlink:to="loc_us-gaap_InterestRateSwapMember_b7dab071-18ef-4c4c-9561-9d8e014b856c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_6f63aaa0-c4db-4c56-bd64-65e942b2761d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_32368712-65a3-48f2-bd5b-1ac255864009" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_6f63aaa0-c4db-4c56-bd64-65e942b2761d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6f63aaa0-c4db-4c56-bd64-65e942b2761d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6f63aaa0-c4db-4c56-bd64-65e942b2761d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6f63aaa0-c4db-4c56-bd64-65e942b2761d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7e997265-9606-4d5d-b4ba-f133b52bd57e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6f63aaa0-c4db-4c56-bd64-65e942b2761d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7e997265-9606-4d5d-b4ba-f133b52bd57e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_48baa57d-d9aa-4979-8bf6-830a5e55571b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7e997265-9606-4d5d-b4ba-f133b52bd57e" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_48baa57d-d9aa-4979-8bf6-830a5e55571b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_53cabcbe-342c-4484-8c6d-de0ce3a4758b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7e997265-9606-4d5d-b4ba-f133b52bd57e" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_53cabcbe-342c-4484-8c6d-de0ce3a4758b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_86090936-af0b-459b-9ef6-8fc585f9b528" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7e997265-9606-4d5d-b4ba-f133b52bd57e" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_86090936-af0b-459b-9ef6-8fc585f9b528" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails" xlink:type="extended" id="ice6b1e95634b4d178642a2767353b12d_DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e122bb50-22fe-471d-a556-f1923c2f40d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_a3dc906f-e38c-48ba-9edd-64f880afa8d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e122bb50-22fe-471d-a556-f1923c2f40d1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_a3dc906f-e38c-48ba-9edd-64f880afa8d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_890dc5a5-b08c-4666-a4dc-fbdb68146375" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e122bb50-22fe-471d-a556-f1923c2f40d1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_890dc5a5-b08c-4666-a4dc-fbdb68146375" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e19d33bc-8766-4d02-bd66-5d38b8ece161" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e122bb50-22fe-471d-a556-f1923c2f40d1" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e19d33bc-8766-4d02-bd66-5d38b8ece161" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_ed6fff5a-b725-4310-b866-966499f5c61e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e19d33bc-8766-4d02-bd66-5d38b8ece161" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_ed6fff5a-b725-4310-b866-966499f5c61e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ed6fff5a-b725-4310-b866-966499f5c61e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ed6fff5a-b725-4310-b866-966499f5c61e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ed6fff5a-b725-4310-b866-966499f5c61e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c68f7f77-962c-486f-bda2-a2cb209caeed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ed6fff5a-b725-4310-b866-966499f5c61e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c68f7f77-962c-486f-bda2-a2cb209caeed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_17b17fed-8556-419a-99ff-da23c3b3244f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c68f7f77-962c-486f-bda2-a2cb209caeed" xlink:to="loc_us-gaap_InterestRateSwapMember_17b17fed-8556-419a-99ff-da23c3b3244f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_bb899cd0-1504-416a-a8ed-7cd1cad07dbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c68f7f77-962c-486f-bda2-a2cb209caeed" xlink:to="loc_us-gaap_InterestRateCapMember_bb899cd0-1504-416a-a8ed-7cd1cad07dbb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsandContingenciesDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#CommitmentsandContingenciesDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/CommitmentsandContingenciesDetail" xlink:type="extended" id="i69f56e8cd7274568b06cc93173fcd8c8_CommitmentsandContingenciesDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_30b814d5-bc0e-483b-ba8a-24c0f2cce6a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmountAssessedInDamages_9244485a-2be6-4478-a1ff-dc298d816abd" xlink:href="holx-20210626.xsd#holx_AmountAssessedInDamages"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_30b814d5-bc0e-483b-ba8a-24c0f2cce6a9" xlink:to="loc_holx_AmountAssessedInDamages_9244485a-2be6-4478-a1ff-dc298d816abd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_dac66945-40a0-48ef-b5d8-6fb92c7237ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_30b814d5-bc0e-483b-ba8a-24c0f2cce6a9" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_dac66945-40a0-48ef-b5d8-6fb92c7237ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LegalAccrual_68943323-4a1c-4726-8d47-4f3c56944896" xlink:href="holx-20210626.xsd#holx_LegalAccrual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_30b814d5-bc0e-483b-ba8a-24c0f2cce6a9" xlink:to="loc_holx_LegalAccrual_68943323-4a1c-4726-8d47-4f3c56944896" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_77a8c6c0-0474-4a8a-bfad-018131dc7510" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_30b814d5-bc0e-483b-ba8a-24c0f2cce6a9" xlink:to="loc_us-gaap_LossContingenciesTable_77a8c6c0-0474-4a8a-bfad-018131dc7510" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_2fb235fc-14db-44f5-858e-8f3adf19f6f3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_77a8c6c0-0474-4a8a-bfad-018131dc7510" xlink:to="loc_dei_LegalEntityAxis_2fb235fc-14db-44f5-858e-8f3adf19f6f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_2fb235fc-14db-44f5-858e-8f3adf19f6f3_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_2fb235fc-14db-44f5-858e-8f3adf19f6f3" xlink:to="loc_dei_EntityDomain_2fb235fc-14db-44f5-858e-8f3adf19f6f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_52c8027f-77b2-4ac1-93d0-8e8e8b0aa0e3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_2fb235fc-14db-44f5-858e-8f3adf19f6f3" xlink:to="loc_dei_EntityDomain_52c8027f-77b2-4ac1-93d0-8e8e8b0aa0e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinervaMember_390ce685-8e77-4d3f-b3ed-53cd583a02b1" xlink:href="holx-20210626.xsd#holx_MinervaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_52c8027f-77b2-4ac1-93d0-8e8e8b0aa0e3" xlink:to="loc_holx_MinervaMember_390ce685-8e77-4d3f-b3ed-53cd583a02b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_9709d3cb-b5a1-4961-9c60-beb02913afb2" xlink:href="holx-20210626.xsd#holx_MedicalAestheticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_52c8027f-77b2-4ac1-93d0-8e8e8b0aa0e3" xlink:to="loc_holx_MedicalAestheticsMember_9709d3cb-b5a1-4961-9c60-beb02913afb2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="extended" id="i3eb9b06cca784f7796c42a1e0fed3765_NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareLineItems_d1cc00ca-90e5-47b8-a9f8-8604d0bd51a3" xlink:href="holx-20210626.xsd#holx_EarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_aec50c98-2b4e-4c0c-ab37-3347c96dc86f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_EarningsPerShareLineItems_d1cc00ca-90e5-47b8-a9f8-8604d0bd51a3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_aec50c98-2b4e-4c0c-ab37-3347c96dc86f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4b8f6a4d-3c28-420c-91b4-5797581467cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_EarningsPerShareLineItems_d1cc00ca-90e5-47b8-a9f8-8604d0bd51a3" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4b8f6a4d-3c28-420c-91b4-5797581467cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_85d4207f-6d30-421f-a93a-7cff2628e9f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_EarningsPerShareLineItems_d1cc00ca-90e5-47b8-a9f8-8604d0bd51a3" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_85d4207f-6d30-421f-a93a-7cff2628e9f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_b806dea0-0682-4f80-a8a4-6354c3f2f38a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_EarningsPerShareLineItems_d1cc00ca-90e5-47b8-a9f8-8604d0bd51a3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_b806dea0-0682-4f80-a8a4-6354c3f2f38a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_78af2228-3e44-4dd1-b661-6976557043d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_b806dea0-0682-4f80-a8a4-6354c3f2f38a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_78af2228-3e44-4dd1-b661-6976557043d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareTable_a79ec8c5-5e67-44e0-acd8-c0b54c16f7d3" xlink:href="holx-20210626.xsd#holx_EarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_EarningsPerShareLineItems_d1cc00ca-90e5-47b8-a9f8-8604d0bd51a3" xlink:to="loc_holx_EarningsPerShareTable_a79ec8c5-5e67-44e0-acd8-c0b54c16f7d3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3317f1a4-a5bb-4f5e-b3bc-897335650863" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_EarningsPerShareTable_a79ec8c5-5e67-44e0-acd8-c0b54c16f7d3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3317f1a4-a5bb-4f5e-b3bc-897335650863" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3317f1a4-a5bb-4f5e-b3bc-897335650863_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3317f1a4-a5bb-4f5e-b3bc-897335650863" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3317f1a4-a5bb-4f5e-b3bc-897335650863_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c8aebcf2-d746-4603-935e-7e90ff853fa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3317f1a4-a5bb-4f5e-b3bc-897335650863" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c8aebcf2-d746-4603-935e-7e90ff853fa2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_bd8ce938-9448-4b45-9a28-f8e5218b7ba0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c8aebcf2-d746-4603-935e-7e90ff853fa2" xlink:to="loc_us-gaap_StockCompensationPlanMember_bd8ce938-9448-4b45-9a28-f8e5218b7ba0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_c037a841-db7e-4943-8ba0-714fa8e00d32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c8aebcf2-d746-4603-935e-7e90ff853fa2" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_c037a841-db7e-4943-8ba0-714fa8e00d32" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail" xlink:type="extended" id="ie24ad60bab144317bbf088c47875c62a_StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c5a7480f-f221-49fd-bf66-1f0005e8c499" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_3c5f5b2f-c8c3-4405-a6ca-622baf30de12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c5a7480f-f221-49fd-bf66-1f0005e8c499" xlink:to="loc_us-gaap_ShareBasedCompensation_3c5f5b2f-c8c3-4405-a6ca-622baf30de12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_95a057cf-79eb-4315-8e26-b23c70f09834" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c5a7480f-f221-49fd-bf66-1f0005e8c499" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_95a057cf-79eb-4315-8e26-b23c70f09834" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7529b21c-2fdc-4fd3-b2a8-bc914e0b89a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_95a057cf-79eb-4315-8e26-b23c70f09834" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7529b21c-2fdc-4fd3-b2a8-bc914e0b89a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7529b21c-2fdc-4fd3-b2a8-bc914e0b89a6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7529b21c-2fdc-4fd3-b2a8-bc914e0b89a6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7529b21c-2fdc-4fd3-b2a8-bc914e0b89a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_cdd51534-486d-42cf-b525-c6b7dfb6f2b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7529b21c-2fdc-4fd3-b2a8-bc914e0b89a6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_cdd51534-486d-42cf-b525-c6b7dfb6f2b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_59a5fe9d-ea12-4908-a2ec-17d5589a6474" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cdd51534-486d-42cf-b525-c6b7dfb6f2b7" xlink:to="loc_us-gaap_CostOfSalesMember_59a5fe9d-ea12-4908-a2ec-17d5589a6474" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_e7d98c43-4262-4f40-8667-e73b9079e7bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cdd51534-486d-42cf-b525-c6b7dfb6f2b7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_e7d98c43-4262-4f40-8667-e73b9079e7bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_45422c62-64b2-4d54-9f83-6acaff6406b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cdd51534-486d-42cf-b525-c6b7dfb6f2b7" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_45422c62-64b2-4d54-9f83-6acaff6406b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_299c9c19-a467-490c-b93d-a5e52568bf5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cdd51534-486d-42cf-b525-c6b7dfb6f2b7" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_299c9c19-a467-490c-b93d-a5e52568bf5d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember_5616b789-4245-4677-ab6d-50c3f0787930" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cdd51534-486d-42cf-b525-c6b7dfb6f2b7" xlink:to="loc_us-gaap_RestructuringChargesMember_5616b789-4245-4677-ab6d-50c3f0787930" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#StockBasedCompensationAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:type="extended" id="ibc0a8a6177f640c0bf42754ea838d8f6_StockBasedCompensationAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9acb7d3b-11c8-4b17-825c-b5c1eb54bb1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_378fb95c-38e0-4291-82ad-48a9dcd178c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9acb7d3b-11c8-4b17-825c-b5c1eb54bb1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_378fb95c-38e0-4291-82ad-48a9dcd178c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_74ad7900-232e-4411-bcf9-e665f068ff9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9acb7d3b-11c8-4b17-825c-b5c1eb54bb1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_74ad7900-232e-4411-bcf9-e665f068ff9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_056710bf-b98d-4891-b8ef-c54d2b14e374" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9acb7d3b-11c8-4b17-825c-b5c1eb54bb1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_056710bf-b98d-4891-b8ef-c54d2b14e374" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b5f79729-616d-4a54-bcbe-ce623b7217af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9acb7d3b-11c8-4b17-825c-b5c1eb54bb1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b5f79729-616d-4a54-bcbe-ce623b7217af" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7f4d243e-b31c-4bde-989a-ea0d81f9b627" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9acb7d3b-11c8-4b17-825c-b5c1eb54bb1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7f4d243e-b31c-4bde-989a-ea0d81f9b627" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_bb73a80c-7c7b-4e0c-b078-bed8692fb013" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9acb7d3b-11c8-4b17-825c-b5c1eb54bb1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_bb73a80c-7c7b-4e0c-b078-bed8692fb013" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f7ba3950-c4be-4041-89eb-1fb70f72aed3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9acb7d3b-11c8-4b17-825c-b5c1eb54bb1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f7ba3950-c4be-4041-89eb-1fb70f72aed3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_aba033e3-84da-4d18-99e7-fc11931eaa85" xlink:href="holx-20210626.xsd#holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9acb7d3b-11c8-4b17-825c-b5c1eb54bb1f" xlink:to="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_aba033e3-84da-4d18-99e7-fc11931eaa85" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_82b2543c-adef-4ea3-9bef-f328c5180e9a" xlink:href="holx-20210626.xsd#holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9acb7d3b-11c8-4b17-825c-b5c1eb54bb1f" xlink:to="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_82b2543c-adef-4ea3-9bef-f328c5180e9a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_37a643c8-fe88-4b40-b786-8baad9e2528e" xlink:href="holx-20210626.xsd#holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9acb7d3b-11c8-4b17-825c-b5c1eb54bb1f" xlink:to="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_37a643c8-fe88-4b40-b786-8baad9e2528e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_9b74259a-2813-4da5-86fc-333b1f36daa8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9acb7d3b-11c8-4b17-825c-b5c1eb54bb1f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_9b74259a-2813-4da5-86fc-333b1f36daa8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9dfb2630-09a7-452c-8ac8-82dca5a5b3fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9acb7d3b-11c8-4b17-825c-b5c1eb54bb1f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9dfb2630-09a7-452c-8ac8-82dca5a5b3fd" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_18e80af5-5af2-43e8-8ad4-c657b069925d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9acb7d3b-11c8-4b17-825c-b5c1eb54bb1f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_18e80af5-5af2-43e8-8ad4-c657b069925d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_185ab6af-749b-46b0-b9a5-fd6efa18e662" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_18e80af5-5af2-43e8-8ad4-c657b069925d" xlink:to="loc_us-gaap_AwardTypeAxis_185ab6af-749b-46b0-b9a5-fd6efa18e662" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_185ab6af-749b-46b0-b9a5-fd6efa18e662_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_185ab6af-749b-46b0-b9a5-fd6efa18e662" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_185ab6af-749b-46b0-b9a5-fd6efa18e662_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_02580d00-ddcf-45eb-9363-bb6c8be39702" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_185ab6af-749b-46b0-b9a5-fd6efa18e662" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_02580d00-ddcf-45eb-9363-bb6c8be39702" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_56a6378d-fe64-4549-8b08-b912daada87f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_02580d00-ddcf-45eb-9363-bb6c8be39702" xlink:to="loc_us-gaap_EmployeeStockOptionMember_56a6378d-fe64-4549-8b08-b912daada87f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d0725f57-2574-4baf-a27f-cc52ee99d512" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_02580d00-ddcf-45eb-9363-bb6c8be39702" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d0725f57-2574-4baf-a27f-cc52ee99d512" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_30e63b7c-530a-4503-8217-74a008a16da4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_02580d00-ddcf-45eb-9363-bb6c8be39702" xlink:to="loc_us-gaap_PerformanceSharesMember_30e63b7c-530a-4503-8217-74a008a16da4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MarketBasedAwardsMember_0f4351dd-952d-4d16-9461-10ea4a3048df" xlink:href="holx-20210626.xsd#holx_MarketBasedAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_02580d00-ddcf-45eb-9363-bb6c8be39702" xlink:to="loc_holx_MarketBasedAwardsMember_0f4351dd-952d-4d16-9461-10ea4a3048df" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PSUFreeCashFlowMember_ce76fafa-6810-46a8-9dbc-43ba2f199479" xlink:href="holx-20210626.xsd#holx_PSUFreeCashFlowMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_02580d00-ddcf-45eb-9363-bb6c8be39702" xlink:to="loc_holx_PSUFreeCashFlowMember_ce76fafa-6810-46a8-9dbc-43ba2f199479" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RSUPSUMSUMember_0d4ccaac-89ad-453e-89c1-73be36a78332" xlink:href="holx-20210626.xsd#holx_RSUPSUMSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_02580d00-ddcf-45eb-9363-bb6c8be39702" xlink:to="loc_holx_RSUPSUMSUMember_0d4ccaac-89ad-453e-89c1-73be36a78332" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#BusinessSegmentsandGeographicInformationAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail" xlink:type="extended" id="i21924debc00b484182f1eb4fa127cd2d_BusinessSegmentsandGeographicInformationAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_holx_SegmentReportingDisclosureLineItems_ae38cab5-683b-49cb-81c8-3c1cef2ecd1d" xlink:href="holx-20210626.xsd#holx_SegmentReportingDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_47490d4f-2533-4b97-b6e6-88b356c3af1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_ae38cab5-683b-49cb-81c8-3c1cef2ecd1d" xlink:to="loc_us-gaap_NumberOfReportableSegments_47490d4f-2533-4b97-b6e6-88b356c3af1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_1928e8a4-7b0f-43f4-8f52-9aab5e4eb26c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_ae38cab5-683b-49cb-81c8-3c1cef2ecd1d" xlink:to="loc_us-gaap_Revenues_1928e8a4-7b0f-43f4-8f52-9aab5e4eb26c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_be020137-e7b9-401b-9243-97ca938a75c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_ae38cab5-683b-49cb-81c8-3c1cef2ecd1d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_be020137-e7b9-401b-9243-97ca938a75c9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_1686f6f9-c3f7-482e-935a-8d36fa34d416" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_be020137-e7b9-401b-9243-97ca938a75c9" xlink:to="loc_srt_ConsolidationItemsAxis_1686f6f9-c3f7-482e-935a-8d36fa34d416" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_1686f6f9-c3f7-482e-935a-8d36fa34d416_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_1686f6f9-c3f7-482e-935a-8d36fa34d416" xlink:to="loc_srt_ConsolidationItemsDomain_1686f6f9-c3f7-482e-935a-8d36fa34d416_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_5e63ecd7-d0af-4ba8-bb8a-4c2832a54b3a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_1686f6f9-c3f7-482e-935a-8d36fa34d416" xlink:to="loc_srt_ConsolidationItemsDomain_5e63ecd7-d0af-4ba8-bb8a-4c2832a54b3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_3b6f671e-8fb7-415f-a928-ef3eb67220c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_5e63ecd7-d0af-4ba8-bb8a-4c2832a54b3a" xlink:to="loc_us-gaap_IntersegmentEliminationMember_3b6f671e-8fb7-415f-a928-ef3eb67220c9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#BusinessSegmentsandGeographicInformationSegmentInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail" xlink:type="extended" id="i28ff14ee3a8a4896a4327b2be78a5d26_BusinessSegmentsandGeographicInformationSegmentInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_6813ad04-d8ee-4d6a-b9a4-a4b3312645cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_c03d5ef3-360e-416d-b74f-3d074b843710" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6813ad04-d8ee-4d6a-b9a4-a4b3312645cb" xlink:to="loc_us-gaap_Revenues_c03d5ef3-360e-416d-b74f-3d074b843710" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_feb1d2d0-a816-4755-a0a3-0f4f4ff8df41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6813ad04-d8ee-4d6a-b9a4-a4b3312645cb" xlink:to="loc_us-gaap_OperatingIncomeLoss_feb1d2d0-a816-4755-a0a3-0f4f4ff8df41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_1de856f7-0975-4b97-80d5-5dc137327790" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6813ad04-d8ee-4d6a-b9a4-a4b3312645cb" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_1de856f7-0975-4b97-80d5-5dc137327790" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_2cede1e8-73f1-495b-9006-bc3d47d154ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6813ad04-d8ee-4d6a-b9a4-a4b3312645cb" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_2cede1e8-73f1-495b-9006-bc3d47d154ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_7fa1224a-fd83-48ce-90fa-25125fdbed42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6813ad04-d8ee-4d6a-b9a4-a4b3312645cb" xlink:to="loc_us-gaap_Assets_7fa1224a-fd83-48ce-90fa-25125fdbed42" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8a03d615-1de8-4f34-a8b7-f1bed43eb465" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6813ad04-d8ee-4d6a-b9a4-a4b3312645cb" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8a03d615-1de8-4f34-a8b7-f1bed43eb465" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a0e10458-2e6f-43f1-9e61-0a24d7e33047" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8a03d615-1de8-4f34-a8b7-f1bed43eb465" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a0e10458-2e6f-43f1-9e61-0a24d7e33047" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a0e10458-2e6f-43f1-9e61-0a24d7e33047_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a0e10458-2e6f-43f1-9e61-0a24d7e33047" xlink:to="loc_us-gaap_SegmentDomain_a0e10458-2e6f-43f1-9e61-0a24d7e33047_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f4c00bca-df29-4ee8-8551-5d551f38ef73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a0e10458-2e6f-43f1-9e61-0a24d7e33047" xlink:to="loc_us-gaap_SegmentDomain_f4c00bca-df29-4ee8-8551-5d551f38ef73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember_54dc51d0-ffbe-4105-ac60-dcc1a3ea9301" xlink:href="holx-20210626.xsd#holx_DiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f4c00bca-df29-4ee8-8551-5d551f38ef73" xlink:to="loc_holx_DiagnosticsMember_54dc51d0-ffbe-4105-ac60-dcc1a3ea9301" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember_1581b53c-b18f-4cd6-ab29-2da079975852" xlink:href="holx-20210626.xsd#holx_BreastHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f4c00bca-df29-4ee8-8551-5d551f38ef73" xlink:to="loc_holx_BreastHealthMember_1581b53c-b18f-4cd6-ab29-2da079975852" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember_cea29455-2028-42de-9303-360f119fdcc3" xlink:href="holx-20210626.xsd#holx_GynSurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f4c00bca-df29-4ee8-8551-5d551f38ef73" xlink:to="loc_holx_GynSurgicalMember_cea29455-2028-42de-9303-360f119fdcc3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember_c2929d0b-94af-4422-b9f7-9be421a5fcd8" xlink:href="holx-20210626.xsd#holx_SkeletalHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f4c00bca-df29-4ee8-8551-5d551f38ef73" xlink:to="loc_holx_SkeletalHealthMember_c2929d0b-94af-4422-b9f7-9be421a5fcd8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_13102e76-5062-4bd3-8b7f-a4fa793bb821" xlink:href="holx-20210626.xsd#holx_MedicalAestheticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f4c00bca-df29-4ee8-8551-5d551f38ef73" xlink:to="loc_holx_MedicalAestheticsMember_13102e76-5062-4bd3-8b7f-a4fa793bb821" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_dd1443f4-fbeb-4dcb-a4b2-ac964c251afc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f4c00bca-df29-4ee8-8551-5d551f38ef73" xlink:to="loc_us-gaap_CorporateMember_dd1443f4-fbeb-4dcb-a4b2-ac964c251afc" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" xlink:type="extended" id="icd94a9c15d93435ca948c35b08cd4301_BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail">
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsLineItems_bdc30651-f16b-48d3-8032-f1f92419ef55" xlink:href="holx-20210626.xsd#holx_ScheduleOfGeographicalSegmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfRevenues_473560ac-e616-439f-bea7-89fe19a23d6a" xlink:href="holx-20210626.xsd#holx_PercentageOfRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsLineItems_bdc30651-f16b-48d3-8032-f1f92419ef55" xlink:to="loc_holx_PercentageOfRevenues_473560ac-e616-439f-bea7-89fe19a23d6a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsTable_581c74eb-773b-470f-8eb9-23566d6800a6" xlink:href="holx-20210626.xsd#holx_ScheduleOfGeographicalSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsLineItems_bdc30651-f16b-48d3-8032-f1f92419ef55" xlink:to="loc_holx_ScheduleOfGeographicalSegmentsTable_581c74eb-773b-470f-8eb9-23566d6800a6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_3b776b78-8f10-4f30-86da-8d9775549061" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsTable_581c74eb-773b-470f-8eb9-23566d6800a6" xlink:to="loc_srt_StatementGeographicalAxis_3b776b78-8f10-4f30-86da-8d9775549061" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3b776b78-8f10-4f30-86da-8d9775549061_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_3b776b78-8f10-4f30-86da-8d9775549061" xlink:to="loc_srt_SegmentGeographicalDomain_3b776b78-8f10-4f30-86da-8d9775549061_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_37e658fc-114b-4c09-be6c-40d4fde6a06a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_3b776b78-8f10-4f30-86da-8d9775549061" xlink:to="loc_srt_SegmentGeographicalDomain_37e658fc-114b-4c09-be6c-40d4fde6a06a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_07953bb8-efd8-40c4-b5d5-79bdbcc19ece" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_37e658fc-114b-4c09-be6c-40d4fde6a06a" xlink:to="loc_country_US_07953bb8-efd8-40c4-b5d5-79bdbcc19ece" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_a72bb5de-f9f1-4acd-808c-9adf62c07cc9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_37e658fc-114b-4c09-be6c-40d4fde6a06a" xlink:to="loc_srt_EuropeMember_a72bb5de-f9f1-4acd-808c-9adf62c07cc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_3a3710b6-88ac-42dc-b0ea-f7eee9e9b9ad" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_37e658fc-114b-4c09-be6c-40d4fde6a06a" xlink:to="loc_srt_AsiaPacificMember_3a3710b6-88ac-42dc-b0ea-f7eee9e9b9ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AllOtherCountriesMember_b7a4a74e-0c83-4365-af58-92e5c5b1c171" xlink:href="holx-20210626.xsd#holx_AllOtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_37e658fc-114b-4c09-be6c-40d4fde6a06a" xlink:to="loc_holx_AllOtherCountriesMember_b7a4a74e-0c83-4365-af58-92e5c5b1c171" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#IncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/IncomeTaxesDetails" xlink:type="extended" id="ie2814b7c89d34264bfe2a4653d88897d_IncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_c19d0035-ac65-4ee4-839d-0300755a6a5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cfd6a533-a8b2-42b4-a9a3-4b7604d86eb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c19d0035-ac65-4ee4-839d-0300755a6a5e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cfd6a533-a8b2-42b4-a9a3-4b7604d86eb2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_86ca110f-c086-4f53-8db2-c384e69215bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c19d0035-ac65-4ee4-839d-0300755a6a5e" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_86ca110f-c086-4f53-8db2-c384e69215bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_12e3755e-45ad-46e1-b754-8ba04e394ef5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c19d0035-ac65-4ee4-839d-0300755a6a5e" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_12e3755e-45ad-46e1-b754-8ba04e394ef5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1ba269ce-7d1e-4828-9578-65d88b77a1cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_12e3755e-45ad-46e1-b754-8ba04e394ef5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1ba269ce-7d1e-4828-9578-65d88b77a1cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1ba269ce-7d1e-4828-9578-65d88b77a1cd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1ba269ce-7d1e-4828-9578-65d88b77a1cd" xlink:to="loc_us-gaap_SegmentDomain_1ba269ce-7d1e-4828-9578-65d88b77a1cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f62235f8-85df-4c06-9b63-a2e62d7a90c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1ba269ce-7d1e-4828-9578-65d88b77a1cd" xlink:to="loc_us-gaap_SegmentDomain_f62235f8-85df-4c06-9b63-a2e62d7a90c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_94e539c1-c599-49f1-b64d-d9f39a18b2ef" xlink:href="holx-20210626.xsd#holx_MedicalAestheticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f62235f8-85df-4c06-9b63-a2e62d7a90c8" xlink:to="loc_holx_MedicalAestheticsMember_94e539c1-c599-49f1-b64d-d9f39a18b2ef" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail" xlink:type="extended" id="i555cb420d8c64784baeeecf0cc526e85_IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_853152a3-e7e6-4916-9847-3682fb57331b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_e6b9a0e7-1ca3-431f-9a37-c9e043d28bae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_853152a3-e7e6-4916-9847-3682fb57331b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_e6b9a0e7-1ca3-431f-9a37-c9e043d28bae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c63f946e-cd67-4e6a-96e8-c5549edee9a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_853152a3-e7e6-4916-9847-3682fb57331b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c63f946e-cd67-4e6a-96e8-c5549edee9a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_deb5be12-01cf-416b-b340-cf9fa567419f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_853152a3-e7e6-4916-9847-3682fb57331b" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_deb5be12-01cf-416b-b340-cf9fa567419f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b06011bc-3a2f-408c-bddf-72b721c273e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_deb5be12-01cf-416b-b340-cf9fa567419f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b06011bc-3a2f-408c-bddf-72b721c273e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b06011bc-3a2f-408c-bddf-72b721c273e2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b06011bc-3a2f-408c-bddf-72b721c273e2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b06011bc-3a2f-408c-bddf-72b721c273e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c891b877-d965-4e1f-897b-138380594ac6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b06011bc-3a2f-408c-bddf-72b721c273e2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c891b877-d965-4e1f-897b-138380594ac6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_c691982e-000b-49ab-bb3b-2afff876160c" xlink:href="holx-20210626.xsd#holx_DevelopedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c891b877-d965-4e1f-897b-138380594ac6" xlink:to="loc_holx_DevelopedTechnologyMember_c691982e-000b-49ab-bb3b-2afff876160c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_15c35dc7-f812-4fcb-906d-d9fdadeeda9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c891b877-d965-4e1f-897b-138380594ac6" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_15c35dc7-f812-4fcb-906d-d9fdadeeda9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CustomerRelationshipsContractsMember_320c0458-8281-4e12-95ac-e5e2e4c66c2f" xlink:href="holx-20210626.xsd#holx_CustomerRelationshipsContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c891b877-d965-4e1f-897b-138380594ac6" xlink:to="loc_holx_CustomerRelationshipsContractsMember_320c0458-8281-4e12-95ac-e5e2e4c66c2f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_9f697c4f-90f8-4233-b6b1-65981d7eb4d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c891b877-d965-4e1f-897b-138380594ac6" xlink:to="loc_us-gaap_TradeNamesMember_9f697c4f-90f8-4233-b6b1-65981d7eb4d0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_7e363b6a-c644-4e77-a0f9-f7c56cc937a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c891b877-d965-4e1f-897b-138380594ac6" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_7e363b6a-c644-4e77-a0f9-f7c56cc937a0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessLicensesMember_4b1541c2-3f37-44d1-afdf-274365178c37" xlink:href="holx-20210626.xsd#holx_BusinessLicensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c891b877-d965-4e1f-897b-138380594ac6" xlink:to="loc_holx_BusinessLicensesMember_4b1541c2-3f37-44d1-afdf-274365178c37" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcquiredintangibleassetsMember_19d1769e-09a3-462b-ab47-5f1985ff79a0" xlink:href="holx-20210626.xsd#holx_AcquiredintangibleassetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c891b877-d965-4e1f-897b-138380594ac6" xlink:to="loc_holx_AcquiredintangibleassetsMember_19d1769e-09a3-462b-ab47-5f1985ff79a0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternalusesoftwareMember_4dbb98da-e8b9-47e8-85a7-5205a698ea63" xlink:href="holx-20210626.xsd#holx_InternalusesoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c891b877-d965-4e1f-897b-138380594ac6" xlink:to="loc_holx_InternalusesoftwareMember_4dbb98da-e8b9-47e8-85a7-5205a698ea63" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalizedsoftwareMember_b39a6c4b-1f3d-4696-8a47-d0ba0319158e" xlink:href="holx-20210626.xsd#holx_CapitalizedsoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c891b877-d965-4e1f-897b-138380594ac6" xlink:to="loc_holx_CapitalizedsoftwareMember_b39a6c4b-1f3d-4696-8a47-d0ba0319158e" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#AccumulatedOtherComprehensiveIncomeDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail" xlink:type="extended" id="ib32c9bf4f9d94a559007875f055bc26b_AccumulatedOtherComprehensiveIncomeDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3828110e-c1e9-4d39-afd0-ddbefd8047eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5eae6afe-f988-4ed2-a044-4da0d82a4dfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3828110e-c1e9-4d39-afd0-ddbefd8047eb" xlink:to="loc_us-gaap_StockholdersEquity_5eae6afe-f988-4ed2-a044-4da0d82a4dfc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_29d11f9c-592f-488a-8e4b-3b5f7642ea2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3828110e-c1e9-4d39-afd0-ddbefd8047eb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_29d11f9c-592f-488a-8e4b-3b5f7642ea2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_f81c0b97-904e-4fe2-a0e5-5cb9a63e2743" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3828110e-c1e9-4d39-afd0-ddbefd8047eb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_f81c0b97-904e-4fe2-a0e5-5cb9a63e2743" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_6b298936-02f7-4269-b791-56348d5227d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3828110e-c1e9-4d39-afd0-ddbefd8047eb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_6b298936-02f7-4269-b791-56348d5227d7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_fcf82b4c-bf1e-416a-8ab4-37780411c624" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3828110e-c1e9-4d39-afd0-ddbefd8047eb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_fcf82b4c-bf1e-416a-8ab4-37780411c624" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_46c59911-fac5-4c1f-85e2-a517e0c666a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3828110e-c1e9-4d39-afd0-ddbefd8047eb" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_46c59911-fac5-4c1f-85e2-a517e0c666a4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_d8b6afc5-3f69-47e0-8d01-f9a94c43617a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3828110e-c1e9-4d39-afd0-ddbefd8047eb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_d8b6afc5-3f69-47e0-8d01-f9a94c43617a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_31ac7846-d2a6-4c01-a1f5-add35ac00ef8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a48e0e06-5f96-4396-809c-59f56a854ca8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3828110e-c1e9-4d39-afd0-ddbefd8047eb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a48e0e06-5f96-4396-809c-59f56a854ca8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_0f689565-5a91-493d-8b55-62d6f46ba898" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a48e0e06-5f96-4396-809c-59f56a854ca8" xlink:to="loc_us-gaap_FinancialInstrumentAxis_0f689565-5a91-493d-8b55-62d6f46ba898" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0f689565-5a91-493d-8b55-62d6f46ba898_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_0f689565-5a91-493d-8b55-62d6f46ba898" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0f689565-5a91-493d-8b55-62d6f46ba898_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7ab7a293-9d94-4521-b748-3d93f850d777" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_0f689565-5a91-493d-8b55-62d6f46ba898" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7ab7a293-9d94-4521-b748-3d93f850d777" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_053af4c9-064f-4d41-915e-8848a37fc812" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7ab7a293-9d94-4521-b748-3d93f850d777" xlink:to="loc_us-gaap_InterestRateCapMember_053af4c9-064f-4d41-915e-8848a37fc812" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_e54a0bf9-4afe-47ca-9679-7c490b288eb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7ab7a293-9d94-4521-b748-3d93f850d777" xlink:to="loc_us-gaap_InterestRateSwapMember_e54a0bf9-4afe-47ca-9679-7c490b288eb7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b5d789ad-bae3-4282-8334-6d8cf4fe88c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a48e0e06-5f96-4396-809c-59f56a854ca8" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b5d789ad-bae3-4282-8334-6d8cf4fe88c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b5d789ad-bae3-4282-8334-6d8cf4fe88c8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b5d789ad-bae3-4282-8334-6d8cf4fe88c8" xlink:to="loc_us-gaap_EquityComponentDomain_b5d789ad-bae3-4282-8334-6d8cf4fe88c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9cee1794-6aa1-41e0-8528-a1ec84bd6b77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b5d789ad-bae3-4282-8334-6d8cf4fe88c8" xlink:to="loc_us-gaap_EquityComponentDomain_9cee1794-6aa1-41e0-8528-a1ec84bd6b77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_365d0d36-333e-4c5a-a666-c269dd019a60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9cee1794-6aa1-41e0-8528-a1ec84bd6b77" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_365d0d36-333e-4c5a-a666-c269dd019a60" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f456e3af-ab44-4915-9369-b6f2b629b9c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9cee1794-6aa1-41e0-8528-a1ec84bd6b77" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f456e3af-ab44-4915-9369-b6f2b629b9c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_e0360a10-97c2-477a-b150-7da117a841e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9cee1794-6aa1-41e0-8528-a1ec84bd6b77" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_e0360a10-97c2-477a-b150-7da117a841e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_97d675ae-5f98-43e9-961d-d97dc03be620" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9cee1794-6aa1-41e0-8528-a1ec84bd6b77" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_97d675ae-5f98-43e9-961d-d97dc03be620" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#ShareRepurchaseSharerepurchaseDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails" xlink:type="extended" id="icbb71afa255147c0b13a1387cba0771a_ShareRepurchaseSharerepurchaseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharerepurchaseplanLineItems_c2a0d10c-12e8-4c75-85be-0ce77a8cb2ab" xlink:href="holx-20210626.xsd#holx_SharerepurchaseplanLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_a5c52c9b-9334-4016-a9f8-3e55880b7d54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SharerepurchaseplanLineItems_c2a0d10c-12e8-4c75-85be-0ce77a8cb2ab" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_a5c52c9b-9334-4016-a9f8-3e55880b7d54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_0c9e3942-8cdc-4b8f-98e1-519ab9e328b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SharerepurchaseplanLineItems_c2a0d10c-12e8-4c75-85be-0ce77a8cb2ab" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_0c9e3942-8cdc-4b8f-98e1-519ab9e328b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepurchaseOfEquity_8b950b2f-d0c6-4769-b3c3-c34454ebd7df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepurchaseOfEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SharerepurchaseplanLineItems_c2a0d10c-12e8-4c75-85be-0ce77a8cb2ab" xlink:to="loc_us-gaap_ProceedsFromRepurchaseOfEquity_8b950b2f-d0c6-4769-b3c3-c34454ebd7df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_2459c01e-027f-485c-9170-7039df139d14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SharerepurchaseplanLineItems_c2a0d10c-12e8-4c75-85be-0ce77a8cb2ab" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_2459c01e-027f-485c-9170-7039df139d14" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_d97ce378-96b8-4aea-82e9-a57c20c217fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SharerepurchaseplanLineItems_c2a0d10c-12e8-4c75-85be-0ce77a8cb2ab" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_d97ce378-96b8-4aea-82e9-a57c20c217fb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharerepurchaseplanTable_03a791e7-a77a-4511-b2fe-0da0ac4bd80b" xlink:href="holx-20210626.xsd#holx_SharerepurchaseplanTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_SharerepurchaseplanLineItems_c2a0d10c-12e8-4c75-85be-0ce77a8cb2ab" xlink:to="loc_holx_SharerepurchaseplanTable_03a791e7-a77a-4511-b2fe-0da0ac4bd80b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_69789188-5af8-4488-96f5-b8f6e04b0bf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_SharerepurchaseplanTable_03a791e7-a77a-4511-b2fe-0da0ac4bd80b" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_69789188-5af8-4488-96f5-b8f6e04b0bf0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_69789188-5af8-4488-96f5-b8f6e04b0bf0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_69789188-5af8-4488-96f5-b8f6e04b0bf0" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_69789188-5af8-4488-96f5-b8f6e04b0bf0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_8a96d8a7-d03c-4ad1-853e-89b481bba61d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_69789188-5af8-4488-96f5-b8f6e04b0bf0" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_8a96d8a7-d03c-4ad1-853e-89b481bba61d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_December112019Member_50fb9756-f5a5-4a27-ab9e-d9c47a716b8f" xlink:href="holx-20210626.xsd#holx_December112019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_8a96d8a7-d03c-4ad1-853e-89b481bba61d" xlink:to="loc_holx_December112019Member_50fb9756-f5a5-4a27-ab9e-d9c47a716b8f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_December112020Member_ab0b4142-7ffb-4a4e-a007-b2c5e1be2e55" xlink:href="holx-20210626.xsd#holx_December112020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_8a96d8a7-d03c-4ad1-853e-89b481bba61d" xlink:to="loc_holx_December112020Member_ab0b4142-7ffb-4a4e-a007-b2c5e1be2e55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_c687ee6a-68eb-4197-b579-2faa8616be03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_SharerepurchaseplanTable_03a791e7-a77a-4511-b2fe-0da0ac4bd80b" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_c687ee6a-68eb-4197-b579-2faa8616be03" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_c687ee6a-68eb-4197-b579-2faa8616be03_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_c687ee6a-68eb-4197-b579-2faa8616be03" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_c687ee6a-68eb-4197-b579-2faa8616be03_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_2eb2848c-2403-44e1-bc1b-9fcd8114bf09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_c687ee6a-68eb-4197-b579-2faa8616be03" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_2eb2848c-2403-44e1-bc1b-9fcd8114bf09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_December112019Member_98f203ed-26b2-4449-b0c4-a3c9c2fce9e4" xlink:href="holx-20210626.xsd#holx_December112019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_2eb2848c-2403-44e1-bc1b-9fcd8114bf09" xlink:to="loc_holx_December112019Member_98f203ed-26b2-4449-b0c4-a3c9c2fce9e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_December112020Member_08002129-62be-4358-8ef7-7a27f3d9216b" xlink:href="holx-20210626.xsd#holx_December112020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_2eb2848c-2403-44e1-bc1b-9fcd8114bf09" xlink:to="loc_holx_December112020Member_08002129-62be-4358-8ef7-7a27f3d9216b" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>holx-20210626_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c74485e8-ec97-423d-9317-27784965d1fb,g:cd3e0a2e-ccc2-417e-9556-0c4f43775051-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7aa1dac5-62cf-4d71-943b-8e7912fdd9a9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DebtRedemptionPremiumPaid_8ee5a3cc-170e-4490-884c-81d0c1545931_terseLabel_en-US" xlink:label="lab_holx_DebtRedemptionPremiumPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium payment</link:label>
    <link:label id="lab_holx_DebtRedemptionPremiumPaid_label_en-US" xlink:label="lab_holx_DebtRedemptionPremiumPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Redemption, Premium Paid</link:label>
    <link:label id="lab_holx_DebtRedemptionPremiumPaid_documentation_en-US" xlink:label="lab_holx_DebtRedemptionPremiumPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Redemption, Premium Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtRedemptionPremiumPaid" xlink:href="holx-20210626.xsd#holx_DebtRedemptionPremiumPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtRedemptionPremiumPaid" xlink:to="lab_holx_DebtRedemptionPremiumPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_0fba9384-27d1-47f1-86c4-4b4d7efd093d_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_2590aa23-6e79-489a-b80b-238ff91b2889_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_5fd3ab43-30bb-4c3f-aab8-490d32066756_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Warranty Liability [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_b6d9e840-d1bc-4798-a1b0-bf891c9ff33d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_7b229fc9-00a5-42a7-86d8-575ed41645f3_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ResearchAndDevelopmentInProcessCompletionPeriod_7a069bbe-4208-4b62-a20a-6de1a62c6c0d_terseLabel_en-US" xlink:label="lab_holx_ResearchAndDevelopmentInProcessCompletionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development in process, completion period</link:label>
    <link:label id="lab_holx_ResearchAndDevelopmentInProcessCompletionPeriod_label_en-US" xlink:label="lab_holx_ResearchAndDevelopmentInProcessCompletionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development in Process, Completion Period</link:label>
    <link:label id="lab_holx_ResearchAndDevelopmentInProcessCompletionPeriod_documentation_en-US" xlink:label="lab_holx_ResearchAndDevelopmentInProcessCompletionPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development in Process, Completion Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ResearchAndDevelopmentInProcessCompletionPeriod" xlink:href="holx-20210626.xsd#holx_ResearchAndDevelopmentInProcessCompletionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ResearchAndDevelopmentInProcessCompletionPeriod" xlink:to="lab_holx_ResearchAndDevelopmentInProcessCompletionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_95c580a0-a7a8-4734-a9a6-b7e1a8025879_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest in acquiree, percentage</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_6f2cdea0-83a9-409f-9741-0dd4ca96bfa0_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_96a15679-91ac-467c-a25e-cdc4d21d0525_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_4e8bd01b-20a6-490a-87c1-ed8bcff88670_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EquipmentUnderCustomerUsageAgreements_c9172455-d427-4729-a152-7bbc0995f55e_terseLabel_en-US" xlink:label="lab_holx_EquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment under customer usage agreements</link:label>
    <link:label id="lab_holx_EquipmentUnderCustomerUsageAgreements_label_en-US" xlink:label="lab_holx_EquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment Under Customer Usage Agreements</link:label>
    <link:label id="lab_holx_EquipmentUnderCustomerUsageAgreements_documentation_en-US" xlink:label="lab_holx_EquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross amount at the balance sheet date of long-lived, depreciable asset that are equipment placed at customer locations for which title is not transferred to the Company's customers.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquipmentUnderCustomerUsageAgreements" xlink:href="holx-20210626.xsd#holx_EquipmentUnderCustomerUsageAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EquipmentUnderCustomerUsageAgreements" xlink:to="lab_holx_EquipmentUnderCustomerUsageAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_0cdba709-6423-49ea-8315-8875929d7f47_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_299e4b6f-3249-430a-ada2-14d0a845a265_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_4e1f7e79-d903-4128-93ee-11d795dc4be9_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationAdditionalSharesAcquiredShares_774acab6-f218-4dfb-94dd-574ffbd23b99_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationAdditionalSharesAcquiredShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional outstanding shares purchased (in shares)</link:label>
    <link:label id="lab_holx_BusinessCombinationAdditionalSharesAcquiredShares_label_en-US" xlink:label="lab_holx_BusinessCombinationAdditionalSharesAcquiredShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Additional Shares Acquired, Shares</link:label>
    <link:label id="lab_holx_BusinessCombinationAdditionalSharesAcquiredShares_documentation_en-US" xlink:label="lab_holx_BusinessCombinationAdditionalSharesAcquiredShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Additional Shares Acquired, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationAdditionalSharesAcquiredShares" xlink:href="holx-20210626.xsd#holx_BusinessCombinationAdditionalSharesAcquiredShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationAdditionalSharesAcquiredShares" xlink:to="lab_holx_BusinessCombinationAdditionalSharesAcquiredShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_cfd04a0d-df55-427f-9565-e80e1237fea2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Unobservable Inputs&#160;(Level&#160;3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_802703f4-77ac-4fe8-8729-6b12eddac7f6_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyDisclosureTextBlock_b70d9985-f719-44c1-938a-464c87c49db5_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranties</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:to="lab_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_ba79aeda-8f2a-4a07-b2e6-41de1ad79d6e_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BreastHealthMember_f450dd48-7bc0-48ea-bb5b-159a1ee0e0a3_terseLabel_en-US" xlink:label="lab_holx_BreastHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Health</link:label>
    <link:label id="lab_holx_BreastHealthMember_label_en-US" xlink:label="lab_holx_BreastHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Health [Member]</link:label>
    <link:label id="lab_holx_BreastHealthMember_documentation_en-US" xlink:label="lab_holx_BreastHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast health.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember" xlink:href="holx-20210626.xsd#holx_BreastHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BreastHealthMember" xlink:to="lab_holx_BreastHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8e3b3042-a81f-46da-89ba-00e5af327471_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_316ae18e-f394-4026-89c7-652b831f4ce0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_fcfd29eb-55da-4380-a975-52f0abd44cde_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:to="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_c77f7bbc-d5af-4c27-84d9-6b281161562f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_b55a47a2-5547-4d32-aca8-8e8706f3c413_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_f4c17bd4-1c99-4078-a465-03b395f7381e_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_b61b2c97-f746-4ab2-ad62-35706d39286c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unused Borrowing Capacity, Amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unused Borrowing Capacity, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:to="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease_d3125509-8852-4dbb-a767-c52b5ba78869_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual, Period Increase (Decrease)</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard Product Warranty Accrual, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease" xlink:to="lab_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_e0a3909f-aee0-4df8-9455-f4b26813246a_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:to="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_91a28906-5d86-463b-bc8e-5333e3201e7c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_fd47384e-e531-4a11-8be6-1dba4b99da7f_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_545de16c-111e-4974-abea-4f477395e4e2_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_4d0218f3-11ac-4615-bb20-c687b2d4c439_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable_360affb9-f276-4d2c-829d-37ca4160afc0_verboseLabel_en-US" xlink:label="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap Agreements Aggregate Premium Payable</link:label>
    <link:label id="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable_label_en-US" xlink:label="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap Agreements Aggregate Premium Payable</link:label>
    <link:label id="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable_documentation_en-US" xlink:label="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cap agreements aggregate premium payable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable" xlink:href="holx-20210626.xsd#holx_InterestRateCapAgreementsAggregatePremiumPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable" xlink:to="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Acceleratedsharerepurchaseagreement_fb48b118-474c-4695-a74d-fbfff24efa1f_negatedTerseLabel_en-US" xlink:label="lab_holx_Acceleratedsharerepurchaseagreement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchase agreement</link:label>
    <link:label id="lab_holx_Acceleratedsharerepurchaseagreement_label_en-US" xlink:label="lab_holx_Acceleratedsharerepurchaseagreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchase agreement</link:label>
    <link:label id="lab_holx_Acceleratedsharerepurchaseagreement_documentation_en-US" xlink:label="lab_holx_Acceleratedsharerepurchaseagreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchase agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Acceleratedsharerepurchaseagreement" xlink:href="holx-20210626.xsd#holx_Acceleratedsharerepurchaseagreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Acceleratedsharerepurchaseagreement" xlink:to="lab_holx_Acceleratedsharerepurchaseagreement" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_RepaymentOfSeniorNotes_553e49af-a809-4e8b-9f5f-3b2b5366091b_negatedTerseLabel_en-US" xlink:label="lab_holx_RepaymentOfSeniorNotes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Senior Debt</link:label>
    <link:label id="lab_holx_RepaymentOfSeniorNotes_label_en-US" xlink:label="lab_holx_RepaymentOfSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of Senior Notes</link:label>
    <link:label id="lab_holx_RepaymentOfSeniorNotes_documentation_en-US" xlink:label="lab_holx_RepaymentOfSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RepaymentOfSeniorNotes" xlink:href="holx-20210626.xsd#holx_RepaymentOfSeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_RepaymentOfSeniorNotes" xlink:to="lab_holx_RepaymentOfSeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_d7057369-34b3-48be-bf52-709ea531b3ad_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_ef74c8f4-3f4a-43c6-9787-df85b91cfeec_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_4ab4441f-145b-4c6a-88eb-e57ce7318f1b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest in acquiree, remeasurement gain</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_cfc112a6-f2e4-4d44-9529-af3cf4e59928_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_6c6edc2f-0e92-428e-9eed-894914ea4efe_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Business Combination</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PercentageOfRevenues_e3e64e56-f043-4427-abfa-d0bfb4113fe4_terseLabel_en-US" xlink:label="lab_holx_PercentageOfRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_holx_PercentageOfRevenues_label_en-US" xlink:label="lab_holx_PercentageOfRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Revenues</link:label>
    <link:label id="lab_holx_PercentageOfRevenues_documentation_en-US" xlink:label="lab_holx_PercentageOfRevenues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of revenues.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfRevenues" xlink:href="holx-20210626.xsd#holx_PercentageOfRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PercentageOfRevenues" xlink:to="lab_holx_PercentageOfRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_93bc8242-262c-4aaa-8e39-96868b8be0bd_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_5dbf8a44-9e70-4a56-8ec6-77600fa18bc4_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_7c7ae28e-812c-4af3-8a77-0573aa72eb51_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_065a48d9-40e4-4ba3-9a59-c8931e15943b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_7551f730-f7e6-486b-ae9c-aed1ebd2eff4_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AnnualIncrementalRevenueGrowthPeriod_11377ee1-9e6a-4751-9d34-37696db4331b_terseLabel_en-US" xlink:label="lab_holx_AnnualIncrementalRevenueGrowthPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual incremental revenue growth period</link:label>
    <link:label id="lab_holx_AnnualIncrementalRevenueGrowthPeriod_label_en-US" xlink:label="lab_holx_AnnualIncrementalRevenueGrowthPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Incremental Revenue Growth Period</link:label>
    <link:label id="lab_holx_AnnualIncrementalRevenueGrowthPeriod_documentation_en-US" xlink:label="lab_holx_AnnualIncrementalRevenueGrowthPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Incremental Revenue Growth Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AnnualIncrementalRevenueGrowthPeriod" xlink:href="holx-20210626.xsd#holx_AnnualIncrementalRevenueGrowthPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AnnualIncrementalRevenueGrowthPeriod" xlink:to="lab_holx_AnnualIncrementalRevenueGrowthPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_a09e3388-0bc9-468c-807b-1a5d0bfa1635_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AlphaImagingMember_2c04efad-30d0-4fca-bb05-70964a43d332_terseLabel_en-US" xlink:label="lab_holx_AlphaImagingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alpha Imaging</link:label>
    <link:label id="lab_holx_AlphaImagingMember_label_en-US" xlink:label="lab_holx_AlphaImagingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alpha Imaging [Member]</link:label>
    <link:label id="lab_holx_AlphaImagingMember_documentation_en-US" xlink:label="lab_holx_AlphaImagingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alpha Imaging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AlphaImagingMember" xlink:href="holx-20210626.xsd#holx_AlphaImagingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AlphaImagingMember" xlink:to="lab_holx_AlphaImagingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessLicensesMember_07c27da5-bef9-4ddb-ac87-0f1c021e5745_terseLabel_en-US" xlink:label="lab_holx_BusinessLicensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business licenses</link:label>
    <link:label id="lab_holx_BusinessLicensesMember_label_en-US" xlink:label="lab_holx_BusinessLicensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Licenses [Member]</link:label>
    <link:label id="lab_holx_BusinessLicensesMember_documentation_en-US" xlink:label="lab_holx_BusinessLicensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business licenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessLicensesMember" xlink:href="holx-20210626.xsd#holx_BusinessLicensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessLicensesMember" xlink:to="lab_holx_BusinessLicensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3c114388-308f-4613-9e78-cfd96b610576_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_e3d30e20-cb56-42c0-9fc4-2c290835462d_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_39565350-e0d3-443c-9198-0b1885306dc3_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment under revolving credit line</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_1648083b-e83e-4873-ae98-d84af0721ae8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_cc979f3e-1a5b-4956-bfb3-b3e3e063cffb_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguishment loss</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_cee063c6-8720-443f-b9bc-026a84a37afc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguishment loss</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_9732c814-724c-4f71-bae0-22cf9235c7c4_negatedLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguishment losses</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SomatexMedicalTechnologiesMember_62118c5b-5c8f-4273-9408-a40ea346403a_terseLabel_en-US" xlink:label="lab_holx_SomatexMedicalTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Somatex Medical Technologies</link:label>
    <link:label id="lab_holx_SomatexMedicalTechnologiesMember_label_en-US" xlink:label="lab_holx_SomatexMedicalTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Somatex Medical Technologies [Member]</link:label>
    <link:label id="lab_holx_SomatexMedicalTechnologiesMember_documentation_en-US" xlink:label="lab_holx_SomatexMedicalTechnologiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Somatex Medical Technologies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SomatexMedicalTechnologiesMember" xlink:href="holx-20210626.xsd#holx_SomatexMedicalTechnologiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SomatexMedicalTechnologiesMember" xlink:to="lab_holx_SomatexMedicalTechnologiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_ea76693d-0251-4e67-a81e-b457e9641077_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets useful life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2028SeniorNotesMember_51477244-ceb5-47be-9644-6c0c58ccd88a_terseLabel_en-US" xlink:label="lab_holx_A2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Senior Notes</link:label>
    <link:label id="lab_holx_A2028SeniorNotesMember_label_en-US" xlink:label="lab_holx_A2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Senior Notes [Member]</link:label>
    <link:label id="lab_holx_A2028SeniorNotesMember_documentation_en-US" xlink:label="lab_holx_A2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember" xlink:href="holx-20210626.xsd#holx_A2028SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2028SeniorNotesMember" xlink:to="lab_holx_A2028SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_aeede047-a07b-4790-9406-a29f9762e3ac_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PurchaseOfIntellectualProperty_1d1745bd-8db7-45b5-b3da-6b72ce88f74a_negatedTerseLabel_en-US" xlink:label="lab_holx_PurchaseOfIntellectualProperty" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of intellectual property</link:label>
    <link:label id="lab_holx_PurchaseOfIntellectualProperty_label_en-US" xlink:label="lab_holx_PurchaseOfIntellectualProperty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of intellectual property</link:label>
    <link:label id="lab_holx_PurchaseOfIntellectualProperty_documentation_en-US" xlink:label="lab_holx_PurchaseOfIntellectualProperty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of intellectual property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PurchaseOfIntellectualProperty" xlink:href="holx-20210626.xsd#holx_PurchaseOfIntellectualProperty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PurchaseOfIntellectualProperty" xlink:to="lab_holx_PurchaseOfIntellectualProperty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_11ef9ef2-0a2a-458d-ba1a-04a217c69aba_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation, stock options outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_ee3cef95-8ec7-4b0f-9bda-a777e36b5e02_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_c2a94fd2-94b4-4cd5-9a06-105f6edb4ad2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_5cb4576e-ccc7-4fd8-a398-99ad4ff84c8d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_7533ba7b-8ace-43b0-a7a1-744d83b4be07_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AccountsReceivableAllowanceForCreditLossTransfers_4ba1fb29-7286-48ee-a8bc-823596f9db54_negatedTerseLabel_en-US" xlink:label="lab_holx_AccountsReceivableAllowanceForCreditLossTransfers" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Divested</link:label>
    <link:label id="lab_holx_AccountsReceivableAllowanceForCreditLossTransfers_label_en-US" xlink:label="lab_holx_AccountsReceivableAllowanceForCreditLossTransfers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Transfers</link:label>
    <link:label id="lab_holx_AccountsReceivableAllowanceForCreditLossTransfers_documentation_en-US" xlink:label="lab_holx_AccountsReceivableAllowanceForCreditLossTransfers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Transfers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableAllowanceForCreditLossTransfers" xlink:href="holx-20210626.xsd#holx_AccountsReceivableAllowanceForCreditLossTransfers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccountsReceivableAllowanceForCreditLossTransfers" xlink:to="lab_holx_AccountsReceivableAllowanceForCreditLossTransfers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_63192e6a-a486-4109-b1e6-16fdc679a218_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.01 par value &#8211; 1,623 shares authorized; 0 shares issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_72825bdf-2b5b-47f9-9bb0-93f4ebcd8be3_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BreastImagingMember_9a7f14c6-aa99-4703-a1b5-8cd503486d7a_terseLabel_en-US" xlink:label="lab_holx_BreastImagingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Imaging</link:label>
    <link:label id="lab_holx_BreastImagingMember_label_en-US" xlink:label="lab_holx_BreastImagingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Imaging [Member]</link:label>
    <link:label id="lab_holx_BreastImagingMember_documentation_en-US" xlink:label="lab_holx_BreastImagingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Imaging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastImagingMember" xlink:href="holx-20210626.xsd#holx_BreastImagingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BreastImagingMember" xlink:to="lab_holx_BreastImagingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_decea610-7256-4017-8777-a1e536836ce3_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_a0df1e05-a178-4774-8a7a-82024c12d65d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AssetsofBusinessHeldforSaleAbstract_11cc25ce-f985-419f-ae17-93bf7e7e4a12_terseLabel_en-US" xlink:label="lab_holx_AssetsofBusinessHeldforSaleAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets of Business Held-for-Sale [Abstract]</link:label>
    <link:label id="lab_holx_AssetsofBusinessHeldforSaleAbstract_label_en-US" xlink:label="lab_holx_AssetsofBusinessHeldforSaleAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets of Business Held-for-Sale [Abstract]</link:label>
    <link:label id="lab_holx_AssetsofBusinessHeldforSaleAbstract_documentation_en-US" xlink:label="lab_holx_AssetsofBusinessHeldforSaleAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets of Business Held-for-Sale [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AssetsofBusinessHeldforSaleAbstract" xlink:href="holx-20210626.xsd#holx_AssetsofBusinessHeldforSaleAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AssetsofBusinessHeldforSaleAbstract" xlink:to="lab_holx_AssetsofBusinessHeldforSaleAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_TotalPaymentsToNonControllingInterest_659538d0-b7f2-4223-8b04-e94b082b5f03_terseLabel_en-US" xlink:label="lab_holx_TotalPaymentsToNonControllingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total payments to non-controlling interest</link:label>
    <link:label id="lab_holx_TotalPaymentsToNonControllingInterest_label_en-US" xlink:label="lab_holx_TotalPaymentsToNonControllingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total payments to non-controlling interest</link:label>
    <link:label id="lab_holx_TotalPaymentsToNonControllingInterest_documentation_en-US" xlink:label="lab_holx_TotalPaymentsToNonControllingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total payments to non-controlling interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TotalPaymentsToNonControllingInterest" xlink:href="holx-20210626.xsd#holx_TotalPaymentsToNonControllingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TotalPaymentsToNonControllingInterest" xlink:to="lab_holx_TotalPaymentsToNonControllingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_6e1a0db7-94aa-4216-9623-bcf79aaf6990_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_5c3caf4c-7e02-4633-b94c-2f28989ec7c7_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs of revenues:</link:label>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenueAbstract" xlink:to="lab_us-gaap_CostOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_1e4c3115-7f9d-4b11-8300-1aea4e5177ae_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_14f5f293-0f6c-4d3b-b211-02f3e98d4ffb_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_2fb5ced1-8872-4036-ae08-8ee6e90c31ae_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Period in Force</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Period in Force</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:to="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_GrantsReceivedFromDepartmentOfDefense_00152275-f137-4dbf-b42b-6e8ed398b3ea_terseLabel_en-US" xlink:label="lab_holx_GrantsReceivedFromDepartmentOfDefense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grants received from Department of defense</link:label>
    <link:label id="lab_holx_GrantsReceivedFromDepartmentOfDefense_label_en-US" xlink:label="lab_holx_GrantsReceivedFromDepartmentOfDefense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grants received from Department of defense</link:label>
    <link:label id="lab_holx_GrantsReceivedFromDepartmentOfDefense_documentation_en-US" xlink:label="lab_holx_GrantsReceivedFromDepartmentOfDefense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grants received from Department of defense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GrantsReceivedFromDepartmentOfDefense" xlink:href="holx-20210626.xsd#holx_GrantsReceivedFromDepartmentOfDefense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_GrantsReceivedFromDepartmentOfDefense" xlink:to="lab_holx_GrantsReceivedFromDepartmentOfDefense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_12708640-a202-4c5e-9d49-fba5507c4585_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_8ddac098-86cb-4574-89db-e1eb4961b993_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_9558b39e-8c77-4a7e-95e4-a883614f1e3d_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average anti-dilutive shares related to:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateDomain_2154a69b-30c8-497e-bab0-ef2ea65a3b7c_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Domain]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateDomain_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_987733bb-114e-49c5-af1e-51b083676c1c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_bf099684-561e-4fd9-bb7c-8e4225f60f4d_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_93e7a68c-13cd-4667-95af-49115fefc85f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_e2e442a5-3c46-4520-a3bb-9d88bffa18f4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DevelopedTechnologyMember_aec58c9e-d775-4715-bf65-0fc165ad25b6_terseLabel_en-US" xlink:label="lab_holx_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology</link:label>
    <link:label id="lab_holx_DevelopedTechnologyMember_44a59b9e-2f55-459d-a401-2ab38a6738ef_verboseLabel_en-US" xlink:label="lab_holx_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed&#160;technology</link:label>
    <link:label id="lab_holx_DevelopedTechnologyMember_label_en-US" xlink:label="lab_holx_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology [Member]</link:label>
    <link:label id="lab_holx_DevelopedTechnologyMember_documentation_en-US" xlink:label="lab_holx_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember" xlink:href="holx-20210626.xsd#holx_DevelopedTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DevelopedTechnologyMember" xlink:to="lab_holx_DevelopedTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_ef2954d7-cdae-49a9-ab2d-61255fe5f1dd_terseLabel_en-US" xlink:label="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum eligible percentage to receive target number of shares of company's common stock</link:label>
    <link:label id="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_label_en-US" xlink:label="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Target Number Of Shares Issued Based On Stock Performance In Percent</link:label>
    <link:label id="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_documentation_en-US" xlink:label="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum target number percentage of shares issued based on stock performance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:href="holx-20210626.xsd#holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:to="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_a6b39b06-348f-4625-9fd9-48886aa98827_terseLabel_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Receivables and Allowance for Credit Losses</link:label>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans, Notes, Trade and Other Receivables Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CustomerRelationshipsContractsMember_9fb9b713-3f80-4af1-b814-e8b465f2f524_terseLabel_en-US" xlink:label="lab_holx_CustomerRelationshipsContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_holx_CustomerRelationshipsContractsMember_label_en-US" xlink:label="lab_holx_CustomerRelationshipsContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships Contracts [Member]</link:label>
    <link:label id="lab_holx_CustomerRelationshipsContractsMember_documentation_en-US" xlink:label="lab_holx_CustomerRelationshipsContractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships contracts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CustomerRelationshipsContractsMember" xlink:href="holx-20210626.xsd#holx_CustomerRelationshipsContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CustomerRelationshipsContractsMember" xlink:to="lab_holx_CustomerRelationshipsContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_61ea5249-f0c1-42c7-8b85-4064b3ef8046_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, fair value (percentage)</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_19728e29-2fb5-4c71-a695-72afcce4b9ec_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_InterventionalBreastSolutionsMember_0b570448-bf9f-4296-af3f-e897d51cec68_terseLabel_en-US" xlink:label="lab_holx_InterventionalBreastSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional Breast Solutions</link:label>
    <link:label id="lab_holx_InterventionalBreastSolutionsMember_label_en-US" xlink:label="lab_holx_InterventionalBreastSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional Breast Solutions [Member]</link:label>
    <link:label id="lab_holx_InterventionalBreastSolutionsMember_documentation_en-US" xlink:label="lab_holx_InterventionalBreastSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional Breast Solutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterventionalBreastSolutionsMember" xlink:href="holx-20210626.xsd#holx_InterventionalBreastSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InterventionalBreastSolutionsMember" xlink:to="lab_holx_InterventionalBreastSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PurchaseOfNonControllingInterestReclassifiedToAPIC_5ebaf706-d185-406b-aec7-f4e72814e96e_negatedTerseLabel_en-US" xlink:label="lab_holx_PurchaseOfNonControllingInterestReclassifiedToAPIC" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of non-controlling interest reclassified to APIC</link:label>
    <link:label id="lab_holx_PurchaseOfNonControllingInterestReclassifiedToAPIC_label_en-US" xlink:label="lab_holx_PurchaseOfNonControllingInterestReclassifiedToAPIC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of non-controlling interest reclassified to APIC</link:label>
    <link:label id="lab_holx_PurchaseOfNonControllingInterestReclassifiedToAPIC_documentation_en-US" xlink:label="lab_holx_PurchaseOfNonControllingInterestReclassifiedToAPIC" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of non-controlling interest reclassified to APIC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PurchaseOfNonControllingInterestReclassifiedToAPIC" xlink:href="holx-20210626.xsd#holx_PurchaseOfNonControllingInterestReclassifiedToAPIC"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PurchaseOfNonControllingInterestReclassifiedToAPIC" xlink:to="lab_holx_PurchaseOfNonControllingInterestReclassifiedToAPIC" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_e6fda78e-08fa-4e39-baa2-afdbb35d40d9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_07e93a41-8713-488e-9c14-da1b98df7e74_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write- offs and Payments</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_3a909992-4c01-40b7-a571-f2ed100d9ce2_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_171a7bd2-8804-4a13-9a22-7a88b5404d10_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of debt instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Costofservice_eb25e466-9017-4882-b048-fe4b21ffe146_terseLabel_en-US" xlink:label="lab_holx_Costofservice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service and other</link:label>
    <link:label id="lab_holx_Costofservice_label_en-US" xlink:label="lab_holx_Costofservice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of service</link:label>
    <link:label id="lab_holx_Costofservice_documentation_en-US" xlink:label="lab_holx_Costofservice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of service</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Costofservice" xlink:href="holx-20210626.xsd#holx_Costofservice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Costofservice" xlink:to="lab_holx_Costofservice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_a0e794c0-0d45-4339-8bd6-454fa589671a_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Land_1951e284-8e89-460c-8cf1-5ca967dbbf41_terseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_label_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Land"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land" xlink:to="lab_us-gaap_Land" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_68b063ad-5a25-4b91-8765-f5ff7c42bd9d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_2900a144-a9ee-44fe-9993-60197883dcf0_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AccountsReceivableSecuritizationMember_0d3d8420-5006-42c2-87a2-8ab2b46796e1_terseLabel_en-US" xlink:label="lab_holx_AccountsReceivableSecuritizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Securitization</link:label>
    <link:label id="lab_holx_AccountsReceivableSecuritizationMember_label_en-US" xlink:label="lab_holx_AccountsReceivableSecuritizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Securitization [Member]</link:label>
    <link:label id="lab_holx_AccountsReceivableSecuritizationMember_documentation_en-US" xlink:label="lab_holx_AccountsReceivableSecuritizationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Securitization [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember" xlink:href="holx-20210626.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccountsReceivableSecuritizationMember" xlink:to="lab_holx_AccountsReceivableSecuritizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0a7f48ad-e965-4635-a8f8-94717cd042cb_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition_8669498d-73cb-4663-8fb6-6daed3730add_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Additions from Business Acquisition</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Additions from Business Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition" xlink:to="lab_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_cbf64baa-f1ff-4034-995b-2528a36ddf92_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation Expense in Consolidated Statements of Operations</link:label>
    <link:label id="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_label_en-US" xlink:label="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation Expense [Table Text Block]</link:label>
    <link:label id="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_documentation_en-US" xlink:label="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of share-based compensation expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:href="holx-20210626.xsd#holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:to="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_792165d6-1064-4bb0-a590-a8da7bc114d5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings and Credit Arrangements</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_80260752-1e71-42a0-8a94-0570acc5b1b2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_fb79446a-7837-45f1-b070-c6fa567dc445_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_8c2dbf36-6ea2-464b-bf3e-30128ee5cbbb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_b7f2b424-0bac-4103-b16a-f9eed3317169_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MarketBasedAwardsMember_137b5f9f-9e93-4514-a19b-e02a55bf8abf_terseLabel_en-US" xlink:label="lab_holx_MarketBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Based Awards</link:label>
    <link:label id="lab_holx_MarketBasedAwardsMember_label_en-US" xlink:label="lab_holx_MarketBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Based Awards [Member]</link:label>
    <link:label id="lab_holx_MarketBasedAwardsMember_documentation_en-US" xlink:label="lab_holx_MarketBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Based Awards [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MarketBasedAwardsMember" xlink:href="holx-20210626.xsd#holx_MarketBasedAwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MarketBasedAwardsMember" xlink:to="lab_holx_MarketBasedAwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_466f8ecf-2dbd-43e9-8909-4d96fb6b38c3_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_ef14a582-1809-463b-a0ae-f5f86480328e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Basic and Diluted Share Amounts</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c62bb6e7-c4bc-4682-86c8-7c511130d1e5_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2bb3bdea-6a86-47c0-8695-6e9907c97998_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_2916e24b-4744-4e25-a869-5eeb0e7358c4_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7e399cc1-c85e-44db-ae3d-d91f94612da2_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_b6ee1e3a-3a3d-4ea9-b93b-ba92b4807a3e_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_ac2853b6-38e5-403a-89b7-a366a76fe75e_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_4f54739a-5d04-4cbd-a6d8-c30a35806428_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_6d8a31f2-10c7-44a2-b9d8-04fc6546d8b0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_ddc8853b-93bb-4d95-9ef6-c0f1c74bde0a_negatedTerseLabel_en-US" xlink:label="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of minimum tax withholdings on net share settlements of equity awards</link:label>
    <link:label id="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_label_en-US" xlink:label="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment For Tax Withholding Related To Vested And Released Restricted Stock Units</link:label>
    <link:label id="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_documentation_en-US" xlink:label="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The payment of minimum statutory tax withholdings to taxing authorities on the behalf of employees from the net share settlement upon vesting of restricted stock units. This payment is not an expense of the Company nor an operating activity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:href="holx-20210626.xsd#holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:to="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CreditAgreementMember_35d17daa-381d-4772-ba78-3ee8cdc531ad_terseLabel_en-US" xlink:label="lab_holx_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement</link:label>
    <link:label id="lab_holx_CreditAgreementMember_68ea60cb-f396-431a-9c10-ddd295c7de5b_verboseLabel_en-US" xlink:label="lab_holx_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement</link:label>
    <link:label id="lab_holx_CreditAgreementMember_label_en-US" xlink:label="lab_holx_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:label id="lab_holx_CreditAgreementMember_documentation_en-US" xlink:label="lab_holx_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember" xlink:href="holx-20210626.xsd#holx_CreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CreditAgreementMember" xlink:to="lab_holx_CreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ManufacturingEquipmentAndSoftware_8413988f-ed08-48eb-8d1a-5ea75891aeca_terseLabel_en-US" xlink:label="lab_holx_ManufacturingEquipmentAndSoftware" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment</link:label>
    <link:label id="lab_holx_ManufacturingEquipmentAndSoftware_label_en-US" xlink:label="lab_holx_ManufacturingEquipmentAndSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Equipment And Software</link:label>
    <link:label id="lab_holx_ManufacturingEquipmentAndSoftware_documentation_en-US" xlink:label="lab_holx_ManufacturingEquipmentAndSoftware" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross amount as of the balance sheet date of long-lived, depreciable assets that include manufacturing and other equipment with finite lives used to produce goods and services, and computer equipment and software.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ManufacturingEquipmentAndSoftware" xlink:href="holx-20210626.xsd#holx_ManufacturingEquipmentAndSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ManufacturingEquipmentAndSoftware" xlink:to="lab_holx_ManufacturingEquipmentAndSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PrincipalAmountOfBorrowings_24b41bdc-3746-482b-8d17-14679ddc235c_verboseLabel_en-US" xlink:label="lab_holx_PrincipalAmountOfBorrowings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowed principal</link:label>
    <link:label id="lab_holx_PrincipalAmountOfBorrowings_label_en-US" xlink:label="lab_holx_PrincipalAmountOfBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Amount Of Borrowings</link:label>
    <link:label id="lab_holx_PrincipalAmountOfBorrowings_documentation_en-US" xlink:label="lab_holx_PrincipalAmountOfBorrowings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the aggregate outstanding principal of amounts borrowed under the Credit Agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrincipalAmountOfBorrowings" xlink:href="holx-20210626.xsd#holx_PrincipalAmountOfBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PrincipalAmountOfBorrowings" xlink:to="lab_holx_PrincipalAmountOfBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_25585733-4a8b-415a-9c0d-173679356ef3_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_fcebc18c-1dfa-4e91-a48f-f6761b3bf543_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_63420b74-627b-4f5d-b56e-7b876378c3a1_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_95b0af91-88d0-48d4-9aea-f9823a0fa497_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_441586a2-99fe-4f07-a3dd-db249911d262_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_0a7aceaf-c05e-495b-b281-3c77f79c7f28_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_75c11aad-a075-4ffc-ac0f-d72d521fb0ad_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_19ab1b2d-7ab6-4e33-9995-558649225f56_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AmortizationCostofGoodsSold_a938f787-87a5-4051-a12e-8f982b68ab18_terseLabel_en-US" xlink:label="lab_holx_AmortizationCostofGoodsSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization, Cost of Goods Sold</link:label>
    <link:label id="lab_holx_AmortizationCostofGoodsSold_label_en-US" xlink:label="lab_holx_AmortizationCostofGoodsSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization, Cost of Goods Sold</link:label>
    <link:label id="lab_holx_AmortizationCostofGoodsSold_documentation_en-US" xlink:label="lab_holx_AmortizationCostofGoodsSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization, Cost of Goods Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmortizationCostofGoodsSold" xlink:href="holx-20210626.xsd#holx_AmortizationCostofGoodsSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AmortizationCostofGoodsSold" xlink:to="lab_holx_AmortizationCostofGoodsSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_68c79787-e194-45d2-a47f-f9663f9e9654_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_2a0d74a4-ed9a-4429-991f-72fb30f68c8c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of realized gain (loss) recognized in income</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_2cbeaca5-af67-4842-a616-c183f008ac7e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_f12c0694-27d2-4657-aa4f-3caf02344fba_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Three</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PercentageAddedtoEurodollarRateMember_dcfabaa7-f9d0-49f6-b0d0-c375b9ab8728_terseLabel_en-US" xlink:label="lab_holx_PercentageAddedtoEurodollarRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Added to Eurodollar Rate</link:label>
    <link:label id="lab_holx_PercentageAddedtoEurodollarRateMember_label_en-US" xlink:label="lab_holx_PercentageAddedtoEurodollarRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Added to Eurodollar Rate [Member]</link:label>
    <link:label id="lab_holx_PercentageAddedtoEurodollarRateMember_documentation_en-US" xlink:label="lab_holx_PercentageAddedtoEurodollarRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Added to Eurodollar Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageAddedtoEurodollarRateMember" xlink:href="holx-20210626.xsd#holx_PercentageAddedtoEurodollarRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PercentageAddedtoEurodollarRateMember" xlink:to="lab_holx_PercentageAddedtoEurodollarRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CytologyPerinatalMember_19e02df3-5783-4a0d-a9da-4e191ccb4135_terseLabel_en-US" xlink:label="lab_holx_CytologyPerinatalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cytology &amp; Perinatal</link:label>
    <link:label id="lab_holx_CytologyPerinatalMember_label_en-US" xlink:label="lab_holx_CytologyPerinatalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cytology &amp; Perinatal [Member]</link:label>
    <link:label id="lab_holx_CytologyPerinatalMember_documentation_en-US" xlink:label="lab_holx_CytologyPerinatalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cytology &amp; Perinatal [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CytologyPerinatalMember" xlink:href="holx-20210626.xsd#holx_CytologyPerinatalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CytologyPerinatalMember" xlink:to="lab_holx_CytologyPerinatalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_88b50091-06a3-4c67-babb-0d0a5b1527e1_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_47afb75a-2975-4f01-891a-414a8dfa1865_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ComprehensiveIncome_f2517fe2-e8bb-426a-884e-577ff92df039_totalLabel_en-US" xlink:label="lab_holx_ComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income</link:label>
    <link:label id="lab_holx_ComprehensiveIncome_label_en-US" xlink:label="lab_holx_ComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income</link:label>
    <link:label id="lab_holx_ComprehensiveIncome_documentation_en-US" xlink:label="lab_holx_ComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ComprehensiveIncome" xlink:href="holx-20210626.xsd#holx_ComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ComprehensiveIncome" xlink:to="lab_holx_ComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SharerepurchaseplanLineItems_6bd43954-1269-4c5b-9640-cec44a73c1f3_terseLabel_en-US" xlink:label="lab_holx_SharerepurchaseplanLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">share repurchase plan [Line Items]</link:label>
    <link:label id="lab_holx_SharerepurchaseplanLineItems_label_en-US" xlink:label="lab_holx_SharerepurchaseplanLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">share repurchase plan [Line Items]</link:label>
    <link:label id="lab_holx_SharerepurchaseplanLineItems_documentation_en-US" xlink:label="lab_holx_SharerepurchaseplanLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for share repurchase plan [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharerepurchaseplanLineItems" xlink:href="holx-20210626.xsd#holx_SharerepurchaseplanLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SharerepurchaseplanLineItems" xlink:to="lab_holx_SharerepurchaseplanLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsLineItems_1ebd3f54-4124-4728-905f-f963c7e63334_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Line Items]</link:label>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsLineItems_label_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Line Items]</link:label>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsLineItems_documentation_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:href="holx-20210626.xsd#holx_ScheduleOfGeographicalSegmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:to="lab_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_0d870c24-8af3-4d32-b1f3-1d999ebd1aa7_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration related to newly acquired shares</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_label_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Newly Acquired Shares</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_documentation_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Newly Acquired Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" xlink:href="holx-20210626.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" xlink:to="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_b61f4822-e20a-41c1-b0f8-b1763d033895_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup_9b9c2d85-c7bc-4794-929f-ef5036544ffe_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Segment that Includes Disposal Group</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Segment that Includes Disposal Group</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_159078c8-b4ee-47bf-9168-b2003ceff7aa_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_IndemnificationLiability_f719e1a4-dc5e-4f7a-b21e-d49e73a03741_terseLabel_en-US" xlink:label="lab_holx_IndemnificationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification liability</link:label>
    <link:label id="lab_holx_IndemnificationLiability_label_en-US" xlink:label="lab_holx_IndemnificationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification liability</link:label>
    <link:label id="lab_holx_IndemnificationLiability_documentation_en-US" xlink:label="lab_holx_IndemnificationLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IndemnificationLiability" xlink:href="holx-20210626.xsd#holx_IndemnificationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_IndemnificationLiability" xlink:to="lab_holx_IndemnificationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EarningsPerShareTable_05fbf07e-2b90-4260-8104-770826069257_terseLabel_en-US" xlink:label="lab_holx_EarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Table]</link:label>
    <link:label id="lab_holx_EarningsPerShareTable_label_en-US" xlink:label="lab_holx_EarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Table]</link:label>
    <link:label id="lab_holx_EarningsPerShareTable_documentation_en-US" xlink:label="lab_holx_EarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareTable" xlink:href="holx-20210626.xsd#holx_EarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EarningsPerShareTable" xlink:to="lab_holx_EarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_81c95e67-e977-4dc1-9a8a-591e51693989_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Line of Credit Facilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Line of Credit Facilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:to="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_0050e593-1f30-4e49-a9a7-39bf387c5ce2_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_bfd946ed-3d63-41a0-9df1-74b19e3cf2eb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_792fed91-7f40-4900-8bfb-b979b9e8a441_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, reserves</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_8e8e6f92-65f0-4575-bd8c-bb78bad2c8d9_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at Beginning of Period</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_0656f50f-bc04-478f-87f7-ff68abcdf674_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at End of Period</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_463e6c6e-364f-485a-a0b8-10353f1799a4_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue_3c0b9401-3d5e-452b-829d-d2cdb7041171_terseLabel_en-US" xlink:label="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Offering Price, Percent Of Face Value</link:label>
    <link:label id="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue_label_en-US" xlink:label="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Offering Price, Percent Of Face Value</link:label>
    <link:label id="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue_documentation_en-US" xlink:label="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Offering Price, Percent Of Face Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentOfferingPricePercentOfFaceValue" xlink:href="holx-20210626.xsd#holx_DebtInstrumentOfferingPricePercentOfFaceValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtInstrumentOfferingPricePercentOfFaceValue" xlink:to="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_242a5503-3fc1-4670-8ae2-a267aedca620_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_6c145149-a308-4b25-94c4-d802e92584b2_verboseLabel_en-US" xlink:label="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance stock units vesting period</link:label>
    <link:label id="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_label_en-US" xlink:label="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shared Based Compensation Arrangement Restricted Stock Vesting Period</link:label>
    <link:label id="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_documentation_en-US" xlink:label="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period of time that must lapse in order for the restricted stock units to vest.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" xlink:href="holx-20210626.xsd#holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" xlink:to="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_67c66046-7ac4-4865-af03-4da18a08fcb5_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_8a90112d-7f46-424b-b776-42d1da0c676c_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_label_en-US" xlink:label="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock, Shares Issued Net of Shares for Tax Withholdings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:to="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_558717c2-a7aa-4f1e-a646-d539d5ad3d7a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Debt Obligations</link:label>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Debt Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDebtSecuritiesMember" xlink:to="lab_us-gaap_OtherDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_66cbcb4b-0885-450a-956f-2223a6dd13f5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_2de0aa88-b971-49ff-bb1e-50c5f646db9f_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesGross" xlink:to="lab_us-gaap_FurnitureAndFixturesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_51ceb361-64c1-4381-b33c-985ef76ca360_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of acquired intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_a859aab9-b40f-4503-8fdd-ba71d0f05741_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues by Geography</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_d08ccb61-47d7-4889-a12d-b8f1f5c271a0_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward foreign currency contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_504d25b7-b926-43d5-a7ea-a7fe830b6020_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:to="lab_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_d30da6bd-2cc9-4cd1-bf06-59850421309a_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AcquiredintangibleassetsMember_40881729-d4b7-4155-9280-ce8b24605e7d_terseLabel_en-US" xlink:label="lab_holx_AcquiredintangibleassetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total acquired intangible assets</link:label>
    <link:label id="lab_holx_AcquiredintangibleassetsMember_label_en-US" xlink:label="lab_holx_AcquiredintangibleassetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired intangible assets [Member]</link:label>
    <link:label id="lab_holx_AcquiredintangibleassetsMember_documentation_en-US" xlink:label="lab_holx_AcquiredintangibleassetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired intangible assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcquiredintangibleassetsMember" xlink:href="holx-20210626.xsd#holx_AcquiredintangibleassetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AcquiredintangibleassetsMember" xlink:to="lab_holx_AcquiredintangibleassetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_3f2d866d-f0d7-40e8-ac4d-a71002eb069b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_46c2e761-d744-4bec-bea1-31b6673261a8_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segments and Geographic Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_02a65f45-2bd8-4479-828f-4f43e18d7c43_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_56912366-6ab9-4dfb-aa91-70e97ac3171d_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identifiable assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_70cf7295-25f2-4185-bd37-314ceb01cf9c_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets and equipment</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SkeletalHealthMember_fbf4c46f-797f-4a1e-8d65-10d3ea1afc4c_terseLabel_en-US" xlink:label="lab_holx_SkeletalHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skeletal Health</link:label>
    <link:label id="lab_holx_SkeletalHealthMember_label_en-US" xlink:label="lab_holx_SkeletalHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skeletal Health [Member]</link:label>
    <link:label id="lab_holx_SkeletalHealthMember_documentation_en-US" xlink:label="lab_holx_SkeletalHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skeletal health.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember" xlink:href="holx-20210626.xsd#holx_SkeletalHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SkeletalHealthMember" xlink:to="lab_holx_SkeletalHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_InternalusesoftwareMember_c534311a-08a6-486a-9e86-b44e35398ee3_terseLabel_en-US" xlink:label="lab_holx_InternalusesoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal-use software</link:label>
    <link:label id="lab_holx_InternalusesoftwareMember_label_en-US" xlink:label="lab_holx_InternalusesoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal-use software [Member]</link:label>
    <link:label id="lab_holx_InternalusesoftwareMember_documentation_en-US" xlink:label="lab_holx_InternalusesoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal-use software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternalusesoftwareMember" xlink:href="holx-20210626.xsd#holx_InternalusesoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InternalusesoftwareMember" xlink:to="lab_holx_InternalusesoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_6a34d231-3ea4-4c76-83c2-820ba2aedd6b_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateMember_5f76ddbb-cfeb-42de-921f-e1929cfa9e7d_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateMember_label_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateMember" xlink:to="lab_us-gaap_CorporateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_a0556528-2d60-4611-afd6-bdef63268ed7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_855e2bd4-7c59-496e-ae99-2c2ab06b5435_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_5e473f67-3ccf-45bc-898c-7d91b2eefd66_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_12f8eb90-ca9f-4c59-9d37-82c04e2e45ea_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average fair value of options granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_631b745d-ff45-44b4-a68f-ec78fd1df6d5_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_1070a7ea-ca53-44f2-a145-081254d1e894_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenues</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BloodScreeningMember_506af9bd-be91-4164-b3c1-50f14c2e1ce2_terseLabel_en-US" xlink:label="lab_holx_BloodScreeningMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blood Screening</link:label>
    <link:label id="lab_holx_BloodScreeningMember_label_en-US" xlink:label="lab_holx_BloodScreeningMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blood Screening [Member]</link:label>
    <link:label id="lab_holx_BloodScreeningMember_documentation_en-US" xlink:label="lab_holx_BloodScreeningMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blood Screening [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BloodScreeningMember" xlink:href="holx-20210626.xsd#holx_BloodScreeningMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BloodScreeningMember" xlink:to="lab_holx_BloodScreeningMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsNoncurrent_909765af-837e-4d55-83c5-bd527cf89dcb_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease obligations, net of current portion</link:label>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsNoncurrent_label_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Lease Obligations, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeaseObligationsNoncurrent" xlink:to="lab_us-gaap_CapitalLeaseObligationsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_fd60dbc6-1c70-45bb-98c3-3279675f1061_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_1b5bfcb9-f7d3-4399-a095-3c30d3b1139c_terseLabel_en-US" xlink:label="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum eligible percentage to receive target number of shares of company's common stock</link:label>
    <link:label id="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_label_en-US" xlink:label="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Target Number Of Shares Issued On Stock Performance In Percent</link:label>
    <link:label id="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_documentation_en-US" xlink:label="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum target number percentage of shares that would be issued based on stock price performance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:href="holx-20210626.xsd#holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:to="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_6c609db5-9764-4384-bd5c-63bd002f611c_terseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dispositions</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ResearchAndDevelopmentInProcessNumberOfProjects_123c5545-0780-4552-a2c1-3466b8cb4987_terseLabel_en-US" xlink:label="lab_holx_ResearchAndDevelopmentInProcessNumberOfProjects" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development in process, number of projects</link:label>
    <link:label id="lab_holx_ResearchAndDevelopmentInProcessNumberOfProjects_label_en-US" xlink:label="lab_holx_ResearchAndDevelopmentInProcessNumberOfProjects" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development in Process, Number Of Projects</link:label>
    <link:label id="lab_holx_ResearchAndDevelopmentInProcessNumberOfProjects_documentation_en-US" xlink:label="lab_holx_ResearchAndDevelopmentInProcessNumberOfProjects" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development in Process, Number Of Projects</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ResearchAndDevelopmentInProcessNumberOfProjects" xlink:href="holx-20210626.xsd#holx_ResearchAndDevelopmentInProcessNumberOfProjects"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ResearchAndDevelopmentInProcessNumberOfProjects" xlink:to="lab_holx_ResearchAndDevelopmentInProcessNumberOfProjects" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromAccountsReceivableSecuritization_7ffc8970-186e-43df-a5a3-a0f18e9ba0ad_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromAccountsReceivableSecuritization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from accounts receivable securitization agreement</link:label>
    <link:label id="lab_us-gaap_ProceedsFromAccountsReceivableSecuritization_label_en-US" xlink:label="lab_us-gaap_ProceedsFromAccountsReceivableSecuritization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Accounts Receivable Securitization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromAccountsReceivableSecuritization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromAccountsReceivableSecuritization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromAccountsReceivableSecuritization" xlink:to="lab_us-gaap_ProceedsFromAccountsReceivableSecuritization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_922b1236-8f2e-4bc7-8ba7-5c1351835bd8_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_42ec2962-7ce3-4e82-8ea6-6a26659b89d8_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_722174c7-1fbc-4250-98cc-d8938e11811c_terseLabel_en-US" xlink:label="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Balance Sheet Information</link:label>
    <link:label id="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_label_en-US" xlink:label="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Details Of Certain Balance Sheet Accounts [Text Block]</link:label>
    <link:label id="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_documentation_en-US" xlink:label="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Details of certain balance sheet accounts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DetailsOfCertainBalanceSheetAccountsTextBlock" xlink:href="holx-20210626.xsd#holx_DetailsOfCertainBalanceSheetAccountsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DetailsOfCertainBalanceSheetAccountsTextBlock" xlink:to="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BiotheranosticsMember_0a26e6d1-a758-4496-8339-72806ec4a57c_terseLabel_en-US" xlink:label="lab_holx_BiotheranosticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biotheranostics</link:label>
    <link:label id="lab_holx_BiotheranosticsMember_label_en-US" xlink:label="lab_holx_BiotheranosticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biotheranostics [Member]</link:label>
    <link:label id="lab_holx_BiotheranosticsMember_documentation_en-US" xlink:label="lab_holx_BiotheranosticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biotheranostics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BiotheranosticsMember" xlink:href="holx-20210626.xsd#holx_BiotheranosticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BiotheranosticsMember" xlink:to="lab_holx_BiotheranosticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_1b9e5a55-9872-4e0b-9ded-b6aa54de65e6_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average period for recognition of unrecognized stock-based compensation, years</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_8188ae21-4778-4d2d-bc79-5c7baf816295_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateAxis_e2603542-007b-49be-a9c0-e64151a3b285_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Axis]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateAxis_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_6c08cfef-1624-45a0-9c69-afeefe4b9f09_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b6712bd6-c474-46d6-8513-74965c62a9ef_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_c480c2d7-956e-4025-afed-d43233ff3d2f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_c138a64c-bc15-46b0-a0a7-f435094e4bf4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration fair value adjustments</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_59fdfb97-c955-4dac-b16a-6657780c1c2f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of gain (loss) recognized in other comprehensive income, net of taxes:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_4502341b-5180-40a3-86dc-87a5255e7db1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_52f6ee0e-a6af-4737-87a8-5a84cfa6f7f8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Weighted Average Interest Rate</link:label>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Weighted Average Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_595cf562-06b0-4ef6-9b75-2548e50bd60d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_3aec827a-054a-4973-9bf5-3bfe65105cbb_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueNoncurrent_574637b0-d3b8-49c1-9bc7-39072e7217fc_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, net of current portion</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueNoncurrent" xlink:to="lab_us-gaap_DeferredRevenueNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_cf75bb72-581d-42a0-bca1-c474e6457b8c_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of unrealized gain (loss) recognized in income</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsCurrent_c373f7db-f523-4458-8412-419447bd4468_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of capital lease obligations</link:label>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Lease Obligations, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_CapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes_b8622e04-c39b-4829-8565-ff9ec1b2e8ec_terseLabel_en-US" xlink:label="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt obligations. excluding convertible notes</link:label>
    <link:label id="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes_label_en-US" xlink:label="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Debt Obligations Without Convertible Notes</link:label>
    <link:label id="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes_documentation_en-US" xlink:label="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt obligations without convertible notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:href="holx-20210626.xsd#holx_LongTermDebtObligationsWithoutConvertibleNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:to="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_8955a403-539e-43e9-91c6-003de2cb44a7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_0c64644a-0096-426e-ac90-1e3b7affe9c8_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PSUFreeCashFlowMember_c51f60d9-3ddd-4db7-8bc9-836f90d60393_terseLabel_en-US" xlink:label="lab_holx_PSUFreeCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PSU Free Cash Flow [Member]</link:label>
    <link:label id="lab_holx_PSUFreeCashFlowMember_label_en-US" xlink:label="lab_holx_PSUFreeCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PSU Free Cash Flow [Member]</link:label>
    <link:label id="lab_holx_PSUFreeCashFlowMember_documentation_en-US" xlink:label="lab_holx_PSUFreeCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PSU Free Cash Flow [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PSUFreeCashFlowMember" xlink:href="holx-20210626.xsd#holx_PSUFreeCashFlowMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PSUFreeCashFlowMember" xlink:to="lab_holx_PSUFreeCashFlowMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_2e1e87a7-0cd7-42a4-bebb-98715067d4c4_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment_89e02c78-1ddf-4e20-b507-aabac06825c5_terseLabel_en-US" xlink:label="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets and equipment</link:label>
    <link:label id="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment_label_en-US" xlink:label="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Goods Sold Impairment Of Intangible Assets and equipment</link:label>
    <link:label id="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment_documentation_en-US" xlink:label="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of impairment loss recognized in cost of product sales in the period resulting from the write-down of the carrying amount of an intangible asset to fair value.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment" xlink:href="holx-20210626.xsd#holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment" xlink:to="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AmountAssessedInDamages_0015b142-be20-42b6-b148-a279d533ca29_terseLabel_en-US" xlink:label="lab_holx_AmountAssessedInDamages" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assessed damages</link:label>
    <link:label id="lab_holx_AmountAssessedInDamages_label_en-US" xlink:label="lab_holx_AmountAssessedInDamages" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount Assessed In Damages</link:label>
    <link:label id="lab_holx_AmountAssessedInDamages_documentation_en-US" xlink:label="lab_holx_AmountAssessedInDamages" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount assessed in damages.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmountAssessedInDamages" xlink:href="holx-20210626.xsd#holx_AmountAssessedInDamages"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AmountAssessedInDamages" xlink:to="lab_holx_AmountAssessedInDamages" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_efc175eb-af1a-4978-900b-8826abe18448_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_6b33433f-2a84-4271-bb39-85ddf42bc3bc_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_84756f39-92b7-4cde-9a23-445cad432bfc_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_6a9b3b2d-dd96-4ad4-9e78-4d71078d8a61_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss reclassified from accumulated other comprehensive loss to the statements of income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_4312edb6-6737-4ae8-826a-ef8c38ea5a1e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MolecularDiagnosticsMember_e048fb3d-ef71-4db2-9e74-5dfa8f401ce9_terseLabel_en-US" xlink:label="lab_holx_MolecularDiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostics</link:label>
    <link:label id="lab_holx_MolecularDiagnosticsMember_label_en-US" xlink:label="lab_holx_MolecularDiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostics [Member]</link:label>
    <link:label id="lab_holx_MolecularDiagnosticsMember_documentation_en-US" xlink:label="lab_holx_MolecularDiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostics [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MolecularDiagnosticsMember" xlink:href="holx-20210626.xsd#holx_MolecularDiagnosticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MolecularDiagnosticsMember" xlink:to="lab_holx_MolecularDiagnosticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f95921e7-6877-4962-bf5e-1fc63b7fe1a8_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_3ce2b12a-7615-480a-94f5-40433a82416d_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_cab41473-7195-4b4c-a97f-9a9ff87b5495_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_782bf117-d6b4-4dab-8086-3707b91f1ea4_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_d655d0ac-1883-4529-9e4e-a62b51bf782c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_0602a7b1-9c35-4e2f-ba0a-2b2b3bb75c57_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Interest Expense Under Convertible Notes</link:label>
    <link:label id="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_label_en-US" xlink:label="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Interest Expense Under Convertible Notes [Table Text Block]</link:label>
    <link:label id="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_documentation_en-US" xlink:label="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of interest expense under convertible notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:href="holx-20210626.xsd#holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:to="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_December112020Member_c7baaf0b-34ac-45e9-9233-949af7338164_terseLabel_en-US" xlink:label="lab_holx_December112020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 11, 2020</link:label>
    <link:label id="lab_holx_December112020Member_label_en-US" xlink:label="lab_holx_December112020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 11, 2020 [Member]</link:label>
    <link:label id="lab_holx_December112020Member_documentation_en-US" xlink:label="lab_holx_December112020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 11, 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_December112020Member" xlink:href="holx-20210626.xsd#holx_December112020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_December112020Member" xlink:to="lab_holx_December112020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_b7122fc4-467a-44fd-a206-ef3c632e04b8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LeaseRevenuePercentageOfTotalRevenue_dd7713bb-ecd9-4cbb-b98d-6710171c43e3_terseLabel_en-US" xlink:label="lab_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease revenue as a percentage of total (percentage)</link:label>
    <link:label id="lab_holx_LeaseRevenuePercentageOfTotalRevenue_label_en-US" xlink:label="lab_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Revenue, Percentage Of Total Revenue</link:label>
    <link:label id="lab_holx_LeaseRevenuePercentageOfTotalRevenue_documentation_en-US" xlink:label="lab_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Revenue, Percentage Of Total Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:href="holx-20210626.xsd#holx_LeaseRevenuePercentageOfTotalRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:to="lab_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_fa18b4b2-8878-41b7-acbd-9a78dee98fca_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AcessaHealthMember_0df76cd3-b89b-453b-aec5-55c8c4f480fa_terseLabel_en-US" xlink:label="lab_holx_AcessaHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acessa Health</link:label>
    <link:label id="lab_holx_AcessaHealthMember_label_en-US" xlink:label="lab_holx_AcessaHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acessa Health [Member]</link:label>
    <link:label id="lab_holx_AcessaHealthMember_documentation_en-US" xlink:label="lab_holx_AcessaHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acessa Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember" xlink:href="holx-20210626.xsd#holx_AcessaHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AcessaHealthMember" xlink:to="lab_holx_AcessaHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_1f825264-11c4-4c9c-b20f-4d8d08bcb2ac_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b5ced89c-8b7c-423a-8e76-d311b81a642c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average exercise price of options outstanding (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SegmentReportingDisclosureLineItems_20233a9a-0808-4316-b21a-45658c032364_terseLabel_en-US" xlink:label="lab_holx_SegmentReportingDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Line Items]</link:label>
    <link:label id="lab_holx_SegmentReportingDisclosureLineItems_label_en-US" xlink:label="lab_holx_SegmentReportingDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Line Items]</link:label>
    <link:label id="lab_holx_SegmentReportingDisclosureLineItems_documentation_en-US" xlink:label="lab_holx_SegmentReportingDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SegmentReportingDisclosureLineItems" xlink:href="holx-20210626.xsd#holx_SegmentReportingDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SegmentReportingDisclosureLineItems" xlink:to="lab_holx_SegmentReportingDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_def8be8f-2e1a-4598-98f8-16887d1302ce_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of businesses, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_2a0a9a3f-8f0c-4b62-abae-74e134d90bf7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_15110c0b-30b4-48ab-a6b1-1c633ce55bf8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of outstanding shares acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_615d4fc7-5f0f-4576-999e-b24bf61f593a_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_42c25648-4ff1-48bb-b83d-46545f60cfd4_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common stock equivalents from assumed exercise of stock options and issuance of stock units</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_de7af79e-e90b-44da-a484-e14e4d6652a8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenseMember_c81c9fcd-be00-4c88-9548-c9ae33f53ad9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expense</link:label>
    <link:label id="lab_us-gaap_OperatingExpenseMember_label_en-US" xlink:label="lab_us-gaap_OperatingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenseMember" xlink:to="lab_us-gaap_OperatingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeOptionMember_d2cc5629-5f97-4c43-9afe-d7fa096f7bde_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency option contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeOptionMember_69adf056-269a-4027-b2e4-6634ec8a5748_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Option</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeOptionMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeOptionMember" xlink:to="lab_us-gaap_ForeignExchangeOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MedicalAestheticsMember_91c1777f-7bcf-40a7-a9c1-ddcf08634c39_verboseLabel_en-US" xlink:label="lab_holx_MedicalAestheticsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Aesthetics</link:label>
    <link:label id="lab_holx_MedicalAestheticsMember_93ba45bf-a761-41e9-82ff-95adb8840b7e_terseLabel_en-US" xlink:label="lab_holx_MedicalAestheticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Aesthetics</link:label>
    <link:label id="lab_holx_MedicalAestheticsMember_label_en-US" xlink:label="lab_holx_MedicalAestheticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Aesthetics [Member]</link:label>
    <link:label id="lab_holx_MedicalAestheticsMember_documentation_en-US" xlink:label="lab_holx_MedicalAestheticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Aesthetic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember" xlink:href="holx-20210626.xsd#holx_MedicalAestheticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MedicalAestheticsMember" xlink:to="lab_holx_MedicalAestheticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BasisofPresentationAbstract_92af4749-6450-40ab-bfc0-fd98882cd2a0_terseLabel_en-US" xlink:label="lab_holx_BasisofPresentationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Abstract]</link:label>
    <link:label id="lab_holx_BasisofPresentationAbstract_label_en-US" xlink:label="lab_holx_BasisofPresentationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Abstract]</link:label>
    <link:label id="lab_holx_BasisofPresentationAbstract_documentation_en-US" xlink:label="lab_holx_BasisofPresentationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BasisofPresentationAbstract" xlink:href="holx-20210626.xsd#holx_BasisofPresentationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BasisofPresentationAbstract" xlink:to="lab_holx_BasisofPresentationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_25b17619-58c2-4d9e-a854-6128331e0c84_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_81b510dd-359f-4165-8cb7-775486135c64_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_17c3635b-7843-4df3-80ee-0f9856d948a4_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_44a6fcf8-df90-4a98-824f-34f90a6bdab8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchaseProgramAdjustment_c25b68db-7ee5-4df6-badd-b71ef20a5089_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchaseProgramAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchase agreement</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchaseProgramAdjustment_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchaseProgramAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase Program, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchaseProgramAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchaseProgramAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchaseProgramAdjustment" xlink:to="lab_us-gaap_AcceleratedShareRepurchaseProgramAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsTable_7eb1ea5f-5f9c-45a4-b8c9-8666178e1ef8_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Table]</link:label>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsTable_label_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Table]</link:label>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsTable_documentation_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsTable" xlink:href="holx-20210626.xsd#holx_ScheduleOfGeographicalSegmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsTable" xlink:to="lab_holx_ScheduleOfGeographicalSegmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_08990247-26cf-4f32-9818-a834349ff75a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_e50334ef-d4e3-40e9-aa44-6a35d8428d7f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in value of hedged interest rate swaps and interest rate caps, net of tax of $1.0 and $2.2 for the three and nine months ended June 26, 2021 and $(1.5) and $(7.9) for the three and nine months ended June 27, 2020.</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_1b2f3a55-3082-454a-8fc7-f6dcb0503ad8_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_ebb32249-edf5-4608-8d02-75f30fee9ccf_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_b865a9a7-7f97-4b55-bcb0-744dcc5dc41b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration recorded at acquisition</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_bab7f6d6-e3f2-4390-984b-e3e5ec40bdb1_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_8f7e76ba-12be-49d6-af53-0701f30c49e4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Obligations, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_c1da3fe5-fec1-4261-9255-38c21dea7f10_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_685eeb50-7d54-4052-8d27-af1ceda830cd_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of acquired intangibles</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_e64008f9-f07f-46d1-b3d6-ba7a68cad36f_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets measured at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_aecf8667-78a2-4e82-bb79-a9613ab12d68_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_04a76bd7-c056-4b83-904e-9d7273429e5d_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_0ec6b73e-03e5-446b-8d7f-45f97f307828_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CapitalEquipmentComponentsandSoftwareMember_dc6a9566-a067-430f-acb3-7fd3059b3e6b_terseLabel_en-US" xlink:label="lab_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital equipment, components and software</link:label>
    <link:label id="lab_holx_CapitalEquipmentComponentsandSoftwareMember_label_en-US" xlink:label="lab_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Equipment, Components and Software [Member]</link:label>
    <link:label id="lab_holx_CapitalEquipmentComponentsandSoftwareMember_documentation_en-US" xlink:label="lab_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Equipment, Components and Software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:href="holx-20210626.xsd#holx_CapitalEquipmentComponentsandSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:to="lab_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EarningsPerShareLineItems_4d8c9956-3feb-430b-b99d-79210290c767_terseLabel_en-US" xlink:label="lab_holx_EarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_holx_EarningsPerShareLineItems_label_en-US" xlink:label="lab_holx_EarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_holx_EarningsPerShareLineItems_documentation_en-US" xlink:label="lab_holx_EarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareLineItems" xlink:href="holx-20210626.xsd#holx_EarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EarningsPerShareLineItems" xlink:to="lab_holx_EarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCapMember_b4b28a23-35b2-49ad-803a-5ea0b761da91_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate caps - derivative</link:label>
    <link:label id="lab_us-gaap_InterestRateCapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCapMember" xlink:to="lab_us-gaap_InterestRateCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_5a85390f-10f8-4342-8e82-32be45131620_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_cac84c9e-d478-4d16-8a41-020fd2086a55_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia-Pacific</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_40d35bf5-6cca-49f9-8893-755c3cb201d2_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_1324fe16-7558-41f1-9cbb-b5c5a73d908b_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_46d2bdac-4320-4737-be0e-66ac7681ef3a_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2029SeniorNotesMember_ab9f298d-0cfb-444f-a54d-ab49f327d99e_terseLabel_en-US" xlink:label="lab_holx_A2029SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2029 Senior Notes</link:label>
    <link:label id="lab_holx_A2029SeniorNotesMember_label_en-US" xlink:label="lab_holx_A2029SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2029 Senior Notes [Member]</link:label>
    <link:label id="lab_holx_A2029SeniorNotesMember_documentation_en-US" xlink:label="lab_holx_A2029SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2029 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember" xlink:href="holx-20210626.xsd#holx_A2029SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2029SeniorNotesMember" xlink:to="lab_holx_A2029SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_64ee865d-3655-4318-bcab-df78b64bb782_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod_533ded8f-4d8a-4301-83fc-acbeadc588f5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Par Value Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_a4fcad0c-c177-49d6-9e1a-6b439fcb2ac6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price withheld</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_December112019Member_49b51dfa-9d79-480d-b2f4-2b906cfdebb6_terseLabel_en-US" xlink:label="lab_holx_December112019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 11, 2019</link:label>
    <link:label id="lab_holx_December112019Member_label_en-US" xlink:label="lab_holx_December112019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 11, 2019 [Member]</link:label>
    <link:label id="lab_holx_December112019Member_documentation_en-US" xlink:label="lab_holx_December112019Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 11, 2019</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_December112019Member" xlink:href="holx-20210626.xsd#holx_December112019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_December112019Member" xlink:to="lab_holx_December112019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Holdback_0cb62e21-7a36-419d-a909-8b2c3713da2a_terseLabel_en-US" xlink:label="lab_holx_Holdback" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Holdback</link:label>
    <link:label id="lab_holx_Holdback_label_en-US" xlink:label="lab_holx_Holdback" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Holdback</link:label>
    <link:label id="lab_holx_Holdback_documentation_en-US" xlink:label="lab_holx_Holdback" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Holdback</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Holdback" xlink:href="holx-20210626.xsd#holx_Holdback"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Holdback" xlink:to="lab_holx_Holdback" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_d5e2a63f-b306-4b0f-9856-bfa7973e737f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ProceedsFromSeniorNotes_84d3c70c-1630-4682-b579-29e5f04821e2_terseLabel_en-US" xlink:label="lab_holx_ProceedsFromSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Notes Payable</link:label>
    <link:label id="lab_holx_ProceedsFromSeniorNotes_label_en-US" xlink:label="lab_holx_ProceedsFromSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Senior Notes</link:label>
    <link:label id="lab_holx_ProceedsFromSeniorNotes_documentation_en-US" xlink:label="lab_holx_ProceedsFromSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProceedsFromSeniorNotes" xlink:href="holx-20210626.xsd#holx_ProceedsFromSeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ProceedsFromSeniorNotes" xlink:to="lab_holx_ProceedsFromSeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1d3156d9-69cd-4a97-8924-959764e91701_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_8d050e88-227f-4f42-852a-2d688dc90498_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1402eb23-a513-4912-9f33-8136cc896209_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_f2349099-1d2c-4a2f-ad06-4f7f18c3cf4a_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified to statement of income</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_9ebe76f0-e688-4e43-b630-159e8bc74775_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DiagnosticsMember_bcdd4e35-7a74-4b0e-b6fc-b975f22a9225_terseLabel_en-US" xlink:label="lab_holx_DiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics</link:label>
    <link:label id="lab_holx_DiagnosticsMember_label_en-US" xlink:label="lab_holx_DiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics [Member]</link:label>
    <link:label id="lab_holx_DiagnosticsMember_documentation_en-US" xlink:label="lab_holx_DiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember" xlink:href="holx-20210626.xsd#holx_DiagnosticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DiagnosticsMember" xlink:to="lab_holx_DiagnosticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_94bf60c6-59e5-443c-950f-f967caa1819b_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AmendedTermLoanMember_999b1ff2-3104-4241-9f4c-a7e48c691495_terseLabel_en-US" xlink:label="lab_holx_AmendedTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Term Loan</link:label>
    <link:label id="lab_holx_AmendedTermLoanMember_label_en-US" xlink:label="lab_holx_AmendedTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Term Loan [Member]</link:label>
    <link:label id="lab_holx_AmendedTermLoanMember_documentation_en-US" xlink:label="lab_holx_AmendedTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmendedTermLoanMember" xlink:href="holx-20210626.xsd#holx_AmendedTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AmendedTermLoanMember" xlink:to="lab_holx_AmendedTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_90f9e464-f7c3-4742-badd-5bda83850d25_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Balance Sheet Information of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_76214858-a00c-42c8-b8c2-2177dc8c941a_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_8f3920a7-3c66-4a05-b996-5f96a23972a8_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_e525025a-daf2-47ae-9455-95e2ef926667_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_2e7a8bc0-fa32-40df-8870-27ca887ca468_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_89345513-2765-41f3-b77c-d3ced1b6fa63_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LegalAccrual_fb4e6f77-d843-4f2b-975b-ddf3ebdf1f42_terseLabel_en-US" xlink:label="lab_holx_LegalAccrual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Accrual</link:label>
    <link:label id="lab_holx_LegalAccrual_label_en-US" xlink:label="lab_holx_LegalAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Accrual</link:label>
    <link:label id="lab_holx_LegalAccrual_documentation_en-US" xlink:label="lab_holx_LegalAccrual" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LegalAccrual" xlink:href="holx-20210626.xsd#holx_LegalAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LegalAccrual" xlink:to="lab_holx_LegalAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationAdditionalSharesAcquiredValue_47e6f411-da54-4c7c-b7f1-83aba8e59a88_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationAdditionalSharesAcquiredValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional outstanding shares purchased, amount</link:label>
    <link:label id="lab_holx_BusinessCombinationAdditionalSharesAcquiredValue_label_en-US" xlink:label="lab_holx_BusinessCombinationAdditionalSharesAcquiredValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Additional Shares Acquired, Value</link:label>
    <link:label id="lab_holx_BusinessCombinationAdditionalSharesAcquiredValue_documentation_en-US" xlink:label="lab_holx_BusinessCombinationAdditionalSharesAcquiredValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Additional Shares Acquired, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationAdditionalSharesAcquiredValue" xlink:href="holx-20210626.xsd#holx_BusinessCombinationAdditionalSharesAcquiredValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationAdditionalSharesAcquiredValue" xlink:to="lab_holx_BusinessCombinationAdditionalSharesAcquiredValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_ac2c7d02-be5a-48b5-aed0-064ea165ff55_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted stock units, net of shares withheld for employee taxes</link:label>
    <link:label id="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_label_en-US" xlink:label="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock, Value, Shares Issued Net of Tax Withholdings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:to="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_03b8ea3d-89f5-4a32-8ea9-ce3c68bc4290_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_c3f65849-196c-44a5-a317-150c1d45f8a4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_f6e7f7d0-e965-4e0b-a3b9-943b58dcbf7d_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_df1f2524-97b8-488d-b521-b3cfc75d940a_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and Goodwill</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_501d45b6-da2b-49a3-bc9f-a3630cfa39d9_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SuperSonicImagineMember_26ff11fb-2ee0-458a-818f-2389b475d5ed_terseLabel_en-US" xlink:label="lab_holx_SuperSonicImagineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SuperSonic Imagine</link:label>
    <link:label id="lab_holx_SuperSonicImagineMember_label_en-US" xlink:label="lab_holx_SuperSonicImagineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SuperSonic Imagine [Member]</link:label>
    <link:label id="lab_holx_SuperSonicImagineMember_documentation_en-US" xlink:label="lab_holx_SuperSonicImagineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SuperSonic Imagine [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SuperSonicImagineMember" xlink:href="holx-20210626.xsd#holx_SuperSonicImagineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SuperSonicImagineMember" xlink:to="lab_holx_SuperSonicImagineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_d043ebda-ab94-40fc-9d0f-cf2a1cdb06a6_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_acc5e4ff-3779-48ec-a33f-8787b2ca1732_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_9baa2f66-0b3d-4be9-b5d0-0de3cf76a722_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_e19d25b1-0779-430f-9571-c2d4426dc591_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_825d3799-a67e-4d49-90f6-7f93edaa3e9a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ContingentHoldbackMember_759dd70c-c2fd-4888-bf63-1a0ab4851c85_terseLabel_en-US" xlink:label="lab_holx_ContingentHoldbackMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Holdback</link:label>
    <link:label id="lab_holx_ContingentHoldbackMember_label_en-US" xlink:label="lab_holx_ContingentHoldbackMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Holdback [Member]</link:label>
    <link:label id="lab_holx_ContingentHoldbackMember_documentation_en-US" xlink:label="lab_holx_ContingentHoldbackMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Holdback</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ContingentHoldbackMember" xlink:href="holx-20210626.xsd#holx_ContingentHoldbackMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ContingentHoldbackMember" xlink:to="lab_holx_ContingentHoldbackMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_3d3f3951-468e-47af-8d30-b29c386fa077_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration, portion related to loan repayment</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_label_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Loan Repayment</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_documentation_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Loan Repayment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" xlink:href="holx-20210626.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" xlink:to="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_fb045aaa-7a68-4771-9798-f469480608eb_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_7dda526f-ea67-4070-8e99-a7d3a8ae7b73_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ContingentConsiderationMember_bb74991c-fdd4-4387-bc2f-4c1030435bcc_terseLabel_en-US" xlink:label="lab_holx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_holx_ContingentConsiderationMember_label_en-US" xlink:label="lab_holx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:label id="lab_holx_ContingentConsiderationMember_documentation_en-US" xlink:label="lab_holx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ContingentConsiderationMember" xlink:href="holx-20210626.xsd#holx_ContingentConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ContingentConsiderationMember" xlink:to="lab_holx_ContingentConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_53a12c78-d733-4401-97e7-d77206297305_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPayments_73836908-c02c-4ff0-b1c3-9eb653d99574_negatedLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements/ Adjustments</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Decrease for Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualPayments" xlink:to="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_d5d5a8a8-6aa7-445e-b31a-4e3a0da2cebb_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_8a07748c-8ea9-4fd6-bd83-fcbb5defb0cd_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7a5ccb34-3c61-4937-a932-b79fb72367f7_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_2204fa54-a699-4702-abc9-79fdabe08cb0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesAbstract_label_en-US" xlink:label="lab_us-gaap_ReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesAbstract" xlink:to="lab_us-gaap_ReceivablesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_d07d3f85-abcd-4df7-99b3-4147dcc52542_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_HealthBeaconsMember_3cafef6d-c6ed-40fe-9571-ff2505c901f3_terseLabel_en-US" xlink:label="lab_holx_HealthBeaconsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Beacons</link:label>
    <link:label id="lab_holx_HealthBeaconsMember_label_en-US" xlink:label="lab_holx_HealthBeaconsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Beacons [Member]</link:label>
    <link:label id="lab_holx_HealthBeaconsMember_documentation_en-US" xlink:label="lab_holx_HealthBeaconsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Beacons [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_HealthBeaconsMember" xlink:href="holx-20210626.xsd#holx_HealthBeaconsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_HealthBeaconsMember" xlink:to="lab_holx_HealthBeaconsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_118a45a0-e305-48d3-b8dc-40e0e2d2fdbf_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_FairValueAssumptionDiscountRate_047922a4-c1fa-48dc-8782-39425111522b_terseLabel_en-US" xlink:label="lab_holx_FairValueAssumptionDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate percentage</link:label>
    <link:label id="lab_holx_FairValueAssumptionDiscountRate_label_en-US" xlink:label="lab_holx_FairValueAssumptionDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Assumption, Discount Rate</link:label>
    <link:label id="lab_holx_FairValueAssumptionDiscountRate_documentation_en-US" xlink:label="lab_holx_FairValueAssumptionDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Assumption, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FairValueAssumptionDiscountRate" xlink:href="holx-20210626.xsd#holx_FairValueAssumptionDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_FairValueAssumptionDiscountRate" xlink:to="lab_holx_FairValueAssumptionDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_d99ea053-824a-4fbf-a366-5de7e631bb67_periodStartLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at Beginning&#160;of Period</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_82cd97e6-e9e5-443a-9ead-6539df11ed1c_periodEndLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at End&#160;of&#160;Period</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrual" xlink:to="lab_us-gaap_ProductWarrantyAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_f73cdf3e-299a-47c3-a186-e2b96d7e5a71_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_5b096f5c-938a-4491-bf85-86da7f6901b9_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount_792e6c7f-15b0-4395-8fcf-774f9fe1928c_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_f07e165f-cea0-43ff-ac45-98c7ab0020ae_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_e8e005fb-f972-4657-b295-bbbdf2c7aeda_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Assumptions Utilized to Value Stock Options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_35394b8a-c2a9-4dee-a6e8-d18ebc863cd4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_47a401a1-7e4c-4ff7-ada6-0ab21e3cdb06_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_a8d12080-9aa8-4368-b006-654425dd3062_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_8ff31ae5-3e56-47a0-8442-31c60110a58f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2c418b93-fea3-46a7-8ad8-b85312087b66_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ServiceRevenue_66d4c9b1-4090-455a-b938-be8167645668_terseLabel_en-US" xlink:label="lab_holx_ServiceRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service and other</link:label>
    <link:label id="lab_holx_ServiceRevenue_label_en-US" xlink:label="lab_holx_ServiceRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Revenue</link:label>
    <link:label id="lab_holx_ServiceRevenue_documentation_en-US" xlink:label="lab_holx_ServiceRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ServiceRevenue" xlink:href="holx-20210626.xsd#holx_ServiceRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ServiceRevenue" xlink:to="lab_holx_ServiceRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_a0722796-fd03-4eb6-a824-c27048a81138_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_566b86db-90ea-4b81-a1e3-126c9b884131_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of Fiscal 2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_4d1525ba-a464-401f-abae-7b2e0f218baf_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_9ea514ba-b81e-4990-af53-c43046b7d8f8_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_eaad7b77-5bb3-4f98-8531-a24c57e685cd_negatedTerseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAmortizationAndAccretionNet_caaa1a8b-24dd-47c7-8036-b4e43d84d6b0_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAmortizationAndAccretionNet_label_en-US" xlink:label="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Amortization and Accretion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:to="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_6eee8ec9-eba8-4ebd-91b0-3bbb2e60992d_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_acfefa1e-c356-4c84-9e5f-63ece96dbd34_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_114ee058-ef3b-4d77-b327-98c68c7f3367_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_f5cf2c9c-d36c-432d-9489-4af9de37498f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_71ecd090-a87b-4216-aafb-9c25e7a7948c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess_4f280306-2992-4120-a9a1-e0aee916e8ac_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In process research and development</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Research And Development In Process</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Research And Development In Process</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_f5783e31-83d9-4a6f-a951-a8d5c100a24a_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset and equipment impairment charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_b5e6fd57-0f19-4c4e-8830-660023ec275f_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_5d4b3283-9d2c-4852-b3cb-a71572abb208_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_35babf7a-c0d9-4e84-a72d-68b83bd81507_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_OtherTypeofRevenueMember_246ad20f-f4cb-4cc0-a272-7a5a078fbb1f_terseLabel_en-US" xlink:label="lab_holx_OtherTypeofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_holx_OtherTypeofRevenueMember_label_en-US" xlink:label="lab_holx_OtherTypeofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Type of Revenue [Member]</link:label>
    <link:label id="lab_holx_OtherTypeofRevenueMember_documentation_en-US" xlink:label="lab_holx_OtherTypeofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Type of Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherTypeofRevenueMember" xlink:href="holx-20210626.xsd#holx_OtherTypeofRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_OtherTypeofRevenueMember" xlink:to="lab_holx_OtherTypeofRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_e8da3bfd-8059-4a08-be4e-3e148798404b_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_aabaff7d-fee4-4f97-bfd9-a8f39403f24a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued_b99b1cca-835f-42ca-9cee-6b302e8401b1_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Increase for Warranties Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualWarrantiesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:to="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfAccountsReceivableSecuritization_1866ee61-68a4-4f77-804b-7c33bf14ecd3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfAccountsReceivableSecuritization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Accounts Receivable Securitization</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfAccountsReceivableSecuritization_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfAccountsReceivableSecuritization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Accounts Receivable Securitization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfAccountsReceivableSecuritization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfAccountsReceivableSecuritization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfAccountsReceivableSecuritization" xlink:to="lab_us-gaap_RepaymentsOfAccountsReceivableSecuritization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_000075f2-a056-4560-b17d-d183ad00b6c8_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_af44d766-a298-40be-9751-2c3ebbff01d2_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_df8850eb-8637-4efa-b051-1a8b1094c911_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives not designated as hedging instruments</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_0e6ac216-9636-4a34-8858-356c5ec2f951_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_NotationalAmount_5e5cb51c-9d69-45a5-9571-b3510d5a72ec_terseLabel_en-US" xlink:label="lab_holx_NotationalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notational Amount</link:label>
    <link:label id="lab_holx_NotationalAmount_label_en-US" xlink:label="lab_holx_NotationalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notational Amount</link:label>
    <link:label id="lab_holx_NotationalAmount_documentation_en-US" xlink:label="lab_holx_NotationalAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notational Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NotationalAmount" xlink:href="holx-20210626.xsd#holx_NotationalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_NotationalAmount" xlink:to="lab_holx_NotationalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_7a6b17cf-c932-40ed-988c-cb3552b5b509_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_6d7c5a8b-8bd6-4b58-b70a-c0809835490d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, less reserves</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_e32eb4d3-c4a3-4857-8e71-6e54fa0fbf12_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringChargesMember_e457ec55-9921-41a6-9eb0-e328c713df7e_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringChargesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges [Member]</link:label>
    <link:label id="lab_us-gaap_RestructuringChargesMember_label_en-US" xlink:label="lab_us-gaap_RestructuringChargesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringChargesMember" xlink:to="lab_us-gaap_RestructuringChargesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_f8397716-15bb-4e3d-b337-7e01d97aa90e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ConsumablesMember_79fd4000-b362-454f-9b2a-b1c3fd13b2b5_terseLabel_en-US" xlink:label="lab_holx_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposables</link:label>
    <link:label id="lab_holx_ConsumablesMember_label_en-US" xlink:label="lab_holx_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables [Member]</link:label>
    <link:label id="lab_holx_ConsumablesMember_documentation_en-US" xlink:label="lab_holx_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ConsumablesMember" xlink:href="holx-20210626.xsd#holx_ConsumablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ConsumablesMember" xlink:to="lab_holx_ConsumablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_93516447-46be-4732-b753-543bb6e0cf05_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_dff33260-1598-4d31-a12a-63249a68ba78_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_026023a3-acbd-495f-9a02-59bd6d7561c7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_ce8057ed-2e0b-4ad8-8652-4386ae1e1b90_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_6fd2a752-b431-4e06-8ac3-94f04c581e99_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_95a683cb-d757-41e8-bc1c-794e483b62e5_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_3e2fbab6-aee6-4673-9492-b572d9972bdf_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_a3171637-f5dc-459f-8095-d1699b819ed1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityMember_3ac3b38a-ac0e-482e-80be-919c22abdd53_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability</link:label>
    <link:label id="lab_us-gaap_LiabilityMember_label_en-US" xlink:label="lab_us-gaap_LiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityMember" xlink:to="lab_us-gaap_LiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_GynSurgicalMember_073643c2-c04d-47ab-8c0a-8e658bc9a04e_terseLabel_en-US" xlink:label="lab_holx_GynSurgicalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GYN Surgical</link:label>
    <link:label id="lab_holx_GynSurgicalMember_label_en-US" xlink:label="lab_holx_GynSurgicalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gyn Surgical [Member]</link:label>
    <link:label id="lab_holx_GynSurgicalMember_documentation_en-US" xlink:label="lab_holx_GynSurgicalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GYN surgical.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember" xlink:href="holx-20210626.xsd#holx_GynSurgicalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_GynSurgicalMember" xlink:to="lab_holx_GynSurgicalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_0a7ae791-e993-4953-bc77-6b5f25a39d63_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ChangeInParValue_4ae35710-3dc6-4273-815d-ef208e47b384_terseLabel_en-US" xlink:label="lab_holx_ChangeInParValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in par value</link:label>
    <link:label id="lab_holx_ChangeInParValue_label_en-US" xlink:label="lab_holx_ChangeInParValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in par value</link:label>
    <link:label id="lab_holx_ChangeInParValue_documentation_en-US" xlink:label="lab_holx_ChangeInParValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in par value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ChangeInParValue" xlink:href="holx-20210626.xsd#holx_ChangeInParValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ChangeInParValue" xlink:to="lab_holx_ChangeInParValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_36425c3a-c7cc-496b-8ddb-a48bed49b092_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes, face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_a48200b1-9105-4ad0-b945-e20756241eb3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Other Observable Inputs&#160;(Level&#160;2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_d576cc81-f334-406b-998c-752403b9e0c6_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_961db954-8a8c-4ddd-9148-3ac298b75f9b_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_0e95f7b0-764e-4fd9-91e4-90e1702a05ce_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ProceedsFromSaleOfBusiness_0fedd0a8-d8f9-4064-a27c-a3bdeb85246a_terseLabel_en-US" xlink:label="lab_holx_ProceedsFromSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sale Of Business</link:label>
    <link:label id="lab_holx_ProceedsFromSaleOfBusiness_label_en-US" xlink:label="lab_holx_ProceedsFromSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sale Of Business</link:label>
    <link:label id="lab_holx_ProceedsFromSaleOfBusiness_documentation_en-US" xlink:label="lab_holx_ProceedsFromSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of business.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProceedsFromSaleOfBusiness" xlink:href="holx-20210626.xsd#holx_ProceedsFromSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ProceedsFromSaleOfBusiness" xlink:to="lab_holx_ProceedsFromSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_b3161f3d-a354-4fe5-a701-3a4e119e9f4b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_6436f3b7-ef4b-4948-bacc-ba8537f845a2_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepurchaseOfEquity_907fd9b4-ce74-4374-b737-efb9a55d9e2a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepurchaseOfEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of equity</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepurchaseOfEquity_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepurchaseOfEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repurchase of) Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepurchaseOfEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepurchaseOfEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepurchaseOfEquity" xlink:to="lab_us-gaap_ProceedsFromRepurchaseOfEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_5bfe8456-4c48-4694-8f56-ce77d6161a55_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average exercise prices (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_f321f3bf-35f4-4000-bce3-0aaed78f7930_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Estimated Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_ed7d1126-f4ed-4c46-8ba2-d6cbdc3435bb_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6d02eb60-f6c1-4636-89a2-38860ee3de8c_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2a80f7d1-de02-42ff-9e90-bd2f4ce2a53e_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted average common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_8f132177-9769-416c-bf63-e0aa0f73048d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_94301d7c-fab2-45dd-9500-cff1d53811e2_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_5f43864a-7733-4a76-b03b-b32d1de83fe0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Five</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Five [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_7928fb8b-959c-4ac0-84d1-59a0aff395f5_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_4228cccc-a3d1-4c7d-9c40-71f69cd73d63_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_2544b01e-8505-419d-86b4-918f92ec3a6c_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_b8e68a25-c4dd-49bb-a1d6-b7438ada4d44_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_6f71d25e-c0c8-4c0c-8b02-ca35565818de_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DiagenodeMember_3d22515d-67d2-40e3-8548-5cd679c2f7e7_terseLabel_en-US" xlink:label="lab_holx_DiagenodeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagenode</link:label>
    <link:label id="lab_holx_DiagenodeMember_label_en-US" xlink:label="lab_holx_DiagenodeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagenode [Member]</link:label>
    <link:label id="lab_holx_DiagenodeMember_documentation_en-US" xlink:label="lab_holx_DiagenodeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagenode</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagenodeMember" xlink:href="holx-20210626.xsd#holx_DiagenodeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DiagenodeMember" xlink:to="lab_holx_DiagenodeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_69068886-71a0-47b6-8408-e78d801d3db2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_fdedc13c-84fa-4472-b503-1b020e94082f_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_6230dbd2-7d3f-412b-a303-b5889a8ec2bc_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_cac02d09-b5fb-4d93-a99b-d38db457054f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under the employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_a6b48ee8-6f99-4c86-8567-6efde27c3e40_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.01 par value &#8211;750,000 shares authorized; 296,945 and 295,107 shares issued, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c86a4a71-2b91-44b3-b0dd-f7f0d5e04e7c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_d45118aa-8391-4e45-b58c-f3ab9d34a5b6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_6b0799eb-f3ea-4582-ae09-7397fa1760e6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_b54f9f72-c5d5-4c35-8cbf-a8daa1e15437_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_4e32be72-98ce-4957-8b9c-f5f588026772_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_bb7ec7f9-729b-419f-9f1a-659c4828392e_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_0f37742f-d30d-4e3d-933d-0ee6a0945348_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_f591a164-5e27-4443-92d8-6586eb8c5dce_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_4ed51541-a3ae-42b7-bc51-1597e69522d1_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_a92a1636-8886-4df4-b55c-cb80c8f2e2da_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value adjustments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201801Member_9769cf15-d580-405c-a4df-6d04bf8e0094_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201801Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2018-01 [Member]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201801Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201801Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2018-01 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201801Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201801Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201801Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201801Member" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MinervaMember_5d998fc0-d25e-43ab-a194-51b5adabf63c_terseLabel_en-US" xlink:label="lab_holx_MinervaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minerva</link:label>
    <link:label id="lab_holx_MinervaMember_label_en-US" xlink:label="lab_holx_MinervaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minerva [Member]</link:label>
    <link:label id="lab_holx_MinervaMember_documentation_en-US" xlink:label="lab_holx_MinervaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minerva [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinervaMember" xlink:href="holx-20210626.xsd#holx_MinervaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MinervaMember" xlink:to="lab_holx_MinervaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_887e1cf0-c08c-4c48-8edd-7ff689a82a81_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments under finance lease obligations</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Capital Lease Obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:to="lab_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesAndFairValueTextBlock_fe69e4e5-affe-4da1-b4d9-c24af30835aa_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesAndFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativesAndFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesAndFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives and Fair Value [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesAndFairValueTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesAndFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesAndFairValueTextBlock" xlink:to="lab_us-gaap_DerivativesAndFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_4d7ecec7-d279-4d2e-8ea1-e0b58358490a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ShareRepurchaseProgramMember_d17ec72a-20d0-4c19-9afd-ea6243029eeb_terseLabel_en-US" xlink:label="lab_holx_ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program</link:label>
    <link:label id="lab_holx_ShareRepurchaseProgramMember_label_en-US" xlink:label="lab_holx_ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Member]</link:label>
    <link:label id="lab_holx_ShareRepurchaseProgramMember_documentation_en-US" xlink:label="lab_holx_ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareRepurchaseProgramMember" xlink:href="holx-20210626.xsd#holx_ShareRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ShareRepurchaseProgramMember" xlink:to="lab_holx_ShareRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_93ce52ec-a4bc-4107-97c8-e5da502d69b9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net acquired tangible assets and liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_35d008a9-10c5-4a01-9f76-04aed00c2b9a_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e820d8a3-f2f7-40d0-ae4d-7438660830c2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units (RSUs), weighted average grant date fair values (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeVariableInterestRate_5698224b-5ade-461b-83d9-0f034da14312_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeVariableInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable interest rate</link:label>
    <link:label id="lab_us-gaap_DerivativeVariableInterestRate_label_en-US" xlink:label="lab_us-gaap_DerivativeVariableInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Variable Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeVariableInterestRate" xlink:to="lab_us-gaap_DerivativeVariableInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5d7e6632-80a7-48a8-87b6-0ad3d37faafc_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_49618a87-46a4-472c-95fa-a179f7323688_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_ead8d6da-14d1-4695-afe1-04950578992f_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash less assets held for sale</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_951b5cb3-3ece-4f5c-ae3d-10b194742a01_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_aa286f2a-6d90-4c56-b551-ce45820cf5df_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_a38f24e2-b4cb-4393-95da-4e3f7a40ad1b_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward foreign currency contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c41482ac-991e-455e-af5c-f625473528d9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_ecd46457-a0b9-4dbc-bfd4-f7c277b37baf_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_26ece016-2280-44b7-af36-65ed436704f2_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net of current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_57a8e823-412d-46ba-b3aa-3effc07bafc2_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_a32b52ad-1982-4d01-b1c7-35f9e2ac2c90_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_4d9622a8-f9d2-4ae2-b8b9-e00c3ddf09c2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare_ba4e9609-5fd1-4aef-bcdc-af7b26ce989e_terseLabel_en-US" xlink:label="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash tender offer price (per share)</link:label>
    <link:label id="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare_label_en-US" xlink:label="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Cash Tender Offer Price Per Share</link:label>
    <link:label id="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare_documentation_en-US" xlink:label="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Cash Tender Offer Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessAcquisitionCashTenderOfferPricePerShare" xlink:href="holx-20210626.xsd#holx_BusinessAcquisitionCashTenderOfferPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessAcquisitionCashTenderOfferPricePerShare" xlink:to="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_e585f8c1-d1f0-452d-a65a-4bb838199f81_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_e40c6ac4-d61e-4c91-ac25-ab97ff59f2b6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_c63baff9-403e-4e5d-9e60-c8c968dde017_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Hologic's stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_62090a7c-d7ec-470b-abe0-91d374303c12_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_42c97e72-2900-4b4a-a8d7-6706cca54fe8_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b63e8f9a-032e-4050-9098-4e6bb5547c11_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_14e11ac4-e1b8-49b8-8d77-f23a4e58a3a8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_d8d6efe2-b7b9-4420-812b-c6bb88b268af_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_e55259aa-6774-47c8-95ca-5474ad72b04b_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_label_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingsAndImprovementsGross" xlink:to="lab_us-gaap_BuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_633fbac9-71dd-42af-9a55-11f26c1bb394_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_64aedc0f-f845-4bf3-bcc3-54fddcd74732_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4b114e08-0de0-424b-9f48-8b7c73a6468f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_d63d2878-83a8-430d-99c3-3273ebbf9ef5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_944f75ac-d63e-4e36-a6c4-de70cd0bde8c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_15f24e92-4663-4cc4-be78-d39488ad4e52_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_f924cf52-8a8a-4506-b877-31f75809e980_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_RestofWorldMember_7d59cf29-9d27-480f-a149-23302cd52965_terseLabel_en-US" xlink:label="lab_holx_RestofWorldMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World</link:label>
    <link:label id="lab_holx_RestofWorldMember_label_en-US" xlink:label="lab_holx_RestofWorldMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World [Member]</link:label>
    <link:label id="lab_holx_RestofWorldMember_documentation_en-US" xlink:label="lab_holx_RestofWorldMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RestofWorldMember" xlink:href="holx-20210626.xsd#holx_RestofWorldMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_RestofWorldMember" xlink:to="lab_holx_RestofWorldMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_e8c46d83-296e-4195-b7f6-c844d611c8a6_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_0557aaa7-e03b-44b6-9b69-dbfe23b76d0d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_f27f4569-f818-4edb-b1c0-80bdf8942367_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_98ef36bd-297e-4c56-afc9-e8cdd022d996_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_InternationalMember_72c6ef7a-10f3-44dd-b5d2-a276812391a2_terseLabel_en-US" xlink:label="lab_holx_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_holx_InternationalMember_label_en-US" xlink:label="lab_holx_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International [Member]</link:label>
    <link:label id="lab_holx_InternationalMember_documentation_en-US" xlink:label="lab_holx_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternationalMember" xlink:href="holx-20210626.xsd#holx_InternationalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InternationalMember" xlink:to="lab_holx_InternationalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_8d245154-a438-4ab0-8050-443ac41f06e1_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f15d49e1-d26a-4d8a-a872-644ad4feaefe_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average anti-dilutive shares (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_6c94fa98-f036-4a4f-92a4-a32cd12038ae_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_4f9c720f-bf8f-4cd6-91a6-5c139ae75fa8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other adjustments and non-cash items</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_71f8e1e4-a150-4f32-993a-4936f45c16de_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_4a993d4f-8569-498f-b816-d3e0e17ab494_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrealized Loss Recognized in AOCI</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_b80c786b-1bd5-43ae-abc2-52f6795aad79_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_f37fdd56-b0de-4e73-8962-162c60432f6e_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate at end of period</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate at Period End</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:to="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_67cd5012-411f-40fe-a747-ffc7b277d0b3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other activity</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_a25e07df-4ad6-464e-8691-84cf7f88a0ee_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_1b0484f7-1b86-4a75-8520-b078605f909c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_de097c1c-50b2-4e5d-a889-4194bc2845e9_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_771bfe71-9975-46ec-a7d2-67a54e754a7a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2025SeniorNotesMember_fc10a4d1-05c3-4c20-a34e-33874b909504_terseLabel_en-US" xlink:label="lab_holx_A2025SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Senior Notes</link:label>
    <link:label id="lab_holx_A2025SeniorNotesMember_label_en-US" xlink:label="lab_holx_A2025SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Senior Notes [Member]</link:label>
    <link:label id="lab_holx_A2025SeniorNotesMember_documentation_en-US" xlink:label="lab_holx_A2025SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember" xlink:href="holx-20210626.xsd#holx_A2025SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2025SeniorNotesMember" xlink:to="lab_holx_A2025SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AllOtherCountriesMember_f7261046-2c02-4bce-8548-968d68aabb3d_terseLabel_en-US" xlink:label="lab_holx_AllOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World</link:label>
    <link:label id="lab_holx_AllOtherCountriesMember_label_en-US" xlink:label="lab_holx_AllOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other Countries [Member]</link:label>
    <link:label id="lab_holx_AllOtherCountriesMember_documentation_en-US" xlink:label="lab_holx_AllOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other countries.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AllOtherCountriesMember" xlink:href="holx-20210626.xsd#holx_AllOtherCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AllOtherCountriesMember" xlink:to="lab_holx_AllOtherCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_ec5e5f0f-3e3d-4e24-9820-690dc22d21e6_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_2ded45a9-d9e2-4bae-bbf6-800c71020e56_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_b1902396-1796-4c42-bb82-fada7c6cee35_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_ccdae04a-a4aa-4392-85ab-10942d8bcc32_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_76d43d5d-05d7-4d43-8331-96742f9e2f19_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, excluding the effect of acquisitions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_82a37044-73b1-419e-b28a-3df83fe618fa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToMinorityShareholders" xlink:to="lab_us-gaap_PaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_17fd7e09-aa9a-429f-bf67-b8a472d83817_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income activity</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_dbb9673b-d1c7-464b-b446-cfb10df8d880_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsGross" xlink:to="lab_us-gaap_LeaseholdImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_e06e82d3-bd1b-4e45-ad7c-db7c53a96a3f_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_5f2987aa-552c-4599-a85b-8bd68f555d35_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_d9a0d16b-4176-4dfd-8510-3688bafa32ff_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MobidiagOyMember_705faeef-0792-4185-96c7-a0faf8b115a8_terseLabel_en-US" xlink:label="lab_holx_MobidiagOyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mobidiag Oy</link:label>
    <link:label id="lab_holx_MobidiagOyMember_label_en-US" xlink:label="lab_holx_MobidiagOyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mobidiag Oy [Member]</link:label>
    <link:label id="lab_holx_MobidiagOyMember_documentation_en-US" xlink:label="lab_holx_MobidiagOyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mobidiag Oy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MobidiagOyMember" xlink:href="holx-20210626.xsd#holx_MobidiagOyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MobidiagOyMember" xlink:to="lab_holx_MobidiagOyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_4a122ba4-12b1-4c3f-88db-58055bd4151e_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_11ae801d-9489-430d-8cf3-79f000e0f3b3_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_78ef2e12-7aba-4618-95c9-194a2af6d16c_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_7e33d633-0249-460c-851b-b691a425b40b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_5d2684b4-fd73-4b95-80f9-c92e244fc041_terseLabel_en-US" xlink:label="lab_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_label_en-US" xlink:label="lab_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of New Accounting Pronouncements Not yet Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:to="lab_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_d9e3056e-3668-44b0-9a37-639bec5e03d8_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per common share attributable to Hologic:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ProductRevenue_aecedd60-eab5-4448-9dd2-02f2b5be1b16_terseLabel_en-US" xlink:label="lab_holx_ProductRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product</link:label>
    <link:label id="lab_holx_ProductRevenue_label_en-US" xlink:label="lab_holx_ProductRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Revenue</link:label>
    <link:label id="lab_holx_ProductRevenue_documentation_en-US" xlink:label="lab_holx_ProductRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProductRevenue" xlink:href="holx-20210626.xsd#holx_ProductRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ProductRevenue" xlink:to="lab_holx_ProductRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_d657dc80-800e-49d1-8383-1acd9f339136_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and divestiture charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_RSUPSUMSUMember_4d403398-a0de-470b-86e7-aaa84eb6984c_terseLabel_en-US" xlink:label="lab_holx_RSUPSUMSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSU, PSU, MSU</link:label>
    <link:label id="lab_holx_RSUPSUMSUMember_label_en-US" xlink:label="lab_holx_RSUPSUMSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSU, PSU, MSU [Member]</link:label>
    <link:label id="lab_holx_RSUPSUMSUMember_documentation_en-US" xlink:label="lab_holx_RSUPSUMSUMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSU, PSU, MSU [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RSUPSUMSUMember" xlink:href="holx-20210626.xsd#holx_RSUPSUMSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_RSUPSUMSUMember" xlink:to="lab_holx_RSUPSUMSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_92fc4742-99d6-4acc-b7db-2d871567da77_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Classified as Equity, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:to="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_356932fe-f5b9-4c6b-af0a-690b2157e3d3_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_NXCImagingMember_5610006a-1aa7-4ea7-9152-2f364db65610_terseLabel_en-US" xlink:label="lab_holx_NXCImagingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NXC Imaging</link:label>
    <link:label id="lab_holx_NXCImagingMember_label_en-US" xlink:label="lab_holx_NXCImagingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NXC Imaging [Member]</link:label>
    <link:label id="lab_holx_NXCImagingMember_documentation_en-US" xlink:label="lab_holx_NXCImagingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NXC Imaging</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NXCImagingMember" xlink:href="holx-20210626.xsd#holx_NXCImagingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_NXCImagingMember" xlink:to="lab_holx_NXCImagingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_afba1b85-3906-432d-ab6c-c9f1af9e8ecd_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plans</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract_fb85c65d-2dd6-437c-a72c-e87c92894626_terseLabel_en-US" xlink:label="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract_documentation_en-US" xlink:label="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract" xlink:href="holx-20210626.xsd#holx_AccumulatedOtherComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract" xlink:to="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_TermLoanMember_22f53ae8-b399-47b6-b1be-ad5b2653acd8_terseLabel_en-US" xlink:label="lab_holx_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_holx_TermLoanMember_label_en-US" xlink:label="lab_holx_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:label id="lab_holx_TermLoanMember_documentation_en-US" xlink:label="lab_holx_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember" xlink:href="holx-20210626.xsd#holx_TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TermLoanMember" xlink:to="lab_holx_TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_ac476256-d1c1-4826-84c0-4b3aa4dd156e_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_125f8caf-dcef-4c8e-a5a7-31451dbf2020_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_e5c85e05-17fb-4814-baf4-62f30621bce7_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_f6c6c979-7238-421a-861f-3c284fa39415_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DepartmentOfDefenseFundsReceived_5d519bf7-a239-4a52-9a41-bbac2ed7a7af_terseLabel_en-US" xlink:label="lab_holx_DepartmentOfDefenseFundsReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Department of defense funds received</link:label>
    <link:label id="lab_holx_DepartmentOfDefenseFundsReceived_label_en-US" xlink:label="lab_holx_DepartmentOfDefenseFundsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Department of defense funds received</link:label>
    <link:label id="lab_holx_DepartmentOfDefenseFundsReceived_documentation_en-US" xlink:label="lab_holx_DepartmentOfDefenseFundsReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Department of defense funds received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DepartmentOfDefenseFundsReceived" xlink:href="holx-20210626.xsd#holx_DepartmentOfDefenseFundsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DepartmentOfDefenseFundsReceived" xlink:to="lab_holx_DepartmentOfDefenseFundsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_c37e431a-cc72-453d-af1a-79b741c90089_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_b53e2e23-77db-419e-8f83-0e880a4b09aa_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_74ba72d0-81b5-47b5-a9e6-0723d60141ce_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_ff955161-2eb1-4bcd-9037-65729554ca5b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_525495ca-7227-4c0f-9b16-8325198ac072_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under the employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_44dde2ac-38de-4b3a-bc46-439f0241ecd8_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_87878552-70c7-43b3-a5ab-22b1076cb517_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_8a556d65-9778-4792-a237-821e25932054_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_9dd823d0-998a-40f7-85f0-16c09ef4f335_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_8b37def3-e946-4f10-96d3-8df748ef4b74_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_d04e2024-bf05-4873-99cd-64933f59dd87_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Balance Sheet Information of Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_RevolverMember_a8bec2d0-fabe-42d6-a528-78de05c4b5d3_terseLabel_en-US" xlink:label="lab_holx_RevolverMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver</link:label>
    <link:label id="lab_holx_RevolverMember_label_en-US" xlink:label="lab_holx_RevolverMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver [Member]</link:label>
    <link:label id="lab_holx_RevolverMember_documentation_en-US" xlink:label="lab_holx_RevolverMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevolverMember" xlink:href="holx-20210626.xsd#holx_RevolverMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_RevolverMember" xlink:to="lab_holx_RevolverMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_38dcdf41-97f2-461c-aa62-38bc2f16e6d5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Value</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Netincome_5c3452f0-7221-4e5d-95f7-cd8c6dbb5885_totalLabel_en-US" xlink:label="lab_holx_Netincome" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Hologic</link:label>
    <link:label id="lab_holx_Netincome_d56a480d-586a-4741-8b25-ce3b058c4e48_terseLabel_en-US" xlink:label="lab_holx_Netincome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_holx_Netincome_label_en-US" xlink:label="lab_holx_Netincome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_holx_Netincome_documentation_en-US" xlink:label="lab_holx_Netincome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Hologic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Netincome" xlink:href="holx-20210626.xsd#holx_Netincome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Netincome" xlink:to="lab_holx_Netincome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotes_8e3907db-2d10-4df1-aaf9-f0efa9f5c6a0_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotes_label_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotes" xlink:to="lab_us-gaap_SeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_7a609179-b8ad-4339-805e-159973a0dcaf_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_a794cd60-d0c2-4d36-b7c2-987629b69b3d_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Loss</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_099cfb1d-f2d5-4e95-808d-67ce5f751847_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration related to fair value of noncontrolling interest</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_label_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Fair Value Of Noncontrolling Interest</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_documentation_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Fair Value Of Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" xlink:href="holx-20210626.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" xlink:to="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_49aac9b2-d12a-47db-869a-8ff2a66a6740_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_6eff6c48-2bbc-49d9-b81c-53b44aa7e587_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Stock Options and stock units</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c12cfb08-513a-4ca8-ac69-585573186f2e_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less &#8211; accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SharerepurchaseplanTable_f8def6ef-f91b-464f-b4da-3523b3ff5759_terseLabel_en-US" xlink:label="lab_holx_SharerepurchaseplanTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">share repurchase plan [Table]</link:label>
    <link:label id="lab_holx_SharerepurchaseplanTable_label_en-US" xlink:label="lab_holx_SharerepurchaseplanTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">share repurchase plan [Table]</link:label>
    <link:label id="lab_holx_SharerepurchaseplanTable_documentation_en-US" xlink:label="lab_holx_SharerepurchaseplanTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">share repurchase plan [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharerepurchaseplanTable" xlink:href="holx-20210626.xsd#holx_SharerepurchaseplanTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SharerepurchaseplanTable" xlink:to="lab_holx_SharerepurchaseplanTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_1badd9db-c4b2-4387-9282-1df2dc813ff8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_9f9535b3-4a4d-400b-a920-f27408efd9a1_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c1579b9f-e7eb-45f0-ac1c-51c3dfbce31d_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_97d4fdf6-fd47-43dc-a278-3d62f7f5cf36_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_183db9f6-acab-4e09-ba75-82b0b06ad9a0_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_168e0f94-9e4b-497e-a408-510b8dfce480_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_81078f66-53f1-4a9e-92db-4a8a247e3fcb_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option plans</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4ab7d439-29d7-40f4-ada6-0a65c384f7f6_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2cc878d5-328a-49cc-bca6-e392cbc655a2_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted average common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2562149b-8964-4506-9277-0144329f46a4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_23c6e12f-2bf5-48a5-9ec7-d15a81ad8124_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_6788e6c1-ee1c-4e5d-9c3b-fb9d52a1fdc8_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_01f9439b-66a9-4cc7-b37e-b36d938af6d6_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_06d088d8-e257-4567-8e0a-34e7710b0e66_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:to="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_7f2d0942-954e-46bd-aacd-f787c866998d_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_b2b11643-7d6c-42d5-9e68-16c653ff59ed_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d9b827aa-29d4-434f-8f41-c29c18d7a71d_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_46ac07d6-df4c-4ca1-a2b0-d82af92f8607_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_c5339b8f-aa3f-4367-bcf4-052913aa0ca2_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in-capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_bcf031ed-bf88-47ad-a7fd-4183de4e8051_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_914d6d36-690e-4d29-802e-a8d8886e4278_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_cfd164e0-1dbd-4316-8c56-0b9ff862648c_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_75e2c51d-b5ac-4112-a117-1354de4e5f24_verboseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_75bc071c-929d-480b-9578-01c981444b2d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Off-balance Sheet Risks [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Off-balance Sheet Risks [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_72dd3e25-65e8-42af-8287-fc6480985084_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision (benefit) for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_664b672d-62c0-407b-8e3b-33eb5e6b4c16_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Assets at Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Assets at Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_147c6e93-2100-47a3-b2fd-28c6589e9f5b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MaximumBorrowingUnderAssetSecuritizationAgreement_99051368-fb4f-4b06-80a0-115d36c7a2f0_terseLabel_en-US" xlink:label="lab_holx_MaximumBorrowingUnderAssetSecuritizationAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing under asset securitization agreement</link:label>
    <link:label id="lab_holx_MaximumBorrowingUnderAssetSecuritizationAgreement_label_en-US" xlink:label="lab_holx_MaximumBorrowingUnderAssetSecuritizationAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing under asset securitization agreement</link:label>
    <link:label id="lab_holx_MaximumBorrowingUnderAssetSecuritizationAgreement_documentation_en-US" xlink:label="lab_holx_MaximumBorrowingUnderAssetSecuritizationAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing under asset securitization agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumBorrowingUnderAssetSecuritizationAgreement" xlink:href="holx-20210626.xsd#holx_MaximumBorrowingUnderAssetSecuritizationAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MaximumBorrowingUnderAssetSecuritizationAgreement" xlink:to="lab_holx_MaximumBorrowingUnderAssetSecuritizationAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_ae24fc39-19e7-4c84-923f-9595518e08a9_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_ab908777-d9cb-4f03-ac3f-19f55f200bdd_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_52bcbc6c-9a2b-4a24-b003-faca4b1210d7_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_729960ed-9b7b-4b82-bd2f-75b94ab8c203_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_2f2bd485-c3b6-4d58-b3bb-ed3437505bd2_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Income (Loss)</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteesAbstract_4229b26c-c6fe-49aa-b503-d86577420cf4_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees [Abstract]</link:label>
    <link:label id="lab_us-gaap_GuaranteesAbstract_label_en-US" xlink:label="lab_us-gaap_GuaranteesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteesAbstract" xlink:to="lab_us-gaap_GuaranteesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_fb5485b2-899d-47e7-a0e7-03f4b3c0a8d7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company's Borrowings</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_baade69f-b7d5-44f3-834f-7bf6e8a1ab79_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in value of hedged interest rate swap and interest rate cap, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_34fe60f4-628c-4dc3-a7aa-371665a640cd_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_9c82598a-9129-4e52-8df7-3efd7210c399_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PrepaidIncomeTaxesCurrent_3855eeae-50a7-49a3-a893-2d4e42a12e50_terseLabel_en-US" xlink:label="lab_holx_PrepaidIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Income Taxes-Current</link:label>
    <link:label id="lab_holx_PrepaidIncomeTaxesCurrent_label_en-US" xlink:label="lab_holx_PrepaidIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Income Taxes-Current</link:label>
    <link:label id="lab_holx_PrepaidIncomeTaxesCurrent_documentation_en-US" xlink:label="lab_holx_PrepaidIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Income Taxes-Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrepaidIncomeTaxesCurrent" xlink:href="holx-20210626.xsd#holx_PrepaidIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PrepaidIncomeTaxesCurrent" xlink:to="lab_holx_PrepaidIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_eb00e775-939c-46e2-9f42-0a694360d9aa_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_083e526d-90e7-4deb-8995-61aa3118e164_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-competition agreements</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_c9e8dae6-4045-4771-9c04-6dd95e32b4c9_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_d30540cd-eae7-4688-9858-5cb2fc8a1d82_negatedLabel_en-US" xlink:label="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in equipment under customer usage agreements</link:label>
    <link:label id="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_label_en-US" xlink:label="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Manufacture Equipment Under Customer Usage Agreements</link:label>
    <link:label id="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_documentation_en-US" xlink:label="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The cash outflow related to equipment placed at customer locations for which title is not transferred to the Company's customers.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:href="holx-20210626.xsd#holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:to="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_ed4321f5-c022-48de-a656-193e4609ab72_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseBorrowings_e699dfa8-5dd0-4247-a8ec-0b8e7d572c88_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseBorrowings_label_en-US" xlink:label="lab_us-gaap_InterestExpenseBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseBorrowings" xlink:to="lab_us-gaap_InterestExpenseBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_db2969ea-b730-4b2b-9fd0-aa7cca09440a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_5928f594-e74e-4781-a96a-e6eef9d94bca_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember_cb4b8ded-a435-44a9-b07f-333b160f20a2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Four</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Four [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CapitalizedsoftwareMember_c6543b31-f1d3-4650-bf86-785bc821a65b_terseLabel_en-US" xlink:label="lab_holx_CapitalizedsoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software embedded in products</link:label>
    <link:label id="lab_holx_CapitalizedsoftwareMember_label_en-US" xlink:label="lab_holx_CapitalizedsoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software [Member]</link:label>
    <link:label id="lab_holx_CapitalizedsoftwareMember_documentation_en-US" xlink:label="lab_holx_CapitalizedsoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalizedsoftwareMember" xlink:href="holx-20210626.xsd#holx_CapitalizedsoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CapitalizedsoftwareMember" xlink:to="lab_holx_CapitalizedsoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_0d1a4d55-9480-406b-9e00-6cdce7f8b8e1_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility borrowings</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_f175c114-fa4d-42ca-aeae-33272a84588b_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_93f4ffb0-6192-4cd5-8b80-92459c6254d9_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e2631f3c-496f-4875-9c97-9027724d03f3_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_bb0dfc16-37c6-4fee-b957-7aa10e0b2937_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_18b4c55a-5587-4d59-87a4-a3dd0c978391_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_5fc8760e-165f-444b-b9f3-841da4e85174_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_a7a405d2-240a-4039-94db-65d6bb8f3894_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_8fbb3373-a025-44b0-97f9-8a8a59f7f247_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_0f15aa9f-6943-485a-9b0e-1a6e59e1be7c_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_56e13fd5-df81-4ed2-bcbd-cd18a58146a0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of deferred acquisition consideration</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_81270c13-f6d1-4061-9caf-2e8b653cefdb_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company's effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_b4eca72f-b805-437f-b5ad-721ca2fa772a_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Petitions filed</link:label>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, New Claims Filed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:to="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_adb42420-cbd7-4964-8224-a598220b2f37_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_94c17e9e-a32a-4ca1-8fa7-6d8f89d255dc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_04bc2a54-333b-41c9-b6c4-9c25c6b4b867_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_cb000b50-d500-4745-993b-aac04f6c41fd_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_0bdc891e-c134-491f-bde5-ed5ae6f8a855_negatedTerseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short and long-term debt</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_7b196b09-896f-4236-aae5-06636a0881c9_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_bcdddc6b-6ade-4f3c-90f1-4bfabbe7077d_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_0429e8d3-f1e9-4b0a-b4bf-5236d6c864bf_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_cd113533-ad39-481d-9418-b9278c0e0ac4_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock pursuant to employee stock plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_45ff6c66-16e3-4a23-9e8f-5d1f8cba65dd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_ffd3ec4a-ddfd-4874-9c22-5b6918f4ea64_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap at fair value</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Derivative Instrument Assets at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:to="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_7afedd95-2d3e-4f98-8216-adbd22627dfa_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost &#8211; 43,653 and 37,609 shares, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_9e04f99f-af72-401d-a318-ad48eee1b094_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_b08925bd-0406-4b1c-92cd-88186392e372_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration related to equity method investment</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_label_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Equity Method Investment</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_documentation_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Equity Method Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" xlink:href="holx-20210626.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" xlink:to="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationOwnershipPercentage_5e9af35c-a0e3-4315-9790-a9c9a7e99952_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage</link:label>
    <link:label id="lab_holx_BusinessCombinationOwnershipPercentage_label_en-US" xlink:label="lab_holx_BusinessCombinationOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Ownership Percentage</link:label>
    <link:label id="lab_holx_BusinessCombinationOwnershipPercentage_documentation_en-US" xlink:label="lab_holx_BusinessCombinationOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationOwnershipPercentage" xlink:href="holx-20210626.xsd#holx_BusinessCombinationOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationOwnershipPercentage" xlink:to="lab_holx_BusinessCombinationOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_cae0f502-fa0b-4202-9698-34ad99c03d42_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_b0d74635-3c85-4ff6-a495-d6bb8c9ae7ee_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_1a07af01-38f1-46ac-bc96-fedf2c04dd09_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_3a290090-0e52-4d84-b3b9-3ffa10edf98a_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_2145f850-266c-4d10-a95a-50b0c559a278_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from revolving credit line</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_b7712c51-034f-4445-a354-b5c9e0fa90c8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>holx-20210626_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c74485e8-ec97-423d-9317-27784965d1fb,g:cd3e0a2e-ccc2-417e-9556-0c4f43775051-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.hologic.com/role/CoverPage" xlink:type="simple" xlink:href="holx-20210626.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_b4f996a9-42ff-4dcd-b30b-9792afa77f6b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_b797fbb6-16db-4785-bb86-66844c6591b7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4f996a9-42ff-4dcd-b30b-9792afa77f6b" xlink:to="loc_dei_Security12bTitle_b797fbb6-16db-4785-bb86-66844c6591b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_397e1fe0-285a-4c55-8d08-035cb66e62f6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4f996a9-42ff-4dcd-b30b-9792afa77f6b" xlink:to="loc_dei_DocumentTransitionReport_397e1fe0-285a-4c55-8d08-035cb66e62f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_d97f646c-213e-4ee3-9e51-554fd6549a59" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4f996a9-42ff-4dcd-b30b-9792afa77f6b" xlink:to="loc_dei_DocumentQuarterlyReport_d97f646c-213e-4ee3-9e51-554fd6549a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_5922201e-6402-4fe5-bcb7-26cd9fae635c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4f996a9-42ff-4dcd-b30b-9792afa77f6b" xlink:to="loc_dei_EntityIncorporationStateCountryCode_5922201e-6402-4fe5-bcb7-26cd9fae635c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_20354307-4914-43ef-b977-1839379f266c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4f996a9-42ff-4dcd-b30b-9792afa77f6b" xlink:to="loc_dei_EntityAddressPostalZipCode_20354307-4914-43ef-b977-1839379f266c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_f9512419-bdc9-4b1e-bf38-ab2060268800" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4f996a9-42ff-4dcd-b30b-9792afa77f6b" xlink:to="loc_dei_EntityFileNumber_f9512419-bdc9-4b1e-bf38-ab2060268800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_6f01c8fd-2ac1-4eb8-962c-8665b8c8a740" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4f996a9-42ff-4dcd-b30b-9792afa77f6b" xlink:to="loc_dei_DocumentType_6f01c8fd-2ac1-4eb8-962c-8665b8c8a740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_fee2de41-6cb2-4ab7-a7cc-3422416d52d8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4f996a9-42ff-4dcd-b30b-9792afa77f6b" xlink:to="loc_dei_AmendmentFlag_fee2de41-6cb2-4ab7-a7cc-3422416d52d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_d8bc810b-e85b-4a72-b6a5-db1574fc755a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4f996a9-42ff-4dcd-b30b-9792afa77f6b" xlink:to="loc_dei_DocumentPeriodEndDate_d8bc810b-e85b-4a72-b6a5-db1574fc755a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_f763d796-a11d-4c3b-bb63-2b687988482f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4f996a9-42ff-4dcd-b30b-9792afa77f6b" xlink:to="loc_dei_DocumentFiscalYearFocus_f763d796-a11d-4c3b-bb63-2b687988482f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_6c3bdf42-89cc-4c61-a13c-58ca0bec287b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4f996a9-42ff-4dcd-b30b-9792afa77f6b" xlink:to="loc_dei_DocumentFiscalPeriodFocus_6c3bdf42-89cc-4c61-a13c-58ca0bec287b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_19a7f663-8ab5-4eab-ac02-a4dc7999ca97" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4f996a9-42ff-4dcd-b30b-9792afa77f6b" xlink:to="loc_dei_EntityRegistrantName_19a7f663-8ab5-4eab-ac02-a4dc7999ca97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_d2f8e3af-2136-4192-8a53-ccf4b9a781fe" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4f996a9-42ff-4dcd-b30b-9792afa77f6b" xlink:to="loc_dei_EntityCentralIndexKey_d2f8e3af-2136-4192-8a53-ccf4b9a781fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_a3957335-e35f-46d1-942a-4eaa911d711a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4f996a9-42ff-4dcd-b30b-9792afa77f6b" xlink:to="loc_dei_CurrentFiscalYearEndDate_a3957335-e35f-46d1-942a-4eaa911d711a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_ab122db3-61d5-49d5-9352-02fea58b022b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4f996a9-42ff-4dcd-b30b-9792afa77f6b" xlink:to="loc_dei_EntityFilerCategory_ab122db3-61d5-49d5-9352-02fea58b022b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_835a93cd-3944-48fb-8e92-e1149e1bcd68" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4f996a9-42ff-4dcd-b30b-9792afa77f6b" xlink:to="loc_dei_EntityEmergingGrowthCompany_835a93cd-3944-48fb-8e92-e1149e1bcd68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_683189f9-53e0-47a0-bb59-45b99cad344a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4f996a9-42ff-4dcd-b30b-9792afa77f6b" xlink:to="loc_dei_EntitySmallBusiness_683189f9-53e0-47a0-bb59-45b99cad344a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_e83bb715-0f19-461b-a34b-fd8834d000c5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4f996a9-42ff-4dcd-b30b-9792afa77f6b" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_e83bb715-0f19-461b-a34b-fd8834d000c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_bc6fca01-8e30-42b0-b674-b1f888adf7f3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4f996a9-42ff-4dcd-b30b-9792afa77f6b" xlink:to="loc_dei_EntityShellCompany_bc6fca01-8e30-42b0-b674-b1f888adf7f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_6b2e1fd6-261c-4730-8896-acbd19230552" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4f996a9-42ff-4dcd-b30b-9792afa77f6b" xlink:to="loc_dei_EntityCurrentReportingStatus_6b2e1fd6-261c-4730-8896-acbd19230552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_ed975ef7-7f7a-4c5a-95aa-4a0b6a57282d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4f996a9-42ff-4dcd-b30b-9792afa77f6b" xlink:to="loc_dei_EntityInteractiveDataCurrent_ed975ef7-7f7a-4c5a-95aa-4a0b6a57282d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_426bb224-61d0-4e8d-ba8c-ff7851b80148" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4f996a9-42ff-4dcd-b30b-9792afa77f6b" xlink:to="loc_dei_CityAreaCode_426bb224-61d0-4e8d-ba8c-ff7851b80148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_ca28eddf-ea8e-4d2e-ae50-6d467fb2d4cd" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4f996a9-42ff-4dcd-b30b-9792afa77f6b" xlink:to="loc_dei_LocalPhoneNumber_ca28eddf-ea8e-4d2e-ae50-6d467fb2d4cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_219f155a-900a-4121-985e-0181aec0c4d8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4f996a9-42ff-4dcd-b30b-9792afa77f6b" xlink:to="loc_dei_EntityTaxIdentificationNumber_219f155a-900a-4121-985e-0181aec0c4d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_2481855a-f474-40ac-ac90-0836cc7a363a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4f996a9-42ff-4dcd-b30b-9792afa77f6b" xlink:to="loc_dei_EntityAddressAddressLine1_2481855a-f474-40ac-ac90-0836cc7a363a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_e0867a4b-1c32-421a-8e32-ddd06fd1f241" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4f996a9-42ff-4dcd-b30b-9792afa77f6b" xlink:to="loc_dei_EntityAddressCityOrTown_e0867a4b-1c32-421a-8e32-ddd06fd1f241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_e9066a80-d270-44c8-91e1-84b9238124f9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4f996a9-42ff-4dcd-b30b-9792afa77f6b" xlink:to="loc_dei_EntityAddressStateOrProvince_e9066a80-d270-44c8-91e1-84b9238124f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_2b5902da-fc3d-4265-8ed0-e624fa35faf7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4f996a9-42ff-4dcd-b30b-9792afa77f6b" xlink:to="loc_dei_TradingSymbol_2b5902da-fc3d-4265-8ed0-e624fa35faf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_58f96809-0569-4041-bad3-38520492982a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b4f996a9-42ff-4dcd-b30b-9792afa77f6b" xlink:to="loc_dei_SecurityExchangeName_58f96809-0569-4041-bad3-38520492982a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="holx-20210626.xsd#ConsolidatedStatementsofIncome"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_ab4413f6-8265-49b6-b1de-d79cd58170ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_bdfa1a5b-1a71-4fb3-91d0-81c5df0a5b50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ab4413f6-8265-49b6-b1de-d79cd58170ae" xlink:to="loc_us-gaap_RevenuesAbstract_bdfa1a5b-1a71-4fb3-91d0-81c5df0a5b50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProductRevenue_3e5d92ff-df2b-41e0-9196-5b2b430c16c7" xlink:href="holx-20210626.xsd#holx_ProductRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_bdfa1a5b-1a71-4fb3-91d0-81c5df0a5b50" xlink:to="loc_holx_ProductRevenue_3e5d92ff-df2b-41e0-9196-5b2b430c16c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ServiceRevenue_202f85b8-e9e6-4b9e-92c2-db2dddf71046" xlink:href="holx-20210626.xsd#holx_ServiceRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_bdfa1a5b-1a71-4fb3-91d0-81c5df0a5b50" xlink:to="loc_holx_ServiceRevenue_202f85b8-e9e6-4b9e-92c2-db2dddf71046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_fff1aefd-a2b6-4366-8bcf-fd0dd70d582c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_bdfa1a5b-1a71-4fb3-91d0-81c5df0a5b50" xlink:to="loc_us-gaap_Revenues_fff1aefd-a2b6-4366-8bcf-fd0dd70d582c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_9679479a-3837-4364-a7f3-84b020f6b5c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ab4413f6-8265-49b6-b1de-d79cd58170ae" xlink:to="loc_us-gaap_CostOfRevenueAbstract_9679479a-3837-4364-a7f3-84b020f6b5c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_ddb1c518-d8f8-444d-86da-492db12bf7cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_9679479a-3837-4364-a7f3-84b020f6b5c7" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_ddb1c518-d8f8-444d-86da-492db12bf7cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmortizationCostofGoodsSold_d7b63877-a8b0-42b2-a37b-20c4224cd5d2" xlink:href="holx-20210626.xsd#holx_AmortizationCostofGoodsSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_9679479a-3837-4364-a7f3-84b020f6b5c7" xlink:to="loc_holx_AmortizationCostofGoodsSold_d7b63877-a8b0-42b2-a37b-20c4224cd5d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment_24475ff5-fce7-4126-83dc-11f1950ba19a" xlink:href="holx-20210626.xsd#holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_9679479a-3837-4364-a7f3-84b020f6b5c7" xlink:to="loc_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment_24475ff5-fce7-4126-83dc-11f1950ba19a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Costofservice_66cbb227-d5b7-475c-a8a5-0d5f971367aa" xlink:href="holx-20210626.xsd#holx_Costofservice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_9679479a-3837-4364-a7f3-84b020f6b5c7" xlink:to="loc_holx_Costofservice_66cbb227-d5b7-475c-a8a5-0d5f971367aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_e23c039c-d1d1-4258-9c4f-13666f894e03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_9679479a-3837-4364-a7f3-84b020f6b5c7" xlink:to="loc_us-gaap_GrossProfit_e23c039c-d1d1-4258-9c4f-13666f894e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_2ae33202-6568-4c1a-8d28-e7ec0becb4c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ab4413f6-8265-49b6-b1de-d79cd58170ae" xlink:to="loc_us-gaap_OperatingExpensesAbstract_2ae33202-6568-4c1a-8d28-e7ec0becb4c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_f2dd6c57-c057-4ef8-80cd-3d5527a2ae78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2ae33202-6568-4c1a-8d28-e7ec0becb4c5" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_f2dd6c57-c057-4ef8-80cd-3d5527a2ae78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_444a1e26-caac-47f5-9763-68c48b8268b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2ae33202-6568-4c1a-8d28-e7ec0becb4c5" xlink:to="loc_us-gaap_SellingAndMarketingExpense_444a1e26-caac-47f5-9763-68c48b8268b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_da943752-c70e-4f10-8508-78513a3901e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2ae33202-6568-4c1a-8d28-e7ec0becb4c5" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_da943752-c70e-4f10-8508-78513a3901e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_77af34f8-b481-4c76-85f7-4ad2000f7129" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2ae33202-6568-4c1a-8d28-e7ec0becb4c5" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_77af34f8-b481-4c76-85f7-4ad2000f7129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_8fa61722-0242-4e9e-854e-c972e1571217" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2ae33202-6568-4c1a-8d28-e7ec0becb4c5" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_8fa61722-0242-4e9e-854e-c972e1571217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_eb3cbaeb-97b9-46ec-a3e1-9292e7082669" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2ae33202-6568-4c1a-8d28-e7ec0becb4c5" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_eb3cbaeb-97b9-46ec-a3e1-9292e7082669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_5e8e2227-beb1-4924-8e01-2b6f1a0e0c3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2ae33202-6568-4c1a-8d28-e7ec0becb4c5" xlink:to="loc_us-gaap_RestructuringCharges_5e8e2227-beb1-4924-8e01-2b6f1a0e0c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_675aa7ee-01b7-456e-b724-3ace43530dae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2ae33202-6568-4c1a-8d28-e7ec0becb4c5" xlink:to="loc_us-gaap_OperatingExpenses_675aa7ee-01b7-456e-b724-3ace43530dae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9849881a-4dcc-4473-ab48-9b29f7d9ec15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2ae33202-6568-4c1a-8d28-e7ec0becb4c5" xlink:to="loc_us-gaap_OperatingIncomeLoss_9849881a-4dcc-4473-ab48-9b29f7d9ec15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_d56ddf9b-f7e8-49d0-a3c4-a49593321f7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2ae33202-6568-4c1a-8d28-e7ec0becb4c5" xlink:to="loc_us-gaap_InvestmentIncomeInterest_d56ddf9b-f7e8-49d0-a3c4-a49593321f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_9411b933-9550-4a14-bfd3-d63a5ea3f4a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2ae33202-6568-4c1a-8d28-e7ec0becb4c5" xlink:to="loc_us-gaap_InterestExpense_9411b933-9550-4a14-bfd3-d63a5ea3f4a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6462c0a6-ff84-4c4c-9749-8e10c54af750" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2ae33202-6568-4c1a-8d28-e7ec0becb4c5" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6462c0a6-ff84-4c4c-9749-8e10c54af750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_dfe25b6e-bc38-4621-9ef7-cae605b430bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2ae33202-6568-4c1a-8d28-e7ec0becb4c5" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_dfe25b6e-bc38-4621-9ef7-cae605b430bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d46228a8-54a5-4ac8-b6da-3921ec7c1aa5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2ae33202-6568-4c1a-8d28-e7ec0becb4c5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d46228a8-54a5-4ac8-b6da-3921ec7c1aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_98bcf6e4-e459-4aa5-b81e-798d2ea1c53f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2ae33202-6568-4c1a-8d28-e7ec0becb4c5" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_98bcf6e4-e459-4aa5-b81e-798d2ea1c53f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d176e6be-d165-4fbb-a4a0-63b18b01b46e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2ae33202-6568-4c1a-8d28-e7ec0becb4c5" xlink:to="loc_us-gaap_NetIncomeLoss_d176e6be-d165-4fbb-a4a0-63b18b01b46e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_d82f712d-49bd-4625-a361-51fa7e784599" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2ae33202-6568-4c1a-8d28-e7ec0becb4c5" xlink:to="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_d82f712d-49bd-4625-a361-51fa7e784599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Netincome_6b432fca-a85e-4e5e-80c1-b306d9ea159f" xlink:href="holx-20210626.xsd#holx_Netincome"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_2ae33202-6568-4c1a-8d28-e7ec0becb4c5" xlink:to="loc_holx_Netincome_6b432fca-a85e-4e5e-80c1-b306d9ea159f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_9430053a-ab1f-4127-ab3f-21bd6a935aeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ab4413f6-8265-49b6-b1de-d79cd58170ae" xlink:to="loc_us-gaap_EarningsPerShareAbstract_9430053a-ab1f-4127-ab3f-21bd6a935aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_d4732c93-19a0-42db-b645-58d8b4c48f09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9430053a-ab1f-4127-ab3f-21bd6a935aeb" xlink:to="loc_us-gaap_EarningsPerShareBasic_d4732c93-19a0-42db-b645-58d8b4c48f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_0572f9f2-a15c-4685-bffe-02db4244a889" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_9430053a-ab1f-4127-ab3f-21bd6a935aeb" xlink:to="loc_us-gaap_EarningsPerShareDiluted_0572f9f2-a15c-4685-bffe-02db4244a889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_61d8e1ba-983c-4766-9281-1af7206e1756" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ab4413f6-8265-49b6-b1de-d79cd58170ae" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_61d8e1ba-983c-4766-9281-1af7206e1756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6020cf67-bf97-4ead-8971-5634b13312ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_61d8e1ba-983c-4766-9281-1af7206e1756" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6020cf67-bf97-4ead-8971-5634b13312ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_32a17715-aea7-4dd2-9d12-f54e4bad0528" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_61d8e1ba-983c-4766-9281-1af7206e1756" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_32a17715-aea7-4dd2-9d12-f54e4bad0528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="holx-20210626.xsd#ConsolidatedStatementsofComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4472a55f-4e27-4877-9b13-37855d53717b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7abe9f89-0ad9-4eb8-b66d-79df4eeeb599" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4472a55f-4e27-4877-9b13-37855d53717b" xlink:to="loc_us-gaap_NetIncomeLoss_7abe9f89-0ad9-4eb8-b66d-79df4eeeb599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_8cd04cff-875c-4e77-8da6-14c508bc612b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4472a55f-4e27-4877-9b13-37855d53717b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_8cd04cff-875c-4e77-8da6-14c508bc612b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_ee6c20f4-e5a1-40cc-8c69-fa1929bb5c19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4472a55f-4e27-4877-9b13-37855d53717b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_ee6c20f4-e5a1-40cc-8c69-fa1929bb5c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_e63ca2c3-bec8-4af9-8156-e9bbdfa38725" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4472a55f-4e27-4877-9b13-37855d53717b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_e63ca2c3-bec8-4af9-8156-e9bbdfa38725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ecf94350-b1f8-4224-a13f-299b31ea5621" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4472a55f-4e27-4877-9b13-37855d53717b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ecf94350-b1f8-4224-a13f-299b31ea5621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_fb42ff2d-0391-430b-a35a-3be5b91fd9ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4472a55f-4e27-4877-9b13-37855d53717b" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_fb42ff2d-0391-430b-a35a-3be5b91fd9ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_079451d8-c7ee-423d-b2b6-2a3461b4cbd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4472a55f-4e27-4877-9b13-37855d53717b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_079451d8-c7ee-423d-b2b6-2a3461b4cbd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ComprehensiveIncome_85c0dd6b-93b3-44d4-918f-d9d2a4b228d8" xlink:href="holx-20210626.xsd#holx_ComprehensiveIncome"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4472a55f-4e27-4877-9b13-37855d53717b" xlink:to="loc_holx_ComprehensiveIncome_85c0dd6b-93b3-44d4-918f-d9d2a4b228d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical" xlink:type="simple" xlink:href="holx-20210626.xsd#ConsolidatedStatementsofComprehensiveLossParenthetical"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_effd3c46-2840-4e1c-ad5a-46fd11842e4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_12ddcf73-def0-463d-874d-b4cbbd1981c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_effd3c46-2840-4e1c-ad5a-46fd11842e4e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_12ddcf73-def0-463d-874d-b4cbbd1981c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="holx-20210626.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_9f6466df-1ef7-4a8a-ac9e-df0da699acef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_148a3de2-aa3d-4db9-95c8-2d8d1c18bf07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9f6466df-1ef7-4a8a-ac9e-df0da699acef" xlink:to="loc_us-gaap_AssetsAbstract_148a3de2-aa3d-4db9-95c8-2d8d1c18bf07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_beb3643a-8a4c-40a6-82bb-8f5d7a9ccdad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_148a3de2-aa3d-4db9-95c8-2d8d1c18bf07" xlink:to="loc_us-gaap_AssetsCurrentAbstract_beb3643a-8a4c-40a6-82bb-8f5d7a9ccdad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ff61a4b6-5eb2-4484-8b0a-333b132d51d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_beb3643a-8a4c-40a6-82bb-8f5d7a9ccdad" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ff61a4b6-5eb2-4484-8b0a-333b132d51d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_d68a1d35-8530-423e-8fff-19d3728c9a8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_beb3643a-8a4c-40a6-82bb-8f5d7a9ccdad" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_d68a1d35-8530-423e-8fff-19d3728c9a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_1f421ffc-1893-4ed7-8a82-bec711f352b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_beb3643a-8a4c-40a6-82bb-8f5d7a9ccdad" xlink:to="loc_us-gaap_InventoryNet_1f421ffc-1893-4ed7-8a82-bec711f352b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrepaidIncomeTaxesCurrent_601faf17-9fb0-4efb-b98a-3f0b9d169d36" xlink:href="holx-20210626.xsd#holx_PrepaidIncomeTaxesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_beb3643a-8a4c-40a6-82bb-8f5d7a9ccdad" xlink:to="loc_holx_PrepaidIncomeTaxesCurrent_601faf17-9fb0-4efb-b98a-3f0b9d169d36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_dbb67cd5-2538-4848-9742-0eb25ab41f0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_beb3643a-8a4c-40a6-82bb-8f5d7a9ccdad" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_dbb67cd5-2538-4848-9742-0eb25ab41f0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_fa4175e2-e0e2-43fc-9f0e-711f072f1273" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_beb3643a-8a4c-40a6-82bb-8f5d7a9ccdad" xlink:to="loc_us-gaap_AssetsCurrent_fa4175e2-e0e2-43fc-9f0e-711f072f1273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_87d650af-fee0-4445-a9dd-04a27d74e719" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_148a3de2-aa3d-4db9-95c8-2d8d1c18bf07" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_87d650af-fee0-4445-a9dd-04a27d74e719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_47104be7-8b02-4b37-9d51-4f532a9a7072" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_148a3de2-aa3d-4db9-95c8-2d8d1c18bf07" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_47104be7-8b02-4b37-9d51-4f532a9a7072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ae310eeb-ede4-4ba6-941f-2fca5cf12f8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_148a3de2-aa3d-4db9-95c8-2d8d1c18bf07" xlink:to="loc_us-gaap_Goodwill_ae310eeb-ede4-4ba6-941f-2fca5cf12f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_e0a465d3-1b5d-4eeb-9583-9c303c4b8d4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_148a3de2-aa3d-4db9-95c8-2d8d1c18bf07" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_e0a465d3-1b5d-4eeb-9583-9c303c4b8d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b653181e-f8c3-4081-a22a-ecd57a95fa36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_148a3de2-aa3d-4db9-95c8-2d8d1c18bf07" xlink:to="loc_us-gaap_Assets_b653181e-f8c3-4081-a22a-ecd57a95fa36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8b7d61cb-320e-4b51-a64e-5313956186aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_9f6466df-1ef7-4a8a-ac9e-df0da699acef" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8b7d61cb-320e-4b51-a64e-5313956186aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_79b6cfa2-c7c9-4cc1-ae7a-ed20e5aa90f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8b7d61cb-320e-4b51-a64e-5313956186aa" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_79b6cfa2-c7c9-4cc1-ae7a-ed20e5aa90f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_d1690ef6-8dd8-452b-9829-ccdf825417c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_79b6cfa2-c7c9-4cc1-ae7a-ed20e5aa90f4" xlink:to="loc_us-gaap_LongTermDebtCurrent_d1690ef6-8dd8-452b-9829-ccdf825417c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_59b7232a-b21d-443c-8ce3-3edaeb215e59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_79b6cfa2-c7c9-4cc1-ae7a-ed20e5aa90f4" xlink:to="loc_us-gaap_AccountsPayableCurrent_59b7232a-b21d-443c-8ce3-3edaeb215e59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_0ad1eca7-2902-4b07-96e0-98a35ac47449" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_79b6cfa2-c7c9-4cc1-ae7a-ed20e5aa90f4" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_0ad1eca7-2902-4b07-96e0-98a35ac47449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_6a8eafa5-ca56-4717-b48e-b3c5f1274f01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_79b6cfa2-c7c9-4cc1-ae7a-ed20e5aa90f4" xlink:to="loc_us-gaap_DeferredRevenueCurrent_6a8eafa5-ca56-4717-b48e-b3c5f1274f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsCurrent_06524a1e-1927-4e44-b6e1-1cf4a144d611" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_79b6cfa2-c7c9-4cc1-ae7a-ed20e5aa90f4" xlink:to="loc_us-gaap_CapitalLeaseObligationsCurrent_06524a1e-1927-4e44-b6e1-1cf4a144d611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_5488be08-9b9c-411b-91c7-542476578352" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_79b6cfa2-c7c9-4cc1-ae7a-ed20e5aa90f4" xlink:to="loc_us-gaap_LiabilitiesCurrent_5488be08-9b9c-411b-91c7-542476578352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_930fbfc4-125d-46cf-afa2-95ec4a3222af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8b7d61cb-320e-4b51-a64e-5313956186aa" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_930fbfc4-125d-46cf-afa2-95ec4a3222af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsNoncurrent_438e04b9-8a96-406b-9a74-d6f80a1d36b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8b7d61cb-320e-4b51-a64e-5313956186aa" xlink:to="loc_us-gaap_CapitalLeaseObligationsNoncurrent_438e04b9-8a96-406b-9a74-d6f80a1d36b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e82d1fc3-fd67-4ac6-a18f-e18e6c21e1a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8b7d61cb-320e-4b51-a64e-5313956186aa" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_e82d1fc3-fd67-4ac6-a18f-e18e6c21e1a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_b50edcc7-d553-41eb-80cd-510379ef8c29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8b7d61cb-320e-4b51-a64e-5313956186aa" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_b50edcc7-d553-41eb-80cd-510379ef8c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_2042a20f-010f-41c8-9e4b-ea0766eb749a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8b7d61cb-320e-4b51-a64e-5313956186aa" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_2042a20f-010f-41c8-9e4b-ea0766eb749a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_a2aff4b9-0e6a-4554-b891-c511a0a2fe53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8b7d61cb-320e-4b51-a64e-5313956186aa" xlink:to="loc_us-gaap_StockholdersEquityAbstract_a2aff4b9-0e6a-4554-b891-c511a0a2fe53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_712718d7-2271-4e88-bbfe-2798e2461f77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a2aff4b9-0e6a-4554-b891-c511a0a2fe53" xlink:to="loc_us-gaap_PreferredStockValue_712718d7-2271-4e88-bbfe-2798e2461f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_f27127c5-13da-4cae-a58f-2ab4dde4682e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a2aff4b9-0e6a-4554-b891-c511a0a2fe53" xlink:to="loc_us-gaap_CommonStockValue_f27127c5-13da-4cae-a58f-2ab4dde4682e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_a0d067bc-7cb5-4d67-b837-93e9120eb92d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a2aff4b9-0e6a-4554-b891-c511a0a2fe53" xlink:to="loc_us-gaap_AdditionalPaidInCapital_a0d067bc-7cb5-4d67-b837-93e9120eb92d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4af7867f-9e1c-43ff-85c9-acd7141aa387" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a2aff4b9-0e6a-4554-b891-c511a0a2fe53" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4af7867f-9e1c-43ff-85c9-acd7141aa387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_0c522974-f8be-4bda-89c8-0f0241d33ece" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a2aff4b9-0e6a-4554-b891-c511a0a2fe53" xlink:to="loc_us-gaap_TreasuryStockValue_0c522974-f8be-4bda-89c8-0f0241d33ece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_92997afb-c5e6-4a6d-837e-71e69b86188e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a2aff4b9-0e6a-4554-b891-c511a0a2fe53" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_92997afb-c5e6-4a6d-837e-71e69b86188e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7073755b-ada4-4fd1-8ea0-df043b68770c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_a2aff4b9-0e6a-4554-b891-c511a0a2fe53" xlink:to="loc_us-gaap_StockholdersEquity_7073755b-ada4-4fd1-8ea0-df043b68770c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_7443e323-8d2e-43b5-a62f-d41be61b5319" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8b7d61cb-320e-4b51-a64e-5313956186aa" xlink:to="loc_us-gaap_MinorityInterest_7443e323-8d2e-43b5-a62f-d41be61b5319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a74ad401-9fed-4eeb-96fa-cf72e76f8f19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8b7d61cb-320e-4b51-a64e-5313956186aa" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a74ad401-9fed-4eeb-96fa-cf72e76f8f19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_927f7470-92f7-42dc-9879-7db0549d58dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8b7d61cb-320e-4b51-a64e-5313956186aa" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_927f7470-92f7-42dc-9879-7db0549d58dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="holx-20210626.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_8f8cdf65-4344-49e4-8368-0fde60bd66fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_83407090-9b94-47e9-83da-34659c3ff358" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8f8cdf65-4344-49e4-8368-0fde60bd66fb" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_83407090-9b94-47e9-83da-34659c3ff358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_70679834-ae2e-4ea2-b593-b09a0b2ba82d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8f8cdf65-4344-49e4-8368-0fde60bd66fb" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_70679834-ae2e-4ea2-b593-b09a0b2ba82d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_05ef8453-c23c-4dd6-b04c-e4ed853bd4fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8f8cdf65-4344-49e4-8368-0fde60bd66fb" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_05ef8453-c23c-4dd6-b04c-e4ed853bd4fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_378c2c6d-07ef-4e51-b91a-239c1d72a42d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8f8cdf65-4344-49e4-8368-0fde60bd66fb" xlink:to="loc_us-gaap_PreferredStockSharesIssued_378c2c6d-07ef-4e51-b91a-239c1d72a42d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_4fe56f69-016f-4cba-9d92-9753e624aae9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8f8cdf65-4344-49e4-8368-0fde60bd66fb" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_4fe56f69-016f-4cba-9d92-9753e624aae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_5e1116b3-efe2-4966-9715-1be4d229244a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8f8cdf65-4344-49e4-8368-0fde60bd66fb" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_5e1116b3-efe2-4966-9715-1be4d229244a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_c527694d-b304-41b1-a448-f4c37a611773" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8f8cdf65-4344-49e4-8368-0fde60bd66fb" xlink:to="loc_us-gaap_CommonStockSharesIssued_c527694d-b304-41b1-a448-f4c37a611773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_ab2d7b83-1177-4ab3-9e9d-cac15448ab0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8f8cdf65-4344-49e4-8368-0fde60bd66fb" xlink:to="loc_us-gaap_TreasuryStockShares_ab2d7b83-1177-4ab3-9e9d-cac15448ab0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="holx-20210626.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_c4aefd3d-ea88-43d9-8405-b19b1148e356" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_331e5282-773d-45e9-9d98-f8537bce7e6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_c4aefd3d-ea88-43d9-8405-b19b1148e356" xlink:to="loc_us-gaap_StatementTable_331e5282-773d-45e9-9d98-f8537bce7e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_50218818-d525-45db-bfea-1b606c556f40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_331e5282-773d-45e9-9d98-f8537bce7e6a" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_50218818-d525-45db-bfea-1b606c556f40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_c39d93a2-e666-4715-b42b-d593723dcd51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_50218818-d525-45db-bfea-1b606c556f40" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_c39d93a2-e666-4715-b42b-d593723dcd51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareRepurchaseProgramMember_a874cda5-3abb-4af6-8758-14aac73ea6b1" xlink:href="holx-20210626.xsd#holx_ShareRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_c39d93a2-e666-4715-b42b-d593723dcd51" xlink:to="loc_holx_ShareRepurchaseProgramMember_a874cda5-3abb-4af6-8758-14aac73ea6b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e4a83df5-3b16-412e-bc8a-8885f90cfa10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_331e5282-773d-45e9-9d98-f8537bce7e6a" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e4a83df5-3b16-412e-bc8a-8885f90cfa10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2c160712-15a5-4213-9369-df4ba38414a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e4a83df5-3b16-412e-bc8a-8885f90cfa10" xlink:to="loc_us-gaap_EquityComponentDomain_2c160712-15a5-4213-9369-df4ba38414a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_3524e9e5-b2a3-44eb-b14b-c8652acd6296" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2c160712-15a5-4213-9369-df4ba38414a8" xlink:to="loc_us-gaap_CommonStockMember_3524e9e5-b2a3-44eb-b14b-c8652acd6296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_99c80f8c-0bf6-45a4-8247-25852f39c448" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2c160712-15a5-4213-9369-df4ba38414a8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_99c80f8c-0bf6-45a4-8247-25852f39c448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_83705582-9d61-4ac2-a609-e8244ef92abc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2c160712-15a5-4213-9369-df4ba38414a8" xlink:to="loc_us-gaap_RetainedEarningsMember_83705582-9d61-4ac2-a609-e8244ef92abc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_22f6d8cc-e5c0-4dd0-b274-eb3e8b1b6c92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2c160712-15a5-4213-9369-df4ba38414a8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_22f6d8cc-e5c0-4dd0-b274-eb3e8b1b6c92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_a4ae47f2-3d4c-43ec-9cbe-d4e7c7e236f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2c160712-15a5-4213-9369-df4ba38414a8" xlink:to="loc_us-gaap_TreasuryStockMember_a4ae47f2-3d4c-43ec-9cbe-d4e7c7e236f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9f3cedad-38de-49d3-b646-b10d1021af60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_331e5282-773d-45e9-9d98-f8537bce7e6a" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9f3cedad-38de-49d3-b646-b10d1021af60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_38c86c26-9da0-4991-80c8-4d54187eea36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_9f3cedad-38de-49d3-b646-b10d1021af60" xlink:to="loc_us-gaap_TypeOfAdoptionMember_38c86c26-9da0-4991-80c8-4d54187eea36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201801Member_3f9efae3-85b3-482f-ab35-501cf11baddd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201801Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_38c86c26-9da0-4991-80c8-4d54187eea36" xlink:to="loc_us-gaap_AccountingStandardsUpdate201801Member_3f9efae3-85b3-482f-ab35-501cf11baddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_8f01ef4f-7890-4426-a706-5691a3080d92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_331e5282-773d-45e9-9d98-f8537bce7e6a" xlink:to="loc_us-gaap_StatementLineItems_8f01ef4f-7890-4426-a706-5691a3080d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount_f6630350-c857-476e-b55a-e660fc579007" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8f01ef4f-7890-4426-a706-5691a3080d92" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount_f6630350-c857-476e-b55a-e660fc579007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_4f480f20-c791-47fa-a282-d7d2916810f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8f01ef4f-7890-4426-a706-5691a3080d92" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_4f480f20-c791-47fa-a282-d7d2916810f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8f01ef4f-7890-4426-a706-5691a3080d92" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_66c86142-e19a-413b-b6ff-b9605a7e86a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_us-gaap_SharesIssued_66c86142-e19a-413b-b6ff-b9605a7e86a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_099460bb-cb74-4da7-bde3-537a04cc6ca8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_us-gaap_StockholdersEquity_099460bb-cb74-4da7-bde3-537a04cc6ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_59f5f746-6545-4ba2-9152-7d358672f054" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_59f5f746-6545-4ba2-9152-7d358672f054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_8da3f7ea-b0f6-4708-b57e-3fedcae3e396" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_8da3f7ea-b0f6-4708-b57e-3fedcae3e396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ChangeInParValue_9eeb0702-7f38-43be-9d0a-c54b8bdc1e1e" xlink:href="holx-20210626.xsd#holx_ChangeInParValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_holx_ChangeInParValue_9eeb0702-7f38-43be-9d0a-c54b8bdc1e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_44f2020e-ec60-4558-979c-7944f558a547" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_44f2020e-ec60-4558-979c-7944f558a547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_9d6c7854-83b2-4f6a-ae68-7066aca2c573" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_9d6c7854-83b2-4f6a-ae68-7066aca2c573" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e764c8a1-300a-42b9-ab88-b4a3923d3a35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_e764c8a1-300a-42b9-ab88-b4a3923d3a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_023681ed-2970-4f19-b4ad-0d7595ff7473" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_023681ed-2970-4f19-b4ad-0d7595ff7473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b7905574-0234-4463-9fff-35b684e00847" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_b7905574-0234-4463-9fff-35b684e00847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_503f84c6-3771-48a7-a263-b91bfbd312fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_us-gaap_NetIncomeLoss_503f84c6-3771-48a7-a263-b91bfbd312fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ca22ad0c-6538-4d09-82b1-82b7150a7410" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ca22ad0c-6538-4d09-82b1-82b7150a7410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_9be9ce60-298e-441e-a51b-e732753c3734" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_9be9ce60-298e-441e-a51b-e732753c3734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_09960130-ff3d-4482-ba60-19f4e960b210" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_09960130-ff3d-4482-ba60-19f4e960b210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TotalPaymentsToNonControllingInterest_086977c2-cb6b-4733-9b27-7adf3b661be6" xlink:href="holx-20210626.xsd#holx_TotalPaymentsToNonControllingInterest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_holx_TotalPaymentsToNonControllingInterest_086977c2-cb6b-4733-9b27-7adf3b661be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PurchaseOfNonControllingInterestReclassifiedToAPIC_967d7c32-4850-4cd3-80d1-50842c4ba33b" xlink:href="holx-20210626.xsd#holx_PurchaseOfNonControllingInterestReclassifiedToAPIC"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_holx_PurchaseOfNonControllingInterestReclassifiedToAPIC_967d7c32-4850-4cd3-80d1-50842c4ba33b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchaseProgramAdjustment_5703c8d1-05dd-437b-ad7c-1bdce9a5bdfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchaseProgramAdjustment"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_us-gaap_AcceleratedShareRepurchaseProgramAdjustment_5703c8d1-05dd-437b-ad7c-1bdce9a5bdfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_30c6bb15-d273-4186-b9a4-f477faa320fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_us-gaap_SharesIssued_30c6bb15-d273-4186-b9a4-f477faa320fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5a43be3b-206d-4661-9ca2-53a1324ce24f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_us-gaap_StockholdersEquity_5a43be3b-206d-4661-9ca2-53a1324ce24f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_22cae603-da2b-47e8-ae03-11b58eb234c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_22cae603-da2b-47e8-ae03-11b58eb234c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Netincome_af061996-849d-40e7-a0d4-a6395e6f6f5d" xlink:href="holx-20210626.xsd#holx_Netincome"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_holx_Netincome_af061996-849d-40e7-a0d4-a6395e6f6f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Acceleratedsharerepurchaseagreement_93abb125-4048-4818-846c-f6b705a68194" xlink:href="holx-20210626.xsd#holx_Acceleratedsharerepurchaseagreement"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_holx_Acceleratedsharerepurchaseagreement_93abb125-4048-4818-846c-f6b705a68194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_2c405b31-6a40-4df5-a5c3-3efa64b5096b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_99e40c07-36b2-46d1-91d9-e6706e5561ad" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_2c405b31-6a40-4df5-a5c3-3efa64b5096b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_154e1729-0b92-401d-8c1f-a926f0da2d8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8f01ef4f-7890-4426-a706-5691a3080d92" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_154e1729-0b92-401d-8c1f-a926f0da2d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="holx-20210626.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_6e1206f8-cb82-4710-b05a-6dcaa49bc4f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3bb3dd8f-f767-45a6-bf6c-000b7a3b2a05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6e1206f8-cb82-4710-b05a-6dcaa49bc4f6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3bb3dd8f-f767-45a6-bf6c-000b7a3b2a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_42e4c53a-9ea7-42ac-817e-b027e5614729" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3bb3dd8f-f767-45a6-bf6c-000b7a3b2a05" xlink:to="loc_us-gaap_NetIncomeLoss_42e4c53a-9ea7-42ac-817e-b027e5614729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2ca7ecf8-1b3c-4e24-a903-6c4627b82066" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3bb3dd8f-f767-45a6-bf6c-000b7a3b2a05" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2ca7ecf8-1b3c-4e24-a903-6c4627b82066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_3fc1fb3a-2640-4f2e-9b8a-38c1e98b68ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2ca7ecf8-1b3c-4e24-a903-6c4627b82066" xlink:to="loc_us-gaap_Depreciation_3fc1fb3a-2640-4f2e-9b8a-38c1e98b68ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_bb72d0c7-ed18-4624-b05d-18e28875cc30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2ca7ecf8-1b3c-4e24-a903-6c4627b82066" xlink:to="loc_us-gaap_AdjustmentForAmortization_bb72d0c7-ed18-4624-b05d-18e28875cc30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_5d4d4815-d3ce-4c90-8731-2ea3b3f82ced" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2ca7ecf8-1b3c-4e24-a903-6c4627b82066" xlink:to="loc_us-gaap_ShareBasedCompensation_5d4d4815-d3ce-4c90-8731-2ea3b3f82ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_d943332f-e6e2-4a41-a15c-52d011aee442" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2ca7ecf8-1b3c-4e24-a903-6c4627b82066" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_d943332f-e6e2-4a41-a15c-52d011aee442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_01856189-e03f-4a80-b277-08b78186f803" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2ca7ecf8-1b3c-4e24-a903-6c4627b82066" xlink:to="loc_us-gaap_AssetImpairmentCharges_01856189-e03f-4a80-b277-08b78186f803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_8bc1d062-e8b6-4584-9feb-f22cb77d2af2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2ca7ecf8-1b3c-4e24-a903-6c4627b82066" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_8bc1d062-e8b6-4584-9feb-f22cb77d2af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_51131c81-c7b3-401d-a06e-37878d84b319" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_2ca7ecf8-1b3c-4e24-a903-6c4627b82066" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_51131c81-c7b3-401d-a06e-37878d84b319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6a866c5c-2e05-43ee-ae38-46cd0ea51a80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3bb3dd8f-f767-45a6-bf6c-000b7a3b2a05" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6a866c5c-2e05-43ee-ae38-46cd0ea51a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_86b4a2e8-5d9e-45b5-91b2-2dd15ba02355" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6a866c5c-2e05-43ee-ae38-46cd0ea51a80" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_86b4a2e8-5d9e-45b5-91b2-2dd15ba02355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_cfb8786e-f16a-4a71-a67b-90eed60d5fcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6a866c5c-2e05-43ee-ae38-46cd0ea51a80" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_cfb8786e-f16a-4a71-a67b-90eed60d5fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_ec3e084c-896b-43d7-aec5-10bffd7a8381" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6a866c5c-2e05-43ee-ae38-46cd0ea51a80" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_ec3e084c-896b-43d7-aec5-10bffd7a8381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_bc7186f1-69c4-4136-8f0a-71e8b598e6be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6a866c5c-2e05-43ee-ae38-46cd0ea51a80" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_bc7186f1-69c4-4136-8f0a-71e8b598e6be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_8a161e9b-1546-49d2-b92a-228dceba035c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6a866c5c-2e05-43ee-ae38-46cd0ea51a80" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_8a161e9b-1546-49d2-b92a-228dceba035c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_976015e6-bd69-4852-9e96-48377a8a1409" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6a866c5c-2e05-43ee-ae38-46cd0ea51a80" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_976015e6-bd69-4852-9e96-48377a8a1409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_e5fdc013-5756-4801-a2bc-8cf670ea5381" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6a866c5c-2e05-43ee-ae38-46cd0ea51a80" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_e5fdc013-5756-4801-a2bc-8cf670ea5381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_eb965c8a-649f-4f9b-a36b-6bfc2d2eb3c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_3bb3dd8f-f767-45a6-bf6c-000b7a3b2a05" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_eb965c8a-649f-4f9b-a36b-6bfc2d2eb3c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_412b84f3-5fd8-48ac-a825-c26d986333d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6e1206f8-cb82-4710-b05a-6dcaa49bc4f6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_412b84f3-5fd8-48ac-a825-c26d986333d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_91f2e13d-b54c-4e06-b83d-9a01ed9bb0d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_412b84f3-5fd8-48ac-a825-c26d986333d4" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_91f2e13d-b54c-4e06-b83d-9a01ed9bb0d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProceedsFromSaleOfBusiness_79eef4a0-2707-4fcb-9922-e2524445046d" xlink:href="holx-20210626.xsd#holx_ProceedsFromSaleOfBusiness"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_412b84f3-5fd8-48ac-a825-c26d986333d4" xlink:to="loc_holx_ProceedsFromSaleOfBusiness_79eef4a0-2707-4fcb-9922-e2524445046d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_cef2bdcc-c4a6-45c7-a333-eb28cbfaa5d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_412b84f3-5fd8-48ac-a825-c26d986333d4" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_cef2bdcc-c4a6-45c7-a333-eb28cbfaa5d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_a732f621-80ee-47ba-ac9d-350dff90d55a" xlink:href="holx-20210626.xsd#holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_412b84f3-5fd8-48ac-a825-c26d986333d4" xlink:to="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_a732f621-80ee-47ba-ac9d-350dff90d55a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PurchaseOfIntellectualProperty_bae43d7e-2e06-45b4-89ce-eba2987afb0f" xlink:href="holx-20210626.xsd#holx_PurchaseOfIntellectualProperty"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_412b84f3-5fd8-48ac-a825-c26d986333d4" xlink:to="loc_holx_PurchaseOfIntellectualProperty_bae43d7e-2e06-45b4-89ce-eba2987afb0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_5effdc92-a22c-43d1-a3d0-63ca4f11e9c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_412b84f3-5fd8-48ac-a825-c26d986333d4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_5effdc92-a22c-43d1-a3d0-63ca4f11e9c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_57af9406-8a78-4e68-b786-8b27ad5a8026" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_412b84f3-5fd8-48ac-a825-c26d986333d4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_57af9406-8a78-4e68-b786-8b27ad5a8026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f90153b-7139-4dda-9349-d2f016ffbc37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6e1206f8-cb82-4710-b05a-6dcaa49bc4f6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f90153b-7139-4dda-9349-d2f016ffbc37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_b8c06107-b09a-449b-a757-d7979a279d23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f90153b-7139-4dda-9349-d2f016ffbc37" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_b8c06107-b09a-449b-a757-d7979a279d23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProceedsFromSeniorNotes_2870ab47-ecb1-4fe5-8992-bdc9249ef32e" xlink:href="holx-20210626.xsd#holx_ProceedsFromSeniorNotes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f90153b-7139-4dda-9349-d2f016ffbc37" xlink:to="loc_holx_ProceedsFromSeniorNotes_2870ab47-ecb1-4fe5-8992-bdc9249ef32e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RepaymentOfSeniorNotes_2626f024-2f78-4c6e-a440-922b9f46636f" xlink:href="holx-20210626.xsd#holx_RepaymentOfSeniorNotes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f90153b-7139-4dda-9349-d2f016ffbc37" xlink:to="loc_holx_RepaymentOfSeniorNotes_2626f024-2f78-4c6e-a440-922b9f46636f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_6256fee3-4dfb-468d-bd9c-de3d1bf6d608" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f90153b-7139-4dda-9349-d2f016ffbc37" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_6256fee3-4dfb-468d-bd9c-de3d1bf6d608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_1ae41bdd-0477-4020-a89a-3e792a9e0d4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f90153b-7139-4dda-9349-d2f016ffbc37" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_1ae41bdd-0477-4020-a89a-3e792a9e0d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromAccountsReceivableSecuritization_297fe407-f367-4806-aa93-4c3fcc622204" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromAccountsReceivableSecuritization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f90153b-7139-4dda-9349-d2f016ffbc37" xlink:to="loc_us-gaap_ProceedsFromAccountsReceivableSecuritization_297fe407-f367-4806-aa93-4c3fcc622204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfAccountsReceivableSecuritization_d071eff4-32fc-4e5c-a78b-c01edc046e44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfAccountsReceivableSecuritization"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f90153b-7139-4dda-9349-d2f016ffbc37" xlink:to="loc_us-gaap_RepaymentsOfAccountsReceivableSecuritization_d071eff4-32fc-4e5c-a78b-c01edc046e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_dd923d66-d2ca-40bf-a2ad-867e0229a2c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f90153b-7139-4dda-9349-d2f016ffbc37" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_dd923d66-d2ca-40bf-a2ad-867e0229a2c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_00d762fb-61bd-4e86-b050-10a0698e1807" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f90153b-7139-4dda-9349-d2f016ffbc37" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_00d762fb-61bd-4e86-b050-10a0698e1807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_b4be2bd4-ed74-4059-8938-65aeaebed1ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f90153b-7139-4dda-9349-d2f016ffbc37" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_b4be2bd4-ed74-4059-8938-65aeaebed1ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d968e4cd-154c-4606-b018-00dcc7942c04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f90153b-7139-4dda-9349-d2f016ffbc37" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d968e4cd-154c-4606-b018-00dcc7942c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_c17a9c00-9a68-402f-8044-f7f550ed38c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f90153b-7139-4dda-9349-d2f016ffbc37" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_c17a9c00-9a68-402f-8044-f7f550ed38c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_3bd932e3-664d-46ed-be10-98cba0c37050" xlink:href="holx-20210626.xsd#holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f90153b-7139-4dda-9349-d2f016ffbc37" xlink:to="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_3bd932e3-664d-46ed-be10-98cba0c37050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_befade11-bb40-493b-8089-76214e2ea3f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f90153b-7139-4dda-9349-d2f016ffbc37" xlink:to="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_befade11-bb40-493b-8089-76214e2ea3f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_36314053-27ef-44ee-8585-dfee174aaff7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f90153b-7139-4dda-9349-d2f016ffbc37" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_36314053-27ef-44ee-8585-dfee174aaff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_fd6e96e9-add6-4fd8-ad88-6849730541ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6e1206f8-cb82-4710-b05a-6dcaa49bc4f6" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_fd6e96e9-add6-4fd8-ad88-6849730541ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4121a2a2-c065-401c-be2f-563633e91e12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6e1206f8-cb82-4710-b05a-6dcaa49bc4f6" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4121a2a2-c065-401c-be2f-563633e91e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8e58d667-2b48-4250-9544-5a6c4f169c00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6e1206f8-cb82-4710-b05a-6dcaa49bc4f6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8e58d667-2b48-4250-9544-5a6c4f169c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9a6f918e-bc06-43bb-9e50-1876ff36da6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_6e1206f8-cb82-4710-b05a-6dcaa49bc4f6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9a6f918e-bc06-43bb-9e50-1876ff36da6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BasisofPresentation" xlink:type="simple" xlink:href="holx-20210626.xsd#BasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_BasisofPresentationAbstract_ec44a676-c4e6-4237-9a77-c5207dbbd6e7" xlink:href="holx-20210626.xsd#holx_BasisofPresentationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_402babed-6942-4a05-83a1-dd49503516d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_BasisofPresentationAbstract_ec44a676-c4e6-4237-9a77-c5207dbbd6e7" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_402babed-6942-4a05-83a1-dd49503516d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/Revenue" xlink:type="simple" xlink:href="holx-20210626.xsd#Revenue"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/Revenue" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueTables" xlink:type="simple" xlink:href="holx-20210626.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3c919633-9281-4b7a-9502-ea895b91f716" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_c4f12cb6-3b82-4f5a-89db-6008d947b5dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3c919633-9281-4b7a-9502-ea895b91f716" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_c4f12cb6-3b82-4f5a-89db-6008d947b5dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueBusinessRevenueDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#RevenueBusinessRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueBusinessRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_54bb7f7f-d5fb-43c5-84e6-0171e9c21847" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_7f38a409-c122-4952-ab63-3554a10f16d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_54bb7f7f-d5fb-43c5-84e6-0171e9c21847" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_7f38a409-c122-4952-ab63-3554a10f16d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_bcfe787a-4b39-4289-9435-646bb0a44860" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_7f38a409-c122-4952-ab63-3554a10f16d2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_bcfe787a-4b39-4289-9435-646bb0a44860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1855fc41-0f91-4e4d-b83d-741701c95af5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_bcfe787a-4b39-4289-9435-646bb0a44860" xlink:to="loc_us-gaap_SegmentDomain_1855fc41-0f91-4e4d-b83d-741701c95af5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember_5ac7bf4f-da15-42dc-9914-680c4f9f93aa" xlink:href="holx-20210626.xsd#holx_DiagnosticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1855fc41-0f91-4e4d-b83d-741701c95af5" xlink:to="loc_holx_DiagnosticsMember_5ac7bf4f-da15-42dc-9914-680c4f9f93aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember_c2cb152e-6778-4492-ae50-efe29885d381" xlink:href="holx-20210626.xsd#holx_BreastHealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1855fc41-0f91-4e4d-b83d-741701c95af5" xlink:to="loc_holx_BreastHealthMember_c2cb152e-6778-4492-ae50-efe29885d381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember_3cc08746-656b-48ac-9be1-72a102f17657" xlink:href="holx-20210626.xsd#holx_GynSurgicalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1855fc41-0f91-4e4d-b83d-741701c95af5" xlink:to="loc_holx_GynSurgicalMember_3cc08746-656b-48ac-9be1-72a102f17657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_55b9ff20-a32d-4449-a47f-4c814f4cc884" xlink:href="holx-20210626.xsd#holx_MedicalAestheticsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1855fc41-0f91-4e4d-b83d-741701c95af5" xlink:to="loc_holx_MedicalAestheticsMember_55b9ff20-a32d-4449-a47f-4c814f4cc884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember_613ef2f1-c638-426a-98b4-0eff8a9b6c9e" xlink:href="holx-20210626.xsd#holx_SkeletalHealthMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1855fc41-0f91-4e4d-b83d-741701c95af5" xlink:to="loc_holx_SkeletalHealthMember_613ef2f1-c638-426a-98b4-0eff8a9b6c9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9553ea8a-6dab-4fef-8b90-8d3eb58b3e8e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_7f38a409-c122-4952-ab63-3554a10f16d2" xlink:to="loc_srt_ProductOrServiceAxis_9553ea8a-6dab-4fef-8b90-8d3eb58b3e8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d2ca2b6e-6432-4ca7-9888-69092da50cdd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_9553ea8a-6dab-4fef-8b90-8d3eb58b3e8e" xlink:to="loc_srt_ProductsAndServicesDomain_d2ca2b6e-6432-4ca7-9888-69092da50cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CytologyPerinatalMember_0d93f185-b103-4eca-bb0e-b3322fc95780" xlink:href="holx-20210626.xsd#holx_CytologyPerinatalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d2ca2b6e-6432-4ca7-9888-69092da50cdd" xlink:to="loc_holx_CytologyPerinatalMember_0d93f185-b103-4eca-bb0e-b3322fc95780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MolecularDiagnosticsMember_238a80c4-be6b-4a4b-ba62-ea202c20130e" xlink:href="holx-20210626.xsd#holx_MolecularDiagnosticsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d2ca2b6e-6432-4ca7-9888-69092da50cdd" xlink:to="loc_holx_MolecularDiagnosticsMember_238a80c4-be6b-4a4b-ba62-ea202c20130e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BloodScreeningMember_cc18fc9a-07fb-4be6-beec-f4d988313f9c" xlink:href="holx-20210626.xsd#holx_BloodScreeningMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d2ca2b6e-6432-4ca7-9888-69092da50cdd" xlink:to="loc_holx_BloodScreeningMember_cc18fc9a-07fb-4be6-beec-f4d988313f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastImagingMember_ff962e9d-07eb-4daa-93f0-790298393539" xlink:href="holx-20210626.xsd#holx_BreastImagingMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d2ca2b6e-6432-4ca7-9888-69092da50cdd" xlink:to="loc_holx_BreastImagingMember_ff962e9d-07eb-4daa-93f0-790298393539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterventionalBreastSolutionsMember_d887a6c1-da71-4bb8-a840-532a1368012a" xlink:href="holx-20210626.xsd#holx_InterventionalBreastSolutionsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_d2ca2b6e-6432-4ca7-9888-69092da50cdd" xlink:to="loc_holx_InterventionalBreastSolutionsMember_d887a6c1-da71-4bb8-a840-532a1368012a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_53678891-6810-4119-975f-48d5f36c5c1f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_7f38a409-c122-4952-ab63-3554a10f16d2" xlink:to="loc_srt_StatementGeographicalAxis_53678891-6810-4119-975f-48d5f36c5c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_50701e57-2949-4ffc-af6c-ea63da84db19" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_53678891-6810-4119-975f-48d5f36c5c1f" xlink:to="loc_srt_SegmentGeographicalDomain_50701e57-2949-4ffc-af6c-ea63da84db19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_824276f0-e54b-47d4-b2f2-3100cfdc7c91" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_50701e57-2949-4ffc-af6c-ea63da84db19" xlink:to="loc_country_US_824276f0-e54b-47d4-b2f2-3100cfdc7c91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternationalMember_ec06cde6-b022-4259-91d6-8468a776a957" xlink:href="holx-20210626.xsd#holx_InternationalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_50701e57-2949-4ffc-af6c-ea63da84db19" xlink:to="loc_holx_InternationalMember_ec06cde6-b022-4259-91d6-8468a776a957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_36c77692-5065-4ab7-a84b-b492f0ceecd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_7f38a409-c122-4952-ab63-3554a10f16d2" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_36c77692-5065-4ab7-a84b-b492f0ceecd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_39607065-f55a-4834-ad36-06438a41b679" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_36c77692-5065-4ab7-a84b-b492f0ceecd8" xlink:to="loc_us-gaap_Revenues_39607065-f55a-4834-ad36-06438a41b679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_5e635b98-515b-4dce-8182-3188cfd10674" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_54bb7f7f-d5fb-43c5-84e6-0171e9c21847" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_5e635b98-515b-4dce-8182-3188cfd10674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueGeographicalRevenueDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#RevenueGeographicalRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueGeographicalRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e54641af-5cbd-425f-a522-b5d7df793561" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_1b7837da-1438-49a4-b4b4-913b0f42dd06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e54641af-5cbd-425f-a522-b5d7df793561" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_1b7837da-1438-49a4-b4b4-913b0f42dd06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_0c00d131-04c7-4841-a5e7-6959e3d8bb8b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1b7837da-1438-49a4-b4b4-913b0f42dd06" xlink:to="loc_srt_StatementGeographicalAxis_0c00d131-04c7-4841-a5e7-6959e3d8bb8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8bce6e3d-114e-41db-a500-4454fe676323" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_0c00d131-04c7-4841-a5e7-6959e3d8bb8b" xlink:to="loc_srt_SegmentGeographicalDomain_8bce6e3d-114e-41db-a500-4454fe676323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_25f0b197-dcb3-460a-a0db-c4a3a8717cb4" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8bce6e3d-114e-41db-a500-4454fe676323" xlink:to="loc_country_US_25f0b197-dcb3-460a-a0db-c4a3a8717cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_395d64fa-052b-45d0-8e53-b9d005011022" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8bce6e3d-114e-41db-a500-4454fe676323" xlink:to="loc_srt_EuropeMember_395d64fa-052b-45d0-8e53-b9d005011022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_f531c3e3-6dee-490b-867e-6af43496fbcb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8bce6e3d-114e-41db-a500-4454fe676323" xlink:to="loc_srt_AsiaPacificMember_f531c3e3-6dee-490b-867e-6af43496fbcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RestofWorldMember_f853de0b-3796-4a20-b9c8-105bc178824f" xlink:href="holx-20210626.xsd#holx_RestofWorldMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8bce6e3d-114e-41db-a500-4454fe676323" xlink:to="loc_holx_RestofWorldMember_f853de0b-3796-4a20-b9c8-105bc178824f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_6f005080-c395-4426-8f3b-caf64aa10876" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1b7837da-1438-49a4-b4b4-913b0f42dd06" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_6f005080-c395-4426-8f3b-caf64aa10876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_dbe91f2e-046e-46ed-993d-512a85335a43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_6f005080-c395-4426-8f3b-caf64aa10876" xlink:to="loc_us-gaap_Revenues_dbe91f2e-046e-46ed-993d-512a85335a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRevenuebyTypeDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#RevenueRevenuebyTypeDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueRevenuebyTypeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3c05788f-7b18-49f5-ab2e-4dfc0d94c3c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_48336bf8-a10f-4dee-906a-67fd5f547474" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3c05788f-7b18-49f5-ab2e-4dfc0d94c3c3" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_48336bf8-a10f-4dee-906a-67fd5f547474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a06ce225-c28a-43a9-94a7-61f0d491a0f2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_48336bf8-a10f-4dee-906a-67fd5f547474" xlink:to="loc_srt_ProductOrServiceAxis_a06ce225-c28a-43a9-94a7-61f0d491a0f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_cf93a43a-7766-4ccb-9c5e-842b306193a2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_a06ce225-c28a-43a9-94a7-61f0d491a0f2" xlink:to="loc_srt_ProductsAndServicesDomain_cf93a43a-7766-4ccb-9c5e-842b306193a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ConsumablesMember_7cbc64d5-ee72-423c-8b88-efdd7f4724f9" xlink:href="holx-20210626.xsd#holx_ConsumablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_cf93a43a-7766-4ccb-9c5e-842b306193a2" xlink:to="loc_holx_ConsumablesMember_7cbc64d5-ee72-423c-8b88-efdd7f4724f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalEquipmentComponentsandSoftwareMember_24c90b4d-74bb-49cc-b427-1cba0f7063b2" xlink:href="holx-20210626.xsd#holx_CapitalEquipmentComponentsandSoftwareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_cf93a43a-7766-4ccb-9c5e-842b306193a2" xlink:to="loc_holx_CapitalEquipmentComponentsandSoftwareMember_24c90b4d-74bb-49cc-b427-1cba0f7063b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_2b0855cb-8583-43fb-a191-d2fa38545bda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_cf93a43a-7766-4ccb-9c5e-842b306193a2" xlink:to="loc_us-gaap_ServiceMember_2b0855cb-8583-43fb-a191-d2fa38545bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherTypeofRevenueMember_7de345a4-fb6e-498b-b3d7-62738013fc33" xlink:href="holx-20210626.xsd#holx_OtherTypeofRevenueMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_cf93a43a-7766-4ccb-9c5e-842b306193a2" xlink:to="loc_holx_OtherTypeofRevenueMember_7de345a4-fb6e-498b-b3d7-62738013fc33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_bfc903e2-28c5-49dd-baeb-adba74d2e1cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_48336bf8-a10f-4dee-906a-67fd5f547474" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_bfc903e2-28c5-49dd-baeb-adba74d2e1cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_b08b985e-0a3c-4338-8792-49e6a5dbe5b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_bfc903e2-28c5-49dd-baeb-adba74d2e1cb" xlink:to="loc_us-gaap_Revenues_b08b985e-0a3c-4338-8792-49e6a5dbe5b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_e1bc0e05-3c50-448f-ae9b-e6a4886b5b55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3c05788f-7b18-49f5-ab2e-4dfc0d94c3c3" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_e1bc0e05-3c50-448f-ae9b-e6a4886b5b55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#RevenueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_21426071-2fcf-4553-ad20-f6940abfdad3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_cfc2ce91-f3e7-4c19-b38f-f05c6cd6e7f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_21426071-2fcf-4553-ad20-f6940abfdad3" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_cfc2ce91-f3e7-4c19-b38f-f05c6cd6e7f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_3b5bdf4a-f154-42fd-be01-d1cbe82721be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_21426071-2fcf-4553-ad20-f6940abfdad3" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_3b5bdf4a-f154-42fd-be01-d1cbe82721be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#RevenueRemainingPerformanceObligationDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_307b5d93-9197-4cda-9f12-775b44bf3354" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_1e88c274-8d12-481e-b96b-04707b240563" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_307b5d93-9197-4cda-9f12-775b44bf3354" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_1e88c274-8d12-481e-b96b-04707b240563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_5663e44e-336b-40b5-818f-711a097cfe67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1e88c274-8d12-481e-b96b-04707b240563" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_5663e44e-336b-40b5-818f-711a097cfe67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_f15efe8d-94bb-43b5-ad3b-9676537c5e01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1e88c274-8d12-481e-b96b-04707b240563" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_f15efe8d-94bb-43b5-ad3b-9676537c5e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_b36f9731-a774-4567-a7af-f28abffd771b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f15efe8d-94bb-43b5-ad3b-9676537c5e01" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_b36f9731-a774-4567-a7af-f28abffd771b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_bc17ef7b-65d0-478f-9b71-499b998c60ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f15efe8d-94bb-43b5-ad3b-9676537c5e01" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_bc17ef7b-65d0-478f-9b71-499b998c60ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails_1" xlink:type="simple" xlink:href="holx-20210626.xsd#RevenueRemainingPerformanceObligationDetails_1"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/Leases" xlink:type="simple" xlink:href="holx-20210626.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_41ed8a89-1a18-4d4e-800c-36ae195472b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_f952e716-2bcf-4e2f-b6ef-6d441056c7ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_41ed8a89-1a18-4d4e-800c-36ae195472b4" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_f952e716-2bcf-4e2f-b6ef-6d441056c7ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_612a843d-f9ca-4adb-9b00-9194089d9669" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_41ed8a89-1a18-4d4e-800c-36ae195472b4" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_612a843d-f9ca-4adb-9b00-9194089d9669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#LeasesAdditionalLeaseInformationDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_8efe0635-8dd6-4e22-a2da-7709fdfcf61c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LeaseRevenuePercentageOfTotalRevenue_0b98eeab-faac-4c09-ae70-55bd64167579" xlink:href="holx-20210626.xsd#holx_LeaseRevenuePercentageOfTotalRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8efe0635-8dd6-4e22-a2da-7709fdfcf61c" xlink:to="loc_holx_LeaseRevenuePercentageOfTotalRevenue_0b98eeab-faac-4c09-ae70-55bd64167579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="holx-20210626.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0d66ae9e-4aa2-4ef0-8453-49642c3ac1c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_4545a5ee-1ca4-4b8e-91c2-b3e2975e7c11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0d66ae9e-4aa2-4ef0-8453-49642c3ac1c6" xlink:to="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_4545a5ee-1ca4-4b8e-91c2-b3e2975e7c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="holx-20210626.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_729e4c73-0981-4f08-887e-8d04463d5d58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_80417ab4-160c-4cd2-b14a-1b1eb4ad5960" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_729e4c73-0981-4f08-887e-8d04463d5d58" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_80417ab4-160c-4cd2-b14a-1b1eb4ad5960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_8584d17a-2166-4e7e-9f35-cd656cf01be0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d8324262-118e-44b0-8f83-c40e5e497381" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8584d17a-2166-4e7e-9f35-cd656cf01be0" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d8324262-118e-44b0-8f83-c40e5e497381" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_35e43f59-cfe1-4ddf-a95c-3a24507282dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d8324262-118e-44b0-8f83-c40e5e497381" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_35e43f59-cfe1-4ddf-a95c-3a24507282dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3060c27e-fbf2-480c-9a7f-a133d8891701" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_35e43f59-cfe1-4ddf-a95c-3a24507282dd" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3060c27e-fbf2-480c-9a7f-a133d8891701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_297b4724-90ed-4b86-919a-5fc26045733f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3060c27e-fbf2-480c-9a7f-a133d8891701" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_297b4724-90ed-4b86-919a-5fc26045733f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_2e6b6acb-1ca2-4611-8c30-6e56da27138d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3060c27e-fbf2-480c-9a7f-a133d8891701" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_2e6b6acb-1ca2-4611-8c30-6e56da27138d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_3b2e16f3-85c3-4883-ae52-d0b89a743e29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3060c27e-fbf2-480c-9a7f-a133d8891701" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_3b2e16f3-85c3-4883-ae52-d0b89a743e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_a1021f34-b2eb-47b4-a26c-dbba1014e922" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d8324262-118e-44b0-8f83-c40e5e497381" xlink:to="loc_us-gaap_FinancialInstrumentAxis_a1021f34-b2eb-47b4-a26c-dbba1014e922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ff213eac-6505-4465-ae7f-501551a3f1fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_a1021f34-b2eb-47b4-a26c-dbba1014e922" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ff213eac-6505-4465-ae7f-501551a3f1fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_92834ab1-efa0-4ce8-ae8a-703385cdd0fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ff213eac-6505-4465-ae7f-501551a3f1fc" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_92834ab1-efa0-4ce8-ae8a-703385cdd0fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ContingentConsiderationMember_5ad4c59f-1cf7-4af3-bade-8a526cd7460c" xlink:href="holx-20210626.xsd#holx_ContingentConsiderationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ff213eac-6505-4465-ae7f-501551a3f1fc" xlink:to="loc_holx_ContingentConsiderationMember_5ad4c59f-1cf7-4af3-bade-8a526cd7460c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_2a99b58b-210e-424c-a707-089aa8999a1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ff213eac-6505-4465-ae7f-501551a3f1fc" xlink:to="loc_us-gaap_InterestRateSwapMember_2a99b58b-210e-424c-a707-089aa8999a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_9dbd8627-6659-4339-96c2-07863ca2f546" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ff213eac-6505-4465-ae7f-501551a3f1fc" xlink:to="loc_us-gaap_ForeignExchangeContractMember_9dbd8627-6659-4339-96c2-07863ca2f546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_04573e02-b167-4234-8990-d4306d29f74a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d8324262-118e-44b0-8f83-c40e5e497381" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_04573e02-b167-4234-8990-d4306d29f74a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_906a04a9-ba6e-4500-be6c-fe6fab089741" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_04573e02-b167-4234-8990-d4306d29f74a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_906a04a9-ba6e-4500-be6c-fe6fab089741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_04d370c9-1aec-421a-a673-4899ab876928" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_906a04a9-ba6e-4500-be6c-fe6fab089741" xlink:to="loc_us-gaap_LiabilityMember_04d370c9-1aec-421a-a673-4899ab876928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_d6afe43d-20ad-4815-98ab-c33a224b5bab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d8324262-118e-44b0-8f83-c40e5e497381" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_d6afe43d-20ad-4815-98ab-c33a224b5bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_8231e69b-f88b-4a3b-abaf-412cfbd2d78c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_d6afe43d-20ad-4815-98ab-c33a224b5bab" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_8231e69b-f88b-4a3b-abaf-412cfbd2d78c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_f3157519-cd64-4fa0-9e9c-b35db9032b2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_8231e69b-f88b-4a3b-abaf-412cfbd2d78c" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_f3157519-cd64-4fa0-9e9c-b35db9032b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_7d2cabcc-3964-4fd1-a380-2a38dcd0a53c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_d6afe43d-20ad-4815-98ab-c33a224b5bab" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_7d2cabcc-3964-4fd1-a380-2a38dcd0a53c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_164267f7-8e54-4274-9f94-354afea634a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_7d2cabcc-3964-4fd1-a380-2a38dcd0a53c" xlink:to="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_164267f7-8e54-4274-9f94-354afea634a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_b61eb4cf-fbbb-43f2-82ad-89c69269a0ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_7d2cabcc-3964-4fd1-a380-2a38dcd0a53c" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_b61eb4cf-fbbb-43f2-82ad-89c69269a0ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#FairValueMeasurementsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7e952bd0-68b7-4d9d-9b98-fb6ea90fc15c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_9b94d4c0-6670-4450-a21b-1f677bb816c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7e952bd0-68b7-4d9d-9b98-fb6ea90fc15c" xlink:to="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_9b94d4c0-6670-4450-a21b-1f677bb816c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0d5e8fe6-0f08-4a4b-9f75-b03988b315e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_9b94d4c0-6670-4450-a21b-1f677bb816c9" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0d5e8fe6-0f08-4a4b-9f75-b03988b315e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_43771b9f-cc78-484d-a1ea-4750f738b88f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0d5e8fe6-0f08-4a4b-9f75-b03988b315e6" xlink:to="loc_us-gaap_SegmentDomain_43771b9f-cc78-484d-a1ea-4750f738b88f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_d90950b4-7ed1-41eb-8255-eab6d97750a9" xlink:href="holx-20210626.xsd#holx_MedicalAestheticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_43771b9f-cc78-484d-a1ea-4750f738b88f" xlink:to="loc_holx_MedicalAestheticsMember_d90950b4-7ed1-41eb-8255-eab6d97750a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_dbc4ab08-c04a-4279-b682-81b27716fda4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_9b94d4c0-6670-4450-a21b-1f677bb816c9" xlink:to="loc_us-gaap_DebtInstrumentAxis_dbc4ab08-c04a-4279-b682-81b27716fda4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_00c853ae-04ae-48a2-90d1-a72e3deb6fae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_dbc4ab08-c04a-4279-b682-81b27716fda4" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_00c853ae-04ae-48a2-90d1-a72e3deb6fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember_ab8f05b3-c725-486b-a144-1f8cb19f695c" xlink:href="holx-20210626.xsd#holx_CreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_00c853ae-04ae-48a2-90d1-a72e3deb6fae" xlink:to="loc_holx_CreditAgreementMember_ab8f05b3-c725-486b-a144-1f8cb19f695c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_87a99cbb-60df-446a-b7d3-e56dad4d7e85" xlink:href="holx-20210626.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_00c853ae-04ae-48a2-90d1-a72e3deb6fae" xlink:to="loc_holx_A2028SeniorNotesMember_87a99cbb-60df-446a-b7d3-e56dad4d7e85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_0ce59da9-7a31-4133-ae59-e5f9b86944a4" xlink:href="holx-20210626.xsd#holx_A2029SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_00c853ae-04ae-48a2-90d1-a72e3deb6fae" xlink:to="loc_holx_A2029SeniorNotesMember_0ce59da9-7a31-4133-ae59-e5f9b86944a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_4fa566e1-a8d8-4694-8811-88fd96e896ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_9b94d4c0-6670-4450-a21b-1f677bb816c9" xlink:to="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_4fa566e1-a8d8-4694-8811-88fd96e896ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_c29ce980-36b1-4b31-ad6c-a8ce5e92fc1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_4fa566e1-a8d8-4694-8811-88fd96e896ed" xlink:to="loc_us-gaap_AssetImpairmentCharges_c29ce980-36b1-4b31-ad6c-a8ce5e92fc1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrincipalAmountOfBorrowings_a2693702-f4ae-4d14-ad04-0596bb7cceb6" xlink:href="holx-20210626.xsd#holx_PrincipalAmountOfBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_4fa566e1-a8d8-4694-8811-88fd96e896ed" xlink:to="loc_holx_PrincipalAmountOfBorrowings_a2693702-f4ae-4d14-ad04-0596bb7cceb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_8ec171cc-231a-4c23-99e4-8e79f2a605d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_4fa566e1-a8d8-4694-8811-88fd96e896ed" xlink:to="loc_us-gaap_DebtInstrumentFairValue_8ec171cc-231a-4c23-99e4-8e79f2a605d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#FairValueMeasurementsRollForwardDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5bd6e27e-acc3-4b0e-8a7a-764a8bf9df38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6ab46fa5-c009-4592-b64f-d7a8489a1554" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5bd6e27e-acc3-4b0e-8a7a-764a8bf9df38" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_6ab46fa5-c009-4592-b64f-d7a8489a1554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_b55ff518-a8e8-40be-8265-d7bb1d7e07fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5bd6e27e-acc3-4b0e-8a7a-764a8bf9df38" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_b55ff518-a8e8-40be-8265-d7bb1d7e07fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_f6b91009-c0d6-4374-98ca-7d2bcf0a7586" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5bd6e27e-acc3-4b0e-8a7a-764a8bf9df38" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_f6b91009-c0d6-4374-98ca-7d2bcf0a7586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_2ac1aad4-6fd1-4864-a960-113b83e52f76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5bd6e27e-acc3-4b0e-8a7a-764a8bf9df38" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_2ac1aad4-6fd1-4864-a960-113b83e52f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_08cf7179-fe5c-4f43-ac28-c40140808b4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5bd6e27e-acc3-4b0e-8a7a-764a8bf9df38" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_08cf7179-fe5c-4f43-ac28-c40140808b4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinations" xlink:type="simple" xlink:href="holx-20210626.xsd#BusinessCombinations"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_fc641eed-aec7-494c-a49b-12f18df52c82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_e0c2902d-1e22-4707-b199-333cd97f0efc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_fc641eed-aec7-494c-a49b-12f18df52c82" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_e0c2902d-1e22-4707-b199-333cd97f0efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsTables" xlink:type="simple" xlink:href="holx-20210626.xsd#BusinessCombinationsTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_d55d165c-478d-430f-b0f3-e4c08d9a029f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_ebbec4ec-149b-4e53-a71c-1c76fdde20cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_d55d165c-478d-430f-b0f3-e4c08d9a029f" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_ebbec4ec-149b-4e53-a71c-1c76fdde20cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationNarrativeDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#BusinessCombinationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_265c7ba1-3169-4ce3-b3d1-3b166f18ca19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c8ef2378-7379-4b48-999b-ec90851a7e46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_265c7ba1-3169-4ce3-b3d1-3b166f18ca19" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c8ef2378-7379-4b48-999b-ec90851a7e46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_99dc0aa8-644d-483e-badf-8ca1b95cb811" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c8ef2378-7379-4b48-999b-ec90851a7e46" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_99dc0aa8-644d-483e-badf-8ca1b95cb811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9640387e-b989-423c-b1e3-6ba03bb38bca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_99dc0aa8-644d-483e-badf-8ca1b95cb811" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9640387e-b989-423c-b1e3-6ba03bb38bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MobidiagOyMember_5cf4e84a-3dfb-4f30-b7ca-bdb742eec27e" xlink:href="holx-20210626.xsd#holx_MobidiagOyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9640387e-b989-423c-b1e3-6ba03bb38bca" xlink:to="loc_holx_MobidiagOyMember_5cf4e84a-3dfb-4f30-b7ca-bdb742eec27e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BiotheranosticsMember_fb4a3688-3e69-40af-a801-ae80b04f84e5" xlink:href="holx-20210626.xsd#holx_BiotheranosticsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9640387e-b989-423c-b1e3-6ba03bb38bca" xlink:to="loc_holx_BiotheranosticsMember_fb4a3688-3e69-40af-a801-ae80b04f84e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagenodeMember_488e70a0-d01e-42de-a3a8-bbf68bc04010" xlink:href="holx-20210626.xsd#holx_DiagenodeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9640387e-b989-423c-b1e3-6ba03bb38bca" xlink:to="loc_holx_DiagenodeMember_488e70a0-d01e-42de-a3a8-bbf68bc04010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SomatexMedicalTechnologiesMember_45f73345-6ecf-4605-aa15-f20e510764c9" xlink:href="holx-20210626.xsd#holx_SomatexMedicalTechnologiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9640387e-b989-423c-b1e3-6ba03bb38bca" xlink:to="loc_holx_SomatexMedicalTechnologiesMember_45f73345-6ecf-4605-aa15-f20e510764c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NXCImagingMember_6bbf93d9-4268-4871-856e-e5d2df57b566" xlink:href="holx-20210626.xsd#holx_NXCImagingMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9640387e-b989-423c-b1e3-6ba03bb38bca" xlink:to="loc_holx_NXCImagingMember_6bbf93d9-4268-4871-856e-e5d2df57b566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_fa91b2a2-560f-41e4-8040-61c235ccbbc9" xlink:href="holx-20210626.xsd#holx_AcessaHealthMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9640387e-b989-423c-b1e3-6ba03bb38bca" xlink:to="loc_holx_AcessaHealthMember_fa91b2a2-560f-41e4-8040-61c235ccbbc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_HealthBeaconsMember_b3db07aa-d489-4333-ae6b-7f68d22d80a5" xlink:href="holx-20210626.xsd#holx_HealthBeaconsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9640387e-b989-423c-b1e3-6ba03bb38bca" xlink:to="loc_holx_HealthBeaconsMember_b3db07aa-d489-4333-ae6b-7f68d22d80a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AlphaImagingMember_64a97ffa-8e98-4ad7-849b-9fc63bb8efcb" xlink:href="holx-20210626.xsd#holx_AlphaImagingMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9640387e-b989-423c-b1e3-6ba03bb38bca" xlink:to="loc_holx_AlphaImagingMember_64a97ffa-8e98-4ad7-849b-9fc63bb8efcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SuperSonicImagineMember_0182b56f-9bd8-4428-bc81-88dac3a6cc9c" xlink:href="holx-20210626.xsd#holx_SuperSonicImagineMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9640387e-b989-423c-b1e3-6ba03bb38bca" xlink:to="loc_holx_SuperSonicImagineMember_0182b56f-9bd8-4428-bc81-88dac3a6cc9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_4243d672-8cff-42a3-bc42-a0764d43f62b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c8ef2378-7379-4b48-999b-ec90851a7e46" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_4243d672-8cff-42a3-bc42-a0764d43f62b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_a1a2b277-7b27-4699-b18d-b86abc5f65bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_4243d672-8cff-42a3-bc42-a0764d43f62b" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_a1a2b277-7b27-4699-b18d-b86abc5f65bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ContingentHoldbackMember_0075b26a-ccb7-415f-bcb0-1f82544519ad" xlink:href="holx-20210626.xsd#holx_ContingentHoldbackMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_a1a2b277-7b27-4699-b18d-b86abc5f65bc" xlink:to="loc_holx_ContingentHoldbackMember_0075b26a-ccb7-415f-bcb0-1f82544519ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_56b8f4a5-7a97-4d9e-9841-66323041aae1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c8ef2378-7379-4b48-999b-ec90851a7e46" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_56b8f4a5-7a97-4d9e-9841-66323041aae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_83d0a54e-dd05-47a1-a32e-14be35a14f13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_56b8f4a5-7a97-4d9e-9841-66323041aae1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_83d0a54e-dd05-47a1-a32e-14be35a14f13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_a0bd42d3-250a-41d2-a158-248b779119e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_83d0a54e-dd05-47a1-a32e-14be35a14f13" xlink:to="loc_us-gaap_CustomerRelationshipsMember_a0bd42d3-250a-41d2-a158-248b779119e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_9e230ce6-b811-405f-be74-d12205730428" xlink:href="holx-20210626.xsd#holx_DevelopedTechnologyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_83d0a54e-dd05-47a1-a32e-14be35a14f13" xlink:to="loc_holx_DevelopedTechnologyMember_9e230ce6-b811-405f-be74-d12205730428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_15913130-0f1a-4b35-aae3-0c7f7514f1b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_83d0a54e-dd05-47a1-a32e-14be35a14f13" xlink:to="loc_us-gaap_TradeNamesMember_15913130-0f1a-4b35-aae3-0c7f7514f1b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d7865881-c9d5-4505-ab74-fbb6618b2d3f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c8ef2378-7379-4b48-999b-ec90851a7e46" xlink:to="loc_srt_RangeAxis_d7865881-c9d5-4505-ab74-fbb6618b2d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f0085273-afe2-46bf-9890-b4b8df103355" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d7865881-c9d5-4505-ab74-fbb6618b2d3f" xlink:to="loc_srt_RangeMember_f0085273-afe2-46bf-9890-b4b8df103355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2358ce64-ca50-45c4-8902-17f7a5d00d1b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f0085273-afe2-46bf-9890-b4b8df103355" xlink:to="loc_srt_MinimumMember_2358ce64-ca50-45c4-8902-17f7a5d00d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9a9f6908-89ed-41a5-a4d9-412bf1c76131" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f0085273-afe2-46bf-9890-b4b8df103355" xlink:to="loc_srt_MaximumMember_9a9f6908-89ed-41a5-a4d9-412bf1c76131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c8ef2378-7379-4b48-999b-ec90851a7e46" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_aaa4c39d-4c0d-4dee-82ac-e92c7594b828" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_aaa4c39d-4c0d-4dee-82ac-e92c7594b828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_016c1cf6-c887-44e2-9690-c6230fa98d19" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_016c1cf6-c887-44e2-9690-c6230fa98d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess_ad1bc0a2-1d3f-4e15-a0d1-d851a17d79f0" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess_ad1bc0a2-1d3f-4e15-a0d1-d851a17d79f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ResearchAndDevelopmentInProcessNumberOfProjects_f04ae630-81ef-414b-851a-1d7b7dce2324" xlink:href="holx-20210626.xsd#holx_ResearchAndDevelopmentInProcessNumberOfProjects"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_ResearchAndDevelopmentInProcessNumberOfProjects_f04ae630-81ef-414b-851a-1d7b7dce2324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ResearchAndDevelopmentInProcessCompletionPeriod_e285ffca-7229-4619-9021-62c92b3f893a" xlink:href="holx-20210626.xsd#holx_ResearchAndDevelopmentInProcessCompletionPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_ResearchAndDevelopmentInProcessCompletionPeriod_e285ffca-7229-4619-9021-62c92b3f893a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_3b94870a-6dcc-460c-8f5c-322ea4d4f258" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_3b94870a-6dcc-460c-8f5c-322ea4d4f258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_e2ce522e-8ed6-4e4b-a8e2-7f59d29d71a5" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_e2ce522e-8ed6-4e4b-a8e2-7f59d29d71a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_f234ffe6-5598-4975-b884-4393130aa098" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_f234ffe6-5598-4975-b884-4393130aa098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_521fd77d-2b4f-4d5a-8729-c20587f1634f" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_521fd77d-2b4f-4d5a-8729-c20587f1634f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_454eda22-0d7a-434d-a06a-1433ef8f6c08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_454eda22-0d7a-434d-a06a-1433ef8f6c08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_66514d8e-3424-472e-bf11-dd675a2a1bb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_66514d8e-3424-472e-bf11-dd675a2a1bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AnnualIncrementalRevenueGrowthPeriod_1c30a933-3fbf-44f7-bdb6-0368924d2015" xlink:href="holx-20210626.xsd#holx_AnnualIncrementalRevenueGrowthPeriod"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_AnnualIncrementalRevenueGrowthPeriod_1c30a933-3fbf-44f7-bdb6-0368924d2015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_e7edebd5-2c7d-4ae4-8d1c-62ec7f1b8d6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_e7edebd5-2c7d-4ae4-8d1c-62ec7f1b8d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Holdback_aa6abb3d-8817-4333-8bef-ca9a2f27a8ec" xlink:href="holx-20210626.xsd#holx_Holdback"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_Holdback_aa6abb3d-8817-4333-8bef-ca9a2f27a8ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_95e6b473-f49f-4471-9ccb-97aa6bc07063" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_95e6b473-f49f-4471-9ccb-97aa6bc07063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_43bca03a-45d3-406d-8861-2687bb52c330" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_us-gaap_Goodwill_43bca03a-45d3-406d-8861-2687bb52c330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_4b991acb-9ac3-41be-9820-f418f62f0933" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_4b991acb-9ac3-41be-9820-f418f62f0933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_404230a4-dd84-432a-a24f-d12e613ae73b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_404230a4-dd84-432a-a24f-d12e613ae73b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessAcquisitionCashTenderOfferPricePerShare_0768b85a-949b-47a5-ad0a-0b13695dce80" xlink:href="holx-20210626.xsd#holx_BusinessAcquisitionCashTenderOfferPricePerShare"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_BusinessAcquisitionCashTenderOfferPricePerShare_0768b85a-949b-47a5-ad0a-0b13695dce80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationOwnershipPercentage_32d35a2c-d0aa-478c-adde-9b49d87fed7d" xlink:href="holx-20210626.xsd#holx_BusinessCombinationOwnershipPercentage"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_BusinessCombinationOwnershipPercentage_32d35a2c-d0aa-478c-adde-9b49d87fed7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_cbb839bd-6df0-4322-96a7-1fc52c07b9bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_cbb839bd-6df0-4322-96a7-1fc52c07b9bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_bd382f31-ffd9-4d5c-9c48-de76b18de6c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_bd382f31-ffd9-4d5c-9c48-de76b18de6c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_18938555-65b7-45c6-8282-3ce4bf8d1cfa" xlink:href="holx-20210626.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_18938555-65b7-45c6-8282-3ce4bf8d1cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_fb73de15-11e6-44f8-9de9-af2ad2f4520c" xlink:href="holx-20210626.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_fb73de15-11e6-44f8-9de9-af2ad2f4520c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_4368fcd7-5428-4fc3-9445-59e7823bfce5" xlink:href="holx-20210626.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_4368fcd7-5428-4fc3-9445-59e7823bfce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_41bb7c14-b356-4ef4-b624-5e30081b1521" xlink:href="holx-20210626.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_41bb7c14-b356-4ef4-b624-5e30081b1521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationAdditionalSharesAcquiredShares_e877ac87-fd5c-4add-ba11-f15682513983" xlink:href="holx-20210626.xsd#holx_BusinessCombinationAdditionalSharesAcquiredShares"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_BusinessCombinationAdditionalSharesAcquiredShares_e877ac87-fd5c-4add-ba11-f15682513983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationAdditionalSharesAcquiredValue_1ccffdfc-8f4d-4677-8aff-0e80ab3b13f0" xlink:href="holx-20210626.xsd#holx_BusinessCombinationAdditionalSharesAcquiredValue"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_BusinessCombinationAdditionalSharesAcquiredValue_1ccffdfc-8f4d-4677-8aff-0e80ab3b13f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FairValueAssumptionDiscountRate_c85fbd8e-8ac8-4ea8-aae1-358bd2a3c9be" xlink:href="holx-20210626.xsd#holx_FairValueAssumptionDiscountRate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_1bc24cb5-db70-474e-a96f-03c7802151e6" xlink:to="loc_holx_FairValueAssumptionDiscountRate_c85fbd8e-8ac8-4ea8-aae1-358bd2a3c9be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_c7a91ec8-1dd6-4d4e-92eb-4b87455e5719" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e2518124-fa0b-40c2-aeb8-6c3f5f431584" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_c7a91ec8-1dd6-4d4e-92eb-4b87455e5719" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e2518124-fa0b-40c2-aeb8-6c3f5f431584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d3a12313-dc3b-4cb6-8260-11acee4e0437" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e2518124-fa0b-40c2-aeb8-6c3f5f431584" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d3a12313-dc3b-4cb6-8260-11acee4e0437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98323aad-fadd-40d9-82a7-c6bedd3c0cff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d3a12313-dc3b-4cb6-8260-11acee4e0437" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98323aad-fadd-40d9-82a7-c6bedd3c0cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MobidiagOyMember_63aebd2e-1bb6-4783-9e2e-fcb62f5fe1ee" xlink:href="holx-20210626.xsd#holx_MobidiagOyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98323aad-fadd-40d9-82a7-c6bedd3c0cff" xlink:to="loc_holx_MobidiagOyMember_63aebd2e-1bb6-4783-9e2e-fcb62f5fe1ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BiotheranosticsMember_c5d61b5c-7cfc-4f8f-a7f2-93c81c29fb45" xlink:href="holx-20210626.xsd#holx_BiotheranosticsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98323aad-fadd-40d9-82a7-c6bedd3c0cff" xlink:to="loc_holx_BiotheranosticsMember_c5d61b5c-7cfc-4f8f-a7f2-93c81c29fb45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagenodeMember_e77edcc6-aed9-4abb-b69e-a8962eabe805" xlink:href="holx-20210626.xsd#holx_DiagenodeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98323aad-fadd-40d9-82a7-c6bedd3c0cff" xlink:to="loc_holx_DiagenodeMember_e77edcc6-aed9-4abb-b69e-a8962eabe805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SuperSonicImagineMember_219e468b-1261-455f-ab37-71f60f898601" xlink:href="holx-20210626.xsd#holx_SuperSonicImagineMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98323aad-fadd-40d9-82a7-c6bedd3c0cff" xlink:to="loc_holx_SuperSonicImagineMember_219e468b-1261-455f-ab37-71f60f898601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_208ddf43-560e-43bd-b219-c7de7655fb2b" xlink:href="holx-20210626.xsd#holx_AcessaHealthMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98323aad-fadd-40d9-82a7-c6bedd3c0cff" xlink:to="loc_holx_AcessaHealthMember_208ddf43-560e-43bd-b219-c7de7655fb2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e2518124-fa0b-40c2-aeb8-6c3f5f431584" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_03aa3b9e-5766-44d7-880c-8419e784c7ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_03aa3b9e-5766-44d7-880c-8419e784c7ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_3c55cb53-8207-4653-9738-cfbd39ee253d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_3c55cb53-8207-4653-9738-cfbd39ee253d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_70e159f5-f027-4116-ac25-cd7c9ec37926" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_70e159f5-f027-4116-ac25-cd7c9ec37926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c46fc1a1-90c2-4396-ac21-ab28eb0706c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_c46fc1a1-90c2-4396-ac21-ab28eb0706c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_59cb32e3-8fc6-4feb-891c-1e31ee2f9cb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_59cb32e3-8fc6-4feb-891c-1e31ee2f9cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_08a57502-6663-4617-a66a-44021c074d8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_08a57502-6663-4617-a66a-44021c074d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_ff0c378f-c3d8-496f-8dbe-7ae5d06b7200" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_ff0c378f-c3d8-496f-8dbe-7ae5d06b7200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_0903a5d4-8934-4fda-8921-93e580b7a774" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_0903a5d4-8934-4fda-8921-93e580b7a774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_a010591e-2946-4f2b-bb17-2234e4744580" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_a010591e-2946-4f2b-bb17-2234e4744580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_c347705f-6f8a-4fb8-b121-5658684ccca2" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_c347705f-6f8a-4fb8-b121-5658684ccca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess_1d27b018-33c9-491a-bc3e-1cb7bbcf51b5" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess_1d27b018-33c9-491a-bc3e-1cb7bbcf51b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_26ffcd45-8b9b-42e1-9d9b-cd4c919ed95f" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_26ffcd45-8b9b-42e1-9d9b-cd4c919ed95f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_568b06fd-0026-4723-833c-186f5a47e221" xlink:href="holx-20210626.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_568b06fd-0026-4723-833c-186f5a47e221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_7eecd64e-a686-40a0-a68a-0e3d89956bd2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_7eecd64e-a686-40a0-a68a-0e3d89956bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0c405d7f-e1dc-4111-b4e5-43fb4df668d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0c405d7f-e1dc-4111-b4e5-43fb4df668d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_89df20fa-7988-4209-b168-1fe99fc1ae0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_us-gaap_Goodwill_89df20fa-7988-4209-b168-1fe99fc1ae0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d80cfdbd-af9d-4230-91a0-b7a71d5b2716" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ab779e0c-f879-44fd-bd82-8c39cb6db10a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d80cfdbd-af9d-4230-91a0-b7a71d5b2716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses" xlink:type="simple" xlink:href="holx-20210626.xsd#TradeReceivablesandAllowanceforCreditLosses"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_88a8b424-ec80-45fc-9e44-0217d5da680e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_7994c93c-024d-4a7e-8e6e-a25882abba7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_88a8b424-ec80-45fc-9e44-0217d5da680e" xlink:to="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_7994c93c-024d-4a7e-8e6e-a25882abba7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables" xlink:type="simple" xlink:href="holx-20210626.xsd#TradeReceivablesandAllowanceforCreditLossesTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_38c18e52-47c4-4bac-bacb-3558cfdc1be3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_0655491f-4855-4244-923f-da037e3d2f9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_38c18e52-47c4-4bac-bacb-3558cfdc1be3" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_0655491f-4855-4244-923f-da037e3d2f9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#TradeReceivablesandAllowanceforCreditLossesDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_523ed699-48d2-4464-8c64-12b86b2d37e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_22b584e6-582a-4a64-bcde-09a2f945d3f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_523ed699-48d2-4464-8c64-12b86b2d37e3" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_22b584e6-582a-4a64-bcde-09a2f945d3f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_12463a92-f541-4db9-8a73-a827817adb61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_22b584e6-582a-4a64-bcde-09a2f945d3f0" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_12463a92-f541-4db9-8a73-a827817adb61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_ab6c782a-1b57-43d6-8a14-96eadcd13af0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_22b584e6-582a-4a64-bcde-09a2f945d3f0" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_ab6c782a-1b57-43d6-8a14-96eadcd13af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableAllowanceForCreditLossTransfers_e0a77bc5-a8dc-4701-8ced-f27bdf4f4b91" xlink:href="holx-20210626.xsd#holx_AccountsReceivableAllowanceForCreditLossTransfers"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_22b584e6-582a-4a64-bcde-09a2f945d3f0" xlink:to="loc_holx_AccountsReceivableAllowanceForCreditLossTransfers_e0a77bc5-a8dc-4701-8ced-f27bdf4f4b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_6fa2c5c2-8f64-4800-a74f-13ed1414bb1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_22b584e6-582a-4a64-bcde-09a2f945d3f0" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_6fa2c5c2-8f64-4800-a74f-13ed1414bb1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_88cb26e4-9800-4cbc-abd6-bd988af7d31f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_22b584e6-582a-4a64-bcde-09a2f945d3f0" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_88cb26e4-9800-4cbc-abd6-bd988af7d31f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/Disposition" xlink:type="simple" xlink:href="holx-20210626.xsd#Disposition"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/Disposition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_2c9f3296-6290-40e9-8d56-4d4c55c16e75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_731ae48a-c6af-46a5-8ce8-77a4b20a3fc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_2c9f3296-6290-40e9-8d56-4d4c55c16e75" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_731ae48a-c6af-46a5-8ce8-77a4b20a3fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DispositionDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#DispositionDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DispositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_259b4145-eef3-4601-b111-96349fc9d5e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AssetsofBusinessHeldforSaleAbstract_93cb2073-dded-4ca6-8b96-fd99dad2a219" xlink:href="holx-20210626.xsd#holx_AssetsofBusinessHeldforSaleAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_259b4145-eef3-4601-b111-96349fc9d5e5" xlink:to="loc_holx_AssetsofBusinessHeldforSaleAbstract_93cb2073-dded-4ca6-8b96-fd99dad2a219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_02f174bc-7494-4f08-80a6-1e61ec6dcffd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_AssetsofBusinessHeldforSaleAbstract_93cb2073-dded-4ca6-8b96-fd99dad2a219" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_02f174bc-7494-4f08-80a6-1e61ec6dcffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_05ed65e4-087f-45d1-b023-3fa305a68b65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_02f174bc-7494-4f08-80a6-1e61ec6dcffd" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_05ed65e4-087f-45d1-b023-3fa305a68b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5115ed43-2373-48d4-9e95-5e7c385dc0cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_05ed65e4-087f-45d1-b023-3fa305a68b65" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5115ed43-2373-48d4-9e95-5e7c385dc0cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_57d255ce-379f-49fc-ac53-72929025d463" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5115ed43-2373-48d4-9e95-5e7c385dc0cb" xlink:to="loc_us-gaap_CostOfSalesMember_57d255ce-379f-49fc-ac53-72929025d463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenseMember_9439c94b-82c5-419d-982a-74adad608449" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5115ed43-2373-48d4-9e95-5e7c385dc0cb" xlink:to="loc_us-gaap_OperatingExpenseMember_9439c94b-82c5-419d-982a-74adad608449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_40754a4c-2e78-44b7-ab9f-60e70beaf8c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_02f174bc-7494-4f08-80a6-1e61ec6dcffd" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_40754a4c-2e78-44b7-ab9f-60e70beaf8c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_d856b36c-ca63-4cb6-bb1e-394035a2f58d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_40754a4c-2e78-44b7-ab9f-60e70beaf8c8" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_d856b36c-ca63-4cb6-bb1e-394035a2f58d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_24f34915-ce46-4f64-b16a-915fb9a659c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_d856b36c-ca63-4cb6-bb1e-394035a2f58d" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_24f34915-ce46-4f64-b16a-915fb9a659c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_71dc922f-89ba-40c1-8c27-ff62a646cb43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_02f174bc-7494-4f08-80a6-1e61ec6dcffd" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_71dc922f-89ba-40c1-8c27-ff62a646cb43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_07225120-a6d1-46c1-b283-cc7f2056d9f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_71dc922f-89ba-40c1-8c27-ff62a646cb43" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_07225120-a6d1-46c1-b283-cc7f2056d9f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_b46eebe4-5a49-42cd-97e7-3af6e75f381a" xlink:href="holx-20210626.xsd#holx_MedicalAestheticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_07225120-a6d1-46c1-b283-cc7f2056d9f6" xlink:to="loc_holx_MedicalAestheticsMember_b46eebe4-5a49-42cd-97e7-3af6e75f381a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7f8dea2a-8a95-4c2c-a325-6e911cdf4814" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_02f174bc-7494-4f08-80a6-1e61ec6dcffd" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7f8dea2a-8a95-4c2c-a325-6e911cdf4814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_58b5e890-703f-404c-97c2-f65b80d1cd96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7f8dea2a-8a95-4c2c-a325-6e911cdf4814" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_58b5e890-703f-404c-97c2-f65b80d1cd96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_0da91749-3191-4845-88df-3774577614be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7f8dea2a-8a95-4c2c-a325-6e911cdf4814" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_0da91749-3191-4845-88df-3774577614be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IndemnificationLiability_44d8aee7-f602-4505-b00a-fd1621268c80" xlink:href="holx-20210626.xsd#holx_IndemnificationLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7f8dea2a-8a95-4c2c-a325-6e911cdf4814" xlink:to="loc_holx_IndemnificationLiability_44d8aee7-f602-4505-b00a-fd1621268c80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_db447216-cd0f-495d-9428-7220e36b7adb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7f8dea2a-8a95-4c2c-a325-6e911cdf4814" xlink:to="loc_us-gaap_AssetImpairmentCharges_db447216-cd0f-495d-9428-7220e36b7adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_4c78aec8-7d3a-4128-a563-c142cabb45cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7f8dea2a-8a95-4c2c-a325-6e911cdf4814" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_4c78aec8-7d3a-4128-a563-c142cabb45cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup_706b7cf6-8743-4cca-a185-755e1278ffc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_7f8dea2a-8a95-4c2c-a325-6e911cdf4814" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup_706b7cf6-8743-4cca-a185-755e1278ffc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangements" xlink:type="simple" xlink:href="holx-20210626.xsd#BorrowingsandCreditArrangements"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_1c5d5afa-ea7b-43eb-a992-ee4cc6c14e55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_1aff10f5-ee3f-411d-b9d3-eedd277e59a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_1c5d5afa-ea7b-43eb-a992-ee4cc6c14e55" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_1aff10f5-ee3f-411d-b9d3-eedd277e59a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsTables" xlink:type="simple" xlink:href="holx-20210626.xsd#BorrowingsandCreditArrangementsTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_cfb0962c-4e79-45df-8f3e-96085501edf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_67eb8fbe-e58a-4666-affe-71dcef539fdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cfb0962c-4e79-45df-8f3e-96085501edf5" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_67eb8fbe-e58a-4666-affe-71dcef539fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_18b6367c-c9b5-4f31-8fc2-052f904633b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cfb0962c-4e79-45df-8f3e-96085501edf5" xlink:to="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_18b6367c-c9b5-4f31-8fc2-052f904633b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_1ec729f4-64a3-4eeb-8633-f482d0cd8668" xlink:href="holx-20210626.xsd#holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_cfb0962c-4e79-45df-8f3e-96085501edf5" xlink:to="loc_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_1ec729f4-64a3-4eeb-8633-f482d0cd8668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#BorrowingsandCreditArrangementsCompanysBorrowingsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_209b65ab-4460-47ce-b1d1-a7aae9325b88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_1d2cb7cb-e9c5-4e77-9f96-6aa4fd0fef82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_209b65ab-4460-47ce-b1d1-a7aae9325b88" xlink:to="loc_us-gaap_DebtInstrumentTable_1d2cb7cb-e9c5-4e77-9f96-6aa4fd0fef82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_984002a8-a312-4ca3-86fd-35d5403c7fbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1d2cb7cb-e9c5-4e77-9f96-6aa4fd0fef82" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_984002a8-a312-4ca3-86fd-35d5403c7fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_1701b899-d708-4c8c-afd2-0477857b2c84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_984002a8-a312-4ca3-86fd-35d5403c7fbf" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_1701b899-d708-4c8c-afd2-0477857b2c84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember_3c079caa-e9f3-427e-8daf-397b722404ed" xlink:href="holx-20210626.xsd#holx_TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1701b899-d708-4c8c-afd2-0477857b2c84" xlink:to="loc_holx_TermLoanMember_3c079caa-e9f3-427e-8daf-397b722404ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevolverMember_be774fa9-4a24-4e22-88ea-2e01ded298e6" xlink:href="holx-20210626.xsd#holx_RevolverMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1701b899-d708-4c8c-afd2-0477857b2c84" xlink:to="loc_holx_RevolverMember_be774fa9-4a24-4e22-88ea-2e01ded298e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_a0518c08-3249-449c-8c44-a71c0d86350d" xlink:href="holx-20210626.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1701b899-d708-4c8c-afd2-0477857b2c84" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_a0518c08-3249-449c-8c44-a71c0d86350d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_ea191a31-c811-4ee3-9321-eef9f0042c3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1701b899-d708-4c8c-afd2-0477857b2c84" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_ea191a31-c811-4ee3-9321-eef9f0042c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_9e120d5d-187d-4d21-ad31-26be11601e73" xlink:href="holx-20210626.xsd#holx_A2025SeniorNotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1701b899-d708-4c8c-afd2-0477857b2c84" xlink:to="loc_holx_A2025SeniorNotesMember_9e120d5d-187d-4d21-ad31-26be11601e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_75e05d48-47e6-4a1d-9b36-03028e5d2c07" xlink:href="holx-20210626.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1701b899-d708-4c8c-afd2-0477857b2c84" xlink:to="loc_holx_A2028SeniorNotesMember_75e05d48-47e6-4a1d-9b36-03028e5d2c07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_52a12c2b-bc47-4f3b-8740-4cab8eb11102" xlink:href="holx-20210626.xsd#holx_A2029SeniorNotesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_1701b899-d708-4c8c-afd2-0477857b2c84" xlink:to="loc_holx_A2029SeniorNotesMember_52a12c2b-bc47-4f3b-8740-4cab8eb11102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_69edbeff-b84a-491a-93ed-5d8fe7ca1d4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_1d2cb7cb-e9c5-4e77-9f96-6aa4fd0fef82" xlink:to="loc_us-gaap_DebtInstrumentLineItems_69edbeff-b84a-491a-93ed-5d8fe7ca1d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_218913c2-060c-4405-928a-dbb8b2f26453" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_69edbeff-b84a-491a-93ed-5d8fe7ca1d4f" xlink:to="loc_us-gaap_LongTermDebtCurrent_218913c2-060c-4405-928a-dbb8b2f26453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_4904b4aa-461b-4177-b73d-f3b863112c8e" xlink:href="holx-20210626.xsd#holx_LongTermDebtObligationsWithoutConvertibleNotes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_69edbeff-b84a-491a-93ed-5d8fe7ca1d4f" xlink:to="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_4904b4aa-461b-4177-b73d-f3b863112c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_1f4f00e6-2060-48e3-82af-5d41ed33591d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_69edbeff-b84a-491a-93ed-5d8fe7ca1d4f" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_1f4f00e6-2060-48e3-82af-5d41ed33591d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_cccc207f-3bb7-4bf9-a87a-380bb2b989be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_69edbeff-b84a-491a-93ed-5d8fe7ca1d4f" xlink:to="loc_us-gaap_LongTermDebt_cccc207f-3bb7-4bf9-a87a-380bb2b989be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#BorrowingsandCreditArrangementsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_39ea0fe1-86cc-4ffc-92b7-c7e7957bf428" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_c6e55fcf-e03c-4d03-8b62-861c16d215d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_39ea0fe1-86cc-4ffc-92b7-c7e7957bf428" xlink:to="loc_us-gaap_DebtInstrumentTable_c6e55fcf-e03c-4d03-8b62-861c16d215d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7923bade-0584-4d0a-9bec-2467568e9da3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c6e55fcf-e03c-4d03-8b62-861c16d215d9" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7923bade-0584-4d0a-9bec-2467568e9da3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_04f8ec9c-b8bb-4683-85f2-99d61aed96ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7923bade-0584-4d0a-9bec-2467568e9da3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_04f8ec9c-b8bb-4683-85f2-99d61aed96ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevolverMember_d661ba7d-5775-4033-9cfe-0888ffaee481" xlink:href="holx-20210626.xsd#holx_RevolverMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_04f8ec9c-b8bb-4683-85f2-99d61aed96ae" xlink:to="loc_holx_RevolverMember_d661ba7d-5775-4033-9cfe-0888ffaee481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmendedTermLoanMember_6719ece2-3257-43ac-ad89-6a86383a147c" xlink:href="holx-20210626.xsd#holx_AmendedTermLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_04f8ec9c-b8bb-4683-85f2-99d61aed96ae" xlink:to="loc_holx_AmendedTermLoanMember_6719ece2-3257-43ac-ad89-6a86383a147c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_00203cef-3224-479d-af24-a45ddc6316a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_04f8ec9c-b8bb-4683-85f2-99d61aed96ae" xlink:to="loc_us-gaap_SeniorNotesMember_00203cef-3224-479d-af24-a45ddc6316a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_8573c58e-e6c0-4a01-b9b1-200f1c81e4d5" xlink:href="holx-20210626.xsd#holx_A2025SeniorNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_04f8ec9c-b8bb-4683-85f2-99d61aed96ae" xlink:to="loc_holx_A2025SeniorNotesMember_8573c58e-e6c0-4a01-b9b1-200f1c81e4d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_72c27ed6-fae5-4bf7-887d-3c8c8614afc1" xlink:href="holx-20210626.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_04f8ec9c-b8bb-4683-85f2-99d61aed96ae" xlink:to="loc_holx_A2028SeniorNotesMember_72c27ed6-fae5-4bf7-887d-3c8c8614afc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_c59394d6-fc68-46b9-8332-c96fb2ed44ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_04f8ec9c-b8bb-4683-85f2-99d61aed96ae" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_c59394d6-fc68-46b9-8332-c96fb2ed44ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember_ba094eb2-6978-475f-ae4c-8348883aa72c" xlink:href="holx-20210626.xsd#holx_TermLoanMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_04f8ec9c-b8bb-4683-85f2-99d61aed96ae" xlink:to="loc_holx_TermLoanMember_ba094eb2-6978-475f-ae4c-8348883aa72c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_d902eaa9-269c-4a67-8788-71515eb2c079" xlink:href="holx-20210626.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_04f8ec9c-b8bb-4683-85f2-99d61aed96ae" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_d902eaa9-269c-4a67-8788-71515eb2c079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_bde4861c-6b7f-4610-8e15-ae64d9a1a3da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c6e55fcf-e03c-4d03-8b62-861c16d215d9" xlink:to="loc_us-gaap_DebtInstrumentAxis_bde4861c-6b7f-4610-8e15-ae64d9a1a3da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ddb20d3a-f5fa-468a-9ac5-53a86dbc1095" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_bde4861c-6b7f-4610-8e15-ae64d9a1a3da" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ddb20d3a-f5fa-468a-9ac5-53a86dbc1095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmendedTermLoanMember_b7c1f250-08a1-48d0-8c50-15204c4ff63a" xlink:href="holx-20210626.xsd#holx_AmendedTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ddb20d3a-f5fa-468a-9ac5-53a86dbc1095" xlink:to="loc_holx_AmendedTermLoanMember_b7c1f250-08a1-48d0-8c50-15204c4ff63a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember_693bf82c-4ef6-47ef-924f-f6b45195752e" xlink:href="holx-20210626.xsd#holx_CreditAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ddb20d3a-f5fa-468a-9ac5-53a86dbc1095" xlink:to="loc_holx_CreditAgreementMember_693bf82c-4ef6-47ef-924f-f6b45195752e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_938eab67-1c15-48a0-bee4-78442c4e188e" xlink:href="holx-20210626.xsd#holx_A2025SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ddb20d3a-f5fa-468a-9ac5-53a86dbc1095" xlink:to="loc_holx_A2025SeniorNotesMember_938eab67-1c15-48a0-bee4-78442c4e188e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_f82fb057-c749-4280-8aa2-0477933ebaf2" xlink:href="holx-20210626.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ddb20d3a-f5fa-468a-9ac5-53a86dbc1095" xlink:to="loc_holx_A2028SeniorNotesMember_f82fb057-c749-4280-8aa2-0477933ebaf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_f3861eca-20fc-4ece-8d76-d3af29f88994" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ddb20d3a-f5fa-468a-9ac5-53a86dbc1095" xlink:to="loc_us-gaap_SeniorNotesMember_f3861eca-20fc-4ece-8d76-d3af29f88994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_dbe895ef-e2be-4827-8d07-9f28f0fc4c4e" xlink:href="holx-20210626.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ddb20d3a-f5fa-468a-9ac5-53a86dbc1095" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_dbe895ef-e2be-4827-8d07-9f28f0fc4c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_b252be82-00ec-4de3-abf3-d8d5efe4235f" xlink:href="holx-20210626.xsd#holx_A2029SeniorNotesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ddb20d3a-f5fa-468a-9ac5-53a86dbc1095" xlink:to="loc_holx_A2029SeniorNotesMember_b252be82-00ec-4de3-abf3-d8d5efe4235f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevolverMember_9370a249-dfe7-43d1-b7e1-299e27813a07" xlink:href="holx-20210626.xsd#holx_RevolverMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ddb20d3a-f5fa-468a-9ac5-53a86dbc1095" xlink:to="loc_holx_RevolverMember_9370a249-dfe7-43d1-b7e1-299e27813a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_eb1856ee-b1cc-4a2d-b633-b223fbccfe38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c6e55fcf-e03c-4d03-8b62-861c16d215d9" xlink:to="loc_us-gaap_FinancialInstrumentAxis_eb1856ee-b1cc-4a2d-b633-b223fbccfe38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7b8e9d27-a8b4-4a57-89a4-507a16ce6e08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_eb1856ee-b1cc-4a2d-b633-b223fbccfe38" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7b8e9d27-a8b4-4a57-89a4-507a16ce6e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageAddedtoEurodollarRateMember_4da735c2-5d8c-47d1-b13d-8e0dd234ad5c" xlink:href="holx-20210626.xsd#holx_PercentageAddedtoEurodollarRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7b8e9d27-a8b4-4a57-89a4-507a16ce6e08" xlink:to="loc_holx_PercentageAddedtoEurodollarRateMember_4da735c2-5d8c-47d1-b13d-8e0dd234ad5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_574701e1-397b-4870-af46-16935c29e315" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c6e55fcf-e03c-4d03-8b62-861c16d215d9" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_574701e1-397b-4870-af46-16935c29e315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_fe098ed3-6f2f-415c-96c9-35e939a24476" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_574701e1-397b-4870-af46-16935c29e315" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_fe098ed3-6f2f-415c-96c9-35e939a24476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_70d07e99-98dc-43ae-b7a7-c3020bb8a96b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_fe098ed3-6f2f-415c-96c9-35e939a24476" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_70d07e99-98dc-43ae-b7a7-c3020bb8a96b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_b6b4caae-0e68-469c-b6f8-8661f690ea70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_fe098ed3-6f2f-415c-96c9-35e939a24476" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_b6b4caae-0e68-469c-b6f8-8661f690ea70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_784fb3b5-4f25-403f-a9fc-44c8ccbea7a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_fe098ed3-6f2f-415c-96c9-35e939a24476" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_784fb3b5-4f25-403f-a9fc-44c8ccbea7a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_09dafc4f-6688-4c2d-b580-09d3a53bfe79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_fe098ed3-6f2f-415c-96c9-35e939a24476" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_09dafc4f-6688-4c2d-b580-09d3a53bfe79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_7b164839-3d26-4aec-9ff2-62c39d511185" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodFiveMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_fe098ed3-6f2f-415c-96c9-35e939a24476" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_7b164839-3d26-4aec-9ff2-62c39d511185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cd8bf7b0-07df-400d-b1f0-39b900cf0632" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c6e55fcf-e03c-4d03-8b62-861c16d215d9" xlink:to="loc_srt_RangeAxis_cd8bf7b0-07df-400d-b1f0-39b900cf0632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_86cdda0d-679e-47ad-b5a3-41e27226bd12" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_cd8bf7b0-07df-400d-b1f0-39b900cf0632" xlink:to="loc_srt_RangeMember_86cdda0d-679e-47ad-b5a3-41e27226bd12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_822c49c8-679c-477b-9726-ae955800dfbf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_86cdda0d-679e-47ad-b5a3-41e27226bd12" xlink:to="loc_srt_MinimumMember_822c49c8-679c-477b-9726-ae955800dfbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_46aa5a47-d733-4fd0-acba-8bcc83bb14c4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_86cdda0d-679e-47ad-b5a3-41e27226bd12" xlink:to="loc_srt_MaximumMember_46aa5a47-d733-4fd0-acba-8bcc83bb14c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_36e9bc9b-faa4-4880-bef1-a747f05a9bb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c6e55fcf-e03c-4d03-8b62-861c16d215d9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_36e9bc9b-faa4-4880-bef1-a747f05a9bb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0ed584bc-791b-4b3f-b997-3d25f678b9ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_36e9bc9b-faa4-4880-bef1-a747f05a9bb7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0ed584bc-791b-4b3f-b997-3d25f678b9ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MobidiagOyMember_bf4fd532-d9ad-41c8-a861-9c78c75d1483" xlink:href="holx-20210626.xsd#holx_MobidiagOyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_0ed584bc-791b-4b3f-b997-3d25f678b9ab" xlink:to="loc_holx_MobidiagOyMember_bf4fd532-d9ad-41c8-a861-9c78c75d1483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_c6e55fcf-e03c-4d03-8b62-861c16d215d9" xlink:to="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_729c0af7-239d-4231-a662-ce3f8212c9c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_729c0af7-239d-4231-a662-ce3f8212c9c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_fc1fa81e-7fbe-4a32-8e5c-680616f8ea9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_us-gaap_LongTermDebt_fc1fa81e-7fbe-4a32-8e5c-680616f8ea9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_62276867-e9f8-4518-b6af-64bc7b7894e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_62276867-e9f8-4518-b6af-64bc7b7894e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_32d44ece-ddd8-4a31-9c65-142979de6a18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_32d44ece-ddd8-4a31-9c65-142979de6a18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_f807525f-6a34-434a-99a1-8813066acb54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_f807525f-6a34-434a-99a1-8813066acb54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_31c2c244-bc04-4047-8cc4-0e979146d3d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_us-gaap_LongTermDebtCurrent_31c2c244-bc04-4047-8cc4-0e979146d3d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_52ed67f0-0359-4d29-b39a-ebfc5ec38d92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_us-gaap_RepaymentsOfDebt_52ed67f0-0359-4d29-b39a-ebfc5ec38d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_51448a73-bdbf-4449-9507-5ce7e62238e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_51448a73-bdbf-4449-9507-5ce7e62238e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_2a984e8b-a80b-4e48-8443-911b53aa790a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotes"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_us-gaap_SeniorNotes_2a984e8b-a80b-4e48-8443-911b53aa790a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentOfferingPricePercentOfFaceValue_26f74cfb-496e-4d50-9b38-18cb7b9df468" xlink:href="holx-20210626.xsd#holx_DebtInstrumentOfferingPricePercentOfFaceValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_holx_DebtInstrumentOfferingPricePercentOfFaceValue_26f74cfb-496e-4d50-9b38-18cb7b9df468" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_f5c9eddf-c689-438a-86d4-4bfea3aaad44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_f5c9eddf-c689-438a-86d4-4bfea3aaad44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_0c6e4737-12b4-4f1e-b50a-9812b478da76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_us-gaap_InterestExpenseDebt_0c6e4737-12b4-4f1e-b50a-9812b478da76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_239892f9-5053-45c2-8832-5d206a83256f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_239892f9-5053-45c2-8832-5d206a83256f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_fc31eea6-3e7b-4d6e-a086-ac8367343a93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_fc31eea6-3e7b-4d6e-a086-ac8367343a93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e7a8f883-aa34-4852-9a2e-732826fe4c5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e7a8f883-aa34-4852-9a2e-732826fe4c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtRedemptionPremiumPaid_9a341902-4e5f-4248-8521-de38d907d833" xlink:href="holx-20210626.xsd#holx_DebtRedemptionPremiumPaid"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_holx_DebtRedemptionPremiumPaid_9a341902-4e5f-4248-8521-de38d907d833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_57e4f53e-96db-43bb-b03f-835ae2a36af6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_57e4f53e-96db-43bb-b03f-835ae2a36af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumBorrowingUnderAssetSecuritizationAgreement_f8e581a8-1a45-40ee-bc19-a55799554a69" xlink:href="holx-20210626.xsd#holx_MaximumBorrowingUnderAssetSecuritizationAgreement"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_holx_MaximumBorrowingUnderAssetSecuritizationAgreement_f8e581a8-1a45-40ee-bc19-a55799554a69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_e35af8b6-c1a6-4699-bd1b-006e1231563d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3bcb34b8-7450-4d44-9882-3e39f483e507" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_e35af8b6-c1a6-4699-bd1b-006e1231563d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_5fd66f88-6133-440f-b39d-3b0c5b417a37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_03cd8246-7797-4b48-9980-84a001134c64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5fd66f88-6133-440f-b39d-3b0c5b417a37" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_03cd8246-7797-4b48-9980-84a001134c64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_df41ac5b-c3fb-4337-aa18-67ca2531092a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_03cd8246-7797-4b48-9980-84a001134c64" xlink:to="loc_us-gaap_DebtInstrumentAxis_df41ac5b-c3fb-4337-aa18-67ca2531092a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e3b08bcb-5964-4e34-a317-48ac30f174e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_df41ac5b-c3fb-4337-aa18-67ca2531092a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e3b08bcb-5964-4e34-a317-48ac30f174e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember_afc45884-2983-4171-8e1d-4a5d0f4144d2" xlink:href="holx-20210626.xsd#holx_CreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_e3b08bcb-5964-4e34-a317-48ac30f174e8" xlink:to="loc_holx_CreditAgreementMember_afc45884-2983-4171-8e1d-4a5d0f4144d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_9bdac77e-c8d0-4c6d-9d17-644395c335b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_03cd8246-7797-4b48-9980-84a001134c64" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_9bdac77e-c8d0-4c6d-9d17-644395c335b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_743e000d-b3da-4917-871d-9643f2b29b00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9bdac77e-c8d0-4c6d-9d17-644395c335b1" xlink:to="loc_us-gaap_InterestExpenseBorrowings_743e000d-b3da-4917-871d-9643f2b29b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_123e70e4-65c0-4759-b216-d7c15fa28bab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9bdac77e-c8d0-4c6d-9d17-644395c335b1" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_123e70e4-65c0-4759-b216-d7c15fa28bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_9ca7b1f0-040d-459d-8f67-c0c34e3fd86d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9bdac77e-c8d0-4c6d-9d17-644395c335b1" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_9ca7b1f0-040d-459d-8f67-c0c34e3fd86d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2e68a625-eede-4a45-9c35-6a2a60f0b4eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_bd32cf71-0eb1-4b60-85d1-b1a340a39075" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2e68a625-eede-4a45-9c35-6a2a60f0b4eb" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_bd32cf71-0eb1-4b60-85d1-b1a340a39075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_41d0da95-45cb-4688-822d-d909c68d5057" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_bd32cf71-0eb1-4b60-85d1-b1a340a39075" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_41d0da95-45cb-4688-822d-d909c68d5057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5ab16e9c-292b-4daa-b816-98967f0d9726" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_41d0da95-45cb-4688-822d-d909c68d5057" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5ab16e9c-292b-4daa-b816-98967f0d9726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_2d959bd4-2a09-4ff6-a0dd-9893fa6ce695" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_5ab16e9c-292b-4daa-b816-98967f0d9726" xlink:to="loc_us-gaap_SeniorNotesMember_2d959bd4-2a09-4ff6-a0dd-9893fa6ce695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_67647cd7-d1b7-4ad1-8f51-dec019dc0fec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_bd32cf71-0eb1-4b60-85d1-b1a340a39075" xlink:to="loc_us-gaap_DebtInstrumentAxis_67647cd7-d1b7-4ad1-8f51-dec019dc0fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b84011df-ba38-454c-91a2-0e3f9448dc41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_67647cd7-d1b7-4ad1-8f51-dec019dc0fec" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b84011df-ba38-454c-91a2-0e3f9448dc41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_ce3d6cab-6008-4732-9b32-2a724e97d78d" xlink:href="holx-20210626.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b84011df-ba38-454c-91a2-0e3f9448dc41" xlink:to="loc_holx_A2028SeniorNotesMember_ce3d6cab-6008-4732-9b32-2a724e97d78d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_541e8ec0-4874-47fa-b755-7461c765b155" xlink:href="holx-20210626.xsd#holx_A2025SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b84011df-ba38-454c-91a2-0e3f9448dc41" xlink:to="loc_holx_A2025SeniorNotesMember_541e8ec0-4874-47fa-b755-7461c765b155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_dafb40b2-7e87-4b9e-8426-f28427c84bdb" xlink:href="holx-20210626.xsd#holx_A2029SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_b84011df-ba38-454c-91a2-0e3f9448dc41" xlink:to="loc_holx_A2029SeniorNotesMember_dafb40b2-7e87-4b9e-8426-f28427c84bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_c394fbee-0ccc-4b29-978e-129209699f25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_bd32cf71-0eb1-4b60-85d1-b1a340a39075" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_c394fbee-0ccc-4b29-978e-129209699f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8a319a84-6d96-4e65-840c-41e0d843ad61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c394fbee-0ccc-4b29-978e-129209699f25" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_8a319a84-6d96-4e65-840c-41e0d843ad61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_f991c0fa-2b7a-471c-8c56-b714e3876f0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c394fbee-0ccc-4b29-978e-129209699f25" xlink:to="loc_us-gaap_InterestExpenseBorrowings_f991c0fa-2b7a-471c-8c56-b714e3876f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/Derivatives" xlink:type="simple" xlink:href="holx-20210626.xsd#Derivatives"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/Derivatives" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d8d369ec-92df-44c4-a59a-b71f04b41661" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesAndFairValueTextBlock_31e3b1f4-99d2-49bd-892a-c5b7fe32d56f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesAndFairValueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d8d369ec-92df-44c4-a59a-b71f04b41661" xlink:to="loc_us-gaap_DerivativesAndFairValueTextBlock_31e3b1f4-99d2-49bd-892a-c5b7fe32d56f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesTables" xlink:type="simple" xlink:href="holx-20210626.xsd#DerivativesTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DerivativesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b86e1347-4fd2-41b6-bbbd-d21cd4c623f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_2972165e-c6a2-4663-95e8-1c7871731f62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b86e1347-4fd2-41b6-bbbd-d21cd4c623f8" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_2972165e-c6a2-4663-95e8-1c7871731f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_663e4e69-c173-42ba-bb3f-62d6af6e8f42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b86e1347-4fd2-41b6-bbbd-d21cd4c623f8" xlink:to="loc_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_663e4e69-c173-42ba-bb3f-62d6af6e8f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_30c1f3a1-8dfb-488c-a4c7-457e4bca0fdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b86e1347-4fd2-41b6-bbbd-d21cd4c623f8" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_30c1f3a1-8dfb-488c-a4c7-457e4bca0fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesAdditionalInformationDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#DerivativesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DerivativesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0267d1b5-2440-45e0-8fa3-64f2b6af3a43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_7dc18f90-d221-4fd1-a1a2-f71a2cbf6524" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_0267d1b5-2440-45e0-8fa3-64f2b6af3a43" xlink:to="loc_us-gaap_DerivativeTable_7dc18f90-d221-4fd1-a1a2-f71a2cbf6524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_38ebb5be-79f5-466a-a8f8-eb00671f4571" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_7dc18f90-d221-4fd1-a1a2-f71a2cbf6524" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_38ebb5be-79f5-466a-a8f8-eb00671f4571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_58407cbc-116e-4e0c-8729-00b0cffaba46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_38ebb5be-79f5-466a-a8f8-eb00671f4571" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_58407cbc-116e-4e0c-8729-00b0cffaba46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_2adf2556-3808-48b9-88dc-4ae97a88e545" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_58407cbc-116e-4e0c-8729-00b0cffaba46" xlink:to="loc_us-gaap_InterestRateSwapMember_2adf2556-3808-48b9-88dc-4ae97a88e545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_dee19026-e881-4a17-a549-2b69301abd0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_58407cbc-116e-4e0c-8729-00b0cffaba46" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_dee19026-e881-4a17-a549-2b69301abd0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_f0c4aa91-c9c2-4559-89df-39c178520139" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_7dc18f90-d221-4fd1-a1a2-f71a2cbf6524" xlink:to="loc_us-gaap_DerivativeLineItems_f0c4aa91-c9c2-4559-89df-39c178520139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable_bc57870d-5b27-4aad-a017-14302e5c5436" xlink:href="holx-20210626.xsd#holx_InterestRateCapAgreementsAggregatePremiumPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_f0c4aa91-c9c2-4559-89df-39c178520139" xlink:to="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable_bc57870d-5b27-4aad-a017-14302e5c5436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrincipalAmountOfBorrowings_33b1f513-2aec-414d-a5a7-5261a485ddc1" xlink:href="holx-20210626.xsd#holx_PrincipalAmountOfBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_f0c4aa91-c9c2-4559-89df-39c178520139" xlink:to="loc_holx_PrincipalAmountOfBorrowings_33b1f513-2aec-414d-a5a7-5261a485ddc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_28fbc374-9098-4752-b739-ab72d2ffe6c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_f0c4aa91-c9c2-4559-89df-39c178520139" xlink:to="loc_us-gaap_DerivativeNotionalAmount_28fbc374-9098-4752-b739-ab72d2ffe6c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate_9f17df8c-dfd0-4975-83e9-8bfad8b346a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_f0c4aa91-c9c2-4559-89df-39c178520139" xlink:to="loc_us-gaap_DerivativeVariableInterestRate_9f17df8c-dfd0-4975-83e9-8bfad8b346a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_ac893e19-49ee-4bdc-9581-cd20e8d26589" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_f0c4aa91-c9c2-4559-89df-39c178520139" xlink:to="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_ac893e19-49ee-4bdc-9581-cd20e8d26589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NotationalAmount_9cad12bd-082a-473b-a1b1-dde7dea16bd9" xlink:href="holx-20210626.xsd#holx_NotationalAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_f0c4aa91-c9c2-4559-89df-39c178520139" xlink:to="loc_holx_NotationalAmount_9cad12bd-082a-473b-a1b1-dde7dea16bd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_720e6dff-d504-4e85-840d-5126ca700deb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a0c96686-e503-41e9-9d3d-4ade4f4e966f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_720e6dff-d504-4e85-840d-5126ca700deb" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a0c96686-e503-41e9-9d3d-4ade4f4e966f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8c57c533-2c37-4c1f-8674-1128b1b876e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a0c96686-e503-41e9-9d3d-4ade4f4e966f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8c57c533-2c37-4c1f-8674-1128b1b876e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0b77ec31-6832-48de-86ac-818d51a7cf84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8c57c533-2c37-4c1f-8674-1128b1b876e2" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0b77ec31-6832-48de-86ac-818d51a7cf84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_9feca2de-ab73-4b3b-a80a-86f4436fa582" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0b77ec31-6832-48de-86ac-818d51a7cf84" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_9feca2de-ab73-4b3b-a80a-86f4436fa582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_893e1342-39d6-4956-bb76-cf7a9e9dcf2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_0b77ec31-6832-48de-86ac-818d51a7cf84" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_893e1342-39d6-4956-bb76-cf7a9e9dcf2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d51e77f4-f31c-4792-85ba-11e1e54316af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a0c96686-e503-41e9-9d3d-4ade4f4e966f" xlink:to="loc_us-gaap_HedgingDesignationAxis_d51e77f4-f31c-4792-85ba-11e1e54316af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_5aa94975-4694-4f33-9a34-b7a085f020e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_d51e77f4-f31c-4792-85ba-11e1e54316af" xlink:to="loc_us-gaap_HedgingDesignationDomain_5aa94975-4694-4f33-9a34-b7a085f020e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_ba977ceb-ddc9-43be-97bc-72842bb79888" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_5aa94975-4694-4f33-9a34-b7a085f020e5" xlink:to="loc_us-gaap_NondesignatedMember_ba977ceb-ddc9-43be-97bc-72842bb79888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0023d1e7-ff67-4096-93da-7425e31b5998" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_a0c96686-e503-41e9-9d3d-4ade4f4e966f" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0023d1e7-ff67-4096-93da-7425e31b5998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_21256a78-bc3f-4ecb-9bd1-06fc659703cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0023d1e7-ff67-4096-93da-7425e31b5998" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_21256a78-bc3f-4ecb-9bd1-06fc659703cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_24dfa582-7037-413a-9372-b5a6e3027f68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0023d1e7-ff67-4096-93da-7425e31b5998" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_24dfa582-7037-413a-9372-b5a6e3027f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_e14ff7c3-5f33-4d65-8837-3580ad22b49c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_0023d1e7-ff67-4096-93da-7425e31b5998" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_e14ff7c3-5f33-4d65-8837-3580ad22b49c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#DerivativesFairValueofDerivativeFinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_173b148b-dc7b-4816-ae1e-d2ef5aff1133" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_32368712-65a3-48f2-bd5b-1ac255864009" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_173b148b-dc7b-4816-ae1e-d2ef5aff1133" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_32368712-65a3-48f2-bd5b-1ac255864009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_188e47e9-aa4a-44e5-825f-eae6c3475de0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_32368712-65a3-48f2-bd5b-1ac255864009" xlink:to="loc_us-gaap_HedgingDesignationAxis_188e47e9-aa4a-44e5-825f-eae6c3475de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_61dfb6ed-1130-4f2e-84aa-a8f8b042eed0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_188e47e9-aa4a-44e5-825f-eae6c3475de0" xlink:to="loc_us-gaap_HedgingDesignationDomain_61dfb6ed-1130-4f2e-84aa-a8f8b042eed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_df31a199-78a9-4a8b-9dc0-673fa6774b05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_61dfb6ed-1130-4f2e-84aa-a8f8b042eed0" xlink:to="loc_us-gaap_NondesignatedMember_df31a199-78a9-4a8b-9dc0-673fa6774b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_cea25d52-4e67-49ad-9628-5bff29ed7cac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_32368712-65a3-48f2-bd5b-1ac255864009" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_cea25d52-4e67-49ad-9628-5bff29ed7cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b7f0748f-a3bd-4c16-a540-e08ab0ee32e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_cea25d52-4e67-49ad-9628-5bff29ed7cac" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b7f0748f-a3bd-4c16-a540-e08ab0ee32e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_57ecafb4-38a1-49c5-bd7d-43ebfc31b397" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b7f0748f-a3bd-4c16-a540-e08ab0ee32e6" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_57ecafb4-38a1-49c5-bd7d-43ebfc31b397" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_f0827d06-4bea-4902-8f88-1fbeb1d55d36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b7f0748f-a3bd-4c16-a540-e08ab0ee32e6" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_f0827d06-4bea-4902-8f88-1fbeb1d55d36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_b7dab071-18ef-4c4c-9561-9d8e014b856c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b7f0748f-a3bd-4c16-a540-e08ab0ee32e6" xlink:to="loc_us-gaap_InterestRateSwapMember_b7dab071-18ef-4c4c-9561-9d8e014b856c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_6f63aaa0-c4db-4c56-bd64-65e942b2761d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_32368712-65a3-48f2-bd5b-1ac255864009" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_6f63aaa0-c4db-4c56-bd64-65e942b2761d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_7e997265-9606-4d5d-b4ba-f133b52bd57e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6f63aaa0-c4db-4c56-bd64-65e942b2761d" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_7e997265-9606-4d5d-b4ba-f133b52bd57e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_48baa57d-d9aa-4979-8bf6-830a5e55571b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7e997265-9606-4d5d-b4ba-f133b52bd57e" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_48baa57d-d9aa-4979-8bf6-830a5e55571b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_53cabcbe-342c-4484-8c6d-de0ce3a4758b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7e997265-9606-4d5d-b4ba-f133b52bd57e" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_53cabcbe-342c-4484-8c6d-de0ce3a4758b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_86090936-af0b-459b-9ef6-8fc585f9b528" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_7e997265-9606-4d5d-b4ba-f133b52bd57e" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_86090936-af0b-459b-9ef6-8fc585f9b528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_e4b247f3-3a42-434a-9412-b23473bc1678" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_32368712-65a3-48f2-bd5b-1ac255864009" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_e4b247f3-3a42-434a-9412-b23473bc1678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_c495b042-4136-4e75-abb7-45c309b9ae38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_e4b247f3-3a42-434a-9412-b23473bc1678" xlink:to="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_c495b042-4136-4e75-abb7-45c309b9ae38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_1a24597b-c856-43a7-b02d-c909b6b71489" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_e4b247f3-3a42-434a-9412-b23473bc1678" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_1a24597b-c856-43a7-b02d-c909b6b71489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_0b3d5aad-aaa5-4bac-8de9-959da688690a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_e4b247f3-3a42-434a-9412-b23473bc1678" xlink:to="loc_us-gaap_DerivativeLiabilities_0b3d5aad-aaa5-4bac-8de9-959da688690a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_92923cb8-212d-406d-b77b-8b5d492c0f6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e19d33bc-8766-4d02-bd66-5d38b8ece161" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_92923cb8-212d-406d-b77b-8b5d492c0f6f" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e19d33bc-8766-4d02-bd66-5d38b8ece161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_ed6fff5a-b725-4310-b866-966499f5c61e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e19d33bc-8766-4d02-bd66-5d38b8ece161" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_ed6fff5a-b725-4310-b866-966499f5c61e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c68f7f77-962c-486f-bda2-a2cb209caeed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ed6fff5a-b725-4310-b866-966499f5c61e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c68f7f77-962c-486f-bda2-a2cb209caeed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_17b17fed-8556-419a-99ff-da23c3b3244f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c68f7f77-962c-486f-bda2-a2cb209caeed" xlink:to="loc_us-gaap_InterestRateSwapMember_17b17fed-8556-419a-99ff-da23c3b3244f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_bb899cd0-1504-416a-a8ed-7cd1cad07dbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_c68f7f77-962c-486f-bda2-a2cb209caeed" xlink:to="loc_us-gaap_InterestRateCapMember_bb899cd0-1504-416a-a8ed-7cd1cad07dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e122bb50-22fe-471d-a556-f1923c2f40d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e19d33bc-8766-4d02-bd66-5d38b8ece161" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e122bb50-22fe-471d-a556-f1923c2f40d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_a3dc906f-e38c-48ba-9edd-64f880afa8d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e122bb50-22fe-471d-a556-f1923c2f40d1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_a3dc906f-e38c-48ba-9edd-64f880afa8d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_890dc5a5-b08c-4666-a4dc-fbdb68146375" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_e122bb50-22fe-471d-a556-f1923c2f40d1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_890dc5a5-b08c-4666-a4dc-fbdb68146375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="holx-20210626.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b70d250d-9212-4849-bba1-aa394fd1f3d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_b198bb75-f254-4121-ad00-8ccbe3e99f73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b70d250d-9212-4849-bba1-aa394fd1f3d6" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_b198bb75-f254-4121-ad00-8ccbe3e99f73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsandContingenciesDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#CommitmentsandContingenciesDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/CommitmentsandContingenciesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_50b4526b-1d3b-4fb0-9541-b297e1bc6d29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_77a8c6c0-0474-4a8a-bfad-018131dc7510" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_50b4526b-1d3b-4fb0-9541-b297e1bc6d29" xlink:to="loc_us-gaap_LossContingenciesTable_77a8c6c0-0474-4a8a-bfad-018131dc7510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_2fb235fc-14db-44f5-858e-8f3adf19f6f3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_77a8c6c0-0474-4a8a-bfad-018131dc7510" xlink:to="loc_dei_LegalEntityAxis_2fb235fc-14db-44f5-858e-8f3adf19f6f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_52c8027f-77b2-4ac1-93d0-8e8e8b0aa0e3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_2fb235fc-14db-44f5-858e-8f3adf19f6f3" xlink:to="loc_dei_EntityDomain_52c8027f-77b2-4ac1-93d0-8e8e8b0aa0e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinervaMember_390ce685-8e77-4d3f-b3ed-53cd583a02b1" xlink:href="holx-20210626.xsd#holx_MinervaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_52c8027f-77b2-4ac1-93d0-8e8e8b0aa0e3" xlink:to="loc_holx_MinervaMember_390ce685-8e77-4d3f-b3ed-53cd583a02b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_9709d3cb-b5a1-4961-9c60-beb02913afb2" xlink:href="holx-20210626.xsd#holx_MedicalAestheticsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_52c8027f-77b2-4ac1-93d0-8e8e8b0aa0e3" xlink:to="loc_holx_MedicalAestheticsMember_9709d3cb-b5a1-4961-9c60-beb02913afb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_30b814d5-bc0e-483b-ba8a-24c0f2cce6a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_77a8c6c0-0474-4a8a-bfad-018131dc7510" xlink:to="loc_us-gaap_LossContingenciesLineItems_30b814d5-bc0e-483b-ba8a-24c0f2cce6a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmountAssessedInDamages_9244485a-2be6-4478-a1ff-dc298d816abd" xlink:href="holx-20210626.xsd#holx_AmountAssessedInDamages"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_30b814d5-bc0e-483b-ba8a-24c0f2cce6a9" xlink:to="loc_holx_AmountAssessedInDamages_9244485a-2be6-4478-a1ff-dc298d816abd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_dac66945-40a0-48ef-b5d8-6fb92c7237ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_30b814d5-bc0e-483b-ba8a-24c0f2cce6a9" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_dac66945-40a0-48ef-b5d8-6fb92c7237ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LegalAccrual_68943323-4a1c-4726-8d47-4f3c56944896" xlink:href="holx-20210626.xsd#holx_LegalAccrual"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_30b814d5-bc0e-483b-ba8a-24c0f2cce6a9" xlink:to="loc_holx_LegalAccrual_68943323-4a1c-4726-8d47-4f3c56944896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomeLossPerShare" xlink:type="simple" xlink:href="holx-20210626.xsd#NetIncomeLossPerShare"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/NetIncomeLossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e62def7a-b11a-4b7b-9e8a-f3f4fe213cc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_0f1b74b7-e16e-4b60-afa5-db582c09e5ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e62def7a-b11a-4b7b-9e8a-f3f4fe213cc0" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_0f1b74b7-e16e-4b60-afa5-db582c09e5ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomeLossPerShareTables" xlink:type="simple" xlink:href="holx-20210626.xsd#NetIncomeLossPerShareTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/NetIncomeLossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_bc9957ad-066c-406d-8d7d-c56514dbe80f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_c2fa1ff0-ab15-4fb9-b0e2-16763f5e56fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_bc9957ad-066c-406d-8d7d-c56514dbe80f" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_c2fa1ff0-ab15-4fb9-b0e2-16763f5e56fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_aecb522d-24fd-4e76-95b7-46918c35fce6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareTable_a79ec8c5-5e67-44e0-acd8-c0b54c16f7d3" xlink:href="holx-20210626.xsd#holx_EarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_aecb522d-24fd-4e76-95b7-46918c35fce6" xlink:to="loc_holx_EarningsPerShareTable_a79ec8c5-5e67-44e0-acd8-c0b54c16f7d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3317f1a4-a5bb-4f5e-b3bc-897335650863" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareTable_a79ec8c5-5e67-44e0-acd8-c0b54c16f7d3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3317f1a4-a5bb-4f5e-b3bc-897335650863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c8aebcf2-d746-4603-935e-7e90ff853fa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3317f1a4-a5bb-4f5e-b3bc-897335650863" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c8aebcf2-d746-4603-935e-7e90ff853fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_bd8ce938-9448-4b45-9a28-f8e5218b7ba0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c8aebcf2-d746-4603-935e-7e90ff853fa2" xlink:to="loc_us-gaap_StockCompensationPlanMember_bd8ce938-9448-4b45-9a28-f8e5218b7ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_c037a841-db7e-4943-8ba0-714fa8e00d32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c8aebcf2-d746-4603-935e-7e90ff853fa2" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_c037a841-db7e-4943-8ba0-714fa8e00d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareLineItems_d1cc00ca-90e5-47b8-a9f8-8604d0bd51a3" xlink:href="holx-20210626.xsd#holx_EarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareTable_a79ec8c5-5e67-44e0-acd8-c0b54c16f7d3" xlink:to="loc_holx_EarningsPerShareLineItems_d1cc00ca-90e5-47b8-a9f8-8604d0bd51a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_aec50c98-2b4e-4c0c-ab37-3347c96dc86f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareLineItems_d1cc00ca-90e5-47b8-a9f8-8604d0bd51a3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_aec50c98-2b4e-4c0c-ab37-3347c96dc86f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4b8f6a4d-3c28-420c-91b4-5797581467cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareLineItems_d1cc00ca-90e5-47b8-a9f8-8604d0bd51a3" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4b8f6a4d-3c28-420c-91b4-5797581467cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_85d4207f-6d30-421f-a93a-7cff2628e9f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareLineItems_d1cc00ca-90e5-47b8-a9f8-8604d0bd51a3" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_85d4207f-6d30-421f-a93a-7cff2628e9f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_b806dea0-0682-4f80-a8a4-6354c3f2f38a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareLineItems_d1cc00ca-90e5-47b8-a9f8-8604d0bd51a3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_b806dea0-0682-4f80-a8a4-6354c3f2f38a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_78af2228-3e44-4dd1-b661-6976557043d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_b806dea0-0682-4f80-a8a4-6354c3f2f38a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_78af2228-3e44-4dd1-b661-6976557043d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="holx-20210626.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ec2a50bd-9cae-426a-8002-b8a176d281dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_6a853a8b-2e08-4ab1-b849-681a56144a89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ec2a50bd-9cae-426a-8002-b8a176d281dc" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_6a853a8b-2e08-4ab1-b849-681a56144a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="holx-20210626.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_44941877-92f8-4590-9edf-f3e821c98bf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_1f8f462f-dcf6-40d2-b538-aa0083057b19" xlink:href="holx-20210626.xsd#holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_44941877-92f8-4590-9edf-f3e821c98bf3" xlink:to="loc_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_1f8f462f-dcf6-40d2-b538-aa0083057b19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_636f778a-9392-49d8-9f67-0e1218f7b5f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_44941877-92f8-4590-9edf-f3e821c98bf3" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_636f778a-9392-49d8-9f67-0e1218f7b5f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_562e54d8-4003-4533-b544-7f8dbc97d903" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_95a057cf-79eb-4315-8e26-b23c70f09834" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_562e54d8-4003-4533-b544-7f8dbc97d903" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_95a057cf-79eb-4315-8e26-b23c70f09834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7529b21c-2fdc-4fd3-b2a8-bc914e0b89a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_95a057cf-79eb-4315-8e26-b23c70f09834" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7529b21c-2fdc-4fd3-b2a8-bc914e0b89a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_cdd51534-486d-42cf-b525-c6b7dfb6f2b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7529b21c-2fdc-4fd3-b2a8-bc914e0b89a6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_cdd51534-486d-42cf-b525-c6b7dfb6f2b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_59a5fe9d-ea12-4908-a2ec-17d5589a6474" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cdd51534-486d-42cf-b525-c6b7dfb6f2b7" xlink:to="loc_us-gaap_CostOfSalesMember_59a5fe9d-ea12-4908-a2ec-17d5589a6474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_e7d98c43-4262-4f40-8667-e73b9079e7bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cdd51534-486d-42cf-b525-c6b7dfb6f2b7" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_e7d98c43-4262-4f40-8667-e73b9079e7bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_45422c62-64b2-4d54-9f83-6acaff6406b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cdd51534-486d-42cf-b525-c6b7dfb6f2b7" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_45422c62-64b2-4d54-9f83-6acaff6406b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_299c9c19-a467-490c-b93d-a5e52568bf5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cdd51534-486d-42cf-b525-c6b7dfb6f2b7" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_299c9c19-a467-490c-b93d-a5e52568bf5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember_5616b789-4245-4677-ab6d-50c3f0787930" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cdd51534-486d-42cf-b525-c6b7dfb6f2b7" xlink:to="loc_us-gaap_RestructuringChargesMember_5616b789-4245-4677-ab6d-50c3f0787930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c5a7480f-f221-49fd-bf66-1f0005e8c499" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_95a057cf-79eb-4315-8e26-b23c70f09834" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c5a7480f-f221-49fd-bf66-1f0005e8c499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_3c5f5b2f-c8c3-4405-a6ca-622baf30de12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c5a7480f-f221-49fd-bf66-1f0005e8c499" xlink:to="loc_us-gaap_ShareBasedCompensation_3c5f5b2f-c8c3-4405-a6ca-622baf30de12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#StockBasedCompensationAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_89eeb0d2-1bf5-44f7-a240-2debe74c0d0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_18e80af5-5af2-43e8-8ad4-c657b069925d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_89eeb0d2-1bf5-44f7-a240-2debe74c0d0a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_18e80af5-5af2-43e8-8ad4-c657b069925d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_185ab6af-749b-46b0-b9a5-fd6efa18e662" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_18e80af5-5af2-43e8-8ad4-c657b069925d" xlink:to="loc_us-gaap_AwardTypeAxis_185ab6af-749b-46b0-b9a5-fd6efa18e662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_02580d00-ddcf-45eb-9363-bb6c8be39702" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_185ab6af-749b-46b0-b9a5-fd6efa18e662" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_02580d00-ddcf-45eb-9363-bb6c8be39702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_56a6378d-fe64-4549-8b08-b912daada87f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_02580d00-ddcf-45eb-9363-bb6c8be39702" xlink:to="loc_us-gaap_EmployeeStockOptionMember_56a6378d-fe64-4549-8b08-b912daada87f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d0725f57-2574-4baf-a27f-cc52ee99d512" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_02580d00-ddcf-45eb-9363-bb6c8be39702" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d0725f57-2574-4baf-a27f-cc52ee99d512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_30e63b7c-530a-4503-8217-74a008a16da4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_02580d00-ddcf-45eb-9363-bb6c8be39702" xlink:to="loc_us-gaap_PerformanceSharesMember_30e63b7c-530a-4503-8217-74a008a16da4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MarketBasedAwardsMember_0f4351dd-952d-4d16-9461-10ea4a3048df" xlink:href="holx-20210626.xsd#holx_MarketBasedAwardsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_02580d00-ddcf-45eb-9363-bb6c8be39702" xlink:to="loc_holx_MarketBasedAwardsMember_0f4351dd-952d-4d16-9461-10ea4a3048df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PSUFreeCashFlowMember_ce76fafa-6810-46a8-9dbc-43ba2f199479" xlink:href="holx-20210626.xsd#holx_PSUFreeCashFlowMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_02580d00-ddcf-45eb-9363-bb6c8be39702" xlink:to="loc_holx_PSUFreeCashFlowMember_ce76fafa-6810-46a8-9dbc-43ba2f199479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RSUPSUMSUMember_0d4ccaac-89ad-453e-89c1-73be36a78332" xlink:href="holx-20210626.xsd#holx_RSUPSUMSUMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_02580d00-ddcf-45eb-9363-bb6c8be39702" xlink:to="loc_holx_RSUPSUMSUMember_0d4ccaac-89ad-453e-89c1-73be36a78332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9acb7d3b-11c8-4b17-825c-b5c1eb54bb1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_18e80af5-5af2-43e8-8ad4-c657b069925d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9acb7d3b-11c8-4b17-825c-b5c1eb54bb1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_378fb95c-38e0-4291-82ad-48a9dcd178c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9acb7d3b-11c8-4b17-825c-b5c1eb54bb1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_378fb95c-38e0-4291-82ad-48a9dcd178c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_74ad7900-232e-4411-bcf9-e665f068ff9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9acb7d3b-11c8-4b17-825c-b5c1eb54bb1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_74ad7900-232e-4411-bcf9-e665f068ff9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_056710bf-b98d-4891-b8ef-c54d2b14e374" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9acb7d3b-11c8-4b17-825c-b5c1eb54bb1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_056710bf-b98d-4891-b8ef-c54d2b14e374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b5f79729-616d-4a54-bcbe-ce623b7217af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9acb7d3b-11c8-4b17-825c-b5c1eb54bb1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b5f79729-616d-4a54-bcbe-ce623b7217af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7f4d243e-b31c-4bde-989a-ea0d81f9b627" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9acb7d3b-11c8-4b17-825c-b5c1eb54bb1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7f4d243e-b31c-4bde-989a-ea0d81f9b627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_bb73a80c-7c7b-4e0c-b078-bed8692fb013" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9acb7d3b-11c8-4b17-825c-b5c1eb54bb1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_bb73a80c-7c7b-4e0c-b078-bed8692fb013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f7ba3950-c4be-4041-89eb-1fb70f72aed3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9acb7d3b-11c8-4b17-825c-b5c1eb54bb1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f7ba3950-c4be-4041-89eb-1fb70f72aed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_aba033e3-84da-4d18-99e7-fc11931eaa85" xlink:href="holx-20210626.xsd#holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9acb7d3b-11c8-4b17-825c-b5c1eb54bb1f" xlink:to="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_aba033e3-84da-4d18-99e7-fc11931eaa85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_82b2543c-adef-4ea3-9bef-f328c5180e9a" xlink:href="holx-20210626.xsd#holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9acb7d3b-11c8-4b17-825c-b5c1eb54bb1f" xlink:to="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_82b2543c-adef-4ea3-9bef-f328c5180e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_37a643c8-fe88-4b40-b786-8baad9e2528e" xlink:href="holx-20210626.xsd#holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9acb7d3b-11c8-4b17-825c-b5c1eb54bb1f" xlink:to="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_37a643c8-fe88-4b40-b786-8baad9e2528e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_9b74259a-2813-4da5-86fc-333b1f36daa8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9acb7d3b-11c8-4b17-825c-b5c1eb54bb1f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_9b74259a-2813-4da5-86fc-333b1f36daa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9dfb2630-09a7-452c-8ac8-82dca5a5b3fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9acb7d3b-11c8-4b17-825c-b5c1eb54bb1f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9dfb2630-09a7-452c-8ac8-82dca5a5b3fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8d3830ee-6869-4cde-bd5c-a800fad18667" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_5f455a82-1b6b-4acd-a719-9a0ecb05e9f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8d3830ee-6869-4cde-bd5c-a800fad18667" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_5f455a82-1b6b-4acd-a719-9a0ecb05e9f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_a804dd3f-83d2-421b-9467-3d2b4b698e37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8d3830ee-6869-4cde-bd5c-a800fad18667" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_a804dd3f-83d2-421b-9467-3d2b4b698e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_684a46b1-77df-491e-a0c3-9d5d6206e872" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8d3830ee-6869-4cde-bd5c-a800fad18667" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_684a46b1-77df-491e-a0c3-9d5d6206e872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_c571e36d-a40e-4973-bd8b-9ba786c5f5a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8d3830ee-6869-4cde-bd5c-a800fad18667" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_c571e36d-a40e-4973-bd8b-9ba786c5f5a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b93ae434-3c3d-4888-acac-056f27d9adea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8d3830ee-6869-4cde-bd5c-a800fad18667" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b93ae434-3c3d-4888-acac-056f27d9adea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformation" xlink:type="simple" xlink:href="holx-20210626.xsd#OtherBalanceSheetInformation"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_3ee1cb66-2d5e-4e02-9e5f-bb6ec140ba7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_cf0eb77f-fd07-40a6-ac90-128c1c8ce930" xlink:href="holx-20210626.xsd#holx_DetailsOfCertainBalanceSheetAccountsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_3ee1cb66-2d5e-4e02-9e5f-bb6ec140ba7d" xlink:to="loc_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_cf0eb77f-fd07-40a6-ac90-128c1c8ce930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationTables" xlink:type="simple" xlink:href="holx-20210626.xsd#OtherBalanceSheetInformationTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_68562628-0f51-4877-be8d-375d7343b0b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_368e07c0-3f07-45e8-bb63-a911de946457" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_68562628-0f51-4877-be8d-375d7343b0b2" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_368e07c0-3f07-45e8-bb63-a911de946457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_cbe72f49-f186-4e8a-9856-ac07f904fbc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_68562628-0f51-4877-be8d-375d7343b0b2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_cbe72f49-f186-4e8a-9856-ac07f904fbc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#OtherBalanceSheetInformationInventoriesDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_1327241d-491f-45a3-a867-ddb3b081a6f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_da62835d-67c2-4f3b-9161-27d7471f8cb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_1327241d-491f-45a3-a867-ddb3b081a6f9" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_da62835d-67c2-4f3b-9161-27d7471f8cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_e48c0747-288e-43bc-81d6-d24a8751ea2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_1327241d-491f-45a3-a867-ddb3b081a6f9" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_e48c0747-288e-43bc-81d6-d24a8751ea2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_b03889b0-1856-472d-9206-c5d7997d8f5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_1327241d-491f-45a3-a867-ddb3b081a6f9" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_b03889b0-1856-472d-9206-c5d7997d8f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_d75bde1b-8665-4717-aeae-52c243c6db40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_1327241d-491f-45a3-a867-ddb3b081a6f9" xlink:to="loc_us-gaap_InventoryNet_d75bde1b-8665-4717-aeae-52c243c6db40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_d1bc02b5-db28-4e9c-bba3-36a89d7974a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ManufacturingEquipmentAndSoftware_dfde51af-4a76-4a43-92aa-8a8592bc8e55" xlink:href="holx-20210626.xsd#holx_ManufacturingEquipmentAndSoftware"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_d1bc02b5-db28-4e9c-bba3-36a89d7974a4" xlink:to="loc_holx_ManufacturingEquipmentAndSoftware_dfde51af-4a76-4a43-92aa-8a8592bc8e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquipmentUnderCustomerUsageAgreements_64c936a9-e3f3-4d9b-a158-a29e2874517a" xlink:href="holx-20210626.xsd#holx_EquipmentUnderCustomerUsageAgreements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_d1bc02b5-db28-4e9c-bba3-36a89d7974a4" xlink:to="loc_holx_EquipmentUnderCustomerUsageAgreements_64c936a9-e3f3-4d9b-a158-a29e2874517a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_cd5daa5e-5749-4983-a46e-f7b4288cb239" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_d1bc02b5-db28-4e9c-bba3-36a89d7974a4" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_cd5daa5e-5749-4983-a46e-f7b4288cb239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_b7cd7cd7-0b54-45f3-8cf8-fec7d3efdd42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_d1bc02b5-db28-4e9c-bba3-36a89d7974a4" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_b7cd7cd7-0b54-45f3-8cf8-fec7d3efdd42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_e174417c-f33b-4125-9668-9f5a0b8f3ca8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Land"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_d1bc02b5-db28-4e9c-bba3-36a89d7974a4" xlink:to="loc_us-gaap_Land_e174417c-f33b-4125-9668-9f5a0b8f3ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_0b459630-dd41-4f52-bcaa-795c592565bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_d1bc02b5-db28-4e9c-bba3-36a89d7974a4" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_0b459630-dd41-4f52-bcaa-795c592565bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_2d75a364-753d-48a6-adf8-2e19f54bb855" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_d1bc02b5-db28-4e9c-bba3-36a89d7974a4" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_2d75a364-753d-48a6-adf8-2e19f54bb855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_42c4a931-bee0-4e89-9482-d0fd17d6930c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_d1bc02b5-db28-4e9c-bba3-36a89d7974a4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_42c4a931-bee0-4e89-9482-d0fd17d6930c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f44e5661-6217-4a9f-9412-3be016e53bda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_d1bc02b5-db28-4e9c-bba3-36a89d7974a4" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f44e5661-6217-4a9f-9412-3be016e53bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_fdfaca6c-08e3-459b-bb5c-e2af77ea9eba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_d1bc02b5-db28-4e9c-bba3-36a89d7974a4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_fdfaca6c-08e3-459b-bb5c-e2af77ea9eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DepartmentOfDefenseFundsReceived_8f400fe9-1e68-4efc-8b79-16c6890239ec" xlink:href="holx-20210626.xsd#holx_DepartmentOfDefenseFundsReceived"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_d1bc02b5-db28-4e9c-bba3-36a89d7974a4" xlink:to="loc_holx_DepartmentOfDefenseFundsReceived_8f400fe9-1e68-4efc-8b79-16c6890239ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GrantsReceivedFromDepartmentOfDefense_077e0961-6a42-4f2b-884a-1fdfca2ea365" xlink:href="holx-20210626.xsd#holx_GrantsReceivedFromDepartmentOfDefense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_d1bc02b5-db28-4e9c-bba3-36a89d7974a4" xlink:to="loc_holx_GrantsReceivedFromDepartmentOfDefense_077e0961-6a42-4f2b-884a-1fdfca2ea365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformation" xlink:type="simple" xlink:href="holx-20210626.xsd#BusinessSegmentsandGeographicInformation"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_cab707a0-e8f5-4582-ad0f-a76545176700" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_617b9cf7-93bf-4521-85e0-2d63055989e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_cab707a0-e8f5-4582-ad0f-a76545176700" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_617b9cf7-93bf-4521-85e0-2d63055989e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables" xlink:type="simple" xlink:href="holx-20210626.xsd#BusinessSegmentsandGeographicInformationTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_5d430eba-573b-4a50-8b0e-4e8b0273676f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_f7c6b1d8-2a76-4f0e-88f4-daec9fc79c44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5d430eba-573b-4a50-8b0e-4e8b0273676f" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_f7c6b1d8-2a76-4f0e-88f4-daec9fc79c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_c7c369d0-8151-41ea-93e3-a47c56108f20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5d430eba-573b-4a50-8b0e-4e8b0273676f" xlink:to="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_c7c369d0-8151-41ea-93e3-a47c56108f20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#BusinessSegmentsandGeographicInformationAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_7305ea6a-8735-42ac-a5fa-ec88c465dab4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_be020137-e7b9-401b-9243-97ca938a75c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7305ea6a-8735-42ac-a5fa-ec88c465dab4" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_be020137-e7b9-401b-9243-97ca938a75c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_1686f6f9-c3f7-482e-935a-8d36fa34d416" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_be020137-e7b9-401b-9243-97ca938a75c9" xlink:to="loc_srt_ConsolidationItemsAxis_1686f6f9-c3f7-482e-935a-8d36fa34d416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_5e63ecd7-d0af-4ba8-bb8a-4c2832a54b3a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_1686f6f9-c3f7-482e-935a-8d36fa34d416" xlink:to="loc_srt_ConsolidationItemsDomain_5e63ecd7-d0af-4ba8-bb8a-4c2832a54b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_3b6f671e-8fb7-415f-a928-ef3eb67220c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_5e63ecd7-d0af-4ba8-bb8a-4c2832a54b3a" xlink:to="loc_us-gaap_IntersegmentEliminationMember_3b6f671e-8fb7-415f-a928-ef3eb67220c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SegmentReportingDisclosureLineItems_ae38cab5-683b-49cb-81c8-3c1cef2ecd1d" xlink:href="holx-20210626.xsd#holx_SegmentReportingDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_be020137-e7b9-401b-9243-97ca938a75c9" xlink:to="loc_holx_SegmentReportingDisclosureLineItems_ae38cab5-683b-49cb-81c8-3c1cef2ecd1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_47490d4f-2533-4b97-b6e6-88b356c3af1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_ae38cab5-683b-49cb-81c8-3c1cef2ecd1d" xlink:to="loc_us-gaap_NumberOfReportableSegments_47490d4f-2533-4b97-b6e6-88b356c3af1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_1928e8a4-7b0f-43f4-8f52-9aab5e4eb26c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_ae38cab5-683b-49cb-81c8-3c1cef2ecd1d" xlink:to="loc_us-gaap_Revenues_1928e8a4-7b0f-43f4-8f52-9aab5e4eb26c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#BusinessSegmentsandGeographicInformationSegmentInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_9b8dcd30-41b2-412a-8521-c43a9547643c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8a03d615-1de8-4f34-a8b7-f1bed43eb465" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_9b8dcd30-41b2-412a-8521-c43a9547643c" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8a03d615-1de8-4f34-a8b7-f1bed43eb465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a0e10458-2e6f-43f1-9e61-0a24d7e33047" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8a03d615-1de8-4f34-a8b7-f1bed43eb465" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a0e10458-2e6f-43f1-9e61-0a24d7e33047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f4c00bca-df29-4ee8-8551-5d551f38ef73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a0e10458-2e6f-43f1-9e61-0a24d7e33047" xlink:to="loc_us-gaap_SegmentDomain_f4c00bca-df29-4ee8-8551-5d551f38ef73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember_54dc51d0-ffbe-4105-ac60-dcc1a3ea9301" xlink:href="holx-20210626.xsd#holx_DiagnosticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f4c00bca-df29-4ee8-8551-5d551f38ef73" xlink:to="loc_holx_DiagnosticsMember_54dc51d0-ffbe-4105-ac60-dcc1a3ea9301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember_1581b53c-b18f-4cd6-ab29-2da079975852" xlink:href="holx-20210626.xsd#holx_BreastHealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f4c00bca-df29-4ee8-8551-5d551f38ef73" xlink:to="loc_holx_BreastHealthMember_1581b53c-b18f-4cd6-ab29-2da079975852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember_cea29455-2028-42de-9303-360f119fdcc3" xlink:href="holx-20210626.xsd#holx_GynSurgicalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f4c00bca-df29-4ee8-8551-5d551f38ef73" xlink:to="loc_holx_GynSurgicalMember_cea29455-2028-42de-9303-360f119fdcc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember_c2929d0b-94af-4422-b9f7-9be421a5fcd8" xlink:href="holx-20210626.xsd#holx_SkeletalHealthMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f4c00bca-df29-4ee8-8551-5d551f38ef73" xlink:to="loc_holx_SkeletalHealthMember_c2929d0b-94af-4422-b9f7-9be421a5fcd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_13102e76-5062-4bd3-8b7f-a4fa793bb821" xlink:href="holx-20210626.xsd#holx_MedicalAestheticsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f4c00bca-df29-4ee8-8551-5d551f38ef73" xlink:to="loc_holx_MedicalAestheticsMember_13102e76-5062-4bd3-8b7f-a4fa793bb821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_dd1443f4-fbeb-4dcb-a4b2-ac964c251afc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f4c00bca-df29-4ee8-8551-5d551f38ef73" xlink:to="loc_us-gaap_CorporateMember_dd1443f4-fbeb-4dcb-a4b2-ac964c251afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_6813ad04-d8ee-4d6a-b9a4-a4b3312645cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8a03d615-1de8-4f34-a8b7-f1bed43eb465" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_6813ad04-d8ee-4d6a-b9a4-a4b3312645cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_c03d5ef3-360e-416d-b74f-3d074b843710" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6813ad04-d8ee-4d6a-b9a4-a4b3312645cb" xlink:to="loc_us-gaap_Revenues_c03d5ef3-360e-416d-b74f-3d074b843710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_feb1d2d0-a816-4755-a0a3-0f4f4ff8df41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6813ad04-d8ee-4d6a-b9a4-a4b3312645cb" xlink:to="loc_us-gaap_OperatingIncomeLoss_feb1d2d0-a816-4755-a0a3-0f4f4ff8df41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_1de856f7-0975-4b97-80d5-5dc137327790" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6813ad04-d8ee-4d6a-b9a4-a4b3312645cb" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_1de856f7-0975-4b97-80d5-5dc137327790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_2cede1e8-73f1-495b-9006-bc3d47d154ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6813ad04-d8ee-4d6a-b9a4-a4b3312645cb" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_2cede1e8-73f1-495b-9006-bc3d47d154ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_7fa1224a-fd83-48ce-90fa-25125fdbed42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6813ad04-d8ee-4d6a-b9a4-a4b3312645cb" xlink:to="loc_us-gaap_Assets_7fa1224a-fd83-48ce-90fa-25125fdbed42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_3eec9b58-dbc9-4623-8f3f-9650d662a744" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsTable_581c74eb-773b-470f-8eb9-23566d6800a6" xlink:href="holx-20210626.xsd#holx_ScheduleOfGeographicalSegmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_3eec9b58-dbc9-4623-8f3f-9650d662a744" xlink:to="loc_holx_ScheduleOfGeographicalSegmentsTable_581c74eb-773b-470f-8eb9-23566d6800a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_3b776b78-8f10-4f30-86da-8d9775549061" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsTable_581c74eb-773b-470f-8eb9-23566d6800a6" xlink:to="loc_srt_StatementGeographicalAxis_3b776b78-8f10-4f30-86da-8d9775549061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_37e658fc-114b-4c09-be6c-40d4fde6a06a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_3b776b78-8f10-4f30-86da-8d9775549061" xlink:to="loc_srt_SegmentGeographicalDomain_37e658fc-114b-4c09-be6c-40d4fde6a06a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_07953bb8-efd8-40c4-b5d5-79bdbcc19ece" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_37e658fc-114b-4c09-be6c-40d4fde6a06a" xlink:to="loc_country_US_07953bb8-efd8-40c4-b5d5-79bdbcc19ece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_a72bb5de-f9f1-4acd-808c-9adf62c07cc9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_37e658fc-114b-4c09-be6c-40d4fde6a06a" xlink:to="loc_srt_EuropeMember_a72bb5de-f9f1-4acd-808c-9adf62c07cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_3a3710b6-88ac-42dc-b0ea-f7eee9e9b9ad" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_37e658fc-114b-4c09-be6c-40d4fde6a06a" xlink:to="loc_srt_AsiaPacificMember_3a3710b6-88ac-42dc-b0ea-f7eee9e9b9ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AllOtherCountriesMember_b7a4a74e-0c83-4365-af58-92e5c5b1c171" xlink:href="holx-20210626.xsd#holx_AllOtherCountriesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_37e658fc-114b-4c09-be6c-40d4fde6a06a" xlink:to="loc_holx_AllOtherCountriesMember_b7a4a74e-0c83-4365-af58-92e5c5b1c171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsLineItems_bdc30651-f16b-48d3-8032-f1f92419ef55" xlink:href="holx-20210626.xsd#holx_ScheduleOfGeographicalSegmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsTable_581c74eb-773b-470f-8eb9-23566d6800a6" xlink:to="loc_holx_ScheduleOfGeographicalSegmentsLineItems_bdc30651-f16b-48d3-8032-f1f92419ef55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfRevenues_473560ac-e616-439f-bea7-89fe19a23d6a" xlink:href="holx-20210626.xsd#holx_PercentageOfRevenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsLineItems_bdc30651-f16b-48d3-8032-f1f92419ef55" xlink:to="loc_holx_PercentageOfRevenues_473560ac-e616-439f-bea7-89fe19a23d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxes" xlink:type="simple" xlink:href="holx-20210626.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_450a9ba6-aa02-4028-9278-0f58e96f4445" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_6f0fdb85-70e6-4536-8d8a-0661c3cd7866" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_450a9ba6-aa02-4028-9278-0f58e96f4445" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_6f0fdb85-70e6-4536-8d8a-0661c3cd7866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_02c2d98f-16a6-4ccc-b243-52c281508f13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_12e3755e-45ad-46e1-b754-8ba04e394ef5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_02c2d98f-16a6-4ccc-b243-52c281508f13" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_12e3755e-45ad-46e1-b754-8ba04e394ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1ba269ce-7d1e-4828-9578-65d88b77a1cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_12e3755e-45ad-46e1-b754-8ba04e394ef5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1ba269ce-7d1e-4828-9578-65d88b77a1cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f62235f8-85df-4c06-9b63-a2e62d7a90c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1ba269ce-7d1e-4828-9578-65d88b77a1cd" xlink:to="loc_us-gaap_SegmentDomain_f62235f8-85df-4c06-9b63-a2e62d7a90c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_94e539c1-c599-49f1-b64d-d9f39a18b2ef" xlink:href="holx-20210626.xsd#holx_MedicalAestheticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f62235f8-85df-4c06-9b63-a2e62d7a90c8" xlink:to="loc_holx_MedicalAestheticsMember_94e539c1-c599-49f1-b64d-d9f39a18b2ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_c19d0035-ac65-4ee4-839d-0300755a6a5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_12e3755e-45ad-46e1-b754-8ba04e394ef5" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_c19d0035-ac65-4ee4-839d-0300755a6a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cfd6a533-a8b2-42b4-a9a3-4b7604d86eb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c19d0035-ac65-4ee4-839d-0300755a6a5e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cfd6a533-a8b2-42b4-a9a3-4b7604d86eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_86ca110f-c086-4f53-8db2-c384e69215bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_c19d0035-ac65-4ee4-839d-0300755a6a5e" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_86ca110f-c086-4f53-8db2-c384e69215bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwill" xlink:type="simple" xlink:href="holx-20210626.xsd#IntangibleAssetsandGoodwill"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2096ad24-9e9b-4c78-bc5f-7384d6476aae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_bb9b2146-b177-4bea-b973-0adf85c50ede" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2096ad24-9e9b-4c78-bc5f-7384d6476aae" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_bb9b2146-b177-4bea-b973-0adf85c50ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillTables" xlink:type="simple" xlink:href="holx-20210626.xsd#IntangibleAssetsandGoodwillTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwillTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6064a2d1-495b-439c-b4b1-5779a5b53741" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_28ab7789-b3a7-43f7-9337-c893ecd40d8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6064a2d1-495b-439c-b4b1-5779a5b53741" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_28ab7789-b3a7-43f7-9337-c893ecd40d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_8b79d4cc-0124-4bb2-abe0-0f77cdcbad5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6064a2d1-495b-439c-b4b1-5779a5b53741" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_8b79d4cc-0124-4bb2-abe0-0f77cdcbad5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a4372ef8-4895-43d8-946a-03f6325e3258" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_deb5be12-01cf-416b-b340-cf9fa567419f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a4372ef8-4895-43d8-946a-03f6325e3258" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_deb5be12-01cf-416b-b340-cf9fa567419f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b06011bc-3a2f-408c-bddf-72b721c273e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_deb5be12-01cf-416b-b340-cf9fa567419f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b06011bc-3a2f-408c-bddf-72b721c273e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c891b877-d965-4e1f-897b-138380594ac6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b06011bc-3a2f-408c-bddf-72b721c273e2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c891b877-d965-4e1f-897b-138380594ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_c691982e-000b-49ab-bb3b-2afff876160c" xlink:href="holx-20210626.xsd#holx_DevelopedTechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c891b877-d965-4e1f-897b-138380594ac6" xlink:to="loc_holx_DevelopedTechnologyMember_c691982e-000b-49ab-bb3b-2afff876160c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_15c35dc7-f812-4fcb-906d-d9fdadeeda9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c891b877-d965-4e1f-897b-138380594ac6" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_15c35dc7-f812-4fcb-906d-d9fdadeeda9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CustomerRelationshipsContractsMember_320c0458-8281-4e12-95ac-e5e2e4c66c2f" xlink:href="holx-20210626.xsd#holx_CustomerRelationshipsContractsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c891b877-d965-4e1f-897b-138380594ac6" xlink:to="loc_holx_CustomerRelationshipsContractsMember_320c0458-8281-4e12-95ac-e5e2e4c66c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_9f697c4f-90f8-4233-b6b1-65981d7eb4d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c891b877-d965-4e1f-897b-138380594ac6" xlink:to="loc_us-gaap_TradeNamesMember_9f697c4f-90f8-4233-b6b1-65981d7eb4d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_7e363b6a-c644-4e77-a0f9-f7c56cc937a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c891b877-d965-4e1f-897b-138380594ac6" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_7e363b6a-c644-4e77-a0f9-f7c56cc937a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessLicensesMember_4b1541c2-3f37-44d1-afdf-274365178c37" xlink:href="holx-20210626.xsd#holx_BusinessLicensesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c891b877-d965-4e1f-897b-138380594ac6" xlink:to="loc_holx_BusinessLicensesMember_4b1541c2-3f37-44d1-afdf-274365178c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcquiredintangibleassetsMember_19d1769e-09a3-462b-ab47-5f1985ff79a0" xlink:href="holx-20210626.xsd#holx_AcquiredintangibleassetsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c891b877-d965-4e1f-897b-138380594ac6" xlink:to="loc_holx_AcquiredintangibleassetsMember_19d1769e-09a3-462b-ab47-5f1985ff79a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternalusesoftwareMember_4dbb98da-e8b9-47e8-85a7-5205a698ea63" xlink:href="holx-20210626.xsd#holx_InternalusesoftwareMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c891b877-d965-4e1f-897b-138380594ac6" xlink:to="loc_holx_InternalusesoftwareMember_4dbb98da-e8b9-47e8-85a7-5205a698ea63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalizedsoftwareMember_b39a6c4b-1f3d-4696-8a47-d0ba0319158e" xlink:href="holx-20210626.xsd#holx_CapitalizedsoftwareMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c891b877-d965-4e1f-897b-138380594ac6" xlink:to="loc_holx_CapitalizedsoftwareMember_b39a6c4b-1f3d-4696-8a47-d0ba0319158e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_853152a3-e7e6-4916-9847-3682fb57331b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_deb5be12-01cf-416b-b340-cf9fa567419f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_853152a3-e7e6-4916-9847-3682fb57331b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_e6b9a0e7-1ca3-431f-9a37-c9e043d28bae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_853152a3-e7e6-4916-9847-3682fb57331b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_e6b9a0e7-1ca3-431f-9a37-c9e043d28bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c63f946e-cd67-4e6a-96e8-c5549edee9a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_853152a3-e7e6-4916-9847-3682fb57331b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c63f946e-cd67-4e6a-96e8-c5549edee9a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_da2b3fb3-3162-4d20-8a43-eeb0c7eb4a48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_b16c0281-dd7c-42c8-b00d-e101c5e0abf9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_da2b3fb3-3162-4d20-8a43-eeb0c7eb4a48" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_b16c0281-dd7c-42c8-b00d-e101c5e0abf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f024f0a6-e5f6-408d-8ad9-e8d515d6f6dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_da2b3fb3-3162-4d20-8a43-eeb0c7eb4a48" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_f024f0a6-e5f6-408d-8ad9-e8d515d6f6dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_ee9c2779-abaa-44d8-b754-5ec73aa2c6db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_da2b3fb3-3162-4d20-8a43-eeb0c7eb4a48" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_ee9c2779-abaa-44d8-b754-5ec73aa2c6db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_f9523111-07fd-4ec5-b749-6ddd45fb7fc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_da2b3fb3-3162-4d20-8a43-eeb0c7eb4a48" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_f9523111-07fd-4ec5-b749-6ddd45fb7fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_d087617a-c4cc-4c93-bfbf-dd86a2b41a16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_da2b3fb3-3162-4d20-8a43-eeb0c7eb4a48" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_d087617a-c4cc-4c93-bfbf-dd86a2b41a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarranties" xlink:type="simple" xlink:href="holx-20210626.xsd#ProductWarranties"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ProductWarranties" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesAbstract_6a9be593-519d-4de0-9e90-46d0c6927212" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyDisclosureTextBlock_9ccda6f1-1847-4604-8dc1-e6bdb2a1a772" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteesAbstract_6a9be593-519d-4de0-9e90-46d0c6927212" xlink:to="loc_us-gaap_ProductWarrantyDisclosureTextBlock_9ccda6f1-1847-4604-8dc1-e6bdb2a1a772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarrantiesTables" xlink:type="simple" xlink:href="holx-20210626.xsd#ProductWarrantiesTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ProductWarrantiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesAbstract_3f511ae2-0baf-4157-b056-5bea6556ce72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_6fc56933-40cb-4ce7-9aac-6bd1f3f31f03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteesAbstract_3f511ae2-0baf-4157-b056-5bea6556ce72" xlink:to="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_6fc56933-40cb-4ce7-9aac-6bd1f3f31f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#ProductWarrantiesProductWarrantyActivityDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesAbstract_8f9b19f3-aaba-4912-b111-d93d6ff3cba7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_3f5fe536-5d0d-4e4f-aa63-f9e058e4aef5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteesAbstract_8f9b19f3-aaba-4912-b111-d93d6ff3cba7" xlink:to="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_3f5fe536-5d0d-4e4f-aa63-f9e058e4aef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual_526b590a-31ae-42e5-8dba-57ca0f21bc90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_3f5fe536-5d0d-4e4f-aa63-f9e058e4aef5" xlink:to="loc_us-gaap_ProductWarrantyAccrual_526b590a-31ae-42e5-8dba-57ca0f21bc90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued_b074c3d6-785c-4da0-afd3-faae49de0516" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualWarrantiesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_3f5fe536-5d0d-4e4f-aa63-f9e058e4aef5" xlink:to="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued_b074c3d6-785c-4da0-afd3-faae49de0516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition_14e8832f-5273-47e1-9c96-465cfec5152b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_3f5fe536-5d0d-4e4f-aa63-f9e058e4aef5" xlink:to="loc_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition_14e8832f-5273-47e1-9c96-465cfec5152b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease_01ea62eb-dd44-4240-8431-d8c108e891d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_3f5fe536-5d0d-4e4f-aa63-f9e058e4aef5" xlink:to="loc_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease_01ea62eb-dd44-4240-8431-d8c108e891d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments_1910c618-80e3-4509-9ac7-da77d4dd33e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualPayments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_3f5fe536-5d0d-4e4f-aa63-f9e058e4aef5" xlink:to="loc_us-gaap_ProductWarrantyAccrualPayments_1910c618-80e3-4509-9ac7-da77d4dd33e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual_d1c5c33f-53f8-4642-8b59-6c21c82760c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_3f5fe536-5d0d-4e4f-aa63-f9e058e4aef5" xlink:to="loc_us-gaap_ProductWarrantyAccrual_d1c5c33f-53f8-4642-8b59-6c21c82760c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="simple" xlink:href="holx-20210626.xsd#AccumulatedOtherComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_21bb1f32-1305-498b-9805-ebef18c246c0" xlink:href="holx-20210626.xsd#holx_AccumulatedOtherComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_ac69c7fa-db96-4bf8-827b-17398c47057f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_21bb1f32-1305-498b-9805-ebef18c246c0" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_ac69c7fa-db96-4bf8-827b-17398c47057f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="simple" xlink:href="holx-20210626.xsd#AccumulatedOtherComprehensiveLossTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_1991fc27-a7be-42af-92ad-0a3b24c8fa64" xlink:href="holx-20210626.xsd#holx_AccumulatedOtherComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_547b1fc1-117d-4308-8dc2-b460addd7ec9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_1991fc27-a7be-42af-92ad-0a3b24c8fa64" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_547b1fc1-117d-4308-8dc2-b460addd7ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail" xlink:type="simple" xlink:href="holx-20210626.xsd#AccumulatedOtherComprehensiveIncomeDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_7da49dbe-5e63-4783-a3f0-2b24d0d011aa" xlink:href="holx-20210626.xsd#holx_AccumulatedOtherComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a48e0e06-5f96-4396-809c-59f56a854ca8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_7da49dbe-5e63-4783-a3f0-2b24d0d011aa" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a48e0e06-5f96-4396-809c-59f56a854ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_0f689565-5a91-493d-8b55-62d6f46ba898" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a48e0e06-5f96-4396-809c-59f56a854ca8" xlink:to="loc_us-gaap_FinancialInstrumentAxis_0f689565-5a91-493d-8b55-62d6f46ba898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7ab7a293-9d94-4521-b748-3d93f850d777" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_0f689565-5a91-493d-8b55-62d6f46ba898" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7ab7a293-9d94-4521-b748-3d93f850d777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_053af4c9-064f-4d41-915e-8848a37fc812" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7ab7a293-9d94-4521-b748-3d93f850d777" xlink:to="loc_us-gaap_InterestRateCapMember_053af4c9-064f-4d41-915e-8848a37fc812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_e54a0bf9-4afe-47ca-9679-7c490b288eb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7ab7a293-9d94-4521-b748-3d93f850d777" xlink:to="loc_us-gaap_InterestRateSwapMember_e54a0bf9-4afe-47ca-9679-7c490b288eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b5d789ad-bae3-4282-8334-6d8cf4fe88c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a48e0e06-5f96-4396-809c-59f56a854ca8" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b5d789ad-bae3-4282-8334-6d8cf4fe88c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9cee1794-6aa1-41e0-8528-a1ec84bd6b77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b5d789ad-bae3-4282-8334-6d8cf4fe88c8" xlink:to="loc_us-gaap_EquityComponentDomain_9cee1794-6aa1-41e0-8528-a1ec84bd6b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_365d0d36-333e-4c5a-a666-c269dd019a60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9cee1794-6aa1-41e0-8528-a1ec84bd6b77" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_365d0d36-333e-4c5a-a666-c269dd019a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f456e3af-ab44-4915-9369-b6f2b629b9c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9cee1794-6aa1-41e0-8528-a1ec84bd6b77" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_f456e3af-ab44-4915-9369-b6f2b629b9c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_e0360a10-97c2-477a-b150-7da117a841e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9cee1794-6aa1-41e0-8528-a1ec84bd6b77" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_e0360a10-97c2-477a-b150-7da117a841e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_97d675ae-5f98-43e9-961d-d97dc03be620" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9cee1794-6aa1-41e0-8528-a1ec84bd6b77" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_97d675ae-5f98-43e9-961d-d97dc03be620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3828110e-c1e9-4d39-afd0-ddbefd8047eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_a48e0e06-5f96-4396-809c-59f56a854ca8" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3828110e-c1e9-4d39-afd0-ddbefd8047eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_5eae6afe-f988-4ed2-a044-4da0d82a4dfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3828110e-c1e9-4d39-afd0-ddbefd8047eb" xlink:to="loc_us-gaap_StockholdersEquity_5eae6afe-f988-4ed2-a044-4da0d82a4dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_29d11f9c-592f-488a-8e4b-3b5f7642ea2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3828110e-c1e9-4d39-afd0-ddbefd8047eb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_29d11f9c-592f-488a-8e4b-3b5f7642ea2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_f81c0b97-904e-4fe2-a0e5-5cb9a63e2743" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3828110e-c1e9-4d39-afd0-ddbefd8047eb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_f81c0b97-904e-4fe2-a0e5-5cb9a63e2743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_6b298936-02f7-4269-b791-56348d5227d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3828110e-c1e9-4d39-afd0-ddbefd8047eb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_6b298936-02f7-4269-b791-56348d5227d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_fcf82b4c-bf1e-416a-8ab4-37780411c624" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3828110e-c1e9-4d39-afd0-ddbefd8047eb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_fcf82b4c-bf1e-416a-8ab4-37780411c624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_46c59911-fac5-4c1f-85e2-a517e0c666a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3828110e-c1e9-4d39-afd0-ddbefd8047eb" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_46c59911-fac5-4c1f-85e2-a517e0c666a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_d8b6afc5-3f69-47e0-8d01-f9a94c43617a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3828110e-c1e9-4d39-afd0-ddbefd8047eb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_d8b6afc5-3f69-47e0-8d01-f9a94c43617a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_31ac7846-d2a6-4c01-a1f5-add35ac00ef8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_3828110e-c1e9-4d39-afd0-ddbefd8047eb" xlink:to="loc_us-gaap_StockholdersEquity_31ac7846-d2a6-4c01-a1f5-add35ac00ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ShareRepurchase" xlink:type="simple" xlink:href="holx-20210626.xsd#ShareRepurchase"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ShareRepurchase" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_47a62669-9ea7-4bce-9730-e70474c65c67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_a1a92a60-e508-4e4c-8e41-568391172dc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_47a62669-9ea7-4bce-9730-e70474c65c67" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_a1a92a60-e508-4e4c-8e41-568391172dc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails" xlink:type="simple" xlink:href="holx-20210626.xsd#ShareRepurchaseSharerepurchaseDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_36003a5d-5eb8-405b-bb58-9c028b25c2f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharerepurchaseplanTable_03a791e7-a77a-4511-b2fe-0da0ac4bd80b" xlink:href="holx-20210626.xsd#holx_SharerepurchaseplanTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_36003a5d-5eb8-405b-bb58-9c028b25c2f8" xlink:to="loc_holx_SharerepurchaseplanTable_03a791e7-a77a-4511-b2fe-0da0ac4bd80b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_69789188-5af8-4488-96f5-b8f6e04b0bf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharerepurchaseplanTable_03a791e7-a77a-4511-b2fe-0da0ac4bd80b" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_69789188-5af8-4488-96f5-b8f6e04b0bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_8a96d8a7-d03c-4ad1-853e-89b481bba61d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_69789188-5af8-4488-96f5-b8f6e04b0bf0" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_8a96d8a7-d03c-4ad1-853e-89b481bba61d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_December112019Member_50fb9756-f5a5-4a27-ab9e-d9c47a716b8f" xlink:href="holx-20210626.xsd#holx_December112019Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_8a96d8a7-d03c-4ad1-853e-89b481bba61d" xlink:to="loc_holx_December112019Member_50fb9756-f5a5-4a27-ab9e-d9c47a716b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_December112020Member_ab0b4142-7ffb-4a4e-a007-b2c5e1be2e55" xlink:href="holx-20210626.xsd#holx_December112020Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_8a96d8a7-d03c-4ad1-853e-89b481bba61d" xlink:to="loc_holx_December112020Member_ab0b4142-7ffb-4a4e-a007-b2c5e1be2e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_c687ee6a-68eb-4197-b579-2faa8616be03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharerepurchaseplanTable_03a791e7-a77a-4511-b2fe-0da0ac4bd80b" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_c687ee6a-68eb-4197-b579-2faa8616be03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_2eb2848c-2403-44e1-bc1b-9fcd8114bf09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_c687ee6a-68eb-4197-b579-2faa8616be03" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_2eb2848c-2403-44e1-bc1b-9fcd8114bf09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_December112019Member_98f203ed-26b2-4449-b0c4-a3c9c2fce9e4" xlink:href="holx-20210626.xsd#holx_December112019Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_2eb2848c-2403-44e1-bc1b-9fcd8114bf09" xlink:to="loc_holx_December112019Member_98f203ed-26b2-4449-b0c4-a3c9c2fce9e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_December112020Member_08002129-62be-4358-8ef7-7a27f3d9216b" xlink:href="holx-20210626.xsd#holx_December112020Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_2eb2848c-2403-44e1-bc1b-9fcd8114bf09" xlink:to="loc_holx_December112020Member_08002129-62be-4358-8ef7-7a27f3d9216b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharerepurchaseplanLineItems_c2a0d10c-12e8-4c75-85be-0ce77a8cb2ab" xlink:href="holx-20210626.xsd#holx_SharerepurchaseplanLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharerepurchaseplanTable_03a791e7-a77a-4511-b2fe-0da0ac4bd80b" xlink:to="loc_holx_SharerepurchaseplanLineItems_c2a0d10c-12e8-4c75-85be-0ce77a8cb2ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_a5c52c9b-9334-4016-a9f8-3e55880b7d54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharerepurchaseplanLineItems_c2a0d10c-12e8-4c75-85be-0ce77a8cb2ab" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_a5c52c9b-9334-4016-a9f8-3e55880b7d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_0c9e3942-8cdc-4b8f-98e1-519ab9e328b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharerepurchaseplanLineItems_c2a0d10c-12e8-4c75-85be-0ce77a8cb2ab" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_0c9e3942-8cdc-4b8f-98e1-519ab9e328b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepurchaseOfEquity_8b950b2f-d0c6-4769-b3c3-c34454ebd7df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepurchaseOfEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharerepurchaseplanLineItems_c2a0d10c-12e8-4c75-85be-0ce77a8cb2ab" xlink:to="loc_us-gaap_ProceedsFromRepurchaseOfEquity_8b950b2f-d0c6-4769-b3c3-c34454ebd7df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_2459c01e-027f-485c-9170-7039df139d14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharerepurchaseplanLineItems_c2a0d10c-12e8-4c75-85be-0ce77a8cb2ab" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_2459c01e-027f-485c-9170-7039df139d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_d97ce378-96b8-4aea-82e9-a57c20c217fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharerepurchaseplanLineItems_c2a0d10c-12e8-4c75-85be-0ce77a8cb2ab" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_d97ce378-96b8-4aea-82e9-a57c20c217fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/NewAccountingPronouncements" xlink:type="simple" xlink:href="holx-20210626.xsd#NewAccountingPronouncements"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/NewAccountingPronouncements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_026e37a2-50c0-4019-8a8a-f8bfbe39e7e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_6ca2ea45-e05c-4d49-a8ec-c3b91e08450f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_026e37a2-50c0-4019-8a8a-f8bfbe39e7e3" xlink:to="loc_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_6ca2ea45-e05c-4d49-a8ec-c3b91e08450f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/NewAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="holx-20210626.xsd#NewAccountingPronouncementsPolicies"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/NewAccountingPronouncementsPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e9ffe943-3492-4182-89ce-2154a8062ec6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f754b209-50b1-400d-b0e7-dacfd83bc080" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e9ffe943-3492-4182-89ce-2154a8062ec6" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f754b209-50b1-400d-b0e7-dacfd83bc080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>holx-20210626_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:holx="http://www.hologic.com/20210626"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="holx-20210626.xsd" xlink:type="simple"/>
    <context id="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i0a0de2fed4294accb0517140fae5643e_I20210722">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2021-07-22</instant>
        </period>
    </context>
    <context id="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="ie7b19d82c50249db846d3d1201e12c40_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i01a2cc93a0514785a37164641018ee66_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i62775b7338924094b35155c0fdc56937_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="idcdf880adb9b48f2929f4a34dd835119_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i6acad958eada4806ab9891959584319e_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i1b3baf3186c74c05b772abe2f32104e9_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="ib7667b1c57034541bf5cdb336c4b3647_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="ia1bbf9311cb649308affbf16f61bb3ff_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="id01db50d7a6347809cb98adf4b5c0c66_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i6c7cb3ce35044cba97822b408ab5d23c_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201801Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i6977def5ccec49a2980c424062f9fee1_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i309460864a314d9aa0d13fb0a8698091_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="ib1bc73f8ae9c492f9eb4404fb7e44230_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="ia342626413704afc8513005d7219aead_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i22a1e068cbb54742b0e792558e5f9d7c_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:ShareRepurchaseProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="ide9ab086aa8846ac877a20195abb5f25_I20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-28</instant>
        </period>
    </context>
    <context id="id78e1a3ad6024d799c3f1727c967cf29_I20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-28</instant>
        </period>
    </context>
    <context id="i77063f41174f4d989415517706f4fb93_I20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-28</instant>
        </period>
    </context>
    <context id="icc0e0f0a89824c5996ab98b928cc9aa4_I20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-28</instant>
        </period>
    </context>
    <context id="ibe21cf98d68c43dca6569043732410ff_I20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-28</instant>
        </period>
    </context>
    <context id="i419ae5d90cab427883eac5b35fd93d36_I20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2019-12-28</instant>
        </period>
    </context>
    <context id="i02e7a8da3b754bdb85993a3ca3484508_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="ia2ba3a87732c4c6ab5006e5cb0228a5d_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i588c3d9c7d924cc6a15149930f01d74e_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i33460b16b0364f3589df795f209d0c8d_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="ib8b6b6f42e894fca9dca1d45bc960c8a_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i17e8693dbcd546e5a55176fe7546128f_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:ShareRepurchaseProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i0657c7323336470abd636ab465e98a96_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="ia15ef37ae8ca4fbca76c1b7b2851f56c_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i047c6f422b294cb08c1476a194dc7470_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i4470f8e9e21d45a78c67f110baf7a543_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i490aca9b8aa2403e8983cfb2aee1071b_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i5ae541164c564e1394017ca8fb281f3c_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i5bf322985c424f509995e217f5ba7921_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i73253768170f4c9b8e05dfb1368cf18d_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="idd3a77457cf340cf9428c91d5c99c147_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="idc53cfef88da4ccfb2e145cc906d6511_I20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="idfd99b340a8c407e9acd3394fcb87cb8_I20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="i63c68ea38c5d4987adbac8981ccfb7a3_I20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="ibe15f7e0e20e47c29d5afb6680fcde66_I20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="i226a72a6ad6e4aa4a08a9eaebf99bb78_I20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="i81ab5863e2124accb342d2df86a1ee96_I20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="i738e3649fa5648b981781aa15132a8f6_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i8272ade1ac594482a34d29229657da9b_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i09304699beed432b98cea40faccb3e67_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ic24013ff47294a37b8d0497bd4190df5_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="if9d0114a6df941bbb221d574874bf165_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ib40a5a6185e8452498ab7f6ce2457f01_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i88ca4c5253d94e03a7eb9af69544692d_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i237512b46fca4a7db28715ee5c66af27_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i5b78eb3d900e4dc388e35dc09cd76568_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i820217fec55c42d7a9aeb5cfc0f49fdb_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i52f506beb69441ce875d650d0e5966ba_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i9223d1ed5b7d47208efe550fae77bef3_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i8a980ec9354548a89245ad56600f024d_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ic3516193c4744e1cb240679a20e265f8_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="if83bdefcff814ab0800ee9e105ed777e_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i2c17808393cc4b1a91fd6c22e278253d_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i3e2de70ed942467287b4930863d9692e_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="iebc58209d8514f5c93b78fa003903508_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i73d6f95b696549cfb0e4d525d8488ac7_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="ia4bb35a550a74469afbfef16e89e4881_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="if9811e9a2cf24d19b278bc2bf9a5c5cb_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="icdca8dc2d5f84891bd139bc79d3231ab_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i36833f09bd344e93a23947c92c866cf5_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="if8c4f5a123e145abb53ba94d3255b7da_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i049e1cee29c84dde8735ff6f859f7c56_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i84edd5ea5c5241b5a06d1be5e9eb4872_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="ib2c3c861c8f34c17aa93621dcb13cd4a_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="ib6cf91736f1949678b7354ef10d99150_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="icc0d86296d91494f843aeb441d2af697_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="ic0aa0fa3e3474453bc759752889ebcd8_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i379f68e2cb5c471e83994c37a86c01b6_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i31e8abc772ad4ffe894ec7ec188dc5df_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i1c99a5bb5b144cf9b610e175a4ecc587_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="ic97a10fe6e144c24b4eafc07f4a2428b_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i8226181576f245bba94e4a5ec64e87f6_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i537a20393d1e493cbe6493d3a8188d64_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i6bae2f1749954b73b3a6ead022748861_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i5e17ab66a75e4420b799cd5146ba9ceb_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i71a06870de924d918ff5abbf56a8d25d_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i875c4235807f46d2acc9a2e5e2e9e7a8_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i999599ea2b584e2d8e6e8e7edce3637b_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i4e77ae6b121e4933b196860cc147365e_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i1a4ec39647f042768fb079e46c124d64_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="ibe2790b0becc4992ab4a86ed0f47b8b0_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i6b4d9d4a1d51468d9eb84de80c70c52f_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="if395d4107ff1436d8ecfbc976a4eccac_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i89acd5d341534bbfacfac9fb7fd346a3_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="if6e8ba7ac1ad4788936366e6a2a40bcf_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i14b4ef7fc8f6486f8099a60d145ae4e9_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="iac5bd9bb07344043bdbb2c9c3b03b313_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="if23b3ae36b644acc87ec67b72cd7b730_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i531234c15a6c43f8ba2e74a3bc5979be_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i441afbe7ea704a97a13d7f01cda317fe_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i2cd4c64d0a9b44e7b731b80d7ff2cff9_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i0450e1103e8241cc93052d9df1a6f6bf_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="icf7456bf9a8f47acacea66bd647d61be_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i14fe0f286fe8418d8408a5ef9a8ded4b_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i9ce0088f110146f9abc2c378a66d90fd_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="ic0db9249ce324df6b69e1002079a0170_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="ief5d5ac299f444e7a11589340f1d8811_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i4b8441cccd184c4486e57f87f71f3656_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i286bca0d89644bd0b3205f4b93ed5c1d_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i4ee2782511e24cde8d011a55e9af48b7_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i410f2d6c20c4496eb68a1ac00b260536_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i79c862e1f99d4e7bb053e7bea309372c_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i75e45ed7d25546e591e76bfdf91c98d0_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i7ed178edd5ad495c90c1b54255909fa8_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="if47061debb804420a5e14a803176e8ce_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="ia942e9f26e244360b3ce4f6c390b9d93_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i6f248925f2ee4c69b3f784a04ba9a364_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="ifcf29874b0924e36855919d6b73c66f7_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="ic22fe1d383e84feaadba1dc8f408d3dc_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="ic9c3b5b875444c0689eae7d05cf36d7e_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i4bf0a79818e54f1fbf147be4c1ef864d_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="ib3ce04ac38db44279190e17fe5e2384a_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i60f75ab143d84b689500c2e5bfebcf87_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i5393210c850e49b78aace5bb63c4e69c_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i5b239d22f00e4502a2fe462334f74606_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i942bad789f284e31a5f43dcf1fedf43d_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="id09b1799f368487b906ce59a96d2e408_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="icfcab7983d0848b082ee034a8af8e64b_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="iaa28816934d4448282f6c7faf7a4d548_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="ie9773235748348dd8da0c1995d6ed993_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i57d8e5448f0d4ad48c2c716944cec78f_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="id31306d0e2234478a749fe0b4889a65a_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i4cc1b7e15e774991a987400605125d1c_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i987b8ad71b084e15ae9ba9e8338b3bd0_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i85493aa01af94bd8b1f7328b463dd8e5_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="ia27da4de68874f0fb714ee7967b38fd7_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="iaf75ce65865145c3aa67cc9f1814b5d6_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i96d4eb19ed154f9f9df012f7ce7ee57a_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="ifd7f591f4d6846419f3ba29d469f7d3f_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="ifcbb80af093740f9a361c5448ab37e4c_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="icabdcbbe69c545579aa33835b5f3d4eb_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i16a0b171d8b2414ebdc3554e167249d2_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i5cc68c7458734cd2a8a7c981e8515c76_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="ie8818dd7702142cf95a9d19c729ddf8a_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i88586a6659324a6e94cec1cb09cf2a46_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i9991425506644c169e0b162c4eec7947_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="iace9270559714986aaabca0d4ebdff24_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="ieeb7d864535e4e7f9bce653f4b168b96_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i8be39ed1f1aa46c3894324d319834486_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="ic4c0e43445d04743bcb9261bbcc78b53_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i8f0c0208131f49b39c73659c82a02222_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="iea063f8d161b4a0b85a574fa46b7f7b4_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i1feb000741a14589b76e0f21beb6c5c0_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="id62f94911ce54ef68438afc76c05b4b2_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i99435d39a02440deadad10c369f19565_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i87eaf0bf3c6d48658f4c2c3e78a71ac2_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i7491e43b952d4c61b87c261b016b3e1b_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i5d6ad39df725417db4cda9327284076d_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i075e000f08f64e8883de52eb2ec429b6_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="ie416f1bb45be4de39749bd46c36fe698_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i869637ca6659448691978af8788531f9_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i163df94df0de411eb1ec6ff91ad044d1_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i1aa19225dcc7437aad83c6bad124ebec_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i0e4faefdffaf4617a9f21a886228d428_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="id9ba7888ec484e89a44484a6c3048d8f_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i0a7e9769dab647d2ba4a287635864018_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i27eae9a50641400fb1c2541bd52dad61_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="iff62125937204878a658f0c5628606fa_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="ie82bb12476164052a5d97847ecbff323_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="ibac682b2841e4347b6671d6949367197_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="iaa51fa0830194b718e4598c66cc20822_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="idaa1c66f7d6d4ab9b6669c1d61bd937a_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i46fb7e93d58d4db1824c75dcbca92ff7_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="id7a0cc313a77477ba010d815081c9a07_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="ie85bcce039094bae9db0bf4313fb7e60_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i7711c49f92c04e2b9466ed524ee8bc2e_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="if96887e76d944d08b5519f53cef01904_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i1eca047fb0c84048ab9cb90facfbf706_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i3df779d8bf47483e9f292cc7612b6774_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="iee9eab84d6ad4c45a2dd7d811f7fb06e_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="iebeafdaf8b04495394d947c38fcd54be_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="iad6089c03fe04694a4932756918fb99d_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="ib6fbe86d934c4d18a2a5e07b6312d943_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="ifd2db6ee06b94cddafde9fe932029265_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="ic99b704f095f4cd69b8a4ae90368d2d7_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i94cf4a747ee64dfd93739c74eb4cd66d_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="ib0fc4831c77847b3a201ce54a4e2db2f_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="icbfaf422f9724422b8b06418613c842d_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i561c02d7c245409293cfa0a1562f677a_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="id50cd5f65a25492abef4ce8286035326_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i5293327445f541ed891801a24fba467c_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i6bdefe68c3ea42e58988c6e8a69fd673_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i25dced02445e4b87a13031b8d51a8173_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i3d4e9da2a2c14f13984e3286a479cede_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i391a26685f56401ea4adc59b7d80011f_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i52c4985d417b4421a13ef783c7e19a9f_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="ifa3d63fea23c46bcb179fec3fd524a11_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i03551c738e78426f82dbe57a0c1bf66e_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="ic2a56d2bb725478f82e31f1329449f9a_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i6bafd189711f4ec19e64d26761bc3318_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="id0c8406167274863803b6b1fb7cf1d04_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i86db2b9cd67f4199811130ee684b41e2_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i85f7ecac32784df6a536dad78a0e43e9_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="icf42837162e3410ea1fc194837543b32_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i1af39200976349b393f0094f2c751da6_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i8ed43d6f3b9e467c9e24d43594b26b14_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i386d807f9c604702afb89ac48d4f3997_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i476b388d782a4d1188664e75bb1926f9_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i2107dfda459c464ba7795fbb3263a45f_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i3db408b0437e4aee94b6507a2f00f132_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i82e0f458672c41aabd0a7ccc0ecba719_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i63bf14aa150b470d8cda291a8e3dd66f_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="if97a9823a91c48f6879659548ae4a3e1_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i9aa28665b0b14585a3f36c725cdb23a2_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="idadd999b632a42d7b0d65121528aa81a_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i877644a05fce44e28b7a923b72578d44_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="ie9abeb75d8db4dec84473529c4e293f5_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i070ab836e0a141d2815638fcced72af6_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="iba84d4a948cd406cad1198d4bdc90dcb_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:RestofWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="ic351acb54a3849d8aedcfca04d87ab1d_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:RestofWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="ic7d1d8a90959436b8aca4870757f76ba_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:RestofWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i98e039107e7742dc92ff616d5e0b45fa_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:RestofWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="icfb85da295454d3fa7ac34d45ba8399a_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i997d2963735445798702be9238bd61d3_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i6fc238f172a84daa9f0b0b392fc8265b_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i969332a55fc94c40b1890a3c159072e5_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="iaea9eeace8bc48a6853ad4eb8c570984_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="if064abfbec784952a50564f775aa48b4_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i066e06a75605450685297c3e282a6b6f_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i93a5b58ca8ab490bb807f3f47ed0695a_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="if5fbe2f2ff664952a86162b814c29dc5_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i39c233f5360f46839440a89ec92db102_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="ic7caffadd2bf4a08a5a93de29b5b1702_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="ie4271982162541bca84afd4b29071784_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i125ef810b16745dbb51cab70e0c74868_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i6b102cbde6ac4145a026f275552c9233_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i615b149ad3534e4ba9e847115a8c8104_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="ia599da9d0cec404bb29f0dc029068fb1_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i3077d84f238341b6b299f541f5f835d3_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2020-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i6ac5e12a191d4b3dba030b9849f5d77b_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2021-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i4fa166ab972a4216b61bb29fe09583b5_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="ia3c7225d747b441aa0d9f695fe415128_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="icaee218d084046ed9e76934876d4b3ff_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i08c883de92e74d7b85fd3ca1fb82d546_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i02c12e832a964220b8e957d85bd7f1be_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="iefc73cc720144ee2abfd4e56a2ab1c22_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="ib02ab7302c2f46079c7e79da871a6eb7_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="id05ddebb6ac948d3924f040045e9f869_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i6a527b50af5e47a99433bc012cfe40e9_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i2d9a236240c14cf8bef2d68626067a47_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i2f25431c4bd346aca079e50943a25050_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i59f5f7477c54411fb844f52b13896113_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="ib04dea42a16c43599c49cc706c336cc8_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="ia57c3dc6f5744ed28ba4ec3d78ac0431_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="ifcbbabd8e7cd43b49b4c4141972ac3df_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i44028ddaa4d449f19b250514e6f25c11_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i87af1fc6220349d08bb58531b16ae309_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i3e4d1ac8689444b3b830cfd194640a8d_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="ia7359c2fb7ca43ffb3bf9416afa4079f_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i354883b38ce9409b8864c231c916bc8b_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="ib8ccf9bb036a4a48a18392eeed90c59b_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i67c6607b6ca1481688b2c7ed6a2b6fab_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i421a1ec2406e4269a476846874e71421_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="id56c8faa0e884b19a2eebe191531428a_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="ie2bfa4cc508a42c08b7fe0e7f3b786a3_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i1493df5a7c09426b9e8dba13c3704251_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i92fd2ed585e64792981f77c6077751ee_D20210617-20210617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-17</startDate>
            <endDate>2021-06-17</endDate>
        </period>
    </context>
    <context id="i30d680096df04f59bf3edf5694f74758_I20210617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-17</instant>
        </period>
    </context>
    <context id="i93d6e126b5db43d7917d1e320241c5a5_D20210617-20210617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-17</startDate>
            <endDate>2021-06-17</endDate>
        </period>
    </context>
    <context id="i7e9787cddf8548e6b7fe58450c3ac4ea_D20210617-20210617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-17</startDate>
            <endDate>2021-06-17</endDate>
        </period>
    </context>
    <context id="i2cc7db962d0a469b91ad71f47641afa1_D20210617-20210617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-17</startDate>
            <endDate>2021-06-17</endDate>
        </period>
    </context>
    <context id="i5b84fc74ea2e43499ee65a3ee48d7788_D20210617-20210617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-17</startDate>
            <endDate>2021-06-17</endDate>
        </period>
    </context>
    <context id="ia28b5293c7a442a1b282883ce9f51714_D20210617-20210617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-17</startDate>
            <endDate>2021-06-17</endDate>
        </period>
    </context>
    <context id="if0b5328ab51c4ca5b5843c926066e713_D20210617-20210617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-17</startDate>
            <endDate>2021-06-17</endDate>
        </period>
    </context>
    <context id="ia0066f33074743339653dd14619b7e1e_D20210617-20210617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-17</startDate>
            <endDate>2021-06-17</endDate>
        </period>
    </context>
    <context id="i4cf345ba0efd409ab1d3a3013de7de83_D20210617-20210617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-17</startDate>
            <endDate>2021-06-17</endDate>
        </period>
    </context>
    <context id="i33bd27ed8fae4b699caa054e910ef6da_D20210222-20210222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BiotheranosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-22</startDate>
            <endDate>2021-02-22</endDate>
        </period>
    </context>
    <context id="iec8c75e6a6ac424c8336a8c73d23c503_I20210222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BiotheranosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-22</instant>
        </period>
    </context>
    <context id="icf15ef9e7b8d4ce0b6f697ed71d50240_D20210301-20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:DiagenodeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-01</endDate>
        </period>
    </context>
    <context id="ibfa5ce4594b64da29ce0bdebe52e6a48_I20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:DiagenodeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-01</instant>
        </period>
    </context>
    <context id="i2ff71b48fe0e4e9d9e59ac8a919283de_D20210301-20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:DiagenodeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-01</endDate>
        </period>
    </context>
    <context id="i0e52565dcf6d4e319cc9bb4516138aec_D20210301-20210301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:DiagenodeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-01</endDate>
        </period>
    </context>
    <context id="i601f6bd5a6a04f1ba94dff4501f86d1d_D20210104-20210104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SomatexMedicalTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-04</startDate>
            <endDate>2021-01-04</endDate>
        </period>
    </context>
    <context id="id9cb5bfd9d0b4a7bb1e06960147c3f37_I20210104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SomatexMedicalTechnologiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-04</instant>
        </period>
    </context>
    <context id="i95400d7ffd0145a6902213bb3a8fd6e5_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:NXCImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="ic7e22da3089645eda9e0ac21e97119f1_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:NXCImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="if19332d7f2bc4032add3a47ca74898dd_D20200823-20200823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-23</startDate>
            <endDate>2020-08-23</endDate>
        </period>
    </context>
    <context id="ib2c5f4cc59d642e7b734717eb34e002e_I20200823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">holx:ContingentHoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-23</instant>
        </period>
    </context>
    <context id="if929571277ff41218f0486d616483faa_I20200823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-23</instant>
        </period>
    </context>
    <context id="icb56805faa3a44cd9925ebb00f16e8b2_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i0f02945eed7a4b80bf799a5f378886e3_D20200823-20200823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-23</startDate>
            <endDate>2020-08-23</endDate>
        </period>
    </context>
    <context id="icb63ed4e502448c29aeca44e256133e3_D20200823-20200823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-23</startDate>
            <endDate>2020-08-23</endDate>
        </period>
    </context>
    <context id="i7c4ac52d74224b66838d0679adb1ed3b_D20200203-20200203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:HealthBeaconsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-03</startDate>
            <endDate>2020-02-03</endDate>
        </period>
    </context>
    <context id="ie1847e23bfb6472dbc395f6d1338a8db_I20200203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:HealthBeaconsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-03</instant>
        </period>
    </context>
    <context id="i264ebea292b04fd29f44c37de6914f8c_D20191230-20191230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AlphaImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2019-12-30</endDate>
        </period>
    </context>
    <context id="i043ca86798494f61b2666b1a7f46ddd4_I20191230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AlphaImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-30</instant>
        </period>
    </context>
    <context id="ie6fd1be7827e4d14a8a0c3642ea41642_D20191230-20191230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AlphaImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2019-12-30</endDate>
        </period>
    </context>
    <context id="i7606589a8d9a46508518e654ca7bc3cd_I20190801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-01</instant>
        </period>
    </context>
    <context id="iee122e2193954283b59296f2f329c3f5_D20190801-20190801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-01</endDate>
        </period>
    </context>
    <context id="i09ddd178ba8e4ea48372984e4d5984f4_D20190901-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="iafd366364b034ade874e71b313ac5811_I20191120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-20</instant>
        </period>
    </context>
    <context id="i2d5a252316d24ba8bf7db1b4788097eb_D20191121-20191121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-21</startDate>
            <endDate>2019-11-21</endDate>
        </period>
    </context>
    <context id="i14f9866ecdf54b2f82e4e696f4ee2148_D20191101-20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2019-11-30</endDate>
        </period>
    </context>
    <context id="i6cf6aa2100404a05becfe250085e5d00_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i14df8e75f81d4e468e9e9ccc3560103e_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="id1eaaa8f5b1844eca34f3c569e39abce_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i64adc24ac247463eb19f42515cbcb2b1_I20191121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-21</instant>
        </period>
    </context>
    <context id="i93381ce7098c4e4fa2bb4eea52c5dce4_D20191121-20191121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-21</startDate>
            <endDate>2019-11-21</endDate>
        </period>
    </context>
    <context id="i13826201466c4300b5dd607143edc940_D20191121-20191121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-21</startDate>
            <endDate>2019-11-21</endDate>
        </period>
    </context>
    <context id="iaa6bff4ae2dc4a33986e101d589e889a_D20191121-20191121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-21</startDate>
            <endDate>2019-11-21</endDate>
        </period>
    </context>
    <context id="i89c6030b3fa74130a05c86c5566ac9b5_I20191120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-20</instant>
        </period>
    </context>
    <context id="icd5055934cbe40cc89289656c936a8cd_D20191120-20191120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-20</startDate>
            <endDate>2019-11-20</endDate>
        </period>
    </context>
    <context id="id999567ff4ad4d47967ba1b3ba2d4f74_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ieb526c3393b94999af44e0f2283027b9_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="ie01a803f233b45f4a49380b21ad6bb32_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i8d24eb58cd394fae908cb1b14bef726b_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="ife6cd667a004466dbd21c797fb6eb40b_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i4475d98ff97042aab50ce4cee82db95b_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ice236c25c4d740418e834bf0afc51506_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i1964d49d44004c788bf1f11e793a2e68_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i5ff6e83c3f4f43a292e67915ac446908_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i9c8160a52fd54288931c8a6169582fbc_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i2f1fa7442a694b4fbb79b5dea180468f_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="ia5529a4948994271968a3ed7d11437fa_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ibf97edf455654668b98e5a775e14b2d5_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i023aa7ed3f4f4c63b7915aaca3a74a20_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ibfa1efc297734235ad6cd2cb7b00179e_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i27fc517175434926997757aeb6acf88f_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i1e480c0e3a7a477b9e530aae1be7fb57_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i07ebc1d0fd124863ae761151644bf529_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i31d3ec20ba1341c886214cb33feb29ee_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:PercentageAddedtoEurodollarRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i4f04002445d14733ac6500556e77b603_I20181217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-17</instant>
        </period>
    </context>
    <context id="i9dcce0b55c1f4c47947079e2231dd5ff_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:RevolverMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:PercentageAddedtoEurodollarRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i452a598227b942de9d498139c901ddd7_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i7e72c82ce3de4fdfbe618331b89acadd_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i4b58c2da43604857b653e5db4b73edfd_D20201227-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i9b5b7a6104f348f895e5d94b65b73817_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i445296b9bcdf4ecfb15eb4fdf4e5f027_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i8ce4e8f765314eb29fce3b97b407943b_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i591133f22d3243e1ad73bed94da1fe58_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="ic3a95a70aff44f249453fd1c435fc905_I20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="i4907eca3275146f2be21f4eb741ba4b0_I20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-28</instant>
        </period>
    </context>
    <context id="i6dadc087c8a44b1da848875eb301fdf0_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="icb207831ddaa4d53943e75a7eb55d27d_I20201015">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-15</instant>
        </period>
    </context>
    <context id="idcd52cb6d519499f96285824f70d71e3_D20201015-20201015">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-15</startDate>
            <endDate>2020-10-15</endDate>
        </period>
    </context>
    <context id="i35ee10ac5818441fa558f668e84866f4_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i99efd783beac43bc87299f6deef20b60_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="if5751d5d110e4560bd36bc872e1c4b0e_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="ia37016a8326544bf8a213352899c6992_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i272408a201f84cd288d1a786c8851839_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="i58a7d1a68082480f9d9f002f635ba871_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="i1fbee7ea3857414fa862793ac5e38693_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="i9b55461839564a798b7bb1fc48436aca_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="i258e1d37987f4730b42e74f9f49dd3b4_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="i7f78f01fcb324006bd1e7e387d41e29e_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="i329f003f9cc04450b29fe980f0e42689_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="ie522d6c7b67b40d19313f779c8b07346_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i7d1ba28aff8c4b5eb47bf61baea22a44_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i2247e22bbae24374988ac11163883a5c_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i8698881588e046c79a6a901616722216_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="if54bade04c4249debfc877171a9be8f7_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="iaeeaee82866e48a589b1b33acc7cf61a_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="id87e5e40d00a4f109965253aef07499a_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i7f75b26e46cf4818a4e3b058a04c9785_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i6e93a00f39ec434891148097002f9117_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="ice0bd1095b304c78a2f49ad45c325064_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i866deb20efa24ed4b2313072a748ba62_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i683d2ded0a1c4448856d8951affc8993_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i51b89923ffd8491d8c6ac3b49ee1985b_D20210326-20210326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-26</startDate>
            <endDate>2021-03-26</endDate>
        </period>
    </context>
    <context id="i799dc9d3fd134b658546a8859e0bb7ae_I20210611">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-11</instant>
        </period>
    </context>
    <context id="i50f502634b964d3ca840a4e7ff046d9d_I20210617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-17</instant>
        </period>
    </context>
    <context id="i9d26208b685b4dc0a4c5422ac184fb3b_I20210617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:MobidiagOyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-17</instant>
        </period>
    </context>
    <context id="i04634b19698943588e231edf3a1fa51a_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="i1965b6dfa45f42e1a36b9b6f6c6d19d2_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="ic2fab027ef184f10a81089fce6835a3e_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i2cfbe0dfa54a401c9663f0101346df6a_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i53fb7ba0b756458fae9440481e4b1c22_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="ib59ed9e2e7fe4b71b57f28d948814de5_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="ic1ec4ff7f312462e92283befc2b78645_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="ic77447b8b8db4b3697eaad437ad6372d_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i23614fef663042c1aef8cb0f986983b3_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i52de0b3b7ed043329021533a23fc5c50_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i9b050d1edde04dccb1a376a9d0b26d1f_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i1b53a2d42b634620b3416e3dd2c3f7fd_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i02decbf01d7d47ad8413a646bb6b58c6_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="ifd2ee8ee3be840b8b6afa6175fefbb69_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="icee5b045a830452083febd09cec762d0_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i41d042b1583d4cb0a63cc089c4cd48d0_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i8538addfef6040808efa59ad875c5c67_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i18ac8b8a2f674e00a863ad723f51cfd6_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i8385c3be2e32406d80f1e6926ed63258_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i4ba1880cecac4f61867704cf61543765_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="if95c5e17cb0246e28396e701eba8a8b6_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i5816cff90a9247a296c2e48045af6f9b_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i1aa79e6d2f224939b78d3422b131e66e_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ied7c65430e934024b713ad4d1d12d274_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="ifc35c56bdabd41c5a37c1ec58d24f4f5_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="icd682c98bcc54a639ecf216a7a2959ac_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="ic10b5e7bddbb4679b081afb2b91bfb10_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i8f76a7b44a7f4089bbc36c650997a1cf_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i6fe6078ee0384409bc3ef5dd79db3bdd_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i4e9af5310502412a90c2f809682d972d_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i03f4085d035d44bdb57e7576c9d82462_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i00326496b5524aacb14a40d333ddb070_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="id8706ab009f34acbab9f1c8ba66a6842_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="ieab668871ebf4bef88a6c7d0534148b3_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i16e7d68e0cf04c83bf036bb7dfc90e9b_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="iaae1b64b6b3f48efa2eeddd04c00405c_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i4dd1442bbab54dbc9df7a9a1b52d46fe_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i39a6ba9e2ef34dbe8c1dcffcf164d2cf_I20180727">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:MinervaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-27</instant>
        </period>
    </context>
    <context id="ie3638767d08c4249aa0ae3d34c62d59b_D20160304-20160304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:MinervaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-03-04</startDate>
            <endDate>2016-03-04</endDate>
        </period>
    </context>
    <context id="id9a4160e20ff4e29b6e0bd222066214d_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="idaa68ec927564bfca7dcc39909e9c4fa_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i1234ad1f257543fbb603a27545e882e2_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i9d84692aad2a413f82da74256f73cc99_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i2230d555087a45db84354397ed80a969_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="ida25fb7963fd417b8fbb79c5404488ed_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="id0987e1d0aaa4f3383d2308a12f86767_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i553a342864f64203bc6682daf196a414_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="ic39037a65c534a348a1153bbf85b4fc5_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i59e3e6acc75043868fc4bc1208d0fa04_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i8c5f40b1155e42a0be6aa12fbb7f0a8f_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i7a1e2756a1a84d33aa95630ed4272394_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="idaa0f682791b44ba8313cfd9634b51ee_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i9731e33a8f0b424eaba61dcf82dc6156_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i0b98263fc02a43c48ac6469052188efc_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i2537666870e44ae59702cc35894247ad_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="ic00ad5ce544040b6afe86e61bdea57b5_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i435b9707d2fe407aa57aa940706fcc51_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i1b21698ef10e487fa17ed0655685000f_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i264336fb43c14902b7b5f7a3b3df7d37_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i7d848d86c60e4d0aa176969dea483771_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i18f952d8a51d45a9bffe628448f2117a_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i1422e12662974138ae356309626aef3b_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="ic793a7813f49401bb24c5dd7cc020e8e_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="ib360d5983d9344da99378ac890629c00_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i8cf709f04c574bb7bf53a2294a770b40_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="icddd037fe3094f77b5b90963f5441115_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i84f82c4a5b2041568af213a793563e12_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i9a91ec6a807647289f3e38f578c2885a_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i27dc34faa8364f4eb609e7d27d755da2_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i24d5fbce3a404b1b9a92d452b7bb7142_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i5f3a48b77de044949e38a6dcf4477c25_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i6fa919d800b84313aa121769ee6efa38_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i4e3cad14bf6540c18eb9197a41e6af8e_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="if46a501e3c8143fda11f33dbbf4fbbcd_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="ia749d5e6937a406db2e72272ecc2a906_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="ib37462047fc345a18bfadcd2c9728203_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:MarketBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="id8baaf1fbd5542649315b37eae7cf33e_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:PSUFreeCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i77a3c47ab1fb449ba0ebc5b0c207c416_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:PSUFreeCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i6c9fca34b58b4ebba0cc95c584d6b02b_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:MarketBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="id4b184eeb519428da954a2668ba86020_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:RSUPSUMSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i3caedad63674472cbf33284dfc9a7524_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="ie88ebb9dd3ef4963ba6b902a27fde1c5_D20200927-20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-03-27</endDate>
        </period>
    </context>
    <context id="i2a95db51a148444d8df50afc67ece6af_D20190929-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ic40f282c064341a7b2e6d34548211fb3_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i19b4c219fe024c889dd3632f6507458c_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="if66a8dd5446541e3be680d3c337846e5_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="ib955694d82bc4bff8c3031d2c76b5e8e_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="ide8ecf9b05cf4aea8c640173d743b3ce_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="id09f54a49ec641f7a9c21dbaaf2c903b_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="ia95ae01021fa4b75996e32a548c2726f_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="ic41dd5b435484b6ba40f0f2cd734acdc_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="iea58530cbef34fd4931abfeb77c65007_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i1dbaa5c4c5c5468289373830c34f9e6e_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="ica1034e428864cd1afdca20ce40a8586_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i17f5a2a375e1486ca6d00e2139870be1_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i5912cf2562634c4897ffcde39c504296_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="idaca532c37e24e76abac2b8d66a14f2a_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="iee210605634a465684ebf982ac3ed2bc_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="id9a3a9e2d8cd44ed88d12970a32c6cef_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i9949f8f813ca4908bd00edad279fdace_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i18d768e600b245188ed95ec4ca093d27_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ia430a857ed8348cb98df45af3bff355a_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i0eacccfdfc914a0fb2100fb0647df849_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i4d7a7aca5d7d45618edcd0ce6bd59a88_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i6943392b65c14cf3ab969335b3f5c944_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i8cad5c97002944c5ab199f630a9804e6_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i028a89b44bdc443fbc942f81e8a81c2a_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i1e661b9ad8374ea08e1defa5f7c60aba_I20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="i0cc9805487b14e7296d764cc86233f69_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i43cbf5cabe2d4af2b65badbd45477dcf_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i169a132e711041b39b7f4c5100d3224a_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i49753b0eae784ff2ab9d20c18d01ffec_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i57d0a50ebf48490aa0a913feb0708380_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CustomerRelationshipsContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i863480533e024d8fa95b6d2bedd39955_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CustomerRelationshipsContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i354e119d0fae46c79299b854fd149cf0_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i777f5551309a464794664ce33991c02b_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i7a1d948b692943219190603362c58948_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i9a5f442490284f8eb7d19616e6f5a406_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i216e8a1391484fcf90993e52fcce3926_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:BusinessLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i80816070e8814fa082717580347899ab_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:BusinessLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i71465b2ac88b48b0a8a65c9d19ca9e43_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:AcquiredintangibleassetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="id6d5a0c8113a44b1ab58702864454fbd_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:AcquiredintangibleassetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i1c78f81f4dc14e4c80085b6397cfbbc4_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:InternalusesoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i9346ea30a0ce48709755099832433c82_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:InternalusesoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ia9374a44c792409bb6e84be04009cf2c_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CapitalizedsoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="id992e72f22404311bf2349ba1f18c100_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CapitalizedsoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i17ce81e7ee4c430192d40261507faf9e_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i67bef9095bf547108bf64353f12a5efa_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="ie1d03b89c2cd46c8b689923ced265e84_I20210327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-27</instant>
        </period>
    </context>
    <context id="i4ff2910c781f4a73b76fc57f6588936e_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ie54cb9e528944fd09a387c1fbd3869b2_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i10eb8034808e433f8c962dfd384c4804_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ifebb08681666403a84ebbf74112b4eb6_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i94e3de8bf3624135ab7d18e1e91c29f6_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i0087149b23e7436988b3b251c5cba1cd_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i6d4b5d09721f44e6aab3f827d2d52aee_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i61d813ca92d74906813eda4366974a47_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i0c7acad28e074461824c04de2811d59b_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i4cda94d3c28e41afb2a42d1c640a9558_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i8b595945346f488591f6734675e5bbc7_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i7e9aeea6421a483a9877f65783d68521_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="ibc95c0525971424ca911fedd93ca98cf_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i9d40f0fd77d34330b52e8a8f921c4b22_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i8fe14ed2af474833a427512772ec787c_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i8c2348d216e0450a960b7ddce90b14d8_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <context id="i8f16f7fecd444a7e839c00b1e6b16900_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="ie1db5b374d2e42f2980c21955a6c48d7_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i7bf24f113b134bd6ad61f3c2d4372c97_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i9d147650821f4b7eafa8239fe1a67337_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i202bf7e9908f4a88988d987295f24bf9_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i50d0a909334a49d38f7058d971ae3d3e_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="id83350261e414219bbdc2563d9573d29_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i082299dec4444554933007b3eb2589d9_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="id64f5775615a48e3b594627ba96e48e2_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="ifa6aa9d198924a13b4507ae621cfca92_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i961c9373b1364d32bae836297e84a344_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="id4e6817a851b427a92b0c7fe72a3bbfb_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i20f566a19c874603ae7ac1c2f276af8b_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i4075c4c45421491e8f17e3328901d09b_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i2d085e73dd1a41b2ac1e4ef320989c1c_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i3114f8a48396426d88640981268e8d43_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="iccef93e68c604a7c8257204c91951d7d_D20190929-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="iab35dca88c4a489cb3a6e5e8db0006d8_I20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="iaa0f9b8412b64c26a40f845a43f78503_I20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="i91d506f85cee45e586282ab07a85b12d_I20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="i2a003aff269b4a04b704dad4de10b923_I20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="ib0df6681d8a44b95b7eecdf8e0e95b6c_I20191211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">holx:December112019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-11</instant>
        </period>
    </context>
    <context id="i42410f9e1104449eae75741c00a10044_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:December112019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="icbb1f800737f42a09fc4ad36d6f50272_D20201209-20201209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">holx:December112020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-09</startDate>
            <endDate>2020-12-09</endDate>
        </period>
    </context>
    <context id="iecca63b99d6b4da2bfd35be5986c1ad1_I20201209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">holx:December112020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-09</instant>
        </period>
    </context>
    <context id="i2af30393c63846529254a9f5fdc55b28_D20210328-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:December112020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-28</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="iae354d54c17140f88ee32c1be6023458_D20200927-20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:December112020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2021-06-26</endDate>
        </period>
    </context>
    <context id="i44c5cb5c5b47462190024c645f543472_I20210626">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:December112020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-26</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="project">
        <measure>holx:project</measure>
    </unit>
    <unit id="petition">
        <measure>holx:petition</measure>
    </unit>
    <unit id="segment">
        <measure>holx:Segment</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80L2ZyYWc6YWM0NmVjMzg2NTJmNDUwMTkwZGNhYWE5MWY3NzNlYmYvdGFibGU6NGUxZjE1ZDc0YmExNGNmMzlhZDJjZmU5ZmY5N2VhNDMvdGFibGVyYW5nZTo0ZTFmMTVkNzRiYTE0Y2YzOWFkMmNmZTlmZjk3ZWE0M18yLTEtMS0xLTA_21c9534f-40c0-4e7e-9e6d-d93c854d33bd">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80L2ZyYWc6YWM0NmVjMzg2NTJmNDUwMTkwZGNhYWE5MWY3NzNlYmYvdGFibGU6NGUxZjE1ZDc0YmExNGNmMzlhZDJjZmU5ZmY5N2VhNDMvdGFibGVyYW5nZTo0ZTFmMTVkNzRiYTE0Y2YzOWFkMmNmZTlmZjk3ZWE0M18zLTEtMS0xLTA_2f43af16-ffd8-48a7-bc82-59c1e8ce653e">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80L2ZyYWc6YWM0NmVjMzg2NTJmNDUwMTkwZGNhYWE5MWY3NzNlYmYvdGFibGU6NGUxZjE1ZDc0YmExNGNmMzlhZDJjZmU5ZmY5N2VhNDMvdGFibGVyYW5nZTo0ZTFmMTVkNzRiYTE0Y2YzOWFkMmNmZTlmZjk3ZWE0M180LTEtMS0xLTA_3b302a5a-bfa2-4bb2-b02a-afe9821a967c">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80L2ZyYWc6YWM0NmVjMzg2NTJmNDUwMTkwZGNhYWE5MWY3NzNlYmYvdGFibGU6NGUxZjE1ZDc0YmExNGNmMzlhZDJjZmU5ZmY5N2VhNDMvdGFibGVyYW5nZTo0ZTFmMTVkNzRiYTE0Y2YzOWFkMmNmZTlmZjk3ZWE0M181LTEtMS0xLTA_8a443a5a-6da7-4d8e-b1f1-e67be2047279">0000859737</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80L2ZyYWc6YWM0NmVjMzg2NTJmNDUwMTkwZGNhYWE5MWY3NzNlYmYvdGFibGU6NGUxZjE1ZDc0YmExNGNmMzlhZDJjZmU5ZmY5N2VhNDMvdGFibGVyYW5nZTo0ZTFmMTVkNzRiYTE0Y2YzOWFkMmNmZTlmZjk3ZWE0M182LTEtMS0xLTA_0f795e9d-b201-4fbb-9e6b-4c8b7a8f7fbf">--09-28</dei:CurrentFiscalYearEndDate>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i3077d84f238341b6b299f541f5f835d3_I20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80MC9mcmFnOjQ5ZjJhN2I2MWFhNDRhYTNhZmE5ODgxZGRmZTI0Mjk1L3RhYmxlOmMzYjNlN2ViOGJlYjRlMjFhYTA0NjYzZTNiMGMwY2NjL3RhYmxlcmFuZ2U6YzNiM2U3ZWI4YmViNGUyMWFhMDQ2NjNlM2IwYzBjY2NfMi0yLTEtMS0w_dd27be1a-a7a0-4c4f-ad50-de8c54948322">P6M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i6ac5e12a191d4b3dba030b9849f5d77b_I20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80MC9mcmFnOjQ5ZjJhN2I2MWFhNDRhYTNhZmE5ODgxZGRmZTI0Mjk1L3RhYmxlOmMzYjNlN2ViOGJlYjRlMjFhYTA0NjYzZTNiMGMwY2NjL3RhYmxlcmFuZ2U6YzNiM2U3ZWI4YmViNGUyMWFhMDQ2NjNlM2IwYzBjY2NfMy0yLTEtMS0w_570c00d9-8466-4c74-925b-0be94c984bf2">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i4fa166ab972a4216b61bb29fe09583b5_I20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80MC9mcmFnOjQ5ZjJhN2I2MWFhNDRhYTNhZmE5ODgxZGRmZTI0Mjk1L3RhYmxlOmMzYjNlN2ViOGJlYjRlMjFhYTA0NjYzZTNiMGMwY2NjL3RhYmxlcmFuZ2U6YzNiM2U3ZWI4YmViNGUyMWFhMDQ2NjNlM2IwYzBjY2NfNC0yLTEtMS0w_b3aba6b8-441e-4e3d-9158-47417e00db3b">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="ia3c7225d747b441aa0d9f695fe415128_I20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80MC9mcmFnOjQ5ZjJhN2I2MWFhNDRhYTNhZmE5ODgxZGRmZTI0Mjk1L3RhYmxlOmMzYjNlN2ViOGJlYjRlMjFhYTA0NjYzZTNiMGMwY2NjL3RhYmxlcmFuZ2U6YzNiM2U3ZWI4YmViNGUyMWFhMDQ2NjNlM2IwYzBjY2NfNS0yLTEtMS0w_de12258c-b2f8-4b4c-8220-b1719e072561">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="icaee218d084046ed9e76934876d4b3ff_I20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80MC9mcmFnOjQ5ZjJhN2I2MWFhNDRhYTNhZmE5ODgxZGRmZTI0Mjk1L3RhYmxlOmMzYjNlN2ViOGJlYjRlMjFhYTA0NjYzZTNiMGMwY2NjL3RhYmxlcmFuZ2U6YzNiM2U3ZWI4YmViNGUyMWFhMDQ2NjNlM2IwYzBjY2NfNi0yLTEtMS0w_542a2827-6f2e-42b9-87b9-de0ee0b34bd0">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <dei:DocumentType
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGV4dHJlZ2lvbjo0NDVhODZmOTNmNTE0YTAyODU0YWIyNzBhMDZkMjVkZF8yMjg0_bd765da0-bcbc-4a25-bcff-4aa026ac5f28">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGFibGU6YmRiMDBmNWVkNmVlNGJiODkzNzQ1OWIwNjQzODk5ZWQvdGFibGVyYW5nZTpiZGIwMGY1ZWQ2ZWU0YmI4OTM3NDU5YjA2NDM4OTllZF8wLTAtMS0xLTA_c1135136-72b0-421c-8b8a-c3a991780082">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGV4dHJlZ2lvbjo0NDVhODZmOTNmNTE0YTAyODU0YWIyNzBhMDZkMjVkZF8yNjA_0e7ce81f-a331-495d-a2cd-453aad64cb35">2021-06-26</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGFibGU6N2Q5OWRkZTQ1ODFmNDJjMDhlYzQ4MTBjNzc1YWNiMzIvdGFibGVyYW5nZTo3ZDk5ZGRlNDU4MWY0MmMwOGVjNDgxMGM3NzVhY2IzMl8wLTAtMS0xLTA_5fba6855-4dcd-449e-9480-2d20a07d1416">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGV4dHJlZ2lvbjo0NDVhODZmOTNmNTE0YTAyODU0YWIyNzBhMDZkMjVkZF8yMjg1_a3a82e30-5d8f-4c96-9977-59202e8a9d0b">1-36214</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGV4dHJlZ2lvbjo0NDVhODZmOTNmNTE0YTAyODU0YWIyNzBhMDZkMjVkZF8yMjg2_77da53cf-4d29-40cb-8394-85abd4728bf0">HOLOGIC, INC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGFibGU6ZDE0YjJkZGM0M2NhNGEwMmJlYmU3MWI4OTlmOTM4MmUvdGFibGVyYW5nZTpkMTRiMmRkYzQzY2E0YTAyYmViZTcxYjg5OWY5MzgyZV8wLTAtMS0xLTA_b105c742-2eea-404a-99cb-7539f37f2644">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGFibGU6ZDE0YjJkZGM0M2NhNGEwMmJlYmU3MWI4OTlmOTM4MmUvdGFibGVyYW5nZTpkMTRiMmRkYzQzY2E0YTAyYmViZTcxYjg5OWY5MzgyZV8wLTItMS0xLTA_ca732fe7-52bf-4eef-b151-3c982b205807">04-2902449</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGFibGU6ZDE0YjJkZGM0M2NhNGEwMmJlYmU3MWI4OTlmOTM4MmUvdGFibGVyYW5nZTpkMTRiMmRkYzQzY2E0YTAyYmViZTcxYjg5OWY5MzgyZV8yLTAtMS0xLTA_083ce827-142f-4fd3-950e-3865c8bedbb3">250 Campus Drive,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGFibGU6ZDE0YjJkZGM0M2NhNGEwMmJlYmU3MWI4OTlmOTM4MmUvdGFibGVyYW5nZTpkMTRiMmRkYzQzY2E0YTAyYmViZTcxYjg5OWY5MzgyZV8zLTAtMS0xLTA_a8b5f758-5eb9-4a74-995e-0bcc284e5e06">Marlborough,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGFibGU6ZDE0YjJkZGM0M2NhNGEwMmJlYmU3MWI4OTlmOTM4MmUvdGFibGVyYW5nZTpkMTRiMmRkYzQzY2E0YTAyYmViZTcxYjg5OWY5MzgyZV80LTAtMS0xLTA_5e35f54c-e1ed-4b4c-92d6-185f81aa1c08">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGFibGU6ZDE0YjJkZGM0M2NhNGEwMmJlYmU3MWI4OTlmOTM4MmUvdGFibGVyYW5nZTpkMTRiMmRkYzQzY2E0YTAyYmViZTcxYjg5OWY5MzgyZV80LTItMS0xLTA_aaa739dd-0975-4c78-ad75-afd8b783f507">01752</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGV4dHJlZ2lvbjo0NDVhODZmOTNmNTE0YTAyODU0YWIyNzBhMDZkMjVkZF8yMjg3_3cbf6238-8e1d-4345-a9e0-48d5b6fa4ede">(508)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGV4dHJlZ2lvbjo0NDVhODZmOTNmNTE0YTAyODU0YWIyNzBhMDZkMjVkZF8yMjg4_d594aae1-6940-4ced-b42d-5fcb232c2429">263-2900</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGFibGU6Nzk0NGM0OWNlMWU1NDAxNDkyN2UzMGNiYWE5MTJiYTYvdGFibGVyYW5nZTo3OTQ0YzQ5Y2UxZTU0MDE0OTI3ZTMwY2JhYTkxMmJhNl8xLTAtMS0xLTA_98be97c2-5800-4d92-980e-3944931ab35e">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGFibGU6Nzk0NGM0OWNlMWU1NDAxNDkyN2UzMGNiYWE5MTJiYTYvdGFibGVyYW5nZTo3OTQ0YzQ5Y2UxZTU0MDE0OTI3ZTMwY2JhYTkxMmJhNl8xLTEtMS0xLTA_ee630f55-fded-40b8-9b07-92dd60cbebbb">HOLX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGFibGU6Nzk0NGM0OWNlMWU1NDAxNDkyN2UzMGNiYWE5MTJiYTYvdGFibGVyYW5nZTo3OTQ0YzQ5Y2UxZTU0MDE0OTI3ZTMwY2JhYTkxMmJhNl8xLTItMS0xLTA_f7cff6a2-47d3-477b-b4fc-6ead0f71d0e0">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGV4dHJlZ2lvbjo0NDVhODZmOTNmNTE0YTAyODU0YWIyNzBhMDZkMjVkZF8yMjg5_05a9c17c-3b25-4b9c-a3ec-02cac8b5ed84">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGV4dHJlZ2lvbjo0NDVhODZmOTNmNTE0YTAyODU0YWIyNzBhMDZkMjVkZF8yMjkw_626ea319-8bf1-476d-b3f2-58e1c99b8152">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGFibGU6ZDhlODRmY2FmYWMxNGQyNmExNTA1NjA2MDMxNTg1ODQvdGFibGVyYW5nZTpkOGU4NGZjYWZhYzE0ZDI2YTE1MDU2MDYwMzE1ODU4NF8wLTAtMS0xLTA_30cdc33f-0852-42d9-b2b8-ad1fb10e059a">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGFibGU6ZDhlODRmY2FmYWMxNGQyNmExNTA1NjA2MDMxNTg1ODQvdGFibGVyYW5nZTpkOGU4NGZjYWZhYzE0ZDI2YTE1MDU2MDYwMzE1ODU4NF8xLTYtMS0xLTA_72eb0257-280b-40f7-be71-bba1a6b18927">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGFibGU6ZDhlODRmY2FmYWMxNGQyNmExNTA1NjA2MDMxNTg1ODQvdGFibGVyYW5nZTpkOGU4NGZjYWZhYzE0ZDI2YTE1MDU2MDYwMzE1ODU4NF8yLTYtMS0xLTA_602b87ea-66dc-470f-9763-ad2f682e9422">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGV4dHJlZ2lvbjo0NDVhODZmOTNmNTE0YTAyODU0YWIyNzBhMDZkMjVkZF8yMjgz_eca745e8-e025-4205-9372-20c616cb2681">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i0a0de2fed4294accb0517140fae5643e_I20210722"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xL2ZyYWc6NDQ1YTg2ZjkzZjUxNGEwMjg1NGFiMjcwYTA2ZDI1ZGQvdGV4dHJlZ2lvbjo0NDVhODZmOTNmNTE0YTAyODU0YWIyNzBhMDZkMjVkZF8yMjAz_4a2f1032-5fe7-4868-b81f-8ca3a1143fff"
      unitRef="shares">253487389</dei:EntityCommonStockSharesOutstanding>
    <holx:ProductRevenue
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMy0xLTEtMS0w_9543635d-51f6-4f97-b86f-a91d6f4300a9"
      unitRef="usd">995200000</holx:ProductRevenue>
    <holx:ProductRevenue
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMy0zLTEtMS0w_e02d1b2a-9efb-4260-a357-edc9318778c8"
      unitRef="usd">701600000</holx:ProductRevenue>
    <holx:ProductRevenue
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMy01LTEtMS0w_2013a8c3-83bf-4166-aa84-577bed122f19"
      unitRef="usd">3829400000</holx:ProductRevenue>
    <holx:ProductRevenue
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMy03LTEtMS0w_d0a65780-42bd-4d54-a15f-15a2d2224eb2"
      unitRef="usd">2024500000</holx:ProductRevenue>
    <holx:ServiceRevenue
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfNC0xLTEtMS0w_d9330061-7f7c-4e92-87f6-e658deda902a"
      unitRef="usd">173100000</holx:ServiceRevenue>
    <holx:ServiceRevenue
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfNC0zLTEtMS0w_94da7801-dfea-46fd-8531-2206dbbbdac8"
      unitRef="usd">121300000</holx:ServiceRevenue>
    <holx:ServiceRevenue
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfNC01LTEtMS0w_a653ba17-0c2e-4789-96aa-2029ecc5e330"
      unitRef="usd">486300000</holx:ServiceRevenue>
    <holx:ServiceRevenue
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfNC03LTEtMS0w_d4472762-d5ae-4b18-bd0a-ef33e8780382"
      unitRef="usd">405000000.0</holx:ServiceRevenue>
    <us-gaap:Revenues
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfNS0xLTEtMS0w_312fc218-9ab3-43c9-8ab4-3ad6183f2466"
      unitRef="usd">1168300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfNS0zLTEtMS0w_17f44034-2541-4073-8560-fd5c966a6454"
      unitRef="usd">822900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfNS01LTEtMS0w_b689516e-3744-4e8e-a46a-075a6a9e432b"
      unitRef="usd">4315700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfNS03LTEtMS0w_763908e1-036d-4620-af2b-5e0c0436eded"
      unitRef="usd">2429500000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfNy0xLTEtMS0w_5b702baf-26f5-4937-a9ce-dd33cdbdf996"
      unitRef="usd">303900000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfNy0zLTEtMS0w_4597afb3-3394-4be4-b988-5f7508a45d1a"
      unitRef="usd">225100000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfNy01LTEtMS0w_d8bed872-9932-44df-94b5-fbbd6b08612d"
      unitRef="usd">889100000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfNy03LTEtMS0w_e48f5e1e-5e49-455b-a5d1-35d10364a4c9"
      unitRef="usd">685900000</us-gaap:CostOfGoodsAndServicesSold>
    <holx:AmortizationCostofGoodsSold
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfOC0xLTEtMS0w_3e3604f7-4b77-44e2-ab92-5654b1750482"
      unitRef="usd">68100000</holx:AmortizationCostofGoodsSold>
    <holx:AmortizationCostofGoodsSold
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfOC0zLTEtMS0w_24d6d1b2-7385-43cc-a4a8-1b3398af507d"
      unitRef="usd">62900000</holx:AmortizationCostofGoodsSold>
    <holx:AmortizationCostofGoodsSold
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfOC01LTEtMS0w_1136fd77-31d4-408e-baf0-876406acd696"
      unitRef="usd">194200000</holx:AmortizationCostofGoodsSold>
    <holx:AmortizationCostofGoodsSold
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfOC03LTEtMS0w_2653d55c-4a0c-44e3-b94f-80f5f96146d3"
      unitRef="usd">189400000</holx:AmortizationCostofGoodsSold>
    <holx:CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfOS0xLTEtMS0w_832d7d68-e0a5-455d-a974-87f622ca6f3e"
      unitRef="usd">0</holx:CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment>
    <holx:CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfOS0zLTEtMS0w_71e52ea5-6836-405a-a2e4-a1482956988d"
      unitRef="usd">0</holx:CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment>
    <holx:CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfOS01LTEtMS0w_a90ff3a7-806f-47c3-9d2a-6326bed84d9f"
      unitRef="usd">0</holx:CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment>
    <holx:CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfOS03LTEtMS0w_cedffe0c-4155-4618-aa40-29847bc70f39"
      unitRef="usd">25800000</holx:CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment>
    <holx:Costofservice
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTAtMS0xLTEtMA_56afa27c-b0d5-4042-9c63-40ab2bb83874"
      unitRef="usd">94700000</holx:Costofservice>
    <holx:Costofservice
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTAtMy0xLTEtMA_3d89f044-7e36-47f3-9863-e7db3cc20ecc"
      unitRef="usd">68800000</holx:Costofservice>
    <holx:Costofservice
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTAtNS0xLTEtMA_d3e9d840-2f92-4d0a-b8ff-702eaf0757bc"
      unitRef="usd">264700000</holx:Costofservice>
    <holx:Costofservice
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTAtNy0xLTEtMA_b73eb6ea-bc67-4c70-b5f2-8722ce129c19"
      unitRef="usd">232700000</holx:Costofservice>
    <us-gaap:GrossProfit
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTEtMS0xLTEtMA_4fa75c3c-421c-4d20-b016-e754c4974979"
      unitRef="usd">701600000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTEtMy0xLTEtMA_e59be032-7f80-4f03-84ac-bdfca1ed9613"
      unitRef="usd">466100000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTEtNS0xLTEtMA_034fb45f-af87-46c0-a70d-8c2742d6700d"
      unitRef="usd">2967700000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTEtNy0xLTEtMA_76143fc7-915d-4ecb-93e3-62bb001ac89e"
      unitRef="usd">1295700000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTMtMS0xLTEtMA_ad238b92-a588-4e79-81fe-3f5b1e5ea6ce"
      unitRef="usd">69000000.0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTMtMy0xLTEtMA_a9439290-93bc-4642-ac88-6849f3df5e79"
      unitRef="usd">55100000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTMtNS0xLTEtMA_054f94ab-9bca-4e12-a669-a79840498b53"
      unitRef="usd">199800000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTMtNy0xLTEtMA_692e7a30-9bea-4fd4-9c29-8856198d5b67"
      unitRef="usd">165500000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTQtMS0xLTEtMA_26d18212-2ae5-4a36-805b-fb9851276c8d"
      unitRef="usd">142700000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTQtMy0xLTEtMA_5036c692-f956-403b-bc72-4025ecc159b7"
      unitRef="usd">103500000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTQtNS0xLTEtMA_f044f2bc-1095-484e-bf08-b1d9cddc486b"
      unitRef="usd">402200000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTQtNy0xLTEtMA_a0261263-55a4-41cd-b108-b87b6cb7b97a"
      unitRef="usd">359000000.0</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTUtMS0xLTEtMA_129fb652-1b39-4e80-a84e-cd578f319ff8"
      unitRef="usd">117300000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTUtMy0xLTEtMA_21bde664-d234-48d8-9d2c-3a4b9e6d067f"
      unitRef="usd">105300000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTUtNS0xLTEtMA_414c1bc3-8933-43c5-8ae4-7409fa70703d"
      unitRef="usd">297700000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTUtNy0xLTEtMA_83d23c2e-93db-4d1c-8827-b0a7a643bca3"
      unitRef="usd">259900000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTYtMS0xLTEtMA_e76e7404-dd26-4f5a-8d85-d52e93633157"
      unitRef="usd">10400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTYtMy0xLTEtMA_d31487b4-c4a7-4e20-8d24-3c3410bee113"
      unitRef="usd">10200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTYtNS0xLTEtMA_82dbddec-94ce-4efb-aba6-167be3eed86a"
      unitRef="usd">30700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTYtNy0xLTEtMA_48512354-b84f-4fcd-a132-f17c28539393"
      unitRef="usd">29500000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTctMS0xLTEtMA_160c6ef0-214e-4957-b892-4795222b6798"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTctMy0xLTEtMA_6e657c59-e810-4190-bd0e-0856d5590323"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTctNS0xLTEtMA_53a3196b-1911-4c98-9e44-2baceb19ff14"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTctNy0xLTEtMA_c5283d0b-ac61-4288-b916-c0116272c220"
      unitRef="usd">4400000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTktMS0xLTEtMA_83acd7ee-2328-484b-99fa-783c4f80dba5"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTktMy0xLTEtMA_3258d143-f592-4840-9d78-0ce5e2939ebd"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTktNS0xLTEtMA_9ae1dbb0-c7ab-4e3f-8013-aa52a0816d8f"
      unitRef="usd">10100000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMTktNy0xLTEtMA_f7b0535c-08c5-4699-977d-1a51e953c09f"
      unitRef="usd">-400000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1>
    <us-gaap:RestructuringCharges
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjItMS0xLTEtMA_869e0323-2ca2-4e28-9450-76e6109290ac"
      unitRef="usd">3600000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjItMy0xLTEtMA_a7195ec8-0dd5-4f5a-b943-4e3c09722e9c"
      unitRef="usd">1000000.0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjItNS0xLTEtMA_13e53d86-9a2a-40a0-a48f-65353feb16de"
      unitRef="usd">6600000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjItNy0xLTEtMA_947738a0-6f9a-4883-abad-c4e246829377"
      unitRef="usd">4800000</us-gaap:RestructuringCharges>
    <us-gaap:OperatingExpenses
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjMtMS0xLTEtMA_96d2cc75-5846-4c77-a7ff-c997fa2a4cb5"
      unitRef="usd">343000000.0</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjMtMy0xLTEtMA_4964d5c5-2795-4228-a00b-3d129eebd8e3"
      unitRef="usd">275100000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjMtNS0xLTEtMA_7f3d472d-bb90-440e-b906-b44af687ae90"
      unitRef="usd">926900000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjMtNy0xLTEtMA_e4746e27-d93d-4cf6-8a8b-7d98688191b7"
      unitRef="usd">823500000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjQtMS0xLTEtMA_a68e90c2-0c54-422e-9b58-eb749531f3b1"
      unitRef="usd">358600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjQtMy0xLTEtMA_cbcd2a9a-35b4-4499-a563-125a9adedf73"
      unitRef="usd">191000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjQtNS0xLTEtMA_8d58ca43-afbb-4127-8e04-d528368e53f2"
      unitRef="usd">2040800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjQtNy0xLTEtMA_74001d05-4e4e-42ad-a21f-b5a9a6211014"
      unitRef="usd">472200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjUtMS0xLTEtMA_f0c85aa1-5327-4391-829d-c461682bb167"
      unitRef="usd">400000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjUtMy0xLTEtMA_09039469-0ac2-43d3-b460-291dabb78c39"
      unitRef="usd">500000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjUtNS0xLTEtMA_a50b20d6-d968-45a2-9ee5-8c94e14d9810"
      unitRef="usd">1100000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjUtNy0xLTEtMA_f8a801c0-1467-47eb-91a9-1d1f8d720ab4"
      unitRef="usd">4000000.0</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjYtMS0xLTEtMA_b5a6012b-6449-4215-84d2-813a9a895a74"
      unitRef="usd">21600000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjYtMy0xLTEtMA_1c10482e-9afc-4b24-b526-921d2c2c9d80"
      unitRef="usd">27400000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjYtNS0xLTEtMA_98980795-615f-4128-ba9d-e19061e2ede8"
      unitRef="usd">70900000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjYtNy0xLTEtMA_b3a9b826-6212-46d0-9da7-4253747cc557"
      unitRef="usd">91500000</us-gaap:InterestExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjctMS0xLTEtMA_3687952c-68da-47c6-9da8-a2197f652e23"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjctMy0xLTEtMA_864387c1-44ad-48b4-8ea6-e510d4697152"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjctNS0xLTEtMA_8195198f-e725-4c5e-9beb-5278ef1db3cc"
      unitRef="usd">-21600000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjctNy0xLTEtMA_83546580-672f-42ab-b12f-c103ca0c953e"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjgtMS0xLTEtMA_f8a6f053-8886-451c-805d-d0c115d45cb0"
      unitRef="usd">100000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjgtMy0xLTEtMA_e32fe34c-bffd-40ce-a686-f57cc466dde7"
      unitRef="usd">4300000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjgtNS0xLTEtMA_57a371d8-c9f9-494d-a841-1a4bdfa25ea7"
      unitRef="usd">1100000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjgtNy0xLTEtMA_fc3df5f0-16dd-48bc-a357-d927c081797a"
      unitRef="usd">100000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjktMS0xLTEtMA_b60b5bd3-028a-4f98-8279-bc4030d824d6"
      unitRef="usd">337500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjktMy0xLTEtMA_5375fb48-8425-41a2-ae07-d461d4c296b0"
      unitRef="usd">168400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjktNS0xLTEtMA_0ecc1f44-5804-46d3-9f67-4e3b739540a2"
      unitRef="usd">1950500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMjktNy0xLTEtMA_dbbc108f-606e-42a9-a1c2-cbb0a6abf246"
      unitRef="usd">384800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzAtMS0xLTEtMA_d13b4276-349a-43d3-a5e5-f22dbeed6e84"
      unitRef="usd">69400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzAtMy0xLTEtMA_984443da-51b5-4d0d-a05c-cac122559464"
      unitRef="usd">32000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzAtNS0xLTEtMA_8208f5ab-1a5f-4c0c-a1bf-bf531798df32"
      unitRef="usd">409600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzAtNy0xLTEtMA_10676aab-9b1f-487c-918b-efb57ee72923"
      unitRef="usd">-232100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzEtMS0xLTEtMA_fc9b4fef-c11b-4cd3-81c9-7f1164e45bb4"
      unitRef="usd">268100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzEtMy0xLTEtMA_a1ebf42e-bb5c-46e2-93f9-1044ea1a8174"
      unitRef="usd">136400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzEtNS0xLTEtMA_651bfd97-03b2-4653-857b-b53624225f52"
      unitRef="usd">1540900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzEtNy0xLTEtMA_cb3f2730-aad4-4f8e-a6a6-8383a256931c"
      unitRef="usd">616900000</us-gaap:NetIncomeLoss>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzItMS0xLTEtMA_54279529-6acd-4f45-a5fe-e4239c14eb40"
      unitRef="usd">-300000</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzItMy0xLTEtMA_36ed1392-db9d-42d9-8fb1-9e1e03ccebf0"
      unitRef="usd">-1500000</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzItNS0xLTEtMA_be77ce92-4aaa-49e1-9cf1-12524c78932e"
      unitRef="usd">-1800000</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzItNy0xLTEtMA_b297c116-208f-48f3-af3d-e831b996d536"
      unitRef="usd">-3400000</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <holx:Netincome
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzMtMS0xLTEtMA_d8bf7c9c-44c2-4989-83a6-57eaab86be7d"
      unitRef="usd">268400000</holx:Netincome>
    <holx:Netincome
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzMtMy0xLTEtMA_250b96c7-e4ab-410b-80ac-dedcdae2989c"
      unitRef="usd">137900000</holx:Netincome>
    <holx:Netincome
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzMtNS0xLTEtMA_637f45a2-dc7c-40c4-993b-8faf33f0fe02"
      unitRef="usd">1542700000</holx:Netincome>
    <holx:Netincome
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzMtNy0xLTEtMA_a813372d-4043-4d28-b213-2bca83195895"
      unitRef="usd">620300000</holx:Netincome>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzUtMS0xLTEtMA_610e8576-0ecb-4a67-a78a-ceca357884e5"
      unitRef="usdPerShare">1.05</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzUtMy0xLTEtMA_9ad4235b-f39e-4f70-a61b-f4af47635f6b"
      unitRef="usdPerShare">0.53</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzUtNS0xLTEtMA_0d66fbb0-8a82-41d4-88e3-4504209d05a1"
      unitRef="usdPerShare">5.98</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzUtNy0xLTEtMA_7fbc003c-e502-4c23-b575-a6f4df56c87b"
      unitRef="usdPerShare">2.35</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzYtMS0xLTEtMA_295030a6-d060-45e1-959b-103c012444b7"
      unitRef="usdPerShare">1.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzYtMy0xLTEtMA_8c3cc91c-a419-49b5-a96e-72e0b7d6b335"
      unitRef="usdPerShare">0.53</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzYtNS0xLTEtMA_eb23d583-dd05-437a-b5c8-2613bb7c161e"
      unitRef="usdPerShare">5.93</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzYtNy0xLTEtMA_a97f8a71-41d3-4559-8d88-68476e64c6db"
      unitRef="usdPerShare">2.34</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzgtMS0xLTEtMA_0fff3b40-380a-4443-a811-a4b559c5d641"
      unitRef="shares">256230000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzgtMy0xLTEtMA_b187e632-cc16-4fd9-9939-e41a4155c9e4"
      unitRef="shares">259870000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzgtNS0xLTEtMA_1335417b-5c06-4f73-b2ec-79f5127d930b"
      unitRef="shares">257769000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzgtNy0xLTEtMA_3d7a9c80-2894-468b-9596-366c73cfa8ce"
      unitRef="shares">263667000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzktMS0xLTEtMA_00d58d21-d25a-40d4-b31e-a81ef9b7c2c6"
      unitRef="shares">258581000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzktMy0xLTEtMA_1fc915a6-24af-4008-adb8-5d63fd26c1be"
      unitRef="shares">261047000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzktNS0xLTEtMA_38ac8521-10d3-4b91-8bfd-3e3358acd0c8"
      unitRef="shares">260371000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xNi9mcmFnOjU5NDk2OWUxOGNhMjQ3ZGJiNjAxZDY1OGUyMmQ0ZGQ1L3RhYmxlOjY4MWJiNGYzMTc4NTQ5MGVhNDExY2M1ZDAzZWE1ZDhhL3RhYmxlcmFuZ2U6NjgxYmI0ZjMxNzg1NDkwZWE0MTFjYzVkMDNlYTVkOGFfMzktNy0xLTEtMA_37edcb67-8d3f-4ad1-9446-866ea5ac24ec"
      unitRef="shares">265092000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMi0xLTEtMS0w_e10b46f3-b3eb-4e43-b621-366801f97a21"
      unitRef="usd">268100000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMi0zLTEtMS0w_989be1f3-bf70-4b60-a186-4034e9d2ce36"
      unitRef="usd">136400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMi01LTEtMS0w_651bfd97-03b2-4653-857b-b53624225f52"
      unitRef="usd">1540900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMi03LTEtMS0w_1861cdbd-4db1-4278-853a-c662afed091d"
      unitRef="usd">616900000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMy0xLTEtMS0w_5873000a-67ca-4131-b35e-9a7b5d5cc5ac"
      unitRef="usd">-9400000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMy0zLTEtMS0w_a72ba506-561e-4f08-ac3f-61b00045bdcf"
      unitRef="usd">1400000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMy01LTEtMS0w_6d412da7-9a20-4915-bd73-d567516f00f7"
      unitRef="usd">-1000000.0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMy03LTEtMS0w_8909b7d5-9c7c-453e-af95-08d840acdfb2"
      unitRef="usd">4300000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfOC0wLTEtMS0wL3RleHRyZWdpb246ZGZjYzgyZGEyY2MxNDIyNmJkMjA5ZmQ1MDc3YTIxMTRfODk_9c035bbb-340d-41da-aecd-e4b9c71e66e9"
      unitRef="usd">1000000.0</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfOC0wLTEtMS0wL3RleHRyZWdpb246ZGZjYzgyZGEyY2MxNDIyNmJkMjA5ZmQ1MDc3YTIxMTRfOTc_6d36c724-6659-47f2-beda-c8de0cd074c2"
      unitRef="usd">2200000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfOC0wLTEtMS0wL3RleHRyZWdpb246ZGZjYzgyZGEyY2MxNDIyNmJkMjA5ZmQ1MDc3YTIxMTRfMTU0_e33a6d9d-3497-4968-bff7-a4d3dfcaf3a9"
      unitRef="usd">-1500000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfOC0wLTEtMS0wL3RleHRyZWdpb246ZGZjYzgyZGEyY2MxNDIyNmJkMjA5ZmQ1MDc3YTIxMTRfMTYy_947ed9e6-3e1d-4aa2-ab17-dc81c1cf7ff7"
      unitRef="usd">-7900000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfOS0xLTEtMS0w_66a72ab3-9e71-4b74-9d06-e7f0855ee5a8"
      unitRef="usd">3000000.0</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfOS0zLTEtMS0w_b5cf0b1a-3e1a-401b-ac2c-92e19583ecec"
      unitRef="usd">-4700000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfOS01LTEtMS0w_923b734c-2453-483e-aede-c825fd2773d4"
      unitRef="usd">8000000.0</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfOS03LTEtMS0w_51c990d5-7523-4ea4-80e2-f6189c11b9a2"
      unitRef="usd">-25900000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTAtMS0xLTEtMA_d2be1ce7-0e3e-46f0-a061-024c7cdedd4d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTAtMy0xLTEtMA_cdf89676-fc94-4d8f-8687-6d8e4b4c6981"
      unitRef="usd">-300000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTAtNS0xLTEtMA_f3845a6b-6740-4a79-8a6e-11405eeeabd0"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTAtNy0xLTEtMA_ad9c3767-74c5-4151-995a-906bf555d7bc"
      unitRef="usd">-2000000.0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTEtMS0xLTEtMA_4f8dd1ed-034c-4cfa-a3c3-137f7ea4b885"
      unitRef="usd">-6400000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTEtMy0xLTEtMA_0332b86b-6cda-4e3e-b044-0ee23c38d5b0"
      unitRef="usd">-3000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTEtNS0xLTEtMA_886d9648-4e20-4c83-b28f-2a593b7badb5"
      unitRef="usd">7500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTEtNy0xLTEtMA_71d193dd-2374-4f98-bb4d-0670a72c3248"
      unitRef="usd">-19600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTItMS0xLTEtMA_9088cd85-0398-42ce-a646-18a5275e91e0"
      unitRef="usd">261700000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTItMy0xLTEtMA_49578e4f-4562-4175-bf25-7d9c9b74166e"
      unitRef="usd">133400000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTItNS0xLTEtMA_9cd1a76d-0769-4f12-be74-dfb9e222a9f8"
      unitRef="usd">1548400000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTItNy0xLTEtMA_10cb266f-5ca3-4dea-9b42-13d6bf5588f2"
      unitRef="usd">597300000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTQtMS0xLTEtMA_b4697293-8317-4ee5-bdf1-90bdb17eb1a0"
      unitRef="usd">-300000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTQtMy0xLTEtMA_baf871c4-e459-44c0-b602-4c9ef98ceb42"
      unitRef="usd">-1500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTQtNS0xLTEtMA_f0635d2c-ec55-4197-abb6-d96f53c04f08"
      unitRef="usd">-1800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTQtNy0xLTEtMA_2085b6e3-991a-4ad6-a446-2b68891eee07"
      unitRef="usd">-3400000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTUtMS0xLTEtMA_dda4abfe-db5c-42bd-9185-58aa2e54b0df"
      unitRef="usd">-300000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTUtMy0xLTEtMA_8150b6b2-b2dd-4648-af4b-db6fe4599da9"
      unitRef="usd">-1500000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTUtNS0xLTEtMA_38f4354b-82bd-4f69-9a33-c08cd85461c9"
      unitRef="usd">-1800000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTUtNy0xLTEtMA_ae5cff80-e1e9-4109-b1d2-7de52f4a3bac"
      unitRef="usd">-3400000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <holx:ComprehensiveIncome
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTYtMS0xLTEtMA_e0d5488c-e377-437a-bba4-a9ea6821fb01"
      unitRef="usd">262000000.0</holx:ComprehensiveIncome>
    <holx:ComprehensiveIncome
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTYtMy0xLTEtMA_1b29d958-279b-45bc-8f94-58d17184413a"
      unitRef="usd">134900000</holx:ComprehensiveIncome>
    <holx:ComprehensiveIncome
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTYtNS0xLTEtMA_9957ed99-c527-4a54-827f-ea6320419e9e"
      unitRef="usd">1550200000</holx:ComprehensiveIncome>
    <holx:ComprehensiveIncome
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8xOS9mcmFnOmQ2MjY3NDliNjE0ODQ1N2JhYWZjZTRmZTUzNGJiM2VjL3RhYmxlOjk2MTdjOWY0ZWZiMzQyODc4M2ZjZTk2Y2I1ZDMzMTNmL3RhYmxlcmFuZ2U6OTYxN2M5ZjRlZmIzNDI4NzgzZmNlOTZjYjVkMzMxM2ZfMTYtNy0xLTEtMA_e6806ab5-d881-4665-956d-e840627f1196"
      unitRef="usd">600700000</holx:ComprehensiveIncome>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMy0xLTEtMS0w_6dd967ae-8687-4b85-8947-7c92d6e245c8"
      unitRef="usd">827600000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMy0zLTEtMS0w_b89d31bd-b627-4353-b179-f19147bfcda4"
      unitRef="usd">701000000.0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfNi0xLTEtMS0w_c62c8e90-a562-4228-b0af-ae0922f25e55"
      unitRef="usd">943200000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfNi0zLTEtMS0w_64204c86-94a6-4dbc-814a-70360cf10a3d"
      unitRef="usd">1028900000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfNy0xLTEtMS0w_3b3fcb34-33e8-4a96-bb81-a727020df461"
      unitRef="usd">502900000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfNy0zLTEtMS0w_4537c19e-de87-402b-b914-2c321ddfdcf1"
      unitRef="usd">395100000</us-gaap:InventoryNet>
    <holx:PrepaidIncomeTaxesCurrent
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfOC0xLTEtMS0w_716a56ec-54e0-4226-91d1-d33c94ade517"
      unitRef="usd">63000000.0</holx:PrepaidIncomeTaxesCurrent>
    <holx:PrepaidIncomeTaxesCurrent
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfOC0zLTEtMS0w_8f5cc89c-d255-4d80-8288-9c7718cf76de"
      unitRef="usd">38800000</holx:PrepaidIncomeTaxesCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfOS0xLTEtMS0w_19b6f43a-3cb8-444f-8ad6-841e9f732a7f"
      unitRef="usd">81500000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfOS0zLTEtMS0w_4b82bcf8-c2a3-44c7-a3a8-12237cc9aa60"
      unitRef="usd">58500000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMTItMS0xLTEtMA_73417dc9-06c7-41c8-bae8-c11e888cad57"
      unitRef="usd">2418200000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMTItMy0xLTEtMA_43bad2c5-e829-4a23-a68f-a7c4f40c8290"
      unitRef="usd">2222300000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMTMtMS0xLTEtMA_9791000b-90ca-4479-8acc-e32b25aa10c0"
      unitRef="usd">551100000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMTMtMy0xLTEtMA_8d674908-8012-4d75-a5ec-76dfa6ccd3ad"
      unitRef="usd">491500000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMTQtMS0xLTEtMA_433a8292-0163-4413-a80c-d2c0445f9b14"
      unitRef="usd">1800800000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMTQtMy0xLTEtMA_3efa6c0a-94b7-4f1d-b333-8e3c14ab136d"
      unitRef="usd">1307500000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMTUtMS0xLTEtMA_b5b2c5cc-0156-4797-8781-fad84f6a87e3"
      unitRef="usd">3264200000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMTUtMy0xLTEtMA_24839604-c22b-4616-bbbb-22d797592782"
      unitRef="usd">2657900000</us-gaap:Goodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMTYtMS0xLTEtMA_0f05393c-b302-420e-96c6-fafc9123ee20"
      unitRef="usd">556300000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMTYtMy0xLTEtMA_10c04409-1a2a-450f-ad5a-2ec83047d92d"
      unitRef="usd">516600000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMTctMS0xLTEtMA_7562b4d6-162d-4af7-b299-2c3cd2a78f83"
      unitRef="usd">8590600000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMTctMy0xLTEtMA_2e60659e-553f-4f9a-b8e0-78dc273068c1"
      unitRef="usd">7195800000</us-gaap:Assets>
    <us-gaap:LongTermDebtCurrent
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMjAtMS0xLTEtMA_689f8290-1786-4b9a-a4ba-175b11108222"
      unitRef="usd">460600000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMjAtMy0xLTEtMA_beff2aec-4971-4e2e-9b92-6d26c5a53e7a"
      unitRef="usd">324900000</us-gaap:LongTermDebtCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMjEtMS0xLTEtMA_37083d92-319c-4a9c-95a3-62e762ff6376"
      unitRef="usd">208400000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMjEtMy0xLTEtMA_b63aaddb-7690-4c05-8e94-f870501fc3a4"
      unitRef="usd">178800000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMjItMS0xLTEtMA_1d9d1912-55bd-4bb8-921b-9e59e8961254"
      unitRef="usd">579400000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMjItMy0xLTEtMA_492f9c09-f27d-46b9-b7e6-4badec9884b9"
      unitRef="usd">547600000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMjMtMS0xLTEtMA_333b4e10-799f-48db-a947-235ad3552d43"
      unitRef="usd">213100000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMjMtMy0xLTEtMA_0d6c99b7-9526-4f17-acff-c68f9bf7b193"
      unitRef="usd">186100000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:CapitalLeaseObligationsCurrent
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMjQtMS0xLTEtMA_ce977045-3114-44f8-aafc-3243600918a1"
      unitRef="usd">3100000</us-gaap:CapitalLeaseObligationsCurrent>
    <us-gaap:CapitalLeaseObligationsCurrent
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMjQtMy0xLTEtMA_c373ef6d-e504-41c8-aca7-a9e147e73981"
      unitRef="usd">1900000</us-gaap:CapitalLeaseObligationsCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMjctMS0xLTEtMA_fb870b34-be40-4266-9cc8-04c43840252b"
      unitRef="usd">1464600000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMjctMy0xLTEtMA_f8a9a4cb-dece-43b0-9ba0-26d4802b6350"
      unitRef="usd">1239300000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMjgtMS0xLTEtMA_daf12290-fa96-488a-bbf5-a9c507febfff"
      unitRef="usd">2654700000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMjgtMy0xLTEtMA_71aeed95-50d1-42f7-80ee-7bb52bb51aaa"
      unitRef="usd">2713900000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:CapitalLeaseObligationsNoncurrent
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMjktMS0xLTEtMA_dbef0bbe-5c3b-4c4f-8cca-8684b653f6de"
      unitRef="usd">22900000</us-gaap:CapitalLeaseObligationsNoncurrent>
    <us-gaap:CapitalLeaseObligationsNoncurrent
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMjktMy0xLTEtMA_6bd321be-9794-4e6d-bb03-4894482d228a"
      unitRef="usd">17400000</us-gaap:CapitalLeaseObligationsNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzAtMS0xLTEtMA_747f2d79-2856-4b9e-a7c3-d3d923c106ea"
      unitRef="usd">284800000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzAtMy0xLTEtMA_e0dc1347-3528-4baf-8dfc-31d0bba4d91d"
      unitRef="usd">201800000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzEtMS0xLTEtMA_9e19c38a-49af-492e-bc42-7e80b9421b80"
      unitRef="usd">15000000.0</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzEtMy0xLTEtMA_ff478743-93b3-4ee8-bec5-39df567d4ff5"
      unitRef="usd">12900000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzItMS0xLTEtMA_bb0efb0f-8b98-4b4f-a7da-8a7cbdc1ee31"
      unitRef="usd">271500000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzItMy0xLTEtMA_02efb039-2c1a-4c04-80e0-f5e1a496fe38"
      unitRef="usd">303200000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjkxY2YyOGY4ZmFmNDRlMWRhMzk0MmVhNDFlNzM3YTY5XzIx_5b1262b5-59fb-4ff0-aa1d-025c0ffb1f5c"
      unitRef="usdPerShare">10000.00</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjkxY2YyOGY4ZmFmNDRlMWRhMzk0MmVhNDFlNzM3YTY5XzIx_c499fc67-d275-4819-bf8e-6ec8e7c4f404"
      unitRef="usdPerShare">10000.00</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjkxY2YyOGY4ZmFmNDRlMWRhMzk0MmVhNDFlNzM3YTY5XzM2_0621e09d-bedf-41e7-bfae-304b46990e64"
      unitRef="shares">1623000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjkxY2YyOGY4ZmFmNDRlMWRhMzk0MmVhNDFlNzM3YTY5XzM2_3b883b56-dff9-490b-a89c-88af7c1019c5"
      unitRef="shares">1623000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjkxY2YyOGY4ZmFmNDRlMWRhMzk0MmVhNDFlNzM3YTY5XzU4_27dea9cd-7d0e-441b-bd0b-760bab0da13d"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjkxY2YyOGY4ZmFmNDRlMWRhMzk0MmVhNDFlNzM3YTY5XzU4_7f17c873-6f52-4274-b999-43226676340d"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzQtMS0xLTEtMA_226f563e-f253-43a9-b9de-dc0760175007"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzQtMy0xLTEtMA_8c22a550-85ad-4b2b-958d-37ed1ac12c3b"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjY5YmRlYTRlNTVlZDQyMWE5MWVmMWYzYTRhOTFiMzc1XzE4_2ad48f27-32c7-42af-a127-3f6ed41aaa9f"
      unitRef="usdPerShare">10000.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjY5YmRlYTRlNTVlZDQyMWE5MWVmMWYzYTRhOTFiMzc1XzE4_64c7e6a6-260a-456e-9723-69c211be2d29"
      unitRef="usdPerShare">10000.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjY5YmRlYTRlNTVlZDQyMWE5MWVmMWYzYTRhOTFiMzc1XzMy_311b56f1-81d5-4e79-9f33-2ad9291843dd"
      unitRef="shares">750000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjY5YmRlYTRlNTVlZDQyMWE5MWVmMWYzYTRhOTFiMzc1XzMy_b01fd910-9b1a-49e1-8093-c1b2eda1e177"
      unitRef="shares">750000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjY5YmRlYTRlNTVlZDQyMWE5MWVmMWYzYTRhOTFiMzc1XzU0_101b0337-9b03-475a-bb4e-21546a379e7f"
      unitRef="shares">296945000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjY5YmRlYTRlNTVlZDQyMWE5MWVmMWYzYTRhOTFiMzc1XzYx_1cfd0fae-21b7-47b3-ac30-408aaf40b512"
      unitRef="shares">295107000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzUtMS0xLTEtMA_a16d13fa-60ed-4225-925a-ec4df277ea31"
      unitRef="usd">3000000.0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzUtMy0xLTEtMA_f953cdee-a4d5-4bd9-806f-1e6a926ecbf2"
      unitRef="usd">2900000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzYtMS0xLTEtMA_35e3e702-90f6-4bd5-8ddb-8ae4a67b178f"
      unitRef="usd">5936200000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzYtMy0xLTEtMA_1066b4c3-2615-4a1a-a401-7318df96d40d"
      unitRef="usd">5904800000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzctMS0xLTEtMA_f6902628-635c-4c00-b1a3-690cfbee943d"
      unitRef="usd">-30500000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzctMy0xLTEtMA_aa40629d-82f2-43fe-9a1d-de48eb5b1a7c"
      unitRef="usd">-1573200000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockShares
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOmExODI0MzQ3NzgyYzQ2MDE5YTdjMGE2NTA0MmZmMzIzXzMw_472359dd-1773-483c-814c-53e036aba2fd"
      unitRef="shares">43653000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOmExODI0MzQ3NzgyYzQ2MDE5YTdjMGE2NTA0MmZmMzIzXzM3_61e4a9c7-b7cf-40e7-88fb-a91b993347c8"
      unitRef="shares">37609000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzgtMS0xLTEtMA_a70008a9-9a1b-4679-9125-f330dd341c7a"
      unitRef="usd">1989400000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzgtMy0xLTEtMA_0fb4b95f-4f6f-46aa-b497-d993525fdda0"
      unitRef="usd">1579600000</us-gaap:TreasuryStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzktMS0xLTEtMA_a17ce489-22b9-4fd9-8202-139a6b82c119"
      unitRef="usd">-42200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfMzktMy0xLTEtMA_b02dab79-21d6-4230-8000-ab4b75d86702"
      unitRef="usd">-49700000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfNDAtMS0xLTEtMA_47875c6b-b2d4-4df6-bf26-bf386ff200c2"
      unitRef="usd">3877100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfNDAtMy0xLTEtMA_801f02f7-9bc7-4009-986b-799a7bb6dc37"
      unitRef="usd">2705200000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfNDEtMS0xLTEtMA_0394f3b0-0d03-490e-ac50-532c29f49a64"
      unitRef="usd">0</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfNDEtMy0xLTEtMA_3fe6df03-fdf9-4bad-853b-bb0655dc7d93"
      unitRef="usd">2100000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfNDItMS0xLTEtMA_8e1aa11d-bb02-4922-8b5f-9c6ecf7f6521"
      unitRef="usd">3877100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfNDItMy0xLTEtMA_1696be9d-b722-48b4-9a2c-b75c2da46948"
      unitRef="usd">2707300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfNDMtMS0xLTEtMA_52f08bba-7e1a-431d-9e26-719a36d3c5ac"
      unitRef="usd">8590600000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yMi9mcmFnOjMyNzA2OWQ4NGI1NDQ1ZDViNzY4YzM5MDEyYTMyY2ZlL3RhYmxlOjMwNTkxYzIxYTg3OTQ4N2Q4M2U2NjUzNTNjNzk4NGMwL3RhYmxlcmFuZ2U6MzA1OTFjMjFhODc5NDg3ZDgzZTY2NTM1M2M3OTg0YzBfNDMtMy0xLTEtMA_87f7e87d-736d-45f0-a6dd-be29308e95fd"
      unitRef="usd">7195800000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i62775b7338924094b35155c0fdc56937_I20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTE2LTItMS0xLTA_9203bc09-5472-4d9b-a067-cd5b9958a615"
      unitRef="shares">292323000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i62775b7338924094b35155c0fdc56937_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTE2LTQtMS0xLTA_7c040cb8-3d69-415c-97dd-f532306cdd4a"
      unitRef="usd">2900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idcdf880adb9b48f2929f4a34dd835119_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTE2LTYtMS0xLTA_d34b5e49-9a10-447f-997a-6458f14ea5a7"
      unitRef="usd">5769800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6acad958eada4806ab9891959584319e_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTE2LTgtMS0xLTA_24e73de9-b58d-4680-9e9a-eeac013819a7"
      unitRef="usd">-2688700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1b3baf3186c74c05b772abe2f32104e9_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTE2LTEwLTEtMS0w_85ae6a58-8a4b-4ffc-af7d-df8e9abde274"
      unitRef="usd">-42300000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="ib7667b1c57034541bf5cdb336c4b3647_I20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTE2LTEyLTEtMS0w_43f3e3c6-1b18-4843-b412-be35817effe6"
      unitRef="shares">24638000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ib7667b1c57034541bf5cdb336c4b3647_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTE2LTE0LTEtMS0w_0469b3b5-4a7d-49c5-8e1d-9b986c30107c"
      unitRef="usd">-926000000.0</us-gaap:StockholdersEquity>
    <us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount
      contextRef="ia1bbf9311cb649308affbf16f61bb3ff_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTE2LTE2LTEtMS0w_b43dd327-8af5-4231-a76c-da8fd765e742"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount>
    <us-gaap:StockholdersEquity
      contextRef="ia1bbf9311cb649308affbf16f61bb3ff_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTE2LTE4LTEtMS0w_741b865d-b97e-4eb7-9f49-9afdfff4b8be"
      unitRef="usd">2115700000</us-gaap:StockholdersEquity>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="id01db50d7a6347809cb98adf4b5c0c66_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTE3LTE2LTEtMS0w_452d0449-5485-480c-8e24-1c5398a5847f"
      unitRef="usd">8600000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="id01db50d7a6347809cb98adf4b5c0c66_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTE3LTE4LTEtMS0w_ab1ca06e-16f7-4995-af71-f2626c56455f"
      unitRef="usd">8600000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:StockholdersEquity
      contextRef="i6c7cb3ce35044cba97822b408ab5d23c_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTE4LTgtMS0xLTA_e4ec3fc8-20de-417e-bb3e-e2dbd23e3cd0"
      unitRef="usd">300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6c7cb3ce35044cba97822b408ab5d23c_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTE4LTE4LTEtMS0w_e629100d-8688-4f52-84fa-6f0f6b09c465"
      unitRef="usd">300000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i6977def5ccec49a2980c424062f9fee1_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTE5LTItMS0xLTA_aed311f9-ee18-4bea-9a60-1589795d7309"
      unitRef="shares">540000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i309460864a314d9aa0d13fb0a8698091_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTE5LTYtMS0xLTA_5b1ceec9-59b6-462d-aa84-73e5cec8ea51"
      unitRef="usd">13800000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i309460864a314d9aa0d13fb0a8698091_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTE5LTE4LTEtMS0w_4f36a172-4830-4912-aeab-87d944cfcb19"
      unitRef="usd">13800000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="i6977def5ccec49a2980c424062f9fee1_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTIwLTItMS0xLTA_19efcff5-8aed-4837-b039-b2ad759c77c0"
      unitRef="shares">476000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i309460864a314d9aa0d13fb0a8698091_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTIwLTYtMS0xLTA_f93fd7db-b6b5-4a5f-9ed7-ac3f9b15666e"
      unitRef="usd">10900000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i309460864a314d9aa0d13fb0a8698091_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTIwLTE4LTEtMS0w_10eb0f6f-f9b9-4bf9-91c1-697367da2c1d"
      unitRef="usd">10900000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i309460864a314d9aa0d13fb0a8698091_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTIyLTYtMS0xLTA_c1345c00-1561-4538-8cd0-261a10276790"
      unitRef="usd">18100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i309460864a314d9aa0d13fb0a8698091_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTIyLTE4LTEtMS0w_db8cfe82-8cbb-4e9c-89a2-c09d7762ff72"
      unitRef="usd">18100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <holx:Netincome
      contextRef="id01db50d7a6347809cb98adf4b5c0c66_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTIzLTgtMS0xLTA_7e7e4dc3-a622-48ca-81e8-f443fe200f02"
      unitRef="usd">386100000</holx:Netincome>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="id01db50d7a6347809cb98adf4b5c0c66_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTIzLTE2LTEtMS0w_7eac629a-c013-470c-8fa2-f5ad80df60fa"
      unitRef="usd">-300000</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NetIncomeLoss
      contextRef="id01db50d7a6347809cb98adf4b5c0c66_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTIzLTE4LTEtMS0w_3a3f495a-0863-403f-b5f4-71090dbfff86"
      unitRef="usd">385800000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib1bc73f8ae9c492f9eb4404fb7e44230_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI0LTEwLTEtMS0w_3abb2424-614e-431e-b02a-ef386f8f0e0c"
      unitRef="usd">13600000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib1bc73f8ae9c492f9eb4404fb7e44230_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI0LTE4LTEtMS0w_cd7cac61-219d-496a-bbc4-fdb65e0ed16d"
      unitRef="usd">13600000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ia342626413704afc8513005d7219aead_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI1LTEyLTEtMS0w_900fe666-be4d-45f7-88f0-d23b9c9c2a2a"
      unitRef="shares">1545000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="ia342626413704afc8513005d7219aead_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI1LTE0LTEtMS0w_b40ceb1c-73aa-4f42-850d-3608f20218b3"
      unitRef="usd">80900000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="id01db50d7a6347809cb98adf4b5c0c66_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI1LTE4LTEtMS0w_818fc339-299b-4625-b047-418ca8d3b46b"
      unitRef="usd">80900000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:AcceleratedShareRepurchaseProgramAdjustment
      contextRef="ia342626413704afc8513005d7219aead_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI2LTYtMS0xLTA_55e05655-17ea-4bf8-b855-520d530ab9c0"
      unitRef="usd">-41000000.0</us-gaap:AcceleratedShareRepurchaseProgramAdjustment>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i22a1e068cbb54742b0e792558e5f9d7c_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI2LTEyLTEtMS0w_cf39eba5-b8a2-427d-b576-f9bf7183e4b1"
      unitRef="shares">3279000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i22a1e068cbb54742b0e792558e5f9d7c_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI2LTE0LTEtMS0w_f7e876a8-908b-4009-9651-b88d2bc1075b"
      unitRef="usd">164000000.0</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <holx:Acceleratedsharerepurchaseagreement
      contextRef="id01db50d7a6347809cb98adf4b5c0c66_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI2LTE4LTEtMS0w_a55a8eb7-d025-47ea-a4aa-edf4199f7408"
      unitRef="usd">205000000.0</holx:Acceleratedsharerepurchaseagreement>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="id01db50d7a6347809cb98adf4b5c0c66_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI3LTE2LTEtMS0w_6741434b-75ea-4e19-a871-79847cebb81e"
      unitRef="usd">1400000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="id01db50d7a6347809cb98adf4b5c0c66_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI3LTE4LTEtMS0w_7e4b3d0e-9a41-4ea3-b27c-9782cbdb1c60"
      unitRef="usd">1400000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:SharesIssued
      contextRef="ide9ab086aa8846ac877a20195abb5f25_I20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI4LTItMS0xLTA_e3d43ca7-6fa8-47c4-ad6d-d4bb3470919e"
      unitRef="shares">293339000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ide9ab086aa8846ac877a20195abb5f25_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI4LTQtMS0xLTA_42608091-4d0b-4075-98cb-714240a0ec79"
      unitRef="usd">2900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id78e1a3ad6024d799c3f1727c967cf29_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI4LTYtMS0xLTA_13b48de0-ecbf-4f50-9336-56ab37e80c88"
      unitRef="usd">5749800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i77063f41174f4d989415517706f4fb93_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI4LTgtMS0xLTA_b0b88996-cc67-4c29-bff7-e2b6823e1291"
      unitRef="usd">-2302300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icc0e0f0a89824c5996ab98b928cc9aa4_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI4LTEwLTEtMS0w_723286ee-91d8-4c3f-87b2-511e4aea4cb5"
      unitRef="usd">-28700000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="ibe21cf98d68c43dca6569043732410ff_I20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI4LTEyLTEtMS0w_8c6a0823-cde4-412d-97b6-535194037381"
      unitRef="shares">29462000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ibe21cf98d68c43dca6569043732410ff_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI4LTE0LTEtMS0w_8794d984-429e-4d37-8188-cda3e44aba60"
      unitRef="usd">-1170900000</us-gaap:StockholdersEquity>
    <us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount
      contextRef="i419ae5d90cab427883eac5b35fd93d36_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI4LTE2LTEtMS0w_bd3da1e5-07bd-45dc-b8b4-808386c6ff2e"
      unitRef="usd">6900000</us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i419ae5d90cab427883eac5b35fd93d36_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTI4LTE4LTEtMS0w_73439a5e-71b7-45d6-ab0e-69fc7e8f7653"
      unitRef="usd">2257700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i02e7a8da3b754bdb85993a3ca3484508_D20191229-20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTMxLTItMS0xLTA_b08f99a6-886e-4a53-8036-835bfd8ea14a"
      unitRef="shares">503000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ia2ba3a87732c4c6ab5006e5cb0228a5d_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTMxLTYtMS0xLTA_fbfec4f5-34ce-4164-b945-010e64b2ddfe"
      unitRef="usd">13900000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ia2ba3a87732c4c6ab5006e5cb0228a5d_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTMxLTE4LTEtMS0w_f65aedf9-0785-47d5-88e4-a2fac92909d1"
      unitRef="usd">13900000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="i02e7a8da3b754bdb85993a3ca3484508_D20191229-20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTMyLTItMS0xLTA_4f68edf0-0fc4-4a76-9f3a-459c86dc429c"
      unitRef="shares">86000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="ia2ba3a87732c4c6ab5006e5cb0228a5d_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTMyLTYtMS0xLTA_f75aa1cd-6d7d-4282-9238-d4f609f475e2"
      unitRef="usd">1600000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="ia2ba3a87732c4c6ab5006e5cb0228a5d_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTMyLTE4LTEtMS0w_48e3d35b-2162-413f-97fd-c957f7959d80"
      unitRef="usd">1600000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i02e7a8da3b754bdb85993a3ca3484508_D20191229-20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTMzLTItMS0xLTA_e60adc55-26c6-48b4-917f-157c5740f635"
      unitRef="shares">214000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ia2ba3a87732c4c6ab5006e5cb0228a5d_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTMzLTYtMS0xLTA_807022b5-2471-4228-9fc8-6ec2ff989537"
      unitRef="usd">8800000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ia2ba3a87732c4c6ab5006e5cb0228a5d_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTMzLTE4LTEtMS0w_1473ee57-e0f2-4cd2-be61-1221b3de6319"
      unitRef="usd">8800000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia2ba3a87732c4c6ab5006e5cb0228a5d_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTM0LTYtMS0xLTA_4a7a259d-2367-42dc-9aae-42697bb64222"
      unitRef="usd">15700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia2ba3a87732c4c6ab5006e5cb0228a5d_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTM0LTE4LTEtMS0w_4ceef810-9218-4bcb-b417-983dbee24dde"
      unitRef="usd">15700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <holx:Netincome
      contextRef="i588c3d9c7d924cc6a15149930f01d74e_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTM1LTgtMS0xLTA_38a92f2a-4cea-4e5f-8cc1-3866901dd699"
      unitRef="usd">96300000</holx:Netincome>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="i588c3d9c7d924cc6a15149930f01d74e_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTM1LTE2LTEtMS0w_09fdf48b-b856-4c31-bba1-025f201af1da"
      unitRef="usd">-1500000</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NetIncomeLoss
      contextRef="i588c3d9c7d924cc6a15149930f01d74e_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTM1LTE4LTEtMS0w_a552f777-dfe3-4d51-b45a-0cbb67c4c438"
      unitRef="usd">94800000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i33460b16b0364f3589df795f209d0c8d_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTM2LTEwLTEtMS0w_f85c66ba-f699-4d9e-a28b-7ed8cb3bc77b"
      unitRef="usd">-30200000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i33460b16b0364f3589df795f209d0c8d_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTM2LTE4LTEtMS0w_f4eda854-33b0-48ae-84a3-bf8ae4872c36"
      unitRef="usd">-30200000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ib8b6b6f42e894fca9dca1d45bc960c8a_D20191229-20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTM3LTEyLTEtMS0w_2737e6b2-d607-4db2-9a2d-5928793a665e"
      unitRef="shares">5851000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="ib8b6b6f42e894fca9dca1d45bc960c8a_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTM3LTE0LTEtMS0w_5942eecc-ff02-4fda-90d8-4b1621390c38"
      unitRef="usd">267600000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="ib8b6b6f42e894fca9dca1d45bc960c8a_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTM3LTE4LTEtMS0w_027746cf-bec6-4954-9ebf-cdb35dafa6b7"
      unitRef="usd">267600000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:AcceleratedShareRepurchaseProgramAdjustment
      contextRef="ib8b6b6f42e894fca9dca1d45bc960c8a_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTM4LTYtMS0xLTA_97e46c3a-de23-4c4b-840d-cae64ce6e30a"
      unitRef="usd">41000000.0</us-gaap:AcceleratedShareRepurchaseProgramAdjustment>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i17e8693dbcd546e5a55176fe7546128f_D20191229-20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTM4LTEyLTEtMS0w_99d15781-e675-4515-83b8-894d7a854975"
      unitRef="shares">628000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i17e8693dbcd546e5a55176fe7546128f_D20191229-20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTM4LTE0LTEtMS0w_103fb101-42cd-4d16-b72c-39204a3591e2"
      unitRef="usd">41000000.0</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <holx:Acceleratedsharerepurchaseagreement
      contextRef="i588c3d9c7d924cc6a15149930f01d74e_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTM4LTE4LTEtMS0w_581c1ad8-8fd9-4a78-a50a-8858deeec1c1"
      unitRef="usd">0</holx:Acceleratedsharerepurchaseagreement>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i588c3d9c7d924cc6a15149930f01d74e_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTM5LTE2LTEtMS0w_5ec57aae-89e9-4520-9ffa-a411a602a5e6"
      unitRef="usd">300000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i588c3d9c7d924cc6a15149930f01d74e_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTM5LTE4LTEtMS0w_a94c3dad-71f6-46c9-b9ea-1e624736252e"
      unitRef="usd">300000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:SharesIssued
      contextRef="i0657c7323336470abd636ab465e98a96_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQwLTItMS0xLTA_e755de3a-f9a5-4c9b-b70d-58b57ff26f4b"
      unitRef="shares">294142000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i0657c7323336470abd636ab465e98a96_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQwLTQtMS0xLTA_dd2abacb-2767-477a-b85e-8565ec3db93c"
      unitRef="usd">2900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia15ef37ae8ca4fbca76c1b7b2851f56c_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQwLTYtMS0xLTA_b13bff8c-9af8-4034-a126-98838d495193"
      unitRef="usd">5827600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i047c6f422b294cb08c1476a194dc7470_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQwLTgtMS0xLTA_76d792de-596f-4f3c-a82c-a8c5bed5bf8e"
      unitRef="usd">-2206000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4470f8e9e21d45a78c67f110baf7a543_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQwLTEwLTEtMS0w_1cb385e1-1b0d-40cd-89e3-c6a936855f2f"
      unitRef="usd">-58900000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i490aca9b8aa2403e8983cfb2aee1071b_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQwLTEyLTEtMS0w_b072054f-1d28-4d28-9da5-933d6653571b"
      unitRef="shares">35941000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i490aca9b8aa2403e8983cfb2aee1071b_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQwLTE0LTEtMS0w_0b62215e-16d3-4edf-b5b6-86ca0124ca04"
      unitRef="usd">-1479500000</us-gaap:StockholdersEquity>
    <us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount
      contextRef="i5ae541164c564e1394017ca8fb281f3c_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQwLTE2LTEtMS0w_487e3893-8626-44af-9661-1b7391188773"
      unitRef="usd">5100000</us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5ae541164c564e1394017ca8fb281f3c_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQwLTE4LTEtMS0w_de9ea802-2b2b-4049-8726-8d68ff0cabab"
      unitRef="usd">2091200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i5bf322985c424f509995e217f5ba7921_D20200329-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQxLTItMS0xLTA_a027aefc-fcd0-4c3e-bf62-789774f3b8c6"
      unitRef="shares">533000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i73253768170f4c9b8e05dfb1368cf18d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQxLTYtMS0xLTA_f067aae4-81d5-411a-a186-24fac89c5717"
      unitRef="usd">14400000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i73253768170f4c9b8e05dfb1368cf18d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQxLTE4LTEtMS0w_ce1cecf8-7525-4715-ae1d-8766016bb9e3"
      unitRef="usd">14400000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="i5bf322985c424f509995e217f5ba7921_D20200329-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQyLTItMS0xLTA_06f326a9-d0d5-4223-8954-aad7c74b59d8"
      unitRef="shares">9000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i73253768170f4c9b8e05dfb1368cf18d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQyLTYtMS0xLTA_1f480f36-e817-4617-8826-bd8a879a7758"
      unitRef="usd">200000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i73253768170f4c9b8e05dfb1368cf18d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQyLTE4LTEtMS0w_aeac6d1d-ac92-4bbb-a602-4abc3a742d59"
      unitRef="usd">200000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i73253768170f4c9b8e05dfb1368cf18d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQ0LTYtMS0xLTA_07a15f04-fa6d-4821-aa1a-106f3e47f559"
      unitRef="usd">19900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i73253768170f4c9b8e05dfb1368cf18d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQ0LTE4LTEtMS0w_32273420-5c2c-4c6e-9d24-5b4384edf82a"
      unitRef="usd">19900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <holx:Netincome
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQ1LTgtMS0xLTA_461a906f-97e1-4b10-9a32-ea3d0335ac45"
      unitRef="usd">137900000</holx:Netincome>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQ1LTE2LTEtMS0w_f3082797-e9b0-4b04-9508-e2a2fa1d24b7"
      unitRef="usd">-1500000</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NetIncomeLoss
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQ1LTE4LTEtMS0w_7a126a52-3992-44a5-a15f-d1d67584c051"
      unitRef="usd">136400000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="idd3a77457cf340cf9428c91d5c99c147_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQ2LTEwLTEtMS0w_528786a1-d8be-450a-aae6-3b23f1059b77"
      unitRef="usd">-3000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="idd3a77457cf340cf9428c91d5c99c147_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQ2LTE4LTEtMS0w_28c66ca3-8b14-45c2-96df-34db9177ac76"
      unitRef="usd">-3000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQ5LTE2LTEtMS0w_7e8758f9-154c-4c41-821b-4469356f77cd"
      unitRef="usd">100000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTQ5LTE4LTEtMS0w_36429e5d-2b29-44e4-9efd-37f91acdcd62"
      unitRef="usd">100000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:SharesIssued
      contextRef="idc53cfef88da4ccfb2e145cc906d6511_I20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUwLTItMS0xLTA_b2602d50-a6fc-4482-9a72-8a7a3f39b765"
      unitRef="shares">294684000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="idc53cfef88da4ccfb2e145cc906d6511_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUwLTQtMS0xLTA_9a9458db-9de7-47a4-9bcf-91ce2c74507f"
      unitRef="usd">2900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idfd99b340a8c407e9acd3394fcb87cb8_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUwLTYtMS0xLTA_26d7d3dd-8d8f-4ad5-8d48-d2e7982bd217"
      unitRef="usd">5861700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i63c68ea38c5d4987adbac8981ccfb7a3_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUwLTgtMS0xLTA_7d3a5b85-c874-4b07-b7f9-d6bb7853acf4"
      unitRef="usd">-2068100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibe15f7e0e20e47c29d5afb6680fcde66_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUwLTEwLTEtMS0w_252d8fe9-d90c-44d0-909f-aec8cd52c35b"
      unitRef="usd">-61900000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i226a72a6ad6e4aa4a08a9eaebf99bb78_I20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUwLTEyLTEtMS0w_fb6939b4-c082-4416-a61b-f7f1cefe6243"
      unitRef="shares">35941000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i226a72a6ad6e4aa4a08a9eaebf99bb78_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUwLTE0LTEtMS0w_89023960-3937-4d80-bd42-fd08ae42b329"
      unitRef="usd">-1479500000</us-gaap:StockholdersEquity>
    <us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount
      contextRef="i81ab5863e2124accb342d2df86a1ee96_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUwLTE2LTEtMS0w_cdccdda6-c5a3-4291-9765-8007aebcbf87"
      unitRef="usd">3500000</us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i81ab5863e2124accb342d2df86a1ee96_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUwLTE4LTEtMS0w_3f250061-4995-4c17-ae20-ae292139b744"
      unitRef="usd">2258600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i738e3649fa5648b981781aa15132a8f6_D20200628-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUxLTItMS0xLTA_b5eaba8a-fe28-41f8-9e6a-ba96a63801d6"
      unitRef="shares">185000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i8272ade1ac594482a34d29229657da9b_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUxLTYtMS0xLTA_c43299ea-af7e-4927-aa3f-5ca0deb02a94"
      unitRef="usd">6200000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i8272ade1ac594482a34d29229657da9b_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUxLTE4LTEtMS0w_7d7cd21e-eabb-4046-92cb-8baefee052d8"
      unitRef="usd">6200000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="i738e3649fa5648b981781aa15132a8f6_D20200628-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUyLTItMS0xLTA_c8840748-e4db-41fe-ac50-892b77e1a56e"
      unitRef="shares">40000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i8272ade1ac594482a34d29229657da9b_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUyLTYtMS0xLTA_51391415-c8c2-411a-aaea-f14134849973"
      unitRef="usd">1500000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i8272ade1ac594482a34d29229657da9b_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUyLTE4LTEtMS0w_e1fbaf4b-c897-4b4b-b5f0-b033f685b949"
      unitRef="usd">1500000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i738e3649fa5648b981781aa15132a8f6_D20200628-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUzLTItMS0xLTA_65f11b40-d50b-40dd-b94b-d7b900a39097"
      unitRef="shares">198000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i8272ade1ac594482a34d29229657da9b_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUzLTYtMS0xLTA_3bc16e8c-b302-4687-90a6-04b0012bb4e4"
      unitRef="usd">8800000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i09304699beed432b98cea40faccb3e67_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTUzLTE4LTEtMS0w_dc1e549c-c880-48db-8314-362cfffb4f3f"
      unitRef="usd">8800000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i8272ade1ac594482a34d29229657da9b_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU0LTYtMS0xLTA_dc0ce5db-ec73-4808-8b15-d0ad5b8ab0f3"
      unitRef="usd">29600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i8272ade1ac594482a34d29229657da9b_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU0LTE4LTEtMS0w_03ae74e0-f2f9-4f27-94a3-e95bf2d1a893"
      unitRef="usd">29600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <holx:Netincome
      contextRef="ic24013ff47294a37b8d0497bd4190df5_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU1LTgtMS0xLTA_f87eb752-dc68-4e8a-9295-fc4541650a0f"
      unitRef="usd">494900000</holx:Netincome>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="ic24013ff47294a37b8d0497bd4190df5_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU1LTE2LTEtMS0w_17d8249b-2dcd-4d48-975d-f53bc91aa679"
      unitRef="usd">-1400000</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NetIncomeLoss
      contextRef="ic24013ff47294a37b8d0497bd4190df5_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU1LTE4LTEtMS0w_28483331-60eb-4c04-8742-ad8fe385a2c0"
      unitRef="usd">493500000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if9d0114a6df941bbb221d574874bf165_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU2LTEwLTEtMS0w_bf7c9b3b-c8f1-4440-b107-f2e72aadbe4c"
      unitRef="usd">12200000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if9d0114a6df941bbb221d574874bf165_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU2LTE4LTEtMS0w_8d66f0c8-5249-4220-a0f6-097dd9683f39"
      unitRef="usd">12200000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ib40a5a6185e8452498ab7f6ce2457f01_D20200628-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU3LTEyLTEtMS0w_24213c5f-7e53-4730-8ba4-567d97fb719f"
      unitRef="shares">1668000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="ib40a5a6185e8452498ab7f6ce2457f01_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU3LTE0LTEtMS0w_22731bf9-a7db-45bf-b3b8-6973f4fe0895"
      unitRef="usd">100100000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="ib40a5a6185e8452498ab7f6ce2457f01_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU3LTE4LTEtMS0w_47d67673-798b-4ce2-a03a-586f2d4dcdb5"
      unitRef="usd">100100000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:SharesIssued
      contextRef="i88ca4c5253d94e03a7eb9af69544692d_I20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU4LTItMS0xLTA_c4475933-8f33-4631-ae58-fd8f0422d816"
      unitRef="shares">295107000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i88ca4c5253d94e03a7eb9af69544692d_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU4LTQtMS0xLTA_745eccf4-afb2-450c-bb87-1df513708454"
      unitRef="usd">2900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i237512b46fca4a7db28715ee5c66af27_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU4LTYtMS0xLTA_f95c2833-01f2-44c7-b0cb-62aa4492d94c"
      unitRef="usd">5904800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5b78eb3d900e4dc388e35dc09cd76568_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU4LTgtMS0xLTA_c2ab79ca-b4be-40af-98ce-6771c0f442ab"
      unitRef="usd">-1573200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i820217fec55c42d7a9aeb5cfc0f49fdb_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU4LTEwLTEtMS0w_e168cbc6-e130-4b7b-8ec1-9f5e1389f198"
      unitRef="usd">-49700000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i52f506beb69441ce875d650d0e5966ba_I20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU4LTEyLTEtMS0w_41e3e148-d43f-4c68-8c17-cbcbe271eaf5"
      unitRef="shares">37609000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i52f506beb69441ce875d650d0e5966ba_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU4LTE0LTEtMS0w_fd37e4b5-e3d2-4999-81e4-0acf12e7324d"
      unitRef="usd">-1579600000</us-gaap:StockholdersEquity>
    <us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU4LTE2LTEtMS0w_cf55c24b-2d90-4d1e-ab38-bdd58aff65cf"
      unitRef="usd">2100000</us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU4LTE4LTEtMS0w_9d505173-a9b5-461e-ac72-60cc83f87e38"
      unitRef="usd">2707300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i9223d1ed5b7d47208efe550fae77bef3_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU5LTItMS0xLTA_999f9724-a331-4f85-9be5-2d855184f8f4"
      unitRef="shares">490000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i09304699beed432b98cea40faccb3e67_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU5LTYtMS0xLTA_99a9086c-5fda-47f4-8e06-813a73a6079c"
      unitRef="usd">18400000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i09304699beed432b98cea40faccb3e67_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTU5LTE4LTEtMS0w_798fc86a-25e0-4a1b-b369-679b9861a3a9"
      unitRef="usd">18400000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="i9223d1ed5b7d47208efe550fae77bef3_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTYwLTItMS0xLTA_d53d80e4-ca29-46a6-8109-d1ec0c74bf79"
      unitRef="shares">936000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <holx:ChangeInParValue
      contextRef="i8a980ec9354548a89245ad56600f024d_D20200927-20201226"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTYwLTQtMS0xLTA_67407553-061a-42cf-ac05-13511749642f"
      unitRef="usd">100000</holx:ChangeInParValue>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i09304699beed432b98cea40faccb3e67_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTYwLTYtMS0xLTA_f6c9228f-4df7-4e99-9118-06a635817396"
      unitRef="usd">46500000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i8a980ec9354548a89245ad56600f024d_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTYwLTE4LTEtMS0w_69ceb1c0-106e-43e0-acde-98a650d001de"
      unitRef="usd">46400000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i09304699beed432b98cea40faccb3e67_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTYyLTYtMS0xLTA_5d23320b-c60f-4a21-99a7-aa0859ff5851"
      unitRef="usd">18600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i09304699beed432b98cea40faccb3e67_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTYyLTE4LTEtMS0w_8c7dfedc-3577-43c4-949c-562d6ac82a4d"
      unitRef="usd">18600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <holx:Netincome
      contextRef="i8a980ec9354548a89245ad56600f024d_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTYzLTgtMS0xLTA_48716e85-0af6-46a1-a009-99ae1b924301"
      unitRef="usd">654400000</holx:Netincome>
    <holx:Netincome
      contextRef="i8a980ec9354548a89245ad56600f024d_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTYzLTgtMS0xLTA_eedf81ba-bcd7-4b5d-a021-87cf7f273232"
      unitRef="usd">654400000</holx:Netincome>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="i8a980ec9354548a89245ad56600f024d_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTYzLTE2LTEtMS0w_f7ed223b-1700-4e8d-b458-efbede899921"
      unitRef="usd">-1000000.0</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NetIncomeLoss
      contextRef="i8a980ec9354548a89245ad56600f024d_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTYzLTE4LTEtMS0w_2a598ba8-9cba-4fcf-9c7b-6686ea266e41"
      unitRef="usd">653400000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic3516193c4744e1cb240679a20e265f8_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY0LTEwLTEtMS0w_e8c97110-d7a4-49d1-a307-70443745e1f6"
      unitRef="usd">19000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic3516193c4744e1cb240679a20e265f8_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY0LTE4LTEtMS0w_1bfc8548-32b7-4a46-af8e-a9b542ab4350"
      unitRef="usd">19000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="if83bdefcff814ab0800ee9e105ed777e_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY1LTEyLTEtMS0w_bbc70406-a934-47c0-a331-994c9eca4108"
      unitRef="shares">1469000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="if83bdefcff814ab0800ee9e105ed777e_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY1LTE0LTEtMS0w_92c961e6-b84f-4241-96da-b31e768b9cf7"
      unitRef="usd">101300000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i8a980ec9354548a89245ad56600f024d_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY1LTE4LTEtMS0w_979c90fc-277e-4992-9c19-cb6f0d76a14f"
      unitRef="usd">101300000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:SharesIssued
      contextRef="i2c17808393cc4b1a91fd6c22e278253d_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY2LTItMS0xLTA_6279d874-f8d4-4ccc-a636-9e1152593cbf"
      unitRef="shares">296533000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i2c17808393cc4b1a91fd6c22e278253d_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY2LTQtMS0xLTA_c21d71cd-071a-4748-b672-bdc0863f3840"
      unitRef="usd">3000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3e2de70ed942467287b4930863d9692e_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY2LTYtMS0xLTA_3fdae514-ffd1-421f-bade-5099db6e5b21"
      unitRef="usd">5895300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iebc58209d8514f5c93b78fa003903508_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY2LTgtMS0xLTA_79c5d9d7-7fd2-41ff-bbe0-3b378530d159"
      unitRef="usd">-918800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i73d6f95b696549cfb0e4d525d8488ac7_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY2LTEwLTEtMS0w_63abd14f-fbeb-4cfe-b74d-d600d03d17a6"
      unitRef="usd">-30700000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="ia4bb35a550a74469afbfef16e89e4881_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY2LTEyLTEtMS0w_60941eac-ce41-42a3-893f-0f5b25237ae2"
      unitRef="shares">39078000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ia4bb35a550a74469afbfef16e89e4881_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY2LTE0LTEtMS0w_f4fb7078-0eef-4229-bcea-d922966d2203"
      unitRef="usd">-1680900000</us-gaap:StockholdersEquity>
    <us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount
      contextRef="if9811e9a2cf24d19b278bc2bf9a5c5cb_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY2LTE2LTEtMS0w_951da207-dbd5-4bc3-bd5e-7651a79ac5bf"
      unitRef="usd">1100000</us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if9811e9a2cf24d19b278bc2bf9a5c5cb_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY2LTE4LTEtMS0w_6cdd6b88-4e8a-4cc1-9e90-fcd1e1b452dc"
      unitRef="usd">3269000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="icdca8dc2d5f84891bd139bc79d3231ab_D20201227-20210327"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY3LTItMS0xLTA_83f1667d-2cdb-4b40-82aa-4abb05f13fb9"
      unitRef="shares">146000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i36833f09bd344e93a23947c92c866cf5_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY3LTYtMS0xLTA_5a52f80b-27d4-411e-b227-7a7ac6d93d32"
      unitRef="usd">5800000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i36833f09bd344e93a23947c92c866cf5_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY3LTE4LTEtMS0w_7b31437e-e44f-49f0-85ab-2e8a7da1df18"
      unitRef="usd">5800000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="icdca8dc2d5f84891bd139bc79d3231ab_D20201227-20210327"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY4LTItMS0xLTA_74ac1a23-d529-4a77-ba35-01aafcc08dae"
      unitRef="shares">17000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i36833f09bd344e93a23947c92c866cf5_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY4LTYtMS0xLTA_027dc74f-be9d-4727-9f7c-ce6eecf7f8a6"
      unitRef="usd">300000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="if8c4f5a123e145abb53ba94d3255b7da_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY4LTE4LTEtMS0w_577db626-c91b-4ebe-a897-bc8f3c4199e0"
      unitRef="usd">300000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="icdca8dc2d5f84891bd139bc79d3231ab_D20201227-20210327"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY5LTItMS0xLTA_267c9ae4-faca-4011-9762-8de75490ac21"
      unitRef="shares">191000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i36833f09bd344e93a23947c92c866cf5_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY5LTYtMS0xLTA_b682331e-b598-40f3-8ebe-a835dabc8317"
      unitRef="usd">9200000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i36833f09bd344e93a23947c92c866cf5_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTY5LTE4LTEtMS0w_6c5fef7f-4fec-4805-b2f3-d37b8715846d"
      unitRef="usd">9200000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i36833f09bd344e93a23947c92c866cf5_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTcwLTYtMS0xLTA_5434b0ae-88af-4433-9ad7-ef0645131d23"
      unitRef="usd">17100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i36833f09bd344e93a23947c92c866cf5_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTcwLTE4LTEtMS0w_01743b50-16eb-47ec-933a-b1f5ebb8fc27"
      unitRef="usd">17100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <holx:Netincome
      contextRef="if8c4f5a123e145abb53ba94d3255b7da_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTcxLTgtMS0xLTA_a2c02458-3bca-496c-97c2-644c600a0835"
      unitRef="usd">619900000</holx:Netincome>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="if8c4f5a123e145abb53ba94d3255b7da_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTcxLTE2LTEtMS0w_a70686b3-9653-44d3-b0b0-23f6e882668a"
      unitRef="usd">-500000</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NetIncomeLoss
      contextRef="if8c4f5a123e145abb53ba94d3255b7da_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTcxLTE4LTEtMS0w_95836592-f4c7-401d-bb23-54aad6da4a65"
      unitRef="usd">619400000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i049e1cee29c84dde8735ff6f859f7c56_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTcyLTEwLTEtMS0w_28771092-ee4b-4c5b-a369-4acd1bc8b9de"
      unitRef="usd">-5100000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i049e1cee29c84dde8735ff6f859f7c56_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTcyLTE4LTEtMS0w_66860e2e-522d-42af-8825-41dab289d0b6"
      unitRef="usd">-5100000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i84edd5ea5c5241b5a06d1be5e9eb4872_D20201227-20210327"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTczLTEyLTEtMS0w_a938eb13-e641-4e9c-99c7-c7ec0b679598"
      unitRef="shares">1604000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i84edd5ea5c5241b5a06d1be5e9eb4872_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTczLTE0LTEtMS0w_e3e8ac00-fa0c-4489-9888-41242eddb4e6"
      unitRef="usd">120100000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="if8c4f5a123e145abb53ba94d3255b7da_D20201227-20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTczLTE4LTEtMS0w_b9e2b137-7fc1-4876-a84e-2f6629f2148a"
      unitRef="usd">120100000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:SharesIssued
      contextRef="ib2c3c861c8f34c17aa93621dcb13cd4a_I20210327"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc0LTItMS0xLTA_676daf4d-eb8f-41c7-908c-2f3faffe9f98"
      unitRef="shares">296887000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ib2c3c861c8f34c17aa93621dcb13cd4a_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc0LTQtMS0xLTA_8ce28c86-32ba-4baf-8e6f-c3e9d28400c4"
      unitRef="usd">3000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib6cf91736f1949678b7354ef10d99150_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc0LTYtMS0xLTA_b1940ab1-0921-41a4-b9df-f44496443ddc"
      unitRef="usd">5927100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icc0d86296d91494f843aeb441d2af697_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc0LTgtMS0xLTA_ca7d01f7-351a-4d4f-bc51-ad904c754651"
      unitRef="usd">-298900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic0aa0fa3e3474453bc759752889ebcd8_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc0LTEwLTEtMS0w_300e96a6-cff0-49d6-b3dc-b10afaf93cba"
      unitRef="usd">-35800000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i379f68e2cb5c471e83994c37a86c01b6_I20210327"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc0LTEyLTEtMS0w_bba5bde0-721b-4e15-ac5d-215c20efde20"
      unitRef="shares">40682000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i379f68e2cb5c471e83994c37a86c01b6_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc0LTE0LTEtMS0w_cacc1505-6595-4539-bc79-f3d864f98500"
      unitRef="usd">-1801000000.0</us-gaap:StockholdersEquity>
    <us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount
      contextRef="i31e8abc772ad4ffe894ec7ec188dc5df_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc0LTE2LTEtMS0w_bdce3537-c995-461b-a550-422646707413"
      unitRef="usd">600000</us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i31e8abc772ad4ffe894ec7ec188dc5df_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc0LTE4LTEtMS0w_8744301c-f270-4533-967b-ba84d5465473"
      unitRef="usd">3795000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i1c99a5bb5b144cf9b610e175a4ecc587_D20210328-20210626"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc1LTItMS0xLTUzMDA_0c0f393e-d6bb-4d53-ad1e-bcc544e1c52d"
      unitRef="shares">53000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ic97a10fe6e144c24b4eafc07f4a2428b_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc1LTYtMS0xLTUzMDY_c5f89666-ebf1-48f1-915f-38dc4ec634ae"
      unitRef="usd">2100000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ic97a10fe6e144c24b4eafc07f4a2428b_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc1LTE4LTEtMS01MzQw_c4165ff9-4e24-48af-8a64-de82cc67dd5a"
      unitRef="usd">2100000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="i1c99a5bb5b144cf9b610e175a4ecc587_D20210328-20210626"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc2LTItMS0xLTUzMDI_54cab8aa-22ec-451f-98da-c14b08bd2fe9"
      unitRef="shares">5000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="ic97a10fe6e144c24b4eafc07f4a2428b_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc2LTYtMS0xLTUzMDg_0d28c677-b4c0-462f-9be9-2a10f887630b"
      unitRef="usd">200000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc2LTE4LTEtMS01MzQy_5af1daaf-e3cb-484f-a544-ba3069f30508"
      unitRef="usd">200000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic97a10fe6e144c24b4eafc07f4a2428b_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc4LTYtMS0xLTUzMTA_ccc3eda3-4dcb-4486-acd1-5b150481e66d"
      unitRef="usd">15400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic97a10fe6e144c24b4eafc07f4a2428b_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc4LTE4LTEtMS01MzQ0_780edf8c-94dc-4e92-b65f-5ba83b5f8174"
      unitRef="usd">15400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <holx:Netincome
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc5LTgtMS0xLTMzNjY_c9e1ff1f-8994-4982-9140-87a46aebf59d"
      unitRef="usd">268400000</holx:Netincome>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc5LTE2LTEtMS01MzM0_ff57ba87-2265-4d1b-ac24-845b5477b9c8"
      unitRef="usd">-300000</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NetIncomeLoss
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTc5LTE4LTEtMS0zMzY4_7fdc7730-e6d3-42c5-bc33-d2c1ffdd578c"
      unitRef="usd">268100000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8226181576f245bba94e4a5ec64e87f6_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTgwLTEwLTEtMS01MzIy_42d58ac2-a4f4-4446-bb35-72d00fe1b0dc"
      unitRef="usd">-6400000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8226181576f245bba94e4a5ec64e87f6_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTgwLTE4LTEtMS01MzQ4_938e810b-cc8b-46cd-aa18-aa34ac60993a"
      unitRef="usd">-6400000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i537a20393d1e493cbe6493d3a8188d64_D20210328-20210626"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTgxLTEyLTEtMS01MzI2_964b34a1-62c1-4f6f-80ca-aad1eb92daa6"
      unitRef="shares">2971000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i537a20393d1e493cbe6493d3a8188d64_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTgxLTE0LTEtMS01MzMw_b3bd3712-16e4-4de0-bdf4-c0ac43287ed1"
      unitRef="usd">188400000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTgxLTE4LTEtMS01MzUw_cca94616-0eb7-4174-bb2e-b31e7f5a85dc"
      unitRef="usd">188400000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <holx:PurchaseOfNonControllingInterestReclassifiedToAPIC
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTgzLTYtMS0xLTMzNzQ_1a49c3aa-598a-485b-85d5-778ff3741722"
      unitRef="usd">8200000</holx:PurchaseOfNonControllingInterestReclassifiedToAPIC>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTgzLTE2LTEtMS0zMzc2_6dc622d3-03f2-4084-9f73-e29ad8ea7a83"
      unitRef="usd">300000</us-gaap:PaymentsToMinorityShareholders>
    <holx:TotalPaymentsToNonControllingInterest
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTgyLTE4LTEtMS01MzUy_ff932259-6a1f-45bc-9353-600bced5ab5d"
      unitRef="usd">8500000</holx:TotalPaymentsToNonControllingInterest>
    <us-gaap:SharesIssued
      contextRef="i6bae2f1749954b73b3a6ead022748861_I20210626"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTgzLTItMS0xLTUzMDQ_e7ed4d96-00a3-4042-96c6-ef53ada8e7e4"
      unitRef="shares">296945000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i6bae2f1749954b73b3a6ead022748861_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTgzLTQtMS0xLTUzMTU_91f78c69-a5e5-40d3-b341-ee0d3df65b7c"
      unitRef="usd">3000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5e17ab66a75e4420b799cd5146ba9ceb_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTgzLTYtMS0xLTUzMTQ_c744f8d9-298d-40c7-bfad-31b9a6c937d2"
      unitRef="usd">5936200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i71a06870de924d918ff5abbf56a8d25d_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTgzLTgtMS0xLTUzMjA_b7c47077-b412-4685-8826-f759c098d0e2"
      unitRef="usd">-30500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i875c4235807f46d2acc9a2e5e2e9e7a8_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTgzLTEwLTEtMS01MzI0_bf24642a-7e12-4be0-870e-1687d75f8bd8"
      unitRef="usd">-42200000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i999599ea2b584e2d8e6e8e7edce3637b_I20210626"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTgzLTEyLTEtMS01MzI4_bb145879-8a1f-4742-ab24-724ab2787f05"
      unitRef="shares">43653000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i999599ea2b584e2d8e6e8e7edce3637b_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTgzLTE0LTEtMS01MzMy_732665eb-e737-47f9-a149-d02cba63ad46"
      unitRef="usd">-1989400000</us-gaap:StockholdersEquity>
    <us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTgzLTE2LTEtMS01MzM4_281378ee-7ffd-4009-b023-492fb1516ca6"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yNS9mcmFnOjIwMGM3ZjA4ZjQxYTQ2Mzc5YjhkY2FiNDFkNzc0NGI1L3RhYmxlOjYwNTA1MDlmNDMxMDQwZDg4ZWRlOWQ3MjgwYmJmN2QxL3RhYmxlcmFuZ2U6NjA1MDUwOWY0MzEwNDBkODhlZGU5ZDcyODBiYmY3ZDFfMTgzLTE4LTEtMS01MzU0_353b8d3d-b793-42f1-a189-20175055df73"
      unitRef="usd">3877100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMy0xLTEtMS0w_9b6a7727-8c4d-4df3-991c-6ef060d57a17"
      unitRef="usd">1540900000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMy0zLTEtMS0w_1861cdbd-4db1-4278-853a-c662afed091d"
      unitRef="usd">616900000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNS0xLTEtMS0w_5739fdb9-322b-44c5-ae07-88e7931ff975"
      unitRef="usd">64200000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNS0zLTEtMS0w_e005c4bb-c776-42e6-97c8-7c1e16382e43"
      unitRef="usd">62800000</us-gaap:Depreciation>
    <us-gaap:AdjustmentForAmortization
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNi0xLTEtMS0w_58ae0d8a-8b21-4359-aac6-8ffd4fe1b954"
      unitRef="usd">224900000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNi0zLTEtMS0w_f8bffb0f-f54f-4ef9-8011-b289fcda5487"
      unitRef="usd">218900000</us-gaap:AdjustmentForAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfOC0xLTEtMS0w_99dd7f92-494b-4850-938f-789cc5ebd4ca"
      unitRef="usd">51000000.0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfOC0zLTEtMS0w_ca560f43-f4b0-4496-a8ad-891cac8807ba"
      unitRef="usd">53700000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfOS0xLTEtMS0w_ec647ce5-3253-4806-ad63-f513a1ba5e95"
      unitRef="usd">-44300000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfOS0zLTEtMS0w_ae561ff9-0895-461b-9784-9b36b1c13fb9"
      unitRef="usd">-63300000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:AssetImpairmentCharges
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMTEtMS0xLTEtMA_7f0cc88e-0807-4902-aba7-b29bab46f59b"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMTEtMy0xLTEtMA_00b38f96-01b0-4a69-bee1-3a4c2a7767b9"
      unitRef="usd">30200000</us-gaap:AssetImpairmentCharges>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMTMtMS0xLTEtMA_4e5035f3-cbb9-463c-8707-81d43d19174b"
      unitRef="usd">-21600000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMTMtMy0xLTEtMA_cf33cc48-4d9e-43bd-8ecb-3ec465b9b54e"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjAtMS0xLTEtMA_0f56269f-19d5-4c4e-98bf-87b70b6a0550"
      unitRef="usd">-19800000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjAtMy0xLTEtMA_7cd609c1-f8fb-478f-b3ad-4acc3e37cbfd"
      unitRef="usd">-23600000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjItMS0xLTEtMA_39bee1ee-22e3-42cc-9f28-ad95cd7264be"
      unitRef="usd">-111500000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjItMy0xLTEtMA_d06e6c65-cb66-4c8b-9f94-7c4427db63f0"
      unitRef="usd">130500000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjMtMS0xLTEtMA_3237f1f3-43bf-4173-a021-20edb7215c1f"
      unitRef="usd">82400000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjMtMy0xLTEtMA_e994907c-f0c5-4ddf-bc8f-03fdf15c2e19"
      unitRef="usd">48000000.0</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjQtMS0xLTEtMA_5471a5ae-a7ca-470b-99f2-58919bc5e630"
      unitRef="usd">24300000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjQtMy0xLTEtMA_c8695318-b6c3-4a3c-bb0b-935e84de2a7a"
      unitRef="usd">10600000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjUtMS0xLTEtMA_f8cb9945-327e-4e92-99d7-77bbb757d75b"
      unitRef="usd">22300000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjUtMy0xLTEtMA_dd939c09-f61a-49c8-97fd-58e78e6c3017"
      unitRef="usd">290000000.0</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjYtMS0xLTEtMA_32aae1ad-1016-4c2b-bddd-2052a5546c68"
      unitRef="usd">9400000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjYtMy0xLTEtMA_d6cead3a-47e3-474f-8ea7-546e967c177d"
      unitRef="usd">-55100000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjctMS0xLTEtMA_46ec33be-c4cb-43a5-9d55-93da3679bb6f"
      unitRef="usd">-27600000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjctMy0xLTEtMA_094aedb3-ddf6-47c4-9dc0-14a56e28ae35"
      unitRef="usd">40500000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjgtMS0xLTEtMA_a5b54173-19e4-454a-8023-308fe1aaa413"
      unitRef="usd">22600000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjgtMy0xLTEtMA_0df12021-7776-4781-afc8-8f9d77797181"
      unitRef="usd">5500000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjktMS0xLTEtMA_562deff8-176e-429e-8349-2c6a37feac9e"
      unitRef="usd">1865000000.0</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMjktMy0xLTEtMA_4a6214f0-898b-4697-9049-f60838139131"
      unitRef="usd">454600000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMzEtMS0xLTEtMA_7ecae9ab-32a0-4628-adb1-686b2a2b3e6a"
      unitRef="usd">1163300000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMzEtMy0xLTEtMA_a518e8ed-d6fb-4756-a116-ab1a86fd6dc9"
      unitRef="usd">43200000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <holx:ProceedsFromSaleOfBusiness
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMzMtMS0xLTEtMA_3ba67aeb-8cc7-4f4c-91bb-d508fd8077c2"
      unitRef="usd">0</holx:ProceedsFromSaleOfBusiness>
    <holx:ProceedsFromSaleOfBusiness
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMzMtMy0xLTEtMA_a8bb46a9-b823-4add-b106-fad83f16fbd7"
      unitRef="usd">142700000</holx:ProceedsFromSaleOfBusiness>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMzQtMS0xLTEtMA_5f102bc4-cd90-4ca9-ab5e-63ec967d4a89"
      unitRef="usd">71200000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMzQtMy0xLTEtMA_a1484124-d48b-4b4c-b2ec-a21053963ea9"
      unitRef="usd">53200000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMzYtMS0xLTEtMA_d3e97054-a361-4a7b-84a4-a82e3d3af29a"
      unitRef="usd">43400000</holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements>
    <holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfMzYtMy0xLTEtMA_813dc368-c6f3-42db-ae42-f0d35b810160"
      unitRef="usd">44900000</holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements>
    <holx:PurchaseOfIntellectualProperty
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNDQtMS0xLTEtMA_f4b30046-ff42-4827-9753-4aca37393e60"
      unitRef="usd">6500000</holx:PurchaseOfIntellectualProperty>
    <holx:PurchaseOfIntellectualProperty
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNDQtMy0xLTEtMA_be04cf95-1eb3-4076-8b72-df3b71f5b5a0"
      unitRef="usd">0</holx:PurchaseOfIntellectualProperty>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNDYtMS0xLTEtMA_25cb6143-b736-4dbd-8833-270615a3fdf5"
      unitRef="usd">2100000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNDYtMy0xLTEtMA_e3df5dee-79a5-45b0-9d6f-b30b83e6c076"
      unitRef="usd">5100000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNDctMS0xLTEtMA_30a5e237-6b5c-46cd-abbe-4383ca9aa370"
      unitRef="usd">-1286500000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNDctMy0xLTEtMA_f37cdfe2-e458-4e93-83af-a408bec00e7e"
      unitRef="usd">-3700000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTAtMS0xLTEtMA_9ce1874b-d22a-4e2e-9565-c8431f5f16e1"
      unitRef="usd">56300000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTAtMy0xLTEtMA_c3509f72-4121-4bb9-b7c5-01eb0f9166b3"
      unitRef="usd">36400000</us-gaap:RepaymentsOfLongTermDebt>
    <holx:ProceedsFromSeniorNotes
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTEtMS0xLTEtMA_2572245b-49fe-4dad-b382-bf07878be1cd"
      unitRef="usd">950000000.0</holx:ProceedsFromSeniorNotes>
    <holx:ProceedsFromSeniorNotes
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTEtMy0xLTEtMA_7c38e6e3-3014-4e13-9ef6-585462517a4a"
      unitRef="usd">0</holx:ProceedsFromSeniorNotes>
    <holx:RepaymentOfSeniorNotes
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTItMS0xLTEtMA_6908338f-e246-45e5-80d1-4ba191e9c3b1"
      unitRef="usd">970800000</holx:RepaymentOfSeniorNotes>
    <holx:RepaymentOfSeniorNotes
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTItMy0xLTEtMA_d5c00464-71d0-4c31-ba11-3083ecf15bdd"
      unitRef="usd">0</holx:RepaymentOfSeniorNotes>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTQtMS0xLTEtMA_846e349c-3e35-4589-8281-d302f52f599a"
      unitRef="usd">0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTQtMy0xLTEtMA_c6f12928-8355-46f4-b067-9b558a5e2778"
      unitRef="usd">750000000.0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTUtMS0xLTEtMA_69aaab0b-ead0-48ae-826f-899edcabef38"
      unitRef="usd">250000000.0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTUtMy0xLTEtMA_9a1599c0-8243-461b-86c2-4b6a31644818"
      unitRef="usd">250000000.0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromAccountsReceivableSecuritization
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTYtMS0xLTEtMA_020c9c68-a867-4fc8-a988-40650f2fb0af"
      unitRef="usd">320000000.0</us-gaap:ProceedsFromAccountsReceivableSecuritization>
    <us-gaap:ProceedsFromAccountsReceivableSecuritization
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTYtMy0xLTEtMA_e53f2203-09e1-47c0-b5f7-e205a82204ba"
      unitRef="usd">16000000.0</us-gaap:ProceedsFromAccountsReceivableSecuritization>
    <us-gaap:RepaymentsOfAccountsReceivableSecuritization
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTctMS0xLTEtMA_1060b722-ceb6-4a43-b74c-fc0ba820693e"
      unitRef="usd">0</us-gaap:RepaymentsOfAccountsReceivableSecuritization>
    <us-gaap:RepaymentsOfAccountsReceivableSecuritization
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTctMy0xLTEtMA_85efedc6-bab7-494c-b0f4-f3934bb3fad9"
      unitRef="usd">250000000.0</us-gaap:RepaymentsOfAccountsReceivableSecuritization>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTgtMS0xLTEtMA_dada700d-1575-46eb-a666-123b5d1d8e0e"
      unitRef="usd">8500000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTgtMy0xLTEtMA_42b0865f-6016-4d6f-b8ca-ee23be595342"
      unitRef="usd">1800000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTktMS0xLTEtMA_253632cb-ef0b-48e4-a5e8-d69154e17780"
      unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNTktMy0xLTEtMA_e00a31de-f22c-48cc-9366-20443c832451"
      unitRef="usd">24300000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNjEtMS0xLTEtMA_e457878d-a559-43bc-84f2-09c79fc05b06"
      unitRef="usd">13700000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNjEtMy0xLTEtMA_b7aa5592-e8ed-4a97-8f52-0b4da40baea7"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNjMtMS0xLTEtMA_49883ebd-ea6b-45be-a4c8-2341f9261265"
      unitRef="usd">409700000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNjMtMy0xLTEtMA_325d7d23-6ba9-47ba-ae16-27fc4c116ac1"
      unitRef="usd">553400000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNjUtMS0xLTEtMA_2c5316d9-40e1-4c51-be31-e2b438de72b6"
      unitRef="usd">39600000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNjUtMy0xLTEtMA_78eba778-5fb0-4736-87bd-269f489ff370"
      unitRef="usd">54700000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNjYtMS0xLTEtMA_0c5d4fff-9a6c-4010-bbea-495544d293eb"
      unitRef="usd">46900000</holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits>
    <holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNjYtMy0xLTEtMA_d4ed78f1-d19a-460c-97d0-c0cf2deb9b3b"
      unitRef="usd">12600000</holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits>
    <us-gaap:RepaymentsOfLongTermCapitalLeaseObligations
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNjctMS0xLTEtMA_d83876ce-9f96-4456-915b-b67194a381b0"
      unitRef="usd">1500000</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>
    <us-gaap:RepaymentsOfLongTermCapitalLeaseObligations
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNjctMy0xLTEtMA_1904f55e-d5f7-40d3-a123-d58d3eacb0ef"
      unitRef="usd">1200000</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNjgtMS0xLTEtMA_bea1b884-640a-4bf0-bc1b-aaca1c7fb1e7"
      unitRef="usd">-447800000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNjgtMy0xLTEtMA_9ddfaaa7-2ec8-451d-89fa-f82582479592"
      unitRef="usd">-309000000.0</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNjktMS0xLTEtMA_0e25d147-12af-47c4-a5c0-92c0477ee9d5"
      unitRef="usd">-4100000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNjktMy0xLTEtMA_987b9ef5-5523-47fd-af28-160dff9e5d88"
      unitRef="usd">500000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNzAtMS0xLTEtMA_b2ed1147-60c3-47ca-9662-eafc1ed2904a"
      unitRef="usd">126600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNzAtMy0xLTEtMA_3de96b3f-7a3c-4d5b-b3ad-eae0abb4d01b"
      unitRef="usd">142400000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNzEtMS0xLTEtMA_b89d31bd-b627-4353-b179-f19147bfcda4"
      unitRef="usd">701000000.0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia1bbf9311cb649308affbf16f61bb3ff_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNzEtMy0xLTEtMA_613e19f1-f3b8-4c77-bb77-eff44a98005d"
      unitRef="usd">601800000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNzItMS0xLTEtMA_ec14872f-db16-49f1-9285-fed5fadc92f8"
      unitRef="usd">827600000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i81ab5863e2124accb342d2df86a1ee96_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8yOC9mcmFnOjk3ZjRiOWJlODI1MzQ0ZmVhZWI5NjAxZGJmYTEwMWNkL3RhYmxlOmI1ZDgyYmZjYjNlNTQ5NzdiZTZhMThkOWJlYTg2YzEyL3RhYmxlcmFuZ2U6YjVkODJiZmNiM2U1NDk3N2JlNmExOGQ5YmVhODZjMTJfNzItMy0xLTEtMA_e783db22-588e-4089-acf8-69b6869ae14b"
      unitRef="usd">744200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNC9mcmFnOmZmZjg4ZDIzNTBiNzQ1NDg5NDNhNDUwY2EwOTYzMGM0L3RleHRyZWdpb246ZmZmODhkMjM1MGI3NDU0ODk0M2E0NTBjYTA5NjMwYzRfNDU2OQ_6320dd15-948a-4998-a377-214a34b6fc0a">Basis of Presentation&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements of Hologic, Inc. (&#x201c;Hologic&#x201d; or the &#x201c;Company&#x201d;) presented herein have been prepared pursuant to the rules of the Securities and Exchange Commission (the &#x201c;SEC&#x201d;) for quarterly reports on Form 10-Q and do not include all of the information and disclosures required by U.S. generally accepted accounting principles (&#x201c;GAAP&#x201d;) for annual financial statements. These financial statements should be read in conjunction with the consolidated financial statements and related notes for the fiscal year ended September&#160;26, 2020 included in the Company&#x2019;s Form&#160;10-K filed with the SEC on November&#160;17, 2020. In the opinion of management, the financial statements and notes contain all adjustments (consisting of normal recurring accruals and all other necessary adjustments) considered necessary for a fair presentation of the Company&#x2019;s financial position, results of operations and cash flows for the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with GAAP requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from management&#x2019;s estimates if past experience or other assumptions do not turn out to be substantially accurate. Operating results for the three and nine months ended June&#160;26, 2021 are not necessarily indicative of the results to be expected for any other interim period or the entire fiscal year ending September&#160;25, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments &#x2013; Credit Losses (Topic 326)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The purpose of ASU 2016-13 is to replace the current incurred loss impairment methodology for financial assets measured at amortized cost with a methodology that reflects expected credit losses over the lifetime of the financial asset. As a result, credit losses are recorded when financial assets are established if credit losses are expected over the asset's contractual life. The measurement of expected credit losses is based upon historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The Company adopted the standard during the first quarter of fiscal 2021. The adoption of ASU 2016-13 did not have a material effect on the Company's consolidated financial statements. See Note 8 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2019, the FASB issued ASU No. 2019-08, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation - Stock Compensation (Topic 718) and Revenue from Contracts with Customers (Topic 606)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This ASU identifies, evaluates, and improves areas of GAAP for which cost and complexity can be reduced while maintaining or improving the usefulness of the information provided. The amendments in this Update expanded the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. The Company adopted this ASU in the first quarter of fiscal 2021, which did not have a material effect on the Company's financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Subsequent Events Consideration&lt;/span&gt;&lt;/div&gt;The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence for certain estimates or to identify matters that may require additional disclosure. Subsequent events have been evaluated as required. There were no material recognized or unrecognized subsequent events affecting the unaudited consolidated financial statements as of and for the three and nine months ended June&#160;26, 2021.</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RleHRyZWdpb246M2M2NDJkZDhmZjJhNDczOWJkMzNkYTQwMzU5ODMxNDVfODA1Nw_8ad255d5-dfed-48b1-9691-de06061f2cd5">The following tables provide revenue from contracts with customers by business and geographic region on a disaggregated basis:&#160;&#160;&#160;&#160;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.576%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.843%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.230%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Business (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;in millions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cytology &amp;amp; Perinatal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molecular Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;536.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;391.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Screening&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;665.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Imaging&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;280.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional Breast Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;273.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;749.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;418.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,168.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;660.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;822.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.139%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.157%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.869%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended June 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Business &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cytology &amp;amp; Perinatal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;230.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;357.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molecular Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,561.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,467.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;683.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;829.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Screening&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,825.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,032.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,858.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;909.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;254.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,163.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Imaging&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;817.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;718.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional Breast Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;784.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,018.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;862.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;296.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;227.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,951.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,364.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,315.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,868.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;561.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,429.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.358%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.863%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Geographic Regions (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;in millions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;749.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;660.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,951.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,868.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;963.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,168.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;822.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,315.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,429.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides revenue recognized by source:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.543%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.435%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.961%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.065%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.333%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Revenue by type &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disposables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;797.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;588.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,239.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,511.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital equipment, components and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;590.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;437.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;388.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,168.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;822.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,315.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,429.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="i4e77ae6b121e4933b196860cc147365e_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMy0yLTEtMS0w_a2c48536-8c3a-4f50-a394-dd0ad460ace1"
      unitRef="usd">73900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1a4ec39647f042768fb079e46c124d64_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMy0zLTEtMS0w_5850130f-a403-473c-8591-cd1f4e4259fc"
      unitRef="usd">42000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibe2790b0becc4992ab4a86ed0f47b8b0_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMy00LTEtMS0w_7c729952-acee-4b44-8335-6901ae924b05"
      unitRef="usd">115900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6b4d9d4a1d51468d9eb84de80c70c52f_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMy02LTEtMS0w_5c0251ed-17be-4791-ae22-63b103e63faa"
      unitRef="usd">40300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if395d4107ff1436d8ecfbc976a4eccac_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMy03LTEtMS0w_4809e500-fdb7-4414-975a-8c1ea72fc009"
      unitRef="usd">23800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i89acd5d341534bbfacfac9fb7fd346a3_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMy04LTEtMS0w_0ba17a42-875b-4680-a9e0-1dd15f3e462b"
      unitRef="usd">64100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if6e8ba7ac1ad4788936366e6a2a40bcf_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNC0yLTEtMS0w_48f81116-281b-4782-99fd-d371550c93a7"
      unitRef="usd">270100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i14b4ef7fc8f6486f8099a60d145ae4e9_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNC0zLTEtMS0w_a2f54c6f-da88-4e5a-9a19-519a219bf91e"
      unitRef="usd">266300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iac5bd9bb07344043bdbb2c9c3b03b313_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNC00LTEtMS0w_25bb6406-b04c-4c10-964d-5d763c28e0d0"
      unitRef="usd">536400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if23b3ae36b644acc87ec67b72cd7b730_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNC02LTEtMS0w_c6e62d56-ce51-4a9f-b0e2-1445dac093e0"
      unitRef="usd">391000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i531234c15a6c43f8ba2e74a3bc5979be_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNC03LTEtMS0w_50877d4a-469f-4521-8c15-698b422a7fd7"
      unitRef="usd">69300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i441afbe7ea704a97a13d7f01cda317fe_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNC04LTEtMS0w_226f9c3a-a59e-4dac-8af1-3249eb4853b7"
      unitRef="usd">460300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2cd4c64d0a9b44e7b731b80d7ff2cff9_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNS0yLTEtMS0w_0ee94c7f-2bf6-4335-818f-28eaceabecc7"
      unitRef="usd">13200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0450e1103e8241cc93052d9df1a6f6bf_D20210328-20210626"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNS0zLTEtMS0w_a8ed2f75-a8c6-45c0-8cf1-351de347c049"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icf7456bf9a8f47acacea66bd647d61be_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNS00LTEtMS0w_ad77e71a-9616-42fd-81db-42090f0ea323"
      unitRef="usd">13200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i14fe0f286fe8418d8408a5ef9a8ded4b_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNS02LTEtMS0w_60d8770e-b20e-45e1-8a35-46443d6c7b5d"
      unitRef="usd">7800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9ce0088f110146f9abc2c378a66d90fd_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNS03LTEtMS0w_5c2d703d-f89f-475c-b59d-d0917798e1a2"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic0db9249ce324df6b69e1002079a0170_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNS04LTEtMS0w_e2d1a2a1-50f9-4ada-b959-36e1a9ea7761"
      unitRef="usd">7800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ief5d5ac299f444e7a11589340f1d8811_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNi0yLTEtMS0w_471b3962-fc5f-4b00-ae50-d605dc994849"
      unitRef="usd">357200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4b8441cccd184c4486e57f87f71f3656_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNi0zLTEtMS0w_c725214d-c393-4c39-9c68-e0267037fa25"
      unitRef="usd">308300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i286bca0d89644bd0b3205f4b93ed5c1d_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNi00LTEtMS0w_0a896b00-266b-4cfa-841b-a0db41046438"
      unitRef="usd">665500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4ee2782511e24cde8d011a55e9af48b7_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNi02LTEtMS0w_6086127a-1e75-45c5-9c95-3514ce2aa612"
      unitRef="usd">439100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i410f2d6c20c4496eb68a1ac00b260536_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNi03LTEtMS0w_e4229594-5905-44f2-b05c-14775fedb2cb"
      unitRef="usd">93100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i79c862e1f99d4e7bb053e7bea309372c_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfNi04LTEtMS0w_9dc2c0a5-dc34-4cd2-9bed-f5404c831195"
      unitRef="usd">532200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i75e45ed7d25546e591e76bfdf91c98d0_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfOS0yLTEtMS0w_d15f88e5-1579-42e9-922f-ffb72b584994"
      unitRef="usd">218400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7ed178edd5ad495c90c1b54255909fa8_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfOS0zLTEtMS0w_5509f631-ee70-4695-9916-451bbc0f07c8"
      unitRef="usd">61900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if47061debb804420a5e14a803176e8ce_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfOS00LTEtMS0w_1a00e149-3fb6-4d95-813c-a842ab5f9b63"
      unitRef="usd">280300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia942e9f26e244360b3ce4f6c390b9d93_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfOS02LTEtMS0w_fb8cee79-dc94-4005-b821-860cb9c7d990"
      unitRef="usd">145600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6f248925f2ee4c69b3f784a04ba9a364_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfOS03LTEtMS0w_c74bf305-c436-44c5-b241-ea0afa18d5d5"
      unitRef="usd">47600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifcf29874b0924e36855919d6b73c66f7_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfOS04LTEtMS0w_ed03630a-14b7-4c97-b553-711081b4a840"
      unitRef="usd">193200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic22fe1d383e84feaadba1dc8f408d3dc_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTAtMi0xLTEtMA_5baa43ed-36e8-4d9e-9615-ee22f320ce91"
      unitRef="usd">54800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic9c3b5b875444c0689eae7d05cf36d7e_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTAtMy0xLTEtMA_28b862e7-171b-405c-a872-60cb0cfcd721"
      unitRef="usd">13900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4bf0a79818e54f1fbf147be4c1ef864d_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTAtNC0xLTEtMA_a97ca196-f5e2-45db-bd52-088b8c5ecf0a"
      unitRef="usd">68700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib3ce04ac38db44279190e17fe5e2384a_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTAtNi0xLTEtMA_0d6ab3f5-ba9c-4611-ab98-0eb931a80f19"
      unitRef="usd">25000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i60f75ab143d84b689500c2e5bfebcf87_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTAtNy0xLTEtMA_3d175ef8-45d6-436b-a535-63a0be1aa15e"
      unitRef="usd">5800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5393210c850e49b78aace5bb63c4e69c_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTAtOC0xLTEtMA_32112115-52ce-4fda-9e9a-4c97d7612dc9"
      unitRef="usd">30800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5b239d22f00e4502a2fe462334f74606_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTItMi0xLTEtMA_b04ab474-c798-4f02-9f58-94f9bf68c2e2"
      unitRef="usd">273200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i942bad789f284e31a5f43dcf1fedf43d_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTItMy0xLTEtMA_1bd6c41e-5a19-4482-b953-db7d3fc7b647"
      unitRef="usd">75800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id09b1799f368487b906ce59a96d2e408_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTItNC0xLTEtMA_b7d15e56-6d7c-423c-800b-d9e01422c512"
      unitRef="usd">349000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icfcab7983d0848b082ee034a8af8e64b_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTItNi0xLTEtMA_d3512c6a-428d-4d12-b508-ce58fb8a2330"
      unitRef="usd">170600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaa28816934d4448282f6c7faf7a4d548_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTItNy0xLTEtMA_ffcd6976-673c-4f1b-9140-d1ee9e0ea9e0"
      unitRef="usd">53400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie9773235748348dd8da0c1995d6ed993_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTItOC0xLTEtMA_71591dc0-f605-4e84-8170-7e867db230c0"
      unitRef="usd">224000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i57d8e5448f0d4ad48c2c716944cec78f_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTQtMi0xLTEtMA_5f88439d-b168-4e78-8b8a-746fb9709d2b"
      unitRef="usd">103900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id31306d0e2234478a749fe0b4889a65a_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTQtMy0xLTEtMA_a7f3e01f-2dae-4d94-aca9-3d5f58e8ca7a"
      unitRef="usd">24000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4cc1b7e15e774991a987400605125d1c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTQtNC0xLTEtMA_e8f344ba-5c20-41a2-9f81-a2310c7f7511"
      unitRef="usd">127900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i987b8ad71b084e15ae9ba9e8338b3bd0_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTQtNi0xLTEtMA_00753fc4-9087-437b-802d-da1719d125f4"
      unitRef="usd">42100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i85493aa01af94bd8b1f7328b463dd8e5_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTQtNy0xLTEtMA_fe29701b-3479-4e07-a81b-2c32ff5a3d5f"
      unitRef="usd">9400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia27da4de68874f0fb714ee7967b38fd7_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTQtOC0xLTEtMA_8f8e7b70-4a3f-4d00-b22d-5dd914e0324e"
      unitRef="usd">51500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaf75ce65865145c3aa67cc9f1814b5d6_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTgtMi0xLTEtMA_2205aab7-e024-4436-a68b-b75b92fcb4b2"
      unitRef="usd">15600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i96d4eb19ed154f9f9df012f7ce7ee57a_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTgtMy0xLTEtMA_de06b7f8-83ca-42d5-8dea-9b561029fc6c"
      unitRef="usd">10300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifd7f591f4d6846419f3ba29d469f7d3f_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTgtNC0xLTEtMA_17df26f8-ea69-4ff5-80cc-66bf694d7951"
      unitRef="usd">25900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifcbb80af093740f9a361c5448ab37e4c_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTgtNi0xLTEtMA_d9f50185-ed68-492b-9efe-096b60491009"
      unitRef="usd">9000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icabdcbbe69c545579aa33835b5f3d4eb_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTgtNy0xLTEtMA_a198f6f6-967c-4674-9ef3-b932b553f839"
      unitRef="usd">6200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i16a0b171d8b2414ebdc3554e167249d2_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTgtOC0xLTEtMA_794a8f58-da36-48ae-b830-7314d4d714c5"
      unitRef="usd">15200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5cc68c7458734cd2a8a7c981e8515c76_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTktMi0xLTEtMA_875c5629-911e-4ae7-83fe-ac7e4d936e5d"
      unitRef="usd">749900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie8818dd7702142cf95a9d19c729ddf8a_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTktMy0xLTEtMA_ae1e4615-18a8-4d59-bfbd-69a58ee06dc8"
      unitRef="usd">418400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTktNC0xLTEtMA_5762fa3b-c80e-4681-8108-73ef237c70ca"
      unitRef="usd">1168300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i88586a6659324a6e94cec1cb09cf2a46_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTktNi0xLTEtMA_5e0b78b5-69b2-44e8-bec2-d4d2b7c047b2"
      unitRef="usd">660800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9991425506644c169e0b162c4eec7947_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTktNy0xLTEtMA_c7d83dc6-11a7-4c66-b44f-384c6f8fd452"
      unitRef="usd">162100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjdjZmY3ZjU1ZWM3ZTRhNzY5ZDU2M2Y0ZjY1ZDRjYjkyL3RhYmxlcmFuZ2U6N2NmZjdmNTVlYzdlNGE3NjlkNTYzZjRmNjVkNGNiOTJfMTktOC0xLTEtMA_d68912bb-907a-448c-ba37-5eba33468fb2"
      unitRef="usd">822900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iace9270559714986aaabca0d4ebdff24_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMy0yLTEtMS0w_abf1c56f-4919-4981-b993-61ba26e074d9"
      unitRef="usd">230800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ieeb7d864535e4e7f9bce653f4b168b96_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMy0zLTEtMS0w_cbd0ea0e-ad2c-4762-a9ec-39f4426c544a"
      unitRef="usd">127100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8be39ed1f1aa46c3894324d319834486_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMy00LTEtMS0w_98ca27a1-424f-4fb1-b575-95216dba20da"
      unitRef="usd">357900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic4c0e43445d04743bcb9261bbcc78b53_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMy02LTEtMS0w_db18111d-5a5f-4a71-88b0-b67df855d4c2"
      unitRef="usd">191100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8f0c0208131f49b39c73659c82a02222_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMy03LTEtMS0w_26c7a52f-d215-4c66-954a-6ddc01a52d7b"
      unitRef="usd">107600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iea063f8d161b4a0b85a574fa46b7f7b4_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMy04LTEtMS0w_9f6487af-5d07-4783-a4f8-fce6ee626221"
      unitRef="usd">298700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1feb000741a14589b76e0f21beb6c5c0_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNC0yLTEtMS0w_f941b559-9db0-4094-987a-df3bff945add"
      unitRef="usd">1561700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id62f94911ce54ef68438afc76c05b4b2_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNC0zLTEtMS0w_f77550b5-e778-4ec0-bcc5-99acb8e9b5d6"
      unitRef="usd">905300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i99435d39a02440deadad10c369f19565_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNC00LTEtMS0w_9ad0517f-a151-4364-8cdc-12ec8ff7bbee"
      unitRef="usd">2467000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i87eaf0bf3c6d48658f4c2c3e78a71ac2_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNC02LTEtMS0w_3a51ef39-11d2-45ba-9b6f-5a4be6e121e0"
      unitRef="usd">683000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7491e43b952d4c61b87c261b016b3e1b_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNC03LTEtMS0w_985231d7-24a8-4cad-9810-6bb94389f984"
      unitRef="usd">146500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5d6ad39df725417db4cda9327284076d_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNC04LTEtMS0w_49368b42-7530-4783-8444-4100b6d5c15b"
      unitRef="usd">829500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i075e000f08f64e8883de52eb2ec429b6_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNS0yLTEtMS0w_8604ee62-1f31-4240-9471-25d92a46497d"
      unitRef="usd">33300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie416f1bb45be4de39749bd46c36fe698_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNS0zLTEtMS0w_34a02216-d21c-4e10-a8a6-85bb5862b556"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i869637ca6659448691978af8788531f9_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNS00LTEtMS0w_56e91df6-6053-4c8c-9dfe-2fc4f8b79af5"
      unitRef="usd">33300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i163df94df0de411eb1ec6ff91ad044d1_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNS02LTEtMS0w_3aac70fd-f973-4d99-b913-a5757b688ccb"
      unitRef="usd">35000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1aa19225dcc7437aad83c6bad124ebec_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNS03LTEtMS0w_de871912-5458-4aca-97a3-613315c335be"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0e4faefdffaf4617a9f21a886228d428_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNS04LTEtMS0w_2ed1d855-c646-4c54-906c-c02da488b3bd"
      unitRef="usd">35000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id9ba7888ec484e89a44484a6c3048d8f_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNi0yLTEtMS0w_9da9b5ca-fd03-46c1-ae40-44491b8dd117"
      unitRef="usd">1825800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0a7e9769dab647d2ba4a287635864018_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNi0zLTEtMS0w_7deac6cf-d473-4d12-af76-2fa0eab6d85e"
      unitRef="usd">1032400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i27eae9a50641400fb1c2541bd52dad61_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNi00LTEtMS0w_b4b579ba-5fca-4a07-ba08-5c93ce15682a"
      unitRef="usd">2858200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iff62125937204878a658f0c5628606fa_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNi02LTEtMS0w_fd9a634d-8aa9-49ab-a61a-4f094101650f"
      unitRef="usd">909100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie82bb12476164052a5d97847ecbff323_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNi03LTEtMS0w_9131e926-a2e8-4ed4-a9b6-827a484c424e"
      unitRef="usd">254100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibac682b2841e4347b6671d6949367197_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfNi04LTEtMS0w_c82014f2-f285-4257-bf9c-24fbb5ae85e8"
      unitRef="usd">1163200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaa51fa0830194b718e4598c66cc20822_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfOS0yLTEtMS0w_5f8fd101-ef3a-4ea2-b2c4-6e98c3b36976"
      unitRef="usd">619500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idaa1c66f7d6d4ab9b6669c1d61bd937a_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfOS0zLTEtMS0w_10108484-8faf-43ac-b9fb-b7e9da26c63d"
      unitRef="usd">198300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i46fb7e93d58d4db1824c75dcbca92ff7_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfOS00LTEtMS0w_349fdf40-650d-497a-ba0c-8da2c048eb4c"
      unitRef="usd">817800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id7a0cc313a77477ba010d815081c9a07_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfOS02LTEtMS0w_7c3613da-8539-4cea-9e57-f0a5c3482752"
      unitRef="usd">541100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie85bcce039094bae9db0bf4313fb7e60_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfOS03LTEtMS0w_44ab6c8c-d181-42c6-9052-99557541e21c"
      unitRef="usd">177100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7711c49f92c04e2b9466ed524ee8bc2e_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfOS04LTEtMS0w_95439d69-2229-47f7-a4f9-ccf4a9103f4e"
      unitRef="usd">718200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if96887e76d944d08b5519f53cef01904_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTAtMi0xLTEtMA_215693e7-c40d-4503-abd8-2fc37817dbd6"
      unitRef="usd">164900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1eca047fb0c84048ab9cb90facfbf706_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTAtMy0xLTEtMA_2087a179-c42f-4201-b38e-4a8aa0b8292c"
      unitRef="usd">35300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3df779d8bf47483e9f292cc7612b6774_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTAtNC0xLTEtMA_110527a9-e73f-46f4-ace3-25e2cb2336bb"
      unitRef="usd">200200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iee9eab84d6ad4c45a2dd7d811f7fb06e_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTAtNi0xLTEtMA_da6d6849-43fa-47b8-8118-1febd3923b62"
      unitRef="usd">120400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iebeafdaf8b04495394d947c38fcd54be_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTAtNy0xLTEtMA_e97833e1-e77d-45a1-907c-087112a11a17"
      unitRef="usd">24200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iad6089c03fe04694a4932756918fb99d_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTAtOC0xLTEtMA_2486a2bf-9904-4e5a-a38a-43257c2bce28"
      unitRef="usd">144600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib6fbe86d934c4d18a2a5e07b6312d943_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTItMi0xLTEtMA_f7619571-2e78-4b8d-b750-91d09a1633fc"
      unitRef="usd">784400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifd2db6ee06b94cddafde9fe932029265_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTItMy0xLTEtMA_4bcefd0e-d27e-40a6-9225-fcfcdc579171"
      unitRef="usd">233600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic99b704f095f4cd69b8a4ae90368d2d7_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTItNC0xLTEtMA_b5586500-cc62-4a64-9a69-d28d0bd996bb"
      unitRef="usd">1018000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i94cf4a747ee64dfd93739c74eb4cd66d_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTItNi0xLTEtMA_1dee606c-fdaa-4bda-9dbb-2d1a1f0ca6fa"
      unitRef="usd">661500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib0fc4831c77847b3a201ce54a4e2db2f_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTItNy0xLTEtMA_a4d907af-940a-4403-9fb0-f26ad69cc743"
      unitRef="usd">201300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icbfaf422f9724422b8b06418613c842d_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTItOC0xLTEtMA_be54ea39-0046-4617-b2ef-374848d78dfe"
      unitRef="usd">862800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i561c02d7c245409293cfa0a1562f677a_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTQtMi0xLTEtMA_df9ff96e-000d-41d1-9a8b-380db78bc6ea"
      unitRef="usd">296800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id50cd5f65a25492abef4ce8286035326_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTQtMy0xLTEtMA_194a4b1f-9d03-46bf-8987-458e3f20c54e"
      unitRef="usd">69400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5293327445f541ed891801a24fba467c_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTQtNC0xLTEtMA_f33be3db-322f-44b2-b9d2-868706af8a61"
      unitRef="usd">366200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6bdefe68c3ea42e58988c6e8a69fd673_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTQtNi0xLTEtMA_5be488e3-8135-4cbe-b0e9-9c102840bda7"
      unitRef="usd">227600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i25dced02445e4b87a13031b8d51a8173_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTQtNy0xLTEtMA_61494ab3-caed-45c1-8287-a0639ee08f99"
      unitRef="usd">48300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3d4e9da2a2c14f13984e3286a479cede_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTQtOC0xLTEtMA_2888f419-e040-49a6-836c-71a524f5164c"
      unitRef="usd">275900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i391a26685f56401ea4adc59b7d80011f_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTYtMi0xLTEtMA_74acd5ae-4651-44a0-804f-2bb2baf67d5e"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i52c4985d417b4421a13ef783c7e19a9f_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTYtMy0xLTEtMA_b63260d4-db59-4cc4-a7a0-57520f7433de"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifa3d63fea23c46bcb179fec3fd524a11_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTYtNC0xLTEtMA_422e1860-952d-42a6-959a-9071107c7900"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i03551c738e78426f82dbe57a0c1bf66e_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTYtNi0xLTEtMA_2c5a3240-4cad-4c17-b4cb-dde109951844"
      unitRef="usd">30900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic2a56d2bb725478f82e31f1329449f9a_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTYtNy0xLTEtMA_99dfa7b2-fbc7-4c3f-ae88-148c535961b8"
      unitRef="usd">34400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6bafd189711f4ec19e64d26761bc3318_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTYtOC0xLTEtMA_3eb3790d-bff3-4ab6-bbf4-fe168c4f18ef"
      unitRef="usd">65300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id0c8406167274863803b6b1fb7cf1d04_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTgtMi0xLTEtMA_cabac798-0901-4302-b1ec-5f3ea51bbcdc"
      unitRef="usd">44700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i86db2b9cd67f4199811130ee684b41e2_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTgtMy0xLTEtMA_5164dba0-684e-41b8-9849-9ac45d474965"
      unitRef="usd">28600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i85f7ecac32784df6a536dad78a0e43e9_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTgtNC0xLTEtMA_f80778fa-ba23-4dfc-abd8-a75bd3cfbab1"
      unitRef="usd">73300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icf42837162e3410ea1fc194837543b32_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTgtNi0xLTEtMA_9c7458ea-5133-477a-a91d-9b3d5abb37e8"
      unitRef="usd">39400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1af39200976349b393f0094f2c751da6_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTgtNy0xLTEtMA_b4f0948e-8d57-4d40-87e0-bdda7cf22a76"
      unitRef="usd">22900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8ed43d6f3b9e467c9e24d43594b26b14_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTgtOC0xLTEtMA_2f70c751-8772-4e02-bfe9-236d2138ee39"
      unitRef="usd">62300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i386d807f9c604702afb89ac48d4f3997_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTktMi0xLTEtMA_fc3f6bf1-3017-4fe5-87be-67e8d63cb170"
      unitRef="usd">2951700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i476b388d782a4d1188664e75bb1926f9_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTktMy0xLTEtMA_64129c3c-9bf4-48ee-9118-4e8c4a95b641"
      unitRef="usd">1364000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTktNC0xLTEtMA_d36baca5-3d84-40a9-aeb9-c62399ea7dd9"
      unitRef="usd">4315700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2107dfda459c464ba7795fbb3263a45f_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTktNi0xLTEtMA_739bbc52-3f6a-4fc4-b55d-583b3d1d663a"
      unitRef="usd">1868500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3db408b0437e4aee94b6507a2f00f132_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTktNy0xLTEtMA_42392dd8-fbd6-4603-b6b8-91db196fce83"
      unitRef="usd">561000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjZmNmY5NDE0MWExNzQyMTc5OGMyOTMyOTY1MWNjOWE3L3RhYmxlcmFuZ2U6NmY2Zjk0MTQxYTE3NDIxNzk4YzI5MzI5NjUxY2M5YTdfMTktOC0xLTEtMA_6de2f5a4-ba79-42f7-8437-d4dfb4771c63"
      unitRef="usd">2429500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5cc68c7458734cd2a8a7c981e8515c76_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfMi0yLTEtMS0w_7ae7a8a5-0c7c-49f4-94a3-d6d5c92efba8"
      unitRef="usd">749900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i88586a6659324a6e94cec1cb09cf2a46_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfMi0zLTEtMS0w_75ef292c-99d7-4ce5-b124-de4d0e677450"
      unitRef="usd">660800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i386d807f9c604702afb89ac48d4f3997_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfMi01LTEtMS0w_1b80ca1f-e5d5-46a9-b37b-76ae40a4e50f"
      unitRef="usd">2951700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2107dfda459c464ba7795fbb3263a45f_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfMi02LTEtMS0w_d002950e-14fd-43b8-9cb5-30984cba4b9a"
      unitRef="usd">1868500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i82e0f458672c41aabd0a7ccc0ecba719_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfMy0yLTEtMS0w_4027cf4c-4829-4928-8441-a22350f6b210"
      unitRef="usd">289000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i63bf14aa150b470d8cda291a8e3dd66f_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfMy0zLTEtMS0w_7bc9dd80-d377-4f2b-8c4f-fe8de99d301d"
      unitRef="usd">101700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if97a9823a91c48f6879659548ae4a3e1_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfMy01LTEtMS0w_ce720e0c-b4e2-4588-8f46-1c483a96b6b5"
      unitRef="usd">963900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9aa28665b0b14585a3f36c725cdb23a2_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfMy02LTEtMS0w_870f0c24-f292-4f9a-9900-f3aed54c3c1f"
      unitRef="usd">322900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idadd999b632a42d7b0d65121528aa81a_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfNC0yLTEtMS0w_48ed8e37-f3e7-4bc5-b7c1-2c968f1e9771"
      unitRef="usd">89600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i877644a05fce44e28b7a923b72578d44_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfNC0zLTEtMS0w_7c909443-8deb-403f-a344-3875357008bf"
      unitRef="usd">43700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie9abeb75d8db4dec84473529c4e293f5_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfNC01LTEtMS0w_21facb2d-63f6-4e51-a56f-a2a209c00edd"
      unitRef="usd">268100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i070ab836e0a141d2815638fcced72af6_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfNC02LTEtMS0w_a9ce2570-8a42-49af-a0b6-99e338f43c16"
      unitRef="usd">155500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iba84d4a948cd406cad1198d4bdc90dcb_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfNS0yLTEtMS0w_ad28ad22-ceb5-4c83-a07f-f803b1e2d20d"
      unitRef="usd">39800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic351acb54a3849d8aedcfca04d87ab1d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfNS0zLTEtMS0w_36659d6f-956a-40b3-b758-42a452255c4e"
      unitRef="usd">16700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic7d1d8a90959436b8aca4870757f76ba_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfNS01LTEtMS0w_d1f8bd02-6e6d-44e6-a8c2-74db0a560fe7"
      unitRef="usd">132000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i98e039107e7742dc92ff616d5e0b45fa_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfNS02LTEtMS0w_0f5d8ff3-73b4-4cfb-87a3-d31140e2593a"
      unitRef="usd">82600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfNi0yLTEtMS0w_fb89469b-58e4-4d74-9b32-a309a65b22e0"
      unitRef="usd">1168300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfNi0zLTEtMS0w_584bca47-51a3-4bb7-a053-16f6b6c71b28"
      unitRef="usd">822900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfNi01LTEtMS0w_74b6804e-6609-4b2f-ac3b-226d4a7fdae5"
      unitRef="usd">4315700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjhlYjJlMjQyMmFhZTQxMGU4MDBmZDhlODMyYjBlNDgyL3RhYmxlcmFuZ2U6OGViMmUyNDIyYWFlNDEwZTgwMGZkOGU4MzJiMGU0ODJfNi02LTEtMS0w_5eef2c15-87ee-4566-91bb-679978a2fb58"
      unitRef="usd">2429500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icfb85da295454d3fa7ac34d45ba8399a_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfMi0yLTEtMS0w_3a15aba3-a3ac-45f5-b61f-4b4a341761a3"
      unitRef="usd">797700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i997d2963735445798702be9238bd61d3_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfMi0zLTEtMS0w_cdc2d482-9b97-4c20-98a2-0c23d33cb249"
      unitRef="usd">588100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6fc238f172a84daa9f0b0b392fc8265b_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfMi01LTEtMS0w_ae7f44c4-66ff-48b1-8c94-ae208007610a"
      unitRef="usd">3239200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i969332a55fc94c40b1890a3c159072e5_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfMi02LTEtMS0w_8373f0f5-2308-4955-9c12-e228ee644770"
      unitRef="usd">1511400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaea9eeace8bc48a6853ad4eb8c570984_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfMy0yLTEtMS0w_e13df379-bc2f-4c7e-a0ae-abf688b2d559"
      unitRef="usd">197500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if064abfbec784952a50564f775aa48b4_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfMy0zLTEtMS0w_6e70514e-9d6a-4f3d-aa63-ac2eaf05dc74"
      unitRef="usd">113500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i066e06a75605450685297c3e282a6b6f_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfMy01LTEtMS0w_0d8cb356-f77c-4f1a-ac79-a3954908bf27"
      unitRef="usd">590200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i93a5b58ca8ab490bb807f3f47ed0695a_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfMy02LTEtMS0w_f6414cd9-f13c-491b-bef5-0e720d02be4a"
      unitRef="usd">513100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if5fbe2f2ff664952a86162b814c29dc5_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfNC0yLTEtMS0w_76120852-9a3a-4fa4-bfa3-4791f320b25f"
      unitRef="usd">158400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i39c233f5360f46839440a89ec92db102_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfNC0zLTEtMS0w_1eb13208-d0e6-43f4-bedd-850e3f14bc98"
      unitRef="usd">116400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic7caffadd2bf4a08a5a93de29b5b1702_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfNC01LTEtMS0w_d1bebb99-8e1b-4965-af16-65b0c7f9e46f"
      unitRef="usd">437200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie4271982162541bca84afd4b29071784_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfNC02LTEtMS0w_4440be1a-1c8a-4bfe-86bf-7adacf848177"
      unitRef="usd">388600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i125ef810b16745dbb51cab70e0c74868_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfNS0yLTEtMS0w_94a1fbb6-f750-400c-9f6e-5a089c83b014"
      unitRef="usd">14700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6b102cbde6ac4145a026f275552c9233_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfNS0zLTEtMS0w_258117ea-7832-4d04-b8dc-828366fc7bf9"
      unitRef="usd">4900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i615b149ad3534e4ba9e847115a8c8104_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfNS01LTEtMS0w_05c3a6d6-8fa5-4e6a-938d-c56300ed44c0"
      unitRef="usd">49100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia599da9d0cec404bb29f0dc029068fb1_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfNS02LTEtMS0w_003cd07d-d167-44ca-b9dd-09661147a917"
      unitRef="usd">16400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfNi0yLTEtMS0w_df9b8024-f04c-4161-9969-6eb1fb558da4"
      unitRef="usd">1168300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfNi0zLTEtMS0w_5bb9435d-ed3f-42fd-8411-04489eb2ad97"
      unitRef="usd">822900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfNi01LTEtMS0w_1140b57f-8ec6-42a6-89b5-65529c810d1a"
      unitRef="usd">4315700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RhYmxlOjFmZWU3OTMwN2M5MTRkMTg5NmM5NzcxMGEwZWMzZjY1L3RhYmxlcmFuZ2U6MWZlZTc5MzA3YzkxNGQxODk2Yzk3NzEwYTBlYzNmNjVfNi02LTEtMS0w_8ca19062-94ee-4bf7-bfec-31c4f8e01edd"
      unitRef="usd">2429500000</us-gaap:Revenues>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RleHRyZWdpb246M2M2NDJkZDhmZjJhNDczOWJkMzNkYTQwMzU5ODMxNDVfNjAyOA_2d2d2590-efed-40e8-976c-553a6029b6c8"
      unitRef="usd">804400000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i3077d84f238341b6b299f541f5f835d3_I20210626"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RleHRyZWdpb246M2M2NDJkZDhmZjJhNDczOWJkMzNkYTQwMzU5ODMxNDVfNjI2OQ_34c9699d-c180-4d1d-b37f-27eab9b6cb75"
      unitRef="number">0.11</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i6ac5e12a191d4b3dba030b9849f5d77b_I20210626"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RleHRyZWdpb246M2M2NDJkZDhmZjJhNDczOWJkMzNkYTQwMzU5ODMxNDVfNjMwNw_07161c37-099a-46d9-9cab-6592e9926ca0"
      unitRef="number">0.36</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i4fa166ab972a4216b61bb29fe09583b5_I20210626"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RleHRyZWdpb246M2M2NDJkZDhmZjJhNDczOWJkMzNkYTQwMzU5ODMxNDVfNjMxOQ_d54d474a-131a-411f-ad57-167ab242d60e"
      unitRef="number">0.25</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="ia3c7225d747b441aa0d9f695fe415128_I20210626"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RleHRyZWdpb246M2M2NDJkZDhmZjJhNDczOWJkMzNkYTQwMzU5ODMxNDVfNjMzMQ_8776263c-fbf9-4c5b-a168-fd05f79ca1d7"
      unitRef="number">0.16</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="icaee218d084046ed9e76934876d4b3ff_I20210626"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RleHRyZWdpb246M2M2NDJkZDhmZjJhNDczOWJkMzNkYTQwMzU5ODMxNDVfNjM0Nw_d1c9014a-8778-430c-91ac-978b06b70be8"
      unitRef="number">0.12</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RleHRyZWdpb246M2M2NDJkZDhmZjJhNDczOWJkMzNkYTQwMzU5ODMxNDVfNzczMw_a365bb26-9aa7-4f9a-b05f-c0635cc90afa"
      unitRef="usd">20100000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RleHRyZWdpb246M2M2NDJkZDhmZjJhNDczOWJkMzNkYTQwMzU5ODMxNDVfNzc0MA_9f6807d1-abdc-4677-9e70-8f8e68cfe8d2"
      unitRef="usd">100900000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RleHRyZWdpb246M2M2NDJkZDhmZjJhNDczOWJkMzNkYTQwMzU5ODMxNDVfNzkwNg_69b3b4ae-8ced-43f6-adf4-5ae87cb73433"
      unitRef="usd">18000000.0</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF8zNy9mcmFnOjNjNjQyZGQ4ZmYyYTQ3MzliZDMzZGE0MDM1OTgzMTQ1L3RleHRyZWdpb246M2M2NDJkZDhmZjJhNDczOWJkMzNkYTQwMzU5ODMxNDVfNzkxMw_b1ac8df7-a0af-4292-b636-10f41858016b"
      unitRef="usd">95500000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80My9mcmFnOjgyNWUyNjIwMTBmOTQwZDBhOTI5YWU5Yjg0M2IxYTMyL3RleHRyZWdpb246ODI1ZTI2MjAxMGY5NDBkMGE5MjlhZTliODQzYjFhMzJfMTAyNA_466c406e-ae6e-4fc9-a311-8389b8f707b1">LeasesLessor Activity - Leases where Hologic is the LessorCertain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating lease and performance obligations for disposables, reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. Sales-type leases are immaterial. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented less than 5% of the Company's consolidated revenue for all periods presented.</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80My9mcmFnOjgyNWUyNjIwMTBmOTQwZDBhOTI5YWU5Yjg0M2IxYTMyL3RleHRyZWdpb246ODI1ZTI2MjAxMGY5NDBkMGE5MjlhZTliODQzYjFhMzJfMTAyNA_eea5321e-bd63-467f-ac3b-ba9123a1ae30">LeasesLessor Activity - Leases where Hologic is the LessorCertain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating lease and performance obligations for disposables, reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. Sales-type leases are immaterial. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented less than 5% of the Company's consolidated revenue for all periods presented.</us-gaap:LesseeFinanceLeasesTextBlock>
    <holx:LeaseRevenuePercentageOfTotalRevenue
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80My9mcmFnOjgyNWUyNjIwMTBmOTQwZDBhOTI5YWU5Yjg0M2IxYTMyL3RleHRyZWdpb246ODI1ZTI2MjAxMGY5NDBkMGE5MjlhZTliODQzYjFhMzJfOTU1_0f83b7d1-0f55-405a-8127-9b6f55034098"
      unitRef="number">0.05</holx:LeaseRevenuePercentageOfTotalRevenue>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RleHRyZWdpb246MzhjYmIwNzRhYjM5NGNmMzgwNDBiODE0YjNkY2FjMzRfMzMwNg_ed6d74c1-3bb9-4bff-ad1c-c7b9d70395db">Fair Value Measurements&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets/Liabilities Measured and Recorded at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has investments in derivative instruments comprised of an interest rate swap, forward foreign currency contracts and foreign currency option contracts, which are valued using analyses obtained from independent third party valuation specialists based on market observable inputs, representing Level 2 measurements. The fair values of these derivative &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;contracts represent the estimated amounts the Company would receive or pay to terminate the contracts. Refer to Note 9 for further discussion and information on derivative instruments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following at June&#160;26, 2021:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value at Reporting Date Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&#160;in&lt;br/&gt;Active&#160;Market&#160;for&lt;br/&gt;Identical&#160;Assets&lt;br/&gt;(Level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&#160;(Level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&#160;(Level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Liabilities Measured and Recorded at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of recurring fair value measurements using significant unobservable inputs (Level 3), which solely consisted of contingent consideration liabilities, during the three and nine month periods ended June 26, 2021 and June 27, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;text-align:center;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.580%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Month Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration recorded at acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets Measured and Recorded at Fair Value on a Nonrecurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company remeasures the fair value of certain assets and liabilities upon the occurrence of certain events. Such assets are comprised of equity investments and long-lived assets, including property, plant and equipment, intangible assets and goodwill. There were no such remeasurements to equity investments in the three and nine months ended June&#160;26, 2021 and June&#160;27, 2020. During the first quarter of fiscal 2020, the Company's Medical Aesthetics division met the criteria to be classified as assets-held-for sale, and the Company recorded a $30.2 million loss to record the asset group at its fair value less costs to sell. This was a level 1 measurement. See Note 6 for additional information. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disclosure of Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s financial instruments mainly consist of cash and cash equivalents, accounts receivable, equity investments, an interest rate swap, forward foreign currency contracts, foreign currency option contracts, insurance contracts, accounts payable and debt obligations. The carrying amounts of the Company&#x2019;s cash and cash equivalents, accounts receivable and accounts payable approximate their fair value due to the short-term nature of these instruments. The Company&#x2019;s interest rate swap, forward foreign currency contracts and foreign currency option contracts are recorded at fair value. The carrying amount of the insurance contracts are recorded at the cash surrender value, as required by GAAP, which approximates fair value. The Company believes the carrying amounts of its cost-method equity investments approximate fair value.&lt;/span&gt;&lt;/div&gt;Amounts outstanding under the Company&#x2019;s 2018 Credit Agreement (as defined below) of $1.4 billion aggregate principal as of June&#160;26, 2021 are subject to variable interest rates of interest based on current market rates, and as such, the Company believes the carrying amount of these obligations approximates fair value. The Company&#x2019;s 2028 Senior Notes and 2029 Senior Notes had fair values of $420.8 million and $940.0 million, respectively, as of June&#160;26, 2021 based on their trading prices, representing Level 1 measurements. Refer to Note 7 for the carrying amounts of the various components of the Company&#x2019;s debt.</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RleHRyZWdpb246MzhjYmIwNzRhYjM5NGNmMzgwNDBiODE0YjNkY2FjMzRfMzMwMg_9c060bb2-0285-481f-bae9-0248d23784a1">&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following at June&#160;26, 2021:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value at Reporting Date Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&#160;in&lt;br/&gt;Active&#160;Market&#160;for&lt;br/&gt;Identical&#160;Assets&lt;br/&gt;(Level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&#160;(Level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&#160;(Level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Liabilities Measured and Recorded at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of recurring fair value measurements using significant unobservable inputs (Level 3), which solely consisted of contingent consideration liabilities, during the three and nine month periods ended June 26, 2021 and June 27, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;text-align:center;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.580%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.473%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Month Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration recorded at acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i08c883de92e74d7b85fd3ca1fb82d546_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfNS0xLTEtMS0w_0a0a8b40-a6fe-4365-8c38-b545d3c4abb1"
      unitRef="usd">100000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i02c12e832a964220b8e957d85bd7f1be_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfNS0zLTEtMS0w_aa238754-3188-4765-a4da-19a744b5e4e5"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="iefc73cc720144ee2abfd4e56a2ab1c22_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfNS01LTEtMS0w_709f9026-2011-4c6c-bb97-993121b84c2c"
      unitRef="usd">100000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ib02ab7302c2f46079c7e79da871a6eb7_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfNS03LTEtMS0w_2a62ee0e-bf8c-4998-8c97-3abd3cf6bed8"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfNy0xLTEtMS0w_fa728f27-4b59-4a16-8e24-af02f6127aa3"
      unitRef="usd">100000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="id05ddebb6ac948d3924f040045e9f869_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfNy0zLTEtMS0w_7b3e85ff-1475-4a1a-855c-f38d7b1d443f"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i6a527b50af5e47a99433bc012cfe40e9_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfNy01LTEtMS0w_6e270279-1584-44f4-85cd-a0b89de714ba"
      unitRef="usd">100000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i2d9a236240c14cf8bef2d68626067a47_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfNy03LTEtMS0w_fe823c6b-5f3a-4dfb-adf1-a0add47a69bd"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="i2f25431c4bd346aca079e50943a25050_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfOS0xLTEtMS0w_3488e63f-2263-432d-b704-83028408702f"
      unitRef="usd">71700000</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="i59f5f7477c54411fb844f52b13896113_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfOS0zLTEtMS0w_cebf20cd-29f1-4354-bdea-5a4c8aa2e610"
      unitRef="usd">0</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="ib04dea42a16c43599c49cc706c336cc8_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfOS01LTEtMS0w_15549268-d9cc-4643-821e-f97a96da68a6"
      unitRef="usd">0</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="ia57c3dc6f5744ed28ba4ec3d78ac0431_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfOS03LTEtMS0w_3330f02d-b22f-4e6c-817d-37171f3cef24"
      unitRef="usd">71700000</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ifcbbabd8e7cd43b49b4c4141972ac3df_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfMTAtMS0xLTEtMA_5b7c645a-8aa0-449a-af29-0bcc084f59bd"
      unitRef="usd">21000000.0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i44028ddaa4d449f19b250514e6f25c11_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfMTAtMy0xLTEtMA_abad229b-752c-4881-971a-4097dfe0f405"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i87af1fc6220349d08bb58531b16ae309_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfMTAtNS0xLTEtMA_95994028-ab37-461e-a8db-d2946d536c59"
      unitRef="usd">21000000.0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i3e4d1ac8689444b3b830cfd194640a8d_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfMTAtNy0xLTEtMA_fc70c21c-36d8-4894-aa46-ebddd04f4a1c"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ia7359c2fb7ca43ffb3bf9416afa4079f_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfMTEtMS0xLTEtMA_4bec210a-da23-4075-8faa-3f2c3f3cd0e0"
      unitRef="usd">1700000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i354883b38ce9409b8864c231c916bc8b_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfMTEtMy0xLTEtMA_fd213735-5ac9-4905-986d-d91d8a63ec39"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ib8ccf9bb036a4a48a18392eeed90c59b_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfMTEtNS0xLTEtMA_06544307-b283-4123-9233-77674723c486"
      unitRef="usd">1700000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i67c6607b6ca1481688b2c7ed6a2b6fab_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfMTEtNy0xLTEtMA_494a7de3-3ae5-4513-8384-816b61b4c0a8"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfMTItMS0xLTEtMA_0a23a611-173d-4a23-a831-6995a82b9087"
      unitRef="usd">94400000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="id05ddebb6ac948d3924f040045e9f869_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfMTItMy0xLTEtMA_4dc2e705-9192-4651-8fb3-e259634a72d8"
      unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i6a527b50af5e47a99433bc012cfe40e9_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfMTItNS0xLTEtMA_bec9c561-1661-42bf-b391-98da26630fb0"
      unitRef="usd">22700000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i2d9a236240c14cf8bef2d68626067a47_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOjAzYjI1ODc4OTliYzQ4NDdhMWE1OWU2YTlkYzMwYzZkL3RhYmxlcmFuZ2U6MDNiMjU4Nzg5OWJjNDg0N2ExYTU5ZTZhOWRjMzBjNmRfMTItNy0xLTEtMA_04521731-ef46-4611-8cfd-a4f982127cc9"
      unitRef="usd">71700000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i31e8abc772ad4ffe894ec7ec188dc5df_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfMi0yLTEtMS0w_3862beeb-733a-4bda-bfed-2671c17b35ae"
      unitRef="usd">71700000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i5ae541164c564e1394017ca8fb281f3c_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfMi00LTEtMS0w_67c556a8-3178-4108-aae8-0806f29c3c44"
      unitRef="usd">800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfMi02LTEtMS0w_04a182a8-e2fc-4dd0-803a-7d5d747e2f80"
      unitRef="usd">81800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ia1bbf9311cb649308affbf16f61bb3ff_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfMi04LTEtMS0w_eebcfa08-8529-4c0f-8b15-db4136863f40"
      unitRef="usd">9100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfMy0yLTEtMS0w_4055dc58-e2d7-4056-ac39-686b3f0c2b0f"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfMy00LTEtMS0w_1ed97780-62a8-48c9-8935-1ebda6f2ac9d"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfMy02LTEtMS0w_1736c441-acb9-4a7b-b2ef-25b641a3a02a"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfMy04LTEtMS0w_42b494a8-d384-438e-9581-2b57789099e6"
      unitRef="usd">900000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfNC0yLTEtMS0w_1136f44d-248b-44ef-aac4-2841f8aa97a0"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfNC00LTEtMS0w_73891b79-fe20-49ef-8623-1dae7fdb13e4"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfNC02LTEtMS0w_607e76d4-3869-4b89-a243-50efb434fbcd"
      unitRef="usd">-10100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfNC04LTEtMS0w_ef63ca9c-9ef0-446d-b0bd-c5793a732964"
      unitRef="usd">400000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfNS0yLTEtMS0w_237a0cc0-8245-4ead-a86f-c206bcb08918"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfNS00LTEtMS0w_63c6517e-8884-4820-9345-4d8bb224b2d6"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfNS02LTEtMS0w_6ddcc2e0-7f97-4855-b05b-2c3af49df9f9"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfNS04LTEtMS0w_93cce32e-9a25-4110-9d05-6ce5ff1e2c72"
      unitRef="usd">-9600000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfNi0yLTEtMS0w_5475427f-6f1e-4f85-88bb-5654fa295b14"
      unitRef="usd">71700000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i81ab5863e2124accb342d2df86a1ee96_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfNi00LTEtMS0w_83c32252-9b13-47b7-a9b8-d8be3fc25f82"
      unitRef="usd">800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfNi02LTEtMS0w_813270dd-796f-4e5a-954e-f2b14e8c8d7e"
      unitRef="usd">71700000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i81ab5863e2124accb342d2df86a1ee96_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RhYmxlOmU2YmI5ZjA2YTRmODQyMjc4N2JhN2ZmOGRmYmMxODczL3RhYmxlcmFuZ2U6ZTZiYjlmMDZhNGY4NDIyNzg3YmE3ZmY4ZGZiYzE4NzNfNi04LTEtMS0w_7c45e0f1-46a5-41d9-93f4-14731b8de0d9"
      unitRef="usd">800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:AssetImpairmentCharges
      contextRef="i421a1ec2406e4269a476846874e71421_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RleHRyZWdpb246MzhjYmIwNzRhYjM5NGNmMzgwNDBiODE0YjNkY2FjMzRfMTY5Ng_919e5f18-6ddc-47c2-b3cf-9c48d0ee775a"
      unitRef="usd">30200000</us-gaap:AssetImpairmentCharges>
    <holx:PrincipalAmountOfBorrowings
      contextRef="id56c8faa0e884b19a2eebe191531428a_I20210626"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RleHRyZWdpb246MzhjYmIwNzRhYjM5NGNmMzgwNDBiODE0YjNkY2FjMzRfMjgxNQ_9fb9d3c7-ada9-4ebf-be85-89a7ac76f486"
      unitRef="usd">1400000000</holx:PrincipalAmountOfBorrowings>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ie2bfa4cc508a42c08b7fe0e7f3b786a3_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RleHRyZWdpb246MzhjYmIwNzRhYjM5NGNmMzgwNDBiODE0YjNkY2FjMzRfMzEwMg_df639a5a-a344-4b7e-8004-cbefcb37defd"
      unitRef="usd">420800000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i1493df5a7c09426b9e8dba13c3704251_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80Ni9mcmFnOjM4Y2JiMDc0YWIzOTRjZjM4MDQwYjgxNGIzZGNhYzM0L3RleHRyZWdpb246MzhjYmIwNzRhYjM5NGNmMzgwNDBiODE0YjNkY2FjMzRfMzEwOQ_3ad7df4e-22c3-44f9-9a96-a8a2933ed86f"
      unitRef="usd">940000000.0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTU2OTY_d28d2f59-74e6-457b-8f88-a7995b33c384">Business Combinations&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fiscal 2021 Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Mobidiag Oy&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 17, 2021, the Company completed the acquisition of Mobidiag Oy ("Mobidiag"), for a purchase price of $729.6&#160;million. Mobidiag, located in Finland, manufactures molecular diagnostic solutions for gastrointestinal infections, antimicrobial resistance management and other infections. Mobidiag's results of operations are reported in the Company's Diagnostics reportable segment from the date of acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to Mobidiag's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of June 17, 2021, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center;text-indent:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.865%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;729.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Mobidiag's business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, including but not limited to the estimation of the fair value of the identifiable intangible assets, long-term debt, and deferred income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets are development technology, in-process research and development ("IPR&amp;amp;D"), customer relationships and trade names. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using rates ranging from 14.5% to 16.0%. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The developed technology assets are comprised of know-how, patents and technologies embedded in Mobidiag's products and relate to currently marketed products. The developed technology assets comprise the primary product families under the Novodiag and Amplidiag technology platforms.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;IPR&amp;amp;D projects relate to in-process projects that have not reached technological feasibility as of the acquisition date and have no alternative future use. The primary basis for determining technological feasibility of these projects is obtaining regulatory approval to market the underlying project or expected commercial release depending on the project. The Company recorded, on a preliminary basis, $103.0&#160;million of IPR&amp;amp;D related to three projects. The Company expects to complete these three projects over the next three years. Given the uncertainties inherent with product development and introduction, there can be no assurance that any of the Company's product development efforts will be successful, completed on a timely basis or within budget, if at all. All of the IPR&amp;amp;D assets were valued using the income approach.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preliminary estimate of the weighted average life for the developed technology assets range from 10 to 12 years, customer relationships range from 5 to 11 years, and tradenames range from 10 to 12 years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the preliminary amount of goodwill were primarily based on anticipated strategic and synergistic benefits that are expected to be realized from the Mobidiag acquisition. These benefits include expanding the Company's molecular diagnostics portfolio into the near-patient testing market and utilizing Diagnostic's sales and regulatory expertise to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Biotheranostics&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 22, 2021, the Company completed the acquisition of Biotheranostics, Inc. ("Biotheranostics"), for a purchase price of $231.3&#160;million. Biotheranostics, located in San Diego, California, manufactures molecular diagnostic tests for breast and metastatic cancers and performs the lab testing procedures at its facility. Biotheranostics' results of operations are reported in the Company's Diagnostics reportable segment from the date of acquisition and its revenues are reported within Service and other revenue in the Company's Consolidated Statements of Income and within service revenue in our disclosure of disaggregated revenue in Note 2.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to Biotheranostics' preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of February 22, 2021, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.865%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Biotheranostics' business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, the estimation of the fair value of the identifiable intangible assets, and income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets are developed technology and trade names. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a 18.0% rate. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and trade names is 10 years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the preliminary amount of goodwill were primarily based on anticipated synergistic benefits of adding Biotheranostics' CLIA (Clinical &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Laboratory Improvement Amendments) lab to the Company's portfolio of offerings and utilizing Diagnostic's marketing and regulatory expertise to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Diagenode&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 1, 2021, the Company completed the acquisition of Diagenode SA ("Diagenode") for a purchase price of $155.1&#160;million. Diagenode, located in Belgium, is a developer and manufacturer of molecular diagnostic assays based on PCR (polymerase chain reaction) technology to detect infectious diseases of bacterial, viral or parasite origin. Diagenode's results of operations are reported in the Company's Diagnostics reportable segment from the date of acquisition. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to Diagenode's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of March 1, 2021, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.865%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Diagenode's business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, the estimation of the fair value of the identifiable intangible assets, and income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets are developed technology and customer relationships. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a 14.5% rate for developed technology and a 13.5% rate for customer relationships. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and customer relationships is 10 years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the preliminary amount of goodwill were based on anticipated synergistic benefits of Diagenode's products broadening the Diagnostics portfolio of molecular diagnostics products primarily in the transplant and acute care gastrointestinal and respiratory space as customers seek a broader menu of tests, utilizing Diagnostic's sales force to drive menu expansion and revenue growth and gaining additional PCR assay development expertise. None of the goodwill is expected to be deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Somatex Medical Technologies&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 30, 2020, the Company completed the acquisition of Somatex Medical Technologies GmbH ("Somatex") for a purchase price of $62.9&#160;million. Somatex, located in Germany, is a manufacturer of biopsy site markers, including the Tumark product line of tissue markers, which were distributed by the Company in the U.S. prior to the acquisition. The allocation of the purchase price is based on the Company's preliminary valuation, and it allocated $38.0&#160;million to the preliminary value of developed technology, $1.2&#160;million to customer relationships, $0.9&#160;million to trade names and $32.4&#160;million to goodwill. The remaining $9.6&#160;million of the purchase price was allocated to the net acquired tangible assets and liabilities. The allocation of the purchase price is preliminary as the Company continues to gather information supporting &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the acquired assets and liabilities. Somatex' results of operations are reported in the Company's Breast Health reportable segment from the date of acquisition. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NXC Imaging&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 28, 2020, the Company completed the acquisition of assets from NXC Imaging, for a purchase price of $5.6&#160;million. NXC Imaging was a long-standing distributor of the Company's Breast and Skeletal products in the U.S. Based on the Company's preliminary valuation, the majority of the purchase price was allocated to a customer relationships intangible asset with a useful life of 5 years. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fiscal 2020 Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Acessa Health&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 23, 2020, the Company completed the acquisition of Acessa Health, Inc. ("Acessa") for a purchase price of &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$161.3&#160;million, which included a hold-back of $3.0&#160;million that was paid in January 2021, and contingent consideration, which the Company estimated the fair value to be $81.8&#160;million as of the measurement date. Acessa, located in Austin, Texas, manufactures and markets its ProVu system, a laparoscopic radio frequency ablation system for use in treatment of uterine fibroids. Acessa's results of operations are reported in the Company's GYN Surgical reportable segment from the date of acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The contingent payments are based on a multiple of annual incremental revenue growth over a three-year period ending annually in December. There is no maximum earnout. Pursuant to ASC 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company recorded its estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation based on future revenue projections of Acessa, comparable companies revenue growth rates, implied volatility and applying a risk adjusted discount rate. Each quarter the Company will be required to remeasure the fair value of the liability as assumptions change and such adjustments will be recorded in operating expenses. This fair value measurement was based on significant inputs not observable in the market and thus represented a Level 3 measurement as defined in ASC 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This fair value measurement is directly impacted by the Company's estimate of future incremental revenue growth of the business. Accordingly, if actual revenue growth is higher or lower than the estimates within the fair value measurement, the Company would record additional charges or benefits, respectively. There was no remeasurement for the three months ended June 26, 2021. For the nine months ended June 26, 2021, the Company remeasured the contingent consideration liability and recorded a gain of $10.1&#160;million to record the liability at fair value. The reduction in fair value was primarily due to a decrease in forecasted revenues over the measurement period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to Acessa's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of August 23, 2020, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.596%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.865%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Acessa's business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, primarily taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets were developed technology and trade names. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using an 18.0% rate. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and trade names was 10 years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the preliminary amount of goodwill were based on anticipated synergistic benefits of Acessa's products being complementary to the GYN Surgical portfolio of products and utilizing the GYN Surgical sales force to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Health Beacons&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 3, 2020, the Company completed the acquisition of Health Beacons, Inc. ("Health Beacons"), for a purchase price of $19.7&#160;million, which included hold-backs of $2.3&#160;million that are payable up to eighteen months from the date of acquisition. Health Beacons manufactures the LOCalizer product. Based on the Company's valuation, it allocated $10.7&#160;million to developed technology and $6.2&#160;million to goodwill. The remaining $2.8&#160;million of the purchase price was allocated to acquired tangible assets and liabilities. Health Beacons' results of operations are reported in the Company's Breast Health reportable segment from the date of acquisition. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Alpha Imaging&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 30, 2019, the Company completed the acquisition of assets from Alpha Imaging, LLC ("Alpha Imaging"), for a purchase price of $18.0&#160;million, which included a hold-back of $1.0&#160;million and contingent consideration, which the Company has estimated at $0.9&#160;million. The contingent consideration was payable upon shipment of backlog orders entered into by Alpha Imaging prior to the acquisition. Alpha Imaging was a long-standing distributor of the Company's Breast and Skeletal products in the U.S. The majority of the purchase price was allocated to a customer relationships intangible asset with a useful life of 5 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SuperSonic Imagine&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 1, 2019, the Company purchased 46% of the outstanding shares of SuperSonic Imagine ("SSI") for $18.2 million. SSI was a public company located in Aix-en-Provence, France that manufactures and markets ultrasound medical imaging equipment. In September 2019, the Company launched a cash tender offer to acquire the remaining outstanding shares for a price of&#160;&#x20ac;1.50 per share in cash. The Company determined that SSI was a Variable Interest Entity (&#x201c;VIE&#x201d;) but it was not the primary beneficiary as it was not a party to the initial design of the entity nor did it have control over SSI's operations until November 21, 2019 when the Company's ownership of SSI's voting stock exceeded 50%. Accordingly, the Company initially accounted for this investment under the equity method of accounting.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 21, 2019, the Company acquired an additional 7.6 million shares of SSI for $12.6 million. As a result, the Company's ownership interest increased to approximately 78% of the outstanding common shares of SSI at November 21, 2019, and it now controlled SSI's voting interest and operations. The Company performed purchase accounting as of November 21, 2019 and beginning on that date the financial results of SSI are included within the Company's consolidated financial statements, specifically the Breast Health reportable segment. The Company remeasured the initial investment of 46% of the outstanding shares of SSI to its fair value at the acquisition date, resulting in a gain of $3.2 million recorded to other income (expense), net in the first quarter of fiscal 2020. The total accounting purchase price was $69.3 million, which consisted of $17.9 million for the equity method investment in SSI, $12.6 million for shares acquired on November 21, 2019, $30.2 million for loans the Company provided to SSI prior to the acquisition to pay-off pre-existing loans and fund operations that are considered forgiven, and $8.6 million representing the fair value of the noncontrolling interest as of November 21, 2019. The Company purchased an additional 1.1&#160;million outstanding shares in fiscal 2020 for $1.8&#160;million. In the third quarter of fiscal 2021, the Company purchased the remaining 4.8&#160;million shares outstanding for $8.5&#160;million, and as of June 26, 2021, the Company owned 100% of the outstanding shares of SSI.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to SSI's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of November 21, 2019, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.333%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.849%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short and long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In performing the purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of SSI's business. As part of the purchase price allocation, the Company determined the identifiable intangible assets were developed technology, customer relationships, and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a 12.0% rate. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life for the developed technology is 9 years, customer relationships is 9 years and trade names is 8.6 years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the amount of goodwill were based on anticipated synergistic benefits of SSI's products being complementary to Breast Health's 3D mammography systems and using the Company's existing U.S. sales force as SSI's presence in the U.S. is limited. None of the goodwill is expected to be deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i92fd2ed585e64792981f77c6077751ee_D20210617-20210617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTA5OTUxMTY0NDA3NA_37d12040-b2a2-4dd2-b837-230a78e18442"
      unitRef="usd">729600000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI2NDQzODM3NTIxMTU_14d00b1a-f96e-4637-8e76-98312895f74f">&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to Mobidiag's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of June 17, 2021, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:center;text-indent:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.865%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;284.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(66.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;729.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to Biotheranostics' preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of February 22, 2021, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.865%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to Diagenode's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of March 1, 2021, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.865%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to Acessa's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of August 23, 2020, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.596%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.865%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The total purchase price was allocated to SSI's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of November 21, 2019, as set forth below.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.333%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.849%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short and long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i30d680096df04f59bf3edf5694f74758_I20210617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjA0Zjc1ZjFkZWNkZDQ3Mjc5OWVkODUyMDQ4YjU0YzhkL3RhYmxlcmFuZ2U6MDRmNzVmMWRlY2RkNDcyNzk5ZWQ4NTIwNDhiNTRjOGRfMC0yLTEtMS02MjMy_8e7cc23a-1581-405a-bfd2-571337e9bf04"
      unitRef="usd">6800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i30d680096df04f59bf3edf5694f74758_I20210617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjA0Zjc1ZjFkZWNkZDQ3Mjc5OWVkODUyMDQ4YjU0YzhkL3RhYmxlcmFuZ2U6MDRmNzVmMWRlY2RkNDcyNzk5ZWQ4NTIwNDhiNTRjOGRfMS0yLTEtMS02MjMy_011e6eae-e5cf-424d-883e-b3d02b6a9e8f"
      unitRef="usd">8700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i30d680096df04f59bf3edf5694f74758_I20210617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjA0Zjc1ZjFkZWNkZDQ3Mjc5OWVkODUyMDQ4YjU0YzhkL3RhYmxlcmFuZ2U6MDRmNzVmMWRlY2RkNDcyNzk5ZWQ4NTIwNDhiNTRjOGRfMi0yLTEtMS02MjMy_e1478a00-6c52-4106-91a7-a9216363591b"
      unitRef="usd">11900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i30d680096df04f59bf3edf5694f74758_I20210617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjA0Zjc1ZjFkZWNkZDQ3Mjc5OWVkODUyMDQ4YjU0YzhkL3RhYmxlcmFuZ2U6MDRmNzVmMWRlY2RkNDcyNzk5ZWQ4NTIwNDhiNTRjOGRfNC0yLTEtMS02MjMy_d04e81a9-8dc8-4cb5-b2de-208a1fa39cbb"
      unitRef="usd">26600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i30d680096df04f59bf3edf5694f74758_I20210617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjA0Zjc1ZjFkZWNkZDQ3Mjc5OWVkODUyMDQ4YjU0YzhkL3RhYmxlcmFuZ2U6MDRmNzVmMWRlY2RkNDcyNzk5ZWQ4NTIwNDhiNTRjOGRfNS0yLTEtMS02MjM1_80502f49-b33d-41ed-9880-a362c56bdbf0"
      unitRef="usd">18200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities
      contextRef="i30d680096df04f59bf3edf5694f74758_I20210617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjA0Zjc1ZjFkZWNkZDQ3Mjc5OWVkODUyMDQ4YjU0YzhkL3RhYmxlcmFuZ2U6MDRmNzVmMWRlY2RkNDcyNzk5ZWQ4NTIwNDhiNTRjOGRfNi0yLTEtMS02MjM1_6b16a29c-6615-4394-81d3-26c92d3ed119"
      unitRef="usd">7900000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology
      contextRef="i30d680096df04f59bf3edf5694f74758_I20210617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjA0Zjc1ZjFkZWNkZDQ3Mjc5OWVkODUyMDQ4YjU0YzhkL3RhYmxlcmFuZ2U6MDRmNzVmMWRlY2RkNDcyNzk5ZWQ4NTIwNDhiNTRjOGRfOS0yLTEtMS02MjM3_0fd0ad1a-817f-45a2-a242-c86f52e50233"
      unitRef="usd">284000000.0</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess
      contextRef="i30d680096df04f59bf3edf5694f74758_I20210617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjA0Zjc1ZjFkZWNkZDQ3Mjc5OWVkODUyMDQ4YjU0YzhkL3RhYmxlcmFuZ2U6MDRmNzVmMWRlY2RkNDcyNzk5ZWQ4NTIwNDhiNTRjOGRfMTAtMi0xLTEtNjIzNw_d1b08647-e8a7-40c2-8a4d-f24d8583be1e"
      unitRef="usd">103000000.0</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships
      contextRef="i30d680096df04f59bf3edf5694f74758_I20210617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjA0Zjc1ZjFkZWNkZDQ3Mjc5OWVkODUyMDQ4YjU0YzhkL3RhYmxlcmFuZ2U6MDRmNzVmMWRlY2RkNDcyNzk5ZWQ4NTIwNDhiNTRjOGRfMTEtMi0xLTEtNjIzNw_a2e8afe7-da03-48a0-bf90-8581d0b01d18"
      unitRef="usd">26300000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames
      contextRef="i30d680096df04f59bf3edf5694f74758_I20210617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjA0Zjc1ZjFkZWNkZDQ3Mjc5OWVkODUyMDQ4YjU0YzhkL3RhYmxlcmFuZ2U6MDRmNzVmMWRlY2RkNDcyNzk5ZWQ4NTIwNDhiNTRjOGRfMTItMi0xLTEtNjIzNw_e8e8d410-d626-40f7-8775-77377605282a"
      unitRef="usd">21000000.0</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt
      contextRef="i30d680096df04f59bf3edf5694f74758_I20210617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjA0Zjc1ZjFkZWNkZDQ3Mjc5OWVkODUyMDQ4YjU0YzhkL3RhYmxlcmFuZ2U6MDRmNzVmMWRlY2RkNDcyNzk5ZWQ4NTIwNDhiNTRjOGRfMTQtMi0xLTEtNjIzOQ_6296ff5e-7599-4668-838a-e1991fa82ed4"
      unitRef="usd">66000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i30d680096df04f59bf3edf5694f74758_I20210617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjA0Zjc1ZjFkZWNkZDQ3Mjc5OWVkODUyMDQ4YjU0YzhkL3RhYmxlcmFuZ2U6MDRmNzVmMWRlY2RkNDcyNzk5ZWQ4NTIwNDhiNTRjOGRfMTUtMi0xLTEtNjIzOQ_49a04688-ca11-4805-b08a-8ffc0da68fdc"
      unitRef="usd">72800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:Goodwill
      contextRef="i30d680096df04f59bf3edf5694f74758_I20210617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjA0Zjc1ZjFkZWNkZDQ3Mjc5OWVkODUyMDQ4YjU0YzhkL3RhYmxlcmFuZ2U6MDRmNzVmMWRlY2RkNDcyNzk5ZWQ4NTIwNDhiNTRjOGRfMTYtMi0xLTEtNjIzOQ_8d57d108-51d1-4c53-adaf-06802046922f"
      unitRef="usd">406200000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i30d680096df04f59bf3edf5694f74758_I20210617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjA0Zjc1ZjFkZWNkZDQ3Mjc5OWVkODUyMDQ4YjU0YzhkL3RhYmxlcmFuZ2U6MDRmNzVmMWRlY2RkNDcyNzk5ZWQ4NTIwNDhiNTRjOGRfMTctMi0xLTEtNjIzOQ_ade56395-38d9-46ff-b0b0-d5ae3a960368"
      unitRef="usd">729600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue
      contextRef="i93d6e126b5db43d7917d1e320241c5a5_D20210617-20210617"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI2NDQzODM3NTIxMTc_c0adeda3-68a9-46d6-af7b-74218193cd52"
      unitRef="number">0.145</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue
      contextRef="i7e9787cddf8548e6b7fe58450c3ac4ea_D20210617-20210617"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI2NDQzODM3NTIxMjQ_0a023ce6-9f8e-4150-9ec8-639d85f1a12a"
      unitRef="number">0.160</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess
      contextRef="i30d680096df04f59bf3edf5694f74758_I20210617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI2NDQzODM3NTIxMzE_02f1651e-c137-4895-a8ec-70951f5dbf36"
      unitRef="usd">103000000.0</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess>
    <holx:ResearchAndDevelopmentInProcessNumberOfProjects
      contextRef="i30d680096df04f59bf3edf5694f74758_I20210617"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI2NDQzODM3NTIyNjA_b866724d-5a17-4c26-99d9-cff53fddd3be"
      unitRef="project">3</holx:ResearchAndDevelopmentInProcessNumberOfProjects>
    <holx:ResearchAndDevelopmentInProcessNumberOfProjects
      contextRef="i30d680096df04f59bf3edf5694f74758_I20210617"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI2NDQzODM3NTIyNzY_b866724d-5a17-4c26-99d9-cff53fddd3be"
      unitRef="project">3</holx:ResearchAndDevelopmentInProcessNumberOfProjects>
    <holx:ResearchAndDevelopmentInProcessCompletionPeriod
      contextRef="i92fd2ed585e64792981f77c6077751ee_D20210617-20210617"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI2NDQzODM3NTIxNTU_b2c9f4e2-972f-4dd7-a2d6-3cb570bc9acd">P3Y</holx:ResearchAndDevelopmentInProcessCompletionPeriod>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i2cc7db962d0a469b91ad71f47641afa1_D20210617-20210617"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI2NDQzODM3NTIxNzM_ea5af693-cb35-4e7b-b9a0-c4eb596b9402">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i5b84fc74ea2e43499ee65a3ee48d7788_D20210617-20210617"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI2NDQzODM3NTIxODU_b4632894-d8b2-4c26-a067-0f643bff5c08">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ia28b5293c7a442a1b282883ce9f51714_D20210617-20210617"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI2NDQzODM3NTIyMDY_fcca8d9e-b97d-4d99-8491-f9b524124dfc">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="if0b5328ab51c4ca5b5843c926066e713_D20210617-20210617"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI2NDQzODM3NTIyMTc_32cb1724-1f12-4ab5-8ad1-31c1a89fe50e">P11Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ia0066f33074743339653dd14619b7e1e_D20210617-20210617"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI2NDQzODM3NTIyMzY_6f6140d8-0796-4c7d-af0c-63b952df7a94">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i4cf345ba0efd409ab1d3a3013de7de83_D20210617-20210617"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI2NDQzODM3NTIyNDg_97d91a79-10e5-4d81-9cb8-7d77746056b4">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i33bd27ed8fae4b699caa054e910ef6da_D20210222-20210222"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMjA2_56cb34cf-cc7a-49c7-8af0-b32d6acef640"
      unitRef="usd">231300000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="iec8c75e6a6ac424c8336a8c73d23c503_I20210222"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZkNTkyNDQ1NTE5ZTQ1OWRhMjQ5OTY5YjBlNjc3M2VlL3RhYmxlcmFuZ2U6ZmQ1OTI0NDU1MTllNDU5ZGEyNDk5NjliMGU2NzczZWVfMS0yLTEtMS0w_c054d48f-2823-404f-9196-1ebe92b5c3b5"
      unitRef="usd">9600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="iec8c75e6a6ac424c8336a8c73d23c503_I20210222"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZkNTkyNDQ1NTE5ZTQ1OWRhMjQ5OTY5YjBlNjc3M2VlL3RhYmxlcmFuZ2U6ZmQ1OTI0NDU1MTllNDU5ZGEyNDk5NjliMGU2NzczZWVfMi0yLTEtMS0w_648b8e83-0766-4c79-8972-4c9d371e0586"
      unitRef="usd">2900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="iec8c75e6a6ac424c8336a8c73d23c503_I20210222"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZkNTkyNDQ1NTE5ZTQ1OWRhMjQ5OTY5YjBlNjc3M2VlL3RhYmxlcmFuZ2U6ZmQ1OTI0NDU1MTllNDU5ZGEyNDk5NjliMGU2NzczZWVfNS0yLTEtMS0w_ed54d3d6-bc07-4ace-b73d-a29b2149dbdf"
      unitRef="usd">6500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="iec8c75e6a6ac424c8336a8c73d23c503_I20210222"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZkNTkyNDQ1NTE5ZTQ1OWRhMjQ5OTY5YjBlNjc3M2VlL3RhYmxlcmFuZ2U6ZmQ1OTI0NDU1MTllNDU5ZGEyNDk5NjliMGU2NzczZWVfNi0yLTEtMS0w_96ff4692-a4f7-4bf1-98d3-6d1cc89f2a82"
      unitRef="usd">8200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities
      contextRef="iec8c75e6a6ac424c8336a8c73d23c503_I20210222"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZkNTkyNDQ1NTE5ZTQ1OWRhMjQ5OTY5YjBlNjc3M2VlL3RhYmxlcmFuZ2U6ZmQ1OTI0NDU1MTllNDU5ZGEyNDk5NjliMGU2NzczZWVfNy0yLTEtMS0w_05bec8d7-953e-44fd-8a81-2c95160c8d73"
      unitRef="usd">8100000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology
      contextRef="iec8c75e6a6ac424c8336a8c73d23c503_I20210222"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZkNTkyNDQ1NTE5ZTQ1OWRhMjQ5OTY5YjBlNjc3M2VlL3RhYmxlcmFuZ2U6ZmQ1OTI0NDU1MTllNDU5ZGEyNDk5NjliMGU2NzczZWVfOS0yLTEtMS0w_71269855-ef00-463d-afa1-c043c2115d5f"
      unitRef="usd">160300000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames
      contextRef="iec8c75e6a6ac424c8336a8c73d23c503_I20210222"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZkNTkyNDQ1NTE5ZTQ1OWRhMjQ5OTY5YjBlNjc3M2VlL3RhYmxlcmFuZ2U6ZmQ1OTI0NDU1MTllNDU5ZGEyNDk5NjliMGU2NzczZWVfMTEtMi0xLTEtMA_04fa0e91-b2d7-4e58-8b4e-bbe11813ccd7"
      unitRef="usd">2100000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="iec8c75e6a6ac424c8336a8c73d23c503_I20210222"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZkNTkyNDQ1NTE5ZTQ1OWRhMjQ5OTY5YjBlNjc3M2VlL3RhYmxlcmFuZ2U6ZmQ1OTI0NDU1MTllNDU5ZGEyNDk5NjliMGU2NzczZWVfMTQtMi0xLTEtMA_293755c7-bd62-46df-a204-ff3b5e91a436"
      unitRef="usd">18400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:Goodwill
      contextRef="iec8c75e6a6ac424c8336a8c73d23c503_I20210222"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZkNTkyNDQ1NTE5ZTQ1OWRhMjQ5OTY5YjBlNjc3M2VlL3RhYmxlcmFuZ2U6ZmQ1OTI0NDU1MTllNDU5ZGEyNDk5NjliMGU2NzczZWVfMTUtMi0xLTEtMA_ae44bca1-3735-4a98-a800-2fb2623b6e93"
      unitRef="usd">84600000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="iec8c75e6a6ac424c8336a8c73d23c503_I20210222"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZkNTkyNDQ1NTE5ZTQ1OWRhMjQ5OTY5YjBlNjc3M2VlL3RhYmxlcmFuZ2U6ZmQ1OTI0NDU1MTllNDU5ZGEyNDk5NjliMGU2NzczZWVfMTYtMi0xLTEtMA_fd79b650-c904-40eb-a4ad-c00d92b12285"
      unitRef="usd">231300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue
      contextRef="i33bd27ed8fae4b699caa054e910ef6da_D20210222-20210222"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTcyOA_19431878-22c8-4815-9042-aedc6226057e"
      unitRef="number">0.180</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i33bd27ed8fae4b699caa054e910ef6da_D20210222-20210222"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMjAzNg_e1ceef20-b18b-46b6-ae6a-72ea8b8d493d">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="icf15ef9e7b8d4ce0b6f697ed71d50240_D20210301-20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMjc3NA_874624d9-258f-4e08-8b3c-8d19248cfba7"
      unitRef="usd">155100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="ibfa5ce4594b64da29ce0bdebe52e6a48_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZhNjFjZDQ5ZTUxOTQ3YTdhMGE1ZmFkYjI5ZmI1NGI3L3RhYmxlcmFuZ2U6ZmE2MWNkNDllNTE5NDdhN2EwYTVmYWRiMjlmYjU0YjdfMS0yLTEtMS0w_cbf1ed33-015c-4b95-9d31-32bb1a821f77"
      unitRef="usd">5600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="ibfa5ce4594b64da29ce0bdebe52e6a48_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZhNjFjZDQ5ZTUxOTQ3YTdhMGE1ZmFkYjI5ZmI1NGI3L3RhYmxlcmFuZ2U6ZmE2MWNkNDllNTE5NDdhN2EwYTVmYWRiMjlmYjU0YjdfMi0yLTEtMS0w_2083f08b-e16c-4458-8330-0ba47312530a"
      unitRef="usd">9300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="ibfa5ce4594b64da29ce0bdebe52e6a48_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZhNjFjZDQ5ZTUxOTQ3YTdhMGE1ZmFkYjI5ZmI1NGI3L3RhYmxlcmFuZ2U6ZmE2MWNkNDllNTE5NDdhN2EwYTVmYWRiMjlmYjU0YjdfMy0yLTEtMS0w_4f003f4d-7ce0-4ca0-ae57-79e05268ee7e"
      unitRef="usd">9000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="ibfa5ce4594b64da29ce0bdebe52e6a48_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZhNjFjZDQ5ZTUxOTQ3YTdhMGE1ZmFkYjI5ZmI1NGI3L3RhYmxlcmFuZ2U6ZmE2MWNkNDllNTE5NDdhN2EwYTVmYWRiMjlmYjU0YjdfNS0yLTEtMS0w_701555d4-4340-4bf1-8820-1e553423d0ae"
      unitRef="usd">13900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="ibfa5ce4594b64da29ce0bdebe52e6a48_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZhNjFjZDQ5ZTUxOTQ3YTdhMGE1ZmFkYjI5ZmI1NGI3L3RhYmxlcmFuZ2U6ZmE2MWNkNDllNTE5NDdhN2EwYTVmYWRiMjlmYjU0YjdfNi0yLTEtMS0w_0c9e8f0e-bfdf-4236-8391-adc1b102e863"
      unitRef="usd">12800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities
      contextRef="ibfa5ce4594b64da29ce0bdebe52e6a48_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZhNjFjZDQ5ZTUxOTQ3YTdhMGE1ZmFkYjI5ZmI1NGI3L3RhYmxlcmFuZ2U6ZmE2MWNkNDllNTE5NDdhN2EwYTVmYWRiMjlmYjU0YjdfNy0yLTEtMS0w_68ceeaee-8cd5-4f0f-afc3-cf890a2449a9"
      unitRef="usd">9200000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology
      contextRef="ibfa5ce4594b64da29ce0bdebe52e6a48_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZhNjFjZDQ5ZTUxOTQ3YTdhMGE1ZmFkYjI5ZmI1NGI3L3RhYmxlcmFuZ2U6ZmE2MWNkNDllNTE5NDdhN2EwYTVmYWRiMjlmYjU0YjdfOS0yLTEtMS0w_57e7694e-040f-4d26-894b-6c189ec72d83"
      unitRef="usd">69800000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships
      contextRef="ibfa5ce4594b64da29ce0bdebe52e6a48_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZhNjFjZDQ5ZTUxOTQ3YTdhMGE1ZmFkYjI5ZmI1NGI3L3RhYmxlcmFuZ2U6ZmE2MWNkNDllNTE5NDdhN2EwYTVmYWRiMjlmYjU0YjdfMTEtMi0xLTEtMA_0af40759-912c-4180-b97d-a37dd2533f81"
      unitRef="usd">9200000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="ibfa5ce4594b64da29ce0bdebe52e6a48_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZhNjFjZDQ5ZTUxOTQ3YTdhMGE1ZmFkYjI5ZmI1NGI3L3RhYmxlcmFuZ2U6ZmE2MWNkNDllNTE5NDdhN2EwYTVmYWRiMjlmYjU0YjdfMTQtMi0xLTEtMA_e36fbb56-d0d5-480c-9275-726e51d62019"
      unitRef="usd">19300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:Goodwill
      contextRef="ibfa5ce4594b64da29ce0bdebe52e6a48_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZhNjFjZDQ5ZTUxOTQ3YTdhMGE1ZmFkYjI5ZmI1NGI3L3RhYmxlcmFuZ2U6ZmE2MWNkNDllNTE5NDdhN2EwYTVmYWRiMjlmYjU0YjdfMTUtMi0xLTEtMA_118081ab-171f-40e8-9913-2020c3291086"
      unitRef="usd">79600000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ibfa5ce4594b64da29ce0bdebe52e6a48_I20210301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmZhNjFjZDQ5ZTUxOTQ3YTdhMGE1ZmFkYjI5ZmI1NGI3L3RhYmxlcmFuZ2U6ZmE2MWNkNDllNTE5NDdhN2EwYTVmYWRiMjlmYjU0YjdfMTYtMi0xLTEtMA_5cbe90ba-bdef-419e-b16a-9e8caa51fff0"
      unitRef="usd">155100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue
      contextRef="i2ff71b48fe0e4e9d9e59ac8a919283de_D20210301-20210301"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfNDEzMQ_ac75ff99-0acf-4e45-8c43-329c5383ab73"
      unitRef="number">0.145</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue
      contextRef="i0e52565dcf6d4e319cc9bb4516138aec_D20210301-20210301"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfNDE3MA_e1acd291-7e1e-479c-bd32-3186aa2f77f2"
      unitRef="number">0.135</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="icf15ef9e7b8d4ce0b6f697ed71d50240_D20210301-20210301"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfNDUxNg_749e3168-f38d-45a5-9ff4-a9164e2d4836">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i601f6bd5a6a04f1ba94dff4501f86d1d_D20210104-20210104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfNTQxNg_a7ca6325-0daa-4449-b939-ea8cd0a9b12f"
      unitRef="usd">62900000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology
      contextRef="id9cb5bfd9d0b4a7bb1e06960147c3f37_I20210104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfNTcyMw_f3172cd6-60a8-43ac-a544-453cbf0b353a"
      unitRef="usd">38000000.0</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships
      contextRef="id9cb5bfd9d0b4a7bb1e06960147c3f37_I20210104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfNTc3Ng_ae929107-b869-4d8b-bc90-81562154f2dd"
      unitRef="usd">1200000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames
      contextRef="id9cb5bfd9d0b4a7bb1e06960147c3f37_I20210104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfNTgwNg_014d630c-781f-4a84-9314-d9de55ae7cbb"
      unitRef="usd">900000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames>
    <us-gaap:Goodwill
      contextRef="id9cb5bfd9d0b4a7bb1e06960147c3f37_I20210104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfNTgyOA_50718179-3873-4e39-bdaa-1eed0a821dbd"
      unitRef="usd">32400000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="id9cb5bfd9d0b4a7bb1e06960147c3f37_I20210104"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfNTg1OA_eea65f3b-4f78-4d05-b559-9b664f3f9e77"
      unitRef="usd">9600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i95400d7ffd0145a6902213bb3a8fd6e5_D20200928-20200928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfNjM0OQ_6f1979b4-2856-4206-bbd5-28988e6757ec"
      unitRef="usd">5600000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ic7e22da3089645eda9e0ac21e97119f1_D20200928-20200928"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfNjYxNw_ce61d0d1-c94e-4d5a-b575-8de194ea0a00">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="if19332d7f2bc4032add3a47ca74898dd_D20200823-20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfNjkyNw_e1bb1389-eb66-4487-a465-626fd045ab8d"
      unitRef="usd">161300000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="ib2c5f4cc59d642e7b734717eb34e002e_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfNjk2MQ_44cc8579-b1d5-4162-b304-278864f76467"
      unitRef="usd">3000000.0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="if929571277ff41218f0486d616483faa_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfNzA3NA_5a9dbfe3-7e8d-47e1-b108-63bf8996ac6d"
      unitRef="usd">81800000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <holx:AnnualIncrementalRevenueGrowthPeriod
      contextRef="if19332d7f2bc4032add3a47ca74898dd_D20200823-20200823"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTU3MDE_b7e4cbe8-c4c9-4d34-9c5d-560912a5f31f">P3Y</holx:AnnualIncrementalRevenueGrowthPeriod>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="icb56805faa3a44cd9925ebb00f16e8b2_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfODczMg_4a36a2d2-829f-4d80-9d22-93afaad775d7"
      unitRef="usd">-10100000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="if929571277ff41218f0486d616483faa_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmY3OTYzZTgxMzUzMjQzNGRiZGZiOGU3NDc3MjllM2VkL3RhYmxlcmFuZ2U6Zjc5NjNlODEzNTMyNDM0ZGJkZmI4ZTc0NzcyOWUzZWRfMC0yLTEtMS0w_f230b0a9-e568-4d12-9859-1f8d3597e9e0"
      unitRef="usd">1200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="if929571277ff41218f0486d616483faa_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmY3OTYzZTgxMzUzMjQzNGRiZGZiOGU3NDc3MjllM2VkL3RhYmxlcmFuZ2U6Zjc5NjNlODEzNTMyNDM0ZGJkZmI4ZTc0NzcyOWUzZWRfMS0yLTEtMS0w_1449a909-0fd8-46aa-8dd2-af42af1eefd2"
      unitRef="usd">4000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="if929571277ff41218f0486d616483faa_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmY3OTYzZTgxMzUzMjQzNGRiZGZiOGU3NDc3MjllM2VkL3RhYmxlcmFuZ2U6Zjc5NjNlODEzNTMyNDM0ZGJkZmI4ZTc0NzcyOWUzZWRfMi0yLTEtMS0w_296de96e-947c-4c5b-b171-074752e83eba"
      unitRef="usd">4400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="if929571277ff41218f0486d616483faa_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmY3OTYzZTgxMzUzMjQzNGRiZGZiOGU3NDc3MjllM2VkL3RhYmxlcmFuZ2U6Zjc5NjNlODEzNTMyNDM0ZGJkZmI4ZTc0NzcyOWUzZWRfMy0yLTEtMS0w_3e6e33ea-8a18-47b7-849d-9bcf8c87c13c"
      unitRef="usd">4700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology
      contextRef="if929571277ff41218f0486d616483faa_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmY3OTYzZTgxMzUzMjQzNGRiZGZiOGU3NDc3MjllM2VkL3RhYmxlcmFuZ2U6Zjc5NjNlODEzNTMyNDM0ZGJkZmI4ZTc0NzcyOWUzZWRfNS0yLTEtMS0w_b2434819-478a-452e-b98d-62d979baecca"
      unitRef="usd">127000000.0</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames
      contextRef="if929571277ff41218f0486d616483faa_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmY3OTYzZTgxMzUzMjQzNGRiZGZiOGU3NDc3MjllM2VkL3RhYmxlcmFuZ2U6Zjc5NjNlODEzNTMyNDM0ZGJkZmI4ZTc0NzcyOWUzZWRfNy0yLTEtMS0w_281492b2-daad-4c03-937c-8749b45b33a8"
      unitRef="usd">1200000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="if929571277ff41218f0486d616483faa_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmY3OTYzZTgxMzUzMjQzNGRiZGZiOGU3NDc3MjllM2VkL3RhYmxlcmFuZ2U6Zjc5NjNlODEzNTMyNDM0ZGJkZmI4ZTc0NzcyOWUzZWRfOC0yLTEtMS0w_0672512b-9ecc-46ce-83e9-d7170b797140"
      unitRef="usd">20200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:Goodwill
      contextRef="if929571277ff41218f0486d616483faa_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmY3OTYzZTgxMzUzMjQzNGRiZGZiOGU3NDc3MjllM2VkL3RhYmxlcmFuZ2U6Zjc5NjNlODEzNTMyNDM0ZGJkZmI4ZTc0NzcyOWUzZWRfOS0yLTEtMS0w_e2a02c04-b732-44a1-9035-8767d042341d"
      unitRef="usd">48400000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="if929571277ff41218f0486d616483faa_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOmY3OTYzZTgxMzUzMjQzNGRiZGZiOGU3NDc3MjllM2VkL3RhYmxlcmFuZ2U6Zjc5NjNlODEzNTMyNDM0ZGJkZmI4ZTc0NzcyOWUzZWRfMTAtMi0xLTEtMA_8c2721c7-7913-4120-998c-eaba947345b2"
      unitRef="usd">161300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue
      contextRef="if19332d7f2bc4032add3a47ca74898dd_D20200823-20200823"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfOTg0NQ_bdcb1374-c3ba-4f9d-9def-e5c2aaa08171"
      unitRef="number">0.180</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i0f02945eed7a4b80bf799a5f378886e3_D20200823-20200823"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTAxNTM_729cba18-d389-47c1-956e-d08b70455b0b">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="icb63ed4e502448c29aeca44e256133e3_D20200823-20200823"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTAxNTM_ec635e29-32df-476b-947f-da27d878f349">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i7c4ac52d74224b66838d0679adb1ed3b_D20200203-20200203"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTA4NDU_3907a7df-ad40-4569-af78-286db00f9600"
      unitRef="usd">19700000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <holx:Holdback
      contextRef="ie1847e23bfb6472dbc395f6d1338a8db_I20200203"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTA4Nzg_bc01203a-8e46-4818-b43d-86f7ef178d38"
      unitRef="usd">2300000</holx:Holdback>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ie1847e23bfb6472dbc395f6d1338a8db_I20200203"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTEwNDg_10d50452-69ce-44cc-b33b-f7a475e3574d"
      unitRef="usd">10700000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="ie1847e23bfb6472dbc395f6d1338a8db_I20200203"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTEwNzk_f13c2646-b1ff-45a0-b1ff-370a38e87649"
      unitRef="usd">6200000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="ie1847e23bfb6472dbc395f6d1338a8db_I20200203"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTExMDk_410f07ac-6802-429b-a24b-7d699af34a86"
      unitRef="usd">2800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i264ebea292b04fd29f44c37de6914f8c_D20191230-20191230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTE0Nzg_841dd99a-ea17-4796-b5b8-0359b9757478"
      unitRef="usd">18000000.0</us-gaap:BusinessCombinationConsiderationTransferred1>
    <holx:Holdback
      contextRef="i043ca86798494f61b2666b1a7f46ddd4_I20191230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTE1MTI_01a33698-78c9-4331-abdc-1c6840cd7b2b"
      unitRef="usd">1000000.0</holx:Holdback>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i043ca86798494f61b2666b1a7f46ddd4_I20191230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTE1Nzk_5b49e0ae-5e66-4510-ac1b-5e5e0b5105d7"
      unitRef="usd">900000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ie6fd1be7827e4d14a8a0c3642ea41642_D20191230-20191230"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTE5MzI_628a6373-6e6b-4fec-aa96-e4534033607f">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i7606589a8d9a46508518e654ca7bc3cd_I20190801"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTE5OTg_46e45725-3a42-44b9-930f-4038c201f3eb"
      unitRef="number">0.46</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="iee122e2193954283b59296f2f329c3f5_D20190801-20190801"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTIwNjE_3e52ed1b-5730-4cd5-9607-07a4b41b3183"
      unitRef="usd">18200000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <holx:BusinessAcquisitionCashTenderOfferPricePerShare
      contextRef="i09ddd178ba8e4ea48372984e4d5984f4_D20190901-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTIzMTE_c9d3c0c8-5c37-4adf-8549-db1ee06cfb8c"
      unitRef="usdPerShare">1.50</holx:BusinessAcquisitionCashTenderOfferPricePerShare>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="iafd366364b034ade874e71b313ac5811_I20191120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI2MzE_16c5d34a-64a8-4985-bb71-a9144a27d1a1"
      unitRef="number">0.50</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <holx:BusinessCombinationAdditionalSharesAcquiredShares
      contextRef="i2d5a252316d24ba8bf7db1b4788097eb_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI3OTc_125fa98d-0db6-48f3-90c5-1bfc9cc00af6"
      unitRef="shares">7600000</holx:BusinessCombinationAdditionalSharesAcquiredShares>
    <holx:BusinessCombinationAdditionalSharesAcquiredValue
      contextRef="i2d5a252316d24ba8bf7db1b4788097eb_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI4MTg_b5f5e325-7c4f-4f4c-bfa1-c1139f02c421"
      unitRef="usd">12600000</holx:BusinessCombinationAdditionalSharesAcquiredValue>
    <holx:BusinessCombinationOwnershipPercentage
      contextRef="i2d5a252316d24ba8bf7db1b4788097eb_D20191121-20191121"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI4OTU_644a5877-43cc-430a-8c97-ebe8d7b5bfd0"
      unitRef="number">0.78</holx:BusinessCombinationOwnershipPercentage>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
      contextRef="i7606589a8d9a46508518e654ca7bc3cd_I20190801"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTMzMTE_d34e4654-e584-44b0-b087-5944dc2cdb72"
      unitRef="number">0.46</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
      contextRef="i2d5a252316d24ba8bf7db1b4788097eb_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTM0MTM_d28ff541-a106-4e3e-ac4e-5013e660a6c2"
      unitRef="usd">3200000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i2d5a252316d24ba8bf7db1b4788097eb_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTM1MzM_b4bc0632-9661-4680-ab83-1ea7095479de"
      unitRef="usd">69300000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <holx:BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment
      contextRef="i2d5a252316d24ba8bf7db1b4788097eb_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTM1NTY_c5ba7483-76aa-4ca4-9e34-d940007bdc43"
      unitRef="usd">17900000</holx:BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment>
    <holx:BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares
      contextRef="i14f9866ecdf54b2f82e4e696f4ee2148_D20191101-20191130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTM2MDA_79940b52-1f70-469b-a071-69a01011e894"
      unitRef="usd">12600000</holx:BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares>
    <holx:BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment
      contextRef="i2d5a252316d24ba8bf7db1b4788097eb_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTM2NDU_dc478deb-3734-4bcc-88ec-b41dd29959bc"
      unitRef="usd">30200000</holx:BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment>
    <holx:BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest
      contextRef="i2d5a252316d24ba8bf7db1b4788097eb_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTM3OTU_aa4ab261-47e8-4073-8bfa-75c0ac0e9ff2"
      unitRef="usd">8600000</holx:BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest>
    <holx:BusinessCombinationAdditionalSharesAcquiredShares
      contextRef="i6cf6aa2100404a05becfe250085e5d00_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTM5MTg_91c5a8e3-b4b9-4068-ade0-996642166e55"
      unitRef="shares">1100000</holx:BusinessCombinationAdditionalSharesAcquiredShares>
    <holx:BusinessCombinationAdditionalSharesAcquiredValue
      contextRef="i6cf6aa2100404a05becfe250085e5d00_D20190929-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTM5NTk_cc94fdc3-fcc6-4a58-b9fe-cbc170c32700"
      unitRef="usd">1800000</holx:BusinessCombinationAdditionalSharesAcquiredValue>
    <holx:BusinessCombinationAdditionalSharesAcquiredShares
      contextRef="i14df8e75f81d4e468e9e9ccc3560103e_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI2NDQzODM3NTIyNzk_fbdf0096-0fe7-49f2-a3ba-ca6b4d0c79b6"
      unitRef="shares">4800000</holx:BusinessCombinationAdditionalSharesAcquiredShares>
    <holx:BusinessCombinationAdditionalSharesAcquiredValue
      contextRef="i14df8e75f81d4e468e9e9ccc3560103e_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTI2NDQzODM3NTIyOTI_653a2cb8-830f-4ff0-9b50-974f2e501300"
      unitRef="usd">8500000</holx:BusinessCombinationAdditionalSharesAcquiredValue>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
      contextRef="id1eaaa8f5b1844eca34f3c569e39abce_I20210626"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTQwMjE_79f9ed76-5b03-4264-9d7e-aab8586d2ed5"
      unitRef="number">1</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i64adc24ac247463eb19f42515cbcb2b1_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjYyYzk3YjI4YmVjZjRjNzJiNWI0NjE4MmQwYmFiMWIzL3RhYmxlcmFuZ2U6NjJjOTdiMjhiZWNmNGM3MmI1YjQ2MTgyZDBiYWIxYjNfMC0xLTEtMS0w_28f3c723-f4f7-4a25-b9f8-76e64ad3a35b"
      unitRef="usd">2600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i64adc24ac247463eb19f42515cbcb2b1_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjYyYzk3YjI4YmVjZjRjNzJiNWI0NjE4MmQwYmFiMWIzL3RhYmxlcmFuZ2U6NjJjOTdiMjhiZWNmNGM3MmI1YjQ2MTgyZDBiYWIxYjNfMS0xLTEtMS0w_42e4b7fc-4604-40c6-82f2-256a61946944"
      unitRef="usd">7100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i64adc24ac247463eb19f42515cbcb2b1_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjYyYzk3YjI4YmVjZjRjNzJiNWI0NjE4MmQwYmFiMWIzL3RhYmxlcmFuZ2U6NjJjOTdiMjhiZWNmNGM3MmI1YjQ2MTgyZDBiYWIxYjNfMi0xLTEtMS0w_f257ba7d-e98f-45b2-8e06-b6d86256ef58"
      unitRef="usd">10000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i64adc24ac247463eb19f42515cbcb2b1_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjYyYzk3YjI4YmVjZjRjNzJiNWI0NjE4MmQwYmFiMWIzL3RhYmxlcmFuZ2U6NjJjOTdiMjhiZWNmNGM3MmI1YjQ2MTgyZDBiYWIxYjNfMy0xLTEtMS0w_406c5844-3563-421d-a666-278ee72e9f85"
      unitRef="usd">6500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i64adc24ac247463eb19f42515cbcb2b1_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjYyYzk3YjI4YmVjZjRjNzJiNWI0NjE4MmQwYmFiMWIzL3RhYmxlcmFuZ2U6NjJjOTdiMjhiZWNmNGM3MmI1YjQ2MTgyZDBiYWIxYjNfNC0xLTEtMS0w_487a0e75-4fda-4b12-8e89-fb2ccf001367"
      unitRef="usd">4300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i64adc24ac247463eb19f42515cbcb2b1_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjYyYzk3YjI4YmVjZjRjNzJiNWI0NjE4MmQwYmFiMWIzL3RhYmxlcmFuZ2U6NjJjOTdiMjhiZWNmNGM3MmI1YjQ2MTgyZDBiYWIxYjNfNS0xLTEtMS0w_641751cc-7705-4a29-ba09-b5194ee1452a"
      unitRef="usd">24500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="i64adc24ac247463eb19f42515cbcb2b1_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjYyYzk3YjI4YmVjZjRjNzJiNWI0NjE4MmQwYmFiMWIzL3RhYmxlcmFuZ2U6NjJjOTdiMjhiZWNmNGM3MmI1YjQ2MTgyZDBiYWIxYjNfNi0xLTEtMS0w_f6ac2c4c-5706-4d97-bd43-e92e906001df"
      unitRef="usd">1800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt
      contextRef="i64adc24ac247463eb19f42515cbcb2b1_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjYyYzk3YjI4YmVjZjRjNzJiNWI0NjE4MmQwYmFiMWIzL3RhYmxlcmFuZ2U6NjJjOTdiMjhiZWNmNGM3MmI1YjQ2MTgyZDBiYWIxYjNfNy0xLTEtMS0w_bc89d158-4038-4731-8a05-5ea8b25081fc"
      unitRef="usd">8800000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities
      contextRef="i64adc24ac247463eb19f42515cbcb2b1_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjYyYzk3YjI4YmVjZjRjNzJiNWI0NjE4MmQwYmFiMWIzL3RhYmxlcmFuZ2U6NjJjOTdiMjhiZWNmNGM3MmI1YjQ2MTgyZDBiYWIxYjNfOC0xLTEtMS0w_19863086-a1f8-488d-87c2-cb32633da7f8"
      unitRef="usd">3800000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology
      contextRef="i64adc24ac247463eb19f42515cbcb2b1_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjYyYzk3YjI4YmVjZjRjNzJiNWI0NjE4MmQwYmFiMWIzL3RhYmxlcmFuZ2U6NjJjOTdiMjhiZWNmNGM3MmI1YjQ2MTgyZDBiYWIxYjNfMTAtMS0xLTEtMA_e0e8be6f-8a67-4c7b-b9b2-31862147e41a"
      unitRef="usd">38300000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships
      contextRef="i64adc24ac247463eb19f42515cbcb2b1_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjYyYzk3YjI4YmVjZjRjNzJiNWI0NjE4MmQwYmFiMWIzL3RhYmxlcmFuZ2U6NjJjOTdiMjhiZWNmNGM3MmI1YjQ2MTgyZDBiYWIxYjNfMTEtMS0xLTEtMA_3dc64a8c-8337-48ee-97fa-2444edf43b97"
      unitRef="usd">4000000.0</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames
      contextRef="i64adc24ac247463eb19f42515cbcb2b1_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjYyYzk3YjI4YmVjZjRjNzJiNWI0NjE4MmQwYmFiMWIzL3RhYmxlcmFuZ2U6NjJjOTdiMjhiZWNmNGM3MmI1YjQ2MTgyZDBiYWIxYjNfMTItMS0xLTEtMA_f691f872-b309-4685-b41f-9cd09236e44d"
      unitRef="usd">3000000.0</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i64adc24ac247463eb19f42515cbcb2b1_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjYyYzk3YjI4YmVjZjRjNzJiNWI0NjE4MmQwYmFiMWIzL3RhYmxlcmFuZ2U6NjJjOTdiMjhiZWNmNGM3MmI1YjQ2MTgyZDBiYWIxYjNfMTMtMS0xLTEtMA_04d90bae-f0fd-4828-af5c-c5bcbba520a4"
      unitRef="usd">1900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:Goodwill
      contextRef="i64adc24ac247463eb19f42515cbcb2b1_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjYyYzk3YjI4YmVjZjRjNzJiNWI0NjE4MmQwYmFiMWIzL3RhYmxlcmFuZ2U6NjJjOTdiMjhiZWNmNGM3MmI1YjQ2MTgyZDBiYWIxYjNfMTQtMS0xLTEtMA_4bbc48ea-a9d6-4900-aa34-41a1080a7333"
      unitRef="usd">34300000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i64adc24ac247463eb19f42515cbcb2b1_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RhYmxlOjYyYzk3YjI4YmVjZjRjNzJiNWI0NjE4MmQwYmFiMWIzL3RhYmxlcmFuZ2U6NjJjOTdiMjhiZWNmNGM3MmI1YjQ2MTgyZDBiYWIxYjNfMTUtMS0xLTEtMA_1d7398be-1907-4498-8e15-9dd100dc9fae"
      unitRef="usd">69300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <holx:FairValueAssumptionDiscountRate
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTQ4MDU_4b515330-da55-48e8-921f-ff3ee73d4d2b"
      unitRef="number">0.120</holx:FairValueAssumptionDiscountRate>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i93381ce7098c4e4fa2bb4eea52c5dce4_D20191121-20191121"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTUxMDQ_3fc71a54-2ef6-4482-b2e7-876e69b5a9a0">P9Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i13826201466c4300b5dd607143edc940_D20191121-20191121"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTUxMzQ_39baf0e4-c7e0-413d-9d5f-159dbeec50b1">P9Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="iaa6bff4ae2dc4a33986e101d589e889a_D20191121-20191121"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF80OS9mcmFnOjFlMGJkYWIzOWJiZDQzZjFiYjIxMTUwOTljMGMwZWM3L3RleHRyZWdpb246MWUwYmRhYjM5YmJkNDNmMWJiMjExNTA5OWMwYzBlYzdfMTUxNTY_5a5ad9f1-22af-4e28-a8b8-d894a585a500">P8Y7M6D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81NS9mcmFnOmUxMzBmYjUzYzZhMzQ1Mjk5NzAwODk4YjczYTI5MjY5L3RleHRyZWdpb246ZTEzMGZiNTNjNmEzNDUyOTk3MDA4OThiNzNhMjkyNjlfMjYwOQ_ee265667-0747-4fe6-831d-fd075f42cbc0">Disposition - Sale of Medical Aesthetics&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 20, 2019, the Company entered into a definitive agreement to sell its Medical Aesthetics business to Clayton Dubilier &amp;amp; Rice ("CD&amp;amp;R") for a sales price of&#160;$205.0 million&#160;in cash, less certain adjustments. The sale was completed on December 30, 2019, and the Company received cash proceeds of $153.4 million in the second quarter of fiscal 2020. The sale price was subject to adjustment pursuant to the terms of the definitive agreement, and the parties agreed to a final sales price of $150.0&#160;million in the fourth quarter of fiscal 2020. The Company agreed to provide certain transition services for three to fifteen months, depending on the nature of the service. The Company also agreed to indemnify CD&amp;amp;R for certain legal and tax matters that existed as of the date of disposition. In connection with its accounting for the sale, the Company recorded indemnification liabilities of $10.9&#160;million within accrued expenses associated with its obligations under the sale agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of this transaction, the Medical Aesthetics asset group was designated as assets held-for-sale in the first quarter of fiscal 2020. Pursuant to ASC 360, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Impairment and Disposal of Long-Lived Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, asset groups under this designation are required to be recorded at fair value less costs to sell. The Company determined that this disposal did not qualify as a discontinued operation as the sale of the Medical Aesthetics business was deemed to not be a strategic shift having or will have a major effect on the Company's operations and financial results. Based on the terms in the agreement of the sales price and formula for net working capital and related adjustments, its estimate of the fair value for transition services and the amount that must be carved out of the sale proceeds, and liabilities the Company will retain or for which it has agreed to indemnify CD&amp;amp;R, the Company recorded an impairment charge of $30.2 million in the first quarter of fiscal 2020. The impairment charge was allocated to Medical Aesthetics long-lived assets, of which $25.8 million was allocated to cost of product revenues and $4.4 million to operating expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of fiscal 2020, this business incurred a loss from operations of $46.5&#160;million, which excludes corporate allocations. The operating expenses include only those that were incurred directly by and were retained by the &lt;/span&gt;&lt;/div&gt;disposed business. The Company will continue to incur expenses related to this business under the indemnification provisions primarily related to legal and tax matters that existed as of the date of disposition. These expenses were not significant in the first, second and third quarters of fiscal 2021.</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i89c6030b3fa74130a05c86c5566ac9b5_I20191120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81NS9mcmFnOmUxMzBmYjUzYzZhMzQ1Mjk5NzAwODk4YjczYTI5MjY5L3RleHRyZWdpb246ZTEzMGZiNTNjNmEzNDUyOTk3MDA4OThiNzNhMjkyNjlfMjE5_ca7d0151-4c75-44e4-906c-3b1a4c12f61d"
      unitRef="usd">205000000.0</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="icd5055934cbe40cc89289656c936a8cd_D20191120-20191120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81NS9mcmFnOmUxMzBmYjUzYzZhMzQ1Mjk5NzAwODk4YjczYTI5MjY5L3RleHRyZWdpb246ZTEzMGZiNTNjNmEzNDUyOTk3MDA4OThiNzNhMjkyNjlfMzQ0_5938d7d3-a8a8-4294-9b6a-be179507934f"
      unitRef="usd">153400000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup
      contextRef="id999567ff4ad4d47967ba1b3ba2d4f74_D20200628-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81NS9mcmFnOmUxMzBmYjUzYzZhMzQ1Mjk5NzAwODk4YjczYTI5MjY5L3RleHRyZWdpb246ZTEzMGZiNTNjNmEzNDUyOTk3MDA4OThiNzNhMjkyNjlfNTI2_7dc954db-1903-40a8-a1f0-53b0016d14f1">150.0&#160;million</us-gaap:DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup>
    <holx:IndemnificationLiability
      contextRef="ieb526c3393b94999af44e0f2283027b9_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81NS9mcmFnOmUxMzBmYjUzYzZhMzQ1Mjk5NzAwODk4YjczYTI5MjY5L3RleHRyZWdpb246ZTEzMGZiNTNjNmEzNDUyOTk3MDA4OThiNzNhMjkyNjlfOTE0_54af8c59-c56e-4851-8613-3dd613e715cc"
      unitRef="usd">10900000</holx:IndemnificationLiability>
    <us-gaap:AssetImpairmentCharges
      contextRef="id01db50d7a6347809cb98adf4b5c0c66_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81NS9mcmFnOmUxMzBmYjUzYzZhMzQ1Mjk5NzAwODk4YjczYTI5MjY5L3RleHRyZWdpb246ZTEzMGZiNTNjNmEzNDUyOTk3MDA4OThiNzNhMjkyNjlfMTg4NA_f13495b7-8caf-4a87-862d-3eaeaa94a2a9"
      unitRef="usd">30200000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="ie01a803f233b45f4a49380b21ad6bb32_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81NS9mcmFnOmUxMzBmYjUzYzZhMzQ1Mjk5NzAwODk4YjczYTI5MjY5L3RleHRyZWdpb246ZTEzMGZiNTNjNmEzNDUyOTk3MDA4OThiNzNhMjkyNjlfMjAxMA_1e189e89-1f5f-4f20-9ccf-70c63cd7fb78"
      unitRef="usd">25800000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i8d24eb58cd394fae908cb1b14bef726b_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81NS9mcmFnOmUxMzBmYjUzYzZhMzQ1Mjk5NzAwODk4YjczYTI5MjY5L3RleHRyZWdpb246ZTEzMGZiNTNjNmEzNDUyOTk3MDA4OThiNzNhMjkyNjlfMjA1OQ_154429d4-cc1a-4d2c-a19d-afacd0e25d36"
      unitRef="usd">4400000</us-gaap:AssetImpairmentCharges>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
      contextRef="id01db50d7a6347809cb98adf4b5c0c66_D20190929-20191228"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81NS9mcmFnOmUxMzBmYjUzYzZhMzQ1Mjk5NzAwODk4YjczYTI5MjY5L3RleHRyZWdpb246ZTEzMGZiNTNjNmEzNDUyOTk3MDA4OThiNzNhMjkyNjlfMjE3Mg_738e2815-469c-44ec-b1ef-53b3a6701384"
      unitRef="usd">46500000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfNjQ4MA_75cca42c-ff40-45ed-8e0e-cd6a53c580dd">Borrowings and Credit Arrangements&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s borrowings consisted of the following:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.365%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current debt obligations, net of debt discount and deferred issuance costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolver&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Securitization Program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt obligations, net of debt discount and issuance costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,325.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,379.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;939.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;934.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,654.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,713.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,115.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,038.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2018 Amended and Restated Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 17, 2018, the Company and certain of its subsidiaries refinanced its term loan and revolving credit facility by entering into an Amended and Restated Credit and Guaranty Agreement as of December 17, 2018 (the "2018 Credit Agreement") with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders. The 2018 Credit Agreement amended and restated the Company's prior credit and guaranty agreement dated as of October 3, 2017 (the "2017 Credit Agreement"). As of June 26, 2021, the principal amount outstanding of the term loan under the 2018 Credit Agreement (the "Term Loan") was $1.4&#160;billion. The Term Loan bears interest at an annual rate equal to the Eurocurrency Rate (i.e., the LIBOR rate) plus an Applicable Rate, which was 1.00% as of June 26, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also has a $1.5&#160;billion revolving credit facility (the "Revolver") under the 2018 Credit Agreement. The borrowings of the Revolver bear interest at a rate equal to the LIBOR Daily Floating Rate plus an Applicable Rate, which was 1.00% as of June 26, 2021. In response to the market uncertainties created by the COVID-19 pandemic in March 2020, the Company borrowed $750.0 million under the Revolver, $250.0 million of which, at the time, was used to pay off amounts outstanding under the asset securitization agreement, in order to have sufficient cash on hand. During the first quarter of fiscal 2021, the Company paid off the remaining outstanding balance of $250.0&#160;million. As of June 26, 2021, the full amount of the Revolver was available to borrow by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense, weighted average interest rates, and the interest rate at the end of period under the Credit Agreements were as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2018 Credit Agreement contains two financial covenants; a total leverage ratio and an interest coverage ratio, both of which are measured as of the last day of each fiscal quarter. These terms, and calculations thereof, are defined in further detail in the 2018 Credit Agreement. As of June 26, 2021, the Company was in compliance with these covenants.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 28, 2020, the Company completed a private placement of $950&#160;million aggregate principal amount of its 3.250% Senior Notes due 2029 (the "2029 Senior Notes") at an offering price of 100% of the aggregate principal amount of the 2029 Senior Notes. The Company used the net proceeds of the 2029 Senior Notes offering and cash on hand to redeem in full its 4.375% Senior Notes due 2025 (the "2025 Senior Notes") in the aggregate principal amount of $950.0&#160;million on October 15, 2020 at an aggregate redemption price of $970.8&#160;million, which included a premium payment $20.8&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2025 Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Immediately prior to redemption in full of the 2025 Senior Notes on October 15, 2020, the total aggregate principal balance of 2025 Senior Notes was $950.0 million. As the Company planned to use the proceeds from the 2029 Senior Notes offering to redeem the 2025 Senior Notes, the Company evaluated the accounting for this transaction under ASC 470, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, to determine modification versus extinguishment accounting on a creditor-by-creditor basis. Certain 2025 Senior Note holders either did not participate in this refinancing transaction or reduced their holdings, and these transactions were accounted for as extinguishments. As a result, the Company recorded a debt extinguishment loss in the first quarter of fiscal 2021 of $21.6&#160;million. For the remaining 2025 Senior Notes holders who participated in the refinancing, these transactions were accounted for as modifications because on a creditor-by-creditor basis the present value of the cash flows between the debt instruments before and after the transaction was less than 10%. The Company recorded a portion of the transaction expenses of $5.8&#160;million to interest expense pursuant to ASC 470, subtopic 50-40. The remaining debt issuance costs of $7.9&#160;million and debt discount of $6.4&#160;million related to the modified debt will be amortized over the new term of the 2029 Senior Notes using the effective interest method.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June 26, 2021, the Company had 4.625% Senior Notes due 2028 (the "2028 Senior Notes") outstanding in the aggregate principal balance of $400 million. The 2028 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries and mature on February&#160;1, 2028. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June 26, 2021, the Company had 2029 Senior Notes outstanding in the aggregate principal balance of $950&#160;million. The 2029 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2029 Senior Notes mature on February&#160;15, 2029 and bear interest at the rate of 3.250%&#160;per year, payable semi-annually on February&#160;15 and August&#160;15 of each year, commencing on February&#160;15, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may redeem the 2029 Senior Notes at any time prior to September 28, 2023 at a price equal to 100% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. The Company may also redeem up to 40% of the aggregate principal amount of the 2029 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before September 28, 2023, at a redemption price equal to 103.250% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. The Company also has the option to redeem the 2029 Senior Notes on or after: September 28, 2023 through September 27, 2024 at 101.625% of par; September 28, 2024 through September 27, 2025 at 100.813% of par; and September 28, 2025 and thereafter at 100% of par. In addition, if the Company undergoes a change of control coupled with a decline in ratings, as provided in the indenture, the Company will be required to make an offer to purchase each holder&#x2019;s 2029 Senior Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluated the 2029 Senior Notes for derivatives pursuant to ASC 815, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives and Hedging,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and did not identify any embedded derivatives that require bifurcation. All features were deemed to be clearly and closely related to the host instrument.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense for the 2029 Senior Notes, 2028 Senior Notes and 2025 Senior Notes was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt;text-align:center;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.503%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:17pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounts Receivable Securitization Program&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In response to the market uncertainties created by the COVID-19 pandemic, on March 26, 2020, the Company paid-off the total amount outstanding of $250.0&#160;million previously borrowed under the Accounts Receivable Securitization Program (the "Securitization Program"). On April 13, 2020, the Company amended the Credit and Security agreement with the lenders, temporarily suspending the ability to borrow and the need to comply with covenants for up to a year. On June 11, 2021, the Company amended and restated the Credit and Security agreement to restart the Securitization Program and increase the maximum borrowing amount to $320.0&#160;million. Loans outstanding under the Securitization Program bear interest at LIBOR plus an applicable margin for defined tranches. As of June 26, 2021, there was $320.0&#160;million outstanding under this program. The weighted average interest rate under the Securitization Program was 0.78% as of June 26, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other represents debt acquired in the Mobidiag acquisition, which is primarily with the European Investment Bank ("EIB"). Multiple tranches were withdrawn under the agreement and were primarily used to fund research and development projects and expansion efforts. The debt agreement contains change-in-control provisions allowing the EIB to call the debt at any time after a change-in-control, which occurred as a result of Hologic acquiring Mobidiag. Accordingly, the Company has classified the debt as current. The tranches withdrawn under this agreement have interest rates ranging from 6.0% to 7.0%. The debt agreement includes additional payments to the EIB based on revenues generated by products developed under the funding as well as prepayment penalties.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfNjUwMw_1a7c383a-63bf-43b3-8381-04452204b4da">&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s borrowings consisted of the following:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.365%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current debt obligations, net of debt discount and deferred issuance costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolver&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Securitization Program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt obligations, net of debt discount and issuance costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,325.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,379.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;939.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;934.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,654.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,713.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,115.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,038.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:LongTermDebtCurrent
      contextRef="ife6cd667a004466dbd21c797fb6eb40b_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfMi0xLTEtMS0w_dabf2107-3f78-40eb-835f-58f352229243"
      unitRef="usd">74800000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i4475d98ff97042aab50ce4cee82db95b_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfMi0zLTEtMS0w_546e2b79-2c98-4753-b6f2-d67236a61467"
      unitRef="usd">74900000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ice236c25c4d740418e834bf0afc51506_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfMy0xLTEtMS0w_d73356d8-9535-4a50-a2c3-0cf4572d9c1b"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i1964d49d44004c788bf1f11e793a2e68_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfMy0zLTEtMS0w_87bc71b1-ffa0-4d22-965b-1405a03780de"
      unitRef="usd">250000000.0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i5ff6e83c3f4f43a292e67915ac446908_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfNC0xLTEtMS0w_24a91a74-79a3-40eb-8ccb-99603f26ee05"
      unitRef="usd">320000000.0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i9c8160a52fd54288931c8a6169582fbc_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfNC0zLTEtMS0w_ee5d8130-16bd-4114-963c-0f8f9863a4ae"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i2f1fa7442a694b4fbb79b5dea180468f_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfNi0xLTEtMS01MjYx_67416232-8002-4986-864b-456b3c7ea66f"
      unitRef="usd">65800000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ia5529a4948994271968a3ed7d11437fa_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfNi0zLTEtMS01MjYz_6885c5ec-8442-4db4-8de5-6b62fdf5bfa4"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfNi0xLTEtMS0w_731abf7b-d73f-4c71-b942-513e80888ced"
      unitRef="usd">460600000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfNi0zLTEtMS0w_beff2aec-4971-4e2e-9b92-6d26c5a53e7a"
      unitRef="usd">324900000</us-gaap:LongTermDebtCurrent>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="ife6cd667a004466dbd21c797fb6eb40b_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfOC0xLTEtMS0w_ad04bf16-ee81-4d8d-af51-100c510196b1"
      unitRef="usd">1325500000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="i4475d98ff97042aab50ce4cee82db95b_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfOC0zLTEtMS0w_8378578c-23f9-42e1-9fd0-69df5f91456a"
      unitRef="usd">1379900000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="ibf97edf455654668b98e5a775e14b2d5_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfMTAtMS0xLTEtMA_7308072d-057f-4383-9b1a-5d7758413a50"
      unitRef="usd">0</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="i023aa7ed3f4f4c63b7915aaca3a74a20_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfMTAtMy0xLTEtMA_8f022b9d-3203-419f-a620-8888eab2b85c"
      unitRef="usd">939400000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="ibfa1efc297734235ad6cd2cb7b00179e_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfMTEtMS0xLTEtMA_364793b0-405a-472a-96e4-ad7c318a8dd4"
      unitRef="usd">395200000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="i27fc517175434926997757aeb6acf88f_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfMTEtMy0xLTEtMA_c3c0d486-3dae-436b-80e0-b75e1cad6bf2"
      unitRef="usd">394600000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="i1e480c0e3a7a477b9e530aae1be7fb57_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfMTItMS0xLTEtMA_1bbac5cc-f972-4eb6-beec-c9f6081604b2"
      unitRef="usd">934000000.0</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="i07ebc1d0fd124863ae761151644bf529_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfMTItMy0xLTEtMA_c6fbb597-6f5f-410b-bbf3-3343ee3017f3"
      unitRef="usd">0</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfMTMtMS0xLTEtMA_682228ac-da58-4640-b51e-5d841b21b469"
      unitRef="usd">2654700000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfMTMtMy0xLTEtMA_71aeed95-50d1-42f7-80ee-7bb52bb51aaa"
      unitRef="usd">2713900000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebt
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfMTQtMS0xLTEtMA_ccbd6289-5e68-4eb3-bd35-c16e401c8bd2"
      unitRef="usd">3115300000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOjc2YmRlMTA1YTY3MzQyMmI4NzAwMjE2NTg1Y2IyOWFkL3RhYmxlcmFuZ2U6NzZiZGUxMDVhNjczNDIyYjg3MDAyMTY1ODVjYjI5YWRfMTQtMy0xLTEtMA_e54219bd-01a4-481f-9a16-ebeaf4da0365"
      unitRef="usd">3038800000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount
      contextRef="ife6cd667a004466dbd21c797fb6eb40b_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfODAw_f715ebd5-e8bb-403b-8629-c2669685db84"
      unitRef="usd">1400000000</us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i31d3ec20ba1341c886214cb33feb29ee_D20200927-20210626"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfOTQw_472cbb06-2f38-4fe0-a2be-b91c1b971c1a"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i4f04002445d14733ac6500556e77b603_I20181217"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfOTg5_062c26ad-5dfb-42a7-b292-5fedfd66df6d"
      unitRef="usd">1500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i9dcce0b55c1f4c47947079e2231dd5ff_D20200927-20210626"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMTI2NDQzODM3NDY0MzY_e527e139-c599-4d30-9a3e-ddf258366a26"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LongTermDebtCurrent
      contextRef="i452a598227b942de9d498139c901ddd7_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMTMzNA_d5757540-1bb5-48ad-9235-e2de26093510"
      unitRef="usd">750000000.0</us-gaap:LongTermDebtCurrent>
    <us-gaap:RepaymentsOfDebt
      contextRef="i7e72c82ce3de4fdfbe618331b89acadd_D20190929-20200627"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMTM1Nw_623c2bc6-5df5-4970-ba74-556d58cebe7b"
      unitRef="usd">250000000.0</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="i4b58c2da43604857b653e5db4b73edfd_D20201227-20210327"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMTU5Mg_faa0c58e-f6ce-4139-9a0d-e20579d15d7a"
      unitRef="usd">250000000.0</us-gaap:RepaymentsOfDebt>
    <us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfNjQ5Mg_ee5fcef2-3f02-4aa8-953d-a890b9114ddd">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense, weighted average interest rates, and the interest rate at the end of period under the Credit Agreements were as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i9b5b7a6104f348f895e5d94b65b73817_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQzNDBhY2ZmZWZkNzQwYTRhMjZhOGQ4Yzc2NzBhOWNlL3RhYmxlcmFuZ2U6ZDM0MGFjZmZlZmQ3NDBhNGEyNmE4ZDhjNzY3MGE5Y2VfMi0xLTEtMS0w_13ddeb07-8947-4cd3-b6b4-d37eee2ee6d8"
      unitRef="usd">5100000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i445296b9bcdf4ecfb15eb4fdf4e5f027_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQzNDBhY2ZmZWZkNzQwYTRhMjZhOGQ4Yzc2NzBhOWNlL3RhYmxlcmFuZ2U6ZDM0MGFjZmZlZmQ3NDBhNGEyNmE4ZDhjNzY3MGE5Y2VfMi0zLTEtMS0w_f72b5c1f-62c4-4347-a453-1a9648934fd2"
      unitRef="usd">11400000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i8ce4e8f765314eb29fce3b97b407943b_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQzNDBhY2ZmZWZkNzQwYTRhMjZhOGQ4Yzc2NzBhOWNlL3RhYmxlcmFuZ2U6ZDM0MGFjZmZlZmQ3NDBhNGEyNmE4ZDhjNzY3MGE5Y2VfMi01LTEtMS0w_bdb84baf-bb4c-43f7-a495-c05189b2edda"
      unitRef="usd">17000000.0</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i591133f22d3243e1ad73bed94da1fe58_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQzNDBhY2ZmZWZkNzQwYTRhMjZhOGQ4Yzc2NzBhOWNlL3RhYmxlcmFuZ2U6ZDM0MGFjZmZlZmQ3NDBhNGEyNmE4ZDhjNzY3MGE5Y2VfMi03LTEtMS0w_04928a41-eb48-425f-8532-29090f2dfc8c"
      unitRef="usd">38000000.0</us-gaap:InterestExpenseBorrowings>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="i9b5b7a6104f348f895e5d94b65b73817_D20210328-20210626"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQzNDBhY2ZmZWZkNzQwYTRhMjZhOGQ4Yzc2NzBhOWNlL3RhYmxlcmFuZ2U6ZDM0MGFjZmZlZmQ3NDBhNGEyNmE4ZDhjNzY3MGE5Y2VfMy0xLTEtMS0w_05163d96-8106-4767-86f1-b42085a9cbf3"
      unitRef="number">0.0110</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="i445296b9bcdf4ecfb15eb4fdf4e5f027_D20200329-20200627"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQzNDBhY2ZmZWZkNzQwYTRhMjZhOGQ4Yzc2NzBhOWNlL3RhYmxlcmFuZ2U6ZDM0MGFjZmZlZmQ3NDBhNGEyNmE4ZDhjNzY3MGE5Y2VfMy0zLTEtMS0w_f58280d4-0201-47c2-a376-d85149b3d6a4"
      unitRef="number">0.0168</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="i8ce4e8f765314eb29fce3b97b407943b_D20200927-20210626"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQzNDBhY2ZmZWZkNzQwYTRhMjZhOGQ4Yzc2NzBhOWNlL3RhYmxlcmFuZ2U6ZDM0MGFjZmZlZmQ3NDBhNGEyNmE4ZDhjNzY3MGE5Y2VfMy01LTEtMS0w_ed541452-6ced-4e12-b53d-d11dfa2242ce"
      unitRef="number">0.0115</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="i591133f22d3243e1ad73bed94da1fe58_D20190929-20200627"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQzNDBhY2ZmZWZkNzQwYTRhMjZhOGQ4Yzc2NzBhOWNlL3RhYmxlcmFuZ2U6ZDM0MGFjZmZlZmQ3NDBhNGEyNmE4ZDhjNzY3MGE5Y2VfMy03LTEtMS0w_d278f5be-572c-44a9-b344-62473047efde"
      unitRef="number">0.0252</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="id56c8faa0e884b19a2eebe191531428a_I20210626"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQzNDBhY2ZmZWZkNzQwYTRhMjZhOGQ4Yzc2NzBhOWNlL3RhYmxlcmFuZ2U6ZDM0MGFjZmZlZmQ3NDBhNGEyNmE4ZDhjNzY3MGE5Y2VfNC0xLTEtMS0w_69b23baf-be89-4aff-911e-0c4c19d7e246"
      unitRef="number">0.0109</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="ic3a95a70aff44f249453fd1c435fc905_I20200627"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQzNDBhY2ZmZWZkNzQwYTRhMjZhOGQ4Yzc2NzBhOWNlL3RhYmxlcmFuZ2U6ZDM0MGFjZmZlZmQ3NDBhNGEyNmE4ZDhjNzY3MGE5Y2VfNC0zLTEtMS0w_2a3dd4b1-da32-4228-89c6-01b5d07cc0e8"
      unitRef="number">0.0155</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="id56c8faa0e884b19a2eebe191531428a_I20210626"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQzNDBhY2ZmZWZkNzQwYTRhMjZhOGQ4Yzc2NzBhOWNlL3RhYmxlcmFuZ2U6ZDM0MGFjZmZlZmQ3NDBhNGEyNmE4ZDhjNzY3MGE5Y2VfNC01LTEtMS0w_f03a4b49-d00d-43e3-b856-d742c319a4bb"
      unitRef="number">0.0109</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="ic3a95a70aff44f249453fd1c435fc905_I20200627"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQzNDBhY2ZmZWZkNzQwYTRhMjZhOGQ4Yzc2NzBhOWNlL3RhYmxlcmFuZ2U6ZDM0MGFjZmZlZmQ3NDBhNGEyNmE4ZDhjNzY3MGE5Y2VfNC03LTEtMS0w_6adaaa6e-763e-42e2-9cc0-598d292e4458"
      unitRef="number">0.0155</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:SeniorNotes
      contextRef="i4907eca3275146f2be21f4eb741ba4b0_I20200928"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMjI4Mg_80dda7ae-6f48-46a5-84d6-34135a900655"
      unitRef="usd">950000000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4907eca3275146f2be21f4eb741ba4b0_I20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMjMxOQ_0484746d-8282-4b11-a553-0140039fc48d"
      unitRef="number">0.03250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <holx:DebtInstrumentOfferingPricePercentOfFaceValue
      contextRef="i4907eca3275146f2be21f4eb741ba4b0_I20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMjM5NA_056d10d1-d7e7-4802-9d04-a4587d53d92c"
      unitRef="number">1</holx:DebtInstrumentOfferingPricePercentOfFaceValue>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6dadc087c8a44b1da848875eb301fdf0_I20210626"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMjU2NA_59e2f53b-7db2-45de-b763-340a2fd289ea"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="icb207831ddaa4d53943e75a7eb55d27d_I20201015"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfNjUwNQ_f6fda12e-719f-4759-b0e4-d883ef9ca28c"
      unitRef="usd">950000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="idcd52cb6d519499f96285824f70d71e3_D20201015-20201015"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMjcxMQ_7a5e3ece-5baf-415b-89af-07a7bcdaf37f"
      unitRef="usd">970800000</us-gaap:ExtinguishmentOfDebtAmount>
    <holx:DebtRedemptionPremiumPaid
      contextRef="idcd52cb6d519499f96285824f70d71e3_D20201015-20201015"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMjc0Mw_6bf98ab3-ea05-400f-ac45-b9997d63383f"
      unitRef="usd">20800000</holx:DebtRedemptionPremiumPaid>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i6dadc087c8a44b1da848875eb301fdf0_I20210626"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMjkxNg_6fd2f9a7-334d-4647-abe0-e5aa86437fb1"
      unitRef="usd">950000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i35ee10ac5818441fa558f668e84866f4_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMzQ4NA_d4ce094c-de2e-4ac1-b52c-0d0549c05191"
      unitRef="usd">21600000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i35ee10ac5818441fa558f668e84866f4_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMzg0Mw_ee8674e5-fcc2-456d-bd20-2f91fd8c42f0"
      unitRef="usd">5800000</us-gaap:InterestExpenseDebt>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i99efd783beac43bc87299f6deef20b60_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMzk0MA_d794aca4-3985-4391-baf8-622aaf795e12"
      unitRef="usd">7900000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i99efd783beac43bc87299f6deef20b60_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMzk2NA_e116d04c-61e6-4312-8514-d7c4fe5590cc"
      unitRef="usd">6400000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if5751d5d110e4560bd36bc872e1c4b0e_I20210626"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfNDE1Mw_e6efa623-1243-4cc7-a259-cae01cf12950"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ibfa1efc297734235ad6cd2cb7b00179e_I20210626"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfNDI1NA_72318e01-36a8-4223-9998-226b6ad2235b"
      unitRef="usd">400000000</us-gaap:DebtInstrumentFaceAmount>
    <holx:ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfNjQ5NA_d2b323f6-4d4d-4dbd-8ae6-9f9f2c7fe9a3">&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June 26, 2021, the Company had 2029 Senior Notes outstanding in the aggregate principal balance of $950&#160;million. The 2029 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2029 Senior Notes mature on February&#160;15, 2029 and bear interest at the rate of 3.250%&#160;per year, payable semi-annually on February&#160;15 and August&#160;15 of each year, commencing on February&#160;15, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may redeem the 2029 Senior Notes at any time prior to September 28, 2023 at a price equal to 100% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. The Company may also redeem up to 40% of the aggregate principal amount of the 2029 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before September 28, 2023, at a redemption price equal to 103.250% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. The Company also has the option to redeem the 2029 Senior Notes on or after: September 28, 2023 through September 27, 2024 at 101.625% of par; September 28, 2024 through September 27, 2025 at 100.813% of par; and September 28, 2025 and thereafter at 100% of par. In addition, if the Company undergoes a change of control coupled with a decline in ratings, as provided in the indenture, the Company will be required to make an offer to purchase each holder&#x2019;s 2029 Senior Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluated the 2029 Senior Notes for derivatives pursuant to ASC 815, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives and Hedging,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and did not identify any embedded derivatives that require bifurcation. All features were deemed to be clearly and closely related to the host instrument.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense for the 2029 Senior Notes, 2028 Senior Notes and 2025 Senior Notes was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:17pt;text-align:center;text-indent:24.75pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.503%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</holx:ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock>
    <us-gaap:SeniorNotes
      contextRef="ia37016a8326544bf8a213352899c6992_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfNDU3NA_be253faf-0e5d-4258-b127-24148dce2b11"
      unitRef="usd">950000000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia37016a8326544bf8a213352899c6992_I20210626"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfNDgyMA_92915cb3-fff4-4c97-8f5a-62c8498513ec"
      unitRef="number">0.03250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i272408a201f84cd288d1a786c8851839_D20200928-20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfNTAzNw_3fea4054-2a60-4cd4-be72-a1c958ecdf68"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i58a7d1a68082480f9d9f002f635ba871_D20200928-20200928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfNTIzOQ_eeb9151f-6379-46d9-80f3-93573c46a005"
      unitRef="number">0.40</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i1fbee7ea3857414fa862793ac5e38693_D20200928-20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfNTQ0OA_b04808d5-a796-42e1-b91a-859c3cf1faf4"
      unitRef="number">1.03250</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i9b55461839564a798b7bb1fc48436aca_D20200928-20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfNTY5MA_b1b8b1ac-8563-482a-9a20-be51e167009b"
      unitRef="number">1.01625</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i258e1d37987f4730b42e74f9f49dd3b4_D20200928-20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfNTc1MA_80b33dce-2d0f-48f7-9a4a-a4b0b5af6d3e"
      unitRef="number">1.00813</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i7f78f01fcb324006bd1e7e387d41e29e_D20200928-20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfNTgwMg_5f92c525-ec25-4565-aece-8cc128ab739a"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i329f003f9cc04450b29fe980f0e42689_D20200928-20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfNjA0Ng_f00fbb36-0bd4-4cff-a313-e72e7db15bd3"
      unitRef="number">1.01</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6dadc087c8a44b1da848875eb301fdf0_I20210626"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfMy0xLTEtMS0w_f242c0b8-f448-4778-b68d-f0bad62451ca"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:InterestExpenseBorrowings
      contextRef="ie522d6c7b67b40d19313f779c8b07346_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfMy0zLTEtMS0w_7cb3f9c3-17c3-4879-bed9-6d0a9a86907f"
      unitRef="usd">0</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i7d1ba28aff8c4b5eb47bf61baea22a44_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfMy01LTEtMS0w_c8de5b91-313c-4836-babe-dca61501fb25"
      unitRef="usd">10900000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i2247e22bbae24374988ac11163883a5c_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfMy03LTEtMS0w_f27db88f-6aa3-4573-8107-47c4c0a391ac"
      unitRef="usd">0</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i8698881588e046c79a6a901616722216_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfMy05LTEtMS0w_7a60b88c-775b-45a4-85f3-1f2245aec583"
      unitRef="usd">32700000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if5751d5d110e4560bd36bc872e1c4b0e_I20210626"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfNC0xLTEtMS0w_4b0bd42e-6522-4fd6-a8f3-7d7f79f26659"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:InterestExpenseBorrowings
      contextRef="if54bade04c4249debfc877171a9be8f7_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfNC0zLTEtMS0w_568d60a0-80b5-47bf-8b4b-935fc440d2b2"
      unitRef="usd">4800000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="iaeeaee82866e48a589b1b33acc7cf61a_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfNC01LTEtMS0w_11ce1f0b-fc29-4660-aa91-e17892155409"
      unitRef="usd">4800000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="id87e5e40d00a4f109965253aef07499a_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfNC03LTEtMS0w_6e032e01-f5e3-4aeb-9e5d-87730b97acaf"
      unitRef="usd">14400000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i7f75b26e46cf4818a4e3b058a04c9785_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfNC05LTEtMS0w_c4a6010f-8232-44c8-8724-d202ed7a3b49"
      unitRef="usd">14400000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia37016a8326544bf8a213352899c6992_I20210626"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfNS0xLTEtMS0w_f2bbedae-6c39-41b8-9fa1-47adae5a0e28"
      unitRef="number">0.03250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i6e93a00f39ec434891148097002f9117_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfNS0zLTEtMS0w_d9e4c66f-f17c-4009-a492-c6150657539e"
      unitRef="usd">8200000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="ice0bd1095b304c78a2f49ad45c325064_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfNS01LTEtMS0w_4b05c5a5-b635-4d5c-b893-abb34df2aee4"
      unitRef="usd">0</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i866deb20efa24ed4b2313072a748ba62_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfNS03LTEtMS0w_db1975ec-7f0e-4dd8-90f0-d4153d9e5c53"
      unitRef="usd">24500000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i683d2ded0a1c4448856d8951affc8993_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfNS05LTEtMS0w_82945d49-8a92-4544-b7ca-45668f12323b"
      unitRef="usd">0</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfNi0zLTEtMS0w_09d7a0fd-893e-4a5a-9352-61ec76292456"
      unitRef="usd">13000000.0</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfNi01LTEtMS0w_e6dbf3b2-1681-4fd9-b55a-63cdb8b3975b"
      unitRef="usd">15700000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfNi03LTEtMS0w_9435b2ca-a3d8-4c3c-9044-6513bc45b95d"
      unitRef="usd">38900000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RhYmxlOmQwZTJmNjAzZmQ5NjQ5MzY5YmNlYmI0YTc4NjI0MTZhL3RhYmxlcmFuZ2U6ZDBlMmY2MDNmZDk2NDkzNjliY2ViYjRhNzg2MjQxNmFfNi05LTEtMS0w_c56accb9-71a3-488c-a6c4-0584d4c4652d"
      unitRef="usd">47100000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:RepaymentsOfDebt
      contextRef="i51b89923ffd8491d8c6ac3b49ee1985b_D20210326-20210326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMTA5OTUxMTY0ODYyNQ_02330f6e-2d9c-4ef4-b3d4-dc7e727d2a94"
      unitRef="usd">250000000.0</us-gaap:RepaymentsOfDebt>
    <holx:MaximumBorrowingUnderAssetSecuritizationAgreement
      contextRef="i799dc9d3fd134b658546a8859e0bb7ae_I20210611"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMTA5OTUxMTY0ODYwOQ_2e4cdc95-32c5-4591-bd50-38ede911fb78"
      unitRef="usd">320000000.0</holx:MaximumBorrowingUnderAssetSecuritizationAgreement>
    <us-gaap:LongTermDebtCurrent
      contextRef="i5ff6e83c3f4f43a292e67915ac446908_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMTA5OTUxMTY0ODU5Mw_916e363d-30ad-43ee-97f8-bee350e66f84"
      unitRef="usd">320000000.0</us-gaap:LongTermDebtCurrent>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="i5ff6e83c3f4f43a292e67915ac446908_I20210626"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMTI2NDQzODM3NDY0NDQ_2cf15a27-d40f-421a-bc98-48956a71b8fb"
      unitRef="number">0.0078</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i50f502634b964d3ca840a4e7ff046d9d_I20210617"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMTI2NDQzODM3NDY0NTE_2daaf552-1a14-458d-aab1-ea8248816da3"
      unitRef="number">0.060</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9d26208b685b4dc0a4c5422ac184fb3b_I20210617"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF81OC9mcmFnOjFhOTQyZjBlYzQzOTQ4Yjc5MDBhYjZhZWUxZGY5NWE2L3RleHRyZWdpb246MWE5NDJmMGVjNDM5NDhiNzkwMGFiNmFlZTFkZjk1YTZfMTI2NDQzODM3NDY0NTc_9fea5e37-3e32-45a5-8b7f-960c7bfe8b77"
      unitRef="number">0.070</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82MS9mcmFnOjAxZjlmNmM4ZjZiYjRhNzg5N2QwNWE5ODI3YzE3NDQ2L3RleHRyZWdpb246MDFmOWY2YzhmNmJiNGE3ODk3ZDA1YTk4MjdjMTc0NDZfMTgzOQ_70ad0325-fdae-4437-9691-0474d4249cbd">Trade Receivables and Allowance for Credit Losses&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Effective September 27, 2020, the Company adopted Topic 326, which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The expected credit losses are developed using an estimated loss rate method that considers historical collection experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The estimated loss rates are applied to trade receivables with similar risk characteristics such as the length of time the balance has been outstanding and the location of the customer. In certain instances, the Company may identify individual trade receivable assets that do not share risk characteristics with other trade receivables, in which case the Company records its expected credit losses on an individual asset basis. For example, potential adverse changes to customer liquidity from new macroeconomic events, such as the COVID-19 pandemic, must be taken into consideration. To date, the Company has not experienced significant customer payment defaults, or identified other significant collectability concerns as a result of the pandemic. In connection with assessing credit losses for individual trade receivable assets, the Company considers significant factors relevant to collectability including those specific to the customer such as bankruptcy, length of time an account is outstanding, and the liquidity and financial position of the customer. If a trade receivable asset is evaluated on an individual basis, the Company excludes those assets from the portfolios of trade receivables evaluated on a collective basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a rollforward of the allowance for credit losses as of June 26, 2021 compared to June 27, 2020:&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.662%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;Beginning&lt;br/&gt;of Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Credit Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Divested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Write-&lt;br/&gt;offs and&lt;br/&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;End of&lt;br/&gt;Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82MS9mcmFnOjAxZjlmNmM4ZjZiYjRhNzg5N2QwNWE5ODI3YzE3NDQ2L3RleHRyZWdpb246MDFmOWY2YzhmNmJiNGE3ODk3ZDA1YTk4MjdjMTc0NDZfMTg0MA_59da240e-6a36-4852-8335-1985d167deb5">The following is a rollforward of the allowance for credit losses as of June 26, 2021 compared to June 27, 2020:</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82MS9mcmFnOjAxZjlmNmM4ZjZiYjRhNzg5N2QwNWE5ODI3YzE3NDQ2L3RhYmxlOjAyNGRlNGEwODE2NjQ1MWI5YWMxMzBlMzI4YzZkMTgwL3RhYmxlcmFuZ2U6MDI0ZGU0YTA4MTY2NDUxYjlhYzEzMGUzMjhjNmQxODBfMi0yLTEtMS0w_1c594bb4-c898-4de2-a12b-3896796d803a"
      unitRef="usd">31600000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82MS9mcmFnOjAxZjlmNmM4ZjZiYjRhNzg5N2QwNWE5ODI3YzE3NDQ2L3RhYmxlOjAyNGRlNGEwODE2NjQ1MWI5YWMxMzBlMzI4YzZkMTgwL3RhYmxlcmFuZ2U6MDI0ZGU0YTA4MTY2NDUxYjlhYzEzMGUzMjhjNmQxODBfMi00LTEtMS0w_bddd5a2d-9d87-4c1e-b4d9-2c4d24793b70"
      unitRef="usd">11600000</us-gaap:ProvisionForDoubtfulAccounts>
    <holx:AccountsReceivableAllowanceForCreditLossTransfers
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82MS9mcmFnOjAxZjlmNmM4ZjZiYjRhNzg5N2QwNWE5ODI3YzE3NDQ2L3RhYmxlOjAyNGRlNGEwODE2NjQ1MWI5YWMxMzBlMzI4YzZkMTgwL3RhYmxlcmFuZ2U6MDI0ZGU0YTA4MTY2NDUxYjlhYzEzMGUzMjhjNmQxODBfMi02LTEtMS0w_1ba36a3e-4000-44da-8653-5cd3463b58be"
      unitRef="usd">0</holx:AccountsReceivableAllowanceForCreditLossTransfers>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82MS9mcmFnOjAxZjlmNmM4ZjZiYjRhNzg5N2QwNWE5ODI3YzE3NDQ2L3RhYmxlOjAyNGRlNGEwODE2NjQ1MWI5YWMxMzBlMzI4YzZkMTgwL3RhYmxlcmFuZ2U6MDI0ZGU0YTA4MTY2NDUxYjlhYzEzMGUzMjhjNmQxODBfMi04LTEtMS0w_e3d63614-95e3-42d4-84f1-6083df57e754"
      unitRef="usd">3400000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82MS9mcmFnOjAxZjlmNmM4ZjZiYjRhNzg5N2QwNWE5ODI3YzE3NDQ2L3RhYmxlOjAyNGRlNGEwODE2NjQ1MWI5YWMxMzBlMzI4YzZkMTgwL3RhYmxlcmFuZ2U6MDI0ZGU0YTA4MTY2NDUxYjlhYzEzMGUzMjhjNmQxODBfMi0xMC0xLTEtMA_9d481f7c-7f5a-45d2-aa97-2601e8283832"
      unitRef="usd">39800000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ia1bbf9311cb649308affbf16f61bb3ff_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82MS9mcmFnOjAxZjlmNmM4ZjZiYjRhNzg5N2QwNWE5ODI3YzE3NDQ2L3RhYmxlOjAyNGRlNGEwODE2NjQ1MWI5YWMxMzBlMzI4YzZkMTgwL3RhYmxlcmFuZ2U6MDI0ZGU0YTA4MTY2NDUxYjlhYzEzMGUzMjhjNmQxODBfMy0yLTEtMS0w_7dac5462-841b-48bc-9048-b122120b9044"
      unitRef="usd">17800000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82MS9mcmFnOjAxZjlmNmM4ZjZiYjRhNzg5N2QwNWE5ODI3YzE3NDQ2L3RhYmxlOjAyNGRlNGEwODE2NjQ1MWI5YWMxMzBlMzI4YzZkMTgwL3RhYmxlcmFuZ2U6MDI0ZGU0YTA4MTY2NDUxYjlhYzEzMGUzMjhjNmQxODBfMy00LTEtMS0w_778d6230-0146-45a6-be1d-8a17f7ff207a"
      unitRef="usd">19100000</us-gaap:ProvisionForDoubtfulAccounts>
    <holx:AccountsReceivableAllowanceForCreditLossTransfers
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82MS9mcmFnOjAxZjlmNmM4ZjZiYjRhNzg5N2QwNWE5ODI3YzE3NDQ2L3RhYmxlOjAyNGRlNGEwODE2NjQ1MWI5YWMxMzBlMzI4YzZkMTgwL3RhYmxlcmFuZ2U6MDI0ZGU0YTA4MTY2NDUxYjlhYzEzMGUzMjhjNmQxODBfMy02LTEtMS0w_6c8a76e6-881d-4bfc-814f-b3c0871f0e01"
      unitRef="usd">5800000</holx:AccountsReceivableAllowanceForCreditLossTransfers>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82MS9mcmFnOjAxZjlmNmM4ZjZiYjRhNzg5N2QwNWE5ODI3YzE3NDQ2L3RhYmxlOjAyNGRlNGEwODE2NjQ1MWI5YWMxMzBlMzI4YzZkMTgwL3RhYmxlcmFuZ2U6MDI0ZGU0YTA4MTY2NDUxYjlhYzEzMGUzMjhjNmQxODBfMy04LTEtMS0w_e7cbcecc-76a0-4688-a1b4-7ec85cf02191"
      unitRef="usd">3900000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i81ab5863e2124accb342d2df86a1ee96_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82MS9mcmFnOjAxZjlmNmM4ZjZiYjRhNzg5N2QwNWE5ODI3YzE3NDQ2L3RhYmxlOjAyNGRlNGEwODE2NjQ1MWI5YWMxMzBlMzI4YzZkMTgwL3RhYmxlcmFuZ2U6MDI0ZGU0YTA4MTY2NDUxYjlhYzEzMGUzMjhjNmQxODBfMy0xMC0xLTEtMA_455ae26b-854f-4c85-bab8-490e5c45d220"
      unitRef="usd">27200000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:DerivativesAndFairValueTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RleHRyZWdpb246NDBhMWQ0MDcyNTNlNGYyMDhiZGQxMzVlYWNkYzUxZDVfNTg5MA_e8d857a7-8eb9-4233-9bfe-79910b1b8e04">Derivatives&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Cap - Cash Flow Hedge&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages its exposure to some of its interest rate risk through the use of interest rate caps, which are derivative financial instruments. The Company does not use derivatives for speculative purposes. For a derivative that is designated as a cash flow hedge, changes in the fair value of the derivative are recognized in accumulated other comprehensive income ("AOCI") to the extent the derivative is effective at offsetting the changes in the cash flows being hedged until the hedged item affects earnings. To the extent there is any hedge ineffectiveness, changes in fair value relating to the ineffective portion are immediately recognized in earnings in other income (expense), net in the Consolidated Statements of Income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2018, the Company entered into separate interest rate cap agreements with multiple counter-parties to mitigate the interest rate volatility associated with the variable interest rate on amounts borrowed under the term loan feature of its credit facilities (see Note 7). Interest rate cap agreements provide the right to receive cash if the reference interest rate rises above a contractual rate. The aggregate premium paid for these interest rate cap agreements was $3.7 million, which was the initial fair value of the instruments recorded in the Company's financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal 2019, the Company entered into additional separate interest rate cap agreements with multiple counter-parties to extend the expiration date of its hedges by an additional year. The aggregate premium paid for these interest cap agreements was $1.5 million, which was the initial fair value of the instruments recorded in the Company&#x2019;s financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The critical terms of the interest rate caps were designed to mirror the terms of the Company&#x2019;s LIBOR-based borrowings under its Credit Agreement, that has been amended multiple times, and therefore are highly effective at offsetting the cash flows being hedged. The Company designated these derivatives as cash flow hedges of the variability of the LIBOR-based interest payments on $1.0 billion of principal, which ended on December 27, 2019 (the first quarter of fiscal 2020) for the contracts entered into in fiscal 2018, and on December 23, 2020 (the first quarter of fiscal 2021) for the interest rate cap agreements entered into in fiscal 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The interest rate cap agreements matured as of December 26, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Swap - Cash Flow Hedge&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In fiscal 2019, in order to hedge a portion of its variable rate debt beyond the contracted period under interest cap agreements, the Company entered into an interest rate swap contract with an effective date of December 23, 2020 and a termination date of December 17, 2023. The notional amount of this swap is $1.0 billion. The interest rate swap effectively fixes the LIBOR component of the variable interest rate on $1.0 billion of the notional amount under the 2018 Credit Agreement at 1.23%. The critical terms of the interest rate swap are designed to mirror the terms of the Company&#x2019;s LIBOR-based borrowings under its credit agreement and therefore are highly effective at offsetting the cash flows being hedged. The Company designated this derivative as a cash flow hedge of the variability of the LIBOR-based interest payments on $1.0 billion of principal. Therefore, changes in the fair value of the swap are recorded in AOCI. The fair value of this derivative was in a liability position of $21.0 million as of June&#160;26, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Forward Foreign Currency Contracts and Foreign Currency Option Contracts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company enters into forward foreign currency exchange contracts and foreign currency option contracts to mitigate a portion of its cash balances and certain operational exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company's cash and operations that are denominated in currencies other than the U.S. dollar, primarily the Euro, the UK Pound, the Australian dollar, the Canadian dollar, the Chinese Yuan and the Japanese Yen. These foreign currency exchange contracts are entered into to support transactions made in the ordinary course of business and are not speculative in nature. The contracts are generally for periods of one year or less. The Company did not elect hedge accounting for these contracts; however, the Company may seek to apply hedge accounting in future scenarios. The change in the fair value of these contracts is recognized directly in earnings as a component of other income (expense), net. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Realized and unrealized gains and losses from these contracts, which were the only derivative contracts not designated for hedge accounting, for the three and nine months ended June 26, 2021 and June 27, 2020, respectively, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:center;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of realized gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of unrealized gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;26, 2021, the Company had outstanding forward foreign currency contracts that were not designated for hedge accounting and were used to hedge fluctuations in the U.S. dollar of certain of our cash balances denominated in the Euro and UK pound, as well as forecasted transactions denominated in the Euro, UK pound, Australian Dollar, Canadian Dollar, Chinese Yuan and Japanese Yen with an aggregate notional amount of $253.8&#160;million. As of June&#160;26, 2021, the Company had outstanding foreign currency option contracts that were not designated for hedge accounting and were used to hedge fluctuations in the U.S. dollar of forecasted transactions denominated in the Euro and UK Pound with a notional amount of $65.0 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial Instrument Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of June&#160;26, 2021: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt;text-indent:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments designated as a cash flow hedge:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:13pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate caps and interest rate swap for the following reporting periods:&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount of gain (loss) recognized in other comprehensive income, net of taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DerivativesAndFairValueTextBlock>
    <holx:InterestRateCapAgreementsAggregatePremiumPayable
      contextRef="i04634b19698943588e231edf3a1fa51a_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RleHRyZWdpb246NDBhMWQ0MDcyNTNlNGYyMDhiZGQxMzVlYWNkYzUxZDVfMTM4NA_d6e76e57-ceda-4088-abb8-c1c80e480e5a"
      unitRef="usd">3700000</holx:InterestRateCapAgreementsAggregatePremiumPayable>
    <holx:InterestRateCapAgreementsAggregatePremiumPayable
      contextRef="i1965b6dfa45f42e1a36b9b6f6c6d19d2_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RleHRyZWdpb246NDBhMWQ0MDcyNTNlNGYyMDhiZGQxMzVlYWNkYzUxZDVfMTc0NQ_2a4abe12-fa7f-4082-9ee5-6209889f89f4"
      unitRef="usd">1500000</holx:InterestRateCapAgreementsAggregatePremiumPayable>
    <holx:PrincipalAmountOfBorrowings
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RleHRyZWdpb246NDBhMWQ0MDcyNTNlNGYyMDhiZGQxMzVlYWNkYzUxZDVfMjIzMw_2b097873-1a1a-472d-9ea3-ad0a2bb1bac6"
      unitRef="usd">1000000000.0</holx:PrincipalAmountOfBorrowings>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic2fab027ef184f10a81089fce6835a3e_I20190928"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RleHRyZWdpb246NDBhMWQ0MDcyNTNlNGYyMDhiZGQxMzVlYWNkYzUxZDVfMjgzNQ_7289618a-3a07-4d6e-8a70-2f5ef95bd342"
      unitRef="usd">1000000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic2fab027ef184f10a81089fce6835a3e_I20190928"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RleHRyZWdpb246NDBhMWQ0MDcyNTNlNGYyMDhiZGQxMzVlYWNkYzUxZDVfMjkzMw_cd707f95-d6be-4829-9308-7fc94d67e8a5"
      unitRef="usd">1000000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeVariableInterestRate
      contextRef="ic2fab027ef184f10a81089fce6835a3e_I20190928"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RleHRyZWdpb246NDBhMWQ0MDcyNTNlNGYyMDhiZGQxMzVlYWNkYzUxZDVfMjk5NA_71b66e75-5b48-4dc8-87d6-4decf89bfd93"
      unitRef="number">0.0123</us-gaap:DerivativeVariableInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ic2fab027ef184f10a81089fce6835a3e_I20190928"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RleHRyZWdpb246NDBhMWQ0MDcyNTNlNGYyMDhiZGQxMzVlYWNkYzUxZDVfMzM0MA_26383b0e-bd20-4187-be9a-d44e9a42bf75"
      unitRef="usd">1000000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i2cfbe0dfa54a401c9663f0101346df6a_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RleHRyZWdpb246NDBhMWQ0MDcyNTNlNGYyMDhiZGQxMzVlYWNkYzUxZDVfMzQ5Mw_24801a38-8903-4a81-85de-5dda592f0e59"
      unitRef="usd">21000000.0</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RleHRyZWdpb246NDBhMWQ0MDcyNTNlNGYyMDhiZGQxMzVlYWNkYzUxZDVfNTg4MQ_a37e2a29-df32-4139-bbbc-20543afe1d0b">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.063%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.689%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;June 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of realized gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of unrealized gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i53fb7ba0b756458fae9440481e4b1c22_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfMy0xLTEtMS0w_a38c3d1e-9170-4d66-ad55-731e85590366"
      unitRef="usd">-7000000.0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ib59ed9e2e7fe4b71b57f28d948814de5_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfMy0zLTEtMS0w_5fcd222c-b6ba-4d0b-9064-96097cf539a8"
      unitRef="usd">500000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ic1ec4ff7f312462e92283befc2b78645_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfMy01LTEtMS0w_a242642f-e0b5-4116-a1a5-b9f9969f45e9"
      unitRef="usd">-6500000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ic77447b8b8db4b3697eaad437ad6372d_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfMy03LTEtMS0w_03421c46-17aa-405b-9af8-bbf98e1d9c70"
      unitRef="usd">600000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i23614fef663042c1aef8cb0f986983b3_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfNC0xLTEtMS0w_19400763-f783-451c-bed5-836c116bb09a"
      unitRef="usd">-1400000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i52de0b3b7ed043329021533a23fc5c50_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfNC0zLTEtMS0w_a37b104a-d374-4e6e-8905-1996864af2e0"
      unitRef="usd">-500000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i9b050d1edde04dccb1a376a9d0b26d1f_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfNC01LTEtMS0w_c3271bd6-39ce-41a1-b92a-8502b5aa25c2"
      unitRef="usd">-4400000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i1b53a2d42b634620b3416e3dd2c3f7fd_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfNC03LTEtMS0w_9c781348-d0be-4126-b512-1459945d635a"
      unitRef="usd">-1300000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i02decbf01d7d47ad8413a646bb6b58c6_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfNS0xLTEtMS0w_923b6487-467c-4fcb-90ac-e37a1456c364"
      unitRef="usd">-8400000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ifd2ee8ee3be840b8b6afa6175fefbb69_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfNS0zLTEtMS0w_8e51ea97-d369-4ec6-bc90-c9f925373e99"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="icee5b045a830452083febd09cec762d0_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfNS01LTEtMS0w_61e37496-9008-478e-87a9-ab215056ab3e"
      unitRef="usd">-10900000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i41d042b1583d4cb0a63cc089c4cd48d0_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfNS03LTEtMS0w_71611153-5b48-4fdf-b566-6ca3654afeb4"
      unitRef="usd">-700000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i53fb7ba0b756458fae9440481e4b1c22_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfNy0xLTEtMS0w_b37cc9f3-a61d-4aaa-a184-b43256d67c73"
      unitRef="usd">1500000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="ib59ed9e2e7fe4b71b57f28d948814de5_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfNy0zLTEtMS0w_7eb0d558-cbac-429d-9728-39132116e252"
      unitRef="usd">-1800000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="ic1ec4ff7f312462e92283befc2b78645_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfNy01LTEtMS0w_f7ee34fe-0cdb-4cc1-b46b-a4ed3a675189"
      unitRef="usd">-2000000.0</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="ic77447b8b8db4b3697eaad437ad6372d_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfNy03LTEtMS0w_4d97d9a8-7a9c-4437-a118-1d56988efbea"
      unitRef="usd">-600000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i23614fef663042c1aef8cb0f986983b3_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfOC0xLTEtMS0w_f448fac5-c436-4b5d-9614-df69abdcfdec"
      unitRef="usd">400000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i52de0b3b7ed043329021533a23fc5c50_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfOC0zLTEtMS0w_c0cbdde3-bea2-44b3-9ae0-446d1d8b238f"
      unitRef="usd">-200000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i9b050d1edde04dccb1a376a9d0b26d1f_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfOC01LTEtMS0w_02703afb-db67-42a0-a293-64ec11482bbf"
      unitRef="usd">-5500000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i1b53a2d42b634620b3416e3dd2c3f7fd_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfOC03LTEtMS0w_4088afbb-b4b5-4313-b8bd-b96772748ede"
      unitRef="usd">-500000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i02decbf01d7d47ad8413a646bb6b58c6_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfOS0xLTEtMS0w_32143e39-bbeb-4f2f-b223-4814bbd1e289"
      unitRef="usd">1900000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="ifd2ee8ee3be840b8b6afa6175fefbb69_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfOS0zLTEtMS0w_614addb5-5678-4d62-9d9f-ca92bff651ec"
      unitRef="usd">-2000000.0</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="icee5b045a830452083febd09cec762d0_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfOS01LTEtMS0w_17f26cd4-986b-48e7-9101-710d7c081c59"
      unitRef="usd">-7500000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i41d042b1583d4cb0a63cc089c4cd48d0_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfOS03LTEtMS0w_4bf6eb13-ecd3-4003-9e68-43f22a302320"
      unitRef="usd">-1100000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfMTEtMS0xLTEtMA_44e8d427-4a7c-4bbd-b46b-47810caf3981"
      unitRef="usd">-6500000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfMTEtMy0xLTEtMA_58f55289-2177-4fc7-b340-b11dd3e1b4ae"
      unitRef="usd">-2000000.0</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfMTEtNS0xLTEtMA_3839c8cd-0fec-4591-832a-53d397a3d16d"
      unitRef="usd">-18400000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOmQ5MTQwMTg1YTI0YTRiN2E5NWYyNDlkNjE3MTY2ZTBhL3RhYmxlcmFuZ2U6ZDkxNDAxODVhMjRhNGI3YTk1ZjI0OWQ2MTcxNjZlMGFfMTEtNy0xLTEtMA_00f4c6cc-83b9-41e5-8aa7-143400e742c6"
      unitRef="usd">-1800000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <holx:NotationalAmount
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RleHRyZWdpb246NDBhMWQ0MDcyNTNlNGYyMDhiZGQxMzVlYWNkYzUxZDVfNTIzNQ_4174a764-ed43-4bae-b35e-6b2452a4cf0c"
      unitRef="usd">253800000</holx:NotationalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8538addfef6040808efa59ad875c5c67_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RleHRyZWdpb246NDBhMWQ0MDcyNTNlNGYyMDhiZGQxMzVlYWNkYzUxZDVfNTUwMg_3f402662-220c-4cf4-a40c-b0cc04ad8d8e"
      unitRef="usd">65000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RleHRyZWdpb246NDBhMWQ0MDcyNTNlNGYyMDhiZGQxMzVlYWNkYzUxZDVfNTg2OQ_6d8a8f20-1e8f-41c7-8b18-97cd0658acfa">&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of June&#160;26, 2021: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:11pt;text-indent:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments designated as a cash flow hedge:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i18ac8b8a2f674e00a863ad723f51cfd6_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjhhODcyNjk0NGVlMTQ0MzQ4NjE5ZjZlZWJlYzdkY2Q3L3RhYmxlcmFuZ2U6OGE4NzI2OTQ0ZWUxNDQzNDg2MTlmNmVlYmVjN2RjZDdfOS0zLTEtMS0w_58b33cdd-daa1-4c48-a7b3-a72d824865d2"
      unitRef="usd">0</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i8385c3be2e32406d80f1e6926ed63258_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjhhODcyNjk0NGVlMTQ0MzQ4NjE5ZjZlZWJlYzdkY2Q3L3RhYmxlcmFuZ2U6OGE4NzI2OTQ0ZWUxNDQzNDg2MTlmNmVlYmVjN2RjZDdfOS01LTEtMS0w_164b439b-1a2e-41a2-8112-706dc1a4e934"
      unitRef="usd">1100000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i4ba1880cecac4f61867704cf61543765_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjhhODcyNjk0NGVlMTQ0MzQ4NjE5ZjZlZWJlYzdkY2Q3L3RhYmxlcmFuZ2U6OGE4NzI2OTQ0ZWUxNDQzNDg2MTlmNmVlYmVjN2RjZDdfMTAtMy0xLTEtMA_db410383-e136-4c03-9440-4cd25ac622cc"
      unitRef="usd">100000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="if95c5e17cb0246e28396e701eba8a8b6_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjhhODcyNjk0NGVlMTQ0MzQ4NjE5ZjZlZWJlYzdkY2Q3L3RhYmxlcmFuZ2U6OGE4NzI2OTQ0ZWUxNDQzNDg2MTlmNmVlYmVjN2RjZDdfMTAtNS0xLTEtMA_609f568b-c772-4bc6-990f-38420c02428c"
      unitRef="usd">10100000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i5816cff90a9247a296c2e48045af6f9b_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjhhODcyNjk0NGVlMTQ0MzQ4NjE5ZjZlZWJlYzdkY2Q3L3RhYmxlcmFuZ2U6OGE4NzI2OTQ0ZWUxNDQzNDg2MTlmNmVlYmVjN2RjZDdfMTEtMy0xLTEtMA_817ac381-e9aa-4822-b702-bc8fc5d1ec7d"
      unitRef="usd">100000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i1aa79e6d2f224939b78d3422b131e66e_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjhhODcyNjk0NGVlMTQ0MzQ4NjE5ZjZlZWJlYzdkY2Q3L3RhYmxlcmFuZ2U6OGE4NzI2OTQ0ZWUxNDQzNDg2MTlmNmVlYmVjN2RjZDdfMTEtNS0xLTEtMA_12baaaee-15fa-40cf-870b-a780a2990c9a"
      unitRef="usd">11200000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="ied7c65430e934024b713ad4d1d12d274_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjhhODcyNjk0NGVlMTQ0MzQ4NjE5ZjZlZWJlYzdkY2Q3L3RhYmxlcmFuZ2U6OGE4NzI2OTQ0ZWUxNDQzNDg2MTlmNmVlYmVjN2RjZDdfMTUtMy0xLTEtMA_be2c1410-a6b9-4086-8709-749a310e6d7a"
      unitRef="usd">11100000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="ifc35c56bdabd41c5a37c1ec58d24f4f5_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjhhODcyNjk0NGVlMTQ0MzQ4NjE5ZjZlZWJlYzdkY2Q3L3RhYmxlcmFuZ2U6OGE4NzI2OTQ0ZWUxNDQzNDg2MTlmNmVlYmVjN2RjZDdfMTUtNS0xLTEtMA_54fa0540-270a-459c-a2f7-663359697344"
      unitRef="usd">8200000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="icd682c98bcc54a639ecf216a7a2959ac_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjhhODcyNjk0NGVlMTQ0MzQ4NjE5ZjZlZWJlYzdkY2Q3L3RhYmxlcmFuZ2U6OGE4NzI2OTQ0ZWUxNDQzNDg2MTlmNmVlYmVjN2RjZDdfMTYtMy0xLTEtMA_335797ea-887a-48ac-8051-487c16233def"
      unitRef="usd">9900000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="ic10b5e7bddbb4679b081afb2b91bfb10_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjhhODcyNjk0NGVlMTQ0MzQ4NjE5ZjZlZWJlYzdkY2Q3L3RhYmxlcmFuZ2U6OGE4NzI2OTQ0ZWUxNDQzNDg2MTlmNmVlYmVjN2RjZDdfMTYtNS0xLTEtMA_8a383165-af78-4096-9118-d7f0c4585877"
      unitRef="usd">23000000.0</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:DerivativeLiabilities
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjhhODcyNjk0NGVlMTQ0MzQ4NjE5ZjZlZWJlYzdkY2Q3L3RhYmxlcmFuZ2U6OGE4NzI2OTQ0ZWUxNDQzNDg2MTlmNmVlYmVjN2RjZDdfMTctMy0xLTEtMA_26e2a606-8001-4cdf-9c04-1f07f2e370f9"
      unitRef="usd">21000000.0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjhhODcyNjk0NGVlMTQ0MzQ4NjE5ZjZlZWJlYzdkY2Q3L3RhYmxlcmFuZ2U6OGE4NzI2OTQ0ZWUxNDQzNDg2MTlmNmVlYmVjN2RjZDdfMTctNS0xLTEtMA_5b400ea5-7978-453f-aa9d-ab0c3940a1f5"
      unitRef="usd">31200000</us-gaap:DerivativeLiabilities>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i8f76a7b44a7f4089bbc36c650997a1cf_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjhhODcyNjk0NGVlMTQ0MzQ4NjE5ZjZlZWJlYzdkY2Q3L3RhYmxlcmFuZ2U6OGE4NzI2OTQ0ZWUxNDQzNDg2MTlmNmVlYmVjN2RjZDdfMTktMy0xLTEtMA_41f265e9-8b1a-45f0-82dc-779a37b6c2a2"
      unitRef="usd">1700000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i6fe6078ee0384409bc3ef5dd79db3bdd_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjhhODcyNjk0NGVlMTQ0MzQ4NjE5ZjZlZWJlYzdkY2Q3L3RhYmxlcmFuZ2U6OGE4NzI2OTQ0ZWUxNDQzNDg2MTlmNmVlYmVjN2RjZDdfMTktNS0xLTEtMA_c1a1b08d-ac17-4d27-b42a-3405eb57dfe0"
      unitRef="usd">0</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RleHRyZWdpb246NDBhMWQ0MDcyNTNlNGYyMDhiZGQxMzVlYWNkYzUxZDVfNTg3Ng_d136a2a2-3c9b-4f4a-9d3f-ad9e5818211f">The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate caps and interest rate swap for the following reporting periods:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.577%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount of gain (loss) recognized in other comprehensive income, net of taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i4e9af5310502412a90c2f809682d972d_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjJhMTgyZWI4ZWQ4MjRjOTc5NTE0MTc0YjAyZmJkNjIwL3RhYmxlcmFuZ2U6MmExODJlYjhlZDgyNGM5Nzk1MTQxNzRiMDJmYmQ2MjBfMy0xLTEtMS0w_f951af9d-0593-4f2e-b30f-de674070cb28"
      unitRef="usd">3000000.0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i03f4085d035d44bdb57e7576c9d82462_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjJhMTgyZWI4ZWQ4MjRjOTc5NTE0MTc0YjAyZmJkNjIwL3RhYmxlcmFuZ2U6MmExODJlYjhlZDgyNGM5Nzk1MTQxNzRiMDJmYmQ2MjBfMy0zLTEtMS0w_9e3050f9-ca9e-4ce0-ac5c-857473f4e346"
      unitRef="usd">-4600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i00326496b5524aacb14a40d333ddb070_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjJhMTgyZWI4ZWQ4MjRjOTc5NTE0MTc0YjAyZmJkNjIwL3RhYmxlcmFuZ2U6MmExODJlYjhlZDgyNGM5Nzk1MTQxNzRiMDJmYmQ2MjBfMy01LTEtMS0w_3de039c7-38c4-493c-9288-54bd37956539"
      unitRef="usd">8200000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="id8706ab009f34acbab9f1c8ba66a6842_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjJhMTgyZWI4ZWQ4MjRjOTc5NTE0MTc0YjAyZmJkNjIwL3RhYmxlcmFuZ2U6MmExODJlYjhlZDgyNGM5Nzk1MTQxNzRiMDJmYmQ2MjBfMy03LTEtMS0w_96e0d39b-d8b4-43bd-9330-5de68a7c4bd3"
      unitRef="usd">-25400000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="ieab668871ebf4bef88a6c7d0534148b3_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjJhMTgyZWI4ZWQ4MjRjOTc5NTE0MTc0YjAyZmJkNjIwL3RhYmxlcmFuZ2U6MmExODJlYjhlZDgyNGM5Nzk1MTQxNzRiMDJmYmQ2MjBfNC0xLTEtMS0w_418a6a0c-881e-4302-b0ba-ce35b917901f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i16e7d68e0cf04c83bf036bb7dfc90e9b_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjJhMTgyZWI4ZWQ4MjRjOTc5NTE0MTc0YjAyZmJkNjIwL3RhYmxlcmFuZ2U6MmExODJlYjhlZDgyNGM5Nzk1MTQxNzRiMDJmYmQ2MjBfNC0zLTEtMS0w_131d4cb1-f7e9-490d-bb11-f2ef6153196b"
      unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="iaae1b64b6b3f48efa2eeddd04c00405c_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjJhMTgyZWI4ZWQ4MjRjOTc5NTE0MTc0YjAyZmJkNjIwL3RhYmxlcmFuZ2U6MmExODJlYjhlZDgyNGM5Nzk1MTQxNzRiMDJmYmQ2MjBfNC01LTEtMS0w_3ea08217-849e-42ad-84b7-5d2bb6d8fa17"
      unitRef="usd">-200000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i4dd1442bbab54dbc9df7a9a1b52d46fe_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjJhMTgyZWI4ZWQ4MjRjOTc5NTE0MTc0YjAyZmJkNjIwL3RhYmxlcmFuZ2U6MmExODJlYjhlZDgyNGM5Nzk1MTQxNzRiMDJmYmQ2MjBfNC03LTEtMS0w_8273c67d-48d9-4348-bead-60099851dc8d"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjJhMTgyZWI4ZWQ4MjRjOTc5NTE0MTc0YjAyZmJkNjIwL3RhYmxlcmFuZ2U6MmExODJlYjhlZDgyNGM5Nzk1MTQxNzRiMDJmYmQ2MjBfNS0xLTEtMS0w_792f321c-6419-4ce7-ab8c-59207862579f"
      unitRef="usd">3000000.0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjJhMTgyZWI4ZWQ4MjRjOTc5NTE0MTc0YjAyZmJkNjIwL3RhYmxlcmFuZ2U6MmExODJlYjhlZDgyNGM5Nzk1MTQxNzRiMDJmYmQ2MjBfNS0zLTEtMS0w_a4a98021-40dd-4720-9aea-e69e88bc1592"
      unitRef="usd">-4700000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjJhMTgyZWI4ZWQ4MjRjOTc5NTE0MTc0YjAyZmJkNjIwL3RhYmxlcmFuZ2U6MmExODJlYjhlZDgyNGM5Nzk1MTQxNzRiMDJmYmQ2MjBfNS01LTEtMS0w_65068e10-aad0-437e-bd87-99bd055727d8"
      unitRef="usd">8000000.0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82NC9mcmFnOjQwYTFkNDA3MjUzZTRmMjA4YmRkMTM1ZWFjZGM1MWQ1L3RhYmxlOjJhMTgyZWI4ZWQ4MjRjOTc5NTE0MTc0YjAyZmJkNjIwL3RhYmxlcmFuZ2U6MmExODJlYjhlZDgyNGM5Nzk1MTQxNzRiMDJmYmQ2MjBfNS03LTEtMS0w_794a7407-d3a3-4969-9ef9-bb16903de3a4"
      unitRef="usd">-25900000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82Ny9mcmFnOmY2ZGJhMzg2YzA0MjRlMTFiZmNiYWY5YjliMGMyZGZhL3RleHRyZWdpb246ZjZkYmEzODZjMDQyNGUxMWJmY2JhZjliOWIwYzJkZmFfNjk0NA_7122888d-e964-4db3-909e-c030f8959f1f">Commitments and Contingencies&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Litigation and Related Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On November 6, 2015, the Company filed a suit against Minerva Surgical, Inc. (&#x201c;Minerva&#x201d;) in the United States District Court for the District of Delaware, alleging that Minerva&#x2019;s endometrial ablation device infringes U.S. Patent 6,872,183 (the '183 patent), U.S. Patent 8,998,898 and U.S. Patent 9,095,348 (the '348 patent). On January 25, 2016, the Company amended the complaint to include claims against Minerva for unfair competition, deceptive trade practices and tortious interference with business relationships. On February 5, 2016, the Company filed a second amended complaint to additionally allege that Minerva&#x2019;s endometrial ablation device infringes U.S. Patent 9,247,989 (the '989 patent). On March 4, 2016, Minerva filed an answer and counterclaims against the Company, seeking declaratory judgment on the Company&#x2019;s claims and asserting claims against the Company for unfair competition, deceptive trade practices, interference with contractual relationships, breach of contract and trade libel. On June 2, 2016, the Court denied the Company&#x2019;s motion for a preliminary injunction on its patent claims and denied Minerva&#x2019;s request for preliminary injunction related to the Company&#x2019;s alleged false and deceptive statements regarding the Minerva product. On June 28, 2018, the Court granted the Company's summary judgment motions on infringement and no invalidity with respect to the &#x2018;183 and &#x2018;348 patents. The Court also granted the Company&#x2019;s motion for summary judgment on assignor estoppel, which bars Minerva&#x2019;s invalidity defenses or any reliance on collateral findings regarding invalidity from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;inter partes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; review proceedings. The Court also denied all of Minerva&#x2019;s defenses, including its motions for summary judgment on invalidity, non-infringement, no willfulness, and no unfair competition.&lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On July 27, 2018, after a two-week trial, a jury returned a verdict that: (1) awarded the Company $4.8 million in damages for Minerva&#x2019;s infringement; (2) found that Minerva&#x2019;s infringement was not willful; and (3) found for the Company regarding Minerva&#x2019;s counterclaims. Damages continued to accrue as Minerva continues its infringing conduct. On May 2, 2019, the Court issued rulings that denied the parties' post-trial motions, including the Company's motion for a permanent injunction seeking to prohibit Minerva from selling infringing devices. Both parties appealed the Court's rulings regarding the post-trial motions. On March 4, 2016, Minerva filed two petitions at the USPTO for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;inter partes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; review of the '348 patent. On September 12, 2016, the PTAB declined both petitions to review patentability of the '348 patent. On April 11, 2016, Minerva filed a petition for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;inter partes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; review of the '183 patent. On October 6, 2016, the PTAB granted the petition and instituted a review of the '183 patent. On December 15, 2017, the PTAB issued a final written decision invalidating all claims of the &#x2018;183 patent. On February 9, 2018 the Company appealed this decision to the United States Court of Appeals for the Federal Circuit ("Court of Appeals"). On April 19, 2019, the Court of Appeals affirmed the PTAB's final written decision regarding the '183 patent. On July 16, 2019, the Court of Appeals denied the Company&#x2019;s petition for rehearing in the appeal regarding the '183 patent. On April 22, 2020, the Court of Appeals affirmed the district court&#x2019;s summary judgment ruling in favor of the Company of no invalidity and infringement, and summary judgment that assignor estoppel bars Minerva from challenging the validity of the &#x2018;348 patent. The Court of Appeals also denied the Company&#x2019;s motion for a permanent injunction and ongoing royalties for infringement of the &#x2018;183 patent. The Court of Appeals denied Minerva&#x2019;s arguments for no damages or, alternatively, a new trial. On May 22, 2020 both parties petitioned for en banc review of the Court of Appeals decision. On July 22, 2020, the Court of Appeals denied both parties' petitions for en banc review. On August 28, 2020, the district court entered final judgment against Minerva but stayed execution pending resolution of Minerva&#x2019;s petition for Supreme Court review. On September 30, 2020, Minerva filed a petition requesting Supreme Court review on the issue of assignor estoppel. On November 5, 2020, Hologic filed a cross-petition requesting Supreme Court review on the issue of assignor estoppel. On January 8, 2021, the Supreme Court granted Minerva&#x2019;s petition to address the issue of assignor estoppel and denied Hologic's petition. Oral argument before the Supreme Court was held on April 21, 2021. On June 29, 2021, the Supreme Court ruled 5-4 to uphold but narrow assignor estoppel but limited its application to situations in which an assignor&#x2019;s claim of invalidity contradicts a prior representation the assignor made in assigning the patent. The Court also vacated the ruling of the Court of Appeals and remanded the case for further proceedings consistent with its opinion.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 11, 2017, Minerva filed suit against the Company and Cytyc Surgical Products, LLC (&#x201c;Cytyc&#x201d;) in the United States District Court for the Northern District of California alleging that the Company&#x2019;s and Cytyc&#x2019;s NovaSure ADVANCED endometrial ablation device infringes Minerva&#x2019;s U.S. patent 9,186,208. Minerva is seeking a preliminary and permanent injunction against the Company and Cytyc from selling this NovaSure device as well as enhanced damages and interest, including lost profits, price erosion and/or royalty. On January 5, 2018, the Court denied Minerva's motion for a preliminary injunction. On February 2, 2018, at the parties&#x2019; joint request, this action was transferred to the District of Delaware. On March &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26, 2019, the Magistrate Judge issued a claims construction ruling regarding the disputed terms in the patent, which the District Court Judge adopted in all respects on October 21, 2019. The original trial date of July 20, 2020 was vacated. On October 21, 2020, the trial court scheduled a 10-day trial beginning on August 9, 2021. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or a range of estimates, of potential losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As described in Note 6, the Company has agreed to indemnify CD&amp;amp;R for certain legal matters related to the Medical Aesthetics business that existed at the date of disposition. The Company currently has $8.5&#160;million accrued for such matters as of June&#160;26, 2021. While the Company believes the estimated amounts accrued are reasonable, certain matters are still ongoing and additional accruals could be recorded in the future. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is a party to various other legal proceedings and claims arising out of the ordinary course of its business. The Company believes that except for those matters described above there are no other proceedings or claims pending against it the ultimate resolution of which could have a material adverse effect on its financial condition or results of operations. In all cases, at each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Legal costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <holx:AmountAssessedInDamages
      contextRef="i39a6ba9e2ef34dbe8c1dcffcf164d2cf_I20180727"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82Ny9mcmFnOmY2ZGJhMzg2YzA0MjRlMTFiZmNiYWY5YjliMGMyZGZhL3RleHRyZWdpb246ZjZkYmEzODZjMDQyNGUxMWJmY2JhZjliOWIwYzJkZmFfMTk4Mg_24e81642-5e57-465d-9d5a-5f8da86fa9f3"
      unitRef="usd">4800000</holx:AmountAssessedInDamages>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="ie3638767d08c4249aa0ae3d34c62d59b_D20160304-20160304"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82Ny9mcmFnOmY2ZGJhMzg2YzA0MjRlMTFiZmNiYWY5YjliMGMyZGZhL3RleHRyZWdpb246ZjZkYmEzODZjMDQyNGUxMWJmY2JhZjliOWIwYzJkZmFfMjUzMA_fffc145b-255d-4908-a358-229c4c24cf8b"
      unitRef="petition">2</us-gaap:LossContingencyNewClaimsFiledNumber>
    <holx:LegalAccrual
      contextRef="id9a4160e20ff4e29b6e0bd222066214d_I20210626"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF82Ny9mcmFnOmY2ZGJhMzg2YzA0MjRlMTFiZmNiYWY5YjliMGMyZGZhL3RleHRyZWdpb246ZjZkYmEzODZjMDQyNGUxMWJmY2JhZjliOWIwYzJkZmFfNjEyOA_8176383b-1204-4ac1-bc46-7dd49482790a"
      unitRef="usd">8500000</holx:LegalAccrual>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RleHRyZWdpb246MjMyZjhkZmIwYWRiNGZlNGFkZjg0ZDM5ZGFiY2VmNWZfMTAy_9a4332da-fa97-4d25-ab2c-fba1c062d64f">Net Income Per Share&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of basic and diluted share amounts is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 27,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 27,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257,769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common stock equivalents from assumed exercise of stock options and issuance of stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average anti-dilutive shares related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RleHRyZWdpb246MjMyZjhkZmIwYWRiNGZlNGFkZjg0ZDM5ZGFiY2VmNWZfMTA2_65c9e0ac-e65e-4105-ab73-0809b286fa70">&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of basic and diluted share amounts is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 27,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 27,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;259,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257,769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common stock equivalents from assumed exercise of stock options and issuance of stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258,581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average anti-dilutive shares related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfMi0xLTEtMS0w_0fff3b40-380a-4443-a811-a4b559c5d641"
      unitRef="shares">256230000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfMi0zLTEtMS0w_b187e632-cc16-4fd9-9939-e41a4155c9e4"
      unitRef="shares">259870000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfMi01LTEtMS0w_1335417b-5c06-4f73-b2ec-79f5127d930b"
      unitRef="shares">257769000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfMi03LTEtMS0w_3d7a9c80-2894-468b-9596-366c73cfa8ce"
      unitRef="shares">263667000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfMy0xLTEtMS0w_baf42871-8a2c-4602-b956-6cc438967d6a"
      unitRef="shares">2351000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfMy0zLTEtMS0w_e9504c68-3a9a-43a1-8ad2-43016ad7d119"
      unitRef="shares">1177000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfMy01LTEtMS0w_19c8bb63-8593-470c-a7b1-676a62535c62"
      unitRef="shares">2602000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfMy03LTEtMS0w_82032bd4-50f9-4869-ac53-42f940c5664c"
      unitRef="shares">1425000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfNS0xLTEtMS0w_c3571c2b-b60c-402c-a83d-08370dcf30db"
      unitRef="shares">258581000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfNS0zLTEtMS0w_ee58e722-e902-455d-b75d-808532a5587f"
      unitRef="shares">261047000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfNS01LTEtMS0w_ba1d6cad-91d4-4b13-b492-91ccf7934e71"
      unitRef="shares">260371000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfNS03LTEtMS0w_1813f30a-aea7-4bcb-b22a-1af7a0765963"
      unitRef="shares">265092000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="idaa68ec927564bfca7dcc39909e9c4fa_D20210328-20210626"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfNy0xLTEtMS0w_31ad7e39-eb6b-401e-a4c1-2028eaab343e"
      unitRef="shares">648000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1234ad1f257543fbb603a27545e882e2_D20200329-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfNy0zLTEtMS0w_05c70228-ee79-41f6-87b0-579bea867891"
      unitRef="shares">1597000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9d84692aad2a413f82da74256f73cc99_D20200927-20210626"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfNy01LTEtMS0w_e31ac888-1371-484e-9ffc-cea2da3bd744"
      unitRef="shares">513000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i2230d555087a45db84354397ed80a969_D20190929-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfNy03LTEtMS0w_8f53de85-3431-4a5a-8e65-b8034b94b352"
      unitRef="shares">1521000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ida25fb7963fd417b8fbb79c5404488ed_D20210328-20210626"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfOC0xLTEtMS0w_b23e76dc-6dbc-448a-992f-4f0b693d4f89"
      unitRef="shares">5000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id0987e1d0aaa4f3383d2308a12f86767_D20200329-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfOC0zLTEtMS0w_e8f0ae3c-5d35-4924-85f6-561e30d68afa"
      unitRef="shares">3000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i553a342864f64203bc6682daf196a414_D20200927-20210626"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfOC01LTEtMS0w_14b6aac3-9bc0-4b28-b156-b488f93f648b"
      unitRef="shares">2000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic39037a65c534a348a1153bbf85b4fc5_D20190929-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83MC9mcmFnOjIzMmY4ZGZiMGFkYjRmZTRhZGY4NGQzOWRhYmNlZjVmL3RhYmxlOmI5MDJkY2ExMjkyMjQyOTQ5N2YwY2ZiMDA5MTQ1NzFlL3RhYmxlcmFuZ2U6YjkwMmRjYTEyOTIyNDI5NDk3ZjBjZmIwMDkxNDU3MWVfOC03LTEtMS0w_95cfdc61-c2b5-4c1e-807e-7ffb18407d47"
      unitRef="shares">5000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMzE5Mw_2eeafa40-0ec4-42d7-ba7d-512921672f0c">Stock-Based Compensation&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents stock-based compensation expense in the Company&#x2019;s Consolidated Statements of Income:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 27,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 27,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company granted options to purchase 0.6 million and 0.9 million shares of the Company's common stock during the nine months ended June&#160;26, 2021 and June&#160;27, 2020, respectively, with weighted-average exercise prices of $68.62 and $45.54, respectively. There were 4.4 million options outstanding at June&#160;26, 2021 with a weighted-average exercise price of $44.51.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses a binomial model to determine the fair value of its stock options. The weighted-average assumptions utilized to value these stock options are indicated in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 27,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 27,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average fair value of options granted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company granted 0.5 million and 0.8 million restricted stock units (RSUs) during the nine months ended June&#160;26, 2021 and June&#160;27, 2020, respectively, with weighted-average grant date fair values of $68.45 and $45.67 per unit, respectively. In addition, the Company granted 0.1 million and 0.1 million performance stock units (PSUs) during the nine months ended June&#160;26, 2021 and June&#160;27, 2020, respectively, to members of its senior management team, which have a weighted-average grant date fair value of $68.51 and $45.38 per unit, respectively. Each recipient of PSUs is eligible to receive between zero and 200% of the target number of shares of the Company&#x2019;s common stock at the end of three years provided the Company&#x2019;s defined Return on Invested Capital metrics are achieved. The Company also granted 0.1 million and 0.1&#160;million of PSUs based on a one-year free cash flow measure (FCF) to its senior management team, which had a grant date fair value of $68.51 and $45.38 per unit during the nine months ended June 26, 2021 and June 27, 2020, respectively. Each recipient of FCF PSUs is eligible to receive between zero and 200% of the target number of shares of the Company's common stock at the end of the one-year measurement period, but the FCF PSUs vest at the end of the three year service period. The PSUs and FCF PSUs cliff-vest three years from the date of grant, and the Company recognizes compensation expense ratably over the required service period based on its estimate of the number of shares that will vest upon achieving the measurement criteria. If there is a change in the estimate of the number of shares that are probable of vesting, the Company will cumulatively adjust compensation expense in the period that the change in estimate is made. The Company also granted 0.1 million and 0.1 million market-based awards (MSUs) to its senior management team during the nine months ended June&#160;26, 2021 and June&#160;27, 2020, respectively. Each recipient of MSUs is eligible to receive between zero and 200% of the target number of shares of the Company&#x2019;s common stock at the end of three years based upon achieving a certain total shareholder return relative to a defined peer group. The MSUs were valued at $82.51 and $43.54 per share using the Monte Carlo simulation model. These awards cliff-vest three years from the date of grant, and the Company recognizes compensation expense for the MSUs ratably over the service period. At June&#160;26, 2021, there was 3.0 million in aggregate RSUs, PSUs, FCF PSUs and MSUs outstanding. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:18pt;margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At June&#160;26, 2021, there was $19.4 million and $61.1 million of unrecognized compensation expense related to stock options and stock units (comprised of RSUs, PSUs, FCF PSUs and MSUs), respectively, to be recognized over a weighted-average period of 2.4 and 2.0 years, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMzE5NQ_6db959e9-1fba-4c57-919d-dc0e57014946">&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents stock-based compensation expense in the Company&#x2019;s Consolidated Statements of Income:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 27,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 27,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restructuring&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock>
    <us-gaap:ShareBasedCompensation
      contextRef="i59e3e6acc75043868fc4bc1208d0fa04_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfMi0xLTEtMS0w_d5a04e41-33a8-49de-9444-82fb911e8f97"
      unitRef="usd">1900000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i8c5f40b1155e42a0be6aa12fbb7f0a8f_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfMi0zLTEtMS0w_dc14acd9-607b-46e0-a0ee-f5cf8436c863"
      unitRef="usd">1400000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i7a1e2756a1a84d33aa95630ed4272394_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfMi01LTEtMS0w_2ff601c3-e448-4c23-b247-41487d142bd9"
      unitRef="usd">6400000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="idaa0f682791b44ba8313cfd9634b51ee_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfMi03LTEtMS0w_a1070455-f227-40a3-bb2b-209281f98eb3"
      unitRef="usd">5200000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i9731e33a8f0b424eaba61dcf82dc6156_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfMy0xLTEtMS0w_5b038063-917e-4507-93db-3efbe59aab12"
      unitRef="usd">1400000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i0b98263fc02a43c48ac6469052188efc_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfMy0zLTEtMS0w_6e0022c9-7843-4f64-8719-fe760165286b"
      unitRef="usd">1700000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i2537666870e44ae59702cc35894247ad_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfMy01LTEtMS0w_0298e196-75d2-4b6c-8f6f-1304471c891c"
      unitRef="usd">6200000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ic00ad5ce544040b6afe86e61bdea57b5_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfMy03LTEtMS0w_56ca8d04-de6a-4d50-8703-e86f01866f9f"
      unitRef="usd">6300000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i435b9707d2fe407aa57aa940706fcc51_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfNC0xLTEtMS0w_838d8854-1907-4fce-8d3b-c82326b16aa4"
      unitRef="usd">2300000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i1b21698ef10e487fa17ed0655685000f_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfNC0zLTEtMS0w_f1a6e418-f7d1-4cbb-a393-5a77ff31b76d"
      unitRef="usd">2300000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i264336fb43c14902b7b5f7a3b3df7d37_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfNC01LTEtMS0w_6654a2cd-8f2d-43b0-88e0-dbdd8dd2a35c"
      unitRef="usd">7700000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i7d848d86c60e4d0aa176969dea483771_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfNC03LTEtMS0w_494c330c-315e-4207-b715-514a17afd431"
      unitRef="usd">7900000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i18f952d8a51d45a9bffe628448f2117a_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfNS0xLTEtMS0w_950ea0b9-3451-46a8-876a-27df3b444876"
      unitRef="usd">8900000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i1422e12662974138ae356309626aef3b_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfNS0zLTEtMS0w_c3f5d9e0-1bfe-4841-a647-04a10f69f14a"
      unitRef="usd">14500000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ic793a7813f49401bb24c5dd7cc020e8e_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfNS01LTEtMS0w_fcd26c15-2416-4655-a5a4-935542b3035e"
      unitRef="usd">29800000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ib360d5983d9344da99378ac890629c00_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfNS03LTEtMS0w_f89a6d2d-cc6a-4421-828b-163a25e8c632"
      unitRef="usd">31900000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i8cf709f04c574bb7bf53a2294a770b40_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfNi0xLTEtMS0w_bf4c076d-9a03-41f4-8bb4-7a697c52a764"
      unitRef="usd">900000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="icddd037fe3094f77b5b90963f5441115_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfNi0zLTEtMS0w_89fec224-5cde-482d-b05a-43343d7579fd"
      unitRef="usd">0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i84f82c4a5b2041568af213a793563e12_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfNi01LTEtMS0w_603180a6-d06e-4391-8404-9fb9b5050cb1"
      unitRef="usd">900000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i9a91ec6a807647289f3e38f578c2885a_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfNi03LTEtMS0w_52b9f37e-1b42-4aab-b426-c797d26613de"
      unitRef="usd">2400000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfNy0xLTEtMS0w_32cd50a9-819c-459c-99f2-687720364be5"
      unitRef="usd">15400000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfNy0zLTEtMS0w_f8453769-06d3-4dd9-aa67-2a38d793feb7"
      unitRef="usd">19900000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfNy01LTEtMS0w_99dd7f92-494b-4850-938f-789cc5ebd4ca"
      unitRef="usd">51000000.0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOmVhMjNhY2ExZmYzNDQ4ZDg4MzZmNjFiNzJiMWFiNjJiL3RhYmxlcmFuZ2U6ZWEyM2FjYTFmZjM0NDhkODgzNmY2MWI3MmIxYWI2MmJfNy03LTEtMS0w_ca560f43-f4b0-4496-a8ad-891cac8807ba"
      unitRef="usd">53700000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i27dc34faa8364f4eb609e7d27d755da2_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMTg1_ca009ba1-1f64-4399-a7e6-d9f78b164b87"
      unitRef="shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i24d5fbce3a404b1b9a92d452b7bb7142_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMTky_26c29191-255f-46d6-aade-efa00d6b45af"
      unitRef="shares">900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i27dc34faa8364f4eb609e7d27d755da2_D20200927-20210626"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMzEy_9d71f514-adae-47d9-8888-b8227fd4e6e4"
      unitRef="usdPerShare">68.62</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i24d5fbce3a404b1b9a92d452b7bb7142_D20190929-20200627"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMzE5_99ca3949-b8b3-425a-acf2-d3cfd6d44b85"
      unitRef="usdPerShare">45.54</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i5f3a48b77de044949e38a6dcf4477c25_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMzQ4_fe88e180-db26-44fe-82ae-169b2e3af24f"
      unitRef="shares">4400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i5f3a48b77de044949e38a6dcf4477c25_I20210626"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfNDE5_21fab5a3-8dc9-4213-8859-7ab465c67850"
      unitRef="usdPerShare">44.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMzIxNQ_335daaf2-2a2d-4557-877f-01d300413ef6">&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses a binomial model to determine the fair value of its stock options. The weighted-average assumptions utilized to value these stock options are indicated in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 27,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 27,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average fair value of options granted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.07&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfMi0xLTEtMS0w_da345a48-48ea-438f-9745-af767ecbf7e9"
      unitRef="number">0.004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfMi0zLTEtMS0w_ecbd5382-25d1-423f-8c01-9d84c9115d37"
      unitRef="number">0.017</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfMi01LTEtMS0w_d462981b-6139-40d8-827e-654f30fda794"
      unitRef="number">0.004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfMi03LTEtMS0w_aa4ddaae-c348-4593-ab24-28d00cf00119"
      unitRef="number">0.017</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfMy0xLTEtMS0w_242b7744-208c-488d-a04b-7fbdf3f17ea0"
      unitRef="number">0.350</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfMy0zLTEtMS0w_1f4607a7-6f7c-4a08-94ce-380c08fd9658"
      unitRef="number">0.336</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfMy01LTEtMS0w_0cdcac8f-e8bb-4393-a1d7-e068134746a5"
      unitRef="number">0.350</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfMy03LTEtMS0w_12d4ecbe-21b1-40ad-9aa6-77d4adb4b825"
      unitRef="number">0.336</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfNC0xLTEtMS0w_f1bb251d-ff93-4c88-85ae-9311ee37284c">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfNC0zLTEtMS0w_44f751a0-eabc-4d7e-9e4a-93e86f59d514">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfNC01LTEtMS0w_90ca979f-7287-4488-b284-57bde762ad63">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfNC03LTEtMS0w_16a21b1b-3c83-4f63-ac5a-e5876b451be4">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfNS0xLTEtMS0w_7c57cc9b-1540-48e0-ad43-4afcae46444f"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfNS0zLTEtMS0w_e6771479-ced3-4b99-978b-ae5c59f0b5dd"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfNS01LTEtMS0w_d96e5679-071e-482f-a3d3-32df4f2542db"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfNS03LTEtMS0w_d468b4ff-0610-4ce2-95aa-8975d18c842e"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfNi0xLTEtMS0w_c0a86caa-6181-4196-bf46-73865aeb98d9"
      unitRef="usdPerShare">19.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfNi0zLTEtMS0w_155c2f78-7eda-4d7e-abb5-761da3e89040"
      unitRef="usdPerShare">9.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfNi01LTEtMS0w_4b543b53-8174-43fc-8d75-fd9be12bcdde"
      unitRef="usdPerShare">20.07</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RhYmxlOjZhYTViODQ2OGViYzRjMzRhOTA1OTViZTkyMGIxMmI1L3RhYmxlcmFuZ2U6NmFhNWI4NDY4ZWJjNGMzNGE5MDU5NWJlOTIwYjEyYjVfNi03LTEtMS0w_5cb78a9a-dc62-4ec3-b10d-20f6d608a37b"
      unitRef="usdPerShare">13.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i6fa919d800b84313aa121769ee6efa38_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfNjQw_9d08c89b-81e0-4f9c-8ea1-32193ac7ac19"
      unitRef="shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i4e3cad14bf6540c18eb9197a41e6af8e_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfNjQ3_33b3db6e-d6f9-4ad8-8139-0cf86eb8cdc0"
      unitRef="shares">800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i6fa919d800b84313aa121769ee6efa38_D20200927-20210626"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfNzgw_127aa3a4-92c4-40fc-a09e-8fdbcd9c41fe"
      unitRef="usdPerShare">68.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i4e3cad14bf6540c18eb9197a41e6af8e_D20190929-20200627"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfNzg3_c6737ebf-f6e2-41e0-ad7e-6079565c7c68"
      unitRef="usdPerShare">45.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="if46a501e3c8143fda11f33dbbf4fbbcd_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfODQ3_4ae0e5cb-2d25-4c2d-8ff6-d2766eeaa65f"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ia749d5e6937a406db2e72272ecc2a906_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfODU0_941bba1e-28a3-46e8-9c3b-063403555af7"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="if46a501e3c8143fda11f33dbbf4fbbcd_D20200927-20210626"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMTAzNw_d4a877d1-2f15-424e-bed1-fea86013819e"
      unitRef="usdPerShare">68.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ia749d5e6937a406db2e72272ecc2a906_D20190929-20200627"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMTA0NA_47f1277d-285d-49f4-8ce7-871e3348397f"
      unitRef="usdPerShare">45.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent
      contextRef="ib37462047fc345a18bfadcd2c9728203_D20200927-20210626"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMTEyNQ_1f806f37-c3f8-4047-a4de-eb1217cede09"
      unitRef="number">0</holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent>
    <holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent
      contextRef="ib37462047fc345a18bfadcd2c9728203_D20200927-20210626"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMTEzMg_41cd81c7-f4b2-4c75-854b-047fbf5475e0"
      unitRef="number">2</holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent>
    <holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod
      contextRef="ib37462047fc345a18bfadcd2c9728203_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMTIxMA_b0cfe67b-eceb-41c1-a851-d4db4ae3d92d">P3Y</holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="id8baaf1fbd5542649315b37eae7cf33e_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMTMxOA_7fa8cd00-9888-446c-a2da-5a30be81c908"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i77a3c47ab1fb449ba0ebc5b0c207c416_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMTMyNQ_49180577-f9a9-40a6-83ba-844cb7a3fe54"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="id8baaf1fbd5542649315b37eae7cf33e_D20200927-20210626"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMTQ1Mw_65a81fad-81a8-4192-9e25-d90374ad8274"
      unitRef="usdPerShare">68.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i77a3c47ab1fb449ba0ebc5b0c207c416_D20190929-20200627"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMTQ2MA_74fd8bad-b27a-4c6b-a043-75b71887a310"
      unitRef="usdPerShare">45.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent
      contextRef="id8baaf1fbd5542649315b37eae7cf33e_D20200927-20210626"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMTI2NDQzODM3MjI4Mzg_52e5d9dd-a548-4444-9ab5-8a5bfb1502a4"
      unitRef="number">0</holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent>
    <holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent
      contextRef="id8baaf1fbd5542649315b37eae7cf33e_D20200927-20210626"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMTYxNg_fcb0216b-02ca-4c5f-be9d-cc2b7581e8cd"
      unitRef="number">2</holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent>
    <holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod
      contextRef="id8baaf1fbd5542649315b37eae7cf33e_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMTI2NDQzODM3MjI4NjM_378cd063-6c53-4437-b8a7-db47be8fd83d">P3Y</holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod>
    <holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod
      contextRef="id8baaf1fbd5542649315b37eae7cf33e_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMTI2NDQzODM3MjI4Nzk_f7d5081f-2518-47b7-a2a4-c658095424e0">P3Y</holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ib37462047fc345a18bfadcd2c9728203_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMjI3OQ_217495da-8f4a-495a-9a8f-72c89f305db7"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i6c9fca34b58b4ebba0cc95c584d6b02b_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMjI4Ng_c946e91b-91c2-42aa-9292-65d8acdac4ef"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent
      contextRef="ib37462047fc345a18bfadcd2c9728203_D20200927-20210626"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMjQ1NQ_1f806f37-c3f8-4047-a4de-eb1217cede09"
      unitRef="number">0</holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent>
    <holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent
      contextRef="ib37462047fc345a18bfadcd2c9728203_D20200927-20210626"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMjQ2Mg_41cd81c7-f4b2-4c75-854b-047fbf5475e0"
      unitRef="number">2</holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent>
    <holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod
      contextRef="ib37462047fc345a18bfadcd2c9728203_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMjU0MA_b0cfe67b-eceb-41c1-a851-d4db4ae3d92d">P3Y</holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ib37462047fc345a18bfadcd2c9728203_D20200927-20210626"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMjY1Nw_c044f2de-e4df-4a4e-a393-d46c681cdd7c"
      unitRef="usdPerShare">82.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i6c9fca34b58b4ebba0cc95c584d6b02b_D20190929-20200627"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMjY2NA_d8f42c4c-a571-4267-997a-361b8f72f2dd"
      unitRef="usdPerShare">43.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod
      contextRef="ib37462047fc345a18bfadcd2c9728203_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMTI2NDQzODM3MjI4Mjc_85e4fb6a-d349-4668-a45f-203ae4984224">P3Y</holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="id4b184eeb519428da954a2668ba86020_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMjg4OA_69b89e1f-ce67-488a-8e35-7d52986d42b0"
      unitRef="shares">3000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i5f3a48b77de044949e38a6dcf4477c25_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMjk2NQ_8a2fad9d-14d7-4479-b5e9-47e144d79cbf"
      unitRef="usd">19400000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i3caedad63674472cbf33284dfc9a7524_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMjk3Mg_8355aa24-3ce5-456b-ac16-bed18f3dcabe"
      unitRef="usd">61100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i27dc34faa8364f4eb609e7d27d755da2_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMzE2NA_ed7790c5-36e0-4abd-a36b-89242183046d">P2Y4M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i6fa919d800b84313aa121769ee6efa38_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83My9mcmFnOmE2OGE1NjI4YWYzZTRjNDk4MjMxNGQ1NmYzYTRjN2M4L3RleHRyZWdpb246YTY4YTU2MjhhZjNlNGM0OTgyMzE0ZDU2ZjNhNGM3YzhfMzE3MQ_4ada7906-8d06-455f-b9ca-4e5ea5e3d69e">P2Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <holx:DetailsOfCertainBalanceSheetAccountsTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RleHRyZWdpb246M2I4YjY0YzE1ODBmNDhjNGEwZDcyYWM0YTgwZTI1NDVfMTAyNw_c006eabb-8a32-4c95-b8a3-c893850a2e5d">Other Balance Sheet Information&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.318%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;502.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.318%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment under customer usage agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,290.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,185.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less &#x2013; accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(739.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(694.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;551.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:1pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2020 and October 2020, the Company received grants of $7.6&#160;million and $119.3&#160;million, respectively, from the Department of Defense Joint Acquisition Task Force ("DOD") to expand production capacity for the Company's two SARS-CoV-2 assays. These grants are specifically to fund the capital equipment and labor investments needed to increase manufacturing capacity to enable the Company to provide a certain amount of COVID-19 tests per month for the U.S. market. The Company is accounting for the funds received under these grants as a reimbursement of the purchased capital equipment. The DOD retains title to assets purchased under the agreement, and title is transferred to the Company upon meeting certain milestones of the manufacturing efforts. In the current three and nine month periods, the Company received $8.3&#160;million and $19.4&#160;million, respectively, from the DOD under these grants which has been recorded as a reduction of the cost basis of the purchased equipment.&lt;/span&gt;&lt;/div&gt;</holx:DetailsOfCertainBalanceSheetAccountsTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RleHRyZWdpb246M2I4YjY0YzE1ODBmNDhjNGEwZDcyYWM0YTgwZTI1NDVfMTAyMQ_8051ffc7-bbcf-47ac-9ead-a598e2d2451a">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.318%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;159.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;502.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmZjMGE5Mzg0ZjMzOTRkMTNhNzU0MjIxNTRhZWM0OThjL3RhYmxlcmFuZ2U6ZmMwYTkzODRmMzM5NGQxM2E3NTQyMjE1NGFlYzQ5OGNfMi0xLTEtMS0w_197e5c96-cdaa-42f6-b8be-5b035c9712ca"
      unitRef="usd">159400000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmZjMGE5Mzg0ZjMzOTRkMTNhNzU0MjIxNTRhZWM0OThjL3RhYmxlcmFuZ2U6ZmMwYTkzODRmMzM5NGQxM2E3NTQyMjE1NGFlYzQ5OGNfMi0zLTEtMS0w_4db16a4d-2ef9-4247-8639-c9af2516152a"
      unitRef="usd">152300000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmZjMGE5Mzg0ZjMzOTRkMTNhNzU0MjIxNTRhZWM0OThjL3RhYmxlcmFuZ2U6ZmMwYTkzODRmMzM5NGQxM2E3NTQyMjE1NGFlYzQ5OGNfMy0xLTEtMS0w_27931022-1c5f-4760-bd50-76bd8a7c3cc9"
      unitRef="usd">58500000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmZjMGE5Mzg0ZjMzOTRkMTNhNzU0MjIxNTRhZWM0OThjL3RhYmxlcmFuZ2U6ZmMwYTkzODRmMzM5NGQxM2E3NTQyMjE1NGFlYzQ5OGNfMy0zLTEtMS0w_d9f718b4-386d-4b5e-bdd5-86c8387e9f01"
      unitRef="usd">46500000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmZjMGE5Mzg0ZjMzOTRkMTNhNzU0MjIxNTRhZWM0OThjL3RhYmxlcmFuZ2U6ZmMwYTkzODRmMzM5NGQxM2E3NTQyMjE1NGFlYzQ5OGNfNC0xLTEtMS0w_e52fe3eb-0ee4-40bf-bd53-6c8b8810d0f0"
      unitRef="usd">285000000.0</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmZjMGE5Mzg0ZjMzOTRkMTNhNzU0MjIxNTRhZWM0OThjL3RhYmxlcmFuZ2U6ZmMwYTkzODRmMzM5NGQxM2E3NTQyMjE1NGFlYzQ5OGNfNC0zLTEtMS0w_22573c55-e390-479e-b8c5-b0c8f589559e"
      unitRef="usd">196300000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmZjMGE5Mzg0ZjMzOTRkMTNhNzU0MjIxNTRhZWM0OThjL3RhYmxlcmFuZ2U6ZmMwYTkzODRmMzM5NGQxM2E3NTQyMjE1NGFlYzQ5OGNfNS0xLTEtMS0w_d51e5251-4d25-470a-a85b-e9a5dd0cc6a8"
      unitRef="usd">502900000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmZjMGE5Mzg0ZjMzOTRkMTNhNzU0MjIxNTRhZWM0OThjL3RhYmxlcmFuZ2U6ZmMwYTkzODRmMzM5NGQxM2E3NTQyMjE1NGFlYzQ5OGNfNS0zLTEtMS0w_4537c19e-de87-402b-b914-2c321ddfdcf1"
      unitRef="usd">395100000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RleHRyZWdpb246M2I4YjY0YzE1ODBmNDhjNGEwZDcyYWM0YTgwZTI1NDVfMTAzMg_a2643b23-e047-4136-bcee-7b74c06c645c">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.318%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;541.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment under customer usage agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;446.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,290.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,185.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less &#x2013; accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(739.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(694.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;551.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <holx:ManufacturingEquipmentAndSoftware
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfMS0xLTEtMS0w_083654ae-89fc-4c71-966e-d736a86e2275"
      unitRef="usd">541500000</holx:ManufacturingEquipmentAndSoftware>
    <holx:ManufacturingEquipmentAndSoftware
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfMS0zLTEtMS0w_14005c2d-694d-462f-96f4-30f4bed4f1af"
      unitRef="usd">460700000</holx:ManufacturingEquipmentAndSoftware>
    <holx:EquipmentUnderCustomerUsageAgreements
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfMi0xLTEtMS0w_ec9b5f86-55b7-49ec-b55c-42836c3edbf3"
      unitRef="usd">446000000.0</holx:EquipmentUnderCustomerUsageAgreements>
    <holx:EquipmentUnderCustomerUsageAgreements
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfMi0zLTEtMS0w_60259bdb-f354-49ff-8645-10ab504314dd"
      unitRef="usd">456800000</holx:EquipmentUnderCustomerUsageAgreements>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfMy0xLTEtMS0w_2bd0ae7a-0966-4537-a193-9ca08ccfdb87"
      unitRef="usd">187900000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfMy0zLTEtMS0w_6e622004-cb2d-479f-9bef-0b7c947cd36b"
      unitRef="usd">167300000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfNC0xLTEtMS0w_48b84802-0093-4b58-9a9d-e3bde6b38e9f"
      unitRef="usd">48000000.0</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfNC0zLTEtMS0w_3732a162-5c33-4ba0-a8ef-7aa075877226"
      unitRef="usd">44300000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:Land
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfNS0xLTEtMS0w_26df57da-0590-4d9d-b548-1c6fe3d07875"
      unitRef="usd">41400000</us-gaap:Land>
    <us-gaap:Land
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfNS0zLTEtMS0w_097ee870-69cb-4aca-acf9-31018c6eb37e"
      unitRef="usd">40700000</us-gaap:Land>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfNi0xLTEtMS0w_826e0ba8-59c7-4345-bff5-cf9f7b95f7ef"
      unitRef="usd">16900000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfNi0zLTEtMS0w_7aaaa87b-8168-459e-a1b4-4858d1b44a18"
      unitRef="usd">16100000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfNy0xLTEtMS0w_d6b5a9a9-2c38-4cd5-a558-3e04331725c5"
      unitRef="usd">8500000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfNy0zLTEtMS0w_8f228573-377e-4e6e-8cd4-9a27f0ce556b"
      unitRef="usd">0</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfOC0xLTEtMS0w_a9836856-4a92-483c-a631-63079a9d67ce"
      unitRef="usd">1290200000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfOC0zLTEtMS0w_b90fdc43-38d9-4050-9736-d144b9021f0a"
      unitRef="usd">1185900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfOS0xLTEtMS0w_da4b4998-8d58-4e51-9995-93f3d7e9c0f6"
      unitRef="usd">739100000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfOS0zLTEtMS0w_29d833af-1894-4b5b-a4e9-b7a69a7e3547"
      unitRef="usd">694400000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfMTAtMS0xLTEtMA_7b93c8b4-bdb2-4a52-9fa2-1282696c45c3"
      unitRef="usd">551100000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RhYmxlOmFhNGY3OGQwZjlmOTRkYTViM2I1NzUwOWNiMTNjODE5L3RhYmxlcmFuZ2U6YWE0Zjc4ZDBmOWY5NGRhNWIzYjU3NTA5Y2IxM2M4MTlfMTAtMy0xLTEtMA_8d674908-8012-4d75-a5ec-76dfa6ccd3ad"
      unitRef="usd">491500000</us-gaap:PropertyPlantAndEquipmentNet>
    <holx:GrantsReceivedFromDepartmentOfDefense
      contextRef="ic24013ff47294a37b8d0497bd4190df5_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RleHRyZWdpb246M2I4YjY0YzE1ODBmNDhjNGEwZDcyYWM0YTgwZTI1NDVfMTA5OTUxMTYzMTA0Ng_f5e51fd7-20e8-4d4a-be5a-c26eeb249126"
      unitRef="usd">7600000</holx:GrantsReceivedFromDepartmentOfDefense>
    <holx:GrantsReceivedFromDepartmentOfDefense
      contextRef="i8a980ec9354548a89245ad56600f024d_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RleHRyZWdpb246M2I4YjY0YzE1ODBmNDhjNGEwZDcyYWM0YTgwZTI1NDVfMTA5OTUxMTYzMTA2MA_97e2fe11-c631-484b-a98d-7a4f55ad8959"
      unitRef="usd">119300000</holx:GrantsReceivedFromDepartmentOfDefense>
    <holx:DepartmentOfDefenseFundsReceived
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RleHRyZWdpb246M2I4YjY0YzE1ODBmNDhjNGEwZDcyYWM0YTgwZTI1NDVfMTA5OTUxMTYyODkwOA_cdc9919a-bfe9-466f-829a-30503e57b7cb"
      unitRef="usd">8300000</holx:DepartmentOfDefenseFundsReceived>
    <holx:DepartmentOfDefenseFundsReceived
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83Ni9mcmFnOjNiOGI2NGMxNTgwZjQ4YzRhMGQ3MmFjNGE4MGUyNTQ1L3RleHRyZWdpb246M2I4YjY0YzE1ODBmNDhjNGEwZDcyYWM0YTgwZTI1NDVfMTA5OTUxMTYyODk1MA_bf95e083-7a0b-4f76-860e-bd005d2a4ef7"
      unitRef="usd">19400000</holx:DepartmentOfDefenseFundsReceived>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RleHRyZWdpb246MmIwYjU5YjNhN2MwNGQ1M2I4OWZkNDQ3MTEzMTE4MWZfMTkxNQ_87376520-3ff5-42ac-9e7a-880eb134ed07">Business Segments and Geographic InformationDuring fiscal 2021, the Company had four reportable segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. During fiscal 2020, the Company had five reportable segments that included Medical Aesthetics. The Company completed the sale of its Medical Aesthetics business on December 30, 2019. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense, intangible asset and goodwill impairment charges, transaction and integration expenses for acquisitions, restructuring, consolidation and divestiture charges, litigation charges, and other one-time or unusual items.&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Identifiable assets for the reportable segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its reportable segments. The Company has presented all other identifiable assets as corporate assets. There were no inter-segment revenues during the three and nine months ended June&#160;26, 2021 and June&#160;27, 2020. Segment information is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 27,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 27,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;665.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,858.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,163.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,018.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;862.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,168.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;822.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,315.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,429.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,745.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;358.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,040.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital expenditures:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.058%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.611%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,440.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,161.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,253.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,383.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,438.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,481.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,355.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,590.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,195.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:7pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had no customers that represented greater than 10% of consolidated revenues during the three and nine months ended June&#160;26, 2021 and June&#160;27, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in the following major geographic areas noted in the below chart. Revenue data is based upon customer location. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company&#x2019;s sales in Europe are predominantly derived from France, the United Kingdom and Germany. The Company&#x2019;s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The &#x201c;Rest of world&#x201d; designation includes Canada, Latin America and the Middle East.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues by geography as a percentage of total revenues were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:18pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 27,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 27,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="ie88ebb9dd3ef4963ba6b902a27fde1c5_D20200927-20210327"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RleHRyZWdpb246MmIwYjU5YjNhN2MwNGQ1M2I4OWZkNDQ3MTEzMTE4MWZfMTI2NDQzODM3MjEzNjM_d5311ddd-08f5-4b39-bf7e-426b7b0fd803"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="i2a95db51a148444d8df50afc67ece6af_D20190929-20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RleHRyZWdpb246MmIwYjU5YjNhN2MwNGQ1M2I4OWZkNDQ3MTEzMTE4MWZfMjE1_78107585-6771-40bc-b9fc-5ebbcf0bd2e6"
      unitRef="segment">5</us-gaap:NumberOfReportableSegments>
    <us-gaap:Revenues
      contextRef="ic40f282c064341a7b2e6d34548211fb3_D20190929-20200627"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RleHRyZWdpb246MmIwYjU5YjNhN2MwNGQ1M2I4OWZkNDQ3MTEzMTE4MWZfMTA4Mg_71614188-af56-4a8d-8f8f-37452fe033b9"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i19b4c219fe024c889dd3632f6507458c_D20200927-20210626"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RleHRyZWdpb246MmIwYjU5YjNhN2MwNGQ1M2I4OWZkNDQ3MTEzMTE4MWZfMTA4Mg_a4fba974-4e1c-4c49-9a00-fea87d009943"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if66a8dd5446541e3be680d3c337846e5_D20210328-20210626"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RleHRyZWdpb246MmIwYjU5YjNhN2MwNGQ1M2I4OWZkNDQ3MTEzMTE4MWZfMTA4Mg_f10e3a74-64de-4f6e-bf70-069c214cf29b"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib955694d82bc4bff8c3031d2c76b5e8e_D20200329-20200627"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RleHRyZWdpb246MmIwYjU5YjNhN2MwNGQ1M2I4OWZkNDQ3MTEzMTE4MWZfMTA4Mg_fe88c3af-f528-41cb-98fe-d8a5327b59d2"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RleHRyZWdpb246MmIwYjU5YjNhN2MwNGQ1M2I4OWZkNDQ3MTEzMTE4MWZfMTkwOQ_59263da7-0468-4af3-a448-a1811d5dedd4">egment information is as follows:&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 27,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 27,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;665.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,858.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,163.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,018.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;862.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,168.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;822.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,315.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,429.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;260.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,745.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;358.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;191.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,040.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;179.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;289.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;281.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital expenditures:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.058%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.611%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,440.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,161.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,253.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,383.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,438.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,481.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,355.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,590.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,195.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="i286bca0d89644bd0b3205f4b93ed5c1d_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMy0xLTEtMS0w_e7fde3c9-6bda-42b7-8c04-d97a385407c2"
      unitRef="usd">665500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i79c862e1f99d4e7bb053e7bea309372c_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMy0zLTEtMS0w_8ff1606f-58b8-4c19-8875-993b8b241c4d"
      unitRef="usd">532200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i27eae9a50641400fb1c2541bd52dad61_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMy01LTEtMS0w_07bf9fe7-b712-405d-b594-79d83000d7d1"
      unitRef="usd">2858200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibac682b2841e4347b6671d6949367197_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMy03LTEtMS0w_7c792d69-c420-4060-99ae-8e3820b1f7f9"
      unitRef="usd">1163200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id09b1799f368487b906ce59a96d2e408_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfNC0xLTEtMS0w_d08c24c1-e03a-4f09-8dd1-33755a0207fa"
      unitRef="usd">349000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie9773235748348dd8da0c1995d6ed993_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfNC0zLTEtMS0w_885d28fe-d03a-410a-8115-a33b9767d226"
      unitRef="usd">224000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic99b704f095f4cd69b8a4ae90368d2d7_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfNC01LTEtMS0w_602cddd1-b211-4346-ad4f-764b14da6cae"
      unitRef="usd">1018000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icbfaf422f9724422b8b06418613c842d_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfNC03LTEtMS0w_47a417c8-a6a7-4064-b969-802bb27c5e2f"
      unitRef="usd">862800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4cc1b7e15e774991a987400605125d1c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfNS0xLTEtMS0w_10085ae2-e4d0-48fe-80a0-1ff3ce67079e"
      unitRef="usd">127900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia27da4de68874f0fb714ee7967b38fd7_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfNS0zLTEtMS0w_72f76dd7-ceaf-41c7-8034-1cfef44a6568"
      unitRef="usd">51500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5293327445f541ed891801a24fba467c_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfNS01LTEtMS0w_7f87c3f4-3c6e-4a0d-ba88-575b35d0a57a"
      unitRef="usd">366200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3d4e9da2a2c14f13984e3286a479cede_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfNS03LTEtMS0w_9f57c3e0-6d14-4623-843a-aaaaad18b836"
      unitRef="usd">275900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifd7f591f4d6846419f3ba29d469f7d3f_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfNi0xLTEtMS0w_8c495a37-4e3f-4caf-ac3d-a0df4a357ca8"
      unitRef="usd">25900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i16a0b171d8b2414ebdc3554e167249d2_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfNi0zLTEtMS0w_2e208235-3298-4e96-83c8-051ed68a5b99"
      unitRef="usd">15200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i85f7ecac32784df6a536dad78a0e43e9_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfNi01LTEtMS0w_750c18d2-e0d9-4773-8335-87f9c80ef557"
      unitRef="usd">73300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8ed43d6f3b9e467c9e24d43594b26b14_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfNi03LTEtMS0w_245dac5d-087d-453d-94be-a728d14192cb"
      unitRef="usd">62300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ide8ecf9b05cf4aea8c640173d743b3ce_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfNy0xLTEtMS0w_e4bc99ee-0f96-4188-b0a2-f203cdbf71fd"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id09f54a49ec641f7a9c21dbaaf2c903b_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfNy0zLTEtMS0w_1e22a24b-7f09-435b-a703-6156b7ee83ce"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifa3d63fea23c46bcb179fec3fd524a11_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfNy01LTEtMS0w_8e0262f6-2c06-4139-b9e1-587ec0019062"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6bafd189711f4ec19e64d26761bc3318_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfNy03LTEtMS0w_44a4b10f-5f9e-42d7-bf16-1f01e2881280"
      unitRef="usd">65300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfOC0xLTEtMS0w_f84eedb0-4d42-4091-9ab2-6bb58a2cbbeb"
      unitRef="usd">1168300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfOC0zLTEtMS0w_51e74edf-ee11-4716-8a2c-cb06788696eb"
      unitRef="usd">822900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfOC01LTEtMS0w_11e49031-d2a3-4cd4-b787-e5d74be27fcf"
      unitRef="usd">4315700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfOC03LTEtMS0w_7381c286-17d8-4d47-9147-f01c702aff04"
      unitRef="usd">2429500000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="i286bca0d89644bd0b3205f4b93ed5c1d_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTAtMS0xLTEtMA_947af22c-0336-4d5a-b1f1-2fd55f068eca"
      unitRef="usd">260100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i79c862e1f99d4e7bb053e7bea309372c_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTAtMy0xLTEtMA_d232419f-21d0-4b96-8c7e-9a971eadb5a4"
      unitRef="usd">233900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i27eae9a50641400fb1c2541bd52dad61_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTAtNS0xLTEtMA_f7484b2f-e613-4d7e-bd99-7600cb45a842"
      unitRef="usd">1745100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ibac682b2841e4347b6671d6949367197_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTAtNy0xLTEtMA_ba304741-3909-400a-9def-0458447f6843"
      unitRef="usd">340700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id09b1799f368487b906ce59a96d2e408_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTEtMS0xLTEtMA_f541c8f0-8994-45f8-b6cf-4518eee31e28"
      unitRef="usd">81000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie9773235748348dd8da0c1995d6ed993_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTEtMy0xLTEtMA_9e3e160d-3d02-4522-8910-6307b78c2b27"
      unitRef="usd">-11100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic99b704f095f4cd69b8a4ae90368d2d7_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTEtNS0xLTEtMA_4f34094b-0cb7-416b-b5a2-4ad037793865"
      unitRef="usd">235100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="icbfaf422f9724422b8b06418613c842d_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTEtNy0xLTEtMA_c5ce94f7-3d1b-4765-8199-3130e0560228"
      unitRef="usd">158600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4cc1b7e15e774991a987400605125d1c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTItMS0xLTEtMA_3133ab0e-ed1a-4f67-a21a-c35058f3a0cf"
      unitRef="usd">18200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia27da4de68874f0fb714ee7967b38fd7_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTItMy0xLTEtMA_f34b41d5-be15-4f05-b8c0-26d46bfc71e0"
      unitRef="usd">-23400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5293327445f541ed891801a24fba467c_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTItNS0xLTEtMA_97debaed-cae6-4072-84f7-546b84ba95ff"
      unitRef="usd">60500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3d4e9da2a2c14f13984e3286a479cede_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTItNy0xLTEtMA_10a76dc5-a605-45cd-854e-3661549406e2"
      unitRef="usd">32000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifd7f591f4d6846419f3ba29d469f7d3f_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTMtMS0xLTEtMA_5e658b9f-de49-4412-b2ce-57e8a89d4f5e"
      unitRef="usd">-700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i16a0b171d8b2414ebdc3554e167249d2_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTMtMy0xLTEtMA_67fc6f14-0d85-4c25-9fb9-1b2f8b03ed88"
      unitRef="usd">-7400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i85f7ecac32784df6a536dad78a0e43e9_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTMtNS0xLTEtMA_d9606c3e-20bf-4ff3-a715-634929e95c90"
      unitRef="usd">100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8ed43d6f3b9e467c9e24d43594b26b14_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTMtNy0xLTEtMA_bb7a3220-0466-42e1-91ad-b07c8a53c1be"
      unitRef="usd">-4800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ide8ecf9b05cf4aea8c640173d743b3ce_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTQtMS0xLTEtMA_8d07e5a0-1682-4e91-a089-eea7dfc09875"
      unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id09f54a49ec641f7a9c21dbaaf2c903b_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTQtMy0xLTEtMA_73796767-fac9-4b25-86d2-7f49361f2701"
      unitRef="usd">-1000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifa3d63fea23c46bcb179fec3fd524a11_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTQtNS0xLTEtMA_648b7a3d-1541-4449-8107-9527bfbd43e7"
      unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6bafd189711f4ec19e64d26761bc3318_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTQtNy0xLTEtMA_968dc7e0-1853-414c-ac80-2441f889e776"
      unitRef="usd">-54300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTUtMS0xLTEtMA_12ad83b9-f87d-4330-9967-add79d0f1bd4"
      unitRef="usd">358600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTUtMy0xLTEtMA_559e9444-9e05-4d98-9539-a7779dd7ba4b"
      unitRef="usd">191000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTUtNS0xLTEtMA_350654b3-65cb-411e-98a9-72945533b788"
      unitRef="usd">2040800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTUtNy0xLTEtMA_3a9b5c9a-9794-441d-b870-c11bac05feac"
      unitRef="usd">472200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i286bca0d89644bd0b3205f4b93ed5c1d_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTctMS0xLTEtMA_f2c72c05-fd71-4075-afb0-b9b7fe145dec"
      unitRef="usd">63900000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i79c862e1f99d4e7bb053e7bea309372c_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTctMy0xLTEtMA_92c4107a-293a-4809-8eae-4b937827b250"
      unitRef="usd">59400000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i27eae9a50641400fb1c2541bd52dad61_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTctNS0xLTEtMA_6a5448d4-b999-4e38-8362-7ad1b16f70d6"
      unitRef="usd">179400000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="ibac682b2841e4347b6671d6949367197_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTctNy0xLTEtMA_98c0d839-4b6c-4cba-987b-fc61681e6579"
      unitRef="usd">177800000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="id09b1799f368487b906ce59a96d2e408_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTgtMS0xLTEtMA_1c87acb9-0d21-4a0b-a1e4-7ba93b5ccc31"
      unitRef="usd">13600000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="ie9773235748348dd8da0c1995d6ed993_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTgtMy0xLTEtMA_bce5e0c1-9317-4456-acdf-7ca341450246"
      unitRef="usd">13000000.0</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="ic99b704f095f4cd69b8a4ae90368d2d7_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTgtNS0xLTEtMA_ed12b763-bac6-4624-9227-cb0824a50532"
      unitRef="usd">39700000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="icbfaf422f9724422b8b06418613c842d_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTgtNy0xLTEtMA_a6414222-97f4-43c2-bbd8-64bfc4f8c31b"
      unitRef="usd">36200000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i4cc1b7e15e774991a987400605125d1c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTktMS0xLTEtMA_d682d0a5-e382-4b18-a240-41afb1504064"
      unitRef="usd">23200000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="ia27da4de68874f0fb714ee7967b38fd7_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTktMy0xLTEtMA_33bc7b2b-729a-4f7b-b096-49ea9cb9468b"
      unitRef="usd">21000000.0</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i5293327445f541ed891801a24fba467c_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTktNS0xLTEtMA_b830ad4e-33a8-4306-994b-0a4e506aeb1e"
      unitRef="usd">69500000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i3d4e9da2a2c14f13984e3286a479cede_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMTktNy0xLTEtMA_d4809709-6342-4c46-aadf-f725a1301671"
      unitRef="usd">63100000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="ifd7f591f4d6846419f3ba29d469f7d3f_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjAtMS0xLTEtMA_58a4e091-29ff-4e38-9616-9b6fef3a5117"
      unitRef="usd">200000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i16a0b171d8b2414ebdc3554e167249d2_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjAtMy0xLTEtMA_12be434a-b8f1-41e2-b423-1fe8dec5e93f"
      unitRef="usd">200000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i85f7ecac32784df6a536dad78a0e43e9_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjAtNS0xLTEtMA_4d6c199e-407c-42de-8552-9a3a7bcfb34b"
      unitRef="usd">500000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i8ed43d6f3b9e467c9e24d43594b26b14_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjAtNy0xLTEtMA_982e3275-77d5-48ed-b9bb-37c5dc5f51d3"
      unitRef="usd">500000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="ide8ecf9b05cf4aea8c640173d743b3ce_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjEtMS0xLTEtMA_072ac205-ce25-40aa-9265-7217e340644c"
      unitRef="usd">0</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="id09f54a49ec641f7a9c21dbaaf2c903b_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjEtMy0xLTEtMA_6df0973a-f028-40bf-b672-ef1249ecfc9c"
      unitRef="usd">0</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="ifa3d63fea23c46bcb179fec3fd524a11_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjEtNS0xLTEtMA_7c457c5c-6d7f-4762-b178-c7dd624f52ff"
      unitRef="usd">0</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i6bafd189711f4ec19e64d26761bc3318_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjEtNy0xLTEtMA_a3427029-e933-4d8a-bd22-ad2da3d7d9d6"
      unitRef="usd">4100000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjItMS0xLTEtMA_74635725-a9e7-4af5-94ee-7fef2012bd61"
      unitRef="usd">100900000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjItMy0xLTEtMA_9fe497b8-b26b-44c8-9efb-3e8de8609d1d"
      unitRef="usd">93600000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjItNS0xLTEtMA_86d6c9d8-7654-46d2-8dd8-462571e653eb"
      unitRef="usd">289100000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjItNy0xLTEtMA_8acf2a9f-cef1-4231-9eab-f7cc05baa405"
      unitRef="usd">281700000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i286bca0d89644bd0b3205f4b93ed5c1d_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjQtMS0xLTEtMA_9931df18-74af-4cb9-8d67-e252b9f9988b"
      unitRef="usd">27400000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i79c862e1f99d4e7bb053e7bea309372c_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjQtMy0xLTEtMA_298b982a-bfa7-40c0-9384-de1410e5cc93"
      unitRef="usd">28400000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i27eae9a50641400fb1c2541bd52dad61_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjQtNS0xLTEtMA_7215f41c-aadd-4037-b7f6-59517e40f137"
      unitRef="usd">93800000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ibac682b2841e4347b6671d6949367197_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjQtNy0xLTEtMA_df9e9bcf-7dd4-496f-b48b-c9a1387e18b4"
      unitRef="usd">63700000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="id09b1799f368487b906ce59a96d2e408_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjUtMS0xLTEtMA_99c3ea42-8d3f-4092-ad8c-5ace96f18994"
      unitRef="usd">4500000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ie9773235748348dd8da0c1995d6ed993_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjUtMy0xLTEtMA_0f7100ba-61af-43d1-95eb-d1d2abb50d09"
      unitRef="usd">3000000.0</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ic99b704f095f4cd69b8a4ae90368d2d7_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjUtNS0xLTEtMA_3c5484ae-2e69-400e-9c5c-06687d641a9d"
      unitRef="usd">10100000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="icbfaf422f9724422b8b06418613c842d_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjUtNy0xLTEtMA_ec95a4f8-89f3-446d-823a-7b673e088a46"
      unitRef="usd">17500000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i4cc1b7e15e774991a987400605125d1c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjYtMS0xLTEtMA_8fffd4da-c485-4516-8f21-62f19aa2b1c9"
      unitRef="usd">3000000.0</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ia27da4de68874f0fb714ee7967b38fd7_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjYtMy0xLTEtMA_d97b34a9-0c58-4bb9-b74d-07876494d9d2"
      unitRef="usd">2400000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i5293327445f541ed891801a24fba467c_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjYtNS0xLTEtMA_5a925fc6-2323-47a1-a0fc-61dcdaf240d7"
      unitRef="usd">9500000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i3d4e9da2a2c14f13984e3286a479cede_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjYtNy0xLTEtMA_cd68c397-2b10-4838-b65d-349486d6c988"
      unitRef="usd">12900000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ifd7f591f4d6846419f3ba29d469f7d3f_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjctMS0xLTEtMA_85eb2d6a-99ff-47bb-aa93-eb381cd6cc72"
      unitRef="usd">200000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i16a0b171d8b2414ebdc3554e167249d2_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjctMy0xLTEtMA_fdbd7802-e1e9-4ddd-bdff-8cb324c93512"
      unitRef="usd">100000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i85f7ecac32784df6a536dad78a0e43e9_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjctNS0xLTEtMA_34248c88-2fcc-439e-86dc-2863634c0e50"
      unitRef="usd">200000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i8ed43d6f3b9e467c9e24d43594b26b14_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjctNy0xLTEtMA_6bd0ef67-f4ae-48e9-8610-8f90d9d162fa"
      unitRef="usd">300000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ide8ecf9b05cf4aea8c640173d743b3ce_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjgtMS0xLTEtMA_458411c7-d869-430e-8239-6672a71f7e3f"
      unitRef="usd">0</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="id09f54a49ec641f7a9c21dbaaf2c903b_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjgtMy0xLTEtMA_8e0f854e-d98b-4d68-a346-8040483d0ce6"
      unitRef="usd">0</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ifa3d63fea23c46bcb179fec3fd524a11_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjgtNS0xLTEtMA_14dd8c78-95eb-4bb5-9c9e-f2dbe8a41d0d"
      unitRef="usd">0</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i6bafd189711f4ec19e64d26761bc3318_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjgtNy0xLTEtMA_7de3f209-e3c1-45d9-9cca-3ae04f7b05c2"
      unitRef="usd">1400000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ia95ae01021fa4b75996e32a548c2726f_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjktMS0xLTEtMA_1d63b0f6-30c3-4ee1-b3ec-44a77b3fb63a"
      unitRef="usd">0</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ic41dd5b435484b6ba40f0f2cd734acdc_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjktMy0xLTEtMA_a31aefcc-ffd6-473e-bbc7-aca8ce223f3b"
      unitRef="usd">1100000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="iea58530cbef34fd4931abfeb77c65007_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjktNS0xLTEtMA_60aaba1e-fd19-4e19-92aa-7d3d13349d96"
      unitRef="usd">1000000.0</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i1dbaa5c4c5c5468289373830c34f9e6e_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMjktNy0xLTEtMA_2debe929-b304-4838-a198-da7ca33a71e5"
      unitRef="usd">2200000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMzAtMS0xLTEtMA_334343f8-bba5-4ebb-9361-48f354083c98"
      unitRef="usd">35100000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMzAtMy0xLTEtMA_8c82e3ac-3ab3-4ee8-a6ca-8799ac0f9a3d"
      unitRef="usd">35000000.0</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMzAtNS0xLTEtMA_64ecd441-8fdd-4c9d-bfeb-e4554240b765"
      unitRef="usd">114600000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOmM2MTRiYzQ0ZThmYTRmNGZhODQzNGVjNWMyZGQ5ZjhlL3RhYmxlcmFuZ2U6YzYxNGJjNDRlOGZhNGY0ZmE4NDM0ZWM1YzJkZDlmOGVfMzAtNy0xLTEtMA_773aae40-0d29-42ea-b9a6-a715a2306b32"
      unitRef="usd">98000000.0</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:Assets
      contextRef="ica1034e428864cd1afdca20ce40a8586_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjhmMjY4ZDJmY2RhMzQ3MzhhZWQ2ODQwMjk1ODQ2NjBmL3RhYmxlcmFuZ2U6OGYyNjhkMmZjZGEzNDczOGFlZDY4NDAyOTU4NDY2MGZfMi0xLTEtMS0w_83f8f1a2-dbc1-431b-b3f8-e65648f5554c"
      unitRef="usd">3440900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i17f5a2a375e1486ca6d00e2139870be1_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjhmMjY4ZDJmY2RhMzQ3MzhhZWQ2ODQwMjk1ODQ2NjBmL3RhYmxlcmFuZ2U6OGYyNjhkMmZjZGEzNDczOGFlZDY4NDAyOTU4NDY2MGZfMi0zLTEtMS0w_849ae2ca-cf17-4254-b7f6-a66563866087"
      unitRef="usd">2161400000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i5912cf2562634c4897ffcde39c504296_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjhmMjY4ZDJmY2RhMzQ3MzhhZWQ2ODQwMjk1ODQ2NjBmL3RhYmxlcmFuZ2U6OGYyNjhkMmZjZGEzNDczOGFlZDY4NDAyOTU4NDY2MGZfMy0xLTEtMS0w_ffd4a097-a3d9-46cb-aa98-996e32e68030"
      unitRef="usd">1253400000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="idaca532c37e24e76abac2b8d66a14f2a_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjhmMjY4ZDJmY2RhMzQ3MzhhZWQ2ODQwMjk1ODQ2NjBmL3RhYmxlcmFuZ2U6OGYyNjhkMmZjZGEzNDczOGFlZDY4NDAyOTU4NDY2MGZfMy0zLTEtMS0w_c2533a25-6d0b-4249-a2ec-8db43f370316"
      unitRef="usd">1200900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="iee210605634a465684ebf982ac3ed2bc_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjhmMjY4ZDJmY2RhMzQ3MzhhZWQ2ODQwMjk1ODQ2NjBmL3RhYmxlcmFuZ2U6OGYyNjhkMmZjZGEzNDczOGFlZDY4NDAyOTU4NDY2MGZfNC0xLTEtMS0w_f37ce6f5-522f-4198-8e40-9d1a4d4f14f9"
      unitRef="usd">1383800000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="id9a3a9e2d8cd44ed88d12970a32c6cef_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjhmMjY4ZDJmY2RhMzQ3MzhhZWQ2ODQwMjk1ODQ2NjBmL3RhYmxlcmFuZ2U6OGYyNjhkMmZjZGEzNDczOGFlZDY4NDAyOTU4NDY2MGZfNC0zLTEtMS0w_17c21d90-a39e-42f3-8714-f1893f56d414"
      unitRef="usd">1438700000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i9949f8f813ca4908bd00edad279fdace_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjhmMjY4ZDJmY2RhMzQ3MzhhZWQ2ODQwMjk1ODQ2NjBmL3RhYmxlcmFuZ2U6OGYyNjhkMmZjZGEzNDczOGFlZDY4NDAyOTU4NDY2MGZfNi0xLTEtMS0w_545bd352-ae56-4977-bdf0-b05ad88caf3b"
      unitRef="usd">31400000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i18d768e600b245188ed95ec4ca093d27_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjhmMjY4ZDJmY2RhMzQ3MzhhZWQ2ODQwMjk1ODQ2NjBmL3RhYmxlcmFuZ2U6OGYyNjhkMmZjZGEzNDczOGFlZDY4NDAyOTU4NDY2MGZfNi0zLTEtMS0w_6ddc8d99-1c36-4bfd-84d1-1106c3722f4a"
      unitRef="usd">38900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia430a857ed8348cb98df45af3bff355a_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjhmMjY4ZDJmY2RhMzQ3MzhhZWQ2ODQwMjk1ODQ2NjBmL3RhYmxlcmFuZ2U6OGYyNjhkMmZjZGEzNDczOGFlZDY4NDAyOTU4NDY2MGZfNy0xLTEtMS0w_43fb8214-9944-4a38-a1af-a6b472539d88"
      unitRef="usd">2481100000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i0eacccfdfc914a0fb2100fb0647df849_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjhmMjY4ZDJmY2RhMzQ3MzhhZWQ2ODQwMjk1ODQ2NjBmL3RhYmxlcmFuZ2U6OGYyNjhkMmZjZGEzNDczOGFlZDY4NDAyOTU4NDY2MGZfNy0zLTEtMS0w_45585969-7737-4285-af08-e63f7a9d6657"
      unitRef="usd">2355900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjhmMjY4ZDJmY2RhMzQ3MzhhZWQ2ODQwMjk1ODQ2NjBmL3RhYmxlcmFuZ2U6OGYyNjhkMmZjZGEzNDczOGFlZDY4NDAyOTU4NDY2MGZfOC0xLTEtMS0w_b4ff26b2-38b3-4f74-860d-94f5977985d3"
      unitRef="usd">8590600000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjhmMjY4ZDJmY2RhMzQ3MzhhZWQ2ODQwMjk1ODQ2NjBmL3RhYmxlcmFuZ2U6OGYyNjhkMmZjZGEzNDczOGFlZDY4NDAyOTU4NDY2MGZfOC0zLTEtMS0w_642e732c-36cc-454e-a8c9-9ae83a8c2e16"
      unitRef="usd">7195800000</us-gaap:Assets>
    <us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RleHRyZWdpb246MmIwYjU5YjNhN2MwNGQ1M2I4OWZkNDQ3MTEzMTE4MWZfMTkyNw_36c57924-00f6-4c58-9113-7a39fe282b24">&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues by geography as a percentage of total revenues were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:18pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 27,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 26,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 27,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock>
    <holx:PercentageOfRevenues
      contextRef="i5cc68c7458734cd2a8a7c981e8515c76_D20210328-20210626"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfMi0xLTEtMS0w_481a2fb7-c8fa-46b7-8527-31813fde95de"
      unitRef="number">0.642</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i88586a6659324a6e94cec1cb09cf2a46_D20200329-20200627"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfMi0zLTEtMS0w_fba8a480-b677-4c97-a348-45d41a2f93d1"
      unitRef="number">0.803</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i386d807f9c604702afb89ac48d4f3997_D20200927-20210626"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfMi01LTEtMS0w_986b9f5f-3159-4992-9f71-c7569aa1effc"
      unitRef="number">0.684</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i2107dfda459c464ba7795fbb3263a45f_D20190929-20200627"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfMi03LTEtMS0w_ebd7423e-914f-43a2-a788-948bd83353c3"
      unitRef="number">0.769</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i82e0f458672c41aabd0a7ccc0ecba719_D20210328-20210626"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfMy0xLTEtMS0w_4e616136-fad3-4a72-85d4-f3981ad1736b"
      unitRef="number">0.247</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i63bf14aa150b470d8cda291a8e3dd66f_D20200329-20200627"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfMy0zLTEtMS0w_cc1850f1-e05e-4d33-905c-9a22db8d46ba"
      unitRef="number">0.124</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="if97a9823a91c48f6879659548ae4a3e1_D20200927-20210626"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfMy01LTEtMS0w_3b935bac-cfa2-4fd7-888f-d8d0d64ad1cc"
      unitRef="number">0.223</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i9aa28665b0b14585a3f36c725cdb23a2_D20190929-20200627"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfMy03LTEtMS0w_efd5ae97-8fba-44d9-893e-f124ff381bbd"
      unitRef="number">0.133</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="idadd999b632a42d7b0d65121528aa81a_D20210328-20210626"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfNC0xLTEtMS0w_51107f8d-1938-4321-9ea1-18d49cd0d42e"
      unitRef="number">0.077</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i877644a05fce44e28b7a923b72578d44_D20200329-20200627"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfNC0zLTEtMS0w_ca03866a-b66f-469e-b700-51adea632722"
      unitRef="number">0.053</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="ie9abeb75d8db4dec84473529c4e293f5_D20200927-20210626"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfNC01LTEtMS0w_f53d798e-350d-41f5-9fcb-9aeb559294d2"
      unitRef="number">0.062</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i070ab836e0a141d2815638fcced72af6_D20190929-20200627"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfNC03LTEtMS0w_6d2e38da-94fa-41c4-ba3b-54e3df6581a9"
      unitRef="number">0.064</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i4d7a7aca5d7d45618edcd0ce6bd59a88_D20210328-20210626"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfNS0xLTEtMS0w_7a6236a8-d23a-4e09-8e8b-35bbb3de3782"
      unitRef="number">0.034</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i6943392b65c14cf3ab969335b3f5c944_D20200329-20200627"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfNS0zLTEtMS0w_ef509cc3-03a7-4cf0-a0d9-b27c4f32287f"
      unitRef="number">0.020</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i8cad5c97002944c5ab199f630a9804e6_D20200927-20210626"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfNS01LTEtMS0w_1cbe4d35-7c39-401c-b258-17bd67e0f62a"
      unitRef="number">0.031</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i028a89b44bdc443fbc942f81e8a81c2a_D20190929-20200627"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfNS03LTEtMS0w_839b10a3-d6db-47f3-af55-bcf68e296269"
      unitRef="number">0.034</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfNi0xLTEtMS0w_749a6123-ce96-4e8f-90d4-bdbe22d54aab"
      unitRef="number">1.000</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfNi0zLTEtMS0w_c50430b2-484f-4e98-97f1-2b59c8a59342"
      unitRef="number">1.000</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfNi01LTEtMS0w_98763229-c4b9-4667-9324-68e6c2559ca4"
      unitRef="number">1.000</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF83OS9mcmFnOjJiMGI1OWIzYTdjMDRkNTNiODlmZDQ0NzExMzExODFmL3RhYmxlOjc1YjY3NTljNjIxMzQ5MWQ5NTMwNzY0M2M0NjE0ZGNiL3RhYmxlcmFuZ2U6NzViNjc1OWM2MjEzNDkxZDk1MzA3NjQzYzQ2MTRkY2JfNi03LTEtMS0w_b6136227-2146-47b2-a234-3300c800b94f"
      unitRef="number">1.000</holx:PercentageOfRevenues>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84Mi9mcmFnOmViYThlM2M1OWQ1MjQ1Y2RiYTkyMzJkNzFlOGU5MTM1L3RleHRyZWdpb246ZWJhOGUzYzU5ZDUyNDVjZGJhOTIzMmQ3MWU4ZTkxMzVfMjg4OA_409fd1cd-998e-4bb3-b727-53c0b75fe647">Income Taxes&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with ASC 740, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (ASC 740), each interim period is considered integral to the annual period, and tax expense is measured using an estimated annual effective tax rate. An entity is required to record income tax expense each quarter based on its annual effective tax rate estimated for the full fiscal year and use that rate to provide for income taxes on a current year-to-date basis, adjusted for discrete taxable events that occur during the interim period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s effective tax rate for the three and nine months ended June 26, 2021 was a provision of 20.6% and 21.0%, respectively, compared to a provision of 19.0% and a net benefit of 60.3%, respectively, for the corresponding periods in the prior year. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effective tax rate for the three months ended June 26, 2021 was lower than the U.S. statutory tax rate primarily due to the impact of the U.S. deduction for foreign derived intangible income and the geographic mix of income earned by our international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, and federal and state tax credits, partially offset by state income taxes. The effective tax rate for the nine months ended June 26, 2021 was equal to the U.S. statutory tax rate as the impact of the U.S. deduction for foreign derived intangible income and the geographic mix of income earned by our international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, were offset by state income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effective tax rate for the three months ended June 27, 2020 was lower than the U.S. statutory tax rate primarily due to the geographic mix of income earned by our international subsidiaries which are taxed at rates lower than the U.S. statutory tax rate, including the impact of the U.S. tax imposed on global intangible low-taxed income and the U.S. deduction for foreign derived intangible income, and reserve releases resulting from statute of limitations expirations, partially offset by unbenefited foreign losses. The effective tax rate for the nine months ended June 27, 2020 differed from the statutory tax rate primarily due to a $312.8&#160;million discrete net tax benefit related to the loss on the sale of the Medical Aesthetics business. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Non-Income Tax Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to tax examinations for value-added, sales-based, payroll, and other non-income tax items. A number of these examinations are ongoing in various jurisdictions. The Company takes certain non-income tax positions in the jurisdictions in which it operates. In the normal course of business, the Company's positions and conclusions related to its non-income tax positions could be challenged, resulting in assessments by governmental authorities. Pursuant to ASC 450, the Company has recorded loss contingencies with respect to some of these positions. While the Company believes estimated losses previously recorded are reasonable, certain audits are still ongoing and additional charges could be recorded in the future.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84Mi9mcmFnOmViYThlM2M1OWQ1MjQ1Y2RiYTkyMzJkNzFlOGU5MTM1L3RleHRyZWdpb246ZWJhOGUzYzU5ZDUyNDVjZGJhOTIzMmQ3MWU4ZTkxMzVfNjEw_8d4ffb6c-a953-49fc-8077-392a35afe005"
      unitRef="number">0.206</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84Mi9mcmFnOmViYThlM2M1OWQ1MjQ1Y2RiYTkyMzJkNzFlOGU5MTM1L3RleHRyZWdpb246ZWJhOGUzYzU5ZDUyNDVjZGJhOTIzMmQ3MWU4ZTkxMzVfNjE3_4226fa8e-3bf6-4382-a867-1f4c10b4e231"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ia00e29770e884dc9a747346cc5997f3d_D20200329-20200627"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84Mi9mcmFnOmViYThlM2M1OWQ1MjQ1Y2RiYTkyMzJkNzFlOGU5MTM1L3RleHRyZWdpb246ZWJhOGUzYzU5ZDUyNDVjZGJhOTIzMmQ3MWU4ZTkxMzVfNjYy_4eaf074c-a1fc-4185-9d52-fa4391be0268"
      unitRef="number">0.190</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84Mi9mcmFnOmViYThlM2M1OWQ1MjQ1Y2RiYTkyMzJkNzFlOGU5MTM1L3RleHRyZWdpb246ZWJhOGUzYzU5ZDUyNDVjZGJhOTIzMmQ3MWU4ZTkxMzVfNjg2_55f0825e-0aff-49e3-8edb-d115667d3458"
      unitRef="number">60.3</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i1e661b9ad8374ea08e1defa5f7c60aba_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84Mi9mcmFnOmViYThlM2M1OWQ1MjQ1Y2RiYTkyMzJkNzFlOGU5MTM1L3RleHRyZWdpb246ZWJhOGUzYzU5ZDUyNDVjZGJhOTIzMmQ3MWU4ZTkxMzVfMjAyNQ_096ec097-7429-4cbc-9c26-639631c2ca9f"
      unitRef="usd">312800000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RleHRyZWdpb246NmNkNTRiNzAxNzRkNDdmYTk0YTU0Yzc2NDI0ODViMzdfMjQ5_9e618dc4-1ed5-458a-9c20-7cf8468ab04e">Intangible Assets&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed&#160;technology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,604.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,102.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,054.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,907.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;502.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-competition agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Business licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total acquired intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,578.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,797.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,852.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,569.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internal-use software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software embedded in products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,660.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,859.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,931.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,623.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated remaining amortization expense of the Company's acquired intangible assets as of June&#160;26, 2021 for each of the five succeeding fiscal years is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of Fiscal 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RleHRyZWdpb246NmNkNTRiNzAxNzRkNDdmYTk0YTU0Yzc2NDI0ODViMzdfMjYx_a8a8364a-3331-4889-9254-f7b4120f9432">&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed&#160;technology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,604.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,102.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,054.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,907.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;502.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-competition agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Business licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total acquired intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,578.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,797.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,852.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,569.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internal-use software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software embedded in products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,660.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,859.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,931.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,623.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0cc9805487b14e7296d764cc86233f69_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMy0xLTEtMS0w_32b98212-8909-47dc-af5f-024be3507e92"
      unitRef="usd">4604500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0cc9805487b14e7296d764cc86233f69_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMy0zLTEtMS0w_21886e1a-0e5e-4458-b609-b1ef72f98260"
      unitRef="usd">3102400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i43cbf5cabe2d4af2b65badbd45477dcf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMy01LTEtMS0w_91631670-616a-48a3-a321-1c82d61820ec"
      unitRef="usd">4054000000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i43cbf5cabe2d4af2b65badbd45477dcf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMy03LTEtMS0w_9c92dfeb-e1fd-4c8e-b758-f835094f0857"
      unitRef="usd">2907200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i169a132e711041b39b7f4c5100d3224a_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfNC0xLTEtMS0w_a3adaf7e-35fb-445a-9dfa-d04d71b958d9"
      unitRef="usd">102500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i169a132e711041b39b7f4c5100d3224a_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfNC0zLTEtMS0w_74371eda-a81e-4a38-a525-f50e65e11e0b"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i49753b0eae784ff2ab9d20c18d01ffec_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfNC01LTEtMS0w_e6fe615e-64fc-4463-95ce-75b71408b296"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i49753b0eae784ff2ab9d20c18d01ffec_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfNC03LTEtMS0w_36a3581a-c17c-4da3-89d0-7bc7bdca0847"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i57d0a50ebf48490aa0a913feb0708380_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfNS0xLTEtMS0w_f8b78222-2ddb-443d-8dbd-a248f2bb4722"
      unitRef="usd">598000000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i57d0a50ebf48490aa0a913feb0708380_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfNS0zLTEtMS0w_dd6413f0-9402-4d33-ab4d-62b1406d335e"
      unitRef="usd">502100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i863480533e024d8fa95b6d2bedd39955_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfNS01LTEtMS0w_44293ed8-db4c-47f6-bef1-6ea18660a43b"
      unitRef="usd">549100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i863480533e024d8fa95b6d2bedd39955_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfNS03LTEtMS0w_f216c4c1-723f-4eed-9215-17862fd97257"
      unitRef="usd">477800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i354e119d0fae46c79299b854fd149cf0_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfNi0xLTEtMS0w_bb95e74d-d86c-4eed-8847-20969a1cea00"
      unitRef="usd">269600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i354e119d0fae46c79299b854fd149cf0_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfNi0zLTEtMS0w_ae0a8f82-d7c8-4183-a613-f2d7bb7b3cbb"
      unitRef="usd">188800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i777f5551309a464794664ce33991c02b_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfNi01LTEtMS0w_a7b0b6e9-1431-430e-8f0e-0d9462ddc680"
      unitRef="usd">245500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i777f5551309a464794664ce33991c02b_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfNi03LTEtMS0w_164926b5-d395-4422-9400-12518f700dfd"
      unitRef="usd">181200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7a1d948b692943219190603362c58948_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfOC0xLTEtMS0w_9274a206-fadc-4231-822e-ae1201229a98"
      unitRef="usd">1600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7a1d948b692943219190603362c58948_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfOC0zLTEtMS0w_c0d653cb-5a5a-4fde-97f2-aebaf7b7c45b"
      unitRef="usd">1600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9a5f442490284f8eb7d19616e6f5a406_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfOC01LTEtMS0w_1809d065-367f-4249-a089-8cb8359f38a8"
      unitRef="usd">1500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9a5f442490284f8eb7d19616e6f5a406_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfOC03LTEtMS0w_ad5fb185-03ec-4ba8-b882-59decba4a08f"
      unitRef="usd">1300000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i216e8a1391484fcf90993e52fcce3926_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfOS0xLTEtMS0w_b0e77703-f2bd-4515-ad14-2400c241c72e"
      unitRef="usd">2500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i216e8a1391484fcf90993e52fcce3926_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfOS0zLTEtMS0w_890cbbed-19c3-40aa-aecc-14b06d25774b"
      unitRef="usd">2500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i80816070e8814fa082717580347899ab_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfOS01LTEtMS0w_4dc47011-94bb-48d8-bf5a-85cc98312b42"
      unitRef="usd">2400000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i80816070e8814fa082717580347899ab_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfOS03LTEtMS0w_25841c77-d21e-493c-888d-3ceedf8309cd"
      unitRef="usd">2300000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i71465b2ac88b48b0a8a65c9d19ca9e43_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMTAtMS0xLTEtMA_0d1686b6-23a7-4a71-84c4-d5c8d8f3a3a1"
      unitRef="usd">5578700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i71465b2ac88b48b0a8a65c9d19ca9e43_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMTAtMy0xLTEtMA_e29566f4-9ab6-4498-a099-75fb1a671b84"
      unitRef="usd">3797400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id6d5a0c8113a44b1ab58702864454fbd_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMTAtNS0xLTEtMA_2db14045-19f4-424c-83e7-12c12343183c"
      unitRef="usd">4852500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id6d5a0c8113a44b1ab58702864454fbd_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMTAtNy0xLTEtMA_afc0d991-a87b-43de-8320-254b6fbdf0b5"
      unitRef="usd">3569800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1c78f81f4dc14e4c80085b6397cfbbc4_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMTItMS0xLTEtMA_5e1d0ad3-6280-4ed9-b4a4-1161ea164167"
      unitRef="usd">55400000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1c78f81f4dc14e4c80085b6397cfbbc4_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMTItMy0xLTEtMA_fc6be72a-fa86-4def-a96e-52c459780771"
      unitRef="usd">47600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9346ea30a0ce48709755099832433c82_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMTItNS0xLTEtMA_ed0cedd3-f767-4475-8ec1-b03a4f888ee4"
      unitRef="usd">51800000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9346ea30a0ce48709755099832433c82_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMTItNy0xLTEtMA_5496496f-fbe5-4b18-ad2b-6a1d08c3afb1"
      unitRef="usd">43200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia9374a44c792409bb6e84be04009cf2c_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMTMtMS0xLTEtMA_ddd357ca-9a66-4a0c-91b4-bc3f20643c0c"
      unitRef="usd">25900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia9374a44c792409bb6e84be04009cf2c_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMTMtMy0xLTEtMA_1dd90bf9-3c5c-45a9-85ca-09b7b0703832"
      unitRef="usd">14200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id992e72f22404311bf2349ba1f18c100_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMTMtNS0xLTEtMA_3c6f49c8-643c-4698-9d4c-4b0827813224"
      unitRef="usd">26800000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id992e72f22404311bf2349ba1f18c100_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMTMtNy0xLTEtMA_2635361f-d72c-4c56-9eb6-c4bb19f4fe82"
      unitRef="usd">10600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMTQtMS0xLTEtMA_d441eeb6-ec22-4eee-9163-e6bc38b10a1e"
      unitRef="usd">5660000000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMTQtMy0xLTEtMA_31a29a69-13ae-4d6d-b6af-db8b8a20b809"
      unitRef="usd">3859200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMTQtNS0xLTEtMA_fc962ba7-d1e5-4173-8cb9-c30db2420d8b"
      unitRef="usd">4931100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOjgxOGRkYjlmYjMwNTQ2MzU5YzE1ZjU0NWNhNDMwNjFkL3RhYmxlcmFuZ2U6ODE4ZGRiOWZiMzA1NDYzNTljMTVmNTQ1Y2E0MzA2MWRfMTQtNy0xLTEtMA_e0f55649-79b3-4222-81d5-b33b67096ed2"
      unitRef="usd">3623600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RleHRyZWdpb246NmNkNTRiNzAxNzRkNDdmYTk0YTU0Yzc2NDI0ODViMzdfMjQx_9edb567f-346e-4980-9066-8af726efee5a">&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated remaining amortization expense of the Company's acquired intangible assets as of June&#160;26, 2021 for each of the five succeeding fiscal years is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of Fiscal 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOmEyMWY3ZTNhNzAyYTQwNDlhN2RhNDc4NWRlYWFlODEyL3RhYmxlcmFuZ2U6YTIxZjdlM2E3MDJhNDA0OWE3ZGE0Nzg1ZGVhYWU4MTJfMC0xLTEtMS0w_7135548e-c4e5-4a26-9b66-aca980c5fc62"
      unitRef="usd">86300000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOmEyMWY3ZTNhNzAyYTQwNDlhN2RhNDc4NWRlYWFlODEyL3RhYmxlcmFuZ2U6YTIxZjdlM2E3MDJhNDA0OWE3ZGE0Nzg1ZGVhYWU4MTJfMS0xLTEtMS0w_24fdcd69-ac2c-40a8-80d3-8be04064ffd0"
      unitRef="usd">332300000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOmEyMWY3ZTNhNzAyYTQwNDlhN2RhNDc4NWRlYWFlODEyL3RhYmxlcmFuZ2U6YTIxZjdlM2E3MDJhNDA0OWE3ZGE0Nzg1ZGVhYWU4MTJfMi0xLTEtMS0w_72289df2-4d51-4e18-bfec-794fe1cc508b"
      unitRef="usd">235900000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOmEyMWY3ZTNhNzAyYTQwNDlhN2RhNDc4NWRlYWFlODEyL3RhYmxlcmFuZ2U6YTIxZjdlM2E3MDJhNDA0OWE3ZGE0Nzg1ZGVhYWU4MTJfMy0xLTEtMS0w_9c2e66e5-946b-4fc9-8957-0fec47431b81"
      unitRef="usd">223600000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84NS9mcmFnOjZjZDU0YjcwMTc0ZDQ3ZmE5NGE1NGM3NjQyNDg1YjM3L3RhYmxlOmEyMWY3ZTNhNzAyYTQwNDlhN2RhNDc4NWRlYWFlODEyL3RhYmxlcmFuZ2U6YTIxZjdlM2E3MDJhNDA0OWE3ZGE0Nzg1ZGVhYWU4MTJfNC0xLTEtMS0w_8834c452-16fd-4f06-8088-215805d84d9a"
      unitRef="usd">210100000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:ProductWarrantyDisclosureTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84OC9mcmFnOjY1ZjlhMjJiNzJhZjQyMTNiYzhkZjk1M2RjYzVlNzQxL3RleHRyZWdpb246NjVmOWEyMmI3MmFmNDIxM2JjOGRmOTUzZGNjNWU3NDFfODk_583e77ce-d0b9-4265-8ecd-a7df947e7e51">Product Warranties&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product warranty activity was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:18pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.873%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;Beginning&#160;of&lt;br/&gt;Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Divested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Settlements/&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;End&#160;of&#160;Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nine Months Ended:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ProductWarrantyDisclosureTextBlock>
    <us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84OC9mcmFnOjY1ZjlhMjJiNzJhZjQyMTNiYzhkZjk1M2RjYzVlNzQxL3RleHRyZWdpb246NjVmOWEyMmI3MmFmNDIxM2JjOGRmOTUzZGNjNWU3NDFfODI_40e04978-da13-4a44-bb8b-58afd152c504">&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product warranty activity was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:18pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.823%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.873%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;Beginning&#160;of&lt;br/&gt;Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Divested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Settlements/&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;End&#160;of&#160;Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nine Months Ended:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock>
    <us-gaap:ProductWarrantyAccrual
      contextRef="i01a2cc93a0514785a37164641018ee66_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84OC9mcmFnOjY1ZjlhMjJiNzJhZjQyMTNiYzhkZjk1M2RjYzVlNzQxL3RhYmxlOjhlZTIzYTFjMWFhYjRiOTE4MjE3YjEzMDU4NTNjNjU5L3RhYmxlcmFuZ2U6OGVlMjNhMWMxYWFiNGI5MTgyMTdiMTMwNTg1M2M2NTlfMi0xLTEtMS0w_def8d330-aaf5-43f6-952a-7d795985a19b"
      unitRef="usd">9900000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrualWarrantiesIssued
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84OC9mcmFnOjY1ZjlhMjJiNzJhZjQyMTNiYzhkZjk1M2RjYzVlNzQxL3RhYmxlOjhlZTIzYTFjMWFhYjRiOTE4MjE3YjEzMDU4NTNjNjU5L3RhYmxlcmFuZ2U6OGVlMjNhMWMxYWFiNGI5MTgyMTdiMTMwNTg1M2M2NTlfMi0zLTEtMS0w_65413d02-aef6-47da-8890-7595a68913be"
      unitRef="usd">6100000</us-gaap:ProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:ProductWarrantyAccrualAdditionsFromBusinessAcquisition
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84OC9mcmFnOjY1ZjlhMjJiNzJhZjQyMTNiYzhkZjk1M2RjYzVlNzQxL3RhYmxlOjhlZTIzYTFjMWFhYjRiOTE4MjE3YjEzMDU4NTNjNjU5L3RhYmxlcmFuZ2U6OGVlMjNhMWMxYWFiNGI5MTgyMTdiMTMwNTg1M2M2NTlfMi01LTEtMS0w_ddb58c60-f8bd-4626-822a-5c1e6a12a73e"
      unitRef="usd">300000</us-gaap:ProductWarrantyAccrualAdditionsFromBusinessAcquisition>
    <us-gaap:StandardProductWarrantyAccrualPeriodIncreaseDecrease
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84OC9mcmFnOjY1ZjlhMjJiNzJhZjQyMTNiYzhkZjk1M2RjYzVlNzQxL3RhYmxlOjhlZTIzYTFjMWFhYjRiOTE4MjE3YjEzMDU4NTNjNjU5L3RhYmxlcmFuZ2U6OGVlMjNhMWMxYWFiNGI5MTgyMTdiMTMwNTg1M2M2NTlfMi03LTEtMS0w_7ba8da93-daaa-40ef-99d2-67df87e98c23"
      unitRef="usd">0</us-gaap:StandardProductWarrantyAccrualPeriodIncreaseDecrease>
    <us-gaap:ProductWarrantyAccrualPayments
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84OC9mcmFnOjY1ZjlhMjJiNzJhZjQyMTNiYzhkZjk1M2RjYzVlNzQxL3RhYmxlOjhlZTIzYTFjMWFhYjRiOTE4MjE3YjEzMDU4NTNjNjU5L3RhYmxlcmFuZ2U6OGVlMjNhMWMxYWFiNGI5MTgyMTdiMTMwNTg1M2M2NTlfMi05LTEtMS0w_9e264810-e57e-43c9-9290-d02a90845f74"
      unitRef="usd">6700000</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:ProductWarrantyAccrual
      contextRef="ie7b19d82c50249db846d3d1201e12c40_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84OC9mcmFnOjY1ZjlhMjJiNzJhZjQyMTNiYzhkZjk1M2RjYzVlNzQxL3RhYmxlOjhlZTIzYTFjMWFhYjRiOTE4MjE3YjEzMDU4NTNjNjU5L3RhYmxlcmFuZ2U6OGVlMjNhMWMxYWFiNGI5MTgyMTdiMTMwNTg1M2M2NTlfMi0xMS0xLTEtMA_9985e26e-f86d-47f3-9f50-252af386dcf4"
      unitRef="usd">9600000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrual
      contextRef="ia1bbf9311cb649308affbf16f61bb3ff_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84OC9mcmFnOjY1ZjlhMjJiNzJhZjQyMTNiYzhkZjk1M2RjYzVlNzQxL3RhYmxlOjhlZTIzYTFjMWFhYjRiOTE4MjE3YjEzMDU4NTNjNjU5L3RhYmxlcmFuZ2U6OGVlMjNhMWMxYWFiNGI5MTgyMTdiMTMwNTg1M2M2NTlfMy0xLTEtMS0w_b770a811-4ec6-4d86-9738-06f2c484d470"
      unitRef="usd">13900000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrualWarrantiesIssued
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84OC9mcmFnOjY1ZjlhMjJiNzJhZjQyMTNiYzhkZjk1M2RjYzVlNzQxL3RhYmxlOjhlZTIzYTFjMWFhYjRiOTE4MjE3YjEzMDU4NTNjNjU5L3RhYmxlcmFuZ2U6OGVlMjNhMWMxYWFiNGI5MTgyMTdiMTMwNTg1M2M2NTlfMy0zLTEtMS0w_660a7563-8adf-4a1b-b509-d67c7310b863"
      unitRef="usd">8000000.0</us-gaap:ProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:ProductWarrantyAccrualAdditionsFromBusinessAcquisition
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84OC9mcmFnOjY1ZjlhMjJiNzJhZjQyMTNiYzhkZjk1M2RjYzVlNzQxL3RhYmxlOjhlZTIzYTFjMWFhYjRiOTE4MjE3YjEzMDU4NTNjNjU5L3RhYmxlcmFuZ2U6OGVlMjNhMWMxYWFiNGI5MTgyMTdiMTMwNTg1M2M2NTlfMy01LTEtMS0w_4d6a18ed-321c-47bd-9ec8-544037e75f13"
      unitRef="usd">500000</us-gaap:ProductWarrantyAccrualAdditionsFromBusinessAcquisition>
    <us-gaap:StandardProductWarrantyAccrualPeriodIncreaseDecrease
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84OC9mcmFnOjY1ZjlhMjJiNzJhZjQyMTNiYzhkZjk1M2RjYzVlNzQxL3RhYmxlOjhlZTIzYTFjMWFhYjRiOTE4MjE3YjEzMDU4NTNjNjU5L3RhYmxlcmFuZ2U6OGVlMjNhMWMxYWFiNGI5MTgyMTdiMTMwNTg1M2M2NTlfMy03LTEtMS0w_d1881c2a-e79f-4057-9326-aa889d6c1c1d"
      unitRef="usd">-6100000</us-gaap:StandardProductWarrantyAccrualPeriodIncreaseDecrease>
    <us-gaap:ProductWarrantyAccrualPayments
      contextRef="i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84OC9mcmFnOjY1ZjlhMjJiNzJhZjQyMTNiYzhkZjk1M2RjYzVlNzQxL3RhYmxlOjhlZTIzYTFjMWFhYjRiOTE4MjE3YjEzMDU4NTNjNjU5L3RhYmxlcmFuZ2U6OGVlMjNhMWMxYWFiNGI5MTgyMTdiMTMwNTg1M2M2NTlfMy05LTEtMS0w_7a49ca2c-eb8e-45a8-91d2-e6e1d1f3bdee"
      unitRef="usd">7200000</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:ProductWarrantyAccrual
      contextRef="i81ab5863e2124accb342d2df86a1ee96_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF84OC9mcmFnOjY1ZjlhMjJiNzJhZjQyMTNiYzhkZjk1M2RjYzVlNzQxL3RhYmxlOjhlZTIzYTFjMWFhYjRiOTE4MjE3YjEzMDU4NTNjNjU5L3RhYmxlcmFuZ2U6OGVlMjNhMWMxYWFiNGI5MTgyMTdiMTMwNTg1M2M2NTlfMy0xMS0xLTEtMA_f323f944-419d-459e-8ece-4b28c6bac09f"
      unitRef="usd">9100000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RleHRyZWdpb246ZTIwMjg0ZTZkMjUxNGI4NzhhY2ZkNGIxMzljYThhNzVfMjAx_66a60d17-b39b-442b-960d-e37057149c60">Accumulated Other Comprehensive Loss&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the changes in accumulated balances of other comprehensive loss for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.952%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.242%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nine Months Ended June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(14.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(19.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(35.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(22.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(24.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(49.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to statement of income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(23.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(42.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(23.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(42.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.366%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nine Months Ended June 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(38.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(58.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(41.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(42.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(25.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(21.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to statement of income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(37.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(22.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(61.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(37.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(22.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(61.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RleHRyZWdpb246ZTIwMjg0ZTZkMjUxNGI4NzhhY2ZkNGIxMzljYThhNzVfMTk3_1623b512-5230-4242-a2e6-2ea22705b0fd">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the changes in accumulated balances of other comprehensive loss for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.952%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.087%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.242%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nine Months Ended June 26, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(14.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(19.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(35.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(22.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(24.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(49.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(9.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(6.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to statement of income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(23.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(42.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(23.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(16.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(42.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.490%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.366%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three Months Ended June 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nine Months Ended June 27, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(38.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(17.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(58.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(41.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(42.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(25.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(21.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to statement of income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(37.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(22.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(61.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(37.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(22.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(61.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="i17ce81e7ee4c430192d40261507faf9e_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMi0xLTEtMS0w_32496006-1209-4102-b80d-6a8ff1cb228e"
      unitRef="usd">-14500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i67bef9095bf547108bf64353f12a5efa_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMi0zLTEtMS0w_94ac8ed3-27b5-464e-b617-3663cbe12a14"
      unitRef="usd">-1800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie1d03b89c2cd46c8b689923ced265e84_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMi03LTEtMS0w_fff5ee6d-f7b2-42a0-805d-3f26ede150da"
      unitRef="usd">-19500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic0aa0fa3e3474453bc759752889ebcd8_I20210327"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMi05LTEtMS0w_0765e6bd-354d-413b-90bd-6faeeceb8a5c"
      unitRef="usd">-35800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4ff2910c781f4a73b76fc57f6588936e_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMi0xMS0xLTEtMA_5a5466ee-3dbe-4748-9c24-998402df4e3a"
      unitRef="usd">-22900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie54cb9e528944fd09a387c1fbd3869b2_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMi0xMy0xLTEtMA_6c461e96-24bd-42d7-85a5-5540cc01df04"
      unitRef="usd">-1800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i10eb8034808e433f8c962dfd384c4804_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMi0xNS0xLTEtMA_3ebe1787-6da0-48ca-afa1-dcb8e7390790"
      unitRef="usd">-900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifebb08681666403a84ebbf74112b4eb6_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMi0xNy0xLTEtMA_634b904c-2636-4916-9b1f-138ba923b12a"
      unitRef="usd">-24100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i820217fec55c42d7a9aeb5cfc0f49fdb_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMi0xOC0xLTEtMA_e140fb8b-6fae-4610-8e85-4de1a2e5eef7"
      unitRef="usd">-49700000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i94e3de8bf3624135ab7d18e1e91c29f6_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMy0xLTEtMS0w_b874c964-12f1-4aeb-8e6a-a79bad94313f"
      unitRef="usd">-9400000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i0087149b23e7436988b3b251c5cba1cd_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMy0zLTEtMS0w_e97f133d-5179-4470-a1c9-f21dce7e770f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i6d4b5d09721f44e6aab3f827d2d52aee_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMy03LTEtMS0w_520a7ed0-9e94-4bee-968f-cca94fd53602"
      unitRef="usd">3000000.0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i8226181576f245bba94e4a5ec64e87f6_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMy05LTEtMS0w_993b9f60-d431-4c1e-a348-17467bdd3a45"
      unitRef="usd">-6400000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i61d813ca92d74906813eda4366974a47_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMy0xMS0xLTEtMA_452b87e3-1440-4e4f-b7e1-c382e4897f33"
      unitRef="usd">-1000000.0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i0c7acad28e074461824c04de2811d59b_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMy0xMy0xLTEtMA_a5c6152f-0358-400e-9cea-2dd8a7ed9db6"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i4cda94d3c28e41afb2a42d1c640a9558_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMy0xNS0xLTEtMA_b03623e4-07a6-4da2-86bf-184f18e6d7ff"
      unitRef="usd">400000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i8b595945346f488591f6734675e5bbc7_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMy0xNy0xLTEtMA_30e93f19-04d0-4233-b2df-63875a2cd7df"
      unitRef="usd">7600000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i7e9aeea6421a483a9877f65783d68521_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfMy0xOC0xLTEtMA_3da80bca-f33a-466c-87d7-f34673eec8a0"
      unitRef="usd">7000000.0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i94e3de8bf3624135ab7d18e1e91c29f6_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNC0xLTEtMS0w_c8de0a3f-23b5-4f62-a6f3-963bbbfc7224"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i0087149b23e7436988b3b251c5cba1cd_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNC0zLTEtMS0w_779ddee9-cc60-41e9-bc29-22e6b97ac493"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i6d4b5d09721f44e6aab3f827d2d52aee_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNC03LTEtMS0w_77acfc3d-d494-4b6d-8d7d-3a4078dfa20e"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i8226181576f245bba94e4a5ec64e87f6_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNC05LTEtMS0w_911eb8e8-74e0-4efd-985d-c9cc1aafc05a"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i61d813ca92d74906813eda4366974a47_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNC0xMS0xLTEtMA_7330cef5-55a8-4441-9b8e-0ecc58d13cde"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i0c7acad28e074461824c04de2811d59b_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNC0xMy0xLTEtMA_47fcc03c-144a-464b-97ec-136d36773b38"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i4cda94d3c28e41afb2a42d1c640a9558_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNC0xNS0xLTEtMA_cf810313-254d-4b6a-a0e9-df40fdf04362"
      unitRef="usd">500000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i8b595945346f488591f6734675e5bbc7_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNC0xNy0xLTEtMA_558ff939-649b-4aa5-8388-3ffd668b1c7c"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i7e9aeea6421a483a9877f65783d68521_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNC0xOC0xLTEtMA_b6f9c43d-376b-4e8d-8b1d-69023a6a258f"
      unitRef="usd">500000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="ibc95c0525971424ca911fedd93ca98cf_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNi0xLTEtMS0w_dc214241-45a1-414b-bf5e-8e97702767d8"
      unitRef="usd">-23900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9d40f0fd77d34330b52e8a8f921c4b22_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNi0zLTEtMS0w_68b3c0fb-8c61-4348-b77b-a30a8b357270"
      unitRef="usd">-1800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8fe14ed2af474833a427512772ec787c_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNi03LTEtMS0w_a22a8d85-7dd8-4095-b78d-5e1adba1bb71"
      unitRef="usd">-16500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i875c4235807f46d2acc9a2e5e2e9e7a8_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNi05LTEtMS0w_36d13fef-9802-4290-a46b-f27d46ce7a75"
      unitRef="usd">-42200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibc95c0525971424ca911fedd93ca98cf_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNi0xMS0xLTEtMA_a75f5e85-9259-4e2c-bd7f-c3da493bd970"
      unitRef="usd">-23900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9d40f0fd77d34330b52e8a8f921c4b22_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNi0xMy0xLTEtMA_139d7aff-ef4c-4ef1-aab3-d1e08224ed21"
      unitRef="usd">-1800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8c2348d216e0450a960b7ddce90b14d8_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNi0xNS0xLTEtMA_df36cb89-8e53-4cf3-a54d-2694cd7e8725"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8fe14ed2af474833a427512772ec787c_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNi0xNy0xLTEtMA_dd6d8877-5ac1-4c8d-9d2c-f5dcf81ba3b8"
      unitRef="usd">-16500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i875c4235807f46d2acc9a2e5e2e9e7a8_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjg0MzhjNDk0NjQxMzQzYTM5YTllOTBhZDVhMzg0YWNjL3RhYmxlcmFuZ2U6ODQzOGM0OTQ2NDEzNDNhMzlhOWU5MGFkNWEzODRhY2NfNi0xOC0xLTEtMA_c9e9b633-a27d-4604-9aae-36d73835a831"
      unitRef="usd">-42200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8f16f7fecd444a7e839c00b1e6b16900_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMi0xLTEtMS0w_b8402bc8-ed8f-4019-a6ee-60df04731b3b"
      unitRef="usd">-38500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie1db5b374d2e42f2980c21955a6c48d7_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMi01LTEtMS0w_26fab6e3-735d-4bc1-9441-c80ee563765d"
      unitRef="usd">-1700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7bf24f113b134bd6ad61f3c2d4372c97_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMi03LTEtMS0w_3a23faa3-991e-48b4-87e4-dd909b7cfbcb"
      unitRef="usd">-1100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9d147650821f4b7eafa8239fe1a67337_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMi05LTEtMS0w_b426acbd-0f71-4116-9cd2-73fa4f6f5ece"
      unitRef="usd">-17600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4470f8e9e21d45a78c67f110baf7a543_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMi0xMS0xLTEtMA_e150b667-eddb-4d03-baab-0aa03ddcaab6"
      unitRef="usd">-58900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i202bf7e9908f4a88988d987295f24bf9_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMi0xMy0xLTEtMA_0f8c5bcd-7b9c-4675-8cc1-d772bf0fcc48"
      unitRef="usd">-41400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i50d0a909334a49d38f7058d971ae3d3e_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMi0xNS0xLTEtMA_e9d45d18-708c-4ea9-a84b-2f0fd5df2bef"
      unitRef="usd">-1700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id83350261e414219bbdc2563d9573d29_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMi0xNy0xLTEtMA_34ebdd3b-455d-4315-a9ac-df8075d6dcb2"
      unitRef="usd">-2700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i082299dec4444554933007b3eb2589d9_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMi0xOS0xLTEtMA_e05a1717-9b7c-4406-89bb-dc3ec7f00924"
      unitRef="usd">3500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1b3baf3186c74c05b772abe2f32104e9_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMi0yMC0xLTEtMA_2cf469c6-0257-4ea9-b876-32faec89caef"
      unitRef="usd">-42300000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="id64f5775615a48e3b594627ba96e48e2_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMy0xLTEtMS0w_4d569cde-0fec-4495-8d74-43387aee6726"
      unitRef="usd">1400000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ifa6aa9d198924a13b4507ae621cfca92_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMy01LTEtMS0w_517b42e8-3e38-494f-b25f-ea1021071a02"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i961c9373b1364d32bae836297e84a344_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMy03LTEtMS0w_b2d388df-0797-48b5-aa21-656eb6377fa8"
      unitRef="usd">-100000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="id4e6817a851b427a92b0c7fe72a3bbfb_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMy05LTEtMS0w_f32938e7-0301-4f72-8f78-2f0098b93a30"
      unitRef="usd">-4600000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="idd3a77457cf340cf9428c91d5c99c147_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMy0xMS0xLTEtMA_da65f616-7dcf-4752-ac52-545012fb5aa5"
      unitRef="usd">-3300000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i20f566a19c874603ae7ac1c2f276af8b_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMy0xMy0xLTEtMA_e12d1500-fadc-41d2-9976-a6a32617ebe1"
      unitRef="usd">4300000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i4075c4c45421491e8f17e3328901d09b_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMy0xNS0xLTEtMA_5bab18ef-3fd0-41e8-a02f-5b356d86e78a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i2d085e73dd1a41b2ac1e4ef320989c1c_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMy0xNy0xLTEtMA_f7530e66-44a6-4352-82bf-ec45167c90c9"
      unitRef="usd">-200000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i3114f8a48396426d88640981268e8d43_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMy0xOS0xLTEtMA_9477307f-0771-4f95-85bd-2f896222a1c2"
      unitRef="usd">-25700000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="iccef93e68c604a7c8257204c91951d7d_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfMy0yMC0xLTEtMA_856c5ac7-c543-4432-a7f5-dd0439c96395"
      unitRef="usd">-21600000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="id64f5775615a48e3b594627ba96e48e2_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNC0xLTEtMS0w_68d88443-7006-4213-a617-466da102ba77"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ifa6aa9d198924a13b4507ae621cfca92_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNC01LTEtMS0w_01dbf37b-57e1-4b57-878d-74e1c77454aa"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i961c9373b1364d32bae836297e84a344_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNC03LTEtMS0w_b22b3bef-5965-4514-b2ab-0485e440dd9f"
      unitRef="usd">300000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="id4e6817a851b427a92b0c7fe72a3bbfb_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNC05LTEtMS0w_b557b8e7-1ffc-41e9-85df-123ee41d945c"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="idd3a77457cf340cf9428c91d5c99c147_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNC0xMS0xLTEtMA_b99dc45c-2c70-48a5-a436-db3bf6453c20"
      unitRef="usd">-300000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i20f566a19c874603ae7ac1c2f276af8b_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNC0xMy0xLTEtMA_962b8a07-e73d-4d23-abf9-4a8c4a54dd16"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i4075c4c45421491e8f17e3328901d09b_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNC0xNS0xLTEtMA_938696d2-1781-4c46-8f72-0b4e2dc3c6fc"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i2d085e73dd1a41b2ac1e4ef320989c1c_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNC0xNy0xLTEtMA_4f9589d8-8f5a-4caf-9511-686a7d6016ca"
      unitRef="usd">2000000.0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i3114f8a48396426d88640981268e8d43_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNC0xOS0xLTEtMA_f6e5ce43-18f9-4625-bf68-b60fad9b82bd"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="iccef93e68c604a7c8257204c91951d7d_D20190929-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNC0yMC0xLTEtMA_9e97b953-0d63-41a8-98b3-788c90399d40"
      unitRef="usd">-2000000.0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="iab35dca88c4a489cb3a6e5e8db0006d8_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNS0xLTEtMS0w_91da94a7-4f8a-4a29-ad56-eb1268b61cbe"
      unitRef="usd">-37100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iaa0f9b8412b64c26a40f845a43f78503_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNS01LTEtMS0w_b764e097-6fab-45c9-8f98-842c0c76a6d4"
      unitRef="usd">-1700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i91d506f85cee45e586282ab07a85b12d_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNS03LTEtMS0w_9eba5799-64e2-4672-beb5-6186d2c2f69d"
      unitRef="usd">-900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2a003aff269b4a04b704dad4de10b923_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNS05LTEtMS0w_28f6993a-c301-40a6-ae93-eddeb6e63809"
      unitRef="usd">-22200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2a003aff269b4a04b704dad4de10b923_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNS05LTEtMS0w_55db1ba4-1373-481d-9448-33dd46c839a5"
      unitRef="usd">-22200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibe15f7e0e20e47c29d5afb6680fcde66_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNS0xMS0xLTEtMA_ba2d6ba6-d110-4c9d-8dab-34c51ebaefb5"
      unitRef="usd">-61900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iab35dca88c4a489cb3a6e5e8db0006d8_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNS0xMy0xLTEtMA_4b927cfe-5c60-4f8c-85d5-45ec36187664"
      unitRef="usd">-37100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iaa0f9b8412b64c26a40f845a43f78503_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNS0xNS0xLTEtMA_911a4ad6-10a1-4670-af58-fea4c9e1d8aa"
      unitRef="usd">-1700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i91d506f85cee45e586282ab07a85b12d_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNS0xNy0xLTEtMA_65a15125-9890-4caf-a42a-1a5fc6bf9c1b"
      unitRef="usd">-900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2a003aff269b4a04b704dad4de10b923_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNS0xOS0xLTEtMA_8e28921b-93d3-4e0e-acc2-940e66cecd1a"
      unitRef="usd">-22200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibe15f7e0e20e47c29d5afb6680fcde66_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85MS9mcmFnOmUyMDI4NGU2ZDI1MTRiODc4YWNmZDRiMTM5Y2E4YTc1L3RhYmxlOjBmZWZlZDMxOTM4MjRkNzZhMTQ3OGQxYzMxM2I5MjVhL3RhYmxlcmFuZ2U6MGZlZmVkMzE5MzgyNGQ3NmExNDc4ZDFjMzEzYjkyNWFfNS0yMC0xLTEtMA_785af136-25a7-4e69-b8b4-86dc552e7007"
      unitRef="usd">-61900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85NC9mcmFnOmFhYWUyNWYwZmIxZDQ0YWQ4ODk0Mjc5YjE3N2Q1YjMwL3RleHRyZWdpb246YWFhZTI1ZjBmYjFkNDRhZDg4OTQyNzliMTc3ZDViMzBfMTI2NDQzODM3MjE0MDI_d54fd652-0e99-4cd6-9483-073aa581ed9c">Share RepurchaseOn December 11, 2019, the Board of Directors authorized a share repurchase plan to purchase up to $500.0&#160;million of the Company's outstanding common stock, effective March 2, 2020. During the first quarter of fiscal 2021, the Company repurchased 1.5&#160;million shares of its common stock under this plan for a total consideration of $101.3&#160;million. On December 9, 2020, the Board of Directors authorized a new five-year share repurchase plan to repurchase up to $1.0&#160;billion of the Company's outstanding common stock. The prior plan was terminated in connection with this new authorization. Under the new authorization, during the three and nine months ended June 26, 2021, the Company repurchased 3.0&#160;million and 4.6&#160;million shares of its common stock for a total consideration of $188.4&#160;million and $308.5&#160;million, respectively. As of June 26, 2021, $691.6&#160;million remained available under this authorization.</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ib0df6681d8a44b95b7eecdf8e0e95b6c_I20191211"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85NC9mcmFnOmFhYWUyNWYwZmIxZDQ0YWQ4ODk0Mjc5YjE3N2Q1YjMwL3RleHRyZWdpb246YWFhZTI1ZjBmYjFkNDRhZDg4OTQyNzliMTc3ZDViMzBfMTI3_365d7391-48cc-4265-a893-febc7d590b54"
      unitRef="usd">500000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i42410f9e1104449eae75741c00a10044_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85NC9mcmFnOmFhYWUyNWYwZmIxZDQ0YWQ4ODk0Mjc5YjE3N2Q1YjMwL3RleHRyZWdpb246YWFhZTI1ZjBmYjFkNDRhZDg4OTQyNzliMTc3ZDViMzBfMjc1_b93f874c-06fe-49c0-846a-b507de15334a"
      unitRef="shares">1500000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:ProceedsFromRepurchaseOfEquity
      contextRef="i42410f9e1104449eae75741c00a10044_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85NC9mcmFnOmFhYWUyNWYwZmIxZDQ0YWQ4ODk0Mjc5YjE3N2Q1YjMwL3RleHRyZWdpb246YWFhZTI1ZjBmYjFkNDRhZDg4OTQyNzliMTc3ZDViMzBfMzM0_406ff201-8355-4882-9854-f62986be90bf"
      unitRef="usd">101300000</us-gaap:ProceedsFromRepurchaseOfEquity>
    <us-gaap:StockRepurchaseProgramPeriodInForce1
      contextRef="icbb1f800737f42a09fc4ad36d6f50272_D20201209-20201209"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85NC9mcmFnOmFhYWUyNWYwZmIxZDQ0YWQ4ODk0Mjc5YjE3N2Q1YjMwL3RleHRyZWdpb246YWFhZTI1ZjBmYjFkNDRhZDg4OTQyNzliMTc3ZDViMzBfMTI2NDQzODM3MjE0MTY_bd7862b0-7c3d-41c1-ac95-6a9d900f9ee5">P5Y</us-gaap:StockRepurchaseProgramPeriodInForce1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="iecca63b99d6b4da2bfd35be5986c1ad1_I20201209"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85NC9mcmFnOmFhYWUyNWYwZmIxZDQ0YWQ4ODk0Mjc5YjE3N2Q1YjMwL3RleHRyZWdpb246YWFhZTI1ZjBmYjFkNDRhZDg4OTQyNzliMTc3ZDViMzBfNDc3_b440bba0-451b-41aa-bb6d-8f731e98fe89"
      unitRef="usd">1000000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i2af30393c63846529254a9f5fdc55b28_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85NC9mcmFnOmFhYWUyNWYwZmIxZDQ0YWQ4ODk0Mjc5YjE3N2Q1YjMwL3RleHRyZWdpb246YWFhZTI1ZjBmYjFkNDRhZDg4OTQyNzliMTc3ZDViMzBfMTA5OTUxMTYyODc4Mg_c6bece2e-fcba-4c29-bf13-90e0ff5ffe50"
      unitRef="shares">3000000.0</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="iae354d54c17140f88ee32c1be6023458_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85NC9mcmFnOmFhYWUyNWYwZmIxZDQ0YWQ4ODk0Mjc5YjE3N2Q1YjMwL3RleHRyZWdpb246YWFhZTI1ZjBmYjFkNDRhZDg4OTQyNzliMTc3ZDViMzBfNjkw_b33506d0-3c41-4578-8548-429bcc575674"
      unitRef="shares">4600000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:ProceedsFromRepurchaseOfEquity
      contextRef="i2af30393c63846529254a9f5fdc55b28_D20210328-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85NC9mcmFnOmFhYWUyNWYwZmIxZDQ0YWQ4ODk0Mjc5YjE3N2Q1YjMwL3RleHRyZWdpb246YWFhZTI1ZjBmYjFkNDRhZDg4OTQyNzliMTc3ZDViMzBfNzQ5_7917c17b-6590-44f7-a41f-ca20b78bf8c6"
      unitRef="usd">188400000</us-gaap:ProceedsFromRepurchaseOfEquity>
    <us-gaap:ProceedsFromRepurchaseOfEquity
      contextRef="iae354d54c17140f88ee32c1be6023458_D20200927-20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85NC9mcmFnOmFhYWUyNWYwZmIxZDQ0YWQ4ODk0Mjc5YjE3N2Q1YjMwL3RleHRyZWdpb246YWFhZTI1ZjBmYjFkNDRhZDg4OTQyNzliMTc3ZDViMzBfMTA5OTUxMTYyODgwMw_1bd7007f-f4c2-40f6-8b68-18bd3afe8439"
      unitRef="usd">308500000</us-gaap:ProceedsFromRepurchaseOfEquity>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i44c5cb5c5b47462190024c645f543472_I20210626"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85NC9mcmFnOmFhYWUyNWYwZmIxZDQ0YWQ4ODk0Mjc5YjE3N2Q1YjMwL3RleHRyZWdpb246YWFhZTI1ZjBmYjFkNDRhZDg4OTQyNzliMTc3ZDViMzBfNzc1_5a75c250-30aa-4d96-a983-9fe6f5d80563"
      unitRef="usd">691600000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85Ny9mcmFnOjVmZDA1ZmJlZjU2NjQyZjg5YTBlOWUzZmM0NDBhZDhhL3RleHRyZWdpb246NWZkMDVmYmVmNTY2NDJmODlhMGU5ZTNmYzQ0MGFkOGFfMzc4MQ_7453268f-adab-4c1c-805d-d6a9bdf491c9">New Accounting Pronouncements&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 1 for Recently Adopted Accounting Pronouncements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU No. 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Board issued this Update as part of its initiative to reduce complexity in accounting standards (the Simplification Initiative). For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020 and is applicable to the Company in fiscal 2022. The Company is currently evaluating the impact of the adoption of ASU 2019-12 on its consolidated financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the FASB issued ASU No. 2020-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Board issued this Update to clarify certain interactions between the guidance to account for certain equity securities under Topic 321, the guidance to account for investments under the equity method of accounting in Topic 323, and the guidance in Topic 815. This update could change how an entity accounts for an equity security under the measurement alternative or a forward contract or purchased option to purchase securities that, upon settlement of the forward contract or exercise of the purchased option, would be accounted for under the equity method of accounting or the fair value option in accordance with Topic 825, Financial Instruments. For entities that have adopted the amendments in Update 2020-01, the updated guidance is effective for annual periods beginning after December 15, 2020, and is applicable to the Company in fiscal 2022. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2020-01 on its consolidated financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the FASB issued ASU No. 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Board issued this Update as optional guidance for a limited period of time to ease the potential burden in accounting for or recognizing the effects of reference rate reform on financial reporting. This update will provide optional expedients and exceptions for applying GAAP to only contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. For entities that have adopted the amendments in Update 2020-04, the updated guidance is effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of the adoption of ASU 2020-04 on its consolidated financial position and results of operations.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, FASB issued ASU No. 2021-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848) Scope. &lt;/span&gt;The board issued this Update in response to stakeholder concerns about potential diversity in practice. The Boards decided to clarify the scope of Topic 848 so that derivatives affected by the discounting transition are explicitly eligible for certain optional expedients and exceptions in Topic 848. This update provides optional expedients and exceptions for applying generally accepted accounting principles (GAAP) to only contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. For entities that have adopted the amendments in Update 2021-01, the updated guidance is effective for all entities immediately as of January 2021. The Company is currently evaluating the impact of the adoption of ASU 2021-01 on its consolidated financial position and results of operations.</us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4MWQ5MzBjN2I4NTQ1OTU5NzdlMTdkYjhmZDg0ZWI0L3NlYzoxODFkOTMwYzdiODU0NTk1OTc3ZTE3ZGI4ZmQ4NGViNF85Ny9mcmFnOjVmZDA1ZmJlZjU2NjQyZjg5YTBlOWUzZmM0NDBhZDhhL3RleHRyZWdpb246NWZkMDVmYmVmNTY2NDJmODlhMGU5ZTNmYzQ0MGFkOGFfMzc3MA_83bdc655-16f3-41d0-8e75-b62fe708470c">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU No. 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Board issued this Update as part of its initiative to reduce complexity in accounting standards (the Simplification Initiative). For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020 and is applicable to the Company in fiscal 2022. The Company is currently evaluating the impact of the adoption of ASU 2019-12 on its consolidated financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the FASB issued ASU No. 2020-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Board issued this Update to clarify certain interactions between the guidance to account for certain equity securities under Topic 321, the guidance to account for investments under the equity method of accounting in Topic 323, and the guidance in Topic 815. This update could change how an entity accounts for an equity security under the measurement alternative or a forward contract or purchased option to purchase securities that, upon settlement of the forward contract or exercise of the purchased option, would be accounted for under the equity method of accounting or the fair value option in accordance with Topic 825, Financial Instruments. For entities that have adopted the amendments in Update 2020-01, the updated guidance is effective for annual periods beginning after December 15, 2020, and is applicable to the Company in fiscal 2022. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2020-01 on its consolidated financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the FASB issued ASU No. 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Board issued this Update as optional guidance for a limited period of time to ease the potential burden in accounting for or recognizing the effects of reference rate reform on financial reporting. This update will provide optional expedients and exceptions for applying GAAP to only contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. For entities that have adopted the amendments in Update 2020-04, the updated guidance is effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of the adoption of ASU 2020-04 on its consolidated financial position and results of operations.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, FASB issued ASU No. 2021-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848) Scope. &lt;/span&gt;The board issued this Update in response to stakeholder concerns about potential diversity in practice. The Boards decided to clarify the scope of Topic 848 so that derivatives affected by the discounting transition are explicitly eligible for certain optional expedients and exceptions in Topic 848. This update provides optional expedients and exceptions for applying generally accepted accounting principles (GAAP) to only contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. For entities that have adopted the amendments in Update 2021-01, the updated guidance is effective for all entities immediately as of January 2021. The Company is currently evaluating the impact of the adoption of ASU 2021-01 on its consolidated financial position and results of operations.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452092790312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jul. 22, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">01752<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-36214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 26,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HOLOGIC, INC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000859737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--09-28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">253,487,389<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(508)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">263-2900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-2902449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">250 Campus Drive,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Marlborough,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HOLX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452083037480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Income - USD ($)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ProductRevenue', window );">Product</a></td>
<td class="nump">$ 995,200,000<span></span>
</td>
<td class="nump">$ 701,600,000<span></span>
</td>
<td class="nump">$ 3,829,400,000<span></span>
</td>
<td class="nump">$ 2,024,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ServiceRevenue', window );">Service and other</a></td>
<td class="nump">173,100,000<span></span>
</td>
<td class="nump">121,300,000<span></span>
</td>
<td class="nump">486,300,000<span></span>
</td>
<td class="nump">405,000,000.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,168,300,000<span></span>
</td>
<td class="nump">822,900,000<span></span>
</td>
<td class="nump">4,315,700,000<span></span>
</td>
<td class="nump">2,429,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Costs of revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Product</a></td>
<td class="nump">303,900,000<span></span>
</td>
<td class="nump">225,100,000<span></span>
</td>
<td class="nump">889,100,000<span></span>
</td>
<td class="nump">685,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AmortizationCostofGoodsSold', window );">Amortization, Cost of Goods Sold</a></td>
<td class="nump">68,100,000<span></span>
</td>
<td class="nump">62,900,000<span></span>
</td>
<td class="nump">194,200,000<span></span>
</td>
<td class="nump">189,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment', window );">Impairment of intangible assets and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">25,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Costofservice', window );">Service and other</a></td>
<td class="nump">94,700,000<span></span>
</td>
<td class="nump">68,800,000<span></span>
</td>
<td class="nump">264,700,000<span></span>
</td>
<td class="nump">232,700,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">701,600,000<span></span>
</td>
<td class="nump">466,100,000<span></span>
</td>
<td class="nump">2,967,700,000<span></span>
</td>
<td class="nump">1,295,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">69,000,000.0<span></span>
</td>
<td class="nump">55,100,000<span></span>
</td>
<td class="nump">199,800,000<span></span>
</td>
<td class="nump">165,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing</a></td>
<td class="nump">142,700,000<span></span>
</td>
<td class="nump">103,500,000<span></span>
</td>
<td class="nump">402,200,000<span></span>
</td>
<td class="nump">359,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">117,300,000<span></span>
</td>
<td class="nump">105,300,000<span></span>
</td>
<td class="nump">297,700,000<span></span>
</td>
<td class="nump">259,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">10,400,000<span></span>
</td>
<td class="nump">10,200,000<span></span>
</td>
<td class="nump">30,700,000<span></span>
</td>
<td class="nump">29,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of intangible assets and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1', window );">Contingent consideration fair value adjustments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(10,100,000)<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and divestiture charges</a></td>
<td class="nump">3,600,000<span></span>
</td>
<td class="nump">1,000,000.0<span></span>
</td>
<td class="nump">6,600,000<span></span>
</td>
<td class="nump">4,800,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="nump">343,000,000.0<span></span>
</td>
<td class="nump">275,100,000<span></span>
</td>
<td class="nump">926,900,000<span></span>
</td>
<td class="nump">823,500,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">358,600,000<span></span>
</td>
<td class="nump">191,000,000.0<span></span>
</td>
<td class="nump">2,040,800,000<span></span>
</td>
<td class="nump">472,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="nump">4,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(21,600,000)<span></span>
</td>
<td class="num">(27,400,000)<span></span>
</td>
<td class="num">(70,900,000)<span></span>
</td>
<td class="num">(91,500,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(21,600,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">4,300,000<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes</a></td>
<td class="nump">337,500,000<span></span>
</td>
<td class="nump">168,400,000<span></span>
</td>
<td class="nump">1,950,500,000<span></span>
</td>
<td class="nump">384,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision (benefit) for income taxes</a></td>
<td class="nump">69,400,000<span></span>
</td>
<td class="nump">32,000,000.0<span></span>
</td>
<td class="nump">409,600,000<span></span>
</td>
<td class="num">(232,100,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">268,100,000<span></span>
</td>
<td class="nump">136,400,000<span></span>
</td>
<td class="nump">1,540,900,000<span></span>
</td>
<td class="nump">616,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable', window );">Net loss attributable to noncontrolling interest</a></td>
<td class="num">(300,000)<span></span>
</td>
<td class="num">(1,500,000)<span></span>
</td>
<td class="num">(1,800,000)<span></span>
</td>
<td class="num">(3,400,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Netincome', window );">Net income attributable to Hologic</a></td>
<td class="nump">$ 268,400,000<span></span>
</td>
<td class="nump">$ 137,900,000<span></span>
</td>
<td class="nump">$ 1,542,700,000<span></span>
</td>
<td class="nump">$ 620,300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per common share attributable to Hologic:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in usd per share)</a></td>
<td class="nump">$ 1.05<span></span>
</td>
<td class="nump">$ 0.53<span></span>
</td>
<td class="nump">$ 5.98<span></span>
</td>
<td class="nump">$ 2.35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in usd per share)</a></td>
<td class="nump">$ 1.04<span></span>
</td>
<td class="nump">$ 0.53<span></span>
</td>
<td class="nump">$ 5.93<span></span>
</td>
<td class="nump">$ 2.34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average number of shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">256,230<span></span>
</td>
<td class="nump">259,870<span></span>
</td>
<td class="nump">257,769<span></span>
</td>
<td class="nump">263,667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">258,581<span></span>
</td>
<td class="nump">261,047<span></span>
</td>
<td class="nump">260,371<span></span>
</td>
<td class="nump">265,092<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AmortizationCostofGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization, Cost of Goods Sold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AmortizationCostofGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in cost of product sales in the period resulting from the write-down of the carrying amount of an intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Costofservice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of service</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Costofservice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Netincome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net income attributable to Hologic</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Netincome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ProductRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product Revenue</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ProductRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ServiceRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Service Revenue</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ServiceRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of right to a contingent consideration asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) attributable to other redeemable noncontrolling equity holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452165481048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 268.1<span></span>
</td>
<td class="nump">$ 136.4<span></span>
</td>
<td class="nump">$ 1,540.9<span></span>
</td>
<td class="nump">$ 616.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Changes in foreign currency translation adjustment</a></td>
<td class="num">(9.4)<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Changes in value of hedged interest rate swaps and interest rate caps, net of tax of $1.0 and $2.2 for the three and nine months ended June 26, 2021 and $(1.5) and $(7.9) for the three and nine months ended June 27, 2020.</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="num">(4.7)<span></span>
</td>
<td class="nump">8.0<span></span>
</td>
<td class="num">(25.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax', window );">Loss reclassified from accumulated other comprehensive loss to the statements of income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive (loss) income</a></td>
<td class="num">(6.4)<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="nump">7.5<span></span>
</td>
<td class="num">(19.6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">261.7<span></span>
</td>
<td class="nump">133.4<span></span>
</td>
<td class="nump">1,548.4<span></span>
</td>
<td class="nump">597.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ComprehensiveIncome', window );">Comprehensive Income</a></td>
<td class="nump">$ 262.0<span></span>
</td>
<td class="nump">$ 134.9<span></span>
</td>
<td class="nump">$ 1,550.2<span></span>
</td>
<td class="nump">$ 600.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Comprehensive Income</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph c<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41638-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724391-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558989&amp;loc=d3e80720-113993<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452078452920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax', window );">Change in value of hedged interest rate swap and interest rate cap, tax</a></td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="num">$ (1.5)<span></span>
</td>
<td class="nump">$ 2.2<span></span>
</td>
<td class="num">$ (7.9)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452086233064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash less assets held for sale</a></td>
<td class="nump">$ 827.6<span></span>
</td>
<td class="nump">$ 701.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, less reserves</a></td>
<td class="nump">943.2<span></span>
</td>
<td class="nump">1,028.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">502.9<span></span>
</td>
<td class="nump">395.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PrepaidIncomeTaxesCurrent', window );">Prepaid Income Taxes-Current</a></td>
<td class="nump">63.0<span></span>
</td>
<td class="nump">38.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">81.5<span></span>
</td>
<td class="nump">58.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">2,418.2<span></span>
</td>
<td class="nump">2,222.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">551.1<span></span>
</td>
<td class="nump">491.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">1,800.8<span></span>
</td>
<td class="nump">1,307.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">3,264.2<span></span>
</td>
<td class="nump">2,657.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">556.3<span></span>
</td>
<td class="nump">516.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">8,590.6<span></span>
</td>
<td class="nump">7,195.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">460.6<span></span>
</td>
<td class="nump">324.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">208.4<span></span>
</td>
<td class="nump">178.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">579.4<span></span>
</td>
<td class="nump">547.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">213.1<span></span>
</td>
<td class="nump">186.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligationsCurrent', window );">Current portion of capital lease obligations</a></td>
<td class="nump">3.1<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,464.6<span></span>
</td>
<td class="nump">1,239.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net of current portion</a></td>
<td class="nump">2,654.7<span></span>
</td>
<td class="nump">2,713.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligationsNoncurrent', window );">Finance lease obligations, net of current portion</a></td>
<td class="nump">22.9<span></span>
</td>
<td class="nump">17.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred Income Tax Liabilities, Net</a></td>
<td class="nump">284.8<span></span>
</td>
<td class="nump">201.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Deferred revenue, net of current portion</a></td>
<td class="nump">15.0<span></span>
</td>
<td class="nump">12.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">271.5<span></span>
</td>
<td class="nump">303.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01 par value &#8211; 1,623 shares authorized; 0 shares issued</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value &#8211;750,000 shares authorized; 296,945 and 295,107 shares issued, respectively</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="nump">5,936.2<span></span>
</td>
<td class="nump">5,904.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(30.5)<span></span>
</td>
<td class="num">(1,573.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost &#8211; 43,653 and 37,609 shares, respectively</a></td>
<td class="num">(1,989.4)<span></span>
</td>
<td class="num">(1,579.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(42.2)<span></span>
</td>
<td class="num">(49.7)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Hologic's stockholders&#8217; equity</a></td>
<td class="nump">3,877.1<span></span>
</td>
<td class="nump">2,705.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Stockholders' Equity Attributable to Noncontrolling Interest</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">3,877.1<span></span>
</td>
<td class="nump">2,707.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 8,590.6<span></span>
</td>
<td class="nump">$ 7,195.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PrepaidIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid Income Taxes-Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PrepaidIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of capital lease obligation due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121569800&amp;loc=d3e45023-112735<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121616839&amp;loc=d3e45280-112737<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligationsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121616839&amp;loc=d3e45280-112737<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121569800&amp;loc=d3e45023-112735<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeaseObligationsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452092242792">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, reserves</a></td>
<td class="nump">$ 39.8<span></span>
</td>
<td class="nump">$ 31.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 10,000.00<span></span>
</td>
<td class="nump">$ 10,000.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized (in shares)</a></td>
<td class="nump">1,623,000,000<span></span>
</td>
<td class="nump">1,623,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 10,000.00<span></span>
</td>
<td class="nump">$ 10,000.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">750,000,000,000<span></span>
</td>
<td class="nump">750,000,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">296,945,000,000<span></span>
</td>
<td class="nump">295,107,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">43,653,000,000<span></span>
</td>
<td class="nump">37,609,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452083696952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br> shares in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th">
<div>Share Repurchase Program </div>
<div>Treasury Stock</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount', window );">Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination', window );">Noncontrolling Interest, Increase from Business Combination</a></td>
<td class="nump">8,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Sep. 28, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">292,323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Sep. 28, 2019</a></td>
<td class="nump">2,115,700,000<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="nump">$ 5,769,800,000<span></span>
</td>
<td class="num">$ (2,688,700,000)<span></span>
</td>
<td class="num">$ (42,300,000)<span></span>
</td>
<td class="num">$ (926,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance (Accounting Standards Update 2018-01 [Member]) at Sep. 28, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">385,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,545<span></span>
</td>
<td class="nump">3,279<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Repurchase of common stock</a></td>
<td class="num">(80,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (80,900,000)<span></span>
</td>
<td class="num">$ (164,000,000.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchaseProgramAdjustment', window );">Accelerated share repurchase agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (41,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 28, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">293,339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 28, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="nump">5,749,800,000<span></span>
</td>
<td class="num">(2,302,300,000)<span></span>
</td>
<td class="num">(28,700,000)<span></span>
</td>
<td class="num">$ (1,170,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable', window );">Net loss attributable to noncontrolling interest</a></td>
<td class="num">(300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Netincome', window );">Net income</a></td>
<td class="nump">386,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Acceleratedsharerepurchaseagreement', window );">Accelerated share repurchase agreement</a></td>
<td class="num">(205,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Payments to Noncontrolling Interests</a></td>
<td class="num">(1,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Sep. 28, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">292,323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Sep. 28, 2019</a></td>
<td class="nump">2,115,700,000<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="nump">5,769,800,000<span></span>
</td>
<td class="num">(2,688,700,000)<span></span>
</td>
<td class="num">(42,300,000)<span></span>
</td>
<td class="num">$ (926,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance (Accounting Standards Update 2018-01 [Member]) at Sep. 28, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">616,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Jun. 27, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">294,684<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 27, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="nump">5,861,700,000<span></span>
</td>
<td class="num">(2,068,100,000)<span></span>
</td>
<td class="num">(61,900,000)<span></span>
</td>
<td class="num">$ (1,479,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable', window );">Net loss attributable to noncontrolling interest</a></td>
<td class="num">(3,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Netincome', window );">Net income</a></td>
<td class="nump">620,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Payments to Noncontrolling Interests</a></td>
<td class="num">(1,800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount', window );">Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount</a></td>
<td class="nump">6,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">2,257,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 28, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">293,339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 28, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="nump">5,749,800,000<span></span>
</td>
<td class="num">(2,302,300,000)<span></span>
</td>
<td class="num">(28,700,000)<span></span>
</td>
<td class="num">$ (1,170,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under the employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under the employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">94,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,851<span></span>
</td>
<td class="nump">628<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (267,600,000)<span></span>
</td>
<td class="num">$ (41,000,000.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchaseProgramAdjustment', window );">Accelerated share repurchase agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Mar. 28, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">294,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 28, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="nump">5,827,600,000<span></span>
</td>
<td class="num">(2,206,000,000.0)<span></span>
</td>
<td class="num">(58,900,000)<span></span>
</td>
<td class="num">$ (1,479,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable', window );">Net loss attributable to noncontrolling interest</a></td>
<td class="num">(1,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Netincome', window );">Net income</a></td>
<td class="nump">96,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Acceleratedsharerepurchaseagreement', window );">Accelerated share repurchase agreement</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Payments to Noncontrolling Interests</a></td>
<td class="num">(300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount', window );">Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount</a></td>
<td class="nump">5,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">2,091,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">136,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Jun. 27, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">294,684<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 27, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="nump">5,861,700,000<span></span>
</td>
<td class="num">(2,068,100,000)<span></span>
</td>
<td class="num">(61,900,000)<span></span>
</td>
<td class="num">$ (1,479,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable', window );">Net loss attributable to noncontrolling interest</a></td>
<td class="num">(1,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Netincome', window );">Net income</a></td>
<td class="nump">137,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Payments to Noncontrolling Interests</a></td>
<td class="num">(100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount', window );">Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount</a></td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">2,258,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under the employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under the employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">493,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (100,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Sep. 26, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 26, 2020</a></td>
<td class="nump">2,705,200,000<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="nump">5,904,800,000<span></span>
</td>
<td class="num">(1,573,200,000)<span></span>
</td>
<td class="num">(49,700,000)<span></span>
</td>
<td class="num">$ (1,579,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable', window );">Net loss attributable to noncontrolling interest</a></td>
<td class="num">(1,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Netincome', window );">Net income</a></td>
<td class="nump">494,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount', window );">Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount</a></td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">2,707,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ChangeInParValue', window );">Change in par value</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes</a></td>
<td class="num">(46,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(46,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under the employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">653,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Repurchase of common stock</a></td>
<td class="num">(101,300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (101,300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 26, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">296,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 26, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000.0<span></span>
</td>
<td class="nump">5,895,300,000<span></span>
</td>
<td class="num">(918,800,000)<span></span>
</td>
<td class="num">(30,700,000)<span></span>
</td>
<td class="num">$ (1,680,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable', window );">Net loss attributable to noncontrolling interest</a></td>
<td class="num">(1,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Netincome', window );">Net income</a></td>
<td class="nump">654,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Sep. 26, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Sep. 26, 2020</a></td>
<td class="nump">2,705,200,000<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="nump">5,904,800,000<span></span>
</td>
<td class="num">(1,573,200,000)<span></span>
</td>
<td class="num">(49,700,000)<span></span>
</td>
<td class="num">$ (1,579,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">1,540,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Jun. 26, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">296,945<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 26, 2021</a></td>
<td class="nump">3,877,100,000<span></span>
</td>
<td class="nump">$ 3,000,000.0<span></span>
</td>
<td class="nump">5,936,200,000<span></span>
</td>
<td class="num">(30,500,000)<span></span>
</td>
<td class="num">(42,200,000)<span></span>
</td>
<td class="num">$ (1,989,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable', window );">Net loss attributable to noncontrolling interest</a></td>
<td class="num">(1,800,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Netincome', window );">Net income</a></td>
<td class="nump">1,542,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Payments to Noncontrolling Interests</a></td>
<td class="num">(8,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount', window );">Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount</a></td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">3,269,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 26, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">296,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 26, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000.0<span></span>
</td>
<td class="nump">5,895,300,000<span></span>
</td>
<td class="num">(918,800,000)<span></span>
</td>
<td class="num">(30,700,000)<span></span>
</td>
<td class="num">$ (1,680,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes</a></td>
<td class="num">(300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under the employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under the employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">619,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,604<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Repurchase of common stock</a></td>
<td class="num">(120,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (120,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Mar. 27, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">296,887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 27, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000.0<span></span>
</td>
<td class="nump">5,927,100,000<span></span>
</td>
<td class="num">(298,900,000)<span></span>
</td>
<td class="num">(35,800,000)<span></span>
</td>
<td class="num">$ (1,801,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable', window );">Net loss attributable to noncontrolling interest</a></td>
<td class="num">(500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Netincome', window );">Net income</a></td>
<td class="nump">619,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount', window );">Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount</a></td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">3,795,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes</a></td>
<td class="num">(200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">268,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,971<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Repurchase of common stock</a></td>
<td class="num">(188,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (188,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_TotalPaymentsToNonControllingInterest', window );">Total payments to non-controlling interest</a></td>
<td class="nump">8,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PurchaseOfNonControllingInterestReclassifiedToAPIC', window );">Purchase of non-controlling interest reclassified to APIC</a></td>
<td class="num">(8,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Jun. 26, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">296,945<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 26, 2021</a></td>
<td class="nump">3,877,100,000<span></span>
</td>
<td class="nump">$ 3,000,000.0<span></span>
</td>
<td class="nump">$ 5,936,200,000<span></span>
</td>
<td class="num">$ (30,500,000)<span></span>
</td>
<td class="num">$ (42,200,000)<span></span>
</td>
<td class="num">$ (1,989,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable', window );">Net loss attributable to noncontrolling interest</a></td>
<td class="num">(300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Netincome', window );">Net income</a></td>
<td class="nump">268,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Payments to Noncontrolling Interests</a></td>
<td class="num">(300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount', window );">Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">$ 3,877,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Acceleratedsharerepurchaseagreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accelerated share repurchase agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Acceleratedsharerepurchaseagreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ChangeInParValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in par value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ChangeInParValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Netincome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net income attributable to Hologic</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Netincome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PurchaseOfNonControllingInterestReclassifiedToAPIC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase of non-controlling interest reclassified to APIC</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PurchaseOfNonControllingInterestReclassifiedToAPIC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_TotalPaymentsToNonControllingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total payments to non-controlling interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_TotalPaymentsToNonControllingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchaseProgramAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount needed to adjust previously recorded stockholders' equity balances to the actual aggregate amounts paid, whether in cash or other consideration, to acquire all of the shares purchased under an Accelerated Share Repurchase arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchaseProgramAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) attributable to other redeemable noncontrolling equity holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncontrolling interests which are redeemable by the parent entity, classified as other equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredParValueMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredParValueMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201801Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201801Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452091898328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 1,540,900,000<span></span>
</td>
<td class="nump">$ 616,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">64,200,000<span></span>
</td>
<td class="nump">62,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization of acquired intangibles</a></td>
<td class="nump">224,900,000<span></span>
</td>
<td class="nump">218,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">51,000,000.0<span></span>
</td>
<td class="nump">53,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(44,300,000)<span></span>
</td>
<td class="num">(63,300,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Intangible asset and equipment impairment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">30,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment loss</a></td>
<td class="nump">21,600,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other adjustments and non-cash items</a></td>
<td class="nump">19,800,000<span></span>
</td>
<td class="nump">23,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, excluding the effect of acquisitions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">111,500,000<span></span>
</td>
<td class="num">(130,500,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(82,400,000)<span></span>
</td>
<td class="num">(48,000,000.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidTaxes', window );">Prepaid income taxes</a></td>
<td class="num">(24,300,000)<span></span>
</td>
<td class="num">(10,600,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(22,300,000)<span></span>
</td>
<td class="num">(290,000,000.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">9,400,000<span></span>
</td>
<td class="num">(55,100,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="num">(27,600,000)<span></span>
</td>
<td class="nump">40,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">22,600,000<span></span>
</td>
<td class="nump">5,500,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">1,865,000,000.0<span></span>
</td>
<td class="nump">454,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition of businesses, net of cash acquired</a></td>
<td class="num">(1,163,300,000)<span></span>
</td>
<td class="num">(43,200,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ProceedsFromSaleOfBusiness', window );">Proceeds From Sale Of Business</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">142,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(71,200,000)<span></span>
</td>
<td class="num">(53,200,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements', window );">Increase in equipment under customer usage agreements</a></td>
<td class="num">(43,400,000)<span></span>
</td>
<td class="num">(44,900,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PurchaseOfIntellectualProperty', window );">Purchase of intellectual property</a></td>
<td class="num">(6,500,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other activity</a></td>
<td class="num">(2,100,000)<span></span>
</td>
<td class="num">(5,100,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(1,286,500,000)<span></span>
</td>
<td class="num">(3,700,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayment of long-term debt</a></td>
<td class="num">(56,300,000)<span></span>
</td>
<td class="num">(36,400,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ProceedsFromSeniorNotes', window );">Proceeds from Notes Payable</a></td>
<td class="nump">950,000,000.0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RepaymentOfSeniorNotes', window );">Repayments of Senior Debt</a></td>
<td class="num">(970,800,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from revolving credit line</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">750,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayment under revolving credit line</a></td>
<td class="num">(250,000,000.0)<span></span>
</td>
<td class="num">(250,000,000.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromAccountsReceivableSecuritization', window );">Proceeds from accounts receivable securitization agreement</a></td>
<td class="nump">320,000,000.0<span></span>
</td>
<td class="nump">16,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfAccountsReceivableSecuritization', window );">Repayments of Accounts Receivable Securitization</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(250,000,000.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Payments to Noncontrolling Interests</a></td>
<td class="num">(8,500,000)<span></span>
</td>
<td class="num">(1,800,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment of deferred acquisition consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(24,300,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payment of debt issuance costs</a></td>
<td class="num">(13,700,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="num">(409,700,000)<span></span>
</td>
<td class="num">(553,400,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from issuance of common stock pursuant to employee stock plans</a></td>
<td class="nump">39,600,000<span></span>
</td>
<td class="nump">54,700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits', window );">Payment of minimum tax withholdings on net share settlements of equity awards</a></td>
<td class="num">(46,900,000)<span></span>
</td>
<td class="num">(12,600,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations', window );">Payments under finance lease obligations</a></td>
<td class="num">(1,500,000)<span></span>
</td>
<td class="num">(1,200,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(447,800,000)<span></span>
</td>
<td class="num">(309,000,000.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="num">(4,100,000)<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">126,600,000<span></span>
</td>
<td class="nump">142,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">701,000,000.0<span></span>
</td>
<td class="nump">601,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">$ 827,600,000<span></span>
</td>
<td class="nump">$ 744,200,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The payment of minimum statutory tax withholdings to taxing authorities on the behalf of employees from the net share settlement upon vesting of restricted stock units. This payment is not an expense of the Company nor an operating activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow related to equipment placed at customer locations for which title is not transferred to the Company's customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ProceedsFromSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from sale of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ProceedsFromSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ProceedsFromSeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Senior Notes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ProceedsFromSeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PurchaseOfIntellectualProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase of intellectual property</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PurchaseOfIntellectualProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_RepaymentOfSeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repayment of Senior Notes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_RepaymentOfSeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromAccountsReceivableSecuritization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from securitizations of receivables treated as collateralized borrowings, which are classified as financing transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromAccountsReceivableSecuritization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfAccountsReceivableSecuritization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repayments of securitizations of receivables treated as collateralized borrowings, which are classified as financing transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfAccountsReceivableSecuritization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the obligation for a lease meeting the criteria for capitalization (with maturities exceeding one year or beyond the operating cycle of the entity, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452081095608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 26, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BasisofPresentationAbstract', window );"><strong>Basis of Presentation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of Presentation<div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements of Hologic, Inc. (&#8220;Hologic&#8221; or the &#8220;Company&#8221;) presented herein have been prepared pursuant to the rules of the Securities and Exchange Commission (the &#8220;SEC&#8221;) for quarterly reports on Form 10-Q and do not include all of the information and disclosures required by U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) for annual financial statements. These financial statements should be read in conjunction with the consolidated financial statements and related notes for the fiscal year ended September&#160;26, 2020 included in the Company&#8217;s Form&#160;10-K filed with the SEC on November&#160;17, 2020. In the opinion of management, the financial statements and notes contain all adjustments (consisting of normal recurring accruals and all other necessary adjustments) considered necessary for a fair presentation of the Company&#8217;s financial position, results of operations and cash flows for the periods presented.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from management&#8217;s estimates if past experience or other assumptions do not turn out to be substantially accurate. Operating results for the three and nine months ended June&#160;26, 2021 are not necessarily indicative of the results to be expected for any other interim period or the entire fiscal year ending September&#160;25, 2021. </span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments &#8211; Credit Losses (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The purpose of ASU 2016-13 is to replace the current incurred loss impairment methodology for financial assets measured at amortized cost with a methodology that reflects expected credit losses over the lifetime of the financial asset. As a result, credit losses are recorded when financial assets are established if credit losses are expected over the asset's contractual life. The measurement of expected credit losses is based upon historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The Company adopted the standard during the first quarter of fiscal 2021. The adoption of ASU 2016-13 did not have a material effect on the Company's consolidated financial statements. See Note 8 for additional information.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, the FASB issued ASU No. 2019-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Stock Compensation (Topic 718) and Revenue from Contracts with Customers (Topic 606)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This ASU identifies, evaluates, and improves areas of GAAP for which cost and complexity can be reduced while maintaining or improving the usefulness of the information provided. The amendments in this Update expanded the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. The Company adopted this ASU in the first quarter of fiscal 2021, which did not have a material effect on the Company's financial statements.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events Consideration</span></div>The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence for certain estimates or to identify matters that may require additional disclosure. Subsequent events have been evaluated as required. There were no material recognized or unrecognized subsequent events affecting the unaudited consolidated financial statements as of and for the three and nine months ended June&#160;26, 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BasisofPresentationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Basis of Presentation [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BasisofPresentationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452083591736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 26, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">LeasesLessor Activity - Leases where Hologic is the LessorCertain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating lease and performance obligations for disposables, reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. Sales-type leases are immaterial. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented less than 5% of the Company's consolidated revenue for all periods presented.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">LeasesLessor Activity - Leases where Hologic is the LessorCertain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating lease and performance obligations for disposables, reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. Sales-type leases are immaterial. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented less than 5% of the Company's consolidated revenue for all periods presented.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452082380728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 26, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</a></td>
<td class="text">Fair Value Measurements<div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets/Liabilities Measured and Recorded at Fair Value on a Recurring Basis</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has investments in derivative instruments comprised of an interest rate swap, forward foreign currency contracts and foreign currency option contracts, which are valued using analyses obtained from independent third party valuation specialists based on market observable inputs, representing Level 2 measurements. The fair values of these derivative </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">contracts represent the estimated amounts the Company would receive or pay to terminate the contracts. Refer to Note 9 for further discussion and information on derivative instruments. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following at June&#160;26, 2021:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:17pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.029%"><tr><td style="width:1.0%"/><td style="width:37.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.130%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.130%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.288%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at Reporting Date Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of June 26, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices&#160;in<br/>Active&#160;Market&#160;for<br/>Identical&#160;Assets<br/>(Level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs&#160;(Level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs&#160;(Level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:13pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liabilities Measured and Recorded at Fair Value on a Recurring Basis</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of recurring fair value measurements using significant unobservable inputs (Level 3), which solely consisted of contingent consideration liabilities, during the three and nine month periods ended June 26, 2021 and June 27, 2020 were as follows:</span></div><div style="margin-top:18pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:6.148%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.580%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.480%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Month Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27, 2020</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration recorded at acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets Measured and Recorded at Fair Value on a Nonrecurring Basis</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company remeasures the fair value of certain assets and liabilities upon the occurrence of certain events. Such assets are comprised of equity investments and long-lived assets, including property, plant and equipment, intangible assets and goodwill. There were no such remeasurements to equity investments in the three and nine months ended June&#160;26, 2021 and June&#160;27, 2020. During the first quarter of fiscal 2020, the Company's Medical Aesthetics division met the criteria to be classified as assets-held-for sale, and the Company recorded a $30.2 million loss to record the asset group at its fair value less costs to sell. This was a level 1 measurement. See Note 6 for additional information. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosure of Fair Value of Financial Instruments</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial instruments mainly consist of cash and cash equivalents, accounts receivable, equity investments, an interest rate swap, forward foreign currency contracts, foreign currency option contracts, insurance contracts, accounts payable and debt obligations. The carrying amounts of the Company&#8217;s cash and cash equivalents, accounts receivable and accounts payable approximate their fair value due to the short-term nature of these instruments. The Company&#8217;s interest rate swap, forward foreign currency contracts and foreign currency option contracts are recorded at fair value. The carrying amount of the insurance contracts are recorded at the cash surrender value, as required by GAAP, which approximates fair value. The Company believes the carrying amounts of its cost-method equity investments approximate fair value.</span></div>Amounts outstanding under the Company&#8217;s 2018 Credit Agreement (as defined below) of $1.4 billion aggregate principal as of June&#160;26, 2021 are subject to variable interest rates of interest based on current market rates, and as such, the Company believes the carrying amount of these obligations approximates fair value. The Company&#8217;s 2028 Senior Notes and 2029 Senior Notes had fair values of $420.8 million and $940.0 million, respectively, as of June&#160;26, 2021 based on their trading prices, representing Level 1 measurements. Refer to Note 7 for the carrying amounts of the various components of the Company&#8217;s debt.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452082939976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 26, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combinations</a></td>
<td class="text">Business Combinations<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal 2021 Acquisitions</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Mobidiag Oy</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 17, 2021, the Company completed the acquisition of Mobidiag Oy ("Mobidiag"), for a purchase price of $729.6&#160;million. Mobidiag, located in Finland, manufactures molecular diagnostic solutions for gastrointestinal infections, antimicrobial resistance management and other infections. Mobidiag's results of operations are reported in the Company's Diagnostics reportable segment from the date of acquisition.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Mobidiag's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of June 17, 2021, as set forth below.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="margin-top:6pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.865%"><tr><td style="width:1.0%"/><td style="width:7.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:62.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.878%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">729.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Mobidiag's business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, including but not limited to the estimation of the fair value of the identifiable intangible assets, long-term debt, and deferred income taxes.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets are development technology, in-process research and development ("IPR&amp;D"), customer relationships and trade names. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using rates ranging from 14.5% to 16.0%. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The developed technology assets are comprised of know-how, patents and technologies embedded in Mobidiag's products and relate to currently marketed products. The developed technology assets comprise the primary product families under the Novodiag and Amplidiag technology platforms.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IPR&amp;D projects relate to in-process projects that have not reached technological feasibility as of the acquisition date and have no alternative future use. The primary basis for determining technological feasibility of these projects is obtaining regulatory approval to market the underlying project or expected commercial release depending on the project. The Company recorded, on a preliminary basis, $103.0&#160;million of IPR&amp;D related to three projects. The Company expects to complete these three projects over the next three years. Given the uncertainties inherent with product development and introduction, there can be no assurance that any of the Company's product development efforts will be successful, completed on a timely basis or within budget, if at all. All of the IPR&amp;D assets were valued using the income approach.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preliminary estimate of the weighted average life for the developed technology assets range from 10 to 12 years, customer relationships range from 5 to 11 years, and tradenames range from 10 to 12 years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the preliminary amount of goodwill were primarily based on anticipated strategic and synergistic benefits that are expected to be realized from the Mobidiag acquisition. These benefits include expanding the Company's molecular diagnostics portfolio into the near-patient testing market and utilizing Diagnostic's sales and regulatory expertise to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Biotheranostics</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 22, 2021, the Company completed the acquisition of Biotheranostics, Inc. ("Biotheranostics"), for a purchase price of $231.3&#160;million. Biotheranostics, located in San Diego, California, manufactures molecular diagnostic tests for breast and metastatic cancers and performs the lab testing procedures at its facility. Biotheranostics' results of operations are reported in the Company's Diagnostics reportable segment from the date of acquisition and its revenues are reported within Service and other revenue in the Company's Consolidated Statements of Income and within service revenue in our disclosure of disaggregated revenue in Note 2.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Biotheranostics' preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of February 22, 2021, as set forth below.</span></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.865%"><tr><td style="width:1.0%"/><td style="width:7.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:62.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.878%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Biotheranostics' business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, the estimation of the fair value of the identifiable intangible assets, and income taxes.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets are developed technology and trade names. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a 18.0% rate. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and trade names is 10 years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the preliminary amount of goodwill were primarily based on anticipated synergistic benefits of adding Biotheranostics' CLIA (Clinical </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laboratory Improvement Amendments) lab to the Company's portfolio of offerings and utilizing Diagnostic's marketing and regulatory expertise to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diagenode</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 1, 2021, the Company completed the acquisition of Diagenode SA ("Diagenode") for a purchase price of $155.1&#160;million. Diagenode, located in Belgium, is a developer and manufacturer of molecular diagnostic assays based on PCR (polymerase chain reaction) technology to detect infectious diseases of bacterial, viral or parasite origin. Diagenode's results of operations are reported in the Company's Diagnostics reportable segment from the date of acquisition. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Diagenode's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of March 1, 2021, as set forth below.</span></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.865%"><tr><td style="width:1.0%"/><td style="width:7.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:62.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.878%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Diagenode's business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, the estimation of the fair value of the identifiable intangible assets, and income taxes.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets are developed technology and customer relationships. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a 14.5% rate for developed technology and a 13.5% rate for customer relationships. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and customer relationships is 10 years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the preliminary amount of goodwill were based on anticipated synergistic benefits of Diagenode's products broadening the Diagnostics portfolio of molecular diagnostics products primarily in the transplant and acute care gastrointestinal and respiratory space as customers seek a broader menu of tests, utilizing Diagnostic's sales force to drive menu expansion and revenue growth and gaining additional PCR assay development expertise. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Somatex Medical Technologies</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2020, the Company completed the acquisition of Somatex Medical Technologies GmbH ("Somatex") for a purchase price of $62.9&#160;million. Somatex, located in Germany, is a manufacturer of biopsy site markers, including the Tumark product line of tissue markers, which were distributed by the Company in the U.S. prior to the acquisition. The allocation of the purchase price is based on the Company's preliminary valuation, and it allocated $38.0&#160;million to the preliminary value of developed technology, $1.2&#160;million to customer relationships, $0.9&#160;million to trade names and $32.4&#160;million to goodwill. The remaining $9.6&#160;million of the purchase price was allocated to the net acquired tangible assets and liabilities. The allocation of the purchase price is preliminary as the Company continues to gather information supporting </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the acquired assets and liabilities. Somatex' results of operations are reported in the Company's Breast Health reportable segment from the date of acquisition. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NXC Imaging</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2020, the Company completed the acquisition of assets from NXC Imaging, for a purchase price of $5.6&#160;million. NXC Imaging was a long-standing distributor of the Company's Breast and Skeletal products in the U.S. Based on the Company's preliminary valuation, the majority of the purchase price was allocated to a customer relationships intangible asset with a useful life of 5 years. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal 2020 Acquisitions</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acessa Health</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 23, 2020, the Company completed the acquisition of Acessa Health, Inc. ("Acessa") for a purchase price of </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$161.3&#160;million, which included a hold-back of $3.0&#160;million that was paid in January 2021, and contingent consideration, which the Company estimated the fair value to be $81.8&#160;million as of the measurement date. Acessa, located in Austin, Texas, manufactures and markets its ProVu system, a laparoscopic radio frequency ablation system for use in treatment of uterine fibroids. Acessa's results of operations are reported in the Company's GYN Surgical reportable segment from the date of acquisition.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent payments are based on a multiple of annual incremental revenue growth over a three-year period ending annually in December. There is no maximum earnout. Pursuant to ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company recorded its estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation based on future revenue projections of Acessa, comparable companies revenue growth rates, implied volatility and applying a risk adjusted discount rate. Each quarter the Company will be required to remeasure the fair value of the liability as assumptions change and such adjustments will be recorded in operating expenses. This fair value measurement was based on significant inputs not observable in the market and thus represented a Level 3 measurement as defined in ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This fair value measurement is directly impacted by the Company's estimate of future incremental revenue growth of the business. Accordingly, if actual revenue growth is higher or lower than the estimates within the fair value measurement, the Company would record additional charges or benefits, respectively. There was no remeasurement for the three months ended June 26, 2021. For the nine months ended June 26, 2021, the Company remeasured the contingent consideration liability and recorded a gain of $10.1&#160;million to record the liability at fair value. The reduction in fair value was primarily due to a decrease in forecasted revenues over the measurement period.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Acessa's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of August 23, 2020, as set forth below.</span></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.596%"><tr><td style="width:1.0%"/><td style="width:7.865%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:71.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.292%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Acessa's business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, primarily taxes.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets were developed technology and trade names. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using an 18.0% rate. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and trade names was 10 years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the preliminary amount of goodwill were based on anticipated synergistic benefits of Acessa's products being complementary to the GYN Surgical portfolio of products and utilizing the GYN Surgical sales force to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Beacons</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 3, 2020, the Company completed the acquisition of Health Beacons, Inc. ("Health Beacons"), for a purchase price of $19.7&#160;million, which included hold-backs of $2.3&#160;million that are payable up to eighteen months from the date of acquisition. Health Beacons manufactures the LOCalizer product. Based on the Company's valuation, it allocated $10.7&#160;million to developed technology and $6.2&#160;million to goodwill. The remaining $2.8&#160;million of the purchase price was allocated to acquired tangible assets and liabilities. Health Beacons' results of operations are reported in the Company's Breast Health reportable segment from the date of acquisition. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Alpha Imaging</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2019, the Company completed the acquisition of assets from Alpha Imaging, LLC ("Alpha Imaging"), for a purchase price of $18.0&#160;million, which included a hold-back of $1.0&#160;million and contingent consideration, which the Company has estimated at $0.9&#160;million. The contingent consideration was payable upon shipment of backlog orders entered into by Alpha Imaging prior to the acquisition. Alpha Imaging was a long-standing distributor of the Company's Breast and Skeletal products in the U.S. The majority of the purchase price was allocated to a customer relationships intangible asset with a useful life of 5 years.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SuperSonic Imagine</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2019, the Company purchased 46% of the outstanding shares of SuperSonic Imagine ("SSI") for $18.2 million. SSI was a public company located in Aix-en-Provence, France that manufactures and markets ultrasound medical imaging equipment. In September 2019, the Company launched a cash tender offer to acquire the remaining outstanding shares for a price of&#160;&#8364;1.50 per share in cash. The Company determined that SSI was a Variable Interest Entity (&#8220;VIE&#8221;) but it was not the primary beneficiary as it was not a party to the initial design of the entity nor did it have control over SSI's operations until November 21, 2019 when the Company's ownership of SSI's voting stock exceeded 50%. Accordingly, the Company initially accounted for this investment under the equity method of accounting.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 21, 2019, the Company acquired an additional 7.6 million shares of SSI for $12.6 million. As a result, the Company's ownership interest increased to approximately 78% of the outstanding common shares of SSI at November 21, 2019, and it now controlled SSI's voting interest and operations. The Company performed purchase accounting as of November 21, 2019 and beginning on that date the financial results of SSI are included within the Company's consolidated financial statements, specifically the Breast Health reportable segment. The Company remeasured the initial investment of 46% of the outstanding shares of SSI to its fair value at the acquisition date, resulting in a gain of $3.2 million recorded to other income (expense), net in the first quarter of fiscal 2020. The total accounting purchase price was $69.3 million, which consisted of $17.9 million for the equity method investment in SSI, $12.6 million for shares acquired on November 21, 2019, $30.2 million for loans the Company provided to SSI prior to the acquisition to pay-off pre-existing loans and fund operations that are considered forgiven, and $8.6 million representing the fair value of the noncontrolling interest as of November 21, 2019. The Company purchased an additional 1.1&#160;million outstanding shares in fiscal 2020 for $1.8&#160;million. In the third quarter of fiscal 2021, the Company purchased the remaining 4.8&#160;million shares outstanding for $8.5&#160;million, and as of June 26, 2021, the Company owned 100% of the outstanding shares of SSI.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to SSI's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of November 21, 2019, as set forth below.</span></div><div style="text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.333%"><tr><td style="width:1.0%"/><td style="width:78.849%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.951%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short and long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of SSI's business. As part of the purchase price allocation, the Company determined the identifiable intangible assets were developed technology, customer relationships, and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a 12.0% rate. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life for the developed technology is 9 years, customer relationships is 9 years and trade names is 8.6 years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the amount of goodwill were based on anticipated synergistic benefits of SSI's products being complementary to Breast Health's 3D mammography systems and using the Company's existing U.S. sales force as SSI's presence in the U.S. is limited. None of the goodwill is expected to be deductible for income tax purposes.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452082264536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade Receivables and Allowance for Credit Losses<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 26, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">Trade Receivables and Allowance for Credit Losses</a></td>
<td class="text">Trade Receivables and Allowance for Credit Losses<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Effective September 27, 2020, the Company adopted Topic 326, which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The expected credit losses are developed using an estimated loss rate method that considers historical collection experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The estimated loss rates are applied to trade receivables with similar risk characteristics such as the length of time the balance has been outstanding and the location of the customer. In certain instances, the Company may identify individual trade receivable assets that do not share risk characteristics with other trade receivables, in which case the Company records its expected credit losses on an individual asset basis. For example, potential adverse changes to customer liquidity from new macroeconomic events, such as the COVID-19 pandemic, must be taken into consideration. To date, the Company has not experienced significant customer payment defaults, or identified other significant collectability concerns as a result of the pandemic. In connection with assessing credit losses for individual trade receivable assets, the Company considers significant factors relevant to collectability including those specific to the customer such as bankruptcy, length of time an account is outstanding, and the liquidity and financial position of the customer. If a trade receivable asset is evaluated on an individual basis, the Company excludes those assets from the portfolios of trade receivables evaluated on a collective basis. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a rollforward of the allowance for credit losses as of June 26, 2021 compared to June 27, 2020:</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:25.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.662%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.812%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning<br/>of Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Credit Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divested</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Write-<br/>offs and<br/>Payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End of<br/>Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 26, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 27, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -URI http://asc.fasb.org/subtopic&amp;trid=2196772<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452081234712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disposition<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 26, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">Dispositions</a></td>
<td class="text">Disposition - Sale of Medical Aesthetics<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 20, 2019, the Company entered into a definitive agreement to sell its Medical Aesthetics business to Clayton Dubilier &amp; Rice ("CD&amp;R") for a sales price of&#160;$205.0 million&#160;in cash, less certain adjustments. The sale was completed on December 30, 2019, and the Company received cash proceeds of $153.4 million in the second quarter of fiscal 2020. The sale price was subject to adjustment pursuant to the terms of the definitive agreement, and the parties agreed to a final sales price of $150.0&#160;million in the fourth quarter of fiscal 2020. The Company agreed to provide certain transition services for three to fifteen months, depending on the nature of the service. The Company also agreed to indemnify CD&amp;R for certain legal and tax matters that existed as of the date of disposition. In connection with its accounting for the sale, the Company recorded indemnification liabilities of $10.9&#160;million within accrued expenses associated with its obligations under the sale agreement.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of this transaction, the Medical Aesthetics asset group was designated as assets held-for-sale in the first quarter of fiscal 2020. Pursuant to ASC 360, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment and Disposal of Long-Lived Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, asset groups under this designation are required to be recorded at fair value less costs to sell. The Company determined that this disposal did not qualify as a discontinued operation as the sale of the Medical Aesthetics business was deemed to not be a strategic shift having or will have a major effect on the Company's operations and financial results. Based on the terms in the agreement of the sales price and formula for net working capital and related adjustments, its estimate of the fair value for transition services and the amount that must be carved out of the sale proceeds, and liabilities the Company will retain or for which it has agreed to indemnify CD&amp;R, the Company recorded an impairment charge of $30.2 million in the first quarter of fiscal 2020. The impairment charge was allocated to Medical Aesthetics long-lived assets, of which $25.8 million was allocated to cost of product revenues and $4.4 million to operating expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of fiscal 2020, this business incurred a loss from operations of $46.5&#160;million, which excludes corporate allocations. The operating expenses include only those that were incurred directly by and were retained by the </span></div>disposed business. The Company will continue to incur expenses related to this business under the indemnification provisions primarily related to legal and tax matters that existed as of the date of disposition. These expenses were not significant in the first, second and third quarters of fiscal 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452082399288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 26, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Borrowings and Credit Arrangements</a></td>
<td class="text">Borrowings and Credit Arrangements<div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s borrowings consisted of the following:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:73.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.365%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current debt obligations, net of debt discount and deferred issuance costs:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securitization Program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current debt obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt obligations, net of debt discount and issuance costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,379.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">939.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">934.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,654.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,713.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,115.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,038.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2018 Amended and Restated Credit Agreement</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 17, 2018, the Company and certain of its subsidiaries refinanced its term loan and revolving credit facility by entering into an Amended and Restated Credit and Guaranty Agreement as of December 17, 2018 (the "2018 Credit Agreement") with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders. The 2018 Credit Agreement amended and restated the Company's prior credit and guaranty agreement dated as of October 3, 2017 (the "2017 Credit Agreement"). As of June 26, 2021, the principal amount outstanding of the term loan under the 2018 Credit Agreement (the "Term Loan") was $1.4&#160;billion. The Term Loan bears interest at an annual rate equal to the Eurocurrency Rate (i.e., the LIBOR rate) plus an Applicable Rate, which was 1.00% as of June 26, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has a $1.5&#160;billion revolving credit facility (the "Revolver") under the 2018 Credit Agreement. The borrowings of the Revolver bear interest at a rate equal to the LIBOR Daily Floating Rate plus an Applicable Rate, which was 1.00% as of June 26, 2021. In response to the market uncertainties created by the COVID-19 pandemic in March 2020, the Company borrowed $750.0 million under the Revolver, $250.0 million of which, at the time, was used to pay off amounts outstanding under the asset securitization agreement, in order to have sufficient cash on hand. During the first quarter of fiscal 2021, the Company paid off the remaining outstanding balance of $250.0&#160;million. As of June 26, 2021, the full amount of the Revolver was available to borrow by the Company.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, weighted average interest rates, and the interest rate at the end of period under the Credit Agreements were as follows:&#160;</span></div><div style="text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.590%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.590%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate at end of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Credit Agreement contains two financial covenants; a total leverage ratio and an interest coverage ratio, both of which are measured as of the last day of each fiscal quarter. These terms, and calculations thereof, are defined in further detail in the 2018 Credit Agreement. As of June 26, 2021, the Company was in compliance with these covenants.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2020, the Company completed a private placement of $950&#160;million aggregate principal amount of its 3.250% Senior Notes due 2029 (the "2029 Senior Notes") at an offering price of 100% of the aggregate principal amount of the 2029 Senior Notes. The Company used the net proceeds of the 2029 Senior Notes offering and cash on hand to redeem in full its 4.375% Senior Notes due 2025 (the "2025 Senior Notes") in the aggregate principal amount of $950.0&#160;million on October 15, 2020 at an aggregate redemption price of $970.8&#160;million, which included a premium payment $20.8&#160;million.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2025 Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immediately prior to redemption in full of the 2025 Senior Notes on October 15, 2020, the total aggregate principal balance of 2025 Senior Notes was $950.0 million. As the Company planned to use the proceeds from the 2029 Senior Notes offering to redeem the 2025 Senior Notes, the Company evaluated the accounting for this transaction under ASC 470, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to determine modification versus extinguishment accounting on a creditor-by-creditor basis. Certain 2025 Senior Note holders either did not participate in this refinancing transaction or reduced their holdings, and these transactions were accounted for as extinguishments. As a result, the Company recorded a debt extinguishment loss in the first quarter of fiscal 2021 of $21.6&#160;million. For the remaining 2025 Senior Notes holders who participated in the refinancing, these transactions were accounted for as modifications because on a creditor-by-creditor basis the present value of the cash flows between the debt instruments before and after the transaction was less than 10%. The Company recorded a portion of the transaction expenses of $5.8&#160;million to interest expense pursuant to ASC 470, subtopic 50-40. The remaining debt issuance costs of $7.9&#160;million and debt discount of $6.4&#160;million related to the modified debt will be amortized over the new term of the 2029 Senior Notes using the effective interest method.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2028 Senior Notes</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 26, 2021, the Company had 4.625% Senior Notes due 2028 (the "2028 Senior Notes") outstanding in the aggregate principal balance of $400 million. The 2028 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries and mature on February&#160;1, 2028. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2029 Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 26, 2021, the Company had 2029 Senior Notes outstanding in the aggregate principal balance of $950&#160;million. The 2029 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2029 Senior Notes mature on February&#160;15, 2029 and bear interest at the rate of 3.250%&#160;per year, payable semi-annually on February&#160;15 and August&#160;15 of each year, commencing on February&#160;15, 2021.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may redeem the 2029 Senior Notes at any time prior to September 28, 2023 at a price equal to 100% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. The Company may also redeem up to 40% of the aggregate principal amount of the 2029 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before September 28, 2023, at a redemption price equal to 103.250% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. The Company also has the option to redeem the 2029 Senior Notes on or after: September 28, 2023 through September 27, 2024 at 101.625% of par; September 28, 2024 through September 27, 2025 at 100.813% of par; and September 28, 2025 and thereafter at 100% of par. In addition, if the Company undergoes a change of control coupled with a decline in ratings, as provided in the indenture, the Company will be required to make an offer to purchase each holder&#8217;s 2029 Senior Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated the 2029 Senior Notes for derivatives pursuant to ASC 815, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and did not identify any embedded derivatives that require bifurcation. All features were deemed to be clearly and closely related to the host instrument.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the 2029 Senior Notes, 2028 Senior Notes and 2025 Senior Notes was as follows:</span></div><div style="margin-top:17pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.794%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.503%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 27, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 27, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:17pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable Securitization Program</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the market uncertainties created by the COVID-19 pandemic, on March 26, 2020, the Company paid-off the total amount outstanding of $250.0&#160;million previously borrowed under the Accounts Receivable Securitization Program (the "Securitization Program"). On April 13, 2020, the Company amended the Credit and Security agreement with the lenders, temporarily suspending the ability to borrow and the need to comply with covenants for up to a year. On June 11, 2021, the Company amended and restated the Credit and Security agreement to restart the Securitization Program and increase the maximum borrowing amount to $320.0&#160;million. Loans outstanding under the Securitization Program bear interest at LIBOR plus an applicable margin for defined tranches. As of June 26, 2021, there was $320.0&#160;million outstanding under this program. The weighted average interest rate under the Securitization Program was 0.78% as of June 26, 2021.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other represents debt acquired in the Mobidiag acquisition, which is primarily with the European Investment Bank ("EIB"). Multiple tranches were withdrawn under the agreement and were primarily used to fund research and development projects and expansion efforts. The debt agreement contains change-in-control provisions allowing the EIB to call the debt at any time after a change-in-control, which occurred as a result of Hologic acquiring Mobidiag. Accordingly, the Company has classified the debt as current. The tranches withdrawn under this agreement have interest rates ranging from 6.0% to 7.0%. The debt agreement includes additional payments to the EIB based on revenues generated by products developed under the funding as well as prepayment penalties.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452082407128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 26, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesAndFairValueTextBlock', window );">Derivatives</a></td>
<td class="text">Derivatives<div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Cap - Cash Flow Hedge</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages its exposure to some of its interest rate risk through the use of interest rate caps, which are derivative financial instruments. The Company does not use derivatives for speculative purposes. For a derivative that is designated as a cash flow hedge, changes in the fair value of the derivative are recognized in accumulated other comprehensive income ("AOCI") to the extent the derivative is effective at offsetting the changes in the cash flows being hedged until the hedged item affects earnings. To the extent there is any hedge ineffectiveness, changes in fair value relating to the ineffective portion are immediately recognized in earnings in other income (expense), net in the Consolidated Statements of Income.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2018, the Company entered into separate interest rate cap agreements with multiple counter-parties to mitigate the interest rate volatility associated with the variable interest rate on amounts borrowed under the term loan feature of its credit facilities (see Note 7). Interest rate cap agreements provide the right to receive cash if the reference interest rate rises above a contractual rate. The aggregate premium paid for these interest rate cap agreements was $3.7 million, which was the initial fair value of the instruments recorded in the Company's financial statements. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2019, the Company entered into additional separate interest rate cap agreements with multiple counter-parties to extend the expiration date of its hedges by an additional year. The aggregate premium paid for these interest cap agreements was $1.5 million, which was the initial fair value of the instruments recorded in the Company&#8217;s financial statements. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical terms of the interest rate caps were designed to mirror the terms of the Company&#8217;s LIBOR-based borrowings under its Credit Agreement, that has been amended multiple times, and therefore are highly effective at offsetting the cash flows being hedged. The Company designated these derivatives as cash flow hedges of the variability of the LIBOR-based interest payments on $1.0 billion of principal, which ended on December 27, 2019 (the first quarter of fiscal 2020) for the contracts entered into in fiscal 2018, and on December 23, 2020 (the first quarter of fiscal 2021) for the interest rate cap agreements entered into in fiscal 2019.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rate cap agreements matured as of December 26, 2020.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Swap - Cash Flow Hedge</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2019, in order to hedge a portion of its variable rate debt beyond the contracted period under interest cap agreements, the Company entered into an interest rate swap contract with an effective date of December 23, 2020 and a termination date of December 17, 2023. The notional amount of this swap is $1.0 billion. The interest rate swap effectively fixes the LIBOR component of the variable interest rate on $1.0 billion of the notional amount under the 2018 Credit Agreement at 1.23%. The critical terms of the interest rate swap are designed to mirror the terms of the Company&#8217;s LIBOR-based borrowings under its credit agreement and therefore are highly effective at offsetting the cash flows being hedged. The Company designated this derivative as a cash flow hedge of the variability of the LIBOR-based interest payments on $1.0 billion of principal. Therefore, changes in the fair value of the swap are recorded in AOCI. The fair value of this derivative was in a liability position of $21.0 million as of June&#160;26, 2021.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Forward Foreign Currency Contracts and Foreign Currency Option Contracts</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into forward foreign currency exchange contracts and foreign currency option contracts to mitigate a portion of its cash balances and certain operational exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company's cash and operations that are denominated in currencies other than the U.S. dollar, primarily the Euro, the UK Pound, the Australian dollar, the Canadian dollar, the Chinese Yuan and the Japanese Yen. These foreign currency exchange contracts are entered into to support transactions made in the ordinary course of business and are not speculative in nature. The contracts are generally for periods of one year or less. The Company did not elect hedge accounting for these contracts; however, the Company may seek to apply hedge accounting in future scenarios. The change in the fair value of these contracts is recognized directly in earnings as a component of other income (expense), net. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized and unrealized gains and losses from these contracts, which were the only derivative contracts not designated for hedge accounting, for the three and nine months ended June 26, 2021 and June 27, 2020, respectively, were as follows:</span></div><div style="margin-top:9pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.695%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 27, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 27, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of realized gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of unrealized gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;26, 2021, the Company had outstanding forward foreign currency contracts that were not designated for hedge accounting and were used to hedge fluctuations in the U.S. dollar of certain of our cash balances denominated in the Euro and UK pound, as well as forecasted transactions denominated in the Euro, UK pound, Australian Dollar, Canadian Dollar, Chinese Yuan and Japanese Yen with an aggregate notional amount of $253.8&#160;million. As of June&#160;26, 2021, the Company had outstanding foreign currency option contracts that were not designated for hedge accounting and were used to hedge fluctuations in the U.S. dollar of forecasted transactions denominated in the Euro and UK Pound with a notional amount of $65.0 million.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instrument Presentation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of June&#160;26, 2021: </span></div><div style="margin-top:11pt;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments designated as a cash flow hedge:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:13pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate caps and interest rate swap for the following reporting periods:</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.577%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) recognized in other comprehensive income, net of taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesAndFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivatives and fair value of assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesAndFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452082263512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 26, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation and Related Matters</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On November 6, 2015, the Company filed a suit against Minerva Surgical, Inc. (&#8220;Minerva&#8221;) in the United States District Court for the District of Delaware, alleging that Minerva&#8217;s endometrial ablation device infringes U.S. Patent 6,872,183 (the '183 patent), U.S. Patent 8,998,898 and U.S. Patent 9,095,348 (the '348 patent). On January 25, 2016, the Company amended the complaint to include claims against Minerva for unfair competition, deceptive trade practices and tortious interference with business relationships. On February 5, 2016, the Company filed a second amended complaint to additionally allege that Minerva&#8217;s endometrial ablation device infringes U.S. Patent 9,247,989 (the '989 patent). On March 4, 2016, Minerva filed an answer and counterclaims against the Company, seeking declaratory judgment on the Company&#8217;s claims and asserting claims against the Company for unfair competition, deceptive trade practices, interference with contractual relationships, breach of contract and trade libel. On June 2, 2016, the Court denied the Company&#8217;s motion for a preliminary injunction on its patent claims and denied Minerva&#8217;s request for preliminary injunction related to the Company&#8217;s alleged false and deceptive statements regarding the Minerva product. On June 28, 2018, the Court granted the Company's summary judgment motions on infringement and no invalidity with respect to the &#8216;183 and &#8216;348 patents. The Court also granted the Company&#8217;s motion for summary judgment on assignor estoppel, which bars Minerva&#8217;s invalidity defenses or any reliance on collateral findings regarding invalidity from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> review proceedings. The Court also denied all of Minerva&#8217;s defenses, including its motions for summary judgment on invalidity, non-infringement, no willfulness, and no unfair competition.</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July 27, 2018, after a two-week trial, a jury returned a verdict that: (1) awarded the Company $4.8 million in damages for Minerva&#8217;s infringement; (2) found that Minerva&#8217;s infringement was not willful; and (3) found for the Company regarding Minerva&#8217;s counterclaims. Damages continued to accrue as Minerva continues its infringing conduct. On May 2, 2019, the Court issued rulings that denied the parties' post-trial motions, including the Company's motion for a permanent injunction seeking to prohibit Minerva from selling infringing devices. Both parties appealed the Court's rulings regarding the post-trial motions. On March 4, 2016, Minerva filed two petitions at the USPTO for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> review of the '348 patent. On September 12, 2016, the PTAB declined both petitions to review patentability of the '348 patent. On April 11, 2016, Minerva filed a petition for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> review of the '183 patent. On October 6, 2016, the PTAB granted the petition and instituted a review of the '183 patent. On December 15, 2017, the PTAB issued a final written decision invalidating all claims of the &#8216;183 patent. On February 9, 2018 the Company appealed this decision to the United States Court of Appeals for the Federal Circuit ("Court of Appeals"). On April 19, 2019, the Court of Appeals affirmed the PTAB's final written decision regarding the '183 patent. On July 16, 2019, the Court of Appeals denied the Company&#8217;s petition for rehearing in the appeal regarding the '183 patent. On April 22, 2020, the Court of Appeals affirmed the district court&#8217;s summary judgment ruling in favor of the Company of no invalidity and infringement, and summary judgment that assignor estoppel bars Minerva from challenging the validity of the &#8216;348 patent. The Court of Appeals also denied the Company&#8217;s motion for a permanent injunction and ongoing royalties for infringement of the &#8216;183 patent. The Court of Appeals denied Minerva&#8217;s arguments for no damages or, alternatively, a new trial. On May 22, 2020 both parties petitioned for en banc review of the Court of Appeals decision. On July 22, 2020, the Court of Appeals denied both parties' petitions for en banc review. On August 28, 2020, the district court entered final judgment against Minerva but stayed execution pending resolution of Minerva&#8217;s petition for Supreme Court review. On September 30, 2020, Minerva filed a petition requesting Supreme Court review on the issue of assignor estoppel. On November 5, 2020, Hologic filed a cross-petition requesting Supreme Court review on the issue of assignor estoppel. On January 8, 2021, the Supreme Court granted Minerva&#8217;s petition to address the issue of assignor estoppel and denied Hologic's petition. Oral argument before the Supreme Court was held on April 21, 2021. On June 29, 2021, the Supreme Court ruled 5-4 to uphold but narrow assignor estoppel but limited its application to situations in which an assignor&#8217;s claim of invalidity contradicts a prior representation the assignor made in assigning the patent. The Court also vacated the ruling of the Court of Appeals and remanded the case for further proceedings consistent with its opinion.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 11, 2017, Minerva filed suit against the Company and Cytyc Surgical Products, LLC (&#8220;Cytyc&#8221;) in the United States District Court for the Northern District of California alleging that the Company&#8217;s and Cytyc&#8217;s NovaSure ADVANCED endometrial ablation device infringes Minerva&#8217;s U.S. patent 9,186,208. Minerva is seeking a preliminary and permanent injunction against the Company and Cytyc from selling this NovaSure device as well as enhanced damages and interest, including lost profits, price erosion and/or royalty. On January 5, 2018, the Court denied Minerva's motion for a preliminary injunction. On February 2, 2018, at the parties&#8217; joint request, this action was transferred to the District of Delaware. On March </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26, 2019, the Magistrate Judge issued a claims construction ruling regarding the disputed terms in the patent, which the District Court Judge adopted in all respects on October 21, 2019. The original trial date of July 20, 2020 was vacated. On October 21, 2020, the trial court scheduled a 10-day trial beginning on August 9, 2021. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or a range of estimates, of potential losses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Note 6, the Company has agreed to indemnify CD&amp;R for certain legal matters related to the Medical Aesthetics business that existed at the date of disposition. The Company currently has $8.5&#160;million accrued for such matters as of June&#160;26, 2021. While the Company believes the estimated amounts accrued are reasonable, certain matters are still ongoing and additional accruals could be recorded in the future. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to various other legal proceedings and claims arising out of the ordinary course of its business. The Company believes that except for those matters described above there are no other proceedings or claims pending against it the ultimate resolution of which could have a material adverse effect on its financial condition or results of operations. In all cases, at each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Legal costs are expensed as incurred.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452081098776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 26, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income (Loss) Per Share</a></td>
<td class="text">Net Income Per Share<div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of basic and diluted share amounts is as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257,769&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263,667&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common stock equivalents from assumed exercise of stock options and issuance of stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,581&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261,047&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260,371&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265,092&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average anti-dilutive shares related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452083594040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 26, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation<div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents stock-based compensation expense in the Company&#8217;s Consolidated Statements of Income:</span></div><div style="margin-top:5pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-top:7pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted options to purchase 0.6 million and 0.9 million shares of the Company's common stock during the nine months ended June&#160;26, 2021 and June&#160;27, 2020, respectively, with weighted-average exercise prices of $68.62 and $45.54, respectively. There were 4.4 million options outstanding at June&#160;26, 2021 with a weighted-average exercise price of $44.51.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a binomial model to determine the fair value of its stock options. The weighted-average assumptions utilized to value these stock options are indicated in the following table:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average fair value of options granted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:7pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted 0.5 million and 0.8 million restricted stock units (RSUs) during the nine months ended June&#160;26, 2021 and June&#160;27, 2020, respectively, with weighted-average grant date fair values of $68.45 and $45.67 per unit, respectively. In addition, the Company granted 0.1 million and 0.1 million performance stock units (PSUs) during the nine months ended June&#160;26, 2021 and June&#160;27, 2020, respectively, to members of its senior management team, which have a weighted-average grant date fair value of $68.51 and $45.38 per unit, respectively. Each recipient of PSUs is eligible to receive between zero and 200% of the target number of shares of the Company&#8217;s common stock at the end of three years provided the Company&#8217;s defined Return on Invested Capital metrics are achieved. The Company also granted 0.1 million and 0.1&#160;million of PSUs based on a one-year free cash flow measure (FCF) to its senior management team, which had a grant date fair value of $68.51 and $45.38 per unit during the nine months ended June 26, 2021 and June 27, 2020, respectively. Each recipient of FCF PSUs is eligible to receive between zero and 200% of the target number of shares of the Company's common stock at the end of the one-year measurement period, but the FCF PSUs vest at the end of the three year service period. The PSUs and FCF PSUs cliff-vest three years from the date of grant, and the Company recognizes compensation expense ratably over the required service period based on its estimate of the number of shares that will vest upon achieving the measurement criteria. If there is a change in the estimate of the number of shares that are probable of vesting, the Company will cumulatively adjust compensation expense in the period that the change in estimate is made. The Company also granted 0.1 million and 0.1 million market-based awards (MSUs) to its senior management team during the nine months ended June&#160;26, 2021 and June&#160;27, 2020, respectively. Each recipient of MSUs is eligible to receive between zero and 200% of the target number of shares of the Company&#8217;s common stock at the end of three years based upon achieving a certain total shareholder return relative to a defined peer group. The MSUs were valued at $82.51 and $43.54 per share using the Monte Carlo simulation model. These awards cliff-vest three years from the date of grant, and the Company recognizes compensation expense for the MSUs ratably over the service period. At June&#160;26, 2021, there was 3.0 million in aggregate RSUs, PSUs, FCF PSUs and MSUs outstanding. </span></div><div style="margin-bottom:18pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At June&#160;26, 2021, there was $19.4 million and $61.1 million of unrecognized compensation expense related to stock options and stock units (comprised of RSUs, PSUs, FCF PSUs and MSUs), respectively, to be recognized over a weighted-average period of 2.4 and 2.0 years, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452082393784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Balance Sheet Information<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 26, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DetailsOfCertainBalanceSheetAccountsTextBlock', window );">Other Balance Sheet Information</a></td>
<td class="text">Other Balance Sheet Information<div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:71.318%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.321%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.324%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:71.318%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.321%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.324%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment under customer usage agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,290.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,185.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less &#8211; accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(739.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(694.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:1pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020 and October 2020, the Company received grants of $7.6&#160;million and $119.3&#160;million, respectively, from the Department of Defense Joint Acquisition Task Force ("DOD") to expand production capacity for the Company's two SARS-CoV-2 assays. These grants are specifically to fund the capital equipment and labor investments needed to increase manufacturing capacity to enable the Company to provide a certain amount of COVID-19 tests per month for the U.S. market. The Company is accounting for the funds received under these grants as a reimbursement of the purchased capital equipment. The DOD retains title to assets purchased under the agreement, and title is transferred to the Company upon meeting certain milestones of the manufacturing efforts. In the current three and nine month periods, the Company received $8.3&#160;million and $19.4&#160;million, respectively, from the DOD under these grants which has been recorded as a reduction of the cost basis of the purchased equipment.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DetailsOfCertainBalanceSheetAccountsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Details of certain balance sheet accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DetailsOfCertainBalanceSheetAccountsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452082448392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 26, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Business Segments and Geographic Information</a></td>
<td class="text">Business Segments and Geographic InformationDuring fiscal 2021, the Company had four reportable segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. During fiscal 2020, the Company had five reportable segments that included Medical Aesthetics. The Company completed the sale of its Medical Aesthetics business on December 30, 2019. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense, intangible asset and goodwill impairment charges, transaction and integration expenses for acquisitions, restructuring, consolidation and divestiture charges, litigation charges, and other one-time or unusual items.<div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identifiable assets for the reportable segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its reportable segments. The Company has presented all other identifiable assets as corporate assets. There were no inter-segment revenues during the three and nine months ended June&#160;26, 2021 and June&#160;27, 2020. Segment information is as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,858.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,163.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,315.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,429.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,745.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,040.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.058%"><tr><td style="width:1.0%"/><td style="width:69.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.611%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.025%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,440.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,161.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,253.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,383.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,438.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,481.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,355.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,590.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,195.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:7pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no customers that represented greater than 10% of consolidated revenues during the three and nine months ended June&#160;26, 2021 and June&#160;27, 2020.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in the following major geographic areas noted in the below chart. Revenue data is based upon customer location. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company&#8217;s sales in Europe are predominantly derived from France, the United Kingdom and Germany. The Company&#8217;s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The &#8220;Rest of world&#8221; designation includes Canada, Latin America and the Middle East.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues by geography as a percentage of total revenues were as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:18pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452082263512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 26, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 740, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 740), each interim period is considered integral to the annual period, and tax expense is measured using an estimated annual effective tax rate. An entity is required to record income tax expense each quarter based on its annual effective tax rate estimated for the full fiscal year and use that rate to provide for income taxes on a current year-to-date basis, adjusted for discrete taxable events that occur during the interim period.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s effective tax rate for the three and nine months ended June 26, 2021 was a provision of 20.6% and 21.0%, respectively, compared to a provision of 19.0% and a net benefit of 60.3%, respectively, for the corresponding periods in the prior year. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate for the three months ended June 26, 2021 was lower than the U.S. statutory tax rate primarily due to the impact of the U.S. deduction for foreign derived intangible income and the geographic mix of income earned by our international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, and federal and state tax credits, partially offset by state income taxes. The effective tax rate for the nine months ended June 26, 2021 was equal to the U.S. statutory tax rate as the impact of the U.S. deduction for foreign derived intangible income and the geographic mix of income earned by our international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, were offset by state income taxes.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate for the three months ended June 27, 2020 was lower than the U.S. statutory tax rate primarily due to the geographic mix of income earned by our international subsidiaries which are taxed at rates lower than the U.S. statutory tax rate, including the impact of the U.S. tax imposed on global intangible low-taxed income and the U.S. deduction for foreign derived intangible income, and reserve releases resulting from statute of limitations expirations, partially offset by unbenefited foreign losses. The effective tax rate for the nine months ended June 27, 2020 differed from the statutory tax rate primarily due to a $312.8&#160;million discrete net tax benefit related to the loss on the sale of the Medical Aesthetics business. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Income Tax Matters</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to tax examinations for value-added, sales-based, payroll, and other non-income tax items. A number of these examinations are ongoing in various jurisdictions. The Company takes certain non-income tax positions in the jurisdictions in which it operates. In the normal course of business, the Company's positions and conclusions related to its non-income tax positions could be challenged, resulting in assessments by governmental authorities. Pursuant to ASC 450, the Company has recorded loss contingencies with respect to some of these positions. While the Company believes estimated losses previously recorded are reasonable, certain audits are still ongoing and additional charges could be recorded in the future.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452081096728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets and Goodwill<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 26, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets and Goodwill</a></td>
<td class="text">Intangible Assets<div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consisted of the following:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June 26, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 26, 2020</span></td></tr><tr style="height:29pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed&#160;technology</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,604.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,102.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,054.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,907.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-competition agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,578.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,797.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,852.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,569.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal-use software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software embedded in products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,660.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,859.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,931.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,623.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated remaining amortization expense of the Company's acquired intangible assets as of June&#160;26, 2021 for each of the five succeeding fiscal years is as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.766%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of Fiscal 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452081087240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Warranties<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 26, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteesAbstract', window );"><strong>Guarantees [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyDisclosureTextBlock', window );">Product Warranties</a></td>
<td class="text">Product Warranties<div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product warranty activity was as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:18pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.625%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.873%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning&#160;of<br/>Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provisions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acquired</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divested</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlements/<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End&#160;of&#160;Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 26, 2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 27, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -URI http://asc.fasb.org/topic&amp;trid=2155896<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452082234120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 26, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccumulatedOtherComprehensiveIncomeAbstract', window );"><strong>Accumulated Other Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">Accumulated Other Comprehensive Loss<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the changes in accumulated balances of other comprehensive loss for the periods presented:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.952%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.242%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended June 26, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine Months Ended June 26, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(35.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(22.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(24.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(49.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified to statement of income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(23.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(42.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(23.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(42.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.366%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended June 27, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine Months Ended June 27, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(38.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(58.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(41.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(42.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(21.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified to statement of income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(37.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(22.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(61.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(37.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(22.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(61.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccumulatedOtherComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccumulatedOtherComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452082352552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Repurchase<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 26, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Share Repurchase</a></td>
<td class="text">Share RepurchaseOn December 11, 2019, the Board of Directors authorized a share repurchase plan to purchase up to $500.0&#160;million of the Company's outstanding common stock, effective March 2, 2020. During the first quarter of fiscal 2021, the Company repurchased 1.5&#160;million shares of its common stock under this plan for a total consideration of $101.3&#160;million. On December 9, 2020, the Board of Directors authorized a new five-year share repurchase plan to repurchase up to $1.0&#160;billion of the Company's outstanding common stock. The prior plan was terminated in connection with this new authorization. Under the new authorization, during the three and nine months ended June 26, 2021, the Company repurchased 3.0&#160;million and 4.6&#160;million shares of its common stock for a total consideration of $188.4&#160;million and $308.5&#160;million, respectively. As of June 26, 2021, $691.6&#160;million remained available under this authorization.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452080868632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Pronouncements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 26, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted', window );">New Accounting Pronouncements</a></td>
<td class="text">New Accounting Pronouncements<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 1 for Recently Adopted Accounting Pronouncements.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Board issued this Update as part of its initiative to reduce complexity in accounting standards (the Simplification Initiative). For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020 and is applicable to the Company in fiscal 2022. The Company is currently evaluating the impact of the adoption of ASU 2019-12 on its consolidated financial position and results of operations.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU No. 2020-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Board issued this Update to clarify certain interactions between the guidance to account for certain equity securities under Topic 321, the guidance to account for investments under the equity method of accounting in Topic 323, and the guidance in Topic 815. This update could change how an entity accounts for an equity security under the measurement alternative or a forward contract or purchased option to purchase securities that, upon settlement of the forward contract or exercise of the purchased option, would be accounted for under the equity method of accounting or the fair value option in accordance with Topic 825, Financial Instruments. For entities that have adopted the amendments in Update 2020-01, the updated guidance is effective for annual periods beginning after December 15, 2020, and is applicable to the Company in fiscal 2022. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2020-01 on its consolidated financial position and results of operations.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Board issued this Update as optional guidance for a limited period of time to ease the potential burden in accounting for or recognizing the effects of reference rate reform on financial reporting. This update will provide optional expedients and exceptions for applying GAAP to only contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. For entities that have adopted the amendments in Update 2020-04, the updated guidance is effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of the adoption of ASU 2020-04 on its consolidated financial position and results of operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, FASB issued ASU No. 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848) Scope. </span>The board issued this Update in response to stakeholder concerns about potential diversity in practice. The Boards decided to clarify the scope of Topic 848 so that derivatives affected by the discounting transition are explicitly eligible for certain optional expedients and exceptions in Topic 848. This update provides optional expedients and exceptions for applying generally accepted accounting principles (GAAP) to only contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. For entities that have adopted the amendments in Update 2021-01, the updated guidance is effective for all entities immediately as of January 2021. The Company is currently evaluating the impact of the adoption of ASU 2021-01 on its consolidated financial position and results of operations.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a new accounting pronouncement that has been issued but not yet adopted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452082943608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Pronouncements (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 26, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Board issued this Update as part of its initiative to reduce complexity in accounting standards (the Simplification Initiative). For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020 and is applicable to the Company in fiscal 2022. The Company is currently evaluating the impact of the adoption of ASU 2019-12 on its consolidated financial position and results of operations.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU No. 2020-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Board issued this Update to clarify certain interactions between the guidance to account for certain equity securities under Topic 321, the guidance to account for investments under the equity method of accounting in Topic 323, and the guidance in Topic 815. This update could change how an entity accounts for an equity security under the measurement alternative or a forward contract or purchased option to purchase securities that, upon settlement of the forward contract or exercise of the purchased option, would be accounted for under the equity method of accounting or the fair value option in accordance with Topic 825, Financial Instruments. For entities that have adopted the amendments in Update 2020-01, the updated guidance is effective for annual periods beginning after December 15, 2020, and is applicable to the Company in fiscal 2022. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2020-01 on its consolidated financial position and results of operations.</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Board issued this Update as optional guidance for a limited period of time to ease the potential burden in accounting for or recognizing the effects of reference rate reform on financial reporting. This update will provide optional expedients and exceptions for applying GAAP to only contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. For entities that have adopted the amendments in Update 2020-04, the updated guidance is effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of the adoption of ASU 2020-04 on its consolidated financial position and results of operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, FASB issued ASU No. 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848) Scope. </span>The board issued this Update in response to stakeholder concerns about potential diversity in practice. The Boards decided to clarify the scope of Topic 848 so that derivatives affected by the discounting transition are explicitly eligible for certain optional expedients and exceptions in Topic 848. This update provides optional expedients and exceptions for applying generally accepted accounting principles (GAAP) to only contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. For entities that have adopted the amendments in Update 2021-01, the updated guidance is effective for all entities immediately as of January 2021. The Company is currently evaluating the impact of the adoption of ASU 2021-01 on its consolidated financial position and results of operations.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452081114408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 26, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text">The following tables provide revenue from contracts with customers by business and geographic region on a disaggregated basis:&#160;&#160;&#160;&#160;<div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"/><td style="width:3.221%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.226%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.226%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.226%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.843%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.226%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.226%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.230%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 26, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 27, 2020</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytology &amp; Perinatal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">536.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Screening</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Imaging</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Breast Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">660.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:3.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.869%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended June 26, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended June 27, 2020</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytology &amp; Perinatal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,561.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,467.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">683.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">829.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Screening</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,825.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,858.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">909.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">254.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,163.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Imaging</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">817.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Breast Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">784.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,951.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,364.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,315.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,868.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,429.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"><tr><td style="width:1.0%"/><td style="width:30.358%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:15.769%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.769%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.863%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.769%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.772%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Geographic Regions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 27, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 27, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">660.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,951.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,868.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,315.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,429.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides revenue recognized by source:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.543%"><tr><td style="width:1.0%"/><td style="width:31.601%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:16.435%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.961%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.065%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.333%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue by type </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 27, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 27, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposables</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">797.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">588.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,239.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,511.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital equipment, components and software</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,315.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,429.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452081162472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 26, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Fair Value Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following at June&#160;26, 2021:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:17pt;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.029%"><tr><td style="width:1.0%"/><td style="width:37.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.130%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.130%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.288%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at Reporting Date Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of June 26, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices&#160;in<br/>Active&#160;Market&#160;for<br/>Identical&#160;Assets<br/>(Level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs&#160;(Level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs&#160;(Level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:13pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liabilities Measured and Recorded at Fair Value on a Recurring Basis</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of recurring fair value measurements using significant unobservable inputs (Level 3), which solely consisted of contingent consideration liabilities, during the three and nine month periods ended June 26, 2021 and June 27, 2020 were as follows:</span></div><div style="margin-top:18pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:6.148%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.580%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.480%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Month Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27, 2020</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration recorded at acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452082461368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 26, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Mobidiag's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of June 17, 2021, as set forth below.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="margin-top:6pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.865%"><tr><td style="width:1.0%"/><td style="width:7.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:62.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.878%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(66.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">729.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Biotheranostics' preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of February 22, 2021, as set forth below.</span></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.865%"><tr><td style="width:1.0%"/><td style="width:7.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:62.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.878%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Diagenode's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of March 1, 2021, as set forth below.</span></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.865%"><tr><td style="width:1.0%"/><td style="width:7.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:62.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.878%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Acessa's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of August 23, 2020, as set forth below.</span></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:63.596%"><tr><td style="width:1.0%"/><td style="width:7.865%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:71.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.292%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>The total purchase price was allocated to SSI's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of November 21, 2019, as set forth below.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.333%"><tr><td style="width:1.0%"/><td style="width:78.849%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.951%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short and long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452081162472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade Receivables and Allowance for Credit Losses (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 26, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of Accounts, Notes, Loans and Financing Receivable</a></td>
<td class="text">The following is a rollforward of the allowance for credit losses as of June 26, 2021 compared to June 27, 2020:<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452174784264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 26, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Company's Borrowings</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s borrowings consisted of the following:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:73.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.365%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current debt obligations, net of debt discount and deferred issuance costs:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securitization Program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current debt obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt obligations, net of debt discount and issuance costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,325.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,379.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">939.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">934.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,654.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,713.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,115.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,038.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock', window );">Schedule of Line of Credit Facilities</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, weighted average interest rates, and the interest rate at the end of period under the Credit Agreements were as follows:&#160;</span></div><div style="text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.590%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.590%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate at end of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock', window );">Schedule Of Interest Expense Under Convertible Notes</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2029 Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 26, 2021, the Company had 2029 Senior Notes outstanding in the aggregate principal balance of $950&#160;million. The 2029 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2029 Senior Notes mature on February&#160;15, 2029 and bear interest at the rate of 3.250%&#160;per year, payable semi-annually on February&#160;15 and August&#160;15 of each year, commencing on February&#160;15, 2021.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may redeem the 2029 Senior Notes at any time prior to September 28, 2023 at a price equal to 100% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. The Company may also redeem up to 40% of the aggregate principal amount of the 2029 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before September 28, 2023, at a redemption price equal to 103.250% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. The Company also has the option to redeem the 2029 Senior Notes on or after: September 28, 2023 through September 27, 2024 at 101.625% of par; September 28, 2024 through September 27, 2025 at 100.813% of par; and September 28, 2025 and thereafter at 100% of par. In addition, if the Company undergoes a change of control coupled with a decline in ratings, as provided in the indenture, the Company will be required to make an offer to purchase each holder&#8217;s 2029 Senior Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated the 2029 Senior Notes for derivatives pursuant to ASC 815, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and did not identify any embedded derivatives that require bifurcation. All features were deemed to be clearly and closely related to the host instrument.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the 2029 Senior Notes, 2028 Senior Notes and 2025 Senior Notes was as follows:</span></div><div style="margin-top:17pt;text-align:center;text-indent:24.75pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.794%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.503%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 27, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 27, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of interest expense under convertible notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452082493880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 26, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Derivative Instruments, Gain (Loss)</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.063%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.695%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 27, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 27, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of realized gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of unrealized gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock', window );">Schedule of Derivative Assets at Fair Value</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of June&#160;26, 2021: </span></div><div style="margin-top:11pt;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments designated as a cash flow hedge:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Unrealized Loss Recognized in AOCI</a></td>
<td class="text">The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate caps and interest rate swap for the following reporting periods:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.577%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) recognized in other comprehensive income, net of taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative assets at fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452082307784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 26, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Reconciliation of Basic and Diluted Share Amounts</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of basic and diluted share amounts is as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.625%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259,870&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257,769&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263,667&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common stock equivalents from assumed exercise of stock options and issuance of stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,177&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,581&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261,047&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260,371&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265,092&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average anti-dilutive shares related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452081103656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 26, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock', window );">Stock-Based Compensation Expense in Consolidated Statements of Operations</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents stock-based compensation expense in the Company&#8217;s Consolidated Statements of Income:</span></div><div style="margin-top:5pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Weighted-Average Assumptions Utilized to Value Stock Options</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a binomial model to determine the fair value of its stock options. The weighted-average assumptions utilized to value these stock options are indicated in the following table:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average fair value of options granted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of share-based compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452081157016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Balance Sheet Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 26, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Other Balance Sheet Information of Inventories</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:71.318%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.321%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.324%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Other Balance Sheet Information of Property, Plant and Equipment</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:71.318%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.321%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.324%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment under customer usage agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,290.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,185.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less &#8211; accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(739.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(694.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">551.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452082345944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 26, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Segment Information</a></td>
<td class="text">egment information is as follows:<div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,858.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,163.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,018.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,168.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,315.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,429.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,745.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,040.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.058%"><tr><td style="width:1.0%"/><td style="width:69.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.611%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.025%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,440.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,161.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,253.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,383.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,438.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,481.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,355.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,590.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,195.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock', window );">Revenues by Geography</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues by geography as a percentage of total revenues were as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:18pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 26,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 27,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452082609880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets and Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 26, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Intangible Assets</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consisted of the following:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June 26, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 26, 2020</span></td></tr><tr style="height:29pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed&#160;technology</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,604.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,102.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,054.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,907.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-competition agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,578.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,797.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,852.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,569.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal-use software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software embedded in products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,660.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,859.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,931.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,623.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Estimated Amortization Expense</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated remaining amortization expense of the Company's acquired intangible assets as of June&#160;26, 2021 for each of the five succeeding fiscal years is as follows:</span></div><div style="margin-bottom:9pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.766%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of Fiscal 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452082579848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Warranties (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 26, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteesAbstract', window );"><strong>Guarantees [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock', window );">Product Warranty Activity</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product warranty activity was as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:18pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.625%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.873%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning&#160;of<br/>Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provisions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acquired</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divested</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlements/<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End&#160;of&#160;Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nine Months Ended:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 26, 2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 27, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452082345944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 26, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccumulatedOtherComprehensiveIncomeAbstract', window );"><strong>Accumulated Other Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Changes in Accumulated Other Comprehensive Income</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the changes in accumulated balances of other comprehensive loss for the periods presented:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.952%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.242%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended June 26, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine Months Ended June 26, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(35.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(22.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(24.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(49.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified to statement of income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(23.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(42.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(23.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16.5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(42.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.490%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.366%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended June 27, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nine Months Ended June 27, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(38.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(58.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(41.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(42.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(21.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified to statement of income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(37.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(22.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(61.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(37.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(22.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(61.9)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccumulatedOtherComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccumulatedOtherComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452181813384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Business Revenue (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 1,168,300,000<span></span>
</td>
<td class="nump">$ 822,900,000<span></span>
</td>
<td class="nump">$ 4,315,700,000<span></span>
</td>
<td class="nump">$ 2,429,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Contract with Customer, Liability, Revenue Recognized</a></td>
<td class="nump">20,100,000<span></span>
</td>
<td class="nump">18,000,000.0<span></span>
</td>
<td class="nump">100,900,000<span></span>
</td>
<td class="nump">95,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">749,900,000<span></span>
</td>
<td class="nump">660,800,000<span></span>
</td>
<td class="nump">2,951,700,000<span></span>
</td>
<td class="nump">1,868,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=holx_InternationalMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">418,400,000<span></span>
</td>
<td class="nump">162,100,000<span></span>
</td>
<td class="nump">1,364,000,000.0<span></span>
</td>
<td class="nump">561,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">665,500,000<span></span>
</td>
<td class="nump">532,200,000<span></span>
</td>
<td class="nump">2,858,200,000<span></span>
</td>
<td class="nump">1,163,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">357,200,000<span></span>
</td>
<td class="nump">439,100,000<span></span>
</td>
<td class="nump">1,825,800,000<span></span>
</td>
<td class="nump">909,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">308,300,000<span></span>
</td>
<td class="nump">93,100,000<span></span>
</td>
<td class="nump">1,032,400,000<span></span>
</td>
<td class="nump">254,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Cytology &amp; Perinatal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">115,900,000<span></span>
</td>
<td class="nump">64,100,000<span></span>
</td>
<td class="nump">357,900,000<span></span>
</td>
<td class="nump">298,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Cytology &amp; Perinatal | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">73,900,000<span></span>
</td>
<td class="nump">40,300,000<span></span>
</td>
<td class="nump">230,800,000<span></span>
</td>
<td class="nump">191,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Cytology &amp; Perinatal | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">42,000,000.0<span></span>
</td>
<td class="nump">23,800,000<span></span>
</td>
<td class="nump">127,100,000<span></span>
</td>
<td class="nump">107,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Molecular Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">536,400,000<span></span>
</td>
<td class="nump">460,300,000<span></span>
</td>
<td class="nump">2,467,000,000.0<span></span>
</td>
<td class="nump">829,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Molecular Diagnostics | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">270,100,000<span></span>
</td>
<td class="nump">391,000,000.0<span></span>
</td>
<td class="nump">1,561,700,000<span></span>
</td>
<td class="nump">683,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Molecular Diagnostics | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">266,300,000<span></span>
</td>
<td class="nump">69,300,000<span></span>
</td>
<td class="nump">905,300,000<span></span>
</td>
<td class="nump">146,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Blood Screening</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">13,200,000<span></span>
</td>
<td class="nump">7,800,000<span></span>
</td>
<td class="nump">33,300,000<span></span>
</td>
<td class="nump">35,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Blood Screening | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">13,200,000<span></span>
</td>
<td class="nump">7,800,000<span></span>
</td>
<td class="nump">33,300,000<span></span>
</td>
<td class="nump">35,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Blood Screening | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">349,000,000.0<span></span>
</td>
<td class="nump">224,000,000.0<span></span>
</td>
<td class="nump">1,018,000,000.0<span></span>
</td>
<td class="nump">862,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">273,200,000<span></span>
</td>
<td class="nump">170,600,000<span></span>
</td>
<td class="nump">784,400,000<span></span>
</td>
<td class="nump">661,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">75,800,000<span></span>
</td>
<td class="nump">53,400,000<span></span>
</td>
<td class="nump">233,600,000<span></span>
</td>
<td class="nump">201,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Breast Imaging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">280,300,000<span></span>
</td>
<td class="nump">193,200,000<span></span>
</td>
<td class="nump">817,800,000<span></span>
</td>
<td class="nump">718,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Breast Imaging | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">218,400,000<span></span>
</td>
<td class="nump">145,600,000<span></span>
</td>
<td class="nump">619,500,000<span></span>
</td>
<td class="nump">541,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Breast Imaging | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">61,900,000<span></span>
</td>
<td class="nump">47,600,000<span></span>
</td>
<td class="nump">198,300,000<span></span>
</td>
<td class="nump">177,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Interventional Breast Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">68,700,000<span></span>
</td>
<td class="nump">30,800,000<span></span>
</td>
<td class="nump">200,200,000<span></span>
</td>
<td class="nump">144,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Interventional Breast Solutions | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">54,800,000<span></span>
</td>
<td class="nump">25,000,000.0<span></span>
</td>
<td class="nump">164,900,000<span></span>
</td>
<td class="nump">120,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Interventional Breast Solutions | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">13,900,000<span></span>
</td>
<td class="nump">5,800,000<span></span>
</td>
<td class="nump">35,300,000<span></span>
</td>
<td class="nump">24,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember', window );">GYN Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">127,900,000<span></span>
</td>
<td class="nump">51,500,000<span></span>
</td>
<td class="nump">366,200,000<span></span>
</td>
<td class="nump">275,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember', window );">GYN Surgical | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">103,900,000<span></span>
</td>
<td class="nump">42,100,000<span></span>
</td>
<td class="nump">296,800,000<span></span>
</td>
<td class="nump">227,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember', window );">GYN Surgical | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">24,000,000.0<span></span>
</td>
<td class="nump">9,400,000<span></span>
</td>
<td class="nump">69,400,000<span></span>
</td>
<td class="nump">48,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">65,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">30,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">34,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember', window );">Skeletal Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">25,900,000<span></span>
</td>
<td class="nump">15,200,000<span></span>
</td>
<td class="nump">73,300,000<span></span>
</td>
<td class="nump">62,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember', window );">Skeletal Health | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">15,600,000<span></span>
</td>
<td class="nump">9,000,000.0<span></span>
</td>
<td class="nump">44,700,000<span></span>
</td>
<td class="nump">39,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember', window );">Skeletal Health | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 10,300,000<span></span>
</td>
<td class="nump">$ 6,200,000<span></span>
</td>
<td class="nump">$ 28,600,000<span></span>
</td>
<td class="nump">$ 22,900,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=holx_InternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=holx_InternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_CytologyPerinatalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_CytologyPerinatalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_MolecularDiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_MolecularDiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_BloodScreeningMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_BloodScreeningMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_BreastImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_BreastImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_InterventionalBreastSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_InterventionalBreastSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452093115224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Geographical Revenue (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 1,168.3<span></span>
</td>
<td class="nump">$ 822.9<span></span>
</td>
<td class="nump">$ 4,315.7<span></span>
</td>
<td class="nump">$ 2,429.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">749.9<span></span>
</td>
<td class="nump">660.8<span></span>
</td>
<td class="nump">2,951.7<span></span>
</td>
<td class="nump">1,868.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">289.0<span></span>
</td>
<td class="nump">101.7<span></span>
</td>
<td class="nump">963.9<span></span>
</td>
<td class="nump">322.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia-Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">89.6<span></span>
</td>
<td class="nump">43.7<span></span>
</td>
<td class="nump">268.1<span></span>
</td>
<td class="nump">155.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=holx_RestofWorldMember', window );">Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 39.8<span></span>
</td>
<td class="nump">$ 16.7<span></span>
</td>
<td class="nump">$ 132.0<span></span>
</td>
<td class="nump">$ 82.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=holx_RestofWorldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=holx_RestofWorldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452091906872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Revenue by Type (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 1,168,300,000<span></span>
</td>
<td class="nump">$ 822,900,000<span></span>
</td>
<td class="nump">$ 4,315,700,000<span></span>
</td>
<td class="nump">$ 2,429,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Contract with Customer, Liability, Revenue Recognized</a></td>
<td class="nump">20,100,000<span></span>
</td>
<td class="nump">18,000,000.0<span></span>
</td>
<td class="nump">100,900,000<span></span>
</td>
<td class="nump">95,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=holx_ConsumablesMember', window );">Disposables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">797,700,000<span></span>
</td>
<td class="nump">588,100,000<span></span>
</td>
<td class="nump">3,239,200,000<span></span>
</td>
<td class="nump">1,511,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=holx_CapitalEquipmentComponentsandSoftwareMember', window );">Capital equipment, components and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">197,500,000<span></span>
</td>
<td class="nump">113,500,000<span></span>
</td>
<td class="nump">590,200,000<span></span>
</td>
<td class="nump">513,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">158,400,000<span></span>
</td>
<td class="nump">116,400,000<span></span>
</td>
<td class="nump">437,200,000<span></span>
</td>
<td class="nump">388,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=holx_OtherTypeofRevenueMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 14,700,000<span></span>
</td>
<td class="nump">$ 4,900,000<span></span>
</td>
<td class="nump">$ 49,100,000<span></span>
</td>
<td class="nump">$ 16,400,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_ConsumablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_ConsumablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_CapitalEquipmentComponentsandSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_CapitalEquipmentComponentsandSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_OtherTypeofRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_OtherTypeofRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452081081048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="nump">$ 804,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 804,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Contract with Customer, Liability, Revenue Recognized</a></td>
<td class="nump">$ 20,100,000<span></span>
</td>
<td class="nump">$ 18,000,000.0<span></span>
</td>
<td class="nump">$ 100,900,000<span></span>
</td>
<td class="nump">$ 95,500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452175668216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue - Remaining Performance Obligation (Details)<br></strong></div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-03-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-03-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue, Remaining Performance Obligation, Percentage</a></td>
<td class="nump">11.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</a></td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-03-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-03-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue, Remaining Performance Obligation, Percentage</a></td>
<td class="nump">36.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-03-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-03-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue, Remaining Performance Obligation, Percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-03-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-03-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue, Remaining Performance Obligation, Percentage</a></td>
<td class="nump">16.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-03-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-03-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue, Remaining Performance Obligation, Percentage</a></td>
<td class="nump">12.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-03-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-03-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-03-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-03-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-03-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-03-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-03-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-03-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-03-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-03-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452081127080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Additional Lease Information (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 26, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LeaseRevenuePercentageOfTotalRevenue', window );">Lease revenue as a percentage of total (percentage)</a></td>
<td class="nump">0.05<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LeaseRevenuePercentageOfTotalRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease Revenue, Percentage Of Total Revenue</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LeaseRevenuePercentageOfTotalRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452085962216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jun. 26, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">$ 0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Total</a></td>
<td class="nump">94.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeOptionMember', window );">Foreign currency option contracts</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=holx_ContingentConsiderationMember', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Contingent consideration</a></td>
<td class="nump">71.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">21.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeContractMember', window );">Forward foreign currency contracts | Liability</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Total</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1) | Foreign currency option contracts</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1) | Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Contingent consideration</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1) | Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1) | Forward foreign currency contracts | Liability</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs&#160;(Level&#160;2)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Total</a></td>
<td class="nump">22.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs&#160;(Level&#160;2) | Foreign currency option contracts</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs&#160;(Level&#160;2) | Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Contingent consideration</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs&#160;(Level&#160;2) | Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">21.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs&#160;(Level&#160;2) | Forward foreign currency contracts | Liability</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">1.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs&#160;(Level&#160;3)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Total</a></td>
<td class="nump">71.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs&#160;(Level&#160;3) | Foreign currency option contracts</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs&#160;(Level&#160;3) | Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Contingent consideration</a></td>
<td class="nump">71.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs&#160;(Level&#160;3) | Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs&#160;(Level&#160;3) | Forward foreign currency contracts | Liability</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of contingent consideration in a business combination that is classified in shareholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of obligations measured on a recurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=holx_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=holx_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452174009624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Intangible asset and equipment impairment charges</a></td>
<td class="nump">$ 30.2<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 30.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PrincipalAmountOfBorrowings', window );">Borrowed principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember', window );">Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PrincipalAmountOfBorrowings', window );">Borrowed principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember', window );">2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">420.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember', window );">2029 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 940.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Intangible asset and equipment impairment charges</a></td>
<td class="nump">$ 30.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PrincipalAmountOfBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate outstanding principal of amounts borrowed under the Credit Agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PrincipalAmountOfBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452088531272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Roll Forward (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="nump">$ 71.7<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="nump">$ 81.8<span></span>
</td>
<td class="nump">$ 9.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Contingent consideration recorded at acquisition</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Fair value adjustments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(10.1)<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Payments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(9.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="nump">$ 71.7<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="nump">$ 71.7<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452071746488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination - Narrative (Details)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 17, 2021 </div>
<div>USD ($) </div>
<div>project</div>
</th>
<th class="th">
<div>Mar. 01, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 22, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 04, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 28, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 23, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 03, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 21, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 01, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 26, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 26, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th"><div>Nov. 20, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800.8<span></span>
</td>
<td class="nump">$ 1,800.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,307.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,264.2<span></span>
</td>
<td class="nump">3,264.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,657.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FairValueAssumptionDiscountRate', window );">Discount rate percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember', window );">Developed Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember', window );">Mobidiag Oy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="nump">$ 729.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess', window );">In process research and development</a></td>
<td class="nump">$ 103.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ResearchAndDevelopmentInProcessNumberOfProjects', window );">Research and development in process, number of projects | project</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ResearchAndDevelopmentInProcessCompletionPeriod', window );">Research and development in process, completion period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="nump">$ 284.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships', window );">Customer relationships</a></td>
<td class="nump">26.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames', window );">Trade names</a></td>
<td class="nump">21.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 406.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember', window );">Mobidiag Oy | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue', window );">Intangible assets, fair value (percentage)</a></td>
<td class="nump">14.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember', window );">Mobidiag Oy | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue', window );">Intangible assets, fair value (percentage)</a></td>
<td class="nump">16.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember', window );">Mobidiag Oy | Customer Relationships | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember', window );">Mobidiag Oy | Customer Relationships | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">11 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember', window );">Mobidiag Oy | Developed Technology | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember', window );">Mobidiag Oy | Developed Technology | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember', window );">Mobidiag Oy | Trade Names | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember', window );">Mobidiag Oy | Trade Names | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_BiotheranosticsMember', window );">Biotheranostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 231.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue', window );">Intangible assets, fair value (percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 160.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_DiagenodeMember', window );">Diagenode</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 155.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_DiagenodeMember', window );">Diagenode | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue', window );">Intangible assets, fair value (percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_DiagenodeMember', window );">Diagenode | Developed Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue', window );">Intangible assets, fair value (percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SomatexMedicalTechnologiesMember', window );">Somatex Medical Technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net acquired tangible assets and liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_NXCImagingMember', window );">NXC Imaging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_NXCImagingMember', window );">NXC Imaging | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember', window );">Acessa Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 161.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue', window );">Intangible assets, fair value (percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 127.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Purchase price withheld</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 81.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AnnualIncrementalRevenueGrowthPeriod', window );">Annual incremental revenue growth period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (10.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember', window );">Acessa Health | Contingent Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Purchase price withheld</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_HealthBeaconsMember', window );">Health Beacons</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Holdback', window );">Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Remainder of purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AlphaImagingMember', window );">Alpha Imaging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Purchase price withheld</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Holdback', window );">Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AlphaImagingMember', window );">Alpha Imaging | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember', window );">SuperSonic Imagine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69.3<span></span>
</td>
<td class="nump">$ 18.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of outstanding shares acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessAcquisitionCashTenderOfferPricePerShare', window );">Cash tender offer price (per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage', window );">Equity interest in acquiree, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain', window );">Equity interest in acquiree, remeasurement gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment', window );">Consideration related to equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares', window );">Consideration related to newly acquired shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment', window );">Consideration, portion related to loan repayment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest', window );">Consideration related to fair value of noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationAdditionalSharesAcquiredShares', window );">Additional outstanding shares purchased (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationAdditionalSharesAcquiredValue', window );">Additional outstanding shares purchased, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember', window );">SuperSonic Imagine | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember', window );">SuperSonic Imagine | Developed Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember', window );">SuperSonic Imagine | Trade Names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AnnualIncrementalRevenueGrowthPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual Incremental Revenue Growth Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AnnualIncrementalRevenueGrowthPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessAcquisitionCashTenderOfferPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Cash Tender Offer Price Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessAcquisitionCashTenderOfferPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationAdditionalSharesAcquiredShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Additional Shares Acquired, Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationAdditionalSharesAcquiredShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationAdditionalSharesAcquiredValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Additional Shares Acquired, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationAdditionalSharesAcquiredValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Portion Allocable To Equity Method Investment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Portion Allocable To Fair Value Of Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Portion Allocable To Loan Repayment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Portion Allocable To Newly Acquired Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Research And Development In Process</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_FairValueAssumptionDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value Assumption, Discount Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_FairValueAssumptionDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Holdback">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Holdback</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Holdback</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ResearchAndDevelopmentInProcessCompletionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research and Development in Process, Completion Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ResearchAndDevelopmentInProcessCompletionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ResearchAndDevelopmentInProcessNumberOfProjects">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research and Development in Process, Number Of Projects</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ResearchAndDevelopmentInProcessNumberOfProjects</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_BiotheranosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_BiotheranosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_DiagenodeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_DiagenodeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_SomatexMedicalTechnologiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_SomatexMedicalTechnologiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_NXCImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_NXCImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=holx_ContingentHoldbackMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=holx_ContingentHoldbackMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_HealthBeaconsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_HealthBeaconsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_AlphaImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_AlphaImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452093031784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combinations Business Combinations - Purchase Price Allocation (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 17, 2021</div></th>
<th class="th"><div>Mar. 01, 2021</div></th>
<th class="th"><div>Feb. 22, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Aug. 23, 2020</div></th>
<th class="th"><div>Nov. 21, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 3,264.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,657.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember', window );">Mobidiag Oy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">284.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess', window );">In process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(66.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(72.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">406.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Purchase Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 729.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_BiotheranosticsMember', window );">Biotheranostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Purchase Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 231.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_DiagenodeMember', window );">Diagenode</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Purchase Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 155.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember', window );">SuperSonic Imagine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt', window );">Short and long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Purchase Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember', window );">Acessa Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Purchase Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 161.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Research And Development In Process</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_BiotheranosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_BiotheranosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_DiagenodeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_DiagenodeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452176810392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade Receivables and Allowance for Credit Losses (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Accounts Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Balance&#160;at Beginning of Period</a></td>
<td class="nump">$ 31.6<span></span>
</td>
<td class="nump">$ 17.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Credit Loss</a></td>
<td class="nump">11.6<span></span>
</td>
<td class="nump">19.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccountsReceivableAllowanceForCreditLossTransfers', window );">Divested</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(5.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Write- offs and Payments</a></td>
<td class="num">(3.4)<span></span>
</td>
<td class="num">(3.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Balance&#160;at End of Period</a></td>
<td class="nump">$ 39.8<span></span>
</td>
<td class="nump">$ 27.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccountsReceivableAllowanceForCreditLossTransfers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Allowance for Credit Loss, Transfers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccountsReceivableAllowanceForCreditLossTransfers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452086295464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disposition (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 20, 2019</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Intangible asset and equipment impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,200,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 30,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss', window );">Disposal Group, Including Discontinued Operation, Operating Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Disposal Group, Including Discontinued Operation, Consideration</a></td>
<td class="nump">$ 205,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from Divestiture of Businesses</a></td>
<td class="nump">$ 153,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IndemnificationLiability', window );">Indemnification liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup', window );">Disposal Group, Including Discontinued Operation, Segment that Includes Disposal Group</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">150.0&#160;million<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Intangible asset and equipment impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingExpenseMember', window );">Operating Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Intangible asset and equipment impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_IndemnificationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indemnification liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_IndemnificationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Identification of the segment that the disposal group, including discontinued operation is reported.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=holx_MedicalAestheticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=holx_MedicalAestheticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452079727624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Company's Borrowings (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">$ 460.6<span></span>
</td>
<td class="nump">$ 324.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt obligations</a></td>
<td class="nump">2,654.7<span></span>
</td>
<td class="nump">2,713.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt obligations</a></td>
<td class="nump">3,115.3<span></span>
</td>
<td class="nump">3,038.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">74.8<span></span>
</td>
<td class="nump">74.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LongTermDebtObligationsWithoutConvertibleNotes', window );">Long term debt obligations. excluding convertible notes</a></td>
<td class="nump">1,325.5<span></span>
</td>
<td class="nump">1,379.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_RevolverMember', window );">Revolver</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">250.0<span></span>
</td>
<td class="nump">$ 750.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_AccountsReceivableSecuritizationMember', window );">Accounts Receivable Securitization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">320.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other Debt Obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">65.8<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_A2025SeniorNotesMember', window );">2025 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LongTermDebtObligationsWithoutConvertibleNotes', window );">Long term debt obligations. excluding convertible notes</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">939.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember', window );">2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LongTermDebtObligationsWithoutConvertibleNotes', window );">Long term debt obligations. excluding convertible notes</a></td>
<td class="nump">395.2<span></span>
</td>
<td class="nump">394.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_A2029SeniorNotesMember', window );">2029 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LongTermDebtObligationsWithoutConvertibleNotes', window );">Long term debt obligations. excluding convertible notes</a></td>
<td class="nump">$ 934.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LongTermDebtObligationsWithoutConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long term debt obligations without convertible notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LongTermDebtObligationsWithoutConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_RevolverMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_RevolverMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_AccountsReceivableSecuritizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_AccountsReceivableSecuritizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_OtherDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_OtherDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_A2025SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_A2025SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_A2029SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_A2029SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452071661128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 26, 2021</div></th>
<th class="th"><div>Oct. 15, 2020</div></th>
<th class="th"><div>Sep. 28, 2020</div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Mar. 27, 2021</div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Jun. 17, 2021</div></th>
<th class="th"><div>Jun. 11, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 17, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,115,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,115,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,038,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">21,600,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long-term Debt, Current Maturities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">460,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 460,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">324,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt Instrument, Redemption Price, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Mobidiag Oy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Mobidiag Oy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_AmendedTermLoanMember', window );">Amended Term Loan | Percentage Added to Eurodollar Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_RevolverMember', window );">Revolver | Percentage Added to Eurodollar Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_RevolverMember', window );">Revolver</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long-term Debt, Current Maturities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000,000.0<span></span>
</td>
<td class="nump">$ 750,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Revolving credit facility borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2025 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (21,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior notes, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest Expense, Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt Issuance Costs, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt Instrument, Unamortized Discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtRedemptionPremiumPaid', window );">Premium payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of Debt, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 970,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950,000,000<span></span>
</td>
<td class="nump">$ 950,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentOfferingPricePercentOfFaceValue', window );">Debt Instrument, Offering Price, Percent Of Face Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt Instrument, Redemption Price, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes | Debt Instrument, Redemption, Period One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt Instrument, Redemption Price, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes | Debt Instrument, Redemption, Period Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt Instrument, Redemption Price, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes | Debt Instrument, Redemption, Period Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt Instrument, Redemption Price, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.813%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes | Debt Instrument, Redemption, Period Four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt Instrument, Redemption Price, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes | Debt Instrument, Redemption, Period Five</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt Instrument, Redemption Price, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember', window );">2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior notes, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long-term Debt, Current Maturities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount', window );">Debt Instrument, Unused Borrowing Capacity, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_AccountsReceivableSecuritizationMember', window );">Accounts Receivable Securitization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long-term Debt, Current Maturities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 320,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 320,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="nump">$ 250,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MaximumBorrowingUnderAssetSecuritizationAgreement', window );">Maximum borrowing under asset securitization agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 320,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtWeightedAverageInterestRate', window );">Debt, Weighted Average Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.78%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.78%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtInstrumentOfferingPricePercentOfFaceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Offering Price, Percent Of Face Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtInstrumentOfferingPricePercentOfFaceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtRedemptionPremiumPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Redemption, Premium Paid</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtRedemptionPremiumPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_MaximumBorrowingUnderAssetSecuritizationAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing under asset securitization agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_MaximumBorrowingUnderAssetSecuritizationAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unused borrowing capacity under the long-term financing arrangement that is available to the entity as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of debt outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_MobidiagOyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_AmendedTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_AmendedTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=holx_PercentageAddedtoEurodollarRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=holx_PercentageAddedtoEurodollarRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_RevolverMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_RevolverMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_RevolverMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_RevolverMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_AccountsReceivableSecuritizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_AccountsReceivableSecuritizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452092276264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">$ 13.0<span></span>
</td>
<td class="nump">$ 15.7<span></span>
</td>
<td class="nump">$ 38.9<span></span>
</td>
<td class="nump">$ 47.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember', window );">Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">$ 5.1<span></span>
</td>
<td class="nump">$ 11.4<span></span>
</td>
<td class="nump">$ 17.0<span></span>
</td>
<td class="nump">$ 38.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Weighted average interest rate</a></td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">1.68%<span></span>
</td>
<td class="nump">1.15%<span></span>
</td>
<td class="nump">2.52%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Interest rate at end of period</a></td>
<td class="nump">1.09%<span></span>
</td>
<td class="nump">1.55%<span></span>
</td>
<td class="nump">1.09%<span></span>
</td>
<td class="nump">1.55%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of interest expense on all borrowings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.7,8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452085500280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Sep. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">$ 13.0<span></span>
</td>
<td class="nump">$ 15.7<span></span>
</td>
<td class="nump">$ 38.9<span></span>
</td>
<td class="nump">$ 47.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">$ 4.8<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
<td class="nump">$ 14.4<span></span>
</td>
<td class="nump">14.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2025 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">10.9<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">32.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">$ 8.2<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 24.5<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of interest expense on all borrowings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.7,8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452173971960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_InterestRateCapAgreementsAggregatePremiumPayable', window );">Interest Rate Cap Agreements Aggregate Premium Payable</a></td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="nump">$ 3.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PrincipalAmountOfBorrowings', window );">Borrowed principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_NotationalAmount', window );">Notational Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">253.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative notional amount</a></td>
<td class="nump">$ 1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeVariableInterestRate', window );">Variable interest rate</a></td>
<td class="nump">1.23%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Interest rate swap at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember', window );">Foreign Exchange Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_InterestRateCapAgreementsAggregatePremiumPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest rate cap agreements aggregate premium payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_InterestRateCapAgreementsAggregatePremiumPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_NotationalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Notational Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_NotationalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PrincipalAmountOfBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate outstanding principal of amounts borrowed under the Credit Agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PrincipalAmountOfBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of all asset derivatives designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeVariableInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Variable interest rate in effect as of the balance sheet date related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeVariableInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452086526312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives - Schedule Of Change in Fair Value Of Derivative Contracts (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Total</a></td>
<td class="num">$ (6.5)<span></span>
</td>
<td class="num">$ (2.0)<span></span>
</td>
<td class="num">$ (18.4)<span></span>
</td>
<td class="num">$ (1.8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of realized gain (loss) recognized in income</a></td>
<td class="num">(8.4)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(10.9)<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Amount of unrealized gain (loss) recognized in income</a></td>
<td class="nump">1.9<span></span>
</td>
<td class="num">(2.0)<span></span>
</td>
<td class="num">(7.5)<span></span>
</td>
<td class="num">(1.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Forward foreign currency contracts | Derivatives not designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of realized gain (loss) recognized in income</a></td>
<td class="num">(7.0)<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="num">(6.5)<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Amount of unrealized gain (loss) recognized in income</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(2.0)<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember', window );">Foreign currency option contracts | Derivatives not designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of realized gain (loss) recognized in income</a></td>
<td class="num">(1.4)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(4.4)<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Amount of unrealized gain (loss) recognized in income</a></td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="num">$ (0.2)<span></span>
</td>
<td class="num">$ (5.5)<span></span>
</td>
<td class="num">$ (0.5)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998890-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452086644872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivatives - Fair Value of Derivative Financial Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liability</a></td>
<td class="nump">$ 21.0<span></span>
</td>
<td class="nump">$ 31.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Interest rate swap at fair value</a></td>
<td class="nump">21.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">11.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Forward foreign currency contracts | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Interest rate swap at fair value</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Forward foreign currency contracts | Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Interest rate swap at fair value</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Foreign currency option contracts | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">10.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Interest rate swap | Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Interest rate swap at fair value</a></td>
<td class="nump">11.1<span></span>
</td>
<td class="nump">8.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Interest rate swap | Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Interest rate swap at fair value</a></td>
<td class="nump">$ 9.9<span></span>
</td>
<td class="nump">$ 23.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of all asset derivatives designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452092826568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives - Gain (Loss) on Fair Value Hedges Recognized in AOCI (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount of gain (loss) recognized in other comprehensive income, net of taxes:</a></td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="num">$ (4.7)<span></span>
</td>
<td class="nump">$ 8.0<span></span>
</td>
<td class="num">$ (25.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Changes in value of hedged interest rate swaps and interest rate caps, net of tax of $1.0 and $2.2 for the three and nine months ended June 26, 2021 and $(1.5) and $(7.9) for the three and nine months ended June 27, 2020.</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="num">(4.7)<span></span>
</td>
<td class="nump">8.0<span></span>
</td>
<td class="num">(25.9)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount of gain (loss) recognized in other comprehensive income, net of taxes:</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="num">(4.6)<span></span>
</td>
<td class="nump">8.2<span></span>
</td>
<td class="num">(25.4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">Interest rate caps - derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Changes in value of hedged interest rate swaps and interest rate caps, net of tax of $1.0 and $2.2 for the three and nine months ended June 26, 2021 and $(1.5) and $(7.9) for the three and nine months ended June 27, 2020.</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="num">$ (0.1)<span></span>
</td>
<td class="num">$ (0.2)<span></span>
</td>
<td class="num">$ (0.5)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558989&amp;loc=d3e80720-113993<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452165331544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies (Detail)<br></strong></div></th>
<th class="th">
<div>Mar. 04, 2016 </div>
<div>petition</div>
</th>
<th class="th">
<div>Jun. 26, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 27, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=holx_MinervaMember', window );">Minerva</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AmountAssessedInDamages', window );">Assessed damages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Petitions filed | petition</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LegalAccrual', window );">Legal Accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AmountAssessedInDamages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount assessed in damages.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AmountAssessedInDamages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LegalAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Legal Accrual</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LegalAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNewClaimsFiledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total number of new claims filed pertaining to a loss contingency during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNewClaimsFiledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=holx_MinervaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=holx_MinervaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=holx_MedicalAestheticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=holx_MedicalAestheticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452092969464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share - Reconciliation of Basic and Diluted Share Amounts (Detail) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average common shares outstanding</a></td>
<td class="nump">256,230<span></span>
</td>
<td class="nump">259,870<span></span>
</td>
<td class="nump">257,769<span></span>
</td>
<td class="nump">263,667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Weighted average common stock equivalents from assumed exercise of stock options and issuance of stock units</a></td>
<td class="nump">2,351<span></span>
</td>
<td class="nump">1,177<span></span>
</td>
<td class="nump">2,602<span></span>
</td>
<td class="nump">1,425<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average common shares outstanding</a></td>
<td class="nump">258,581<span></span>
</td>
<td class="nump">261,047<span></span>
</td>
<td class="nump">260,371<span></span>
</td>
<td class="nump">265,092<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">Outstanding Stock Options and stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Weighted-average anti-dilutive shares related to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Weighted-average anti-dilutive shares (in shares)</a></td>
<td class="nump">648<span></span>
</td>
<td class="nump">1,597<span></span>
</td>
<td class="nump">513<span></span>
</td>
<td class="nump">1,521<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Weighted-average anti-dilutive shares related to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Weighted-average anti-dilutive shares (in shares)</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_EarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Earnings Per Share [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_EarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452087130952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statements of Operations (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 15.4<span></span>
</td>
<td class="nump">$ 19.9<span></span>
</td>
<td class="nump">$ 51.0<span></span>
</td>
<td class="nump">$ 53.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">6.4<span></span>
</td>
<td class="nump">5.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">6.2<span></span>
</td>
<td class="nump">6.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Selling and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
<td class="nump">7.7<span></span>
</td>
<td class="nump">7.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">8.9<span></span>
</td>
<td class="nump">14.5<span></span>
</td>
<td class="nump">29.8<span></span>
</td>
<td class="nump">31.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember', window );">Restructuring Charges [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">$ 2.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452091797976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Additional Information (Detail) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock option plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Options granted (in shares)</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted-average exercise prices (in dollars per share)</a></td>
<td class="nump">$ 68.62<span></span>
</td>
<td class="nump">$ 45.54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-based compensation, stock options outstanding (in shares)</a></td>
<td class="nump">4.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted-average exercise price of options outstanding (in dollars per share)</a></td>
<td class="nump">$ 44.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense</a></td>
<td class="nump">$ 19.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period for recognition of unrecognized stock-based compensation, years</a></td>
<td class="text">2 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares granted (in shares)</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock units (RSUs), weighted average grant date fair values (in dollars per share)</a></td>
<td class="nump">$ 68.45<span></span>
</td>
<td class="nump">$ 45.67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense</a></td>
<td class="nump">$ 61.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period for recognition of unrecognized stock-based compensation, years</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares granted (in shares)</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock units (RSUs), weighted average grant date fair values (in dollars per share)</a></td>
<td class="nump">$ 68.51<span></span>
</td>
<td class="nump">$ 45.38<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=holx_MarketBasedAwardsMember', window );">Market Based Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares granted (in shares)</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock units (RSUs), weighted average grant date fair values (in dollars per share)</a></td>
<td class="nump">$ 82.51<span></span>
</td>
<td class="nump">$ 43.54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent', window );">Minimum eligible percentage to receive target number of shares of company's common stock</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent', window );">Maximum eligible percentage to receive target number of shares of company's common stock</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod', window );">Performance stock units vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=holx_PSUFreeCashFlowMember', window );">PSU Free Cash Flow [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares granted (in shares)</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock units (RSUs), weighted average grant date fair values (in dollars per share)</a></td>
<td class="nump">$ 68.51<span></span>
</td>
<td class="nump">$ 45.38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent', window );">Minimum eligible percentage to receive target number of shares of company's common stock</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent', window );">Maximum eligible percentage to receive target number of shares of company's common stock</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod', window );">Performance stock units vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=holx_RSUPSUMSUMember', window );">RSU, PSU, MSU</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number (in shares)</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum target number percentage of shares issued based on stock performance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum target number percentage of shares that would be issued based on stock price performance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time that must lapse in order for the restricted stock units to vest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=holx_MarketBasedAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=holx_MarketBasedAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=holx_PSUFreeCashFlowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=holx_PSUFreeCashFlowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=holx_RSUPSUMSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=holx_RSUPSUMSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452183499640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Weighted-Average Assumptions Utilized to Value Stock Options (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">33.60%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">33.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend', window );">Dividend yield</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value of options granted</a></td>
<td class="nump">$ 19.17<span></span>
</td>
<td class="nump">$ 9.90<span></span>
</td>
<td class="nump">$ 20.07<span></span>
</td>
<td class="nump">$ 13.79<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452080869192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Balance Sheet Information - Inventories (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 159.4<span></span>
</td>
<td class="nump">$ 152.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">58.5<span></span>
</td>
<td class="nump">46.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">285.0<span></span>
</td>
<td class="nump">196.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">$ 502.9<span></span>
</td>
<td class="nump">$ 395.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452083355272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Balance Sheet Information - Property, Plant and Equipment (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ManufacturingEquipmentAndSoftware', window );">Equipment</a></td>
<td class="nump">$ 541.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 460.7<span></span>
</td>
<td class="nump">$ 541.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_EquipmentUnderCustomerUsageAgreements', window );">Equipment under customer usage agreements</a></td>
<td class="nump">446.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">456.8<span></span>
</td>
<td class="nump">446.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Building and improvements</a></td>
<td class="nump">187.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167.3<span></span>
</td>
<td class="nump">187.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold improvements</a></td>
<td class="nump">48.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44.3<span></span>
</td>
<td class="nump">48.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">41.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.7<span></span>
</td>
<td class="nump">41.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Furniture and fixtures</a></td>
<td class="nump">16.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.1<span></span>
</td>
<td class="nump">16.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</a></td>
<td class="nump">8.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">8.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">1,290.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,185.9<span></span>
</td>
<td class="nump">1,290.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less &#8211; accumulated depreciation and amortization</a></td>
<td class="num">(739.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(694.4)<span></span>
</td>
<td class="num">(739.1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">551.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">491.5<span></span>
</td>
<td class="nump">551.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DepartmentOfDefenseFundsReceived', window );">Department of defense funds received</a></td>
<td class="nump">$ 8.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_GrantsReceivedFromDepartmentOfDefense', window );">Grants received from Department of defense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 119.3<span></span>
</td>
<td class="nump">$ 7.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DepartmentOfDefenseFundsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Department of defense funds received</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DepartmentOfDefenseFundsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_EquipmentUnderCustomerUsageAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount at the balance sheet date of long-lived, depreciable asset that are equipment placed at customer locations for which title is not transferred to the Company's customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_EquipmentUnderCustomerUsageAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_GrantsReceivedFromDepartmentOfDefense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Grants received from Department of defense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_GrantsReceivedFromDepartmentOfDefense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ManufacturingEquipmentAndSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount as of the balance sheet date of long-lived, depreciable assets that include manufacturing and other equipment with finite lives used to produce goods and services, and computer equipment and software.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ManufacturingEquipmentAndSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseholdImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452092004712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 26, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 27, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 27, 2021 </div>
<div>Segment</div>
</th>
<th class="th">
<div>Jun. 26, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 27, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>Segment</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SegmentReportingDisclosureLineItems', window );"><strong>Segment Reporting Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 1,168,300,000<span></span>
</td>
<td class="nump">$ 822,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,315,700,000<span></span>
</td>
<td class="nump">$ 2,429,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SegmentReportingDisclosureLineItems', window );"><strong>Segment Reporting Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_SegmentReportingDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Segment Reporting Disclosure [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_SegmentReportingDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452092382472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information - Segment Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">$ 1,168.3<span></span>
</td>
<td class="nump">$ 822.9<span></span>
</td>
<td class="nump">$ 4,315.7<span></span>
</td>
<td class="nump">$ 2,429.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">358.6<span></span>
</td>
<td class="nump">191.0<span></span>
</td>
<td class="nump">2,040.8<span></span>
</td>
<td class="nump">472.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">100.9<span></span>
</td>
<td class="nump">93.6<span></span>
</td>
<td class="nump">289.1<span></span>
</td>
<td class="nump">281.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">35.1<span></span>
</td>
<td class="nump">35.0<span></span>
</td>
<td class="nump">114.6<span></span>
</td>
<td class="nump">98.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">8,590.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,590.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,195.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">665.5<span></span>
</td>
<td class="nump">532.2<span></span>
</td>
<td class="nump">2,858.2<span></span>
</td>
<td class="nump">1,163.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">260.1<span></span>
</td>
<td class="nump">233.9<span></span>
</td>
<td class="nump">1,745.1<span></span>
</td>
<td class="nump">340.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">63.9<span></span>
</td>
<td class="nump">59.4<span></span>
</td>
<td class="nump">179.4<span></span>
</td>
<td class="nump">177.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">27.4<span></span>
</td>
<td class="nump">28.4<span></span>
</td>
<td class="nump">93.8<span></span>
</td>
<td class="nump">63.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">3,440.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,440.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,161.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">349.0<span></span>
</td>
<td class="nump">224.0<span></span>
</td>
<td class="nump">1,018.0<span></span>
</td>
<td class="nump">862.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">81.0<span></span>
</td>
<td class="num">(11.1)<span></span>
</td>
<td class="nump">235.1<span></span>
</td>
<td class="nump">158.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">13.6<span></span>
</td>
<td class="nump">13.0<span></span>
</td>
<td class="nump">39.7<span></span>
</td>
<td class="nump">36.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">4.5<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">10.1<span></span>
</td>
<td class="nump">17.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">1,253.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,253.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember', window );">GYN Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">127.9<span></span>
</td>
<td class="nump">51.5<span></span>
</td>
<td class="nump">366.2<span></span>
</td>
<td class="nump">275.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">18.2<span></span>
</td>
<td class="num">(23.4)<span></span>
</td>
<td class="nump">60.5<span></span>
</td>
<td class="nump">32.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">23.2<span></span>
</td>
<td class="nump">21.0<span></span>
</td>
<td class="nump">69.5<span></span>
</td>
<td class="nump">63.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">9.5<span></span>
</td>
<td class="nump">12.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">1,383.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,383.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,438.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember', window );">Skeletal Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">25.9<span></span>
</td>
<td class="nump">15.2<span></span>
</td>
<td class="nump">73.3<span></span>
</td>
<td class="nump">62.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="num">(0.7)<span></span>
</td>
<td class="num">(7.4)<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="num">(4.8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">31.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">65.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(54.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">$ 2.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">$ 2,481.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,481.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,355.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAmortizationAndAccretionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAmortizationAndAccretionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452083355688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information - Revenues by Geography (Detail)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">64.20%<span></span>
</td>
<td class="nump">80.30%<span></span>
</td>
<td class="nump">68.40%<span></span>
</td>
<td class="nump">76.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">24.70%<span></span>
</td>
<td class="nump">12.40%<span></span>
</td>
<td class="nump">22.30%<span></span>
</td>
<td class="nump">13.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia-Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">7.70%<span></span>
</td>
<td class="nump">5.30%<span></span>
</td>
<td class="nump">6.20%<span></span>
</td>
<td class="nump">6.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=holx_AllOtherCountriesMember', window );">Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">3.40%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">3.10%<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PercentageOfRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PercentageOfRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ScheduleOfGeographicalSegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Geographical Segments [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ScheduleOfGeographicalSegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=holx_AllOtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=holx_AllOtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452173940152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Company's effective tax rate</a></td>
<td class="nump">20.60%<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">6030.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized Tax Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 312.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 312.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452092355880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">$ 5,660.0<span></span>
</td>
<td class="nump">$ 4,931.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">3,859.2<span></span>
</td>
<td class="nump">3,623.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember', window );">Developed&#160;technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">4,604.5<span></span>
</td>
<td class="nump">4,054.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">3,102.4<span></span>
</td>
<td class="nump">2,907.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">102.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CustomerRelationshipsContractsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">598.0<span></span>
</td>
<td class="nump">549.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">502.1<span></span>
</td>
<td class="nump">477.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">269.6<span></span>
</td>
<td class="nump">245.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">188.8<span></span>
</td>
<td class="nump">181.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-competition agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_BusinessLicensesMember', window );">Business licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_AcquiredintangibleassetsMember', window );">Total acquired intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">5,578.7<span></span>
</td>
<td class="nump">4,852.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">3,797.4<span></span>
</td>
<td class="nump">3,569.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_InternalusesoftwareMember', window );">Internal-use software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">55.4<span></span>
</td>
<td class="nump">51.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">47.6<span></span>
</td>
<td class="nump">43.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CapitalizedsoftwareMember', window );">Capitalized software embedded in products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">25.9<span></span>
</td>
<td class="nump">26.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">$ 14.2<span></span>
</td>
<td class="nump">$ 10.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CustomerRelationshipsContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CustomerRelationshipsContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_BusinessLicensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_BusinessLicensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_AcquiredintangibleassetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_AcquiredintangibleassetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_InternalusesoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_InternalusesoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CapitalizedsoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CapitalizedsoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452082402904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense (Detail)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jun. 26, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Remainder of Fiscal 2021</a></td>
<td class="nump">$ 86.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Fiscal 2022</a></td>
<td class="nump">332.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Fiscal 2023</a></td>
<td class="nump">235.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Fiscal 2024</a></td>
<td class="nump">223.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Fiscal 2025</a></td>
<td class="nump">$ 210.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452089489336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Warranties - Product Warranty Activity (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward', window );"><strong>Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrual', window );">Balance&#160;at Beginning&#160;of Period</a></td>
<td class="nump">$ 9.9<span></span>
</td>
<td class="nump">$ 13.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualWarrantiesIssued', window );">Provisions</a></td>
<td class="nump">6.1<span></span>
</td>
<td class="nump">8.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition', window );">Standard and Extended Product Warranty Accrual, Additions from Business Acquisition</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease', window );">Standard Product Warranty Accrual, Period Increase (Decrease)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(6.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualPayments', window );">Settlements/ Adjustments</a></td>
<td class="num">(6.7)<span></span>
</td>
<td class="num">(7.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrual', window );">Balance&#160;at End&#160;of&#160;Period</a></td>
<td class="nump">$ 9.6<span></span>
</td>
<td class="nump">$ 9.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in the standard and extended product warranty accrual from a business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualWarrantiesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in the standard and extended product warranty accrual from warranties issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualWarrantiesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the standard product warranty accrual. Excludes extended product warranties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452165074024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,705.2<span></span>
</td>
<td class="nump">$ 2,115.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Changes in foreign currency translation adjustment</a></td>
<td class="num">$ (9.4)<span></span>
</td>
<td class="nump">$ 1.4<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="num">(4.7)<span></span>
</td>
<td class="nump">8.0<span></span>
</td>
<td class="num">(25.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">3,877.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,877.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(14.5)<span></span>
</td>
<td class="num">(38.5)<span></span>
</td>
<td class="num">(22.9)<span></span>
</td>
<td class="num">(41.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Changes in foreign currency translation adjustment</a></td>
<td class="num">(9.4)<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to statement of income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(23.9)<span></span>
</td>
<td class="num">(37.1)<span></span>
</td>
<td class="num">(23.9)<span></span>
</td>
<td class="num">(37.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Pension Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to statement of income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(35.8)<span></span>
</td>
<td class="num">(58.9)<span></span>
</td>
<td class="num">(49.7)<span></span>
</td>
<td class="num">(42.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to statement of income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="num">(2.0)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(6.4)<span></span>
</td>
<td class="num">(3.3)<span></span>
</td>
<td class="nump">7.0<span></span>
</td>
<td class="num">(21.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(42.2)<span></span>
</td>
<td class="num">(61.9)<span></span>
</td>
<td class="num">(42.2)<span></span>
</td>
<td class="num">(61.9)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateCapMember', window );">Interest rate caps - derivative | Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.1)<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
<td class="num">(2.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to statement of income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(19.5)<span></span>
</td>
<td class="num">(17.6)<span></span>
</td>
<td class="num">(24.1)<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="num">(4.6)<span></span>
</td>
<td class="nump">7.6<span></span>
</td>
<td class="num">(25.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to statement of income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">$ (16.5)<span></span>
</td>
<td class="num">$ (22.2)<span></span>
</td>
<td class="num">$ (16.5)<span></span>
</td>
<td class="num">$ (22.2)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558989&amp;loc=d3e80720-113993<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724394-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140452166120104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Repurchase Share repurchase (Details) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 09, 2020</div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Jun. 26, 2021</div></th>
<th class="th"><div>Dec. 11, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesDateAxis=holx_December112019Member', window );">December 11, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SharerepurchaseplanLineItems', window );"><strong>share repurchase plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock Repurchase Program, Authorized Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesDateAxis=holx_December112020Member', window );">December 11, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SharerepurchaseplanLineItems', window );"><strong>share repurchase plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock Repurchase Program, Authorized Amount</a></td>
<td class="nump">$ 1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramPeriodInForce1', window );">Stock Repurchase Program, Period in Force</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=holx_December112019Member', window );">December 11, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SharerepurchaseplanLineItems', window );"><strong>share repurchase plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock Repurchased During Period, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepurchaseOfEquity', window );">Repurchase of equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 101.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=holx_December112020Member', window );">December 11, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SharerepurchaseplanLineItems', window );"><strong>share repurchase plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock Repurchased During Period, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepurchaseOfEquity', window );">Repurchase of equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 188.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 308.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock Repurchase Program, Remaining Authorized Repurchase Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 691.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 691.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_SharerepurchaseplanLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for share repurchase plan [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_SharerepurchaseplanLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepurchaseOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow resulting from the entity's share transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepurchaseOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramPeriodInForce1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramPeriodInForce1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesDateAxis=holx_December112019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesDateAxis=holx_December112019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesDateAxis=holx_December112020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesDateAxis=holx_December112020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=holx_December112019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=holx_December112019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=holx_December112020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=holx_December112020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>92
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M*3:;2K$G4C\-:OH@STT>#5\3Q+H95TK"W0#BU,P1.R[)$EJ,]$CJ,\G3J:%
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M>FS/Q)*:9F>ZS<3;[3,M0A(W)*&2H)WMKR] T:)$'$*>)@^Q1!T /(<7]QZ
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M.M9,;A%_MOG>0& !]JR;&RMR&;*\#%D!" MBEP@GMH3^>"+M^S@=/_'1_%\
M9!C'* 0 DH6PTQ6"<A:Y^+.!/W/R_U3+IB'[6FYR_(R9-?9$85P J!^&,!$
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M54+_1X?6UANA;"<DJULPS* N:?/$KZT0/0#XL0."%A , =$)0-@"PO=&B%I
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M%%B KS=OP*\O?@,O "_!1Y[G9N;5V4J;&]?#5YON)J_;F^")F_Q9E4N HSG
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MV^!"G"7[ >(Y%N(L^0\(Z'_\D/0!D0*A9^PL11 (2(($H(<H?VCHD:_'$O^
M@/I'[V4X1."#KA%+X0,"$A]'RFD060^OLQ8- WH>ITAGI$M%9 !:/\*Y]:V!
M[1=5?LJK^XG.3*;%G2X<_]P>[JW67_VX_J$I%ZLO$KPMFZ:<K3Z.BUP_3FN@
M_WY7ELWVA_:["7??P/GF?U!+ P04    " "L@?Q2I/>0K'$(  #@)   &
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MPL4<5=VWI-'4%V8'G=!/G>4>$D64D-;'M=3F3.-&)OE&9G5=_027(\FJU%J
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M(8'#O+"J4"&@X^P;.^;4ZE(1''8KN*2BDMKW+$A(RN#Z-#N[0%H7-*T<PY^
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M&KJA/=.T4;%V)4T:24AW-,C4:90D7I7$&: ?@/X=%X4##ED Y",3S&/,Z#3
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M*BS@_/I2C'K'';'Y.86VH]0@G_9S]9K.>BFQS4IK)UY&.+;DBQR R.)2VLP
M)LU#;5/KSE,<04-Q$5M[JKO+)"WO&_^9$\Q;T2I?M>S4=>"-H:G<M3N"[B@F
MEZX(MKH #$]_@Z&C7:OF[(KO45V+W^&;I2^L@J+"%2NR9P<$#$$+YU);M-4H
MA4(X -]\X9:&R$)WC?BB3$47;UD:9UK-1&%G\F#M$#_0=&0/= &PF3/V;BZ9
M@XH+C9IL OO/B<A=5&7!UQ7-F$[V/>'A\U!]XZ6<5<RVTM5@9A"D>$T@3@Q;
M\V":%)59[D,'&1Y%XA](JE]9JC=-ZT+L%EH3N8Q5T]50[*),U@'PUVT;]<:S
MR]7<1C0T&7&@EKPL6[I+;PAMZ]T@R@SE/H%\B^!XR[8@VSQN$2Y(K.Q]M*2V
MJ]V:*DO]ML8U&8S!3A5?R@N%;H=+2<7/PV7+X/NTJWED=2Y^^4MS[J[BW#WC
MY;A)?E D/*&%U.I;YA1=MS=<C0]^LO2A_N^*46^[DHM0ESU[S6F'<QY6Q(J?
ME)$J W[WUR;)Q"(]<SJM"_;493\Z(DDL7S^EU@:3R"*ZDA+=\(R5Z.+O8XX+
MZISTT<\*UG#/CM,"JK":4X&CU5.!(]1-#SP4..J>/O7FR> 4\\8W3_KW,/Z#
M'ATT- _<C"#F.N-_\M>Y>5(;VV=-]S?.^(E8>L>>_#^]*9)_N2KRA*LBM(8O
M;/K3V?0HC04J79$(KGYF3&670:!6*=7BU5N/^K0+@%:GC63VQ[KHX:F#"R4I
MX+=N1S^>0V@/5I,([:]W7HWNGW5/MY()-950N&O4#>\@ZDOT(6%7"U*"<R.5
M!V2WNZY=T46KRJ=.K]]>\I5\&[9V*Z\5<5EM=AAX[S3&>UO]>?^DS0-OI6\'
M$:OQ4*KLP;1M6R.?A"H]SQ8S&9.E*R<D_;,G<J6M@3OB]>M+XKOB+W=;:L3S
MWTM[]2/:Z[&\UJR586'F,?6_1L:T"Q#'K@6/(/@RTXO *9%TL#=!$=A2U5,J
MASTI>BQ7%+_]8*7=[L^CD-]_2E+XNH*Y7YL<F<*M5$5L:W^3'0;14G%T\E60
MUU1EK94"%:[#MQL&/]B[OK[RM"N9VB ZD+N^\EI>5..,'N7P,\9\I;Y[KO+G
M[^C:(F!+1_P0/4BWE;V$:UM9(('2DR+N"%'[;25^APVG2]5%=%ZQMNY,5CD_
M\2D=5N,"P;J;D%'P\<D\A+$-BO&>%QSN;_\Q&IX<?=OO'O>H$G"M:*TT2_O!
MQA9 QH(;C?T**,[.<,7&CKW['IX#>SK \(-![]M?K[[GO_K?/N/'XW7I"8;2
M0PW_H"FC!50NKH"(6DE&]S4ZT 15H,=4$>%4XRTW:4ZW330?(/)3KHQW3.80
M%X2&=T11%KA&9_3LKM>\MSI$#+4:<LTM@ T9.EL7#W1C&$7!&1"2".\IBE/'
M])1WB_UI'ZRR\*A=9!* N6-6-'G0C7+L7/1D,9D)%C97Y<RD+I1S1PS>)8=9
MD[X]85--Y3$7=!J=4$9>@UUU[C&(S[/.:9]=GNIL58L.V\\LF?0% Q<K=QQH
ML>;3T4:WI6=ZU^2 D6U8FC\<SE'K^*W-,%%K/VI!^ &E>K/;]NP+7_2MXUVC
M5T^ K-L%C3A6\-Z\?MI8NB,.1\[5M7>4U'DMCCQTB2QB\QH])O&34LTX1?W,
M5$<03\?T*ED/];X/!:P^_]PBV((7138'8>^/JU@-/:1>MMA56:XA UI)Q^O!
M[4K,T0TC)!87+.$U/8RJ#SPK],S1-8$!U1:+#LPY41G-25Y,K$7;N2&E[9^<
MK1^Q<:)G%H\!QFET'2"PGVUOC)1'#\9=7W7:KL/=O/)J1S0;?79_V(MT,F$Z
M& 5O._\A]VBO*=J(;0""*W6Y?(X$097<<W6GW<.';DBRXDG5<HX&[#<<%0DQ
MI6?1G=?MCZ)UU8Q]J+[6R]?<Y,%#VUZYV;=6W+/.].VPU8^HW0T&2E1L=*[K
M0ED#YCG1.@Y;VW2S#?6W08YV<CV*2H3@'9$\//.H>]Q8&+.=S6N5-I/@%$U3
MT>_U[O?"QW#(+CS^R:0Q"VR*9HC-^[R31AYLN71^RG>NZ_=(]0#]@</H+AG2
M:W-MKD94_ CD"@,]?"@#/3CJ'D<O:@I$P4&?;JM?SR"V4\_*^YU&6RZS#^G[
M)Q':PQ&$WG*9_6B%ZJ9+ #LOM]-+LFJF>TCJ6&.Z3\XV$]W_)N2V\X+HA&Z%
M-?ZH3/&VMTAT-E/(GYXV%LAK'X,U_NQ>8O2$5XC ;L_N>5E(TV334XF4:B.J
M^=^.7OY#*&7GS_?QR2V0C/;#5ZC-46Y,K5S,EOZ.D.>3:Y>);@$$Z,1\24PK
M0Q=! D)"B6HQ*]A$_PJX/Y):WO1JTL/HC:^PLRF_UY9V AIV+W^MOZU?G7ON
MWAC;-'?OW7TCH6>$@$Q-T+77/3W>$]:]R]9]*,V"WQ\[-B6,FO^<*;IC3@WP
M^\28,GR@">H7"K_\/U!+ P04    " "L@?Q2_)]F!#L%  !9#   &0   'AL
M+W=O<FMS:&5E=',O<VAE970Q,RYX;6RU5]MNW#80_97!MB@28+,7V8XOM0W8
M3HJZ:-H@29.'H@]<:;0B+)$*2>W:_?J>H;2R9,<N^M 7KTC.Y<S,F2%]NK7N
MQA?,@6ZKTOBS21%"?3*?^[3@2OF9K=G@)+>N4@%+MY[[VK'*HE)5SI/%XO6\
M4MI,SD_CWGMW?FJ;4&K#[QWYIJJ4N[ODTF[/)LO);N.#7A=!-N;GI[5:\T<.
M?]3O'5;SWDJF*S9>6T..\[/)Q?+D<E_DH\!GS5L_^":)9&7MC2RNL[/)0@!Q
MR6D0"PH_&[[BLA1#@/&ULSGI78KB\'MG_:<8.V)9*<]7MORBLU"<38XFE'&N
MFC)\L-N?N8OG0.REMO3Q+VU;V8/%A-+&!UMURD!0:=/^JMLN#P.%HZ<4DDXA
MB;A;1Q'E&Q74^:FS6W(B#6OR$4.-V@"GC13E8W XU= +YY^<RI@^<,IZHU8E
M>U(FHXL2Q5(F94+9Z<IQI@/]:KUG?SH/<"O*\[1S<=FZ2)YP<4SOK F%I[<F
MXVRL/P?<'G.RPWR9/&OPE\;,*'D]I621+)^QM]?G8"_:VWO"WC#Z/R]6/CAP
MY:]G#._WAO>CX?W_,[G/NI">/?&U2OEL@J;T[#8\^>]^Z6V><^P/^LAUX&K%
MCI+#F.'%E$+!=&6K6ID[4IF%0$:?;*U3VI,R; N=%NC0KXT&!$BK0+DV<*55
M20H.@J>*E6_@DW"H*NN"_AN+U/I *Z:(W83V6-P9CF*-"<2W-;#A*%@1!>/+
MN)[1)PCVIVD;4-D&I!RC.3<8.C7.&J_-&DD@]D&CE;$E<N3P"62AL%D+.[48
M-QD[3X5&[SF=(H+.HPP1\>8T(XE3=*=SP"PZ<(Q3/XUYQFSTUDC>X](W=8UP
MXQJ)YU3YT"5)Q:S'>#L?:J5+'>[(YG'7L:A*5F(JNH@?Q]#&J^JZU&V>0F2
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M'_ 1X=)G1GH(MHY7^[4-^%"(/TM\F9'C#5@OK W= P?HO_7._P=02P,$%
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M9:XQ'H5L(^O>A*2ZJHPR# 5F*0E\%26JHF:J\:%'#PS(E,%IR!9C0_U8(JN
M@%N!?CVR]XID4]B"]]J%$F+U"EVM>@"; $;EK;;VM55SN2IA-2/GC\4L.)\V
MY<B%2.<RJ2(A*(^'MX"*= :C34^&G"5BEZNJMB#Y6X& QC-0J/-H.MZK(K!&
M"]?-)BHW;2 GFW98'7#G.7Z1U:1AM34;-W,_"S[8NCME-.9V ]P;*4-_/![U
M^L'[Q[4-X5W6Q1HJC9:QWY3E6=;5M42 NHRP5+&:>83/RI2P41D7DJ%)U*:J
M)1N2?ANZ93T#.%*AHA^P#&N:"*]@ZKG'R)624Q/)WX&T>NV$ VEZ$"R/KC#
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MK!+^0D[PM0S7"AC6"V\@;U;4.2[B2NGV+$YFJJN9U)8?4UZ3LGUHFZDE09I
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MX],B"T#W;;&?6+7QK>A.66ILWJSI3X+:.=#^2BE[F+@$P[]I\0=02P,$%
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M0L3_4O?['8F0N!A%8>@,7L2. YXO?# 1IXS=B(TB9:ZPE*ZN/@]_YCSDN1L
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MPE%Y-IA/?KDX9/I(\+>BC>]]"[9D8>T'7KPJS@9C!D2:\L 2)/ZLZ9*T9D&
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MRD9K42*^8-B2=-&F!N)#)4-B HJ5LVNX)'+=08$W^7) K3D'])'_(-B#@KF
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M7UBD_S\& E3T- ??F_K'T</C)Z?^D]WT="]!H6Z*[HK\/ 68%-NV[0=+;1<
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ML^/G ^'2(S0M@EW%A]_"!CPCXV>%=SLY)L!Y:6W8+5A!]Y^ \_\ 4$L#!!0
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MB0"^KRUHV2[$07\S/_D'4$L#!!0    ( *R!_%+A#<C>O 4  %</   9
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M9#S_B0K@Z F%AXT@1!$V<!$!* B+SSA&' =OLCP.'L#K-/@$"\3'E!,B$?&
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MLW<)V.Z^[Q;>-.&.G1M/-W;XK.@7"2T+T/G"T#Q;+]A _],U_1]02P,$%
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M-VWL14?L#>&S%";7\)/(,/MV?X>P;0%&&X#3Z*3!7VKA0Y1<011$X0E[W6W
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M_[B>.6Q(RV9Y+_R^$QZ_('S%?M2U*RW[OBY$<;I^AFT';>.#MO?Q18'_;.N
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MX65KN8'6/F$%[ [0;X3/'WU)U7D9:8$CR14BNNH2&=W"A*)HK3JS.A!*E-Z
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M$8$9&N0P<?H0FM)6.VIQP6SIGX+&.]#^3FMWGO@$XU]J]1]02P,$%     @
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M;FIWI[?O5.^/-[#4M?7_L.WN)O$ RHUUNNF%T8*F:KM1?NUYV!/(HQ<$>"_
MO=V=(F_E:^GDY,SH+1BZC6@T\:YZ:32N:BDH4V?PM$(Y-[G<6-RQ%J9JB5P[
M"[*=PUNEET:N5U4)UVT7>:)P^$'.:F5'9V.'J@E@7/9J+CLU_ 4U!=SHUJTL
MO&GG:GXH/T:3=W;S![LO^5' 7S=M"#P-@$><'<$3.QZ$QQ,OX/7NPYU::^.J
M=@E_7,RL,Y@U?QZ!CW?PL8>/_P5^C\WG2#P*0O5Y:M>R5.<#+$"KS!<UF/3
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M3^UJE\:%=][T5I#>"S8MDX+T7KAGYBXF#T6[<U8-GTD 5&H\4 &42QW 9Q*
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M^P/F^S=5_M">H/Z25U6^;5_>VWAMBP90?W^7Y]73F^8"QW/^U_\'4$L#!!0
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MS7=);EK+S4"+A6OGID*;YM"]SDT[#M)N,.LS(?1V8#O$LL$?_@-02P,$%
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M*J";J5M-:B*BS:4\PI,O\D7FE[#OUHH!-/BT81T(@(4$1ZA#/DFYPX.WJT"
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M<(WZN=:(,^WH P909$UE'0. L6/(.K:[#U>YV\$ B,P/Q')1'N/DQP4)?>J
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M\#, E#V ^UN)-ZJ>6 '-A\7L%U!+ P04    " "L@?Q2XQ]A_AH#   X"@
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M#)FEYT%/8IFG/*L(!%."$>\HSS7*M6<5@0!1H,D@,]L#SX.>= [+5UA)8"N
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M2+?5GSFZ3PN.E^K'->.6S\H'^.\?TK1H/I1_.>GPM^%._@]02P,$%     @
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M#Z7:U$__+%1IDFW]=B7-TNOJ!//]K5+ECP_5 T7[I^;._P502P,$%     @
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MOY_MA(Q+FK)6>R&^?-]W+C[89[!F_$G, 21Z+G(JAM9<RL6YXXCI' HL;+8
MJG9FC!=8JBG/'+'@@%-#*G+'=]VN4V!"K=' K-WPT8 M94XHW' DED6!^<L8
M<K8>6IZU6;@EV5SJ!6<T6. ,[D#>+VZXFCFU2DH*H((PBCC,AM:%=Y[T-=X
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M+W-H965T-3@N>&ULM5?;;N,V$/T50M@"NT KB;I9#FP#\0W-HBF"-;9]*/K
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M30BGIW.4R8X9L11<P%O*+#C]()0Z U+Q#4LD?&+I%N$=1FLRN<>E6//D+XR
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M8I)")@C+$(=D8(V\RZBK[8W!'8&M.!@CG<F,L0<]^18/+%<'!!3F4C-@]=G
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MN%0=-7!MH/83QN1^HAV4/?KP+U!+ P04    " "L@?Q20<%887P"  !7!@
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M!8JVC;43Q6O;"59<Z;YBAZ7N_" ,0.^O.5>?$]-<^O^2[!]02P,$%     @
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M&[K]BLH-=11?3%.N?\&VF-N5D^.<"YJ58+F"#)/B'SZ5@3@ 2)YZ@%\"_)>
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M(TPB"JF6\GI#?<BB:E_51/'2UN=;KG2UM\-<=WP0QD&OIYRK_<0(-/\A)K\
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MQ.'@/V:T=WM=([QG>LVE(0)6&!>'8RR7;II+,[%JZR_T0EEL#WZXP7X,VAW
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M3[6/%\?F8B#9)C_F+9A4A\;\,E*?&L!U@+J_8DP^#?3)L?QX&?\%4$L#!!0
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MHB3Q(X#Y'401AL#;B".8 _" (5%4[8,'^U&XW:?"]O>M\2]02P,$%     @
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MWWDASZ33+=+8*@>[MGL@M!\$V@]>M!LEG<*]8CB@AND!+\VEU%8\RF*EQ'\
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MK>8/>H2@Q_F#TA)E7!(D3; FT#HAUXG ZX1@)P*Q$Y*=",Q.B'8B4#LAVXG
M[81P)P*Y$]*=".Q.B'<BT%M0;R'06U!O(=!;)B_;!'H+ZBT$>@OJ+01Z"^HM
M!'H+ZBT$>@OJ+01Z"^HM!'H+ZBT$>BOJK01Z*^JM!'HKZJT$>NMDLX1 ;T6]
ME4!O1;V50&]%O95 ;T6]E4!O1;V50&]%O95 ;T.]C4!O0[V-0&]#O8U ;T.]
MC4!OFVQV$^AMJ+<1Z&VHMQ'H;:BW$>AMJ+<1Z&VHMQ'H[:BW$^CMJ+<3Z.VH
MMQ/H[:BW$^CMJ+<3Z.V3CY4$>COJ[01Z.^KM!'H[ZNT$>COJ[01Z!^H=!'H'
MZAT$>@?J'01Z!^H=!'H'ZAT$>@?J'01ZQ^1G$P*] _4. KT#]0X"O0/U#@*]
M,^J="?3.J'<FT#NCWIE [XQZ9P*],^J="?3.J'<FT#NCWIE [SSY69! [XQZ
MY^_4>Q@_CV6X]7RM\?G?2?5XN;?<'G]=?IU$"5=7G.O[BN'Y+U!+ P04
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M<' N>&UL4$L! A0#%     @ K('\4EIQIM#N    *P(  !$
M ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ K('\4IE<G",0
M!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q0
M2P$"% ,4    " "L@?Q2=\:2:BL%  !4%0  &               @($-"
M>&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ K('\4K108S3.
M!P  ?"4  !@              ("!;@T  'AL+W=O<FMS:&5E=',O<VAE970R
M+GAM;%!+ 0(4 Q0    ( *R!_%)'6282300  (\.   8              "
M@7(5  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " "L@?Q2
M1T?SEIT"  #G!@  &               @('U&0  >&PO=V]R:W-H965T<R]S
M:&5E=#0N>&UL4$L! A0#%     @ K('\4EC;9KVR!@  ,1L  !@
M     ("!R!P  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    (
M *R!_%(9&;>W!0,  *8)   8              " @; C  !X;"]W;W)K<VAE
M971S+W-H965T-BYX;6Q02P$"% ,4    " "L@?Q2JO21Y?0/  "-<P  &
M            @('K)@  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#
M%     @ K('\4J3WD*QQ"   X"0  !@              ("!%3<  'AL+W=O
M<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( *R!_%((@^D%G <  &P2
M   8              " @;P_  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q0
M2P$"% ,4    " "L@?Q2AGF.];(#  !3#   &0              @(&.1P
M>&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( *R!_%*Y.;6C
MPP8  ) 2   9              " @7=+  !X;"]W;W)K<VAE971S+W-H965T
M,3$N>&UL4$L! A0#%     @ K('\4JAJCGG!%   7%@  !D
M ("!<5(  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " "L
M@?Q2_)]F!#L%  !9#   &0              @(%I9P  >&PO=V]R:W-H965T
M<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( *R!_%+T"\-2W04  /<-   9
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M970Q."YX;6Q02P$"% ,4    " "L@?Q2NW-&<@P'  "N%   &0
M    @('DFP  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    (
M *R!_%)3;T[NVP0  &$*   9              " @2>C  !X;"]W;W)K<VAE
M971S+W-H965T,C N>&UL4$L! A0#%     @ K('\4O'RD$Q8!P  5!(  !D
M             ("!.:@  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"
M% ,4    " "L@?Q2;ZW 3.H%   5$   &0              @('(KP  >&PO
M=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( *R!_%)\N-?0YP,
M &@(   9              " @>FU  !X;"]W;W)K<VAE971S+W-H965T,C,N
M>&UL4$L! A0#%     @ K('\4E*7.\II @  3@4  !D              ("!
M![H  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " "L@?Q2
MUEEM784#  !?"@  &0              @(&GO   >&PO=V]R:W-H965T<R]S
M:&5E=#(U+GAM;%!+ 0(4 Q0    ( *R!_%)@^Q[W0@,  /L'   9
M      " @6/   !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%
M  @ K('\4F<P]!G(!0  I0\  !D              ("!W,,  'AL+W=O<FMS
M:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    " "L@?Q2X0W(WKP%  !7#P
M&0              @(';R0  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+
M 0(4 Q0    ( *R!_%)A%37?UP4  /X-   9              " @<[/  !X
M;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ K('\4HLC2,[>
M P  @ D  !D              ("!W-4  'AL+W=O<FMS:&5E=',O<VAE970S
M,"YX;6Q02P$"% ,4    " "L@?Q2[\*2SJ0$  #E#0  &0
M@('QV0  >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( *R!
M_%(_?()Y2@(  /P$   9              " @<S>  !X;"]W;W)K<VAE971S
M+W-H965T,S(N>&UL4$L! A0#%     @ K('\4C+C!-U!!P  /1,  !D
M         ("!3>$  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4
M    " "L@?Q2.X^&&[0$   <#0  &0              @('%Z   >&PO=V]R
M:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( *R!_%+M<K\;#@,  +$&
M   9              " @;#M  !X;"]W;W)K<VAE971S+W-H965T,S4N>&UL
M4$L! A0#%     @ K('\4C</PO'E P  'PD  !D              ("!]?
M 'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " "L@?Q2L&:Q
MWU #  !8!P  &0              @($1]0  >&PO=V]R:W-H965T<R]S:&5E
M=#,W+GAM;%!+ 0(4 Q0    ( *R!_%+WROH"V 0  )0+   9
M  " @9CX  !X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @
MK('\4A*_&]P.!   $@D  !D              ("!I_T  'AL+W=O<FMS:&5E
M=',O<VAE970S.2YX;6Q02P$"% ,4    " "L@?Q2>:A6A'0"  !+!0  &0
M            @('L 0$ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4
M Q0    ( *R!_%(9*I2GE0,  % *   9              " @9<$ 0!X;"]W
M;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ K('\4G,QUJ4^"0
M\S\  !D              ("!8P@! 'AL+W=O<FMS:&5E=',O<VAE970T,BYX
M;6Q02P$"% ,4    " "L@?Q2R^^C$F\#   N#0  &0              @('8
M$0$ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( *R!_%(!
M(2S6J@,  (D.   9              " @7X5 0!X;"]W;W)K<VAE971S+W-H
M965T-#0N>&UL4$L! A0#%     @ K('\4MHM ?2E @  A@<  !D
M     ("!7QD! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( *R!_%+C'V'^&@,  #@*   9              "
M@><J 0!X;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ K('\
M4H4644M:#   )TX  !D              ("!."X! 'AL+W=O<FMS:&5E=',O
M<VAE970U,2YX;6Q02P$"% ,4    " "L@?Q2ON VGU@'  !!)P  &0
M        @(').@$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0
M   ( *R!_%*EP9!-V0(  ,T'   9              " @5A" 0!X;"]W;W)K
M<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ K('\4J,:-%2W P  90X
M !D              ("!:$4! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q0
M2P$"% ,4    " "L@?Q20V)M?P($  !H$0  &0              @(%620$
M>&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( *R!_%+]JR(,
M&@@  $$P   9              " @8]- 0!X;"]W;W)K<VAE971S+W-H965T
M-38N>&UL4$L! A0#%     @ K('\4LAW6; G P  TPH  !D
M ("!X%4! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4    " "L
M@?Q2R'Y[CY4#  #A#@  &0              @($^60$ >&PO=V]R:W-H965T
M<R]S:&5E=#4X+GAM;%!+ 0(4 Q0    ( *R!_%)!PCJ>-@,  " *   9
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M970V,RYX;6Q02P$"% ,4    " "L@?Q2/@K+6;\#  #]#   &0
M    @($0;P$ >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    (
M *R!_%*5L\9#Y ,  )(0   9              " @09S 0!X;"]W;W)K<VAE
M971S+W-H965T-C4N>&UL4$L! A0#%     @ K('\4B,>7R^@!0  @1L  !D
M             ("!(7<! 'AL+W=O<FMS:&5E=',O<VAE970V-BYX;6Q02P$"
M% ,4    " "L@?Q2XL6KZE,#  "O"P  &0              @('X? $ >&PO
M=V]R:W-H965T<R]S:&5E=#8W+GAM;%!+ 0(4 Q0    ( *R!_%)!P5AA? (
M %<&   9              " @8*  0!X;"]W;W)K<VAE971S+W-H965T-C@N
M>&UL4$L! A0#%     @ K('\4L1?XKE:!   B0\  !D              ("!
M-8,! 'AL+W=O<FMS:&5E=',O<VAE970V.2YX;6Q02P$"% ,4    " "L@?Q2
MLHOZ]PL#  " "@  &0              @('&AP$ >&PO=V]R:W-H965T<R]S
M:&5E=#<P+GAM;%!+ 0(4 Q0    ( *R!_%)L1V/++ <  $ G   9
M      " @0B+ 0!X;"]W;W)K<VAE971S+W-H965T-S$N>&UL4$L! A0#%
M  @ K('\4HW0RAY$ P  L0X  !D              ("!:Y(! 'AL+W=O<FMS
M:&5E=',O<VAE970W,BYX;6Q02P$"% ,4    " "L@?Q2-\]8;L$"  !/"
M&0              @('FE0$ >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+
M 0(4 Q0    ( *R!_%**+31>^ 0  #X8   9              " @=Z8 0!X
M;"]W;W)K<VAE971S+W-H965T-S0N>&UL4$L! A0#%     @ K('\4LUQ^X%B
M @  [04  !D              ("!#9X! 'AL+W=O<FMS:&5E=',O<VAE970W
M-2YX;6Q02P$"% ,4    " "L@?Q2V1HS/!\#  #\"   &0
M@(&FH $ >&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4 Q0    ( *R!
M_%(])FK\' 8  .@@   9              " @?RC 0!X;"]W;W)K<VAE971S
M+W-H965T-S<N>&UL4$L! A0#%     @ K('\4F!1CM0] P  R P  !D
M         ("!3ZH! 'AL+W=O<FMS:&5E=',O<VAE970W."YX;6Q02P$"% ,4
M    " "L@?Q2HL13B"@#  #L$@  #0              @ '#K0$ >&PO<W1Y
M;&5S+GAM;%!+ 0(4 Q0    ( *R!_%*7BKL<P    !,"   +
M  "  1:Q 0!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( *R!_%)3\B+YU@4  'XS
M   /              "  ?^Q 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M" "L@?Q2>@0#75P"   A+@  &@              @ $"N $ >&PO7W)E;',O
M=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " "L@?Q2+B@*V!4"  #\+
M$P              @ &6N@$ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
..5@!6 )$7  #<O $    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>545</ContextCount>
  <ElementCount>428</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>115</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Consolidated Statements of Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofIncome</Role>
      <ShortName>Consolidated Statements of Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Consolidated Statements of Comprehensive Loss (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BasisofPresentation</Role>
      <ShortName>Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2109103 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2111104 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2116105 - Disclosure - Business Combinations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinations</Role>
      <ShortName>Business Combinations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2120106 - Disclosure - Trade Receivables and Allowance for Credit Losses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses</Role>
      <ShortName>Trade Receivables and Allowance for Credit Losses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2123107 - Disclosure - Disposition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/Disposition</Role>
      <ShortName>Disposition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2125108 - Disclosure - Borrowings and Credit Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangements</Role>
      <ShortName>Borrowings and Credit Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2131109 - Disclosure - Derivatives</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/Derivatives</Role>
      <ShortName>Derivatives</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2137110 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2139111 - Disclosure - Net Income (Loss) Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/NetIncomeLossPerShare</Role>
      <ShortName>Net Income (Loss) Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2142112 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2147113 - Disclosure - Other Balance Sheet Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/OtherBalanceSheetInformation</Role>
      <ShortName>Other Balance Sheet Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2151114 - Disclosure - Business Segments and Geographic Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformation</Role>
      <ShortName>Business Segments and Geographic Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2156115 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2158116 - Disclosure - Intangible Assets and Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IntangibleAssetsandGoodwill</Role>
      <ShortName>Intangible Assets and Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2162117 - Disclosure - Product Warranties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ProductWarranties</Role>
      <ShortName>Product Warranties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2165118 - Disclosure - Accumulated Other Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss</Role>
      <ShortName>Accumulated Other Comprehensive Loss</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2168119 - Disclosure - Share Repurchase</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ShareRepurchase</Role>
      <ShortName>Share Repurchase</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2170120 - Disclosure - New Accounting Pronouncements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/NewAccountingPronouncements</Role>
      <ShortName>New Accounting Pronouncements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2271201 - Disclosure - New Accounting Pronouncements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/NewAccountingPronouncementsPolicies</Role>
      <ShortName>New Accounting Pronouncements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.hologic.com/role/NewAccountingPronouncements</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2303301 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2312302 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/FairValueMeasurements</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2317303 - Disclosure - Business Combinations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinationsTables</Role>
      <ShortName>Business Combinations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/BusinessCombinations</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2321304 - Disclosure - Trade Receivables and Allowance for Credit Losses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables</Role>
      <ShortName>Trade Receivables and Allowance for Credit Losses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2326305 - Disclosure - Borrowings and Credit Arrangements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsTables</Role>
      <ShortName>Borrowings and Credit Arrangements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/BorrowingsandCreditArrangements</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2332306 - Disclosure - Derivatives (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DerivativesTables</Role>
      <ShortName>Derivatives (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/Derivatives</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2340307 - Disclosure - Net Income (Loss) Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/NetIncomeLossPerShareTables</Role>
      <ShortName>Net Income (Loss) Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/NetIncomeLossPerShare</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2343308 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/StockBasedCompensation</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2348309 - Disclosure - Other Balance Sheet Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/OtherBalanceSheetInformationTables</Role>
      <ShortName>Other Balance Sheet Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/OtherBalanceSheetInformation</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2352310 - Disclosure - Business Segments and Geographic Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables</Role>
      <ShortName>Business Segments and Geographic Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/BusinessSegmentsandGeographicInformation</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2359311 - Disclosure - Intangible Assets and Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IntangibleAssetsandGoodwillTables</Role>
      <ShortName>Intangible Assets and Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/IntangibleAssetsandGoodwill</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2363312 - Disclosure - Product Warranties (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ProductWarrantiesTables</Role>
      <ShortName>Product Warranties (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/ProductWarranties</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2366313 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables</Role>
      <ShortName>Accumulated Other Comprehensive Loss (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2404401 - Disclosure - Revenue - Business Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueBusinessRevenueDetails</Role>
      <ShortName>Revenue - Business Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Revenue - Geographical Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueGeographicalRevenueDetails</Role>
      <ShortName>Revenue - Geographical Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2406403 - Disclosure - Revenue - Revenue by Type (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueRevenuebyTypeDetails</Role>
      <ShortName>Revenue - Revenue by Type (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2407404 - Disclosure - Revenue - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueNarrativeDetails</Role>
      <ShortName>Revenue - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2408405 - Disclosure - Revenue - Remaining Performance Obligation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails</Role>
      <ShortName>Revenue - Remaining Performance Obligation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2410406 - Disclosure - Leases - Additional Lease Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails</Role>
      <ShortName>Leases - Additional Lease Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2413407 - Disclosure - Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail</Role>
      <ShortName>Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2414408 - Disclosure - Fair Value Measurements - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail</Role>
      <ShortName>Fair Value Measurements - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2415409 - Disclosure - Fair Value Measurements - Roll Forward (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails</Role>
      <ShortName>Fair Value Measurements - Roll Forward (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2418410 - Disclosure - Business Combination - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinationNarrativeDetails</Role>
      <ShortName>Business Combination - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2419411 - Disclosure - Business Combinations Business Combinations - Purchase Price Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails</Role>
      <ShortName>Business Combinations Business Combinations - Purchase Price Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2422412 - Disclosure - Trade Receivables and Allowance for Credit Losses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails</Role>
      <ShortName>Trade Receivables and Allowance for Credit Losses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2424413 - Disclosure - Disposition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DispositionDetails</Role>
      <ShortName>Disposition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/Disposition</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2427414 - Disclosure - Borrowings and Credit Arrangements - Company's Borrowings (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail</Role>
      <ShortName>Borrowings and Credit Arrangements - Company's Borrowings (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2428415 - Disclosure - Borrowings and Credit Arrangements - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail</Role>
      <ShortName>Borrowings and Credit Arrangements - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2429416 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails</Role>
      <ShortName>Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2430417 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails</Role>
      <ShortName>Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2433418 - Disclosure - Derivatives - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DerivativesAdditionalInformationDetails</Role>
      <ShortName>Derivatives - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2434419 - Disclosure - Derivatives - Schedule Of Change in Fair Value Of Derivative Contracts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails</Role>
      <ShortName>Derivatives - Schedule Of Change in Fair Value Of Derivative Contracts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2435420 - Disclosure - Derivatives - Fair Value of Derivative Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails</Role>
      <ShortName>Derivatives - Fair Value of Derivative Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2436421 - Disclosure - Derivatives - Gain (Loss) on Fair Value Hedges Recognized in AOCI (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails</Role>
      <ShortName>Derivatives - Gain (Loss) on Fair Value Hedges Recognized in AOCI (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2438422 - Disclosure - Commitments and Contingencies (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/CommitmentsandContingenciesDetail</Role>
      <ShortName>Commitments and Contingencies (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/CommitmentsandContingencies</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2441423 - Disclosure - Net Income (Loss) Per Share - Reconciliation of Basic and Diluted Share Amounts (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail</Role>
      <ShortName>Net Income (Loss) Per Share - Reconciliation of Basic and Diluted Share Amounts (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/NetIncomeLossPerShareTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2444424 - Disclosure - Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statements of Operations (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail</Role>
      <ShortName>Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statements of Operations (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2445425 - Disclosure - Stock-Based Compensation - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail</Role>
      <ShortName>Stock-Based Compensation - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2446426 - Disclosure - Stock-Based Compensation - Weighted-Average Assumptions Utilized to Value Stock Options (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail</Role>
      <ShortName>Stock-Based Compensation - Weighted-Average Assumptions Utilized to Value Stock Options (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2449427 - Disclosure - Other Balance Sheet Information - Inventories (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail</Role>
      <ShortName>Other Balance Sheet Information - Inventories (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2450428 - Disclosure - Other Balance Sheet Information - Property, Plant and Equipment (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail</Role>
      <ShortName>Other Balance Sheet Information - Property, Plant and Equipment (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2453429 - Disclosure - Business Segments and Geographic Information - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail</Role>
      <ShortName>Business Segments and Geographic Information - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2454430 - Disclosure - Business Segments and Geographic Information - Segment Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail</Role>
      <ShortName>Business Segments and Geographic Information - Segment Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2455431 - Disclosure - Business Segments and Geographic Information - Revenues by Geography (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail</Role>
      <ShortName>Business Segments and Geographic Information - Revenues by Geography (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2457432 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/IncomeTaxes</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2460433 - Disclosure - Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail</Role>
      <ShortName>Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2461434 - Disclosure - Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail</Role>
      <ShortName>Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2464435 - Disclosure - Product Warranties - Product Warranty Activity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail</Role>
      <ShortName>Product Warranties - Product Warranty Activity (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2467436 - Disclosure - Accumulated Other Comprehensive Income (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail</Role>
      <ShortName>Accumulated Other Comprehensive Income (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="holx-20210626.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2469437 - Disclosure - Share Repurchase Share repurchase (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails</Role>
      <ShortName>Share Repurchase Share repurchase (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="holx-20210626.htm">holx-20210626.htm</File>
    <File>ex101-hellmanncic.htm</File>
    <File>ex102-bebotransitionagreem.htm</File>
    <File>holx-20210626.xsd</File>
    <File>holx-20210626_cal.xml</File>
    <File>holx-20210626_def.xml</File>
    <File>holx-20210626_lab.xml</File>
    <File>holx-20210626_pre.xml</File>
    <File>holx_q3-2021xex311.htm</File>
    <File>holx_q3-2021xex312.htm</File>
    <File>holx_q3-2021xex321.htm</File>
    <File>holx_q3-2021xex322.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>98
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "holx-20210626.htm": {
   "axisCustom": 0,
   "axisStandard": 27,
   "contextCount": 545,
   "dts": {
    "calculationLink": {
     "local": [
      "holx-20210626_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "holx-20210626_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "holx-20210626.htm"
     ]
    },
    "labelLink": {
     "local": [
      "holx-20210626_lab.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "holx-20210626_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "holx-20210626.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 602,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 5,
    "http://xbrl.sec.gov/dei/2020-01-31": 5,
    "total": 10
   },
   "keyCustom": 61,
   "keyStandard": 367,
   "memberCustom": 49,
   "memberStandard": 54,
   "nsprefix": "holx",
   "nsuri": "http://www.hologic.com/20210626",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:Security12bTitle",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.hologic.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:Security12bTitle",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2109103 - Disclosure - Leases",
     "role": "http://www.hologic.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2111104 - Disclosure - Fair Value Measurements",
     "role": "http://www.hologic.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2116105 - Disclosure - Business Combinations",
     "role": "http://www.hologic.com/role/BusinessCombinations",
     "shortName": "Business Combinations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2120106 - Disclosure - Trade Receivables and Allowance for Credit Losses",
     "role": "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses",
     "shortName": "Trade Receivables and Allowance for Credit Losses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2123107 - Disclosure - Disposition",
     "role": "http://www.hologic.com/role/Disposition",
     "shortName": "Disposition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2125108 - Disclosure - Borrowings and Credit Arrangements",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangements",
     "shortName": "Borrowings and Credit Arrangements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativesAndFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2131109 - Disclosure - Derivatives",
     "role": "http://www.hologic.com/role/Derivatives",
     "shortName": "Derivatives",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativesAndFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2137110 - Disclosure - Commitments and Contingencies",
     "role": "http://www.hologic.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2139111 - Disclosure - Net Income (Loss) Per Share",
     "role": "http://www.hologic.com/role/NetIncomeLossPerShare",
     "shortName": "Net Income (Loss) Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2142112 - Disclosure - Stock-Based Compensation",
     "role": "http://www.hologic.com/role/StockBasedCompensation",
     "shortName": "Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:ProductRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Consolidated Statements of Income",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
     "shortName": "Consolidated Statements of Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:ProductRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:DetailsOfCertainBalanceSheetAccountsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2147113 - Disclosure - Other Balance Sheet Information",
     "role": "http://www.hologic.com/role/OtherBalanceSheetInformation",
     "shortName": "Other Balance Sheet Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:DetailsOfCertainBalanceSheetAccountsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2151114 - Disclosure - Business Segments and Geographic Information",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformation",
     "shortName": "Business Segments and Geographic Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2156115 - Disclosure - Income Taxes",
     "role": "http://www.hologic.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2158116 - Disclosure - Intangible Assets and Goodwill",
     "role": "http://www.hologic.com/role/IntangibleAssetsandGoodwill",
     "shortName": "Intangible Assets and Goodwill",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2162117 - Disclosure - Product Warranties",
     "role": "http://www.hologic.com/role/ProductWarranties",
     "shortName": "Product Warranties",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2165118 - Disclosure - Accumulated Other Comprehensive Loss",
     "role": "http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss",
     "shortName": "Accumulated Other Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2168119 - Disclosure - Share Repurchase",
     "role": "http://www.hologic.com/role/ShareRepurchase",
     "shortName": "Share Repurchase",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2170120 - Disclosure - New Accounting Pronouncements",
     "role": "http://www.hologic.com/role/NewAccountingPronouncements",
     "shortName": "New Accounting Pronouncements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2271201 - Disclosure - New Accounting Pronouncements (Policies)",
     "role": "http://www.hologic.com/role/NewAccountingPronouncementsPolicies",
     "shortName": "New Accounting Pronouncements (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2303301 - Disclosure - Revenue (Tables)",
     "role": "http://www.hologic.com/role/RevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Consolidated Statements of Comprehensive Loss",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss",
     "shortName": "Consolidated Statements of Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2312302 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.hologic.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2317303 - Disclosure - Business Combinations (Tables)",
     "role": "http://www.hologic.com/role/BusinessCombinationsTables",
     "shortName": "Business Combinations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2321304 - Disclosure - Trade Receivables and Allowance for Credit Losses (Tables)",
     "role": "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables",
     "shortName": "Trade Receivables and Allowance for Credit Losses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2326305 - Disclosure - Borrowings and Credit Arrangements (Tables)",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsTables",
     "shortName": "Borrowings and Credit Arrangements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2332306 - Disclosure - Derivatives (Tables)",
     "role": "http://www.hologic.com/role/DerivativesTables",
     "shortName": "Derivatives (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2340307 - Disclosure - Net Income (Loss) Per Share (Tables)",
     "role": "http://www.hologic.com/role/NetIncomeLossPerShareTables",
     "shortName": "Net Income (Loss) Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2343308 - Disclosure - Stock-Based Compensation (Tables)",
     "role": "http://www.hologic.com/role/StockBasedCompensationTables",
     "shortName": "Stock-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2348309 - Disclosure - Other Balance Sheet Information (Tables)",
     "role": "http://www.hologic.com/role/OtherBalanceSheetInformationTables",
     "shortName": "Other Balance Sheet Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2352310 - Disclosure - Business Segments and Geographic Information (Tables)",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables",
     "shortName": "Business Segments and Geographic Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2359311 - Disclosure - Intangible Assets and Goodwill (Tables)",
     "role": "http://www.hologic.com/role/IntangibleAssetsandGoodwillTables",
     "shortName": "Intangible Assets and Goodwill (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Consolidated Statements of Comprehensive Loss (Parenthetical)",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical",
     "shortName": "Consolidated Statements of Comprehensive Loss (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2363312 - Disclosure - Product Warranties (Tables)",
     "role": "http://www.hologic.com/role/ProductWarrantiesTables",
     "shortName": "Product Warranties (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2366313 - Disclosure - Accumulated Other Comprehensive Loss (Tables)",
     "role": "http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables",
     "shortName": "Accumulated Other Comprehensive Loss (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2404401 - Disclosure - Revenue - Business Revenue (Details)",
     "role": "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
     "shortName": "Revenue - Business Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ie8818dd7702142cf95a9d19c729ddf8a_D20210328-20210626",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Revenue - Geographical Revenue (Details)",
     "role": "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
     "shortName": "Revenue - Geographical Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "i82e0f458672c41aabd0a7ccc0ecba719_D20210328-20210626",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406403 - Disclosure - Revenue - Revenue by Type (Details)",
     "role": "http://www.hologic.com/role/RevenueRevenuebyTypeDetails",
     "shortName": "Revenue - Revenue by Type (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "icfb85da295454d3fa7ac34d45ba8399a_D20210328-20210626",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ie7b19d82c50249db846d3d1201e12c40_I20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407404 - Disclosure - Revenue - Narrative (Details)",
     "role": "http://www.hologic.com/role/RevenueNarrativeDetails",
     "shortName": "Revenue - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "i3077d84f238341b6b299f541f5f835d3_I20210626",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408405 - Disclosure - Revenue - Remaining Performance Obligation (Details)",
     "role": "http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails",
     "shortName": "Revenue - Remaining Performance Obligation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "i3077d84f238341b6b299f541f5f835d3_I20210626",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "holx:LeaseRevenuePercentageOfTotalRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410406 - Disclosure - Leases - Additional Lease Information (Details)",
     "role": "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails",
     "shortName": "Leases - Additional Lease Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "holx:LeaseRevenuePercentageOfTotalRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ie7b19d82c50249db846d3d1201e12c40_I20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413407 - Disclosure - Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)",
     "role": "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail",
     "shortName": "Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ie7b19d82c50249db846d3d1201e12c40_I20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "id01db50d7a6347809cb98adf4b5c0c66_D20190929-20191228",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414408 - Disclosure - Fair Value Measurements - Additional Information (Detail)",
     "role": "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
     "shortName": "Fair Value Measurements - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "id56c8faa0e884b19a2eebe191531428a_I20210626",
      "decimals": "-8",
      "lang": "en-US",
      "name": "holx:PrincipalAmountOfBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ie7b19d82c50249db846d3d1201e12c40_I20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Consolidated Balance Sheets",
     "role": "http://www.hologic.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ie7b19d82c50249db846d3d1201e12c40_I20210626",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "i31e8abc772ad4ffe894ec7ec188dc5df_I20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415409 - Disclosure - Fair Value Measurements - Roll Forward (Details)",
     "role": "http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails",
     "shortName": "Fair Value Measurements - Roll Forward (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "i31e8abc772ad4ffe894ec7ec188dc5df_I20210327",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ie7b19d82c50249db846d3d1201e12c40_I20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsNetExcludingGoodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418410 - Disclosure - Business Combination - Narrative (Details)",
     "role": "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
     "shortName": "Business Combination - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "i46e7875e7b834fee8636a142ea38ec34_D20190929-20200627",
      "decimals": "3",
      "lang": "en-US",
      "name": "holx:FairValueAssumptionDiscountRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ie7b19d82c50249db846d3d1201e12c40_I20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419411 - Disclosure - Business Combinations Business Combinations - Purchase Price Allocation (Details)",
     "role": "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails",
     "shortName": "Business Combinations Business Combinations - Purchase Price Allocation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "i30d680096df04f59bf3edf5694f74758_I20210617",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "i01a2cc93a0514785a37164641018ee66_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422412 - Disclosure - Trade Receivables and Allowance for Credit Losses (Details)",
     "role": "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails",
     "shortName": "Trade Receivables and Allowance for Credit Losses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ia1bbf9311cb649308affbf16f61bb3ff_I20190928",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "id01db50d7a6347809cb98adf4b5c0c66_D20190929-20191228",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424413 - Disclosure - Disposition (Details)",
     "role": "http://www.hologic.com/role/DispositionDetails",
     "shortName": "Disposition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "id01db50d7a6347809cb98adf4b5c0c66_D20190929-20191228",
      "decimals": "5",
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ie7b19d82c50249db846d3d1201e12c40_I20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427414 - Disclosure - Borrowings and Credit Arrangements - Company's Borrowings (Detail)",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
     "shortName": "Borrowings and Credit Arrangements - Company's Borrowings (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ife6cd667a004466dbd21c797fb6eb40b_I20210626",
      "decimals": "-5",
      "lang": "en-US",
      "name": "holx:LongTermDebtObligationsWithoutConvertibleNotes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ie7b19d82c50249db846d3d1201e12c40_I20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428415 - Disclosure - Borrowings and Credit Arrangements - Additional Information (Detail)",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
     "shortName": "Borrowings and Credit Arrangements - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "holx:ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "i58a7d1a68082480f9d9f002f635ba871_D20200928-20200928",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentRedemptionPricePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseBorrowings",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429416 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
     "shortName": "Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "i9b5b7a6104f348f895e5d94b65b73817_D20210328-20210626",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseBorrowings",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430417 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
     "shortName": "Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "if54bade04c4249debfc877171a9be8f7_D20210328-20210626",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "i1965b6dfa45f42e1a36b9b6f6c6d19d2_D20180930-20190928",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:InterestRateCapAgreementsAggregatePremiumPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433418 - Disclosure - Derivatives - Additional Information (Details)",
     "role": "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
     "shortName": "Derivatives - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "i1965b6dfa45f42e1a36b9b6f6c6d19d2_D20180930-20190928",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:InterestRateCapAgreementsAggregatePremiumPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ie7b19d82c50249db846d3d1201e12c40_I20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ie7b19d82c50249db846d3d1201e12c40_I20210626",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434419 - Disclosure - Derivatives - Schedule Of Change in Fair Value Of Derivative Contracts (Details)",
     "role": "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails",
     "shortName": "Derivatives - Schedule Of Change in Fair Value Of Derivative Contracts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ie7b19d82c50249db846d3d1201e12c40_I20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435420 - Disclosure - Derivatives - Fair Value of Derivative Financial Instruments (Details)",
     "role": "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
     "shortName": "Derivatives - Fair Value of Derivative Financial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ie7b19d82c50249db846d3d1201e12c40_I20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436421 - Disclosure - Derivatives - Gain (Loss) on Fair Value Hedges Recognized in AOCI (Details)",
     "role": "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails",
     "shortName": "Derivatives - Gain (Loss) on Fair Value Hedges Recognized in AOCI (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "i39a6ba9e2ef34dbe8c1dcffcf164d2cf_I20180727",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:AmountAssessedInDamages",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438422 - Disclosure - Commitments and Contingencies (Detail)",
     "role": "http://www.hologic.com/role/CommitmentsandContingenciesDetail",
     "shortName": "Commitments and Contingencies (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "i39a6ba9e2ef34dbe8c1dcffcf164d2cf_I20180727",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:AmountAssessedInDamages",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441423 - Disclosure - Net Income (Loss) Per Share - Reconciliation of Basic and Diluted Share Amounts (Detail)",
     "role": "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail",
     "shortName": "Net Income (Loss) Per Share - Reconciliation of Basic and Diluted Share Amounts (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444424 - Disclosure - Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statements of Operations (Detail)",
     "role": "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail",
     "shortName": "Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statements of Operations (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "i27dc34faa8364f4eb609e7d27d755da2_D20200927-20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445425 - Disclosure - Stock-Based Compensation - Additional Information (Detail)",
     "role": "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail",
     "shortName": "Stock-Based Compensation - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "i27dc34faa8364f4eb609e7d27d755da2_D20200927-20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446426 - Disclosure - Stock-Based Compensation - Weighted-Average Assumptions Utilized to Value Stock Options (Detail)",
     "role": "http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail",
     "shortName": "Stock-Based Compensation - Weighted-Average Assumptions Utilized to Value Stock Options (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ie7b19d82c50249db846d3d1201e12c40_I20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449427 - Disclosure - Other Balance Sheet Information - Inventories (Detail)",
     "role": "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail",
     "shortName": "Other Balance Sheet Information - Inventories (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ie7b19d82c50249db846d3d1201e12c40_I20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ie7b19d82c50249db846d3d1201e12c40_I20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:ManufacturingEquipmentAndSoftware",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450428 - Disclosure - Other Balance Sheet Information - Property, Plant and Equipment (Detail)",
     "role": "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail",
     "shortName": "Other Balance Sheet Information - Property, Plant and Equipment (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "i01a2cc93a0514785a37164641018ee66_I20200926",
      "decimals": "-5",
      "lang": "en-US",
      "name": "holx:ManufacturingEquipmentAndSoftware",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ia1bbf9311cb649308affbf16f61bb3ff_I20190928",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Consolidated Statements of Stockholders' Equity",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
     "shortName": "Consolidated Statements of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ia1bbf9311cb649308affbf16f61bb3ff_I20190928",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ie88ebb9dd3ef4963ba6b902a27fde1c5_D20200927-20210327",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453429 - Disclosure - Business Segments and Geographic Information - Additional Information (Detail)",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail",
     "shortName": "Business Segments and Geographic Information - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ie88ebb9dd3ef4963ba6b902a27fde1c5_D20200927-20210327",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454430 - Disclosure - Business Segments and Geographic Information - Segment Information (Detail)",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
     "shortName": "Business Segments and Geographic Information - Segment Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DepreciationAmortizationAndAccretionNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "holx:PercentageOfRevenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455431 - Disclosure - Business Segments and Geographic Information - Revenues by Geography (Detail)",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
     "shortName": "Business Segments and Geographic Information - Revenues by Geography (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "holx:PercentageOfRevenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2457432 - Disclosure - Income Taxes (Details)",
     "role": "http://www.hologic.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ic5f575766c234c2ebc31b674d0112c0c_D20210328-20210626",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ie7b19d82c50249db846d3d1201e12c40_I20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2460433 - Disclosure - Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail)",
     "role": "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail",
     "shortName": "Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ie7b19d82c50249db846d3d1201e12c40_I20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ie7b19d82c50249db846d3d1201e12c40_I20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2461434 - Disclosure - Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense (Detail)",
     "role": "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail",
     "shortName": "Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ie7b19d82c50249db846d3d1201e12c40_I20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "i01a2cc93a0514785a37164641018ee66_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyAccrual",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2464435 - Disclosure - Product Warranties - Product Warranty Activity (Detail)",
     "role": "http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail",
     "shortName": "Product Warranties - Product Warranty Activity (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "i01a2cc93a0514785a37164641018ee66_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyAccrual",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "i01a2cc93a0514785a37164641018ee66_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2467436 - Disclosure - Accumulated Other Comprehensive Income (Detail)",
     "role": "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
     "shortName": "Accumulated Other Comprehensive Income (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "i17ce81e7ee4c430192d40261507faf9e_I20210327",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ib0df6681d8a44b95b7eecdf8e0e95b6c_I20191211",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2469437 - Disclosure - Share Repurchase Share repurchase (Details)",
     "role": "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails",
     "shortName": "Share Repurchase Share repurchase (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "ib0df6681d8a44b95b7eecdf8e0e95b6c_I20191211",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Basis of Presentation",
     "role": "http://www.hologic.com/role/BasisofPresentation",
     "shortName": "Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20210626.htm",
      "contextRef": "idf983f42f499419cbffd99eaa98d43ab_D20200927-20210626",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 115,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "holx_A2025SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2025 Senior Notes [Member]",
        "label": "2025 Senior Notes [Member]",
        "terseLabel": "2025 Senior Notes"
       }
      }
     },
     "localname": "A2025SeniorNotesMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_A2028SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2028 Senior Notes [Member]",
        "label": "2028 Senior Notes [Member]",
        "terseLabel": "2028 Senior Notes"
       }
      }
     },
     "localname": "A2028SeniorNotesMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_A2029SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2029 Senior Notes",
        "label": "2029 Senior Notes [Member]",
        "terseLabel": "2029 Senior Notes"
       }
      }
     },
     "localname": "A2029SeniorNotesMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_Acceleratedsharerepurchaseagreement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated share repurchase agreement",
        "label": "Accelerated share repurchase agreement",
        "negatedTerseLabel": "Accelerated share repurchase agreement"
       }
      }
     },
     "localname": "Acceleratedsharerepurchaseagreement",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AccountsReceivableAllowanceForCreditLossTransfers": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable, Allowance for Credit Loss, Transfers",
        "label": "Accounts Receivable, Allowance for Credit Loss, Transfers",
        "negatedTerseLabel": "Divested"
       }
      }
     },
     "localname": "AccountsReceivableAllowanceForCreditLossTransfers",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AccountsReceivableSecuritizationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable Securitization [Member]",
        "label": "Accounts Receivable Securitization [Member]",
        "terseLabel": "Accounts Receivable Securitization"
       }
      }
     },
     "localname": "AccountsReceivableSecuritizationMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AccumulatedOtherComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Other Comprehensive Income [Abstract]",
        "label": "Accumulated Other Comprehensive Income [Abstract]",
        "terseLabel": "Accumulated Other Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeAbstract",
     "nsuri": "http://www.hologic.com/20210626",
     "xbrltype": "stringItemType"
    },
    "holx_AcessaHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acessa Health",
        "label": "Acessa Health [Member]",
        "terseLabel": "Acessa Health"
       }
      }
     },
     "localname": "AcessaHealthMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AcquiredintangibleassetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquired intangible assets [Member]",
        "label": "Acquired intangible assets [Member]",
        "terseLabel": "Total acquired intangible assets"
       }
      }
     },
     "localname": "AcquiredintangibleassetsMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AllOtherCountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All other countries.",
        "label": "All Other Countries [Member]",
        "terseLabel": "Rest of World"
       }
      }
     },
     "localname": "AllOtherCountriesMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AlphaImagingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Alpha Imaging [Member]",
        "label": "Alpha Imaging [Member]",
        "terseLabel": "Alpha Imaging"
       }
      }
     },
     "localname": "AlphaImagingMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AmendedTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amended Term Loan [Member]",
        "label": "Amended Term Loan [Member]",
        "terseLabel": "Amended Term Loan"
       }
      }
     },
     "localname": "AmendedTermLoanMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AmortizationCostofGoodsSold": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization, Cost of Goods Sold",
        "label": "Amortization, Cost of Goods Sold",
        "terseLabel": "Amortization, Cost of Goods Sold"
       }
      }
     },
     "localname": "AmortizationCostofGoodsSold",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AmountAssessedInDamages": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount assessed in damages.",
        "label": "Amount Assessed In Damages",
        "terseLabel": "Assessed damages"
       }
      }
     },
     "localname": "AmountAssessedInDamages",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AnnualIncrementalRevenueGrowthPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual Incremental Revenue Growth Period",
        "label": "Annual Incremental Revenue Growth Period",
        "terseLabel": "Annual incremental revenue growth period"
       }
      }
     },
     "localname": "AnnualIncrementalRevenueGrowthPeriod",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "holx_AssetsofBusinessHeldforSaleAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets of Business Held-for-Sale [Abstract]",
        "label": "Assets of Business Held-for-Sale [Abstract]",
        "terseLabel": "Assets of Business Held-for-Sale [Abstract]"
       }
      }
     },
     "localname": "AssetsofBusinessHeldforSaleAbstract",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_BasisofPresentationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis of Presentation [Abstract]",
        "label": "Basis of Presentation [Abstract]",
        "terseLabel": "Basis of Presentation [Abstract]"
       }
      }
     },
     "localname": "BasisofPresentationAbstract",
     "nsuri": "http://www.hologic.com/20210626",
     "xbrltype": "stringItemType"
    },
    "holx_BiotheranosticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Biotheranostics",
        "label": "Biotheranostics [Member]",
        "terseLabel": "Biotheranostics"
       }
      }
     },
     "localname": "BiotheranosticsMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_BloodScreeningMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Blood Screening [Member]",
        "label": "Blood Screening [Member]",
        "terseLabel": "Blood Screening"
       }
      }
     },
     "localname": "BloodScreeningMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_BreastHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Breast health.",
        "label": "Breast Health [Member]",
        "terseLabel": "Breast Health"
       }
      }
     },
     "localname": "BreastHealthMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_BreastImagingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Breast Imaging [Member]",
        "label": "Breast Imaging [Member]",
        "terseLabel": "Breast Imaging"
       }
      }
     },
     "localname": "BreastImagingMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_BusinessAcquisitionCashTenderOfferPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Cash Tender Offer Price Per Share",
        "label": "Business Acquisition, Cash Tender Offer Price Per Share",
        "terseLabel": "Cash tender offer price (per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionCashTenderOfferPricePerShare",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "holx_BusinessCombinationAdditionalSharesAcquiredShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Additional Shares Acquired, Shares",
        "label": "Business Combination, Additional Shares Acquired, Shares",
        "terseLabel": "Additional outstanding shares purchased (in shares)"
       }
      }
     },
     "localname": "BusinessCombinationAdditionalSharesAcquiredShares",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "holx_BusinessCombinationAdditionalSharesAcquiredValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Additional Shares Acquired, Value",
        "label": "Business Combination, Additional Shares Acquired, Value",
        "terseLabel": "Additional outstanding shares purchased, amount"
       }
      }
     },
     "localname": "BusinessCombinationAdditionalSharesAcquiredValue",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Portion Allocable To Equity Method Investment",
        "label": "Business Combination, Consideration Transferred, Portion Allocable To Equity Method Investment",
        "terseLabel": "Consideration related to equity method investment"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Portion Allocable To Fair Value Of Noncontrolling Interest",
        "label": "Business Combination, Consideration Transferred, Portion Allocable To Fair Value Of Noncontrolling Interest",
        "terseLabel": "Consideration related to fair value of noncontrolling interest"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Portion Allocable To Loan Repayment",
        "label": "Business Combination, Consideration Transferred, Portion Allocable To Loan Repayment",
        "terseLabel": "Consideration, portion related to loan repayment"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Portion Allocable To Newly Acquired Shares",
        "label": "Business Combination, Consideration Transferred, Portion Allocable To Newly Acquired Shares",
        "terseLabel": "Consideration related to newly acquired shares"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationOwnershipPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Ownership Percentage",
        "label": "Business Combination, Ownership Percentage",
        "terseLabel": "Ownership percentage"
       }
      }
     },
     "localname": "BusinessCombinationOwnershipPercentage",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 15.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Research And Development In Process",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Research And Development In Process",
        "terseLabel": "In process research and development"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedResearchAndDevelopmentInProcess",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt",
        "negatedTerseLabel": "Short and long-term debt"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology",
        "terseLabel": "Developed technology"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value",
        "terseLabel": "Intangible assets, fair value (percentage)"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities",
        "negatedTerseLabel": "Other liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names",
        "terseLabel": "Trade names"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessLicensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business licenses.",
        "label": "Business Licenses [Member]",
        "terseLabel": "Business licenses"
       }
      }
     },
     "localname": "BusinessLicensesMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CapitalEquipmentComponentsandSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital Equipment, Components and Software [Member]",
        "label": "Capital Equipment, Components and Software [Member]",
        "terseLabel": "Capital equipment, components and software"
       }
      }
     },
     "localname": "CapitalEquipmentComponentsandSoftwareMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CapitalizedsoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitalized software [Member]",
        "label": "Capitalized software [Member]",
        "terseLabel": "Capitalized software embedded in products"
       }
      }
     },
     "localname": "CapitalizedsoftwareMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_ChangeInParValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in par value",
        "label": "Change in par value",
        "terseLabel": "Change in par value"
       }
      }
     },
     "localname": "ChangeInParValue",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ComprehensiveIncome": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Comprehensive Income",
        "label": "Comprehensive Income",
        "totalLabel": "Comprehensive Income"
       }
      }
     },
     "localname": "ComprehensiveIncome",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ConsumablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consumables [Member]",
        "label": "Consumables [Member]",
        "terseLabel": "Disposables"
       }
      }
     },
     "localname": "ConsumablesMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_ContingentConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration",
        "label": "Contingent Consideration [Member]",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "ContingentConsiderationMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_ContingentHoldbackMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Holdback",
        "label": "Contingent Holdback [Member]",
        "terseLabel": "Contingent Holdback"
       }
      }
     },
     "localname": "ContingentHoldbackMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in cost of product sales in the period resulting from the write-down of the carrying amount of an intangible asset to fair value.",
        "label": "Cost Of Goods Sold Impairment Of Intangible Assets and equipment",
        "terseLabel": "Impairment of intangible assets and equipment"
       }
      }
     },
     "localname": "CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_Costofservice": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of service",
        "label": "Cost of service",
        "terseLabel": "Service and other"
       }
      }
     },
     "localname": "Costofservice",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_CreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit agreement.",
        "label": "Credit Agreement [Member]",
        "terseLabel": "Credit Agreement",
        "verboseLabel": "Credit Agreement"
       }
      }
     },
     "localname": "CreditAgreementMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CustomerRelationshipsContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationships contracts.",
        "label": "Customer Relationships Contracts [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsContractsMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CytologyPerinatalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cytology &amp; Perinatal [Member]",
        "label": "Cytology &amp; Perinatal [Member]",
        "terseLabel": "Cytology &amp; Perinatal"
       }
      }
     },
     "localname": "CytologyPerinatalMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_DebtInstrumentOfferingPricePercentOfFaceValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Offering Price, Percent Of Face Value",
        "label": "Debt Instrument, Offering Price, Percent Of Face Value",
        "terseLabel": "Debt Instrument, Offering Price, Percent Of Face Value"
       }
      }
     },
     "localname": "DebtInstrumentOfferingPricePercentOfFaceValue",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "pureItemType"
    },
    "holx_DebtRedemptionPremiumPaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Redemption, Premium Paid",
        "label": "Debt Redemption, Premium Paid",
        "terseLabel": "Premium payment"
       }
      }
     },
     "localname": "DebtRedemptionPremiumPaid",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_December112019Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "December 11, 2019",
        "label": "December 11, 2019 [Member]",
        "terseLabel": "December 11, 2019"
       }
      }
     },
     "localname": "December112019Member",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_December112020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "December 11, 2020",
        "label": "December 11, 2020 [Member]",
        "terseLabel": "December 11, 2020"
       }
      }
     },
     "localname": "December112020Member",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_DepartmentOfDefenseFundsReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Department of defense funds received",
        "label": "Department of defense funds received",
        "terseLabel": "Department of defense funds received"
       }
      }
     },
     "localname": "DepartmentOfDefenseFundsReceived",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_DetailsOfCertainBalanceSheetAccountsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Details of certain balance sheet accounts.",
        "label": "Details Of Certain Balance Sheet Accounts [Text Block]",
        "terseLabel": "Other Balance Sheet Information"
       }
      }
     },
     "localname": "DetailsOfCertainBalanceSheetAccountsTextBlock",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_DevelopedTechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Developed technology.",
        "label": "Developed Technology [Member]",
        "terseLabel": "Developed Technology",
        "verboseLabel": "Developed\u00a0technology"
       }
      }
     },
     "localname": "DevelopedTechnologyMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_DiagenodeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diagenode",
        "label": "Diagenode [Member]",
        "terseLabel": "Diagenode"
       }
      }
     },
     "localname": "DiagenodeMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_DiagnosticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diagnostics.",
        "label": "Diagnostics [Member]",
        "terseLabel": "Diagnostics"
       }
      }
     },
     "localname": "DiagnosticsMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_EarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Per Share [Line Items]",
        "label": "Earnings Per Share [Line Items]",
        "terseLabel": "Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareLineItems",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_EarningsPerShareTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Per Share [Table]",
        "label": "Earnings Per Share [Table]",
        "terseLabel": "Earnings Per Share [Table]"
       }
      }
     },
     "localname": "EarningsPerShareTable",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_EquipmentUnderCustomerUsageAgreements": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount at the balance sheet date of long-lived, depreciable asset that are equipment placed at customer locations for which title is not transferred to the Company's customers.",
        "label": "Equipment Under Customer Usage Agreements",
        "terseLabel": "Equipment under customer usage agreements"
       }
      }
     },
     "localname": "EquipmentUnderCustomerUsageAgreements",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_FairValueAssumptionDiscountRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Assumption, Discount Rate",
        "label": "Fair Value Assumption, Discount Rate",
        "terseLabel": "Discount rate percentage"
       }
      }
     },
     "localname": "FairValueAssumptionDiscountRate",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "holx_GrantsReceivedFromDepartmentOfDefense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grants received from Department of defense",
        "label": "Grants received from Department of defense",
        "terseLabel": "Grants received from Department of defense"
       }
      }
     },
     "localname": "GrantsReceivedFromDepartmentOfDefense",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_GynSurgicalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "GYN surgical.",
        "label": "Gyn Surgical [Member]",
        "terseLabel": "GYN Surgical"
       }
      }
     },
     "localname": "GynSurgicalMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_HealthBeaconsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Beacons [Member]",
        "label": "Health Beacons [Member]",
        "terseLabel": "Health Beacons"
       }
      }
     },
     "localname": "HealthBeaconsMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_Holdback": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Holdback",
        "label": "Holdback",
        "terseLabel": "Holdback"
       }
      }
     },
     "localname": "Holdback",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_IndemnificationLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indemnification liability",
        "label": "Indemnification liability",
        "terseLabel": "Indemnification liability"
       }
      }
     },
     "localname": "IndemnificationLiability",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_InterestRateCapAgreementsAggregatePremiumPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate cap agreements aggregate premium payable.",
        "label": "Interest Rate Cap Agreements Aggregate Premium Payable",
        "verboseLabel": "Interest Rate Cap Agreements Aggregate Premium Payable"
       }
      }
     },
     "localname": "InterestRateCapAgreementsAggregatePremiumPayable",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_InternalusesoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Internal-use software [Member]",
        "label": "Internal-use software [Member]",
        "terseLabel": "Internal-use software"
       }
      }
     },
     "localname": "InternalusesoftwareMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_InternationalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International [Member]",
        "label": "International [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "InternationalMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_InterventionalBreastSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interventional Breast Solutions [Member]",
        "label": "Interventional Breast Solutions [Member]",
        "terseLabel": "Interventional Breast Solutions"
       }
      }
     },
     "localname": "InterventionalBreastSolutionsMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_LeaseRevenuePercentageOfTotalRevenue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Revenue, Percentage Of Total Revenue",
        "label": "Lease Revenue, Percentage Of Total Revenue",
        "terseLabel": "Lease revenue as a percentage of total (percentage)"
       }
      }
     },
     "localname": "LeaseRevenuePercentageOfTotalRevenue",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "holx_LegalAccrual": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legal Accrual",
        "label": "Legal Accrual",
        "terseLabel": "Legal Accrual"
       }
      }
     },
     "localname": "LegalAccrual",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_LongTermDebtObligationsWithoutConvertibleNotes": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long term debt obligations without convertible notes.",
        "label": "Long Term Debt Obligations Without Convertible Notes",
        "terseLabel": "Long term debt obligations. excluding convertible notes"
       }
      }
     },
     "localname": "LongTermDebtObligationsWithoutConvertibleNotes",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ManufacturingEquipmentAndSoftware": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount as of the balance sheet date of long-lived, depreciable assets that include manufacturing and other equipment with finite lives used to produce goods and services, and computer equipment and software.",
        "label": "Manufacturing Equipment And Software",
        "terseLabel": "Equipment"
       }
      }
     },
     "localname": "ManufacturingEquipmentAndSoftware",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_MarketBasedAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Market Based Awards [Member]",
        "label": "Market Based Awards [Member]",
        "terseLabel": "Market Based Awards"
       }
      }
     },
     "localname": "MarketBasedAwardsMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_MaximumBorrowingUnderAssetSecuritizationAgreement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing under asset securitization agreement",
        "label": "Maximum borrowing under asset securitization agreement",
        "terseLabel": "Maximum borrowing under asset securitization agreement"
       }
      }
     },
     "localname": "MaximumBorrowingUnderAssetSecuritizationAgreement",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum target number percentage of shares issued based on stock performance.",
        "label": "Maximum Target Number Of Shares Issued Based On Stock Performance In Percent",
        "terseLabel": "Maximum eligible percentage to receive target number of shares of company's common stock"
       }
      }
     },
     "localname": "MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_MedicalAestheticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Aesthetic",
        "label": "Medical Aesthetics [Member]",
        "terseLabel": "Medical Aesthetics",
        "verboseLabel": "Medical Aesthetics"
       }
      }
     },
     "localname": "MedicalAestheticsMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail",
      "http://www.hologic.com/role/DispositionDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/IncomeTaxesDetails",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_MinervaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minerva [Member]",
        "label": "Minerva [Member]",
        "terseLabel": "Minerva"
       }
      }
     },
     "localname": "MinervaMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum target number percentage of shares that would be issued based on stock price performance.",
        "label": "Minimum Target Number Of Shares Issued On Stock Performance In Percent",
        "terseLabel": "Minimum eligible percentage to receive target number of shares of company's common stock"
       }
      }
     },
     "localname": "MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_MobidiagOyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mobidiag Oy",
        "label": "Mobidiag Oy [Member]",
        "terseLabel": "Mobidiag Oy"
       }
      }
     },
     "localname": "MobidiagOyMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_MolecularDiagnosticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Molecular Diagnostics [Member]",
        "label": "Molecular Diagnostics [Member]",
        "terseLabel": "Molecular Diagnostics"
       }
      }
     },
     "localname": "MolecularDiagnosticsMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_NXCImagingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NXC Imaging",
        "label": "NXC Imaging [Member]",
        "terseLabel": "NXC Imaging"
       }
      }
     },
     "localname": "NXCImagingMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_Netincome": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net income attributable to Hologic",
        "label": "Net income",
        "terseLabel": "Net income",
        "totalLabel": "Net income attributable to Hologic"
       }
      }
     },
     "localname": "Netincome",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_NotationalAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notational Amount",
        "label": "Notational Amount",
        "terseLabel": "Notational Amount"
       }
      }
     },
     "localname": "NotationalAmount",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_OtherTypeofRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Type of Revenue [Member]",
        "label": "Other Type of Revenue [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherTypeofRevenueMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_PSUFreeCashFlowMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PSU Free Cash Flow [Member]",
        "label": "PSU Free Cash Flow [Member]",
        "terseLabel": "PSU Free Cash Flow [Member]"
       }
      }
     },
     "localname": "PSUFreeCashFlowMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The payment of minimum statutory tax withholdings to taxing authorities on the behalf of employees from the net share settlement upon vesting of restricted stock units. This payment is not an expense of the Company nor an operating activity.",
        "label": "Payment For Tax Withholding Related To Vested And Released Restricted Stock Units",
        "negatedTerseLabel": "Payment of minimum tax withholdings on net share settlements of equity awards"
       }
      }
     },
     "localname": "PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow related to equipment placed at customer locations for which title is not transferred to the Company's customers.",
        "label": "Payments To Manufacture Equipment Under Customer Usage Agreements",
        "negatedLabel": "Increase in equipment under customer usage agreements"
       }
      }
     },
     "localname": "PaymentsToManufactureEquipmentUnderCustomerUsageAgreements",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_PercentageAddedtoEurodollarRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Added to Eurodollar Rate [Member]",
        "label": "Percentage Added to Eurodollar Rate [Member]",
        "terseLabel": "Percentage Added to Eurodollar Rate"
       }
      }
     },
     "localname": "PercentageAddedtoEurodollarRateMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_PercentageOfRevenues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of revenues.",
        "label": "Percentage Of Revenues",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "PercentageOfRevenues",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_PrepaidIncomeTaxesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid Income Taxes-Current",
        "label": "Prepaid Income Taxes-Current",
        "terseLabel": "Prepaid Income Taxes-Current"
       }
      }
     },
     "localname": "PrepaidIncomeTaxesCurrent",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_PrincipalAmountOfBorrowings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregate outstanding principal of amounts borrowed under the Credit Agreement.",
        "label": "Principal Amount Of Borrowings",
        "verboseLabel": "Borrowed principal"
       }
      }
     },
     "localname": "PrincipalAmountOfBorrowings",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ProceedsFromSaleOfBusiness": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from sale of business.",
        "label": "Proceeds From Sale Of Business",
        "terseLabel": "Proceeds From Sale Of Business"
       }
      }
     },
     "localname": "ProceedsFromSaleOfBusiness",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ProceedsFromSeniorNotes": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Senior Notes",
        "label": "Proceeds From Senior Notes",
        "terseLabel": "Proceeds from Notes Payable"
       }
      }
     },
     "localname": "ProceedsFromSeniorNotes",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ProductRevenue": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product Revenue",
        "label": "Product Revenue",
        "terseLabel": "Product"
       }
      }
     },
     "localname": "ProductRevenue",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_PurchaseOfIntellectualProperty": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase of intellectual property",
        "label": "Purchase of intellectual property",
        "negatedTerseLabel": "Purchase of intellectual property"
       }
      }
     },
     "localname": "PurchaseOfIntellectualProperty",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_PurchaseOfNonControllingInterestReclassifiedToAPIC": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase of non-controlling interest reclassified to APIC",
        "label": "Purchase of non-controlling interest reclassified to APIC",
        "negatedTerseLabel": "Purchase of non-controlling interest reclassified to APIC"
       }
      }
     },
     "localname": "PurchaseOfNonControllingInterestReclassifiedToAPIC",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_RSUPSUMSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "RSU, PSU, MSU [Member]",
        "label": "RSU, PSU, MSU [Member]",
        "terseLabel": "RSU, PSU, MSU"
       }
      }
     },
     "localname": "RSUPSUMSUMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_RepaymentOfSeniorNotes": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayment of Senior Notes",
        "label": "Repayment of Senior Notes",
        "negatedTerseLabel": "Repayments of Senior Debt"
       }
      }
     },
     "localname": "RepaymentOfSeniorNotes",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ResearchAndDevelopmentInProcessCompletionPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and Development in Process, Completion Period",
        "label": "Research and Development in Process, Completion Period",
        "terseLabel": "Research and development in process, completion period"
       }
      }
     },
     "localname": "ResearchAndDevelopmentInProcessCompletionPeriod",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "holx_ResearchAndDevelopmentInProcessNumberOfProjects": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and Development in Process, Number Of Projects",
        "label": "Research and Development in Process, Number Of Projects",
        "terseLabel": "Research and development in process, number of projects"
       }
      }
     },
     "localname": "ResearchAndDevelopmentInProcessNumberOfProjects",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "holx_RestofWorldMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rest of World [Member]",
        "label": "Rest of World [Member]",
        "terseLabel": "Rest of World"
       }
      }
     },
     "localname": "RestofWorldMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_RevolverMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolver [Member]",
        "label": "Revolver [Member]",
        "terseLabel": "Revolver"
       }
      }
     },
     "localname": "RevolverMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_ScheduleOfGeographicalSegmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Geographical Segments [Line Items]",
        "label": "Schedule Of Geographical Segments [Line Items]",
        "terseLabel": "Schedule Of Geographical Segments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfGeographicalSegmentsLineItems",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_ScheduleOfGeographicalSegmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Geographical Segments [Table]",
        "label": "Schedule Of Geographical Segments [Table]",
        "terseLabel": "Schedule Of Geographical Segments [Table]"
       }
      }
     },
     "localname": "ScheduleOfGeographicalSegmentsTable",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of interest expense under convertible notes.",
        "label": "Schedule Of Interest Expense Under Convertible Notes [Table Text Block]",
        "terseLabel": "Schedule Of Interest Expense Under Convertible Notes"
       }
      }
     },
     "localname": "ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of share-based compensation expense.",
        "label": "Schedule Of Share Based Compensation Expense [Table Text Block]",
        "terseLabel": "Stock-Based Compensation Expense in Consolidated Statements of Operations"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationExpenseTableTextBlock",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_SegmentReportingDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segment Reporting Disclosure [Line Items]",
        "label": "Segment Reporting Disclosure [Line Items]",
        "terseLabel": "Segment Reporting Disclosure [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingDisclosureLineItems",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_ServiceRevenue": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service Revenue",
        "label": "Service Revenue",
        "terseLabel": "Service and other"
       }
      }
     },
     "localname": "ServiceRevenue",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ShareRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Repurchase Program [Member]",
        "label": "Share Repurchase Program [Member]",
        "terseLabel": "Share Repurchase Program"
       }
      }
     },
     "localname": "ShareRepurchaseProgramMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time that must lapse in order for the restricted stock units to vest.",
        "label": "Shared Based Compensation Arrangement Restricted Stock Vesting Period",
        "verboseLabel": "Performance stock units vesting period"
       }
      }
     },
     "localname": "SharedBasedCompensationArrangementRestrictedStockVestingPeriod",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "holx_SharerepurchaseplanLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for share repurchase plan [Table]",
        "label": "share repurchase plan [Line Items]",
        "terseLabel": "share repurchase plan [Line Items]"
       }
      }
     },
     "localname": "SharerepurchaseplanLineItems",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_SharerepurchaseplanTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "share repurchase plan [Table]",
        "label": "share repurchase plan [Table]",
        "terseLabel": "share repurchase plan [Table]"
       }
      }
     },
     "localname": "SharerepurchaseplanTable",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_SkeletalHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Skeletal health.",
        "label": "Skeletal Health [Member]",
        "terseLabel": "Skeletal Health"
       }
      }
     },
     "localname": "SkeletalHealthMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_SomatexMedicalTechnologiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Somatex Medical Technologies",
        "label": "Somatex Medical Technologies [Member]",
        "terseLabel": "Somatex Medical Technologies"
       }
      }
     },
     "localname": "SomatexMedicalTechnologiesMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_SuperSonicImagineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SuperSonic Imagine [Member]",
        "label": "SuperSonic Imagine [Member]",
        "terseLabel": "SuperSonic Imagine"
       }
      }
     },
     "localname": "SuperSonicImagineMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan [Member]",
        "label": "Term Loan [Member]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "localname": "TermLoanMember",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_TotalPaymentsToNonControllingInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total payments to non-controlling interest",
        "label": "Total payments to non-controlling interest",
        "terseLabel": "Total payments to non-controlling interest"
       }
      }
     },
     "localname": "TotalPaymentsToNonControllingInterest",
     "nsuri": "http://www.hologic.com/20210626",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia Pacific [Member]",
        "terseLabel": "Asia-Pacific"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r170",
      "r183",
      "r184",
      "r185",
      "r186",
      "r188",
      "r190",
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r170",
      "r183",
      "r184",
      "r185",
      "r186",
      "r188",
      "r190",
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r329",
      "r331",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r514",
      "r553",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r329",
      "r331",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r514",
      "r553",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r196",
      "r310",
      "r312",
      "r515",
      "r552",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r196",
      "r310",
      "r312",
      "r515",
      "r552",
      "r554"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r319",
      "r329",
      "r331",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r514",
      "r553",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r319",
      "r329",
      "r331",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r514",
      "r553",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r197",
      "r198",
      "r310",
      "r313",
      "r555",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r197",
      "r198",
      "r310",
      "r313",
      "r555",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchaseProgramAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount needed to adjust previously recorded stockholders' equity balances to the actual aggregate amounts paid, whether in cash or other consideration, to acquire all of the shares purchased under an Accelerated Share Repurchase arrangement.",
        "label": "Accelerated Share Repurchase Program, Adjustment",
        "terseLabel": "Accelerated share repurchase agreement"
       }
      }
     },
     "localname": "AcceleratedShareRepurchaseProgramAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesDateAxis": {
     "auth_ref": [
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by date of execution of accelerated share repurchases.",
        "label": "Accelerated Share Repurchases, Date [Axis]",
        "terseLabel": "Accelerated Share Repurchases, Date [Axis]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesDateDomain": {
     "auth_ref": [
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date upon which the accelerated share repurchase agreement was executed.",
        "label": "Accelerated Share Repurchases, Date [Domain]",
        "terseLabel": "Accelerated Share Repurchases, Date [Domain]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesDateDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201801Member": {
     "auth_ref": [
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2018-01 Leases (Topic 842): Land Easement Practical Expedient for Transition to Topic 842.",
        "label": "Accounting Standards Update 2018-01 [Member]",
        "terseLabel": "Accounting Standards Update 2018-01 [Member]"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201801Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r18",
      "r33",
      "r202",
      "r203"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, less reserves"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesMember": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.",
        "label": "Accrued Liabilities [Member]",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r75",
      "r81",
      "r84",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Pension Plans"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r50",
      "r253"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less \u2013 accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r81",
      "r91",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r36",
      "r78",
      "r80",
      "r81",
      "r541",
      "r564",
      "r568"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r77",
      "r81",
      "r84",
      "r132",
      "r133",
      "r134",
      "r417",
      "r559",
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r71",
      "r81",
      "r84",
      "r417",
      "r467",
      "r468",
      "r469",
      "r470",
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Intangible assets useful life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r34",
      "r360"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in-capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r132",
      "r133",
      "r134",
      "r357",
      "r358",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r122",
      "r244"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization of acquired intangibles"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r135",
      "r136",
      "r137",
      "r138",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r376",
      "r377",
      "r378",
      "r379",
      "r517",
      "r518",
      "r519",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r332",
      "r334",
      "r362",
      "r363"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r40",
      "r204",
      "r217"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "periodEndLabel": "Balance\u00a0at End of Period",
        "periodStartLabel": "Balance\u00a0at Beginning of Period",
        "terseLabel": "Accounts receivable, reserves"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "auth_ref": [
      "r220"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "negatedTerseLabel": "Write- offs and Payments"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r122",
      "r237",
      "r244"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of acquired intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Weighted-average anti-dilutive shares (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r122",
      "r249"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Intangible asset and equipment impairment charges"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/DispositionDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r126",
      "r178",
      "r185",
      "r192",
      "r210",
      "r413",
      "r418",
      "r464",
      "r522",
      "r539"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Identifiable assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r20",
      "r22",
      "r66",
      "r126",
      "r210",
      "r413",
      "r418",
      "r464"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r335",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r429",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Related Disclosures [Abstract]",
        "terseLabel": "Balance Sheet Related Disclosures [Abstract]"
       }
      }
     },
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BuildingsAndImprovementsGross": {
     "auth_ref": [
      "r24",
      "r252"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Buildings and Improvements, Gross",
        "terseLabel": "Building and improvements"
       }
      }
     },
     "localname": "BuildingsAndImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r328",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r328",
      "r330",
      "r392",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Percentage of outstanding shares acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r402",
      "r403",
      "r405"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Consideration transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1": {
     "auth_ref": [
      "r121",
      "r407"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of right to a contingent consideration asset.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset",
        "negatedTerseLabel": "Contingent consideration fair value adjustments"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r121",
      "r407"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Change in contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r401",
      "r404",
      "r406"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Purchase price withheld"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Business Combinations"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r395"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "verboseLabel": "Cash"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r395"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "verboseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r395"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 14.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "negatedLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": {
     "auth_ref": [
      "r395"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r395"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedTerseLabel": "Deferred income taxes, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r394",
      "r395"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "verboseLabel": "Inventory"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r395"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "terseLabel": "Remainder of purchase price"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r394",
      "r395"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "terseLabel": "Net acquired tangible assets and liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt": {
     "auth_ref": [
      "r395"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 16.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt",
        "negatedTerseLabel": "Long-term debt"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r395"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "verboseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r394",
      "r395"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r395"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Purchase Price"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage",
        "terseLabel": "Equity interest in acquiree, percentage"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain": {
     "auth_ref": [
      "r391"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain",
        "terseLabel": "Equity interest in acquiree, remeasurement gain"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r28",
      "r478",
      "r479"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of capital lease obligation due within one year or the normal operating cycle, if longer.",
        "label": "Capital Lease Obligations, Current",
        "terseLabel": "Current portion of capital lease obligations"
       }
      }
     },
     "localname": "CapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalLeaseObligationsNoncurrent": {
     "auth_ref": [
      "r59",
      "r478",
      "r479"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date.",
        "label": "Capital Lease Obligations, Noncurrent",
        "terseLabel": "Finance lease obligations, net of current portion"
       }
      }
     },
     "localname": "CapitalLeaseObligationsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r16",
      "r48",
      "r124"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "periodStartLabel": "Cash and cash equivalents, beginning of period",
        "terseLabel": "Cash less assets held for sale"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r119",
      "r465"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue": {
     "auth_ref": [
      "r434"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of all asset derivatives designated as cash flow hedging instruments.",
        "label": "Cash Flow Hedge Derivative Instrument Assets at Fair Value",
        "terseLabel": "Interest rate swap at fair value"
       }
      }
     },
     "localname": "CashFlowHedgeDerivativeInstrumentAssetsAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r266",
      "r267",
      "r268",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r132",
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.01 par value \u2013750,000 shares authorized; 296,945 and 295,107 shares issued, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r87",
      "r89",
      "r90",
      "r96",
      "r531",
      "r549"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "holx_ComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r95",
      "r108",
      "r530",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure": {
     "auth_ref": [
      "r454"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of contingent consideration in a business combination that is classified in shareholders' equity.",
        "label": "Contingent Consideration Classified as Equity, Fair Value Disclosure",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "ContingentConsiderationClassifiedAsEquityFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r311"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Contract with Customer, Liability, Revenue Recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueNarrativeDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateMember": {
     "auth_ref": [
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component of an entity that usually provides financial, operational and administrative support and is considered an operating segment. Excludes intersegment elimination and reconciling items.",
        "label": "Corporate Segment [Member]",
        "terseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r103",
      "r515"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Product"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Revenue [Abstract]",
        "terseLabel": "Costs of revenues:"
       }
      }
     },
     "localname": "CostOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of revenues"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails",
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Borrowings and Credit Arrangements"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r28",
      "r29",
      "r30",
      "r523",
      "r524",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r475",
      "r477"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Senior notes, face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r461"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Fair value of debt instrument"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Stated interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodFiveMember": {
     "auth_ref": [
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period five representing fifth most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Five [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period Five"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodFiveMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodFourMember": {
     "auth_ref": [
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period four representing fourth most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Four [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period Four"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodFourMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "auth_ref": [
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period One"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodThreeMember": {
     "auth_ref": [
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period three representing third most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Three [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period Three"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodThreeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "auth_ref": [
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period Two"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Debt Instrument, Redemption Price, Percentage"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r59",
      "r128",
      "r298",
      "r299",
      "r300",
      "r301",
      "r474",
      "r475",
      "r477",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r474",
      "r477"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "terseLabel": "Debt Instrument, Unamortized Discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount": {
     "auth_ref": [
      "r58"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unused borrowing capacity under the long-term financing arrangement that is available to the entity as of the balance sheet date.",
        "label": "Debt Instrument, Unused Borrowing Capacity, Amount",
        "terseLabel": "Debt Instrument, Unused Borrowing Capacity, Amount"
       }
      }
     },
     "localname": "DebtInstrumentUnusedBorrowingCapacityAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of debt outstanding.",
        "label": "Debt, Weighted Average Interest Rate",
        "terseLabel": "Debt, Weighted Average Interest Rate"
       }
      }
     },
     "localname": "DebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r51",
      "r476"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "terseLabel": "Debt Issuance Costs, Net"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r122",
      "r127",
      "r375",
      "r382",
      "r383",
      "r384"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r367",
      "r368"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred Income Tax Liabilities, Net"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueNoncurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Deferred Revenue, Noncurrent",
        "terseLabel": "Deferred revenue, net of current portion"
       }
      }
     },
     "localname": "DeferredRevenueNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r122",
      "r251"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAmortizationAndAccretionNet": {
     "auth_ref": [
      "r122"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Depreciation, Amortization and Accretion, Net",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAmortizationAndAccretionNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r67",
      "r70",
      "r433",
      "r496"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Derivative asset"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r431"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Amount of realized gain (loss) recognized in income"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r430",
      "r434",
      "r440",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r426",
      "r430",
      "r440",
      "r445",
      "r446",
      "r449",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": {
     "auth_ref": [
      "r439",
      "r441"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r68",
      "r69",
      "r461"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Derivative liability"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r423",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r422",
      "r424",
      "r425",
      "r426",
      "r428",
      "r436",
      "r440",
      "r447",
      "r448",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeVariableInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable interest rate in effect as of the balance sheet date related to the interest rate derivative.",
        "label": "Derivative, Variable Interest Rate",
        "terseLabel": "Variable interest rate"
       }
      }
     },
     "localname": "DerivativeVariableInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativesAndFairValueTextBlock": {
     "auth_ref": [
      "r453",
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivatives and fair value of assets and liabilities.",
        "label": "Derivatives and Fair Value [Text Block]",
        "terseLabel": "Derivatives"
       }
      }
     },
     "localname": "DerivativesAndFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/Derivatives"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a new accounting pronouncement that has been issued but not yet adopted.",
        "label": "Description of New Accounting Pronouncements Not yet Adopted [Text Block]",
        "terseLabel": "New Accounting Pronouncements"
       }
      }
     },
     "localname": "DescriptionOfNewAccountingPronouncementsNotYetAdopted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/NewAccountingPronouncements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r310",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r250",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Disposed of by Sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Consideration"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss": {
     "auth_ref": [
      "r8"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Operating Income (Loss)",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Operating Income (Loss)"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup": {
     "auth_ref": [
      "r1",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the segment that the disposal group, including discontinued operation is reported.",
        "label": "Disposal Group, Including Discontinued Operation, Segment that Includes Disposal Group",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Segment that Includes Disposal Group"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r328",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income per common share attributable to Hologic:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r97",
      "r139",
      "r140",
      "r141",
      "r142",
      "r143",
      "r148",
      "r150",
      "r155",
      "r156",
      "r157",
      "r161",
      "r162",
      "r532",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r97",
      "r139",
      "r140",
      "r141",
      "r142",
      "r143",
      "r150",
      "r155",
      "r156",
      "r157",
      "r161",
      "r162",
      "r532",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r158",
      "r159",
      "r160",
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Income (Loss) Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": {
     "auth_ref": [
      "r465"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.",
        "label": "Effect of Exchange Rate on Cash and Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Company's effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r350"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted-average period for recognition of unrecognized stock-based compensation, years"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock option plans"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r132",
      "r133",
      "r134",
      "r136",
      "r144",
      "r146",
      "r164",
      "r214",
      "r297",
      "r302",
      "r357",
      "r358",
      "r359",
      "r378",
      "r379",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r472",
      "r559",
      "r560",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of debt extinguished.",
        "label": "Extinguishment of Debt, Amount",
        "terseLabel": "Extinguishment of Debt, Amount"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r454",
      "r462",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r455",
      "r486",
      "r487",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r320",
      "r321",
      "r326",
      "r327",
      "r455",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted\u00a0Prices\u00a0in Active\u00a0Market\u00a0for Identical\u00a0Assets (Level\u00a01)"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r320",
      "r321",
      "r326",
      "r327",
      "r455",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Significant Other Observable Inputs\u00a0(Level\u00a02)"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r455",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Significant Unobservable Inputs\u00a0(Level\u00a03)"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations": {
     "auth_ref": [
      "r454",
      "r455"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of obligations measured on a recurring basis.",
        "label": "Obligations, Fair Value Disclosure",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": {
     "auth_ref": [
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.",
        "label": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]",
        "terseLabel": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]"
       }
      }
     },
     "localname": "FairValueMeasurementInputsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r457"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Fair value adjustments"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": {
     "auth_ref": [
      "r458"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases",
        "terseLabel": "Contingent consideration recorded at acquisition"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r458"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "terseLabel": "Payments"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r456"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r486",
      "r487",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]",
        "terseLabel": "Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]"
       }
      }
     },
     "localname": "FairValueOffBalanceSheetRisksDisclosureInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r429",
      "r436",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r481"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 7.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r207",
      "r208",
      "r218",
      "r221",
      "r222",
      "r223",
      "r224",
      "r226",
      "r227",
      "r228",
      "r229",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r243"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r245"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Fiscal 2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Remainder of Fiscal 2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r245"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Fiscal 2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r245"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Fiscal 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r245"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Fiscal 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r238",
      "r240",
      "r243",
      "r246",
      "r516",
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r243",
      "r520"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Value"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r238",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r320",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Forward foreign currency contracts"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Forward foreign currency contracts"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An option that allows the holder to buy (if call) or sell (if put) an underlying currency at a fixed exercise rate, expressed as an exchange, during a specified period (an American option) or at a specified date (a European option).",
        "label": "Foreign Exchange Option [Member]",
        "terseLabel": "Foreign currency option contracts",
        "verboseLabel": "Foreign Exchange Option"
       }
      }
     },
     "localname": "ForeignExchangeOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesGross": {
     "auth_ref": [
      "r252"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 6.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures, Gross",
        "terseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r122",
      "r290",
      "r291"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Debt extinguishment losses",
        "negatedTerseLabel": "Debt extinguishment loss",
        "terseLabel": "Debt extinguishment loss"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r233",
      "r234",
      "r521"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r101",
      "r126",
      "r178",
      "r184",
      "r188",
      "r191",
      "r194",
      "r210",
      "r464"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Guarantees [Abstract]",
        "terseLabel": "Guarantees [Abstract]"
       }
      }
     },
     "localname": "GuaranteesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r426",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r122",
      "r247"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)",
        "terseLabel": "Impairment of intangible assets and equipment"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In-process research and development"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r130",
      "r178",
      "r184",
      "r188",
      "r191",
      "r194"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r328",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r0",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r9",
      "r11",
      "r12",
      "r13",
      "r257",
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails",
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails",
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r371",
      "r373",
      "r374",
      "r380",
      "r385",
      "r387",
      "r388",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r127",
      "r145",
      "r146",
      "r176",
      "r369",
      "r381",
      "r386",
      "r551"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision (benefit) for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued expenses and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, excluding the effect of acquisitions:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedTerseLabel": "Other activity"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidTaxes": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.",
        "label": "Increase (Decrease) in Prepaid Taxes",
        "negatedTerseLabel": "Prepaid income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r151",
      "r152",
      "r153",
      "r157"
     ],
     "calculation": {
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Weighted average common stock equivalents from assumed exercise of stock options and issuance of stock units"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets and Goodwill"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r236",
      "r241"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r92",
      "r172",
      "r473",
      "r476",
      "r534"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseBorrowings": {
     "auth_ref": [
      "r533"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate amount of interest expense on all borrowings.",
        "label": "Interest Expense, Borrowings",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r106",
      "r289"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest Expense, Debt"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCapMember": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract in which the cap writer, in return for a premium, agrees to limit, or cap, the cap holder's risk associated with an increase in interest rates. If rates go above a specified interest-rate-level (the strike price or the cap rate), the cap holder is entitled to receive cash payments equal to the excess of the market rate over the strike price multiplied by the notional principal amount.",
        "label": "Interest Rate Cap [Member]",
        "terseLabel": "Interest rate caps - derivative"
       }
      }
     },
     "localname": "InterestRateCapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap",
        "verboseLabel": "Interest rate swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r170",
      "r183",
      "r184",
      "r185",
      "r186",
      "r188",
      "r190",
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r42",
      "r230"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r17",
      "r65"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r44",
      "r230"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r43",
      "r230"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r105",
      "r171"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r454"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Assets measured at fair value on a recurring basis"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Land": {
     "auth_ref": [
      "r23",
      "r49"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.",
        "label": "Land",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "Land",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsGross": {
     "auth_ref": [
      "r24",
      "r252"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements, Gross",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r39",
      "r126",
      "r210",
      "r464",
      "r526",
      "r544"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r56",
      "r126",
      "r210",
      "r414",
      "r418",
      "r419",
      "r464"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liability [Member]",
        "terseLabel": "Liability"
       }
      }
     },
     "localname": "LiabilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective interest rate at the end of the reporting period.",
        "label": "Line of Credit Facility, Interest Rate at Period End",
        "terseLabel": "Interest rate at end of period"
       }
      }
     },
     "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityInterestRateDuringPeriod": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective interest rate during the reporting period.",
        "label": "Line of Credit Facility, Interest Rate During Period",
        "terseLabel": "Weighted average interest rate"
       }
      }
     },
     "localname": "LineOfCreditFacilityInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r53"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Revolving credit facility borrowings"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r53",
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": {
     "auth_ref": [
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.",
        "label": "Loans, Notes, Trade and Other Receivables Disclosure [Text Block]",
        "terseLabel": "Trade Receivables and Allowance for Credit Losses"
       }
      }
     },
     "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r30",
      "r288",
      "r524",
      "r540"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term debt",
        "totalLabel": "Total debt obligations"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "terseLabel": "Long-term Debt, Current Maturities",
        "verboseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt, net of current portion",
        "verboseLabel": "Total long-term debt obligations"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r59",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r269",
      "r270",
      "r271",
      "r273",
      "r274",
      "r275",
      "r276",
      "r278",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyNewClaimsFiledNumber": {
     "auth_ref": [
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total number of new claims filed pertaining to a loss contingency during the period.",
        "label": "Loss Contingency, New Claims Filed, Number",
        "terseLabel": "Petitions filed"
       }
      }
     },
     "localname": "LossContingencyNewClaimsFiledNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r14",
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "terseLabel": "Dispositions"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/Disposition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r64",
      "r126",
      "r210",
      "r464",
      "r525",
      "r543"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Stockholders' Equity Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]",
        "terseLabel": "Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]"
       }
      }
     },
     "localname": "MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r119"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r119",
      "r120",
      "r123"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r13",
      "r85",
      "r88",
      "r94",
      "r123",
      "r126",
      "r135",
      "r139",
      "r140",
      "r141",
      "r142",
      "r145",
      "r146",
      "r154",
      "r178",
      "r184",
      "r188",
      "r191",
      "r194",
      "r210",
      "r464",
      "r529",
      "r547"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "holx_Netincome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss",
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/NewAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Non-competition agreements"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "holx_Netincome",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) attributable to other redeemable noncontrolling equity holder.",
        "label": "Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable",
        "terseLabel": "Net loss attributable to noncontrolling interest"
       }
      }
     },
     "localname": "NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination": {
     "auth_ref": [
      "r303",
      "r396",
      "r415"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from a business combination.",
        "label": "Noncontrolling Interest, Increase from Business Combination",
        "terseLabel": "Noncontrolling Interest, Increase from Business Combination"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromBusinessCombination",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives not designated as hedging instruments"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenseMember": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing expenses associated with normal operations.",
        "label": "Operating Expense [Member]",
        "terseLabel": "Operating Expense"
       }
      }
     },
     "localname": "OperatingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r178",
      "r184",
      "r188",
      "r191",
      "r194"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations",
        "verboseLabel": "Income (loss) from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r15",
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r76",
      "r78",
      "r411",
      "r416"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r411",
      "r412",
      "r416"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax",
       "weight": -1.0
      },
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Changes in foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r73",
      "r74",
      "r78"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax",
        "totalLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r72",
      "r78",
      "r432",
      "r437",
      "r450"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Amount of gain (loss) recognized in other comprehensive income, net of taxes:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax": {
     "auth_ref": [
      "r72",
      "r79"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax",
        "terseLabel": "Change in value of hedged interest rate swap and interest rate cap, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r86",
      "r89",
      "r91",
      "r95",
      "r297",
      "r466",
      "r471",
      "r472",
      "r530",
      "r548"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income activity"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r86",
      "r89",
      "r411",
      "r412",
      "r416"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "holx_ComprehensiveIncome",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r86",
      "r89",
      "r411",
      "r412",
      "r416"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Other comprehensive (loss) income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax": {
     "auth_ref": [
      "r78",
      "r82",
      "r83",
      "r427"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax",
        "negatedTerseLabel": "Loss reclassified from accumulated other comprehensive loss to the statements of income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r72",
      "r78",
      "r452"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax",
       "weight": -1.0
      },
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax",
        "terseLabel": "Changes in value of hedged interest rate swaps and interest rate caps, net of tax of $1.0 and $2.2 for the three and nine months ended June 26, 2021 and $(1.5) and $(7.9) for the three and nine months ended June 27, 2020.",
        "verboseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss",
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherDebtSecuritiesMember": {
     "auth_ref": [
      "r209",
      "r225",
      "r320",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in debt securities classified as other.",
        "label": "Other Debt Obligations [Member]",
        "terseLabel": "Other Debt Obligations"
       }
      }
     },
     "localname": "OtherDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r123"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other adjustments and non-cash items"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "negatedTerseLabel": "Payment of deferred acquisition consideration"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedLabel": "Payment of debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Acquisition of businesses, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r111"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Payments to Acquire Productive Assets",
        "terseLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Payments to Noncontrolling Interests",
        "negatedTerseLabel": "Payments to Noncontrolling Interests"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Shares"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.01 par value \u2013 1,623 shares authorized; 0 shares issued"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r19",
      "r21",
      "r231",
      "r232"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromAccountsReceivableSecuritization": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from securitizations of receivables treated as collateralized borrowings, which are classified as financing transactions.",
        "label": "Proceeds from Accounts Receivable Securitization",
        "terseLabel": "Proceeds from accounts receivable securitization agreement"
       }
      }
     },
     "localname": "ProceedsFromAccountsReceivableSecuritization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r109"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from Divestiture of Businesses"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r112",
      "r352"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Proceeds from issuance of common stock pursuant to employee stock plans"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r113",
      "r129"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Proceeds from revolving credit line"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepurchaseOfEquity": {
     "auth_ref": [
      "r131"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or outflow resulting from the entity's share transaction.",
        "label": "Proceeds from (Repurchase of) Equity",
        "terseLabel": "Repurchase of equity"
       }
      }
     },
     "localname": "ProceedsFromRepurchaseOfEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrual": {
     "auth_ref": [
      "r283",
      "r284",
      "r527"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.",
        "label": "Standard and Extended Product Warranty Accrual",
        "periodEndLabel": "Balance\u00a0at End\u00a0of\u00a0Period",
        "periodStartLabel": "Balance\u00a0at Beginning\u00a0of Period"
       }
      }
     },
     "localname": "ProductWarrantyAccrual",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition": {
     "auth_ref": [
      "r282"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in the standard and extended product warranty accrual from a business acquisition.",
        "label": "Standard and Extended Product Warranty Accrual, Additions from Business Acquisition",
        "terseLabel": "Standard and Extended Product Warranty Accrual, Additions from Business Acquisition"
       }
      }
     },
     "localname": "ProductWarrantyAccrualAdditionsFromBusinessAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualPayments": {
     "auth_ref": [
      "r280"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.",
        "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments",
        "negatedLabel": "Settlements/ Adjustments"
       }
      }
     },
     "localname": "ProductWarrantyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualWarrantiesIssued": {
     "auth_ref": [
      "r281"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in the standard and extended product warranty accrual from warranties issued.",
        "label": "Standard and Extended Product Warranty Accrual, Increase for Warranties Issued",
        "terseLabel": "Provisions"
       }
      }
     },
     "localname": "ProductWarrantyAccrualWarrantiesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyDisclosureTextBlock": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.",
        "label": "Product Warranty Disclosure [Text Block]",
        "terseLabel": "Product Warranties"
       }
      }
     },
     "localname": "ProductWarrantyDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ProductWarranties"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r49",
      "r252"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "totalLabel": "Property, plant and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r26",
      "r27",
      "r254",
      "r545"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r26",
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Other Balance Sheet Information of Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r99",
      "r219"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Credit Loss"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]"
       }
      }
     },
     "localname": "ReceivablesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r81",
      "r84",
      "r91",
      "r466",
      "r470",
      "r472"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "terseLabel": "Amounts reclassified to statement of income"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount": {
     "auth_ref": [
      "r293",
      "r294",
      "r295",
      "r296"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncontrolling interests which are redeemable by the parent entity, classified as other equity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount",
        "terseLabel": "Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityOtherCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfAccountsReceivableSecuritization": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayments of securitizations of receivables treated as collateralized borrowings, which are classified as financing transactions.",
        "label": "Repayments of Accounts Receivable Securitization",
        "negatedTerseLabel": "Repayments of Accounts Receivable Securitization"
       }
      }
     },
     "localname": "RepaymentsOfAccountsReceivableSecuritization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r115"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "terseLabel": "Repayments of Debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r115",
      "r129"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedLabel": "Repayment under revolving credit line"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermCapitalLeaseObligations": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the obligation for a lease meeting the criteria for capitalization (with maturities exceeding one year or beyond the operating cycle of the entity, if longer).",
        "label": "Repayments of Long-term Capital Lease Obligations",
        "negatedTerseLabel": "Payments under finance lease obligations"
       }
      }
     },
     "localname": "RepaymentsOfLongTermCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedLabel": "Repayment of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r365",
      "r579"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 7.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.",
        "label": "Restricted Stock, Shares Issued Net of Shares for Tax Withholdings",
        "terseLabel": "Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)"
       }
      }
     },
     "localname": "RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted stock units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail",
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.",
        "label": "Restricted Stock, Value, Shares Issued Net of Tax Withholdings",
        "negatedTerseLabel": "Vesting of restricted stock units, net of shares withheld for employee taxes"
       }
      }
     },
     "localname": "RestrictedStockValueSharesIssuedNetOfTaxWithholdings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r122",
      "r259",
      "r262",
      "r263"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring and divestiture charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringChargesMember": {
     "auth_ref": [
      "r260",
      "r262",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about restructuring charges have been included.",
        "label": "Restructuring Charges [Member]",
        "terseLabel": "Restructuring Charges [Member]"
       }
      }
     },
     "localname": "RestructuringChargesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r35",
      "r302",
      "r360",
      "r542",
      "r563",
      "r568"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r132",
      "r133",
      "r134",
      "r136",
      "r144",
      "r146",
      "r214",
      "r357",
      "r358",
      "r359",
      "r378",
      "r379",
      "r559",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r308"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Revenue, Remaining Performance Obligation, Amount"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in CCYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationPercentage": {
     "auth_ref": [
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Percentage",
        "terseLabel": "Revenue, Remaining Performance Obligation, Percentage"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r93",
      "r126",
      "r169",
      "r170",
      "r183",
      "r189",
      "r190",
      "r196",
      "r197",
      "r200",
      "r210",
      "r464",
      "r535"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenues",
        "totalLabel": "Revenues",
        "verboseLabel": "Total revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail",
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility [Member]"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r81",
      "r471",
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "verboseLabel": "Changes in Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r392",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Unrealized Loss Recognized in AOCI"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Company's Borrowings"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative assets at fair value.",
        "label": "Schedule of Derivative Assets at Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Derivative Assets at Fair Value"
       }
      }
     },
     "localname": "ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r430",
      "r440",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Derivative Instruments, Gain (Loss)"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Reconciliation of Basic and Diluted Share Amounts"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r454",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Fair Value Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable": {
     "auth_ref": [
      "r461",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing the information required and determined to be disclosed regarding the fair value of financial assets and financial liabilities, which are not recognized in the financial statements (off-balance sheet) because they fail to meet some other criterion for recognition.",
        "label": "Schedule of Fair Value, Off-balance Sheet Risks [Table]",
        "terseLabel": "Schedule of Fair Value, Off-balance Sheet Risks [Table]"
       }
      }
     },
     "localname": "ScheduleOfFairValueOffBalanceSheetRisksTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r238",
      "r242",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r238",
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r25",
      "r45",
      "r46",
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Other Balance Sheet Information of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock": {
     "auth_ref": [
      "r53",
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Schedule of Line of Credit Facilities [Table Text Block]",
        "terseLabel": "Schedule of Line of Credit Facilities"
       }
      }
     },
     "localname": "ScheduleOfLineOfCreditFacilitiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": {
     "auth_ref": [
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.",
        "label": "Schedule of Product Warranty Liability [Table Text Block]",
        "terseLabel": "Product Warranty Activity"
       }
      }
     },
     "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ProductWarrantiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock": {
     "auth_ref": [
      "r100",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]",
        "terseLabel": "Revenues by Geography"
       }
      }
     },
     "localname": "ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r178",
      "r181",
      "r187",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail",
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r178",
      "r181",
      "r187",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r335",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Weighted-Average Assumptions Utilized to Value Stock Options"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Estimated Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r165",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r183",
      "r184",
      "r185",
      "r186",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r194",
      "r200",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/IncomeTaxesDetails",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r165",
      "r167",
      "r168",
      "r178",
      "r182",
      "r188",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r199",
      "r200",
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Business Segments and Geographic Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Selling and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling and marketing expense.",
        "label": "Selling and Marketing Expense [Member]",
        "terseLabel": "Selling and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeniorNotes": {
     "auth_ref": [
      "r528",
      "r546"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.",
        "label": "Senior Notes",
        "terseLabel": "Senior notes"
       }
      }
     },
     "localname": "SeniorNotes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Service"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Shares granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Restricted stock units (RSUs), weighted average grant date fair values (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend": {
     "auth_ref": [
      "r347"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Options granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average fair value of options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r338",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "terseLabel": "Share-based compensation, stock options outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Weighted-average exercise price of options outstanding (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r333",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted-average exercise prices (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r345",
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "verboseLabel": "Expected life (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StandardProductWarrantyAccrualPeriodIncreaseDecrease": {
     "auth_ref": [
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the standard product warranty accrual. Excludes extended product warranties.",
        "label": "Standard Product Warranty Accrual, Period Increase (Decrease)",
        "terseLabel": "Standard Product Warranty Accrual, Period Increase (Decrease)"
       }
      }
     },
     "localname": "StandardProductWarrantyAccrualPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r1",
      "r165",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r179",
      "r180",
      "r183",
      "r184",
      "r185",
      "r186",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r194",
      "r200",
      "r235",
      "r256",
      "r261",
      "r265",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/IncomeTaxesDetails",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r62",
      "r132",
      "r133",
      "r134",
      "r136",
      "r144",
      "r146",
      "r164",
      "r214",
      "r297",
      "r302",
      "r357",
      "r358",
      "r359",
      "r378",
      "r379",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r472",
      "r559",
      "r560",
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r132",
      "r133",
      "r134",
      "r164",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockCompensationPlanMember": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.",
        "label": "Share-based Payment Arrangement [Member]",
        "terseLabel": "Outstanding Stock Options and stock units"
       }
      }
     },
     "localname": "StockCompensationPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r31",
      "r32",
      "r297",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Common stock issued under the employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r31",
      "r32",
      "r297",
      "r302",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "terseLabel": "Exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r31",
      "r32",
      "r297",
      "r302"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Common stock issued under the employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r62",
      "r297",
      "r302"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock Repurchase Program, Authorized Amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramPeriodInForce1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Stock Repurchase Program, Period in Force",
        "terseLabel": "Stock Repurchase Program, Period in Force"
       }
      }
     },
     "localname": "StockRepurchaseProgramPeriodInForce1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock Repurchase Program, Remaining Authorized Repurchase Amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r31",
      "r32",
      "r297",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "terseLabel": "Stock Repurchased During Period, Shares"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r32",
      "r37",
      "r38",
      "r126",
      "r205",
      "r210",
      "r464"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total Hologic's stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r126",
      "r132",
      "r133",
      "r134",
      "r136",
      "r144",
      "r210",
      "r214",
      "r302",
      "r357",
      "r358",
      "r359",
      "r378",
      "r379",
      "r409",
      "r410",
      "r420",
      "r464",
      "r466",
      "r467",
      "r472",
      "r560",
      "r561"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r125",
      "r302",
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Share Repurchase"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchase"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade Names",
        "verboseLabel": "Trade names"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r207",
      "r208",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r61",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r61",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r32",
      "r297",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Repurchase of common stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r61",
      "r305",
      "r306"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock, at cost \u2013 43,653 and 37,609 shares, respectively"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredParValueMethod": {
     "auth_ref": [
      "r297",
      "r302",
      "r305"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method.",
        "label": "Treasury Stock, Value, Acquired, Par Value Method",
        "negatedTerseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredParValueMethod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r135",
      "r136",
      "r137",
      "r138",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r376",
      "r377",
      "r378",
      "r379",
      "r517",
      "r518",
      "r519",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnDerivatives": {
     "auth_ref": [
      "r122"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.",
        "label": "Unrealized Gain (Loss) on Derivatives",
        "terseLabel": "Amount of unrealized gain (loss) recognized in income"
       }
      }
     },
     "localname": "UnrealizedGainLossOnDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r366",
      "r372"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r149",
      "r157"
     ],
     "calculation": {
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Diluted weighted average common shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average number of shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r148",
      "r157"
     ],
     "calculation": {
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Basic weighted average common shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Basic [Abstract]",
        "terseLabel": "Weighted-average anti-dilutive shares related to:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/subtopic&trid=2196772"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2443-110228"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(c))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(2))",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(3))",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(5)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "460",
   "URI": "http://asc.fasb.org/topic&trid=2155896"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "c",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998890-113959"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41641-113959"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121558989&loc=d3e80720-113993"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "http://asc.fasb.org/topic&trid=2155941"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13467-108611"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13476-108611"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121569800&loc=d3e45023-112735"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121616839&loc=d3e45280-112737"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121329987&loc=SL77916155-209984"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.16)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.7,8)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r581": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r582": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r583": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r584": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r585": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e640-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e689-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724391-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>99
<FILENAME>0000859737-21-000019-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000859737-21-000019-xbrl.zip
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M 0FBOW1UP T ?"ZX'ZX5B'R'\^<N<&5J68,^;HX7PI=\#''BSD9<ZB;I5\;
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MA(9U5\0(Q:"S$_@B1^YJA:)<9Y8T^:=H\OTT6L'2+-U"V,/@A5!>HS!JR_
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MVNO/$8D6@*5A5W=2\49^#I!PHS"XVV6=WY]5V07\LVQ7Q8__'U!+ P04
M" "L@?Q2\%V&P>4V  #09P$ '@   &5X,3 R+6)E8F]T<F%N<VET:6]N86=R
M965M+FAT;>U]:7/;QI;V]_=78)R:.](4+8NR%B^YJ9)E)5;*EEV6$M_WTZTF
MT"01@P 'BVC.KY^S]0(0T)(H(FG1'V2)Q-)]NOOLYSD__L?;CR>7___3:3 N
M)TGPZ;<W[\].@B=/GSW[\OSDV;.WEV^#=Y<?W@?[.[O]X#)7:1&7<9:JY-FS
MT_,GP9-Q64Y?/7LVF\UV9L]WLGST[/+S,WS4_K,DRPJ]$Y71DY]^Q$_@IU;1
M3__OQ_]X^C1XFX751*=E$.9:E3H*JB).1\&72!=?@Z=/Y:J3;#K/X]&X#/9V
M]_K!ERS_&E\I_KZ,RT3_9)[SXS/^^\=G])(?!UDT_^G'*+X*XNB?3^+#ET=[
M_7UU>/1B[VA_=[>O!GHWVM?#%T=[!P>[AX-_]V&0S^!ROJ<HYXG^YY-)G#X=
M:WS_JZ.]:?EZ%D?E^%5_=_<_G]2N*_6W\JE*XE'ZBD8+WPXSF)M\'69)EK_Z
M89?^O<9OG@[5)$[FK_[K,I[H(CC7L^!S-E'I?_4*H/#30N?QD"\LXO_5K_I]
M>#G].>/1P!1>)W&JS>CZ>[O_^9I&$>DPRQ4NT:LJC72.5SWYZ?3;.![$9=#?
MW=G[\1D^R<QV8<[>7$*@J\[O?3)[C<D<M4SFR4^7GX_/+\XNSSZ>!\>_?#X]
M_7!Z?ED?>ON@_ZB*,A[.9=2P$?*?[G[;WS?9MI5[\M,_?N@?[KY>_&EG'M!2
MP#&)TS(+5!%DPZ <QT6PET9!I.;X]Z]5,N_Q01G, P5?#'0YTSH-WL$T1G'8
M"\[2<*<7J."M3M1,Y3J S3*5_1+,XG(<Q&413/,X#>.I2H)IHD*-SQ[@\=1%
M$2@XB@>[P8F:3*LB>)O'5[H7?%!%H<)Q5>@2;M_M'QWL!5OE6 ?_^.'%WM[N
MZY-L,E7IG/[JO][NT>".DR0NX+6?=H(W>I#AAS [6)TXJN#58W6%#&&L<V\\
MN2[B2*<PIC@-+LIL!B__7><37#+_A:??=%B5,#;SRIU'MW6^O#O]?'I\T0N0
M+)8>05CE.>RE9![ ^ZY@&+"7+G0:9WGP>PQT_20D+GO!NPH&%WS615;EH98M
MIP.[F <O7V^HRE3%_>S1!G:LOHJSJ@ RUP\NT/I*@Q0-^9Z3L4I'=,!.8$AY
ME@3'HUSK"=$_(KEXH:>EG@S@&/2?X^GN']5VNGN>O=/L^4>^0J&:QB6,]'^!
MB+ $DP)4#/AU4)5!FI5!I(?PS @9C 9F4HQ50DQ'TT).M$J!_2 OS( AT?K1
M%ZWT?M1T]O?]&+@)$#<>QCIJ')%R#*(#5! X!SJ-B@!. ZY*G,(NKU^*^[=_
M]+H(]&2:9'/2$DDV^6_"#S)8RA,%JTHK@ ?J<:]"-S\"K3H&:0\TE_T<#('A
M W>'L89JD&B0!E,E>@"N#+P\#R95B9)XH%,X*V60\0G@LX1O"#,0UWA+ ;>7
M^$A8)#Y/CT_>GG_\T@LN<3E^_OCYM(?\ NB#LE3(*N)3B!IF5SI5:<F45(:7
M%$(_-00R.ZKR^L(*E;'F2TI0F#3H7'*>4%6"=1OH(-$CX&3S8)"!_@]")*/+
M42'$=Z"X'V9)DLT*.#0O[IUM356$8WF:Z*'83(L/XH] U8/YOGKZ_'!Z__;2
M[4R,OMVE#__VUS5*[1T92K7;;Y?"*7$?P0K:@_XPXV\_"#M!\.@.>=?/Y>VC
M)S]MJ>UE;H/5(\FU!\EZL(*WH'@L^?R<#H<Z)($-XT'S/=@3 ]Y7\1MC=E:T
MT8%0P@\K$!,@,E#[ N4TU_]3Q6AVU(VV *1^35-H*@ZL!@^TT\TB=";XCQCF
MV83-\DQ&]6=-R![>.=/P0E70)$@4PI_FR2CJ$AH OB].PZ1"GNEFGL03T/'Q
MTAX_0W1&#1/+AD,830XB$ @1EAG\!H-1(_P(ACHAHXIOFTX35H-Z37J9$?$S
M\#YT4=#O136 :<8JCQ<F5M=.8:'/LW(LW@QG;("1B!-J:+],7R3A""T0LV(U
MZIO%(:F_>#-9H):$TQQ7AI6ZH+&7=OX$"W_H<[(&0UPK<3'8B(M;BXNW%2K<
M2Y82GZXYP.W\&PP/X T5&7SDYOL++)HL;WPH?@JW3=&H&<1)3*8(\L>HXE^+
M(@MCDAAT3U&!=6+8T..S!U=OH\/9#[=7;UC7G3_<A3HMZ/,EG\*?2?#"&4"W
M+ ER."D5G+.D_5Q6:8+QDKM[MN+"5[ZT E*@GC*M\J)2< .<Z0O4&K.45VX/
M.#IH;&#2]X*M6!:X0ZN#%V*4-,*'^$P"-!&-%PY4 5>K1.5SC/2H(,?)@BZI
M$KP,M3 )( 3':8J?OL$[+N@.&*.:DS,)5!P5PGI&Y"AMSM!2(=>C"F[$V_*,
M%"(5HO9:L#]O*S:S >[5R0C\^*SA-J]RG2B<>6?$=I"5939YM>MN48,B2ZIR
M\99.;N3_'.?. S+23P>Y5E^?DA/GE4IF:EX\N5-@^89WKB(?])7H]DT/"G%1
M*O95%646?@VR*:FH/90K91Z'N.'YFRJ-Q34VU?DPRR>TD[SO>D$\#$1 -23>
M%3RL;0OBTT!I_P.5=Y&F-_@RQ>?OIH9'(2[G:(K@48(3,TV 9FPFS%3N>_*L
M4QHW\AW.)7GY,-Q9\D'RK)!<EV![$-O8@AT\#O!@LK,=+TFS]*G]!.S#*Q6*
MRRB-_O'#_M%K$/]%#!2$ P?&D(Y@4@G81_ \_!_NPS<6E8M/9613&IO*>H)Y
MTC"XV3@&(5^,_;BB-WY8)=(<F-BP4W'D=1+ =!2\,]"PA6.D,'%_;W& R[(F
M80E]FS5LW%6 Z3='0L.8-1G=8DC!":#GP/\]9V &6XL&YG8K"PN!?2ETIQ+)
MIGDVRM5D)_B8WD99HYUK6"\2>@A,/\'5"<<:EHEW;1CFE2QPE4Y5'.$%\*0\
MJT9C#JN02/)MZ<5[[%Z@*=/!4BR @%2X2/[IM-%^_0W%+ZY2/!F  !(?-9\L
M\3G;F&<&AV3^-W@%U\JGO+<V/N4+%_%YP^>ZV&CIRU>'R:&[>L.ZXTY:KK)^
M#"R*HF\@KBE;2(S:T@NCR$?7ZN; 2E&QP$](&1?W'7)/^&]8D6.P",<J'^F%
M]!BC]0Q@^RN62A$K*,W .#R5J%F/I8N3$'E]\Q:0XR@N,$A;X!^@\)!X097(
M4\,:@M+=K_DW\AZ"N6$S&6AF_I<Z^*P3C2J^=TU9*I!/D80A T\Y?_C5ODW2
MX_$R-V/-DR_$-!Y\$O"H8\Z KO.G6:J#K;W^-N;S63],0X6PD7VS+@.8^@07
M2]M8 FU/T,:NLK#+&D/EFO6FCERB25;5$HE>O.ZP+>T^7[0'*<< YI; F+;Z
M>]L!INF-3?S9;+ %'>F.1F2*QD%RG0W9<<Z/<;)P;LW L[0J:F]/JLD4SM#$
M/@D>12D32!MG%%-D/L^B*B1=:NN87_@.-@$:(O[CV1IX X\!]5.%'+? B]-J
M@FD"0"]X BO5<6&^P=PO^)AVA5@DQ@@? O>!A\^URCV-L(6H9MN ?I01"VR\
MZOGAP35S9R/F"L<=JF)L54>\,-85/NF+3H:84"H"@/+9P"!C7KO(@?")I/'2
MF?OK.\6,%]3/,UBBB.T \UYXO!YE%#E:Y+"E^JI) TY!$R\*<GV$YFZ3+D-J
M-JG)76(#]VJ%RK$S8)I;]1B(%HE:_IEY=A2\U4.=8Z3.]W4%G]B2<!8B"ILY
MF;;X@"[V@-YB7AOTKB02(3)[%.;'QG<U*-B#5."IMCN'EMAXD"<3DIQ;L#(#
M3#V)K<P3GS#Z@D6Z&.J;C5%LFV2A(4BH<M'1 [PTBYBHDHTB%N(TKF?++(H?
MYFMTC3S&9V$R>R0FC9_^\*.FO*%-5E]/%A;-ET6Z=1"-:(8[MCX=6),0SR5>
MS.D[7?R[%I'K'+%;^XF*M"%HY^4N*!I3QFE1[@27E#0D\S+[,BX:_L, SZVG
M*WCN#GSD.$N( ,1"U#>]L1)60!VG.-[J#>NV.4QX>B@VOF2G_GE6XA:WC@]@
M!!RHE\.)VG^.$H$U?]*PZX*L[JUOIDJ8:0;"9,CY<EU G@14VAK4PZ3EAJO0
M^([\!!![WHEQLS7FG_VZLK\H#BD%.LWL\WS[94&,MSVW!VP\U-.RX?:S&2E
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M@:%*9<U884<4!RM:^Y*R.XA-A5D%YK95<GEBE"5")3:4#STEKN<!.TX4I2K
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M:AR33B;I6K$[F *B>:TFN#/X3)W561]DL=2>44/CU*!XQ5@KM%@(<W.>\\Y
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M%A*RF\&*MC^DP)]8.S4S"JQQ678LSF?"&'(::X&0@H\Q!:RUY5K#]E/@ PU
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M[Y,;=5L5LV;/HI0*SRGRW7: I_'!$!/;J"T2NH(K9*B:2+9'+O?6DM\U'_Q
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M3@4S.%KO?<I!381;G!Q( 7YBR55(FIN%Q\QL!5,=8GA05F6E.:C A21 9CZ
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MEU9UE@*1QA)&HR($<^*8<2J!8@)V7&"4\@6PK>\EK:M(Q]>]K@>:O+FV_Z)
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MY7GK!=B/ /:5-A&%<1&F':F4FR ES)#FUB,7DK<D!B,)6UGC4E:6_EJ O53
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M5<$PG&U]H9XK^>C:'@7@M0;X8W.["\!K _")^M%!6>,U1E0;CKC4+H>62,3
M$E/,)ZM]S*7'V',I'UW?HD* /ZE,U%O"^N[$3M<]-*/'N,E)LW2E;A?._S"6
M\@\<5^CM7O3VZ9H' @>A R4H4&$1QX$CQTC,;HB8C%.>>IGU%_U<Z(H[UE8!
MM3FG7!2"62K_1R&8J@CF2G\BR1LBK$24VP0$@S6RP6DD@F0I4.F)&^I/Y#GF
M%=<'*P13"*9>_I=",!41S(0'AFGKM0 -AN <;>$,0=JE@%AD3,![ 7N="08_
M9ZIH,(5@EMK_4PBF*H*9\ "I&#R8ND@'!AJ,#009SB724D8KK*<\^DPPXCF(
M=GD(9NA ^M>PA![\&UJ?U_X-/RY&/G$O'W/7F=DCE&:$[L78L-YW3^"[SW._
MU$YW$/NKE_/]_;C''\[%: 5\P6FWW\IB>M&+;3MH?8Z_?VF%P?$%_"<^.!8%
MOOJ(=?UN1MNM'ZG+'+'KLS'Y,X]VR =$DWQ6X8&[!!=&@"$6B0)%/06=.VA^
M(&;EXD/'O8LG. 7J0:X7[2=D$SS@"]O^8L_[*_^Z-@\GK0[Z;MZ_G[);)R:E
M2B9&W3 Q(SP OW9[=BA0@&'LY:M@3+8V8VD<]_+N\E^_%I%:6=L?5KSLIL9&
MWI@Z@_Z__V77;A+_7)?I33.PLM;X<_?OW5?;&\\;V\V-VQ%\8GM'L*"&Q5/I
M=05BKL/?V&WN[?Z]O;F^O[79V-N'?W:VFOM[C=V7C8W=G==OM_[<:NYM_[.5
MGVYW9^O6YZO+\SQ[U[%GH07:Q&]U&.OPCB]: _@V?P?.>[;=:< 7M0%+_=O'
M/[&6Q"U+:51#]G(3&.ZZ\%AM>]J/+RY^^3VT^J=M>_ZBU1D.9?BAW\=W'^\<
M^0N^VW"'WS=Z>\R(1JTRJ3,ICH]NQE\\YLO5(5]^IT2,WN-B51AYZ]MXE=SZ
MWL]N2\BJE/1!M_WY>T+<_J5EL+4<K+[3;7]Q\%B+C !])^OO9M7]\IG,79YI
MQ"/S>:H?>'WX5/N@3\3&#EQWW&]L@9IQ^['ICU*[U7VPH)/1A%=NGXN%+J->
MR1J_7Y7L7Q:SK_=B^.L,%@.5S__M>O]:RR[@J4]+1=7)EV+>U>6\X\?,>YG:
MLJ3K,N^W+>FGD$UYU9ZCM-R=UO,OZ.')%%ON7C90GVR47IOF2+M[X\./DS=T
MY^,!:VZV6\V/6WAW\PUITK^.#]X??CS<?WMRN/_N6_/57ZT=^L_'J\./3Q3&
M\''W_0%\_V%KY]N;\]U-SW=H_LPG>D"WR>'FSK>=_>;)]X<?N_L'7YMT1QQ^
M?-L^/-G^UMR$9_MV].WPI-G>W3_\>/#QGT_PR:]PK[33&A]\[.$O'R+!CLO$
MD&/1(1XY_"8IR<&O&I-DE*5DU'>WXI/5TMJM7E@N)#;#OKN%Q"H@L6^7)&:T
M<9%D$LO-"+B3&%FB)>*8\6@"]9')W'Q7EN;AA<2>.HG-HOENX;<*^(U<\IL4
MQ(&0%,+,4<2E8$@+Y9 33%).*>C6XPZ\N+07+PSWU!FNL@Z\A<8JH#%V26.@
MDA$?7$ \.((X51IHC%GDI:0VQ8 -"2MKDLC%(;&%/C^Z(_(VCFWG"&[7ZN2-
M'][I-/Q9KQ<[_KPQZ,&-V\. IH8-'\_Z@Y/8&3RFS-/C^+I^O/5LMDZR/CPP
M_/8]@^T.CF-OHWMRVHO'L=-O?8XC0GLY$NC&6)[[69RC<:YWPOZ5<-<O90M<
MN)OV[=?7W=[PC8D^S/O=UQ9N,R@,>1^&/)_PQ@FM&"Q'BZ3R%G'""'),1&2L
M<B(([X7U*VOF!C/VM_MFH-=&OZNP_L2R<<<\75.%,6K,&%>N+ZNHLP)+)"3)
MS3AS\J5G"4GB8&URX8)/N2_*% K1%MJH*6W<1^6HP!M45([%(Y )WU+@A :K
M0,>@&'%#!')!,12$5(+(A'$:-58J*L=3X(YYNED*8]28,:[<.!IDZE00R'CE
M$1<L(IN,0%@'S;'U(3FZLL97I]#58RY.G(O,#WB2^'.F*5=>O[),;)G8Q;JR
M3.Q\)K;R@-B?91S/REO^V;;/AJFZQS$<Q0 O#6(O]@>-GAW$1O^+/>TW;.?[
MUSV\_+S1B8/\R8']FO_Y[WE&6MZFEN7#L$V8I,_#M/K^FS,00<H9^NO]/_,#
M]T$!*UK6/;2LW0W\Y4++@ONTXY]OSP_?AU-'N3Q\!==^.SH_?+5U?D!WOL)]
MSILG?WW:^;@NX#G)SJ9G!_O;7W?VWZ;=S4\?C,=,..<0XSCD-D46V>@#BMR!
MVD:BE-'<;-8-E^1]%EP%+H2RX!9[P>W[#S(PZ17E2$IA$%>)(A=AU7D=(O8!
M*^"BW!+KQ_HI^52Q 2*'_^6\Q;S\.CEI[V24M!=STE[C(LVED9?0:(G>Q\U5
M@7O\GFZNLEAKNEAW]M_A#Y$Q*X,)0(]&(6ZD1D!;"ED>6$C>)F:']"A^]'K=
M?_%5X"@IBV]9%M_!^0?#50PF2L0B@;W96HJL(PH%KXDG/JF47:[JABB8W^[!
ME6K(E?B[,BM3J2Q7[E&?>U395(Z*42VG.D<GO;)@:3UK ^']UNA%WSWJP(>S
M3=7H9G)L^$EV'.<K#LVKTHMN[A;DNTXOPM2 O+(4\Z:UVYG8MM9[K3[,\N99
M#WZ^AM>[X8^80]#*[G7/W6MO(L9(2JNH=0R9F!O8.L61"5BBJ!+60L0HK%Y9
M8S=8AJ673;TA7F^#J(!]9F"_"@]RPB?LB,VJ9F[^0!RRGGID:"1&:!9]KFS*
M5W^LRW[OT_V"\QINY3/SS15TSPS=5[$[AC('K.T1Y8(AKO-)? P1>4U%"E0I
M%OC*FBY;^<)!O-[NI0+VF8']*NQ&$&\,#@(I00'LT7*D08=#21)M/"'.V.Q@
M%S>YC1:]/=TB."(R#+('HFW[_59JQ=!(O>Y)+EU^=G+6M@-XX2:/1/9<- ;=
MH5.O/X#+<OQ:/Q_ZWEQ;Z4[$=\-4+@CQS=9-,9G(_BWVNL'VC^_C8W][*6[_
M703B2Y#]^N[&]C5BO A++"1XG]C#_?7)=G:!NDA\5 A'4'>X3!A9+ G"E'OE
M0PR!AUST4E-"?Z\HC;1&Z>X%_O,]TBV(GQ'BK[JS^)"TD4JBY'-_WJ 3TE(K
M)(..W'$OC28K:_CQ\<8%[?5%^^SSE K:9X?VB69OB6DNK'0(-#F,N%4&:2LC
M(H1C$6.T+N",]A\C,PK:EP;M\XF8*6B?$=JO]G8;C&=**J2X%X@309 QPB*#
MI4M"B*!<[KSV> ]FA6A_"C5?=F_P5(R#+![AEEC2G,EZEWC)S%;R(:MFL:U)
MGP1/.@02 \+Y,(;[9)%EGB'"5%+1<J>U6%F[J?IHR:%^XGPP'R]&X8,I\,&5
M5H,9HTYG&\8'BWAV5#K,.<(Q4N %'83#-X=8%3Y80CZH8[Q&88'IL,"$)T-K
M&8SD&@@@5U;QFB%'=4+4"L.<<C8XD</\'^W)*%2P,%10[[B.0@I3(H4KU4"1
M0 P+ 5&F..) ]\@Y#I:#5-@JZAGE>F6-F%6Y +K!4^ARM7%#_DCI=U5JD,\Z
MA^8&NBX.Z ?Q\?:DZ\9@K7W0 F$&5,RIC\A*+A'15E#8? V)./>_(C>$R->T
M)GEIK%!(K;8A-X74ID9J5THF-T+IR!/B0E+$B1+()2J0"L8;ISB1,N9^6*ST
MPRJD]M1);9;]L K?5<=W$YXVXP.Q2H(5K:0!HYKDVD-@7H?D3*246I/TJ#^6
M+HQ7&.^I,U[EA9L+K55(:U=J','>42D3$MXRQ$.TR#A.$6%A&!VE=:(K:\*H
MRD*?Z^<Q7,#8J8R&;N<BB^NF^C,-.^%5S\E?(+F,T%ZW#;<[NBP(^N+6**LJ
MCE_*/>ISCZ>6+ G;PRCS\8Y(*%F0"Q10V+PFP^VQ"(LF<"]-X,VDE]IQ:10U
M#&E&%.(QYB8MB2"#77!$14<L+BE02X[T&H8*%J17@_0KG=_9I!7Q'$6>RRAS
MCY&3F"+N34Q&^P@&P,V%:0O2EP;I\TEV+$B?/M(G$QVQ9")0CZ(7.?7)*&2=
MDR@8F03S./=RS$C7!>G+B_0:QO@5I%>#]*L]G6(MG(P,&9.+,-H@D>5<(NJD
MUH;$&+'*Z0!5'4T41]U#0ONF[HY8TI#FXJMX\FSW[EJ!IF"Y=2FBX(1'G+J
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M4J;&A?B?@SYTN%YMUH :![M&V9.'.A9OBZY!HVHS T+/#,AWN)ISE^-PS=C
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M.$B&^"BR"TQIK:$XG_22'F]SUXE%"J/0(DJ($J*$*"%*B!*BU$J4< /P\#<
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M#0L8DK]W]D\O9@9J.%4R$Y9XV=+5+RYY19P026LE5 %L95VH52=O7>3Q88@
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M2"N=,V)EG2TB]1L9C#J+*"%*B!*BA"@A2HA2*U%"___A^_\SD6E@.?@L0]D
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MIS.:^0;^.>B.NF-X"\-/W0@3U^(-Q,&'?O,NC9>!SL1\S@2=C2BF2".HXD%
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M\B$H$;R327"E@DF^ZO_5U/]S86EE3 J::Q(="T1" .*M,R1$FT64S#F@*^0
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M KL3%@(3!+1D1(*+Q+EH2#00:=#&*6?7-M@S35<I2[:B><G;6#?%\C>)[&<
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M+@[/:5#XZ\[7M_*=R2D:(R@!G021/"J")A(D\8AN24K*V-BZ'\MJ/5WKLB^
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MS@F>#@*Y/#/NC <=.#SJ#4X ID_U\-N?5@QH5<X535W(O=QLZ(_^*.G9V_A
M?]S]!)O]U#S\$Q)P0OX]@OZH";N_*A;#E_6.R[PWG+QW5)ZH;NABU'SF<#./
M2C"=D)5I.<D0%2,!!"/ @Q0V@>%!KVT(MZY7R >MD:25BR15N*\PW.=*T%H(
MWAA+5 X4E9C0Q!KTI+AV65J7<].D3<D+/*>5#3D]M@C.W+[58;??/3P^[(S]
ME\[G[OB@)+_A%8TZB.<^C#NC IW.",;C7G-N:53>!/\][HY/.OZS'Z9:L_;V
M-4Y;+OLT:V#??_G/S%2OH>?'D/8'?\((_T6ZPT=*3UW\=S0>=B,^V)#;'SC2
M2FV+4=O9(]51)8F40YS7$>4,HR0$\$0ZI:1,W D(:QM2K[O5\#%K4&A5@T(5
MT/<(Z+GZMQ*2L9F1Q!S"6--(G$F41!HS3Q!<$ AH7-"_=4U6,6CTZ&(PDY#I
MY'AU;I+AH--@H3,(.+Y&QS^Q(,OJE'^;M/C:\D?=L>_]5LRR-[-*)::%B.G,
MJ>EDA34Z G'9:2*ETL0Q%4C0ACF)JPT+I=-U/>KT2'%[)ZWY*FZ7A-N9H$";
MR*P4D%1JM4B:!/&,"_S3)@$^!@JYX):O!FZ7&?809K7%Q"Z,.]&/#CK'**0[
MW?Y$3I13TOXTN?XFL8PK-PU_?'2U!)DQPNO%W\[S%EIM"XWV:CCXU$V0?CKY
M ZVWW:_G(FY*6V=.5@?P+%@KB984_:"0*0F1!>)]]"R:'!B8M0TIS3*Z]UP9
M)P\H[/&$L;\$J5*Q?^?8GZMIFU+VWB,S0[1$*I:(==F3;+FR7!JG'%_;$-0M
MH[S+K6-_21&2518R+W.&V.S=P)=XX/OOH3/T8^BTOS<;-XW.\?W4_E)V:SXA
M//KU2-)]2)C67GOYY<1:K]%8>_W";)O]5/YY.;-/);*%B.S,>6T*7"4F#6'<
MYU(QLYS7CI0X'JDT!L"EDK.[SE;#]ZHQDQ7/,*FXO4W<S@D0:X*#K(A27"!N
M<R(^<TN8IBEG!RI9N[9!+XAU/OA\D566&25>TNW'8;/9TEVVIGB<?M-][LP4
M1CK'2K/MX@EKG7U@[I6O\'('Z%NUYGX![;^GN7'S%-C28B6\10COZ^:9: N'
MQ(I0T306PHN>.*TY 9\C@\0=+4W:&=<WSXBM(9='2!U+5SJ5.E:;.N:..25P
M.HA,C!>1R%2VA(4OQQ2!^A!DHJPDK$A^P3&G%:6.)Q"QV;I,.CWK!'C?[??+
M)M0@=XX:*#VM&,T"O$>9YS$ZX:G"U=,J+PS34DM&F070^MWV1#)=02E]Z\)M
MCK?\<'B"L_>G[QU#9:F%6.I,V9A@71(L)!)PZ2%2*$$",XYDYM!P(<?DY=J&
MH6REFI?4@,QRX>I9"-D)QF+0T@EJ?<XA,YTU*U7C<X%K(U-LA>L]P'4F*C03
MP%QF)(M@B8S&D!#P!R[_4J(_2JE*:QN:7E2NMX9@[D<W #YZJ6*XHJ9K+^VY
M0 .DP7%I5C2]HIOY5JLVC?][C_/S6,@<G4WFDN5142Y="E;J)!)#!@?&HZ2-
M]KIBE*J2^7+)?/M,R;[(I#4\DQ1*Y?5"Z[C"*I(AJ>Q3=#S;M0W+S;*#2TM
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M(@<D>$!G)44G"5I8D6!+M3--8W#1).?HV@:3:EVO%M%4DGBD)*$SE]9QE3F
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M875;)\(S]<999D')S'+(3)J ;CB#;+6LIS+O#%:[6Z>P\LY$SYPF60$G4J5
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MJ40BZ0-J9<^(B50WP9D)@207YXMW0*H;F.MW2V]<=4,EP9-!DC!3L5*#L"E
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M4YA(FL>DB]$H-7B)(1>(V=4^3$HKV3+]5@<3<Z.(J/&\013FQ_UW0V'..\M
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MSRI7O+VNV/IX'(^7D!3K#@>CY57%Y(]^*M<^@YW]V'D]/(1O/NMD "N/8KQ
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MX58^T+Y:-)./E1-<:Y3_<V&55EQ5<!LL]2H0(7B2WFKM@"=[0RSG+L%LKD\
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ME"UW!+#W:C(!G<8,C"_MA-W*^M6UIK^0H]\\VOF[LS:K,+KHF'#<4^N4Y '
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M.^,_9L9W_"ZCWA$()!!)!*  I@AI&PABQ!.K38H"YU8>Y"HHF)8>E,J#6T,
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MSA4+I64:=UXS=.O\S2Z17@1X]$A"1(BXT0(YIPBRAG">:R:))1"'+"@,OZ"
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M"!?5R";AD1<PR\X*BFUN3;N@V7&[_7%/B_3M<!A.>_U^2Y_N&YHF3[H%D*4
MY%T30+AS'N(TBZP)$G&#,;(V]R4FEF"-K6*, >=I2VD?_(32I!]4$75=%JSK
M'BQU5Q4&SSD,3_)6QV3@]1N.AT>_Y%DHHD73%Y]S,X[O_X!:7/X^E'$"YPNI
M8S>V13++P?S')LR3H)C1+B)BL$*<&XUT) *9$,!,@C?)7B6K<K?,W/=;7]_D
M)/Z[-)E:U'QN<3/"9]7$<',PT<>;-%>_T&2P;C!86H8V.X/.FORO=NSA,&OD
ME9J>K. ^'(U7:^6Y(K.>M0*RK'OG9!PKI=Z)_&Q9W+D7J>V?C7NED^!^;PP7
M*"KO,W&\>HQ%++Z<PZU;$Y9/U!=OOF>J..UJG"F:E5D4>]+5\I:W.:?B'6]J
MIW@*SP,^<GD/>[7C%VX$56U8CV<)U:HS_>4&]PN^RXX;'1KS;>[5[RP)D**S
M:?U^_0WP0I&]3_WA:1:!.(B^4FVHAMP;3T27JPO9)7N^<AF55B(JIQE/,6K)
MI"6<1LMT](Q?[&,NJ6KZ!S:7]9R**A1</\I?OU$/\#W<[(MNZLJW-CX"(0>'
MRQA&P0J1MU T,I0DE!*+4;'  W5%;&915]<1/,+*RJ8&45O!M/GG;'6=U*JM
MU2(I?<RS'$9UL9EI3>RG7'R<;:_?R_*7Y:IQX/</[>A+K8<)"R#!W_,JG<C3
M'U9OSQ_.]CZ*L)X'G30:'E[\RL[A,,3^]'LK:,M  C!O][+TR+BL<&^/>L>V
M7]WGI7?U>RE.!9P6+=<.0%&] +K +.#FY\W=,*:)CPH;[7GDR5+G>(Q64"^"
MCWRA.$FC.3:@M?\EG(S.HAU=9$83JO-[ENV,?_3^R5TV)HN_8D-_US>T7MW/
MQW%,)_T_X*9>W'KX^'5KX]TN2UX1*SBB,4& RC5%CD:%=&Y 9IRPQN*55]/\
M5CVEKSKY\8^O@N:;;( P327,+I?2<X:Q$R%(K AG$;@2QZT-/)P-G(,-&&<3
MCAQY%3'BA 4@KB(A(DQP,7J!';G2!BYZX9OFWEKI4N(VTN"Y94";9228!*%-
MU-K8=NX?;.ZSGI^PP@:3X&%3FQ"/.<.MG49!FRS< 2]7/?'EXMF?>,.^/ZG6
M_X1TQ:\>J.,5C'$(#__*-MF3STQ)6U8R;?3<7M")>\*),Z]K:J/NU2'O6N?W
MBEI7:M@]=U+I(0UKF9 2/#='#ZS\I))ZGESB@INW0&5][Z@,?7PVB*.]K/'E
ML\>.J3>5M 86#80QG'CXBXNUB/=1OXCAVM%9'L&</#6\GVUT#NWAX7!O9(_V
MS^#BX^-X6-WYC*C.%+&GXF(?USZL=<9 [L9YM61:/IZ.("M ^3B1@RWOA%7:
M[QW"*@EKG>YP,'WJT_OMC<N)<E_W1W?9V^<;*0\^$X#9;F&>WJ/A&!CX;5J2
MEV5V8P/GK"ITFV#PKD'DO<>,BUI;K[SZ2?Y\+3J&9#1+N?F],9P8#U 9C(G6
M&ATXLT6ZK6@9J8:0R#P(;H$QQM&X(?8P7A\$B (FG=?'.2+H#[,H\W@'OODW
M"-^^_%CX(]T)_!UFE_3;X:>#C^>?SC_O@WLB6P=?X'O63[<WOO!/!_[\T\ZF
MV#KX)"["'USW?.OMYUYWIWO0/7QSWMWX>+:]\X5M;:SS[9W]7O>\NP_7.NL>
M]!-\_G3[W6Z,5 HI%<***P31ET2:D8!2P$K -'CG+ZD..&:8([ 8I(</!:RC
M,AY'XFG$6&EP)!&"K*-L=:.3N/*J\>0[J//!5DW)MV(H<?HZ0.!^!.@87P38
M[Y 16;0J%O8@O_F>YI^!P";2)*+PT7!#G".8&A=]((G#4]-7=D=_9"F<[:9$
M*)ZH+S23&*6;>ZF- !"T@($I<PM@%AV[-XH%R#,\CF.&3$#YR_,ZS:/D][WN
MV[-C>.H;)SD!"]_Z7_;PZ-?.^^P5?UIYO5%^?;_R<T%86^-Y[313E2I<1I=(
M&R\QPXXEJX#788N%U](+L'GK@=U/4\[+:^%.X*8R;]M_.QJ>'&T.?/\DIQ9+
MTJ&VF.V)SN6<-N1C23?_ .AY(W:]A55&!,F5Z0+"+B#?!DN/8!5:[@E-DH25
M5Q2+!7F(B;AC90[@U',R8K73SR;FX^C8]K(48UYIV3IKBI8MJ?"CBH <5S1F
M(_K*^-G4^"?Y@<D"J/H?P]M+R@/8C(\QC)?5_/9!8"$,X]Y%CKW7AFH#T.L-
MDU;[,&7]&'VS1?Y9C_'WT?!PHY=%I7LYR;F=)ALGCZ<FYN&-[_P=WH5YT$$%
M!DS?:L2I >-STB('%,P(K&":<J<!P=;XU<JB-9F$:&PXN$*<#S=,;R:[,SYQ
M.8.:T7!FI9E"CD]L!::%_<?1X31\6(2Z,TO-J>DLP%->*F35EO1W_P)\3@UV
M,?,RQ@BI<F@:>.#*2.4L<<Q9&GA2O&9>LI)PJ^4D[PR%'^)>OHF=?7M<O3&.
MYS[]PLRRN[-)=U7P1O#@\B8:0QR#;5J2,!+,84QD(#R1;)9X#<_IL5V*3&O3
M3,.3+)]TG6E.0&YF.K7(\Q1(2P*U(F_ ,?X!2QK7Z4_X1/Y ZJ7C&'-V=7"\
M/UX%6SV*E>!7+04UL&6+I3;E^B(7OKX_'C;&D'G1X0!H4F="",I73H;4CWNV
MSN-"[ 68"'=72TB7:#!.Q.G*TJD3PV'&0HNN)ICDH-K'J#++O1)'ETST1 #Q
MN%Z[JQ?]015?3T;9J_9^YK2PEO0.T0DJ/<LD%.BD,1989,2)4LTP5<XLEKV[
MO6KBYOQ0)]O?C^: W8.OM^V=-^ &N$W:"X.\D!%Q#6Q$2\(0"P'^%Q41WI?N
MR9>K&^<%-+,!9<YQH1%=3L\,?:_D2*8V-G00!]2JYT78:6IF,VB_NS@>+Y):
M3WUC>1T>':RS\4F_WG+MC>?WCO(C6Q!HE'18)]<+'!5/"TX%[L[6@% GR_9C
M'^+;X0B59SZ!RMYH?'PE4O[9\,WK'UYWF 2V.'FN]_2 RA5_R1M1/7^;O7@
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M ',P,LL9D55&Q95]3MHMTV>PH.]>,=TNZ!^_H!L%5@RHO](>498,XC029%+
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MNH" VQU)@*5"JY2+(SM00,632=R$P!RO!>0.!,03$!"-'6/!1T0#3B @28&
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ML A+;0H]&!RQ*;\PYTCIA*2U8 H)Q9 F6(&'Z+G'EAEB?6T*U8BT%GU; 9'
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M,&%L&\\$$MDS/GAY>^O"P>M/-%B;A*"(6,+!^M4!6>L(BE93KC61P;*-+;G
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M<=S&VXW7UP!8 ^"Z]'P5  S):)8X3=P83HQW*05CHK4&+ AFW6T4.*P!\'X
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MOMRC'M9,G@Z.P,<Y.O*BT8[EYK[]]H-U3)XHV6#=R'NB;7QR==PO'A+\D8,
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M$1E5/QS5=!W6K_R__Z4I4:][N6YCN=&UW)'Y&6A+=5(^9S:K:LC=IF#6L)+
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M(2B_MJGI4M?R[N@?U-*TBM)$=[8. GB9U'./K% $G 2ID#'*(B:)TTE1D#2
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MTF,PWT-_?#UK:!FQGVRC!&,,MU2Y-\8O:\'/#ZM[QM^50P7#T(6!C*@/QK6
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M5)<ZC5'#0-N$D@#]X,0[!)PIHJ"M8%0Y80)=VVQW+GBJM_BB])^ZZ()#&*I
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M O=^@#OCH:-U5/*34CG"& CPF(B1DA/KA-,^9"]* :VJK;O<P+V[_D\%[ER
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MB2IZ CH+XK*4Q(>L3.(6&=:NH@7>MK3)+8YPW5?%_L7K^IO129!9:JF5"EQ
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M2ZW!5^ N.7 --3B6FB9C&&0T#KEF6AHJ0!MK7<T\>""8SIP"B $T98Q8\)Z
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M43H:#&/" 2!"O#2:<J, )&0?JX+'XK%==VKM\5AJW( DS"+E 0?TR472A/'
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MB9PRL886]75+B0/E2>8Z@@HX/EJN;0!?YY4E*TM6EJRASM5AR=D,::3!+(N
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M.\20,YJ=1U,6/;D#80 S#:(3%QS!@'> ;F56@EB!7!0Q?,TA%>[>!,P>4XX
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M"B@&_;.$?H7@"#.7I)TG2W["@X$P2 %!$=%$'2A0/^N'D?(&4Z&5#S17_*J
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MZOX$/FZ=Z5P@#VH8%WV>]$Y(P [:JW"@P@_/ZGMO>\=94F2#.Z_#YBTP!Y;
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M3K!K+!R#8]P/6%L <3">D,\&+9G?APE\M#UY:PK7,Q4XYQB58S:9%S&$NOP
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MIKP!-/-U>?NUGV#,<"^\XUV'S_0KF?9,$[P&4VM\%SS("&Z6%W9DF9SP04
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MCC*Q>%X?M'+GD<#<?TD LD'JGO6+'OJU!0/EC)T65__;E'>+/S_FV><*_HK
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M ]N5A7T_FD  T"+G^?^_F[TR=?\I=H)SO<6-=<ON-%#]K=[(P6KP U9V2NL
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MES:SN;DSN &!Q9$)#6*O(L@8), L0U%D>AIW;BWH>(KW &%>T8!.?5!"0QV
M^FD>Y[I/P2BD. /!LUN5?'3@YH69R"[2+A&#6J^?:JH[LA480(*"A=KU5!O8
MICDRZP\!0'.@R\CBQD0SC9%VPYK$R]1OA6W:FN7I*?.[#("E2N"Z[M2!LT\M
M?:0OSM!RK9'7SK _&;RF]^SS>0EL&\^5_R+3V7/E(PPQ)26("WN\-K+ZC[?<
M+O6ZSQXI+Y,,U.8"'DY3KE(]WG198[8C7$[?GN;BFU$;HX24WZSGJW@ X#:)
M(=A@^G@%:HSZ"/JT.*M%M;Y%WS1G@(^#[P'Z.%^!)E=Q2)4D2\=#N'X*YB?
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M*5-^!K\CZYH%$G\(;G(4H\THY2%5 FTL""4OD*08"CYPICC_+)R$ORN[DIX
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MLM%GI%N,(.>!VF:KD=HO&*E]M^[;O^4EM1D$^@H:*)ZG%+\J:*L\/(6:"?>
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M4PW?RY\U9%"M"_*F>?!;>#J=Q?RE>V[2%CK1TSM8HLD]U>&JE>L9K%$Z/BW
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M=FDXKQ*0N<SYN_ GV4W#^=M_?G&NYK#*0![)5U] *C/X"S_A.K]&63AQ7HM
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M3,3,^>C/G,\BS38B_C@A_H,5IQEUDDAOPIDV&PI]AI!VI;?#"/:9.MK(!CU
M;,D"XU!,P F!'X)I((>O,##\:0QS_-U7!_-LX@>P-1_]*.,3/LV2N>SJ(-MJ
MP8]@,M@,"<>X\4T;+06A#L?@<$09K)I8%XTBV5RN8%&LVIQ%2P)W1*ZLL!WR
MU%YF4F@#HK&!55"V]0HS)):HV$\V.7@:Z=)Y+&\TL;DR/ "MJA3,KJUZR4DX
M'LR'F1^_*7L[@=F'W; BU>)F),8BP>\67@!1X;> $_UD43AOA#^B3C-J1K'N
M7J1> TJ,!'(52=C""##I+T(>1R U9$<N/O7I3_YT]M-K9-3_">S. E,<P5.2
M-5^=?WI]+IOU(7\^;[EMW=UJK5!H?6*X*DZ6 #?X;,RK+54=[G2/F^>>YW;U
MA_ @]?G%,;9!PP9<Q09:[^,A-E&[-K\D?2*I,\"9T0RD/8M788R:RE>.([Z
MCJ2(XI$H.%@E_;->Y:!R&ZGU#^&/(S',U!3HM$ESA2$]D$J5K\98V(JNVUFV
M%0OS:<C]',;1/%6SD*U P2;4[$#;3XW9T'9)?#@:[Z]]]L:LHQ$W;Y%3:*EE
MF^38)CFU:(YAYVKG:N=JYVJ;Y)0N'@^T[8MMDF.;Y%AX?-MZP[;>J!$5;9,<
M*ZE64O>!BK9)SF'MIVV[8*ECFU+8)CEU(8R5.$L=JX]LDYS[+]@VR7D\@(+#
M@K9M=P:'#FQK&?D8&+G5ZEA&MHR\_XSLU;./RHXK.P\%:AS3S>NWN8=2E6DU
MY%%HR$;3.SMT'6E9^1A8^:S7JN-Y8!G9,O*6.AD,FP/O]73$5FL]C]N=6ZW[
M<.O_L&UPC@25]D# 9\^\=6*[(X#9=;:"9;-]8K,3SW.]%Y;%+(L]VOH&K758
M?#5CL]4WY>NG6.O=^.&'[TB_L *XCP+8:J_M+U(S";1\MH]\YG7/W)[ELYWO
MPZ'S6;_G=O>*S:JB3P>&:=LY6Q="/&ADVB/(.+3],A[)./O.V+L%@[9(Y8\6
M'>JZS:7!(<N7%J1\SV9I9;SR +*M,NH@Z)8Y*R^OM^V_:)GS>/7[CEME$(@_
MCW"*[AM!*E8TSWAH!MD04_>''SZ*!&OW_&OA1''F3(4?P5S'\\DF")+U;@12
M0.>L32L0$W87P5L1[M+3\*WX]>>>UW0')J)KJ5U(&0J]U%UB :";X'H[,"2-
MWND4X6(5N'?EX(MHZ*7'OQ\0O81#G&.-1UGBYXM6P.'%7=6 ^OAX"(_1!L%?
M4 U+R%S\O.)QB:Q=0A^'GX[":X1]=:;^=!I?)_[LYLY)[]),3!E/O32KU)G/
M&+8X3#3J.4[OUD\2/\KN--PN_E#!!>-#BR-I$.)?_M^%<SGUKY&C3*#D"L#U
M%)F18()UDYLC@.?=SZX+ZSA^:?\%)?8$\UT4NP?LR=#MR4X,8*K<W(\:G:[;
MD?T7VMC@X1'[+U2JD#7ME:H(N-"29PGF=G #E!(+B.<EU/$0:!$0&#=HC-D,
M3_OYC$4?Y3@A3E--%N"=L1\FSE=_POIS-D_@,PC#'1#2NX;=AO>O0#! P$Q]
ML$D'A"+E#5XT-#%/&G7@';VD>R&!\([$- P4&#L,-9]D+"T*(WQ4[)S@!S0+
M'&;J_R].PDQWL"HTKVHH6'1N)4&K%--9G/A F+$?A!-\,[V99Z>C^%9"W /Y
MYMA. E3$')[)Y@FN:I[!P[_GJ/NF4)?[6;B.58[[VSPA?W0:IBEU/B U:30,
M(5[$UU<W6L!^!L_[;E/+L13ODCAK@006KNZ"5B+9;W-0'M@>9,.F"ALT:*@Z
M]<%F0$G$)VFD+;H'5*#^-TJ0_XSRWP ?@"8#L@H_&0F0QO@V9QO:HZHN!H69
MKNZ) &>R/TFQ<QJK%F4\K5%;LBL$F4>*3\S.>6#S 2/@8*;UI/86E&L">R@)
MZ]S$DQ&ZA,O-IJ/LQ79F>['58RZ/WHO-\..]LUT[\C3BYHTW_O:?7YRK.<P_
M\)<'*IX@RO(D+3E@UK8#QUXA[]NYVKG:N=JYV@X<I?O, ^TI83MPV X<%GO;
MXOI;7/\:4=%VX+"2:B5U'ZAH.W <UGY:3'=+'8MX;SMPU(4P5N(L=:P^LATX
M[K]@VX'CP1 '#ATYL]5W!_4#5WS(V@K+R,? R%UO':2&Y6/+Q_7GXW[O.^L%
M:\_']R@7/1@DX\[W5H,>)I2QU9!60V[>-*[7.W2P=\O(Q\#(K7[7^EZ6D?>?
MD0=-MWW8?'S$-FN[Y?;KM[D[-UFWC@^/Z9]]B@]OVI9CV5*/!93V =9?:\;W
MUB*C?C\%'EN_EZ1O8SO%LO)!L?))J^UV-L>#M&QLV;B.;-SQUL'4[STK;S/&
MD?4VL6K!JH7*A?>:6]^![IM:L*Q\'*S<;FW=\].RLF7E.K)RZ^S@M?)&X=&'
M8>O:;>_98&OT\:?8WOT+D.Y? JUM*/-(63*VH4PM(-,M<U9$$!$\UG:4V2UC
M'C.6OQ7R)SB!UO9GM()N3Z!=,>?VP7_+G,>KWVU'F558IP?=4<:$G:U-0YDU
MS0_2<J>#%5CXQD8,:KT1A]?KX^'[>O1:V(H#U]># ^Z/VRR_W&#(I$:[Y_9E
MKX^!VWJ<7A_&*E:R>ZD)16F%A887LGM008(UKR0B ,&0"YPEXI1:83@3V!.)
M%U]L\E'9+<.)%[E!D?-P^FBLW[ *]IU'8_\KS U/0;6,:?BMLG&5E(<03I#H
M.L0W_!2'\:<Q#"SG*=D^!_\_#V ?_4*7E$VT' %X[X.:JTO7#BE]DWDJNX<!
M<TK:ZREBKYRVVR_W-'-[ZB=E]6*(,W:UP"E1WX84I@!B@^^/4!3C&6ETV4P#
M9$#R2E7_#-5J0_<.*7;.:&S3?V1U3Q&3:Q=:E)0/9Q+V9;V&KGTFZ'//; FW
MMIM&J7F)T5O('R%#(]%817"3M&L<!@D2CH1L7E8:XK[2M&]M!*Z^B(E S [N
M)K>P1MLNP+8+,']G(<WM7.U<[5QMNP#;+L"V"W@B:MEV >6P\\$@!%H0<@M"
M7A<JVG8!5E*MI.X#%6V[@,/:3PM ;:ECX;EMNX"Z$,9*G*6.U4>V7<#]%VS;
M!3Q>,>MA(?VU+&*EY>,#X&.O:R&$+1\? !\WZPC.N>-2H$-!7NTW;;, VRS
M*LCODJ'VH4-36SX^!C[NM2P?6S[>?S[VO*UQW?:,CX_88/7Z=?1&=FZPVE8!
M:Y=JL0X/ ^OPI.GV+;RZY>(]Y^*^;1)@N7C?N;BWM3&V;YR\D:E]H+"S@WIB
MO>_<V+9*TBK)+1;>K"5XL^5DR\E;&ZT=]\P:K9:+]YN+.UOGE^T;)V\SQGVS
M96NWK:6^5D>0+6M[ SQ2 \=M HP6]W:W%UM'Q)>=,\N8NV;,8P9DMD)>QV"!
ME7/+FT]V9V7/'WO^V(8 MB' \L65 &1KU1,@()@4VQ%@WSL"5$#[8P=4QN!O
MMUWOP:#]6^Z9'-7;!;*_7'<!#[^(?9\6$>++Z/15U.?I'B@8_*U(!"-YIQES
M]J/S\W)*RLEV6FZ?CJ28D<-?$K8X,$6.%HU(IL:+TEIJYJ_XPQ2V/UO^2A7H
M]2[VI#,HDL/\]TVB9C.#H^]T")+PY=0?PV1?^I-;_RY]]F.1$X$-2S0L+W_I
M(L?C!UED%4HZL_]( '\05OQ+L&Y$@D_!G/S:S,4!7A__]=D?0N_,&PW:S: _
M/.MVNH/NH-\77G\T/!N/SCIBV/EO_]G/GPD?'73+!7P0T?'_\J/_<]5.'@C.
M_7LQHH8GYR(%:0;?(5TJQ19.OA*:>9]@I.U<[5SM7.U<#PA.?KTY9O'D+9[\
ML>#)/XPT'"*&G(6IMC#5=:&B!92WDFHE=1^HN*> \M8,L!C%ECH6P;DVI+.(
M\E;B+'6L/JH+Z2RB_'V2%RT@W%X#POWI#V<MK_53_6##'C+WTK*R967+RI:5
M+2O7B97O44]R*$B=M=W?0ZD)L6K2JLD#49.6E8^!E7M="S!O^7C_^?@$&?F^
MA;"UY^$C-EE/*-&^5CN[<V/UJ)#EW\7IYC%B"PMW4+!P]S.T]PT:SG+S<7#S
MB;?-06:YV')Q';EX^TY.^\;)&UG;!XHOOZVY;<'EK8:T&M):K9:;#Y6;3[J=
M;2)KEHTM&]>1C9&+#UPC6[NU7FIJYW;K$>02%^/$%FV_-OD-%ES6@A[71=E;
MSGP,SCQFV&,KY?84JA>U["GTY*?06=MMV4/('D*UQ]ZO-SK](NRK A4G4.A8
M>W@3]/!&XBEAT0V@>B M3##,Y@EA\N*/*F:NT-OCR'DM C$=BL1I-QM.J^D-
M&O32.$Q2V%__3J&&IR* >3B_S?TD@Z?AI^,PQ6$1*8<1RDLT@'D:CR!^^60^
M0IA\Q&S/_.@Z1-[QTU1(+'+QVSR<,:H\T"%,Z(_!#7 (;"-\\'F[Z;8<V-M)
M&$>+V-G,%S\3?,\B)&\X^NNS]7C&GM=]5L&E.V@ 40T^_.[RG[]>OK[\_!_G
M_)?7SL7YQ\O/Y^^<3V^N/OSZZ>+-U2;([+U:B]EYYB .$YM3K1ZR9,MK.+?"
MN?%'SG.O 1SJMA43(%?<QLD7Y+G GR&&,TLC,&S@IS?T%_H#\M97?X+XU" J
M\!PPXO.S5M_M:89R/JQ\:^A/_"@01L>#X1U,J-7+AP!!3' JN0#E0IX61<9;
MA.RG+UZ+"(4(1J?V!;E(^=@,(,Q"D38<4!)9Z$\F*)QC$!^<";T]EQH'X?Q3
M?@V6,@XCF'EQD(U _.O-*I?11H1N$#=4$1([(7P-4241\5##>(VS7M=MJ@UM
M+.Y2)#+5%8-?Z'::[B!_(8JC4QI.*2[LG3$2LT0$(>&LTY;XTQBV\'?Y@^OK
M1%SS[)ZWS@:NEP^79G'PY71(_(;'@XA2?DGV+:!)=#USRC0^?'*8P4,XZ#Q,
M;TB7DEK&%UI>SK35[.3K(PSY:23&(DF(MVCEF?]-JN1.QY#&RM8IA:7"*PNZ
MWW4ND%YZ,^#K<K?B**7N%A%1!UMAT,D09/R43YO!>S?/QI/XEK>DG1.0I8B[
MM]")5.*%_/"9A/XPG+!LT&FV,':IST8"$XIX&J!(W([^I-FH(^^KL:YUR>O0
MOX[BE([G_"UX+IW/9D!!HN75^:>KTXOX7Z<MG#H<SB,QI>V&_\NV'L10V,UB
M,J$X<_$KK_!/F>JP4QK=?'#J3Z?Q=>+/;NZ<]"[-Q!3T3I$I_"!(YK 3NH,&
M<9:A41?7///OIJ1,42C& DQ)$-("3^%*0./.Q2G8DF@)^=_T6TLXM;A"-:N"
ML)!U,9U-XCLPOH:@8L<A#E=Z%604S(X*)F\ADS.=*U_0%*"S)\.&*I*SZ.W6
M*A$I#9F)X"8"!7I-K#X1N'!>0P#,P5_ O<K"*3(PC%^F%B@: 8<6R!<S,HQK
MLK%L=+)>YH&0"):3&@.R>'F>V]U@B_DU=9 %<'8 41,X?6_\C [S">I'=:RF
M_-C%AW]=OC[U!I*]N7V-%%M30N"\"E.UL[ JH\6/LH^SFS!98J]Z"Y;V&#X
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M&.LWAA\UKOH0';-1N)+4J"Y-3FX8YG"@Y,<9L1\3<I6C/IRG@(.2M'$HVY?
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M6 .!N&HSK,A86V&\MX+3JIW@?# ZWPT8)H(EXU5,+:G'SFM@4PE5P8Q'0*_
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M^74B*(??X>:?#.&CT-N'=_3:4&2W0D3.FTF8^O"7&^?D'?SIA?-W^3EZZN]
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MA/UQ&(_NX#\WV73R\_\'4$L#!!0    ( *R!_%)NE.V4X!8  ) % 0 1
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M 4<89R/D+FYL^KJWZQ++D8-VWNU>5)C50*HFQ+8(JL_()="CDU0C%,')XY3
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M*+.MLH\=90A_7.7%)]U<L/A+].FG_P)02P,$%     @ K('\4CADM:+!)
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MI]_F2,!L@9Q/E^&]57#QU>P"::=AP&L^.;R#!'#LT7.=V"2!48.\9RIQ*4+
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M5WL=/226V)=82W@_X.+O-Z.'J_\'&M%/X\D?,,F#$%#SQ!U3-I(G8;-@0>1
M\X#$A.13",@M*+4ESA=/II9Z>4@CN2^-/IX#D?W-='J%>6!M\E9HR5 $(&]3
M119M*2P&RPTX]!9,D[W]#HC#$Z"IQL8]B;O!"O)PE ,>@K8\1I:BTTQG<"QF
M5,PH!URG9,G^;&/<=5OC)TN#_43?8AVHB!:\_.%J0MO@>YP,QWG!U_DOWWVJ
M\I_^^"?Y_\,IT=>$8HK3EEFC#=,1) G 2.:R,MXZ6;C1S<BR%=0O@$SM5/>0
M;*H1V?X!%U?8#=AG4,4AL$A6%1E;W),5[Y"I@CD!*E2AB4&\-=(ODFH]*>XA
MT_2N3*N!H,'K<QB=D3S>PV2.<! 0(W><>%Z49UI%9"%S8,GHZ&-. L63 :7.
M)Y^FUO<7XD.-FOVC-M/99)CFD2\:\%V#ZA><O2N+']"P?X4__SF<G5>)$%&G
M ZU+G>3(,%DRZHWQ++B0F OT&_H.C&X4M-D-\&ERZJ!J?$@_VS/]%BO?*OA5
MS"';Y+S1S*LJJ&*! 5K/2$P6$LADG#H ]38"^T71KG_U/:2<:VJ:_WCYZ6+\
M&1>[[_NK23HG";Z_@-%T@,[JY(%8P6EYUC(&!M'3_JM!!:FR M7&F]\-[VD3
M[Q!*?,@]W])27XMZP*6R7F!F,CA:HXL(%6]F/#L33"'/H\UZMQ/:+Y)W/2KP
M(>O"OJQ[E?_[:CJ;'VK^.GZ5\UP?</$>AOG-Z#5\&L[@8CYS:E)'?CV^_(2C
MZ3PJ_P%)>M/A##_BY/=APL5H/V :GRVTNK!AHPO<&*<9#50SK:UBH93"E(G6
M:^3<M[$%6P_LM+E\5+3H",CN?UB(]=1I?(EOQ]/IP'!5O$Z6*><$TQX< TF0
M8A"QQ*R$+*G)(>!=%*?-J-T%WJ'^O0/RB^-KHNT$SVL.T.]X"VYIF [(WI20
M>6+65/<[\\"\C*+^X83AX#3QL $K-@%WVF3I73T='-H[CO]K%</5Y/,=K_I5
M(C%,D 8?,20DKUD&C[2\"61@1&3HE'1&)>54DX#](YA.FS%]*:.#*'O'X.]A
MFV]_2VC+2-_/.#L?YWHP9;E0G)6B,@'UDD4@W"(4C?2K*-LL.)L"_((HU)>:
M.OBT7Z3]U_&LVF&?KVVS7\:CUP\3:@;<V^!<DBQ%&QFY$&1>1>F8@UQ4M%9$
M7#W$Z0Z_;_2ZT^1%(W%W,&+G2/T<XM*=?%>ZT9'M?0'3Z; ,,9,Q__[-ZT&P
M+KND2!+>D-.9LF*>DTP,F=TRZ0A*Q8WHL?V[3Y@KC17109R]8^RO4L(+G,RS
MF^NF^0$_+8,3D_'9!"YO'<&!<5PE3^"XR;3L*1<9$'@F8DX8P,1<NM/;]_7D
M-\=XFN1JK:P.8NT?2;^;?:5XLC$*P[)TBFGA+3EZH%G1SA4 )7E976X:)[OU
MDL)EH![)JDBOMR1C6N99(*>$&05"29U0ZO(<*5S]I4[?<]KG3EGW)Z>W2>,#
M*1.0L:U8!EGW0O0,L-X%$]%XC%+I) Z94+W#&$Y[&7DN97>DTNT<QIOOMP1X
M. <\@,*M(*N<>1UH)G)T#'C6#*P*!FVQQ:QF7'?;,S>//$T*["&V#NWM'(6;
MP[BSFTWK.CVYV<W@;(+S-/%!4$#[AC2$37NRD80GJ#:Q8J/C!JP7836,TJW7
M#5YVPAKO6]0=7-@[FG;K8_T\'(TG-/3Y[GTMC $9P]Q$)9@%389R+H:!28HI
M+&!U-#S8)B;$X[!.DS,-5-+!F'Y26^\-G(1S<5432=Z/)W,US&:38;R:U:UJ
M[KMW[&8#830*)P/C,9"$N,C,)U$8!&D+IWTM^R9G/_W ?_&7>)Y!BTW2K*^%
M\NO<+%)*H*DWU)RK$4*#@84</"O>D">6T*&%-IRZ"Z-';MRIOG  1NPLRZZK
M.]\L[M+_-5V,IYC_]NUL<H6W/R0JX9^S'R_F+_S;MU,\>V@+[.C]/G3/_QS6
MDT\I?-U=LZF;K<F1Q8) CKGE-M&"7'23&/]Z2#W2Y)&"&(_09@<]=]WUVE_>
M+6Y^=2+[8;[4;H1ML%*FHSTG?KA3#*.?C65=R9$.3O2DR(WXL8<6#LV4I&@N
M*)#U+GV]VR$,BYH\[FR"<E+EE$V3H,KA&7*OR,MQ$&0;X?=(C+GKU@WLY[F-
M-@#O=,I@6/7=F(9"GKPSG@D-D)Q"L'&5%=WN\6-O>08+LS=EC%M(LD'IBINM
M<&$!U\R7\:BZ7G-BHP:OJGNEHJ A"XDL)@_,>V]*X*E F[2 1U&=@M70F]0;
MW!)>P73-_DU M;08.E$]DZG0G_;&K43?P$SH!B>3L-P)R82A14Q+H5A0-K!<
MZAFRU[2.-:DF<$ ^/&48')@.VTB\ 0T(SN5X$?N[WL*4D1H#TG8H09'+C63^
M"!U9\M9(2-G*-O>V'R YO,'0@X;&?8JW@86P)@?_&EP(R?/B$^.Q7OTVH)F7
MVC%IO)%%A:1UD^G_**I3X$%_8F^P!GS &8T/\X\P&=7;D]>HO'+<&#*)0K:"
M;-DD&5@>&!(VC25(B$T"VMUP3H$%/0BZ@87X*J6KRZN+>JJW+E_^&JB4Q6:?
M$D.3ZDE-YK2*.<TP*O21_./4II#DQ@A/@21MU-'@K.)>GO/2_]6 VA7)5-:)
M:86)A50=,HTN.93*EO:9YZ?#A7U%W&-YEMN=[.9&WT_CR2_X!_&U5NVLYVR3
M\8B^3(O:MG-[.125,$-FRF=D.F3%HM663!Z>!9<"BFW"AZU0GD (HIU66BP<
M]+EWY54>SRL/+6V@#3"UC$AT@7J>@$1#7:XN+WTIHH%1VHE->7*3DK0T,8!V
MO! $\SS52WM&"^\0037Q30]'CB>B$\_,C6WDWX 3MX.EI7.489*GOWVJ)=4E
M%YZ+)<@2B)VHF#>1/&PO"X.H##-<I")$A)R;E,W="-WAK9+]%?G00.U9"VOC
M'/_^W8J8WM*W.S8M^("_X^@*EW6AK[_]H;ID%]/[2#;K4_#X _=O3; %X)5N
M!*ZXC !%9AFUU2IH.2^3@-Z8DK(://[H_2;I#\,IG)U-\&Q>QN%=N7[XVYN<
M'F63<S9(HH(E@QBB8^!U9%$'67A"3+E)D.DI8/N'4>;/HP$&,OCKV$JM6J^]
MT@RRLHR3*CQH<LQ<:!,X60 X_!K3J\X?1DUVD&N#T.F:02Z,]UI9$30/+ DI
M:4$UDI8[JY@R1H/@1=C<)#3R&*A#Y>TUU7YO4C^:G+ZEU[=<?3\NGKLPV6(J
MZ+PC>D<5F):>G$!-VR:9;3%RT-JW<9@?1?5<#G)_NE]W8K^W#EHD<"VP7(>/
M-@'3-+?O+IIG/J'?7UNK/-A;U,WU+^8VFQ:,E]JS!'5FT:O,G!:.3.E@H+0I
M"=E>[YN>Q#=6^S82[CLM[X<AG(W&T]DP+0^##"07:\9[!E'#Q3DQ\LXTL[XV
MD PE*%A-^>_.Q7OPZ&=(P-M=SN/>A-2C)3A'\WV-R<_^$^%B=GX-)\D4A9'(
MK'/D0Y-5PP -9UA0!N]-5GZS_,F'SWZQ2MM33'U/M+]_'GV\FI!_?7/HKE+B
M?M%0H=9:\4 <BBB8DV0]R"*<-:L%);N5]N#1+U9G^PFIQZ/I.9J?,5<DKW Z
M.\>[D]_$4&H7+U"REDW2@8%VA>GDA2XZ)>\WN\R[Y@4O5GU]"*S'XYY%MO2_
M\ )G<'%O(;!"82'VL&1KQ3UI@04?->-8BH=0#ZXW:^K0]?07J[Z]1=7C:>]T
M,AN\GXSS59J]FUQ78%T<*1BC$#PPFX$6A(*%^1@X\UEA-+YF'FQ2O(>>?\<4
MI>]6S=!U $[&%>U%PCTNN7?P3%^-\C6BZ36I-P&UA1>ZC?H?HCFL%]J/HAYJ
MO2<I]V@H/0XNRP0R6K+>=*TSEL#12N0]LX$'F<'PM-&QVC&J?HTC>D#-;R/<
MODWCUY]G]>CI<ZVP/8+;K%2>@RJTF]7C8D4;60)&GC6RJ)24A38RYU=#D6M:
M+W6_X' ;=8^R'_<LN+Z]TY])'.GJ B8/G69)FU3UCUG$:LM##<"#E0R!5)9D
MK42ZF=6U_ATO7J4]B:_O*?K]Q7B</Z8)8LT;7KK327AB$S#N"@$B6 0-$RLZ
MTV"54"6LYF>OB3IT//W%:W)OD?7MSBX"(F\NX>P63RG!2@R9\&"L'43)NE>%
M,Q>X#%X%9=3J2?%C@:-[#W_Y&MQ38'V[LO,:,63U+^YQ+-!]'%]<S=LG7N/+
MWCNP2; ,M1]!C+Z>=')FE 2AK.=";A:]W>!E+U[!?0NT9__WYOSA[UBO>'\Z
MGP=7YA4"E'7>DW=?6\8S+41@P9G"M,^F*)M,$IL4[-S(%%Z+XJ0\X7YDW>.,
MGX-:Q'7N0EJ6^M@ 5-_N\%HTAW>'>]+6N)6H>_:)'P'''1=H')-!!W($2V)0
M;"*;T*I,ZU2.8I-,KV/4_R,^\4'5OX6$>U3[/,-U\GGPV\>!EUHZ2S8&&EU+
MTV;R &2]?B,X3R4GET)'R9SI4LQ33'\Y&__^W?43%WJ^_F95S;=O/>S>WI/X
MQWO)KF]/>&Y=C&!A7%Q;$YBX3;E:_;QN3]*$6L6RUJVU'IRS$#8\\^MX^$M6
M62\"6SO]&F1QWQUW;YG<CSRTMVSN38&O9'07K:-4 %FYI&52080@G2C6"@\8
M;C*Z'WE\XZQNFN7<<,\9@3.+2HV^J,@2D4\#V7[>-;F:<["L[APQB"*1<4V^
M#OT_LQ!49H8\$&^4JE7\O["L[FUTOC:K>QNY'CJK6T3GE<O A*ZGK[771-11
MTQJH(B]:YLP/2>KCRNK>1_N]2?VYL[H?MX=YXCP+)8C;R9$5K 4#@X[98 *J
M[&/TFU0;/\% P58ZWBA0L(VL#^8@;@+JBPP4;*6MC3S%741],![XF- 2"B:$
MIDU.Y$C@>*UH;71!ZZR2FQ@/QZC_G0(%_:M_&PFW"11(4SCY5H[E5&^\6@ZU
M"PKMAQH4>"=<BAV]6D\D4+"5^!\&"K:178]&8!W3CU>3\:=E21VR9++5!1@W
MM0^1R9QY-+6?=*[&CA#D!O<U3^^^^"6K<2\A]KP"OYH.X3VD81FFY8FA42(I
M5,QFK#40>&3>.F06BE8ZV!)3;R;8@[>_=+7N)\Z^3] _X'0V+O\<DQV_1$,.
M8D;"H%RP3 -I)(;DF> F)N&\?]@YKSN>]^#1+UES/0AK[4E:@UC>]5_Q<ZU4
ML7\4K_-QO<7OG@:[$KG3/-I8G#3<@@X1O?")*Q4T1ZUH+@T>>W#CF%TL*7"%
MDDF?3*T/DUD$K!T^(SB=)8J-UL;CC=E%[F/P!AD'56NED:OI7>WK$]""R1%-
M;')Y\HAC=MOH?&W,;ANY'CIFI[U2-.,\J_D&3-=M*M#<8]:5;(K1CO[WQ<;L
M]M%^;U(_AIA=9UXW<)M02L.2]$"TAGJG&,@K%85G'03PTIOU_V(NMVREV:<N
MMVPCX8/=;-@$U)=VN64K16UTQ6$7*1^, JE>&2=,S+G:#2:ER$*B_<UK&55M
M;JN@[YE_K)=;^M?\-L+M_7++>#2]FO>87F:4NA23U=DP1%=3&LB \=%[AB5G
M5[0C+VBSG.L'CSZ6A-RMY#WN35A])_!<U\BO594_U>W^MA4'T)#'9?8'3&Y*
M86NR:Z*NMVQKWZ604NWFY!B9,\17QZV*J_-WC5(W?^G+5W<C 3>IB3,?\A(,
M^1_&T#B]\8J6J$(&K B"95E >:--S&W:HMY%\9+5O[]8^X[MS4O=U]#'>&E]
M+E>@C&K>$:/4*P8Z^,BBRK0=2:<\%ZHDM7IRUCVSU[WA)>NQ/]$=-N!7!UQ+
M%N.DC">7,$KX+EX,%^Y''Q' 39[?8TAPZ^&LUFM-4<7,0<E:M\K(&+A6OF1R
MST4(.0RV>E/CH&$1!@OZ3%9AW0E4-+4*)Y'5.FN4(\KR)BU$#Q0T?%S&],-$
M&R2<X2 J6X)3@H%SFFEC'7T%A14RFV,IV3G1)'BZ)<XC#$%NPZ U(<@F6FH0
MJ=P([H]_?L(TP_SK\)(^\JY\I)]."Z3KH0S'60SJ"0T6%YFMQZG:^<)"K#?B
M0H@A^&0Y/!_;-AC ETC#OO7:P*Y^/$</O4^UH9#/@IP_+Y#%8"/CVG$7I>;&
M-LEX?A&1]'W8TYO4GSN2WMMT^#B#R>P'F"U"4,9:A5HCJY%GICG)U@N:&4X(
MX,&E>O!]E(O=O6$<931_*W;UO>CMKN5#WBW:R,H>B-8.RD <V$59'=**DR*#
M0V,S@(SSZKI11EN<D4XFHX416SDI]*ZO;LI7-^6KF_+533F.G?NKF_+53?GJ
MIKP(-Z5/D^\G&$[^ 1<U9%X;K2YZY]W\\-5TBO/#L+=#B,,+>ED]&)U_,(]'
M'S!=328T9;Z'Z7"Z,&QV,0I[Q["_V=A6+*MWVPW9E(8[Y66H9TP^!*A_&E "
M4DB#WM'LMQC=O/E[N*@KZ<=SQ-G?)^.K3_2:GX8C^MD0+F[N/KV&>>.]Z>V<
MS!8*:I6)!I#KU#$LT#;/DE(@I8XFMMDD]P6^=_O&N:9N4-#R4B<_Z>E5G,XF
MM.$,O%0";8BL>%]K+-)"!9',("UD*C'+['R3EO-/(CN\77!0ECUH\=BKIAH8
MK&]&O^.R#^I#E(.BA'%&!):R)7.Z &<!0V)1F1P#5S+*)BU 'X=U>!+UK,=Q
M,R4TL!GO; >/"<#5\H4Q):;"'&4F'TQYSB3]F5/F8%23)6<S>%_8NM- 9PV8
M]7H\[WX[SY@:38?TT+F!_/H"IM-A&6)^-:TY5;//7;-"6"VM*ZY>B23LU8(.
M)6BFC":Y@54:FI04V0?TX5G8@@CC9])B P;>0.JP>=^MV+RWCOYT$*W J%-A
M)<Z]P2*9ES1+?4@V2!N IFQ3RW,[O"?)NT/HKL?LO(?[PN>NG6$1%,A>29H8
MD@GAD6D=.?/%*Y8T1X,ZN(>-T'KV;-:#.U1(YEDWT-ZU="PGS'<&=O/E?PYI
MS9ZD\\]O\7=<U!51A%\50S9G0<%TSH5!,#1/06K#G?1RHR8E^Q#P$7C/=2+<
M/RO6TZXO[;3<-3OC2#=XK_-Q-P';LO'N5FB?IS%O"[6O8U8SG3T_T;CE23JD
MC;W42#I/+( CY$*I7*LINS8GU4= L"<Z !\?O[9054M>O1E]NII-YQ(0R\L;
MP<5Z'XL%CF0U1&]9$ &8*4E:KHU3:I.>!+NSZ"&F9PQ>]*_-=;S94Q4-8J-=
MT.02&MIH(44F$M"0K1#,)\69G:?V2"?(?SD42^27R9)=5'&@M40M"WA%B<(6
MQ;Q)BH9,5B"@D2SSZ&GL6J'<I*U!+RQ17R9+=E%%"Z]_Z:^^&4W)S:LR6%P2
M%UR*HFHY_]J'B=8[!M(FEF.D7PF-8:,Z>=LSI!O/Z3I6/<B_ 2U^G<!H6G!R
M>XUQGCG4@79:+R9.NW^U+ RQP5A:.EI]#N:9_+ ^6#(^,A4WV/-Z'5,I4BB$
MQ*SAM?RY-;0RTXION#!&@"JB-#DX/'ZZ/N75'3M;M]%L"\ML/,'AV>C'/],Y
MC,[PW3P^?&T.!.F5AB@8UN-TG= 3- _,<:7(0LB9MR'=(Y@.;YD]G[)7=^>>
M--5[Y93NH\UK9 :R3B84<CR*8QK(N(R0D7DP--VRTV3)/I6S^/1KOD!:]"S[
M!DO+O,433F<?8(8?_X!/2U<40JA]RQEIF"Q4J1,#QQWCY&* #R& :+*J=,/Y
M IG3HWY:.('WE[G*\'H*OESH<LS>2L>L-:'6 @TLV"09=]ZJ!+(8W22AY5%4
M7S"'^M-6C^U4E^#N>LEOZZ>K3N8-(6I8%+ED45A7"XUI1L3F+&O%;9:A.-VD
MI-,Z0"<;4>A% P=BQK*SRP;(6@8(UD-['G>_'Q5NP(L]Y-_ >'D$82U(RS4$
M,J9JI:M:(#\BN8X%;8%(VZ3338Y0#\V,)SSK0Q-C&[$WS/#^?+VW<9V5XRDP
M 9AHE (86%>CYO5&D7>6?+*6J=R?G\OVZ$M%:[*Q=Y'O6I>V^>V]5SG/GUOM
MJOEEU]NR [W=SGOL'8UNWVT\K)7;=0%!0]*V7M_5)>CH+#F9-I9H$QF7JON<
MZ[&W]73N^*Z4N[S],)S^:WJ;:GOGM6]O,B-U 6,M"@8^>Z9MH&7,UW/36BO/
MHJ?_MSV]WAYS+W?FWEQ^(@3S;-%SF)SA=)!D2!@\9\I&P72LE0,R36OPB2S
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M++ 6W1KO6<-S@N:8=(T^LL0UU.OS@47K)?,B2AJ\+1G:]&A\ .7DM_,]I=_
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MQ7OB4,JA2?Q]5\"'7R2/E>FKON=!*-"@:,<\]0_S]">2_ _#WY',\AD)\38
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M4]9DK^Z==K![^6,NV]L(S-V:,+F!<A?XBSDI;DG5B["DK;Z>1UQ)^F,)4HN
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M?8AHFB?][@/FNT[Z/DA:CV;_/H?5[9.^K93*E)I5DFNF)+<L1$M&ET0KLX-
M;N$+E?M12=_]B?T0#O>=B[HKUXM.+Z-JD]=D0F"ZANBBU9GE4%0 008W[MEE
M^TR3XP[A^3[)<8<P;)!V+;].ES#],*:;:E4265-X9K/\UW@RN;GM9F7S'ST_
M:>J8Y?J(N_1$[$: QAB3HI8\^V2U\SH"(J;"ZP0%B]Z,CEGXN%/ZY\HG_ =Y
MRGGS^W=FLC=*&$D^,3HDCRC4INU>.Z:LER4:IY1HXHON ^[8:^J1-7Z9UXX2
M:&, CHZ)5*,"2A060#F6 G*MLB1#K4D8ZRE@PY]]O>O*YH76JRP:Q&H>P7>5
MTO6GZPG4D:3WNDN,DE4ED%7/4K:./$P++-"6I_/=Z( 9,4 3S_QPJ-^7/O4A
MKZ;!GT>PKQS'C-%$%)*$7QOSU_RXJ#1GJ80"QCHM0I.Y7/M#'"K4TUR/&DGE
M7"(\CQ#UT]=_PG_-YJ\FL%CY*Y%;+D1,3($D^NI3>\QD^SH9G11).H5-7C,.
MP'CZZ$^_6K+_H7:4M!J<9H] O0-Z;];(/G!;!HD.Q'N:,%(S^>^O9[T)[PQT
M+OD@HG>.7.SN"8!,2A]<9$)YY;D)&M(^/<I?IJX]$;HZ5U4[1&:]]S? +SB9
M?<;\'M/':8T@?+VI3K5!A-K$F7->AP0 '>I112:AE.*=%99O5A+NZ'.P:XFS
M,M&/E\RL=[8V\/E^G;Z=SQ(N%G_@ NG+'Z^F>0VVVEZWC0"2,CDY5CS=ZKJD
MV@;.=G&[#.0U9 A-(B1[H;M,M6DGH+Z/C%?7B^7L$\[_P,DJY^3C^/.BYJ+,
M(2UOAV1*GKKN+UYZ45D@63"U(LV@1)VL37*_4/D^JUVF1K1A=H,FG^_GI'*5
MV-NP?['!)5UJ=\':E$(I%FT4S)K@1788=6[2#G83R&7J12]L;]"\\[=934[[
MC$N\^C#'U83&-3*'RJIH@26K-9%)! ,O@167C$TI* =-%&(WI,M6C9Y$T?>L
MTILGXW^,$YGLMWJKHS":;&JFBG),ZRP8%+*UI:MYU<+YI#8[+>[HSK3U^Y<I
MZKX8NK-CQ7,K#5:=A?/XEG!8$;XV7$(6S@8R?[ND5"LC@Z@=,X6L8E.*"P].
M@AT%!X^N<\$R[Y'!#V5OCY)]-[ME"I-K4L596?X%\YNZ)IUC##X#0U^'@;FN
M'PL0*LD-V. 1['Z]O'8N<<$2[X>M#X7MCG,#X/-X"9.:;KR!*JH -FFBK*B:
M Q@L\Z#K-* (7(D@C'\R<^+Q)2Y8V/VP]:&P??_)-/<>'=<U4I\^S_%CC<;=
M5"H\/W5F_X\?GRCS3$(VTF*BDBG$HDNHC82,"9P[[TSAQL0D;1SMO\R17?2?
M7J<.%[E[3%35;Q0<61)(QTA6H=H+=49ZK$7%G Z6)N&>0X$>G_L]2_\BZ=.&
M6+RA6W3Y=600T$*I!;>>?";,DLSA:AAGX-E+T+E-O[2'4(8_TYKJR</D[J-X
MWV+"T0Z:?Y[-<?QA^NIZ/L=I^DIN]G0!:3U<I?O39#W*_;^N%\OJ6_V&R]_+
M>_C[;<V\H!\LE_-QO.Y&9[^?O:43?+H<2;++1 F)F5 ?%+P'YI$.<Q5-<59+
M!-DD[VI0*B]<A\]78QJ\/#[&SJLO=$M5L$3Y.Z@#XM/UG"2-BX<DCHH7B=?!
M0X%K9+I@W>9HF$F1#!J%U2L=4O,/)> [5>JF<FX0A=YM4I' ,*_K(=].:#<>
MM@]ME,$'91F7=:ZMM(%%%P0S5FF?C90N-QD$THJ@[U2?!]6#!N'U7735NM^5
MO_@+R:+R\??I:YR/OT M&%]<S<>+\?3#:]JWTP]OZ>]GQ()"%U:W95/Q,NK$
M8A'=C$FZ8B!JIIPC)@N1K-1#JO81M'RG6CV4]!NTKOX#4PV:U XYG77T,W%X
M#YZNK*SEBIC;RT?;6F(D!"N0#-.IQEM,O8&,<,B3M1:::'*?1%RX"I],WCT^
M<>QC-*TVV":UBXHZ^T@.+P%6Q7;Q6LY\)J4J 8).6EGA]NEEV*LIO!ONA>OC
M #+L\8'ED3B*$I"<UY9E";:6;0H&HA@&.2L#B7,L;8J1GXAA-8M<KK+.07OD
MR"TS)71=KBWSO'.7B['@C4[0A.Q#0 Y5,S+HQFDFI3.J((%I&L/DU^F"UJN?
M[)*">;$^&$LN+80Z'5=EYJ,QS,ILB[81?&BB<3OPG*HRI)W\'R92'RV'!I&Q
M+J)7Z-"[FN9W./\R3K4%5]F"=O&>/KG8_J/U0^$^M+0L$NF3F)-5D!RO)0]S
MZTXKXG-76P?1@0R*U<=.IHVL?7ZT9RH'5;SAV;DF0;'S5]>GBU#.6UL/D6P#
M+>V277"Q[!H<PN=U[@,W"HI.@7&K"YDK6K @##+OM0?E2O*B29WF5C3#^T6G
M$_"#ZH1CI=.DIN4.U+N_;E&AT<!C(>NVOC%KEVKMNPO,)1UXE-YC;')$;8?S
M0VF.D4^+W@0WC:Q6KFLU8F?3VT96T63G V06 173TDOFE=+,9I^*+NA]HP9?
MCZ&Z>(._/YDT>&#<P'13)[P'J);V^U94)^X(>+ST-OL?]\;Z!@?)=G A(0I'
M9Z4%('M.U#"AD9Z!P.1US#:V,9 'U(=].P4.I Z'<+R!&MP[)+>F_-S4ZEF3
M>5:6*:7HUDL&&%AK69(VY,Q% -ND%&H_>,-;*3W(<G=XLB]!-#!:[Z%\-#-A
MC;9H8Y&L[%K,H6N_'\."JAD(MLAH98@AM5:;/6!>F/KT+9BVI\Y- L!ON'P%
MBX\_3V9__0?F#[A*7[DQNKFR' 1GP25)1K<#%H7AS&40PH$G7NTSI>D8/=H'
MYX4I4N^B:6#>[F'DW]09NVR= :P6OB<+'P,Y;J(V'W Y<171RM9GT>,(+TQ[
M>A3'(*.(WGV$^G;^^7J>/L("NS_.;_]XQ'2B_3Y\?#W0,PC8G"4>HQ-00!HC
MM$L\"@5">9<B<$<_&>VWQ#%SF+_]XF>ZO.Y>?Y,$G@5/3$@DE4G.D&+&.LP*
MZ=CQ*4K8+/C9,8#YD55ZR72X8]';>9WJ]>GJ>OEQ-J\);U>?ZDPN,0*33*V\
MHGN7_ ?-A640BF<*C?&>1Y=-D]2O/?$-/7&\+[EO+>#I61P-[.H-F/E^ZF/'
MF\6(IU G49##F7)B.OK"@D?!#-G\D7XD?1Q"8;9 NU!=.58(#>SFKLD2YD5-
M0KP#^GM9IU3Y& R/LK#,DR5;K!KT*BF6E-9&8\PN-^E&^SBL2U&/'IG?P!#>
M?M#]@95AI,5W)][=O[DY^Z0VY.X)XH)TM63+)!:$(Q.>JY"+H%_$@%?1/I O
M1:4&$EJ#NH[MR%=GY:_3GV?SA&)$MGQ"Y3Q9]I%8 PC,2S+TP9"OR),4KC2I
MT-X'W&6KT!&"Z+M]TA;*5T]N7($+ AV#&C301@A&QR=1G8%#(D>3S*[GFO.#
MI+&V$6Q_3#N7Q-0-K_'&!J_O*38X'X3WS$!M_J9]5=%B&!E6%KF./)8F09G=
MD(9^K>Y1W)LG0S]L;Y'$L!79.ORT#[:F0^H> 7>B%^J>!+F7?APAA:$UQ4.P
MV4/M):3(&8,LZ'15R'R(VHL8P8HV8R\'UY"GWJQ/H""',+__]M^IL[6$D%R$
M=4#9\!*#,Y85 X8 23HTR25G.23MP FR?/;KW;OMZR>8<=<;\V=]<J['V-<#
M0)*O 0&II19:,E=*)$ :&7#NZ.I+!D5$B69S7M/3HKSY^B6*\EF<:_.NBY,Z
MU!WS!M&+U_27W8F4K'=81SI9CP11!$)G7&"R 'A+RH:\26.5/;!=CNW7MR#:
MO-P^!O&F(^$>(%M:@WNA/(U9V+N,#].A(P0T_,FS!BLQ2J]]8E)S1=90G?.=
M1&2AI.R%T&0,M<HC.946/6$ZGH<2'2*708S)X(OD"C.3-DH"I .+/&D&*H4D
M2\* FR'Q<S8F&TCA2:OR$!8.8E5RSTD\,C KZ5K6JDZ>P.*8(X.WJ!PD:?(+
MLBH'E.FS6+ASG^Y(VEG_=?TE$A'_]__\+U!+ P04    " "L@?Q2P1\2%_\:
M 0"FO L %0   &AO;'@M,C R,3 V,C9?;&%B+GAM;-2]Z9+DN)4F^K^? E>Z
MIBZ9!51<P 52=X]%;J6P267FS<Q2S5C9-3>L$1QY.*-)>E:&GGX +KX[':"#
M#.I/560$"9SS@?AP )SE/_[']\<E^":*,LM7__D[_T_>[X!8L9QGJ_O__-W/
M7]_!]'?_X[_^[=_^X_^!\'^]^OP>O,G9^E&L*O"Z$*02'/R650_@%R[*?P!9
MY(_@E[SX1_:-0/A?]4NO\Z?G(KM_J$#@!?[A7XL_LP2A-!(I% PG$ 4AASCT
M$Q@D28IP''%?TIO[/S,>"H\$ C+& HC\1$ <13'T&)(H3)+(B_RZT66V^L>?
M]7\H*050RJW*^I__^;N'JGKZ\X\__O;;;W_Z3HOEG_+B_L? \\(?NZ=_US[^
M_>CYW\+Z:1]C_&/]U\VC97;J0=6L_^/_^MO[+^Q!/!*8K<J*K)CNH,S^7-:_
M?)\S4M687Y0+G'U"_PMVCT']*^@',/3_]+WDO_NO?P.@@:/(E^*SD$#__^?/
M=V>[Q#_J)WY<B7L]LI]$D>7\2T6*ZCVA8JFDKUNKGI_$?_ZNS!Z?EJ+[W4,A
MY.EFET6QUZJ6$FLI_5A+^?MSG?UXA?B.Y*V.974@7*WN!U<R]F'ZP9FX7Q4_
MB/$%WNGF:I&;#^KMBD_U[6ZZNEKT\25V]5GD%5E.\%ELN]D1>:E_\5[]U':C
M&^HAT[J?EKIW1!7?*['BHF'+O:9!QO_S=^JGQ;J$]X0\+;X\D$*\4D3+7^>/
M3V)5UOQ]6Q1D=2_TDOCJ>?O()_*L?W7[&RGXV_]>9]7SG5H$BGKI+#]6#Z+X
M^D!6'Y]T$^5/JHFJO%LU'](B(<3GA$4P#IB$B"<^Q"BD,!4)]@/).29X46WF
MRD*LX,]?.K5JV5]&\-]9C$1UAE$*4>;K@FW7XL?EJ056K:UZ-4Y_7)%'43Z1
M]@6EO39;&D#^JU:J!/=:2&6H_)"M0%G_ZH__\>,6JQD-_/)?=CB7$XPDU$8.
M![M*@QVM 7T&N\^UFH-:]1O0* ]VM >U^J!2^H,6@!O00 #4I]* </9+R=F>
MMDMMSN7%X;#E[,6&;8]VZR&3I*0UYJU(:OP"[T>QK,KN-U#_!GI^:T+^?G+9
M?SR:C;=%!S0IV(5/L7WB1Y8K8_NI@GM?I=Z<O.R(5/G+3N3F2U4@_0[D!1>%
MVNZ= 'Q#?P_Y\OOBC:#59\'%8]WPIT(\9NO'3R3CBU2(B(2,03_Q!$0(>S!-
M$8.ISSWF1RA2VSB35:J_F[FM*:UHX*D9#K.%Y *2_;3O#I^125K+"+9"WH .
M*RVG$Z!X>_90SY,) -OK;V[ &2] 9GBTRX5Z5B\"OA<'C0U^X>U)"-M,@XY>
M#9^V(T,NLD5W]/55O;KP)"4X3!$,$NY#E$@?IC%#$%%EL O)/1QR$_H[;'AN
MA+<Y[]/"F<WB(ZSZ">X:!,:F-"/EC6?B.4VWIEK9V6JE8'^ZS[_]J%YIS#3U
MPZ%U=M3<))/QG!+=]#O[=[L)UQE)M6GS(5_E3Z)0/+RZOUNQ_%&\_:X-)K$(
M(NP1$H0P5IMCB%),($T]"H,PE1+[-$A3J[UR?W=SFYS-#B:K100_B$;(/]Z
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M_0BF:1+A /-$HL3*[.OK;6XK1R<;^%5+=]X(&H"KH7GH"JW1S44SH.RM11,
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M);X=&[D<4S,&>Z&1&IGU3M<VTXJ!'<UNNMR5=SN#>;L9S#T%P4]]@VG-F"/
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M9UU6[=[GEO-,[WCU?BCC=ZO7Y"E3FZ/ZDH$>!G5^UEFPRJSJ0C\_B2++>1O
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MY<<VO:(H9%X\ZKHV=ROU#Z83B @9X CQ!#).] 4,P9#0@,/8#Z)(BDCZW.C
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MH0P$]SUEHS 1F":<VK0Z1^LD*ZLZ@=+?!-&'P,WR;)%Q;A^V?LX9#,8$ALD
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M/NN"6UW^!!8'E,8B@0Q1IIA4<6H:LQ0F+/)]/_2X+ZSNN6P%F!N%=O(#TB@
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MCLH =/*#6H&Z%(!600=>:R5 K87%7;/=P!C<T(\&]\B<-#.D+6[[1T-\(B\
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M-Z+8E5;O\3<5(;*-X(#4DEO&7/2#;L8@[J <F48.4=R*"F[[P;./GS#"Q&G
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M$2,J(FXU"5V&GQI+M=*#/[3XH)7_9AOP]6KBQ"H=]LX07*L:.LV/'7<-A_K
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M7=<@4^.S5DQ@)K9QMG^AKZ9XE8/9<0E1"[LK $X#\\\6(B.B;[3&)80<[+0
M2(UDMGD@YF;(78&BTZZ[=.]X9MX5Z0^LOFO7AJQ NZN^V-8JC44:9[D@,"=<
M0$1) 3%)$"09*7(D25Q$3DG/EN-.C20OUS'=JUX:KHSLZ3S8F7@#H#LPM88
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M!17)"TYIC&-B5?#+9K#I45>WO\/1<NG$N;_':%)DYPM<4._0V$ZAZ?B"?%Q
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M0LRIRO3%H:9&@K6DYLU=;V4%S6[=\=RY U\[HR@,:@/3Y ZPG9C@VS7 W*M
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MA@@G.<2(1Q"QE%(D1)SE3B6$//68&[6U9H#*CJKP)OB]5M6QS)#OP-@MTB>
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MR:K=732O6^[N\L4>6]WOY /=5">H7]0[J4RMK ^/*U%^DUQJDC&UJ[*8,%5
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M:,X&WO^IG4?]-IM@X_=*26ZV+K.",**@+*1>^YIBDY2;0Y.8IT(Q+M-8V&2
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M2%Y $6<4QU3@.'F];J*G-)X;01H=H=)*#JF,._XXVW'JK$9OPOV&P&U#C>7
MF'Y8VW>FW4+[QFFV34)/*OWOVQNT;PQ&;0G:*]AOTKHQX6"/F^=JIZCVXA=Y
M@;',>0REC'G3E8:G#"I&1);06 ENU5BE1\;<)H96Q2;+PWN;YA2<=FP^$*21
M^7>'3Z7>5;.4#\>1/=:'9+538B;EH1X[7S)'WZ5^W[HI'&W.E/3R7*[X4I;U
M87$4*X)2O7K.<TH@XMJA9&FA9]$T%R3%5.7":9OVM)BY??%5%>T#-?U.\<^
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MQM!R0V[T(9FTV&55$G%O"3@P97>.\GP%=M: O3D!=_1"H!ITPV^00M/N!X;
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MAXJ&@YC'LK,)-!",+^J-W2S]X\,Y,6[Q]G)9\[AJ:MP(G8S1<@VL<%J#X61
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MAS^[8W$36-GD$V[^>D-^.!\)Y;BKBRB*S&;%0B*3R).8G30IV2"-["ZJL8.
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M;E4(M?%<1X%E9FQ,8%/4H*KO$%U-!);H.6GEZ$4_Q?2[Z1FZ"W(OV.F"]PU
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MA$*5AE)A^8]SX7&X'!I!TT/5+[?BAJO(SNYO+J[KND9"I$!>MX0<1+5*T4%
M5EN;1^TP"JE2+YU2.US#?JG</\0]Q5"2']H?H?6-5^L;A<(,)_<<G/*T71E:
M""PK"$9ZC::8HN\6.>UV,ZX>N1]\ONN+A2-X.+3D;QB4BVH$S*\,RG VQU4E
MU\C7!K*\]BYFRI&GPQVMS"0H)EJF@W'<WPWJ[L;$'B_;#RW?]=U +WQOQ[F\
M#M1L)]*OK,L-"T?D%3,=)0<35.UP530$G21(+,&HJ)DW_8Q'?)2L_6#W0UP2
M="B?=D#7T5!YKA5R*SRPZ(FOC&=PB1<(7IC"Z"#/KI>;^&[(;Z0CQYM.*G\'
MD.AW-DOH15B<_S*9_;&X3?]Q(X2N']KGY* '2.]^8-#5BZXFPACDY(D6!RDZ
M47OM,XATF(+)*03E8U+]-)5XC*@.THGJ,]_-9Y_'Q+[G7W]?8'X]??NI&ABU
M:4A:CC^/EV.\9H.,4>;L"A1K;.V+:R 6LBT88]$&&45@O>0Y/YW41CJ^'(NE
M'4E(?<JL@8#N[30K)5 E+0-X#$2\" D<MT@,$Q;)8%&DI!M)<NL+2WV+_-$T
MMZ?POXDTMULYHS7A<YK&$[RUJ(^SI_)3I& QT8[EL0X"1T%>N6<23%)&6-K%
MS/2B_?M8S+ M%DX,YL'1T(!"?8GTYC1>-UN2A<S82/M9F.JG%8'@HPL@R;Q%
M[Z)QJ9=[V9M$--.R="!(S#J23P/8NF;F+[/YLXOJ8?USO9 8K<@L6<#,'1 7
M5#5R,G"'PCFK4Y(]]V"^0]&P>J\YU'4CN08@N I#/;]; #+2667EZG6T3 @J
M>0;.2@X"Z<B0Q8F$O;1=VTW.L(UDF@-?!S)K 'DO-Z]=<_%C^/+J2UT+/L<I
MEO%RE+V24HH":)#\O* X!*X3:-I>G =$I7IINOL-NH:-]S6'Q2ZEV  HGRT6
MQ,N+3V$\KTQ^03OM#!<CQAUY:\X#,EEH%6XU(<0"<]$Z[DQQK)=2W]WD#-M^
MICD(=B"S!I#WUS">+BKS</%V^NI+Y=/E>'&^CH*]Q+@<N9AX9D8 DB%+GIQ3
MX M&*$*D:&T6H?2B$+])V;#M9YK#8[>2;.>Z[RH%AWBYYNU&UX\TYY(GQR'9
MVN&_WO<$9A"D==9EIZ+DO809'Z1HV.XRS2&R&\FU@\3[-_=7G-O4M5_?%@1G
M3"*#0R#3=5(30L!:\&E29A@TIW.A#VCN3^*PSLV)(XH]2:Z!\_O^RC;341:D
M 7#\>96>Z$Q40: #G3VY:#IJ\#P*$#ES'0,34O=R ;@/<:UUH>X&&-_$WY%2
M:EDIOIY^)L[/YK1Y1ZE$TNBDV0LW@:QA2WZ8L1$\0\R&95U2+TDVCU+56K_J
M$T'N4+FTC+5W<R0'+'\,7VA1F"0RIQ(X7ZM"9;;$KJ2!LUA*ML%)UTO^_>-D
MM=:.^D1H.U@RWP'<MM&GC3G[;+H>];J*""Q&,=GJYW,P/JDZ8," *RR Y>1W
M:>_0Q%YNZPXCM[4VU*>%9W>2;!FV6V/C7?BZMC0"-QQ]!*Z5J2,=!40O @CA
M<D(R-:0^T:E\A[+6.ER?V!@\1#ZM^B#S2Z)C'.)XLG+C1MX:QC62TY:-KR7T
M CQZ6IV3E@Z P!7K)5BS#W&M-;(^'>R.D5*3R-LJ]/=(QNXECE"7G!B7H*VN
MRR" !!')$$G%V,JRD]F$=RAKK1/UB3!WC'P: -S^<:L11F]T<@&,\@54(74>
M)%F_)I8DLL HT\!9U\.:?J?/D.U#<H=CLC8ZZA.3U=U?/,!(Q45TJM"N*[E6
M&X8$P0D-29CLG9%2YEY:]SV=U$9&;9ZH(J KF36@*:]+#S>-X;931''=#+,N
M_[IA(2\"N<P0M:JW3(PVMJ,??6 <LX^1Y5Z,PZ<0V60]06> >;!PM&/I#>\F
MK]M_S6<),2_J>-L/88)ORW:!(^L1BPH,A&5TR)04P7LA (462BG-E-FO*\+#
M[V@RF[]K*'7)YQ;U&2V-;(?EU]K'?_ELFFOAZJ=5+7_"(F)."9(*-<\B6;(?
MI 2,PJ580M"YE\F<^Y/8Y.7OR719-Y([5I-UH,2NJ_O#]+(0GR[G>+68WZ<D
MQ1>7B^7L N>_+\(9/MMVFUB,@I6B&,'!,?+GE(T!0O(9I&:Y%,^RUF$_)7<P
M#4UZ'_THP=/(J0% 7C75K#7YDPG22L-DN]U&,6"]^L$:2:B[*RIP/B'MKB"\
MLZ%$=K=-V[?:FNYZS[!!Y),"JSM^#V^7/1*:VN:17<ZK!#:7,QI+R<D+"$*D
M>J?(25=G!D:FH KGZ%,OHV+VI&_8F/*)C]@^9-8.(O=GYDC3KO**=IL+EIA8
M9^=%Z^C'*&S(.C@F>JDYWI_$8>/.)\9E3Y)K-^CWRW@:IFDW(SG9"US+")9+
M#RKG %XJ#UD4QDTI,<E>%.;321W6/3EUT*\KF37@)+_'3QM;]VUY,YN>D0Z^
M6)4>1)>8X>3G1^8#*%5#ZE9;R-9;'X3U6?0T(W8W04T&\SH#PKU1L!U(I0'O
MXF8L":?C&=D72]+<PED6HK* *7)0!369N61CQ&II*(]%BOWFK3_P@B:C=5UC
MI3,.#]WD] KL;\NM)9C: TXH$*4>[\D@!*48>"&B+\H8:?;S/7<_O\F 6B\8
MZ8"_[5CV-P'_IH:EZ<@G8L9TS@MM"J*L73$C*.,RH=TGR$A.2RPF&]9/#/<A
MBIH,E_5U8G4CE]8,HEL+X0$5CSD#4]:"JF@(CDYAB=:+X)%EU4L.YH,4-1DV
M.XE)=+!<!K6)=NV5^U5%'S!=SL=7;6*$MP4567Q%U@P:1_YN")YV4Y(E)2.$
M8+TD?CR%R"8C9Z?0=)U*KS'E]\VU968YEJ) BE*3"'0B7\1%2#6'(#%E4/6"
MS*<0V63L[!0JLE/I-63^/=X>/6<O9#:&V)7(/6:Q0! A@S,6F1#D(?<SSZ6#
M]O6]3:HZM7KL3D+-P>Z7V;P.'B2FU?8QL^F"&#K?]-U>9^1_W<'6$6/9&D'&
MKR$SA;9:'=G%- /. C/>(7>LES#N453O!=K>QF(- ]H3R+<Y3"_6K6;J=#E:
M&+Z8+6H9G8HH8E: V2K:I=J#\]*!T0$#1LR\]#*>[1&:]HO_]C;G:B M>JQP
MVO!W-HNA[74]$9/<M]G%Q6P]2F64O7&H4J[U<V2-F)J0RK@#VEHI6:]$ZLG+
M^29I^^'N1[EXZ%A4;<#OAL.VW4EORWJHYBJ5ZS7]@K3^YUI,O+ME9LT[7%Q-
M.%GQX>VG^L%BE+@-/C$&/AA7HP\%'%,*BBU:,\S2I=[#CIVO:C_0?^\W*.T!
M9.BKF&L[Z&/X\O?Q\KR:[;2@]SA9&1^S_\ %_4ULH-_4M"'ZFP0P3JL),K3H
MWZ=C.J%DS%X*E&",JE-%,4-$3AQP*09&DB#KZ"FYJD?2LQ^:?XB[G@$$V(Y%
MN^O6?%,;^Z:N]6V<C,_">E=&+"$CYQ!C;0#OB=>..0]DR'.%M1-RZ252\ 0:
M]X/MCW*!U)?PVH'G_@P=22,Y&?82A,4"2B&"TTY#+HC<JA!*&3CQ:S]P_BB7
M3SV)KH&LQ%>E8%J^+:^^D*D_/</WA/FWTU6QX#37OVK5P^<P6=4VE&S0T_\@
MY&Q U>S.D!UYGDYY*YE6/84%GD)D(V,6N\Y$[$U.#=PZ5?+O+.':*MDL\?8O
M;GSSW6JX_/UT]HTI?I-?:Q[6]&0>1!"0F*G3>WDBXX:L<FUH[TKT'*\]FRY1
M?-IE#IL<T-L^:!@K#6CSW?K@&1U>\_E76N%_A,DECAQJEXVQ(&*=7"TT&?::
M/%(=#+&>F^JM]K4!ODG=L+D$O>*V6\D<#+=/JUU *YTO3P@Z'TSQW"'$5$O;
M9(S@L5Z2.$O&ES0YF+OUJXV!KK<T@8%!]Q3)' FZ5].;(=UN!S$_#XOQ8E;>
MW7C:;:KW&[V\ZS%=#%O^)GE'CE=>A7]VO.0*2)B4"L8:2 I)S$):\,%:2%HP
MFV,DF_&N3[D[*/?(2XZ>'#$_"]--ALKU=.KZ@FF^^;ZW9>-ZA<GUX.J7XT6:
MS!:7<_Q(O'P^J9<5BHE(K\E@O*I3A9@&)P.'G)773&IN^FE3T_5"AJE^Z113
M]V9-#"GK1H?);SL-'J"W;C4I/%)7[23C2C_]?-SB/M9DM,412]P\H,.%[B*I
MHVGWFS?4JZ6:6E)W30W+;[M'7#?*2YY[<BG "\=!11O(\F,",#BOH^?%\E[*
MD/>D[^@9?N-%.#N;X]EF2]]D_/4.KC:N2-& 7-DZA<P<YW,$PYC+7MFH<R_#
M)/>B;M@"Q#YP=&]$7^=":EO-;AM;;7Y\B<LPGARCF1YX8(>::A^23ZRYM(K1
M%EL@ZUK?(Q,=N]4:8-S6[A"".]7+744#FFMDBW1!,0^)"]H+7@L(T4B06JO
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M3LF;36NGI4 LFI7E'\33;<V;2IY%50OT8Z2C-R7R&84%7J>,%<N,C'>5Q@.
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M5[4;VSR9<:WN6[$_OYV^QW0YGY-#^3PLQFM17&\0QQ2W(2K@AM63.]/>X"H
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MZ4:\]/H^4Y6@C4'BE<MDV=/:P+E:UNY*]@8=_;_?>XRGTSPL"$]F[9Y*J@T
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MI!%$9P'300$S#+='UQM[.N,1G==T%J*(2*I0D#.>6;V#(ERA59)]M.>!,ES
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M96Y27W;L/+,SQ1Z'-Z2.87@'F'F+G\*7U96(VQ-;"\S&%I*IU+Y.@_40I0^
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M5:%/$"/!5IK@/&DFJ]JTUS]#DN"7,+TIX7;@[#W+R<-^-RO+/VG;7^624?-
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MGIE]G,"];MX\2<68)<I#"WHV--?'ALZ:%9M+N(WY2HM&NY* <T5L2<Q#1)-
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M6.3&,A,1K#$V89LE-[Q]>;@:W<+WNPG$R72R^KE5X&U+,C8H50=\U;XQZ%@
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MP&:8P:O\KYOEZI>1&,K6BV-EF5**C&\RP,!:RY*T(5/D'\ VN9/?C[QQ$38
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MF[*FVFIOQ6Y_4;]$\AK_\S_^'U!+ P04    " "L@?Q2E!%_"0D(   A)@
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M2F199SARH!K[WE^2>$'W(#7:U1HBI]T%Q.3_ SWFBT0/BQ$AJZ(&^:B%H&2
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M^UZ.EZ<GM68WE\]B2QP^OS03'>,]]GP2M&<B1!>Q*WTUT+N-*%M$BK%+(A;
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M+FAT;5!+ 0(4 Q0    ( *R!_%)BAE(-1V,# !'V+0 1              "
M <]Q  !H;VQX+3(P,C$P-C(V+FAT;5!+ 0(4 Q0    ( *R!_%)NE.V4X!8
M ) % 0 1              "  475 P!H;VQX+3(P,C$P-C(V+GAS9%!+ 0(4
M Q0    ( *R!_%(X9+6BP20  )QN 0 5              "  53L P!H;VQX
M+3(P,C$P-C(V7V-A;"YX;6Q02P$"% ,4    " "L@?Q20TL<8,QP  !_SP0
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M<3,M,C R,7AE>#,R,2YH=&U02P$"% ,4    " "L@?Q2M]<%B3L%  !)$P
M%@              @ &S9 8 :&]L>%]Q,RTR,#(Q>&5X,S(R+FAT;5!+!08
1    #  , "D#   B:@8    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
